Psyllid ID: psy11580

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------29
Protein Sequence
MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY
Secondary Structure (PSIPRED)
cccccccccccHHHHHccccccccccccccccccccccccccccccccHHHHHHHHHcccccccccccccccccccEEEEEEEcccccEEEEEccccccccHHHHHHHHHHHHHHccccccccccccccccccccccccccEEEEEcccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccccccccEEEcccccccccccccccccccccccccccccccccccHHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccc
Secondary Structure Prediction (SSPRO)
ccEEcccccEEcccccccccccccccccccccccccccccccEEccccccccccccHcccccccEcccccEEEEEccEEEEEEccccEEEEEEEEEcccccHHHHHHHHHHHHHHHHcccccEccccEEEccccccccccEEEEEEEccccEHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEccccccccccHHHHHcccccccccccHHHHcccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccc
Coil and Loop (DISEMBL)
mlvidpekrisvddalmhpyinvwfddaevhapapgpydhsvdereHTVDQWKELIYqelpishqmgkkrhntshlgagaaydtaTQQNVAIKKlsrpfqnvTHAKRAYREFKLMKLVNHKNIIGLlnaftpqkslEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKhlhsagiihrdlkpsnivvksdcTLKILDFglartagttfmmtpyvvtryyrapevilgmgykenvdIWSVGCIMGemirggvlfpgtdhiDQWNKIIGKMREAHDKLDY
Flexible Loop (DISEMBL)
mlvidpekrisvddALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKklsrpfqnvTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFglartagttfmmtpyvVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY
Low Complexity Region (SEG)
MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY
Disordered region (IsUnstruct)
*********ISVDDALMHPYINVWFDDAEVHAP*************HTVDQWKELIYQELPIS*************GAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK**********
Disordered Region (DISOPRED)
MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK***A******
Disordered Region (DISEMBL)
MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY
Disordered Region (DISPRO)
*L**DPEKRISVDDALMHPYINVWFDDA***APAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	288	2.2.26 [Sep-21-2011]
P92208	372	Stress-activated protein	yes	N/A	0.722	0.559	0.906	1e-112
Q8QHK8	426	Mitogen-activated protein	N/A	N/A	0.736	0.497	0.834	1e-106
P53779	464	Mitogen-activated protein	no	N/A	0.736	0.456	0.825	1e-104
P49185	411	Mitogen-activated protein	yes	N/A	0.736	0.515	0.821	1e-104
Q61831	464	Mitogen-activated protein	yes	N/A	0.736	0.456	0.821	1e-104
Q91Y86	384	Mitogen-activated protein	no	N/A	0.736	0.552	0.821	1e-104
P45983	427	Mitogen-activated protein	no	N/A	0.736	0.496	0.821	1e-104
P49187	464	Mitogen-activated protein	yes	N/A	0.736	0.456	0.816	1e-103
Q9DGD9	384	Mitogen-activated protein	no	N/A	0.736	0.552	0.802	1e-102
O42099	427	Mitogen-activated protein	N/A	N/A	0.736	0.496	0.802	1e-102

>sp|P92208|JNK_DROME Stress-activated protein kinase JNK OS=Drosophila melanogaster GN=bsk PE=1 SV=1

 Score =  405 bits (1042), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 194/214 (90%), Positives = 202/214 (94%), Gaps = 6/214 (2%)

Query: 72  NTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           N   +G+GA      AYDT TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG
Sbjct: 26  NLRPIGSGAQGIVCAAYDTITQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 85

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           LLNAFTPQ++LEEFQDVYLVMELMDANLCQVIQMDLDH+RMSYLLYQMLCGIKHLHSAGI
Sbjct: 86  LLNAFTPQRNLEEFQDVYLVMELMDANLCQVIQMDLDHDRMSYLLYQMLCGIKHLHSAGI 145

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
           IHRDLKPSNIVVK+DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY ENVD
Sbjct: 146 IHRDLKPSNIVVKADCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYTENVD 205

Query: 246 IWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           IWSVGCIMGEMIRGGVLFPGTDHIDQWNKII ++
Sbjct: 206 IWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIEQL 239

Responds to activation by environmental stress by phosphorylating a number of transcription factors, primarily components of AP-1 such as Jra and also the transcriptional repressor aop, and thus regulates transcriptional activity. Component of the immune response activated by bacterial infection, and is involved in wound healing and in dorsal closure, a morphogenetic movement during embryogenesis. Controls the expression of a phosphatase, puckered, at the edges of wounded epidermal tissue and in the dorsal epithelium during dorsal closure.
Drosophila melanogaster (taxid: 7227)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q8QHK8|MK08_XENLA Mitogen-activated protein kinase 8 OS=Xenopus laevis GN=mapk8 PE=2 SV=2

 Score =  385 bits (989), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 182/218 (83%), Positives = 198/218 (90%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      A+D   +++VAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAFDAVLERHVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQD+Y+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDLYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCI+GEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct: 204 ENVDIWSVGCILGEMIKGGVLFPGTDHIDQWNKVIEQL 241

Responds to activation by environmental stress and pro-inflammatory cytokines by phosphorylating a number of transcription factors, and thus regulating transcriptional activity (By similarity). Regulates morphogenic cell movements, controlling convergent extension during gastrulation.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|P53779|MK10_HUMAN Mitogen-activated protein kinase 10 OS=Homo sapiens GN=MAPK10 PE=1 SV=2

 Score =  379 bits (973), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 180/218 (82%), Positives = 193/218 (88%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 241

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 242 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279

Serine/threonine-protein kinase involved in various processes such as neuronal proliferation, differentiation, migration and programmed cell death. Extracellular stimuli such as proinflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK10/JNK3. In turn, MAPK10/JNK3 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional activity. Plays regulatory roles in the signaling pathways during neuronal apoptosis. Phosphorylates the neuronal microtubule regulator STMN2. Acts in the regulation of the beta-amyloid precursor protein/APP signaling during neuronal differentiation by phosphorylating APP. Participates also in neurite growth in spiral ganglion neurons.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|P49185|MK08_RAT Mitogen-activated protein kinase 8 OS=Rattus norvegicus GN=Mapk8 PE=1 SV=1

 Score =  378 bits (970), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 179/218 (82%), Positives = 194/218 (88%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVD+WSVGCIMGEM+   +LFPG D+IDQWNK+I ++
Sbjct: 204 ENVDLWSVGCIMGEMVCLKILFPGRDYIDQWNKVIEQL 241

Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as proinflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK8/JNK1. In turn, MAPK8/JNK1 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN, JDP2 and ATF2 and thus regulates AP-1 transcriptional activity. Phosphorylates the replication licensing factor CDT1, inhibiting the interaction between CDT1 and the histone H4 acetylase HBO1 to replication origins. Loss of this interaction abrogates the acetylation required for replication initiation. Promotes stressed cell apoptosis by phosphorylating key regulatory factors including p53/TP53 and Yes-associates protein YAP1. In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells. Contributes to the survival of erythroid cells by phosphorylating the antagonist of cell death BAD upon EPO stimulation. Mediates starvation-induced BCL2 phosphorylation, BCL2 dissociation from BECN1, and thus activation of autophagy. Phosphorylates STMN2 and hence regulates microtubule dynamics, controlling neurite elongation in cortical neurons. In the developing brain, through its cytoplasmic activity on STMN2, negatively regulates the rate of exit from multipolar stage and of radial migration from the ventricular zone (By similarity). Phosphorylates several other substrates including heat shock factor protein 4 (HSF4), the deacetylase SIRT1, ELK1, or the E3 ligase ITCH.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q61831|MK10_MOUSE Mitogen-activated protein kinase 10 OS=Mus musculus GN=Mapk10 PE=1 SV=2

 Score =  377 bits (969), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 179/218 (82%), Positives = 192/218 (88%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 241

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG  +IDQWNK+I ++
Sbjct: 242 ENVDIWSVGCIMGEMVRHKILFPGRSYIDQWNKVIEQL 279

Serine/threonine-protein kinase involved in various processes such as neuronal proliferation, differentiation, migration and programmed cell death. Extracellular stimuli such as proinflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK10/JNK3. In turn, MAPK10/JNK3 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional activity. Plays regulatory roles in the signaling pathways during neuronal apoptosis. Phosphorylates the neuronal microtubule regulator STMN2. Acts in the regulation of the beta-amyloid precursor protein/APP signaling during neuronal differentiation by phosphorylating APP. Participates also in neurite growth in spiral ganglion neurons.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q91Y86|MK08_MOUSE Mitogen-activated protein kinase 8 OS=Mus musculus GN=Mapk8 PE=1 SV=1

 Score =  377 bits (968), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 179/218 (82%), Positives = 194/218 (88%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVD+WSVGCIMGEM+   +LFPG D+IDQWNK+I ++
Sbjct: 204 ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQL 241

Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as proinflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK8/JNK1. In turn, MAPK8/JNK1 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN, JDP2 and ATF2 and thus regulates AP-1 transcriptional activity. Phosphorylates the replication licensing factor CDT1, inhibiting the interaction between CDT1 and the histone H4 acetylase HBO1 to replication origins. Loss of this interaction abrogates the acetylation required for replication initiation. Promotes stressed cell apoptosis by phosphorylating key regulatory factors including p53/TP53 and Yes-associates protein YAP1. In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells. Contributes to the survival of erythroid cells by phosphorylating the antagonist of cell death BAD upon EPO stimulation. Mediates starvation-induced BCL2 phosphorylation, BCL2 dissociation from BECN1, and thus activation of autophagy. Phosphorylates STMN2 and hence regulates microtubule dynamics, controlling neurite elongation in cortical neurons. In the developing brain, through its cytoplasmic activity on STMN2, negatively regulates the rate of exit from multipolar stage and of radial migration from the ventricular zone (By similarity). Phosphorylates several other substrates including heat shock factor protein 4 (HSF4), the deacetylase SIRT1, ELK1, or the E3 ligase ITCH.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|P45983|MK08_HUMAN Mitogen-activated protein kinase 8 OS=Homo sapiens GN=MAPK8 PE=1 SV=2

 Score =  377 bits (967), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 179/218 (82%), Positives = 194/218 (88%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVD+WSVGCIMGEM+   +LFPG D+IDQWNK+I ++
Sbjct: 204 ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQL 241

JNK1 isoforms display different binding patterns: beta-1 preferentially binds to c-Jun, whereas alpha-1, alpha-2, and beta-2 have a similar low level of binding to both c-Jun or ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|P49187|MK10_RAT Mitogen-activated protein kinase 10 OS=Rattus norvegicus GN=Mapk10 PE=1 SV=2

 Score =  373 bits (958), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 178/218 (81%), Positives = 191/218 (87%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQML  IKHLH
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLSAIKHLH 181

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 241

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 242 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279

Serine/threonine-protein kinase involved in various processes such as neuronal proliferation, differentiation, migration and programmed cell death. Extracellular stimuli such as proinflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK10/JNK3. In turn, MAPK10/JNK3 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional activity. Plays regulatory roles in the signaling pathways during neuronal apoptosis. Phosphorylates the neuronal microtubule regulator STMN2. Acts in the regulation of the beta-amyloid precursor protein/APP signaling during neuronal differentiation by phosphorylating APP. Participates also in neurite growth in spiral ganglion neurons.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9DGD9|MK08_DANRE Mitogen-activated protein kinase 8 OS=Danio rerio GN=mapk8 PE=2 SV=1

 Score =  373 bits (957), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 175/218 (80%), Positives = 191/218 (87%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLRPIGSGAQGIVCSAYDHVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHER+SYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERLSYLLYQMLCGIKHLH 143

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           +AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA T  +MTPYVVTRYYRAPEVILGMGY+
Sbjct: 144 AAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAATGLLMTPYVVTRYYRAPEVILGMGYQ 203

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
            NVD+WS+GCIM EM+RG VLFPGTDHIDQWNK+I ++
Sbjct: 204 ANVDVWSIGCIMAEMVRGSVLFPGTDHIDQWNKVIEQL 241

Responds to activation by environmental stress and pro-inflammatory cytokines by phosphorylating a number of transcription factors, primarily components of AP-1 such as c-Jun and ATF2 and thus regulates AP-1 transcriptional activity.

Danio rerio (taxid: 7955)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|O42099|MK08B_CYPCA Mitogen-activated protein kinase 8B OS=Cyprinus carpio GN=mapk8b PE=2 SV=1

 Score =  372 bits (954), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 175/218 (80%), Positives = 191/218 (87%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLRPIGSGAQGIVCSAYDHNLERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHER+SYLLYQMLCG KHLH
Sbjct: 84  NIIGLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERLSYLLYQMLCGTKHLH 143

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA T  +MTPYVVTRYYRAPEVILGMGY+
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAATGLLMTPYVVTRYYRAPEVILGMGYQ 203

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
            NVD+WSVGCIM EM+RG VLFPG+DHIDQWNK+I ++
Sbjct: 204 ANVDVWSVGCIMAEMVRGSVLFPGSDHIDQWNKVIEQL 241

Responds to activation by environmental stress and pro-inflammatory cytokines by phosphorylating a number of transcription factors, primarily components of AP-1 such as c-Jun and ATF2 and thus regulates AP-1 transcriptional activity.

Cyprinus carpio (taxid: 7962)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	288
118780573	375	AGAP009461-PA [Anopheles gambiae str. PE	0.736	0.565	0.908	1e-113
350401433	551	PREDICTED: stress-activated protein kina	0.736	0.384	0.899	1e-113
170029896	376	jnk [Culex quinquefasciatus] gi|16786480	0.736	0.563	0.908	1e-113
383865498	454	PREDICTED: stress-activated protein kina	0.736	0.466	0.903	1e-112
340729092	521	PREDICTED: stress-activated protein kina	0.736	0.406	0.899	1e-112
380030516	553	PREDICTED: stress-activated protein kina	0.736	0.383	0.899	1e-112
158186758	396	c-Jun NH2-terminal kinase [Bombyx mori]	0.736	0.535	0.908	1e-112
357613266	393	c-Jun NH2-terminal kinase [Danaus plexip	0.736	0.539	0.908	1e-112
307177278	389	Stress-activated protein kinase JNK [Cam	0.736	0.544	0.903	1e-112
28144310	359	MAP kinase JNK [Aedes albopictus]	0.694	0.557	0.97	1e-112

>gi|118780573|ref|XP_310236.3| AGAP009461-PA [Anopheles gambiae str. PEST] gi|116131141|gb|EAA05905.3| AGAP009461-PA [Anopheles gambiae str. PEST]

 Score =  413 bits (1061), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 198/218 (90%), Positives = 205/218 (94%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYDT TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK
Sbjct: 21  KRYQNLKPIGSGAQGIVCAAYDTVTQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 80

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLNAFTPQ++LEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH
Sbjct: 81  NIIGLLNAFTPQRTLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 140

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 200

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII ++
Sbjct: 201 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIEQL 238

Source: Anopheles gambiae str. PEST

Species: Anopheles gambiae

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350401433|ref|XP_003486150.1| PREDICTED: stress-activated protein kinase JNK-like [Bombus impatiens]

 Score =  412 bits (1060), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 196/218 (89%), Positives = 204/218 (93%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYDT T QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK
Sbjct: 192 KRYQNLKPIGSGAQGIVCAAYDTVTAQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 251

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLNAFTPQ+SL+EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH
Sbjct: 252 NIIGLLNAFTPQRSLDEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 311

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVK+DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 312 SAGIIHRDLKPSNIVVKADCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 371

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII ++
Sbjct: 372 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIEQL 409

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|170029896|ref|XP_001842827.1| jnk [Culex quinquefasciatus] gi|167864809|gb|EDS28192.1| jnk [Culex quinquefasciatus]

 Score =  412 bits (1060), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 198/218 (90%), Positives = 205/218 (94%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYDT TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK
Sbjct: 22  KRYQNLKPIGSGAQGIVCAAYDTITQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 81

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLNAFTPQ++LEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH
Sbjct: 82  NIIGLLNAFTPQRTLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 141

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 142 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 201

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII ++
Sbjct: 202 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIEQL 239

Source: Culex quinquefasciatus

Species: Culex quinquefasciatus

Genus: Culex

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383865498|ref|XP_003708210.1| PREDICTED: stress-activated protein kinase JNK-like [Megachile rotundata]

 Score =  412 bits (1059), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 197/218 (90%), Positives = 204/218 (93%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYDT T QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK
Sbjct: 95  KRYQNLKPIGSGAQGIVCAAYDTVTAQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 154

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLNAFTPQ+SL+EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH
Sbjct: 155 NIIGLLNAFTPQRSLDEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 214

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 215 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 274

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII ++
Sbjct: 275 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIEQL 312

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340729092|ref|XP_003402842.1| PREDICTED: stress-activated protein kinase JNK [Bombus terrestris]

 Score =  412 bits (1058), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 196/218 (89%), Positives = 204/218 (93%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYDT T QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK
Sbjct: 162 KRYQNLKPIGSGAQGIVCAAYDTVTAQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 221

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLNAFTPQ+SL+EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH
Sbjct: 222 NIIGLLNAFTPQRSLDEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 281

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVK+DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 282 SAGIIHRDLKPSNIVVKADCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 341

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII ++
Sbjct: 342 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIEQL 379

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380030516|ref|XP_003698892.1| PREDICTED: stress-activated protein kinase JNK-like [Apis florea]

 Score =  411 bits (1057), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 196/218 (89%), Positives = 204/218 (93%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYDT T QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK
Sbjct: 194 KRYQNLKPIGSGAQGIVCAAYDTVTAQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 253

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLNAFTPQ+SL+EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH
Sbjct: 254 NIIGLLNAFTPQRSLDEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 313

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVK+DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 314 SAGIIHRDLKPSNIVVKADCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 373

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII ++
Sbjct: 374 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIEQL 411

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|158186758|ref|NP_001103396.1| c-Jun NH2-terminal kinase [Bombyx mori] gi|154816105|dbj|BAF75352.1| c-Jun NH2-terminal kinase [Bombyx mori]

 Score =  411 bits (1057), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 198/218 (90%), Positives = 203/218 (93%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYDT TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK
Sbjct: 33  KRYQNLKPIGSGAQGIVCAAYDTVTQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 92

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH
Sbjct: 93  NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 152

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
            AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY 
Sbjct: 153 LAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYT 212

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII ++
Sbjct: 213 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIEQL 250

Source: Bombyx mori

Species: Bombyx mori

Genus: Bombyx

Family: Bombycidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357613266|gb|EHJ68412.1| c-Jun NH2-terminal kinase [Danaus plexippus]

 Score =  411 bits (1056), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 198/218 (90%), Positives = 203/218 (93%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYDT TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK
Sbjct: 31  KRYQNLKPIGSGAQGIVCAAYDTVTQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 90

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH
Sbjct: 91  NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 150

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
            AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY 
Sbjct: 151 LAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYT 210

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII ++
Sbjct: 211 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIEQL 248

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307177278|gb|EFN66456.1| Stress-activated protein kinase JNK [Camponotus floridanus]

 Score =  411 bits (1056), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 197/218 (90%), Positives = 204/218 (93%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYDT T QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK
Sbjct: 30  KRYQNLKPIGSGAQGIVCAAYDTVTAQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 89

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLNAFTPQ+SL+EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH
Sbjct: 90  NIIGLLNAFTPQRSLDEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 149

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 150 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 209

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII ++
Sbjct: 210 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIEQL 247

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|28144310|gb|AAO31950.1| MAP kinase JNK [Aedes albopictus]

 Score =  410 bits (1054), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 194/200 (97%), Positives = 198/200 (99%)

Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           AAYDT TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ++LEEF
Sbjct: 23  AAYDTVTQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQRTLEEF 82

Query: 140 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS
Sbjct: 83  QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 142

Query: 200 DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG
Sbjct: 143 DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 202

Query: 260 GVLFPGTDHIDQWNKIIGKM 279
           GVLFPGTDHIDQWNKII ++
Sbjct: 203 GVLFPGTDHIDQWNKIIEQL 222

Source: Aedes albopictus

Species: Aedes albopictus

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	288
FB|FBgn0000229	372	bsk "basket" [Drosophila melan	0.694	0.537	0.955	4.2e-102
UNIPROTKB|E2QZN1	427	MAPK8 "Uncharacterized protein	0.736	0.496	0.853	4.5e-98
UNIPROTKB|F6Y4G8	384	MAPK8 "Uncharacterized protein	0.736	0.552	0.853	4.5e-98
UNIPROTKB|F1MM73	384	MAPK8 "Uncharacterized protein	0.736	0.552	0.853	4.5e-98
UNIPROTKB|Q8QHK8	426	mapk8 "Mitogen-activated prote	0.736	0.497	0.834	1.4e-96
UNIPROTKB|E1C8C5	426	MAPK10 "Uncharacterized protei	0.736	0.497	0.839	2.2e-96
UNIPROTKB|K7GT04	379	MAPK10 "Uncharacterized protei	0.736	0.559	0.839	2.9e-96
UNIPROTKB|E1C8C6	426	MAPK10 "Uncharacterized protei	0.736	0.497	0.830	1.4e-94
UNIPROTKB|F1RW16	464	MAPK10 "Uncharacterized protei	0.736	0.456	0.825	2.3e-94
UNIPROTKB|K7GP94	426	MAPK10 "Uncharacterized protei	0.736	0.497	0.825	2.3e-94

FB|FBgn0000229 bsk "basket" [Drosophila melanogaster (taxid:7227)]

 Score = 1012 (361.3 bits), Expect = 4.2e-102, P = 4.2e-102
 Identities = 191/200 (95%), Positives = 197/200 (98%)

Query:    80 AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
             AAYDT TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ++LEEF
Sbjct:    40 AAYDTITQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQRNLEEF 99

Query:   140 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
             QDVYLVMELMDANLCQVIQMDLDH+RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK+
Sbjct:   100 QDVYLVMELMDANLCQVIQMDLDHDRMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKA 159

Query:   200 DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
             DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY ENVDIWSVGCIMGEMIRG
Sbjct:   160 DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYTENVDIWSVGCIMGEMIRG 219

Query:   260 GVLFPGTDHIDQWNKIIGKM 279
             GVLFPGTDHIDQWNKII ++
Sbjct:   220 GVLFPGTDHIDQWNKIIEQL 239

GO:0004705 "JUN kinase activity" evidence=ISS;IMP;NAS;IDA;TAS

GO:0007254 "JNK cascade" evidence=ISS;IDA;TAS

GO:0019731 "antibacterial humoral response" evidence=IDA

GO:0007391 "dorsal closure" evidence=NAS;IMP;TAS

GO:0048598 "embryonic morphogenesis" evidence=IDA

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=NAS;TAS

GO:0005634 "nucleus" evidence=ISS

GO:0000165 "MAPK cascade" evidence=NAS

GO:0004674 "protein serine/threonine kinase activity" evidence=NAS

GO:0006952 "defense response" evidence=NAS

GO:0007258 "JUN phosphorylation" evidence=IMP

GO:0046843 "dorsal appendage formation" evidence=IMP

GO:0046844 "micropyle formation" evidence=IMP

GO:0042060 "wound healing" evidence=IMP;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0016055 "Wnt receptor signaling pathway" evidence=NAS

GO:0001736 "establishment of planar polarity" evidence=NAS

GO:0046529 "imaginal disc fusion, thorax closure" evidence=IMP

GO:0005524 "ATP binding" evidence=IEA

GO:0035313 "wound healing, spreading of epidermal cells" evidence=IMP

GO:0043508 "negative regulation of JUN kinase activity" evidence=IMP

GO:0034614 "cellular response to reactive oxygen species" evidence=IDA

GO:0071243 "cellular response to arsenic-containing substance" evidence=IDA

GO:0071276 "cellular response to cadmium ion" evidence=IDA

GO:0030707 "ovarian follicle cell development" evidence=IMP

GO:0048675 "axon extension" evidence=IMP

GO:0035006 "melanization defense response" evidence=IMP

GO:0071907 "determination of digestive tract left/right asymmetry" evidence=IGI

GO:0048615 "embryonic anterior midgut (ectodermal) morphogenesis" evidence=IGI

GO:0007298 "border follicle cell migration" evidence=IGI

GO:0009408 "response to heat" evidence=IMP

GO:0006979 "response to oxidative stress" evidence=IMP

GO:0048812 "neuron projection morphogenesis" evidence=IMP

GO:0030425 "dendrite" evidence=IDA

GO:0048666 "neuron development" evidence=IMP

GO:0030424 "axon" evidence=IDA

GO:0007411 "axon guidance" evidence=IMP

GO:0048674 "collateral sprouting of injured axon" evidence=IMP

GO:0048803 "imaginal disc-derived male genitalia morphogenesis" evidence=IMP

UNIPROTKB|E2QZN1 MAPK8 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 974 (347.9 bits), Expect = 4.5e-98, P = 4.5e-98
 Identities = 186/218 (85%), Positives = 198/218 (90%)

Query:    68 KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
             K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct:    24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query:   122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
             NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct:    84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query:   182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
             SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct:   144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203

Query:   242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
             ENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct:   204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

UNIPROTKB|F6Y4G8 MAPK8 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 974 (347.9 bits), Expect = 4.5e-98, P = 4.5e-98
 Identities = 186/218 (85%), Positives = 198/218 (90%)

Query:    68 KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
             K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct:    24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query:   122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
             NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct:    84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query:   182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
             SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct:   144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203

Query:   242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
             ENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct:   204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

UNIPROTKB|F1MM73 MAPK8 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 974 (347.9 bits), Expect = 4.5e-98, P = 4.5e-98
 Identities = 186/218 (85%), Positives = 198/218 (90%)

Query:    68 KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
             K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct:    24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query:   122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
             NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct:    84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query:   182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
             SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct:   144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203

Query:   242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
             ENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct:   204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241

GO:2001235 "positive regulation of apoptotic signaling pathway" evidence=IEA

GO:2000017 "positive regulation of determination of dorsal identity" evidence=IEA

GO:0090045 "positive regulation of deacetylase activity" evidence=IEA

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA

GO:0046686 "response to cadmium ion" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0042826 "histone deacetylase binding" evidence=IEA

GO:0035033 "histone deacetylase regulator activity" evidence=IEA

GO:0032880 "regulation of protein localization" evidence=IEA

GO:0032091 "negative regulation of protein binding" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0010628 "positive regulation of gene expression" evidence=IEA

GO:0009411 "response to UV" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004705 "JUN kinase activity" evidence=IEA

GO:0001503 "ossification" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|Q8QHK8 mapk8 "Mitogen-activated protein kinase 8" [Xenopus laevis (taxid:8355)]

 Score = 960 (343.0 bits), Expect = 1.4e-96, P = 1.4e-96
 Identities = 182/218 (83%), Positives = 198/218 (90%)

Query:    68 KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
             K+  N   +G+GA      A+D   +++VAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct:    24 KRYQNLKPIGSGAQGIVCAAFDAVLERHVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query:   122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
             NIIGLLN FTPQKSLEEFQD+Y+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct:    84 NIIGLLNVFTPQKSLEEFQDLYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query:   182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
             SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct:   144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203

Query:   242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
             ENVDIWSVGCI+GEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct:   204 ENVDIWSVGCILGEMIKGGVLFPGTDHIDQWNKVIEQL 241

GO:0007254 "JNK cascade" evidence=ISS

UNIPROTKB|E1C8C5 MAPK10 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 958 (342.3 bits), Expect = 2.2e-96, P = 2.2e-96
 Identities = 183/218 (83%), Positives = 195/218 (89%)

Query:    68 KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
             K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct:    24 KRYQNLKPIGSGAQGIVCAAYDAILDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query:   122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
             NII LLN FTPQKSLEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct:    84 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query:   182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
             SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct:   144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203

Query:   242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
             ENVD+WSVGCIMGEM++G VLFPGTDHIDQWNK+I ++
Sbjct:   204 ENVDMWSVGCIMGEMVKGAVLFPGTDHIDQWNKVIEQL 241

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

UNIPROTKB|K7GT04 MAPK10 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 957 (341.9 bits), Expect = 2.9e-96, P = 2.9e-96
 Identities = 183/218 (83%), Positives = 195/218 (89%)

Query:    68 KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
             K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct:    24 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query:   122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
             NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct:    84 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query:   182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
             SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct:   144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203

Query:   242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
             ENVD+WSVGCIMGEMI+G VLFPGTDHIDQWNK+I ++
Sbjct:   204 ENVDMWSVGCIMGEMIKGAVLFPGTDHIDQWNKVIEQL 241

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

UNIPROTKB|E1C8C6 MAPK10 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 941 (336.3 bits), Expect = 1.4e-94, P = 1.4e-94
 Identities = 181/218 (83%), Positives = 193/218 (88%)

Query:    68 KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
             K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct:    24 KRYQNLKPIGSGAQGIVCAAYDAILDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query:   122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
             NII LLN FTPQKSLEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct:    84 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query:   182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
             SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct:   144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203

Query:   242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
             ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct:   204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1RW16 MAPK10 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 939 (335.6 bits), Expect = 2.3e-94, P = 2.3e-94
 Identities = 180/218 (82%), Positives = 193/218 (88%)

Query:    68 KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
             K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct:    62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121

Query:   122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
             NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct:   122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181

Query:   182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
             SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct:   182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 241

Query:   242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
             ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct:   242 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279

GO:0005886 "plasma membrane" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

UNIPROTKB|K7GP94 MAPK10 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 939 (335.6 bits), Expect = 2.3e-94, P = 2.3e-94
 Identities = 180/218 (82%), Positives = 193/218 (88%)

Query:    68 KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
             K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct:    24 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query:   122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
             NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct:    84 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query:   182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
             SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct:   144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203

Query:   242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
             ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct:   204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q750A9	HOG1_ASHGO	2, ., 7, ., 1, 1, ., 2, 4	0.5101	0.6562	0.4228	yes	N/A
P49185	MK08_RAT	2, ., 7, ., 1, 1, ., 2, 4	0.8211	0.7361	0.5158	yes	N/A
P49187	MK10_RAT	2, ., 7, ., 1, 1, ., 2, 4	0.8165	0.7361	0.4568	yes	N/A
Q61831	MK10_MOUSE	2, ., 7, ., 1, 1, ., 2, 4	0.8211	0.7361	0.4568	yes	N/A
P92208	JNK_DROME	2, ., 7, ., 1, 1, ., 2, 4	0.9065	0.7222	0.5591	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.914
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	288
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-172
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-136
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-131
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-131
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-113
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-105
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-96
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-85
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-83
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-82
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-80
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-76
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-75
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-73
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-70
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-70
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-68
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-61
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-61
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-61
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-58
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-56
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-55
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-55
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-52
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-52
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-50
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-48
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-45
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-45
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-45
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-44
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-43
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-43
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-42
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-42
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-40
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-40
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-39
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-39
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-38
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-38
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-38
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-37
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-37
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-36
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-36
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-35
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-34
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-34
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-34
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-33
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-33
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-32
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-32
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-32
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-32
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-31
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-28
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-28
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-27
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-27
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-27
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-26
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-26
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-26
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-26
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-25
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-25
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-25
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-24
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-23
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-23
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-23
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-23
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-22
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-22
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-22
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-22
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-21
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-21
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-21
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-21
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-21
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-19
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-19
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-19
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-19
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-19
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-18
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-18
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-17
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-15
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-14
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-14
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-13
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-12
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-10
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-10
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-09
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-09
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-09
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-09
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-08
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-07
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	4e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-06
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	4e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-06
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	5e-06
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	6e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-05
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	7e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-05
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-04
cd05144	198	cd05144, RIO2_C, RIO kinase family; RIO2, C-termin	1e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-04
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	0.001
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.001
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	0.003
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	0.004

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  480 bits (1238), Expect = e-172
 Identities = 194/215 (90%), Positives = 198/215 (92%), Gaps = 6/215 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYDT T QNVAIKKLSRPFQNVTHAKRAYRE  LMKLVNHK
Sbjct: 16  KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH
Sbjct: 76  NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 135

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 136 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 195

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           ENVDIWSVGCIMGEMIRG VLFPGTDHIDQWNKII
Sbjct: 196 ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII 230

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  389 bits (1001), Expect = e-136
 Identities = 186/218 (85%), Positives = 198/218 (90%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  376 bits (967), Expect = e-131
 Identities = 176/215 (81%), Positives = 188/215 (87%), Gaps = 6/215 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+      +G+GA      A+DT    NVA+KKLSRPFQN THAKRAYRE  L+K VNHK
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQKSLEEFQDVYLVMELMDANLCQVI M+LDHERMSYLLYQMLCGIKHLH
Sbjct: 81  NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 140

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA T FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYK 200

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           ENVDIWSVGCIMGE+++G V+F GTDHIDQWNK+I
Sbjct: 201 ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI 235

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  376 bits (966), Expect = e-131
 Identities = 181/218 (83%), Positives = 193/218 (88%), Gaps = 6/218 (2%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQKSLEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 77  NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  327 bits (842), Expect = e-113
 Identities = 106/214 (49%), Positives = 141/214 (65%), Gaps = 14/214 (6%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G+GA      A D  T + VAIKK+S  F ++  AKR  RE KL++ + H+NIIGLL+ 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIH 187
             P    E+F DVY+V ELM+ +L +VI+    L  + + Y LYQ+L G+K+LHSA +IH
Sbjct: 68  LRPPSP-EDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIH 126

Query: 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTTF----MMTPYVVTRYYRAPEVILG-MGYKE 242
           RDLKPSNI+V S+C LKI DFGLAR           +T YVVTR+YRAPE++L    Y +
Sbjct: 127 RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTK 186

Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            +DIWSVGCI  E++    LFPG D+IDQ N I+
Sbjct: 187 AIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIV 220

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  310 bits (796), Expect = e-105
 Identities = 124/213 (58%), Positives = 158/213 (74%), Gaps = 10/213 (4%)

Query: 72  NTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           N S +G+GA      A+DT T + VAIKKLSRPFQ+  HAKR YRE +L+K ++H+N+IG
Sbjct: 19  NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIG 78

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAG 184
           LL+ FTP  SLE+FQDVYLV  LM A+L  +++   L  + + +L+YQ+L G+K++HSAG
Sbjct: 79  LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG 138

Query: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKEN 243
           IIHRDLKPSNI V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y + 
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQT 196

Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           VDIWSVGCIM E++ G  LFPG+DHIDQ  +I+
Sbjct: 197 VDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM 229

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  284 bits (729), Expect = 3e-96
 Identities = 95/217 (43%), Positives = 126/217 (58%), Gaps = 17/217 (7%)

Query: 72  NTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
               +G G       A D  T + VAIKK+   F++    K A RE KL+K +NH NII 
Sbjct: 3   KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIK 62

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS 182
           LL+ F  +       D+YLV E MD +L ++I+     L    +   LYQ+L G+   HS
Sbjct: 63  LLDVFRHK------GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGM-GY 240
            GI+HRDLKP N+++ ++  LK+ DFGLAR+ G+     T YVVTR+YRAPE++LG  GY
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
              VDIWSVGCI  E++    LFPG   IDQ  KI  
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFR 213

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  258 bits (661), Expect = 3e-85
 Identities = 119/209 (56%), Positives = 148/209 (70%), Gaps = 9/209 (4%)

Query: 75  HLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
            +G+GA      A D  T + VAIKKLSRPFQ+   AKRAYRE  L+K + H+N+IGLL+
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHR 188
            FT   S +EFQD YLVM  M  +L +++   L  +++ YL+YQMLCG+K++HSAGIIHR
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHR 141

Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIW 247
           DLKP N+ V  DC LKILDFGLAR A     MT YVVTR+YRAPEVIL  M Y + VDIW
Sbjct: 142 DLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIW 199

Query: 248 SVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           SVGCIM EM+ G  LF G D++DQ  +I+
Sbjct: 200 SVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  252 bits (645), Expect = 7e-83
 Identities = 117/217 (53%), Positives = 158/217 (72%), Gaps = 10/217 (4%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           ++  N + +G+GA      AYDT  +Q VA+KKLSRPFQ++ HA+R YRE +L+K + H+
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHL 180
           N+IGLL+ FTP  S+E F +VYLV  LM A+L  +++   L  E + +L+YQ+L G+K++
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134

Query: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MG 239
           HSAGIIHRDLKPSN+ V  DC L+ILDFGLAR A     MT YV TR+YRAPE++L  M 
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMH 192

Query: 240 YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           Y + VDIWSVGCIM E+++G  LFPG D+IDQ  +I+
Sbjct: 193 YNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM 229

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  250 bits (639), Expect = 6e-82
 Identities = 125/226 (55%), Positives = 160/226 (70%), Gaps = 16/226 (7%)

Query: 59  ELPISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREF 112
           E+P  +Q      N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE 
Sbjct: 14  EVPERYQ------NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 67

Query: 113 KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLY 171
           +L+K + H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+Y
Sbjct: 68  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 127

Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRA 231
           Q+L G+K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRA
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRA 185

Query: 232 PEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           PE++L  M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  245 bits (626), Expect = 6e-80
 Identities = 116/209 (55%), Positives = 148/209 (70%), Gaps = 10/209 (4%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G+GA      A D  T   VAIKKL RPFQ+   AKRAYRE +L+K + H+N+IGLL+ 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHR 188
           FTP  SL+ F D YLVM  M  +L ++++ + L  +R+ +L+YQML G+K++H+AGIIHR
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHR 142

Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIW 247
           DLKP N+ V  DC LKILDFGLAR   +   MT YVVTR+YRAPEVIL  M Y + VDIW
Sbjct: 143 DLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIW 200

Query: 248 SVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           SVGCIM EM+ G  LF G DH+DQ  +I+
Sbjct: 201 SVGCIMAEMLTGKPLFKGHDHLDQLMEIM 229

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  234 bits (598), Expect = 8e-76
 Identities = 93/216 (43%), Positives = 135/216 (62%), Gaps = 16/216 (7%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G+GA      A DT + + VAIKK+   F   T AKR  RE K+++   H NII + + 
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIH 187
             P  +  +F+DVY+VM+LM+++L  +I     L  E + Y LYQ+L G+K++HSA +IH
Sbjct: 73  LRPPGA--DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIH 130

Query: 188 RDLKPSNIVVKSDCTLKILDFGLARTAGT-----TFMMTPYVVTRYYRAPEVILGMG-YK 241
           RDLKPSN++V  DC L+I DFG+AR   +      + MT YV TR+YRAPE++L +  Y 
Sbjct: 131 RDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYT 190

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
             +D+WSVGCI  EM+    LFPG +++ Q   I+ 
Sbjct: 191 TAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS 226

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  231 bits (592), Expect = 7e-75
 Identities = 102/218 (46%), Positives = 145/218 (66%), Gaps = 14/218 (6%)

Query: 72  NTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           N S++G GA      A    T   VAIKK+S PF++ T  +R  RE K+++   H+NIIG
Sbjct: 9   NLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENIIG 67

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAG 184
           +L+   P  S E F DVY+V ELM+ +L ++I+   L ++ + Y LYQ+L G+K++HSA 
Sbjct: 68  ILDIIRPP-SFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN 126

Query: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTTFMMTPYVVTRYYRAPEVILGM-G 239
           ++HRDLKPSN+++ ++C LKI DFGLAR A      T  +T YV TR+YRAPE++L   G
Sbjct: 127 VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKG 186

Query: 240 YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           Y + +DIWSVGCI+ EM+    LFPG D++ Q N I+G
Sbjct: 187 YTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG 224

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  227 bits (580), Expect = 5e-73
 Identities = 93/210 (44%), Positives = 135/210 (64%), Gaps = 8/210 (3%)

Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           +A ++ T + VAIKK++  F N   AKR  RE KL++ ++H+N+I + +   P    E F
Sbjct: 23  SAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP-HREAF 81

Query: 140 QDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
            DVY+V ELMD +L Q+I+    L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++
Sbjct: 82  NDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL 141

Query: 198 KSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGE 255
            ++C LKI DFGLART       MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E
Sbjct: 142 NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201

Query: 256 MIRGGVLFPGTDHIDQWN---KIIGKMREA 282
           ++    LFPG D++ Q     +++G   E 
Sbjct: 202 LLGRKPLFPGKDYVHQLKLITELLGSPSEE 231

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  220 bits (562), Expect = 3e-70
 Identities = 99/220 (45%), Positives = 141/220 (64%), Gaps = 25/220 (11%)

Query: 75  HLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYRE--FKLMKLVNHKNIIGL 126
            LG GA      A D  T++ VA+KK+   F+N T A+R +RE  F L +L +H NI+ L
Sbjct: 14  KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMF-LQELGDHPNIVKL 72

Query: 127 LNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDL---DHERMSYLLYQMLCGIKHLHSA 183
           LN    +      +D+YLV E M+ +L  VI+ ++    H+R  Y++YQ+L  +K++HS 
Sbjct: 73  LNVIKAEND----KDIYLVFEYMETDLHAVIRANILEDVHKR--YIMYQLLKALKYIHSG 126

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF------MMTPYVVTRYYRAPEVILG 237
            +IHRDLKPSNI++ SDC +K+ DFGLAR+           ++T YV TR+YRAPE++LG
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG 186

Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
              Y + VD+WSVGCI+GEM+ G  LFPGT  ++Q  KII
Sbjct: 187 STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII 226

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  217 bits (554), Expect = 4e-70
 Identities = 81/213 (38%), Positives = 119/213 (55%), Gaps = 16/213 (7%)

Query: 75  HLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
            LG G+      A D  T + VAIK + +        +R  RE K++K + H NI+ L +
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNIVRLYD 64

Query: 129 AFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGI 185
            F      E+   +YLVME  +  +L  +++    L  +   + L Q+L  +++LHS GI
Sbjct: 65  VF------EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
           +HRDLKP NI++  D  +K+ DFGLAR       +T +V T  Y APEV+LG GY + VD
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178

Query: 246 IWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
           IWS+G I+ E++ G   FPG D + +  K IGK
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGK 211

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  215 bits (550), Expect = 1e-68
 Identities = 97/198 (48%), Positives = 131/198 (66%), Gaps = 9/198 (4%)

Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           +A D  T QNVAIKK+ +PF     AKR YRE KL+K + H+NII L + F     +   
Sbjct: 28  SARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIF-----ISPL 82

Query: 140 QDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +D+Y V EL+  +L +++    L+ + + Y LYQ+L G+K++HSAG++HRDLKPSNI++ 
Sbjct: 83  EDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN 142

Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMI 257
            +C LKI DFGLAR       MT YV TRYYRAPE++L    Y   VDIWS GCI  EM+
Sbjct: 143 ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200

Query: 258 RGGVLFPGTDHIDQWNKI 275
            G  LFPG DH++Q++ I
Sbjct: 201 EGKPLFPGKDHVNQFSII 218

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  197 bits (502), Expect = 2e-61
 Identities = 87/202 (43%), Positives = 125/202 (61%), Gaps = 11/202 (5%)

Query: 84  TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMK-LVNHKNIIGLLNAFTPQKSLEEFQDV 142
           T+ ++ VAIKK++  F     AKRA RE KL++    HKNI  L +          F ++
Sbjct: 24  TSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG--NFNEL 81

Query: 143 YLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           YL  ELM+A+L Q+I+    L        +YQ+LCG+K++HSA ++HRDLKP N++V +D
Sbjct: 82  YLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD 141

Query: 201 CTLKILDFGLARTAGTTF-----MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMG 254
           C LKI DFGLAR            MT YV TR+YRAPE++L    Y + +D+WSVGCI+ 
Sbjct: 142 CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILA 201

Query: 255 EMIRGGVLFPGTDHIDQWNKII 276
           E++    +F G D++DQ N+I+
Sbjct: 202 ELLGRKPVFKGKDYVDQLNQIL 223

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  195 bits (498), Expect = 2e-61
 Identities = 85/206 (41%), Positives = 111/206 (53%), Gaps = 23/206 (11%)

Query: 81  AYDTATQQNVAIKK--LSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE 138
           A D  T + VA+KK  L    + +     A RE  L+K + H NI+ LL+    ++ L  
Sbjct: 18  ARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKLLDVIHTERKL-- 73

Query: 139 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
               YLV E  D +L + +      L    +  ++YQ+L G+ + HS  I+HRDLKP NI
Sbjct: 74  ----YLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNI 129

Query: 196 VVKSDCTLKILDFGLARTAGTTFM-----MTPYVVTRYYRAPEVILGM-GYKENVDIWSV 249
           ++  D  LK+ DFGLAR     F       T  VVT +YRAPE++LG   Y   VDIWSV
Sbjct: 130 LINRDGVLKLADFGLAR----AFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSV 185

Query: 250 GCIMGEMIRGGVLFPGTDHIDQWNKI 275
           GCI  EMI G  LFPG   IDQ  KI
Sbjct: 186 GCIFAEMITGKPLFPGDSEIDQLFKI 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  195 bits (498), Expect = 7e-61
 Identities = 90/200 (45%), Positives = 128/200 (64%), Gaps = 9/200 (4%)

Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           +A DT T + VAIKK++  F++V+ A R  RE KL++L+ H +I+ + +   P  S  EF
Sbjct: 18  SAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP-PSRREF 76

Query: 140 QDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
           +D+Y+V ELM+++L QVI+   DL  E   + LYQ+L  +K++H+A + HRDLKP NI+ 
Sbjct: 77  KDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA 136

Query: 198 KSDCTLKILDFGLARTA----GTTFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGC 251
            +DC LKI DFGLAR A     T    T YV TR+YRAPE+       Y   +DIWS+GC
Sbjct: 137 NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 196

Query: 252 IMGEMIRGGVLFPGTDHIDQ 271
           I  E++ G  LFPG + + Q
Sbjct: 197 IFAEVLTGKPLFPGKNVVHQ 216

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  189 bits (482), Expect = 5e-58
 Identities = 83/192 (43%), Positives = 121/192 (63%), Gaps = 6/192 (3%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+KK+   FQN+   KR +RE K++    H N++  L+   P   ++ F+++Y+V ELM
Sbjct: 28  VALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPH-IDPFEEIYVVTELM 86

Query: 150 DANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
            ++L ++I     L  + +   LYQ+L G+K+LHSAGI+HRD+KP N++V S+C LKI D
Sbjct: 87  QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICD 146

Query: 208 FGLARTA--GTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFP 264
           FGLAR      +  MT  VVT+YYRAPE+++G   Y   VDIWSVGCI  E++   +LF 
Sbjct: 147 FGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206

Query: 265 GTDHIDQWNKII 276
               I Q + I 
Sbjct: 207 AQSPIQQLDLIT 218

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  182 bits (463), Expect = 2e-56
 Identities = 76/224 (33%), Positives = 125/224 (55%), Gaps = 18/224 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG+G+      A    T + VA+K L +  +     + A RE ++++ ++H NI+ L++A
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 130 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGII 186
           F      E+   +YLVME  +  +L   +     L  +    +  Q+L G+++LHS GII
Sbjct: 67  F------EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVIL-GMGYKENV 244
           HRDLKP NI++  +  +KI DFGLA+    +   +T +V T +Y APEV+L G GY   V
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180

Query: 245 DIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
           D+WS+G I+ E++ G   F G + +DQ  ++I ++     + D 
Sbjct: 181 DVWSLGVILYELLTGKPPFSGENILDQ-LQLIRRILGPPLEFDE 223

Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  180 bits (458), Expect = 3e-55
 Identities = 80/215 (37%), Positives = 120/215 (55%), Gaps = 15/215 (6%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           + AT + VAIKK      +    K A RE K+++ + H+NI+ L  AF  +  L      
Sbjct: 22  NKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRL------ 75

Query: 143 YLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           YLV E ++  L ++++     L  + +   ++Q+L  I + HS  IIHRD+KP NI+V  
Sbjct: 76  YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE 135

Query: 200 DCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 256
              LK+ DFG AR   A     +T YV TR+YRAPE+++G   Y + VD+W++GCIM E+
Sbjct: 136 SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAEL 195

Query: 257 IRGGVLFPGTDHIDQWNKI---IGKMREAHDKLDY 288
           + G  LFPG   IDQ   I   +G +  +H +L  
Sbjct: 196 LDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  179 bits (456), Expect = 5e-55
 Identities = 75/215 (34%), Positives = 118/215 (54%), Gaps = 22/215 (10%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G GA      A D  T + VA+KK++          +A RE K ++   H  ++ LL+ 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH-----ERMSYLLYQMLCGIKHLHSAG 184
           F             LVME M ++L +V++ D +      +  SY+   +L G+ ++H+ G
Sbjct: 68  FP------HGSGFVLVMEYMPSDLSEVLR-DEERPLPEAQVKSYMR-MLLKGVAYMHANG 119

Query: 185 IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGM-GYK 241
           I+HRDLKP+N+++ +D  LKI DFGLAR  +     + +  V TR+YRAPE++ G   Y 
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
             VD+W+VGCI  E++ G  LFPG + I+Q   + 
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVF 214

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  172 bits (438), Expect = 2e-52
 Identities = 83/212 (39%), Positives = 111/212 (52%), Gaps = 19/212 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK-LMKLVNHKNIIGLLN 128
           LG G       A +  T + VAIKK+ + F +        RE K L KL  H NI+ L  
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPNIVKLKE 65

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVI----QMDLDHERMSYLLYQMLCGIKHLHSAG 184
            F       E  ++Y V E M+ NL Q++            +  ++YQ+L G+ H+H  G
Sbjct: 66  VF------RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119

Query: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKEN 243
             HRDLKP N++V     +KI DFGLAR   +    T YV TR+YRAPE++L    Y   
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSP 179

Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           VDIW++GCIM E+     LFPG+  IDQ  KI
Sbjct: 180 VDIWALGCIMAELYTLRPLFPGSSEIDQLYKI 211

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  171 bits (437), Expect = 4e-52
 Identities = 89/220 (40%), Positives = 121/220 (55%), Gaps = 28/220 (12%)

Query: 74  SHLGAGA------AYDTATQQNVAIKKL---SRPFQNVTHAKRAYREFKLMKLVNHKNII 124
             LG G       A D  T + VAIKK+    R          A RE KL++ + H NII
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 125 GLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERM-------SYLLYQMLCGI 177
           GLL+ F  + ++       LV E M+ +L +VI+   D   +       SY+L   L G+
Sbjct: 66  GLLDVFGHKSNI------NLVFEFMETDLEKVIK---DKSIVLTPADIKSYML-MTLRGL 115

Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TFMMTPYVVTRYYRAPEVIL 236
           ++LHS  I+HRDLKP+N+++ SD  LK+ DFGLAR+ G+    MT  VVTR+YRAPE++ 
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLF 175

Query: 237 GMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           G   Y   VD+WSVGCI  E++      PG   IDQ  KI
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  166 bits (423), Expect = 4e-50
 Identities = 85/215 (39%), Positives = 114/215 (53%), Gaps = 14/215 (6%)

Query: 74  SHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV---NHKNII 124
           + +G GA      A D  T + VA+KK+  P           RE  L+K +    H NI+
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 125 GLLNAFTPQKSLEEFQDVYLVMELMDANLCQVI----QMDLDHERMSYLLYQMLCGIKHL 180
            LL+     ++  E   + LV E +D +L   +    +  L  E +  L+ Q+L G+  L
Sbjct: 65  RLLDVCHGPRTDREL-KLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL 123

Query: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           HS  I+HRDLKP NI+V SD  +KI DFGLAR       +T  VVT +YRAPEV+L   Y
Sbjct: 124 HSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSY 183

Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
              VD+WSVGCI  E+ R   LF GT   DQ +KI
Sbjct: 184 ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  160 bits (408), Expect = 7e-48
 Identities = 74/209 (35%), Positives = 115/209 (55%), Gaps = 24/209 (11%)

Query: 81  AYDTATQQNVAIKKLSRPFQN-----VTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS 135
           A +  T + VA+KK+ R         +T    A RE KL++ + H NI+ L    T    
Sbjct: 18  ARNKKTGELVALKKI-RMENEKEGFPIT----AIREIKLLQKLRHPNIVRLKEIVTS--- 69

Query: 136 LEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
            +    +Y+V E MD +L  ++   ++     ++   + Q+L G+++LHS GI+HRD+K 
Sbjct: 70  -KGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKG 128

Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFM----MTPYVVTRYYRAPEVILG-MGYKENVDIW 247
           SNI++ +D  LK+ DFGLAR    T       T  V+T +YR PE++LG   Y   VD+W
Sbjct: 129 SNILINNDGVLKLADFGLARP--YTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMW 186

Query: 248 SVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           SVGCI+ E+  G  +F G+  ++Q  KI 
Sbjct: 187 SVGCILAELFLGKPIFQGSTELEQLEKIF 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  154 bits (391), Expect = 2e-45
 Identities = 73/195 (37%), Positives = 113/195 (57%), Gaps = 11/195 (5%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEFQDVYL 144
           T +  AIK + + F+++       RE + ++ ++ H NI+ L+     +K+      + L
Sbjct: 23  TGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPNILRLIEVLFDRKT----GRLAL 77

Query: 145 VMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
           V ELMD NL ++I+     L  +R+   +YQ+L  + H+H  GI HRD+KP NI++K D 
Sbjct: 78  VFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDI 137

Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGG 260
            LK+ DFG  R   +    T Y+ TR+YRAPE +L  G Y   +DIW+VGC+  E++   
Sbjct: 138 -LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF 196

Query: 261 VLFPGTDHIDQWNKI 275
            LFPGT+ +DQ  KI
Sbjct: 197 PLFPGTNELDQIAKI 211

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  155 bits (393), Expect = 2e-45
 Identities = 73/214 (34%), Positives = 110/214 (51%), Gaps = 28/214 (13%)

Query: 85  ATQQNVAIKKLSRPFQNVTHAKR-----AYREFKLMKLVNHKNIIGLLNAFT--PQKSLE 137
            T + VA+KK+      + + K      A RE K++K + H N++ L++     P KS  
Sbjct: 31  KTGRVVALKKIL-----MHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85

Query: 138 EFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
           +   VY+V   MD +L  +++   + L   ++   + Q+L GI +LH   I+HRD+K +N
Sbjct: 86  KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAAN 145

Query: 195 IVVKSDCTLKILDFGLAR------------TAGTTFMMTPYVVTRYYRAPEVILGM-GYK 241
           I++ +   LKI DFGLAR              G T   T  VVTR+YR PE++LG   Y 
Sbjct: 146 ILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYT 205

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
             VDIW +GC+  EM     +  G   IDQ + I
Sbjct: 206 TAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  154 bits (390), Expect = 8e-45
 Identities = 86/237 (36%), Positives = 122/237 (51%), Gaps = 42/237 (17%)

Query: 75  HLGAGA------AYDTATQQNVAIKKLS-RPFQNVTHAKRAY-----------REFKLMK 116
           HLG G       AYDT T + VAIKK+      N     R             RE K+M 
Sbjct: 16  HLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 117 LVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQML 174
            + H+NI+GL++ +       +F  + LVM++M ++L +V+  ++ L   ++  +L Q+L
Sbjct: 76  EIKHENIMGLVDVYVEG----DF--INLVMDIMASDLKKVVDRKIRLTESQVKCILLQIL 129

Query: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---------------TTFM 219
            G+  LH    +HRDL P+NI + S    KI DFGLAR  G                   
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 220 MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           MT  VVT +YRAPE+++G   Y   VD+WSVGCI  E++ G  LFPG + IDQ  +I
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246

Length = 335

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  150 bits (381), Expect = 7e-44
 Identities = 82/196 (41%), Positives = 113/196 (57%), Gaps = 11/196 (5%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T Q VAIKK      +    K A RE +++K + H+N++ L+  F  +K L      YLV
Sbjct: 25  TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRL------YLV 78

Query: 146 MELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            E +D  +   ++     LD  R+   L+Q+L GI+  HS  IIHRD+KP NI+V     
Sbjct: 79  FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV 138

Query: 203 LKILDFGLART-AGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGG 260
           +K+ DFG ART A    + T YV TR+YRAPE+++G   Y   VDIW+VGC++ EM+ G 
Sbjct: 139 VKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198

Query: 261 VLFPGTDHIDQWNKII 276
            LFPG   IDQ   II
Sbjct: 199 PLFPGDSDIDQLYHII 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  149 bits (379), Expect = 1e-43
 Identities = 84/205 (40%), Positives = 114/205 (55%), Gaps = 20/205 (9%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A D  T + VA+KK+    ++      A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 18  ARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKL---- 73

Query: 141 DVYLVMELMDANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
             YLV E +D +L +   MD      LD   +   LYQ+L GI + HS  ++HRDLKP N
Sbjct: 74  --YLVFEFLDLDLKK--YMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQN 129

Query: 195 IVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVG 250
           +++  +  LK+ DFGLAR  G    T+  T  VVT +YRAPE++LG   Y   VDIWS+G
Sbjct: 130 LLIDREGALKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGSRQYSTPVDIWSIG 187

Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKI 275
           CI  EM+    LFPG   IDQ  +I
Sbjct: 188 CIFAEMVNRRPLFPGDSEIDQLFRI 212

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  149 bits (378), Expect = 3e-43
 Identities = 76/218 (34%), Positives = 111/218 (50%), Gaps = 45/218 (20%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKR------AYREFKLMKLVNHKNIIGLLNAFTPQK 134
           A D  T + VA+KKL          ++      + RE  ++  + H NI+          
Sbjct: 24  ARDKKTGEIVALKKLK------MEKEKEGFPITSLREINILLKLQHPNIV---------- 67

Query: 135 SLEE------FQDVYLVMELMDANLCQVIQMDLDHERMSY---------LLYQMLCGIKH 179
           +++E         +Y+VME ++ +L  ++      E M           L+ Q+L G+ H
Sbjct: 68  TVKEVVVGSNLDKIYMVMEYVEHDLKSLM------ETMKQPFLQSEVKCLMLQLLSGVAH 121

Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGM 238
           LH   I+HRDLK SN+++ +   LKI DFGLAR  G+     T  VVT +YRAPE++LG 
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181

Query: 239 G-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
             Y   +D+WSVGCI  E++    LFPG   IDQ NKI
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  145 bits (368), Expect = 1e-42
 Identities = 71/194 (36%), Positives = 109/194 (56%), Gaps = 20/194 (10%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G       A D  T + VAIK + +   + +  +   RE +++K +NH NI+ L   
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGI 185
           F      E+   +YLVME  +  +L  +++ +   L  + +  +L Q+L G+++LHS GI
Sbjct: 60  F------EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGI 113

Query: 186 IHRDLKPSNIVVKSDC-TLKILDFGLART-AGTTFMMTPYVVTRYYRAPEVILGMG-YKE 242
           IHRDLKP NI++ SD   +K+ DFGL++       ++   V T  Y APEV+LG G Y E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 243 NVDIWSVGCIMGEM 256
             DIWS+G I+ E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  146 bits (371), Expect = 7e-42
 Identities = 77/222 (34%), Positives = 120/222 (54%), Gaps = 23/222 (10%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G+      A D+   + VA+KK+     +    K A RE K+++ ++H NI+ +   
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIV--LTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 130 FTPQ--------KSLEEFQDVYLVMELMDANLCQVI-QMDLDHERMSYLLYQMLCGIKHL 180
             P          SL E   VY+V E M+ +L  V+ Q  L  E     +YQ+L G+K++
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYI 130

Query: 181 HSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTTFMMTPY----VVTRYYRAPEVI 235
           HSA ++HRDLKP+N+ + + D  LKI DFGLAR     +    Y    +VT++YR+P ++
Sbjct: 131 HSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL 190

Query: 236 LG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           L    Y + +D+W+ GCI  EM+ G  LF G   ++Q   I+
Sbjct: 191 LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  141 bits (357), Expect = 1e-40
 Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 16/196 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G+      A D  T + +A+K +     +    +   RE +++  + H NI+    +
Sbjct: 8   LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67

Query: 130 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGII 186
               +  EE   + + +E +   +L  +++    L    +     Q+L G+ +LHS GI+
Sbjct: 68  ----ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIV 123

Query: 187 HRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFMMTPYVVTRYYRAPEVILGMGYKEN 243
           HRD+K +NI+V SD  +K+ DFG A+      T         T Y+ APEVI G  Y   
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA 183

Query: 244 VDIWSVGCIMGEMIRG 259
            DIWS+GC + EM  G
Sbjct: 184 ADIWSLGCTVIEMATG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  138 bits (351), Expect = 7e-40
 Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 18/194 (9%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G       A    T + VAIK +    ++    ++   E +++K   H NI+    +
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 130 FTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           +  +       ++++VME        +L +     L   +++Y+  ++L G+++LHS GI
Sbjct: 66  YLKKD------ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
           IHRD+K +NI++ SD  +K++DFGL+     T      V T Y+ APEVI G  Y    D
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKAD 179

Query: 246 IWSVGCIMGEMIRG 259
           IWS+G    E+  G
Sbjct: 180 IWSLGITAIELAEG 193

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  138 bits (349), Expect = 3e-39
 Identities = 77/181 (42%), Positives = 102/181 (56%), Gaps = 17/181 (9%)

Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVI-----QMDLD 162
           A RE  LMK + H+NI+ L +    +  L       LV E MD +L + +     +  LD
Sbjct: 45  AIREISLMKELKHENIVRLHDVIHTENKL------MLVFEYMDKDLKKYMDTHGVRGALD 98

Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TTFM 219
              +    YQ+L GI   H   ++HRDLKP N+++     LK+ DFGLAR  G    TF 
Sbjct: 99  PNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF- 157

Query: 220 MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
            +  VVT +YRAP+V+LG   Y  ++DIWSVGCIM EMI G  LFPGT++ DQ  KI   
Sbjct: 158 -SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI 216

Query: 279 M 279
           M
Sbjct: 217 M 217

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  137 bits (346), Expect = 8e-39
 Identities = 76/211 (36%), Positives = 120/211 (56%), Gaps = 14/211 (6%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T++ VAIKK     +N    +   RE K+++ +  +NI+ L  AF  +  L      YLV
Sbjct: 25  TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKL------YLV 78

Query: 146 MELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            E ++ N+ ++++     +  E++   +YQ++  I   H   I+HRD+KP N+++  +  
Sbjct: 79  FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV 138

Query: 203 LKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
           LK+ DFG AR  + G+    T YV TR+YR+PE++LG  Y + VD+WSVGCI+GE+  G 
Sbjct: 139 LKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Query: 261 VLFPGTDHIDQW---NKIIGKMREAHDKLDY 288
            LFPG   IDQ     K++G +     KL Y
Sbjct: 199 PLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  136 bits (345), Expect = 1e-38
 Identities = 77/203 (37%), Positives = 109/203 (53%), Gaps = 16/203 (7%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 19  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 74

Query: 141 DVYLVMELMDANL------CQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
             YLV E +  +L        +  + L     SYL +Q+L G+   HS  ++HRDLKP N
Sbjct: 75  --YLVFEFLHQDLKKFMDASPLSGIPL-PLIKSYL-FQLLQGLAFCHSHRVLHRDLKPQN 130

Query: 195 IVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCI 252
           +++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG   Y   VDIWS+GCI
Sbjct: 131 LLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 190

Query: 253 MGEMIRGGVLFPGTDHIDQWNKI 275
             EM+    LFPG   IDQ  +I
Sbjct: 191 FAEMVTRRALFPGDSEIDQLFRI 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  136 bits (345), Expect = 2e-38
 Identities = 77/206 (37%), Positives = 114/206 (55%), Gaps = 17/206 (8%)

Query: 81  AYDTATQQNVAIKKL----SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL 136
           A DT + + VA+KK+     R    ++    + RE  L+  + H NI+ L       K L
Sbjct: 26  ARDTTSGEIVALKKVRMDNERDGIPIS----SLREITLLLNLRHPNIVELKEVVV-GKHL 80

Query: 137 EEFQDVYLVMELMD---ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
           +    ++LVME  +   A+L   +       ++  L+ Q+L G+++LH   IIHRDLK S
Sbjct: 81  D---SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVS 137

Query: 194 NIVVKSDCTLKILDFGLARTAGTTFM-MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGC 251
           N+++     LKI DFGLART G     MTP VVT +YRAPE++LG   Y   +D+W+VGC
Sbjct: 138 NLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGC 197

Query: 252 IMGEMIRGGVLFPGTDHIDQWNKIIG 277
           I+ E++    L PG   I+Q + II 
Sbjct: 198 ILAELLAHKPLLPGKSEIEQLDLIIQ 223

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  136 bits (343), Expect = 3e-38
 Identities = 82/206 (39%), Positives = 112/206 (54%), Gaps = 21/206 (10%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A D  T + +A+KK+    ++      A RE  L+K + H NI+ L +    +K L    
Sbjct: 21  ARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRL---- 76

Query: 141 DVYLVMELMDANLCQVIQMDL------DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
             YLV E +D +L +   MD       +   +   LYQ+L GI + HS  ++HRDLKP N
Sbjct: 77  --YLVFEYLDLDLKK--HMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQN 132

Query: 195 IVV-KSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSV 249
           +++ +    LK+ DFGLAR  G    TF  T  VVT +YRAPE++LG   Y   VDIWSV
Sbjct: 133 LLIDRRTNALKLADFGLARAFGIPVRTF--THEVVTLWYRAPEILLGSRHYSTPVDIWSV 190

Query: 250 GCIMGEMIRGGVLFPGTDHIDQWNKI 275
           GCI  EM+    LFPG   ID+  KI
Sbjct: 191 GCIFAEMVNQKPLFPGDSEIDELFKI 216

Length = 294

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  132 bits (333), Expect = 7e-37
 Identities = 64/196 (32%), Positives = 102/196 (52%), Gaps = 11/196 (5%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T Q VAIKK      +    K A RE +++K + H N++ L+  F  ++ L      +LV
Sbjct: 25  TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKL------HLV 78

Query: 146 MELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            E  D  +   ++ +   +    +  +++Q L  +   H    IHRD+KP NI++     
Sbjct: 79  FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ 138

Query: 203 LKILDFGLART-AGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGG 260
           +K+ DFG AR   G     T YV TR+YRAPE+++G   Y   VD+W++GC+  E++ G 
Sbjct: 139 IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198

Query: 261 VLFPGTDHIDQWNKII 276
            L+PG   +DQ   I 
Sbjct: 199 PLWPGKSDVDQLYLIR 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  131 bits (332), Expect = 7e-37
 Identities = 56/189 (29%), Positives = 93/189 (49%), Gaps = 17/189 (8%)

Query: 79  GAAY---DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS 135
           G  Y     +  +   +K++     +    + A  E K++K +NH NII    +F     
Sbjct: 14  GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF----- 68

Query: 136 LEEFQDVYLVMELMDA-NLCQVIQ-MDLDHERMS-----YLLYQMLCGIKHLHSAGIIHR 188
            EE   + +VME  D  +L Q I+    + +            Q+   +K+LHS  I+HR
Sbjct: 69  -EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHR 127

Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIW 247
           D+KP NI + S+  +K+ DFG+++   +T  +   VV T YY +PE+     Y    DIW
Sbjct: 128 DIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIW 187

Query: 248 SVGCIMGEM 256
           S+GC++ E+
Sbjct: 188 SLGCVLYEL 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  130 bits (329), Expect = 3e-36
 Identities = 71/201 (35%), Positives = 104/201 (51%), Gaps = 12/201 (5%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+K++     +      A RE  L+K + HKNI+ L +     K L    
Sbjct: 19  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLT--- 75

Query: 141 DVYLVMELMDANL---CQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
              LV E  D +L         D+D E +   ++Q+L G+   HS  ++HRDLKP N+++
Sbjct: 76  ---LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI 132

Query: 198 KSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGE 255
             +  LK+ DFGLAR  G      +  VVT +YR P+V+ G   Y  ++D+WS GCI  E
Sbjct: 133 NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 192

Query: 256 MIRGGV-LFPGTDHIDQWNKI 275
           +   G  LFPG D  DQ  +I
Sbjct: 193 LANAGRPLFPGNDVDDQLKRI 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  130 bits (327), Expect = 5e-36
 Identities = 81/215 (37%), Positives = 110/215 (51%), Gaps = 14/215 (6%)

Query: 74  SHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV---NHKNII 124
           + +G GA      A D  +   VA+K +              RE  L+K +   +H NI+
Sbjct: 6   AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 125 GLLNAFTPQKSLEEFQDVYLVMELMDANL----CQVIQMDLDHERMSYLLYQMLCGIKHL 180
            L++     ++  E + V LV E +D +L     +V    L  E +  L+ Q L G+  L
Sbjct: 66  RLMDVCATSRTDRETK-VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           H+  I+HRDLKP NI+V S   +K+ DFGLAR       +TP VVT +YRAPEV+L   Y
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTY 184

Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
              VD+WSVGCI  EM R   LF G    DQ  KI
Sbjct: 185 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  127 bits (322), Expect = 3e-35
 Identities = 75/200 (37%), Positives = 105/200 (52%), Gaps = 17/200 (8%)

Query: 85  ATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
            T Q VA+KK+    +       A RE  L+K + H NI+ L +       L +   +YL
Sbjct: 23  KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV------LMQESRLYL 76

Query: 145 VMELMDANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
           + E +  +L +   +D       +D E +   LYQ+L GI   HS  ++HRDLKP N+++
Sbjct: 77  IFEFLSMDLKK--YLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI 134

Query: 198 KSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGE 255
            +   +K+ DFGLAR  G    + T  VVT +YRAPEV+LG   Y   VDIWS+G I  E
Sbjct: 135 DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAE 194

Query: 256 MIRGGVLFPGTDHIDQWNKI 275
           M     LF G   IDQ  +I
Sbjct: 195 MATKKPLFHGDSEIDQLFRI 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  126 bits (317), Expect = 2e-34
 Identities = 73/205 (35%), Positives = 101/205 (49%), Gaps = 10/205 (4%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A D  T + VA+KK             A RE  L+++++    I  L      +      
Sbjct: 20  ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79

Query: 141 DVYLVMELMDANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
            +YLV E +D++L + +  +       L  + +   +YQ+L G+ H H  G++HRDLKP 
Sbjct: 80  SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQ 139

Query: 194 NIVV-KSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVG 250
           N++V K    LKI D GL R         T  +VT +YRAPEV+LG   Y   VDIWSVG
Sbjct: 140 NLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVG 199

Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKI 275
           CI  EM R   LFPG   + Q   I
Sbjct: 200 CIFAEMSRKQPLFPGDSELQQLLHI 224

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 3e-34
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 13/200 (6%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
              T +  A+K L +  + +   +  +   E  ++  +NH  I+ L  AF  ++ L    
Sbjct: 14  KKDTGKLYAMKVLKK-KKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL---- 68

Query: 141 DVYLVMELMDAN-LCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
             YLV+E      L   +        ER  +   +++  +++LHS GII+RDLKP NI++
Sbjct: 69  --YLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL 126

Query: 198 KSDCTLKILDFGLARTAGTTFMMT-PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
            +D  +K+ DFGLA+   +    T  +  T  Y APEV+LG GY + VD WS+G ++ EM
Sbjct: 127 DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEM 186

Query: 257 IRGGVLFPGTDHIDQWNKII 276
           + G   F   D  + + KI+
Sbjct: 187 LTGKPPFYAEDRKEIYEKIL 206

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  125 bits (316), Expect = 8e-34
 Identities = 48/60 (80%), Positives = 55/60 (91%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL 60
           MLVIDPEKRISVDDAL HPYINVW+D +EV AP P PYDHS+DEREHTV++WKELIY+E+
Sbjct: 294 MLVIDPEKRISVDDALQHPYINVWYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV 353

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 1e-33
 Identities = 69/213 (32%), Positives = 109/213 (51%), Gaps = 30/213 (14%)

Query: 90  VAIKKL-SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
            AIKK      Q    ++ A RE  L++ + H+N++ L+  F           VYL+ + 
Sbjct: 30  YAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS----VYLLFDY 85

Query: 149 MDANLCQVIQMDLDHERMSY-------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
            + +L Q+I+     +R+S        LL+Q+L G+ +LHS  ++HRDLKP+NI+V  + 
Sbjct: 86  AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEG 145

Query: 202 ----TLKILDFGLAR----TAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCI 252
                +KI D GLAR           + P VVT +YRAPE++LG   Y + +DIW++GCI
Sbjct: 146 PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCI 205

Query: 253 MGEMIRGGVLFPGTD---------HIDQWNKII 276
             E++    +F G +           DQ  +I 
Sbjct: 206 FAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  123 bits (310), Expect = 2e-33
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 22/200 (11%)

Query: 72  NTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           N   +G GA      A D AT + VAIKK+    QN    +    E  +MK   H NI+ 
Sbjct: 23  NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNIVD 79

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDAN-LCQVI---QMDLDHERMSYLLYQMLCGIKHLH 181
             +++     L      ++VME MD   L  +I    + ++  +++Y+  ++L G+++LH
Sbjct: 80  YYDSYLVGDEL------WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH 133

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT--FMMTPYVVTRYYRAPEVILGMG 239
           S  +IHRD+K  NI++  D ++K+ DFG A    T         V T Y+ APEVI    
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFA-AQLTKEKSKRNSVVGTPYWMAPEVIKRKD 192

Query: 240 YKENVDIWSVGCIMGEMIRG 259
           Y   VDIWS+G +  EM  G
Sbjct: 193 YGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  122 bits (305), Expect = 3e-32
 Identities = 68/236 (28%), Positives = 115/236 (48%), Gaps = 34/236 (14%)

Query: 71  HNTSHLGAGA------AYDTATQQNVAIKKLSRPFQN-VTHAKRAYREFKLMKLVNH-KN 122
                LG G+      A D    + VA+K L++  ++     +R  RE +++  +NH  N
Sbjct: 3   RILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 123 IIGLLNAFTPQKSLEEFQDVYLVMELMDANLC-QVIQMDLDHERMSY-----LLYQMLCG 176
           I+ L + F  + SL      YLVME +D      +++       +S      +L Q+L  
Sbjct: 60  IVKLYDFFQDEGSL------YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113

Query: 177 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAG-------TTFMMTPYVVTRY 228
           +++LHS GIIHRD+KP NI++ +    +K++DFGLA+             + +  V T  
Sbjct: 114 LEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173

Query: 229 YRAPEVILGMG---YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE 281
           Y APEV+LG+       + DIWS+G  + E++ G   F G  +    ++ +  + E
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229

Length = 384

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  120 bits (303), Expect = 3e-32
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 11/203 (5%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN-AFTPQKSLEEFQ-DVY 143
           T+Q VA+KK+    +       A RE K+++L+ H+N++ L+    T       ++   Y
Sbjct: 36  TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFY 95

Query: 144 LVMELMD---ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           LV E  +   A L     +      +  ++  +L G+ ++H   I+HRD+K +NI++  D
Sbjct: 96  LVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD 155

Query: 201 CTLKILDFGLAR-----TAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMG 254
             LK+ DFGLAR             T  VVT +YR PE++LG   Y   +D+W  GCIM 
Sbjct: 156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMA 215

Query: 255 EMIRGGVLFPGTDHIDQWNKIIG 277
           EM     +  G     Q   I  
Sbjct: 216 EMWTRSPIMQGNTEQHQLTLISQ 238

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  119 bits (299), Expect = 7e-32
 Identities = 64/160 (40%), Positives = 92/160 (57%), Gaps = 5/160 (3%)

Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD----HERMSYLLYQMLC 175
           H N++ L +  T  ++  E + + LV E +D +L   +    +     E +  +++Q+L 
Sbjct: 63  HPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121

Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI 235
           G+  LHS  ++HRDLKP NI+V S   +K+ DFGLAR       +T  VVT +YRAPEV+
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 181

Query: 236 LGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           L   Y   VD+WSVGCI  EM R   LF G+  +DQ  KI
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  119 bits (299), Expect = 8e-32
 Identities = 76/204 (37%), Positives = 107/204 (52%), Gaps = 29/204 (14%)

Query: 86  TQQNVAIKKLS------RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           T Q VA+K++        PF        A RE  L+K + H NI+ L +    +K+L   
Sbjct: 29  TGQLVALKEIRLEHEEGAPFT-------AIREASLLKDLKHANIVTLHDIIHTKKTLT-- 79

Query: 140 QDVYLVMELMDANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
               LV E +D +L Q   MD     L    +   L+Q+L G+ + H   ++HRDLKP N
Sbjct: 80  ----LVFEYLDTDLKQY--MDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQN 133

Query: 195 IVVKSDCTLKILDFGLARTAGT-TFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 252
           +++     LK+ DFGLAR     +   +  VVT +YR P+V+LG   Y  ++D+W VGCI
Sbjct: 134 LLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCI 193

Query: 253 MGEMIRGGVLFPG-TDHIDQWNKI 275
             EM  G  LFPG TD  DQ +KI
Sbjct: 194 FYEMATGRPLFPGSTDVEDQLHKI 217

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  116 bits (293), Expect = 6e-31
 Identities = 65/201 (32%), Positives = 108/201 (53%), Gaps = 10/201 (4%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT-PQKSLEEF 139
           A D  T + VA+KK+    +       A RE K+++ +NH+NI+ L    T  Q +L+  
Sbjct: 26  ARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85

Query: 140 QD---VYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
           +D    YLV E MD +L  +++   +    + +   + Q+L G+ + H    +HRD+K S
Sbjct: 86  KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCS 145

Query: 194 NIVVKSDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVG 250
           NI++ +   +K+ DFGLAR   +  +   T  V+T +YR PE++LG   Y   +D+WS G
Sbjct: 146 NILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 205

Query: 251 CIMGEMIRGGVLFPGTDHIDQ 271
           CI+GE+     +F     + Q
Sbjct: 206 CILGELFTKKPIFQANQELAQ 226

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  108 bits (272), Expect = 3e-28
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 12/180 (6%)

Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVI----QMDLD 162
           A  E  ++ L+ H NII   N F    +L       + ME  +   L   I        +
Sbjct: 46  ALNEIVILSLLQHPNIIAYYNHFMDDNTL------LIEMEYANGGTLYDKIVRQKGQLFE 99

Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP 222
            E + + L+Q++  + ++H AGI+HRD+K  NI +     +K+ DFG+++  G+ + M  
Sbjct: 100 EEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159

Query: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE 281
            VV T YY +PE+  G+ Y    DIW++GC++ E++     F  T+ ++   KI+     
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  108 bits (272), Expect = 4e-28
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 32/214 (14%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
               +  VA+K L     +    +   RE ++M+ ++H N++ LL   T ++ L      
Sbjct: 24  GGKKKVEVAVKTLKED-ASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPL------ 76

Query: 143 YLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           Y+VME M+  +L   ++     L    +     Q+  G+++L S   IHRDL   N +V 
Sbjct: 77  YIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG 136

Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYR-----------APEVILGMGYKENVDIW 247
            +  +KI DFGL+R               YYR           APE +    +    D+W
Sbjct: 137 ENLVVKISDFGLSRDLY---------DDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVW 187

Query: 248 SVGCIMGEMI-RGGVLFPGTDHIDQWNKIIGKMR 280
           S G ++ E+   G   +PG  + +    +    R
Sbjct: 188 SFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR 221

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  106 bits (268), Expect = 1e-27
 Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 33/212 (15%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
            +  VA+K L     +    +   RE ++M+ ++H NI+ LL   T ++ L       +V
Sbjct: 27  KEVEVAVKTLKED-ASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL------MIV 79

Query: 146 MELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           ME M   +L   ++     +L    +     Q+  G+++L S   IHRDL   N +V  +
Sbjct: 80  MEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN 139

Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYR-----------APEVILGMGYKENVDIWSV 249
             +KI DFGL+R               YY+           APE +    +    D+WS 
Sbjct: 140 LVVKISDFGLSRDLY---------DDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSF 190

Query: 250 GCIMGEMI-RGGVLFPGTDHIDQWNKIIGKMR 280
           G ++ E+   G   +PG  + +    +    R
Sbjct: 191 GVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR 222

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  106 bits (266), Expect = 5e-27
 Identities = 61/164 (37%), Positives = 90/164 (54%), Gaps = 11/164 (6%)

Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHE 164
           A RE  L+K + H NI+ L +    +KSL       LV E +D +L Q +      ++  
Sbjct: 51  AIREVSLLKDLKHANIVTLHDIIHTEKSLT------LVFEYLDKDLKQYLDDCGNSINMH 104

Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TFMMTPY 223
            +   L+Q+L G+ + H   ++HRDLKP N+++     LK+ DFGLAR     T   +  
Sbjct: 105 NVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE 164

Query: 224 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGT 266
           VVT +YR P+++LG   Y   +D+W VGCI  EM  G  LFPG+
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  106 bits (265), Expect = 7e-27
 Identities = 67/175 (38%), Positives = 93/175 (53%), Gaps = 15/175 (8%)

Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-----LD 162
           A RE  L+K + H NI+ L +     KSL       LV E +D +L Q   MD     + 
Sbjct: 51  AIREVSLLKDLKHANIVTLHDIVHTDKSLT------LVFEYLDKDLKQY--MDDCGNIMS 102

Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TFMMT 221
              +   LYQ+L G+ + H   ++HRDLKP N+++     LK+ DFGLAR     T   +
Sbjct: 103 MHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162

Query: 222 PYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
             VVT +YR P+V+LG   Y   +D+W VGCI  EM  G  LFPG+   D+ + I
Sbjct: 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  108 bits (270), Expect = 8e-27
 Identities = 69/203 (33%), Positives = 113/203 (55%), Gaps = 20/203 (9%)

Query: 86  TQQNVAIKK-LSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
           T + VAIKK L  P ++N        RE  +MK +NH NII L + +  +   +  ++++
Sbjct: 90  TSEKVAIKKVLQDPQYKN--------RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141

Query: 144 L--VMELMDANLCQVIQ-MDLDHERMSYLL-----YQMLCGIKHLHSAGIIHRDLKPSNI 195
           L  VME +   + + ++    ++  +   L     YQ+   + ++HS  I HRDLKP N+
Sbjct: 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNL 201

Query: 196 VVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIM 253
           ++  +  TLK+ DFG A+          Y+ +R+YRAPE++LG   Y  ++D+WS+GCI+
Sbjct: 202 LIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCII 261

Query: 254 GEMIRGGVLFPGTDHIDQWNKII 276
            EMI G  +F G   +DQ  +II
Sbjct: 262 AEMILGYPIFSGQSSVDQLVRII 284

Length = 440

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 1e-26
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 22/197 (11%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR---PFQNVTHAKRAYREFKLMKLVNHKNIIGL 126
           +G GA        +  T   VAIK++S      + +   K   +E  L+K + H NI+  
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL---KSIMQEIDLLKNLKHPNIVKY 64

Query: 127 LNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSA 183
           + +     SL      Y+++E  +  +L Q+I+         ++  +YQ+L G+ +LH  
Sbjct: 65  IGSIETSDSL------YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           G+IHRD+K +NI+   D  +K+ DFG+A +    +      V T Y+ APEVI   G   
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178

Query: 243 NVDIWSVGCIMGEMIRG 259
             DIWS+GC + E++ G
Sbjct: 179 ASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (263), Expect = 1e-26
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 46/227 (20%)

Query: 75  HLGAGA------AYDTATQQNVAIKKLSRPF---QNVTHAKRAYREFK-LMKLVNHKNII 124
            +G G+      A +  T +  AIK L +     +     K    E + L +L  H  II
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK--KVKYVKIEKEVLTRLNGHPGII 65

Query: 125 GLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVIQM--DLDHERMSYLLYQMLCGIKHLH 181
            L   F  +++L      Y V+E   +  L Q I+    LD +   +   ++L  +++LH
Sbjct: 66  KLYYTFQDEENL------YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP------------------- 222
           S GIIHRDLKP NI++  D  +KI DFG A+                             
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 223 --YVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLFPG 265
             +V T  Y +PE++     G     D+W++GCI+ +M+ G   F G
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKS--SDLWALGCIIYQMLTGKPPFRG 224

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  105 bits (262), Expect = 2e-26
 Identities = 66/174 (37%), Positives = 96/174 (55%), Gaps = 12/174 (6%)

Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHE 164
           A RE  L+K + H NI+ L +    +++L       LV E +  +LCQ +      L  E
Sbjct: 50  AIREASLLKGLKHANIVLLHDIIHTKETLT------LVFEYVHTDLCQYMDKHPGGLHPE 103

Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TFMMTPY 223
            +   L+Q+L G+ ++H   I+HRDLKP N+++     LK+ DFGLAR     +   +  
Sbjct: 104 NVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163

Query: 224 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI-DQWNKI 275
           VVT +YR P+V+LG   Y   +D+W VGCI  EMI+G   FPG   I DQ  +I
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI 217

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  103 bits (260), Expect = 2e-26
 Identities = 51/164 (31%), Positives = 84/164 (51%), Gaps = 13/164 (7%)

Query: 109 YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY 168
           + E ++++  NH  I+ L   F  +K +    +  L  EL    L      D    R  +
Sbjct: 41  FSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTI-LRDRGLFDEYTAR--F 97

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----TFMMTPY 223
            +  ++   ++LH+ GII+RDLKP N+++ S+  +K++DFG A+   +     TF  TP 
Sbjct: 98  YIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157

Query: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
                Y APE+IL  GY  +VD WS+G ++ E++ G   F   D
Sbjct: 158 -----YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  103 bits (259), Expect = 4e-26
 Identities = 61/168 (36%), Positives = 91/168 (54%), Gaps = 19/168 (11%)

Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH---- 163
           A RE  L+K + H NI+ L +    ++ L       LV E +D++L Q     LD+    
Sbjct: 50  AIREVSLLKNLKHANIVTLHDIIHTERCLT------LVFEYLDSDLKQY----LDNCGNL 99

Query: 164 ---ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TFM 219
                +   ++Q+L G+ + H   I+HRDLKP N+++     LK+ DFGLAR     T  
Sbjct: 100 MSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159

Query: 220 MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGT 266
            +  VVT +YR P+V+LG   Y   +D+W VGCI+ EM  G  +FPG+
Sbjct: 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  102 bits (255), Expect = 1e-25
 Identities = 61/174 (35%), Positives = 92/174 (52%), Gaps = 12/174 (6%)

Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHE 164
           A RE  L+K + H NI+ L +    +++L        V E M  +L Q +      L   
Sbjct: 50  AIREASLLKGLKHANIVLLHDIIHTKETLT------FVFEYMHTDLAQYMIQHPGGLHPY 103

Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TFMMTPY 223
            +   ++Q+L G+ ++H   I+HRDLKP N+++     LK+ DFGLAR     +   +  
Sbjct: 104 NVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163

Query: 224 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI-DQWNKI 275
           VVT +YR P+V+LG   Y   +DIW  GCI  EM++G   FPG   + +Q  KI
Sbjct: 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI 217

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  101 bits (253), Expect = 2e-25
 Identities = 53/186 (28%), Positives = 97/186 (52%), Gaps = 21/186 (11%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
             + +  K++   + N+T  ++     E  +++ + H NI+   +    + +    Q +Y
Sbjct: 24  DGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN----QTLY 77

Query: 144 LVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLK 191
           +VME  +  +L Q+IQ        ++ E +  +L Q+L  +   H+       ++HRDLK
Sbjct: 78  IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLK 137

Query: 192 PSNIVVKSDCTLKILDFGLARTAGT-TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 250
           P+NI + ++  +K+ DFGLA+  G  +     YV T YY +PE +  M Y E  DIWS+G
Sbjct: 138 PANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLG 197

Query: 251 CIMGEM 256
           C++ E+
Sbjct: 198 CLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  102 bits (254), Expect = 5e-25
 Identities = 43/60 (71%), Positives = 51/60 (85%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL 60
           MLVIDP KRISVD+AL HPYINVW+D AEV AP P  YD  +DEREHT+++WKELIY+E+
Sbjct: 294 MLVIDPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEV 353

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.8 bits (249), Expect = 6e-25
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 85  ATQQNVAIKKLSRPFQNVTHAKR--AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           +  Q  A+K++     +++  +R  A  E +++  VNH NII    AF     L      
Sbjct: 23  SDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL------ 74

Query: 143 YLVMELMD-ANLCQVIQMDLDHERM-------SYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
            +VME     +L + I       ++          + Q+L G++ LH   I+HRDLK +N
Sbjct: 75  CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQALHEQKILHRDLKSAN 133

Query: 195 IVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
           I++ ++  +KI D G+++        T  + T +Y APEV  G  Y    DIWS+GC++ 
Sbjct: 134 ILLVANDLVKIGDLGISKVLKKNMAKT-QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLY 192

Query: 255 EMIRGGVLFPGTDHIDQWNKIIG 277
           EM      F      D   K+  
Sbjct: 193 EMATFAPPFEARSMQDLRYKVQR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 98.8 bits (247), Expect = 2e-24
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 23/198 (11%)

Query: 74  SHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLL 127
             LG G+           T +  A+KK+     +    K+  RE K ++      ++   
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESPYVVKCY 65

Query: 128 NAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLD-HERM-SYLLYQMLCGIKHLHS-A 183
            AF  ++      ++ +V+E MD  +L  +++      E + +Y+  Q+L G+ +LH+  
Sbjct: 66  GAF-YKEG-----EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP-YVVTRYYRAPEVILGMGYKE 242
            IIHRD+KPSN+++ S   +KI DFG+++    T      +V T  Y +PE I G  Y  
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179

Query: 243 NVDIWSVG-----CIMGE 255
             DIWS+G     C +G+
Sbjct: 180 AADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 97.4 bits (243), Expect = 5e-24
 Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 33/199 (16%)

Query: 80  AAYDTATQQNVAIKK--LSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE 137
           AA      + VAIK+  L +   +V   ++   E + M   NH N++    +F     L 
Sbjct: 19  AAICLPNNEKVAIKRIDLEKCQTSVDELRK---EVQAMSQCNHPNVVKYYTSFVVGDEL- 74

Query: 138 EFQDVYLVMELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 191
                +LVM  +       I      +  LD   ++ +L ++L G+++LHS G IHRD+K
Sbjct: 75  -----WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIK 129

Query: 192 PSNIVVKSDCTLKILDFGLA----------RTAGTTFMMTPYVVTRYYRAPEVI-LGMGY 240
             NI++  D ++KI DFG++          R    TF+ TP      + APEV+    GY
Sbjct: 130 AGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP-----CWMAPEVMEQVHGY 184

Query: 241 KENVDIWSVGCIMGEMIRG 259
               DIWS G    E+  G
Sbjct: 185 DFKADIWSFGITAIELATG 203

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.3 bits (243), Expect = 6e-24
 Identities = 55/181 (30%), Positives = 89/181 (49%), Gaps = 19/181 (10%)

Query: 86  TQQNVAIKKLS--RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
           T Q VAIK +      Q +       +E  ++K  +   I+    ++   K+     D++
Sbjct: 27  TGQVVAIKVVPVEEDLQEII------KEISILKQCDSPYIVKYYGSY--FKN----TDLW 74

Query: 144 LVMELMDAN----LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           +VME   A     + ++    L  E ++ +LYQ L G+++LHS   IHRD+K  NI++  
Sbjct: 75  IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE 134

Query: 200 DCTLKILDFGLARTAGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
           +   K+ DFG++     T      V+ T ++ APEVI  +GY    DIWS+G    EM  
Sbjct: 135 EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE 194

Query: 259 G 259
           G
Sbjct: 195 G 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 96.5 bits (241), Expect = 1e-23
 Identities = 58/189 (30%), Positives = 93/189 (49%), Gaps = 19/189 (10%)

Query: 84  TATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
            +T    AIK + +          +   E  ++       ++ L  +F  +K+L      
Sbjct: 15  KSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNL------ 68

Query: 143 YLVMELMD-ANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           YLVME +   +L  +++    LD +     + +++  +++LHS GIIHRDLKP NI++ S
Sbjct: 69  YLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS 128

Query: 200 DCTLKILDFGLART---------AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 250
           +  LK+ DFGL++                    V T  Y APEVILG G+ + VD WS+G
Sbjct: 129 NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLG 188

Query: 251 CIMGEMIRG 259
           CI+ E + G
Sbjct: 189 CILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.0 bits (239), Expect = 2e-23
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 44/221 (19%)

Query: 61  PISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPF-QNVTHAKRAYR--- 110
           P + + GK       LG GA       YD  T + +A+K++  PF  +    K+      
Sbjct: 1   PTNWRRGKL------LGQGAFGRVYLCYDVDTGRELAVKQV--PFDPDSPETKKEVNALE 52

Query: 111 -EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYL 169
            E +L+K + H+ I+           L + + + + ME M     +      D  +    
Sbjct: 53  CEIQLLKNLQHERIVQYYGC------LRDDETLSIFMEYMPGGSVK------DQLKAYGA 100

Query: 170 L---------YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM- 219
           L          Q+L G+++LHS  I+HRD+K +NI+  S   +K+ DFG ++   T    
Sbjct: 101 LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160

Query: 220 ---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
              M     T Y+ +PEVI G GY    D+WSVGC + EM+
Sbjct: 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEML 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 96.0 bits (239), Expect = 2e-23
 Identities = 61/180 (33%), Positives = 98/180 (54%), Gaps = 19/180 (10%)

Query: 88  QNVAIKKLSRPFQNVTHAKRA--YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           + VA+KK+ + F+ +    R    +E  L+K ++H N+I  L +F     L       +V
Sbjct: 28  RVVALKKV-QIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELN------IV 80

Query: 146 MELMDA-NLCQVI-----QMDLDHERMSY-LLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +EL DA +L ++I     Q  L  ER  +    Q+   ++H+HS  I+HRD+KP+N+ + 
Sbjct: 81  LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT 140

Query: 199 SDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           +   +K+ D GL R  ++ TT   +  V T YY +PE I   GY    DIWS+GC++ EM
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 95.6 bits (239), Expect = 3e-23
 Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 36/209 (17%)

Query: 75  HLGAGA----------AYDTATQQNVAIKKLSRPFQNVTHAKRA--YREFKLMKLVNHKN 122
            LG GA               T+  VA+K L    +  +  +R     E  +MK ++H N
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSHPN 62

Query: 123 IIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLL---YQMLCGIK 178
           I+ LL   T  + L      Y+V E M   +L   ++   +   +  LL    Q+  G++
Sbjct: 63  IVRLLGVCTQGEPL------YIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVT-------RYYRA 231
           +L S   +HRDL   N +V  +  +KI DFGL+R     +    Y          ++  A
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLSR---DIYEDDYYRKRGGGKLPIKWM-A 172

Query: 232 PEVILGMGYKENVDIWSVGCIMGEMIRGG 260
           PE +    +    D+WS G ++ E+   G
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLG 201

Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 95.5 bits (238), Expect = 3e-23
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 25/204 (12%)

Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHA--KRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE 137
            A +  T + +A+K++    Q+      K    E K+++L+ H N++           +E
Sbjct: 18  TAVNLDTGELMAVKEI--RIQDNDPKTIKEIADEMKVLELLKHPNLVKYY-------GVE 68

Query: 138 -EFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
              + VY+ ME         L +  ++  +H    Y L Q+L G+ +LHS GI+HRD+KP
Sbjct: 69  VHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTL-QLLEGLAYLHSHGIVHRDIKP 127

Query: 193 SNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYVV----TRYYRAPEVILGMGYKEN---V 244
           +NI +  +  +K+ DFG A +    T  M   V     T  Y APEVI G   K +    
Sbjct: 128 ANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAA 187

Query: 245 DIWSVGCIMGEMIRGGVLFPGTDH 268
           DIWS+GC++ EM  G   +   D+
Sbjct: 188 DIWSLGCVVLEMATGKRPWSELDN 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 96.6 bits (240), Expect = 5e-23
 Identities = 39/60 (65%), Positives = 49/60 (81%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL 60
           MLVIDP+KRISVD+AL HPYI VW+D AE  AP P  YD  ++EREH +++WKELIY+E+
Sbjct: 298 MLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEV 357

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 95.1 bits (237), Expect = 5e-23
 Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 19/205 (9%)

Query: 74  SHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLL 127
             LGAG            T + +A  K  R   N    K+  RE  ++   N   I+G  
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMA-VKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 128 NAFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA 183
            AF          D+ + ME MD      + + +Q  +    +  +   +L G+ +LH  
Sbjct: 66  GAFYNNG------DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 184 -GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
             IIHRD+KPSNI+V S   +K+ DFG++     +   T +V T  Y APE I G  Y  
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGNDYSV 178

Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTD 267
             DIWS+G  + E+  G   +P  +
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPEN 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 95.2 bits (237), Expect = 1e-22
 Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 16/193 (8%)

Query: 86  TQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           T + VA+K++       +   +    E  ++     + ++ LL AF      ++ + +YL
Sbjct: 25  TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF------QDDEYLYL 78

Query: 145 VMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
            ME +        L  +  +  DH R  + + +M   +  LH  G IHRDLKP N ++ +
Sbjct: 79  AMEYVPGGDFRTLLNNLGVLSEDHAR--FYMAEMFEAVDALHELGYIHRDLKPENFLIDA 136

Query: 200 DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
              +K+ DFGL+   G        V +  Y APEV+ G GY   VD WS+GC++ E + G
Sbjct: 137 SGHIKLTDFGLS--KGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Query: 260 GVLFPGTDHIDQW 272
              F G+   + W
Sbjct: 195 FPPFSGSTPNETW 207

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 94.8 bits (235), Expect = 2e-22
 Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 33/207 (15%)

Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ--------- 158
           A RE  L++ + H N+I L   F         + V+L+ +  + +L  +I+         
Sbjct: 45  ACREIALLRELKHPNVIALQKVFLSHSD----RKVWLLFDYAEHDLWHIIKFHRASKANK 100

Query: 159 --MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLAR 212
             M L    +  LLYQ+L GI +LH+  ++HRDLKP+NI+V  +      +KI D G AR
Sbjct: 101 KPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160

Query: 213 TAGTTFM----MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLF---- 263
              +       + P VVT +YRAPE++LG   Y + +DIW++GCI  E++    +F    
Sbjct: 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220

Query: 264 -----PGTDHIDQWNKIIGKMREAHDK 285
                    H DQ ++I   M    DK
Sbjct: 221 EDIKTSNPFHHDQLDRIFSVMGFPADK 247

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 93.4 bits (233), Expect = 2e-22
 Identities = 52/201 (25%), Positives = 81/201 (40%), Gaps = 41/201 (20%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+K L              +E ++MK + H N++ LL   T      E + +YLV+E M
Sbjct: 26  VAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVVRLLGVCT------EEEPLYLVLEYM 78

Query: 150 D---------ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVV 197
           +          +       +     +  LL    Q+  G+++L S   +HRDL   N +V
Sbjct: 79  EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV 138

Query: 198 KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVD 245
             D  +KI DFGL+R               YYR            APE +    +    D
Sbjct: 139 GEDLVVKISDFGLSRD---------VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSD 189

Query: 246 IWSVGCIMGEMI-RGGVLFPG 265
           +WS G ++ E+   G   +PG
Sbjct: 190 VWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 92.5 bits (230), Expect = 3e-22
 Identities = 51/178 (28%), Positives = 85/178 (47%), Gaps = 15/178 (8%)

Query: 91  AIKKLSRPFQNVT---HAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
           A+K++S      T     K+  +E  L+  + H NI+  L     + +L      Y+ +E
Sbjct: 29  AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNL------YIFLE 82

Query: 148 LMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
           L+     A L +          +     Q+L G+++LH    +HRD+K +NI+V ++  +
Sbjct: 83  LVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVV 141

Query: 204 KILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGG 260
           K+ DFG+A+          +  + Y+ APEVI   G Y    DIWS+GC + EM  G 
Sbjct: 142 KLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 91.6 bits (227), Expect = 8e-22
 Identities = 63/185 (34%), Positives = 100/185 (54%), Gaps = 27/185 (14%)

Query: 87  QQNVAIKKLSRPFQNVTHAKR--AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           ++ VA+KK+ + F+ +    R    +E  L+K +NH N+I  L++F     L       +
Sbjct: 27  RKPVALKKV-QIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN------I 79

Query: 145 VMELMDA-NLCQVI-----QMDLDHERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIVV 197
           V+EL DA +L Q+I     Q  L  ER  +  +  LC  ++H+HS  ++HRD+KP+N+ +
Sbjct: 80  VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI 139

Query: 198 KSDCTLKILDFGLAR------TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
            +   +K+ D GL R      TA  + + TP     YY +PE I   GY    DIWS+GC
Sbjct: 140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTP-----YYMSPERIHENGYNFKSDIWSLGC 194

Query: 252 IMGEM 256
           ++ EM
Sbjct: 195 LLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 92.8 bits (230), Expect = 1e-21
 Identities = 39/60 (65%), Positives = 48/60 (80%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL 60
           MLVID  KRISVD+AL HPYINVW+D +E  AP P   D  +DEREHT+++WKELIY+E+
Sbjct: 301 MLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEV 360

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 91.8 bits (228), Expect = 1e-21
 Identities = 57/181 (31%), Positives = 91/181 (50%), Gaps = 12/181 (6%)

Query: 85  ATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
           AT +  A KKL +   +     + A  E K+++ V+ + I+ L  AF      E   D+ 
Sbjct: 16  ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF------ETKDDLC 69

Query: 144 LVMELMDA-----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           LVM LM+      ++  V +      R  +   Q++CG++HLH   I++RDLKP N+++ 
Sbjct: 70  LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD 129

Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
               ++I D GLA        +     T  Y APEV+ G  Y  +VD +++GC + EMI 
Sbjct: 130 DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA 189

Query: 259 G 259
           G
Sbjct: 190 G 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 90.6 bits (225), Expect = 2e-21
 Identities = 44/121 (36%), Positives = 69/121 (57%), Gaps = 6/121 (4%)

Query: 142 VYLVMELMDANLCQ-VIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +YLVME ++   C  +I+    L  +     + +++ G++ LH  GIIHRD+KP N+++ 
Sbjct: 72  LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131

Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
               LK+ DFGL+R          +V T  Y APE ILG+G  +  D WS+GC++ E + 
Sbjct: 132 QTGHLKLTDFGLSRNG---LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF 188

Query: 259 G 259
           G
Sbjct: 189 G 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 91.0 bits (226), Expect = 2e-21
 Identities = 54/186 (29%), Positives = 97/186 (52%), Gaps = 17/186 (9%)

Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHAKRA---YREFKLMKLVNHKNIIGLLNAFTPQKSL 136
            A D +T + VA+KK+     ++   +R    + E  +M+   H NI+ + +++     L
Sbjct: 37  IATDKSTGRQVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL 91

Query: 137 EEFQDVYLVMELMDANLCQ--VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
                 ++VME ++       V    ++ E+++ +   +L  +  LH+ G+IHRD+K  +
Sbjct: 92  ------WVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145

Query: 195 IVVKSDCTLKILDFGL-ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
           I++ SD  +K+ DFG  A+ +         V T Y+ APEVI  + Y   VDIWS+G ++
Sbjct: 146 ILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 205

Query: 254 GEMIRG 259
            EM+ G
Sbjct: 206 IEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 90.3 bits (224), Expect = 2e-21
 Identities = 58/180 (32%), Positives = 95/180 (52%), Gaps = 16/180 (8%)

Query: 85  ATQQNVAIKKLSRPFQNVTHAKR--AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           A Q+ V IK++  P + +T  +R  A  E +++KL++H NII     F   K+L      
Sbjct: 23  ADQKLVIIKQI--PVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL------ 74

Query: 143 YLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
            +VME      L + IQ      LD + + +   Q+L  + H+H+  I+HRDLK  NI++
Sbjct: 75  MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL 134

Query: 198 -KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
            K    +KI DFG+++   +       V T  Y +PE+  G  Y +  DIW++GC++ E+
Sbjct: 135 DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 90.9 bits (225), Expect = 3e-21
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 33/207 (15%)

Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ--------- 158
           A RE  L++ + H N+I L   F         + V+L+ +  + +L  +I+         
Sbjct: 45  ACREIALLRELKHPNVISLQKVFLSHAD----RKVWLLFDYAEHDLWHIIKFHRASKANK 100

Query: 159 --MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLAR 212
             + L    +  LLYQ+L GI +LH+  ++HRDLKP+NI+V  +      +KI D G AR
Sbjct: 101 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160

Query: 213 TAGTTFM----MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLF---- 263
              +       + P VVT +YRAPE++LG   Y + +DIW++GCI  E++    +F    
Sbjct: 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220

Query: 264 -----PGTDHIDQWNKIIGKMREAHDK 285
                    H DQ ++I   M    DK
Sbjct: 221 EDIKTSNPYHHDQLDRIFNVMGFPADK 247

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 90.0 bits (223), Expect = 4e-21
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 14/209 (6%)

Query: 86  TQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           T +  A KKL +   +  +  K A  E ++++ VN   I+ L  AF  +  L       L
Sbjct: 17  TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHL------CL 70

Query: 145 VMELMDA-----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           VM LM+      ++  V +  L+ ER+ +   Q+ CGI HLHS  I++RD+KP N+++  
Sbjct: 71  VMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD 130

Query: 200 DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
               ++ D GLA        +T    T  Y APE++    Y   VD +++GC + EM+ G
Sbjct: 131 QGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190

Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
               P  DH ++  K   K R   D++ +
Sbjct: 191 RT--PFKDHKEKVAKEELKRRTLEDEVKF 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 89.3 bits (222), Expect = 6e-21
 Identities = 47/161 (29%), Positives = 86/161 (53%), Gaps = 13/161 (8%)

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-----NLCQVIQMDLDHE 164
            E ++++ +NH  ++ L  +F      ++ +++YLV++L+       +L Q  ++    E
Sbjct: 49  NERRILQELNHPFLVNLWYSF------QDEENMYLVVDLLLGGDLRYHLSQ--KVKFSEE 100

Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           ++ + + +++  +++LHS GIIHRD+KP NI++     + I DF +A       + T   
Sbjct: 101 QVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160

Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
            T  Y APEV+   GY   VD WS+G    E +RG   + G
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 6e-21
 Identities = 51/177 (28%), Positives = 75/177 (42%), Gaps = 42/177 (23%)

Query: 139 FQD---VYLVME------LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
           FQD   +YLVME      LM+  L +      +  R  + + +++  +  +H  G IHRD
Sbjct: 70  FQDEEHLYLVMEYMPGGDLMNL-LIRKDVFPEETAR--FYIAELVLALDSVHKLGFIHRD 126

Query: 190 LKPSNIVVKSDCTLKILDFGLA--------------RTAGTTFMMTPYVVTRY------- 228
           +KP NI++ +D  +K+ DFGL                +    F     V  R        
Sbjct: 127 IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVR 186

Query: 229 ---------YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
                    Y APEV+ G  Y    D WS+G I+ EM+ G   F      + +NKII
Sbjct: 187 ANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKII 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 89.1 bits (222), Expect = 1e-20
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 31/209 (14%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRA---YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           + +  A+K LS     +   K+      E ++++ + H  ++ L  +F    +L      
Sbjct: 25  SGKYYALKILS--KAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNL------ 76

Query: 143 YLVMEL-----MDANLCQVIQMDLDHERMSYLLY--QMLCGIKHLHSAGIIHRDLKPSNI 195
           YLVME      + ++L +  +      R     Y  Q++  +++LHS  I++RDLKP N+
Sbjct: 77  YLVMEYVPGGELFSHLRKSGRFPEPVAR----FYAAQVVLALEYLHSLDIVYRDLKPENL 132

Query: 196 VVKSDCTLKILDFGLA-RTAGTTFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
           ++ SD  +KI DFG A R  G T+ +  TP      Y APE+IL  GY + VD W++G +
Sbjct: 133 LLDSDGYIKITDFGFAKRVKGRTYTLCGTP-----EYLAPEIILSKGYGKAVDWWALGIL 187

Query: 253 MGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
           + EM+ G   F   + I  + KI+ GK+R
Sbjct: 188 IYEMLAGYPPFFDDNPIQIYEKILEGKVR 216

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 87.9 bits (218), Expect = 2e-20
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 34/208 (16%)

Query: 75  HLGAGA-------AYDTATQQNVAIKKLSRPFQNVTHAKRAYR----------EFKLMK- 116
           HLG+GA             Q  +A+K+++    N    K              E  ++K 
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEIN--VHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 117 LVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVI------QMDLDHERMSYL 169
            + H NI+     F       E   +Y+VM+L++ A L +        +     ER+  +
Sbjct: 65  QLRHPNIVRYYKTFL------ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118

Query: 170 LYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             QM+  +++LH    I+HRDL P+NI++  D  + I DFGLA+       +T  V T  
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 229 YRAPEVILGMGYKENVDIWSVGCIMGEM 256
           Y  PE++    Y E  D+W+ GCI+ +M
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 86.8 bits (215), Expect = 9e-20
 Identities = 59/183 (32%), Positives = 91/183 (49%), Gaps = 22/183 (12%)

Query: 81  AYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           A D  T + VAIKK+S    Q+    +   +E + ++ + H N I     +     L E 
Sbjct: 34  ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY-----LRE- 87

Query: 140 QDVYLVMELM---DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
              +LVME      +++ +V +  L    ++ + +  L G+ +LHS   IHRD+K  NI+
Sbjct: 88  HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNIL 147

Query: 197 VKSDCTLKILDFGLARTA--GTTFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVG- 250
           +    T+K+ DFG A       +F+ TP     Y+ APEVIL M    Y   VD+WS+G 
Sbjct: 148 LTEPGTVKLADFGSASLVSPANSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGI 202

Query: 251 -CI 252
            CI
Sbjct: 203 TCI 205

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 86.3 bits (214), Expect = 1e-19
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 19/204 (9%)

Query: 74  SHLGAGAA------YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLL 127
           S LG GA           T    A+K ++    N    K+  RE ++ K      I+   
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTD-PNPDLQKQILRELEINKSCKSPYIVKYY 65

Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH------ER-MSYLLYQMLCGIKHL 180
            AF  + S      + + ME  +      I   +        E+ +  +   +L G+ +L
Sbjct: 66  GAFLDESSSS----IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           HS  IIHRD+KPSNI++     +K+ DFG++     +   T +  T +Y APE I G  Y
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPERIQGKPY 180

Query: 241 KENVDIWSVGCIMGEMIRGGVLFP 264
               D+WS+G  + E+ +    FP
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFP 204

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 85.5 bits (211), Expect = 1e-19
 Identities = 54/160 (33%), Positives = 85/160 (53%), Gaps = 24/160 (15%)

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVI-----QMDLDH 163
           +E  L+K +NH N+I    +F     L       +V+EL DA +L ++I     Q  L  
Sbjct: 51  KEIDLLKQLNHPNVIKYYASFIEDNELN------IVLELADAGDLSRMIKHFKKQKRLIP 104

Query: 164 ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGT 216
           E+  +  +  LC  ++H+HS  ++HRD+KP+N+ + +   +K+ D GL R      TA  
Sbjct: 105 EKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164

Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           + + TP     YY +PE I   GY    DIWS+GC++ EM
Sbjct: 165 SLVGTP-----YYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 86.0 bits (213), Expect = 2e-19
 Identities = 48/135 (35%), Positives = 73/135 (54%), Gaps = 14/135 (10%)

Query: 142 VYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           ++ VME ++  +L   IQ     D  R  +   +++CG++ LH  GII+RDLK  N+++ 
Sbjct: 71  LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD 130

Query: 199 SDCTLKILDFGLART------AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
            D  +KI DFG+ +         +TF  TP      Y APE++ G  Y E+VD WS G +
Sbjct: 131 KDGHIKIADFGMCKENMNGEGKASTFCGTP-----DYIAPEILKGQKYNESVDWWSFGVL 185

Query: 253 MGEMIRGGVLFPGTD 267
           + EM+ G   F G D
Sbjct: 186 LYEMLIGQSPFHGED 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 84.8 bits (210), Expect = 3e-19
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 28/164 (17%)

Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSY 168
           E + +K ++H NI+  L   T ++ L  F +      +   ++   ++     + + + +
Sbjct: 58  EIETLKDLDHLNIVQYLGFETTEEYLSIFLEY-----VPGGSIGSCLRTYGRFEEQLVRF 112

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-------------G 215
              Q+L G+ +LHS GI+HRDLK  N++V +D   KI DFG+++ +             G
Sbjct: 113 FTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172

Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           + F M P V+  Y +        GY   VDIWS+GC++ EM  G
Sbjct: 173 SVFWMAPEVIHSYSQ--------GYSAKVDIWSLGCVVLEMFAG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 84.6 bits (209), Expect = 3e-19
 Identities = 56/180 (31%), Positives = 89/180 (49%), Gaps = 19/180 (10%)

Query: 86  TQQNVAIKKLSRP--FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
           + Q  A+K++  P     V  +++   E  L+  + H NI+    +F     L      Y
Sbjct: 24  SDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAFKESFEADGHL------Y 74

Query: 144 LVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +VME  D  +L Q I++        + +     QM  G++H+H   ++HRD+K  NI + 
Sbjct: 75  IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT 134

Query: 199 SDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
            +  +K+ DFG AR  T+   +  T YV T YY  PE+   M Y    DIWS+GCI+ E+
Sbjct: 135 QNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 84.9 bits (210), Expect = 5e-19
 Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 10/190 (5%)

Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME-LM 149
           A+K L +    V    R   E  ++  VNH  I+ L  AF  +  L      YL+++ L 
Sbjct: 28  AMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKL------YLILDFLR 81

Query: 150 DANLCQVIQMDL--DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
             +L   +  ++    E + + L ++   + HLHS GII+RDLKP NI++  +  +K+ D
Sbjct: 82  GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTD 141

Query: 208 FGLARTAGTTFMMT-PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT 266
           FGL++ +         +  T  Y APEV+   G+ ++ D WS G +M EM+ G + F G 
Sbjct: 142 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201

Query: 267 DHIDQWNKII 276
           D  +    I+
Sbjct: 202 DRKETMTMIL 211

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 84.6 bits (209), Expect = 5e-19
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           KK      +G GA      A D AT Q VAIK+++   Q     +    E  +M+   H 
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKHP 76

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVME-LMDANLCQVI-QMDLDHERMSYLLYQMLCGIKH 179
           NI+  L+++     L      ++VME L   +L  V+ +  +D  +++ +  + L  ++ 
Sbjct: 77  NIVNYLDSYLVGDEL------WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEF 130

Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVVTRYYRAPEVILGM 238
           LHS  +IHRD+K  NI++  D ++K+ DFG  A+        +  V T Y+ APEV+   
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190

Query: 239 GYKENVDIWSVGCIMGEMIRG 259
            Y   VDIWS+G +  EM+ G
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.1 bits (208), Expect = 5e-19
 Identities = 57/184 (30%), Positives = 92/184 (50%), Gaps = 6/184 (3%)

Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           AA D +TQ  +AIK++  P ++  + +  + E  L   + H+NI+  L + +     + F
Sbjct: 26  AARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83

Query: 140 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
            +      L      +   +  + + + +   Q+L G+K+LH   I+HRD+K  N++V +
Sbjct: 84  MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT 143

Query: 200 -DCTLKILDFGLA-RTAGTTFMMTPYVVTRYYRAPEVI-LGM-GYKENVDIWSVGCIMGE 255
               +KI DFG + R AG       +  T  Y APEVI  G  GY    DIWS+GC + E
Sbjct: 144 YSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVE 203

Query: 256 MIRG 259
           M  G
Sbjct: 204 MATG 207

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.8 bits (207), Expect = 6e-19
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 25/208 (12%)

Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR----EFKLMKLVNHK 121
           +GK  + T + G      T   Q +A+K++     NV  A++ Y     E  L+K + H 
Sbjct: 8   LGKGAYGTVYCGL-----TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSYLLY--QMLCGIK 178
           NI+  L       ++  F      ME +   ++  ++          +  Y  Q+L G+ 
Sbjct: 63  NIVQYLGTCLDDNTISIF------MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA 116

Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGT-TFMMTPYVVTRYYRA 231
           +LH+  ++HRD+K +N+++  +  +K++DFG AR        GT + M+     T Y+ A
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 232 PEVILGMGYKENVDIWSVGCIMGEMIRG 259
           PEVI   GY    DIWS+GC + EM  G
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATG 204

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.9 bits (207), Expect = 6e-19
 Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 13/183 (7%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A   +  ++  IK++      V   + + +E  L+  + H NI+          S +E  
Sbjct: 19  AKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA------SFQENG 72

Query: 141 DVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
            +++VME  D  +L + I          +++     Q+  G+KH+H   I+HRD+K  NI
Sbjct: 73  RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNI 132

Query: 196 VVKSDCTL-KILDFGLARTAGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIM 253
            +  +  + K+ DFG+AR    +  +    V T YY +PE+     Y    DIWS+GC++
Sbjct: 133 FLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVL 192

Query: 254 GEM 256
            E+
Sbjct: 193 YEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.0 bits (206), Expect = 1e-18
 Identities = 40/125 (32%), Positives = 71/125 (56%), Gaps = 13/125 (10%)

Query: 143 YLVMELMDANLC-QVIQMDLDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           +++ME      C  +++     E  ++++L ++L G+++LH  G IHRD+K +NI++  +
Sbjct: 75  WIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE 134

Query: 201 CTLKILDFGLA------RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
             +K+ DFG++       +   TF+ TP     ++ APEVI   GY E  DIWS+G    
Sbjct: 135 GDVKLADFGVSGQLTSTMSKRNTFVGTP-----FWMAPEVIKQSGYDEKADIWSLGITAI 189

Query: 255 EMIRG 259
           E+ +G
Sbjct: 190 ELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 2e-18
 Identities = 62/198 (31%), Positives = 89/198 (44%), Gaps = 25/198 (12%)

Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
            A    T Q VAIK +          K  Y    L K  NH NI     AF  +      
Sbjct: 24  KARHKKTGQLVAIKIMDIIEDEEEEIKEEYN--ILRKYSNHPNIATFYGAFIKKNPPGND 81

Query: 140 QDVYLVMELMDA----NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             ++LVMEL       +L + ++     L  E ++Y+L + L G+ +LH   +IHRD+K 
Sbjct: 82  DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKG 141

Query: 193 SNIVVKSDCTLKILDFG----LARTAG--TTFMMTPYVVTRYYRAPEVILGM-----GYK 241
            NI++  +  +K++DFG    L  T G   TF+ TP     Y+ APEVI         Y 
Sbjct: 142 QNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTP-----YWMAPEVIACDEQPDASYD 196

Query: 242 ENVDIWSVGCIMGEMIRG 259
              D+WS+G    E+  G
Sbjct: 197 ARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 82.6 bits (204), Expect = 2e-18
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 12/155 (7%)

Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD----LD 162
           + +E  ++  + H NI+        Q+S EE  ++Y+VM+  +  +L + I         
Sbjct: 46  SRKEVAVLSNMKHPNIV------QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFP 99

Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP 222
            +++     Q+   +KH+H   I+HRD+K  NI +  D T+K+ DFG+AR   +T  +  
Sbjct: 100 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159

Query: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
             + T YY +PE+     Y    DIW++GC++ EM
Sbjct: 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 82.4 bits (203), Expect = 3e-18
 Identities = 53/182 (29%), Positives = 97/182 (53%), Gaps = 11/182 (6%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +     +  + E  +M+  +H+N++ + N++     L    
Sbjct: 41  ATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL---- 94

Query: 141 DVYLVMELMDANLCQ--VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
             ++VME ++       V    ++ E+++ +   +L  + +LH+ G+IHRD+K  +I++ 
Sbjct: 95  --WVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 152

Query: 199 SDCTLKILDFGL-ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
           SD  +K+ DFG  A+ +         V T Y+ APEVI  + Y   VDIWS+G ++ EMI
Sbjct: 153 SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212

Query: 258 RG 259
            G
Sbjct: 213 DG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 81.6 bits (201), Expect = 6e-18
 Identities = 52/187 (27%), Positives = 90/187 (48%), Gaps = 12/187 (6%)

Query: 85  ATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
           AT +  A K+L +   +       A  E ++++ VN + ++ L  A+  + +L       
Sbjct: 23  ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL------C 76

Query: 144 LVMELMDA-----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           LV+ +M+      ++  +     + ER  +   ++LCG++ LH    ++RDLKP NI++ 
Sbjct: 77  LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD 136

Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
               ++I D GLA        +   V T  Y APEV+    Y  + D W +GC++ EMI 
Sbjct: 137 DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE 196

Query: 259 GGVLFPG 265
           G   F G
Sbjct: 197 GQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 81.7 bits (201), Expect = 6e-18
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           KK      +G GA      A D AT Q VAI++++   Q     +    E  +M+   + 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVME-LMDANLCQVI-QMDLDHERMSYLLYQMLCGIKH 179
           NI+  L+++     L      ++VME L   +L  V+ +  +D  +++ +  + L  ++ 
Sbjct: 78  NIVNYLDSYLVGDEL------WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEF 131

Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVVTRYYRAPEVILGM 238
           LHS  +IHRD+K  NI++  D ++K+ DFG  A+        +  V T Y+ APEV+   
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191

Query: 239 GYKENVDIWSVGCIMGEMIRG 259
            Y   VDIWS+G +  EMI G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.0 bits (200), Expect = 7e-18
 Identities = 40/116 (34%), Positives = 61/116 (52%), Gaps = 7/116 (6%)

Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTR---- 227
           Q+L G+ +LH+ GIIHRD+K +NI+V +   +KI DFG+++      + T     R    
Sbjct: 114 QILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173

Query: 228 ---YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR 280
              ++ APEV+    Y    DIWS+GC++ EM+ G   FP    +    KI     
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 81.6 bits (201), Expect = 8e-18
 Identities = 52/147 (35%), Positives = 82/147 (55%), Gaps = 18/147 (12%)

Query: 140 QDVYLVMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           ++++ VME ++  +L   IQ     D  R ++   +++CG++ LHS GI++RDLK  NI+
Sbjct: 69  ENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL 128

Query: 197 VKSDCTLKILDFGL--------ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 248
           + +D  +KI DFG+        A+T   TF  TP      Y APE++LG  Y  +VD WS
Sbjct: 129 LDTDGHIKIADFGMCKENMLGDAKT--CTFCGTP-----DYIAPEILLGQKYNTSVDWWS 181

Query: 249 VGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            G ++ EM+ G   F G D  + +  I
Sbjct: 182 FGVLLYEMLIGQSPFHGHDEEELFQSI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 81.3 bits (200), Expect = 8e-18
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           KK      +G GA      A D AT Q VAIK+++   Q     +    E  +M+   + 
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNP 76

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVME-LMDANLCQVI-QMDLDHERMSYLLYQMLCGIKH 179
           NI+  L+++     L      ++VME L   +L  V+ +  +D  +++ +  + L  +  
Sbjct: 77  NIVNYLDSYLVGDEL------WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDF 130

Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVVTRYYRAPEVILGM 238
           LHS  +IHRD+K  NI++  D ++K+ DFG  A+        +  V T Y+ APEV+   
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190

Query: 239 GYKENVDIWSVGCIMGEMIRG 259
            Y   VDIWS+G +  EM+ G
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 80.4 bits (198), Expect = 2e-17
 Identities = 48/135 (35%), Positives = 75/135 (55%), Gaps = 14/135 (10%)

Query: 142 VYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           ++ VME ++  +L   IQ     D  R ++   +++CG++ LHS GII+RDLK  N+++ 
Sbjct: 71  LFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD 130

Query: 199 SDCTLKILDFGLAR------TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
            D  +KI DFG+ +         +TF  TP      Y APE++ G+ Y  +VD WS G +
Sbjct: 131 RDGHIKIADFGMCKENVFGDNRASTFCGTP-----DYIAPEILQGLKYTFSVDWWSFGVL 185

Query: 253 MGEMIRGGVLFPGTD 267
           + EM+ G   F G D
Sbjct: 186 LYEMLIGQSPFHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 79.5 bits (196), Expect = 2e-17
 Identities = 44/178 (24%), Positives = 86/178 (48%), Gaps = 17/178 (9%)

Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
           + + + K++R  +       A  E +++  ++   II    +F       +   + +VME
Sbjct: 31  KQIDLSKMNRRERE-----EAIDEARVLAKLDSSYIIRYYESFL------DKGKLNIVME 79

Query: 148 LM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
              + +L ++++M     L  +++     Q+L G+ HLHS  I+HRD+K  N+ + +   
Sbjct: 80  YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN 139

Query: 203 LKILDFGLARTAGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           +KI D G+A+           +V T YY +PE+     Y E  D+W++G ++ E   G
Sbjct: 140 VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 79.9 bits (197), Expect = 2e-17
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 12/207 (5%)

Query: 85  ATQQNVAIKKLSRPFQNVTHAKR-AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
           AT +  A KKL +        +  A  E ++++ VN + ++ L  A+  + +L       
Sbjct: 23  ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL------C 76

Query: 144 LVMELMDA-----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           LV+ LM+      ++  +     D ER  +   ++ CG++ LH   I++RDLKP NI++ 
Sbjct: 77  LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD 136

Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
               ++I D GLA        +   V T  Y APEV+    Y  + D W +GC++ EMI 
Sbjct: 137 DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE 196

Query: 259 GGVLFPGTDHIDQWNKIIGKMREAHDK 285
           G   F       +  ++  +++E  ++
Sbjct: 197 GKSPFRQRKEKVKREEVERRVKEDQEE 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.8 bits (196), Expect = 2e-17
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 17/201 (8%)

Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           KK      +G GA      A D AT Q VAIK+++   Q     +    E  +MK + + 
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNP 76

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVME-LMDANLCQVI-QMDLDHERMSYLLYQMLCGIKH 179
           NI+  L++F     L      ++VME L   +L  V+ +  +D  +++ +  + L  ++ 
Sbjct: 77  NIVNFLDSFLVGDEL------FVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEF 130

Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVVTRYYRAPEVILGM 238
           LH+  +IHRD+K  N+++  D ++K+ DFG  A+        +  V T Y+ APEV+   
Sbjct: 131 LHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190

Query: 239 GYKENVDIWSVGCIMGEMIRG 259
            Y   VDIWS+G +  EM+ G
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 4e-17
 Identities = 50/152 (32%), Positives = 79/152 (51%), Gaps = 26/152 (17%)

Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH----ERMSYLLYQMLC 175
           H NI+GL  A+  +  L      ++++E  D      I ++L+      ++ Y+  QML 
Sbjct: 61  HPNIVGLYEAYFYENKL------WILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114

Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGT-----TFMMTPYVVTRYY 229
            +  LHS  +IHRDLK  NI++  D  +K+ DFG+ A+   T     TF+ TP     Y+
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTP-----YW 169

Query: 230 RAPEVILGMGYKEN-----VDIWSVGCIMGEM 256
            APEV+    +K+N      DIWS+G  + E+
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 78.2 bits (193), Expect = 6e-17
 Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 23/187 (12%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VAIK L     ++   +   +E + +K + HK++I L    +        + VY++ ELM
Sbjct: 33  VAIKILKS--DDLLKQQDFQKEVQALKRLRHKHLISLFAVCS------VGEPVYIITELM 84

Query: 150 DANLCQVIQMDLDHE--RMSYLLY---QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204
           +           + +   ++ L+    Q+  G+ +L     IHRDL   NI+V  D   K
Sbjct: 85  EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCK 144

Query: 205 ILDFGLARTAGTTFMMT-----PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-R 258
           + DFGLAR       ++     PY  T    APE      +    D+WS G ++ EM   
Sbjct: 145 VADFGLARLIKEDVYLSSDKKIPYKWT----APEAASHGTFSTKSDVWSFGILLYEMFTY 200

Query: 259 GGVLFPG 265
           G V +PG
Sbjct: 201 GQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 78.7 bits (194), Expect = 9e-17
 Identities = 53/177 (29%), Positives = 92/177 (51%), Gaps = 17/177 (9%)

Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERM---- 166
           E  +++ V H  I+ L+ AF     L      YL++E +       + M L+ E +    
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGKL------YLILEYLSGG---ELFMHLEREGIFMED 100

Query: 167 --SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMT-PY 223
              + L ++   ++HLH  GII+RDLKP NI++ +   +K+ DFGL + +     +T  +
Sbjct: 101 TACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160

Query: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKM 279
             T  Y APE+++  G+ + VD WS+G +M +M+ G   F   +     +KI+ GK+
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL 217

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 78.3 bits (193), Expect = 9e-17
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 37/214 (17%)

Query: 79  GAAY---DTATQQNVAIKKLSRPFQNVTH---AKRAYREFKLMKLVNHKNIIGLLNAFTP 132
           GA Y      T+Q  A+KK+++  QN+      ++ + E  ++    +  ++ +  +F  
Sbjct: 15  GAVYLVRHKETRQRFAMKKINK--QNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET 72

Query: 133 QKSLEEFQDVYLVMELMDANLCQVI-----QMDLDHERMSYLLYQMLCGIKHLHSAGIIH 187
           ++ L       +VME ++   C  +      + +D  RM +   + +  +++LH+ GI+H
Sbjct: 73  KRHL------CMVMEYVEGGDCATLLKNIGALPVDMARMYFA--ETVLALEYLHNYGIVH 124

Query: 188 RDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVV-------------TRYYRA 231
           RDLKP N+++ S   +K+ DFGL++    + TT +   ++              T  Y A
Sbjct: 125 RDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIA 184

Query: 232 PEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
           PEVIL  GY + VD W++G I+ E + G V F G
Sbjct: 185 PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 77.4 bits (190), Expect = 2e-16
 Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 12/181 (6%)

Query: 85  ATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
           AT +  A KKL +   +       A  E ++++ VN + ++ L  A+  + +L       
Sbjct: 23  ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL------C 76

Query: 144 LVMELMDA-----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           LV+ LM+      ++  + +   +  R  +   ++ CG++ LH   I++RDLKP NI++ 
Sbjct: 77  LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD 136

Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
               ++I D GLA        +   V T  Y APEV+    Y  + D W++GC++ EMI 
Sbjct: 137 DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 196

Query: 259 G 259
           G
Sbjct: 197 G 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 2e-16
 Identities = 38/100 (38%), Positives = 59/100 (59%), Gaps = 12/100 (12%)

Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTTFMM 220
           S ++ ++L  +K++H  G+IHRD+K +NI+V +   +K+ DFG+A       +  +TF+ 
Sbjct: 104 SVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVG 163

Query: 221 TPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRG 259
           TP     Y+ APEVI  G  Y    DIWS+G  + EM  G
Sbjct: 164 TP-----YWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 76.5 bits (188), Expect = 3e-16
 Identities = 38/88 (43%), Positives = 55/88 (62%), Gaps = 2/88 (2%)

Query: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPYVVTRY 228
             Q+L G+ ++H   I+HRDLK  NI +K++  LKI DFG++R   G+  + T +  T Y
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPY 170

Query: 229 YRAPEVILGMGYKENVDIWSVGCIMGEM 256
           Y +PE +   GY    DIWS+GCI+ EM
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 3e-16
 Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 41/198 (20%)

Query: 81  AYDTATQQNVAIK--KLS--RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL 136
           A D AT + VAIK  KL     F+ +       +E  ++K   H NI+    ++  +  L
Sbjct: 22  ARDIATGELVAIKVIKLEPGDDFEIIQ------QEISMLKECRHPNIVAYFGSYLRRDKL 75

Query: 137 EEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL 190
                 ++VME      L D  + QV +  L   +++Y+  + L G+ +LH  G IHRD+
Sbjct: 76  ------WIVMEYCGGGSLQD--IYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDI 127

Query: 191 KPSNIVVKSDCTLKILDFGLA----RTAG--TTFMMTPYVVTRYYRAPEVI---LGMGYK 241
           K +NI++  D  +K+ DFG++     T     +F+ TP     Y+ APEV       GY 
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP-----YWMAPEVAAVERKGGYD 182

Query: 242 ENVDIWSVG--CI-MGEM 256
              DIW++G   I + E+
Sbjct: 183 GKCDIWALGITAIELAEL 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 76.7 bits (188), Expect = 5e-16
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 21/207 (10%)

Query: 54  ELIYQELPISHQMGKKRHNTSHLGAGAAY---DTATQQNVAIKKLSRPFQNVTHA-KRAY 109
           EL ++E P   ++        H   GA Y   D  T + VAIKK+S   +      +   
Sbjct: 16  ELFFKEDP--EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII 73

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM---DANLCQVIQMDLDHERM 166
           +E K ++ + H N I     +  + +       +LVME      ++L +V +  L    +
Sbjct: 74  KEVKFLQRIKHPNSIEYKGCYLREHT------AWLVMEYCLGSASDLLEVHKKPLQEVEI 127

Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVT 226
           + + +  L G+ +LHS  +IHRD+K  NI++     +K+ DFG A  A        +V T
Sbjct: 128 AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---NSFVGT 184

Query: 227 RYYRAPEVILGMG---YKENVDIWSVG 250
            Y+ APEVIL M    Y   VD+WS+G
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLG 211

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 75.7 bits (186), Expect = 7e-16
 Identities = 55/189 (29%), Positives = 94/189 (49%), Gaps = 29/189 (15%)

Query: 85  ATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
           AT +  A KKL++   +     + A  E +++  V+ + I+ L  AF      +   D+ 
Sbjct: 16  ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF------QTKTDLC 69

Query: 144 LVMELMDANLCQVIQMDLDHE-------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           LVM +M+    +    ++D E       R  +   Q++ G++HLH   II+RDLKP N++
Sbjct: 70  LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVL 129

Query: 197 VKSDCTLKILDFGLA--------RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 248
           + +D  ++I D GLA        +T G       Y  T  + APE++ G  Y  +VD ++
Sbjct: 130 LDNDGNVRISDLGLAVELKDGQSKTKG-------YAGTPGFMAPELLQGEEYDFSVDYFA 182

Query: 249 VGCIMGEMI 257
           +G  + EMI
Sbjct: 183 LGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 75.3 bits (185), Expect = 7e-16
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 25/203 (12%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY----REFKLMKLVNHKNIIG 125
           LG GA      A D  T   +A+K+++      +  +       +E +LM  +NH +II 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYL---LYQMLCGIKHLHS 182
           +L A T + S        L +E M       +       + + +     Q+L G+ +LH 
Sbjct: 68  MLGA-TCEDS-----HFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121

Query: 183 AGIIHRDLKPSNIVVKSDCT-LKILDFGLA-----RTAGTTFMMTPYVVTRYYRAPEVIL 236
             IIHRD+K +N+++ S    L+I DFG A     +  G        + T  + APEV+ 
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 237 GMGYKENVDIWSVGCIMGEMIRG 259
           G  Y  + D+WSVGC++ EM   
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATA 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 75.7 bits (186), Expect = 7e-16
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 14/151 (9%)

Query: 135 SLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 191
           S +  + +YLV+  ++   L   +Q +   D  R  +   ++LC +++LH   +I+RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 192 PSNIVVKSDCTLKILDFGLAR------TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
           P NI++     + + DFGL +          TF  TP      Y APE++LG GY + VD
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP-----EYLAPELLLGHGYTKAVD 175

Query: 246 IWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            W++G ++ EM+ G   F   +  + + KI+
Sbjct: 176 WWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 75.4 bits (185), Expect = 7e-16
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 19/197 (9%)

Query: 79  GAAYDTATQQN--VAIKKLSRPFQNVTHAKRAYREFKLMK-LVNHKNIIGLLNAFTPQKS 135
           G  Y    +++  +A  K+  P  +V     A  E+ +++ L NH N++     F     
Sbjct: 36  GKVYKVTNKKDGSLAAVKILDPISDVDEEIEA--EYNILQSLPNHPNVVKFYGMFYKADK 93

Query: 136 LEEFQDVYLVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHR 188
           L   Q ++LV+EL +  ++ ++++        LD   +SY+LY  L G++HLH+  IIHR
Sbjct: 94  LVGGQ-LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHR 152

Query: 189 DLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVVTRYYRAPEVI-----LGMGYKE 242
           D+K +NI++ ++  +K++DFG+ A+   T       V T ++ APEVI         Y  
Sbjct: 153 DVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDA 212

Query: 243 NVDIWSVGCIMGEMIRG 259
             D+WS+G    E+  G
Sbjct: 213 RCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 75.8 bits (186), Expect = 9e-16
 Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 25/212 (11%)

Query: 54  ELIYQELPISHQMGKKRHNTSHLGAGAAY---DTATQQNVAIKKLSRPFQNVTHAK--RA 108
           +L Y++ P   ++    H   H   GA Y   ++ T + VA+KK+S   +  T+ K    
Sbjct: 12  DLFYKDDP--EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-TNEKWQDI 68

Query: 109 YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM---DANLCQVIQMDLDHER 165
            +E K ++ + H N I     +  + +       +LVME      ++L +V +  L    
Sbjct: 69  IKEVKFLQQLKHPNTIEYKGCYLKEHT------AWLVMEYCLGSASDLLEVHKKPLQEVE 122

Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
           ++ + +  L G+ +LHS  +IHRD+K  NI++     +K+ DFG A  +        +V 
Sbjct: 123 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---NSFVG 179

Query: 226 TRYYRAPEVILGMG---YKENVDIWSVG--CI 252
           T Y+ APEVIL M    Y   VD+WS+G  CI
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 211

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 14/146 (9%)

Query: 142 VYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           ++ VME ++  +L   IQ     D  R  +   +++ G++ LH  GII+RDLK  N+++ 
Sbjct: 71  LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD 130

Query: 199 SDCTLKILDFGLA------RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
           S+  +KI DFG+           +TF  TP      Y APE++    Y   VD W++G +
Sbjct: 131 SEGHIKIADFGMCKEGILGGVTTSTFCGTP-----DYIAPEILSYQPYGPAVDWWALGVL 185

Query: 253 MGEMIRGGVLFPGTDHIDQWNKIIGK 278
           + EM+ G   F G D  + +  I+  
Sbjct: 186 LYEMLAGQSPFEGDDEDELFQSILED 211

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.1 bits (184), Expect = 1e-15
 Identities = 48/173 (27%), Positives = 90/173 (52%), Gaps = 11/173 (6%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+KK+    +     +  + E  +M+   H+N++ + N++     L      ++VME +
Sbjct: 48  VAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL------WVVMEFL 99

Query: 150 DANLCQ--VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
           +       V    ++ E+++ +   +L  +  LH+ G+IHRD+K  +I++  D  +K+ D
Sbjct: 100 EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSD 159

Query: 208 FGL-ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           FG  A+ +         V T Y+ APE+I  + Y   VDIWS+G ++ EM+ G
Sbjct: 160 FGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 74.7 bits (183), Expect = 1e-15
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 26/201 (12%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYR---EFKLMKLVNHKNIIGL 126
           LG GA       YD  T + +A+K++    ++   +K       E +L+K + H+ I+  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 127 LNAF--TPQKSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHL 180
                   +++L  F      ME M     +  Q+     L          Q+L G+ +L
Sbjct: 70  YGCLRDPMERTLSIF------MEHMPGGSIK-DQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM----MTPYVVTRYYRAPEVIL 236
           HS  I+HRD+K +NI+  S   +K+ DFG ++   T  +    M     T Y+ +PEVI 
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 237 GMGYKENVDIWSVGCIMGEMI 257
           G GY    DIWSVGC + EM+
Sbjct: 183 GEGYGRKADIWSVGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 11/110 (10%)

Query: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTTFMMTPYVVTRY 228
             + +LHS  II+RDLKP NI++ S   + + DFGL +         +TF  TP      
Sbjct: 107 SALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP-----E 161

Query: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
           Y APEV+    Y   VD W +G ++ EM+ G   F   D  + ++ I+ K
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (183), Expect = 2e-15
 Identities = 49/152 (32%), Positives = 80/152 (52%), Gaps = 6/152 (3%)

Query: 135 SLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 191
           S +   D+YLV + M    L   +Q +     +R  + + +++  ++HLH   I++RDLK
Sbjct: 64  SFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLK 123

Query: 192 PSNIVVKSDCTLKILDFGLARTAGTTFMMT-PYVVTRYYRAPEVILG-MGYKENVDIWSV 249
           P NI++ +   + + DFGL++   T    T  +  T  Y APEV+L   GY ++VD WS+
Sbjct: 124 PENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL 183

Query: 250 GCIMGEMIRGGVLFPGTDHIDQWNKI-IGKMR 280
           G ++ EM  G   F   D    +  I  GK+R
Sbjct: 184 GVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR 215

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 74.1 bits (183), Expect = 3e-15
 Identities = 25/59 (42%), Positives = 34/59 (57%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           MLV DP+KRI+ D+AL HPY+    D  +     P       D+ E T ++ KELIY+E
Sbjct: 272 MLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTEEELKELIYEE 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 74.3 bits (183), Expect = 3e-15
 Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 17/145 (11%)

Query: 142 VYLVME-LMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           V  VME     +L   I  D     R  +    ++ G+++LH   I++RDLK  N+++ +
Sbjct: 77  VCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT 136

Query: 200 DCTLKILDFGLA--------RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
           +  +KI DFGL         RT+  TF  TP      + APEV+    Y   VD W +G 
Sbjct: 137 EGFVKIADFGLCKEGMGFGDRTS--TFCGTP-----EFLAPEVLTETSYTRAVDWWGLGV 189

Query: 252 IMGEMIRGGVLFPGTDHIDQWNKII 276
           ++ EM+ G   FPG D  + ++ I+
Sbjct: 190 LIYEMLVGESPFPGDDEEEVFDSIV 214

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 73.3 bits (180), Expect = 3e-15
 Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 28/164 (17%)

Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLC--QVIQMDLDHERMSY 168
           E K+M  ++H N++ L    T Q+ +      ++V E M AN C    ++         +
Sbjct: 49  EAKVMMKLSHPNLVQLYGVCTKQRPI------FIVTEYM-ANGCLLNYLRERKGKLGTEW 101

Query: 169 LL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGT 216
           LL     +   +++L S G IHRDL   N +V  D  +K+ DFGLAR         + GT
Sbjct: 102 LLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161

Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            F +        +  PEV     +    D+WS G +M E+   G
Sbjct: 162 KFPVK-------WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEG 198

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 73.9 bits (181), Expect = 3e-15
 Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 9/154 (5%)

Query: 109 YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ--VIQMDLDHERM 166
           + E  +M+   H+N++ +       KS    ++++++ME +        V Q  L+ E++
Sbjct: 66  FNEVVIMRDYQHQNVVEMY------KSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQI 119

Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVV 225
           + +   +L  + +LHS G+IHRD+K  +I++  D  +K+ DFG  A+ +         V 
Sbjct: 120 ATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179

Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           T Y+ APEVI    Y   VDIWS+G ++ EM+ G
Sbjct: 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.1 bits (179), Expect = 4e-15
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 34/217 (15%)

Query: 61  PISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPF----QNVTHAKRAYR 110
           P++ ++GK       LG GA       YD  T + +A+K++  PF    Q  +    A  
Sbjct: 1   PVNWRLGKL------LGRGAFGEVYLCYDADTGRELAVKQV--PFDPDSQETSKEVNALE 52

Query: 111 -EFKLMKLVNHKNII---GLLNAFTPQK--SLEEFQDVYLVMELMDANLCQVIQMDLDHE 164
            E +L+K + H  I+   G L     +K     E+     + + + A       +   + 
Sbjct: 53  CEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT 112

Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM----M 220
           R      Q+L G+ +LHS  I+HRD+K +NI+  S   +K+ DFG ++   T  M    +
Sbjct: 113 R------QILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166

Query: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
                T Y+ +PEVI G GY    D+WSV C + EM+
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 9e-15
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 47/220 (21%)

Query: 83  DTATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE 138
           D  ++   A+K ++ P     +   H      E +++K V+H  II L      Q+ L  
Sbjct: 22  DRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEVSHPFIIRLFWTEHDQRFL-- 76

Query: 139 FQDVYLVMELMDANLCQVIQMDLDHERMSYL------------LY--QMLCGIKHLHSAG 184
               Y++ME +              E  SYL             Y  +++C +++LHS  
Sbjct: 77  ----YMLMEYVPGG-----------ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE 121

Query: 185 IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           I++RDLKP NI++  +  +K+ DFG A   R    T   TP      Y APEVI   G+ 
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTP-----EYLAPEVIQSKGHN 176

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
           + VD W++G ++ EM+ G   F   +    + KI+ GK+ 
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE 216

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.9 bits (176), Expect = 1e-14
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 12/203 (5%)

Query: 85  ATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
           AT +  A KKL +   +       A  E ++++ VN + ++ L  A+  + +L       
Sbjct: 23  ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL------C 76

Query: 144 LVMELMDA-----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           LV+ +M+      ++  +     D +R  +   ++ CG++ L    I++RDLKP NI++ 
Sbjct: 77  LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD 136

Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
               ++I D GLA        +   V T  Y APEVI    Y  + D W +GC++ EMI+
Sbjct: 137 DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ 196

Query: 259 GGVLFPGTDHIDQWNKIIGKMRE 281
           G   F       +  ++  +++E
Sbjct: 197 GQSPFRKRKERVKREEVDRRVKE 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 71.6 bits (175), Expect = 2e-14
 Identities = 53/163 (32%), Positives = 82/163 (50%), Gaps = 21/163 (12%)

Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMD-LDHERMSY 168
           L K  +H+NI     AF  +        ++LVME   A    +L +  + + L  + ++Y
Sbjct: 66  LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TTFMMTP 222
           +  ++L G+ HLH+  +IHRD+K  N+++  +  +K++DFG    L RT G   TF+ TP
Sbjct: 126 ICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 185

Query: 223 YVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIRGG 260
                Y+ APEVI         Y    DIWS+G    EM  G 
Sbjct: 186 -----YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 17/202 (8%)

Query: 85  ATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           ++Q+  A+K LS+ F+ +  +  A+   E  +M   N   ++ L  AF   K L      
Sbjct: 66  SSQKVYAMKLLSK-FEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL------ 118

Query: 143 YLVMELM-DANLCQVI-QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           Y+VME M   +L  ++   D+  +   +   +++  +  +HS G+IHRD+KP N+++   
Sbjct: 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH 178

Query: 201 CTLKILDFGLARTAGTTFMM--TPYVVTRYYRAPEVILGMG----YKENVDIWSVGCIMG 254
             LK+ DFG       T M+     V T  Y +PEV+   G    Y    D WSVG  + 
Sbjct: 179 GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238

Query: 255 EMIRGGVLFPGTDHIDQWNKII 276
           EM+ G   F     +  ++KI+
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 71.3 bits (174), Expect = 2e-14
 Identities = 36/90 (40%), Positives = 54/90 (60%), Gaps = 4/90 (4%)

Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM----MTPYVVTR 227
           Q+L G+ +LHS  I+HRD+K +NI+  S   +K+ DFG ++   T  M    +     T 
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173

Query: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
           Y+ +PEVI G GY    D+WS+GC + EM+
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 71.6 bits (175), Expect = 2e-14
 Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 16/156 (10%)

Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD----HERM 166
           E +++   NH  I+ LL AF     L      ++++E         I ++LD      ++
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKL------WIMIEFCPGGAVDAIMLELDRGLTEPQI 112

Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVV 225
             +  QML  +++LHS  IIHRDLK  N+++  D  +K+ DFG+ A+   T      ++ 
Sbjct: 113 QVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIG 172

Query: 226 TRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEM 256
           T Y+ APEV++        Y    DIWS+G  + EM
Sbjct: 173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 71.3 bits (174), Expect = 2e-14
 Identities = 53/163 (32%), Positives = 81/163 (49%), Gaps = 21/163 (12%)

Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSY 168
           L K  +H+NI     AF  +        ++LVME   A ++  +I+      L  E ++Y
Sbjct: 56  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 115

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TTFMMTP 222
           +  ++L G+ HLH   +IHRD+K  N+++  +  +K++DFG    L RT G   TF+ TP
Sbjct: 116 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 175

Query: 223 YVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIRGG 260
                Y+ APEVI         Y    D+WS+G    EM  G 
Sbjct: 176 -----YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 213

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 25/210 (11%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFK----LMKLVNHKNIIGLLNAFTPQKSLEE 138
           + AT    A+K + +   +V  A+     F+    ++ + N   I  L  AF  + +L  
Sbjct: 22  EKATGDIYAMKVMKK---SVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL-- 76

Query: 139 FQDVYLVMELMDA----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
               YLVME        +L    +   D +   + L +++  I  +H  G +HRD+KP N
Sbjct: 77  ----YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPEN 132

Query: 195 IVVKSDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMG------YKENVDI 246
           +++     +K+ DFG A   TA         V T  Y APEV+  M       Y    D 
Sbjct: 133 VLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW 192

Query: 247 WSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           WS+G I  EMI G   F        +N I+
Sbjct: 193 WSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 58/195 (29%), Positives = 84/195 (43%), Gaps = 20/195 (10%)

Query: 86  TQQNVAIKKLSRPFQNVTHA-KRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           T   VAIK L        H   R  RE  L   + H NI+ LL++      L     ++ 
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-----LFA 56

Query: 145 VMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-KSD 200
           V E +    L +V+  D  L       L+ Q+L  +   H+ GI+HRDLKP NI+V ++ 
Sbjct: 57  VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116

Query: 201 CT--LKILDFGL--------ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 250
                K+LDFG+             T    T  + T  Y APE + G     N D+++ G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 251 CIMGEMIRGGVLFPG 265
            I  E + G  +  G
Sbjct: 177 LIFLECLTGQRVVQG 191

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 70.0 bits (171), Expect = 6e-14
 Identities = 52/177 (29%), Positives = 94/177 (53%), Gaps = 18/177 (10%)

Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLMK-LVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
              A+K L  P  ++     A  E+ ++K L +H N++     +  +K ++    ++LV+
Sbjct: 44  SKAAVKILD-PIHDIDEEIEA--EYNILKALSDHPNVVKFYGMYY-KKDVKNGDQLWLVL 99

Query: 147 ELMDA-NLCQVIQMDLDH-ERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           EL +  ++  +++  L   ERM      Y+L++ L G++HLH    IHRD+K +NI++ +
Sbjct: 100 ELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT 159

Query: 200 DCTLKILDFGL-ARTAGTTFMMTPYVVTRYYRAPEVI-----LGMGYKENVDIWSVG 250
           +  +K++DFG+ A+   T       V T ++ APEVI     L   Y    D+WS+G
Sbjct: 160 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLG 216

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 70.4 bits (172), Expect = 6e-14
 Identities = 54/173 (31%), Positives = 81/173 (46%), Gaps = 18/173 (10%)

Query: 111 EFKLMKLV-NHKNIIGLLNAFT---PQKSLEEFQDVYLVMELMDA----------NLCQV 156
           E ++MK++  HKNII LL A T   P   L E+     + E + A          + C++
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126

Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
            +  L  + +    YQ+  G+++L S   IHRDL   N++V  D  +KI DFGLAR    
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN 186

Query: 217 TFMMTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
                     R    + APE +    Y    D+WS G ++ E+   GG  +PG
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 69.7 bits (170), Expect = 7e-14
 Identities = 35/100 (35%), Positives = 58/100 (58%), Gaps = 1/100 (1%)

Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFM 219
           LD  +++ +L ++L G+ +LHS   IHRD+K +N+++     +K+ DFG+A +   T   
Sbjct: 98  LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157

Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
              +V T ++ APEVI    Y    DIWS+G    E+ +G
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.2 bits (172), Expect = 7e-14
 Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 15/156 (9%)

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM-----DLDH 163
           RE K++   N   I+G   AF          ++ + ME MD  +L QV++      +   
Sbjct: 48  RELKVLHECNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLKKAGRIPENIL 101

Query: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPY 223
            ++S  + + L  ++  H   I+HRD+KPSNI+V S   +K+ DFG++     + M   +
Sbjct: 102 GKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSF 158

Query: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           V TR Y +PE + G  Y    DIWS+G  + EM  G
Sbjct: 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 70.0 bits (171), Expect = 9e-14
 Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 20/174 (11%)

Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLL 170
           L+K V H  ++GL  +F   + L      Y V++ ++   L   +Q +      R  +  
Sbjct: 49  LLKNVKHPFLVGLHYSFQTTEKL------YFVLDFVNGGELFFHLQRERSFPEPRARFYA 102

Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTTFMMTPYV 224
            ++   + +LHS  I++RDLKP NI++ S   + + DFGL +         TTF  TP  
Sbjct: 103 AEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP-- 160

Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
               Y APEVI    Y   VD W +G ++ EM+ G   F   D  + ++ I+ K
Sbjct: 161 ---EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 69.7 bits (170), Expect = 9e-14
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 25/189 (13%)

Query: 75  HLGAGAAY---DTATQQNVAIKKLSRPFQNVTHA-KRAYREFKLMKLVNHKNIIGLLNAF 130
           H   GA Y   D    + VAIKK+S   +      +   +E + ++ + H N I     +
Sbjct: 25  HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 84

Query: 131 TPQKSLEEFQDVYLVMELM---DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIH 187
             + +       +LVME      ++L +V +  L    ++ + +  L G+ +LHS  +IH
Sbjct: 85  LREHT------AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138

Query: 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP---YVVTRYYRAPEVILGMG---YK 241
           RD+K  NI++     +K+ DFG A       +M P   +V T Y+ APEVIL M    Y 
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSAS------IMAPANXFVGTPYWMAPEVILAMDEGQYD 192

Query: 242 ENVDIWSVG 250
             VD+WS+G
Sbjct: 193 GKVDVWSLG 201

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 21/205 (10%)

Query: 84  TATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD 141
            +++Q  A+K LS+ F+ +  +  A+   E  +M   N + I+ L  AF   K L     
Sbjct: 65  KSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL----- 118

Query: 142 VYLVMELMDA----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
            Y+VME M      NL  +   D+  +   +   +++  +  +HS G IHRD+KP N+++
Sbjct: 119 -YMVMEYMPGGDLVNL--MSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175

Query: 198 KSDCTLKILDFGLARTAGTTFMM--TPYVVTRYYRAPEVILGMG----YKENVDIWSVGC 251
                LK+ DFG         M+     V T  Y +PEV+   G    Y    D WSVG 
Sbjct: 176 DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235

Query: 252 IMGEMIRGGVLFPGTDHIDQWNKII 276
            + EM+ G   F     +  ++KI+
Sbjct: 236 FLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 38/107 (35%), Positives = 58/107 (54%), Gaps = 11/107 (10%)

Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTTFMMTPYVVTRYY 229
           G+  LHS GII+RDLK  N+++ ++  +KI DFG+ +          TF  TP      Y
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP-----DY 167

Query: 230 RAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            APE+I    Y ++VD W+ G ++ EM+ G   F G D  + +  I+
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 41/145 (28%), Positives = 74/145 (51%), Gaps = 34/145 (23%)

Query: 161 LDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSD----------------CTL 203
             H  ++ +++Q    + + H+   ++H DLKP NI++++                 C +
Sbjct: 228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287

Query: 204 KILDFG------LARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
           +I D G       +RTA         V TR+YR+PEV+LG+G+  + D+WS+GCI+ E+ 
Sbjct: 288 RICDLGGCCDERHSRTA--------IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339

Query: 258 RGGVLFPGTD---HIDQWNKIIGKM 279
            G +L+   D   H+    K +G++
Sbjct: 340 TGKLLYDTHDNLEHLHLMEKTLGRL 364

Length = 467

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 51/164 (31%), Positives = 84/164 (51%), Gaps = 19/164 (11%)

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER-MSY 168
           RE ++++ VNH N++   + F      +   ++ +++E MD    +     +  E+ ++ 
Sbjct: 121 REIEILRDVNHPNVVKCHDMF------DHNGEIQVLLEFMDGGSLE--GTHIADEQFLAD 172

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP---YVV 225
           +  Q+L GI +LH   I+HRD+KPSN+++ S   +KI DFG++R    T  M P    V 
Sbjct: 173 VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNSSVG 230

Query: 226 TRYYRAPEVI---LGMGYKENV--DIWSVGCIMGEMIRGGVLFP 264
           T  Y +PE I   L  G  +    DIWS+G  + E   G   F 
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274

Length = 353

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 31/60 (51%), Positives = 43/60 (71%), Gaps = 2/60 (3%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL 60
           MLV+DP+KRI+  +AL HPY+   + D E    AP PYD S + R+ TVD+WKEL+Y+E+
Sbjct: 281 MLVLDPDKRITAAEALAHPYLAE-YHDPEDEPVAP-PYDQSFESRDLTVDEWKELVYKEI 338

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.3 bits (167), Expect = 3e-13
 Identities = 37/131 (28%), Positives = 68/131 (51%), Gaps = 11/131 (8%)

Query: 142 VYLVMELMDA-----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           ++L+++ ++      +L Q  +       +   + +++  + HLH  GII+RD+K  NI+
Sbjct: 80  LHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137

Query: 197 VKSDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCI 252
           + S+  + + DFGL++   A        +  T  Y APEVI G   G+ + VD WS+G +
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVL 197

Query: 253 MGEMIRGGVLF 263
             E++ G   F
Sbjct: 198 TFELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 48/183 (26%), Positives = 76/183 (41%), Gaps = 45/183 (24%)

Query: 139 FQD---VYLVMELMDAN--LCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
           FQD   +YL+ME +     +  +++ D    E   + + + +  I  +H  G IHRD+KP
Sbjct: 70  FQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKP 129

Query: 193 SNIVVKSDCTLKILDFGL----------------ARTAGTTFMMTPY------------- 223
            N+++ +   +K+ DFGL                +    + F+                 
Sbjct: 130 DNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWK 189

Query: 224 ----------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWN 273
                     V T  Y APEV L  GY +  D WS+G IM EM+ G   F   +  + + 
Sbjct: 190 RNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYR 249

Query: 274 KII 276
           KII
Sbjct: 250 KII 252

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 67.9 bits (166), Expect = 3e-13
 Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 21/170 (12%)

Query: 106 KRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LD 162
           K+  RE ++M       I+    AF  +       ++ + ME MD      I      + 
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAFLNEN------NICMCMEFMDCGSLDRIYKKGGPIP 101

Query: 163 HERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFG----LARTAGTT 217
            E +  +   ++ G+ +L++   I+HRD+KPSNI+V S   +K+ DFG    L  +   T
Sbjct: 102 VEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161

Query: 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
           F     V T  Y +PE I G  Y    D+WS+G  + E+  G   FP   
Sbjct: 162 F-----VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK--FPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 68.3 bits (167), Expect = 4e-13
 Identities = 37/108 (34%), Positives = 59/108 (54%), Gaps = 5/108 (4%)

Query: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFMM 220
           +R  +   +++  + +LHS  +++RDLK  N+++  D  +KI DFGL +   + G T  M
Sbjct: 95  DRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 152

Query: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
             +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.7 bits (165), Expect = 4e-13
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 16/156 (10%)

Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD----HERM 166
           E  ++   +H NI+ LL+AF  + +L      ++++E         + ++L+      ++
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNL------WILIEFCAGGAVDAVMLELERPLTEPQI 105

Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVV 225
             +  Q L  + +LH   IIHRDLK  NI+   D  +K+ DFG+ A+   T      ++ 
Sbjct: 106 RVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 165

Query: 226 TRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEM 256
           T Y+ APEV++        Y    D+WS+G  + EM
Sbjct: 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.9 bits (166), Expect = 4e-13
 Identities = 34/85 (40%), Positives = 51/85 (60%), Gaps = 8/85 (9%)

Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMM--TPYVVTRYYRAPEV 234
           ++LHS  II+RDLKP N+++ +   +K+ DFG A +    TF +  TP      Y APEV
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTP-----EYLAPEV 186

Query: 235 ILGMGYKENVDIWSVGCIMGEMIRG 259
           I   G+ + VD W++G ++ E I G
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.8 bits (165), Expect = 6e-13
 Identities = 51/162 (31%), Positives = 81/162 (50%), Gaps = 11/162 (6%)

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERM 166
           RE +++   N   I+G   AF          ++ + ME MD  +L QV++    +  E +
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLKEAKRIPEEIL 105

Query: 167 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
             +   +L G+ +L     I+HRD+KPSNI+V S   +K+ DFG++     + M   +V 
Sbjct: 106 GKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVG 164

Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
           TR Y +PE + G  Y    DIWS+G  + E+  G    P  D
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.2 bits (164), Expect = 6e-13
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 1/89 (1%)

Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI 235
           G+ +L S  I+HRD+KPSN++V +   +K+ DFG++     +   T YV T  Y APE I
Sbjct: 107 GLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-YVGTNAYMAPERI 165

Query: 236 LGMGYKENVDIWSVGCIMGEMIRGGVLFP 264
            G  Y  + D+WS+G    E+  G   +P
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYP 194

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 67.7 bits (165), Expect = 6e-13
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 29/202 (14%)

Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEFQDVYLV 145
           Q+   +KK     QN   A+R      L+K + H  ++GL  +F T +K       +Y V
Sbjct: 29  QKKTILKKKE---QNHIMAERNV----LLKNLKHPFLVGLHYSFQTAEK-------LYFV 74

Query: 146 MELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
           ++ ++   L   +Q +      R  +   ++   I +LHS  II+RDLKP NI++ S   
Sbjct: 75  LDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH 134

Query: 203 LKILDFGLARTA------GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           + + DFGL +         +TF  TP      Y APEV+    Y   VD W +G ++ EM
Sbjct: 135 VVLTDFGLCKEGVEPEETTSTFCGTP-----EYLAPEVLRKEPYDRTVDWWCLGAVLYEM 189

Query: 257 IRGGVLFPGTDHIDQWNKIIGK 278
           + G   F   D    ++ I+ K
Sbjct: 190 LYGLPPFYSRDVSQMYDNILHK 211

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 68.6 bits (167), Expect = 6e-13
 Identities = 52/194 (26%), Positives = 90/194 (46%), Gaps = 37/194 (19%)

Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------DLDH 163
           E  +M+ + HKNI+  ++ F  + +    Q +Y++ME  DA +L + IQ        ++ 
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKAN----QKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117

Query: 164 ERMSYLLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDC--------------- 201
             +  +  Q+L  + + H+         ++HRDLKP NI + +                 
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177

Query: 202 --TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMI 257
               KI DFGL++  G   M    V T YY +PE++L     Y +  D+W++GCI+ E+ 
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 258 RGGVLFPGTDHIDQ 271
            G   F   ++  Q
Sbjct: 238 SGKTPFHKANNFSQ 251

Length = 1021

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.4 bits (164), Expect = 8e-13
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 11/162 (6%)

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--DLDHERM 166
           RE +++   N   I+G   AF          ++ + ME MD  +L QV++    +  + +
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLKKAGRIPEQIL 105

Query: 167 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
             +   ++ G+ +L     I+HRD+KPSNI+V S   +K+ DFG++     + M   +V 
Sbjct: 106 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVG 164

Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
           TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.6 bits (162), Expect = 9e-13
 Identities = 34/100 (34%), Positives = 57/100 (57%), Gaps = 1/100 (1%)

Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFM 219
            D  +++ +L ++L G+ +LHS   IHRD+K +N+++     +K+ DFG+A +   T   
Sbjct: 98  FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157

Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
              +V T ++ APEVI    Y    DIWS+G    E+ +G
Sbjct: 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 57/177 (32%), Positives = 82/177 (46%), Gaps = 26/177 (14%)

Query: 111 EFKLMKLV-NHKNIIGLLNAFT---PQKSLEEFQDVYLVMELMDA----------NLCQV 156
           E ++MK++  HKNII LL A T   P   + E+     + E + A          N  QV
Sbjct: 73  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132

Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--- 213
            +  L  + +    YQ+  G+++L S   IHRDL   N++V  D  +KI DFGLAR    
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192

Query: 214 ----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
                 TT    P      + APE +    Y    D+WS G ++ E+   GG  +PG
Sbjct: 193 IDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 20/156 (12%)

Query: 142 VYLVMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           ++ VME ++  +L   IQ     D  R  +   ++   +  LH  G+I+RDLK  NI++ 
Sbjct: 71  LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD 130

Query: 199 SDCTLKILDFGLARTA------GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
           ++   K+ DFG+ +         TTF  TP      Y APE++  + Y  +VD W++G +
Sbjct: 131 AEGHCKLADFGMCKEGILNGVTTTTFCGTP-----DYIAPEILQELEYGPSVDWWALGVL 185

Query: 253 MGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
           M EM+ G   F   +  D +  I+      HD + Y
Sbjct: 186 MYEMMAGQPPFEADNEDDLFESIL------HDDVLY 215

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)

Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLV-NHK 121
           LG G        + + I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 23  LGEGCFGQVVMAEALGIDK-DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 81

Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   + E+     + E + A     ++   D      E+M++     
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  +KI DFGLAR              R 
Sbjct: 142 CTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201

Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.5 bits (162), Expect = 1e-12
 Identities = 55/173 (31%), Positives = 80/173 (46%), Gaps = 18/173 (10%)

Query: 111 EFKLMKLVN-HKNIIGLLNAFT---PQKSLEEFQDVYLVMELMDA----------NLCQV 156
           E +LMKL+  HKNII LL   T   P   + E+     + E + A          ++ +V
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
            +  L  + +    YQ+  G+++L S   IHRDL   N++V  D  +KI DFGLAR    
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHD 186

Query: 217 TFMMTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
                     R    + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 37/108 (34%), Positives = 60/108 (55%), Gaps = 5/108 (4%)

Query: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFMM 220
           ER  +   +++  +++LHS  +++RD+K  N+++  D  +KI DFGL +   + G T  M
Sbjct: 95  ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 152

Query: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
             +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
           T++  A+K LS+ F+ +  +  A+   E  +M   N   ++ L  AF   + L      Y
Sbjct: 67  TRKVYAMKLLSK-FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL------Y 119

Query: 144 LVMELM-DANLCQVI-QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
           +VME M   +L  ++   D+  +   +   +++  +  +HS G IHRD+KP N+++    
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 179

Query: 202 TLKILDFGLARTAGTTFMM--TPYVVTRYYRAPEVILGMG----YKENVDIWSVGCIMGE 255
            LK+ DFG         M+     V T  Y +PEV+   G    Y    D WSVG  + E
Sbjct: 180 HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239

Query: 256 MIRGGVLFPGTDHIDQWNKII 276
           M+ G   F     +  ++KI+
Sbjct: 240 MLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 56/181 (30%), Positives = 80/181 (44%), Gaps = 19/181 (10%)

Query: 90  VAIKKLSRPFQNVTHAKRA--YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
           VAIK L   +   T  +R     E  +M   +H NII L    T      +F+   ++ E
Sbjct: 36  VAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVT------KFKPAMIITE 86

Query: 148 LMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSDCTL 203
            M+         D D E  SY L  ML GI    K+L     +HRDL   NI+V S+   
Sbjct: 87  YMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLEC 146

Query: 204 KILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           K+ DFGL+R        T+  +   +   + APE I    +    D+WS G +M E++  
Sbjct: 147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSF 206

Query: 260 G 260
           G
Sbjct: 207 G 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 65.6 bits (160), Expect = 2e-12
 Identities = 58/215 (26%), Positives = 89/215 (41%), Gaps = 34/215 (15%)

Query: 59  ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           EL    ++G  +    HLG   A     Q  VAIK ++   +     +    E K+M  +
Sbjct: 5   ELTFMKELGSGQFGVVHLGKWRA-----QIKVAIKAIN---EGAMSEEDFIEEAKVMMKL 56

Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLLY--QMLC 175
           +H  ++ L    T QK L      Y+V E M+   L   ++          LL   Q +C
Sbjct: 57  SHPKLVQLYGVCTQQKPL------YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVC 110

Query: 176 -GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYVV 225
            G+++L     IHRDL   N +V S   +K+ DFG+ R         ++G  F +     
Sbjct: 111 EGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK---- 166

Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
              +  PEV     Y    D+WS G +M E+   G
Sbjct: 167 ---WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG 198

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 66.3 bits (161), Expect = 2e-12
 Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 1/109 (0%)

Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TFM 219
              +R  +   +++  + +LHS  I++RDLK  N+++  D  +KI DFGL +   T    
Sbjct: 92  FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151

Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 47/144 (32%), Positives = 74/144 (51%), Gaps = 14/144 (9%)

Query: 142 VYLVMELMDA-NLCQVIQMDLDHERMSYLLY--QMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +Y VME ++  +L   IQ     +    + Y  ++  G+  LHS GII+RDLK  N+++ 
Sbjct: 76  LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135

Query: 199 SDCTLKILDFGLAR------TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
           S+  +KI DFG+ +          TF  TP      Y APE+I    Y ++VD W+ G +
Sbjct: 136 SEGHIKIADFGMCKENMWDGVTTKTFCGTP-----DYIAPEIIAYQPYGKSVDWWAFGVL 190

Query: 253 MGEMIRGGVLFPGTDHIDQWNKII 276
           + EM+ G   F G D  + +  I+
Sbjct: 191 LYEMLAGQAPFEGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 52/182 (28%), Positives = 75/182 (41%), Gaps = 36/182 (19%)

Query: 111 EFKLMKLV-NHKNIIGLLNAFT------------PQKSLEEF-QDVYLVMELMDANLCQV 156
           E ++MK++  HKNII LL   T               +L +F +      E    +  + 
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124

Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
            +  L  + +    YQ+  G++ L S   IHRDL   N++V  D  +KI DFGLAR    
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184

Query: 217 TFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGE-MIRGGVLF 263
                      YYR            APE +    Y    D+WS G ++ E    GG  +
Sbjct: 185 ---------IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235

Query: 264 PG 265
           PG
Sbjct: 236 PG 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.1 bits (158), Expect = 3e-12
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 13/154 (8%)

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERM 166
           +E  +MK   H NI+    ++  +  L      ++ ME       Q I      L   ++
Sbjct: 55  QEIIMMKDCKHSNIVAYFGSYLRRDKL------WICMEFCGGGSLQDIYHVTGPLSESQI 108

Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVV 225
           +Y+  + L G+ +LHS G +HRD+K +NI++  +  +K+ DFG+ A+   T      ++ 
Sbjct: 109 AYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIG 168

Query: 226 TRYYRAPEVIL---GMGYKENVDIWSVGCIMGEM 256
           T Y+ APEV       GY +  DIW+VG    E+
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.8 bits (158), Expect = 3e-12
 Identities = 49/189 (25%), Positives = 83/189 (43%), Gaps = 25/189 (13%)

Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA------------FTPQKS 135
            +VAIK L +        +   +E +LM  + H NI+ LL              +     
Sbjct: 36  TSVAIKTL-KENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGD 94

Query: 136 LEEFQDVYLVM-----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL 190
           L EF    LV      ++   +  + ++  LD     ++  Q+  G+++L S   +HRDL
Sbjct: 95  LHEF----LVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDL 150

Query: 191 KPSNIVVKSDCTLKILDFGLAR---TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIW 247
              N +V    T+KI DFGL+R   +A    + +  ++   +  PE IL   +    DIW
Sbjct: 151 AARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIW 210

Query: 248 SVGCIMGEM 256
           S G ++ E+
Sbjct: 211 SFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 64.3 bits (156), Expect = 5e-12
 Identities = 34/100 (34%), Positives = 57/100 (57%), Gaps = 1/100 (1%)

Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFM 219
           L+   ++ +L ++L G+ +LHS   IHRD+K +N+++     +K+ DFG+A +   T   
Sbjct: 98  LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157

Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
              +V T ++ APEVI    Y    DIWS+G    E+ +G
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 64.3 bits (157), Expect = 6e-12
 Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 27/186 (14%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ--KSLEEFQDVY 143
           T + VA+K L        H     RE ++++ ++H+NI+           +SL       
Sbjct: 32  TGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR------ 84

Query: 144 LVMELMDA----NLCQVIQMDLDHERMSYLLY--QMLCGIKHLHSAGIIHRDLKPSNIVV 197
           L+ME + +    +  Q  +  ++ +R+  LL+  Q+  G+ +L S   IHRDL   NI+V
Sbjct: 85  LIMEYLPSGSLRDYLQRHRDQINLKRL--LLFSSQICKGMDYLGSQRYIHRDLAARNILV 142

Query: 198 KSDCTLKILDFGLARTAGTTFMMTPYVVTR-------YYRAPEVILGMGYKENVDIWSVG 250
           +S+  +KI DFGLA+          Y   +       ++ APE +    +    D+WS G
Sbjct: 143 ESEDLVKISDFGLAKVLPED---KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFG 199

Query: 251 CIMGEM 256
             + E+
Sbjct: 200 VTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 18/204 (8%)

Query: 80  AAYDTATQQNVAIKKLSR-PFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE 138
           A Y       VAIK+  +            + E K++  +NH   + L  +F  +  L  
Sbjct: 49  ATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL-- 106

Query: 139 FQDVYLVME-LMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
               YLV+E ++       ++ +    ++   +   Q++   ++L S  I++RDLKP N+
Sbjct: 107 ----YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENL 162

Query: 196 VVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
           ++  D  +K+ DFG A+   T   T   TP      Y APE++L +G+ +  D W++G  
Sbjct: 163 LLDKDGFIKMTDFGFAKVVDTRTYTLCGTP-----EYIAPEILLNVGHGKAADWWTLGIF 217

Query: 253 MGEMIRGGVLFPGTDHIDQWNKII 276
           + E++ G   F   + +  + KI+
Sbjct: 218 IYEILVGCPPFYANEPLLIYQKIL 241

Length = 340

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 50/175 (28%)

Query: 139 FQD---VYLVMELMDAN--LCQVIQMDLDHERMS-YLLYQMLCGIKHLHSAGIIHRDLKP 192
           FQD   +Y VM+ +     +  +I++ +  E ++ + + ++ C I+ +H  G IHRD+KP
Sbjct: 70  FQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKP 129

Query: 193 SNIVVKSDCTLKILDF----GLARTAGTTFM----------MTPY--------------- 223
            NI++  D  +K+ DF    G   T  + +           M P                
Sbjct: 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLE 189

Query: 224 ---------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
                          V T  Y APEV+L  GY +  D WSVG I+ EM+ G   F
Sbjct: 190 RRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 63.5 bits (155), Expect = 7e-12
 Identities = 48/185 (25%), Positives = 74/185 (40%), Gaps = 35/185 (18%)

Query: 89  NVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
            VA+K L          K   RE  +M  ++H  I+ L+          E   + LVMEL
Sbjct: 25  EVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVRLIGV-----CKGE--PLMLVMEL 76

Query: 149 MDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
             A L  +++       +       L +Q+  G+ +L S   +HRDL   N+++ +    
Sbjct: 77  --APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQA 134

Query: 204 KILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGC 251
           KI DFG++R  G          + YYR            APE I    +    D+WS G 
Sbjct: 135 KISDFGMSRALGAG--------SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGV 186

Query: 252 IMGEM 256
            + E 
Sbjct: 187 TLWEA 191

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 64.3 bits (156), Expect = 7e-12
 Identities = 49/174 (28%), Positives = 82/174 (47%), Gaps = 20/174 (11%)

Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLL 170
           L+K V H  ++GL  +F     L      Y V++ ++   L   +Q +      R  +  
Sbjct: 49  LLKNVKHPFLVGLHFSFQTADKL------YFVLDYINGGELFYHLQRERCFLEPRARFYA 102

Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTTFMMTPYV 224
            ++   + +LHS  I++RDLKP NI++ S   + + DFGL +         +TF  TP  
Sbjct: 103 AEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP-- 160

Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
               Y APEV+    Y   VD W +G ++ EM+ G   F   +  + ++ I+ K
Sbjct: 161 ---EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 63.5 bits (154), Expect = 8e-12
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 19/156 (12%)

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSY 168
           +E +++K  +H NI+ L+   T QK     Q +Y+VMEL+   +    ++ +    ++  
Sbjct: 42  QEARILKQYSHPNIVRLIGVCT-QK-----QPIYIVMELVQGGDFLTFLRTEGPRLKVKE 95

Query: 169 LLYQM---LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------AGTTFM 219
           L+  +     G+++L S   IHRDL   N +V     LKI DFG++R       A T  M
Sbjct: 96  LIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155

Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
                +   + APE +    Y    D+WS G ++ E
Sbjct: 156 KQ---IPVKWTAPEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.2 bits (156), Expect = 9e-12
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 7/145 (4%)

Query: 139 FQDV---YLVMELMDA-NLCQVIQMDLDHERMSYLLY--QMLCGIKHLHSAGIIHRDLKP 192
           FQ V   Y VME ++  +L   IQ     +    + Y  ++  G+  LH  GII+RDLK 
Sbjct: 70  FQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKL 129

Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMT-PYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
            N+++ S+  +KI DFG+ +      + T  +  T  Y APE+I    Y ++VD W+ G 
Sbjct: 130 DNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGV 189

Query: 252 IMGEMIRGGVLFPGTDHIDQWNKII 276
           ++ EM+ G   F G D  + +  I+
Sbjct: 190 LLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 64.3 bits (156), Expect = 9e-12
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 19/163 (11%)

Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELM---DANLCQVIQMDLDHERMSYLLYQMLC 175
           NH  ++GL + F  +  L      + V+E +   D       Q  L  E   +   ++  
Sbjct: 54  NHPFLVGLHSCFQTESRL------FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 107

Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTTFMMTPYVVTRYYRA 231
            + +LH  GII+RDLK  N+++ S+  +K+ D+G+     R   TT   + +  T  Y A
Sbjct: 108 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIA 164

Query: 232 PEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP---GTDHIDQ 271
           PE++ G  Y  +VD W++G +M EM+ G   F     +D+ DQ
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 38/190 (20%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T Q VA+K +     +VT A+    E  +M  ++HKN++ LL              +Y+V
Sbjct: 28  TGQKVAVKNIK---CDVT-AQAFLEETAVMTKLHHKNLVRLLGVIL-------HNGLYIV 76

Query: 146 MELMD---------------ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL 190
           MELM                 ++ Q++Q  LD          +  G+++L S  ++HRDL
Sbjct: 77  MELMSKGNLVNFLRTRGRALVSVIQLLQFSLD----------VAEGMEYLESKKLVHRDL 126

Query: 191 KPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 250
              NI+V  D   K+ DFGLAR        +   V   + APE +    +    D+WS G
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEALKHKKFSSKSDVWSYG 184

Query: 251 CIMGEMIRGG 260
            ++ E+   G
Sbjct: 185 VLLWEVFSYG 194

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 38/130 (29%), Positives = 66/130 (50%), Gaps = 11/130 (8%)

Query: 141 DVYLVMELMDANLCQVIQMDLDHER------MSYLLYQMLCGIKHLHSA-GIIHRDLKPS 193
           DV++ ME+MD +L +  +   D         +  +   ++  +++LHS   +IHRD+KPS
Sbjct: 74  DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS 133

Query: 194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG----MGYKENVDIWSV 249
           N+++  +  +K+ DFG++     +   T     + Y APE I       GY    D+WS+
Sbjct: 134 NVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSL 193

Query: 250 GCIMGEMIRG 259
           G  M E+  G
Sbjct: 194 GITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.1 bits (153), Expect = 1e-11
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 13/148 (8%)

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERM 166
           +E  ++K   H NI+    ++  ++ L      ++ ME       Q I      L   ++
Sbjct: 55  QEIFMVKECKHCNIVAYFGSYLSREKL------WICMEYCGGGSLQDIYHVTGPLSELQI 108

Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVV 225
           +Y+  + L G+ +LHS G +HRD+K +NI++  +  +K+ DFG+ A+   T      ++ 
Sbjct: 109 AYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIG 168

Query: 226 TRYYRAPEVIL---GMGYKENVDIWSVG 250
           T Y+ APEV       GY +  DIW+VG
Sbjct: 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVG 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 1/60 (1%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL 60
           MLV DP KRI+V++AL HPY+    D ++       P+    +E   T +  KELIY E+
Sbjct: 274 MLVFDPSKRITVEEALAHPYLASLHDPSD-EPVCQTPFSFDFEEDALTEEDIKELIYNEM 332

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 32/96 (33%), Positives = 56/96 (58%), Gaps = 4/96 (4%)

Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV--TRYY 229
           +++  ++HLH  GII+RD+K  NI++ S+  + + DFGL++      +   Y    T  Y
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 230 RAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLF 263
            AP+++ G   G+ + VD WS+G +M E++ G   F
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 42/144 (29%), Positives = 71/144 (49%), Gaps = 14/144 (9%)

Query: 142 VYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           ++ VME ++  +L   IQ     D  R  +   ++   +  LH  GII+RDLK  N+++ 
Sbjct: 71  LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD 130

Query: 199 SDCTLKILDFGLAR------TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
            +   K+ DFG+ +         +TF  TP      Y APE++  M Y  +VD W++G +
Sbjct: 131 HEGHCKLADFGMCKEGIFNGKTTSTFCGTP-----DYIAPEILQEMLYGPSVDWWAMGVL 185

Query: 253 MGEMIRGGVLFPGTDHIDQWNKII 276
           + EM+ G   F   +  D +  I+
Sbjct: 186 LYEMLCGHAPFEAENEDDLFEAIL 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 45/172 (26%), Positives = 84/172 (48%), Gaps = 13/172 (7%)

Query: 92  IKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM----- 146
           IKKL+    +    K A +E +L+  + H NI+    ++  +  L     +Y+VM     
Sbjct: 30  IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL-----LYIVMGFCEG 84

Query: 147 -ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
            +L      Q  ++  +++ + + + Q+   +++LH   I+HRDLK  N+ +     +K+
Sbjct: 85  GDLYHKLKEQKGKLLPENQVVEWFV-QIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKV 143

Query: 206 LDFGLARTAGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
            D G+AR       M   ++ T YY +PE+     Y    D+W++GC + EM
Sbjct: 144 GDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 62.4 bits (151), Expect = 4e-11
 Identities = 28/61 (45%), Positives = 41/61 (67%), Gaps = 4/61 (6%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFD-DAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           MLV+D +KRIS  +AL HPY + + D + E  A    PYD S + +E T+++WKEL Y+E
Sbjct: 281 MLVLDSDKRISASEALAHPYFSQYHDPEDEPEAE---PYDESPENKERTIEEWKELTYEE 337

Query: 60  L 60
           +
Sbjct: 338 V 338

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 62.2 bits (151), Expect = 4e-11
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 20/155 (12%)

Query: 123 IIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ------VIQMDLDHERMSYLLYQMLCG 176
           I+    AF  + +      VY+ ME MDA          V    +  + +  + Y ++ G
Sbjct: 61  IVDFYGAFFIEGA------VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKG 114

Query: 177 IKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI 235
           +K L     IIHRD+KP+N++V  +  +K+ DFG++     +   T  +  + Y APE I
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-IGCQSYMAPERI 173

Query: 236 LGMG------YKENVDIWSVGCIMGEMIRGGVLFP 264
              G      Y    D+WS+G  + EM  G   +P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 62.0 bits (151), Expect = 4e-11
 Identities = 52/193 (26%), Positives = 84/193 (43%), Gaps = 42/193 (21%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+K L RP  +    +   +E K++  ++  NI  LL   T    L       ++ME M
Sbjct: 49  VAVKVL-RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPL------CMIMEYM 101

Query: 150 D-ANLCQVIQ----------MDLDHERMSYLLY---QMLCGIKHLHSAGIIHRDLKPSNI 195
           +  +L Q +Q           +      S LLY   Q+  G+++L S   +HRDL   N 
Sbjct: 102 ENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161

Query: 196 VVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYY----RAP--------EVILGMGYKEN 243
           +V  + T+KI DFG++R   +         + YY    RAP        E +L   +   
Sbjct: 162 LVGKNYTIKIADFGMSRNLYS---------SDYYRVQGRAPLPIRWMAWESVLLGKFTTK 212

Query: 244 VDIWSVGCIMGEM 256
            D+W+ G  + E+
Sbjct: 213 SDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 38/121 (31%), Positives = 64/121 (52%), Gaps = 14/121 (11%)

Query: 162 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------- 213
           +HE    L  Q+L  + H+HS  +IHRD+K +NI++ S+  +K+ DFG ++         
Sbjct: 142 EHE-AGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD 200

Query: 214 AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWN 273
            G TF  TP     YY APE+     Y +  D++S+G ++ E++     F G +  +  +
Sbjct: 201 VGRTFCGTP-----YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255

Query: 274 K 274
           K
Sbjct: 256 K 256

Length = 496

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.1 bits (151), Expect = 5e-11
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 23/165 (13%)

Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELM---DANLCQVIQMDLDHERMSYLLYQMLC 175
           NH  ++GL + F  +  L      + V+E +   D       Q  L  E   +   ++  
Sbjct: 54  NHPFLVGLHSCFQTESRL------FFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL 107

Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTTFMMTPYVVTRYY 229
            +  LH  GII+RDLK  N+++ ++  +K+ D+G+ +         +TF  TP      Y
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP-----NY 162

Query: 230 RAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP---GTDHIDQ 271
            APE++ G  Y  +VD W++G +M EM+ G   F     +D+ DQ
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 61.3 bits (149), Expect = 5e-11
 Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 19/185 (10%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+K L +P       K    E ++MK + H  +I L    T    LEE   +Y+V ELM
Sbjct: 33  VAVKTL-KP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT----LEE--PIYIVTELM 83

Query: 150 -DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204
              +L + +Q      L   ++  +  Q+  G+ +L +   IHRDL   N++V  +   K
Sbjct: 84  KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICK 143

Query: 205 ILDFGLARTAGTTFMMTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GG 260
           + DFGLAR      +       ++   + APE  L   +    D+WS G ++ E++  G 
Sbjct: 144 VADFGLARVIKED-IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202

Query: 261 VLFPG 265
           + +PG
Sbjct: 203 MPYPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 61.6 bits (150), Expect = 6e-11
 Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 21/189 (11%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+KK++    +    K   +E    + + H NI+  + +F          ++Y+V  LM
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI------VDSELYVVSPLM 81

Query: 150 DANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204
               C+ +      E +      ++L  +L  + ++HS G IHR +K S+I++  D  + 
Sbjct: 82  AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVV 141

Query: 205 ILDFGLA--------RTAGTTFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMG 254
           +     +        R           V    + +PEV+     GY E  DI+SVG    
Sbjct: 142 LSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITAC 201

Query: 255 EMIRGGVLF 263
           E+  G V F
Sbjct: 202 ELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 61.6 bits (149), Expect = 6e-11
 Identities = 35/108 (32%), Positives = 57/108 (52%), Gaps = 11/108 (10%)

Query: 158 QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--- 214
           Q  L  E   +   ++   +  LH  GII+RDLK  N+++ +D  +K+ D+G+ +     
Sbjct: 90  QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP 149

Query: 215 ---GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
               +TF  TP      Y APE++ G  Y  +VD W++G +M EM+ G
Sbjct: 150 GDTTSTFCGTP-----NYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 61.5 bits (149), Expect = 8e-11
 Identities = 26/61 (42%), Positives = 38/61 (62%), Gaps = 4/61 (6%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFD-DAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           MLV+D E RI+  +AL HPY   + D + E  AP   PYD S DE + ++++WK L + E
Sbjct: 281 MLVLDAESRITAAEALAHPYFEEFHDPEDETEAP---PYDDSFDEVDQSLEEWKRLTFTE 337

Query: 60  L 60
           +
Sbjct: 338 I 338

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 60.7 bits (147), Expect = 8e-11
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 21/179 (11%)

Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
           Q +VAIK +    +          E K+M  ++H+ ++ L    T Q+       +Y+V 
Sbjct: 28  QYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP------IYIVT 78

Query: 147 ELMDANLC--QVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
           E M +N C    ++      + S LL     +  G+ +L S   IHRDL   N +V    
Sbjct: 79  EYM-SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG 137

Query: 202 TLKILDFGLARTA----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
            +K+ DFGL+R       T+ + + + V   +  PEV+L   +    D+W+ G +M E+
Sbjct: 138 CVKVSDFGLSRYVLDDEYTSSVGSKFPVR--WSPPEVLLYSKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 61.2 bits (148), Expect = 8e-11
 Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 26/195 (13%)

Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA------------FTPQKS 135
           Q VAIK L +   N        +E  LM  ++H NI+ LL              +  Q  
Sbjct: 35  QLVAIKTL-KDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD 93

Query: 136 LEEFQDVYLVMELMDANL-CQ-----VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
           L EF    L+M    +++ C       ++  LDH    ++  Q+  G+++L S   +H+D
Sbjct: 94  LHEF----LIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKD 149

Query: 190 LKPSNIVVKSDCTLKILDFGLAR---TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
           L   NI++     +KI D GL+R   +A    +    ++   +  PE I+   +  + DI
Sbjct: 150 LAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDI 209

Query: 247 WSVGCIMGEMIRGGV 261
           WS G ++ E+   G+
Sbjct: 210 WSFGVVLWEIFSFGL 224

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 61.6 bits (149), Expect = 8e-11
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 2/91 (2%)

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPY--VVT 226
           ++ Q+LC ++++H   +IHRD+K  NI +  D  + + DFG A           Y  V T
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331

Query: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
               +PE++ G GY E  DIWS G I+ +M+
Sbjct: 332 VATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 67/238 (28%), Positives = 101/238 (42%), Gaps = 45/238 (18%)

Query: 59  ELPISHQMGKKRHNTSH---LGAGA--------AYDTATQQ---NVAIKKLSRPFQNVTH 104
           +LP   +    R+N S    LGAGA        AY  +       VA+K L +P  + + 
Sbjct: 23  QLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKML-KPTAHSSE 81

Query: 105 AKRAYREFKLM-KLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME------LMDANLCQVI 157
            +    E K+M  L NH+NI+ LL A T          + ++ E      L++  L +  
Sbjct: 82  REALMSELKIMSHLGNHENIVNLLGACTIGGP------ILVITEYCCYGDLLNF-LRRKR 134

Query: 158 QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----- 212
           +  L  E +    YQ+  G+  L S   IHRDL   N+++     +KI DFGLAR     
Sbjct: 135 ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194

Query: 213 ----TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
                 G   +   ++      APE I    Y    D+WS G ++ E+   G   +PG
Sbjct: 195 SNYVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 3/98 (3%)

Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTTFM 219
           L   +++ +  Q+L  I ++H  GIIHRD+K  N++V     + + DFG A  A G+   
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316

Query: 220 MTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
              Y +  T    APEV+ G  Y  +VDIWS G ++ E
Sbjct: 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 30/86 (34%), Positives = 43/86 (50%)

Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRA 231
           Q+L G+++LH+  IIHRD+K  NI +     + I D G A+             T    A
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNA 224

Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PEV+    Y    DIWS G ++ EM+
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 37/109 (33%), Positives = 58/109 (53%), Gaps = 6/109 (5%)

Query: 164 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTTFM 219
           +R  +   +++  + +LHS   +++RDLK  N+++  D  +KI DFGL +     G T  
Sbjct: 95  DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-- 152

Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 35/122 (28%), Positives = 55/122 (45%), Gaps = 30/122 (24%)

Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG------------------ 215
           L  +++LH  GI++RDLKP NI++     + + DF L++ +                   
Sbjct: 113 LLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172

Query: 216 ------------TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
                        +F    +V T  Y APEVI G G+   VD W++G ++ EM+ G   F
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232

Query: 264 PG 265
            G
Sbjct: 233 KG 234

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 59.9 bits (145), Expect = 2e-10
 Identities = 53/183 (28%), Positives = 76/183 (41%), Gaps = 23/183 (12%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           VAIK L        + ++  R+F     +M   +H NII L    T  K       V +V
Sbjct: 35  VAIKTL-----KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP------VMIV 83

Query: 146 MELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSDC 201
            E M+           D +     L  ML GI    K+L   G +HRDL   NI+V S+ 
Sbjct: 84  TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL 143

Query: 202 TLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
             K+ DFGL+R         +      +   + APE I    +    D+WS G +M E++
Sbjct: 144 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203

Query: 258 RGG 260
             G
Sbjct: 204 SYG 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 17/152 (11%)

Query: 141 DVYLVMELMDANL-------CQVIQMDLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKP 192
           D ++ MELMD +L        +V++  +  E +  +    +  + +L     IIHRD+KP
Sbjct: 77  DCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKP 136

Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSV 249
           SNI++  +  +K+ DFG++     +   T     R Y APE I      GY    D+WS+
Sbjct: 137 SNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSL 196

Query: 250 GCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE 281
           G  + E+  G   FP      +WN +  ++ +
Sbjct: 197 GITLYEVATG--KFP----YPKWNSVFDQLTQ 222

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 32/95 (33%), Positives = 56/95 (58%), Gaps = 3/95 (3%)

Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV--TRYY 229
           +++  ++HLH  GI++RD+K  NI++ S+  + + DFGL++   +      Y    T  Y
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 230 RAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLF 263
            APE+I G  G+ + VD WS+G ++ E++ G   F
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 58.9 bits (142), Expect = 3e-10
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 13/162 (8%)

Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYL 169
           E +++K  +H NI+ L+   T +      Q +Y+VMEL+   +    ++   D  +   L
Sbjct: 42  EARILKQYDHPNIVKLIGVCTQR------QPIYIVMELVPGGDFLSFLRKKKDELKTKQL 95

Query: 170 LYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV-- 224
           +   L    G+ +L S   IHRDL   N +V  +  LKI DFG++R        +  +  
Sbjct: 96  VKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155

Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPG 265
           +   + APE +    Y    D+WS G ++ E    GV  +PG
Sbjct: 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 3e-10
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 14/152 (9%)

Query: 139 FQD---VYLVMEL-MDANLCQVIQMDLDH--ERMS-YLLYQMLCGIKHLHSAGIIHRDLK 191
           FQD   +YLVM+  +  +L  ++    D   E M+ + L +M+  I  +H  G +HRD+K
Sbjct: 70  FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIK 129

Query: 192 PSNIVVKSDCTLKILDFG--LARTAGTTFMMTPYVVTRYYRAPEVILGMG-----YKENV 244
           P N+++  +  +++ DFG  L   A  T      V T  Y +PE++  M      Y    
Sbjct: 130 PDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPEC 189

Query: 245 DIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           D WS+G  M EM+ G   F     ++ + KI+
Sbjct: 190 DWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 59.5 bits (144), Expect = 3e-10
 Identities = 47/192 (24%), Positives = 77/192 (40%), Gaps = 54/192 (28%)

Query: 139 FQD---VYLVMELMDAN--LCQVIQMDLDHERMS-YLLYQMLCGIKHLHSAGIIHRDLKP 192
           FQD   +YL+ME +     +  +I+ D   E ++ + + + +  I+ +H  G IHRD+KP
Sbjct: 70  FQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKP 129

Query: 193 SNIVVKSDCTLKILDFGLA----RTAGTTFMMTPY------------------------- 223
            NI++     +K+ DFGL+    +   + +                              
Sbjct: 130 DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMS 189

Query: 224 -------------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP 264
                              V T  Y APE+ L  GY +  D WS+G IM E + G   F 
Sbjct: 190 SKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFC 249

Query: 265 GTDHIDQWNKII 276
             +  + + KII
Sbjct: 250 SENSHETYRKII 261

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 43/164 (26%), Positives = 69/164 (42%), Gaps = 39/164 (23%)

Query: 135 SLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 191
           S ++ +++YL+ME +       + M    L  E   + + + +  I  +H  G IHRD+K
Sbjct: 69  SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIK 128

Query: 192 PSNIVVKSDCTLKILDFGLA----RTAGTTF----------------------------- 218
           P N+++ +   +K+ DFGL     +   T F                             
Sbjct: 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188

Query: 219 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
              +    V T  Y APEV +  GY +  D WS+G IM EM+ G
Sbjct: 189 RRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 13/97 (13%)

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------AGTTFMM 220
           L YQ++  +  +HS  ++HRDLK +NI +     +K+ DFG ++           ++F  
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
           TP     YY APE+     Y +  D+WS+G I+ E++
Sbjct: 234 TP-----YYLAPELWERKRYSKKADMWSLGVILYELL 265

Length = 478

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 44/176 (25%), Positives = 73/176 (41%), Gaps = 51/176 (28%)

Query: 135 SLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMS-YLLYQMLCGIKHLHSAGIIHRDLK 191
           S ++  ++Y VM+ +     +  +I+M++  E ++ + + ++   I+ +H  G IHRD+K
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIK 128

Query: 192 PSNIVVKSDCTLKILDFGL----------------------------------------- 210
           P NI++  D  +K+ DFGL                                         
Sbjct: 129 PDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDR 188

Query: 211 -------ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
                  A       +    V T  Y APEV+L  GY +  D WSVG I+ EM+ G
Sbjct: 189 LKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 49/168 (29%), Positives = 70/168 (41%), Gaps = 42/168 (25%)

Query: 134 KSLEEFQD---VYLVMELMDANLCQVIQMDLD---HERMSYLLYQMLCGIKHLHSAGIIH 187
           K    FQD   +YL+ME +       + M  D    E   + + + +  I  +H  G IH
Sbjct: 65  KMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124

Query: 188 RDLKPSNIVVKSDCTLKILDFGLA-------RT-----------AGTTF----------- 218
           RD+KP N+++ S   +K+ DFGL        RT           +  TF           
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184

Query: 219 -------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
                  +    V T  Y APEV +  GY +  D WS+G IM EM+ G
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.4 bits (141), Expect = 5e-10
 Identities = 32/97 (32%), Positives = 59/97 (60%), Gaps = 6/97 (6%)

Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPY-- 223
           M +   +++ G++H+H+  +++RDLKP+NI++     ++I D GLA          P+  
Sbjct: 99  MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155

Query: 224 VVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRG 259
           V T  Y APEV+  G+ Y  + D +S+GC++ +++RG
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 58.4 bits (141), Expect = 6e-10
 Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 37/192 (19%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNI--------------IGLLNAFT 131
           T + VA+K L +P     H     +E ++++ + H+NI              I L+  F 
Sbjct: 32  TGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90

Query: 132 PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 191
           P  SL+E    YL       NL Q ++  +          Q+  G+ +L S   +HRDL 
Sbjct: 91  PSGSLKE----YLPRNKNKINLKQQLKYAV----------QICKGMDYLGSRQYVHRDLA 136

Query: 192 PSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTR------YYRAPEVILGMGYKENVD 245
             N++V+S+  +KI DFGL +   T      Y V        ++ APE ++   +    D
Sbjct: 137 ARNVLVESEHQVKIGDFGLTKAIETD--KEYYTVKDDLDSPVFWYAPECLIQSKFYIASD 194

Query: 246 IWSVGCIMGEMI 257
           +WS G  + E++
Sbjct: 195 VWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 58.2 bits (141), Expect = 6e-10
 Identities = 48/185 (25%), Positives = 73/185 (39%), Gaps = 38/185 (20%)

Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
           Q VA+K L     + T A+    E  +M  + H N++ LL        L      Y+V E
Sbjct: 30  QKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL------YIVTE 80

Query: 148 LMDA---------------NLCQVIQMDLDHERMSYLLYQMLC-GIKHLHSAGIIHRDLK 191
            M                  L Q +   LD           +C G+++L     +HRDL 
Sbjct: 81  YMAKGSLVDYLRSRGRAVITLAQQLGFALD-----------VCEGMEYLEEKNFVHRDLA 129

Query: 192 PSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
             N++V  D   K+ DFGLA+ A          V   + APE +    +    D+WS G 
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--WTAPEALREKKFSTKSDVWSFGI 187

Query: 252 IMGEM 256
           ++ E+
Sbjct: 188 LLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 58.1 bits (141), Expect = 7e-10
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 16/165 (9%)

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHE-RMS 167
           +E ++MK + H  ++ L    +      E + +Y+V E M   +L   ++     + R+ 
Sbjct: 50  QEAQIMKKLRHDKLVQLYAVCS------EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP 103

Query: 168 YLLY---QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
            L+    Q+  G+ +L S   IHRDL   NI+V  +   KI DFGLAR        T   
Sbjct: 104 QLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTARE 162

Query: 225 VTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
             ++   + APE      +    D+WS G ++ E++  G V +PG
Sbjct: 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.9 bits (140), Expect = 8e-10
 Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 38/191 (19%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNII---GLLNAFTPQKSLEEFQDV 142
           T + VA+KKL        H +   RE +++K + H NI+   G+   ++  +     +++
Sbjct: 32  TGEVVAVKKLQH--STAEHLRDFEREIEILKSLQHDNIVKYKGV--CYSAGR-----RNL 82

Query: 143 YLVME-LMDANLCQVIQMD---LDHERMSYLLY--QMLCGIKHLHSAGIIHRDLKPSNIV 196
            LVME L   +L   +Q     LDH ++  LLY  Q+  G+++L S   +HRDL   NI+
Sbjct: 83  RLVMEYLPYGSLRDYLQKHRERLDHRKL--LLYASQICKGMEYLGSKRYVHRDLATRNIL 140

Query: 197 VKSDCTLKILDFGLARTAGTTFMMTP-----YVVTR------YYRAPEVILGMGYKENVD 245
           V+S+  +KI DFGL +       + P     Y V        ++ APE +    +    D
Sbjct: 141 VESENRVKIGDFGLTK-------VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASD 193

Query: 246 IWSVGCIMGEM 256
           +WS G ++ E+
Sbjct: 194 VWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.7 bits (140), Expect = 9e-10
 Identities = 48/195 (24%), Positives = 76/195 (38%), Gaps = 47/195 (24%)

Query: 90  VAIKKLSRPFQNVTHAKRA--YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
           VAIK +    +N +  +R     E  +MK  N  +++ LL   +        Q   +VME
Sbjct: 39  VAIKTV---NENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG------QPTLVVME 89

Query: 148 LM--------------DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
           LM              +A            ++   +  ++  G+ +L +   +HRDL   
Sbjct: 90  LMAKGDLKSYLRSRRPEAENNPG-LGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAAR 148

Query: 194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYK 241
           N +V  D T+KI DFG+ R             T YYR            APE +    + 
Sbjct: 149 NCMVAEDLTVKIGDFGMTRDIYE---------TDYYRKGGKGLLPVRWMAPESLKDGVFT 199

Query: 242 ENVDIWSVGCIMGEM 256
              D+WS G ++ EM
Sbjct: 200 TKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 57.6 bits (139), Expect = 1e-09
 Identities = 52/228 (22%), Positives = 101/228 (44%), Gaps = 33/228 (14%)

Query: 54  ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK 113
           E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   +E  
Sbjct: 2   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLT----VAVKTLK---EDTMEVEEFLKEAA 54

Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI----QMDLDHERMSY 168
           +MK + H N++ LL   T +         Y++ E M   NL   +    + +++   + Y
Sbjct: 55  VMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLY 108

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
           +  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R      +MT    T +
Sbjct: 109 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR------LMTGDTYTAH 162

Query: 229 --------YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
                   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 16/105 (15%)

Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMT 221
           YQ+  G++ L S   +HRDL   N+++     +KI DFGLAR         + G+TF+  
Sbjct: 244 YQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
            ++      APE I    Y    D+WS G ++ E+   GG  +PG
Sbjct: 304 KWM------APESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 6/97 (6%)

Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPY-- 223
           M +   +++ G++H+H+  +++RDLKP+NI++     ++I D GLA          P+  
Sbjct: 99  MRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155

Query: 224 VVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRG 259
           V T  Y APEV+  G  Y  + D +S+GC++ +++RG
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 57.8 bits (139), Expect = 1e-09
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 11/169 (6%)

Query: 117 LVNHKN--IIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQML 174
           LVN  N  I  L  AF  + +L    D Y+  +L+   L    +  L  +   + L +M+
Sbjct: 55  LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLL--TLLSKFEDRLPEDMARFYLAEMV 112

Query: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG--LARTAGTTFMMTPYVVTRYYRAP 232
             I  +H    +HRD+KP NI++  +  +++ DFG  L      T   +  V T  Y +P
Sbjct: 113 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172

Query: 233 EVILGMG-----YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           E++  M      Y    D WS+G  M EM+ G   F     ++ + KI+
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 44/213 (20%)

Query: 81  AYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           AYD    + VA+KK+     +N    KR  RE K+   + H  I+       P  S+   
Sbjct: 21  AYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV-------PVYSICSD 73

Query: 140 QD-VYLVME----------LMDANLCQVIQMDLDHERMSY-----LLYQMLCGIKHLHSA 183
            D VY  M           L      + +  +L  E+ S      + +++   I+++HS 
Sbjct: 74  GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKEL-AEKTSVGAFLSIFHKICATIEYVHSK 132

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLA---------------RTAGTTF--MMTP--YV 224
           G++HRDLKP NI++     + ILD+G A                     +  M  P   V
Sbjct: 133 GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIV 192

Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
            T  Y APE +LG+   E+ DI+++G I+ +M+
Sbjct: 193 GTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 58/233 (24%), Positives = 92/233 (39%), Gaps = 49/233 (21%)

Query: 75  HLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK 134
            L   A Y T     VA+K L     + +  +    EF L+K VNH ++I L  A +   
Sbjct: 23  RLKGRAGYTT-----VAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76

Query: 135 SLEEFQDVYLVME---------------------LMDANLCQVIQMDLDHER---MSYLL 170
            L       L++E                     L          +D   ER   M  L+
Sbjct: 77  PL------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLI 130

Query: 171 ---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV--- 224
              +Q+  G+++L    ++HRDL   N++V     +KI DFGL+R     +    YV   
Sbjct: 131 SFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR---DVYEEDSYVKRS 187

Query: 225 ---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWN 273
              +   + A E +    Y    D+WS G ++ E++  GG  +PG      +N
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 22/182 (12%)

Query: 82  YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD 141
           +    ++ V +K        VT  K   RE  ++K ++H+ II L++A+   KS      
Sbjct: 114 HGDEQRKKVIVKA-------VTGGKTPGREIDILKTISHRAIINLIHAYR-WKST----- 160

Query: 142 VYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           V +VM     +L   +     L  E+   +  ++L  + +LH  GIIHRD+K  NI +  
Sbjct: 161 VCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE 220

Query: 200 DCTLKILDFGLA-RTAGTTFMMTP----YVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
                + DFG A +        TP    +  T    +PE++    Y    DIWS G ++ 
Sbjct: 221 PENAVLGDFGAACKLDAHPD--TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLF 278

Query: 255 EM 256
           EM
Sbjct: 279 EM 280

Length = 392

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 3/81 (3%)

Query: 135 SLEEFQDVYLVMELM---DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 191
           SL+   +VYLVME +   D      I    D E     + ++   + +LH  GIIHRDLK
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131

Query: 192 PSNIVVKSDCTLKILDFGLAR 212
           P N+++ ++  +K+ DFGL++
Sbjct: 132 PDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 56.4 bits (136), Expect = 2e-09
 Identities = 52/194 (26%), Positives = 83/194 (42%), Gaps = 34/194 (17%)

Query: 88  QNVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
             VAIK L    +  + +  A+  E  LMK + H  ++ L    T +        +Y++ 
Sbjct: 31  TKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEP-------IYIIT 79

Query: 147 ELM-DANLCQVIQMDLDHERMSYLLYQMLC----GIKHLHSAGIIHRDLKPSNIVVKSDC 201
           E M + +L   ++     +     L  M      G+  +     IHRDL+ +NI+V    
Sbjct: 80  EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL 139

Query: 202 TLKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
             KI DFGLAR       TA  G  F +        + APE I    +    D+WS G +
Sbjct: 140 CCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEAINYGTFTIKSDVWSFGIL 192

Query: 253 MGEMIR-GGVLFPG 265
           + E++  G + +PG
Sbjct: 193 LTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 24/60 (40%), Positives = 39/60 (65%), Gaps = 2/60 (3%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL 60
           ML +D +KR++  +AL HPY +  F DA+       PYD S++  + +VD+WK+ IY+E+
Sbjct: 280 MLELDVDKRLTATEALEHPYFDS-FRDAD-EETEQQPYDDSLENEKLSVDEWKKHIYKEV 337

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 14/152 (9%)

Query: 139 FQD---VYLVMELMDA----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 191
           FQD   +YLVM+         L    +  L  +   + + +M+  I  +H    +HRD+K
Sbjct: 70  FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIK 129

Query: 192 PSNIVVKSDCTLKILDFG--LARTAGTTFMMTPYVVTRYYRAPEVIL----GMG-YKENV 244
           P N+++  +  +++ DFG  L      T   +  V T  Y +PE++     GMG Y    
Sbjct: 130 PDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189

Query: 245 DIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           D WS+G  M EM+ G   F     ++ + KI+
Sbjct: 190 DWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 55.9 bits (135), Expect = 4e-09
 Identities = 50/168 (29%), Positives = 77/168 (45%), Gaps = 22/168 (13%)

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSY 168
           +E +++K  +H NI+ L+     QK     Q +Y+VMEL+   +L   ++   +   +  
Sbjct: 41  QEAEILKQYDHPNIVKLIGVCV-QK-----QPIYIVMELVPGGSLLTFLRKKKNRLTVKK 94

Query: 169 LLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTTF 218
           LL   L    G+++L S   IHRDL   N +V  +  LKI DFG++R       T     
Sbjct: 95  LLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154

Query: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPG 265
              P   T    APE +    Y    D+WS G ++ E    G   +PG
Sbjct: 155 KQIPIKWT----APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 55.8 bits (134), Expect = 4e-09
 Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 29/173 (16%)

Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY-- 168
           E ++MK + H  ++ L    + +        +Y+V E M          D +   +    
Sbjct: 51  EAQIMKKLRHDKLVQLYAVVSEEP-------IYIVTEYMSKGSLLDFLKDGEGRALKLPN 103

Query: 169 ---LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--GT 216
              +  Q+  G+ ++     IHRDL+ +NI+V      KI DFGLAR       TA  G 
Sbjct: 104 LVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163

Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPGTDH 268
            F +        + APE  L   +    D+WS G ++ E++ +G V +PG ++
Sbjct: 164 KFPIK-------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 55.6 bits (134), Expect = 4e-09
 Identities = 52/193 (26%), Positives = 84/193 (43%), Gaps = 35/193 (18%)

Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNII---GLLNAFTPQKSLEEF 139
           +  VAIK L        + ++  R+F     +M   +H NII   G++    P   + EF
Sbjct: 32  EIFVAIKTL-----KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEF 86

Query: 140 Q-----DVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
                 D +L        + Q++ M          L  +  G+K+L     +HRDL   N
Sbjct: 87  MENGALDSFLRQNDGQFTVIQLVGM----------LRGIAAGMKYLSEMNYVHRDLAARN 136

Query: 195 IVVKSDCTLKILDFGLAR-----TAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIW 247
           I+V S+   K+ DFGL+R     T+  T+   +   +  R + APE I    +    D+W
Sbjct: 137 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR-WTAPEAIAYRKFTSASDVW 195

Query: 248 SVGCIMGEMIRGG 260
           S G +M E++  G
Sbjct: 196 SYGIVMWEVMSYG 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 55.7 bits (134), Expect = 5e-09
 Identities = 48/215 (22%), Positives = 88/215 (40%), Gaps = 34/215 (15%)

Query: 59  ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           EL +  ++G  +     LG         ++ VAIK +     +         E ++M  +
Sbjct: 5   ELTLVQEIGSGQFGLVWLGY-----WLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKL 56

Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQML 174
           +H  ++ L    T +        + LV E M+    ++  +  +     E +  +   + 
Sbjct: 57  SHPKLVQLYGVCTERSP------ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVC 110

Query: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYVV 225
            G+ +L S+ +IHRDL   N +V  +  +K+ DFG+ R         + GT F +     
Sbjct: 111 EGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK---- 166

Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
              + +PEV     Y    D+WS G +M E+   G
Sbjct: 167 ---WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEG 198

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.8 bits (135), Expect = 5e-09
 Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 24/143 (16%)

Query: 141 DVYLVMELMDANLCQV---IQMDLDHE---RMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
           DV++ MELM   L ++   IQ  +  +   +M+  + + L  +K  H  G+IHRD+KPSN
Sbjct: 88  DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSN 145

Query: 195 IVVKSDCTLKILDFGLA----------RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENV 244
           I++ +   +K+ DFG++          R+AG    M P  +      P+      Y    
Sbjct: 146 ILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPK------YDIRA 199

Query: 245 DIWSVGCIMGEMIRGGVLFPGTD 267
           D+WS+G  + E+  G   +    
Sbjct: 200 DVWSLGISLVELATGQFPYKNCK 222

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 55.4 bits (134), Expect = 6e-09
 Identities = 50/182 (27%), Positives = 74/182 (40%), Gaps = 22/182 (12%)

Query: 90  VAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           VAIK L          +  +  E  +M   +H NII L    T  +       V ++ E 
Sbjct: 35  VAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP------VMIITEY 86

Query: 149 MDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSDCTLK 204
           M+         + D +     L  ML GI    K+L     +HRDL   NI+V S+   K
Sbjct: 87  MENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCK 146

Query: 205 ILDFGLARTAGTTFMMTPYVVTR------YYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
           + DFGL+R    +        T+       + APE I    +    D+WS G +M E++ 
Sbjct: 147 VSDFGLSRRLEDS---EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203

Query: 259 GG 260
            G
Sbjct: 204 YG 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.4 bits (133), Expect = 6e-09
 Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 27/200 (13%)

Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS 135
           LG GA         VA+K L R     T      +E K+M  + + NII LL        
Sbjct: 33  LGEGAPEFDGQPVLVAVKML-RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP 91

Query: 136 LEEFQDVYLVMELMD-ANLCQVIQM--------------DLDHERMSYLLYQMLCGIKHL 180
           L       ++ E M+  +L Q +                 +    + Y+  Q+  G+K+L
Sbjct: 92  L------CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL 145

Query: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTTFMMTPYVV--TRYYRAPEVIL 236
            S   +HRDL   N +V +  T+KI DFG++R   +G  + +    V   R+     ++L
Sbjct: 146 ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL 205

Query: 237 GMGYKENVDIWSVGCIMGEM 256
           G  +    D+W+ G  + EM
Sbjct: 206 GK-FTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 55.1 bits (132), Expect = 6e-09
 Identities = 52/192 (27%), Positives = 92/192 (47%), Gaps = 34/192 (17%)

Query: 90  VAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           VAIK L +P    T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E 
Sbjct: 33  VAIKTL-KPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVTEY 81

Query: 149 MD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
           M   +L   ++ +    L   ++  +  Q+  G+ ++     +HRDL+ +NI+V  +   
Sbjct: 82  MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 141

Query: 204 KILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
           K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++ 
Sbjct: 142 KVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILLT 194

Query: 255 EM-IRGGVLFPG 265
           E+  +G V +PG
Sbjct: 195 ELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 55.8 bits (134), Expect = 7e-09
 Identities = 26/67 (38%), Positives = 39/67 (58%), Gaps = 2/67 (2%)

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPY--VVT 226
           ++ Q+L G++ LH  GI+HRD+KP N++V  D  +KI+DFG A    T     P   ++ 
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLD 373

Query: 227 RYYRAPE 233
             Y  PE
Sbjct: 374 PRYSPPE 380

Length = 507

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 54.7 bits (131), Expect = 8e-09
 Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 29/171 (16%)

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMS 167
           +E ++MK + H  ++       P  ++   + +Y+V E M     L  + + D  + ++ 
Sbjct: 50  QEAQIMKKLRHDKLV-------PLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLP 102

Query: 168 YLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
            L+    Q+  G+ ++     IHRDL+ +NI+V  +   KI DFGLAR       TA  G
Sbjct: 103 QLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162

Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
             F +        + APE  L   +    D+WS G ++ E++ +G V +PG
Sbjct: 163 AKFPIK-------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 55.4 bits (133), Expect = 8e-09
 Identities = 47/193 (24%), Positives = 80/193 (41%), Gaps = 51/193 (26%)

Query: 135 SLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMS-YLLYQMLCGIKHLHSAGIIHRDLK 191
           S ++  ++Y VM+ +     +  +I+M +  E ++ + + ++ C ++ +H  G IHRD+K
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIK 128

Query: 192 PSNIVVKSDCTLKI----------------------------LDFG-------------- 209
           P NI++  D  +K+                            +DF               
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDR 188

Query: 210 ---LARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
              L R A       +    V T  Y APEV+L  GY +  D WSVG I+ EM+ G   F
Sbjct: 189 LKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248

Query: 264 PGTDHIDQWNKII 276
                ++   K+I
Sbjct: 249 LAQTPLETQMKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 55.4 bits (133), Expect = 9e-09
 Identities = 36/108 (33%), Positives = 53/108 (49%), Gaps = 11/108 (10%)

Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV------ 224
           +Q+  G++ L S   IHRDL   NI++  +  +KI DFGLAR     +    YV      
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRKGDAR 242

Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQ 271
           +   + APE I    Y    D+WS G ++ E+   G   +PG   ID+
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDE 289

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.3 bits (133), Expect = 9e-09
 Identities = 40/115 (34%), Positives = 53/115 (46%), Gaps = 10/115 (8%)

Query: 158 QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT 217
           ++ LD E +    YQ+  G+  L S   IHRDL   NI++      KI DFGLAR     
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 218 FMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + YVV    R      APE I    Y    D+WS G ++ E+   G   +PG
Sbjct: 268 ---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 2/60 (3%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL 60
           MLV+D +KRI+   AL H Y   + D  +   P   PYD S + R+  +D+WK L Y E+
Sbjct: 283 MLVLDSDKRITAAQALAHAYFAQYHDPDD--EPVADPYDQSFESRDLLIDEWKSLTYDEV 340

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 23/60 (38%), Positives = 37/60 (61%), Gaps = 2/60 (3%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFD-DAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           ML  +P KRI+V++AL HPY+  + D   E  A  P P+D  + + +   ++ KELI++E
Sbjct: 275 MLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFD-DLPKEKLKELIFEE 333

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 14/203 (6%)

Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA------------FTPQK 134
           + + AIK++        H   A     L KL +H NII LL A            + P  
Sbjct: 34  RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 93

Query: 135 SLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
           +L +F     V+E   A  +       L  +++ +    +  G+ +L     IHRDL   
Sbjct: 94  NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 153

Query: 194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
           NI+V  +   KI DFGL+R        T   +   + A E +    Y  N D+WS G ++
Sbjct: 154 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213

Query: 254 GEMIR-GGVLFPGTDHIDQWNKI 275
            E++  GG  + G    + + K+
Sbjct: 214 WEIVSLGGTPYCGMTCAELYEKL 236

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 15/161 (9%)

Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD------LDHE 164
           E  +M  + H N++ LL        +EE   +Y+V E M A    V  +       L  +
Sbjct: 49  EASVMTQLRHSNLVQLLGVI-----VEEKGGLYIVTEYM-AKGSLVDYLRSRGRSVLGGD 102

Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
            +      +   +++L +   +HRDL   N++V  D   K+ DFGL + A +T       
Sbjct: 103 CLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 162

Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFP 264
           V   + APE +    +    D+WS G ++ E+   G V +P
Sbjct: 163 VK--WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 49/198 (24%), Positives = 73/198 (36%), Gaps = 49/198 (24%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+K L     N    K   RE +L+    H+NI+      T            +V E M
Sbjct: 38  VAVKTLKETASNDAR-KDFEREAELLTNFQHENIVKFYGVCTEGDPP------IMVFEYM 90

Query: 150 --------------DANLCQVIQMDLDH-----ERMSYLLYQMLCGIKHLHSAGIIHRDL 190
                         DA    +   D         ++  +  Q+  G+ +L S   +HRDL
Sbjct: 91  EHGDLNKFLRSHGPDAAF--LKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDL 148

Query: 191 KPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGM 238
              N +V  D  +KI DFG++R   T         T YYR             PE I+  
Sbjct: 149 ATRNCLVGYDLVVKIGDFGMSRDVYT---------TDYYRVGGHTMLPIRWMPPESIMYR 199

Query: 239 GYKENVDIWSVGCIMGEM 256
            +    D+WS G ++ E+
Sbjct: 200 KFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 40/217 (18%)

Query: 76  LGAG-------AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LGAG         Y+ +T+  VA+K L     +V   +    E  LMK + H  ++ L  
Sbjct: 14  LGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSV---QAFLEEANLMKTLQHDKLVRLYA 68

Query: 129 AFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSYLLY----QMLCGIKHLHSA 183
             T +      + +Y++ E M   +L   ++ D   + +   L     Q+  G+ ++   
Sbjct: 69  VVTKE------EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEV 234
             IHRDL+ +N++V      KI DFGLAR       TA  G  F +        + APE 
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEA 175

Query: 235 ILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHID 270
           I    +    D+WS G ++ E++  G + +PG  + D
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 53.7 bits (129), Expect = 2e-08
 Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 41/225 (18%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           D  +Q  VA+K +       +  +    E   MK  +H N++ L+       SL++    
Sbjct: 23  DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82

Query: 143 YLVMELMDANLCQVIQMDLDHERMSYLLY------------QML--------CGIKHLHS 182
            +++  M          DL     S+LLY            Q L         G+++L +
Sbjct: 83  MVILPFMKHG-------DLH----SFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN 131

Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP------EVIL 236
              IHRDL   N +++ D T+ + DFGL++     +    Y   R  + P      E + 
Sbjct: 132 RNFIHRDLAARNCMLREDMTVCVADFGLSK---KIYSGDYYRQGRIAKMPVKWIAIESLA 188

Query: 237 GMGYKENVDIWSVGCIMGE-MIRGGVLFPGTDHIDQWNKIIGKMR 280
              Y    D+W+ G  M E   RG   +PG ++ + ++ +    R
Sbjct: 189 DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 53.6 bits (129), Expect = 2e-08
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 32/183 (17%)

Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E  +M+  +H +I+ L+   T          V++VMEL     + + L QV +  LD   
Sbjct: 57  EAYIMRQFDHPHIVKLIGVITENP-------VWIVMELAPLGELRSYL-QVNKYSLDLAS 108

Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAGTT 217
           +    YQ+   + +L S   +HRD+   N++V S   +K+ DFGL+R         A   
Sbjct: 109 LILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG 168

Query: 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKII 276
            +   ++      APE I    +    D+W  G  M E++  GV  F G  +    N +I
Sbjct: 169 KLPIKWM------APESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----NDVI 218

Query: 277 GKM 279
           G++
Sbjct: 219 GRI 221

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 4/89 (4%)

Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT---FMMTPYV-VTR 227
           Q+  G+++L S   IHRDL   NI++ SD  +KI DFGL R        ++M  ++ V  
Sbjct: 105 QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164

Query: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEM 256
            + APE +    +    D+W  G  + EM
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.4 bits (128), Expect = 3e-08
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 52/204 (25%)

Query: 82  YDTA---TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE 138
           YD A   T + VA+K L R      +     +E  ++K + H+NI+      + Q     
Sbjct: 25  YDPANDGTGEMVAVKTLKRE-CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG--- 80

Query: 139 FQDVYLVMELM------------DANLCQVIQMDLDHERMSYLLYQMLC-GIKHLHSAGI 185
            + + L+ME +              NL Q++           L  Q +C G+ +LHS   
Sbjct: 81  -KGLQLIMEYVPLGSLRDYLPKHKLNLAQLL-----------LFAQQICEGMAYLHSQHY 128

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APE 233
           IHRDL   N+++ +D  +KI DFGLA+               YYR            A E
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE--------YYRVREDGDSPVFWYAVE 180

Query: 234 VILGMGYKENVDIWSVGCIMGEMI 257
            +    +    D+WS G  + E++
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 44/185 (23%), Positives = 84/185 (45%), Gaps = 30/185 (16%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           +++ VA+K L     +        RE  +M+ +++  I+ ++        + E +   LV
Sbjct: 21  SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI-------GICEAESWMLV 73

Query: 146 MELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
           MEL +   L + +Q +  +  + ++ L++Q+  G+K+L     +HRDL   N+++ +   
Sbjct: 74  MELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY 133

Query: 203 LKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVG 250
            KI DFGL++  G            YY+            APE +    +    D+WS G
Sbjct: 134 AKISDFGLSKALGAD--------ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFG 185

Query: 251 CIMGE 255
            +M E
Sbjct: 186 VLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.9 bits (128), Expect = 4e-08
 Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 15/151 (9%)

Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD--LDHERMSYLL 170
           LMK  ++ N I L  + T  K         L+M+ + D +L  +++ +  L    +  ++
Sbjct: 64  LMK--DNPNFIKLYYSVTTLK------GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKII 115

Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIV-VKSDCTLKILDFGLARTAGTTFMMTPYVVTRYY 229
            Q++  +  LH   IIH D+K  N++  ++   + + D+GL +  GT       +    Y
Sbjct: 116 RQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD---Y 172

Query: 230 RAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            +PE I G  Y  + D W+VG +  E++ G 
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 53.0 bits (127), Expect = 4e-08
 Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 31/220 (14%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           +  + Q VA+K L     + +  +   RE   MK  +H N+I L+      ++       
Sbjct: 23  EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82

Query: 143 YLVMELMD-ANLCQVIQMDLDHERMSYLLYQML--------CGIKHLHSAGIIHRDLKPS 193
            +++  M   +L   + M    E    L  Q L         G+++L S   IHRDL   
Sbjct: 83  MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAAR 142

Query: 194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYK 241
           N ++  + T+ + DFGL++   +           YYR            A E +    Y 
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYS---------GDYYRQGCASKLPVKWLALESLADNVYT 193

Query: 242 ENVDIWSVGCIMGE-MIRGGVLFPGTDHIDQWNKIIGKMR 280
            + D+W+ G  M E M RG   + G ++ + +N +I   R
Sbjct: 194 THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 52.3 bits (125), Expect = 5e-08
 Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 41/212 (19%)

Query: 76  LGAG-------AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LGAG       A Y+  T+  VA+K +     +V        E  +MK + H  ++ L  
Sbjct: 14  LGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVE---AFLAEANVMKTLQHDKLVKLHA 68

Query: 129 AFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHE----RMSYLLYQMLCGIKHLHSA 183
             T +        +Y++ E M   +L   ++ D   +    ++     Q+  G+  +   
Sbjct: 69  VVTKEP-------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLART---------AGTTFMMTPYVVTRYYRAPEV 234
             IHRDL+ +NI+V +    KI DFGLAR           G  F +        + APE 
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEA 174

Query: 235 ILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
           I    +    D+WS G ++ E++  G + +PG
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 54/196 (27%), Positives = 83/196 (42%), Gaps = 42/196 (21%)

Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS---- 135
           A  D  T ++V IK   R     T A        +++ +NH +II L   FT  K     
Sbjct: 110 ACIDNKTCEHVVIKAGQRG-GTATEAH-------ILRAINHPSIIQLKGTFTYNKFTCLI 161

Query: 136 LEEFQ-DVYLVM-ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
           L  ++ D+Y  +    +  +C ++ +    ER       +L  I++LH   IIHRD+K  
Sbjct: 162 LPRYKTDLYCYLAAKRNIAICDILAI----ER------SVLRAIQYLHENRIIHRDIKAE 211

Query: 194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVVT--RYY--------RAPEVILGMGYKEN 243
           NI +     + + DFG A          P  +   +YY         APE++    Y   
Sbjct: 212 NIFINHPGDVCLGDFGAA--------CFPVDINANKYYGWAGTIATNAPELLARDPYGPA 263

Query: 244 VDIWSVGCIMGEMIRG 259
           VDIWS G ++ EM   
Sbjct: 264 VDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 52.1 bits (125), Expect = 8e-08
 Identities = 47/204 (23%), Positives = 82/204 (40%), Gaps = 41/204 (20%)

Query: 83  DTATQQNVAIKKL-SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD 141
           +   +  V +K L     +N+    R  RE  + + ++HKN++ LL          E + 
Sbjct: 31  EEGGETLVLVKALQKTKDENLQSEFR--RELDMFRKLSHKNVVRLLGL------CREAEP 82

Query: 142 VYLVMELMD-ANLCQVIQMDLDHERMSY-----------LLYQMLCGIKHLHSAGIIHRD 189
            Y+++E  D  +L Q ++     +               L  Q+  G+ HL +A  +HRD
Sbjct: 83  HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRD 142

Query: 190 LKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR-----------APEVILGM 238
           L   N +V S   +K+    L++          Y  + YY+           APE +   
Sbjct: 143 LAARNCLVSSQREVKVSLLSLSK--------DVY-NSEYYKLRNALIPLRWLAPEAVQED 193

Query: 239 GYKENVDIWSVGCIMGEMIRGGVL 262
            +    D+WS G +M E+   G L
Sbjct: 194 DFSTKSDVWSFGVLMWEVFTQGEL 217

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 52.0 bits (124), Expect = 8e-08
 Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 47/228 (20%)

Query: 69  KRHN---TSHLGAGA--------AYDTATQQN---VAIKKLSRPFQNVTHAKRAYREFKL 114
           KRHN      LG GA         Y+   +Q+   VA+K L     N    K  +RE +L
Sbjct: 3   KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAEL 60

Query: 115 MKLVNHKNII---GLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM-------DLDHE 164
           +  + H++I+   G+     P   + E+     + + + A+    + M       +L   
Sbjct: 61  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120

Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           +M ++  Q+  G+ +L S   +HRDL   N +V  +  +KI DFG++R   +        
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS-------- 172

Query: 225 VTRYYRA------------PEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            T YYR             PE I+   +    D+WS+G ++ E+   G
Sbjct: 173 -TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYG 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.3 bits (125), Expect = 9e-08
 Identities = 35/102 (34%), Positives = 49/102 (48%), Gaps = 10/102 (9%)

Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR 230
           +Q+  G++ L S   IHRDL   NI++  +  +KI DFGLAR     +    YV     R
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRKGSAR 237

Query: 231 ------APEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
                 APE I    Y    D+WS G ++ E+   G   +PG
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 52.3 bits (125), Expect = 9e-08
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 16/104 (15%)

Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMT 221
           YQ+  G++ L S   +HRDL   N+++     +KI DFGLAR         + G+TF+  
Sbjct: 246 YQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFP 264
            ++      APE I    Y    D+WS G ++ E+   GG  +P
Sbjct: 306 KWM------APESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 22/60 (36%), Positives = 38/60 (63%), Gaps = 2/60 (3%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL 60
           +L  DP KRISV++AL HPY+ +W D  +       P+D S  E E ++++ +++I +E+
Sbjct: 275 LLAFDPTKRISVEEALEHPYLAIWHDPDD-EPVCQKPFDFSF-ESEDSMEELRDMIIEEV 332

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 31/168 (18%)

Query: 124 IGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVI------QMDLDHERM---------- 166
           I +L   T  K+ +E  D   VM  +D  ++ +++      Q+ L  + M          
Sbjct: 41  IKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVR 100

Query: 167 -------SYLLY----QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--- 212
                  S  L     Q+  G+ +L    ++HRDL   N++VK+   +KI DFGLA+   
Sbjct: 101 NHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160

Query: 213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
                +      V   + A E IL   Y    D+WS G  + E++  G
Sbjct: 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFG 208

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 57/222 (25%), Positives = 82/222 (36%), Gaps = 64/222 (28%)

Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
              VA+K L +        K   +E  LM   NH NI+ LL      +        Y++M
Sbjct: 26  PIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP------QYIIM 78

Query: 147 ELMDA--------------------NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGII 186
           ELM+                      L +++ + LD  +    L QM     H      I
Sbjct: 79  ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-----HF-----I 128

Query: 187 HRDLKPSNIVVKS-----DCTLKILDFGLARTAGTTFMMTPYVVTRYYR----------- 230
           HRDL   N +V       D  +KI DFGLAR             + YYR           
Sbjct: 129 HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK---------SDYYRKEGEGLLPVRW 179

Query: 231 -APEVILGMGYKENVDIWSVGCIMGE-MIRGGVLFPGTDHID 270
            APE +L   +    D+WS G +M E +  G   +P  ++ +
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 35/102 (34%), Positives = 49/102 (48%), Gaps = 10/102 (9%)

Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR 230
           +Q+  G++ L S   IHRDL   NI++  +  +KI DFGLAR     +    YV     R
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRKGDAR 236

Query: 231 ------APEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
                 APE I    Y    D+WS G ++ E+   G   +PG
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 26/64 (40%), Positives = 35/64 (54%), Gaps = 11/64 (17%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGP-----YDHSVDEREHTVDQWKEL 55
           MLV DP+KRIS  +AL HPY+      A  H P   P     +D S ++ +  VD WK +
Sbjct: 271 MLVFDPQKRISAAEALAHPYL------APYHDPTDEPVAEEKFDWSFNDADLPVDTWKVM 324

Query: 56  IYQE 59
           +Y E
Sbjct: 325 MYSE 328

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.5 bits (120), Expect = 3e-07
 Identities = 56/210 (26%), Positives = 84/210 (40%), Gaps = 28/210 (13%)

Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA------------FTPQK 134
           + + AIK++        H   A     L KL +H NII LL A            + P  
Sbjct: 22  RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81

Query: 135 SLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC--------GIKHLHSAGII 186
           +L +F     V+E   A         + +   S L  Q L         G+ +L     I
Sbjct: 82  NLLDFLRKSRVLETDPA-------FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 134

Query: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
           HRDL   NI+V  +   KI DFGL+R        T   +   + A E +    Y  N D+
Sbjct: 135 HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDV 194

Query: 247 WSVGCIMGEMIR-GGVLFPGTDHIDQWNKI 275
           WS G ++ E++  GG  + G    + + K+
Sbjct: 195 WSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 18/65 (27%), Positives = 36/65 (55%), Gaps = 2/65 (3%)

Query: 144 LVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
           +VME ++     + ++ LD E    +L ++L  ++  +  GI+H DL   NI+V  D  +
Sbjct: 184 VVMEYIEGVE--LYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI 241

Query: 204 KILDF 208
            ++D+
Sbjct: 242 VVIDW 246

Length = 304

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 34/104 (32%), Positives = 48/104 (46%), Gaps = 13/104 (12%)

Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMM 220
           LD + +     Q+  G+  L S   IHRD+   N+++      KI DFGLAR      +M
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARD-----IM 263

Query: 221 --TPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEM 256
             + YVV    R      APE I    Y    D+WS G ++ E+
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 49.8 bits (119), Expect = 4e-07
 Identities = 47/196 (23%), Positives = 89/196 (45%), Gaps = 20/196 (10%)

Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
           + + A+K L+R   ++   ++  +E  +MK  +H N++ LL    P +       + ++ 
Sbjct: 23  KIHCAVKSLNR-ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSP----LVVLP 77

Query: 147 ELMDANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
            +   +L   I+ +  +  +  L+    Q+  G+++L S   +HRDL   N ++    T+
Sbjct: 78  YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTV 137

Query: 204 KILDFGLARTAGTTFMMTPYVVTRY--------YRAPEVILGMGYKENVDIWSVGCIMGE 255
           K+ DFGLAR     +    Y V  +        + A E +    +    D+WS G ++ E
Sbjct: 138 KVADFGLAR---DIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 194

Query: 256 -MIRGGVLFPGTDHID 270
            M RG   +P  D  D
Sbjct: 195 LMTRGAPPYPDVDSFD 210

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 57/210 (27%), Positives = 83/210 (39%), Gaps = 28/210 (13%)

Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA------------FTPQK 134
           + N AIK L        H   A     L KL +H NII LL A            + P  
Sbjct: 29  KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYG 88

Query: 135 SLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC--------GIKHLHSAGII 186
           +L +F     V+E   A          +H   S L  Q L         G+++L     I
Sbjct: 89  NLLDFLRKSRVLETDPA-------FAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFI 141

Query: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
           HRDL   N++V  +   KI DFGL+R        T   +   + A E +    Y    D+
Sbjct: 142 HRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDV 201

Query: 247 WSVGCIMGEMIR-GGVLFPGTDHIDQWNKI 275
           WS G ++ E++  GG  + G    + + K+
Sbjct: 202 WSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 49.2 bits (117), Expect = 8e-07
 Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 38/197 (19%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG----------LLNAFTPQK--SLE 137
           VA+K L  P   +   K   RE +L+  + H++I+           L+  F   K   L 
Sbjct: 38  VAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95

Query: 138 EFQDVY--LVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
           +F   +    M L+D    Q  + +L   +M ++  Q+  G+ +L S   +HRDL   N 
Sbjct: 96  KFLRAHGPDAMILVDGQPRQA-KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNC 154

Query: 196 VVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRA------------PEVILGMGYKEN 243
           +V ++  +KI DFG++R   +         T YYR             PE I+   +   
Sbjct: 155 LVGANLLVKIGDFGMSRDVYS---------TDYYRVGGHTMLPIRWMPPESIMYRKFTTE 205

Query: 244 VDIWSVGCIMGEMIRGG 260
            D+WS G I+ E+   G
Sbjct: 206 SDVWSFGVILWEIFTYG 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 46/195 (23%), Positives = 87/195 (44%), Gaps = 27/195 (13%)

Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLMKL-VNHKNIIGLLN------------AFTPQK 134
           Q VAIK L    +     +  ++   +M+  + H NI+ LL             ++    
Sbjct: 36  QAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93

Query: 135 SLEEFQDVYLVMELMDANLC-----QVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
            L EF    LVM    +++      + ++  L+     +++ Q+  G++ L S  ++H+D
Sbjct: 94  DLHEF----LVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKD 149

Query: 190 LKPSNIVVKSDCTLKILDFGLAR---TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
           L   N++V     +KI D GL R    A    +M   ++   + +PE I+   +  + DI
Sbjct: 150 LATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDI 209

Query: 247 WSVGCIMGEMIRGGV 261
           WS G ++ E+   G+
Sbjct: 210 WSYGVVLWEVFSYGL 224

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 40/127 (31%), Positives = 59/127 (46%), Gaps = 7/127 (5%)

Query: 142 VYLVMELMDAN-LCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVV 197
           V LV +LM    L   ++ + D      LL    Q+  G+ +L    ++HRDL   N++V
Sbjct: 83  VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV 142

Query: 198 KSDCTLKILDFGLARTAG---TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
           KS   +KI DFGLAR      T +      V   + A E IL   +    D+WS G  + 
Sbjct: 143 KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVW 202

Query: 255 EMIRGGV 261
           E++  G 
Sbjct: 203 ELMTFGA 209

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 50/203 (24%), Positives = 81/203 (39%), Gaps = 51/203 (25%)

Query: 90  VAIKKLSRPFQNVTHAKRA--YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
           VA+K L    +  + + R    RE +L+ ++ H++I+      T      E + + +V E
Sbjct: 38  VAVKAL----KEASESARQDFQREAELLTVLQHQHIVRFYGVCT------EGRPLLMVFE 87

Query: 148 LM--------------DANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
            M              DA +    +      L   +M  +  Q+  G+ +L S   +HRD
Sbjct: 88  YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRD 147

Query: 190 LKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRA------------PEVILG 237
           L   N +V     +KI DFG++R   +         T YYR             PE IL 
Sbjct: 148 LATRNCLVGQGLVVKIGDFGMSRDIYS---------TDYYRVGGRTMLPIRWMPPESILY 198

Query: 238 MGYKENVDIWSVGCIMGEMIRGG 260
             +    DIWS G ++ E+   G
Sbjct: 199 RKFTTESDIWSFGVVLWEIFTYG 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.0 bits (114), Expect = 1e-06
 Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 26/187 (13%)

Query: 87  QQNVAIKKL-SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           Q +VAIK L +   ++V       RE ++M  +++  I+ ++        + E + + LV
Sbjct: 22  QIDVAIKVLKNENEKSVR--DEMMREAEIMHQLDNPYIVRMI-------GVCEAEALMLV 72

Query: 146 MELMDAN-LCQVIQMDLDH---ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
           ME+     L + +    D      +  L++Q+  G+K+L     +HRDL   N+++ +  
Sbjct: 73  MEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH 132

Query: 202 TLKILDFGLARTAGT--------TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
             KI DFGL++  G         +    P    ++Y APE I    +    D+WS G  M
Sbjct: 133 YAKISDFGLSKALGADDSYYKARSAGKWPL---KWY-APECINFRKFSSRSDVWSYGITM 188

Query: 254 GEMIRGG 260
            E    G
Sbjct: 189 WEAFSYG 195

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 26/211 (12%)

Query: 79  GAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE 138
           G A+   ++  V +K+L R            +E +  + +NH N++  L          E
Sbjct: 14  GEAHRGMSKARVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQCLG------QCIE 66

Query: 139 FQDVYLVMELMD-ANLCQVIQMDLDHERM---SYLLYQMLC----GIKHLHSAGIIHRDL 190
                LV+E     +L   ++ +           +L +M C    G+  LH A  IH DL
Sbjct: 67  SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDL 126

Query: 191 KPSNIVVKSDCTLKILDFGLARTA-GTTFMMTP--YVVTRYYRAPEV-------ILGMGY 240
              N  + +D ++KI D+GLA       + +T   + V   + APE+       +L    
Sbjct: 127 ALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ 186

Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ 271
            +  +IWS+G  M E+       P  D  D+
Sbjct: 187 TKKSNIWSLGVTMWELFTAADQ-PYPDLSDE 216

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 26/186 (13%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT---PQKSLEEFQDVYLVM 146
           VA+K L R   N        +E K+M  +   NII LL       P   + E+      M
Sbjct: 49  VAVKML-REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEY------M 101

Query: 147 ELMDAN--LCQV-IQMDLDHERMSYLLYQMLC--------GIKHLHSAGIIHRDLKPSNI 195
           E  D N  L +   Q   +   +  + Y  L         G+K+L S   +HRDL   N 
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161

Query: 196 VVKSDCTLKILDFGLART--AGTTFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGC 251
           +V  + T+KI DFG++R   +G  + +    V   R+     ++LG  +    D+W+ G 
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGV 220

Query: 252 IMGEMI 257
            + E++
Sbjct: 221 TLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 47.2 bits (112), Expect = 3e-06
 Identities = 29/89 (32%), Positives = 47/89 (52%), Gaps = 3/89 (3%)

Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTTFMMTPYVVTRY- 228
           Q+  G+K+L S   +HRDL   N +V  + T+KI DFG++R   AG  + +    V    
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR 205

Query: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMI 257
           + A E IL   +    D+W+ G  + E++
Sbjct: 206 WMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 23/60 (38%), Positives = 35/60 (58%), Gaps = 3/60 (5%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPA-PGPYDHSVDEREHTVDQWKELIYQE 59
           ML  DPE+RI+V+ AL HP++  + D  +   P  P P+D   +  E + +Q KE I +E
Sbjct: 277 MLQFDPEERITVEQALQHPFLAQYHDPDD--EPTCPPPFDFDFEAIELSREQLKEAIVKE 334

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 24/90 (26%)

Query: 1   MLVIDPEKRISVDDALMHPYIN---------------------VWFDDAEVHAPAPGPYD 39
           MLV DP+KRIS  DAL HPY++                     V+  D E    A  P+D
Sbjct: 271 MLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFE--PSANPPFD 328

Query: 40  HSVDEREHTVDQWKELIYQELPISHQMGKK 69
              ++   +V Q KE ++Q   +  Q G +
Sbjct: 329 DEYEKNLTSVRQVKEELHQ-FILEQQQGNR 357

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 46.4 bits (111), Expect = 4e-06
 Identities = 18/33 (54%), Positives = 24/33 (72%), Gaps = 1/33 (3%)

Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212
           LH AGI+H DL  SNI+V+ D  L ++DFGL +
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGK 137

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 46.9 bits (111), Expect = 4e-06
 Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 29/220 (13%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+K +       +  +    E   MK  +H N++ L+         E +    +++  M
Sbjct: 29  VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88

Query: 150 D-ANLCQVIQMDLDHERMSYLLYQMLC--------GIKHLHSAGIIHRDLKPSNIVVKSD 200
              +L   +      +   YL  QML         G+++L S   IHRDL   N ++  +
Sbjct: 89  KHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN 148

Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAP------EVILGMGYKENVDIWSVGCIMG 254
             + + DFGL++     +    Y   R  + P      E +    Y    D+WS G  M 
Sbjct: 149 MNVCVADFGLSK---KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMW 205

Query: 255 EM-IRGGVLFPGT------DHIDQWNKIIGKMREAHDKLD 287
           E+  RG   +PG       D++ Q N    ++++  D LD
Sbjct: 206 EIATRGQTPYPGVENSEIYDYLRQGN----RLKQPPDCLD 241

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 46.1 bits (110), Expect = 5e-06
 Identities = 18/37 (48%), Positives = 25/37 (67%), Gaps = 1/37 (2%)

Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
           LHSAGIIH DL  SN+++ S   + ++DFGLA  +  
Sbjct: 111 LHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAEFSKD 146

Length = 211

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 46.0 bits (109), Expect = 8e-06
 Identities = 50/203 (24%), Positives = 71/203 (34%), Gaps = 41/203 (20%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK------------SLE 137
           VA+K L         A    RE  LM   +H NI+ LL      K             L 
Sbjct: 38  VAVKMLKEEASADMQAD-FQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96

Query: 138 EF-------QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL 190
           EF           L      A  C +  + L       +  Q+  G+ +L     +HRDL
Sbjct: 97  EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156

Query: 191 KPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRA------------PEVILGM 238
              N +V  +  +KI DFGL+R               YY+A            PE I   
Sbjct: 157 ATRNCLVGENMVVKIADFGLSRNI---------YSADYYKASENDAIPIRWMPPESIFYN 207

Query: 239 GYKENVDIWSVGCIMGEMIRGGV 261
            Y    D+W+ G ++ E+   G+
Sbjct: 208 RYTTESDVWAYGVVLWEIFSYGM 230

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 18/66 (27%), Positives = 37/66 (56%), Gaps = 12/66 (18%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGP-YDHSV-----DEREHTVDQWKE 54
           +LV +P KR++ ++AL HPY+      A+ H P+  P   + +     D  + +V +++ 
Sbjct: 278 LLVFNPNKRLTAEEALEHPYV------AQFHNPSDEPVLPYPITIPLDDNVKLSVAEYRN 331

Query: 55  LIYQEL 60
            +Y+E+
Sbjct: 332 KLYEEI 337

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 3/92 (3%)

Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRY 228
           Q+  G+ +L    ++HRDL   N++VK+   +KI DFGLA+  G     +      V   
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
           + A E IL   Y    D+WS G  + E++  G
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFG 208

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 24/68 (35%), Positives = 39/68 (57%), Gaps = 3/68 (4%)

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLART--AGTTFMMTPYVV 225
           ++ Q+L  +  LHS GI+HRD+KP NI+  +   + KI+D G A     G  ++   +++
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL 319

Query: 226 TRYYRAPE 233
              Y APE
Sbjct: 320 DPRYAAPE 327

Length = 566

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 15/108 (13%)

Query: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTTFMMTP 222
           +RM+    ++  G+ HLH    IH DL   N ++ +D T+KI D+GL+       + +TP
Sbjct: 103 QRMAC---EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159

Query: 223 ---YVVTRYYRAPEVI-------LGMGYKENVDIWSVGCIMGEMIRGG 260
              +V  R+  APE++       L +   +  ++WS+G  + E+   G
Sbjct: 160 DQLWVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELG 206

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 27/92 (29%), Positives = 47/92 (51%), Gaps = 9/92 (9%)

Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV----TR 227
           Q+ CG+ +LH  G+IH+D+   N V+  +  +KI D  L+R     F M  + +     R
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCLGDNENR 181

Query: 228 YYR--APEVILGMGYKENVDIWSVGCIMGEMI 257
             +  A E ++   Y    D+WS G ++ E++
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 43.9 bits (103), Expect = 4e-05
 Identities = 27/93 (29%), Positives = 42/93 (45%), Gaps = 21/93 (22%)

Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR----- 230
           G+ +L++   +HRDL   N +V  D T+KI DFG+ R             T YYR     
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE---------TDYYRKGGKG 181

Query: 231 -------APEVILGMGYKENVDIWSVGCIMGEM 256
                  +PE +    +    D+WS G ++ E+
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 42.7 bits (101), Expect = 6e-05
 Identities = 15/34 (44%), Positives = 20/34 (58%), Gaps = 1/34 (2%)

Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
           LH AGI+H DL  SNI++     +  +DFGL   
Sbjct: 108 LHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140

Length = 204

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 43.2 bits (102), Expect = 6e-05
 Identities = 50/208 (24%), Positives = 81/208 (38%), Gaps = 44/208 (21%)

Query: 85  ATQQNVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
           A +  VA+K  + P       +  +  E  +M   NH+NI+ L+       S E     +
Sbjct: 34  AVELQVAVK--TLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGV-----SFER-LPRF 85

Query: 144 LVMELMDA-NLCQVIQMDLDHE------RMSYLLY---QMLCGIKHLHSAGIIHRDLKPS 193
           +++ELM   +L   ++ +           M  LL+    +  G K+L     IHRD+   
Sbjct: 86  ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAAR 145

Query: 194 NIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGM 238
           N ++         KI DFG+AR               YYR             PE  L  
Sbjct: 146 NCLLTCKGPGRVAKIADFGMARDI---------YRASYYRKGGRAMLPIKWMPPEAFLDG 196

Query: 239 GYKENVDIWSVGCIMGEMIRGGVL-FPG 265
            +    D+WS G ++ E+   G + +PG
Sbjct: 197 IFTSKTDVWSFGVLLWEIFSLGYMPYPG 224

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 43.7 bits (104), Expect = 7e-05
 Identities = 16/33 (48%), Positives = 22/33 (66%), Gaps = 1/33 (3%)

Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212
           LH AGI+H DL  SN +V+ D    ++DFGL +
Sbjct: 444 LHKAGIVHGDLTTSNFIVRDDRLY-LIDFGLGK 475

Length = 535

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 43.0 bits (101), Expect = 7e-05
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 3/103 (2%)

Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTT 217
           LD +R+     Q+  G+ +L    ++HR+L   NI++KSD  ++I DFG+A         
Sbjct: 106 LDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165

Query: 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
           +  + +     + A E IL   Y    D+WS G  + EM+  G
Sbjct: 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYG 208

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 43.1 bits (101), Expect = 9e-05
 Identities = 47/168 (27%), Positives = 68/168 (40%), Gaps = 31/168 (18%)

Query: 124 IGLLNAFTPQKSLEEFQDVYLVMELMD---------ANLCQVIQM-----------DLDH 163
           I +LN  T  K+  EF D  L+M  MD           L   IQ+           D  H
Sbjct: 41  IKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVH 100

Query: 164 ERMSYLLYQMLC--------GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 214
           E    +  Q+L         G+ +L    ++HRDL   N++VKS   +KI DFGLAR   
Sbjct: 101 EHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160

Query: 215 --GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
                +      +   + A E I    +    D+WS G  + E++  G
Sbjct: 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 208

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 42.5 bits (101), Expect = 1e-04
 Identities = 12/21 (57%), Positives = 14/21 (66%)

Query: 1   MLVIDPEKRISVDDALMHPYI 21
           ML  +P KRIS  +AL HPY 
Sbjct: 262 MLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain

 Score = 41.7 bits (99), Expect = 1e-04
 Identities = 22/65 (33%), Positives = 34/65 (52%), Gaps = 5/65 (7%)

Query: 145 VMELMDAN-LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
           VME +D   L +V  ++   E    +L ++L  I   +  GIIH DL   NI+V  D  +
Sbjct: 109 VMEYIDGVELYRVRVLEDPEE----VLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164

Query: 204 KILDF 208
            I+D+
Sbjct: 165 YIIDW 169

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 2/91 (2%)

Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRA 231
           +M+  +  LH  GI+ RDL P+NI++     +++  F        +       V   Y A
Sbjct: 93  EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCA 150

Query: 232 PEVILGMGYKENVDIWSVGCIMGEMIRGGVL 262
           PEV       E  D WS+G I+ E++ G  L
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 28/93 (30%), Positives = 43/93 (46%), Gaps = 21/93 (22%)

Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR----- 230
           G+ +L++   +HRDL   N +V  D T+KI DFG+ R             T YYR     
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE---------TDYYRKGGKG 181

Query: 231 -------APEVILGMGYKENVDIWSVGCIMGEM 256
                  APE +    +  + D+WS G ++ E+
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 40.8 bits (96), Expect = 2e-04
 Identities = 26/103 (25%), Positives = 41/103 (39%), Gaps = 16/103 (15%)

Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMM 220
           L+ E +  +  Q L  ++ LH        L   + ++K D              G+    
Sbjct: 14  LNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLD--------------GSVAFK 59

Query: 221 TPYV--VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGV 261
           TP       Y+ APEVI G  Y E  DI+S+G  + E +   +
Sbjct: 60  TPEQSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYEL 102

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 39.2 bits (92), Expect = 0.001
 Identities = 12/21 (57%), Positives = 14/21 (66%)

Query: 1   MLVIDPEKRISVDDALMHPYI 21
           ML  DP KRI+ + AL HPY 
Sbjct: 263 MLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.2 bits (89), Expect = 0.001
 Identities = 26/118 (22%), Positives = 49/118 (41%), Gaps = 9/118 (7%)

Query: 97  RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ--KSLEEFQDVYLVMELMDANLC 154
           +   +        RE  +++L+  K +        P+   S E     YL+ME ++    
Sbjct: 27  KINPSREKGADREREVAILQLLARKGL------PVPKVLASGESDGWSYLLMEWIEGETL 80

Query: 155 QVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212
             +  + + E ++  L ++L  +  L    + H DL P NI+V     L I+D+  A 
Sbjct: 81  DEVS-EEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 38.4 bits (89), Expect = 0.003
 Identities = 28/96 (29%), Positives = 43/96 (44%), Gaps = 6/96 (6%)

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTTFMMTPYV 224
           +L  +  G+K+L   G +H+ L    ++V SD   KI  F   +     A  T M     
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSP 171

Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
           V   + APE I    +    D+WS G +M E++  G
Sbjct: 172 V--LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYG 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 37.9 bits (89), Expect = 0.004
 Identities = 12/21 (57%), Positives = 15/21 (71%)

Query: 1   MLVIDPEKRISVDDALMHPYI 21
           +L +DP+KRIS D AL H Y 
Sbjct: 267 LLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	288
KOG0595|consensus	429		100.0
KOG0600|consensus	560		100.0
KOG0593|consensus	396		100.0
KOG0598|consensus	357		100.0
KOG0581|consensus	364		100.0
KOG0616|consensus	355		100.0
KOG0659|consensus	318		100.0
KOG0615|consensus	475		100.0
KOG0575|consensus	592		100.0
KOG0192|consensus	362		100.0
KOG0591|consensus	375		100.0
KOG0663|consensus	419		100.0
KOG0667|consensus	586		100.0
KOG0197|consensus	468		100.0
KOG0658|consensus	364		100.0
KOG0592|consensus	604		100.0
KOG0661|consensus	538		100.0
KOG0660|consensus	359		100.0
KOG0597|consensus	808		100.0
KOG0583|consensus	370		100.0
KOG0588|consensus	786		100.0
KOG0594|consensus	323		100.0
KOG0605|consensus	550		100.0
KOG0611|consensus	668		100.0
KOG0694|consensus	694		100.0
KOG0585|consensus	576		100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG4717|consensus	864		100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG4721|consensus	904		100.0
KOG0578|consensus	550		100.0
KOG0193|consensus	678		100.0
KOG0033|consensus	355		100.0
KOG0582|consensus	516		100.0
KOG0580|consensus	281		100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0589|consensus	426		100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0610|consensus	459		100.0
KOG1187|consensus	361		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0198|consensus	313		100.0
KOG0194|consensus	474		100.0
KOG1026|consensus	774		100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0599|consensus	411		100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0665|consensus	369		100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0032|consensus	382		100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0662|consensus	292		100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG4236|consensus	888		100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0690|consensus	516		100.0
KOG0586|consensus	596		100.0
KOG0604|consensus	400		100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG1095|consensus	1025		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG4250|consensus	732		100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0201|consensus	467		100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0196|consensus	996		100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0614|consensus	732		100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG4257|consensus	974		100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG1094|consensus	807		100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0584|consensus	632		100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG1989|consensus	738		100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG1290|consensus	590		100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0984|consensus	282		100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0986|consensus	591		100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0666|consensus	438		100.0
KOG0669|consensus	376		100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0664|consensus	449		100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0612|consensus	1317		100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0983|consensus	391		100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG4278|consensus	1157		100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0671|consensus	415		100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0579|consensus	1187		100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0607|consensus	463		100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0199|consensus	1039		100.0
KOG0696|consensus	683		100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0670|consensus	752		100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0577|consensus	948		100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0574|consensus	502		100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG1035|consensus	1351		100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG1006|consensus	361		100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG2345|consensus	302		100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0668|consensus	338		100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG4645|consensus	1509		100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG4279|consensus	1226		100.0
KOG0596|consensus	677		100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG2052|consensus	513		100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0603|consensus	612		100.0
KOG3653|consensus	534		100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.98
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.98
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.98
PHA02882	294	putative serine/threonine kinase; Provisional	99.98
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.98
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.98
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.98
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.98
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.98
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.98
KOG0200|consensus	609		99.98
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.98
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.98
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.98
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.98
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.98
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.98
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
KOG0695|consensus	593		99.97
KOG0608|consensus	1034		99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
KOG0587|consensus	953		99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG1025|consensus	1177		99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1151|consensus	775		99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG1152|consensus	772		99.96
KOG1027|consensus	903		99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
KOG1167|consensus	418		99.95
KOG1345|consensus	378		99.94
KOG1024|consensus	563		99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.93
KOG1165|consensus	449		99.93
KOG0576|consensus	829		99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG1163|consensus	341		99.92
KOG1164|consensus	322		99.91
KOG0195|consensus	448		99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
KOG0590|consensus	601		99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
KOG0603|consensus	612		99.82
KOG1240|consensus	1431		99.81
KOG1166|consensus	974		99.78
PRK10345	210	hypothetical protein; Provisional	99.77
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
smart00090	237	RIO RIO-like kinase.	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
KOG4158|consensus	598		99.69
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
KOG1023|consensus	484		99.66
KOG1033|consensus	516		99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
KOG0606|consensus	1205		99.63
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
KOG1243|consensus	690		99.6
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.57
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.46
KOG0590|consensus	601		99.44
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
KOG0601|consensus	524		99.34
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.33
KOG1266|consensus	458		99.32
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.28
KOG3087|consensus	229		99.24
COG4248	637	Uncharacterized protein with protein kinase and he	99.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.15
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.11
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.06
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.98
KOG3741|consensus	655		98.98
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.98
KOG0601|consensus	524		98.95
KOG0606|consensus	1205		98.9
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.87
PRK09902	216	hypothetical protein; Provisional	98.76
KOG2137|consensus	700		98.75
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.57
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.39
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.32
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.21
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.18
KOG0576|consensus	829		98.16
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.11
KOG0665|consensus	369		98.06
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.05
PF01636	239	APH: Phosphotransferase enzyme family This family	98.01
KOG0660|consensus	359		97.93
KOG1235|consensus	538		97.83
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.82
PLN02876	822	acyl-CoA dehydrogenase	97.81
KOG2270|consensus	520		97.64
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	97.62
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	97.58
KOG1035|consensus	1351		97.54
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.5
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.44
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.44
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.4
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.39
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.25
PRK05231	319	homoserine kinase; Provisional	97.22
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	97.2
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.2
KOG2268|consensus	465		97.09
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	97.0
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.93
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.9
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.87
KOG1826|consensus	2724		96.85
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.77
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.67
PLN02756	418	S-methyl-5-thioribose kinase	96.44
KOG0033|consensus	355		96.32
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	96.19
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.15
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.1
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	95.91
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.85
KOG0663|consensus	419		95.85
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	95.79
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	95.56

>KOG0595|consensus

Probab=100.00  E-value=1.4e-47  Score=313.94  Aligned_cols=210  Identities=29%  Similarity=0.449  Sum_probs=188.0

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+...||.|.+.++|.|    +.+.++..||||.+.+...+.+..+.+..|+.+|+.++|||||.+++++...+.+ 
T Consensus        10 ~~y~~~~~iG~GsfavVykg----~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i-   84 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKG----RHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI-   84 (429)
T ss_pred             ccceehhhccCcceEEEEEe----EeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE-
Confidence            45566777999999999987    3567789999999998666778888899999999999999999999999988876 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC------CcEEEeec
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDF  208 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~------~~~kl~df  208 (288)
                           ++|||||.| +|.+++.  ..+++.+++.++.||+.||++||+++||||||||.|||++..      -.+||+||
T Consensus        85 -----~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   85 -----YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             -----EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence                 999999995 5666665  359999999999999999999999999999999999999875      45899999


Q ss_pred             ccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        209 GLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       209 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      |+|+.........+.+|++-|||||+++...|+.|+|+||+|+++|++++|.+||...+..+....+.+
T Consensus       160 GfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k  228 (429)
T KOG0595|consen  160 GFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK  228 (429)
T ss_pred             chhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence            999999888788888999999999999999999999999999999999999999999999888775543

>KOG0600|consensus

Probab=100.00  E-value=3e-46  Score=313.09  Aligned_cols=231  Identities=32%  Similarity=0.520  Sum_probs=202.0

Q ss_pred             ccHHHhhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCccee
Q psy11580         47 HTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGL  126 (288)
Q Consensus        47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~  126 (288)
                      +....|.......+...+.||+|.++.++.+    .+..+|+.||+|++..+........-..+|+.+|++|+||||+++
T Consensus       106 e~~~~w~~r~~~~feki~kIGeGTyg~VYkA----r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL  181 (560)
T KOG0600|consen  106 EALHGWGPRRADSFEKIEKIGEGTYGQVYKA----RDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKL  181 (560)
T ss_pred             cccccccccchHHHHHHHHhcCcchhheeEe----eecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccce
Confidence            3444555556667778888888888887764    678999999999999876666777788899999999999999999


Q ss_pred             eccccCCCcccccccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcE
Q psy11580        127 LNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL  203 (288)
Q Consensus       127 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~  203 (288)
                      .+..+....    ..+|||+|||+.+|..+...   .+++.++..++.||++||+|||.+||+|||||.+|||+|.+|.+
T Consensus       182 ~eivt~~~~----~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~L  257 (560)
T KOG0600|consen  182 EEIVTSKLS----GSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVL  257 (560)
T ss_pred             eeEEEecCC----ceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCE
Confidence            999987621    23599999999998887764   59999999999999999999999999999999999999999999


Q ss_pred             EEeecccccccCCCc--ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        204 KILDFGLARTAGTTF--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       204 kl~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ||+|||+|++.....  ..+..+.|..|+|||.+.| ..|+.+.|+||.||||.||+.|++.|+|.+..+++.+|.+.||
T Consensus       258 KiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcG  337 (560)
T KOG0600|consen  258 KIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCG  337 (560)
T ss_pred             EeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhC
Confidence            999999999665433  4577789999999999999 4699999999999999999999999999999999999999999


Q ss_pred             CCccC
Q psy11580        281 EAHDK  285 (288)
Q Consensus       281 ~~~~~  285 (288)
                      -|.++
T Consensus       338 SP~e~  342 (560)
T KOG0600|consen  338 SPTED  342 (560)
T ss_pred             CCChh
Confidence            87654

>KOG0593|consensus

Probab=100.00  E-value=2.4e-46  Score=295.79  Aligned_cols=199  Identities=35%  Similarity=0.607  Sum_probs=182.1

Q ss_pred             ceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccccHHHHHh-
Q psy11580         80 AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-  158 (288)
Q Consensus        80 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-  158 (288)
                      +|.++.||+.||||++..+..++.-.+-..+|+++|++++|+|+|.++.+|......      ++|+|||+.+.++.+. 
T Consensus        20 KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrkl------hLVFE~~dhTvL~eLe~   93 (396)
T KOG0593|consen   20 KCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKL------HLVFEYCDHTVLHELER   93 (396)
T ss_pred             EeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhccee------EEEeeecchHHHHHHHh
Confidence            477899999999999987655556566688999999999999999999999888766      9999999999887765 


Q ss_pred             --hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC-CCcccCCcccccccCchHhH
Q psy11580        159 --MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TTFMMTPYVVTRYYRAPEVI  235 (288)
Q Consensus       159 --~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~  235 (288)
                        ...+...+.+++.|++.|+.|+|++++|||||||+|||++.+|.+||||||+|+... .+...+.++.|..|+|||.+
T Consensus        94 ~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELL  173 (396)
T KOG0593|consen   94 YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELL  173 (396)
T ss_pred             ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhh
Confidence              458999999999999999999999999999999999999999999999999999876 55556778999999999999


Q ss_pred             hc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        236 LG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       236 ~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      .| .+|+...|||++||++.||++|.+.|+|.++.+++-.|...+|++.+
T Consensus       174 vGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p  223 (396)
T KOG0593|consen  174 VGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP  223 (396)
T ss_pred             cccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence            98 78999999999999999999999999999999999999999998765

>KOG0598|consensus

Probab=100.00  E-value=1.2e-45  Score=299.71  Aligned_cols=221  Identities=27%  Similarity=0.438  Sum_probs=193.4

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ...+++.+.+.+|+|.++.+++    |.+..+++.+|+|++++.. ...........|.++|.+++||.||+++..|.+.
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~----Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~   97 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQ----VRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE   97 (357)
T ss_pred             CChhheeeeeeeeccCCceEEE----EEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC
Confidence            3456788889999988887776    4567899999999998742 2334677889999999999999999999999888


Q ss_pred             CcccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        134 KSLEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      ..+      |+|+||+.|+ |+..+.  ..+++..++.++..|+.||.|||++|||||||||+|||++.+|.++|+|||+
T Consensus        98 ~kL------ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL  171 (357)
T KOG0598|consen   98 EKL------YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGL  171 (357)
T ss_pred             CeE------EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEecccc
Confidence            776      9999999985 666554  4599999999999999999999999999999999999999999999999999


Q ss_pred             ccc-cCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        211 ART-AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       211 ~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      ++. ...+....+.+||+.|||||++.+..++.++|.||||+++|+|++|.+||.+.+...++.+|.+.....++.
T Consensus       172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~  247 (357)
T KOG0598|consen  172 CKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG  247 (357)
T ss_pred             chhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc
Confidence            984 444555667899999999999999999999999999999999999999999999999999999887444443

>KOG0581|consensus

Probab=100.00  E-value=1.1e-45  Score=299.90  Aligned_cols=211  Identities=27%  Similarity=0.399  Sum_probs=181.1

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +...++.....+|+|-.+.++.    |.++.|++.+|+|++.. .......+++.+|+++++.++||+||.+||+|..++
T Consensus        76 i~~~dle~~~~lG~G~gG~V~k----v~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYK----VRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEE----EEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            4555677777777766555554    67889999999999943 345677889999999999999999999999999887


Q ss_pred             c-ccccccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        135 S-LEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       135 ~-~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      . +      .++||||+++.++.+..   .+++..+.+++.++++||.|||+ .+||||||||+|||++..|++||||||
T Consensus       151 ~~i------sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFG  224 (364)
T KOG0581|consen  151 EEI------SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFG  224 (364)
T ss_pred             ceE------EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecccc
Confidence            4 5      99999999987777664   49999999999999999999995 899999999999999999999999999


Q ss_pred             cccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CchhHHHHHHH
Q psy11580        210 LARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT-----DHIDQWNKIIG  277 (288)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~-----~~~~~~~~i~~  277 (288)
                      .|.....+ ...+++||..|||||.+.+..|+.++||||||+.++|++.|+.||...     +..+++..|+.
T Consensus       225 VS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~  296 (364)
T KOG0581|consen  225 VSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD  296 (364)
T ss_pred             ccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence            99887666 446789999999999999999999999999999999999999999874     34444444443

>KOG0616|consensus

Probab=100.00  E-value=5.4e-45  Score=287.24  Aligned_cols=220  Identities=25%  Similarity=0.431  Sum_probs=195.6

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ...+++.....+|.|.|+.+.+    |..+.+|..+|+|++++. .....+.+...+|..+|+.+.||+++++++.|.+.
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~L----Vr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~  116 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHL----VREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN  116 (355)
T ss_pred             cchhhhhheeeeccCccceEEE----EEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC
Confidence            3456777888889988888877    567788999999999863 33445567788999999999999999999999888


Q ss_pred             CcccccccEEEEEeccccc-HHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        134 KSLEEFQDVYLVMELMDAN-LCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      +.+      +|||||++|+ +++++.+  ++++..++.++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+
T Consensus       117 ~~l------ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGF  190 (355)
T KOG0616|consen  117 SNL------YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGF  190 (355)
T ss_pred             CeE------EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccc
Confidence            776      9999999975 7777764  799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccCC
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL  286 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  286 (288)
                      |+.....  ..+.+|||.|+|||++..++++.++|.|+||+++|||+.|.+||.+.++..++.+|++..-..|..+
T Consensus       191 AK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~f  264 (355)
T KOG0616|consen  191 AKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYF  264 (355)
T ss_pred             eEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCccc
Confidence            9987665  3457999999999999999999999999999999999999999999999999999999887777654

>KOG0659|consensus

Probab=100.00  E-value=2e-44  Score=280.08  Aligned_cols=215  Identities=38%  Similarity=0.573  Sum_probs=190.7

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      ...+.+|+|.++++++|    .+.++|+.||||+++.............+|++.|+.++|+||+.++++|...+.+    
T Consensus         5 ~~~~~lGEG~~gvVyka----~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l----   76 (318)
T KOG0659|consen    5 EKLEKLGEGTYGVVYKA----RDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNL----   76 (318)
T ss_pred             hhhhhhcCcceEEEEEE----EecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCce----
Confidence            44566788887777775    5889999999999997655555567789999999999999999999999988876    


Q ss_pred             cEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        141 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       141 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                        .+|+||++.+|...+..   -++...+..++.++++|++|||++.|+||||||.|+|++.+|.+||+|||+++..+..
T Consensus        77 --~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   77 --SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             --EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence              99999999998887763   3889999999999999999999999999999999999999999999999999987765


Q ss_pred             ccc-CCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        218 FMM-TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       218 ~~~-~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      ... ...+.|..|+|||.+.| ..|+...||||.|||+.||+.|.+.|+|.++.+++..|.+.+|.|.++
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~  224 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPD  224 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcc
Confidence            443 33478999999999998 568999999999999999999999999999999999999999977653

>KOG0615|consensus

Probab=100.00  E-value=8.7e-46  Score=303.41  Aligned_cols=213  Identities=32%  Similarity=0.505  Sum_probs=179.4

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcch-----hhHHHHHHHHHHHHHCCCCCcceeecccc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV-----THAKRAYREFKLMKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  131 (288)
                      .....+.+.+|+|.++.++++    ++++||+.||||++++.....     .......+|+++|++++|||||+++++|.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla----~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~  246 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLA----YEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE  246 (475)
T ss_pred             cceeEeeeeecCCceeEEEEE----EEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence            345577888888888888875    789999999999998642221     12334679999999999999999999999


Q ss_pred             CCCcccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC---CcEEE
Q psy11580        132 PQKSLEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKI  205 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~---~~~kl  205 (288)
                      ..+..      ||||||++|+ |++.+-  ..+.+..-..++.||+.|+.|||+.||+||||||+|||+..+   -.+||
T Consensus       247 ~~ds~------YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  247 VPDSS------YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             cCCce------EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence            88765      9999999975 766664  447778888999999999999999999999999999999876   56899


Q ss_pred             eecccccccCCCcccCCcccccccCchHhHhcCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCchh-HHHHHHHHh
Q psy11580        206 LDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMIRGGVLFPGTDHID-QWNKIIGKM  279 (288)
Q Consensus       206 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Di~slg~il~~l~~g~~p~~~~~~~~-~~~~i~~~~  279 (288)
                      +|||+|+..+....+.+.+|||.|.|||++.++..   ..+.|+||+||++|-+++|.+||.+..... ...+|.+..
T Consensus       321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~  398 (475)
T KOG0615|consen  321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR  398 (475)
T ss_pred             cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence            99999999998888899999999999999987653   347899999999999999999998865444 667776554

>KOG0575|consensus

Probab=100.00  E-value=1.9e-44  Score=308.90  Aligned_cols=217  Identities=29%  Similarity=0.419  Sum_probs=186.6

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      +..++.+|.|.|..++.+    .+..+|..||+|++.+. ........+..+|+++.+.|+|||||+++++|.+....  
T Consensus        20 Y~~g~~LGkGgFA~cYe~----~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nV--   93 (592)
T KOG0575|consen   20 YKRGRFLGKGGFARCYEA----RDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNV--   93 (592)
T ss_pred             eeeeeeeccCcceEEEEE----EEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCce--
Confidence            345555555555444443    45688999999999863 34566678899999999999999999999999988876  


Q ss_pred             cccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          |+|.|+|..+.+..+.   ..+++.+++.+.+||+.||.|||+.+|+|||||..|++++++.++||+|||+|+...
T Consensus        94 ----YivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   94 ----YIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             ----EEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec
Confidence                9999999987555544   469999999999999999999999999999999999999999999999999999876


Q ss_pred             CC-cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccCC
Q psy11580        216 TT-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL  286 (288)
Q Consensus       216 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  286 (288)
                      .. ....+.+|||.|.|||++.+..++..+||||+|||||-|+.|++||...+-.+.+.+|...--..|..+
T Consensus       170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~l  241 (592)
T KOG0575|consen  170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHL  241 (592)
T ss_pred             CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccccc
Confidence            54 667788999999999999999999999999999999999999999999999999998886655555443

>KOG0192|consensus

Probab=100.00  E-value=5.4e-44  Score=302.42  Aligned_cols=215  Identities=30%  Similarity=0.400  Sum_probs=182.9

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCce-EEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQN-VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      .+...++.+...+|+|.++.++.|      ...|.. ||+|++.....+......|.+|+.+|++++|||||+++|+|..
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~------~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKG------KWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEE------EeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            566677788888999888888877      556676 9999998765555557899999999999999999999999998


Q ss_pred             CCcccccccEEEEEecccccHH-HHHh----hhCCHHHHHHHHHHHHHHHHHHHHCC-CEeecCCCCCEEEccCC-cEEE
Q psy11580        133 QKSLEEFQDVYLVMELMDANLC-QVIQ----MDLDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDC-TLKI  205 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~l~-~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~-ivH~dl~~~nil~~~~~-~~kl  205 (288)
                      ...     .+++||||++++.+ +++.    ..+++..+..++.||+.||.|||+++ |||||||++|||++.++ ++||
T Consensus       111 ~~~-----~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI  185 (362)
T KOG0192|consen  111 PPG-----SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKI  185 (362)
T ss_pred             CCC-----ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEE
Confidence            761     24999999997644 4442    35999999999999999999999999 99999999999999997 9999


Q ss_pred             eecccccccCCC-cccCCcccccccCchHhHh--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        206 LDFGLARTAGTT-FMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       206 ~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      +|||+++..... ...+...||+.|||||++.  +..++.++||||||+++|||++|+.||.+....+....++...
T Consensus       186 ~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~  262 (362)
T KOG0192|consen  186 ADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG  262 (362)
T ss_pred             CCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC
Confidence            999999876554 3344478999999999999  5689999999999999999999999999999877666665333

>KOG0591|consensus

Probab=100.00  E-value=1.1e-44  Score=283.85  Aligned_cols=213  Identities=29%  Similarity=0.427  Sum_probs=182.8

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecc-ccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA-FTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~  136 (288)
                      .++.+.+.||.|.|+.++.    |.+..+|..||.|.+.-...+....+...+|+.+|++|+||||+++++. +..+.. 
T Consensus        19 ~~y~Il~~IG~GsFg~vyk----v~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e-   93 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYK----VQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE-   93 (375)
T ss_pred             HHHHHHHHHcCCcchheEE----eeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch-
Confidence            4557788888888777665    5678899999999998766677778889999999999999999999994 433332 


Q ss_pred             cccccEEEEEeccccc-HHHHHh------hhCCHHHHHHHHHHHHHHHHHHHH--CC--CEeecCCCCCEEEccCCcEEE
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ------MDLDHERMSYLLYQMLCGIKHLHS--AG--IIHRDLKPSNIVVKSDCTLKI  205 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~--~~--ivH~dl~~~nil~~~~~~~kl  205 (288)
                          .+++|||+|+.+ |.+.+.      +.+++.++++++.|++.||..+|.  .+  |+||||||.||+++.+|.+||
T Consensus        94 ----vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL  169 (375)
T KOG0591|consen   94 ----VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL  169 (375)
T ss_pred             ----hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence                358999999965 444332      349999999999999999999998  45  999999999999999999999


Q ss_pred             eecccccccCCCcc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        206 LDFGLARTAGTTFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       206 ~dfg~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      +|||+++....... ..+.+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.|.+-.+..++|.++-
T Consensus       170 GDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd  244 (375)
T KOG0591|consen  170 GDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD  244 (375)
T ss_pred             ccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC
Confidence            99999998766433 467899999999999999999999999999999999999999999998888888887763

>KOG0663|consensus

Probab=100.00  E-value=2.7e-43  Score=281.84  Aligned_cols=221  Identities=33%  Similarity=0.573  Sum_probs=191.6

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++..-..|+.|.++++|.|    .|++|++.||+|+++.+.....-.---.+|+++|.+++|||||.+-.+......  
T Consensus        76 ~efe~lnrI~EGtyGiVYRa----kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~--  149 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRA----KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM--  149 (419)
T ss_pred             HHHHHHhhcccCcceeEEEe----ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc--
Confidence            44566677888888888875    578999999999999754333333456789999999999999999999876543  


Q ss_pred             ccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                        ...|+|||||+.++.+.+.   .++...++..++.|+++|++|||.+.|+|||||++|+|++..|.+|++|||+|+..
T Consensus       150 --d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  150 --DKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             --ceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence              3469999999988777664   57999999999999999999999999999999999999999999999999999988


Q ss_pred             CCCcc-cCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccCC
Q psy11580        215 GTTFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL  286 (288)
Q Consensus       215 ~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  286 (288)
                      +.+.. .+..+.|..|+|||.+.| ..|+.+.||||+|||+.||+.+.+.|+|.+..+++.+|.+.+|.|.+.+
T Consensus       228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i  301 (419)
T KOG0663|consen  228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI  301 (419)
T ss_pred             cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence            77533 466788999999999998 5689999999999999999999999999999999999999999887654

>KOG0667|consensus

Probab=100.00  E-value=2.8e-43  Score=304.54  Aligned_cols=216  Identities=35%  Similarity=0.635  Sum_probs=192.9

Q ss_pred             ccccccccCCccccccccCcc------ceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-C-----CCccee
Q psy11580         59 ELPISHQMGKKRHNTSHLGAG------AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-H-----KNIIGL  126 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g------~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~  126 (288)
                      .+...+.++.+|.+...+|.|      +|+|.+|++.||||++++   ...-..+...|+.+|..++ |     -|+|++
T Consensus       177 ~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm  253 (586)
T KOG0667|consen  177 QLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRM  253 (586)
T ss_pred             eEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence            345566667777777777777      589999999999999995   5566788889999999997 3     389999


Q ss_pred             eccccCCCcccccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC--
Q psy11580        127 LNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--  200 (288)
Q Consensus       127 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~--  200 (288)
                      +++|...+++      |||+|.++.+|++++..    .++...++.++.||+.||.+||+.+|||+||||+|||+...  
T Consensus       254 ~d~F~fr~Hl------ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r  327 (586)
T KOG0667|consen  254 LDYFYFRNHL------CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR  327 (586)
T ss_pred             eeccccccce------eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc
Confidence            9999988776      99999999999999873    48999999999999999999999999999999999999764  


Q ss_pred             CcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       201 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ..+||+|||.|+..+....  +++.++.|+|||++.|.+|+.+.||||||||++||++|.+.|+|.+..++++.|++.+|
T Consensus       328 ~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG  405 (586)
T KOG0667|consen  328 SRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG  405 (586)
T ss_pred             CceeEEecccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence            3699999999998876644  67889999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccC
Q psy11580        281 EAHDK  285 (288)
Q Consensus       281 ~~~~~  285 (288)
                      .||+.
T Consensus       406 ~Pp~~  410 (586)
T KOG0667|consen  406 LPPPK  410 (586)
T ss_pred             CCCHH
Confidence            88764

>KOG0197|consensus

Probab=100.00  E-value=2.6e-43  Score=298.43  Aligned_cols=220  Identities=27%  Similarity=0.428  Sum_probs=190.3

Q ss_pred             HHHhhhhhhcccccccccCCccccccccCccceeccCCCc-eEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceee
Q psy11580         49 VDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQ-NVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLL  127 (288)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~  127 (288)
                      ...| ++....+.+.+.||+|.|+.+++|      ...+. +||+|.++.   .....+.|.+|+++|++|+|+|||+++
T Consensus       198 ~d~w-ei~r~~l~l~~~LG~G~FG~V~~g------~~~~~~~vavk~ik~---~~m~~~~f~~Ea~iMk~L~H~~lV~l~  267 (468)
T KOG0197|consen  198 RDPW-EIPREELKLIRELGSGQFGEVWLG------KWNGSTKVAVKTIKE---GSMSPEAFLREAQIMKKLRHEKLVKLY  267 (468)
T ss_pred             cCCe-eecHHHHHHHHHhcCCccceEEEE------EEcCCCcccceEEec---cccChhHHHHHHHHHHhCcccCeEEEE
Confidence            3344 677788899999999999999999      44554 899999984   234457788999999999999999999


Q ss_pred             ccccCCCcccccccEEEEEeccccc-HHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc
Q psy11580        128 NAFTPQKSLEEFQDVYLVMELMDAN-LCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT  202 (288)
Q Consensus       128 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~  202 (288)
                      ++|..++.+      +||||||+.+ |++++..    .++..+.+.++.|||+||+||+++++|||||.++|||++.+..
T Consensus       268 gV~~~~~pi------yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~  341 (468)
T KOG0197|consen  268 GVCTKQEPI------YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV  341 (468)
T ss_pred             EEEecCCce------EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce
Confidence            999987766      9999999965 7777763    3888999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccCCCccc--CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        203 LKILDFGLARTAGTTFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       203 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      +||+|||+++........  ....-+..|+|||.+....++.+|||||||++||||++ |+.||.+.+..+.+..+.++.
T Consensus       342 vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy  421 (468)
T KOG0197|consen  342 VKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY  421 (468)
T ss_pred             EEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC
Confidence            999999999965554432  33344677999999999999999999999999999998 999999999999999999887


Q ss_pred             CCCcc
Q psy11580        280 REAHD  284 (288)
Q Consensus       280 ~~~~~  284 (288)
                      +-+.+
T Consensus       422 Rlp~P  426 (468)
T KOG0197|consen  422 RLPRP  426 (468)
T ss_pred             cCCCC
Confidence            75444

>KOG0658|consensus

Probab=100.00  E-value=1e-43  Score=287.96  Aligned_cols=214  Identities=35%  Similarity=0.584  Sum_probs=184.7

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.-.+.+|.|.|+.++-|.    -..+++.||||+.-.+..      .--+|+++|+.++|||||++.-+|.....- +.
T Consensus        26 ~~~~~liG~GsFg~Vyq~~----~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~-d~   94 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAK----LRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTES-DE   94 (364)
T ss_pred             EEeeEEEeecccceEEEEE----EcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCC-ch
Confidence            3456778888888877763    345689999999863211      122699999999999999999998765532 23


Q ss_pred             ccEEEEEecccccHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC-CcEEEeeccccc
Q psy11580        140 QDVYLVMELMDANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLAR  212 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~-~~~kl~dfg~~~  212 (288)
                      ....+||||++.+|.+.+.      ..++.-.++-+..||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+
T Consensus        95 ~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   95 VYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             hHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            4567999999999998876      457888899999999999999999999999999999999986 899999999999


Q ss_pred             ccCCCcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ....+....++.+++.|+|||.+.| ..|+.+.||||.|||+.||+.|++.|+|.+..+++..|++.+|.|..
T Consensus       175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~  247 (364)
T KOG0658|consen  175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR  247 (364)
T ss_pred             eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence            9888888888999999999999998 57999999999999999999999999999999999999999998764

>KOG0592|consensus

Probab=100.00  E-value=7.2e-43  Score=295.16  Aligned_cols=222  Identities=28%  Similarity=0.439  Sum_probs=192.3

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHC-CCCCcceeeccccC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTP  132 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  132 (288)
                      ....++..++.+|.|.+..+.++    .+..+++.+|||++.+.. ......+....|-+.|.+| .||.|++++-.|.+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A----~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD  145 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLA----REKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD  145 (604)
T ss_pred             CChhhcchhheeccccceeEEEe----eecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec
Confidence            45577889999999998888875    577899999999997642 2223345566888999999 89999999999999


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      +..+      |+|+||+++ +|++++.  ..+++...+.++.+|+.||+|||++|||||||||+|||+++++.++|+|||
T Consensus       146 ~~sL------YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFG  219 (604)
T KOG0592|consen  146 EESL------YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFG  219 (604)
T ss_pred             ccce------EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecc
Confidence            8876      999999986 5888886  569999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc--------------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHH
Q psy11580        210 LARTAGTTF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       210 ~~~~~~~~~--------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i  275 (288)
                      .++..+...              ...+++||..|.+||++.....++.+|+|+|||++|+|+.|.+||.+.++..+.++|
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI  299 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI  299 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence            997653211              124589999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhCCCccCC
Q psy11580        276 IGKMREAHDKL  286 (288)
Q Consensus       276 ~~~~~~~~~~~  286 (288)
                      +...-+.|+.+
T Consensus       300 ~~l~y~fp~~f  310 (604)
T KOG0592|consen  300 QALDYEFPEGF  310 (604)
T ss_pred             HHhcccCCCCC
Confidence            98887777643

>KOG0661|consensus

Probab=100.00  E-value=3.7e-43  Score=292.63  Aligned_cols=218  Identities=37%  Similarity=0.608  Sum_probs=193.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~  136 (288)
                      ..+..-+.+|.|.++.++++    ....+++.||||.+++...... .-.-.+|++.|++++ ||||+++.+++.+.+. 
T Consensus        10 ~RY~~i~klGDGTfGsV~la----~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~-   83 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLA----KSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-   83 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEe----eecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-
Confidence            34456678888888888886    3578899999999997654433 334458999999998 9999999999998772 


Q ss_pred             cccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                          ++++|||||+++|++.+.   ..+++..++.|+.||++||+++|++|+.|||+||+|||+.....+||+|||+|+.
T Consensus        84 ----~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   84 ----ILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             ----eEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc
Confidence                359999999999999886   3499999999999999999999999999999999999999888999999999999


Q ss_pred             cCCCcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        214 AGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       214 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      .......+.++.|+.|+|||++.. .-|+.+.|||++|||++|+++-++.|+|.+..|++-+|.+.+|.|..+
T Consensus       160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~  232 (538)
T KOG0661|consen  160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKD  232 (538)
T ss_pred             cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccc
Confidence            988888888999999999999876 568999999999999999999999999999999999999999987543

>KOG0660|consensus

Probab=100.00  E-value=1.2e-42  Score=281.29  Aligned_cols=217  Identities=47%  Similarity=0.837  Sum_probs=190.7

Q ss_pred             cccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEE
Q psy11580         64 HQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY  143 (288)
Q Consensus        64 ~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~  143 (288)
                      +.+|.|..+.++    .+.+..+|+.||||++.....+....++..+|+++|+.++|+||+.+.+++.. +...+....|
T Consensus        28 ~~iG~GAyGvVc----sA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p-~~~~~f~DvY  102 (359)
T KOG0660|consen   28 EPIGRGAYGVVC----SAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRP-PSRDKFNDVY  102 (359)
T ss_pred             ccccCcceeeEE----EEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccc-ccccccceeE
Confidence            344444444333    36789999999999999877888889999999999999999999999999987 2335567789


Q ss_pred             EEEecccccHHHHHhhh--CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC---Cc
Q psy11580        144 LVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TF  218 (288)
Q Consensus       144 lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~  218 (288)
                      +|+|+|+.+|.+.+..+  ++...+..+.+||+.||.|+|+.+|+||||||+|++++.+..+|+||||+|+....   ..
T Consensus       103 iV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~  182 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDG  182 (359)
T ss_pred             EehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCccc
Confidence            99999999999988743  89999999999999999999999999999999999999999999999999998754   44


Q ss_pred             ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        219 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      ..+.++.|..|.|||++.. ..|+.+.||||.|||+.||++|++.|+|.+..++++.|++.+|.++++
T Consensus       183 ~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  183 FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            4567788999999999876 679999999999999999999999999999999999999999988654

>KOG0597|consensus

Probab=100.00  E-value=9.3e-43  Score=295.70  Aligned_cols=211  Identities=29%  Similarity=0.467  Sum_probs=190.6

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+-+.+|+|.++.+|.|    .++.+.+-||+|.+.+...+.+..+.+.+|+++++.++||||+.+++.|......  
T Consensus         3 ~yhv~e~iG~Gsfg~VYKg----rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~--   76 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKG----RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHL--   76 (808)
T ss_pred             chhHHHHhcCCccceeeec----ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceE--
Confidence            3456677899999988887    3577889999999999888888999999999999999999999999999877665  


Q ss_pred             cccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                          ++|+||+.|+|..++.  ..++++.+..++.|+++||.|||+.+|+|||+||.|||++..+.+|+||||+++.++.
T Consensus        77 ----~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   77 ----WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             ----EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence                9999999999998886  4599999999999999999999999999999999999999999999999999998876


Q ss_pred             Cccc-CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        217 TFMM-TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       217 ~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      .... +...|||.|||||+..+.+|+..+|+|||||++||++.|++||....-.+..+.|..--
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~  216 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP  216 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC
Confidence            5443 56689999999999999999999999999999999999999999988888877776433

>KOG0583|consensus

Probab=100.00  E-value=4.5e-42  Score=293.17  Aligned_cols=222  Identities=28%  Similarity=0.479  Sum_probs=192.4

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcc---hhhHHHHHHHHHHHHHCC-CCCcceeeccc
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN---VTHAKRAYREFKLMKLVN-HKNIIGLLNAF  130 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~  130 (288)
                      .......+++.+|.|.++.++++    .+..+++.||+|++.+....   ......+.+|+.++++++ ||||+++++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a----~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~   89 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLA----KHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF   89 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEe----eeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence            34456788899999988888886    45778899999988764211   134556778999999998 99999999999


Q ss_pred             cCCCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC-CcEEEe
Q psy11580        131 TPQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKIL  206 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~-~~~kl~  206 (288)
                      .....+      ++||||+.+ .|++.+.  .++.+..++.++.|+++|++|||++||+||||||+|||++.+ +++||+
T Consensus        90 ~t~~~~------~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   90 ATPTKI------YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             ecCCeE------EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEe
Confidence            888765      999999997 7888776  468899999999999999999999999999999999999999 999999


Q ss_pred             eccccccc-CCCcccCCcccccccCchHhHhcCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        207 DFGLARTA-GTTFMMTPYVVTRYYRAPEVILGMG-YK-ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       207 dfg~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      |||++... .......+.+|++.|+|||++.+.. |+ .++||||+|++||.|++|+.||.+.+...++.+|.+..-..|
T Consensus       164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p  243 (370)
T KOG0583|consen  164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP  243 (370)
T ss_pred             ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC
Confidence            99999988 5666678889999999999999977 75 899999999999999999999999998889998887776766


Q ss_pred             cCC
Q psy11580        284 DKL  286 (288)
Q Consensus       284 ~~~  286 (288)
                      ..+
T Consensus       244 ~~~  246 (370)
T KOG0583|consen  244 SYL  246 (370)
T ss_pred             CCc
Confidence            654

>KOG0588|consensus

Probab=100.00  E-value=3.8e-42  Score=296.75  Aligned_cols=217  Identities=26%  Similarity=0.412  Sum_probs=195.7

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .++|+.+|.|..+.+.++    .+..||+.+|||++.+. .........+.+|+-+|+.+.|||++++|+++.....+  
T Consensus        14 wkLgkTLG~Gstg~vrla----kh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l--   87 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLA----KHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL--   87 (786)
T ss_pred             eeccccccCCCCceehhh----hcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE--
Confidence            478999999988888887    46899999999999875 33445566788999999999999999999999877655  


Q ss_pred             cccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          |+|.||+++ .|++++.  .++++.++.+++.||+.|+.|||..+|+||||||+|+|++..+++||+|||+|....
T Consensus        88 ----ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   88 ----YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             ----EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence                999999986 4888775  569999999999999999999999999999999999999999999999999999888


Q ss_pred             CCcccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccCC
Q psy11580        216 TTFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL  286 (288)
Q Consensus       216 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  286 (288)
                      .+....+.||++.|.|||+++|.+| +.++||||.|||||.|++|+.||.+.|-..++.++.++.-++|..|
T Consensus       164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~I  235 (786)
T KOG0588|consen  164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNI  235 (786)
T ss_pred             CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcC
Confidence            8888888999999999999999998 4899999999999999999999999999999999998888888765

>KOG0594|consensus

Probab=100.00  E-value=6.6e-41  Score=271.66  Aligned_cols=221  Identities=36%  Similarity=0.594  Sum_probs=188.9

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCC-cceeeccccCCCccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN-IIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~~  139 (288)
                      ..-+.+|.|.++.++.|    .+..+|+.||+|++..+.....-.....+|+.+|+.++|+| |+.+++++.........
T Consensus        14 ~~~eklGeGtyg~Vyka----r~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   14 EKVEKLGEGTYGVVYKA----RSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHhCCCCceEEEEE----EEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            33444788888777765    46788899999999865433334456789999999999999 99999999887743344


Q ss_pred             ccEEEEEecccccHHHHHhh------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        140 QDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      ..+++|+||++.++..++..      ..+...++.++.||+.||+|||+++|+||||||.||+++.+|.+||+|||+|+.
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence            55699999999998888762      366678999999999999999999999999999999999999999999999987


Q ss_pred             cCC-CcccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        214 AGT-TFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       214 ~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      .+- ....++.++|..|+|||++.+. .|+...||||+||+++||+++++.|.|.++.+++..|.+.+|.|..+
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            663 3335677899999999999996 78999999999999999999999999999999999999999987653

>KOG0605|consensus

Probab=100.00  E-value=8.2e-41  Score=282.57  Aligned_cols=215  Identities=27%  Similarity=0.431  Sum_probs=183.8

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      +...++.+-+.||+|.+|.+++.    ..+.||+.+|+|++++.. ....+......|-.+|...++|+||+++..|.+.
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLa----rKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~  213 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLA----RKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK  213 (550)
T ss_pred             CCcccchhheeeccccceeEEEE----EEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence            35577888888899888888884    577899999999998742 2344566778899999999999999999999988


Q ss_pred             CcccccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        134 KSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      ..+      |+||||++|+-..-+.   ..+++..++.++.+++.|++.+|+.|+|||||||+|+|+|..|.+||+|||+
T Consensus       214 ~~L------YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGL  287 (550)
T KOG0605|consen  214 EYL------YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGL  287 (550)
T ss_pred             Cee------EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccc
Confidence            876      9999999987554443   3499999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC----------------------Cc-c-------------------------cCCcccccccCchHhHhcCCCCc
Q psy11580        211 ARTAGT----------------------TF-M-------------------------MTPYVVTRYYRAPEVILGMGYKE  242 (288)
Q Consensus       211 ~~~~~~----------------------~~-~-------------------------~~~~~~~~~~~aPE~~~~~~~~~  242 (288)
                      +.-...                      .. .                         ..+.+|||.|+|||++.+..|+.
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~  367 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK  367 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence            842100                      00 0                         01247999999999999999999


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       243 ~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ..|.||||||+|||+.|.+||.+.++.+.+++|++-.
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr  404 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR  404 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999999999999999999999999999999766

>KOG0611|consensus

Probab=100.00  E-value=3.8e-41  Score=276.13  Aligned_cols=213  Identities=26%  Similarity=0.471  Sum_probs=189.4

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .+.+.+.+|+|..+.+++    +++...|+.||||.++++ ..+....-.+.+|+++|+.|+||||+.+|.+|...+.+ 
T Consensus        54 RyE~~etLGkGTYGKVk~----A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI-  128 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKL----AYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI-  128 (668)
T ss_pred             HHHHHHHhcCCcccceee----hhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE-
Confidence            445566677766666555    577889999999999874 34556667788999999999999999999999888776 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||..+ .|++++.  ..+++.+++.+++||.+|+.|||+++++|||||.+|||+|.++++||+|||++..+
T Consensus       129 -----vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  129 -----VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             -----EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh
Confidence                 999999986 5888886  45999999999999999999999999999999999999999999999999999998


Q ss_pred             CCCcccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCC
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  281 (288)
                      .......+++|++.|.+||+..|.+| ++..|-||||++||-|+.|.+||.|.+...++++|.++--.
T Consensus       204 ~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr  271 (668)
T KOG0611|consen  204 ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR  271 (668)
T ss_pred             ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc
Confidence            88888889999999999999999888 58999999999999999999999999999999999887643

>KOG0694|consensus

Probab=100.00  E-value=1.3e-40  Score=288.59  Aligned_cols=215  Identities=25%  Similarity=0.428  Sum_probs=190.1

Q ss_pred             hhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHC-CCCCcceeeccc
Q psy11580         53 KELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAF  130 (288)
Q Consensus        53 ~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  130 (288)
                      ..+..+++.+..++|+|.||.+.++.    .+.+++.+|||++++. .......+....|..++... +||.+++++.+|
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae----~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f  438 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAE----LKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF  438 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEE----EcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc
Confidence            35677888999999999999888864    4667889999999975 34556677888999999888 599999999999


Q ss_pred             cCCCcccccccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        131 TPQKSLEEFQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      ....++      |+||||+.|+....+.  ..+++..++.++..++.||+|||++||||||||.+|||+|.+|.+||+||
T Consensus       439 QT~~~l------~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADF  512 (694)
T KOG0694|consen  439 QTKEHL------FFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADF  512 (694)
T ss_pred             ccCCeE------EEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccc
Confidence            988766      9999999987632222  45999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC-CCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        209 GLARTAG-TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       209 g~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      |+++..- .....++.+|||.|+|||++.+..|+.++|.|||||+||||+.|+.||+|.+.+++...|+.
T Consensus       513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~  582 (694)
T KOG0694|consen  513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN  582 (694)
T ss_pred             ccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence            9998654 56667889999999999999999999999999999999999999999999999999888874

>KOG0585|consensus

Probab=100.00  E-value=9.4e-41  Score=278.25  Aligned_cols=219  Identities=26%  Similarity=0.402  Sum_probs=179.8

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCc------------chhhHHHHHHHHHHHHHCCCCCcce
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ------------NVTHAKRAYREFKLMKLVNHKNIIG  125 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~  125 (288)
                      +.+.+...+|+|-++.+++    +|+..+++.||||++.+...            .....++..+|+.+|++|.|||||+
T Consensus        97 Nqy~l~~eiG~G~yGkVkL----ar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKL----ARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             hheehhhhhcCCccceEEE----EeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            4556666777776666666    47889999999999975311            1112357889999999999999999


Q ss_pred             eeccccCCCcccccccEEEEEecccccHHHHHh--hh-CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc
Q psy11580        126 LLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT  202 (288)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~-~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~  202 (288)
                      ++.+..+..    ...+|||+|||..+-..+..  .. +++.++++++++++.||+|||.+|||||||||+|+|++++|.
T Consensus       173 LiEvLDDP~----s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  173 LIEVLDDPE----SDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EEEeecCcc----cCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence            999987654    35679999999977655543  22 889999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccC------CCcccCCcccccccCchHhHhcCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCchhHH
Q psy11580        203 LKILDFGLARTAG------TTFMMTPYVVTRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW  272 (288)
Q Consensus       203 ~kl~dfg~~~~~~------~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~  272 (288)
                      +||+|||.+....      .........|||.|+|||...+..    .+.+.||||+||+||.|+.|+.||-+....+..
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence            9999999998652      222234468999999999998732    357899999999999999999999999999999


Q ss_pred             HHHHHHhCCCcc
Q psy11580        273 NKIIGKMREAHD  284 (288)
Q Consensus       273 ~~i~~~~~~~~~  284 (288)
                      .+|++.--..|.
T Consensus       329 ~KIvn~pL~fP~  340 (576)
T KOG0585|consen  329 DKIVNDPLEFPE  340 (576)
T ss_pred             HHHhcCcccCCC
Confidence            999987665554

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.5e-40  Score=283.98  Aligned_cols=223  Identities=77%  Similarity=1.213  Sum_probs=191.4

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..++.+.+.+|+|.++.++.+    .+..+++.||+|++............+.+|+.+++.++||||+++++++...+..
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAA----FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEE----EEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence            355667778888877777664    4667899999999986545555667788999999999999999999999876654


Q ss_pred             cccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      ......++||||+++++.+.+...++...+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++.....
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876          96 EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             cccceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            44556799999999999888877789999999999999999999999999999999999999999999999999976554


Q ss_pred             CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ........+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+.++.+.++.++
T Consensus       176 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  242 (359)
T cd07876         176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS  242 (359)
T ss_pred             CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            4444556789999999999999999999999999999999999999999988888888877766544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.6e-40  Score=283.90  Aligned_cols=223  Identities=81%  Similarity=1.272  Sum_probs=193.2

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..++.+.+.+|+|.++.++.+    ++..+++.||||++............+.+|+.+++.++||||+++++++......
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAA----YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEE----EECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence            345667777888777776654    5677899999999986555555667788999999999999999999998776654


Q ss_pred             cccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      ......++||||+++++.+.+...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++.....
T Consensus        99 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875          99 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             cccCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            45566799999999999888887889999999999999999999999999999999999999999999999999987766


Q ss_pred             CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ........+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+.++++.++.++
T Consensus       179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (364)
T cd07875         179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC  245 (364)
T ss_pred             CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            5555566889999999999999999999999999999999999999999999999998888776544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4717|consensus

Probab=100.00  E-value=3.9e-40  Score=277.34  Aligned_cols=216  Identities=27%  Similarity=0.434  Sum_probs=194.8

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.+|+|-|.+++++    .+..+|+.||||++.+...+.-....+..|+..|+.++|||||++|.+......+   
T Consensus        20 YDLekTlG~GHFAVVKLA----rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl---   92 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLA----RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL---   92 (864)
T ss_pred             ehhhhhhcCCceehhhhh----hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceE---
Confidence            457788999999998886    4678999999999998766777778899999999999999999999999887766   


Q ss_pred             ccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc-CCcEEEeeccccccc
Q psy11580        140 QDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTA  214 (288)
Q Consensus       140 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~-~~~~kl~dfg~~~~~  214 (288)
                         |+|+|.-++ ++++++.   ..++++.+.+++.||+.|+.|+|+.-+|||||||+|+++.. -|-+||+|||++..+
T Consensus        93 ---yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   93 ---YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             ---EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence               999999886 7888886   45999999999999999999999999999999999998865 588999999999988


Q ss_pred             CCCcccCCcccccccCchHhHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      .......+.+|+..|.|||++.|..|+ ++.||||||||||.|++|++||+..++-+.+..|+.+.-..|..
T Consensus       170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPsh  241 (864)
T KOG4717|consen  170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSH  241 (864)
T ss_pred             CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchh
Confidence            888778889999999999999998886 79999999999999999999999999999999999887776654

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-39  Score=280.48  Aligned_cols=221  Identities=80%  Similarity=1.240  Sum_probs=190.6

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+    ++..+++.||+|++............+.+|+.+++.++||||+++++++.......
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAA----YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hceeEEEEeeecCCEEEEEE----EecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            45667777888777777654    56678899999999865555556677889999999999999999999987665544


Q ss_pred             ccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      .....++||||+++++.+.+...++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus        93 ~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~  172 (355)
T cd07874          93 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_pred             ccceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence            45567999999999998888878999999999999999999999999999999999999999999999999999876665


Q ss_pred             cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+.++++.++.+
T Consensus       173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (355)
T cd07874         173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_pred             cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            55556688999999999999899999999999999999999999999988888887777766543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4721|consensus

Probab=100.00  E-value=3e-41  Score=286.77  Aligned_cols=196  Identities=28%  Similarity=0.429  Sum_probs=175.4

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++.++.+.-.+++|+|.++-+++|      ...++.||||+++.         .-..+++-|++|+|+||+.+.|+|...
T Consensus       120 eiPFe~IsELeWlGSGaQGAVF~G------rl~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  120 EIPFEEISELEWLGSGAQGAVFLG------RLHNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             cCCHHHhhhhhhhccCcccceeee------eccCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCC
Confidence            777888888899999999999998      66789999999963         122589999999999999999999988


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      ..+      |||||||.. .|+..+.  ..++...+..+..+||.||.|||...|||||||+-||||+.+..+||+|||.
T Consensus       185 Pcy------CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  185 PCY------CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             cee------EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccc
Confidence            765      999999985 5777775  4588999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      ++........-.+.||..|||||+++..+.+.|+||||||||||||+||..||.+-+...
T Consensus       259 S~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA  318 (904)
T KOG4721|consen  259 SKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA  318 (904)
T ss_pred             hHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe
Confidence            998777666677899999999999999999999999999999999999999998766543

>KOG0578|consensus

Probab=100.00  E-value=3e-40  Score=280.93  Aligned_cols=203  Identities=28%  Similarity=0.461  Sum_probs=172.3

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccE
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      -..+|+|..+.++.    +++..++..||||.+....+.  ..+-+..|+.+|+..+|+|||.+++.|...+.+      
T Consensus       278 ~~kigqgaSG~vy~----A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL------  345 (550)
T KOG0578|consen  278 FKKIGQGATGGVYV----ARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDEL------  345 (550)
T ss_pred             hhhhccccccceee----eeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhccccee------
Confidence            34445544444444    456788899999999874333  345678999999999999999999999888766      


Q ss_pred             EEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc-c
Q psy11580        143 YLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-M  219 (288)
Q Consensus       143 ~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-~  219 (288)
                      ++|||||+|+.+..+.  ..+++.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++....... .
T Consensus       346 WVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             EEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            9999999987554443  458999999999999999999999999999999999999999999999999998765533 5


Q ss_pred             cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       220 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      +.+-+||+.|||||+.....|+++.||||||++++||+.|++||-..++...+..|..
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~  483 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT  483 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh
Confidence            5677999999999999999999999999999999999999999998888777776654

>KOG0193|consensus

Probab=100.00  E-value=6.4e-40  Score=280.52  Aligned_cols=214  Identities=22%  Similarity=0.311  Sum_probs=182.1

Q ss_pred             HHhhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecc
Q psy11580         50 DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA  129 (288)
Q Consensus        50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  129 (288)
                      ..| ++...++.++..||+|.|+.++.|       .-...||||+++.........+.|..|+..+++-+|.||+-+.|+
T Consensus       385 ~~W-eIp~~ev~l~~rIGsGsFGtV~Rg-------~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~  456 (678)
T KOG0193|consen  385 EEW-EIPPEEVLLGERIGSGSFGTVYRG-------RWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGA  456 (678)
T ss_pred             ccc-ccCHHHhhccceeccccccceeec-------ccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence            445 788889999999999988877776       345789999999887888899999999999999999999999999


Q ss_pred             ccCCCcccccccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEE
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI  205 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl  205 (288)
                      |..++.       .||+.+|+|. |+.++.   ..++..+.+.|+.|++.||.|||.++|||||||++||++.++++|||
T Consensus       457 ~~~p~~-------AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkI  529 (678)
T KOG0193|consen  457 CMNPPL-------AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKI  529 (678)
T ss_pred             hcCCce-------eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEE
Confidence            987763       8999999985 555554   56999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCC---CcccCCcccccccCchHhHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        206 LDFGLARTAGT---TFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       206 ~dfg~~~~~~~---~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      +|||++..-..   ........+..-|||||+++.   .+|++.+||||||+|+|||++|..||...+..+++-++-++
T Consensus       530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG  608 (678)
T KOG0193|consen  530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG  608 (678)
T ss_pred             ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc
Confidence            99999964322   222234467788999999986   46889999999999999999999999977776665544443

>KOG0033|consensus

Probab=100.00  E-value=5.5e-40  Score=252.86  Aligned_cols=215  Identities=25%  Similarity=0.369  Sum_probs=185.8

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|+|-|..++.    +.+..+|+.+|+|++..........+.+.+|+.+-+.|+||||+++.+.+...+..  
T Consensus        12 ~y~l~e~igkG~FSvVrR----c~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~--   85 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRR----CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH--   85 (355)
T ss_pred             hhhHHHHHccCchHHHHH----HHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccccee--
Confidence            445667777777776654    56788999999999986555556778899999999999999999999999887765  


Q ss_pred             cccEEEEEeccccc-HHHHHhhh--CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC---CcEEEeeccccc
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLAR  212 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~---~~~kl~dfg~~~  212 (288)
                          ++|+|+++|+ ++..+-.+  +++..+...++||+++|+|+|.++|||||+||.|+++.+.   .-+||+|||++.
T Consensus        86 ----ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   86 ----YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             ----EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence                9999999975 55444333  7888899999999999999999999999999999999754   458999999999


Q ss_pred             ccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ..+.........|+|.|||||+++..+++..+|||+.||++|-|+.|.+||.+.+...++.+|+..--..|
T Consensus       162 ~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~  232 (355)
T KOG0033|consen  162 EVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP  232 (355)
T ss_pred             EeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC
Confidence            88877777788999999999999999999999999999999999999999999999999999987764433

>KOG0582|consensus

Probab=100.00  E-value=9e-39  Score=264.68  Aligned_cols=209  Identities=27%  Similarity=0.412  Sum_probs=176.1

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ....+.+...||.|....++++    +...+++.||||++..+..+.. .+.+.+|+..|+.++||||++.+..|..+..
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A----~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLA----RCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             CccceeEEEEEeccceeEeeee----eecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            3456677888888888777765    4567789999999987644433 7889999999999999999999999998877


Q ss_pred             ccccccEEEEEeccccc-HHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        136 LEEFQDVYLVMELMDAN-LCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~-l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      +      |+||.+|.++ +++.+.    ..+++..+..|.++++.||.|||++|.||||||+.|||++.+|.|||+|||.
T Consensus        99 L------WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen   99 L------WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             e------EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence            6      9999999975 445443    4589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC----ccc-CCcccccccCchHhHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHH
Q psy11580        211 ARTAGTT----FMM-TPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       211 ~~~~~~~----~~~-~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i  275 (288)
                      +.....+    ... ....+++.|||||+++.  ..|+.|+||||||+...||.+|..||....+..++-..
T Consensus       173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t  244 (516)
T KOG0582|consen  173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT  244 (516)
T ss_pred             eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence            8654321    112 55689999999999655  56899999999999999999999999999987765443

>KOG0580|consensus

Probab=100.00  E-value=4.7e-40  Score=252.13  Aligned_cols=222  Identities=26%  Similarity=0.389  Sum_probs=194.4

Q ss_pred             hhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeecccc
Q psy11580         53 KELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        53 ~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  131 (288)
                      .....+++.+++.+|.|-|+.++++    ...+++-.||+|++.++ ........++.+|+++-..|+||||+++|++|.
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYla----rekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh   92 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLA----REKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH   92 (281)
T ss_pred             cccchhhccccccccCCccccEeEe----eeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence            3556688999999999999998887    45678899999999763 223344567889999999999999999999999


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEe
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL  206 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~  206 (288)
                      +....      |+++||... .++..+.    ..+++.....+..|++.||.|+|.++++||||||+|+|++..+.+|++
T Consensus        93 d~~ri------yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiA  166 (281)
T KOG0580|consen   93 DSKRI------YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIA  166 (281)
T ss_pred             cccee------EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeecc
Confidence            98876      999999985 4666654    458999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       207 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      |||-+.... .....+.+||..|.+||...+..++...|+|++|++.||++.|.+||.+.+..+.+++|.+.--..|+.
T Consensus       167 dfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~  244 (281)
T KOG0580|consen  167 DFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPST  244 (281)
T ss_pred             CCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcc
Confidence            999998876 445567899999999999999999999999999999999999999999999999999998776555543

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-38  Score=272.75  Aligned_cols=219  Identities=42%  Similarity=0.734  Sum_probs=177.0

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.+|+|.++.++.+    .+..++..||||+++...........+.+|+++++.++||||+++++++..... ...
T Consensus         2 y~i~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~   76 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSA----IDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REF   76 (338)
T ss_pred             eEEEEEEeecCCeEEEEE----EECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCC-CCC
Confidence            345667777777766664    456789999999997543344445678899999999999999999999865432 222


Q ss_pred             ccEEEEEecccccHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        140 QDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ...++||||+++++.+.+..  .+++..+..++.||++||+|||+++|+||||||+||+++.++.+||+|||++......
T Consensus        77 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          77 KDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             ceEEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            45699999999988887753  4899999999999999999999999999999999999999999999999998754221


Q ss_pred             ----cccCCcccccccCchHhHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        218 ----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       218 ----~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                          .......+++.|+|||++.+  ..++.++||||||+++|+|++|+.||.+.+....+..+...++.++
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  228 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS  228 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence                11234578999999999876  5788999999999999999999999999887777666666555443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0589|consensus

Probab=100.00  E-value=5.2e-39  Score=271.29  Aligned_cols=213  Identities=27%  Similarity=0.416  Sum_probs=188.9

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .....+++|.|.|+...+-    .++.+++.+++|.+.............+.|+.++++++||||+.+.+.|..++.+  
T Consensus         5 ~Ye~~~~iG~GafG~a~lv----rhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~--   78 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLV----RHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQL--   78 (426)
T ss_pred             hhhhhhhcCccccchhhhh----hhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCce--
Confidence            3455677788777776664    4566778999999998777777778899999999999999999999999988763  


Q ss_pred             cccEEEEEecccccHH-HHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        139 FQDVYLVMELMDANLC-QVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~-~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                         .+|||+|++|+.. +.+.    ..++++.+..++.||+.|++|||+++|+|||||+.||+++.++.++|+|||+|+.
T Consensus        79 ---l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   79 ---LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             ---EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhh
Confidence               4999999998644 4443    2389999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        214 AGTTF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       214 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      .+... ...+..||+.|++||.+.+.+|+.|+|||||||++|||++-+++|.+.+....+.+|.+.+.
T Consensus       156 l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~  223 (426)
T KOG0589|consen  156 LNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY  223 (426)
T ss_pred             cCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC
Confidence            88776 66778999999999999999999999999999999999999999999999999999999883

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.3e-38  Score=263.88  Aligned_cols=218  Identities=32%  Similarity=0.544  Sum_probs=176.4

Q ss_pred             cccccccCCccccccccCccceecc-CCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC---CCCCcceeeccccCCCc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDT-ATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV---NHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~  135 (288)
                      +.+.+.+|+|.++.++.+    .+. .++..||+|+++...........+.+|+++++.+   +||||+++++++.....
T Consensus         3 Y~~~~~lg~G~~g~Vy~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           3 YECVAEIGEGAYGKVFKA----RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             cceeeEeccCCCeEEEEE----EEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            456677788777777665    232 3467899999975433333344566777777766   69999999999864321


Q ss_pred             ccccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        136 LEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                       ......++|||++++++.+.+..    .+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++
T Consensus        79 -~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          79 -DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             -CCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence             12245699999999988877752    3788999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .............+++.|+|||++.+..++.++||||||+++|+|++|.+||.+.+..+.+.+|++.++.+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~  228 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  228 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            87655444455678999999999998889999999999999999999999999999999999998876543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.6e-38  Score=264.81  Aligned_cols=215  Identities=33%  Similarity=0.595  Sum_probs=180.2

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.+|+|.++.++.+    .+..+++.||+|+++...........+.+|+++++.++||||+++++++...+..  
T Consensus         2 ~y~~~~~lg~g~~~~v~~~----~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--   75 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKC----RHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKL--   75 (287)
T ss_pred             CceEEEEecccCCEEEEEE----EECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEE--
Confidence            3456677777777766654    4567889999999986544445566788999999999999999999999876654  


Q ss_pred             cccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++||||+++++++.+.   ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||++....
T Consensus        76 ----~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  151 (287)
T cd07848          76 ----YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS  151 (287)
T ss_pred             ----EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence                9999999998777664   348899999999999999999999999999999999999999999999999998654


Q ss_pred             CCc--ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        216 TTF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       216 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ...  ......+++.|+|||++.+..++.++|+||||+++|+|++|++||.+.+..+....+.+..+++|
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP  221 (287)
T ss_pred             ccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence            322  22345688999999999998899999999999999999999999999888887777777666554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.6e-38  Score=274.65  Aligned_cols=210  Identities=24%  Similarity=0.405  Sum_probs=173.9

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+|+|.++.++++    .+..+++.||+|++++.. ........+..|+.++++++|+||+++++.+.+.... 
T Consensus         2 ~y~~~~~LG~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~-   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLV----QKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNL-   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEE----EECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeE-
Confidence            4556677888877777764    456789999999997521 1223345678899999999999999999999877654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||++++ |.+.+.  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        77 -----~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          77 -----YLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             -----EEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence                 9999999874 555554  35889999999999999999999999999999999999999999999999998643


Q ss_pred             CCCc------------------------------------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh
Q psy11580        215 GTTF------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR  258 (288)
Q Consensus       215 ~~~~------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~  258 (288)
                      ....                                    .....+||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence            2110                                    0123478999999999999899999999999999999999


Q ss_pred             CCCCCCCCCchhHHHHHHHH
Q psy11580        259 GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       259 g~~p~~~~~~~~~~~~i~~~  278 (288)
                      |..||.+.+..+.+.++.+.
T Consensus       232 G~~Pf~~~~~~~~~~~i~~~  251 (363)
T cd05628         232 GYPPFCSETPQETYKKVMNW  251 (363)
T ss_pred             CCCCCCCCCHHHHHHHHHcC
Confidence            99999999888888888754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.6e-38  Score=264.16  Aligned_cols=215  Identities=31%  Similarity=0.536  Sum_probs=178.2

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.+|.|.++.++.+    .+..++..||+|+++... .......+.+|+++++.++||||+++++++...+..  
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~----~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--   78 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKG----RSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL--   78 (288)
T ss_pred             cceEeeEEecCCCEEEEEE----EECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE--
Confidence            4556677888777777664    456788999999997532 222345677899999999999999999999876654  


Q ss_pred             cccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++||||+++++.+.+..   .+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++....
T Consensus        79 ----~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          79 ----TLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             ----EEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence                99999999988877653   36888999999999999999999999999999999999999999999999987643


Q ss_pred             CCc-ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        216 TTF-MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       216 ~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ... ......+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+..+.+..+.+.++.++.
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (288)
T cd07871         155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE  225 (288)
T ss_pred             CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            322 2234567899999999876 56789999999999999999999999999988888888887775543

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=265.57  Aligned_cols=214  Identities=27%  Similarity=0.408  Sum_probs=177.3

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+|+|.++.++.+    .+..+++.||+|++.... ........+.+|+++++.++||||+++++++.+.+.. 
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLV----RDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFL-   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEE----EEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeE-
Confidence            3456677888877777764    456789999999997422 1223456688999999999999999999998876654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||+++ +|.+.+.  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus        77 -----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~  151 (291)
T cd05612          77 -----YMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL  151 (291)
T ss_pred             -----EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence                 999999986 4666654  34889999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ...  .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+.++.......|.
T Consensus       152 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  219 (291)
T cd05612         152 RDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR  219 (291)
T ss_pred             cCC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc
Confidence            432  22346899999999999988999999999999999999999999998888888877765544444

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0610|consensus

Probab=100.00  E-value=2.1e-38  Score=260.41  Aligned_cols=221  Identities=27%  Similarity=0.376  Sum_probs=183.3

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      .+....+++-+.+|.|..+.+++.    ....++..+|+|++.+.. ...+...+.+.|-+||+.++||.++.+|..+..
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~----~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet  148 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLV----ELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET  148 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEE----EecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence            445566677777777777777774    455667999999998743 334556788899999999999999999999998


Q ss_pred             CCcccccccEEEEEecccccHHHHH-h----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEee
Q psy11580        133 QKSLEEFQDVYLVMELMDANLCQVI-Q----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD  207 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~l~~~~-~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~d  207 (288)
                      +...      |++||||+|+-+..+ +    ..+++..++.++..++.||+|||..|||+|||||+|||+.++|.+.|+|
T Consensus       149 ~~~~------cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsD  222 (459)
T KOG0610|consen  149 DKYS------CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSD  222 (459)
T ss_pred             ccee------EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeee
Confidence            8766      999999998644444 3    3499999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC-----------------------------------C----------------------cccCCcccccccC
Q psy11580        208 FGLARTAGT-----------------------------------T----------------------FMMTPYVVTRYYR  230 (288)
Q Consensus       208 fg~~~~~~~-----------------------------------~----------------------~~~~~~~~~~~~~  230 (288)
                      |.++.....                                   .                      ....+++||-.|.
T Consensus       223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl  302 (459)
T KOG0610|consen  223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL  302 (459)
T ss_pred             ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence            998842100                                   0                      0112346888999


Q ss_pred             chHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        231 APEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       231 aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      |||++.|...+.++|.|+||+++|||+.|..||.|.+..+.+.+|+..-...|.
T Consensus       303 APEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~  356 (459)
T KOG0610|consen  303 APEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE  356 (459)
T ss_pred             cceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC
Confidence            999999999999999999999999999999999999999999999876655554

>KOG1187|consensus

Probab=100.00  E-value=1e-38  Score=271.96  Aligned_cols=207  Identities=27%  Similarity=0.334  Sum_probs=167.3

Q ss_pred             hhhhhhcccccccccCCccccccccCccceecc--CCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecc
Q psy11580         52 WKELIYQELPISHQMGKKRHNTSHLGAGAAYDT--ATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA  129 (288)
Q Consensus        52 ~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  129 (288)
                      ...+.+.++.....-++....++.+|+|.+|..  .++..||||++.......  ..+|..|++++.+++|||+++++||
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            344556666666666666666666666666653  455799999887532221  4569999999999999999999999


Q ss_pred             ccCCCcccccccEEEEEeccccc-HHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCC---CEeecCCCCCEEEccCC
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDAN-LCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC  201 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---ivH~dl~~~nil~~~~~  201 (288)
                      |.+.+.     +.++|+|||.++ |.+.+..    .++|..+.+||.++|+||+|||+..   |||||||++|||+|.+.
T Consensus       140 C~e~~~-----~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~  214 (361)
T KOG1187|consen  140 CLEGGE-----HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF  214 (361)
T ss_pred             EecCCc-----eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC
Confidence            997763     239999999974 5555542    5799999999999999999999743   99999999999999999


Q ss_pred             cEEEeecccccccCC-CcccCCc-ccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        202 TLKILDFGLARTAGT-TFMMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       202 ~~kl~dfg~~~~~~~-~~~~~~~-~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      +.||+|||+|..... ....... .||.+|+|||++.....+.++||||||+++.||++|+.+...
T Consensus       215 ~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~  280 (361)
T KOG1187|consen  215 NAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ  280 (361)
T ss_pred             CEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence            999999999976654 3333333 799999999999988899999999999999999999988764

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-38  Score=270.09  Aligned_cols=215  Identities=22%  Similarity=0.376  Sum_probs=179.5

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ..++.+.+.+|+|.++.++++    .+..+++.||+|+++... ........+.+|++++++++||||+++++++...+.
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   92 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIA----KHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR   92 (329)
T ss_pred             chheEEEEEEEecCCeEEEEE----EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence            456778888999888888775    456678999999997521 122345678899999999999999999999987765


Q ss_pred             ccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      .      ++||||+.+ +|.+.+.  ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++.
T Consensus        93 ~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         93 V------YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             E------EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCce
Confidence            5      999999986 4555554  347889999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ......  ....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+....+.++.+...+.|
T Consensus       167 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p  235 (329)
T PTZ00263        167 KVPDRT--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP  235 (329)
T ss_pred             EcCCCc--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence            664432  235789999999999998899999999999999999999999999888777777766544433

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.6e-38  Score=269.08  Aligned_cols=209  Identities=25%  Similarity=0.373  Sum_probs=169.7

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY  143 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~  143 (288)
                      .+|+|.++.++++    .+..+|+.||+|+++... ........+.+|++++++++||||+++++++...+..      +
T Consensus         2 ~lG~G~~g~Vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~------~   71 (323)
T cd05571           2 LLGKGTFGKVILV----REKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRL------C   71 (323)
T ss_pred             eeeeCCCeEEEEE----EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEE------E
Confidence            3566666665543    456789999999997532 1233455678899999999999999999999877655      9


Q ss_pred             EEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC-CCcc
Q psy11580        144 LVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TTFM  219 (288)
Q Consensus       144 lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~-~~~~  219 (288)
                      +||||++++ +.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.... ....
T Consensus        72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  151 (323)
T cd05571          72 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence            999999875 545543  348899999999999999999999999999999999999999999999999987532 2223


Q ss_pred             cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       220 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .....|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+...-...|
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p  215 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP  215 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            3445789999999999999999999999999999999999999998887777666654443333

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.1e-37  Score=268.38  Aligned_cols=223  Identities=85%  Similarity=1.302  Sum_probs=189.1

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+...+.+|+|.++.++.+    .+..+++.||+|++............+.+|+.++++++|+||+++++++.......
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAA----YDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             cceEEEEEeccCCCEEEEEE----EECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence            44555566666666655543    56678999999999765445555667889999999999999999999988666544


Q ss_pred             ccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      +....++||||+.+++.+.+...++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus        92 ~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  171 (353)
T cd07850          92 EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  171 (353)
T ss_pred             ccCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence            55667999999999988888777999999999999999999999999999999999999999999999999999876555


Q ss_pred             cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+.+....+.++++.++.+++
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (353)
T cd07850         172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD  238 (353)
T ss_pred             CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            4444557788999999999999999999999999999999999999999888888888887776653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.6e-38  Score=270.55  Aligned_cols=222  Identities=23%  Similarity=0.413  Sum_probs=181.5

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      .+...++.+.+.+|+|.++.++.+.   .....+..||+|++.... ........+..|+.+++.++||||+++++++..
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~---~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~  102 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILAT---YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD  102 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEE---EECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence            3445667778888998888777752   122334689999986421 123345668899999999999999999999987


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .+..      ++||||+.+ +|.+.+.  ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.++|+|||
T Consensus       103 ~~~~------~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG  176 (340)
T PTZ00426        103 ESYL------YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFG  176 (340)
T ss_pred             CCEE------EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCC
Confidence            7654      999999976 4666654  358899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccCC
Q psy11580        210 LARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL  286 (288)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  286 (288)
                      ++......  .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.++...++.+.+.....|..+
T Consensus       177 ~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~  251 (340)
T PTZ00426        177 FAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFL  251 (340)
T ss_pred             CCeecCCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence            99865432  2345789999999999998899999999999999999999999999988888888877665555443

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.2e-38  Score=267.23  Aligned_cols=210  Identities=26%  Similarity=0.372  Sum_probs=169.7

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY  143 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~  143 (288)
                      .+|+|.++.++++    .+..+|..||+|+++... ........+..|+++++.++||||+++++++...+..      +
T Consensus         2 ~lG~G~~g~Vy~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~------~   71 (323)
T cd05595           2 LLGKGTFGKVILV----REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL------C   71 (323)
T ss_pred             eeeeCCCEEEEEE----EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEE------E
Confidence            3566665555543    356789999999997532 1233455677899999999999999999999877654      9


Q ss_pred             EEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-Ccc
Q psy11580        144 LVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TFM  219 (288)
Q Consensus       144 lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~  219 (288)
                      +||||++++ +...+.  ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||++..... ...
T Consensus        72 lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  151 (323)
T cd05595          72 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence            999999875 444443  3488999999999999999999999999999999999999999999999999875322 222


Q ss_pred             cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       220 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+.......|.
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~  216 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR  216 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence            34457899999999999988999999999999999999999999998887777777654444433

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.9e-37  Score=268.78  Aligned_cols=218  Identities=39%  Similarity=0.707  Sum_probs=181.4

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.+|+|.++.++.+    .+..+++.||+|++............+.+|+++++.++|+||+++++++...+. ...
T Consensus         2 ~~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~   76 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSV----TDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI-DPF   76 (372)
T ss_pred             CcccceeeeCCCEEEEEE----EECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc-ccc
Confidence            456777888887777764    456789999999997644444556778899999999999999999999986652 122


Q ss_pred             ccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        140 QDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ...++|+||+.+++.+.+.  ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+|||++......
T Consensus        77 ~~~~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          77 EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             ceEEEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            3569999999998887775  34889999999999999999999999999999999999999999999999999764332


Q ss_pred             --cccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        218 --FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       218 --~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                        .......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||.+.+..+.+..|.+.++.+
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~  224 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP  224 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence              222344678899999999874 47899999999999999999999999999988888888776644

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-37  Score=274.65  Aligned_cols=216  Identities=31%  Similarity=0.494  Sum_probs=174.3

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc-
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL-  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-  136 (288)
                      ..+.+++.+|+|.++.++.|    .+..+++.||||++...      .....+|+.+++.++||||+++++++...... 
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~----~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEA----ICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEE----EECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            45667777777777766664    35668899999998642      12334799999999999999999887543211 


Q ss_pred             -cccccEEEEEecccccHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC-cEEEeec
Q psy11580        137 -EEFQDVYLVMELMDANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDF  208 (288)
Q Consensus       137 -~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~-~~kl~df  208 (288)
                       .....+++||||+++++.+.+.      ..+++..++.++.||+.||+|||+++|+||||||+||+++.++ .+||+||
T Consensus       136 ~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence             1122457999999998876653      3488899999999999999999999999999999999999665 6999999


Q ss_pred             ccccccCCCcccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        209 GLARTAGTTFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       209 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      |++.............+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++++.++.++
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~  291 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT  291 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999876544444456789999999998764 689999999999999999999999999999999999988776553

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.9e-38  Score=266.97  Aligned_cols=209  Identities=26%  Similarity=0.387  Sum_probs=168.6

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY  143 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~  143 (288)
                      .+|+|.++.++++    .+..+++.||+|++.... ........+.+|+++++.++||||+++++++...+..      +
T Consensus         2 ~lG~G~~g~Vy~~----~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~------~   71 (328)
T cd05593           2 LLGKGTFGKVILV----REKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRL------C   71 (328)
T ss_pred             eeeeCCCEEEEEE----EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEE------E
Confidence            3556655555543    456789999999997532 2234456788899999999999999999999877655      9


Q ss_pred             EEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-Ccc
Q psy11580        144 LVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TFM  219 (288)
Q Consensus       144 lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~  219 (288)
                      +||||++++ +...+.  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..... ...
T Consensus        72 lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~  151 (328)
T cd05593          72 FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT  151 (328)
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence            999999875 444443  3488999999999999999999999999999999999999999999999999875322 222


Q ss_pred             cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       220 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+...-...|
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p  215 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP  215 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC
Confidence            3445789999999999998899999999999999999999999998887776666654333333

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0198|consensus

Probab=100.00  E-value=2.5e-38  Score=260.48  Aligned_cols=208  Identities=25%  Similarity=0.404  Sum_probs=167.8

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ....++.+|+|.++.++++    .+.++|...|||.....  +....+.+.+|+.+|++++|||||+.+|.......   
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~----~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---   88 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLA----TNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---   88 (313)
T ss_pred             hhhhhccccCccceEEEEE----EecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---
Confidence            4567888899888888886    35666899999999864  22226778999999999999999999998554432   


Q ss_pred             cccEEEEEeccccc-HHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc-CCcEEEeecccccc
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLART  213 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~-~~~~kl~dfg~~~~  213 (288)
                       ..+++.|||++++ +.+.+..   .+++..++.++.|+++||+|||++||||+||||+|||++. ++.+||+|||++..
T Consensus        89 -~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   89 -DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             -eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence             2359999999975 4454442   4899999999999999999999999999999999999999 79999999999987


Q ss_pred             cCC----CcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchhHHHHHH
Q psy11580        214 AGT----TFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGT-DHIDQWNKII  276 (288)
Q Consensus       214 ~~~----~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~-~~~~~~~~i~  276 (288)
                      ...    ........||+.|||||++.. .....++|||||||++.||++|..||... ...+.+-.|.
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig  236 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG  236 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh
Confidence            653    222345789999999999995 33345999999999999999999999983 4444333333

>KOG0194|consensus

Probab=100.00  E-value=1.2e-38  Score=273.83  Aligned_cols=223  Identities=24%  Similarity=0.372  Sum_probs=188.4

Q ss_pred             cHHHhhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCccee
Q psy11580         48 TVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGL  126 (288)
Q Consensus        48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~  126 (288)
                      ....| ++...++.+++.+|+|.|+.++.|.-...+......||+|..+.. .........+.+|+++|++++||||+++
T Consensus       148 ~r~~W-el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~  226 (474)
T KOG0194|consen  148 PRQKW-ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF  226 (474)
T ss_pred             ccccc-EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            34456 778889999999999999999999644333322233999999863 3566778889999999999999999999


Q ss_pred             eccccCCCcccccccEEEEEeccccc-HHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc
Q psy11580        127 LNAFTPQKSLEEFQDVYLVMELMDAN-LCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT  202 (288)
Q Consensus       127 ~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~  202 (288)
                      ||++.....+      ++|||+|.|+ |.+++..   .++..+...++.+.+.||+|||+++++||||.++|+|++.++.
T Consensus       227 yGVa~~~~Pl------~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~  300 (474)
T KOG0194|consen  227 YGVAVLEEPL------MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV  300 (474)
T ss_pred             EEEEcCCCcc------EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe
Confidence            9999988876      9999999985 6666653   3889999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccCCCcccC-CcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        203 LKILDFGLARTAGTTFMMT-PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       203 ~kl~dfg~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      +||+|||+++......... ...-+.+|+|||.+....++.++|||||||++||+++ |..||.+....++.++|+.
T Consensus       301 vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~  377 (474)
T KOG0194|consen  301 VKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK  377 (474)
T ss_pred             EEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence            9999999988765222222 2235678999999999999999999999999999998 8999999999999999844

>KOG1026|consensus

Probab=100.00  E-value=1.8e-38  Score=281.80  Aligned_cols=223  Identities=24%  Similarity=0.346  Sum_probs=189.2

Q ss_pred             HHhhhhhhcccccccccCCccccccccCccceec-cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeec
Q psy11580         50 DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYD-TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN  128 (288)
Q Consensus        50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~  128 (288)
                      ..-.++...++...+.+|.|.|+.+++|.---.. ..+..-||||.++.. ...+...+|++|++++..++|||||+++|
T Consensus       478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlG  556 (774)
T KOG1026|consen  478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLG  556 (774)
T ss_pred             cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence            3445778889999999999999999998532111 245578999999864 34456788999999999999999999999


Q ss_pred             cccCCCcccccccEEEEEeccc-ccHHHHHhh------------h----CCHHHHHHHHHHHHHHHHHHHHCCCEeecCC
Q psy11580        129 AFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------------D----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  191 (288)
Q Consensus       129 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------------~----~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~  191 (288)
                      +|...+..      ++|+|||. |+|.+++..            +    ++..+.+.||.|||.||+||-++.+|||||.
T Consensus       557 VC~~~~P~------~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLA  630 (774)
T KOG1026|consen  557 VCREGDPL------CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLA  630 (774)
T ss_pred             EEccCCee------EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchh
Confidence            99988876      99999998 566666641            2    6778999999999999999999999999999


Q ss_pred             CCCEEEccCCcEEEeecccccccCCCccc---CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy11580        192 PSNIVVKSDCTLKILDFGLARTAGTTFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTD  267 (288)
Q Consensus       192 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~  267 (288)
                      ++|+|++++..|||+|||+++........   ....-+.+|||||.+...++|.+|||||+||+|||+++ |.-||.+.+
T Consensus       631 TRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS  710 (774)
T KOG1026|consen  631 TRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS  710 (774)
T ss_pred             hhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence            99999999999999999999865443322   24466889999999999999999999999999999997 999999999


Q ss_pred             chhHHHHHHHHh
Q psy11580        268 HIDQWNKIIGKM  279 (288)
Q Consensus       268 ~~~~~~~i~~~~  279 (288)
                      +++.+.-|.+..
T Consensus       711 n~EVIe~i~~g~  722 (774)
T KOG1026|consen  711 NQEVIECIRAGQ  722 (774)
T ss_pred             hHHHHHHHHcCC
Confidence            999988887654

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=263.62  Aligned_cols=208  Identities=27%  Similarity=0.441  Sum_probs=168.9

Q ss_pred             CCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEE
Q psy11580         67 GKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV  145 (288)
Q Consensus        67 ~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv  145 (288)
                      |+|.++.++.+    .+..+++.||+|+++... ........+..|++++++++||||+++++++...+..      ++|
T Consensus         2 g~G~~g~Vy~~----~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------~lv   71 (312)
T cd05585           2 GKGSFGKVMQV----RKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKL------YLV   71 (312)
T ss_pred             CcCCCeEEEEE----EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeE------EEE
Confidence            45555555543    456778999999997421 2334456788999999999999999999999876654      999


Q ss_pred             Eeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-CcccC
Q psy11580        146 MELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TFMMT  221 (288)
Q Consensus       146 ~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~  221 (288)
                      |||++++ |.+.+.  ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++..... .....
T Consensus        72 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  151 (312)
T cd05585          72 LAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN  151 (312)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence            9999875 555554  3488999999999999999999999999999999999999999999999999875432 22234


Q ss_pred             CcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       222 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ...|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......|.
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  214 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD  214 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC
Confidence            457899999999999999999999999999999999999999998887777777654444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.1e-37  Score=259.14  Aligned_cols=201  Identities=28%  Similarity=0.384  Sum_probs=164.3

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      ...+.+|+|.++.++.+    .+..+++.||+|++..... .......+.+|+.+++.++|+||+++++++...+..   
T Consensus         3 ~~~~~lg~G~~g~V~~~----~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~---   75 (285)
T cd05631           3 RHYRVLGKGGFGEVCAC----QVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL---   75 (285)
T ss_pred             eEEEEEecCCCEEEEEE----EEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeE---
Confidence            34456677766666554    4567899999999875321 223344577899999999999999999999877654   


Q ss_pred             ccEEEEEeccccc-HHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        140 QDVYLVMELMDAN-LCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       140 ~~~~lv~e~~~~~-l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                         ++||||++++ +.+.+.    ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++...
T Consensus        76 ---~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          76 ---CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             ---EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence               9999999875 433432    24788999999999999999999999999999999999999999999999999876


Q ss_pred             CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhH
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ  271 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  271 (288)
                      ..........++..|+|||++.+..++.++||||||+++|+|++|+.||.+.+....
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~  209 (285)
T cd05631         153 PEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK  209 (285)
T ss_pred             CCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh
Confidence            544333455789999999999999999999999999999999999999988665433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-38  Score=272.17  Aligned_cols=209  Identities=26%  Similarity=0.413  Sum_probs=170.3

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+|+|.++.++++    .+..+++.||||++.+.. ........+.+|+++++.++||||+++++++...+.. 
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~-   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLV----QKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYL-   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEE----EECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCee-
Confidence            3455677788777776654    456789999999986421 1233456788899999999999999999999877655 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||+++ +|.+.+.  ..+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||+++..
T Consensus        77 -----~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          77 -----YLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             -----EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence                 999999976 4655554  34788999999999999999999999999999999999999999999999998532


Q ss_pred             CCCc------------------------------------------------ccCCcccccccCchHhHhcCCCCchhhH
Q psy11580        215 GTTF------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDI  246 (288)
Q Consensus       215 ~~~~------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di  246 (288)
                      ....                                                ......|++.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  231 (377)
T cd05629         152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW  231 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence            1100                                                0012468999999999999899999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        247 WSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       247 ~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      |||||++|+|++|..||.+.+..+.+.+|.+
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~  262 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSENSHETYRKIIN  262 (377)
T ss_pred             EecchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence            9999999999999999998888777777765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-37  Score=264.05  Aligned_cols=220  Identities=51%  Similarity=0.920  Sum_probs=182.0

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+++.||||++............+.+|+++++.++||||+++++++.......
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSA----YDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhheecccCCCeEEEEE----EECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            45566677788777776654    46678899999999764444445567789999999999999999999987654434


Q ss_pred             ccccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      .....+++++++++++.+.+. ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||++.....
T Consensus        91 ~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          91 NFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             ccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            445679999999888877665 4589999999999999999999999999999999999999999999999999986544


Q ss_pred             CcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        217 TFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .  .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+.+..+.++
T Consensus       171 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07878         171 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS  236 (343)
T ss_pred             C--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            3  234578999999999987 5678999999999999999999999999888888877776665443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.2e-37  Score=259.52  Aligned_cols=212  Identities=33%  Similarity=0.557  Sum_probs=171.5

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|.|.++.++.+    .+..+++.||+|+++.... ......+.+|+++++.++||||+++++++...... 
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-   78 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKG----KSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETL-   78 (303)
T ss_pred             ccceEeeeEEecCCEEEEEE----EECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeE-
Confidence            34566777888777777665    4566889999999975322 22234577899999999999999999999876654 


Q ss_pred             ccccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||+++++.+.+..   .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++...
T Consensus        79 -----~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          79 -----TLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             -----EEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence                 99999999998887753   4788999999999999999999999999999999999999999999999998754


Q ss_pred             CCC-cccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hhHHHHHHHHhC
Q psy11580        215 GTT-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDH-IDQWNKIIGKMR  280 (288)
Q Consensus       215 ~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~-~~~~~~i~~~~~  280 (288)
                      ... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+..+ .+.+..+...++
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  222 (303)
T cd07869         154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLG  222 (303)
T ss_pred             cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhC
Confidence            322 22244567899999999876 4578899999999999999999999988544 445555655444

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=269.08  Aligned_cols=210  Identities=26%  Similarity=0.431  Sum_probs=172.0

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.||+|.++.++++    .+..+++.||||+++... ........+.+|+.+++.++||||+++++++...+.. 
T Consensus         2 ~y~~~~~lG~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~-   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLV----QKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYL-   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEE----EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeE-
Confidence            4556677888877777764    456788999999997521 1223445677899999999999999999999877655 


Q ss_pred             ccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||++++ |.+.+.  ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.++|+|||++...
T Consensus        77 -----~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          77 -----YLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             -----EEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence                 9999999875 555554  34889999999999999999999999999999999999999999999999998643


Q ss_pred             CCCc---------------------------------------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHH
Q psy11580        215 GTTF---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  255 (288)
Q Consensus       215 ~~~~---------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~  255 (288)
                      ....                                       .....+||+.|+|||++.+..++.++|||||||++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  231 (364)
T cd05599         152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE  231 (364)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence            2110                                       0112368999999999999899999999999999999


Q ss_pred             HHhCCCCCCCCCchhHHHHHHHH
Q psy11580        256 MIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       256 l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      |++|..||.+.+..+....+.+.
T Consensus       232 l~~G~~Pf~~~~~~~~~~~i~~~  254 (364)
T cd05599         232 MLVGYPPFCSDNPQETYRKIINW  254 (364)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHcC
Confidence            99999999998887777777653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-37  Score=268.69  Aligned_cols=212  Identities=27%  Similarity=0.449  Sum_probs=170.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+.+|+|.++.++++    .+..+++.||+|++++. .........+.+|+.+++.++||||+++++++...+..
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLV----RHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEE----EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            34455556666665555543    45678899999999642 12223345677899999999999999999999877654


Q ss_pred             cccccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                            ++||||++++ |.+.+. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus       119 ------~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         119 ------YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             ------EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence                  9999999864 555554 34788899999999999999999999999999999999999999999999999865


Q ss_pred             CCCc--ccCCcccccccCchHhHhcCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        215 GTTF--MMTPYVVTRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       215 ~~~~--~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ....  ......|++.|+|||++.+..    ++.++|+||||+++|+|++|..||.+.+....+.+|+...
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~  263 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK  263 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            4322  123457899999999997643    6789999999999999999999999998888888887644

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0599|consensus

Probab=100.00  E-value=7.8e-38  Score=244.59  Aligned_cols=214  Identities=24%  Similarity=0.391  Sum_probs=177.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCC---c---chhhHHHHHHHHHHHHHC-CCCCcceeeccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF---Q---NVTHAKRAYREFKLMKLV-NHKNIIGLLNAF  130 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~---~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  130 (288)
                      +.....+.+|.|...++.    .+....+|+.+|+|++....   +   .....+...+|+.+|+++ .||+|+++.+++
T Consensus        17 ~~y~pkeilgrgvss~vr----Rci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVR----RCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhcChHHHhcccchhhhh----hhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            344455555554433322    24567899999999996321   1   112234566899999999 699999999999


Q ss_pred             cCCCcccccccEEEEEecccc-cHHHHHhhh--CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEee
Q psy11580        131 TPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD  207 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~d  207 (288)
                      ..+...      ++|+|.|+. .|++++...  +++...+++++|+++|+.|||.++||||||||+|||++++.+++|+|
T Consensus        93 es~sF~------FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFV------FLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchh------hhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEec
Confidence            888765      999999985 588888754  88999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcccCCcccccccCchHhHhc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCC
Q psy11580        208 FGLARTAGTTFMMTPYVVTRYYRAPEVILG------MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  281 (288)
                      ||+++....+......+|||+|.|||.+..      ..|+...|+|++||++|-|+.|.+||-.....-+++.|+++.-+
T Consensus       167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq  246 (411)
T KOG0599|consen  167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ  246 (411)
T ss_pred             cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence            999999988888888999999999999975      34778999999999999999999999988888888888887643

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.6e-37  Score=268.62  Aligned_cols=208  Identities=26%  Similarity=0.406  Sum_probs=170.5

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      +.+.+.||+|.++.++++    .+..+++.||+|++.... ........+..|+++++.++||||+++++++.+.+.+  
T Consensus         3 f~~~~~LG~G~~g~Vy~~----~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~--   76 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLA----CKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNL--   76 (381)
T ss_pred             ceEEEEEeecCCEEEEEE----EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEE--
Confidence            456677888888777765    467789999999997532 2334456788999999999999999999999877654  


Q ss_pred             cccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++||||++++ |.+.+.  ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++.++|+|||++....
T Consensus        77 ----~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~  152 (381)
T cd05626          77 ----YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFR  152 (381)
T ss_pred             ----EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence                9999999874 555554  347888999999999999999999999999999999999999999999999875321


Q ss_pred             CC------------------------------------------------cccCCcccccccCchHhHhcCCCCchhhHH
Q psy11580        216 TT------------------------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIW  247 (288)
Q Consensus       216 ~~------------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~  247 (288)
                      ..                                                .......||+.|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw  232 (381)
T cd05626         153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW  232 (381)
T ss_pred             cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence            00                                                001234689999999999998899999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        248 SVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       248 slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      ||||++|||++|..||.+.+..+...+++.
T Consensus       233 SlG~il~elltG~~Pf~~~~~~~~~~~i~~  262 (381)
T cd05626         233 SVGVILFEMLVGQPPFLAPTPTETQLKVIN  262 (381)
T ss_pred             ehhhHHHHHHhCCCCCcCCCHHHHHHHHHc
Confidence            999999999999999998887776666653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.2e-37  Score=267.83  Aligned_cols=214  Identities=26%  Similarity=0.434  Sum_probs=173.2

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.+|+|.++.++++    .+..+++.||+|++... .........+.+|+.+++.++||||+++++++...+
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~----~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLV----RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEE----EECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            3355666677777766666653    56778999999998642 122233455778999999999999999999997766


Q ss_pred             cccccccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        135 SLEEFQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      ..      ++||||++++ |.+.+. ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++.
T Consensus       117 ~~------~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         117 YL------YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EE------EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            54      9999999865 555544 347888899999999999999999999999999999999999999999999997


Q ss_pred             ccCCCc--ccCCcccccccCchHhHhcCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        213 TAGTTF--MMTPYVVTRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       213 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ......  ......||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+.+....+.+|.+..
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  263 (371)
T cd05622         191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK  263 (371)
T ss_pred             EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            654322  223457899999999997643    6789999999999999999999999988888888887644

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0665|consensus

Probab=100.00  E-value=2.1e-38  Score=252.48  Aligned_cols=206  Identities=83%  Similarity=1.296  Sum_probs=194.8

Q ss_pred             ceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccccHHHHHhh
Q psy11580         80 AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM  159 (288)
Q Consensus        80 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~  159 (288)
                      .++|.-+++.||+|....+..+..+.++..+|..++..++|+||++++.+|+.....++....|+|||+|..++.+.+..
T Consensus        34 ~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~  113 (369)
T KOG0665|consen   34 AAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVILM  113 (369)
T ss_pred             ecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHHH
Confidence            36788889999999999887888888999999999999999999999999999998888889999999999999999998


Q ss_pred             hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhHhcCC
Q psy11580        160 DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG  239 (288)
Q Consensus       160 ~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  239 (288)
                      .++-.++..+..|++.|+++||+.||+||||||+||++..+..+|+.|||++...+.....+.++.+..|.|||++.+..
T Consensus       114 elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~  193 (369)
T KOG0665|consen  114 ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG  193 (369)
T ss_pred             hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccC
Confidence            89999999999999999999999999999999999999999999999999999888777778899999999999999999


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        240 YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       240 ~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      +...+||||+||++.||+.|...|+|.+..+++.+|++.+|.+.+.
T Consensus       194 ~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  194 YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence            9999999999999999999999999999999999999999987653

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.3e-37  Score=269.20  Aligned_cols=209  Identities=25%  Similarity=0.422  Sum_probs=170.7

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      +...+.+|+|.++.++++    .+..+++.||+|++.+.. ........+.+|++++++++||||+++++.+...+..  
T Consensus         3 f~~~~~LG~G~~g~Vy~a----~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~--   76 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLA----RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL--   76 (382)
T ss_pred             cEEEEEEEeCCCEEEEEE----EECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEE--
Confidence            456677888888777765    456788999999997521 1233456788999999999999999999999877654  


Q ss_pred             cccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++||||++++ +.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....
T Consensus        77 ----~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~  152 (382)
T cd05625          77 ----YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (382)
T ss_pred             ----EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence                9999999874 555554  347888999999999999999999999999999999999999999999999974221


Q ss_pred             CC------------------------------------------------cccCCcccccccCchHhHhcCCCCchhhHH
Q psy11580        216 TT------------------------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIW  247 (288)
Q Consensus       216 ~~------------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~  247 (288)
                      ..                                                .......||+.|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw  232 (382)
T cd05625         153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW  232 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence            00                                                001224689999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        248 SVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       248 slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ||||++|+|++|+.||.+.++.+...++...
T Consensus       233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~  263 (382)
T cd05625         233 SVGVILYEMLVGQPPFLAQTPLETQMKVINW  263 (382)
T ss_pred             echHHHHHHHhCCCCCCCCCHHHHHHHHHcc
Confidence            9999999999999999998887777777653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.9e-37  Score=264.03  Aligned_cols=209  Identities=25%  Similarity=0.373  Sum_probs=168.3

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY  143 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~  143 (288)
                      .+|+|.++.++++    .+..+++.||+|+++... ........+..|+++++.++||||+++++++...+..      +
T Consensus         2 ~lG~G~~g~V~~~----~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~------~   71 (325)
T cd05594           2 LLGKGTFGKVILV----KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL------C   71 (325)
T ss_pred             eeeeCCCEEEEEE----EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEE------E
Confidence            3566666655543    456789999999997532 1233455677899999999999999999999877655      9


Q ss_pred             EEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeecccccccC-CCc
Q psy11580        144 LVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TTF  218 (288)
Q Consensus       144 lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~-~~~  218 (288)
                      +||||++++ +...+.  ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++.... ...
T Consensus        72 lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          72 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence            999999875 444443  348899999999999999999997 799999999999999999999999999987532 222


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.......|
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p  216 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP  216 (325)
T ss_pred             ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            23345789999999999998999999999999999999999999998887777666654433333

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=263.82  Aligned_cols=207  Identities=28%  Similarity=0.509  Sum_probs=172.8

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+|+|.++.++.+    .+..+++.||+|+++.... .......+..|+++++.++||||+++++++...+.. 
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~-   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLA----KKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYL-   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEE----EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEE-
Confidence            3556777888877777764    4566789999999975321 223456688899999999999999999999877654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||++++ |.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++...
T Consensus        77 -----~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~  151 (333)
T cd05600          77 -----YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI  151 (333)
T ss_pred             -----EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence                 9999999864 555554  34789999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      ..  ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+..
T Consensus       152 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~  212 (333)
T cd05600         152 VT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY  212 (333)
T ss_pred             cc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh
Confidence            44  23445789999999999998999999999999999999999999998888777666654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.9e-37  Score=265.07  Aligned_cols=208  Identities=25%  Similarity=0.271  Sum_probs=168.3

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|.|.++.++.    +.+..+++.||+|....        ..+.+|++++++++||||+++++++......  
T Consensus        93 ~y~~~~~lg~G~~g~V~~----~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~--  158 (391)
T PHA03212         93 GFSILETFTPGAEGFAFA----CIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFT--  158 (391)
T ss_pred             CcEEEEEEcCCCCeEEEE----EEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee--
Confidence            345555555555554444    46788999999997642        3467899999999999999999999776554  


Q ss_pred             cccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                          ++|+|++.+++...+.  ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.++|+|||++.....
T Consensus       159 ----~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        159 ----CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             ----EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence                9999999988887765  3588999999999999999999999999999999999999999999999999865322


Q ss_pred             C--cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CchhHHHHHHHHhCCCcc
Q psy11580        217 T--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT-------DHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       217 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~-------~~~~~~~~i~~~~~~~~~  284 (288)
                      .  .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.       +....+..+++.++..|.
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~  311 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN  311 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence            1  1223457899999999999989999999999999999999999887543       234566777777765553

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.8e-37  Score=261.52  Aligned_cols=213  Identities=23%  Similarity=0.356  Sum_probs=169.7

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHH---HHCCCCCcceeeccccCCCcc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLM---KLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .+.+.+|+|.++.++.+    .+..+++.||||+++... ........+..|++++   +.++||||+++++++...+..
T Consensus         2 ~i~~~lg~G~~g~Vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~   77 (324)
T cd05589           2 RCLAVLGRGHFGKVLLA----EYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV   77 (324)
T ss_pred             eEEEEEeecCCEEEEEE----EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEE
Confidence            34566777777776654    356788999999997532 1223345566666655   556799999999999877654


Q ss_pred             cccccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                            ++||||++++ +...+. ..+++..+..++.||+.||+|||+.+++||||||+||+++.++.+||+|||++...
T Consensus        78 ------~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          78 ------CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             ------EEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence                  9999999975 444433 45899999999999999999999999999999999999999999999999998753


Q ss_pred             CC-CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        215 GT-TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       215 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .. ........+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+.......|
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p  221 (324)
T cd05589         152 MGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP  221 (324)
T ss_pred             CCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            22 2223456789999999999998899999999999999999999999999888887777766544443

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-36  Score=255.03  Aligned_cols=215  Identities=36%  Similarity=0.543  Sum_probs=173.9

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC---CCCCcceeeccccCCCccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV---NHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~  137 (288)
                      .+.+.+|+|.++.++.+    .+..+++.||+|.++.............+|+++++.+   +||||+++++++..... .
T Consensus         3 ~~~~~lg~g~~g~v~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~-~   77 (288)
T cd07863           3 EPVAEIGVGAYGTVYKA----RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT-D   77 (288)
T ss_pred             eEeeEEeecCCeEEEEE----EECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC-C
Confidence            45566777777776654    4677899999999975432222233455677766665   79999999999865432 2


Q ss_pred             ccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      .....++++|++++++.+.+..    .+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++..
T Consensus        78 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          78 RETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             CCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence            2345699999999988777653    378999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        214 AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       214 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ...........++..|+|||++.+..++.++||||||+++|+|++|.+||.+.+..+.+.++....+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~  224 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG  224 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence            6544444455778999999999998899999999999999999999999999888888888877654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.9e-37  Score=261.31  Aligned_cols=214  Identities=26%  Similarity=0.410  Sum_probs=169.1

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCC--cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF--QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++.+.. ..+..+++.||+|+++...  ........+..|+++++.++||||+++++++...+..      
T Consensus         3 ~lg~G~~g~V~~~~~-~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~------   75 (323)
T cd05584           3 VLGKGGYGKVFQVRK-VTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL------   75 (323)
T ss_pred             eeeecCCeEEEEEEE-cccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE------
Confidence            456665555554310 0123578899999997521  1223345677899999999999999999999877654      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-Cc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TF  218 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~  218 (288)
                      ++||||+.++ +.+.+.  ..+.+..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++..... ..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            9999999875 555554  3377888999999999999999999999999999999999999999999999874322 22


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+....+.++.+.....|+.
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPY  222 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            2334578999999999999888999999999999999999999999988887777777665555543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.5e-37  Score=260.15  Aligned_cols=209  Identities=25%  Similarity=0.394  Sum_probs=169.1

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++.+    .+..+++.||+|++++.. ........+..|..+++.+ +||||+++++++...+..      
T Consensus         2 ~lg~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~------   71 (320)
T cd05590           2 VLGKGSFGKVMLA----RLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL------   71 (320)
T ss_pred             eeeeCCCeEEEEE----EEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE------
Confidence            3566666665554    456788999999997531 1223455677888888877 699999999999877654      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC-CCc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TTF  218 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~-~~~  218 (288)
                      ++||||++++ |...+.  ..+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++.... ...
T Consensus        72 ~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~  151 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK  151 (320)
T ss_pred             EEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence            9999999875 544443  358899999999999999999999999999999999999999999999999987532 222


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+..+.+.....|
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~  216 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP  216 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            33445789999999999998899999999999999999999999999988888877765444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-37  Score=264.56  Aligned_cols=214  Identities=28%  Similarity=0.424  Sum_probs=172.1

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      .+|+|.++.++.+.. +.+..+|+.||+|+++...........+..|++++++++||||+++++++...+..      ++
T Consensus         3 ~lg~G~~g~Vy~~~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------~l   75 (318)
T cd05582           3 VLGQGSFGKVFLVRK-ITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKL------YL   75 (318)
T ss_pred             eeeeCCCEEEEEEEE-eccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEE------EE
Confidence            456665555554321 12245789999999975333333445677899999999999999999999877654      99


Q ss_pred             EEecccc-cHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC-ccc
Q psy11580        145 VMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT-FMM  220 (288)
Q Consensus       145 v~e~~~~-~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-~~~  220 (288)
                      ||||+++ ++.+.+..  .+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++...... ...
T Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence            9999986 56565543  4889999999999999999999999999999999999999999999999998765433 222


Q ss_pred             CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       221 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+...++.+.....|..
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~  220 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF  220 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            34578999999999998888999999999999999999999999988888887777655555443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.5e-37  Score=260.20  Aligned_cols=215  Identities=26%  Similarity=0.383  Sum_probs=173.9

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  137 (288)
                      +.+.+.+|+|.++.++++    .+..+++.||+|++++... .......+..|..++..+ +|++|+++++++...+.. 
T Consensus         2 f~~~~~lg~G~~g~Vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~-   76 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLA----ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRL-   76 (323)
T ss_pred             ceEEEEEeeCCCeEEEEE----EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEE-
Confidence            456677888887777764    4567789999999975321 223344566788888887 588999999998776654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||+++ ++...+.  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus        77 -----~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~  151 (323)
T cd05616          77 -----YFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  151 (323)
T ss_pred             -----EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence                 999999986 4555553  35889999999999999999999999999999999999999999999999998754


Q ss_pred             CC-CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        215 GT-TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       215 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      .. ........|++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+..+.+.....|.
T Consensus       152 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~  222 (323)
T cd05616         152 MWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK  222 (323)
T ss_pred             CCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            32 22234457899999999999999999999999999999999999999998888888877765544443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0032|consensus

Probab=100.00  E-value=1.1e-36  Score=260.13  Aligned_cols=211  Identities=30%  Similarity=0.487  Sum_probs=183.4

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~  136 (288)
                      .+.+++.+|.|-|+.++.    +.+..+|+.+|+|++++... +........+|+++|+++. ||||+.++++|.+....
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~----~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYL----CREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cEEehhhhCCCCceEEEE----EEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            345557777777776665    45678899999999987432 2234567889999999998 99999999999988765


Q ss_pred             cccccEEEEEecccc-cHHHHHhhh-CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC----CcEEEeeccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD----CTLKILDFGL  210 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~----~~~kl~dfg~  210 (288)
                            ++|||++.| .|++.+... +++..+..++.|++++++|||+.|++||||||+|+|+...    +.+|++|||+
T Consensus       112 ------~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  112 ------YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             ------EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence                  999999996 477777766 9999999999999999999999999999999999999754    4799999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      +............+||+.|+|||++....++..+||||+|+++|.|++|.+||.+.+......+|.+.-
T Consensus       186 a~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~  254 (382)
T KOG0032|consen  186 AKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD  254 (382)
T ss_pred             ceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC
Confidence            999887767788899999999999999999999999999999999999999999999888888877663

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-37  Score=266.24  Aligned_cols=209  Identities=28%  Similarity=0.443  Sum_probs=175.0

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+|+|.++.++.+    .+..+++.||+|+++.... .......+..|++++..++||||+++++++...+.. 
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~-   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLV----RDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHL-   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEE----EECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeE-
Confidence            3456677888777777764    4566899999999975321 224456788999999999999999999999877654 


Q ss_pred             ccccEEEEEecccc-cHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||+++ +|.+.+..  .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus        77 -----~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  151 (350)
T cd05573          77 -----YLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM  151 (350)
T ss_pred             -----EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence                 999999976 56665543  5889999999999999999999999999999999999999999999999998765


Q ss_pred             CCCc------------------------------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy11580        215 GTTF------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP  264 (288)
Q Consensus       215 ~~~~------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~  264 (288)
                      ....                              ......+++.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~  231 (350)
T cd05573         152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY  231 (350)
T ss_pred             cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence            4332                              2234568999999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHHH
Q psy11580        265 GTDHIDQWNKIIG  277 (288)
Q Consensus       265 ~~~~~~~~~~i~~  277 (288)
                      +.+..+.+.++..
T Consensus       232 ~~~~~~~~~~i~~  244 (350)
T cd05573         232 SDTLQETYNKIIN  244 (350)
T ss_pred             CCCHHHHHHHHhc
Confidence            9888887777776

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.3e-37  Score=260.05  Aligned_cols=206  Identities=26%  Similarity=0.410  Sum_probs=168.0

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++++    .+..+++.||+|+++... ........+..|.++++.+ +||||+++++++...+..      
T Consensus         2 ~lG~G~~g~Vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~------   71 (321)
T cd05591           2 VLGKGSFGKVMLA----ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL------   71 (321)
T ss_pred             ccccCCCeEEEEE----EECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE------
Confidence            4566666666654    356678999999997532 1223445677888998876 799999999999877655      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-Cc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TF  218 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~  218 (288)
                      ++||||++++ +...+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++..... ..
T Consensus        72 ~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  151 (321)
T cd05591          72 FFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV  151 (321)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence            9999999875 544443  3588899999999999999999999999999999999999999999999999875422 22


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+..+.....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~  213 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV  213 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence            23445789999999999998899999999999999999999999999988888877765443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.1e-36  Score=259.27  Aligned_cols=215  Identities=26%  Similarity=0.373  Sum_probs=173.3

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCC-CcceeeccccCCCccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHK-NIIGLLNAFTPQKSLE  137 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~  137 (288)
                      +.+.+.+|+|.++.++++    .+..+++.||+|+++... ........+..|.+++..++|+ +|+.+++++...+.. 
T Consensus         2 y~~~~~lg~G~~g~Vy~~----~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~-   76 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLA----ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL-   76 (324)
T ss_pred             ceEEEEEeeccCeEEEEE----EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEE-
Confidence            456677888887777765    356678899999997532 1223456678899999999765 588888888776654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||++++ |.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++...
T Consensus        77 -----~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          77 -----YFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             -----EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence                 9999999864 555554  34789999999999999999999999999999999999999999999999998653


Q ss_pred             C-CCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        215 G-TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       215 ~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      . .........|++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+.+..+.+.....|.
T Consensus       152 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~  222 (324)
T cd05587         152 IFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK  222 (324)
T ss_pred             CCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            2 222233456899999999999988999999999999999999999999998888888887765544443

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.5e-37  Score=268.46  Aligned_cols=209  Identities=26%  Similarity=0.418  Sum_probs=169.0

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .+.+.+.+|+|.++.++++    .+..+++.||+|++.+.. ........+.+|+++++.++|+||+++++.+...+.. 
T Consensus         2 ~y~~~~~lG~G~~g~V~~a----~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~-   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLV----RKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNL-   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEE----EECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEE-
Confidence            3456677888877777764    456789999999996421 1223345678899999999999999999999877655 


Q ss_pred             ccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||++++ |.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++...
T Consensus        77 -----~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          77 -----YFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             -----EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence                 9999999864 656554  34788889999999999999999999999999999999999999999999997422


Q ss_pred             CC--------------------------------------------CcccCCcccccccCchHhHhcCCCCchhhHHHHH
Q psy11580        215 GT--------------------------------------------TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG  250 (288)
Q Consensus       215 ~~--------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg  250 (288)
                      ..                                            ........|++.|+|||++.+..++.++||||||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  231 (376)
T cd05598         152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  231 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence            10                                            0001124689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        251 CIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       251 ~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      |++|+|++|+.||.+.+..+...++..
T Consensus       232 vilyell~G~~Pf~~~~~~~~~~~i~~  258 (376)
T cd05598         232 VILYEMLVGQPPFLADTPAETQLKVIN  258 (376)
T ss_pred             ceeeehhhCCCCCCCCCHHHHHHHHhc
Confidence            999999999999999887776666554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-36  Score=259.52  Aligned_cols=210  Identities=25%  Similarity=0.394  Sum_probs=166.7

Q ss_pred             hhhcccccccccCCccccccccCccce-eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAA-YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTP  132 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  132 (288)
                      +...++.+.+.+|+|.++.++.+.-.. .+..+++.||+|+++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            455678889999999998888764221 22455678999999743 2334456788999999999 89999999999875


Q ss_pred             CCcccccccEEEEEeccccc-HHHHHhh----------------------------------------------------
Q psy11580        133 QKSLEEFQDVYLVMELMDAN-LCQVIQM----------------------------------------------------  159 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~----------------------------------------------------  159 (288)
                      .+.     .+++||||++++ |.+++..                                                    
T Consensus        83 ~~~-----~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (338)
T cd05102          83 PNG-----PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST  157 (338)
T ss_pred             CCC-----ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence            442     358999999865 5444431                                                    


Q ss_pred             ------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc---ccCCcc
Q psy11580        160 ------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYV  224 (288)
Q Consensus       160 ------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~  224 (288)
                                  .+++..+..++.||++||+|||+++|+||||||+||+++.++.+||+|||++.......   ......
T Consensus       158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  237 (338)
T cd05102         158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR  237 (338)
T ss_pred             ccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence                        26677889999999999999999999999999999999999999999999997543221   112234


Q ss_pred             cccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchh
Q psy11580        225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHID  270 (288)
Q Consensus       225 ~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~  270 (288)
                      ++..|+|||++.+..++.++||||||+++|||++ |..||.+....+
T Consensus       238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~  284 (338)
T cd05102         238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE  284 (338)
T ss_pred             CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence            5678999999999889999999999999999997 999998865433

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.7e-37  Score=265.79  Aligned_cols=214  Identities=26%  Similarity=0.406  Sum_probs=173.1

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.+|+|.++.++++    .+..+++.||+|++++.. ........+..|+.+++.++||||+++++++...+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~  116 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLV----RHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK  116 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEE----EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            3455666777777777766653    456789999999997421 12233445778999999999999999999998776


Q ss_pred             cccccccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        135 SLEEFQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      ..      ++||||++++ |.+.+. ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++.
T Consensus       117 ~~------~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         117 YL------YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EE------EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            54      9999999865 555544 347888999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc--ccCCcccccccCchHhHhcC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        213 TAGTTF--MMTPYVVTRYYRAPEVILGM----GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       213 ~~~~~~--~~~~~~~~~~~~aPE~~~~~----~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ......  ......|++.|+|||++.+.    .++.++|+|||||++|+|++|..||.+.+....+.+|.+..
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  263 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK  263 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC
Confidence            654322  22345789999999999764    37889999999999999999999999988888888887643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0662|consensus

Probab=100.00  E-value=2.9e-37  Score=227.79  Aligned_cols=213  Identities=34%  Similarity=0.577  Sum_probs=185.9

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      ..+.||.|..+.++.+    .+..+++.||+|..+.+..+..-.+...+|+-+|+.++|.|||++++....+..+     
T Consensus         6 kmekigegtygtvfka----rn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkl-----   76 (292)
T KOG0662|consen    6 KMEKIGEGTYGTVFKA----RNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL-----   76 (292)
T ss_pred             HHHhhcCCcceeeEec----ccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee-----
Confidence            4456677666665544    5678999999999987666666677889999999999999999999999888776     


Q ss_pred             EEEEEecccccHHHHH---hhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        142 VYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       142 ~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                       -+|+|+|..++..++   +..++.+.++.++.|+++||.++|+.++.|||+||.|.+++.+|++||+|||+++..+.+.
T Consensus        77 -tlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   77 -TLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             -EEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence             899999998876655   4569999999999999999999999999999999999999999999999999999887765


Q ss_pred             c-cCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        219 M-MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       219 ~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      . .+..+.|..|.+|.++.|. -|+...||||.||++.|+.. |++.|+|.+-.++++.|.+.+|.+.+
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~e  224 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcc
Confidence            3 3566889999999999984 57899999999999999996 99999999999999999999986654

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-36  Score=257.94  Aligned_cols=209  Identities=29%  Similarity=0.478  Sum_probs=166.1

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++.+    .+..+++.||+|+++.... .......+..|..++..+ +||||+++++++...+..      
T Consensus         2 ~lG~G~~g~Vy~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~------   71 (316)
T cd05592           2 VLGKGSFGKVMLA----ELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL------   71 (316)
T ss_pred             eeeeCCCeEEEEE----EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE------
Confidence            4566666666654    3456788999999975321 223344556677777655 899999999999776654      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-Cc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TF  218 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~  218 (288)
                      ++||||++++ |...+.  ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++..... ..
T Consensus        72 ~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  151 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG  151 (316)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence            9999999865 555543  3588999999999999999999999999999999999999999999999999875432 22


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+.......|
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~  216 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP  216 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            23445789999999999998899999999999999999999999999888777777665443333

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-36  Score=259.27  Aligned_cols=209  Identities=26%  Similarity=0.402  Sum_probs=165.6

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHH-HHHHHCCCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREF-KLMKLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++++    .+..+++.||+|++..... .......+..|. .+++.++||||+++++++...+..      
T Consensus         2 ~lg~G~fg~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~------   71 (325)
T cd05602           2 VIGKGSFGKVLLA----RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL------   71 (325)
T ss_pred             eeeeCCCeEEEEE----EECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE------
Confidence            4566666666654    4567789999999975211 112223344444 456788999999999999877655      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-Cc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TF  218 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~  218 (288)
                      ++||||++++ +.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ..
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~  151 (325)
T cd05602          72 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG  151 (325)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence            9999999875 555443  3478888999999999999999999999999999999999999999999999875322 22


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+.......+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  216 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK  216 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC
Confidence            23445789999999999999999999999999999999999999999888888888776544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG4236|consensus

Probab=100.00  E-value=2.5e-37  Score=261.03  Aligned_cols=199  Identities=27%  Similarity=0.449  Sum_probs=180.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +.+--.+.+|+|-|+.+|+|.    +.++|+.||||++.+.....+..+++..|+.+|+.+.||.||.+---|...+.. 
T Consensus       564 YQif~devLGSGQFG~VYgg~----hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv-  638 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGK----HRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV-  638 (888)
T ss_pred             HHhhhHhhccCCcceeeecce----ecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE-
Confidence            455677899999999999984    578999999999998877878889999999999999999999999999888776 


Q ss_pred             ccccEEEEEecccccHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC---CcEEEeeccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGL  210 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~---~~~kl~dfg~  210 (288)
                           ++|||-+.|+.++.+.    .++++.....+..||+.||+|||-++|+|+||||+|||+.+.   -.+||||||+
T Consensus       639 -----FVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGf  713 (888)
T KOG4236|consen  639 -----FVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGF  713 (888)
T ss_pred             -----EEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccc
Confidence                 9999999999877665    458888888899999999999999999999999999999865   3699999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ++..+......+.+||+.|.|||+++.+.|+...||||.|||+|--+.|-.||...
T Consensus       714 ARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd  769 (888)
T KOG4236|consen  714 ARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED  769 (888)
T ss_pred             eeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence            99999888888889999999999999999999999999999999999999999764

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.1e-36  Score=254.93  Aligned_cols=214  Identities=33%  Similarity=0.533  Sum_probs=176.8

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|+|.++.++.+    .+..+++.||+|.++.... ......+.+|++++++++||||+++++++...+..  
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~----~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--   79 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKG----RSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSL--   79 (309)
T ss_pred             ceEEEEEecccCCEEEEEE----EecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE--
Confidence            4566677788777777665    4566788999999975322 22334577899999999999999999999877654  


Q ss_pred             cccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++||||+++++.+.+..   .++...+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++....
T Consensus        80 ----~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          80 ----TLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             ----EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence                99999999988877653   37888999999999999999999999999999999999999999999999987643


Q ss_pred             CCc-ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        216 TTF-MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       216 ~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ... ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+.+..+.+.++.++
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  225 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT  225 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            322 2234467889999999876 4578999999999999999999999999998888888888776544

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.3e-37  Score=259.94  Aligned_cols=209  Identities=27%  Similarity=0.418  Sum_probs=165.6

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHH-HHHHCCCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFK-LMKLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++.+    .+..+++.||+|++..... .......+..|.. +++.++||||+++++.+...+..      
T Consensus         2 ~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~------   71 (323)
T cd05575           2 VIGKGSFGKVLLA----KHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL------   71 (323)
T ss_pred             eeeeCCCeEEEEE----EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE------
Confidence            3566666665554    4567899999999975311 2223344555544 56788999999999999776654      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-Cc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TF  218 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~  218 (288)
                      ++||||++++ +...+.  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... ..
T Consensus        72 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (323)
T cd05575          72 YFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK  151 (323)
T ss_pred             EEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence            9999999875 545543  3488899999999999999999999999999999999999999999999999875322 22


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+...++.......+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  216 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK  216 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            23445789999999999998999999999999999999999999999888887777776544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.7e-37  Score=265.85  Aligned_cols=209  Identities=24%  Similarity=0.417  Sum_probs=171.6

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++...+.+|+|.++.++++    .+..+++.||+|+++... ........+..|+.++..++||||+++++.+...+.. 
T Consensus         2 ~f~~~~~lG~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~-   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLV----QKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNL-   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEE----EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE-
Confidence            3455677788777776654    456789999999997421 2233456778899999999999999999999877654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||++++ |.+.+.  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus        77 -----~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          77 -----YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             -----EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence                 9999999865 655554  35889999999999999999999999999999999999999999999999998643


Q ss_pred             CCCc------------------------------------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh
Q psy11580        215 GTTF------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR  258 (288)
Q Consensus       215 ~~~~------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~  258 (288)
                      ....                                    .....+||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence            2110                                    0113468999999999999999999999999999999999


Q ss_pred             CCCCCCCCCchhHHHHHHH
Q psy11580        259 GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       259 g~~p~~~~~~~~~~~~i~~  277 (288)
                      |..||.+.+....+.++..
T Consensus       232 G~~Pf~~~~~~~~~~~i~~  250 (360)
T cd05627         232 GYPPFCSETPQETYRKVMN  250 (360)
T ss_pred             CCCCCCCCCHHHHHHHHHc
Confidence            9999999888887777765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.2e-36  Score=257.19  Aligned_cols=213  Identities=26%  Similarity=0.380  Sum_probs=171.4

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~  138 (288)
                      .....+|+|.++.++++    .+..+++.||+|++++... .......+..|..+++.+. |++|+++++++...+..  
T Consensus         3 ~~~~~lg~G~~g~Vy~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~--   76 (323)
T cd05615           3 NFLMVLGKGSFGKVMLA----ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRL--   76 (323)
T ss_pred             eEEEEEEecCCeEEEEE----EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEE--
Confidence            45566777777776664    4567899999999975321 2233456778889998885 57788898888776654  


Q ss_pred             cccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++||||++++ |.+.+.  ..+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++....
T Consensus        77 ----~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          77 ----YFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             ----EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence                9999999864 555544  358999999999999999999999999999999999999999999999999987543


Q ss_pred             CC-cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        216 TT-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       216 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .. .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.......+.+.....|
T Consensus       153 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p  221 (323)
T cd05615         153 VDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP  221 (323)
T ss_pred             CCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            22 223345689999999999998899999999999999999999999999888887777776544443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-36  Score=258.54  Aligned_cols=209  Identities=26%  Similarity=0.383  Sum_probs=164.5

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHH-HHHHCCCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFK-LMKLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++++    .+..+++.||+|++.+... .......+..|.. +++.++||||+++++++...+..      
T Consensus         2 ~lg~G~~g~Vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~------   71 (321)
T cd05603           2 VIGKGSFGKVLLA----KRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL------   71 (321)
T ss_pred             eeeeCCCEEEEEE----EECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE------
Confidence            4566666665554    4567789999999975321 2223344555554 67889999999999998776654      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-Cc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TF  218 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~  218 (288)
                      ++||||++++ +...+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++..... ..
T Consensus        72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (321)
T cd05603          72 YFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE  151 (321)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence            9999999875 544443  3478889999999999999999999999999999999999999999999999875322 22


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.......|
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  216 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP  216 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            23445789999999999998899999999999999999999999999887777776665433333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.8e-36  Score=251.15  Aligned_cols=216  Identities=17%  Similarity=0.236  Sum_probs=168.5

Q ss_pred             hhcccccc--cccCCccccccccCccceeccCCCceEEEEeccCCCcch-hhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         56 IYQELPIS--HQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV-THAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        56 ~~~~~~~~--~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      ...++...  ..++.+.++.++.|      ..+|+.||||.++...... ...+.+.+|+.+|++++||||+++++++.+
T Consensus        16 ~~~~i~~~~~~~i~~g~~~~v~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~   89 (283)
T PHA02988         16 ESDDIDKYTSVLIKENDQNSIYKG------IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID   89 (283)
T ss_pred             CHHHcCCCCCeEEeeCCceEEEEE------EECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence            33444433  44555555555554      3478999999998643222 224677899999999999999999999875


Q ss_pred             CCcccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCCEEEccCCcEEEeec
Q psy11580        133 QKSLEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~-~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      ..  ......++||||++++ |.+.+.  ..+++.....++.|++.||++||+. +++||||||+||+++.++.+||+||
T Consensus        90 ~~--~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~df  167 (283)
T PHA02988         90 IV--DDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICH  167 (283)
T ss_pred             cc--cCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEccc
Confidence            11  1113458999999976 555554  3488899999999999999999984 8999999999999999999999999


Q ss_pred             ccccccCCCcccCCcccccccCchHhHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCC
Q psy11580        209 GLARTAGTTFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       209 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  281 (288)
                      |++.......  ....++..|+|||++.+  ..++.++||||||+++|+|++|..||.+.+..+....++.....
T Consensus       168 g~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~  240 (283)
T PHA02988        168 GLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS  240 (283)
T ss_pred             chHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC
Confidence            9987654332  23467889999999987  67899999999999999999999999998888877777654433

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-36  Score=258.85  Aligned_cols=204  Identities=28%  Similarity=0.440  Sum_probs=163.5

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHH-HHHHCCCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFK-LMKLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++.+    .+..+|+.||+|++.... ........+..|.. +++.++||||+++++++...+..      
T Consensus         2 ~lG~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~------   71 (325)
T cd05604           2 VIGKGSFGKVLLA----KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL------   71 (325)
T ss_pred             ceeeCCCeEEEEE----EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE------
Confidence            3566666665554    456789999999997531 12233344555554 56778999999999999877655      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-Cc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TF  218 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~  218 (288)
                      ++||||+.++ +...+.  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... ..
T Consensus        72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  151 (325)
T cd05604          72 YFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD  151 (325)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence            9999999875 544443  3488999999999999999999999999999999999999999999999999875322 22


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+...++...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~  211 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK  211 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC
Confidence            234457899999999999988999999999999999999999999998887777776654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0690|consensus

Probab=100.00  E-value=1.8e-37  Score=248.06  Aligned_cols=221  Identities=25%  Similarity=0.364  Sum_probs=187.0

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      .+..+++...+.+|+|.++.+-+    |..+.+++.+|+|+++++. ...........|-++|+.++||.+..+-..|..
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL----~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt  239 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVIL----CREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT  239 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEE----EeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence            44556777778888888777665    5678899999999999753 234445667789999999999999999989988


Q ss_pred             CCcccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        133 QKSLEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .+.+      |+||||..|+ |+-.+.  .-+++...+.+...|.+||.|||+++||+||||.+|.|++.+|.+||+|||
T Consensus       240 ~drl------CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFG  313 (516)
T KOG0690|consen  240 QDRL------CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFG  313 (516)
T ss_pred             CceE------EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecc
Confidence            8776      9999999876 433333  448999999999999999999999999999999999999999999999999


Q ss_pred             cccc-cCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        210 LART-AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       210 ~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      +++. ........+++|||.|.|||++....|+.+.|.|.+||++|||++|+.||...++..+...|...--..|.
T Consensus       314 LCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr  389 (516)
T KOG0690|consen  314 LCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR  389 (516)
T ss_pred             cchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc
Confidence            9985 44556678899999999999999999999999999999999999999999999998877777655444443

>KOG0586|consensus

Probab=100.00  E-value=4e-37  Score=264.20  Aligned_cols=206  Identities=28%  Similarity=0.468  Sum_probs=183.2

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .....+.+.||+|-+..++++    ++.-++..||||++++...+......+.+|+++|+.++|||||+++.+......+
T Consensus        55 vg~y~i~~tig~g~f~~V~La----~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLA----RHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             ccceeeeeeeccceeEEEEee----EecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            344577888888888888886    5678899999999998877777777899999999999999999999999988876


Q ss_pred             cccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                            |+||||+.++ +++++.  ....+..++.++.|+.+|++|||+++|||||||++|++++.+.++||+|||++..
T Consensus       131 ------ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  131 ------YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             ------EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeecccccee
Confidence                  9999998764 666665  3466689999999999999999999999999999999999999999999999999


Q ss_pred             cCCCcccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhHH
Q psy11580        214 AGTTFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW  272 (288)
Q Consensus       214 ~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~  272 (288)
                      ........+++|++.|.|||++.+..+ ++.+|+||+|+++|-|++|..||.|.+-.+.-
T Consensus       205 ~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr  264 (596)
T KOG0586|consen  205 FDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR  264 (596)
T ss_pred             ecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc
Confidence            988888889999999999999999876 58999999999999999999999987755443

>KOG0604|consensus

Probab=100.00  E-value=1.2e-36  Score=240.64  Aligned_cols=196  Identities=28%  Similarity=0.422  Sum_probs=163.9

Q ss_pred             ceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccEEEEEeccccc-HHHHH
Q psy11580         80 AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-LCQVI  157 (288)
Q Consensus        80 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~  157 (288)
                      .++++.||+.+|+|++..       ..+..+|+++.-+. .|||||.++++|...-  .+...+.+|||.|+|+ |++.+
T Consensus        80 ~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~--~~rkcLLiVmE~meGGeLfsri  150 (400)
T KOG0604|consen   80 QCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSY--QGRKCLLIVMECMEGGELFSRI  150 (400)
T ss_pred             EEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc--cCceeeEeeeecccchHHHHHH
Confidence            377899999999999953       35677899887777 6999999999997432  4456779999999975 77766


Q ss_pred             h----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc---CCcEEEeecccccccCCCcccCCcccccccC
Q psy11580        158 Q----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYR  230 (288)
Q Consensus       158 ~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  230 (288)
                      .    ..+++.++..|+.||+.|++|||+.+|.||||||+|+|.+.   +..+||+|||+++.-..+....+.+.|+.|.
T Consensus       151 q~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYv  230 (400)
T KOG0604|consen  151 QDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYV  230 (400)
T ss_pred             HHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCccccccc
Confidence            5    23999999999999999999999999999999999999975   4579999999999887776777889999999


Q ss_pred             chHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----hHHHHHHHHhCCCcc
Q psy11580        231 APEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI----DQWNKIIGKMREAHD  284 (288)
Q Consensus       231 aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~----~~~~~i~~~~~~~~~  284 (288)
                      |||++....++...|+||+||++|-|++|.+||.+....    .+-++|....-+.|+
T Consensus       231 aPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~  288 (400)
T KOG0604|consen  231 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE  288 (400)
T ss_pred             CHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence            999999999999999999999999999999999876543    344555544444443

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.5e-36  Score=256.65  Aligned_cols=191  Identities=25%  Similarity=0.411  Sum_probs=157.6

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++.+    .+..+++.||+|+++.... .......+..|..+++.+ +||||+++++++...+..      
T Consensus         2 ~lG~G~~g~V~~~----~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~------   71 (329)
T cd05588           2 VIGRGSYAKVLLV----ELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL------   71 (329)
T ss_pred             eEeeCCCeEEEEE----EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE------
Confidence            3566666655543    4567889999999985322 233455678899999999 799999999999877654      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc-CCCc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTTF  218 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~-~~~~  218 (288)
                      ++||||++++ |...+.  ..+++..+..++.||+.||+|||+++++||||||+||+++.++.++|+|||++... ....
T Consensus        72 ~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~  151 (329)
T cd05588          72 FFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD  151 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence            9999999874 555543  45899999999999999999999999999999999999999999999999998753 2222


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            33456789999999999998999999999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4e-36  Score=255.15  Aligned_cols=209  Identities=26%  Similarity=0.421  Sum_probs=167.8

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++.+    .+..+++.||+|++++.. ........+..|.++++.+ +||||+++++++...+..      
T Consensus         2 ~lG~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~------   71 (318)
T cd05570           2 VLGKGSFGKVLLA----ELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL------   71 (318)
T ss_pred             eeeeCCCeEEEEE----EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE------
Confidence            3566666665553    456678999999997532 1223455677888999888 799999999999877654      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-Cc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TF  218 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~  218 (288)
                      ++||||++++ |...+.  ..+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++..... ..
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  151 (318)
T cd05570          72 FFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV  151 (318)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence            9999999865 544444  3589999999999999999999999999999999999999999999999999865322 22


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+.......+.+.....|
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~  216 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP  216 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            22345689999999999999999999999999999999999999998888777777665444333

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.1e-36  Score=254.84  Aligned_cols=208  Identities=27%  Similarity=0.436  Sum_probs=165.9

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++++    .+..+++.||+|+++.... ..........|..++... +||||+++++++...+..      
T Consensus         2 ~lg~G~~g~V~~~----~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~------   71 (316)
T cd05620           2 VLGKGSFGKVLLA----ELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL------   71 (316)
T ss_pred             eeeeCCCeEEEEE----EECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE------
Confidence            4566666666654    4567889999999975321 123345566788888765 899999999999877654      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-Cc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TF  218 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~  218 (288)
                      ++||||+.++ |...+.  ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++..... ..
T Consensus        72 ~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05620          72 FFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN  151 (316)
T ss_pred             EEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence            9999999864 555554  3588999999999999999999999999999999999999999999999999864322 22


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~  215 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHY  215 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            2344578999999999999999999999999999999999999999888777766665443333

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=256.77  Aligned_cols=210  Identities=24%  Similarity=0.362  Sum_probs=170.6

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+|+|.++.++.+    .+..+++.||+|++.+. .........+.+|..+++.++|+||+++++++...+.. 
T Consensus         2 ~y~~~~~lG~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~-   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVV----KMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNL-   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEE----EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeE-
Confidence            4566778888887777664    45678899999999742 12223445678899999999999999999999877655 


Q ss_pred             ccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                           ++||||+.+ +|.+.+.   ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++..
T Consensus        77 -----~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  151 (331)
T cd05597          77 -----YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLR  151 (331)
T ss_pred             -----EEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceee
Confidence                 999999976 5666554   3488999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcc--cCCcccccccCchHhHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        214 AGTTFM--MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       214 ~~~~~~--~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ......  .....+++.|+|||++.+     ..++.++||||||+++|+|++|+.||.+.+..+.+..+...
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~  223 (331)
T cd05597         152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  223 (331)
T ss_pred             cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence            543222  123468999999999974     34678999999999999999999999988877777776653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=248.93  Aligned_cols=204  Identities=28%  Similarity=0.394  Sum_probs=164.4

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      +.+.+|+|.++.++.+    .+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+...+..    
T Consensus         4 ~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----   75 (285)
T cd05605           4 HYRVLGKGGFGEVCAC----QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL----   75 (285)
T ss_pred             EEEEEecCCCeEEEEE----EEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeE----
Confidence            4455666666665553    4566789999999975322 222234567899999999999999999999876654    


Q ss_pred             cEEEEEeccccc-HHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        141 DVYLVMELMDAN-LCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       141 ~~~lv~e~~~~~-l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                        ++||||++++ +.+.+.    ..+++..+..++.|++.||+|||+.+++|+||+|+||++++++.++|+|||++....
T Consensus        76 --~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          76 --CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             --EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence              9999999875 444432    248899999999999999999999999999999999999999999999999988764


Q ss_pred             CCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHH
Q psy11580        216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       216 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i  275 (288)
                      .........+++.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+.......+
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~  213 (285)
T cd05605         154 EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV  213 (285)
T ss_pred             CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH
Confidence            443334457889999999999888999999999999999999999999987665444333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.7e-36  Score=255.27  Aligned_cols=190  Identities=25%  Similarity=0.416  Sum_probs=156.1

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++.+    .+..+++.||+|++++.. ........+..|+.++.++ +||||+++++++...+..      
T Consensus         2 ~lG~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~------   71 (329)
T cd05618           2 VIGRGSYAKVLLV----RLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL------   71 (329)
T ss_pred             eeeeCCCeEEEEE----EECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE------
Confidence            3566666655543    456788999999998642 2334455677899888877 899999999999877654      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC-CCc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TTF  218 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~-~~~  218 (288)
                      ++||||++++ +...+.  ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++.... ...
T Consensus        72 ~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~  151 (329)
T cd05618          72 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  151 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence            9999999975 444443  458999999999999999999999999999999999999999999999999987532 222


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP  264 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~  264 (288)
                      ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence            2344578999999999999999999999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-35  Score=264.91  Aligned_cols=207  Identities=22%  Similarity=0.419  Sum_probs=169.0

Q ss_pred             cccccccCCccccccccCccceeccCC-CceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTAT-QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      +.+.+.+|.|.++.++.+    .+..+ +..||+|.+..  ........+..|+.+++.++||||+++++++...+..  
T Consensus        69 y~~~~~lg~G~~g~vy~a----~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~--  140 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVA----TRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL--  140 (478)
T ss_pred             EEEEEEEEeCCCcEEEEE----EEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE--
Confidence            566677777666666554    34455 67899998754  2334455677899999999999999999999877654  


Q ss_pred             cccEEEEEeccccc-HHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                          ++||||++++ |.+.+.      ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++
T Consensus       141 ----~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        141 ----LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             ----EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence                9999999864 554442      23788899999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        212 RTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       212 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      .......   ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+.++...
T Consensus       217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~  286 (478)
T PTZ00267        217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG  286 (478)
T ss_pred             eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            8654332   234456899999999999988999999999999999999999999988877777766543

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.1e-36  Score=252.94  Aligned_cols=203  Identities=31%  Similarity=0.498  Sum_probs=163.8

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++.+    .+..+++.||+|+++.... ..........|..+++.. +||||+++++++...+..      
T Consensus         2 ~lG~G~~g~Vy~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~------   71 (316)
T cd05619           2 MLGKGSFGKVFLA----ELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL------   71 (316)
T ss_pred             eeeeCCCEEEEEE----EECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE------
Confidence            4566666666654    4567789999999975321 123345566778888765 899999999999877654      


Q ss_pred             EEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-Cc
Q psy11580        143 YLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TF  218 (288)
Q Consensus       143 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~  218 (288)
                      ++||||+++ +|.+.+.  ..+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++..... ..
T Consensus        72 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05619          72 FFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA  151 (316)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence            999999986 5655554  3488999999999999999999999999999999999999999999999999875322 22


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      ......+++.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+..+.+..+..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~  210 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM  210 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            22345689999999999998899999999999999999999999998887776666543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG1095|consensus

Probab=100.00  E-value=4.2e-36  Score=275.59  Aligned_cols=218  Identities=21%  Similarity=0.351  Sum_probs=181.2

Q ss_pred             hhhhhcccccccccCCccccccccCccceeccC-CCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecccc
Q psy11580         53 KELIYQELPISHQMGKKRHNTSHLGAGAAYDTA-TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        53 ~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  131 (288)
                      .++....+.....+|+|.|+.+|.|.-.-.+.. ..-.||+|.+++. .+.....+|.+|..+|+.++||||++++|+|.
T Consensus       687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            345577889999999999999999853222111 1346999999753 45677889999999999999999999999999


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHhhh---------CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQMD---------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC  201 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~  201 (288)
                      +....      ++++|||++ +|++++...         ++..+++.++.|+|.|+.||+++.+|||||.++|+|++...
T Consensus       766 ~~~~~------~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r  839 (1025)
T KOG1095|consen  766 DSGPP------LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR  839 (1025)
T ss_pred             CCCCc------EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC
Confidence            87655      999999986 577777532         88899999999999999999999999999999999999999


Q ss_pred             cEEEeecccccccCC-Cccc-CCc-ccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        202 TLKILDFGLARTAGT-TFMM-TPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       202 ~~kl~dfg~~~~~~~-~~~~-~~~-~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      .+||+|||+|+.... .... ... .-+.+|||||.+....++.++|||||||++||+++ |..||.+.+..++..-.++
T Consensus       840 ~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~  919 (1025)
T KOG1095|consen  840 VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE  919 (1025)
T ss_pred             cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh
Confidence            999999999985433 2222 222 34578999999999999999999999999999998 9999999998887764443

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.8e-36  Score=253.96  Aligned_cols=191  Identities=25%  Similarity=0.394  Sum_probs=157.6

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++++    .+..+++.||+|++++... .......+..|+.++.++ +||||+.+++++...+.+      
T Consensus         2 ~lG~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~------   71 (327)
T cd05617           2 VIGRGSYAKVLLV----RLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL------   71 (327)
T ss_pred             eeeeCCCeEEEEE----EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE------
Confidence            4566666666554    4567789999999986322 233456678899999888 699999999999776654      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC-CCc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TTF  218 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~-~~~  218 (288)
                      ++||||++++ +...+.  ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+|||++.... ...
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  151 (327)
T cd05617          72 FLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD  151 (327)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence            9999999875 544443  458999999999999999999999999999999999999999999999999987532 222


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      ......|++.|+|||++.+..++.++|+||||+++|+|++|..||..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence            33456789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4e-36  Score=256.51  Aligned_cols=210  Identities=22%  Similarity=0.343  Sum_probs=171.2

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+|+|.++.++++    .+..+++.||+|++.+. .........+.+|..+++.++|+||+.+++++...+.. 
T Consensus         2 ~y~i~~~lG~G~fg~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~-   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVV----KMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYL-   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEE----EECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE-
Confidence            4566778888888777765    45677899999999742 11223345577899999999999999999999877654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                           ++||||+.++ |.+.+.   ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++..
T Consensus        77 -----~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~  151 (331)
T cd05624          77 -----YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK  151 (331)
T ss_pred             -----EEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceee
Confidence                 9999999864 555554   3478899999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcc--cCCcccccccCchHhHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        214 AGTTFM--MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       214 ~~~~~~--~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ......  .....|++.|+|||++.+     ..++.++|+||||+++|+|++|+.||.+.+..+.+.++...
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~  223 (331)
T cd05624         152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  223 (331)
T ss_pred             ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC
Confidence            543322  123468999999999976     45788999999999999999999999988877777777653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG4250|consensus

Probab=100.00  E-value=2.6e-36  Score=262.80  Aligned_cols=201  Identities=30%  Similarity=0.438  Sum_probs=171.5

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      ....+.+|+|.++.++.|    .++.+|+.||||.++... .....+.+.+|+++|++++|+|||++.++-.+.....-.
T Consensus        15 W~~~e~LG~Ga~g~V~rg----rnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRG----RNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             eeehhhhcCCccceeeee----cccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence            355667788877777776    367899999999998653 556678899999999999999999999997765523334


Q ss_pred             ccEEEEEeccccc-HHHHHh-----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc--CC--cEEEeecc
Q psy11580        140 QDVYLVMELMDAN-LCQVIQ-----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DC--TLKILDFG  209 (288)
Q Consensus       140 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~--~~--~~kl~dfg  209 (288)
                      ...++|||||.++ |...+.     ..+++.+++.+..++..||.|||++||+||||||.||++-.  +|  ..||+|||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            5679999999975 555554     34999999999999999999999999999999999999953  33  36999999


Q ss_pred             cccccCCCcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        210 LARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      .|+....+....+..||..|.+||.+.. ..++...|.|||||++|+..||..||.-
T Consensus       170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9999988888888999999999999995 7889999999999999999999999953

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.9e-35  Score=246.70  Aligned_cols=192  Identities=29%  Similarity=0.373  Sum_probs=155.5

Q ss_pred             CCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEE
Q psy11580         67 GKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV  145 (288)
Q Consensus        67 ~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv  145 (288)
                      |+|.++.++.+    .+..+++.||+|++..... .......+..|+++++.++|+||+++.+++......      ++|
T Consensus         2 g~G~~g~Vy~~----~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~------~lv   71 (280)
T cd05608           2 GKGGFGEVSAC----QMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDL------CLV   71 (280)
T ss_pred             CCCCceeEEEE----EEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeE------EEE
Confidence            45555555443    4567889999999975321 222345677899999999999999999998776654      999


Q ss_pred             EecccccHH-HHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        146 MELMDANLC-QVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       146 ~e~~~~~l~-~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                      |||++++.+ ..+.      ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++.......
T Consensus        72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  151 (280)
T cd05608          72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ  151 (280)
T ss_pred             EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC
Confidence            999987544 3331      247899999999999999999999999999999999999999999999999987654322


Q ss_pred             c-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        219 M-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       219 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      . .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus       152 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  202 (280)
T cd05608         152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE  202 (280)
T ss_pred             ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence            2 2345688999999999999999999999999999999999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.7e-35  Score=246.27  Aligned_cols=211  Identities=36%  Similarity=0.562  Sum_probs=171.9

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.+++|.++.++.|    .+..++..||+|+++...........+.+|+.++++++||||+++++++...+..   
T Consensus         2 y~~~~~l~~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---   74 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKG----RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL---   74 (285)
T ss_pred             ceEeeEecccCceEEEEE----EECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE---
Confidence            345566777777766664    3566789999999976433434456788999999999999999999999876654   


Q ss_pred             ccEEEEEecccccHHHHHh-----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        140 QDVYLVMELMDANLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                         ++||||+++++.+.+.     ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ---~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          75 ---YLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             ---EEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence               9999999988877664     34789999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcc-cCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        215 GTTFM-MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       215 ~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ..... .....+++.|+|||++.+. .++.++|+||||+++|+|++|++||.+.+..+....+.+..+
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~  219 (285)
T cd07861         152 GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG  219 (285)
T ss_pred             CCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence            43221 2334668889999998764 468899999999999999999999998877766666655544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.6e-35  Score=244.11  Aligned_cols=216  Identities=20%  Similarity=0.266  Sum_probs=174.2

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ...++.+.+.+|+|.++.++.|.-. .+...+..||+|+++... .......+.+|+.++++++||||+++++++...+.
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLK-LPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEe-cCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            4567888999999999888876321 123456799999998642 23445678899999999999999999999987665


Q ss_pred             ccccccEEEEEecccccHHH-HHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        136 LEEFQDVYLVMELMDANLCQ-VIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~l~~-~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      .      ++||||++++.++ .+..   .+++..++.++.|++.||+|||+++++||||||+||+++.++.++++|||.+
T Consensus        81 ~------~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          81 M------MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             c------EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccc
Confidence            4      9999999986544 4432   4789999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCccc--CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        212 RTAGTTFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       212 ~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      .........  ....++..|+|||.+.+..++.++||||||+++|++++ |..||.+.+..+.+..+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~  225 (266)
T cd05064         155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF  225 (266)
T ss_pred             ccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC
Confidence            654322111  12234568999999999999999999999999999875 999999888877777766543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-35  Score=255.45  Aligned_cols=198  Identities=28%  Similarity=0.355  Sum_probs=160.2

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..++...+.+|.|.++.++.+    .+..+++.||||++.... .......+.+|+++++.++|+||+++++++...+..
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKV----IHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEE----EECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            455566778888888777765    356678999999996432 334456788999999999999999999999877655


Q ss_pred             cccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                            ++||||++++.+... ...++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++.....
T Consensus       148 ------~lv~e~~~~~~L~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        148 ------QVLLEFMDGGSLEGT-HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             ------EEEEecCCCCccccc-ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence                  999999998654322 2356777889999999999999999999999999999999999999999999976543


Q ss_pred             Cc-ccCCcccccccCchHhHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        217 TF-MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       217 ~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      .. ......++..|+|||++..     ...+.++|||||||++|+|++|+.||...
T Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  276 (353)
T PLN00034        221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG  276 (353)
T ss_pred             ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            22 2234578999999998743     22356899999999999999999999743

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.3e-35  Score=264.41  Aligned_cols=212  Identities=23%  Similarity=0.429  Sum_probs=169.2

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCC------CCcceeeccccC
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH------KNIIGLLNAFTP  132 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~  132 (288)
                      .+.+.+.||.|.++.++++    .+..+++.||||+++..   .........|+++++.++|      .+++++++++..
T Consensus       130 ~y~i~~~lG~G~fg~V~~a----~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        130 RFKILSLLGEGTFGKVVEA----WDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cEEEEEEEEeccCEEEEEE----EEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3445555666555555543    45677899999999742   2233455667777777754      458888888865


Q ss_pred             CCcccccccEEEEEecccccHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCC--------
Q psy11580        133 QKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC--------  201 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~--------  201 (288)
                      ..     .+.++|||++++++++.+..  .+++..+..++.||+.||+|||+ .||+||||||+|||++.++        
T Consensus       203 ~~-----~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ET-----GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CC-----ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccc
Confidence            43     24699999999888887753  58999999999999999999997 5999999999999998765        


Q ss_pred             --------cEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHH
Q psy11580        202 --------TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWN  273 (288)
Q Consensus       202 --------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~  273 (288)
                              .+||+|||.+......  .....+++.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+.
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  355 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH  355 (467)
T ss_pred             cccCCCCceEEECCCCccccCccc--cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                    4999999987643322  244678999999999999999999999999999999999999999999989888


Q ss_pred             HHHHHhCCCcc
Q psy11580        274 KIIGKMREAHD  284 (288)
Q Consensus       274 ~i~~~~~~~~~  284 (288)
                      .|.+.++.+|.
T Consensus       356 ~i~~~~g~~p~  366 (467)
T PTZ00284        356 LMEKTLGRLPS  366 (467)
T ss_pred             HHHHHcCCCCH
Confidence            88888887764

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.6e-35  Score=250.10  Aligned_cols=210  Identities=31%  Similarity=0.570  Sum_probs=164.2

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccE
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      +..+|+|.++.++++..  .+..+++.||+|.+....    ....+.+|++++++++||||+++++++.....    ...
T Consensus         6 ~~~lG~G~~g~Vy~~~~--~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~~   75 (317)
T cd07868           6 GCKVGRGTYGHVYKAKR--KDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHAD----RKV   75 (317)
T ss_pred             ccccccCCCeEEEEEEE--ccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCC----cEE
Confidence            45677777777776521  123567899999997532    23456789999999999999999999864332    245


Q ss_pred             EEEEecccccHHHHHhh-----------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE----ccCCcEEEee
Q psy11580        143 YLVMELMDANLCQVIQM-----------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILD  207 (288)
Q Consensus       143 ~lv~e~~~~~l~~~~~~-----------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~----~~~~~~kl~d  207 (288)
                      ++++||+++++.+.+..           .+++..+..++.||+.||+|||+++|+||||||+|||+    +.++.+||+|
T Consensus        76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          76 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             EEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            99999999988776531           37888999999999999999999999999999999999    4567899999


Q ss_pred             cccccccCCCc----ccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------hhHHH
Q psy11580        208 FGLARTAGTTF----MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDH---------IDQWN  273 (288)
Q Consensus       208 fg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~---------~~~~~  273 (288)
                      ||++.......    ......+++.|+|||++.+. .++.++||||+|+++|+|++|++||.+...         .+.+.
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~  235 (317)
T cd07868         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  235 (317)
T ss_pred             cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence            99997654322    12345778999999999874 578999999999999999999999975432         34556


Q ss_pred             HHHHHhCCC
Q psy11580        274 KIIGKMREA  282 (288)
Q Consensus       274 ~i~~~~~~~  282 (288)
                      .+.+.++.+
T Consensus       236 ~~~~~~~~~  244 (317)
T cd07868         236 RIFNVMGFP  244 (317)
T ss_pred             HHHHhcCCC
Confidence            666655543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-35  Score=256.46  Aligned_cols=211  Identities=24%  Similarity=0.310  Sum_probs=169.8

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|.|.++.++++.  ..+..++..||+|.+...       ....+|++++++++||||+++++++...... 
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~--~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~-  161 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCT--KHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV-  161 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEE--EcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE-
Confidence            345566666666666655532  113356788999998642       2345799999999999999999998766544 


Q ss_pred             ccccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                           +++||++.+++.+.+.  ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++....
T Consensus       162 -----~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        162 -----CMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             -----EEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence                 9999999999888775  358999999999999999999999999999999999999999999999999987654


Q ss_pred             CCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chhHHHHHHHHhCCCc
Q psy11580        216 TTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD---HIDQWNKIIGKMREAH  283 (288)
Q Consensus       216 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~  283 (288)
                      ....   .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.+..   ....+..+++.++..+
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~  310 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP  310 (392)
T ss_pred             cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence            3221   234578999999999999899999999999999999999999997753   3456677777665443

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.3e-36  Score=257.99  Aligned_cols=210  Identities=26%  Similarity=0.396  Sum_probs=171.7

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+|+|.++.++.+    .+..+++.||+|+++.... .......+.+|+.+++.++|+||+++++++...+.. 
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~-   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVV----REKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL-   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEE----EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeE-
Confidence            3456677788777777664    4567899999999985322 223456678899999999999999999998776654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                           ++||||+++ +|.+.+.   ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++..
T Consensus        77 -----~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          77 -----YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             -----EEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeE
Confidence                 999999976 4555554   3488999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCcc--cCCcccccccCchHhHh------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        214 AGTTFM--MTPYVVTRYYRAPEVIL------GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       214 ~~~~~~--~~~~~~~~~~~aPE~~~------~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ......  .....+++.|+|||++.      +..++.++||||||+++|+|++|..||.+.+....+.++.+.
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~  224 (330)
T cd05601         152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF  224 (330)
T ss_pred             CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence            543322  23346889999999997      445778999999999999999999999988887777777654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-35  Score=245.09  Aligned_cols=213  Identities=25%  Similarity=0.376  Sum_probs=173.0

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.||.|.++.++.|.-...+...+..|+||.++.. ........+.+|++.+++++||||++++|++...+..    
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~----   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPL----   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSE----
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccc----
Confidence            45678899999988887654444566789999999642 3444578899999999999999999999999965544    


Q ss_pred             cEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        141 DVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                        ++|+||+.+ +|.+.+..    .+++..+..++.|+++||+|||+++++|++|+++||+++.++.+||+|||++....
T Consensus        77 --~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   77 --FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             --EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             --cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence              999999985 67776654    48899999999999999999999999999999999999999999999999998763


Q ss_pred             CC---cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        216 TT---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       216 ~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ..   ...........|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+...++.+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~  223 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR  223 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            21   11233456778999999999889999999999999999999 7899999988887777755443

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-35  Score=254.10  Aligned_cols=200  Identities=23%  Similarity=0.369  Sum_probs=161.3

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCC--cchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF--QNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  136 (288)
                      +.+.+.+|+|.++.++++.. +.+..+++.||+|++.+..  ........+..|+++++.+ +|+||+++++++...+..
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRK-VTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEE-cccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            45677788888887776431 2234578999999997421  1223345678899999999 599999999998877654


Q ss_pred             cccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                            ++||||+++ ++.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..
T Consensus        81 ------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 ------HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             ------EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence                  999999987 4656554  3588999999999999999999999999999999999999999999999999875


Q ss_pred             cCCC--cccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        214 AGTT--FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       214 ~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ....  .......|++.|+|||++.+. .++.++||||||+++|+|++|..||...
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence            4322  122345789999999999875 4788999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.9e-35  Score=250.42  Aligned_cols=204  Identities=26%  Similarity=0.388  Sum_probs=169.7

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .+++.+.+.+|+|.++.++.+    .+..++..||+|++.... .......+.+|+++++.++||||+++++++...+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKV----QHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEE----EECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            456677778888877776654    567788999999997532 334456789999999999999999999999876654


Q ss_pred             cccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~-~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                            ++||||++++ |.+.+.  ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++.
T Consensus        79 ------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  152 (331)
T cd06649          79 ------SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG  152 (331)
T ss_pred             ------EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence                  9999999974 555554  3478899999999999999999986 59999999999999999999999999987


Q ss_pred             ccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHH
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW  272 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~  272 (288)
                      ...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||...+..+..
T Consensus       153 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~  211 (331)
T cd06649         153 QLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE  211 (331)
T ss_pred             cccccc-cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            654332 23457899999999999988999999999999999999999999877765543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.2e-35  Score=247.09  Aligned_cols=214  Identities=32%  Similarity=0.542  Sum_probs=175.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +.+.+.+.+|.|.++.++.+    .+..++..||+|.++.... ......+.+|+.+++.++||||+++++++...+.. 
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~----~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~-   79 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKG----RSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL-   79 (301)
T ss_pred             cceEEeeEeccCcCEEEEEE----EEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeE-
Confidence            44566677888777777665    3566789999999975322 22334577899999999999999999999877654 


Q ss_pred             ccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||+++++.+.+.   ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++...
T Consensus        80 -----~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          80 -----TLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             -----EEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence                 9999999998887765   34788999999999999999999999999999999999999999999999998764


Q ss_pred             CCCc-ccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        215 GTTF-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       215 ~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .... ......+++.|+|||++.+. .++.++||||||+++|+|++|++||.+.+..+.+..+.+.++.+
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~  224 (301)
T cd07873         155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP  224 (301)
T ss_pred             CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            4322 22334668899999998764 47889999999999999999999999988888887777766544

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0201|consensus

Probab=100.00  E-value=2.9e-37  Score=255.31  Aligned_cols=198  Identities=25%  Similarity=0.411  Sum_probs=172.0

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      ...+.||+|.|+.++.|    .+..+++.||+|++..+ ........+++|+.+|.+++++||.+.|+.+.....+    
T Consensus        16 ~~~~~IgrGsfG~Vyk~----~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L----   86 (467)
T KOG0201|consen   16 TKLELIGRGSFGEVYKA----IDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL----   86 (467)
T ss_pred             ccchhccccccceeeee----eeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH----
Confidence            33478889888888876    57889999999999865 3446677899999999999999999999999888776    


Q ss_pred             cEEEEEecccccHH-HHHh-hh-CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        141 DVYLVMELMDANLC-QVIQ-MD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       141 ~~~lv~e~~~~~l~-~~~~-~~-~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                        +++||||.|+.. +.+. .. +++..+..++++++.||.|||..+.+|||||+.||++..+|.+||+|||.+......
T Consensus        87 --wiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   87 --WIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             --HHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence              999999998644 4443 22 477888889999999999999999999999999999999999999999999876553


Q ss_pred             c-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy11580        218 F-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI  269 (288)
Q Consensus       218 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~  269 (288)
                      . ...++.||+.|||||++.+..|+.++||||||++.+||++|.+|+....+.
T Consensus       165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm  217 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM  217 (467)
T ss_pred             hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc
Confidence            3 337789999999999999989999999999999999999999999988773

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-35  Score=253.33  Aligned_cols=210  Identities=23%  Similarity=0.337  Sum_probs=169.9

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+|+|.++.++.+    ....+++.||+|++.+.. ........+..|+.++..++|+||+++++++...+.. 
T Consensus         2 ~y~~~~~lG~G~fg~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~-   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVV----KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNL-   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEE----EECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEE-
Confidence            4566777888888777664    346678899999996421 1223344577899999999999999999999877654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                           ++||||+.+ +|.+.+.   ..+++..++.++.||+.||+|||+.+|+||||||+||+++.++.++|+|||++..
T Consensus        77 -----~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          77 -----YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             -----EEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchhee
Confidence                 999999976 5666664   3478889999999999999999999999999999999999999999999999875


Q ss_pred             cCCCc--ccCCcccccccCchHhHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        214 AGTTF--MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       214 ~~~~~--~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      .....  ......|++.|+|||++.+     ..++.++||||||+++|+|++|+.||.+.+..+.+.++...
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~  223 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  223 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence            43221  1233578999999999973     45788999999999999999999999998888877777654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0196|consensus

Probab=100.00  E-value=9.5e-37  Score=267.44  Aligned_cols=226  Identities=23%  Similarity=0.262  Sum_probs=193.4

Q ss_pred             HhhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccc
Q psy11580         51 QWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAF  130 (288)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  130 (288)
                      -.+|+....+.+.+.||.|.|+.++.|.-+.- .+....||||.++. ....+....|+.|+.||-+++||||+++.|+.
T Consensus       622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~p-gkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV  699 (996)
T KOG0196|consen  622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLP-GKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV  699 (996)
T ss_pred             hhhhcChhheEEEEEEecccccceecccccCC-CCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence            34577788899999999999999999864322 23456899999974 34567778899999999999999999999999


Q ss_pred             cCCCcccccccEEEEEecccccHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEe
Q psy11580        131 TPQKSLEEFQDVYLVMELMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL  206 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~  206 (288)
                      +.....      .||+|||+++.++.+.    ..++..++..+.+.|+.||+||-+.++|||||.++|||++.+..+|++
T Consensus       700 Tks~Pv------MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVs  773 (996)
T KOG0196|consen  700 TKSKPV------MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVS  773 (996)
T ss_pred             ecCcee------EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEec
Confidence            988765      9999999987666554    348889999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCcc-cCC---cccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhCC
Q psy11580        207 DFGLARTAGTTFM-MTP---YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       207 dfg~~~~~~~~~~-~~~---~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~~  281 (288)
                      |||+++...+... ..+   ..-+.+|.|||.+....++.+|||||+|++|||.++ |..||=+.+.++.++.|.+..+-
T Consensus       774 DFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRL  853 (996)
T KOG0196|consen  774 DFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRL  853 (996)
T ss_pred             cccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCC
Confidence            9999997754331 111   123578999999999999999999999999999886 99999999999999999999986


Q ss_pred             Ccc
Q psy11580        282 AHD  284 (288)
Q Consensus       282 ~~~  284 (288)
                      ||+
T Consensus       854 PpP  856 (996)
T KOG0196|consen  854 PPP  856 (996)
T ss_pred             CCC
Confidence            665

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5e-35  Score=244.52  Aligned_cols=211  Identities=34%  Similarity=0.577  Sum_probs=170.1

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.+++|.++.++.+    .+..+|+.||+|.++...........+.+|++++++++||||+++++++.+....    
T Consensus         3 ~~~~~l~~g~~~~vy~~----~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~----   74 (284)
T cd07839           3 EKLEKIGEGTYGTVFKA----KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL----   74 (284)
T ss_pred             eeEEEecccCCeEEEEE----EECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce----
Confidence            34455667666655553    4567899999999976433333445677899999999999999999999877654    


Q ss_pred             cEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        141 DVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       141 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                        ++|+||+++++.+.+.   ..+++..++.++.||++||+|||+++++|+||+|+||+++.++.++|+|||++......
T Consensus        75 --~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          75 --TLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             --EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence              9999999998887764   34899999999999999999999999999999999999999999999999998765432


Q ss_pred             c-ccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCC-CCCCCchhHHHHHHHHhCC
Q psy11580        218 F-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       218 ~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p-~~~~~~~~~~~~i~~~~~~  281 (288)
                      . ......++..|+|||++.+. .++.++|+||||+++|+|++|..| |.+.+..+.++.+.+.++.
T Consensus       153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  219 (284)
T cd07839         153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT  219 (284)
T ss_pred             CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCC
Confidence            2 12334668889999998774 468999999999999999998877 5666666677777666554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.8e-35  Score=260.82  Aligned_cols=217  Identities=24%  Similarity=0.334  Sum_probs=176.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc-
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL-  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-  136 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||||++.....+......+.+|+.++..++|+||+++++.+...+.. 
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a----~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCA----KRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEE----EEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            35567788888877777664    4567899999999986555556667788999999999999999998887644321 


Q ss_pred             -cccccEEEEEecccc-cHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        137 -EEFQDVYLVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       137 -~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                       ......++||||+++ +|.+.+.      ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence             111235899999986 4655553      24788999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC---cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        209 GLARTAGTT---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       209 g~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      |++......   .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+.++...
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~  260 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG  260 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            998764332   1223457899999999999989999999999999999999999999988877777666543

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.1e-35  Score=242.51  Aligned_cols=191  Identities=31%  Similarity=0.409  Sum_probs=154.4

Q ss_pred             CCccccccccCccceeccCCCceEEEEeccCCCcc-hhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEE
Q psy11580         67 GKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN-VTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV  145 (288)
Q Consensus        67 ~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv  145 (288)
                      |+|.++.++.    +.+..+|+.||+|++...... ......+..|++++++++||||+++++++......      ++|
T Consensus         2 g~G~~g~Vy~----~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~------~lv   71 (277)
T cd05607           2 GKGGFGEVCA----VQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHL------CLV   71 (277)
T ss_pred             CCCCceEEEE----EEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeE------EEE
Confidence            4444444443    234667999999999742221 12234456799999999999999999999766554      999


Q ss_pred             Eeccccc-HHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCccc
Q psy11580        146 MELMDAN-LCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMM  220 (288)
Q Consensus       146 ~e~~~~~-l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~  220 (288)
                      |||++++ +.+.+.    ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.........
T Consensus        72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee
Confidence            9999865 444442    24788899999999999999999999999999999999999999999999998876554433


Q ss_pred             CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       221 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ....++..|+|||++.+..++.++|+||||+++|+|++|..||.+..
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~  198 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK  198 (277)
T ss_pred             eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence            44578899999999999889999999999999999999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-34  Score=244.73  Aligned_cols=214  Identities=22%  Similarity=0.298  Sum_probs=168.2

Q ss_pred             hcccccccccCCccccccccCccc------------eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGA------------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNII  124 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~  124 (288)
                      ...+.+.+.+|+|.++.++++...            ..+..++..||+|++.... .......+.+|++++++++||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence            356678888999988888876421            0112344579999997532 334456788999999999999999


Q ss_pred             eeeccccCCCcccccccEEEEEecccc-cHHHHHhh---------------------hCCHHHHHHHHHHHHHHHHHHHH
Q psy11580        125 GLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---------------------DLDHERMSYLLYQMLCGIKHLHS  182 (288)
Q Consensus       125 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---------------------~~~~~~~~~~~~~i~~~l~~LH~  182 (288)
                      ++++++...+..      ++||||+.+ ++.+.+..                     .+++..+.+++.||+.||+|||+
T Consensus        83 ~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~  156 (304)
T cd05096          83 RLLGVCVDEDPL------CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS  156 (304)
T ss_pred             EEEEEEecCCce------EEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            999999877654      999999986 45555432                     24667889999999999999999


Q ss_pred             CCCEeecCCCCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-
Q psy11580        183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-  258 (288)
Q Consensus       183 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-  258 (288)
                      .+|+||||||+||+++.++.+||+|||++.......   ......++..|+|||++.+..++.++||||||+++|+|++ 
T Consensus       157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence            999999999999999999999999999987543321   1123345778999999998889999999999999999986 


Q ss_pred             -CCCCCCCCCchhHHHHHHH
Q psy11580        259 -GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       259 -g~~p~~~~~~~~~~~~i~~  277 (288)
                       +..||.+.+..+.+..+..
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~  256 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGE  256 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHH
Confidence             6788988777666655443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0614|consensus

Probab=100.00  E-value=1.3e-36  Score=255.40  Aligned_cols=220  Identities=25%  Similarity=0.440  Sum_probs=190.6

Q ss_pred             HhhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeecc
Q psy11580         51 QWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNA  129 (288)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  129 (288)
                      .+......++..-..+|-|.|+.+.+..    -......+|+|++++. .....+.+....|-++|..++.|.||++|..
T Consensus       413 e~a~v~l~dl~~iaTLGvGgFGRVELV~----~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT  488 (732)
T KOG0614|consen  413 EFAQVKLSDLKRIATLGVGGFGRVELVK----VNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT  488 (732)
T ss_pred             hhcccchhhhhhhhhcccCccceEEEEE----ecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH
Confidence            3444556677777777777777766642    1222235899999863 4466667788899999999999999999999


Q ss_pred             ccCCCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEe
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL  206 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~  206 (288)
                      |.++...      |+.||-|-| .++..+.  ..++..+.+.++..+++|++|||++|||+|||||+|++++.+|-+||.
T Consensus       489 frd~kyv------YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLV  562 (732)
T KOG0614|consen  489 FRDSKYV------YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLV  562 (732)
T ss_pred             hccchhh------hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEe
Confidence            9998876      999998755 5777776  448999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       207 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      |||+++..+.+...-+++||+.|.|||++..+..+.++|.||||+++|||++|.+||.+.++...++.|++.+.
T Consensus       563 DFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid  636 (732)
T KOG0614|consen  563 DFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID  636 (732)
T ss_pred             ehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh
Confidence            99999999988888889999999999999999999999999999999999999999999999999999998876

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2e-34  Score=241.08  Aligned_cols=211  Identities=30%  Similarity=0.543  Sum_probs=171.4

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.....+++|.++.++.+    .+..+++.||+|++..........+.+.+|++++++++|+|++++++++......   
T Consensus         3 y~~~~~l~~g~~~~v~~~----~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~---   75 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKC----RNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKL---   75 (286)
T ss_pred             eeeeeeecccCCeEEEEE----EECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEE---
Confidence            345566677776666654    4566789999999975433333345678999999999999999999999776554   


Q ss_pred             ccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        140 QDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                         ++||||+++++++.+.   ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 ---~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          76 ---HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             ---EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence               9999999998776654   3488999999999999999999999999999999999999999999999999986644


Q ss_pred             Cc-ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        217 TF-MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       217 ~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      .. ......++..|+|||++.+ ..++.++|+||||+++|+|++|.+||.+.+..+....+.+.++
T Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~  218 (286)
T cd07847         153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG  218 (286)
T ss_pred             CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            32 2233457788999999876 4578899999999999999999999998887776666655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG4257|consensus

Probab=100.00  E-value=6.5e-36  Score=256.71  Aligned_cols=220  Identities=24%  Similarity=0.332  Sum_probs=184.7

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++....+.++..||.|.|+.++.|.-.-..+...-.||||..+.+... ...+.|..|..+|+.++||||++++|+|...
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~~e~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence            677788899999999999999998432222223347999999876544 4478899999999999999999999999987


Q ss_pred             CcccccccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      ..       ++|||.++.+ |..++.   ..++..++..++.||+.||+|||++++|||||..+|||+.+..-+||+|||
T Consensus       464 P~-------WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  464 PM-------WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             ce-------eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccc
Confidence            64       9999999955 555554   347888999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccCCccc--ccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhCC
Q psy11580        210 LARTAGTTFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       210 ~~~~~~~~~~~~~~~~--~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~~  281 (288)
                      +++............+  +..|||||-+.-.+++.+||||.|||++||++. |.-||.+....+.+-.|.++-+.
T Consensus       537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl  611 (974)
T KOG4257|consen  537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL  611 (974)
T ss_pred             hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC
Confidence            9998877655433333  567999999998999999999999999999996 99999998887877777665543

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9.7e-35  Score=251.61  Aligned_cols=215  Identities=24%  Similarity=0.346  Sum_probs=168.8

Q ss_pred             hhhcccccccccCCccccccccCcccee-ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAY-DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTP  132 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  132 (288)
                      +...++.+.+.+|+|.++.++.+..... +..++..||+|+++... .......+.+|+++++.+ +|+||++++++|..
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            4556788899999998888876532111 23455689999997542 234456788999999999 89999999999987


Q ss_pred             CCcccccccEEEEEeccccc-HHHHHhh----------------------------------------------------
Q psy11580        133 QKSLEEFQDVYLVMELMDAN-LCQVIQM----------------------------------------------------  159 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~----------------------------------------------------  159 (288)
                      .+..      ++||||+.++ |.+.+..                                                    
T Consensus       114 ~~~~------~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (374)
T cd05106         114 GGPV------LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV  187 (374)
T ss_pred             CCCe------EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence            7665      9999999864 5544421                                                    


Q ss_pred             --------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcc
Q psy11580        160 --------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM  219 (288)
Q Consensus       160 --------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~  219 (288)
                                          .+++..+.+++.||++||+|||+++|+||||||+||+++.++.++|+|||++........
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                                256788899999999999999999999999999999999999999999999876433211


Q ss_pred             ---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHH
Q psy11580        220 ---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       220 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~  276 (288)
                         .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+........+++
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~  328 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV  328 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH
Confidence               112234567999999998889999999999999999997 999998765544444433

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.7e-34  Score=241.59  Aligned_cols=204  Identities=27%  Similarity=0.400  Sum_probs=164.0

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      .+.+|+|.++.++.+    .+..+++.||+|++..... .......+.+|++++++++|+||+++++.+...+..     
T Consensus         5 ~~~lg~G~~g~vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~-----   75 (285)
T cd05632           5 YRVLGKGGFGEVCAC----QVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL-----   75 (285)
T ss_pred             EEEEecCCCeEEEEE----EECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE-----
Confidence            345666666655543    3456789999999975322 222345577899999999999999999999877654     


Q ss_pred             EEEEEeccccc-HHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        142 VYLVMELMDAN-LCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       142 ~~lv~e~~~~~-l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                       +++|||+.++ +.+.+.    ..+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||++.....
T Consensus        76 -~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          76 -CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             -EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence             9999999975 443432    2488999999999999999999999999999999999999999999999999876544


Q ss_pred             CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                      ........++..|+|||++.+..++.++|+||||+++|+|++|..||.+.........+.
T Consensus       155 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~  214 (285)
T cd05632         155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD  214 (285)
T ss_pred             CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            333344578999999999998889999999999999999999999999876654444443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG1094|consensus

Probab=100.00  E-value=3.2e-35  Score=250.68  Aligned_cols=223  Identities=22%  Similarity=0.292  Sum_probs=186.5

Q ss_pred             HHhhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecc
Q psy11580         50 DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA  129 (288)
Q Consensus        50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  129 (288)
                      ....++..+.+.+++.||+|-|+.+.+-.     ...+..||||+++.. ........|.+|+++|.+|+||||+.++|+
T Consensus       530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCe-----veg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGV  603 (807)
T KOG1094|consen  530 PALVEFPRSRLRFKEKIGEGQFGEVHLCE-----VEGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGV  603 (807)
T ss_pred             cchhhcchhheehhhhhcCcccceeEEEE-----ecCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEee
Confidence            45567788889999999999999988863     334689999999853 344556889999999999999999999999


Q ss_pred             ccCCCcccccccEEEEEeccccc-HHHHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEE
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDAN-LCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  204 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~----~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~k  204 (288)
                      |..++.+      ++|+||++++ |.+++...    ..-+...+|+.||++||+||.+.++|||||.++|||++.++++|
T Consensus       604 C~~DePi------cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iK  677 (807)
T KOG1094|consen  604 CVQDDPL------CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIK  677 (807)
T ss_pred             eecCCch------HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEE
Confidence            9998887      9999999965 55555433    34456677999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCchhHHHHHHHHh
Q psy11580        205 ILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI--RGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       205 l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~--~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      |+|||+++.......   ....+-+.+|||+|.+.-.+++.++|+|+||+.+||++  +.+-||...++++...+.-+.+
T Consensus       678 iadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~  757 (807)
T KOG1094|consen  678 IADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFF  757 (807)
T ss_pred             ecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhc
Confidence            999999986543322   23345678999999999999999999999999999977  5899999999999888877776


Q ss_pred             CCCcc
Q psy11580        280 REAHD  284 (288)
Q Consensus       280 ~~~~~  284 (288)
                      ...+.
T Consensus       758 ~~~~~  762 (807)
T KOG1094|consen  758 RDQGR  762 (807)
T ss_pred             CCCCc
Confidence            64443

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.6e-34  Score=242.34  Aligned_cols=213  Identities=26%  Similarity=0.426  Sum_probs=173.7

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      +.+.+.+++|.++.++.+    .+..+++.||+|++.... ........+.+|++++++++||||+++++++...+..  
T Consensus         3 y~~~~~ig~g~~~~vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--   76 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLV----RHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNL--   76 (290)
T ss_pred             eEEEEEeecCCCeEEEEE----EEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeE--
Confidence            455566777666666654    455678999999997422 1233456788999999999999999999999876654  


Q ss_pred             cccEEEEEeccc-ccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMD-ANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++||||++ +++.+.+.  ..+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        77 ----~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          77 ----YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             ----EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence                99999995 46666654  458899999999999999999999999999999999999999999999999988765


Q ss_pred             CCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       216 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ..  .....+++.|+|||.+.+...+.++|+||||+++|+|++|..||...+.....+++.....+.|.
T Consensus       153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  219 (290)
T cd05580         153 GR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS  219 (290)
T ss_pred             CC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc
Confidence            44  23446788999999998888899999999999999999999999988877777777654444443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=253.01  Aligned_cols=204  Identities=27%  Similarity=0.415  Sum_probs=161.0

Q ss_pred             cCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHC---CCCCcceeeccccCCCccccccc
Q psy11580         66 MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLV---NHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        66 ~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      +|+|.++.++.+    .+..+++.||+|++.+.. ...........|..++..+   +||||+++++.+......     
T Consensus         1 lG~G~~g~Vy~~----~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~-----   71 (330)
T cd05586           1 IGKGTFGQVYQV----RKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL-----   71 (330)
T ss_pred             CCCCCceEEEEE----EECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE-----
Confidence            355555555543    456788999999996421 1222334455677777666   699999999999877655     


Q ss_pred             EEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-C
Q psy11580        142 VYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-T  217 (288)
Q Consensus       142 ~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~  217 (288)
                       ++||||+.++ +...+.  ..+++..+..++.||++||+|||+++|+||||||+||+++.++.++|+|||++..... .
T Consensus        72 -~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          72 -YLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             -EEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence             9999999864 555544  3488999999999999999999999999999999999999999999999999875322 2


Q ss_pred             cccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        218 FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      .......|++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+.++++....
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~  213 (330)
T cd05586         151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK  213 (330)
T ss_pred             CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC
Confidence            223445789999999999764 47899999999999999999999999988877777765443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0584|consensus

Probab=100.00  E-value=5.6e-36  Score=257.60  Aligned_cols=212  Identities=26%  Similarity=0.393  Sum_probs=179.9

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCC--CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP--FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++....+|+|.+..+|.|    .|..+|-.||.-.++..  ..++...+++..|+.+|+.|+||||+++|+.|.+...  
T Consensus        42 ~k~~evLGrGafKtVYka----~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n--  115 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKA----FDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN--  115 (632)
T ss_pred             eehhhhcccccceeeeec----cccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC--
Confidence            466778888888888876    47788888887665532  3455667899999999999999999999999987764  


Q ss_pred             ccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCCEEEccC-CcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--ivH~dl~~~nil~~~~-~~~kl~dfg~~  211 (288)
                        ...-+|+|.+..| |..+..  ...+...+..|++||+.||.|||++.  |+|||||=+||+++++ |.|||+|+|+|
T Consensus       116 --~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  116 --KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             --ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHH
Confidence              3458999999865 555554  56899999999999999999999876  9999999999999875 89999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCchhHHHHHHHHhCC
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG-TDHIDQWNKIIGKMRE  281 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~  281 (288)
                      +....+...+ .+|||.|||||++. ..|+..+||||||+++.||+|+..||.. .++.++++++.++.++
T Consensus       194 tl~r~s~aks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP  262 (632)
T KOG0584|consen  194 TLLRKSHAKS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP  262 (632)
T ss_pred             HHhhccccce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH
Confidence            9887776654 79999999999998 6899999999999999999999999987 5677788888877653

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-34  Score=251.15  Aligned_cols=210  Identities=27%  Similarity=0.378  Sum_probs=167.9

Q ss_pred             hhhhcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  131 (288)
                      .+...++.+++.+|+|.++.++.+... ..+..++..||||+++... .......+.+|+.+++.+ +||||++++++|.
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            344557788999999999988876421 2234567799999997432 234456788999999999 8999999999998


Q ss_pred             CCCcccccccEEEEEeccccc-HHHHHhh---------------------------------------------------
Q psy11580        132 PQKSLEEFQDVYLVMELMDAN-LCQVIQM---------------------------------------------------  159 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~---------------------------------------------------  159 (288)
                      ..+..      ++||||++++ |.+.+..                                                   
T Consensus       110 ~~~~~------~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  183 (375)
T cd05104         110 VGGPT------LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKA  183 (375)
T ss_pred             cCCcc------eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccc
Confidence            77765      9999999864 5444421                                                   


Q ss_pred             --------------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        160 --------------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       160 --------------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                                                .+++..+..++.||+.||+|||+++++||||||+||+++.++.++|+|||++..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~  263 (375)
T cd05104         184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD  263 (375)
T ss_pred             ccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCcccee
Confidence                                      256788899999999999999999999999999999999999999999999976


Q ss_pred             cCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchh
Q psy11580        214 AGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHID  270 (288)
Q Consensus       214 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~  270 (288)
                      ......   .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.....
T Consensus       264 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~  324 (375)
T cd05104         264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS  324 (375)
T ss_pred             ccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH
Confidence            543221   112234567999999999899999999999999999997 899998765443

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.7e-35  Score=248.38  Aligned_cols=220  Identities=41%  Similarity=0.740  Sum_probs=179.4

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.+|.|.++.++.+    .+..+++.||+|++............+.+|+.++++++||||+++++++....  ..
T Consensus         6 ~y~~~~~lg~g~~g~v~~~----~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~   79 (334)
T cd07855           6 RYKPIENIGSGAYGVVCSA----IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG--AD   79 (334)
T ss_pred             ceeeeeeeecCCCeEEEEE----EEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC--CC
Confidence            4455666777766665554    45678999999999864444455677888999999999999999999887544  23


Q ss_pred             cccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      ....++|+||+++++.+.+.  ..+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++.....
T Consensus        80 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          80 FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             CceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            34579999999988877774  4489999999999999999999999999999999999999999999999999876433


Q ss_pred             Ccc-----cCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        217 TFM-----MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       217 ~~~-----~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ...     .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+....+..+....+.+|.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~  233 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE  233 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence            211     123467888999999866 45789999999999999999999999998888888888877776654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG1989|consensus

Probab=100.00  E-value=1.3e-34  Score=258.22  Aligned_cols=207  Identities=25%  Similarity=0.408  Sum_probs=170.2

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~  132 (288)
                      .+....+.+.+.|.+|.|..+|+.    .+...+..||+|++-.  .+........+|+++|++|+ |+|||.++|....
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla----~~~~~~~~~AlKrm~~--~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLA----QDVKGGKKYALKRMYV--NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEE----EecCCCceeeeeeeec--CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            566778899999999999888885    3455559999999975  36677788999999999995 9999999995433


Q ss_pred             CCcccc-cccEEEEEeccc-ccHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCCEEEccCCcEE
Q psy11580        133 QKSLEE-FQDVYLVMELMD-ANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK  204 (288)
Q Consensus       133 ~~~~~~-~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--ivH~dl~~~nil~~~~~~~k  204 (288)
                      .....+ .-.++|.||||. ++|.++++    ..+++.++++|+.|+++|+++||...  |||||||.+|||++.+|+.|
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence            222122 234689999999 58999887    34999999999999999999999887  99999999999999999999


Q ss_pred             EeecccccccCCCcccC----------CcccccccCchHhH---hcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        205 ILDFGLARTAGTTFMMT----------PYVVTRYYRAPEVI---LGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       205 l~dfg~~~~~~~~~~~~----------~~~~~~~~~aPE~~---~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      |||||.++..-......          ....|+-|+|||.+   .+.+++.|+|||+|||+||-|+....||.+.
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            99999987432221110          12458899999998   4678899999999999999999999999876

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.9e-34  Score=235.19  Aligned_cols=205  Identities=23%  Similarity=0.347  Sum_probs=164.7

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      .+|+|.++.++.|.  .....++..||+|+++...........+..|+.+++.++||||+++++++....       .++
T Consensus         2 ~lg~G~~g~v~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------~~l   72 (257)
T cd05116           2 ELGSGNFGTVKKGM--YKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAES-------WML   72 (257)
T ss_pred             cCCCcCCcceEEeE--EecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-------cEE
Confidence            35676666666542  123456789999999865445556678899999999999999999999885432       389


Q ss_pred             EEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcc--
Q psy11580        145 VMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM--  219 (288)
Q Consensus       145 v~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~--  219 (288)
                      ||||++++ +.+.+.  ..+++..+..++.|++.||++||+++++|+||||.||+++.++.++|+|||++........  
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          73 VMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            99999965 555554  3488999999999999999999999999999999999999999999999999876543321  


Q ss_pred             --cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        220 --MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       220 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                        .....++..|+|||.+....++.++|+||||+++|||++ |..||.+.+..+....+.+.
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~  214 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG  214 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC
Confidence              122233578999999988888999999999999999997 99999988776666666543

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.7e-34  Score=240.50  Aligned_cols=214  Identities=36%  Similarity=0.596  Sum_probs=173.4

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.++.|.++.++.|    .+..+++.||+|.+............+..|++++++++||||+++++++......  
T Consensus         3 ~y~~~~~l~~g~~~~v~~~----~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--   76 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKA----RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRL--   76 (294)
T ss_pred             ceEEEEEecCCCCEEEEEE----EecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeE--
Confidence            4566677777777766665    3566789999999976433334446788999999999999999999999876654  


Q ss_pred             cccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc-CCcEEEeecccccc
Q psy11580        139 FQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLART  213 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~-~~~~kl~dfg~~~~  213 (288)
                          ++||||+++++.+.+..    ..++..+..++.||+.||+|||+++++|+||+|+||+++. ++.+||+|||++..
T Consensus        77 ----~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         77 ----YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             ----EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence                99999999888777653    2577888899999999999999999999999999999985 55799999999976


Q ss_pred             cCCCc-ccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        214 AGTTF-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       214 ~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ..... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+..+.+.++.+..+.+
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  223 (294)
T PLN00009        153 FGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTP  223 (294)
T ss_pred             cCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            54322 12334667889999998764 57899999999999999999999999988888888877665544

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.7e-34  Score=244.29  Aligned_cols=217  Identities=34%  Similarity=0.560  Sum_probs=177.3

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|.|.++.++.+    .+..+|+.||+|+++.............+|+.++++++|+||+++++++.....  
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--   80 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRA----RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL--   80 (309)
T ss_pred             cceeEeeeeeecCCEEEEEE----EECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC--
Confidence            45677777888887777765    456789999999997543332333456689999999999999999999875431  


Q ss_pred             ccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                        ...++||||+++++.+.+.   ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 --~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          81 --DSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             --CeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence              2359999999988777665   34889999999999999999999999999999999999999999999999999865


Q ss_pred             CCCc-ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        215 GTTF-MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       215 ~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||.+.+..+.+..+.+.++.+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~  228 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP  228 (309)
T ss_pred             CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            4431 2233345778999999876 457899999999999999999999999999999999888876643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.6e-34  Score=236.65  Aligned_cols=209  Identities=26%  Similarity=0.391  Sum_probs=170.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++++.     ..++..+|+|.+...   ......+..|++++++++||||+++++++...+.. 
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~-----~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-   74 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGK-----WRAQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL-   74 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEE-----eccCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCE-
Confidence            456777888998888888763     334568999998743   22345788899999999999999999999877654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                           ++||||+++ ++.+.+.   ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 -----~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~  149 (256)
T cd05114          75 -----YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY  149 (256)
T ss_pred             -----EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccc
Confidence                 999999985 4665554   2378899999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccc--CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        214 AGTTFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       214 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      .......  ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+.+..+.+...
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~  219 (256)
T cd05114         150 VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR  219 (256)
T ss_pred             cCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC
Confidence            5332221  22234567999999998889999999999999999999 9999999888887777766443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-34  Score=238.46  Aligned_cols=203  Identities=31%  Similarity=0.534  Sum_probs=169.5

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.+|+|.++.++.+    .+..+++.||+|++...............|+.++++++||||+++++++......    
T Consensus         2 ~~~~~lg~G~~g~v~~~----~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~----   73 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKA----KNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYL----   73 (260)
T ss_dssp             EEEEEEEEESSEEEEEE----EETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEE----
T ss_pred             EEeEEEEeCCCEEEEEE----EECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccc----
Confidence            35667788777777664    5677888999999987544444444556799999999999999999999876654    


Q ss_pred             cEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc-CC
Q psy11580        141 DVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GT  216 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~-~~  216 (288)
                        ++|||++++ ++.+.+.  ..+++..+..++.|+++||++||+++++|+||||+||+++.++.++|+|||.+... ..
T Consensus        74 --~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~  151 (260)
T PF00069_consen   74 --YIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN  151 (260)
T ss_dssp             --EEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred             --cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence              999999998 6777665  55899999999999999999999999999999999999999999999999999763 33


Q ss_pred             CcccCCcccccccCchHhHh-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHH
Q psy11580        217 TFMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWN  273 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~  273 (288)
                      ........++..|+|||++. +...+.++|+||||+++|+|++|..||...+..+...
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~  209 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE  209 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh
Confidence            33345567889999999998 7888999999999999999999999999874333333

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG1290|consensus

Probab=100.00  E-value=1.3e-34  Score=242.36  Aligned_cols=238  Identities=32%  Similarity=0.505  Sum_probs=201.2

Q ss_pred             cccccccHHHhhhhhhcccccccccC-CccccccccCcc------ceeccCCCceEEEEeccCCCcchhhHHHHHHHHHH
Q psy11580         42 VDEREHTVDQWKELIYQELPISHQMG-KKRHNTSHLGAG------AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKL  114 (288)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~g~g------~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~  114 (288)
                      -++..+....|....|..+.+|+.+. .+|.+..++|+|      .++|.+..+.||+|+.+.   .....+....|+++
T Consensus        51 ~~~eqE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIkl  127 (590)
T KOG1290|consen   51 DDEEQEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKL  127 (590)
T ss_pred             CcccccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHH
Confidence            34456677889999999999999999 899999999999      389999999999999983   33445667899999


Q ss_pred             HHHCC-----C---CCcceeeccccCCCcccccccEEEEEecccccHHHHHh----hhCCHHHHHHHHHHHHHHHHHHH-
Q psy11580        115 MKLVN-----H---KNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLH-  181 (288)
Q Consensus       115 l~~l~-----h---~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH-  181 (288)
                      |++++     |   .+||++++.|...+  .++.|+|||+|+++.+|+.++.    +.++...+.+|++|++.||.||| 
T Consensus       128 L~~v~~~Dp~~~~~~~VV~LlD~FkhsG--pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~  205 (590)
T KOG1290|consen  128 LQQVREGDPNDPGKKCVVQLLDHFKHSG--PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR  205 (590)
T ss_pred             HHHHHhcCCCCCCCceeeeeeccceecC--CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH
Confidence            99994     2   37999999999887  7889999999999999999886    45999999999999999999999 


Q ss_pred             HCCCEeecCCCCCEEEc---------------------------------------------------------------
Q psy11580        182 SAGIIHRDLKPSNIVVK---------------------------------------------------------------  198 (288)
Q Consensus       182 ~~~ivH~dl~~~nil~~---------------------------------------------------------------  198 (288)
                      ++||||.||||+|||+.                                                               
T Consensus       206 ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~  285 (590)
T KOG1290|consen  206 ECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLE  285 (590)
T ss_pred             hcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhh
Confidence            57999999999999990                                                               


Q ss_pred             ---------------------------------------------------c----------------------------
Q psy11580        199 ---------------------------------------------------S----------------------------  199 (288)
Q Consensus       199 ---------------------------------------------------~----------------------------  199 (288)
                                                                         .                            
T Consensus       286 ~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~  365 (590)
T KOG1290|consen  286 ASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSL  365 (590)
T ss_pred             hhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccc
Confidence                                                               0                            


Q ss_pred             ------------------------CCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHH
Q psy11580        200 ------------------------DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  255 (288)
Q Consensus       200 ------------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~  255 (288)
                                              +-.+||+|||.|++.....  +..+.|..|+|||++.|..|++.+||||++|++||
T Consensus       366 ~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khF--T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FE  443 (590)
T KOG1290|consen  366 SSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHF--TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFE  443 (590)
T ss_pred             cCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhhh--chhhhhhhccCcceeecCCCCCchhHHHHHHHHHH
Confidence                                    0125677777776654432  23467888999999999999999999999999999


Q ss_pred             HHhCCCCCCC------CCchhHHHHHHHHhCCCccCC
Q psy11580        256 MIRGGVLFPG------TDHIDQWNKIIGKMREAHDKL  286 (288)
Q Consensus       256 l~~g~~p~~~------~~~~~~~~~i~~~~~~~~~~~  286 (288)
                      |+||...|.-      .-+++.++.|++.+|.+|.++
T Consensus       444 LaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~i  480 (590)
T KOG1290|consen  444 LATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKI  480 (590)
T ss_pred             hhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHH
Confidence            9999999952      247789999999999999765

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.3e-34  Score=240.77  Aligned_cols=196  Identities=29%  Similarity=0.413  Sum_probs=160.4

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      ..+.+|+|.++.++.+    .+..+++.||+|.+..... .......+..|+.++++++|++++++++.+...+..    
T Consensus         4 ~~~~ig~G~~g~v~~~----~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~----   75 (285)
T cd05630           4 QYRVLGKGGFGEVCAC----QVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL----   75 (285)
T ss_pred             eeEEeecCCCeEEEEE----EEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE----
Confidence            4455666666655543    4567889999999875322 222345577899999999999999999999776654    


Q ss_pred             cEEEEEeccccc-HHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        141 DVYLVMELMDAN-LCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       141 ~~~lv~e~~~~~-l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                        ++||||+.++ +.+.+.    ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++....
T Consensus        76 --~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630          76 --CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             --EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence              9999999865 544442    248889999999999999999999999999999999999999999999999987654


Q ss_pred             CCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       216 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      .........++..|+|||++.+..++.++|+||+|+++|+|++|..||.+..
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~  205 (285)
T cd05630         154 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  205 (285)
T ss_pred             CCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            4433344578999999999999889999999999999999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.3e-34  Score=241.71  Aligned_cols=216  Identities=34%  Similarity=0.568  Sum_probs=176.5

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.+|+|.++.++.+    .+..+++.+|+|.++...........+.+|++++++++||||+++++++....    
T Consensus         6 ~y~~~~~lg~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----   77 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRA----RDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN----   77 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEE----EECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC----
Confidence            4566677788777777665    45567899999999854333333445678999999999999999999987652    


Q ss_pred             cccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      ....++|+||+++++.+.+..   .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          78 LDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             CCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            123599999999887776642   37899999999999999999999999999999999999999999999999988665


Q ss_pred             CC-cccCCcccccccCchHhHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        216 TT-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       216 ~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .. .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.+..+.+.++...++.+
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~  226 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP  226 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            43 2223446788899999987644 6889999999999999999999999999888888887776644

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6e-34  Score=236.50  Aligned_cols=213  Identities=19%  Similarity=0.310  Sum_probs=167.7

Q ss_pred             ccccccCCccccccccCccceeccCCC--ceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQ--QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+++.+|+|.++.++.|.    ...++  ..||+|.++...........+..|+++++.++|+||+++++++........
T Consensus         2 ~i~~~ig~G~~g~V~~~~----~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   77 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQ----LNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG   77 (272)
T ss_pred             ccccccCcccCceEEEeE----EccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence            567888888888777763    22333  369999998654555667788999999999999999999998754332122


Q ss_pred             cccEEEEEecccc-cHHHHHh--------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        139 FQDVYLVMELMDA-NLCQVIQ--------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       139 ~~~~~lv~e~~~~-~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      ....++++||+.+ ++.+.+.        ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence            2346899999986 4554442        126889999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        210 LARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       210 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      ++........   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+.+..+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  229 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ  229 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9986543221   122245678999999999889999999999999999998 8999988777666655554

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-34  Score=246.30  Aligned_cols=219  Identities=53%  Similarity=0.920  Sum_probs=178.3

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+++.||+|+++...........+.+|++++++++||||+++++++.......
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~   92 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAA----FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   92 (345)
T ss_pred             CceEEEEEeeecCCeEEEEE----EEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence            45566677777777766654    45678999999999764434444567889999999999999999999987654433


Q ss_pred             ccccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      .....+++++++++++.+.+. ..+++..+..++.|++.||+|||+.+++||||+|+||+++.++.++|+|||++.....
T Consensus        93 ~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          93 EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             ccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            344568999999888776655 3589999999999999999999999999999999999999999999999999876533


Q ss_pred             CcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        217 TFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .  .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+....+.++++..+.+
T Consensus       173 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (345)
T cd07877         173 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  237 (345)
T ss_pred             c--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            2  233467888999999877 567889999999999999999999999888877777777665543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.6e-34  Score=245.51  Aligned_cols=203  Identities=26%  Similarity=0.397  Sum_probs=168.0

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .+++.+.+.+|.|.++.++++    .+..++..+|+|++.... .......+.+|+++++.++||||+++++++...+..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~----~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKV----SHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEE----EECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence            456677788888888877765    456788999999987532 334456788999999999999999999999877654


Q ss_pred             cccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~-~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                            ++||||+.+ +|.+.+.  ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus        79 ------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~  152 (333)
T cd06650          79 ------SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  152 (333)
T ss_pred             ------EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence                  999999986 5655554  3478889999999999999999975 79999999999999999999999999987


Q ss_pred             ccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhH
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ  271 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  271 (288)
                      ..... ......++..|+|||++.+..++.++|+||||+++|+|++|+.||...+..+.
T Consensus       153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~  210 (333)
T cd06650         153 QLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL  210 (333)
T ss_pred             hhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence            55332 12334688999999999998899999999999999999999999987655443

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.6e-34  Score=266.21  Aligned_cols=214  Identities=28%  Similarity=0.467  Sum_probs=171.7

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ...++.+...||.|.++.++++    .+..++..||+|++............+..|+.+++.++||||++++++|.....
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLA----kdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLV----KHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEE----EECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            3456677888888888887775    456788999999998654555667788999999999999999999998864332


Q ss_pred             ccccccEEEEEecccc-cHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHC-------CCEeecCCCCCEEEcc--
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSA-------GIIHRDLKPSNIVVKS--  199 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~-------~ivH~dl~~~nil~~~--  199 (288)
                          ..+++||||+++ +|.+.+.      ..+++..++.|+.||+.||+|||+.       +||||||||+|||++.  
T Consensus        87 ----~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         87 ----QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence                235999999986 5665554      2489999999999999999999984       4999999999999964  


Q ss_pred             ---------------CCcEEEeecccccccCCCcccCCcccccccCchHhHhc--CCCCchhhHHHHHHHHHHHHhCCCC
Q psy11580        200 ---------------DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVL  262 (288)
Q Consensus       200 ---------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~il~~l~~g~~p  262 (288)
                                     .+.+||+|||++.............+++.|+|||++.+  ..++.++|||||||++|+|++|..|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                           23489999999987655444455678999999999965  4578999999999999999999999


Q ss_pred             CCCCCchhHHHHHHH
Q psy11580        263 FPGTDHIDQWNKIIG  277 (288)
Q Consensus       263 ~~~~~~~~~~~~i~~  277 (288)
                      |...+....+..++.
T Consensus       243 F~~~~~~~qli~~lk  257 (1021)
T PTZ00266        243 FHKANNFSQLISELK  257 (1021)
T ss_pred             CCcCCcHHHHHHHHh
Confidence            987666554444433

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=241.28  Aligned_cols=213  Identities=36%  Similarity=0.594  Sum_probs=177.2

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.+++|.++.++.+    .+..+++.||+|+++...........+.+|+++++.++|+||+++++++...+..   
T Consensus         3 y~~~~~i~~g~~~~v~~~----~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---   75 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKC----RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRL---   75 (288)
T ss_pred             eeEEEEecccCCeeEEEE----EeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEE---
Confidence            456667777766666654    4566789999999976444445567889999999999999999999999876554   


Q ss_pred             ccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        140 QDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                         ++++||+++++++.+.   ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 ---~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          76 ---YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA  152 (288)
T ss_pred             ---EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence               9999999998776654   3488999999999999999999999999999999999999999999999999877654


Q ss_pred             Cc--ccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        217 TF--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       217 ~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ..  ......++..|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+.+..+...++.+
T Consensus       153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  221 (288)
T cd07833         153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL  221 (288)
T ss_pred             CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            33  22345678889999999887 78899999999999999999999999888777777766655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.4e-34  Score=235.11  Aligned_cols=208  Identities=26%  Similarity=0.398  Sum_probs=171.0

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.+++|.++.++.+    .+..+++.|++|.+............+..|+++++.++||||+++++++...+..    
T Consensus         3 ~~~~~l~~g~~~~v~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----   74 (256)
T cd08529           3 EILNKIGKGSFGVVFKV----VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL----   74 (256)
T ss_pred             eEeEEecCCCCeEEEEE----EEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE----
Confidence            44556677666655554    4566789999999976444556677888999999999999999999999877654    


Q ss_pred             cEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        141 DVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                        ++||||+++ ++.+.+..    .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        75 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          75 --NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             --EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence              999999976 55555532    47888999999999999999999999999999999999999999999999987654


Q ss_pred             CCcc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        216 TTFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       216 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      .... .....+++.|+|||+..+..++.++|+||||+++|+|++|+.||...+......++.+.
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  216 (256)
T cd08529         153 DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG  216 (256)
T ss_pred             CccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            4322 23346788899999999988999999999999999999999999888876666666543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-34  Score=247.00  Aligned_cols=217  Identities=54%  Similarity=0.891  Sum_probs=177.2

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.|    .+..+++.||+|++............+.+|+++++.++||||+++++++.......
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~   90 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSA----IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD   90 (342)
T ss_pred             cceEEEEEeeecCCeEEEEE----EeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence            34566677777766666654    34567899999999764333344456889999999999999999999987665433


Q ss_pred             ccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ....+++|+|++..++.+.....+++..+..++.|++.||+|||+.+++||||+|+||+++.++.++|+|||++......
T Consensus        91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879          91 EFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             CCceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence            44556999999998777666567899999999999999999999999999999999999999999999999998765332


Q ss_pred             cccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                        .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+....+..+....+
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  232 (342)
T cd07879         171 --MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG  232 (342)
T ss_pred             --CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence              233467888999999876 4678999999999999999999999999887777777776554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0984|consensus

Probab=100.00  E-value=1e-34  Score=218.49  Aligned_cols=214  Identities=23%  Similarity=0.362  Sum_probs=177.5

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  132 (288)
                      ++..+.+.....+|+|..+.+.    +.....+|...|+|.++... +.+...+..+|+.+..+. .+|.+|++||.+..
T Consensus        42 eV~ad~L~~i~elGrGayG~ve----kmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r  116 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVE----KMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR  116 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhh----heeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence            4455566666677776443322    23457899999999998654 346677788888887777 79999999999988


Q ss_pred             CCcccccccEEEEEecccccHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCCEEEccCCcEEE
Q psy11580        133 QKSLEEFQDVYLVMELMDANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKI  205 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~-~ivH~dl~~~nil~~~~~~~kl  205 (288)
                      .+..      ++.||.|.-++..+..      ..+++.-+-+|+..+.+||.|||++ .++|||+||+|||++.+|.+|+
T Consensus       117 egdv------wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKi  190 (282)
T KOG0984|consen  117 EGDV------WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKI  190 (282)
T ss_pred             cccE------EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEE
Confidence            8876      9999999987665543      3488889999999999999999964 7999999999999999999999


Q ss_pred             eecccccccCCCcccCCcccccccCchHhHhc----CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCchhHHHHHHHH
Q psy11580        206 LDFGLARTAGTTFMMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEMIRGGVLFPG-TDHIDQWNKIIGK  278 (288)
Q Consensus       206 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slg~il~~l~~g~~p~~~-~~~~~~~~~i~~~  278 (288)
                      ||||.+-...++...+-..|...|||||.+..    ..|+.++||||||+.+.||.+++.||.. .++.++++++++.
T Consensus       191 CDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  191 CDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             cccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            99999988877766666688889999999864    3688999999999999999999999975 7899999998864

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3e-34  Score=243.55  Aligned_cols=195  Identities=32%  Similarity=0.601  Sum_probs=154.6

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccE
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      +..+|+|.++.++.+.  ..+..++..||+|.+....    ....+.+|+++++.++||||+++++++.....    ...
T Consensus         6 g~~lG~G~~g~Vy~~~--~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~~   75 (317)
T cd07867           6 GCKVGRGTYGHVYKAK--RKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSD----RKV   75 (317)
T ss_pred             ceEeccCCCeeEEEEE--ecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCC----CeE
Confidence            3457777777666652  1123466899999997532    23457789999999999999999999864321    245


Q ss_pred             EEEEecccccHHHHHh-----------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE----ccCCcEEEee
Q psy11580        143 YLVMELMDANLCQVIQ-----------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILD  207 (288)
Q Consensus       143 ~lv~e~~~~~l~~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~----~~~~~~kl~d  207 (288)
                      ++|+||+++++.+.+.           ..+++..+..++.||+.||+|||+.+|+||||||+||++    +.++.+||+|
T Consensus        76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07867          76 WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             EEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence            9999999998877663           137788899999999999999999999999999999999    4567899999


Q ss_pred             cccccccCCCcc----cCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        208 FGLARTAGTTFM----MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       208 fg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ||++........    .....+++.|+|||++.+. .++.++||||||+++|+|++|.+||....
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            999976543221    2344678899999999874 57899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.1e-34  Score=238.96  Aligned_cols=213  Identities=23%  Similarity=0.331  Sum_probs=171.6

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..++.+.+.+|+|.++.++.|.-...+..++..||+|.+... ........+.+|+++++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            456788889999988888887533334567789999999753 2334456788999999999999999999998776654


Q ss_pred             cccccEEEEEecccc-cHHHHHh-------------------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEE
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ-------------------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV  196 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil  196 (288)
                            +++|||+++ ++.+++.                   ..+++..+..++.|++.||+|||+++++|+||||+||+
T Consensus        83 ------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil  156 (283)
T cd05090          83 ------CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL  156 (283)
T ss_pred             ------EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence                  999999986 4555552                   12677888999999999999999999999999999999


Q ss_pred             EccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHH
Q psy11580        197 VKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQW  272 (288)
Q Consensus       197 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~  272 (288)
                      ++.++.++|+|||++.......   ......++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+.....
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI  236 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999999999997643221   1233345677999999988889999999999999999998 99999887765554


Q ss_pred             HHHH
Q psy11580        273 NKII  276 (288)
Q Consensus       273 ~~i~  276 (288)
                      ..+.
T Consensus       237 ~~~~  240 (283)
T cd05090         237 EMVR  240 (283)
T ss_pred             HHHH
Confidence            4443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0986|consensus

Probab=100.00  E-value=1.4e-35  Score=246.28  Aligned_cols=206  Identities=28%  Similarity=0.386  Sum_probs=178.2

Q ss_pred             cccccccCCccccccccCccce---eccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAA---YDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~---~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      .++...-++.|.+.+++|+|.|   ....||+.+|+|.+.+.. ...........|-.+|++++.+.||.+-.+|...+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            4666777888899999999954   457899999999996532 223334567789999999999999999999988887


Q ss_pred             ccccccEEEEEecccccHHHHHh-----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        136 LEEFQDVYLVMELMDANLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      +      |+|+..|.|+.+.+..     ..+++..++.++.+|+.||++||+.+||+||+||+|||+|+.|.++|+|.|+
T Consensus       260 L------ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGL  333 (591)
T KOG0986|consen  260 L------CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGL  333 (591)
T ss_pred             e------EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccce
Confidence            6      9999999987554332     3599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhH
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ  271 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  271 (288)
                      |............+||.+|||||++.+..|+...|.|||||++|+|+.|+.||........
T Consensus       334 Avei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk  394 (591)
T KOG0986|consen  334 AVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK  394 (591)
T ss_pred             EEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh
Confidence            9999888777778999999999999999999999999999999999999999987544333

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-34  Score=247.04  Aligned_cols=190  Identities=22%  Similarity=0.299  Sum_probs=158.7

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++++    .+..+++.||+|+....        ....|+.++++++|+||+++++++...+.. 
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-  132 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVA----TKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT-  132 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEE----EECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCee-
Confidence            35677777788777777664    35567889999986532        234689999999999999999999876654 


Q ss_pred             ccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++|+|++.+++.+.+.   ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++...
T Consensus       133 -----~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        133 -----CMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             -----EEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence                 9999999999888775   34889999999999999999999999999999999999999999999999999765


Q ss_pred             CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG-GVLFPG  265 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g-~~p~~~  265 (288)
                      ..........+++.|+|||++.+..++.++||||||+++|+|+++ ..+|..
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence            443333445789999999999998999999999999999999985 445544

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.2e-34  Score=235.86  Aligned_cols=211  Identities=22%  Similarity=0.374  Sum_probs=171.8

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +...++.+.+.+|+|.++.++.+    .+..+++.||+|+++..   ......+.+|+++++.++|+||+++++++...+
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~----~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEG----VWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   75 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEE----EEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence            34456777788888877776664    34567899999999742   234567889999999999999999999998776


Q ss_pred             cccccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      ..      +++|||+++ ++.+.+..    .+++..++.++.|+++||++||+++++|+||||+||+++.++.++|+|||
T Consensus        76 ~~------~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~  149 (263)
T cd05052          76 PF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG  149 (263)
T ss_pred             Cc------EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCc
Confidence            65      999999975 46555542    37889999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccc--CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        210 LARTAGTTFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       210 ~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ++.........  .....+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  221 (263)
T cd05052         150 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG  221 (263)
T ss_pred             cccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence            98765443221  12233567999999999889999999999999999998 99999987776666665543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0666|consensus

Probab=100.00  E-value=2.8e-35  Score=234.01  Aligned_cols=223  Identities=31%  Similarity=0.549  Sum_probs=178.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.....||+|..+.++.+..+-.+.+-...+|+|.++.+...........+|+.+++.++|||++.+..++...+   
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d---  100 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD---  100 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC---
Confidence            34455666777777777665322111111348999999876444445567889999999999999999999998632   


Q ss_pred             ccccEEEEEecccccHHHHHh-------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC----CcEEEe
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ-------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD----CTLKIL  206 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~----~~~kl~  206 (288)
                        ...++++||.+.+|++.+.       ..++...+..++.||+.|+.|||++-|+||||||.|||+..+    |.|||+
T Consensus       101 --~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  101 --KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             --ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence              2359999999999998875       237888999999999999999999999999999999999987    899999


Q ss_pred             ecccccccCCCc----ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC---------CchhHH
Q psy11580        207 DFGLARTAGTTF----MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGT---------DHIDQW  272 (288)
Q Consensus       207 dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~---------~~~~~~  272 (288)
                      |+|+++......    .....+.|..|+|||.+.| ..||.+.|||+.|||+.||++-++.|.+.         -..+++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999998765532    2244567899999999999 56899999999999999999999999763         245688


Q ss_pred             HHHHHHhCCCccC
Q psy11580        273 NKIIGKMREAHDK  285 (288)
Q Consensus       273 ~~i~~~~~~~~~~  285 (288)
                      ..|.+.+|.|.++
T Consensus       259 ~rIf~vLG~Pt~~  271 (438)
T KOG0666|consen  259 DRIFEVLGTPTDK  271 (438)
T ss_pred             HHHHHHcCCCccc
Confidence            9999999877654

>KOG0669|consensus

Probab=100.00  E-value=9.8e-36  Score=230.40  Aligned_cols=219  Identities=27%  Similarity=0.494  Sum_probs=182.0

Q ss_pred             cccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc--cccc
Q psy11580         64 HQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE--EFQD  141 (288)
Q Consensus        64 ~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~--~~~~  141 (288)
                      ..+|+|.++.++.    +..+.+|+.||+|+.-.+.....-.....+|+++|..+.|+|++.++..|.......  ....
T Consensus        23 ~kigqGtfgeVFk----Ar~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   23 AKIGQGTFGEVFK----ARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HhcCCchHHHHHH----HhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            4566666665554    456788899999988654444444556789999999999999999999997655432  2345


Q ss_pred             EEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC-
Q psy11580        142 VYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT-  217 (288)
Q Consensus       142 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-  217 (288)
                      +|+|+.+|+.+|...+.   .+++..++.+++.+++.||.|+|...|+|||+|+.|+|++.+|.+||+|||+++..+.+ 
T Consensus        99 ~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~  178 (376)
T KOG0669|consen   99 FYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSK  178 (376)
T ss_pred             eeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceeccc
Confidence            89999999988777665   45999999999999999999999999999999999999999999999999999654332 


Q ss_pred             ----cccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccCC
Q psy11580        218 ----FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL  286 (288)
Q Consensus       218 ----~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  286 (288)
                          ...+..+.|..|.+||.+.| ..++++.|||..||++.+|++|.+.|.+.+....+..|...||...+++
T Consensus       179 n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  179 NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence                22345577899999999998 5689999999999999999999999999999999999999999766543

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.8e-34  Score=264.80  Aligned_cols=200  Identities=26%  Similarity=0.372  Sum_probs=162.6

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+|+|.++.++.+    ++..+++.||+|++..... ......++.+|++++++++||||+++++++...+.. 
T Consensus         3 rYeIi~~LGkGgfG~VYlA----~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~l-   77 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLA----YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPV-   77 (932)
T ss_pred             CeEEEEEEecCCCEEEEEE----EECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEE-
Confidence            4566777888777777765    4677899999999975432 233456788999999999999999999999876654 


Q ss_pred             ccccEEEEEeccccc-HHHHHhh-------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcE
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQM-------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL  203 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~~-------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~  203 (288)
                           +++|||++++ +.+.+..             ..+...+..++.||++||+|||++||+||||||+||+++.++.+
T Consensus        78 -----yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~v  152 (932)
T PRK13184         78 -----YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEV  152 (932)
T ss_pred             -----EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCE
Confidence                 9999999875 4444321             24556788999999999999999999999999999999999999


Q ss_pred             EEeecccccccCCC-------------------cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy11580        204 KILDFGLARTAGTT-------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP  264 (288)
Q Consensus       204 kl~dfg~~~~~~~~-------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~  264 (288)
                      +|+|||++......                   .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus       153 KLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~  232 (932)
T PRK13184        153 VILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR  232 (932)
T ss_pred             EEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            99999999755110                   01122468999999999999999999999999999999999999998


Q ss_pred             CCCc
Q psy11580        265 GTDH  268 (288)
Q Consensus       265 ~~~~  268 (288)
                      +.+.
T Consensus       233 ~~~~  236 (932)
T PRK13184        233 RKKG  236 (932)
T ss_pred             Ccch
Confidence            7544

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.8e-34  Score=240.05  Aligned_cols=212  Identities=35%  Similarity=0.605  Sum_probs=172.0

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.++.|.++.++.+    .+..++..||||.++...........+..|++++++++||||+++++++...+..    
T Consensus         3 ~~~~~l~~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~----   74 (284)
T cd07860           3 QKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL----   74 (284)
T ss_pred             eeeeeecCCCceEEEEE----EECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE----
Confidence            44556666666655554    4567889999999976444444456788999999999999999999999876654    


Q ss_pred             cEEEEEecccccHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        141 DVYLVMELMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       141 ~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                        ++||||+.+++.+.+.    ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 --~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          75 --YLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             --EEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence              9999999888777664    3478899999999999999999999999999999999999999999999999876543


Q ss_pred             Ccc-cCCcccccccCchHhHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        217 TFM-MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       217 ~~~-~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+..+...++.+..+.+
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  220 (284)
T cd07860         153 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP  220 (284)
T ss_pred             CccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            221 23345678899999887644 5889999999999999999999999888777777777665544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.1e-34  Score=238.35  Aligned_cols=216  Identities=24%  Similarity=0.339  Sum_probs=173.3

Q ss_pred             hhcccccccccCCccccccccCcccee-ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAY-DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.+|.|.++.++.|..... ...+...||+|.++... .......+.+|++++++++||||+++++++...+
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            345678888899988888887642211 12345789999997432 3344567889999999999999999999998766


Q ss_pred             cccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCE
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  195 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~ni  195 (288)
                      ..      +++|||+++ ++.+++..                  .+++..++.++.|++.||+|||+++++|+||||+||
T Consensus        82 ~~------~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni  155 (283)
T cd05048          82 PT------CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNC  155 (283)
T ss_pred             ce------EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceE
Confidence            54      999999986 56555532                  367788999999999999999999999999999999


Q ss_pred             EEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhH
Q psy11580        196 VVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQ  271 (288)
Q Consensus       196 l~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~  271 (288)
                      +++.++.++|+|||++.......   ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+.
T Consensus       156 l~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~  235 (283)
T cd05048         156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV  235 (283)
T ss_pred             EEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99999999999999987543221   1233456788999999988889999999999999999998 9999999888777


Q ss_pred             HHHHHHH
Q psy11580        272 WNKIIGK  278 (288)
Q Consensus       272 ~~~i~~~  278 (288)
                      ...+...
T Consensus       236 ~~~i~~~  242 (283)
T cd05048         236 IEMIRSR  242 (283)
T ss_pred             HHHHHcC
Confidence            6666543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.7e-34  Score=234.72  Aligned_cols=209  Identities=23%  Similarity=0.370  Sum_probs=168.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+.     ...+..||+|.+....   .....+.+|+.++++++||||+++++++...+.. 
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~-----~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-   74 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGK-----WRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI-   74 (256)
T ss_pred             HHeEEeeEecCcccceEEEEE-----ecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc-
Confidence            456777888888888777763     2234569999987432   2345688999999999999999999999876654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                           +++|||+.++ +.+.+.   ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||.+..
T Consensus        75 -----~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~  149 (256)
T cd05113          75 -----YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY  149 (256)
T ss_pred             -----EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCcccee
Confidence                 9999999864 555554   2478999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCccc--CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        214 AGTTFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       214 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      .......  ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.+...
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~  219 (256)
T cd05113         150 VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR  219 (256)
T ss_pred             cCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC
Confidence            5332211  12234567999999998889999999999999999998 9999998887776666665543

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.5e-34  Score=242.46  Aligned_cols=210  Identities=25%  Similarity=0.299  Sum_probs=166.3

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +...++.+...+|+|.++.++.|............||+|+++.. ........+..|+.+++.++||||+++++++....
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~   82 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   82 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC
Confidence            34456778888999888888876422111222345999999742 23345667889999999999999999999997653


Q ss_pred             cccccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                             .++++|++.+ ++.+.+..   .+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+
T Consensus        83 -------~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          83 -------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             -------ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccc
Confidence                   2789999886 46666643   378889999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccc---CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHH
Q psy11580        211 ARTAGTTFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQW  272 (288)
Q Consensus       211 ~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~  272 (288)
                      +.........   .....+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+..
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~  221 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS  221 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9865432221   12234567999999999899999999999999999997 99999887665543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-34  Score=244.85  Aligned_cols=218  Identities=43%  Similarity=0.767  Sum_probs=174.3

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.+|+|.++.++.|    .+..+++.||+|+++.. ........+.+|+.++++++|+||+++++++..... ..
T Consensus         6 ~y~i~~~lg~G~~g~vy~~----~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~   79 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSA----THKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF-ES   79 (336)
T ss_pred             ceEEEEEEEecCCeEEEEE----EEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccc-cc
Confidence            4556666777666665554    45678899999999642 222345667889999999999999999998765542 23


Q ss_pred             cccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ....++++|++++++.+.+. ..+++..+..++.|++.||++||+.+++||||||+||+++.++.++|+|||++......
T Consensus        80 ~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          80 FNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             cceEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            34569999999998887765 45899999999999999999999999999999999999999999999999998765332


Q ss_pred             cc----cCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        218 FM----MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       218 ~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ..    .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+....+..+...++.+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~  229 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP  229 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            11    123467888999999765 467899999999999999999999999888777777776666543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0664|consensus

Probab=100.00  E-value=8.4e-37  Score=239.05  Aligned_cols=221  Identities=39%  Similarity=0.710  Sum_probs=189.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++....-||-|.|++++    .|.|..+|+.||+|++.+-..+....+.+.+|+++|..++|.|++..+++..... +.
T Consensus        53 ~Di~PDRPIGYGAFGVVW----sVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph-~d  127 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVW----SVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPAN-PS  127 (449)
T ss_pred             ccCCCCCcccccceeEEE----eccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCC-ch
Confidence            345566666666666655    3678999999999999876667777888999999999999999999999987544 24


Q ss_pred             ccccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      .....|+++|.|..+|...+.  ..++.+.+.-+.+||++||.|||+.+|.||||||.|.|++++-.+||||||+++...
T Consensus       128 fFqEiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  128 FFQELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc
Confidence            456678999999999888775  458888999999999999999999999999999999999999999999999998654


Q ss_pred             C--CcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        216 T--TFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       216 ~--~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .  ...++..+.|..|.|||.+.| ..|+.+.||||.||++.|++..+..|+..++.+.+..|.+.+|.+.
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs  278 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPS  278 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCc
Confidence            4  333456678889999999999 4689999999999999999999999999999999999999998764

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-34  Score=252.32  Aligned_cols=182  Identities=25%  Similarity=0.318  Sum_probs=150.4

Q ss_pred             CccccccccCcc------ceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         68 KKRHNTSHLGAG------AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        68 ~~~~~~~~~g~g------~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      .+|.+...+|.|      .+.+..+++.||||....        ..+.+|++++++++|+||+++++++...+..     
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~-----  235 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLT-----  235 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEE-----
Confidence            345554445444      245667789999996532        2356899999999999999999998776654     


Q ss_pred             EEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        142 VYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       142 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                       ++|||++.+++.+.+..   .+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus       236 -~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        236 -CLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             -EEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence             99999999988887753   48999999999999999999999999999999999999999999999999997653321


Q ss_pred             c---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy11580        219 M---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF  263 (288)
Q Consensus       219 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~  263 (288)
                      .   .....|++.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            1   12346899999999999999999999999999999999987654

>KOG0612|consensus

Probab=100.00  E-value=2.1e-35  Score=267.90  Aligned_cols=222  Identities=25%  Similarity=0.394  Sum_probs=188.7

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.||+|+||.+.+    |..+.+++.+|+|++++- -........|..|-.+|-.-+.+-|+.++-+|.++.
T Consensus        73 ~~~DfeilKvIGrGaFGEV~l----Vr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVAL----VRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEE----EEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            457788999999999888777    567889999999999751 112233456888999999999999999999999988


Q ss_pred             cccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        135 SLEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      .+      |+||||++|| ++..+.  ..++++.++.++..|+.||..||+.|+|||||||+|||+|..|.+||+|||.+
T Consensus       149 ~L------YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  149 YL------YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ce------EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence            76      9999999875 665554  24889999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC--cccCCcccccccCchHhHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH--hCCC
Q psy11580        212 RTAGTT--FMMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK--MREA  282 (288)
Q Consensus       212 ~~~~~~--~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~  282 (288)
                      ..+...  ......+|||.|.+||++..     ..|+...|.||+||++|||+.|..||...+-.+.+.+|++.  .-.+
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~F  302 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSF  302 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCC
Confidence            876533  23356689999999999974     35788999999999999999999999999999999999998  4456


Q ss_pred             ccCCC
Q psy11580        283 HDKLD  287 (288)
Q Consensus       283 ~~~~~  287 (288)
                      |+.+|
T Consensus       303 P~~~~  307 (1317)
T KOG0612|consen  303 PDETD  307 (1317)
T ss_pred             Ccccc
Confidence            65443

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.1e-33  Score=237.11  Aligned_cols=215  Identities=21%  Similarity=0.318  Sum_probs=173.2

Q ss_pred             hcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      .+++.+.+.+|.|.++.++.+... ..+..++..+|+|.+...  .......+.+|++++++++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            456788888999888888776321 112345677999999752  33445678899999999999999999999987665


Q ss_pred             ccccccEEEEEecccc-cHHHHHhh---------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQM---------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS  199 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~~---------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~  199 (288)
                      .      ++|+||+++ ++.+++..               .+++..+..++.|++.||+|||+++++||||||+||+++.
T Consensus        82 ~------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~  155 (288)
T cd05093          82 L------IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE  155 (288)
T ss_pred             c------EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            4      999999986 45555531               2789999999999999999999999999999999999999


Q ss_pred             CCcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHH
Q psy11580        200 DCTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       200 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i  275 (288)
                      ++.++|+|||++........   .....++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+.+..+
T Consensus       156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99999999999875533211   122345678999999998889999999999999999998 99999888777777666


Q ss_pred             HHHh
Q psy11580        276 IGKM  279 (288)
Q Consensus       276 ~~~~  279 (288)
                      .+..
T Consensus       236 ~~~~  239 (288)
T cd05093         236 TQGR  239 (288)
T ss_pred             HcCC
Confidence            6543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.7e-34  Score=240.20  Aligned_cols=222  Identities=27%  Similarity=0.456  Sum_probs=176.0

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc--
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL--  136 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--  136 (288)
                      .+.+...+|+|.++.++.+    .+..+++.||+|.+............+.+|++++++++||||+++++++...+..  
T Consensus        13 ~y~~~~~lg~g~~~~v~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKA----RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             heEEEEEeecCCCEEEEEE----EECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            3455666777766666654    4566899999999875433333344567899999999999999999998754421  


Q ss_pred             cccccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      ......++||||+++++.+.+..   .+++.+++.++.|+++||+|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus        89 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          89 RYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             CCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence            12345699999999988776653   489999999999999999999999999999999999999999999999999975


Q ss_pred             cCCCcc-----cCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        214 AGTTFM-----MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       214 ~~~~~~-----~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ......     .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+.......+.+.++.+++
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            533211     1234567889999998764 4688999999999999999999999998887777777777765554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0983|consensus

Probab=100.00  E-value=1.4e-34  Score=226.34  Aligned_cols=197  Identities=24%  Similarity=0.377  Sum_probs=168.4

Q ss_pred             eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcccccccEEEEEecccc---cHHHH
Q psy11580         81 AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA---NLCQV  156 (288)
Q Consensus        81 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~---~l~~~  156 (288)
                      +....+|...|||.+... .+....+++...+.++.... +|+||+.+|+|..+...      ++.||.|..   .|+..
T Consensus       111 ~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV------~IcMelMs~C~ekLlkr  183 (391)
T KOG0983|consen  111 MRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV------FICMELMSTCAEKLLKR  183 (391)
T ss_pred             EEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH------HHHHHHHHHHHHHHHHH
Confidence            455788999999999865 45567888999998888874 99999999999988765      899999875   45555


Q ss_pred             HhhhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhH
Q psy11580        157 IQMDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI  235 (288)
Q Consensus       157 ~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~  235 (288)
                      +..++++..+-++...+..||.||-+ .+|+|||+||+|||+|..|++||||||.+-....+...+...|.+.|||||.+
T Consensus       184 ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERi  263 (391)
T KOG0983|consen  184 IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERI  263 (391)
T ss_pred             hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCcccc
Confidence            66779999999999999999999985 68999999999999999999999999999888777777778999999999999


Q ss_pred             hc---CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchhHHHHHHHHhCCCccCCC
Q psy11580        236 LG---MGYKENVDIWSVGCIMGEMIRGGVLFPGT-DHIDQWNKIIGKMREAHDKLD  287 (288)
Q Consensus       236 ~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~-~~~~~~~~i~~~~~~~~~~~~  287 (288)
                      .-   ..|+.++||||||+.++||.||+.||.+. ++.+.+.+|.+   +.|+-|+
T Consensus       264 dp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~ePP~L~  316 (391)
T KOG0983|consen  264 DPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---EEPPLLP  316 (391)
T ss_pred             CCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---cCCCCCC
Confidence            64   35788999999999999999999999984 67788888877   4445444

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.1e-34  Score=239.21  Aligned_cols=211  Identities=39%  Similarity=0.601  Sum_probs=172.3

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcc---hhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN---VTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .+.+.+|.|.++.++.|    .+..+++.||+|.++.....   ......+..|++++++++|+||+++++++...+.. 
T Consensus         3 ~~~~~lg~g~~~~vy~~----~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~-   77 (298)
T cd07841           3 EKGKKLGEGTYAVVYKA----RDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNI-   77 (298)
T ss_pred             eeeeeeeeccccEEEEE----EECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEE-
Confidence            44566777777766665    34567899999999864322   23345677899999999999999999999876554 


Q ss_pred             ccccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||+.+++.+.+..   .+++..+..++.||++||+|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus        78 -----~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  152 (298)
T cd07841          78 -----NLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF  152 (298)
T ss_pred             -----EEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence                 99999997777777653   4889999999999999999999999999999999999999999999999999766


Q ss_pred             CCCc-ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCC
Q psy11580        215 GTTF-MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       215 ~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  281 (288)
                      .... ......+++.|+|||.+.+ ..++.++|+||||+++++|++|.+||.+.++.+.+.++.+.++.
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~  221 (298)
T cd07841         153 GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGT  221 (298)
T ss_pred             cCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCC
Confidence            4432 2233456778999999865 45789999999999999999999999998888888887766543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1e-33  Score=235.90  Aligned_cols=215  Identities=20%  Similarity=0.315  Sum_probs=169.6

Q ss_pred             hhcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ..+++.+...+|+|.++.++.|... .....++..||+|++... ........+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            3455677888899888888776532 122345678999998643 23344567889999999999999999999997666


Q ss_pred             cccccccEEEEEeccccc-HHHHHhh------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC
Q psy11580        135 SLEEFQDVYLVMELMDAN-LCQVIQM------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC  201 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~-l~~~~~~------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~  201 (288)
                      ..      ++||||++++ |.+++..            ..++..+..++.|++.||+|||+.+++|+||||+||+++.++
T Consensus        83 ~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          83 PT------LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             Ce------EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC
Confidence            54      9999999864 5554432            146678899999999999999999999999999999999999


Q ss_pred             cEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        202 TLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       202 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      .++|+|||++........   .....++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+....+..+..
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME  236 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999875433211   122345678999999998889999999999999999998 7999998877766665544

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-34  Score=234.35  Aligned_cols=208  Identities=26%  Similarity=0.399  Sum_probs=168.7

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcc---hhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN---VTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      .+.+++.+|+|.++.++.+    .+..+++.||+|.+......   ......+.+|++++++++||||+++++++.....
T Consensus         3 ~~~~~~~lg~g~~~~vy~~----~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   78 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLC----YDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET   78 (263)
T ss_pred             cccccceecCCCceEEEEE----EEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe
Confidence            4567778888877776665    45678899999998753222   2234568889999999999999999999987765


Q ss_pred             ccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      .      ++|+|+++++ +.+.+.  ..++...+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        79 ~------~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~  152 (263)
T cd06625          79 L------SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK  152 (263)
T ss_pred             E------EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence            4      9999999864 555554  347888999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccc----CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        213 TAGTTFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       213 ~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                      ........    ....++..|+|||++.+..++.++||||||+++|+|++|+.||.+.+......++.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  220 (263)
T cd06625         153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA  220 (263)
T ss_pred             eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh
Confidence            54332111    23456788999999999889999999999999999999999998876665555444

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.4e-34  Score=242.93  Aligned_cols=209  Identities=25%  Similarity=0.379  Sum_probs=166.4

Q ss_pred             hhcccccccccCCccccccccCccce-eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAA-YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQ  133 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  133 (288)
                      ...++.+.+.+|.|.++.++.+.-.. -+..+++.||+|+++... .......+.+|+++++++ +|+||++++++|...
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            34567888999999999888774321 234567899999997532 234456788999999999 899999999988754


Q ss_pred             CcccccccEEEEEeccccc-HHHHHh------------------------------------------------------
Q psy11580        134 KSLEEFQDVYLVMELMDAN-LCQVIQ------------------------------------------------------  158 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~-l~~~~~------------------------------------------------------  158 (288)
                      +.     .+++++||++++ +.+.+.                                                      
T Consensus        84 ~~-----~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (337)
T cd05054          84 GG-----PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE  158 (337)
T ss_pred             CC-----CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence            42     358999999874 444432                                                      


Q ss_pred             ---------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc---ccCCcccc
Q psy11580        159 ---------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVT  226 (288)
Q Consensus       159 ---------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~  226 (288)
                               ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++.......   ......++
T Consensus       159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                     146888899999999999999999999999999999999999999999999997653221   12223456


Q ss_pred             cccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchh
Q psy11580        227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHID  270 (288)
Q Consensus       227 ~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~  270 (288)
                      ..|+|||++.+..++.++|||||||++|+|++ |..||.+....+
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~  283 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE  283 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH
Confidence            78999999999999999999999999999998 999998754433

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.3e-34  Score=234.01  Aligned_cols=211  Identities=22%  Similarity=0.374  Sum_probs=173.1

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +...++.+.+.+|.|.++.+++|.     ..++..||+|.+...   ....+.+.+|+.++++++|+||+++++.+...+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~-----~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGY-----YNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE   74 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEE-----ecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            455678888899998888888763     235578999998742   234567889999999999999999999988766


Q ss_pred             cccccccEEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      ..      ++++||+++ ++.+.+.    ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||
T Consensus        75 ~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg  148 (261)
T cd05072          75 PI------YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFG  148 (261)
T ss_pred             Cc------EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCc
Confidence            54      999999975 5666553    237888999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        210 LARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       210 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ++........  .....++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+....+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~  221 (261)
T cd05072         149 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY  221 (261)
T ss_pred             cceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC
Confidence            9986543221  122345667999999988889999999999999999998 999999887777766665543

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-33  Score=242.87  Aligned_cols=219  Identities=53%  Similarity=0.875  Sum_probs=178.0

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.+    .+..++..||||++............+.+|+++++.++||||+++++++.......
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSA----LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             cceEEEEEeeecCCeEEEEE----EECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            34556667777776666554    45678999999999754444444567889999999999999999999998766544


Q ss_pred             ccccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      .....++|||++++++.+.+. ..+++..++.++.|++.||+|||+.+|+||||+|+||+++.++.++|+|||++.....
T Consensus        91 ~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          91 RFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             ccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            445569999999877776665 4689999999999999999999999999999999999999999999999999876543


Q ss_pred             CcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        217 TFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .  .....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||.+.+....+.++.+..+..
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07880         171 E--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP  235 (343)
T ss_pred             C--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            2  223466888999999876 457899999999999999999999999988877777776654443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-34  Score=234.16  Aligned_cols=210  Identities=24%  Similarity=0.383  Sum_probs=171.1

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +....+.+.+.+|+|.++.++.+.     ..+++.||+|.++...   .....+.+|++++++++||||+++++++...+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~-----~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGL-----WNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE   74 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEE-----ecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCC
Confidence            445667888888988888777753     2345789999997532   23566889999999999999999999987766


Q ss_pred             cccccccEEEEEeccc-ccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        135 SLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      ..      +++||++. +++.+.+..    .+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||
T Consensus        75 ~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg  148 (261)
T cd05068          75 PI------YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFG  148 (261)
T ss_pred             Ce------eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcc
Confidence            54      99999995 567666642    47899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccC--CcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        210 LARTAGTTFMMT--PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       210 ~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ++..........  ....+..|+|||++.+..++.++|+||||+++|+|++ |+.||.+.+....+..+.+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~  220 (261)
T cd05068         149 LARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG  220 (261)
T ss_pred             eEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            998765332211  1122457999999998889999999999999999998 99999988877777666544

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.1e-34  Score=237.72  Aligned_cols=213  Identities=34%  Similarity=0.607  Sum_probs=176.2

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.+++|.++.++.+    .+..++..||+|++............+.+|+.++++++||||+++++++......   
T Consensus         2 y~~~~~l~~g~~~~v~~~----~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~---   74 (286)
T cd07832           2 YKILGRIGEGAHGIVFKA----KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF---   74 (286)
T ss_pred             ceEEeecccCCCcEEEEE----EECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee---
Confidence            345667777777766654    3556789999999986543344567788999999999999999999999876654   


Q ss_pred             ccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        140 QDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                         ++|+||+.+++.+.+.   ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ---~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~  151 (286)
T cd07832          75 ---VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSE  151 (286)
T ss_pred             ---EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence               9999999777777664   3488999999999999999999999999999999999999999999999999876644


Q ss_pred             Cc--ccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        217 TF--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       217 ~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ..  ......++..|+|||.+.+. .++.++||||+|+++++|++|.+||.+.++...+..+.+.++.+
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~  220 (286)
T cd07832         152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP  220 (286)
T ss_pred             CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCC
Confidence            32  12345678899999998764 46899999999999999999999999988888888888766544

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-34  Score=238.30  Aligned_cols=213  Identities=34%  Similarity=0.554  Sum_probs=169.6

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.|    .+..+++.||+|.+...... .....+.+|++++++++|+||+++++++...+.. 
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~----~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-   78 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKG----RSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTL-   78 (291)
T ss_pred             cceeEEEEEeecCCeEEEEE----EEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeE-
Confidence            34556677777777766665    35667899999999753222 2234567899999999999999999999876654 


Q ss_pred             ccccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||+++++.+.+..   .+++..+..++.|+++||.|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus        79 -----~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          79 -----TLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             -----EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECcccccccc
Confidence                 99999999988876653   4788999999999999999999999999999999999999999999999998754


Q ss_pred             CCCcc-cCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chhHHHHHHHHhCC
Q psy11580        215 GTTFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTD-HIDQWNKIIGKMRE  281 (288)
Q Consensus       215 ~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~-~~~~~~~i~~~~~~  281 (288)
                      ..... .....++..|+|||++.+ ..++.++|+||+|+++|+|++|..||.+.+ ..+.+..+.+.++.
T Consensus       154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  223 (291)
T cd07844         154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT  223 (291)
T ss_pred             CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCC
Confidence            32211 122346788999999876 457899999999999999999999998765 55566666555543

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.5e-34  Score=246.66  Aligned_cols=208  Identities=26%  Similarity=0.386  Sum_probs=166.8

Q ss_pred             hhhhcccccccccCCccccccccCccce-eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAA-YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~  131 (288)
                      ++...++.+++.||+|.++.++.|.... .+..++..||||+++.. ......+.+.+|+++++++. ||||++++++|.
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            5566788899999999999888764321 22344568999999753 23344567889999999996 999999999998


Q ss_pred             CCCcccccccEEEEEeccccc-HHHHHhh---------------------------------------------------
Q psy11580        132 PQKSLEEFQDVYLVMELMDAN-LCQVIQM---------------------------------------------------  159 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~---------------------------------------------------  159 (288)
                      ..+..      ++||||++++ |.+++..                                                   
T Consensus       112 ~~~~~------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (400)
T cd05105         112 KSGPI------YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT  185 (400)
T ss_pred             cCCce------EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence            77655      9999999864 4444321                                                   


Q ss_pred             -----------------------------------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCC
Q psy11580        160 -----------------------------------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP  192 (288)
Q Consensus       160 -----------------------------------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~  192 (288)
                                                                     .+++..+..++.|++.||+|||+.+++|+||||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp  265 (400)
T cd05105         186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA  265 (400)
T ss_pred             cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence                                                           256777889999999999999999999999999


Q ss_pred             CCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q psy11580        193 SNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDH  268 (288)
Q Consensus       193 ~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~  268 (288)
                      +||+++.++.+||+|||++.......   ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus       266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~  345 (400)
T cd05105         266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV  345 (400)
T ss_pred             HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence            99999999999999999987543221   1122345678999999999889999999999999999997 9999987543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG4278|consensus

Probab=100.00  E-value=9.4e-35  Score=249.79  Aligned_cols=216  Identities=24%  Similarity=0.410  Sum_probs=185.5

Q ss_pred             HHhhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecc
Q psy11580         50 DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA  129 (288)
Q Consensus        50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  129 (288)
                      ..| +....++.+...+|.|-.+.+|.|..+-|+    -.||||.++.   +.....+|.+|..+|+.+.|||+|+++|+
T Consensus       260 DkW-EmeRtdItMkhKLGGGQYGeVYeGvWKkys----lTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGV  331 (1157)
T KOG4278|consen  260 DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV  331 (1157)
T ss_pred             chh-hccchheeeeeccCCCcccceeeeeeeccc----eeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhh
Confidence            456 677788999999999999999999765544    4599999984   55678899999999999999999999999


Q ss_pred             ccCCCcccccccEEEEEeccc-ccHHHHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEE
Q psy11580        130 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  204 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~k  204 (288)
                      |+.+..+      |||+|||. |+|++++...    ++.-.++.++.||.+||+||..+++|||||.++|+|+..+..+|
T Consensus       332 CT~EpPF------YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVK  405 (1157)
T KOG4278|consen  332 CTHEPPF------YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVK  405 (1157)
T ss_pred             hccCCCe------EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEE
Confidence            9998876      99999987 5799888632    66677889999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCcccC--CcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        205 ILDFGLARTAGTTFMMT--PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       205 l~dfg~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ++|||+++.+.......  ....+..|.|||-+.-..++.++|||+|||+|||+.+ |-.||+|-+..+.+....+..
T Consensus       406 vADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy  483 (1157)
T KOG4278|consen  406 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY  483 (1157)
T ss_pred             eeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc
Confidence            99999999886654321  1233667999999999999999999999999999998 899999988777766555443

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-33  Score=234.13  Aligned_cols=216  Identities=20%  Similarity=0.332  Sum_probs=169.7

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+++.+|+|.++.++.|.-. .+..++..||+|+++...........+..|++.++.++||||+++++++..........
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLS-QDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             ccccccCcCCCceEEEEEEe-cCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            46777888877777665310 01234578999999865455556678999999999999999999999987665433334


Q ss_pred             cEEEEEeccccc-HHHHHh--------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        141 DVYLVMELMDAN-LCQVIQ--------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       141 ~~~lv~e~~~~~-l~~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      ..++++||+.++ +...+.        ..+++..+..++.|++.||+|||+.+++|+||||+||++++++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence            569999999864 444432        24788999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        212 RTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       212 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      ........   ......+..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~  230 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH  230 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            76543221   112234567999999988889999999999999999998 9999988777666555543

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.3e-34  Score=242.58  Aligned_cols=219  Identities=42%  Similarity=0.759  Sum_probs=175.2

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+...+|.|.++.++.    +.+..+++.||||.++...........+..|+.+++.++|+||+++++++..... ...
T Consensus         7 y~~~~~lg~G~~~~vy~----~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~-~~~   81 (337)
T cd07858           7 YVPIKPIGRGAYGIVCS----AKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR-EAF   81 (337)
T ss_pred             eeEEEEeccCCCeEEEE----EEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc-ccc
Confidence            34455566655555544    3456789999999997643344445677889999999999999999998875432 222


Q ss_pred             ccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        140 QDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ...++|+||+++++.+.+.  ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          82 NDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             CcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            3469999999998887775  35889999999999999999999999999999999999999999999999998765433


Q ss_pred             -cccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        218 -FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       218 -~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                       .......++..|+|||.+.. ..++.++|+||||+++|+|++|+.||.+.+....+..+.+..+.++
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  229 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS  229 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence             22234467888999999875 4588999999999999999999999999887777777776665443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0671|consensus

Probab=100.00  E-value=3e-35  Score=239.54  Aligned_cols=215  Identities=26%  Similarity=0.493  Sum_probs=184.7

Q ss_pred             cccccccCCccccccccCccc------eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCC--C----Ccceee
Q psy11580         60 LPISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH--K----NIIGLL  127 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----~i~~~~  127 (288)
                      +..++.+..+|.++..+|.|.      ++|..++..||||+++.   -....+...-|+++|+++.+  |    -++.+.
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            467788888999998888883      77888899999999983   33445667789999999942  2    367788


Q ss_pred             ccccCCCcccccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc----
Q psy11580        128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS----  199 (288)
Q Consensus       128 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~----  199 (288)
                      ++|...++.      |+|+|.++.++++++..    +++...++.|+.|+++++++||+.+++|.||||+||++.+    
T Consensus       158 ~wFdyrghi------CivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  158 DWFDYRGHI------CIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             hhhhccCce------EEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence            888877766      99999999999998864    4899999999999999999999999999999999999942    


Q ss_pred             ----------------CCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy11580        200 ----------------DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF  263 (288)
Q Consensus       200 ----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~  263 (288)
                                      +..++|+|||.++......  +..+.|..|.|||++.+.+|+...||||+||||+|+++|...|
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence                            2358999999998765543  5567899999999999999999999999999999999999999


Q ss_pred             CCCCchhHHHHHHHHhCCCccC
Q psy11580        264 PGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       264 ~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      ++-++.+.++.+.+.+|++|..
T Consensus       310 qtHen~EHLaMMerIlGp~P~~  331 (415)
T KOG0671|consen  310 QTHENLEHLAMMERILGPIPSR  331 (415)
T ss_pred             ccCCcHHHHHHHHHhhCCCcHH
Confidence            9999999999999999988853

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1e-33  Score=238.72  Aligned_cols=224  Identities=29%  Similarity=0.487  Sum_probs=180.1

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...+++.+.+.++.|.++.++.|    .+..+++.||+|+++...........+..|++++++++||||+++++++....
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~----~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~   79 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKA----RDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQ   79 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEE----EECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence            34456777888888888877776    34567899999999764333334456778999999999999999999987654


Q ss_pred             c----ccccccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEee
Q psy11580        135 S----LEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD  207 (288)
Q Consensus       135 ~----~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~d  207 (288)
                      .    ......+++|+||+++++.+.+..   .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+|
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          80 DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             hhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence            1    111235699999999988776653   489999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcc--cCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        208 FGLARTAGTTFM--MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       208 fg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ||++........  .....++..|+|||.+.+ ..++.++||||||+++++|++|++||...+..+.+..+.+.++.+
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            999876543321  122345778999999875 356889999999999999999999999888888888877766544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-33  Score=235.69  Aligned_cols=215  Identities=23%  Similarity=0.333  Sum_probs=172.2

Q ss_pred             cccccccccCCccccccccCccce-eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAA-YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..+.+.+.+|+|.++.++.|.... .+..+++.||+|+++... .......+.+|+++++.++|+||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            456677888998888888764321 112456899999997532 223457888999999999999999999999877654


Q ss_pred             cccccEEEEEeccccc-HHHHHhh----------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQM----------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS  199 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~  199 (288)
                            ++||||++++ +.+.+..                .+++..+..++.|++.||++||+++++|+||+|+||+++.
T Consensus        84 ------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~  157 (280)
T cd05049          84 ------IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY  157 (280)
T ss_pred             ------EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence                  9999999864 5554431                2678889999999999999999999999999999999999


Q ss_pred             CCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHH
Q psy11580        200 DCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       200 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i  275 (288)
                      ++.++|+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI  237 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            9999999999987543221   1223345678999999999999999999999999999998 99999888877777766


Q ss_pred             HHHh
Q psy11580        276 IGKM  279 (288)
Q Consensus       276 ~~~~  279 (288)
                      .+..
T Consensus       238 ~~~~  241 (280)
T cd05049         238 TQGR  241 (280)
T ss_pred             HcCC
Confidence            6443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9e-34  Score=236.89  Aligned_cols=216  Identities=22%  Similarity=0.314  Sum_probs=171.3

Q ss_pred             hcccccccccCCccccccccCccce-eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAA-YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ..++.+.+.+|.|.++.++.|.... ....++..||+|+++... .......+..|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            3456777888888888877764211 123456789999998542 22334668899999999999999999999987765


Q ss_pred             ccccccEEEEEeccccc-HHHHHh------------------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEE
Q psy11580        136 LEEFQDVYLVMELMDAN-LCQVIQ------------------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV  196 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~-l~~~~~------------------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil  196 (288)
                      .      ++++||+.++ +.+.+.                  ..+++..+..++.|++.||+|||+++++||||||.||+
T Consensus        83 ~------~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil  156 (283)
T cd05091          83 L------SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL  156 (283)
T ss_pred             e------EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence            5      9999999864 444442                  13677889999999999999999999999999999999


Q ss_pred             EccCCcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHH
Q psy11580        197 VKSDCTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQW  272 (288)
Q Consensus       197 ~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~  272 (288)
                      +++++.+||+|||++........   .....+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+.+
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI  236 (283)
T ss_pred             ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999999999876433221   123345678999999988889999999999999999998 88999988887777


Q ss_pred             HHHHHHh
Q psy11580        273 NKIIGKM  279 (288)
Q Consensus       273 ~~i~~~~  279 (288)
                      ..+.+..
T Consensus       237 ~~i~~~~  243 (283)
T cd05091         237 EMIRNRQ  243 (283)
T ss_pred             HHHHcCC
Confidence            7766544

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.6e-33  Score=236.37  Aligned_cols=214  Identities=22%  Similarity=0.337  Sum_probs=170.7

Q ss_pred             hcccccccccCCccccccccCcccee-ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAY-DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ..++.+...+++|.++.++++..... ...++..+++|.++.  ........+.+|++++++++|+||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            34567778888887777777642111 234567799999875  233445678899999999999999999999987665


Q ss_pred             ccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEE
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV  196 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil  196 (288)
                      .      ++||||+++ ++.+++..                  .+++..++.++.||+.||+|||+++++||||||+||+
T Consensus        82 ~------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  155 (291)
T cd05094          82 L------IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL  155 (291)
T ss_pred             e------EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEE
Confidence            4      999999975 55555532                  2678899999999999999999999999999999999


Q ss_pred             EccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHH
Q psy11580        197 VKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQW  272 (288)
Q Consensus       197 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~  272 (288)
                      ++.++.++|+|||++.......   ......++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+.+
T Consensus       156 ~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  235 (291)
T cd05094         156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI  235 (291)
T ss_pred             EccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999987654322   1233455778999999999889999999999999999998 99999887777666


Q ss_pred             HHHHHH
Q psy11580        273 NKIIGK  278 (288)
Q Consensus       273 ~~i~~~  278 (288)
                      ..+...
T Consensus       236 ~~~~~~  241 (291)
T cd05094         236 ECITQG  241 (291)
T ss_pred             HHHhCC
Confidence            665543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-33  Score=232.76  Aligned_cols=209  Identities=25%  Similarity=0.355  Sum_probs=169.1

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..++.+.+.+|+|.++.++++.     ..++..+|+|++....   .....+.+|+++++.++||||+++++++...+..
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~-----~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGK-----WRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI   74 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeE-----ecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence            3456788889999888888763     2346789999987422   2345678899999999999999999998777654


Q ss_pred             cccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                            ++||||+++ ++.+.+..   .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        75 ------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~  148 (256)
T cd05059          75 ------FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR  148 (256)
T ss_pred             ------EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccce
Confidence                  999999976 46666542   47899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccc--CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        213 TAGTTFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       213 ~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ........  ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.++.+....+....
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~  218 (256)
T cd05059         149 YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY  218 (256)
T ss_pred             ecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC
Confidence            65432211  11123457999999998889999999999999999998 899998887777766665443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.2e-33  Score=236.48  Aligned_cols=212  Identities=39%  Similarity=0.632  Sum_probs=172.4

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.+|+|.++.++.+    .+..+++.||+|++............+.+|+++++.++||||+++++++...+..   
T Consensus         3 y~~~~~lg~g~~~~vy~~----~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---   75 (286)
T cd07846           3 YENLGLVGEGSYGMVMKC----KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRL---   75 (286)
T ss_pred             eeEeeeeccCCCeEEEEE----EECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeE---
Confidence            445567777777776664    3456789999999876443434456788999999999999999999999876654   


Q ss_pred             ccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        140 QDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                         ++|+||+++++++.+.   ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 ---~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          76 ---YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             ---EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence               9999999987766553   2488999999999999999999999999999999999999999999999999876533


Q ss_pred             Cc-ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCC
Q psy11580        217 TF-MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       217 ~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  281 (288)
                      .. ......++..|+|||++.+ ..++.++|+||||+++|+|++|.+||.+.+..+.+..+.+..+.
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~  219 (286)
T cd07846         153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN  219 (286)
T ss_pred             CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCC
Confidence            22 2233467888999999876 34678999999999999999999999988777777776655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1e-33  Score=241.42  Aligned_cols=202  Identities=22%  Similarity=0.288  Sum_probs=158.2

Q ss_pred             ccccCCccc--cccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         63 SHQMGKKRH--NTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        63 ~~~~~~~~~--~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.||+|..  +.+++    +.+..+|+.||+|+++...........+.+|+++++.++||||+++++++..++..    
T Consensus         3 ~~~ig~G~~~~~~v~~----~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~----   74 (327)
T cd08227           3 LTVIGRGFEDLMTVNL----ARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL----   74 (327)
T ss_pred             hhhccccccceEEEEE----EeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEE----
Confidence            455666632  33333    45678899999999986544445556788899999999999999999999877654    


Q ss_pred             cEEEEEeccccc-HHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        141 DVYLVMELMDAN-LCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       141 ~~~lv~e~~~~~-l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                        ++||||++++ +.+.+.    ..+++..++.++.|++.||+|||+++|+||||||+||+++.++.++++||+......
T Consensus        75 --~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~  152 (327)
T cd08227          75 --WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  152 (327)
T ss_pred             --EEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccc
Confidence              9999999865 445443    237899999999999999999999999999999999999999999999998654321


Q ss_pred             CC--------cccCCcccccccCchHhHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHH
Q psy11580        216 TT--------FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNK  274 (288)
Q Consensus       216 ~~--------~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~  274 (288)
                      ..        .......++..|+|||++.+  ..++.++||||||+++|+|++|..||.+.........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  221 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE  221 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH
Confidence            11        01122345677999999976  4588999999999999999999999987665444333

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0579|consensus

Probab=100.00  E-value=3.9e-35  Score=252.59  Aligned_cols=204  Identities=25%  Similarity=0.388  Sum_probs=173.2

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      |-..+|.|.||.++.+    .++.++--.|.|++..  .+......+..|+++|..++||+|+++++.|...+.+     
T Consensus        36 IiGELGDGAFGKVyKA----~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkL-----  104 (1187)
T KOG0579|consen   36 IIGELGDGAFGKVYKA----VNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKL-----  104 (1187)
T ss_pred             HHhhhcCccchhhhhh----hcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCce-----
Confidence            4445666666555543    3456667778888865  4567788899999999999999999999999988876     


Q ss_pred             EEEEEecccccHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC-
Q psy11580        142 VYLVMELMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-  216 (288)
Q Consensus       142 ~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~-  216 (288)
                       +|+.|||+|+-.+.+.    ..+++.++.-+++|++.||.|||+++|||||||+.|||++.+|.++|+|||.+..... 
T Consensus       105 -wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  105 -WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             -EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence             9999999998666543    5699999999999999999999999999999999999999999999999999876543 


Q ss_pred             CcccCCcccccccCchHhHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        217 TFMMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      .....+++|||.|||||+..+     .+|+.++||||||+.|.||..+.+|....++.-++-+|..
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK  249 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK  249 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh
Confidence            333477899999999999865     5789999999999999999999999999999888777764

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.4e-33  Score=232.64  Aligned_cols=206  Identities=21%  Similarity=0.309  Sum_probs=161.1

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      .+|+|.++.++.|.  .++......+|+|.+... ........+.+|++.++.++|+||+++++.+......      ++
T Consensus         2 ~lg~G~fg~v~~~~--~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~------~l   72 (269)
T cd05042           2 EIGNGWFGKVLLGE--AHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPY------LL   72 (269)
T ss_pred             cCCccCCceEEEEE--EecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCce------EE
Confidence            46788888888763  334445678999988643 2334456688999999999999999999999877654      99


Q ss_pred             EEecccc-cHHHHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        145 VMELMDA-NLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       145 v~e~~~~-~l~~~~~~~-------~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      ||||+++ ++.+.+...       .++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++.....
T Consensus        73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  152 (269)
T cd05042          73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP  152 (269)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEecccccccccc
Confidence            9999986 455554321       35677889999999999999999999999999999999999999999999865432


Q ss_pred             Cc---ccCCcccccccCchHhHhc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        217 TF---MMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       217 ~~---~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ..   ......++..|+|||++..       ..++.++||||||+++|+|++ |..||....+.+.+.+++...
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  226 (269)
T cd05042         153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ  226 (269)
T ss_pred             chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc
Confidence            21   1122345677999999853       346789999999999999998 889999888777766665543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.6e-34  Score=237.70  Aligned_cols=194  Identities=26%  Similarity=0.435  Sum_probs=163.7

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.+|+|.++.++.+    .+..++..||+|++.... .......+..|++++++++||||+++++.+...+..  
T Consensus         2 ~~~~~~~lg~g~~~~v~~~----~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--   74 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKA----YHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRI--   74 (279)
T ss_pred             cchheeeeccCCCeEEEEE----EEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEE--
Confidence            3455667788777777665    456788999999997532 334456788999999999999999999999877654  


Q ss_pred             cccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        139 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                          ++||||++++.++.. ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus        75 ----~lv~e~~~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~  149 (279)
T cd06619          75 ----SICTEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI  149 (279)
T ss_pred             ----EEEEecCCCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence                999999998766543 357888999999999999999999999999999999999999999999999987654332


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                       .....++..|+|||++.+..++.++|+||||+++|+|++|..||..
T Consensus       150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence             2345788899999999998899999999999999999999999965

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-34  Score=242.88  Aligned_cols=220  Identities=47%  Similarity=0.807  Sum_probs=183.9

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.++.|.++.++.+    .+..+++.||+|++..........+.+.+|+.+++.++|+||+++++++..... ...
T Consensus         2 y~i~~~ig~g~~~~v~~~----~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~   76 (330)
T cd07834           2 YELLKPIGSGAYGVVCSA----VDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP-EDF   76 (330)
T ss_pred             ceeeeeecCCCCeEEEEE----EeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc-ccc
Confidence            345667777777766665    345678999999998644334556788999999999999999999999987652 223


Q ss_pred             ccEEEEEecccccHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        140 QDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ...+++|||+++++.+.+..  .+++..++.++.||+.||++||+.|++|+||||.||+++.++.++|+|||.+......
T Consensus        77 ~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          77 NDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             cceEEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            45699999999888777753  4889999999999999999999999999999999999999999999999999876544


Q ss_pred             c----ccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        218 F----MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       218 ~----~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      .    ......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.+..+.+..+...++.++.
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  228 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE  228 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence            2    23445678889999999887 7899999999999999999999999999999999999888776553

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.2e-33  Score=234.24  Aligned_cols=213  Identities=34%  Similarity=0.572  Sum_probs=170.7

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      +.+.+|+|.++.++.+    .+..++..||+|+++....... .....+|+.+++++. |+|++++++++.+...    .
T Consensus         3 ~~~~lg~g~~~~v~~~----~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~----~   73 (282)
T cd07831           3 ILGKIGEGTFSEVLKA----QSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKT----G   73 (282)
T ss_pred             eEeeccccccceEEEE----EEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCC----C
Confidence            3455666666655554    3456789999999976432222 234457888999885 9999999999986611    2


Q ss_pred             cEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        141 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       141 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ..++|+||+++++++.+..   .+++..+..++.|++.||+|||+.+++|+||+|+||+++. +.++|+|||++......
T Consensus        74 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          74 RLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            3499999999988887753   4799999999999999999999999999999999999999 99999999999876544


Q ss_pred             cccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      .......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+..+.+..+.+.++.+++
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~  220 (282)
T cd07831         153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA  220 (282)
T ss_pred             CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCH
Confidence            43344567889999998754 45688999999999999999999999999988888888777665543

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0607|consensus

Probab=100.00  E-value=2e-34  Score=230.04  Aligned_cols=178  Identities=31%  Similarity=0.460  Sum_probs=150.4

Q ss_pred             eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccEEEEEeccccc-HHHHHh
Q psy11580         81 AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-LCQVIQ  158 (288)
Q Consensus        81 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~  158 (288)
                      +.+..++..+|||++.+.  ..-...+..+|++++.++ .|+||+.++++|.++..+      |+|||-|.|+ +++.+.
T Consensus        97 cv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F------YLVfEKm~GGplLshI~  168 (463)
T KOG0607|consen   97 CVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF------YLVFEKMRGGPLLSHIQ  168 (463)
T ss_pred             eeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE------EEEEecccCchHHHHHH
Confidence            667899999999999874  445567899999999999 599999999999988776      9999999875 777765


Q ss_pred             --hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC---cEEEeecccccccCC--------CcccCCccc
Q psy11580        159 --MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLARTAGT--------TFMMTPYVV  225 (288)
Q Consensus       159 --~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~---~~kl~dfg~~~~~~~--------~~~~~~~~~  225 (288)
                        ..+++.++.++..+|+.||.+||.+||.||||||+|||.....   -+|||||.+..-...        .....+.+|
T Consensus       169 ~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvG  248 (463)
T KOG0607|consen  169 KRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVG  248 (463)
T ss_pred             HhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCccc
Confidence              4599999999999999999999999999999999999997654   479999998753221        111234578


Q ss_pred             ccccCchHhHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        226 TRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       226 ~~~~~aPE~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      +..|||||+..-     .-|+.+.|.||||||+|-|++|.+||.|.
T Consensus       249 SAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  249 SAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             chhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence            889999999753     24788999999999999999999999763

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.4e-33  Score=238.65  Aligned_cols=222  Identities=31%  Similarity=0.518  Sum_probs=177.8

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc-
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL-  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-  136 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|++............+.+|+++++.++||||+++++++...... 
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKA----RQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEE----EECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            45667777888777777765    3566789999999875332222334567899999999999999999988654422 


Q ss_pred             -cccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 -EEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 -~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                       .....+++|+||+++++...+.   ..+++..+..++.|+++||+|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        84 ~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          84 KRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             cccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence             2334579999999998877665   358999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcc------------cCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        213 TAGTTFM------------MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       213 ~~~~~~~------------~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      .......            .....+++.|+|||.+.+. .++.++||||||+++|+|++|.+||.+.+.......+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            5433211            1223457789999998764 57899999999999999999999999999988888888877


Q ss_pred             CCCc
Q psy11580        280 REAH  283 (288)
Q Consensus       280 ~~~~  283 (288)
                      +.++
T Consensus       244 ~~~~  247 (311)
T cd07866         244 GTPT  247 (311)
T ss_pred             CCCC
Confidence            6543

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.3e-33  Score=236.06  Aligned_cols=211  Identities=23%  Similarity=0.342  Sum_probs=166.1

Q ss_pred             cccccccccCCccccccccCccceeccCCC--ceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCC
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQ--QNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQK  134 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  134 (288)
                      .++.+.+.+|+|.++.++.+    .+..++  ..+++|.++.. ........+..|+++++++ +||||+++++++...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~----~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRA----MIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEE----EecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence            35677778888877777765    233333  35788888742 2334456788999999999 7999999999998766


Q ss_pred             cccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCE
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  195 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~ni  195 (288)
                      ..      ++++||+++ ++.+.+..                  .+++..++.++.|++.||+|||+++++||||||+||
T Consensus        77 ~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Ni  150 (297)
T cd05089          77 YL------YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNV  150 (297)
T ss_pred             cc------eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceE
Confidence            54      999999985 56655532                  267889999999999999999999999999999999


Q ss_pred             EEccCCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHH
Q psy11580        196 VVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNK  274 (288)
Q Consensus       196 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~  274 (288)
                      +++.++.+||+|||++..............+..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+...+
T Consensus       151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~  230 (297)
T cd05089         151 LVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK  230 (297)
T ss_pred             EECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999999999864332222222233567999999998889999999999999999997 9999998887777666


Q ss_pred             HHHHh
Q psy11580        275 IIGKM  279 (288)
Q Consensus       275 i~~~~  279 (288)
                      +.+..
T Consensus       231 ~~~~~  235 (297)
T cd05089         231 LPQGY  235 (297)
T ss_pred             HhcCC
Confidence            65543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-33  Score=233.97  Aligned_cols=216  Identities=22%  Similarity=0.320  Sum_probs=174.1

Q ss_pred             hhhhcccccccccCCccccccccCcccee-ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAY-DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      ++..+++.+.+.+|+|.++.++.|..... ...++..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            34556778889999999888887754321 13456899999987432 33445578899999999999999999999987


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHhh------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQM------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS  199 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~  199 (288)
                      ....      ++||||+++ +|.+.+..            .+++..+..++.|++.||+|||+.+++|+||+|+||+++.
T Consensus        81 ~~~~------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~  154 (277)
T cd05032          81 GQPT------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE  154 (277)
T ss_pred             CCCc------EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC
Confidence            7655      999999975 56555532            2567789999999999999999999999999999999999


Q ss_pred             CCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHH
Q psy11580        200 DCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       200 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i  275 (288)
                      ++.++|+|||++.......   ......++..|+|||.+.+..++.++||||||+++|++++ |..||.+.+..+..+.+
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  234 (277)
T cd05032         155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV  234 (277)
T ss_pred             CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence            9999999999987543321   1123355778999999988889999999999999999998 99999988877766666


Q ss_pred             H
Q psy11580        276 I  276 (288)
Q Consensus       276 ~  276 (288)
                      .
T Consensus       235 ~  235 (277)
T cd05032         235 I  235 (277)
T ss_pred             h
Confidence            5

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0199|consensus

Probab=100.00  E-value=1.2e-34  Score=251.72  Aligned_cols=214  Identities=25%  Similarity=0.314  Sum_probs=179.8

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      |....+++.+.+|+|.|++++.|.... -..+.-.||||+++....+. ....|.+|+.+|.+|+|+|++++||++.+..
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~-psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~qp  184 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQ-PSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQP  184 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccC-CCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccch
Confidence            455678899999999999999996543 12223589999998654443 6788999999999999999999999998854


Q ss_pred             cccccccEEEEEeccccc-HHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        135 SLEEFQDVYLVMELMDAN-LCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~-l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                       .      .||+|+++.+ |++.+..    .+-...+..++.||+.||+||..++.|||||.++|+++.....+||||||
T Consensus       185 -~------mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFG  257 (1039)
T KOG0199|consen  185 -A------MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFG  257 (1039)
T ss_pred             -h------hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccc
Confidence             2      8999999964 6665543    36778899999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccc----CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        210 LARTAGTTFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       210 ~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      +++..+.....    ........|+|||.++...++.++|+|++||.+||||+ |+.||.|....++++.|-+
T Consensus       258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~  330 (1039)
T KOG0199|consen  258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA  330 (1039)
T ss_pred             ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc
Confidence            99876553322    22344667999999999999999999999999999997 9999999999998888763

>KOG0696|consensus

Probab=100.00  E-value=6e-35  Score=240.31  Aligned_cols=226  Identities=24%  Similarity=0.358  Sum_probs=187.2

Q ss_pred             HHHhhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHC-CCCCccee
Q psy11580         49 VDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLV-NHKNIIGL  126 (288)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~  126 (288)
                      ......+...++....++|.|.++.+.++.    ++.+.+.+|||+++++.. .....+--..|-++|... +-|.++.+
T Consensus       340 ~~~~d~i~~tDFnFl~VlGKGSFGKVlLae----rkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~ql  415 (683)
T KOG0696|consen  340 SSKRDRIKATDFNFLMVLGKGSFGKVLLAE----RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQL  415 (683)
T ss_pred             CCcccceeecccceEEEeccCccceeeeec----ccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHH
Confidence            333345666788889999999998888874    455678999999997632 223334445677777777 57889999


Q ss_pred             eccccCCCcccccccEEEEEecccccHHHH-Hh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcE
Q psy11580        127 LNAFTPQKSLEEFQDVYLVMELMDANLCQV-IQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL  203 (288)
Q Consensus       127 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~-~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~  203 (288)
                      +.+|...+.+      |+||||+.|+-+-+ +.  ..+.+..+..+|..|+.||-+||++||++||||.+||+++.+|.+
T Consensus       416 HScFQTmDRL------yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHi  489 (683)
T KOG0696|consen  416 HSCFQTMDRL------YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHI  489 (683)
T ss_pred             HHHhhhhhhe------eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCce
Confidence            9999988876      99999999864433 32  458888999999999999999999999999999999999999999


Q ss_pred             EEeecccccccC-CCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        204 KILDFGLARTAG-TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       204 kl~dfg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ||+|||+++..- ......+.+|||.|+|||++...+|+.++|.||+||+||||+.|++||.|.+..++.+.|.+.--.-
T Consensus       490 Ki~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsy  569 (683)
T KOG0696|consen  490 KIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSY  569 (683)
T ss_pred             EeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcC
Confidence            999999998543 3444577899999999999999999999999999999999999999999999999999998876544


Q ss_pred             cc
Q psy11580        283 HD  284 (288)
Q Consensus       283 ~~  284 (288)
                      |.
T Consensus       570 PK  571 (683)
T KOG0696|consen  570 PK  571 (683)
T ss_pred             cc
Confidence            43

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.6e-33  Score=235.44  Aligned_cols=218  Identities=33%  Similarity=0.548  Sum_probs=173.6

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+++|.++.++.+    .+..+++.||+|.++...........+.+|+.+++.++ ||||+++++++...+. .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~----~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~-~   76 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKA----RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK-N   76 (295)
T ss_pred             CceEeeEecccCCeEEEEE----EECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC-C
Confidence            3456677788777777665    45678899999998764333334467888999999995 6999999999876553 1


Q ss_pred             ccccEEEEEecccccHHHHHhh-------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc-CCcEEEeecc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFG  209 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~-------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~-~~~~kl~dfg  209 (288)
                      .....++||||+++++.+.+..       .+++..++.++.||+.||+|||+++++||||+|+||+++. ++.++|+|||
T Consensus        77 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          77 GKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             CCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            1123599999999988777642       3688999999999999999999999999999999999998 8899999999


Q ss_pred             cccccCCCc-ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCC
Q psy11580        210 LARTAGTTF-MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       210 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  281 (288)
                      .+....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+....+.++.+.++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~  230 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT  230 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence            987553321 1223356788999999876 45789999999999999999999999998888877777766543

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.8e-33  Score=229.71  Aligned_cols=207  Identities=28%  Similarity=0.472  Sum_probs=170.9

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      ...+.+|.|.++.++..    .+..+++.+++|.+.....+......+.+|++++++++|+||+++++++...+..    
T Consensus         3 ~~~~~ig~g~~g~v~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~----   74 (256)
T cd08221           3 IPIRVLGKGAFGEATLY----RRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL----   74 (256)
T ss_pred             eEeeEecccCCceEEEE----EEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE----
Confidence            34455666665554443    3567889999999876544556677888999999999999999999999877654    


Q ss_pred             cEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        141 DVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                        +++|||+++ ++.+.+..    .+++..+..++.|++.+|+|||+.+++|+||+|+||+++.++.+||+|||++....
T Consensus        75 --~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          75 --LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             --EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence              999999986 56666643    37889999999999999999999999999999999999999999999999987654


Q ss_pred             CCc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        216 TTF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       216 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      ... ......+++.|.|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+..
T Consensus       153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~  215 (256)
T cd08221         153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ  215 (256)
T ss_pred             cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence            433 22345678999999999988889999999999999999999999998777776666653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-33  Score=241.95  Aligned_cols=219  Identities=54%  Similarity=0.936  Sum_probs=178.9

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+...+|+|.++.++.+    .+..+++.||+|++............+.+|+.+++.++|+|++++++++...+....
T Consensus        16 ~y~~~~~ig~g~~g~vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSA----FDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ceEEEEEeccCCceEEEEE----EECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            3455566666655555544    455678999999997644444555678889999999999999999998876654334


Q ss_pred             cccEEEEEecccccHHHHHhh-hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        139 FQDVYLVMELMDANLCQVIQM-DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ....++|+|++++++.+.+.. .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        92 ~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (343)
T cd07851          92 FQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE  171 (343)
T ss_pred             cccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence            445799999998888777653 5899999999999999999999999999999999999999999999999999866443


Q ss_pred             cccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                        .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..+.+.++.++
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~  236 (343)
T cd07851         172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD  236 (343)
T ss_pred             --ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Confidence              233467888999999876 3678899999999999999999999999888888888888776554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.8e-33  Score=229.35  Aligned_cols=202  Identities=23%  Similarity=0.311  Sum_probs=157.7

Q ss_pred             cCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEE
Q psy11580         66 MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV  145 (288)
Q Consensus        66 ~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv  145 (288)
                      +|+|.++.++.|.-  ....++..||+|++.... .......+.+|+.++++++||||+++++++... .      .++|
T Consensus         3 ig~G~~g~v~~~~~--~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-~------~~lv   72 (257)
T cd05115           3 LGSGNFGCVKKGVY--KMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-A------LMLV   72 (257)
T ss_pred             cCCCCcccEEEEEE--ecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-C------eEEE
Confidence            56666666665421  112345679999997542 334456788999999999999999999988543 2      4999


Q ss_pred             Eeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcc--
Q psy11580        146 MELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM--  219 (288)
Q Consensus       146 ~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~--  219 (288)
                      |||++++ +.+.+.   ..+++..++.++.|++.||+|||+++++|+||||+||+++.++.++|+|||++........  
T Consensus        73 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          73 MEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             EEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            9999864 555543   3478999999999999999999999999999999999999999999999999875433211  


Q ss_pred             --cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        220 --MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       220 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                        .....++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.+..+....+.+
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  213 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ  213 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence              111223568999999988888999999999999999996 9999998877666554443

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.9e-33  Score=235.87  Aligned_cols=212  Identities=33%  Similarity=0.516  Sum_probs=167.3

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.+|+|.++.++.|    .+..+++.||+|++..... ......+.+|+++++.++|+||+++++++...+..  
T Consensus         6 ~y~~~~~ig~g~~~~v~~~----~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~--   78 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKG----ISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETL--   78 (291)
T ss_pred             eeEEEEEEEecCCEEEEEE----EEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeE--
Confidence            4455667777766666654    4566789999999975321 22234567899999999999999999999876544  


Q ss_pred             cccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++|+||+.+++++.+..   .+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++....
T Consensus        79 ----~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          79 ----TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             ----EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence                99999999888876643   36788899999999999999999999999999999999999999999999987543


Q ss_pred             CCc-ccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hhHHHHHHHHhCC
Q psy11580        216 TTF-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDH-IDQWNKIIGKMRE  281 (288)
Q Consensus       216 ~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~-~~~~~~i~~~~~~  281 (288)
                      ... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+. .+.+.+++...+.
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~  223 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGV  223 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCC
Confidence            321 22334568899999998763 478899999999999999999999987543 3455566555443

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=233.40  Aligned_cols=209  Identities=44%  Similarity=0.730  Sum_probs=174.5

Q ss_pred             cccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEE
Q psy11580         64 HQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY  143 (288)
Q Consensus        64 ~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~  143 (288)
                      +.+++|.++.++.+    .+..+++.+++|.++...........+..|++++++++|+||+++++++...+..      +
T Consensus         5 ~~i~~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~------~   74 (283)
T cd05118           5 GKIGEGTYGVVYKA----RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDL------Y   74 (283)
T ss_pred             eeeecCCCceEEEE----EcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCE------E
Confidence            44556555555543    4556789999999986544444567788999999999999999999999877654      9


Q ss_pred             EEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc-c
Q psy11580        144 LVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-M  219 (288)
Q Consensus       144 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-~  219 (288)
                      +|+||+++++.+.+..   .+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        75 ~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          75 LVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             EEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence            9999999988877754   58899999999999999999999999999999999999999999999999987665443 2


Q ss_pred             cCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        220 MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       220 ~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+.+..+.+.++.+
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~  218 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP  218 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            2334577889999999876 78899999999999999999999999999888888887766543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0670|consensus

Probab=100.00  E-value=3.1e-35  Score=247.84  Aligned_cols=227  Identities=33%  Similarity=0.573  Sum_probs=197.2

Q ss_pred             HHhhhh-hhcccccccccCCccccccccCccc------eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC---
Q psy11580         50 DQWKEL-IYQELPISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN---  119 (288)
Q Consensus        50 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~g~g~------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---  119 (288)
                      ..|+.. .|+.+.+++.+..+|.+.++.|.|.      +.|...|..||||++.+   +....+.=+.|+++|++|+   
T Consensus       413 DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---NE~M~KtGl~EleiLkKL~~AD  489 (752)
T KOG0670|consen  413 DNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---NEVMHKTGLKELEILKKLNDAD  489 (752)
T ss_pred             cCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---chHHhhhhhHHHHHHHHhhccC
Confidence            345444 6788999999999999999999983      45667778999999985   4455566778999999995   


Q ss_pred             ---CCCcceeeccccCCCcccccccEEEEEecccccHHHHHh-----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCC
Q psy11580        120 ---HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  191 (288)
Q Consensus       120 ---h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~  191 (288)
                         --|+++++..|....++      |||+|.+.-+|.+++.     -.+....++.++.|++.||..|-.+||+|.|||
T Consensus       490 ~Edk~Hclrl~r~F~hknHL------ClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIK  563 (752)
T KOG0670|consen  490 PEDKFHCLRLFRHFKHKNHL------CLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIK  563 (752)
T ss_pred             chhhhHHHHHHHHhhhccee------EEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccC
Confidence               23889999999877665      9999999999888775     247788999999999999999999999999999


Q ss_pred             CCCEEEccCC-cEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        192 PSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       192 ~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      |+|||++... .+||||||.|...+.... +++..+..|.|||++.|.+|+...|+||.||+||||++|+..|+|.+..+
T Consensus       564 PDNiLVNE~k~iLKLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~  642 (752)
T KOG0670|consen  564 PDNILVNESKNILKLCDFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ  642 (752)
T ss_pred             ccceEeccCcceeeeccCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence            9999999754 579999999988776544 56788889999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCccCC
Q psy11580        271 QWNKIIGKMREAHDKL  286 (288)
Q Consensus       271 ~~~~i~~~~~~~~~~~  286 (288)
                      +++-.+++.|+.|.++
T Consensus       643 MLrl~me~KGk~p~Km  658 (752)
T KOG0670|consen  643 MLRLFMELKGKFPNKM  658 (752)
T ss_pred             HHHHHHHhcCCCcHHH
Confidence            9999999999998764

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.9e-33  Score=237.21  Aligned_cols=210  Identities=24%  Similarity=0.355  Sum_probs=165.8

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCc--eEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQ--NVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTP  132 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  132 (288)
                      ...++.+.+.+|+|.++.++.+.    +..++.  .+|+|.++.. ........+.+|++++.++ +|+||+++++++..
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~----~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~   79 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKAR----IKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   79 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEE----EccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence            34567788888998888777753    334554  4577777532 2334456788999999999 89999999999987


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCC
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS  193 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~  193 (288)
                      .+..      ++||||+++ ++.+.+..                  .+++.+++.++.|++.||+|||++|++||||||+
T Consensus        80 ~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~  153 (303)
T cd05088          80 RGYL------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR  153 (303)
T ss_pred             CCCc------eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchh
Confidence            7655      999999985 56665532                  3678899999999999999999999999999999


Q ss_pred             CEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHH
Q psy11580        194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQW  272 (288)
Q Consensus       194 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~  272 (288)
                      ||+++.++.++|+|||++..............+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+..
T Consensus       154 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  233 (303)
T cd05088         154 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY  233 (303)
T ss_pred             eEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence            99999999999999999864322211122234567999999988888999999999999999998 99999887766655


Q ss_pred             HHHH
Q psy11580        273 NKII  276 (288)
Q Consensus       273 ~~i~  276 (288)
                      ..+.
T Consensus       234 ~~~~  237 (303)
T cd05088         234 EKLP  237 (303)
T ss_pred             HHHh
Confidence            5543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.3e-33  Score=233.54  Aligned_cols=209  Identities=39%  Similarity=0.628  Sum_probs=171.2

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.++.|.++.++.|    .+..++..||+|+++.... ......+..|++++++++|+||+++++++...+..    
T Consensus         3 ~~~~~l~~g~~~~v~~~----~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~----   73 (284)
T cd07836           3 KQLEKLGEGTYATVYKG----RNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKL----   73 (284)
T ss_pred             eEeeeeccCCceEEEEE----EECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE----
Confidence            45566677666666554    4566789999999975422 22345677899999999999999999999877654    


Q ss_pred             cEEEEEecccccHHHHHhh-----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        141 DVYLVMELMDANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       141 ~~~lv~e~~~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                        ++||||+++++.+.+..     .+++..+..++.|+++||+|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus        74 --~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          74 --MLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             --EEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence              99999999988877652     37899999999999999999999999999999999999999999999999987554


Q ss_pred             CCcc-cCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        216 TTFM-MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       216 ~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      .... .....++..|++||++.+. .++.++|+||||+++|+|++|..||.+.+..+...++.+...
T Consensus       152 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~  218 (284)
T cd07836         152 IPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG  218 (284)
T ss_pred             CCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            3221 2334567889999998764 468899999999999999999999999988888887776554

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4e-33  Score=232.57  Aligned_cols=204  Identities=25%  Similarity=0.305  Sum_probs=162.4

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCc----eEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecccc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQ----NVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  131 (288)
                      ...++.+.+.+|.|.++.++.|..    ..++.    .|++|.+... ........+..|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~----~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~   79 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIW----IPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP   79 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEE----cCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence            345677888899988888877632    22333    5888888532 22334567788888999999999999999875


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEee
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD  207 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~d  207 (288)
                      ...       .++++|++.+ ++.+.+.   ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.+||+|
T Consensus        80 ~~~-------~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~D  152 (279)
T cd05111          80 GAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIAD  152 (279)
T ss_pred             CCc-------cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcC
Confidence            432       3789999885 5666664   3478999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhH
Q psy11580        208 FGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQ  271 (288)
Q Consensus       208 fg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~  271 (288)
                      ||++.......   ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+......
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~  220 (279)
T cd05111         153 FGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV  220 (279)
T ss_pred             CccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99997643221   1223345678999999998889999999999999999998 9999988766554

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.4e-33  Score=231.73  Aligned_cols=213  Identities=25%  Similarity=0.276  Sum_probs=166.6

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +...++.+.+.+|+|.++.++.|............||+|+++... .......+..|+.+++.++||||+++++++....
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTST   82 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC
Confidence            344667788889998888887764221111112358999997532 3344567889999999999999999999987543


Q ss_pred             cccccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                             .++++|++++ ++.+.+..   .+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+
T Consensus        83 -------~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~  155 (279)
T cd05109          83 -------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGL  155 (279)
T ss_pred             -------cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCc
Confidence                   2799999985 56666542   478999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHH
Q psy11580        211 ARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       211 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i  275 (288)
                      +........   .....++..|+|||...+..++.++||||||+++|||++ |..||...........+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~  224 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL  224 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            986543222   112234677999999998889999999999999999998 99999877665554433

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=234.05  Aligned_cols=210  Identities=39%  Similarity=0.632  Sum_probs=169.7

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      +.+.++.|.++.++.|    .+..+|..||+|++............+..|+++++.++|||++++++++...+..     
T Consensus         3 ~~~~l~~g~~~~vy~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~-----   73 (283)
T cd07835           3 KVEKIGEGTYGVVYKA----RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKL-----   73 (283)
T ss_pred             hheEecCCCCeEEEEE----EEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeE-----
Confidence            3445566655555553    4566899999999976433334446678899999999999999999999876654     


Q ss_pred             EEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        142 VYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       142 ~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                       ++++||+++++.+.+..    .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        74 -~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~  152 (283)
T cd07835          74 -YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP  152 (283)
T ss_pred             -EEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence             99999998888777653    4789999999999999999999999999999999999999999999999998755332


Q ss_pred             c-ccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCC
Q psy11580        218 F-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       218 ~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  281 (288)
                      . ......++..|+|||++.+. .++.++|+||||+++|+|++|.+||.+.++...+.++.+..+.
T Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (283)
T cd07835         153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGT  218 (283)
T ss_pred             ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            1 11233567889999988764 4688999999999999999999999998887777777665443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.6e-33  Score=234.04  Aligned_cols=207  Identities=22%  Similarity=0.399  Sum_probs=163.0

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHH-HHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKL-MKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+|+|.++.++.+    .+..+|+.||+|+++...... ...++..|+.. ++.++||||+++++++...+.. 
T Consensus         2 ~~~~~~~ig~g~~g~v~~~----~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~-   75 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKM----RHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDV-   75 (283)
T ss_pred             CceEEEEecccCCeEEEEE----EEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcE-
Confidence            4556677888877777664    456789999999997643332 23445556654 6667999999999999876654 


Q ss_pred             ccccEEEEEecccccHHHHHhh------hCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~-~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                           +++|||+++++.+.+..      .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+
T Consensus        76 -----~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~  150 (283)
T cd06617          76 -----WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI  150 (283)
T ss_pred             -----EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence                 99999999887666542      478999999999999999999997 999999999999999999999999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhc----CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchhHHHHHH
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEMIRGGVLFPGT-DHIDQWNKII  276 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slg~il~~l~~g~~p~~~~-~~~~~~~~i~  276 (288)
                      +.............++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||... +..+.+.++.
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  221 (283)
T cd06617         151 SGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV  221 (283)
T ss_pred             ccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH
Confidence            876654333334567888999999865    34678999999999999999999999753 3334444443

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.9e-33  Score=231.00  Aligned_cols=210  Identities=25%  Similarity=0.415  Sum_probs=172.6

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..++.+.+.+|.|.++.++.+.    + ..+..+|+|++...  .......+..|+++++.++|+||+++++++......
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~----~-~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGL----W-KNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPV   77 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeE----e-cCCCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence            3456777888888888777763    2 23789999999753  333456788999999999999999999999877654


Q ss_pred             cccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                            ++||||+++ ++.+.+..    .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+
T Consensus        78 ------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~  151 (261)
T cd05148          78 ------YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLA  151 (261)
T ss_pred             ------EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccch
Confidence                  999999986 56666642    4789999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        212 RTAGTTFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       212 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ........ .....++..|+|||.+.+..++.++|+||||+++++|++ |+.||.+.+..+.+..+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~  221 (261)
T cd05148         152 RLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY  221 (261)
T ss_pred             hhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC
Confidence            76543322 122345667999999988889999999999999999998 899999888777777776543

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0577|consensus

Probab=100.00  E-value=1e-34  Score=248.13  Aligned_cols=202  Identities=27%  Similarity=0.388  Sum_probs=169.3

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .-..||.|.|+-+|.    +++..+.+.||||.++.++. +...-..+.+|+..|++++|||++.+-|+|..+.+.    
T Consensus        30 dLrEIGHGSFGAVYf----Ard~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta----  101 (948)
T KOG0577|consen   30 DLREIGHGSFGAVYF----ARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA----  101 (948)
T ss_pred             HHHHhcCCccceeEE----eeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH----
Confidence            334567766666665    46888999999999986432 223335678999999999999999999999888776    


Q ss_pred             cEEEEEeccccc---HHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        141 DVYLVMELMDAN---LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       141 ~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                        ++|||||-|+   ++++..+++.+..+..|+.+.+.||+|||+.+.||||||+.|||+++.|.|||+|||.+......
T Consensus       102 --WLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  102 --WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             --HHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence              9999999885   56666688999999999999999999999999999999999999999999999999998776554


Q ss_pred             cccCCcccccccCchHhHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        218 FMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                         .+++|||.|||||++..   ..|+-++||||||++..||...++|+-..|-...+--|.
T Consensus       180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA  238 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA  238 (948)
T ss_pred             ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH
Confidence               56799999999999975   468999999999999999999999987766555444443

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.3e-33  Score=228.31  Aligned_cols=201  Identities=24%  Similarity=0.383  Sum_probs=159.0

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      .+|+|.++.++.+    .+..+++.||+|.+... ........+.+|++++++++||||+++++++......      ++
T Consensus         2 ~lg~g~~g~vy~~----~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~l   70 (252)
T cd05084           2 RIGRGNFGEVFSG----RLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI------YI   70 (252)
T ss_pred             ccCcccCccEEEE----EEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCe------EE
Confidence            3555555555543    34567899999998643 2334456788999999999999999999999877655      99


Q ss_pred             EEeccccc-HHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCccc
Q psy11580        145 VMELMDAN-LCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMM  220 (288)
Q Consensus       145 v~e~~~~~-l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~  220 (288)
                      ||||++++ +.+.+..   .+++..++.++.|+++||+|||+++++|+||+|+||+++.++.++|+|||++.........
T Consensus        71 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          71 VMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             EEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccc
Confidence            99999864 5555532   3789999999999999999999999999999999999999999999999998754432111


Q ss_pred             ---CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHH
Q psy11580        221 ---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       221 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~  276 (288)
                         .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+.
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~  210 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE  210 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH
Confidence               11122456999999988889999999999999999997 999998776655544443

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.1e-33  Score=230.71  Aligned_cols=210  Identities=27%  Similarity=0.390  Sum_probs=167.0

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCc---chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ---NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ++.+++.+++|.++.++.|    ++..+++.||+|.+.....   .......+..|+.++++++||||+++++++.....
T Consensus         3 ~~~~~~~l~~g~~g~v~~~----~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   78 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLC----YDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME   78 (265)
T ss_pred             cceEeeEEecCCceEEEEE----EEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence            5567788888877776665    4567899999999864321   22345678889999999999999999998865421


Q ss_pred             ccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                          ..++++|||++++ +.+.+.  ..+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||.+.
T Consensus        79 ----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          79 ----RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             ----ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence                2358999999864 555553  347888899999999999999999999999999999999999999999999987


Q ss_pred             ccCCC----cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        213 TAGTT----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       213 ~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                      .....    .......++..|+|||++.+..++.++|+||||+++|+|++|+.||.+.+....+.++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~  222 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA  222 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh
Confidence            54321    11223457888999999998888999999999999999999999998776555544433

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.9e-33  Score=228.21  Aligned_cols=209  Identities=24%  Similarity=0.376  Sum_probs=166.7

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.++.|.++.++.+    .+..+++.||+|.+............+..|++++++++|+|++++++.+...+.     
T Consensus         3 ~~~~~lg~g~~~~v~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----   73 (257)
T cd08223           3 CFVRVVGKGSYGEVSLV----RHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG-----   73 (257)
T ss_pred             eEEEEecCCCCeEEEEE----EEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCC-----
Confidence            44555666655555543    456678899999997644444556678899999999999999999988754332     


Q ss_pred             cEEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        141 DVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      .+++++|++++ ++.+.+.    ..+++.++..++.|++.|+++||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEec
Confidence            24899999986 4555553    237899999999999999999999999999999999999999999999999987654


Q ss_pred             CCc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        216 TTF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       216 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ... ......+++.|+|||++.+..++.++|+||||+++++|++|+.||.+.+.......+.+.
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~  217 (257)
T cd08223         154 NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG  217 (257)
T ss_pred             ccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence            322 223446788999999999988999999999999999999999999887766655555443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0574|consensus

Probab=100.00  E-value=4e-35  Score=232.50  Aligned_cols=195  Identities=28%  Similarity=0.452  Sum_probs=164.7

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+...+|.|..+.++    ++.++.+|+.+|||.+.-    ....+++.+|+.++++++.|++|++||.|.....+    
T Consensus        36 Di~~KLGEGSYGSV~----KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL----  103 (502)
T KOG0574|consen   36 DIVGKLGEGSYGSVH----KAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL----  103 (502)
T ss_pred             HHHHHhcCCcchHHH----HHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCce----
Confidence            344555555544433    356789999999999963    36678999999999999999999999999877655    


Q ss_pred             cEEEEEecccccHH-HHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        141 DVYLVMELMDANLC-QVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       141 ~~~lv~e~~~~~l~-~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                        ++|||||+.+.. +.+.   +.+++.++..+.++-+.||+|||...-+|||||+.|||++-+|..||+|||.+-....
T Consensus       104 --WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  104 --WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             --EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence              999999996544 3333   5699999999999999999999999999999999999999999999999999976544


Q ss_pred             C-cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy11580        217 T-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI  269 (288)
Q Consensus       217 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~  269 (288)
                      . ....+.+||+.|||||++..-.|+.++||||||+...||..|++||.+-.+.
T Consensus       182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM  235 (502)
T KOG0574|consen  182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM  235 (502)
T ss_pred             hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc
Confidence            2 2345678999999999999999999999999999999999999999876553

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-33  Score=232.09  Aligned_cols=208  Identities=25%  Similarity=0.410  Sum_probs=169.4

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.+|.|.++.++.|    .+..+++.||+|++.... .......+.+|+++++.++|+||+++++++......   
T Consensus         3 y~~~~~lg~g~~~~v~~~----~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---   74 (274)
T cd06609           3 FTLLECIGKGSFGEVYKA----IDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL---   74 (274)
T ss_pred             hhhhhhhcCCCCeEEEEE----EECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeE---
Confidence            344556666666666554    345688999999997542 234456788999999999999999999998766544   


Q ss_pred             ccEEEEEecccc-cHHHHHhh-hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        140 QDVYLVMELMDA-NLCQVIQM-DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       140 ~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                         ++|+|++++ ++.+.+.. .+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        75 ---~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          75 ---WIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             ---EEEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence               999999987 46655554 5899999999999999999999999999999999999999999999999999776543


Q ss_pred             -cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        218 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       218 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                       .......++..|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+...
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~  213 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN  213 (274)
T ss_pred             ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc
Confidence             2223456788899999999988999999999999999999999999877665555544443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.1e-33  Score=238.33  Aligned_cols=214  Identities=46%  Similarity=0.786  Sum_probs=172.3

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.++.+.++.++.    +++..+++.||+|++............+..|+++++.++||||+++++++...+.   
T Consensus        11 ~y~~~~~ig~g~~g~v~~----~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---   83 (328)
T cd07856          11 RYVDLQPVGMGAFGLVCS----ARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE---   83 (328)
T ss_pred             ceEEEEeecccCCeEEEE----EEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC---
Confidence            344556666665555554    3567789999999987544444456778899999999999999999999865332   


Q ss_pred             cccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                        ..++++|++++++.+.+. ..++...+..++.|+++||+|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        84 --~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          84 --DIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             --cEEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence              248999999888877665 45788888999999999999999999999999999999999999999999998754332


Q ss_pred             cccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                        .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+.+.++.+|
T Consensus       162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  226 (328)
T cd07856         162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP  226 (328)
T ss_pred             --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence              233466788999999866 5688999999999999999999999998887776666666655544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=236.82  Aligned_cols=214  Identities=32%  Similarity=0.579  Sum_probs=167.5

Q ss_pred             ccccccCCccccccccCccceeccC--CCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTA--TQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .+.+.+|+|.++.++.|.    +..  +++.||+|.+.... ........+.+|+.+++.++||||+++++++.....  
T Consensus         3 ~~~~~ig~g~~g~v~~~~----~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   76 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAK----RKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD--   76 (316)
T ss_pred             eEEEEeccCCcEEEEEEE----ecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC--
Confidence            445667777777666653    344  78999999998632 122334567889999999999999999999987621  


Q ss_pred             ccccEEEEEecccccHHHHHh-------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc----CCcEEEe
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ-------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS----DCTLKIL  206 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~----~~~~kl~  206 (288)
                        ...++|||++++++.+.+.       ..+++..++.++.|++.||+|||+.+++||||+|+||+++.    ++.+||+
T Consensus        77 --~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          77 --KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             --ceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence              2359999999988877653       14788899999999999999999999999999999999999    8999999


Q ss_pred             ecccccccCCCcc----cCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch---------hHH
Q psy11580        207 DFGLARTAGTTFM----MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHI---------DQW  272 (288)
Q Consensus       207 dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~---------~~~  272 (288)
                      |||++........    .....++..|+|||++.+. .++.++||||||+++++|++|.+||.+.+..         ..+
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            9999886543222    2334668889999998774 5789999999999999999999999875543         245


Q ss_pred             HHHHHHhCCC
Q psy11580        273 NKIIGKMREA  282 (288)
Q Consensus       273 ~~i~~~~~~~  282 (288)
                      .++++.++.+
T Consensus       235 ~~~~~~l~~~  244 (316)
T cd07842         235 ERIFEVLGTP  244 (316)
T ss_pred             HHHHHHhCCC
Confidence            5555555433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.4e-33  Score=237.93  Aligned_cols=218  Identities=40%  Similarity=0.718  Sum_probs=174.9

Q ss_pred             cccccccCCccccccccCccceeccCC--CceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTAT--QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  136 (288)
                      +.+.+.+|+|.++.++.+.    +..+  +..||+|++..........+.+.+|+.+++++ +||||+++++.+....  
T Consensus         2 y~~~~~lg~G~~g~vy~~~----~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--   75 (332)
T cd07857           2 YELIKELGQGAYGIVCSAR----NAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP--   75 (332)
T ss_pred             ceEEEEccccCCeEEEEEE----eCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc--
Confidence            3456677887777776653    3444  78899999875433434456788899999999 5999999998764321  


Q ss_pred             cccccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      ......++++++++++|.+.+.  ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++...
T Consensus        76 ~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          76 GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             ccCCcEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            1123468999999998888775  45889999999999999999999999999999999999999999999999999754


Q ss_pred             CCCc-----ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        215 GTTF-----MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       215 ~~~~-----~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ....     ......++..|+|||++.+ ..++.++|+||+|+++|+|++|.+||.+.+....+.+++..++.++
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD  230 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCC
Confidence            3221     1223467889999999876 4678999999999999999999999999888888888888777554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.2e-33  Score=231.36  Aligned_cols=199  Identities=26%  Similarity=0.452  Sum_probs=166.8

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      +.+.+.+|.|.++.++.+    .+..++..||+|++..... .......+.+|++++++++||||+++++.+......  
T Consensus         2 y~~~~~i~~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--   75 (258)
T cd05578           2 FELLRVIGKGAFGKVCIV----QKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENM--   75 (258)
T ss_pred             ceEEEEeccCCCceEEEE----EEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeE--
Confidence            345677777777766654    4567899999999975322 224567889999999999999999999999776654  


Q ss_pred             cccEEEEEeccccc-HHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++|+||+.++ +...+..  .+++..+..++.|+++||.|||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        76 ----~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~  151 (258)
T cd05578          76 ----YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT  151 (258)
T ss_pred             ----EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence                9999999875 5555542  58899999999999999999999999999999999999999999999999988765


Q ss_pred             CCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       216 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      .........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus       152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  204 (258)
T cd05578         152 PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR  204 (258)
T ss_pred             CCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence            54333445678889999999988889999999999999999999999988764

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.9e-33  Score=232.36  Aligned_cols=206  Identities=24%  Similarity=0.367  Sum_probs=166.6

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.+|+|.++.++.|    .+..++..+++|.+...  .......+..|+++++.++||||+++++++...+..    
T Consensus         8 ~i~~~lg~g~~g~v~~~----~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~----   77 (282)
T cd06643           8 EIIGELGDGAFGKVYKA----QNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL----   77 (282)
T ss_pred             HHHhhcccCCCeEEEEE----EECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE----
Confidence            44566777777766665    35567889999999652  334566788999999999999999999999876654    


Q ss_pred             cEEEEEecccccHHHHH-h---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        141 DVYLVMELMDANLCQVI-Q---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       141 ~~~lv~e~~~~~l~~~~-~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                        ++|+||++++.+... .   ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        78 --~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  155 (282)
T cd06643          78 --WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  155 (282)
T ss_pred             --EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc
Confidence              999999997655433 2   3488999999999999999999999999999999999999999999999999875433


Q ss_pred             Cc-ccCCcccccccCchHhHh-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        217 TF-MMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       217 ~~-~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      .. ......++..|+|||++.     +..++.++|+||||+++|+|++|..||.+.+..+...++...
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~  223 (282)
T cd06643         156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS  223 (282)
T ss_pred             cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc
Confidence            21 223446788999999984     345778999999999999999999999988777666666544

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.8e-33  Score=234.97  Aligned_cols=204  Identities=25%  Similarity=0.491  Sum_probs=165.5

Q ss_pred             cccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEE
Q psy11580         64 HQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY  143 (288)
Q Consensus        64 ~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~  143 (288)
                      ..+++|.++.++.+    .+..++..||||.+..  ........+.+|+.+++.++|+||+++++.+...+..      +
T Consensus        28 ~~lg~g~~g~v~~~----~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~------~   95 (292)
T cd06658          28 IKIGEGSTGIVCIA----TEKHTGKQVAVKKMDL--RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL------W   95 (292)
T ss_pred             hcccCCCCeEEEEE----EECCCCCEEEEEEEec--chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE------E
Confidence            44666666665553    4456789999999864  2334456788999999999999999999998876654      9


Q ss_pred             EEEecccccHHH-HHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc-cc
Q psy11580        144 LVMELMDANLCQ-VIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-MM  220 (288)
Q Consensus       144 lv~e~~~~~l~~-~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~  220 (288)
                      +||||++++.+. .+. ..+++..+..++.||+.||+|||+++++||||+|+||+++.++.++|+|||++....... ..
T Consensus        96 lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658          96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             EEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence            999999876444 332 457899999999999999999999999999999999999999999999999987543322 12


Q ss_pred             CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       221 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+....
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~  234 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL  234 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence            33467889999999988889999999999999999999999999887766655554433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-33  Score=235.77  Aligned_cols=209  Identities=27%  Similarity=0.406  Sum_probs=169.4

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcc-hhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN-VTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+|+|.++.++++    .+..+++.||+|.+...... ......+..|+++++.++|+||+++++.+...... 
T Consensus         2 ~y~~~~~ig~g~~g~vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLV----RLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYL-   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEE----EEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEE-
Confidence            3455667777777766664    44567899999999864322 23556788999999999999999999999776654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                           ++||||+.+ ++.+.+.    ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.
T Consensus        77 -----~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~  151 (316)
T cd05574          77 -----CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSK  151 (316)
T ss_pred             -----EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhh
Confidence                 999999986 5655554    247889999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCc------------------------------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCC
Q psy11580        213 TAGTTF------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL  262 (288)
Q Consensus       213 ~~~~~~------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p  262 (288)
                      ......                              ......++..|+|||++.+..++.++||||||+++|+|++|..|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence            432211                              01123578889999999998899999999999999999999999


Q ss_pred             CCCCCchhHHHHHHH
Q psy11580        263 FPGTDHIDQWNKIIG  277 (288)
Q Consensus       263 ~~~~~~~~~~~~i~~  277 (288)
                      |.+.+....+.++..
T Consensus       232 f~~~~~~~~~~~~~~  246 (316)
T cd05574         232 FKGSNRDETFSNILK  246 (316)
T ss_pred             CCCCchHHHHHHHhc
Confidence            998887776666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.3e-33  Score=233.10  Aligned_cols=207  Identities=24%  Similarity=0.422  Sum_probs=165.7

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.+|+|.++.++.+    .+..++..||+|.++... .......+.+|++++++++|+||+++++.+...+..  
T Consensus         2 ~~~~~~~ig~g~~g~v~~~----~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~--   74 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKV----LHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAV--   74 (286)
T ss_pred             hhhhhhhhcccCCeEEEEE----EEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeE--
Confidence            3456677788777766654    445678999999987532 334456788999999999999999999999876654  


Q ss_pred             cccEEEEEeccccc-HHHHHhh-----hCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                          ++||||++++ +.+.+..     .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+
T Consensus        75 ----~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  150 (286)
T cd06622          75 ----YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS  150 (286)
T ss_pred             ----EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence                9999999975 4444443     58899999999999999999997 59999999999999999999999999998


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMG------YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      ........ ....+++.|+|||.+.+..      ++.++|+||||+++|+|++|..||...+.......+..
T Consensus       151 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  221 (286)
T cd06622         151 GNLVASLA-KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA  221 (286)
T ss_pred             ccccCCcc-ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH
Confidence            76543322 3346788899999986543      47899999999999999999999987665554444443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.6e-33  Score=231.36  Aligned_cols=214  Identities=22%  Similarity=0.335  Sum_probs=169.6

Q ss_pred             hcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ..++...+.+|+|.++.++.+.-. ..+..++..+|+|.+..  ........+..|+++++.++|+||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc--CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            345677788888877777765311 11234567899999875  334456678999999999999999999999987665


Q ss_pred             ccccccEEEEEecccc-cHHHHHhh-----------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQM-----------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV  197 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~  197 (288)
                      .      +++|||+++ ++.+++..                 .+++..++.++.|++.||+|||+.+++|+||||+||++
T Consensus        82 ~------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~  155 (280)
T cd05092          82 L------LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV  155 (280)
T ss_pred             e------EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE
Confidence            4      999999986 45555432                 26788999999999999999999999999999999999


Q ss_pred             ccCCcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHH
Q psy11580        198 KSDCTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWN  273 (288)
Q Consensus       198 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~  273 (288)
                      ++++.++|+|||++........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+...
T Consensus       156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  235 (280)
T cd05092         156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE  235 (280)
T ss_pred             cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            9999999999999875432211   122344678999999999889999999999999999998 999998877776666


Q ss_pred             HHHHH
Q psy11580        274 KIIGK  278 (288)
Q Consensus       274 ~i~~~  278 (288)
                      .+...
T Consensus       236 ~~~~~  240 (280)
T cd05092         236 CITQG  240 (280)
T ss_pred             HHHcC
Confidence            65543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-33  Score=229.65  Aligned_cols=202  Identities=26%  Similarity=0.400  Sum_probs=165.7

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.++.+.++.++.+    .+..+++.+++|++...  .......+.+|++++++++||||+++++++...+..  
T Consensus         4 ~~~~~~~l~~g~~~~v~~~----~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~--   75 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKA----RDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKL--   75 (262)
T ss_pred             ceEEEEEecCCCceEEEEe----EecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEE--
Confidence            4556677777777766664    34567889999999853  223567889999999999999999999998776654  


Q ss_pred             cccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                          +++|||++++ +.+.+.   ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus        76 ----~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  151 (262)
T cd06613          76 ----WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQL  151 (262)
T ss_pred             ----EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhh
Confidence                9999999975 444443   35889999999999999999999999999999999999999999999999998765


Q ss_pred             CCCc-ccCCcccccccCchHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHH
Q psy11580        215 GTTF-MMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW  272 (288)
Q Consensus       215 ~~~~-~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~  272 (288)
                      .... ......++..|+|||.+.+.   .++.++|+||||+++|+|++|..||.+.+.....
T Consensus       152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~  213 (262)
T cd06613         152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL  213 (262)
T ss_pred             hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            4332 22344678889999999876   7889999999999999999999999876654443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.6e-33  Score=230.57  Aligned_cols=198  Identities=29%  Similarity=0.491  Sum_probs=162.7

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.++.|.++.++.+    .+..+++.||+|.++.. .........+..|+++++.++||||+++++++...+.. 
T Consensus         3 ~~~i~~~l~~g~~~~v~~~----~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-   77 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRA----TCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNEL-   77 (267)
T ss_pred             ceeeeeeeccCCCeeEEEE----EEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeE-
Confidence            4567778888877777665    35568899999988642 23344456788999999999999999999998876654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                           ++++||++++ +.+.+.      ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||+
T Consensus        78 -----~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~  152 (267)
T cd08228          78 -----NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL  152 (267)
T ss_pred             -----EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECcccc
Confidence                 9999999974 544442      2278889999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        211 ARTAGTTFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       211 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      +........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             ceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence            876544322 22346788899999999888899999999999999999999999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-33  Score=229.66  Aligned_cols=211  Identities=24%  Similarity=0.380  Sum_probs=172.7

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +..+++.+.+.++.|.++.++.+.     ...+..||+|.+....   .....+.+|++++++++|+||+++++++....
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~-----~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGT-----WNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE   74 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEE-----EcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence            456778888899988887777652     2345779999997532   33467889999999999999999999987765


Q ss_pred             cccccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      ..      ++|||++++ ++.+.+..    .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||
T Consensus        75 ~~------~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g  148 (261)
T cd05034          75 PI------YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFG  148 (261)
T ss_pred             ce------EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccc
Confidence            54      999999986 56666542    47899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        210 LARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       210 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      .+........  ......+..|+|||.+.+..++.++|+||||+++++|++ |+.||.+.+....+.++....
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~  221 (261)
T cd05034         149 LARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY  221 (261)
T ss_pred             cceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9876543211  112234567999999998889999999999999999998 999999888877777776543

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.6e-33  Score=239.90  Aligned_cols=217  Identities=43%  Similarity=0.776  Sum_probs=174.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  136 (288)
                      +++.+.+.+|+|.++.++.|    .+..+++.+|+|.+............+.+|+.+++++ +||||+++++++...+. 
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~----~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~-   81 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKA----IDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND-   81 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEE----EEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC-
Confidence            45566677787777766654    4556789999999865434445556778899999999 99999999999865432 


Q ss_pred             cccccEEEEEecccccHHHHHhh-hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQM-DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                         ...++||||+++++...+.. .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        82 ---~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          82 ---KDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             ---ceEEEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence               23599999999988877754 57888899999999999999999999999999999999999999999999987543


Q ss_pred             CCc------ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        216 TTF------MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       216 ~~~------~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ...      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+....+...++....+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            321      1233467888999998765 457889999999999999999999999888877777776665543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=233.54  Aligned_cols=213  Identities=34%  Similarity=0.556  Sum_probs=173.2

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      +.+.+|+|.++.++.+    .+..++..+|+|.+............+..|++++++++|+|++++++++....    ...
T Consensus         3 ~~~~l~~g~~~~vy~~----~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~   74 (287)
T cd07840           3 KIAQIGEGTYGQVYKA----RNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG----KGS   74 (287)
T ss_pred             eeEEeccCCCeEEEEE----EECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC----CCc
Confidence            4455666666655554    34557899999999865433444567889999999999999999999998761    123


Q ss_pred             EEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        142 VYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       142 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                      .++|+||+++++.+.+..   .+++..++.++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          75 IYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             EEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            499999999888777753   48899999999999999999999999999999999999999999999999997665432


Q ss_pred             --ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        219 --MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       219 --~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                        ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+....+.++.+.++.+
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~  221 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP  221 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence              1233456778999998765 457899999999999999999999999988888888887766544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.7e-33  Score=228.68  Aligned_cols=204  Identities=25%  Similarity=0.400  Sum_probs=165.8

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ...++.+.+.+|+|.++.++.+      ...+..||+|.++..    ...+.+.+|+.++++++|+|++++++++...+ 
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~------~~~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLG------DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-   72 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEE------EEcCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-
Confidence            3456778888899888877776      345888999998642    23457889999999999999999999865433 


Q ss_pred             ccccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                          ...++++||+++ ++.+.+..    .+++..+..++.|++.||++||+++++|+||+|+||+++.++.+||+|||+
T Consensus        73 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~  148 (256)
T cd05082          73 ----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL  148 (256)
T ss_pred             ----CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCcc
Confidence                234999999986 56666542    267889999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHH
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~  276 (288)
                      +.......  .....+..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.
T Consensus       149 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~  213 (256)
T cd05082         149 TKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE  213 (256)
T ss_pred             ceeccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            87654322  22344567999999998889999999999999999997 999998877665555543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.8e-33  Score=233.69  Aligned_cols=198  Identities=24%  Similarity=0.375  Sum_probs=161.5

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.....+|+|.++.++.+    .+..+++.||+|.+...... .....+.+|+.++.++. |+||+++++++...+.. 
T Consensus         5 ~~~~~~~lg~G~~g~vy~~----~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~-   78 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKM----LHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC-   78 (288)
T ss_pred             HhHHHHHhCCCCceEEEEE----EECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE-
Confidence            4455567788777766654    45678899999999753322 44567889999999996 99999999998776554 


Q ss_pred             ccccEEEEEecccccHHHHHh-------hhCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ-------MDLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~-~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                           +++||+++.++.+...       ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||
T Consensus        79 -----~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  153 (288)
T cd06616          79 -----WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFG  153 (288)
T ss_pred             -----EEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecc
Confidence                 9999999876544321       3488899999999999999999974 99999999999999999999999999


Q ss_pred             cccccCCCcccCCcccccccCchHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        210 LARTAGTTFMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ++.............++..|+|||++.+.   .++.++|+||||+++|+|++|+.||...+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  214 (288)
T cd06616         154 ISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN  214 (288)
T ss_pred             hhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence            98765544333444678899999999876   58899999999999999999999997654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-33  Score=228.03  Aligned_cols=204  Identities=26%  Similarity=0.380  Sum_probs=169.5

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ...++.+.+.+|+|.++.++.+      ...++.||+|.++...   ....++.+|+.+++.++|+||+++++++...+.
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~------~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLG------DYRGQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP   74 (256)
T ss_pred             ChhhccceeeeecCCCceEEEE------EecCcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC
Confidence            3456778888899888887776      3357899999998532   256788999999999999999999999987655


Q ss_pred             ccccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      .      ++|||++++ ++.+.+..    .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.
T Consensus        75 ~------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~  148 (256)
T cd05039          75 L------YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGL  148 (256)
T ss_pred             e------EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccc
Confidence            4      999999985 66666542    478999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHH
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~  276 (288)
                      +........  ....+..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+.
T Consensus       149 ~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  213 (256)
T cd05039         149 AKEASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE  213 (256)
T ss_pred             ccccccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence            987643322  2344567999999988888999999999999999997 999998877665544443

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.7e-33  Score=230.04  Aligned_cols=207  Identities=26%  Similarity=0.459  Sum_probs=165.1

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcch-------hhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV-------THAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      .++..+++|.++.++.|    .+..+++.||+|.+.......       .....+.+|++++++++||||+++++++...
T Consensus         3 ~~~~~ig~g~~~~v~~a----~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (267)
T cd06628           3 IKGALIGSGSFGSVYLG----MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA   78 (267)
T ss_pred             cccceeecCCCeEEEEE----EecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Confidence            45566777766666654    345678999999887532221       2235678899999999999999999999877


Q ss_pred             CcccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        134 KSLEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      +..      ++++||++++ +.+.+.  ..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.
T Consensus        79 ~~~------~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~  152 (267)
T cd06628          79 DHL------NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGI  152 (267)
T ss_pred             Ccc------EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCC
Confidence            655      9999999874 555554  3478889999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc-------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        211 ARTAGTTF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       211 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      +.......       ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+....+.++..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  226 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE  226 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence            87654211       11223577889999999988889999999999999999999999998776655555444

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.2e-33  Score=231.60  Aligned_cols=201  Identities=24%  Similarity=0.389  Sum_probs=163.8

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|+++..  .......+.+|+.+++.++||||+++++.+...+.. 
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~----~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~-   81 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKA----RNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL-   81 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEE----EEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE-
Confidence            35566777888877777664    45678899999999753  223445678899999999999999999999776654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++|+||++++ +.+.+.  ..+++.+++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        82 -----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd06645          82 -----WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI  156 (267)
T ss_pred             -----EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence                 9999999874 555543  35889999999999999999999999999999999999999999999999998765


Q ss_pred             CCCc-ccCCcccccccCchHhHh---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        215 GTTF-MMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       215 ~~~~-~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      .... ......++..|+|||++.   ...++.++|+||||+++|+|++|..||.......
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~  216 (267)
T cd06645         157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR  216 (267)
T ss_pred             cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh
Confidence            4322 123446889999999985   3457889999999999999999999997655443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.6e-33  Score=232.65  Aligned_cols=201  Identities=22%  Similarity=0.301  Sum_probs=160.3

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.+|+|.++.++++...+....+++.||+|.++... .......+.+|+++++.++||||+++++++...+.    .
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~   81 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG----K   81 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC----c
Confidence            556677888777776654333445678899999997532 22345678899999999999999999998765321    2


Q ss_pred             cEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        141 DVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       141 ~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                      ..+++|||++++ +.+.+. ..+++..++.++.|++.||+|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            358999999875 545444 358999999999999999999999999999999999999999999999999987654321


Q ss_pred             c----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        219 M----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       219 ~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      .    .....++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            1    12223456699999998888999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.7e-33  Score=238.08  Aligned_cols=213  Identities=37%  Similarity=0.606  Sum_probs=172.6

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchh------------hHHHHHHHHHHHHHCCCCCcceeec
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVT------------HAKRAYREFKLMKLVNHKNIIGLLN  128 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~~i~~~~~  128 (288)
                      .+.+.+|+|.++.++.+    .+..+++.||+|+++.......            ....+.+|+++++.++|+||+++++
T Consensus        12 ~~~~~ig~G~~g~vy~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024         12 QKGAHLGEGTYGKVEKA----YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             hhhhcccCCCceeEEEE----EECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            34566777777766665    4567889999999975322110            0124678999999999999999999


Q ss_pred             cccCCCcccccccEEEEEecccccHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEe
Q psy11580        129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL  206 (288)
Q Consensus       129 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~  206 (288)
                      ++...+..      ++|||++++++.+.+..  .+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+
T Consensus        88 ~~~~~~~~------~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFI------NLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcE------EEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEEC
Confidence            99876654      99999999988887753  48899999999999999999999999999999999999999999999


Q ss_pred             ecccccccCC---------------CcccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        207 DFGLARTAGT---------------TFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       207 dfg~~~~~~~---------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      |||.+.....               ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.++.+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999875541               1111223457789999998764 46899999999999999999999999999988


Q ss_pred             HHHHHHHHhCCCc
Q psy11580        271 QWNKIIGKMREAH  283 (288)
Q Consensus       271 ~~~~i~~~~~~~~  283 (288)
                      .+..+.+.++.++
T Consensus       242 ~~~~i~~~~~~~~  254 (335)
T PTZ00024        242 QLGRIFELLGTPN  254 (335)
T ss_pred             HHHHHHHHhCCCc
Confidence            8888887776443

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.3e-33  Score=234.28  Aligned_cols=202  Identities=27%  Similarity=0.434  Sum_probs=163.6

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|+|.++.++.|    .+..+++.||+|.+....  ......+.+|+.+++.++|+||+++++.+.....   
T Consensus        21 ~y~~~~~lg~g~~~~v~~~----~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~---   91 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTA----MDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE---   91 (296)
T ss_pred             ceeeEEEecCCCCeEEEEE----EECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE---
Confidence            3445556666666665554    456788999999997532  2334668899999999999999999999876654   


Q ss_pred             cccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                         .++||||++++ +.+.+. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        92 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          92 ---LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             ---EEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence               49999999864 555554 3478899999999999999999999999999999999999999999999999875433


Q ss_pred             Cc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHH
Q psy11580        217 TF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW  272 (288)
Q Consensus       217 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~  272 (288)
                      .. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+....+
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~  225 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL  225 (296)
T ss_pred             cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH
Confidence            22 123346788999999999888899999999999999999999999877654443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG1035|consensus

Probab=100.00  E-value=9.8e-34  Score=258.82  Aligned_cols=263  Identities=26%  Similarity=0.371  Sum_probs=185.1

Q ss_pred             CCCCCCCHHHHhcCCCcCCccCCcc-CCCC-----CCCCCcCCcccccccHHHhhhhhhcccccccccCCccccccccCc
Q psy11580          5 DPEKRISVDDALMHPYINVWFDDAE-VHAP-----APGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGA   78 (288)
Q Consensus         5 ~~~~r~~~~~~l~~p~~~~~~~~~e-~~~~-----~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~   78 (288)
                      ++.+|..+.+++.||+.+...+-.. ...+     .|.-..+....-.....++ .....++..-..+|+|.||.++   
T Consensus       421 ~~~~Rl~~~~ll~~~f~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~~r~~-SRY~~DFEEL~lLGkGGFG~Vv---  496 (1351)
T KOG1035|consen  421 DSEERLSALELLTHPFLRFPTDNESSEFAPNDETSVPQFRLRFSGAMSPLQRQF-SRYLNDFEELELLGKGGFGSVV---  496 (1351)
T ss_pred             hhhhccchhhhhhchhcccccccccccccCccccccCccCCCCccccCccccch-hhHhhhhHHHHHhcCCCCceEE---
Confidence            4789999999999999976222111 0111     1111111111111111111 2233456666666766555444   


Q ss_pred             cceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc---------------------
Q psy11580         79 GAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE---------------------  137 (288)
Q Consensus        79 g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~---------------------  137 (288)
                       +|.++-+|+.+|||++.... +.....++.+|++.|.+|+|||||+++..|.....-.                     
T Consensus       497 -kVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~  574 (1351)
T KOG1035|consen  497 -KVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYN  574 (1351)
T ss_pred             -EEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCcc
Confidence             36778899999999998755 6677888999999999999999999877665422000                     


Q ss_pred             --------------------------------------------------------------------------------
Q psy11580        138 --------------------------------------------------------------------------------  137 (288)
Q Consensus       138 --------------------------------------------------------------------------------  137 (288)
                                                                                                      
T Consensus       575 ~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~  654 (1351)
T KOG1035|consen  575 GVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPK  654 (1351)
T ss_pred             cceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhccc
Confidence                                                                                            


Q ss_pred             -----c-------cccEEEEEecccccHHHHHhh-h-C--CHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC
Q psy11580        138 -----E-------FQDVYLVMELMDANLCQVIQM-D-L--DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC  201 (288)
Q Consensus       138 -----~-------~~~~~lv~e~~~~~l~~~~~~-~-~--~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~  201 (288)
                           +       ...+||-||||+..+++.+.. + +  .....++++++|++||.|+|+.|+|||||||.||+++.+.
T Consensus       655 ~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~  734 (1351)
T KOG1035|consen  655 TENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRN  734 (1351)
T ss_pred             cCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCC
Confidence                 0       013689999999987776642 2 3  3678999999999999999999999999999999999999


Q ss_pred             cEEEeecccccccC-------------------CCcccCCcccccccCchHhHhcCC---CCchhhHHHHHHHHHHHHhC
Q psy11580        202 TLKILDFGLARTAG-------------------TTFMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIRG  259 (288)
Q Consensus       202 ~~kl~dfg~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slg~il~~l~~g  259 (288)
                      .|||+|||+++...                   .....+..+||..|+|||++.+..   |+.|+||||||+|++||+.-
T Consensus       735 ~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP  814 (1351)
T KOG1035|consen  735 SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP  814 (1351)
T ss_pred             CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc
Confidence            99999999997510                   011234568999999999998754   99999999999999999864


Q ss_pred             CCCCC-CCCchhHHHHHH
Q psy11580        260 GVLFP-GTDHIDQWNKII  276 (288)
Q Consensus       260 ~~p~~-~~~~~~~~~~i~  276 (288)
                         |. ++.+..+++++.
T Consensus       815 ---F~TsMERa~iL~~LR  829 (1351)
T KOG1035|consen  815 ---FGTSMERASILTNLR  829 (1351)
T ss_pred             ---CCchHHHHHHHHhcc
Confidence               43 344444545444

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-33  Score=231.03  Aligned_cols=211  Identities=40%  Similarity=0.634  Sum_probs=175.3

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccE
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+.++++.++.++.|    .+..+++.||+|++............+..|+.++++++|+|++++++++...+..      
T Consensus         4 ~~~ig~g~~~~vy~~----~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~------   73 (282)
T cd07829           4 LEKLGEGTYGVVYKA----RDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKL------   73 (282)
T ss_pred             ehcccccCcceEEEe----eecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCce------
Confidence            455666666665554    3456789999999986543344456778899999999999999999999877654      


Q ss_pred             EEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc-
Q psy11580        143 YLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-  218 (288)
Q Consensus       143 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-  218 (288)
                      ++|+|++++++.+.+..   .+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        74 ~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          74 YLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             EEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            99999999988887753   48999999999999999999999999999999999999999999999999987654432 


Q ss_pred             ccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        219 MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .......+..|+|||.+.+. .++.++|+||||+++++|++|..||.+.+..+.+.++.+.++.+.
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPT  219 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCc
Confidence            22334557789999999876 788999999999999999999999999988888888887766443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6e-33  Score=234.32  Aligned_cols=217  Identities=28%  Similarity=0.450  Sum_probs=172.8

Q ss_pred             hhhhcccccccccCCccccccccCccceec---cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYD---TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNA  129 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  129 (288)
                      .+...++.+++.+|+|.++.++.+.....+   ..++..||+|.++... .......+.+|+.+++.+ +||||++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            355667788899999998888876432211   2345689999997532 334567788999999999 89999999999


Q ss_pred             ccCCCcccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                      +...+..      ++||||+.+ +|.+++..                  .+++..+..++.|+++||+|||++|++||||
T Consensus        90 ~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dl  163 (304)
T cd05101          90 CTQDGPL------YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDL  163 (304)
T ss_pred             EecCCce------EEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence            9877654      999999986 45555532                  2667888999999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT  266 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~  266 (288)
                      ||+||+++.++.++|+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus       164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999976543221   122344677999999998889999999999999999998 88999888


Q ss_pred             CchhHHHHHHH
Q psy11580        267 DHIDQWNKIIG  277 (288)
Q Consensus       267 ~~~~~~~~i~~  277 (288)
                      +..+....+.+
T Consensus       244 ~~~~~~~~~~~  254 (304)
T cd05101         244 PVEELFKLLKE  254 (304)
T ss_pred             CHHHHHHHHHc
Confidence            77666655543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.4e-33  Score=229.36  Aligned_cols=213  Identities=24%  Similarity=0.332  Sum_probs=167.5

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.|.-. .+..++..||+|+++... .......+..|+.+++.++||||+++++++...... 
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~-~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~-   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLK-LPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV-   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEe-cCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce-
Confidence            45677888888888887775311 011223479999997532 344567899999999999999999999999776654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                           ++||||++++ +.+.+.   ..+++..++.++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus        81 -----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~  155 (269)
T cd05065          81 -----MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF  155 (269)
T ss_pred             -----EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence                 9999999875 444443   2378899999999999999999999999999999999999999999999999875


Q ss_pred             cCCCccc----CCc--ccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        214 AGTTFMM----TPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       214 ~~~~~~~----~~~--~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      .......    ...  ..+..|+|||.+.+..++.++|+||||+++||+++ |..||.+.+..+....+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~  227 (269)
T cd05065         156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD  227 (269)
T ss_pred             cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence            4332111    111  12357999999998889999999999999999886 99999888777766666443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5e-33  Score=228.90  Aligned_cols=206  Identities=28%  Similarity=0.452  Sum_probs=168.7

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.+|.|.++.++++    .+..++..+|+|.++... .......+..|+.+++.++|+||+++++.+...+.+    
T Consensus         3 ~~~~~lg~g~~g~v~~~----~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----   73 (255)
T cd08219           3 NVLRVVGEGSFGRALLV----QHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL----   73 (255)
T ss_pred             eEEEEeeccCCeEEEEE----EEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE----
Confidence            45566777776666654    456788999999986532 234556788999999999999999999999877654    


Q ss_pred             cEEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        141 DVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                        ++++||+++ ++.+.+.    ..++...+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||.+....
T Consensus        74 --~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  151 (255)
T cd08219          74 --YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT  151 (255)
T ss_pred             --EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeec
Confidence              999999986 4655553    237889999999999999999999999999999999999999999999999987654


Q ss_pred             CCc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        216 TTF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       216 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      ... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.......+..
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~  214 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ  214 (255)
T ss_pred             ccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc
Confidence            322 22345678889999999998899999999999999999999999998776666555543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.9e-33  Score=234.30  Aligned_cols=217  Identities=28%  Similarity=0.420  Sum_probs=171.5

Q ss_pred             hhhcccccccccCCccccccccCcccee---ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccc
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAY---DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAF  130 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  130 (288)
                      +...++.+++.+|+|.++.++++.+...   .......||+|+++... .......+..|+++++++ +||||+++++++
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            3445677899999999888888754221   12345689999987532 234456788999999999 699999999999


Q ss_pred             cCCCcccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCC
Q psy11580        131 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  191 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~  191 (288)
                      ...+..      +++|||+.+ +|.+++..                  .+++.++..++.|++.||+|||++|++|+|||
T Consensus        88 ~~~~~~------~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk  161 (314)
T cd05099          88 TQEGPL------YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA  161 (314)
T ss_pred             ccCCce------EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence            876654      999999986 45555532                  26788899999999999999999999999999


Q ss_pred             CCCEEEccCCcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy11580        192 PSNIVVKSDCTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTD  267 (288)
Q Consensus       192 ~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~  267 (288)
                      |+||+++.++.+||+|||++........   .....++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+
T Consensus       162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999976543211   112233467999999998889999999999999999998 899998877


Q ss_pred             chhHHHHHHHH
Q psy11580        268 HIDQWNKIIGK  278 (288)
Q Consensus       268 ~~~~~~~i~~~  278 (288)
                      ..+....+...
T Consensus       242 ~~~~~~~~~~~  252 (314)
T cd05099         242 VEELFKLLREG  252 (314)
T ss_pred             HHHHHHHHHcC
Confidence            76666655543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-32  Score=231.17  Aligned_cols=211  Identities=24%  Similarity=0.374  Sum_probs=166.1

Q ss_pred             cccccccCCccccccccCccce-eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAA-YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      +.+...+|+|.++.++.|.... ........+++|.+.... .......+..|+++++.++||||+++++.+...+..  
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--   78 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL--   78 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc--
Confidence            4567788888888887764321 112234679999987533 234456788999999999999999999999877655  


Q ss_pred             cccEEEEEeccccc-HHHHHh--------------------------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCC
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ--------------------------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  191 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~--------------------------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~  191 (288)
                          ++++||+.++ +.+++.                          ..+++..++.++.|++.||+|||+.+++||||+
T Consensus        79 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik  154 (290)
T cd05045          79 ----LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA  154 (290)
T ss_pred             ----EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence                9999999864 444432                          126788899999999999999999999999999


Q ss_pred             CCCEEEccCCcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy11580        192 PSNIVVKSDCTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTD  267 (288)
Q Consensus       192 ~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~  267 (288)
                      |+||++++++.++|+|||++........   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999999875432211   122244678999999988889999999999999999998 999999887


Q ss_pred             chhHHHHHHH
Q psy11580        268 HIDQWNKIIG  277 (288)
Q Consensus       268 ~~~~~~~i~~  277 (288)
                      +...+..+.+
T Consensus       235 ~~~~~~~~~~  244 (290)
T cd05045         235 PERLFNLLKT  244 (290)
T ss_pred             HHHHHHHHhC
Confidence            7666555443

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-33  Score=232.08  Aligned_cols=207  Identities=26%  Similarity=0.395  Sum_probs=167.0

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.++.|.++.++.+    .+..++..||+|+++.  ........+..|++++++++||||+++++.+......  
T Consensus         6 ~~~i~~~l~~g~~~~v~~~----~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--   77 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKA----QHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKL--   77 (280)
T ss_pred             HHHHHHHhcCCCCceEEEE----EEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeE--
Confidence            3456667788777777665    3345789999999974  2444567788999999999999999999999876654  


Q ss_pred             cccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                          ++||||++++ +.+.+.   ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+...
T Consensus        78 ----~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          78 ----WILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             ----EEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence                9999999985 444443   34889999999999999999999999999999999999999999999999988754


Q ss_pred             CCCc-ccCCcccccccCchHhHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        215 GTTF-MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       215 ~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      .... ......+++.|+|||.+..     ..++.++|+||||+++|+|++|..||.+.+....+.++..
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  222 (280)
T cd06611         154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK  222 (280)
T ss_pred             cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc
Confidence            3322 2233467888999999853     3467799999999999999999999988776665555443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-33  Score=230.96  Aligned_cols=215  Identities=38%  Similarity=0.579  Sum_probs=173.9

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC---CCCCcceeeccccCCCccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV---NHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~  137 (288)
                      .+.+.+++|.++.++++.    +..+++.||+|+++...........+..|+.+++++   +|+|++++++++...+. .
T Consensus         2 ~~~~~l~~g~~~~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~-~   76 (287)
T cd07838           2 EELAEIGEGAYGTVYKAR----DLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT-D   76 (287)
T ss_pred             eEEEEecccCceEEEEEE----ECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC-C
Confidence            345667777777776653    345689999999985433333344566788777766   59999999999987654 1


Q ss_pred             ccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      .....+++||++.+++.+.+..    .+++..++.++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+..
T Consensus        77 ~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          77 RELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             CCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            2234599999999887776642    378999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        214 AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       214 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ...........++..|+|||.+.+..++.++|+||||+++|+|++|.+||.+.+..+.+.++.+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  223 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG  223 (287)
T ss_pred             ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcC
Confidence            6554443444578889999999998899999999999999999999999999988888888876543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-33  Score=250.12  Aligned_cols=215  Identities=22%  Similarity=0.322  Sum_probs=160.3

Q ss_pred             hcccccccccCCccccccccCcccee-----------ccCCCce----EEEEeccCCCcchhhHHHHHHHHHHHHHCCCC
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAY-----------DTATQQN----VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK  121 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~-----------~~~~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~  121 (288)
                      ...+.+.+.||+|.++.++++.....           ....+..    ++.|.+.   ........+.+|+++|++++||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~---~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK---AGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh---cchHHHHHHHHHHHHHHhCCCC
Confidence            35677778888888887776532100           0001111    1222222   2233456788999999999999


Q ss_pred             CcceeeccccCCCcccccccEEEEEecccccHHHHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCC
Q psy11580        122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN  194 (288)
Q Consensus       122 ~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~n  194 (288)
                      ||+++++++...+..      ++|++++.++++..+...       .....++.++.||+.||+|||+++|+||||||+|
T Consensus       224 nIv~l~~~~~~~~~~------~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~N  297 (501)
T PHA03210        224 NILKIEEILRSEANT------YMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLEN  297 (501)
T ss_pred             CcCcEeEEEEECCee------EEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            999999999877654      999999998888766421       3356678899999999999999999999999999


Q ss_pred             EEEccCCcEEEeecccccccCCCc--ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCC-CCC--CCch
Q psy11580        195 IVVKSDCTLKILDFGLARTAGTTF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPG--TDHI  269 (288)
Q Consensus       195 il~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p-~~~--~~~~  269 (288)
                      ||++.++.+||+|||++.......  ......|+..|+|||++.+..++.++|||||||++|||++|..+ |.+  .+..
T Consensus       298 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             EEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            999999999999999997654432  22345789999999999999999999999999999999998764 443  2344


Q ss_pred             hHHHHHHHHhC
Q psy11580        270 DQWNKIIGKMR  280 (288)
Q Consensus       270 ~~~~~i~~~~~  280 (288)
                      ..+.+++..++
T Consensus       378 ~~~~~~~~~~~  388 (501)
T PHA03210        378 KQLLKIIDSLS  388 (501)
T ss_pred             HHHHHHHHhcc
Confidence            45555555443

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1e-32  Score=228.47  Aligned_cols=214  Identities=23%  Similarity=0.307  Sum_probs=171.0

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..++.+.+.+|+|.++.++.|.... ...+...||+|+++... .......+..|+.++++++||||+++++.+...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~-~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKL-PGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEcc-CCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            3457788888888888777763221 12345689999987532 334456788999999999999999999998776654


Q ss_pred             cccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                            +++||++++ ++.+.+..   .+++..+..++.|++.||+|||+++|+|+||+|+||+++.++.++|+|||++.
T Consensus        81 ------~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~  154 (266)
T cd05033          81 ------MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (266)
T ss_pred             ------EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhh
Confidence                  999999987 45555532   47899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        213 TAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       213 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ......   ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~  224 (266)
T cd05033         155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG  224 (266)
T ss_pred             cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence            764211   1112234567999999998889999999999999999997 99999887777776666544

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-32  Score=231.68  Aligned_cols=215  Identities=23%  Similarity=0.321  Sum_probs=173.0

Q ss_pred             hcccccccccCCccccccccCccc------------eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGA------------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNII  124 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~  124 (288)
                      ..++.+.+.+|+|.++.++.+...            +.+...+..||+|++.... .......+.+|++++++++||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence            356778899999988888875432            1223345789999997542 234567788999999999999999


Q ss_pred             eeeccccCCCcccccccEEEEEecccc-cHHHHHhh-------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        125 GLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM-------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       125 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                      ++++++...+..      ++++|++.+ ++.+++..             .+++..++.++.|++.||+|||+.+++|+||
T Consensus        83 ~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dl  156 (296)
T cd05051          83 RLLGVCTVDPPL------CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDL  156 (296)
T ss_pred             EEEEEEecCCCc------EEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence            999999877655      999999986 45555432             4788999999999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR--GGVLFPG  265 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~--g~~p~~~  265 (288)
                      ||+||+++.++.++|+|||++.......   ......++..|+|||++.+..++.++||||||+++|+|++  |..||..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999999987543322   1223345678999999998889999999999999999997  7889988


Q ss_pred             CCchhHHHHHHHH
Q psy11580        266 TDHIDQWNKIIGK  278 (288)
Q Consensus       266 ~~~~~~~~~i~~~  278 (288)
                      .+..+.+..+...
T Consensus       237 ~~~~~~~~~~~~~  249 (296)
T cd05051         237 LTDQQVIENAGHF  249 (296)
T ss_pred             cChHHHHHHHHhc
Confidence            7777776666544

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.3e-33  Score=231.52  Aligned_cols=202  Identities=23%  Similarity=0.362  Sum_probs=163.3

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..++.+.+.+|+|.++.++.|    .+..+++.||+|++...  .......+.+|+.++++++||||+++++.+...+..
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~----~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKA----RNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             hhhcchhheeecCCCeEEEEE----EECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            345677788888877777765    34567899999999743  223345677899999999999999999999776654


Q ss_pred             cccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                            ++||||++++ +.+.+.  ..+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++..
T Consensus        82 ------~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~  155 (267)
T cd06646          82 ------WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAK  155 (267)
T ss_pred             ------EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCcccee
Confidence                  9999999875 545443  3578899999999999999999999999999999999999999999999999976


Q ss_pred             cCCCc-ccCCcccccccCchHhHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        214 AGTTF-MMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       214 ~~~~~-~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      ..... ......++..|+|||.+..   ..++.++|+||+|+++|+|++|+.||...++.+
T Consensus       156 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~  216 (267)
T cd06646         156 ITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR  216 (267)
T ss_pred             ecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh
Confidence            54322 2234467889999999853   446789999999999999999999997654433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8e-33  Score=228.93  Aligned_cols=208  Identities=26%  Similarity=0.410  Sum_probs=166.9

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCc----chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ----NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      +..++.+|+|.++.++.|.     ..+++.+|+|.++....    .......+.+|++++++++|+||+++++++...+.
T Consensus         2 ~~~~~~ig~g~~~~v~~~~-----~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   76 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGL-----TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNT   76 (265)
T ss_pred             ccccceEeccCCeEEEEEE-----EcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCe
Confidence            3566777888877777763     35788999999874322    12334568899999999999999999999987765


Q ss_pred             ccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      .      ++++||++++ +.+.+.  ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        77 ~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  150 (265)
T cd06631          77 I------SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCAR  150 (265)
T ss_pred             E------EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhH
Confidence            4      9999999875 555543  347889999999999999999999999999999999999999999999999987


Q ss_pred             ccCC-------CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        213 TAGT-------TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       213 ~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ....       ........++..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~  223 (265)
T cd06631         151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH  223 (265)
T ss_pred             hhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc
Confidence            5421       11122346788899999999888899999999999999999999999877665554444433

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-32  Score=232.16  Aligned_cols=213  Identities=25%  Similarity=0.361  Sum_probs=169.9

Q ss_pred             hhhcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTP  132 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  132 (288)
                      +..+++.+.+.+|+|.++.++.+... ..+..++..||+|+++... .......+.+|+++++++ +||||+++++++..
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            44467788899999888887776421 1223456789999997532 234456788999999999 79999999999987


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEee
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD  207 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~d  207 (288)
                      .+..      +++|||+.+ +|.+.+...    +++.++..++.|++.||+|||+++++|+||||+||+++.++.++|+|
T Consensus       111 ~~~~------~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         111 GGPI------LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             CCce------EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECC
Confidence            7655      999999985 566665421    78999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHH
Q psy11580        208 FGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNK  274 (288)
Q Consensus       208 fg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~  274 (288)
                      ||++........   .....++..|+|||.+.+..++.++||||+|+++|+|++ |..||.+.+..+...+
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~  255 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK  255 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH
Confidence            999875533211   122345678999999999889999999999999999998 9999987665544333

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.5e-33  Score=228.22  Aligned_cols=205  Identities=23%  Similarity=0.384  Sum_probs=164.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+++|.++.++.+.    +. +...||+|+++...   .....+.+|++++++++|+||+++++.+....   
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~----~~-~~~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~---   74 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGT----WN-GTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---   74 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEE----ec-CCceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEECCCC---
Confidence            456777788888777777652    22 33569999997532   23456889999999999999999999875432   


Q ss_pred             ccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                          .++||||+++ ++.+.+..    .+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+.
T Consensus        75 ----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~  150 (262)
T cd05071          75 ----IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR  150 (262)
T ss_pred             ----cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCcee
Confidence                3899999986 56666542    37889999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCccc--CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        213 TAGTTFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       213 ~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      ........  ....++..|+|||+..+..++.++|+||||+++|+|++ |..||.+.+..+.+..+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~  218 (262)
T cd05071         151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER  218 (262)
T ss_pred             eccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc
Confidence            65433221  22345677999999988889999999999999999999 8999988877666666544

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9.7e-33  Score=228.75  Aligned_cols=214  Identities=25%  Similarity=0.328  Sum_probs=169.7

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.|.. ......+..+|+|.++... .......+..|+.++++++||||+++++++...+.. 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRL-KLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV-   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEE-ecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc-
Confidence            4566788888888887776531 1112234579999997532 234466788999999999999999999999776654 


Q ss_pred             ccccEEEEEeccccc-HHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                           ++||||++++ +.+.+..   .+++.++..++.|++.||++||+.+++|+||||+||+++.++.++|+|||++..
T Consensus        81 -----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          81 -----MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             -----EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence                 9999999864 5555542   378899999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcc----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        214 AGTTFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       214 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ......    .....++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.+..+....+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~  226 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY  226 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC
Confidence            543221    111223467999999998889999999999999999886 999999887777766666543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-32  Score=230.99  Aligned_cols=215  Identities=24%  Similarity=0.326  Sum_probs=168.4

Q ss_pred             hhcccccccccCCccccccccCccce--------ec--cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcce
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAA--------YD--TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG  125 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~--------~~--~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~  125 (288)
                      ...++.+.+.+|+|.++.++++....        ..  ..+...||+|.++... .......+.+|++++++++|+|+++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            34567888899999988888754211        11  1223469999997532 3344567889999999999999999


Q ss_pred             eeccccCCCcccccccEEEEEeccccc-HHHHHhh--------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        126 LLNAFTPQKSLEEFQDVYLVMELMDAN-LCQVIQM--------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~--------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                      +++++...+..      ++||||+.++ +.+.+..              .+++..++.++.|++.||+|||+.+++|+||
T Consensus        82 ~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dl  155 (295)
T cd05097          82 LLGVCVSDDPL------CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDL  155 (295)
T ss_pred             EEEEEcCCCcc------EEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecccc
Confidence            99999877655      9999999874 5444421              2577888999999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR--GGVLFPG  265 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~--g~~p~~~  265 (288)
                      ||+||+++.++.+||+|||++........   .....++..|+|||++.+..++.++|+||||+++++|++  |..||..
T Consensus       156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            99999999999999999999875432211   122344678999999998889999999999999999988  6789988


Q ss_pred             CCchhHHHHHHH
Q psy11580        266 TDHIDQWNKIIG  277 (288)
Q Consensus       266 ~~~~~~~~~i~~  277 (288)
                      .+..+.+..+.+
T Consensus       236 ~~~~~~~~~~~~  247 (295)
T cd05097         236 LSDEQVIENTGE  247 (295)
T ss_pred             cChHHHHHHHHH
Confidence            777666655543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.5e-33  Score=232.78  Aligned_cols=205  Identities=25%  Similarity=0.364  Sum_probs=164.7

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.+|.|.++.++.|    .+..++..|++|++..  ........+..|+++++.++|+||+++++.+...+..   
T Consensus        14 y~i~~~lg~g~~g~vy~~----~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---   84 (292)
T cd06644          14 WEIIGELGDGAFGKVYKA----KNKETGALAAAKVIET--KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL---   84 (292)
T ss_pred             hhhhheecCCCCeEEEEE----EECCCCceEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE---
Confidence            456666777776666665    3456789999999975  3445567788999999999999999999998776654   


Q ss_pred             ccEEEEEecccccHHHH-Hh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        140 QDVYLVMELMDANLCQV-IQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~-~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                         ++||||++++.+.. +.   ..+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        85 ---~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          85 ---WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             ---EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence               99999999875543 32   347999999999999999999999999999999999999999999999999886543


Q ss_pred             CC-cccCCcccccccCchHhHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        216 TT-FMMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       216 ~~-~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                      .. .......+++.|+|||++.+     ..++.++|+||||+++|+|++|..||...+......++.
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~  228 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA  228 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh
Confidence            22 12234467888999999853     446789999999999999999999998876655544443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-32  Score=227.38  Aligned_cols=203  Identities=22%  Similarity=0.321  Sum_probs=156.6

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      .+|+|.++.++.|.  ..+..++..+|+|.++.... ......+.+|+.++++++||||+++++++......      ++
T Consensus         2 ~lg~G~~g~Vy~~~--~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------~l   72 (269)
T cd05087           2 EIGNGWFGKVILGE--VNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPY------LL   72 (269)
T ss_pred             cccccCCceEEEEE--EcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCc------EE
Confidence            45677666666653  22345567899999875432 23345788899999999999999999999876654      99


Q ss_pred             EEecccc-cHHHHHhh-------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        145 VMELMDA-NLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       145 v~e~~~~-~l~~~~~~-------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      ||||+++ ++.+.+..       ..++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||.+.....
T Consensus        73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~  152 (269)
T cd05087          73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK  152 (269)
T ss_pred             EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccC
Confidence            9999986 45555532       245667888999999999999999999999999999999999999999999865433


Q ss_pred             Ccc---cCCcccccccCchHhHhcC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHH
Q psy11580        217 TFM---MTPYVVTRYYRAPEVILGM-------GYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       217 ~~~---~~~~~~~~~~~aPE~~~~~-------~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~  276 (288)
                      ...   .....++..|+|||++.+.       .++.++|+||||+++|+|++ |..||...+..+.....+
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~  223 (269)
T cd05087         153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV  223 (269)
T ss_pred             cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh
Confidence            211   1233567889999998642       35789999999999999996 999998876666544433

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.2e-33  Score=233.87  Aligned_cols=199  Identities=24%  Similarity=0.450  Sum_probs=161.4

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      .+|.|.++.++.+    .+..+++.||+|++...  .......+.+|+.+++.++||||+++++.+...+..      ++
T Consensus        28 ~ig~g~~g~v~~~----~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~------~i   95 (297)
T cd06659          28 KIGEGSTGIVCIA----REKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL------WV   95 (297)
T ss_pred             hcCCCCceeEEEE----EEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE------EE
Confidence            4556555555443    45667899999998642  223356688999999999999999999999876654      99


Q ss_pred             EEecccccHHHHH-h-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc-ccC
Q psy11580        145 VMELMDANLCQVI-Q-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-MMT  221 (288)
Q Consensus       145 v~e~~~~~l~~~~-~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~  221 (288)
                      ++||++++.+..+ . ..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        96 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  175 (297)
T cd06659          96 LMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK  175 (297)
T ss_pred             EEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence            9999997544433 3 357899999999999999999999999999999999999999999999999987543322 123


Q ss_pred             CcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHH
Q psy11580        222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       222 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i  275 (288)
                      ...++..|+|||++.+..++.++|+||||+++++|++|+.||...+..+....+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~  229 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL  229 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            456788999999999888999999999999999999999999877665555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.9e-33  Score=233.38  Aligned_cols=200  Identities=27%  Similarity=0.410  Sum_probs=165.1

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.+|+|.++.++++    .+..++..+|+|.+.... ......++.+|++++++++||||+++++++...+..  
T Consensus         2 ~~~~~~~lg~G~~g~v~~~----~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--   74 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKV----LHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI--   74 (308)
T ss_pred             CceEEeeccCCCCeEEEEE----EEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE--
Confidence            4566777888877777665    456678899999987532 234456788999999999999999999999877655  


Q ss_pred             cccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        139 FQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       139 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                          ++||||+++ +|.+++.  ..+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ----~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          75 ----SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             ----EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence                999999986 4555554  347889999999999999999997 58999999999999999999999999998654


Q ss_pred             CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      .... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+...
T Consensus       151 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~  205 (308)
T cd06615         151 IDSM-ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE  205 (308)
T ss_pred             cccc-cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh
Confidence            3322 234577899999999988888999999999999999999999997665443

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG1006|consensus

Probab=100.00  E-value=7.6e-35  Score=226.91  Aligned_cols=212  Identities=24%  Similarity=0.345  Sum_probs=171.6

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  132 (288)
                      .+...++.....+|.|+++.+..    -..+.+|+..|||.++... ...+..++..|.+...+- +.||||++||++..
T Consensus        60 ~F~~~~Lqdlg~iG~G~fG~V~K----M~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~  134 (361)
T KOG1006|consen   60 TFTSDNLQDLGEIGNGAFGTVNK----MLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS  134 (361)
T ss_pred             ccccchHHHHHHhcCCcchhhhh----hhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence            44445556666677766665443    3457889999999998643 346677888888866655 79999999999998


Q ss_pred             CCcccccccEEEEEecccccHHHHH-------hhhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEE
Q psy11580        133 QKSLEEFQDVYLVMELMDANLCQVI-------QMDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLK  204 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~l~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~k  204 (288)
                      ++..      ++.||.|+-++..+.       ...+++.-+-.|+.-...||.||-+ ..|+|||+||+|||++..|.+|
T Consensus       135 EGdc------WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  135 EGDC------WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             CCce------eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEe
Confidence            8876      999999997654433       2458888888999999999999985 5799999999999999999999


Q ss_pred             EeecccccccCCCcccCCcccccccCchHhHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hhHHHHHH
Q psy11580        205 ILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLFPGTDH-IDQWNKII  276 (288)
Q Consensus       205 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~-~~~~~~i~  276 (288)
                      |||||.+-....+...+...|...|||||.+..  ..++.+||+||||+.|+|+.+|..||++-+. .+++.+++
T Consensus       209 LCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv  283 (361)
T KOG1006|consen  209 LCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV  283 (361)
T ss_pred             eecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH
Confidence            999999988777777777899999999999965  3588999999999999999999999998554 34444444

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.4e-33  Score=232.83  Aligned_cols=204  Identities=27%  Similarity=0.441  Sum_probs=165.6

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.....++.|.++.++.|    .+..+++.|++|.+...  .......+.+|+++++.++||||+++++.+...+..   
T Consensus        21 y~~~~~lg~g~~g~vy~~----~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---   91 (296)
T cd06655          21 YTRYEKIGQGASGTVFTA----IDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDEL---   91 (296)
T ss_pred             EEEEEEEecCCCeEEEEE----EEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceE---
Confidence            455566666666665554    45678999999999753  233456788999999999999999999999776654   


Q ss_pred             ccEEEEEecccccHHH-HHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        140 QDVYLVMELMDANLCQ-VIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~-~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                         ++|+||+.++.+. .+. ..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        92 ---~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          92 ---FVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             ---EEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence               9999999876444 333 34899999999999999999999999999999999999999999999999998765432


Q ss_pred             cc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHH
Q psy11580        218 FM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       218 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i  275 (288)
                      .. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~  227 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI  227 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            22 23346788899999999888999999999999999999999999887765544433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-32  Score=227.57  Aligned_cols=207  Identities=24%  Similarity=0.400  Sum_probs=166.0

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .+++.+.+.+|+|.++.++.+.     ..++..||+|.++....   ....+.+|+.++++++|+|++++++++... . 
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~-----~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-~-   74 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGT-----WNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSEE-P-   74 (260)
T ss_pred             hHHhhhhheeccccCceEEEEE-----ecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECCC-C-
Confidence            3456677778887777776652     34567799999975322   245688999999999999999999987543 2 


Q ss_pred             cccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                           .+++|||+++ ++.+.+..    .+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus        75 -----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          75 -----IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             -----cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceee
Confidence                 3899999986 56665542    3788999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        212 RTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       212 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ........  .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~  219 (260)
T cd05070         150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG  219 (260)
T ss_pred             eeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            76543221  122234567999999988889999999999999999999 99999988877776666543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-32  Score=226.33  Aligned_cols=203  Identities=26%  Similarity=0.411  Sum_probs=167.5

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .+++.+.+.+|+|.++.++.|      ..+++.||+|.++..    .....+.+|+.+++.++|||++++++++...+  
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~------~~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--   72 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQG------EYTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG--   72 (254)
T ss_pred             HHHceeeeeeccCCCCceEec------ccCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC--
Confidence            456788888999888887776      457889999999743    23457889999999999999999999986543  


Q ss_pred             cccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                           .+++|||+.+ ++.+.+..    .+++..+..++.|++.||+|||+.+++||||+|+||+++.++.++|+|||++
T Consensus        73 -----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~  147 (254)
T cd05083          73 -----LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA  147 (254)
T ss_pred             -----cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccc
Confidence                 3899999986 66666542    3788899999999999999999999999999999999999999999999998


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      .......  .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.+.
T Consensus       148 ~~~~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  213 (254)
T cd05083         148 RVGSMGV--DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG  213 (254)
T ss_pred             eeccccC--CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC
Confidence            7643321  22234567999999988889999999999999999997 99999988776666555544

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-32  Score=229.05  Aligned_cols=207  Identities=26%  Similarity=0.411  Sum_probs=161.9

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      .+.+.+|+|.++.++.|    .+..+++.||+|++...   ......+..|+.+++++ +|+||+++++++.........
T Consensus         9 ~~~~~lg~g~~g~vy~~----~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           9 ELVELVGNGTYGQVYKG----RHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hHHHheeecCCeEEEEE----EEcCCCcEEEEEEEEcC---CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            34455677766666654    34667899999999753   23345778899999999 799999999998765432222


Q ss_pred             ccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        140 QDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       140 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      ...+++|||+.+ ++.+.+..    .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            456999999986 45554442    3788999999999999999999999999999999999999999999999998765


Q ss_pred             CCC-cccCCcccccccCchHhHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHH
Q psy11580        215 GTT-FMMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNK  274 (288)
Q Consensus       215 ~~~-~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~  274 (288)
                      ... .......++..|+|||++.+     ..++.++|+||+|+++|+|++|..||...........
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~  227 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL  227 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence            432 22234568889999999863     3577899999999999999999999976655444433

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-32  Score=235.60  Aligned_cols=218  Identities=28%  Similarity=0.448  Sum_probs=172.7

Q ss_pred             hhhhcccccccccCCccccccccCccceec---cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYD---TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNA  129 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  129 (288)
                      ++....+.+++.+|+|.++.++.+.....+   ...+..||+|.++.. ........+.+|+++++++ +||||++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            445556788999999998888876432211   123457999998743 2334467788999999999 89999999999


Q ss_pred             ccCCCcccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                      +...+..      ++++||+++ +|.+.+..                  .+++..+..++.|++.||+|||+++++||||
T Consensus        87 ~~~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dl  160 (334)
T cd05100          87 CTQDGPL------YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDL  160 (334)
T ss_pred             EccCCce------EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence            9877655      999999986 55555432                  2677888999999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT  266 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~  266 (288)
                      ||+||+++.++.++|+|||+++.......   .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus       161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999876543221   122233467999999999889999999999999999998 89999988


Q ss_pred             CchhHHHHHHHH
Q psy11580        267 DHIDQWNKIIGK  278 (288)
Q Consensus       267 ~~~~~~~~i~~~  278 (288)
                      +..+....+.+.
T Consensus       241 ~~~~~~~~~~~~  252 (334)
T cd05100         241 PVEELFKLLKEG  252 (334)
T ss_pred             CHHHHHHHHHcC
Confidence            877776666543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-32  Score=228.86  Aligned_cols=214  Identities=24%  Similarity=0.292  Sum_probs=168.5

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ...++.+.+.+|+|.++.++.|............||+|.+.... .......+.+|+.++++++||||+++++++.. ..
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            34567788889998888877764221112223469999987542 23455678899999999999999999999876 33


Q ss_pred             ccccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                            .++|+||+++ ++.+.+..   .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+
T Consensus        83 ------~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          83 ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             ------eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccc
Confidence                  4999999986 46655543   4789999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc---CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        212 RTAGTTFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       212 ~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      .........   ....++..|+|||.+....++.++|+||||+++|++++ |..||.+.+..+....+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  226 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK  226 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Confidence            765432211   11223567999999988888999999999999999998 9999998877666555543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-32  Score=226.86  Aligned_cols=208  Identities=29%  Similarity=0.423  Sum_probs=169.1

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.+|+|.++.++.+    .+..++..+|+|.+............+..|++++++++|||++++++.+...+..    
T Consensus         3 ~~~~~lg~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~----   74 (256)
T cd08220           3 EKIRVVGRGAFGIVHLC----RRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL----   74 (256)
T ss_pred             eEEEEecccCceEEEEE----EEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE----
Confidence            34455666665555543    4566889999999976544555677889999999999999999999998766544    


Q ss_pred             cEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC-cEEEeeccccccc
Q psy11580        141 DVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA  214 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~-~~kl~dfg~~~~~  214 (288)
                        ++|+||+++ ++.+.+..    .+++..+..++.+++.+|++||+++++|+||+|+||+++.++ .++|+|||.+...
T Consensus        75 --~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          75 --MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             --EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence              999999987 46555542    378899999999999999999999999999999999998654 5799999999876


Q ss_pred             CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ..........++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+......++...
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~  216 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG  216 (256)
T ss_pred             CCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc
Confidence            5544444457788999999999888899999999999999999999999887766665555543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.3e-32  Score=227.27  Aligned_cols=189  Identities=27%  Similarity=0.481  Sum_probs=158.4

Q ss_pred             eccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccc-cHHHHHhh
Q psy11580         82 YDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM  159 (288)
Q Consensus        82 ~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~  159 (288)
                      .+..++..||+|++..... .......+..|+++++.++||||+++++.+......      ++++||+++ +|.+.+..
T Consensus        13 ~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~   86 (262)
T cd05572          13 KVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYI------YMLMEYCLGGELWTILRD   86 (262)
T ss_pred             EECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCcc------EEEEecCCCCcHHHHHhh
Confidence            4566789999999975322 234456788999999999999999999998776654      999999986 56666543


Q ss_pred             --hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhHhc
Q psy11580        160 --DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG  237 (288)
Q Consensus       160 --~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~  237 (288)
                        .++...+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++.............++..|+|||.+.+
T Consensus        87 ~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~  166 (262)
T cd05572          87 RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN  166 (262)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcC
Confidence              478899999999999999999999999999999999999999999999999987655433334567889999999988


Q ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chhHHHHHH
Q psy11580        238 MGYKENVDIWSVGCIMGEMIRGGVLFPGTD--HIDQWNKII  276 (288)
Q Consensus       238 ~~~~~~~Di~slg~il~~l~~g~~p~~~~~--~~~~~~~i~  276 (288)
                      ..++.++|+||+|+++|+|++|..||...+  ....+.++.
T Consensus       167 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  207 (262)
T cd05572         167 KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL  207 (262)
T ss_pred             CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh
Confidence            888999999999999999999999998776  555555555

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.6e-33  Score=233.39  Aligned_cols=215  Identities=28%  Similarity=0.445  Sum_probs=169.7

Q ss_pred             hhhcccccccccCCccccccccCccceec---cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccc
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYD---TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAF  130 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  130 (288)
                      +...++.+++.+|+|.++.++.+.....+   ..+...+|+|.++... .......+..|+++++.+ +||||+++++++
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            33456788999999988888876432111   1234679999998542 234456788899999999 799999999999


Q ss_pred             cCCCcccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCC
Q psy11580        131 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  191 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~  191 (288)
                      ...+..      ++||||+++ +|.+++..                  .+++.+++.++.|++.||+|||+.+++|+|||
T Consensus        94 ~~~~~~------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk  167 (307)
T cd05098          94 TQDGPL------YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA  167 (307)
T ss_pred             ecCCce------EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence            877654      999999986 56666542                  26788999999999999999999999999999


Q ss_pred             CCCEEEccCCcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy11580        192 PSNIVVKSDCTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTD  267 (288)
Q Consensus       192 ~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~  267 (288)
                      |+||+++.++.++|+|||.+........   .....++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+
T Consensus       168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             HHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            9999999999999999999876543211   111233467999999998889999999999999999998 899998776


Q ss_pred             chhHHHHHH
Q psy11580        268 HIDQWNKII  276 (288)
Q Consensus       268 ~~~~~~~i~  276 (288)
                      ..+....+.
T Consensus       248 ~~~~~~~~~  256 (307)
T cd05098         248 VEELFKLLK  256 (307)
T ss_pred             HHHHHHHHH
Confidence            655555443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.8e-32  Score=226.30  Aligned_cols=206  Identities=24%  Similarity=0.391  Sum_probs=164.2

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+...+|.|.++.++.+.     ...+..+|+|.+....   .....+.+|++++++++|+|++++++++... .  
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~-----~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~--   74 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGT-----WNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE-P--   74 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEE-----EcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-C--
Confidence            345666777887777776652     2233569999986422   2345678899999999999999999987543 2  


Q ss_pred             ccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                          .+++|||+.+ ++.+.+..    .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        75 ----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          75 ----IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             ----cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccce
Confidence                3899999986 57776643    26888999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        213 TAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       213 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      .......  .....++..|+|||...+..++.++|+||||+++|+|++ |..||.+.++.+...++.+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~  219 (260)
T cd05069         151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG  219 (260)
T ss_pred             EccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            6543221  122345677999999988889999999999999999999 99999988877776666544

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.3e-32  Score=237.94  Aligned_cols=214  Identities=25%  Similarity=0.383  Sum_probs=169.8

Q ss_pred             hhhhcccccccccCCccccccccCccce-eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAA-YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~  131 (288)
                      ++...++.+++.+|+|.++.++.+.-.- .+..+++.||+|+++... .......+.+|+++|.++. ||||+++++++.
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            5666778899999999999888764211 123456789999998542 2233457889999999997 999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHhh---------------------------------------------------
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQM---------------------------------------------------  159 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---------------------------------------------------  159 (288)
                      ..+..      ++||||+.+ +|.+.+..                                                   
T Consensus       112 ~~~~~------~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (401)
T cd05107         112 KGGPI------YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE  185 (401)
T ss_pred             cCCCc------EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence            77655      999999986 45555431                                                   


Q ss_pred             -------------------------------------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        160 -------------------------------------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       160 -------------------------------------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                                                                       .+++..+..++.||+.||+|||+.+++||||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdl  265 (401)
T cd05107         186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDL  265 (401)
T ss_pred             ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccC
Confidence                                                             1456678889999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT  266 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~  266 (288)
                      ||+||+++.++.++|+|||++.......   ......++..|+|||.+.+..++.++|+||||+++|||++ |..||...
T Consensus       266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         266 AARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             CcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999999999999999997543211   1123356788999999998889999999999999999998 89999876


Q ss_pred             CchhHHHH
Q psy11580        267 DHIDQWNK  274 (288)
Q Consensus       267 ~~~~~~~~  274 (288)
                      ...+....
T Consensus       346 ~~~~~~~~  353 (401)
T cd05107         346 PMNEQFYN  353 (401)
T ss_pred             CchHHHHH
Confidence            55554433

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.6e-33  Score=233.26  Aligned_cols=198  Identities=28%  Similarity=0.445  Sum_probs=161.8

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|+|.++.++.+    .+..+++.||+|.+...  .......+..|+.+++.++|+||+++++++...+..  
T Consensus        20 ~y~~~~~lg~g~~g~v~~~----~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~--   91 (297)
T cd06656          20 KYTRFEKIGQGASGTVYTA----IDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL--   91 (297)
T ss_pred             hceeeeeeccCCCeEEEEE----EECCCCCEEEEEEEecC--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE--
Confidence            3445566666666665554    45678999999999753  223346678899999999999999999999876654  


Q ss_pred             cccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                          ++||||++++ +.+.+. ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        92 ----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          92 ----WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             ----EEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence                9999999875 444443 3478889999999999999999999999999999999999999999999999876543


Q ss_pred             Ccc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        217 TFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       217 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      ... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~  220 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP  220 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            222 2334678889999999998889999999999999999999999977554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.6e-32  Score=226.47  Aligned_cols=209  Identities=24%  Similarity=0.404  Sum_probs=169.3

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +..+.+.+.+.+|+|.++.++++.     ..+++.||+|.+....   .....+.+|+.++++++|+||+++++++... 
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~-----~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   73 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGY-----YNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVTQE-   73 (260)
T ss_pred             cchHHceeeeeeccCccceEEeee-----cCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEccC-
Confidence            344567788889999888888863     3457889999997532   2346788999999999999999999987433 


Q ss_pred             cccccccEEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .      .+++||++.+ ++.+.+.    ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||
T Consensus        74 ~------~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg  147 (260)
T cd05067          74 P------IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFG  147 (260)
T ss_pred             C------cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCc
Confidence            2      4999999975 5666554    247889999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        210 LARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       210 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ++........  .....++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+....+.+.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  219 (260)
T cd05067         148 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG  219 (260)
T ss_pred             ceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Confidence            9876542221  122345678999999988888999999999999999998 99999988776666555443

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.8e-32  Score=227.23  Aligned_cols=212  Identities=21%  Similarity=0.337  Sum_probs=165.4

Q ss_pred             cccccccccCCccccccccCcccee-ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAY-DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..+.+.+.+|+|.++.++.+...-. ...++..||+|.+.... .......+..|+.+++.++|+||+++++++...+..
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4567778888888887776632110 01267789999987432 223345688899999999999999999998876654


Q ss_pred             cccccEEEEEecccc-cHHHHHhh---------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC---cE
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQM---------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TL  203 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~---~~  203 (288)
                            ++||||+++ ++.+.+..         .+++..+..++.||+.||+|||+++++|+||+|+||+++.++   .+
T Consensus        85 ------~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          85 ------FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             ------EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence                  999999975 56655542         378899999999999999999999999999999999998765   58


Q ss_pred             EEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHH
Q psy11580        204 KILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       204 kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~  276 (288)
                      +|+|||++........   ......+..|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+.
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~  235 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT  235 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999876533211   112233567999999998889999999999999999997 999999877766555443

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.1e-32  Score=229.27  Aligned_cols=215  Identities=20%  Similarity=0.304  Sum_probs=168.9

Q ss_pred             hhhcccccccccCCccccccccCccce-eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAA-YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      +...++.+.+.+|+|.++.++.|.... .....+..||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            344567788899999998888874321 122345689999987532 223345678899999999999999999998776


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD  200 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~  200 (288)
                      ...      ++||||+++ +|.+.+..            ..+...+..++.|++.||+|||+++++||||||+||+++.+
T Consensus        82 ~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~  155 (288)
T cd05061          82 QPT------LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD  155 (288)
T ss_pred             CCc------EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC
Confidence            654      999999985 55555532            13556788999999999999999999999999999999999


Q ss_pred             CcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHH
Q psy11580        201 CTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       201 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~  276 (288)
                      +.++|+|||++........   .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999875433211   122244677999999998889999999999999999998 899998877766655554

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.6e-32  Score=225.85  Aligned_cols=199  Identities=27%  Similarity=0.461  Sum_probs=164.7

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++.+.+.++++.++.++.+    ....++..|++|.++..    .....+.+|++++++++|+||+++++.+...... 
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~----~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~-   73 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKA----IHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDL-   73 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEE----EEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcE-
Confidence            34566777788777766665    34456789999999742    2267889999999999999999999999877654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                           ++++|+++++ +.+.+.   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus        74 -----~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~  148 (256)
T cd06612          74 -----WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ  148 (256)
T ss_pred             -----EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchh
Confidence                 9999999975 444443   3478999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        214 AGTTF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       214 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      ..... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...+...
T Consensus       149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~  206 (256)
T cd06612         149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR  206 (256)
T ss_pred             cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence            65433 2233457888999999999889999999999999999999999998765443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.2e-32  Score=226.26  Aligned_cols=216  Identities=20%  Similarity=0.331  Sum_probs=166.4

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.+|+|.++.++.+.-. .+..++..||||+++.........+++.+|++++++++||||+++++++..........
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLK-SEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             cchhcccCCCCCCEEeeEee-ccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            34566777777766665211 02346789999999876555566778899999999999999999999887543211112


Q ss_pred             cEEEEEeccccc-HHHHHh--------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        141 DVYLVMELMDAN-LCQVIQ--------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       141 ~~~lv~e~~~~~-l~~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      ..++++||+.++ +.+.+.        ..++...+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||.+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            347889998864 444432        13678889999999999999999999999999999999999999999999998


Q ss_pred             cccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        212 RTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       212 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      ........   .....+++.|++||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  230 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK  230 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Confidence            76533221   122344577999999998888999999999999999998 8999988777666555553

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-32  Score=224.85  Aligned_cols=205  Identities=26%  Similarity=0.400  Sum_probs=165.0

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      .+|.|.++.++.+.... +..++..|++|+++...... ....+.+|+++++.++|+||+++++++......      ++
T Consensus         2 ~ig~g~~g~v~~~~~~~-~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~------~l   73 (262)
T cd00192           2 KLGEGAFGEVYKGKLKG-KDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPL------YL   73 (262)
T ss_pred             ccccCCceEEEEEEEec-CCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCce------EE
Confidence            35566555555542110 00337899999998643332 467888999999999999999999999876554      99


Q ss_pred             EEeccc-ccHHHHHh-----------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        145 VMELMD-ANLCQVIQ-----------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       145 v~e~~~-~~l~~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      ||||++ +++.+.+.           ..+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||.+.
T Consensus        74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~  153 (262)
T cd00192          74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR  153 (262)
T ss_pred             EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccc
Confidence            999995 55666654           337899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        213 TAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       213 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      ......   ......++..|+|||.+....++.++|+||||+++++|++ |..||.+.+..+....+.+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~  222 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK  222 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            765432   2233456788999999998889999999999999999998 6999999877777766664

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.1e-32  Score=229.95  Aligned_cols=206  Identities=27%  Similarity=0.396  Sum_probs=167.8

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      +...+.+++|.++.++.+    .+..++..||+|++.... ........+..|+++++.++|||++++++++......  
T Consensus        27 f~~~~~lg~G~~~~v~~~----~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--  100 (317)
T cd06635          27 FTDLREIGHGSFGAVYFA----RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA--  100 (317)
T ss_pred             hhhhheeccCCCeEEEEE----EEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE--
Confidence            456666777777766654    345678999999987532 2334456788999999999999999999999876654  


Q ss_pred             cccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++||||+.+++.+.+.   ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus       101 ----~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         101 ----WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             ----EEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence                9999999998777664   347889999999999999999999999999999999999999999999999886544


Q ss_pred             CCcccCCcccccccCchHhHh---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        216 TTFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       216 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ..   ....++..|+|||.+.   ...++.++|+||||+++|+|++|..||.+.+....+..+...
T Consensus       177 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~  239 (317)
T cd06635         177 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN  239 (317)
T ss_pred             Cc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence            32   3346788899999984   345788999999999999999999999887666655555443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.7e-32  Score=229.48  Aligned_cols=212  Identities=23%  Similarity=0.339  Sum_probs=167.1

Q ss_pred             hcccccccccCCccccccccCccce------------eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAA------------YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNII  124 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~  124 (288)
                      ..++.+.+.+|+|.++.++++.-..            ....++..||+|++... ........+.+|+++++.++|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            3456788889998888888753210            12234567999999753 2334456788999999999999999


Q ss_pred             eeeccccCCCcccccccEEEEEecccc-cHHHHHhh-------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        125 GLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM-------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       125 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                      ++++++...+..      ++||||+.+ ++.+++..             .+++.++..++.|++.||+|||+.+++|+||
T Consensus        83 ~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl  156 (296)
T cd05095          83 RLLAVCITSDPL------CMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL  156 (296)
T ss_pred             eEEEEEecCCcc------EEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence            999999877655      999999985 56555542             2556789999999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR--GGVLFPG  265 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~--g~~p~~~  265 (288)
                      ||+||+++.++.++|+|||++........   ......+..|++||...+..++.++|+||||+++|+|++  |..||..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            99999999999999999999875433211   122234578999999988889999999999999999998  7899988


Q ss_pred             CCchhHHHHH
Q psy11580        266 TDHIDQWNKI  275 (288)
Q Consensus       266 ~~~~~~~~~i  275 (288)
                      .+..+.+...
T Consensus       237 ~~~~~~~~~~  246 (296)
T cd05095         237 LSDEQVIENT  246 (296)
T ss_pred             cChHHHHHHH
Confidence            7766655444

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.5e-32  Score=232.14  Aligned_cols=200  Identities=27%  Similarity=0.388  Sum_probs=163.9

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      .+.+.+++|.++.++.|    .+..+++.||+|++.... ........+.+|+++++.++||||+++++++...+..   
T Consensus        18 ~~~~~lg~g~~g~vy~~----~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~---   90 (307)
T cd06607          18 TDLREIGHGSFGAVYFA----RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA---   90 (307)
T ss_pred             hhheeecCCCCeEEEEE----EEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE---
Confidence            44566777777666654    345678999999986432 2334456788999999999999999999999877654   


Q ss_pred             ccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        140 QDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                         ++|+||+.+++.+.+.   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        91 ---~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          91 ---WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             ---EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence               9999999998777664   3588999999999999999999999999999999999999999999999999876543


Q ss_pred             CcccCCcccccccCchHhHh---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHH
Q psy11580        217 TFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWN  273 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~  273 (288)
                      .   ....++..|+|||++.   ...++.++||||||+++|+|++|..||.+.+......
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~  224 (307)
T cd06607         168 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY  224 (307)
T ss_pred             C---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH
Confidence            3   2346778899999985   3457889999999999999999999998766554433

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.8e-32  Score=222.94  Aligned_cols=201  Identities=24%  Similarity=0.402  Sum_probs=159.9

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      .+|+|.++.++.|.     ..++..||+|+++... .......+.+|+++++.++||||+++++++...+..      ++
T Consensus         2 ~ig~g~~g~vy~~~-----~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~l   69 (250)
T cd05085           2 LLGKGNFGEVFKGT-----LKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPI------YI   69 (250)
T ss_pred             ccCCCCCceEEEEE-----ecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCcc------EE
Confidence            45666666666552     3457889999987543 233345688999999999999999999999877654      99


Q ss_pred             EEeccccc-HHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCccc
Q psy11580        145 VMELMDAN-LCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMM  220 (288)
Q Consensus       145 v~e~~~~~-l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~  220 (288)
                      ||||++++ +.+.+..   .+++..+..++.|++.+|.|||+++++|+||+|+||+++.++.++|+|||++.........
T Consensus        70 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          70 VMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence            99999864 5555432   3788999999999999999999999999999999999999999999999998754332221


Q ss_pred             --CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        221 --TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       221 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                        ....++..|+|||++.+..++.++|+||||+++|++++ |..||.+.+.......+..
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~  209 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK  209 (250)
T ss_pred             cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc
Confidence              12234567999999988888999999999999999998 9999988776665555443

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-32  Score=224.88  Aligned_cols=206  Identities=26%  Similarity=0.421  Sum_probs=166.3

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCC---cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF---QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..++.+|+|.++.++.|    .+..+++.|++|.+....   ......+.+..|+++++.++|+||+++++++...... 
T Consensus         3 ~~~~~ig~g~~~~vy~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~-   77 (258)
T cd06632           3 RKGELLGSGSFGSVYEG----LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNL-   77 (258)
T ss_pred             cccceeeecCCceEEEE----EEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeE-
Confidence            34566777766666554    345678999999986532   1234567788999999999999999999998776654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++++||+++ ++.+.+.  ..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus        78 -----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~  152 (258)
T cd06632          78 -----YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQV  152 (258)
T ss_pred             -----EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence                 999999987 4555553  23788999999999999999999999999999999999999999999999998766


Q ss_pred             CCCcccCCcccccccCchHhHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                      ..........++..|+|||.+.... ++.++|+||||+++|+|++|+.||..........++.
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  215 (258)
T cd06632         153 VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG  215 (258)
T ss_pred             cccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH
Confidence            5443334556788899999998766 8899999999999999999999998776555444443

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.8e-32  Score=226.04  Aligned_cols=214  Identities=23%  Similarity=0.306  Sum_probs=168.3

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .+++...+.+|+|.++.++.+.-.. .......+|+|.++... .......+..|++++++++|+||+++.+++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~-~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKM-PGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEec-CCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            3456677788888877777653110 11223479999997532 234456788999999999999999999999877655


Q ss_pred             cccccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                            ++||||++++ +.+.+.   ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.
T Consensus        82 ------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          82 ------MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             ------EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccce
Confidence                  9999999875 444443   247889999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccc----CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        213 TAGTTFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       213 ~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ........    .....+..|+|||++.+..++.++|+||||+++|+|++ |..||...+..+....+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~  226 (268)
T cd05063         156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG  226 (268)
T ss_pred             ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC
Confidence            55332111    11123457999999998888999999999999999997 99999888877777777654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-32  Score=234.39  Aligned_cols=209  Identities=26%  Similarity=0.381  Sum_probs=164.8

Q ss_pred             hhhhcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  131 (288)
                      ++...++.+.+.||+|.++.++.+.-. +-+..+++.||||+++... .......+.+|+.++.++ +||||+++++++.
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            344567889999999999988887421 1234577899999997532 234456788999999999 6899999999886


Q ss_pred             CCCcccccccEEEEEeccccc-HHHHHhh---------------------------------------------------
Q psy11580        132 PQKSLEEFQDVYLVMELMDAN-LCQVIQM---------------------------------------------------  159 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~---------------------------------------------------  159 (288)
                      ..+.     ..+++|||++++ |.+.+..                                                   
T Consensus        82 ~~~~-----~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (343)
T cd05103          82 KPGG-----PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK  156 (343)
T ss_pred             cCCC-----ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence            5543     248999999864 4444321                                                   


Q ss_pred             ------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcc--
Q psy11580        160 ------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM--  219 (288)
Q Consensus       160 ------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~--  219 (288)
                                        .+++..+..++.|+++||+|||+++|+||||||+||+++.++.++|+|||++........  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  236 (343)
T cd05103         157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV  236 (343)
T ss_pred             ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh
Confidence                              256778889999999999999999999999999999999999999999999876432211  


Q ss_pred             -cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q psy11580        220 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDH  268 (288)
Q Consensus       220 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~  268 (288)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+...
T Consensus       237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  287 (343)
T cd05103         237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  287 (343)
T ss_pred             hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc
Confidence             122234567999999998889999999999999999997 9999987543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-32  Score=226.81  Aligned_cols=201  Identities=25%  Similarity=0.356  Sum_probs=156.4

Q ss_pred             cCCccccccccCccceeccCCCc--eEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccE
Q psy11580         66 MGKKRHNTSHLGAGAAYDTATQQ--NVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        66 ~~~~~~~~~~~g~g~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      +|+|.++.++.|    .+..++.  .+++|.++.. ........+..|+++++++ +||||+++++++...+..      
T Consensus         3 lg~g~~g~v~~~----~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~------   71 (270)
T cd05047           3 IGEGNFGQVLKA----RIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL------   71 (270)
T ss_pred             CCCCCCceEEEE----EEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCc------
Confidence            455555555443    2334444  5788888742 2334456788999999999 799999999999877655      


Q ss_pred             EEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcE
Q psy11580        143 YLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL  203 (288)
Q Consensus       143 ~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~  203 (288)
                      +++|||+++ ++.+.+..                  .+++..+..++.|++.||+|||+++++|+||||+||+++.++.+
T Consensus        72 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~  151 (270)
T cd05047          72 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  151 (270)
T ss_pred             eEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeE
Confidence            999999985 56665532                  26788999999999999999999999999999999999999999


Q ss_pred             EEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        204 KILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       204 kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      +|+|||++..............+..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+....+..
T Consensus       152 kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~  226 (270)
T cd05047         152 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  226 (270)
T ss_pred             EECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC
Confidence            9999999864322211122233567999999988889999999999999999997 9999988776666665543

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-32  Score=226.15  Aligned_cols=210  Identities=25%  Similarity=0.393  Sum_probs=168.3

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCC---cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF---QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ++.+++.+++|.++.++.+    .+..++..||+|.+....   ........+.+|++++++++|+||+++++++.....
T Consensus         3 ~~~~~~~lg~g~~g~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   78 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLC----YDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE   78 (264)
T ss_pred             ceeeeeeEccCCCeEEEEE----EEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence            4567788888887777765    456789999999885321   123445678899999999999999999999865421


Q ss_pred             ccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                          ..+++++||++++ +.+.+.  ..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        79 ----~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          79 ----KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             ----CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence                2358999999864 555554  347888999999999999999999999999999999999999999999999997


Q ss_pred             ccCCC----cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        213 TAGTT----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       213 ~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                      .....    .......++..|+|||.+.+..++.++|+||||+++++|++|+.||.+.+......++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  222 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA  222 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH
Confidence            64321    11123467888999999998888999999999999999999999998876655544443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.9e-32  Score=223.77  Aligned_cols=204  Identities=24%  Similarity=0.308  Sum_probs=161.3

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      .+|+|.++.++.+.... ...+...||+|.+...... ...+.+..|++++++++||||+++++.+.. ..      .++
T Consensus         2 ~ig~g~~~~v~~~~~~~-~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~------~~~   72 (257)
T cd05040           2 KLGDGSFGVVRRGEWST-SGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HP------LMM   72 (257)
T ss_pred             cCCccCcccEEeeeEec-CCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-Ce------EEE
Confidence            34555555555542110 0112337999999864333 566788999999999999999999999876 43      499


Q ss_pred             EEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcc
Q psy11580        145 VMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM  219 (288)
Q Consensus       145 v~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~  219 (288)
                      |+|++++ ++.+.+..    .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.+||+|||++........
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          73 VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             EEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence            9999975 56666543    378899999999999999999999999999999999999999999999999876543211


Q ss_pred             ----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        220 ----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       220 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                          .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~  215 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK  215 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence                122346678999999998889999999999999999998 9999988877776666654

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG2345|consensus

Probab=100.00  E-value=2.1e-33  Score=216.66  Aligned_cols=200  Identities=24%  Similarity=0.354  Sum_probs=163.0

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++++...+|.|.+.-++++.    +..+++-+|+|++..  .+.++.+...+|++..++++|||+++++++......- 
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~----~~s~~~~YAlKkI~c--~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D-   93 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVK----GLSTGHLYALKKILC--HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD-   93 (302)
T ss_pred             ceEEEeeeecCCCceeeeeec----ccCcccchhhheeec--cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc-
Confidence            455677777777777666654    467889999999986  3457788899999999999999999999998754430 


Q ss_pred             ccccEEEEEeccc-ccHHHHHhh------hCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCCEEEccCCcEEEeec
Q psy11580        138 EFQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       138 ~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~--ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      .....|++++|.. |++.+.+..      -+++.+++.++.++++||++||+..  +.||||||.||++++.+.++|.||
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence            1123589999987 458777752      3899999999999999999999998  999999999999999999999999


Q ss_pred             ccccccCCCccc----------CCcccccccCchHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCC
Q psy11580        209 GLARTAGTTFMM----------TPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMIRGGVLFP  264 (288)
Q Consensus       209 g~~~~~~~~~~~----------~~~~~~~~~~aPE~~~~~---~~~~~~Di~slg~il~~l~~g~~p~~  264 (288)
                      |.++...-....          ....+|..|+|||.+..+   ..+.++|||||||++|.|+.|..||.
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe  242 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE  242 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence            998764332211          234678999999999653   46789999999999999999999995

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.5e-32  Score=227.54  Aligned_cols=199  Identities=28%  Similarity=0.465  Sum_probs=162.8

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+++|.++.++.+    .+..+++.+|||.+... .........+.+|+++++.++|+||+++++++...+.. 
T Consensus         3 ~y~~~~~ig~g~~g~v~~~----~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~-   77 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRA----TCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL-   77 (267)
T ss_pred             hhhhhhhhcccCCeEEEEE----eecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeE-
Confidence            3456677788777766654    34568899999988642 22334456788999999999999999999999876654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                           +++||+++++ +.+.+.      ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||+
T Consensus        78 -----~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~  152 (267)
T cd08229          78 -----NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL  152 (267)
T ss_pred             -----EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchh
Confidence                 9999999864 555443      2378899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        211 ARTAGTTFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       211 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      +........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08229         153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             hhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence            876543322 233467889999999998889999999999999999999999997643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.4e-32  Score=226.23  Aligned_cols=209  Identities=25%  Similarity=0.384  Sum_probs=165.7

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCc---chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ---NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ++..++.+|+|.++.++.+    .+..+++.||+|++.....   .......+.+|+++++.++||||+++++++.....
T Consensus         3 ~~~~~~~lg~g~~g~vy~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLC----YDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE   78 (266)
T ss_pred             CccccceecCCCCEEEEEE----EEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence            3456677778777766654    4567889999999865322   22345678889999999999999999998865321


Q ss_pred             ccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                          ...++++||+++ ++.+.+.  ..+++...+.++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        79 ----~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          79 ----KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence                235899999986 4665554  347888999999999999999999999999999999999999999999999987


Q ss_pred             ccCCC----cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHH
Q psy11580        213 TAGTT----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       213 ~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i  275 (288)
                      .....    .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.+....+.++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~  221 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI  221 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence            54321    1112345788899999999988999999999999999999999999877655544443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.5e-32  Score=230.61  Aligned_cols=209  Identities=24%  Similarity=0.429  Sum_probs=166.3

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      +.+.+.+++|.++.++++    .+..+++.|++|.+..... .......+.+|+++++.++||||+++++.+...+..  
T Consensus         3 y~~~~~l~~g~~~~v~~~----~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~--   76 (305)
T cd05609           3 FETIKLISNGAYGAVYLV----RHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHL--   76 (305)
T ss_pred             ceEeeEeecCCCeeEEEE----EECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEE--
Confidence            445566777766666553    4667889999999875321 223455778999999999999999999999776654  


Q ss_pred             cccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++||||++++ +.+.+.  ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus        77 ----~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~  152 (305)
T cd05609          77 ----CMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL  152 (305)
T ss_pred             ----EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence                9999999875 544543  347888999999999999999999999999999999999999999999999886321


Q ss_pred             CCc----------------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        216 TTF----------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       216 ~~~----------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ...                ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~  231 (305)
T cd05609         153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD  231 (305)
T ss_pred             cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            100                011235677899999998888999999999999999999999999988777766666543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.9e-32  Score=228.19  Aligned_cols=181  Identities=32%  Similarity=0.450  Sum_probs=151.2

Q ss_pred             eccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccc-cHHHHHhh
Q psy11580         82 YDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM  159 (288)
Q Consensus        82 ~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~  159 (288)
                      .+..+|+.||+|++..... .......+..|++++++++||||+++++.+...+..      ++||||+++ ++.+.+..
T Consensus        13 ~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~   86 (277)
T cd05577          13 QVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDL------CLVMTLMNGGDLKYHIYN   86 (277)
T ss_pred             EEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeE------EEEEecCCCCcHHHHHHH
Confidence            4566789999999975322 223345567899999999999999999999776654      999999986 45555432


Q ss_pred             ----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhH
Q psy11580        160 ----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI  235 (288)
Q Consensus       160 ----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~  235 (288)
                          .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+
T Consensus        87 ~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~  166 (277)
T cd05577          87 VGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL  166 (277)
T ss_pred             cCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHh
Confidence                4889999999999999999999999999999999999999999999999998765543333445677889999999


Q ss_pred             hcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        236 LGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       236 ~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      .+..++.++|+||||+++++|++|+.||.....
T Consensus       167 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  199 (277)
T cd05577         167 QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE  199 (277)
T ss_pred             cCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence            888889999999999999999999999977544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=228.53  Aligned_cols=213  Identities=38%  Similarity=0.639  Sum_probs=174.4

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~  139 (288)
                      .+.+.+|+|.++.++.|    ....+++.|++|.+...... .......+|+..+++++ |+||+++++++...+..   
T Consensus         2 ~~~~~ig~g~~g~v~~~----~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~---   73 (283)
T cd07830           2 KVIKQLGDGTFGSVYLA----RNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL---   73 (283)
T ss_pred             eeheeeccCCceEEEEE----EECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE---
Confidence            34566777766666665    34456889999998754322 22334557999999998 99999999999876654   


Q ss_pred             ccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        140 QDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                         ++||||+++++.+.+..    .+++..+..++.|++.+|.|||+++++|+||+|+||+++.++.++|+|||.+....
T Consensus        74 ---~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~  150 (283)
T cd07830          74 ---YFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIR  150 (283)
T ss_pred             ---EEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceecc
Confidence               99999998888877753    47899999999999999999999999999999999999999999999999998765


Q ss_pred             CCcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        216 TTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       216 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      .........++..|+|||++.+ ..++.++|+||||+++++|++|++||.+.+..+.+.++.+.++.++.
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  220 (283)
T cd07830         151 SRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK  220 (283)
T ss_pred             CCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCCh
Confidence            5444445567888999998854 45789999999999999999999999999888888888877765543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-32  Score=229.29  Aligned_cols=199  Identities=24%  Similarity=0.385  Sum_probs=162.5

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      ..+.+++|.++.++.|    .+..++..||+|.++... .......+..|++++++++||||+++++.+......     
T Consensus         8 ~~~~l~~g~~~~vy~~----~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-----   77 (277)
T cd06642           8 KLERIGKGSFGEVYKG----IDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL-----   77 (277)
T ss_pred             HHHHhcCCCCeeEEEE----EEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCce-----
Confidence            3455677777766665    345678899999987532 234456788999999999999999999999876654     


Q ss_pred             EEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcc
Q psy11580        142 VYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM  219 (288)
Q Consensus       142 ~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~  219 (288)
                       ++|+||++++ +.+.+. ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus        78 -~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          78 -WIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             -EEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence             9999999975 444443 3478899999999999999999999999999999999999999999999999876543321


Q ss_pred             -cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhH
Q psy11580        220 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ  271 (288)
Q Consensus       220 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  271 (288)
                       .....++..|+|||++.+..++.++|+||||+++|+|++|..||...+....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~  209 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV  209 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH
Confidence             2234578889999999998899999999999999999999999986654443

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.1e-32  Score=225.02  Aligned_cols=208  Identities=27%  Similarity=0.463  Sum_probs=167.9

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.++.|.++.++.+    .+..++..||+|+++..........++..|+++++.++|+||+++++++.....    .
T Consensus         3 ~~~~~lg~g~~~~v~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~   74 (265)
T cd08217           3 EVLETIGKGSFGTVRKV----RRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN----Q   74 (265)
T ss_pred             eeeeeeccCCCeEEEEe----eecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC----C
Confidence            34455666666555543    456788999999997654455666788899999999999999999998764332    2


Q ss_pred             cEEEEEecccc-cHHHHHh------hhCCHHHHHHHHHHHHHHHHHHH-----HCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        141 DVYLVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLH-----SAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH-----~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      ..+++|||+++ ++.+.+.      ..+++..++.++.||+.||++||     +.+++|+||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            35899999986 4555543      24788999999999999999999     889999999999999999999999999


Q ss_pred             ccccccCCCcc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        209 GLARTAGTTFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       209 g~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                      |++........ .....+++.|+|||++.+..++.++|+||||+++++|++|..||.+.+.....+.+.
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  223 (265)
T cd08217         155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK  223 (265)
T ss_pred             cccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh
Confidence            99987655432 334568889999999998888999999999999999999999999877555544443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.1e-32  Score=224.27  Aligned_cols=207  Identities=23%  Similarity=0.364  Sum_probs=166.1

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+.     ...+..+|+|.++...   .....+..|++++++++|||++++++++...... 
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~-----~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-   74 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGY-----WLEKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPI-   74 (256)
T ss_pred             hHeEEEeeecCcccceEEEEE-----EeCCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCce-
Confidence            356677888888877777652     1246789999987532   2245688899999999999999999998776654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                           ++++||+.++ +.+.+.   ..+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 -----~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  149 (256)
T cd05112          75 -----CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF  149 (256)
T ss_pred             -----EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceee
Confidence                 9999999875 444443   2378899999999999999999999999999999999999999999999999875


Q ss_pred             cCCCccc--CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        214 AGTTFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       214 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      .......  ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  217 (256)
T cd05112         150 VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG  217 (256)
T ss_pred             cccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC
Confidence            5332211  12234578999999998889999999999999999998 99999887776666665543

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.5e-32  Score=227.87  Aligned_cols=213  Identities=22%  Similarity=0.312  Sum_probs=168.1

Q ss_pred             hcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ..++.+...+|.|.++.++.+... .....++..||+|++.... .......+..|+.++++++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            345677778888877777765321 1123467899999997532 23445678899999999999999999999987765


Q ss_pred             ccccccEEEEEecccc-cHHHHHhh------------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQM------------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~~------------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                      .      ++++||+++ ++.+++..                        .+++..++.++.|++.||++||+++++||||
T Consensus        83 ~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl  156 (288)
T cd05050          83 M------CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL  156 (288)
T ss_pred             c------EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence            5      999999986 55555531                        2567788999999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT  266 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~  266 (288)
                      +|+||+++.++.++|+|||++........   ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999875432211   122344667999999998889999999999999999997 88899887


Q ss_pred             CchhHHHHHH
Q psy11580        267 DHIDQWNKII  276 (288)
Q Consensus       267 ~~~~~~~~i~  276 (288)
                      +..+....+.
T Consensus       237 ~~~~~~~~~~  246 (288)
T cd05050         237 AHEEVIYYVR  246 (288)
T ss_pred             CHHHHHHHHh
Confidence            7766665554

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.6e-32  Score=224.70  Aligned_cols=208  Identities=25%  Similarity=0.422  Sum_probs=168.5

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.+|+|.++.++.+    .+..+++.||+|.+............+.+|+.++++++||||+++++++...+..    
T Consensus         3 ~~~~~lg~g~~g~~~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----   74 (256)
T cd08218           3 VKVKKIGEGSFGKAILV----KSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL----   74 (256)
T ss_pred             eEEEEeccCCceEEEEE----EEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE----
Confidence            44566677666655543    4566789999999975433445566788999999999999999999999776654    


Q ss_pred             cEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        141 DVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                        ++|+||+.+ ++.+.+..    .+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        75 --~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          75 --YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             --EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence              999999976 56665542    36888999999999999999999999999999999999999999999999987654


Q ss_pred             CCcc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        216 TTFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       216 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      .... .....+++.|+|||++.+..++.++|+||||+++++|++|..||...+..+...++...
T Consensus       153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~  216 (256)
T cd08218         153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG  216 (256)
T ss_pred             cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC
Confidence            4322 12345788899999999888899999999999999999999999887776666555443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.7e-32  Score=228.02  Aligned_cols=202  Identities=27%  Similarity=0.381  Sum_probs=162.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +.+.+.+.+|+|.++.++.+.....+..++..||+|.+...  .......+.+|++++++++||||+++++++...+.  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR--   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC--
Confidence            45677788899888888876544446678899999998752  34456678899999999999999999998754331  


Q ss_pred             ccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                        ...++|+||+++ +|.+.+..   .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        80 --~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          80 --RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             --CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence              235899999975 56666542   378999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCcc----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        214 AGTTFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       214 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      ......    .....++..|+|||++.+..++.++|+||||+++++|++|..++..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~  213 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS  213 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence            543221    1112234569999999988899999999999999999998776543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.6e-32  Score=225.86  Aligned_cols=208  Identities=25%  Similarity=0.402  Sum_probs=167.4

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.++.|.++.++.+    ....++..+|+|++....... ....+.+|+++++.++|+||+++++.+......  
T Consensus         2 ~y~~~~~lg~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--   74 (267)
T cd06610           2 DYELIEVIGVGATAVVYAA----ICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL--   74 (267)
T ss_pred             cceeeeeecCCCCeEEEEE----EEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEE--
Confidence            3456677777777666654    334578899999997543332 567889999999999999999999998776654  


Q ss_pred             cccEEEEEeccccc-HHHHHhh-----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                          ++++|+++++ +.+.+..     .+++..+..++.|++.||++||+.+++|+||+|+||++++++.++|+|||++.
T Consensus        75 ----~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~  150 (267)
T cd06610          75 ----WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSA  150 (267)
T ss_pred             ----EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHH
Confidence                9999999875 5555432     37888999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcc-----cCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        213 TAGTTFM-----MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       213 ~~~~~~~-----~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      .......     .....++..|+|||++... .++.++|+||||+++|+|++|+.||...+......++.+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~  221 (267)
T cd06610         151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ  221 (267)
T ss_pred             HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc
Confidence            5543221     1334578889999999876 788999999999999999999999988776555554443

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.9e-32  Score=222.59  Aligned_cols=211  Identities=24%  Similarity=0.394  Sum_probs=167.8

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.+|.|.++.++.+........++..||+|+++.. ........+..|+.+++.++|+||+++++++...+..    
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL----   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee----
Confidence            45667778777777665322211223489999999753 2223567889999999999999999999999877654    


Q ss_pred             cEEEEEecccc-cHHHHHh--hh--CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        141 DVYLVMELMDA-NLCQVIQ--MD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~--~~--~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                        +++||++++ ++.+.+.  ..  +++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus        77 --~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       77 --MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             --EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence              999999986 5555553  22  8999999999999999999999999999999999999999999999999997654


Q ss_pred             CCcccC--CcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        216 TTFMMT--PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       216 ~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ......  ...++..|+|||.+.+..++.++|+||||+++++|++ |..||.+.+..+....+.+.
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~  220 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG  220 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence            432211  1236688999999988888999999999999999998 89999887776666665543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.1e-32  Score=229.08  Aligned_cols=204  Identities=25%  Similarity=0.301  Sum_probs=161.5

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCc----eEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecccc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQ----NVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  131 (288)
                      ...++...+.+|+|.++.++.|.    +..++.    .||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~   79 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGI----WVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCL   79 (303)
T ss_pred             chhhceeccccccCCCccEEEEE----EecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            34566777788888887777653    223343    67999887532 2333456889999999999999999999987


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEee
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD  207 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~d  207 (288)
                      ...       .++++|++++ ++.+.+..   .+++..+..++.|++.||+|||+++++|+||||+||+++.++.+||+|
T Consensus        80 ~~~-------~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~D  152 (303)
T cd05110          80 SPT-------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITD  152 (303)
T ss_pred             CCC-------ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcc
Confidence            543       2789999985 56666543   478889999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhH
Q psy11580        208 FGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQ  271 (288)
Q Consensus       208 fg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~  271 (288)
                      ||++........   .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+.
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~  220 (303)
T cd05110         153 FGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI  220 (303)
T ss_pred             ccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999986543221   122344678999999998889999999999999999997 9999988765444

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.2e-32  Score=227.41  Aligned_cols=208  Identities=25%  Similarity=0.415  Sum_probs=163.3

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~  138 (288)
                      +.+.+.+|.|.++.++.|    .+..+++.||+|++..   .......+..|+.+++++ +|+||+++++++........
T Consensus        18 ~~~~~~lg~g~~~~v~~~----~~~~~~~~~a~K~~~~---~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          18 FELVEVVGNGTYGQVYKG----RHVKTGQLAAIKVMDV---TEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhheeeccCCCeEEEEE----EEcCCCcEEEEEEEec---ChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            355567788777777765    3566789999999864   223446688899999999 79999999999975432233


Q ss_pred             cccEEEEEeccccc-HHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      ...++++|||++++ +.+.+.    ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            45679999999874 555443    2377888899999999999999999999999999999999999999999999875


Q ss_pred             cCCC-cccCCcccccccCchHhHh-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHH
Q psy11580        214 AGTT-FMMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNK  274 (288)
Q Consensus       214 ~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~  274 (288)
                      .... .......+++.|+|||.+.     ...++.++|+||||+++|+|++|..||....+...+..
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~  237 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL  237 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence            5322 1223456888999999986     34577899999999999999999999987665444433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-32  Score=223.33  Aligned_cols=202  Identities=24%  Similarity=0.334  Sum_probs=159.5

Q ss_pred             ccCCccccccccCccceeccC--CCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTA--TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++.|.   +...  ++..||+|.+...... .....+..|+++++.++|+||+++++++....       .
T Consensus         2 ~ig~G~~g~v~~~~---~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------~   70 (257)
T cd05060           2 ELGHGNFGSVVKGV---YLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKGEP-------L   70 (257)
T ss_pred             ccCccCceeEEEeE---eeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCc-------e
Confidence            46666666666552   1122  3478999999864332 45667889999999999999999999876432       4


Q ss_pred             EEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcc
Q psy11580        143 YLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM  219 (288)
Q Consensus       143 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~  219 (288)
                      ++||||+.+ ++.+.+.  ..+++..+..++.|++.||++||..+++|+||+|+||+++.++.++|+|||.+........
T Consensus        71 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          71 MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            999999975 5666664  3488999999999999999999999999999999999999999999999999876533221


Q ss_pred             c----CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        220 M----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       220 ~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      .    ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~  213 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES  213 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence            1    11122457999999998889999999999999999997 9999988777666555543

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.8e-32  Score=233.83  Aligned_cols=215  Identities=33%  Similarity=0.648  Sum_probs=168.4

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc---
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS---  135 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---  135 (288)
                      ++.+.+.+|.|.++.++.|    .+..+++.||+|++...  .......+.+|+++++.++||||+++++.+.....   
T Consensus         6 ~y~~~~~Lg~g~~g~vy~~----~~~~~~~~v~iK~i~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           6 RYMDLRPLGCGSNGLVFSA----VDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             ceEEEEEecCCCCEEEEEE----EECCCCcEEEEEEEecC--CCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            3455566666666555543    56778999999998753  22445678899999999999999999988876532   


Q ss_pred             -----ccccccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc-CCcEEEeec
Q psy11580        136 -----LEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDF  208 (288)
Q Consensus       136 -----~~~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~-~~~~kl~df  208 (288)
                           .......++|+||+++++.+.+. ..+++..++.++.||++||+|||+.|++||||||+||+++. ++.++|+||
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             cccccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                 11123469999999988877665 35889999999999999999999999999999999999985 557899999


Q ss_pred             ccccccCCCcc----cCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        209 GLARTAGTTFM----MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       209 g~~~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      |.+........    .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.++.+...++.+..
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99876433211    122356788999998765 557889999999999999999999999888877776666543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.9e-32  Score=226.67  Aligned_cols=215  Identities=19%  Similarity=0.295  Sum_probs=169.7

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..++.+.+.+++|.++.++.|...-....++..|++|+++.. ........+..|+.+++.++|+||+++++++...+. 
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE-   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC-
Confidence            456677888999888888877432211224688999998743 344556778899999999999999999998876432 


Q ss_pred             cccccEEEEEecccc-cHHHHHh----------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEE
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ----------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI  205 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl  205 (288)
                          ..++++|++++ ++.+++.          ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||
T Consensus        83 ----~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          83 ----PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             ----CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence                24899999985 4555543          23788999999999999999999999999999999999999999999


Q ss_pred             eecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        206 LDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       206 ~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      +|||+++.......   .....++..|+|||++.+..++.++||||||+++|++++ |+.||.+.+..+....+.+
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  234 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD  234 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc
Confidence            99999975432211   122345667999999998889999999999999999998 9999988777665555444

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.1e-32  Score=223.84  Aligned_cols=198  Identities=27%  Similarity=0.436  Sum_probs=162.3

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.+|+|.++.++.|    .+..+++.|++|.++...........+..|+++++.++|+||+++++.+...+..    
T Consensus         3 ~~~~~lg~G~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~----   74 (264)
T cd06626           3 QRGNKIGGGTFGKVYTA----VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV----   74 (264)
T ss_pred             eeeeEeecCCCcEEEEE----EECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE----
Confidence            34566677666666554    3456789999999986544445678899999999999999999999998766554    


Q ss_pred             cEEEEEeccccc-HHHHHhhh--CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        141 DVYLVMELMDAN-LCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       141 ~~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                        ++|+||++++ +.+.+...  +++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        75 --~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          75 --YIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             --EEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence              9999999865 55555443  788999999999999999999999999999999999999999999999998765443


Q ss_pred             ccc-----CCcccccccCchHhHhcCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        218 FMM-----TPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       218 ~~~-----~~~~~~~~~~aPE~~~~~~---~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      ...     ....++..|+|||++.+..   .+.++||||||+++|++++|+.||.+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~  211 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN  211 (264)
T ss_pred             CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc
Confidence            221     1245678899999998765   78999999999999999999999977643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.9e-32  Score=224.52  Aligned_cols=193  Identities=17%  Similarity=0.216  Sum_probs=150.7

Q ss_pred             ccCCccccccccCcccee--------ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         65 QMGKKRHNTSHLGAGAAY--------DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~--------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .+|.|.++.++.|.....        .......|++|.+...  .......+.+|+.+++.++||||+++++++......
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            467777777777642100        1123346899998652  233445678899999999999999999999877655


Q ss_pred             cccccEEEEEecccccHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc-------EEE
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-------LKI  205 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~-------~kl  205 (288)
                            ++||||++++.++.+.    ..+++..+..++.||++||+|||+++++||||||+||+++.++.       +++
T Consensus        80 ------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          80 ------IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             ------EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence                  9999999976554433    23789999999999999999999999999999999999987654       899


Q ss_pred             eecccccccCCCcccCCcccccccCchHhHh-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCc
Q psy11580        206 LDFGLARTAGTTFMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMI-RGGVLFPGTDH  268 (288)
Q Consensus       206 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slg~il~~l~-~g~~p~~~~~~  268 (288)
                      +|||++......   ....++..|+|||.+. +..++.++||||||+++|+|+ .|..||.+...
T Consensus       154 ~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~  215 (262)
T cd05077         154 SDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL  215 (262)
T ss_pred             CCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence            999988654332   2345678899999987 466889999999999999998 58889876543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.7e-32  Score=230.45  Aligned_cols=184  Identities=24%  Similarity=0.346  Sum_probs=151.6

Q ss_pred             ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEeccccc-HHHHHh---
Q psy11580         83 DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-LCQVIQ---  158 (288)
Q Consensus        83 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~---  158 (288)
                      +..+++.||+|+++...........+..|+++++.++|+||+++++++...+..      +++|||++++ +.+.+.   
T Consensus        21 ~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~------~~~~e~~~~~~l~~~l~~~~   94 (314)
T cd08216          21 HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSEL------YVVSPLMAYGSCEDLLKTHF   94 (314)
T ss_pred             ecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeE------EEEEeccCCCCHHHHHHHhc
Confidence            355899999999986544556677899999999999999999999999877654      9999999965 444443   


Q ss_pred             -hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC--------cccCCccccccc
Q psy11580        159 -MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT--------FMMTPYVVTRYY  229 (288)
Q Consensus       159 -~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~~  229 (288)
                       ..+++..+..++.|++.||+|||+++|+|+||+|+||+++.++.++|+|||.+......        .......++..|
T Consensus        95 ~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  174 (314)
T cd08216          95 PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW  174 (314)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccc
Confidence             23788899999999999999999999999999999999999999999999988643221        111233567789


Q ss_pred             CchHhHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHH
Q psy11580        230 RAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW  272 (288)
Q Consensus       230 ~aPE~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~  272 (288)
                      +|||++.+  ..++.++|+||+|+++|+|++|..||.+.+....+
T Consensus       175 ~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~  219 (314)
T cd08216         175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML  219 (314)
T ss_pred             cCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999976  35788999999999999999999999886654433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5e-32  Score=223.64  Aligned_cols=208  Identities=22%  Similarity=0.377  Sum_probs=167.9

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +....+.+.+.+++|.++.++++.     ...+..+|+|.+..   .......+.+|+++++.++|+||+++++.+.. .
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~-----~~~~~~~~iK~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~   73 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMAT-----YNKHTKVAVKTMKP---GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E   73 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEE-----ecCCccEEEEecCC---ChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C
Confidence            445667788888888887777762     23456799999874   22345678899999999999999999999876 3


Q ss_pred             cccccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .      .+++|||+++ ++.+.+..    ..++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||
T Consensus        74 ~------~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~  147 (260)
T cd05073          74 P------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG  147 (260)
T ss_pred             C------eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCc
Confidence            3      3999999985 67666643    36788899999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        210 LARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       210 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      .+........  .....++..|+|||++.+..++.++|+||||++++++++ |..||.+.+..+....+.+
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~  218 (260)
T cd05073         148 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER  218 (260)
T ss_pred             ceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence            9876543221  122344567999999988888999999999999999998 9999998777666655544

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.5e-32  Score=225.61  Aligned_cols=196  Identities=18%  Similarity=0.197  Sum_probs=153.1

Q ss_pred             ccCCccccccccCccce--------------------eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcc
Q psy11580         65 QMGKKRHNTSHLGAGAA--------------------YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNII  124 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~--------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~  124 (288)
                      .||+|.++.++.|...+                    .+......|++|++...  .......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            46788888888775311                    11223357899999642  233455788899999999999999


Q ss_pred             eeeccccCCCcccccccEEEEEecccccHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC
Q psy11580        125 GLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD  200 (288)
Q Consensus       125 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~  200 (288)
                      ++++++...+..      ++||||++++.++.+.    ..+++..+..++.|++.||+|||+++|+||||||+||+++..
T Consensus        80 ~~~~~~~~~~~~------~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~  153 (274)
T cd05076          80 FVHGVCVRGSEN------IMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARL  153 (274)
T ss_pred             eEEEEEEeCCce------EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEecc
Confidence            999999877654      9999999987554443    237889999999999999999999999999999999999864


Q ss_pred             C-------cEEEeecccccccCCCcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCchhH
Q psy11580        201 C-------TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQ  271 (288)
Q Consensus       201 ~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~-~g~~p~~~~~~~~~  271 (288)
                      +       .++++|||.+......   ....++..|+|||.+.+ ..++.++|+||||+++|+|+ +|..||.+.++.+.
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             CcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence            3       3799999987543222   22356778999999876 56789999999999999985 69999987665443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0668|consensus

Probab=100.00  E-value=8.7e-33  Score=211.27  Aligned_cols=213  Identities=27%  Similarity=0.484  Sum_probs=175.7

Q ss_pred             ccccccccCCccccccccCccc------eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeecccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFT  131 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~  131 (288)
                      ...+.......|.+..++|.|+      ..+..+.+.|+||+++.     -..+.+.+|+++|+.|+ ||||++++++..
T Consensus        29 ~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~  103 (338)
T KOG0668|consen   29 SLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVK  103 (338)
T ss_pred             heeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence            3444444455666666666663      34567889999999974     44577899999999996 999999999998


Q ss_pred             CCCcccccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC-CcEEEeeccc
Q psy11580        132 PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL  210 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~-~~~kl~dfg~  210 (288)
                      +...    ..+.+|+|++.+.-+..+-..++...++.++.+++.||.|||+.||.|||+||.|++++.. -.++|+|||+
T Consensus       104 Dp~S----ktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGL  179 (338)
T KOG0668|consen  104 DPES----KTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGL  179 (338)
T ss_pred             Cccc----cCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecch
Confidence            7653    3458999999998777777788999999999999999999999999999999999999975 5689999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCC-CCCCCchhHHHHHHHHhC
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p-~~~~~~~~~~~~i~~~~~  280 (288)
                      |.+.-......-.+.+..|-.||.+... .++...|+|||||++..|+..+-| |.|.+..+++.+|.+.+|
T Consensus       180 AEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG  251 (338)
T KOG0668|consen  180 AEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG  251 (338)
T ss_pred             HhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence            9876555444555777888899999874 578899999999999999986665 578899999999999887

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.5e-32  Score=224.72  Aligned_cols=198  Identities=27%  Similarity=0.403  Sum_probs=160.9

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcc----hhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN----VTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..++.+|+|.++.++.+    .+..+++.||+|++......    ......+..|++++++++|+||+++++++...+..
T Consensus         3 ~~~~~lg~g~~~~v~~~----~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   78 (268)
T cd06630           3 LKGQQLGTGAFSSCYQA----RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHF   78 (268)
T ss_pred             cccceecCcCceEEEEE----EEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeE
Confidence            45667788777777764    35678899999999753211    22356788999999999999999999999877654


Q ss_pred             cccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC-cEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~-~~kl~dfg~~~  212 (288)
                            ++|+||+.++ +.+.+.  ..+++..+..++.|++.||++||+++++|+||+|+||+++.++ .++|+|||.+.
T Consensus        79 ------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~  152 (268)
T cd06630          79 ------NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAA  152 (268)
T ss_pred             ------EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence                  9999999875 444443  3478899999999999999999999999999999999998776 59999999987


Q ss_pred             ccCCCcc-----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        213 TAGTTFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       213 ~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      .......     .....++..|+|||.+.+..++.++|+||+|+++++|++|..||...+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  213 (268)
T cd06630         153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH  213 (268)
T ss_pred             ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            6543211     1234578899999999888889999999999999999999999976543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.4e-32  Score=225.58  Aligned_cols=203  Identities=26%  Similarity=0.498  Sum_probs=162.0

Q ss_pred             cccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEE
Q psy11580         64 HQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY  143 (288)
Q Consensus        64 ~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~  143 (288)
                      ..+|.|.++.++.+    .+..+++.+++|++..  ........+.+|+.+++.++||||+++++++...+..      +
T Consensus        25 ~~lg~g~~g~v~~~----~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~------~   92 (285)
T cd06648          25 VKIGEGSTGIVCIA----TDKSTGRQVAVKKMDL--RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL------W   92 (285)
T ss_pred             eEeccCCCeEEEEE----EECCCCCEEEEEEEec--cchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeE------E
Confidence            34555544444433    3456789999999864  2334456688999999999999999999998766554      9


Q ss_pred             EEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc-cc
Q psy11580        144 LVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-MM  220 (288)
Q Consensus       144 lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~  220 (288)
                      +++||++++ +.+.+. ..+++..+..++.|++.||++||+++++||||+|+||+++.++.++|+|||.+....... ..
T Consensus        93 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~  172 (285)
T cd06648          93 VVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR  172 (285)
T ss_pred             EEEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence            999999864 544443 357889999999999999999999999999999999999999999999999876543322 12


Q ss_pred             CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       221 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+......++...
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~  230 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN  230 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc
Confidence            3346788999999999888999999999999999999999999887766666555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5e-32  Score=225.70  Aligned_cols=200  Identities=25%  Similarity=0.389  Sum_probs=162.7

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      ..+.+|+|.++.++.|    .+..++..||+|+++... .......+..|++++++++|+||+++++++......     
T Consensus         8 ~~~~lg~g~~~~vy~~----~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-----   77 (277)
T cd06640           8 KLERIGKGSFGEVFKG----IDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL-----   77 (277)
T ss_pred             hhhhcccCCCeEEEEE----EEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE-----
Confidence            3455667666666554    345678899999987532 234467788999999999999999999999876654     


Q ss_pred             EEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc-
Q psy11580        142 VYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-  218 (288)
Q Consensus       142 ~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-  218 (288)
                       ++||||++++ +.+.+. ..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        78 -~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          78 -WIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             -EEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence             9999999875 555544 457888999999999999999999999999999999999999999999999987654322 


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHH
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW  272 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~  272 (288)
                      ......++..|+|||++.+..++.++|+||||+++|+|++|..||.+.++....
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~  210 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL  210 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh
Confidence            123345678899999999888999999999999999999999999876654433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.8e-32  Score=222.67  Aligned_cols=198  Identities=28%  Similarity=0.436  Sum_probs=165.3

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.++.+.++..+.+    .+..+++.|++|++...... .....+..|++.+++++|+|++++++++...+..  
T Consensus         2 ~~~~~~~i~~g~~~~v~~~----~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--   74 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKV----RHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI--   74 (264)
T ss_pred             cceeeeeeeecCCeEEEEE----EEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE--
Confidence            3456677777766665554    45668999999999764322 4567889999999999999999999999877654  


Q ss_pred             cccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        139 FQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       139 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                          ++|+||+++ ++.+.+.  ..+++..+..++.|+++||++||+ .+++|+||+|+||+++.++.++|+|||.+...
T Consensus        75 ----~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          75 ----SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             ----EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence                999999995 5655554  458999999999999999999999 99999999999999999999999999998866


Q ss_pred             CCCccc-CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        215 GTTFMM-TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       215 ~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ...... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         151 ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             ccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            443332 24467888999999998888999999999999999999999998774

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.8e-32  Score=223.67  Aligned_cols=212  Identities=24%  Similarity=0.346  Sum_probs=167.7

Q ss_pred             hhcccccccccCCccccccccCccceecc-CCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDT-ATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.+|+|.++.++.|...  +. .+...||+|...... .....+.+..|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~--~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   80 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYM--SPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITENP   80 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEe--cCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCC
Confidence            3456678888888888877776321  11 234579999987532 2345567889999999999999999999987543


Q ss_pred             cccccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                             .++||||+++ ++.+.+..   .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus        81 -------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~  153 (270)
T cd05056          81 -------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGL  153 (270)
T ss_pred             -------cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCce
Confidence                   3899999986 46555542   378999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        211 ARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       211 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                      +........  .....++..|+|||.+....++.++||||||++++++++ |..||.+.+..+....+.+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~  223 (270)
T cd05056         154 SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN  223 (270)
T ss_pred             eeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Confidence            876543321  122234567999999988889999999999999999996 9999988877666655543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.1e-32  Score=225.32  Aligned_cols=195  Identities=29%  Similarity=0.463  Sum_probs=161.4

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +...+.+|+|.++.++.    +.+..+++.||+|.+..... ......+.+|++++++++||||+++++.+...+..   
T Consensus         3 ~~~~~~ig~g~~~~v~~----~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~---   74 (265)
T cd06605           3 LEYLGELGAGNSGVVSK----VLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI---   74 (265)
T ss_pred             chHHHHhcCCCCeEEEE----EEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEE---
Confidence            34555667766665554    35667889999999976432 35567788999999999999999999999877654   


Q ss_pred             ccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        140 QDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       140 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                         ++++|++++ ++.+.+.   ..+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||.+...
T Consensus        75 ---~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          75 ---SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             ---EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence               999999995 5655554   457889999999999999999999 99999999999999999999999999998765


Q ss_pred             CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ....... ..++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus       152 ~~~~~~~-~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         152 VNSLAKT-FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             HHHHhhc-ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            4332222 56788899999999988999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.6e-32  Score=223.98  Aligned_cols=198  Identities=29%  Similarity=0.485  Sum_probs=162.8

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.++.|.++.++.+    .+..+++.||+|.++.. .........+.+|++++++++|+|++++++.+...+.. 
T Consensus         3 ~y~~~~~lg~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~-   77 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKA----ICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNEL-   77 (267)
T ss_pred             ceeeeeeeccCCceEEEEE----EEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE-
Confidence            4566777788777776665    34568899999998642 23334466788999999999999999999999876654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                           ++||||+++ ++.+.+.      ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        78 -----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~  152 (267)
T cd08224          78 -----NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL  152 (267)
T ss_pred             -----EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccce
Confidence                 999999986 4555443      2378899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        211 ARTAGTTFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       211 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      +........ .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             eeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence            876543221 23346788899999999888999999999999999999999999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG4645|consensus

Probab=100.00  E-value=2.2e-34  Score=264.36  Aligned_cols=199  Identities=26%  Similarity=0.362  Sum_probs=166.3

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      .+..+|.|+++.++.+    .+..+|.-.|+|.++......+....+.+|++++..++|||+|+.||+-...+..     
T Consensus      1239 rg~~Ig~G~fG~VYta----vN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv----- 1309 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTA----VNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV----- 1309 (1509)
T ss_pred             cccccCCcceeeeEEe----ecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH-----
Confidence            4455666666666653    5789999999999987655566678899999999999999999999999887765     


Q ss_pred             EEEEEecccccHHHHHh-h--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        142 VYLVMELMDANLCQVIQ-M--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       142 ~~lv~e~~~~~l~~~~~-~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                       +|.||||+++.+..+. .  ..++.....+..|+++|++|||+.|||||||||.||+++.+|.+|++|||.|.....+.
T Consensus      1310 -~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1310 -YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             -HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence             8999999987665554 2  26666778899999999999999999999999999999999999999999998765432


Q ss_pred             -----ccCCcccccccCchHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        219 -----MMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       219 -----~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                           ......||+.|||||++.+.   ....++||||||||+.||++|+.||...+.+=
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~ 1448 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW 1448 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh
Confidence                 23456899999999999873   45679999999999999999999998876544

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.5e-32  Score=230.37  Aligned_cols=191  Identities=21%  Similarity=0.277  Sum_probs=152.9

Q ss_pred             eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccc-cHHHHHh-
Q psy11580         81 AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ-  158 (288)
Q Consensus        81 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-  158 (288)
                      +.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++...+..      ++|+||+.+ ++.+.+. 
T Consensus        19 a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~------~~v~e~~~~~~l~~~l~~   92 (328)
T cd08226          19 ARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL------WVISPFMAYGSANSLLKT   92 (328)
T ss_pred             EEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce------EEEEecccCCCHHHHHHh
Confidence            35667899999999986544445567888999999999999999999999877655      999999986 4555444 


Q ss_pred             ---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcc--------cCCccccc
Q psy11580        159 ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM--------MTPYVVTR  227 (288)
Q Consensus       159 ---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~  227 (288)
                         ..+++..+..++.|++.||+|||+++++||||||+||+++.++.++++||+.+........        .....++.
T Consensus        93 ~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (328)
T cd08226          93 YFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVL  172 (328)
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCcc
Confidence               2378889999999999999999999999999999999999999999999986532211100        01123456


Q ss_pred             ccCchHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        228 YYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       228 ~~~aPE~~~~~--~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      .|+|||++.+.  .++.++||||||+++|+|++|..||.+.........+..
T Consensus       173 ~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  224 (328)
T cd08226         173 PWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK  224 (328)
T ss_pred             CccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc
Confidence            69999999763  468899999999999999999999998776655554443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-31  Score=222.38  Aligned_cols=198  Identities=28%  Similarity=0.404  Sum_probs=156.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +.......+|+|.++.++.|    .+..++..||+|.+...  .......+.+|+++++.++|+||+++++++...+.. 
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~----~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-   80 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAA----RDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF-   80 (268)
T ss_pred             ccCCceEEEecCCceEEEEe----EecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE-
Confidence            34444456666666666654    34567889999998752  334556788999999999999999999999877654 


Q ss_pred             ccccEEEEEecccc-cHHHHHhh---hC--CHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc-CCcEEEeeccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQM---DL--DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGL  210 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~---~~--~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~-~~~~kl~dfg~  210 (288)
                           ++|+||+++ +|.+.+..   .+  +...+..++.|++.||+|||+++|+|+||+|+||+++. ++.++|+|||.
T Consensus        81 -----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~  155 (268)
T cd06624          81 -----KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGT  155 (268)
T ss_pred             -----EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchh
Confidence                 999999986 45555543   23  77888899999999999999999999999999999986 67899999999


Q ss_pred             ccccCCCc-ccCCcccccccCchHhHhcCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        211 ARTAGTTF-MMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       211 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      +....... ......++..|+|||.+.+..  ++.++|+||||+++|+|++|..||....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~  215 (268)
T cd06624         156 SKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG  215 (268)
T ss_pred             heecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence            87653321 223345788999999987643  7889999999999999999999997643

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.3e-32  Score=226.45  Aligned_cols=218  Identities=28%  Similarity=0.451  Sum_probs=170.8

Q ss_pred             hhhhcccccccccCCccccccccCccceec-cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYD-TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  131 (288)
                      .+...++.+.+.+|+|.++.++.+...... ......+|+|.+.... .......+.+|+++++++ +|+||+++++++.
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            344456677788888888877776432211 2345789999997542 234456788999999999 8999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh------------------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCC
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ------------------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP  192 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~------------------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~  192 (288)
                      ..+..      +++|||+++ ++.+.+.                  ..+++..++.++.|++.||+|||+.+++|+||||
T Consensus        87 ~~~~~------~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp  160 (293)
T cd05053          87 QEGPL------YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAA  160 (293)
T ss_pred             CCCCe------EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccce
Confidence            77655      999999986 4555542                  2378889999999999999999999999999999


Q ss_pred             CCEEEccCCcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q psy11580        193 SNIVVKSDCTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDH  268 (288)
Q Consensus       193 ~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~  268 (288)
                      +||+++.++.++|+|||++........   .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            999999999999999999976543211   122234567999999988889999999999999999997 9999988777


Q ss_pred             hhHHHHHHHH
Q psy11580        269 IDQWNKIIGK  278 (288)
Q Consensus       269 ~~~~~~i~~~  278 (288)
                      .+....+...
T Consensus       241 ~~~~~~~~~~  250 (293)
T cd05053         241 EELFKLLKEG  250 (293)
T ss_pred             HHHHHHHHcC
Confidence            6666555443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.9e-32  Score=221.33  Aligned_cols=204  Identities=28%  Similarity=0.404  Sum_probs=166.3

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.++.|.++..+.+    .+..+++.+|+|.+............+.+|+++++.++|+||+++++++......    
T Consensus         3 ~~~~~i~~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----   74 (256)
T cd08530           3 KVLKKLGKGSYGSVYKV----KRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL----   74 (256)
T ss_pred             eEeeeecCCCceeEEEE----EECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE----
Confidence            34555666655555543    4566889999999986444445566788999999999999999999999877554    


Q ss_pred             cEEEEEeccccc-HHHHHhh------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        141 DVYLVMELMDAN-LCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       141 ~~~lv~e~~~~~-l~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                        ++|+||+++. +.+.+..      .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        75 --~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          75 --CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             --EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhh
Confidence              9999999764 5554432      378889999999999999999999999999999999999999999999999877


Q ss_pred             cCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHH
Q psy11580        214 AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       214 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i  275 (288)
                      .... ......++..|+|||.+.+..++.++|+||||+++++|++|+.||...+.......+
T Consensus       153 ~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~  213 (256)
T cd08530         153 LKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV  213 (256)
T ss_pred             hccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            6544 223356788999999999988899999999999999999999999887765544443

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-32  Score=224.16  Aligned_cols=211  Identities=26%  Similarity=0.414  Sum_probs=166.3

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.++++.++.++.+    .+..+++.+++|++...   ......+.+|+.+++++ +|+||+++++++.......
T Consensus         7 ~y~~~~~l~~g~~~~v~~~----~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKA----RHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             heeheeeecCCCCeEEEEE----EECCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            4566777788777766664    45567889999999753   23456788999999999 7999999999997655322


Q ss_pred             ccccEEEEEeccccc-HHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      ....+++||||++++ +.+.+.      ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            334569999999974 444332      3478999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-cccCCcccccccCchHhHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        211 ARTAGTT-FMMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       211 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                      +...... .......++..|+|||++..     ..++.++||||||+++++|++|..||.+.+....+.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  231 (275)
T cd06608         160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP  231 (275)
T ss_pred             ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh
Confidence            8754332 22234567889999999864     246778999999999999999999998766555554444

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-31  Score=225.35  Aligned_cols=202  Identities=24%  Similarity=0.444  Sum_probs=162.0

Q ss_pred             cccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEE
Q psy11580         64 HQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY  143 (288)
Q Consensus        64 ~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~  143 (288)
                      ..+|+|.++.++.+    ....+++.||+|.+..  ........+.+|+.+++.++|+||+++++.+...+..      +
T Consensus        26 ~~lg~g~~g~v~~~----~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~   93 (292)
T cd06657          26 IKIGEGSTGIVCIA----TVKSSGKLVAVKKMDL--RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL------W   93 (292)
T ss_pred             HHcCCCCCeEEEEE----EEcCCCeEEEEEEecc--cchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE------E
Confidence            34555555554443    3456889999999864  2334456788999999999999999999999876654      9


Q ss_pred             EEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc-cc
Q psy11580        144 LVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-MM  220 (288)
Q Consensus       144 lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~  220 (288)
                      ++|||++++.+..+.  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657          94 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             EEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence            999999876444333  347899999999999999999999999999999999999999999999999886553322 12


Q ss_pred             CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       221 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      ....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+..
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~  230 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD  230 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            334678889999999888889999999999999999999999988776655554443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=9.3e-32  Score=225.63  Aligned_cols=211  Identities=26%  Similarity=0.408  Sum_probs=163.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+...++++.++.++.+    .+..+++.+|+|++...   ......+.+|+.+++++ +|||++++++++...+. 
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~----~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~-   93 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKV----TNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK-   93 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEE----EECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc-
Confidence            34556666777666665553    45678899999999742   22345677899999999 89999999999875432 


Q ss_pred             cccccEEEEEeccccc-HHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      ......++|+||++++ +.+.+.      ..+++..++.++.|++.||++||+.+++|+||+|+||+++.++.++|+|||
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg  173 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG  173 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence            1223569999999874 444432      347899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc-ccCCcccccccCchHhHhcC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        210 LARTAGTTF-MMTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       210 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                      ++....... ......++..|+|||.+...     .++.++|+||||+++|+|++|+.||...++...+.++.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~  246 (291)
T cd06639         174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP  246 (291)
T ss_pred             cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence            987654322 22334678889999998653     25789999999999999999999998877655555443

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG4279|consensus

Probab=100.00  E-value=3.5e-33  Score=242.70  Aligned_cols=200  Identities=31%  Similarity=0.433  Sum_probs=165.2

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      .+.+-.-.-++|.|..+.+|-|    .|..++...|||-+..  .+....+-+.+|+.+.++++|.|||+.+|.+..++.
T Consensus       573 eyde~~ervVLGKGTYG~VYA~----RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf  646 (1226)
T KOG4279|consen  573 EYDESNERVVLGKGTYGTVYAA----RDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGF  646 (1226)
T ss_pred             eecCCCceEEeecCceeEEEee----ccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCe
Confidence            3344444455666666665544    5778889999999974  344556678999999999999999999999988776


Q ss_pred             ccccccEEEEEecccccHHHHHhh----hC--CHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc-CCcEEEeec
Q psy11580        136 LEEFQDVYLVMELMDANLCQVIQM----DL--DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDF  208 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~l~~~~~~----~~--~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~-~~~~kl~df  208 (288)
                      +      -|.||-.+|+.++.+..    ++  ++.++..+..||++||.|||++.|||||||-+|+|++- .|.+||+||
T Consensus       647 ~------kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDF  720 (1226)
T KOG4279|consen  647 F------KIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDF  720 (1226)
T ss_pred             E------EEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEeccc
Confidence            5      89999999887766652    24  78899999999999999999999999999999999974 689999999


Q ss_pred             ccccccCC-CcccCCcccccccCchHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        209 GLARTAGT-TFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       209 g~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      |.++.... .....++.||..|||||++...  .|+.++|||||||.+.||.||++||....
T Consensus       721 GTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg  782 (1226)
T KOG4279|consen  721 GTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG  782 (1226)
T ss_pred             ccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence            99987543 4445678999999999999763  58899999999999999999999997643

>KOG0596|consensus

Probab=100.00  E-value=2.2e-32  Score=232.20  Aligned_cols=199  Identities=28%  Similarity=0.453  Sum_probs=164.9

Q ss_pred             ccccccCCccccccccCcc---ceeccC--CCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCC
Q psy11580         61 PISHQMGKKRHNTSHLGAG---AAYDTA--TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQK  134 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g---~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  134 (288)
                      .+-..-|+.|.+...+|.|   +|+...  +.+.+|+|.+.....+....+-+..|++.|.+| .|.+|+++++|-..++
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            3445556667777666666   466543  448899999887777888899999999999999 5999999999999887


Q ss_pred             cccccccEEEEEecccccHHHHHhhh---CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        135 SLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      .+      |||||+=+.+|-+.+...   ...-.++.+..||+.|+.++|+.||||.||||.|+|+- .|.+||+|||.|
T Consensus       434 ~l------YmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA  506 (677)
T KOG0596|consen  434 YL------YMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIA  506 (677)
T ss_pred             eE------EEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechh
Confidence            76      999999999988888643   33237888999999999999999999999999999996 568999999999


Q ss_pred             cccCCC---cccCCcccccccCchHhHhcCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        212 RTAGTT---FMMTPYVVTRYYRAPEVILGMG-----------YKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       212 ~~~~~~---~~~~~~~~~~~~~aPE~~~~~~-----------~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ......   ......+||+.||+||.+....           .+.++||||||||||+|+.|+.||...
T Consensus       507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~  575 (677)
T KOG0596|consen  507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI  575 (677)
T ss_pred             cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence            876543   3346679999999999996532           457899999999999999999999753

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.8e-32  Score=225.00  Aligned_cols=200  Identities=25%  Similarity=0.367  Sum_probs=165.1

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..++.+.+.+|+|.++.++.+    .+..++..||+|++.... .......+.+|+++++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~----~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKV----KHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI   78 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEE----EEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence            345667788888888777765    356678999999987532 234457788999999999999999999999877654


Q ss_pred             cccccEEEEEecccccHHH-HHh--hhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDANLCQ-VIQ--MDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~-~~~--~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                            ++|+||++++.+. .+.  ..+++..+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++.
T Consensus        79 ------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~  152 (284)
T cd06620          79 ------CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG  152 (284)
T ss_pred             ------EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCccc
Confidence                  9999999976444 433  347899999999999999999997 589999999999999999999999999986


Q ss_pred             ccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      ...... .....++..|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus       153 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~  207 (284)
T cd06620         153 ELINSI-ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI  207 (284)
T ss_pred             chhhhc-cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence            543322 2234688999999999888889999999999999999999999986554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.6e-32  Score=222.92  Aligned_cols=205  Identities=25%  Similarity=0.360  Sum_probs=159.7

Q ss_pred             ccCCccccccccCccceec--cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYD--TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+|+|.++.++.|......  ...+..+|+|.+.... .......+.+|+++++.++||||+++++++...+..      
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------   74 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQ------   74 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCe------
Confidence            4566666666665432111  2234689999986532 224456788999999999999999999999877654      


Q ss_pred             EEEEecccc-cHHHHHhh---------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC-----cEEEee
Q psy11580        143 YLVMELMDA-NLCQVIQM---------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-----TLKILD  207 (288)
Q Consensus       143 ~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~-----~~kl~d  207 (288)
                      ++||||+++ ++.+.+..         .+++..+..++.|++.||+|||+++++|+||+|+||+++.++     .++|+|
T Consensus        75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence            999999985 56665542         267788999999999999999999999999999999999877     899999


Q ss_pred             cccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHH
Q psy11580        208 FGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       208 fg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~  276 (288)
                      ||++........   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~  227 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT  227 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh
Confidence            999875433211   122345678999999998889999999999999999998 999998776665554443

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-31  Score=220.67  Aligned_cols=202  Identities=28%  Similarity=0.452  Sum_probs=157.9

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHH-HHCCCCCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLM-KLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .++.|.++.++.+    .+..+++.||+|++.+... .......+..|..++ ...+|+|++++++++...+..      
T Consensus         3 ~l~~g~~~~v~~a----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~------   72 (260)
T cd05611           3 PISKGAFGSVYLA----KKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL------   72 (260)
T ss_pred             cCCcCCCeeEEEE----EecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE------
Confidence            3555555555543    4556789999999975321 122233344555444 445899999999999876654      


Q ss_pred             EEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcc
Q psy11580        143 YLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM  219 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~  219 (288)
                      ++|+||++++ |.+.+.  ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....   
T Consensus        73 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---  149 (260)
T cd05611          73 YLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---  149 (260)
T ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence            9999999875 544443  3478999999999999999999999999999999999999999999999998876443   


Q ss_pred             cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       220 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+....+..+....
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  209 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR  209 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence            233467888999999998888999999999999999999999999888777766665443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.8e-31  Score=220.41  Aligned_cols=206  Identities=23%  Similarity=0.344  Sum_probs=154.3

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      .+|+|.++.++.|.-.. ....+..||+|.+... ........+..|+.+++.++||||+++++++...+.     ..++
T Consensus         2 ~lg~g~~g~v~~~~~~~-~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~~~l   74 (262)
T cd05058           2 VIGKGHFGCVYHGTLID-SDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG-----SPLV   74 (262)
T ss_pred             cccccCCceEEEEEEec-CCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC-----CcEE
Confidence            34565555555542110 1234568999998632 233446678899999999999999999998754332     2489


Q ss_pred             EEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc--
Q psy11580        145 VMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF--  218 (288)
Q Consensus       145 v~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--  218 (288)
                      ++||+.+ ++.+++..   ..++..+..++.|+++||+|||+.+++||||+|+||+++.++.+||+|||++.......  
T Consensus        75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            9999986 55555542   35677888999999999999999999999999999999999999999999987543211  


Q ss_pred             ---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q psy11580        219 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       219 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~  277 (288)
                         ......++..|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+.+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~  217 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ  217 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence               1112344678999999988889999999999999999999 5777877666555554443

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-31  Score=218.88  Aligned_cols=199  Identities=25%  Similarity=0.414  Sum_probs=157.1

Q ss_pred             cCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEE
Q psy11580         66 MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV  145 (288)
Q Consensus        66 ~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv  145 (288)
                      +|.|.++.++.+    .+.. ++.||+|+++..... .....+..|++++++++|+||+++++++......      ++|
T Consensus         3 lg~g~~g~v~~~----~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~------~~v   70 (251)
T cd05041           3 IGKGNFGDVYKG----VLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPI------YIV   70 (251)
T ss_pred             cccCCCceEEEE----EEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCe------EEE
Confidence            445444444443    2334 899999999764332 3556788999999999999999999999877654      999


Q ss_pred             Eeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCccc-
Q psy11580        146 MELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMM-  220 (288)
Q Consensus       146 ~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-  220 (288)
                      +|++.++ +.+.+.   ..++...+..++.+++.+|+|||+++++||||+|+||+++.++.++|+|||++......... 
T Consensus        71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            9999764 655553   23788899999999999999999999999999999999999999999999998765422111 


Q ss_pred             --CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHH
Q psy11580        221 --TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       221 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~  276 (288)
                        .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+.......+.
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~  209 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE  209 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh
Confidence              11223567999999988889999999999999999998 899998877655554444

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.6e-31  Score=222.79  Aligned_cols=190  Identities=24%  Similarity=0.379  Sum_probs=147.1

Q ss_pred             cCCccccccccCccceeccCCCceEEEEeccCCCcch-hhHHHHHHH---HHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         66 MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV-THAKRAYRE---FKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        66 ~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      +|+|.++.++.+    .+..+++.||+|++....... .....+..|   ++.++...||+|+.+++++...+..     
T Consensus         2 ig~g~~g~Vy~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~-----   72 (278)
T cd05606           2 IGRGGFGEVYGC----RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL-----   72 (278)
T ss_pred             cccCCCeEEEEE----EEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEE-----
Confidence            345555554443    345678999999987532221 112223333   3445556799999999999877654     


Q ss_pred             EEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        142 VYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       142 ~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                       ++||||+.++ |...+.  ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        73 -~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~  151 (278)
T cd05606          73 -SFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (278)
T ss_pred             -EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence             9999999875 444443  347899999999999999999999999999999999999999999999999987654332


Q ss_pred             ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        219 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      . ....++..|+|||++.+ ..++.++|+||+|+++|+|++|..||.+.
T Consensus       152 ~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         152 P-HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             C-cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            2 33478899999999975 45789999999999999999999999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG2052|consensus

Probab=100.00  E-value=3e-32  Score=225.94  Aligned_cols=198  Identities=28%  Similarity=0.446  Sum_probs=164.4

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC--CCCCcceeeccccCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV--NHKNIIGLLNAFTPQ  133 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~  133 (288)
                      ....+.+.+.+|+|.++.++.|      .+-|+.||||++..     .+...+.+|.++++..  +|+||+.+++.=..+
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG------~wrGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRG------RWRGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             hhheeEEEEEecCccccceeec------cccCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            4467888999999999999999      78899999999974     4456788888888876  999999999886544


Q ss_pred             CcccccccEEEEEeccc-ccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHC--------CCEeecCCCCCEEEccCCcE
Q psy11580        134 KSLEEFQDVYLVMELMD-ANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDCTL  203 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--------~ivH~dl~~~nil~~~~~~~  203 (288)
                      .  ...+++++|++|.+ |+|++++. ..++.+..++++..+++||++||..        .|.|||||++|||+.++++.
T Consensus       278 ~--gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  278 N--GSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             C--CceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence            4  45688999999998 56888876 4589999999999999999999943        39999999999999999999


Q ss_pred             EEeecccccccCC-----CcccCCcccccccCchHhHhcCC----C--CchhhHHHHHHHHHHHHhC----------CCC
Q psy11580        204 KILDFGLARTAGT-----TFMMTPYVVTRYYRAPEVILGMG----Y--KENVDIWSVGCIMGEMIRG----------GVL  262 (288)
Q Consensus       204 kl~dfg~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~----~--~~~~Di~slg~il~~l~~g----------~~p  262 (288)
                      .|+|+|+|..-..     .......+||.+|||||++...-    +  -..+||||||.|+||++.+          ++|
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            9999999975433     23346679999999999997521    2  1479999999999998853          678


Q ss_pred             CCCC
Q psy11580        263 FPGT  266 (288)
Q Consensus       263 ~~~~  266 (288)
                      |.+.
T Consensus       436 yyd~  439 (513)
T KOG2052|consen  436 YYDV  439 (513)
T ss_pred             cccC
Confidence            8763

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.7e-31  Score=225.04  Aligned_cols=201  Identities=26%  Similarity=0.410  Sum_probs=163.1

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      ...+|+|.++.++.|    .+..+++.|++|++..... .......+..|+++++.++|||++++++++......     
T Consensus        26 ~~~lg~g~~g~v~~~----~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-----   96 (313)
T cd06633          26 LHEIGHGSFGAVYFA----TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA-----   96 (313)
T ss_pred             ceeeccCCCeEEEEE----EECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE-----
Confidence            344666666665554    3566889999999975322 333446788999999999999999999999876654     


Q ss_pred             EEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        142 VYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       142 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                       ++||||+.+++.+.+.   ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.....  
T Consensus        97 -~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633          97 -WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             -EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence             9999999988877664   3478899999999999999999999999999999999999999999999998865332  


Q ss_pred             ccCCcccccccCchHhHh---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        219 MMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                       .....++..|+|||.+.   ...++.++|+||||+++|+|++|..||.+.+.......+.
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~  233 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA  233 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence             23456788899999985   3557889999999999999999999998876655554443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0603|consensus

Probab=100.00  E-value=1.2e-32  Score=237.86  Aligned_cols=189  Identities=31%  Similarity=0.458  Sum_probs=154.2

Q ss_pred             CCccccccccCcc------ceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCccccc
Q psy11580         67 GKKRHNTSHLGAG------AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        67 ~~~~~~~~~~g~g------~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      .+.|.....+|.|      .+.+..++...++|++.+.      ..+..+|+.++... +||||+++.+.+.+....   
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~---  391 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI---  391 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceecCCcee---
Confidence            4455555555555      2456788899999999864      22344678777777 799999999999988766   


Q ss_pred             ccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE-ccCCcEEEeecccccccCC
Q psy11580        140 QDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       140 ~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~-~~~~~~kl~dfg~~~~~~~  216 (288)
                         ++|||.+.|+ +++.+. .......+..|+.+|+.|+.|||++|+|||||||+|||+ +..++++|+|||.++....
T Consensus       392 ---~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  392 ---YLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             ---eeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence               9999999986 344333 223336777899999999999999999999999999999 6889999999999987665


Q ss_pred             CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy11580        217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI  269 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~  269 (288)
                      .  ..+.+.|..|.|||++....++.++|+||||++||+|++|+.||......
T Consensus       469 ~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~  519 (612)
T KOG0603|consen  469 S--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG  519 (612)
T ss_pred             h--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence            5  33457789999999999999999999999999999999999999887665

>KOG3653|consensus

Probab=100.00  E-value=9.9e-32  Score=224.39  Aligned_cols=190  Identities=27%  Similarity=0.411  Sum_probs=156.5

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC--CCCCcceeeccccCCC
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV--NHKNIIGLLNAFTPQK  134 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~  134 (288)
                      ..++.+.+.+++|.++.++.|      .-+++.||||++..     .+.+.|+.|-++.+..  +|+||++++++-....
T Consensus       209 l~pl~l~eli~~Grfg~V~Ka------qL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t  277 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKA------QLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT  277 (534)
T ss_pred             CCchhhHHHhhcCccceeehh------hccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence            467788888999999988887      66789999999964     5567788888888876  7999999999876554


Q ss_pred             cccccccEEEEEecccc-cHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHC---------CCEeecCCCCCEEEccCCcE
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSA---------GIIHRDLKPSNIVVKSDCTL  203 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---------~ivH~dl~~~nil~~~~~~~  203 (288)
                      .  ....+++|++|.++ +|.+++. ..++|....+++..+++||+|||+.         .|+|||||++|||+..|++.
T Consensus       278 ~--~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  278 A--DRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             c--cccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence            2  23457999999986 4666665 4499999999999999999999953         49999999999999999999


Q ss_pred             EEeecccccccCCCccc---CCcccccccCchHhHhcC-CCC-----chhhHHHHHHHHHHHHhC
Q psy11580        204 KILDFGLARTAGTTFMM---TPYVVTRYYRAPEVILGM-GYK-----ENVDIWSVGCIMGEMIRG  259 (288)
Q Consensus       204 kl~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~-~~~-----~~~Di~slg~il~~l~~g  259 (288)
                      .|+|||+|.........   ...+||.+|||||++.|. .+.     .+.||||+|.|+|||+++
T Consensus       356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SR  420 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASR  420 (534)
T ss_pred             EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhh
Confidence            99999999876543222   236899999999999883 222     468999999999999986

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.7e-31  Score=222.55  Aligned_cols=216  Identities=29%  Similarity=0.471  Sum_probs=173.3

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~  136 (288)
                      ++.+.+.+|+|.++.++.+    .+..++..||+|++.... ........+..|++++++++ ||||+++++++...+..
T Consensus         2 ~y~~~~~lg~g~~~~vy~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   77 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLA----KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL   77 (280)
T ss_pred             CceEeeeecCCCceEEEEE----EEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence            3456667777777766654    345689999999997532 22344567888999999998 99999999999877654


Q ss_pred             cccccEEEEEeccc-ccHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMD-ANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                            ++|||+++ +++.+.+..  .+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus        78 ------~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~  151 (280)
T cd05581          78 ------YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKV  151 (280)
T ss_pred             ------EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccc
Confidence                  99999995 566666653  489999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc---------------------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHH
Q psy11580        214 AGTTF---------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW  272 (288)
Q Consensus       214 ~~~~~---------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~  272 (288)
                      .....                     ......++..|+|||+..+..++.++|+||||++++++++|+.||...+.....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  231 (280)
T cd05581         152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF  231 (280)
T ss_pred             cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence            54322                     112335678899999998888899999999999999999999999988776666


Q ss_pred             HHHHHHhCCCcc
Q psy11580        273 NKIIGKMREAHD  284 (288)
Q Consensus       273 ~~i~~~~~~~~~  284 (288)
                      +.+.......|.
T Consensus       232 ~~~~~~~~~~~~  243 (280)
T cd05581         232 QKILKLEYSFPP  243 (280)
T ss_pred             HHHHhcCCCCCC
Confidence            666654444443

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.6e-31  Score=220.81  Aligned_cols=190  Identities=32%  Similarity=0.515  Sum_probs=157.2

Q ss_pred             eccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccc-cHHHHHh-
Q psy11580         82 YDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ-  158 (288)
Q Consensus        82 ~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-  158 (288)
                      .+..+++.+++|++..... .......+.+|++++++++||||+++++.+...+..      ++++|++.+ ++.+.+. 
T Consensus        13 ~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~   86 (265)
T cd05579          13 KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNL------YLVMEYLPGGDLASLLEN   86 (265)
T ss_pred             EECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEE------EEEEecCCCCcHHHHHHH
Confidence            4456789999999975322 234556788999999999999999999998766654      999999986 5555554 


Q ss_pred             -hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc---------ccCCcccccc
Q psy11580        159 -MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF---------MMTPYVVTRY  228 (288)
Q Consensus       159 -~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~  228 (288)
                       ..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++.......         ......++..
T Consensus        87 ~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (265)
T cd05579          87 VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD  166 (265)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCcc
Confidence             357899999999999999999999999999999999999999999999999987543321         1233456788


Q ss_pred             cCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        229 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       229 ~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      |+|||...+...+.++|+||||++++++++|..||...+..+....+..
T Consensus       167 ~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~  215 (265)
T cd05579         167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN  215 (265)
T ss_pred             ccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            9999999888889999999999999999999999988877776666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-31  Score=221.37  Aligned_cols=204  Identities=27%  Similarity=0.449  Sum_probs=160.9

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcc--------hhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN--------VTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      .+++.+|+|.++.++.|    .+..+++.||+|.++.....        ....+.+..|+++++.++|+|++++++++..
T Consensus         4 ~~~~~lg~g~~~~vy~~----~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   79 (272)
T cd06629           4 VKGELIGKGTYGRVYLA----LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT   79 (272)
T ss_pred             eecceecccCceEEEEE----eecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc
Confidence            45667777777776665    34567899999998642111        1123467789999999999999999999987


Q ss_pred             CCcccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        133 QKSLEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .+..      ++|+||+.++ +.+.+.  ..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||
T Consensus        80 ~~~~------~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          80 EEYL------SIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             CCce------EEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecc
Confidence            6654      9999999865 555443  347888999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc---ccCCcccccccCchHhHhcCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHH
Q psy11580        210 LARTAGTTF---MMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNK  274 (288)
Q Consensus       210 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~  274 (288)
                      ++.......   ......++..|+|||.+....  ++.++|+||||+++|++++|..||...+..+.+.+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  223 (272)
T cd06629         154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK  223 (272)
T ss_pred             ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH
Confidence            987643321   122345788899999988754  78999999999999999999999976655444433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.3e-31  Score=219.03  Aligned_cols=205  Identities=18%  Similarity=0.295  Sum_probs=156.6

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      .+|+|.++.+++|.  ..+......+++|.++... .......+.+|+.+++.++||||+++++.+......      ++
T Consensus         2 ~lg~G~~g~v~~~~--~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~------~l   72 (268)
T cd05086           2 EIGNGWFGKVLLSE--IYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPY------LL   72 (268)
T ss_pred             cCCCCcCceEEEEE--EEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCcc------EE
Confidence            36677777666652  2233344567788776432 234467889999999999999999999999876654      99


Q ss_pred             EEecccc-cHHHHHhh------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        145 VMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       145 v~e~~~~-~l~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ||||+++ +|.+++..      ..+...+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~  152 (268)
T cd05086          73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE  152 (268)
T ss_pred             EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc
Confidence            9999996 55555542      2456677899999999999999999999999999999999999999999987643221


Q ss_pred             ---cccCCcccccccCchHhHhc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        218 ---FMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       218 ---~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                         .......++..|+|||++..       ..++.++||||||+++|+|++ |..||...++.+.+..+...
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  224 (268)
T cd05086         153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD  224 (268)
T ss_pred             hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh
Confidence               11233467888999999853       235779999999999999996 67899887777766665543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.98  E-value=2.1e-31  Score=221.92  Aligned_cols=204  Identities=25%  Similarity=0.393  Sum_probs=165.4

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      ...+.+|.|.++.++.|    .+..+++.||+|++.... .......+.+|++++++++||||+++++.+......    
T Consensus         7 ~~~~~ig~G~~~~vy~~----~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~----   77 (277)
T cd06641           7 TKLEKIGKGSFGEVFKG----IDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL----   77 (277)
T ss_pred             hhheeEeecCCeEEEEE----EECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeE----
Confidence            34556777777766664    345678999999986432 234456788999999999999999999999877654    


Q ss_pred             cEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        141 DVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       141 ~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                        ++||||++++ +.+.+. ..+++..+..++.|++.++++||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 --~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          78 --WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             --EEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence              9999999875 554443 458899999999999999999999999999999999999999999999999987654322


Q ss_pred             -ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHH
Q psy11580        219 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       219 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i  275 (288)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  213 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI  213 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH
Confidence             123346788899999998888899999999999999999999999877665544443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.98  E-value=1.6e-31  Score=219.97  Aligned_cols=206  Identities=27%  Similarity=0.451  Sum_probs=165.0

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.+++|.++.++.+    .+..++..||+|.+............+.+|+++++.++|+||+++++.+...+..    
T Consensus         3 ~~~~~l~~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~----   74 (257)
T cd08225           3 EIIKKIGEGSFGKIYLA----KAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL----   74 (257)
T ss_pred             eEEEEecCCCcceEEEE----EEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE----
Confidence            45566677666665554    4566788999999975433334556788999999999999999999999777654    


Q ss_pred             cEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc-EEEeeccccccc
Q psy11580        141 DVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTA  214 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~-~kl~dfg~~~~~  214 (288)
                        ++|+||+.+ ++.+.+..    .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||.+...
T Consensus        75 --~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          75 --FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             --EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence              999999976 56555542    3688999999999999999999999999999999999998864 699999998765


Q ss_pred             CCCcc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        215 GTTFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       215 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                      ..... .....+++.|+|||++.+..++.++|+||||+++++|++|..||...+......++.
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  215 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC  215 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence            44322 123457888999999988888999999999999999999999998776655544433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.98  E-value=1.1e-31  Score=225.44  Aligned_cols=200  Identities=28%  Similarity=0.455  Sum_probs=161.5

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.+|+|.++.++.+    .+..+++.||+|.+...  .......+..|+.+++.++||||+++++.+......  
T Consensus        20 ~~~~~~~lg~g~~g~v~~~----~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~--   91 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTA----IDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL--   91 (293)
T ss_pred             hceeeeEecCCCCeEEEEE----EEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE--
Confidence            3445566677666655554    34567889999998642  233456788999999999999999999999776654  


Q ss_pred             cccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                          ++|+||++++ +.+.+. ..+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus        92 ----~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          92 ----WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             ----EEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence                9999999864 555554 3478889999999999999999999999999999999999999999999998865443


Q ss_pred             Cc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        217 TF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       217 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      .. ......+++.|+|||.+.+..++.++|+||||+++|++++|+.||...+...
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~  222 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR  222 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence            22 2233467888999999988888999999999999999999999998765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.98  E-value=2.4e-31  Score=223.41  Aligned_cols=204  Identities=17%  Similarity=0.171  Sum_probs=150.1

Q ss_pred             cccccccccCCccccccccCccceeccCC---CceEEEEeccCCCcchhh---------HHHHHHHHHHHHHCCCCCcce
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTAT---QQNVAIKKLSRPFQNVTH---------AKRAYREFKLMKLVNHKNIIG  125 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~---~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~  125 (288)
                      .++.+.+.+|+|.++.++.|.    ...+   +..+|+|+..........         ......+...+..++|+|+++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~----~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQ----CASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             CceEEeeEEecCCCceEEEEE----EcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            456677778887777777653    2233   556777765432211100         011223344556678999999


Q ss_pred             eeccccCCCcccccccEEEEEecccccHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcE
Q psy11580        126 LLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL  203 (288)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~  203 (288)
                      +++++......  ....+++++++..++.+.+..  ..++..+..++.|++.||+|||+++++||||||+|||++.++.+
T Consensus        88 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         88 YYGCGSFKRCR--MYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             EEEeeeEecCC--ceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            99976544321  112478888887766555442  36788889999999999999999999999999999999999999


Q ss_pred             EEeecccccccCCC--------cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        204 KILDFGLARTAGTT--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       204 kl~dfg~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      +|+|||++......        .......+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999754321        11123468999999999999999999999999999999999999998874

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.98  E-value=1.8e-31  Score=223.23  Aligned_cols=209  Identities=23%  Similarity=0.403  Sum_probs=161.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+.+++|.++.++.+    .+..+++.+|+|+++..   ......+..|+.+++.+ +||||+++++++..... 
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~----~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-   89 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKV----LNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV-   89 (286)
T ss_pred             cceeeeeeeccCCCcEEEEE----EECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc-
Confidence            34456667777766666543    45677899999998642   12245677899999999 69999999998854321 


Q ss_pred             cccccEEEEEeccccc-HHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      ......++||||++++ |.+.+.      ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence            2234569999999875 444432      247788899999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc-ccCCcccccccCchHhHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHH
Q psy11580        210 LARTAGTTF-MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNK  274 (288)
Q Consensus       210 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~  274 (288)
                      ++....... ......+++.|+|||++..     ..++.++|+||+|+++|+|++|+.||.+.+....+.+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~  240 (286)
T cd06638         170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK  240 (286)
T ss_pred             ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence            987654322 2233468899999999853     3468899999999999999999999987665444433

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=4.7e-31  Score=216.33  Aligned_cols=190  Identities=32%  Similarity=0.522  Sum_probs=159.3

Q ss_pred             eccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEeccc-ccHHHHHhh
Q psy11580         82 YDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM  159 (288)
Q Consensus        82 ~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~  159 (288)
                      .+..+++.||+|++..... .......+..|+++++.++|+||+++++.+...+..      ++|||+++ +++.+.+..
T Consensus        13 ~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~~v~e~~~~~~L~~~l~~   86 (250)
T cd05123          13 RKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL------YLVLEYAPGGELFSHLSK   86 (250)
T ss_pred             EECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCee------EEEEecCCCCcHHHHHHh
Confidence            3455789999999975322 223456788999999999999999999999776655      99999995 567666653


Q ss_pred             --hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC-cccCCcccccccCchHhHh
Q psy11580        160 --DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT-FMMTPYVVTRYYRAPEVIL  236 (288)
Q Consensus       160 --~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~  236 (288)
                        .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||...
T Consensus        87 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  166 (250)
T cd05123          87 EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL  166 (250)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhC
Confidence              4789999999999999999999999999999999999999999999999998765443 2234456788899999999


Q ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        237 GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       237 ~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      +...+.++|+||||+++|++++|..||...+.......+.+
T Consensus       167 ~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~  207 (250)
T cd05123         167 GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK  207 (250)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            88889999999999999999999999988877666666665

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=3.9e-31  Score=221.44  Aligned_cols=197  Identities=25%  Similarity=0.387  Sum_probs=158.7

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +...+.+|.|.++.++.+    .+..+++.||+|.+.... .......+.+|++++++++||||+++++++.....    
T Consensus         3 ~~~~~~lg~g~~~~v~~~----~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----   73 (287)
T cd06621           3 IVELSRLGEGAGGSVTKC----RLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS----   73 (287)
T ss_pred             eEEEEEeccCCceEEEEE----EECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC----
Confidence            344556666666655554    456688999999997532 22456778999999999999999999999865431    


Q ss_pred             ccEEEEEeccccc-HHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        140 QDVYLVMELMDAN-LCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       140 ~~~~lv~e~~~~~-l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      ..+++||||++++ |.+.+.      ..++...+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            2459999999874 444332      237888999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus       154 ~~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         154 ELVNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             ccccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            5543222 2345678899999999888999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.98  E-value=3.1e-31  Score=218.11  Aligned_cols=207  Identities=30%  Similarity=0.462  Sum_probs=168.9

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.++.|.++.++.+    .+..++..|++|++............+.+|+++++.++|+|++++.+.+...+..    
T Consensus         3 ~~~~~l~~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~----   74 (258)
T cd08215           3 EIIKQIGKGSFGKVYLV----RRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL----   74 (258)
T ss_pred             eEEeeeccCCCeEEEEE----EEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE----
Confidence            34455666555555543    4566789999999986544556677889999999999999999999998876544    


Q ss_pred             cEEEEEecccc-cHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        141 DVYLVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                        ++|+|++++ ++.+.+.      ..+++..+..++.+++.||++||+.+++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          75 --CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             --EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceee
Confidence              999999986 5555553      3478999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        214 AGTTF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       214 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      ..... ......+++.|+|||...+..++.++|+||+|+++++|++|..||...+.......+.+
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~  217 (258)
T cd08215         153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK  217 (258)
T ss_pred             cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc
Confidence            55433 22345678889999999988899999999999999999999999988776555554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=2.2e-31  Score=219.42  Aligned_cols=191  Identities=17%  Similarity=0.202  Sum_probs=148.6

Q ss_pred             ccCCccccccccCccceec------cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         65 QMGKKRHNTSHLGAGAAYD------TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+|+|.++.++.|......      ......|++|.+....   .....+.+|+.+++.++||||+++++++.. +..  
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~--   75 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN--   75 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc--
Confidence            3566666666554321111      1112468888876421   226778899999999999999999999876 433  


Q ss_pred             cccEEEEEecccccH-HHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC-------cEEEee
Q psy11580        139 FQDVYLVMELMDANL-CQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-------TLKILD  207 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l-~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~-------~~kl~d  207 (288)
                          ++|+||++++. .+.+..   .+++..+..++.||+.||+|||+++++|+||||+||+++.++       .++|+|
T Consensus        76 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          76 ----IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             ----EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence                99999999764 444432   478899999999999999999999999999999999999887       799999


Q ss_pred             cccccccCCCcccCCcccccccCchHhHhcC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q psy11580        208 FGLARTAGTTFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIR-GGVLFPGTDH  268 (288)
Q Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slg~il~~l~~-g~~p~~~~~~  268 (288)
                      ||++......   ....++..|+|||++.+.  .++.++|+||||+++|+|++ |..||...+.
T Consensus       152 fg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~  212 (259)
T cd05037         152 PGIPITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS  212 (259)
T ss_pred             CCcccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence            9998765442   234566789999999876  78899999999999999998 6888877653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.98  E-value=1.7e-31  Score=223.33  Aligned_cols=199  Identities=22%  Similarity=0.316  Sum_probs=157.6

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.+|+|.++.++++.-......++..||+|.++... .......+.+|+++++.++||||+++++++...+.    
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----   80 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG----   80 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC----
Confidence            3556667777777776653222235678899999997532 33445678999999999999999999999876521    


Q ss_pred             ccEEEEEeccccc-HHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        140 QDVYLVMELMDAN-LCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       140 ~~~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      ...++||||++++ |.+.+..   .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            2348999999764 5555532   37899999999999999999999999999999999999999999999999987654


Q ss_pred             CCcc----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy11580        216 TTFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF  263 (288)
Q Consensus       216 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~  263 (288)
                      ....    .....++..|+|||.+.+..++.++||||||+++|+|++++.|+
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            3211    12334566799999999888999999999999999999977654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.98  E-value=3.4e-31  Score=220.90  Aligned_cols=191  Identities=24%  Similarity=0.381  Sum_probs=147.4

Q ss_pred             cCCccccccccCccceeccCCCceEEEEeccCCCcchhh-HHHHHHHHHHHHH---CCCCCcceeeccccCCCccccccc
Q psy11580         66 MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTH-AKRAYREFKLMKL---VNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        66 ~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~---l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      +|+|.++.++.+    .+..+++.||+|.+......... ...+..|..+++.   .+||||+.+++++...+..     
T Consensus         2 lg~G~~g~Vy~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~-----   72 (279)
T cd05633           2 IGRGGFGEVYGC----RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKL-----   72 (279)
T ss_pred             cccCCCeEEEEE----EECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeE-----
Confidence            455555555543    35667899999999753322121 2233444444433   4799999999999877654     


Q ss_pred             EEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        142 VYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       142 ~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                       ++||||++++ +.+.+.  ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus        73 -~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          73 -CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             -EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence             9999999975 444443  348999999999999999999999999999999999999999999999999987554332


Q ss_pred             ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        219 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      . ....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.+..
T Consensus       152 ~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  200 (279)
T cd05633         152 P-HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (279)
T ss_pred             c-cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence            2 33468899999999874 567899999999999999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=5.8e-31  Score=216.14  Aligned_cols=205  Identities=29%  Similarity=0.474  Sum_probs=167.4

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.+++|.++..+.+    .+..+++.|++|.+............+.+|++++++++|+|++++++++...+..    
T Consensus         3 ~~~~~l~~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----   74 (254)
T cd06627           3 QLGDLIGRGAFGVVYKG----LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL----   74 (254)
T ss_pred             eeeeEEcccCCeEEEEE----EEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE----
Confidence            44566677666655554    3456788999999987544445667899999999999999999999998776544    


Q ss_pred             cEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        141 DVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       141 ~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                        ++++|++++. +.+.+.  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        75 --~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          75 --YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             --EEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence              9999999874 555443  35899999999999999999999999999999999999999999999999999876543


Q ss_pred             cc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHH
Q psy11580        218 FM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       218 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i  275 (288)
                      .. .....++..|+|||...+..++.++|+||+|+++++|++|..||...+......++
T Consensus       153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~  211 (254)
T cd06627         153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI  211 (254)
T ss_pred             cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            32 23346788899999998877889999999999999999999999876655444433

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0200|consensus

Probab=99.98  E-value=1.3e-31  Score=243.73  Aligned_cols=220  Identities=25%  Similarity=0.404  Sum_probs=179.9

Q ss_pred             hhhhcccccccccCCccccccccCccceeccC---CCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTA---TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNA  129 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  129 (288)
                      ++...++.+++.+|.|.++.+..|...-....   ....||||.++..... ...+.+..|+++|+.+ .|+||+.++|+
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            67777788888999999999998875433332   2678999999876444 7788899999999999 69999999999


Q ss_pred             ccCCCcccccccEEEEEecccc-cHHHHHh-hh-----------------CCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQ-MD-----------------LDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~~-----------------~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                      |...+..      ++|+||+.. +|++++. .+                 ++...+..++.||+.|++||+++.+|||||
T Consensus       371 ~t~~~~~------~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDL  444 (609)
T KOG0200|consen  371 CTQDGPL------YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDL  444 (609)
T ss_pred             eccCCce------EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhh
Confidence            9986554      999999985 5666654 33                 778899999999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCccc--CCcc--cccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTFMM--TPYV--VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG  265 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~--~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~  265 (288)
                      ..+|||++.+..+|++|||+++........  ....  -+..|||||.+....++.++||||+|+++|||++ |..||.+
T Consensus       445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            999999999999999999999864332221  2122  3556999999999999999999999999999998 9999998


Q ss_pred             CC-chhHHHHHHHHhC
Q psy11580        266 TD-HIDQWNKIIGKMR  280 (288)
Q Consensus       266 ~~-~~~~~~~i~~~~~  280 (288)
                      -. ..+.+..+.++.+
T Consensus       525 ~~~~~~l~~~l~~G~r  540 (609)
T KOG0200|consen  525 IPPTEELLEFLKEGNR  540 (609)
T ss_pred             CCcHHHHHHHHhcCCC
Confidence            55 5555554544433

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.98  E-value=5.6e-31  Score=219.07  Aligned_cols=212  Identities=22%  Similarity=0.399  Sum_probs=169.1

Q ss_pred             cccccccccCCccccccccCcccee-ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAY-DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+...+|.|.++.++.+..... +..+.+.|++|.+... ........+..|++++++++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            4566777888888888877653221 2335678999998642 2223456788999999999999999999999876655


Q ss_pred             cccccEEEEEecccc-cHHHHHh--h---------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEE
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ--M---------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  204 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~--~---------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~k  204 (288)
                            ++||||+++ +|.+.+.  .         .+++..+..++.|++.||+|||+++++|+||||+||+++.++.++
T Consensus        84 ------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          84 ------YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             ------eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEE
Confidence                  999999985 5655554  2         478999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCC--cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHH
Q psy11580        205 ILDFGLARTAGTT--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       205 l~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~  276 (288)
                      ++|||++......  .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+....+..+.
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~  232 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ  232 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH
Confidence            9999998654322  12233456777999999988888999999999999999998 888998776666555554

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=3.3e-31  Score=224.07  Aligned_cols=199  Identities=26%  Similarity=0.392  Sum_probs=160.4

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      ...++.|.++.++.|    .+..++..||+|.+... .........+.+|+++++.++|+|++++++++......     
T Consensus        20 ~~~lg~g~~g~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-----   90 (308)
T cd06634          20 LREIGHGSFGAVYFA----RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA-----   90 (308)
T ss_pred             HHheeeCCCEEEEEE----EEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee-----
Confidence            345666666666654    34567889999998643 12334456788999999999999999999999876654     


Q ss_pred             EEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        142 VYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       142 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                       ++|+||+.+++.+.+.   ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...... 
T Consensus        91 -~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          91 -WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             -EEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence             9999999988776653   34788999999999999999999999999999999999999999999999998765432 


Q ss_pred             ccCCcccccccCchHhHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHH
Q psy11580        219 MMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNK  274 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~  274 (288)
                        ....+++.|+|||.+.+   ..++.++||||||+++|+|++|..||...+..+....
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  225 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH  225 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH
Confidence              23467888999999853   4578899999999999999999999977655444333

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=3e-31  Score=220.95  Aligned_cols=198  Identities=25%  Similarity=0.416  Sum_probs=159.6

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC---CCCcceeeccccCCCcccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN---HKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~  138 (288)
                      +.+.+++|.++.++.|    .+..+++.||+|.++... .......+.+|++++++++   |||++++++++......  
T Consensus         5 ~~~~l~~g~~g~v~~~----~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~--   77 (277)
T cd06917           5 RLELIGRGAYGAVYRG----KHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL--   77 (277)
T ss_pred             hhhheeccCCceEEEE----EEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE--
Confidence            4456677666666655    345678999999987532 2344567889999999996   99999999998766544  


Q ss_pred             cccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                          ++||||++++ +.+.+. ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        78 ----~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          78 ----WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ----EEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence                9999999875 544443 3578899999999999999999999999999999999999999999999999876544


Q ss_pred             Ccc-cCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        217 TFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       217 ~~~-~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      ... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+...
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~  209 (277)
T cd06917         154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR  209 (277)
T ss_pred             CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence            322 233467888999999875 456889999999999999999999997765443

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=1.6e-31  Score=220.33  Aligned_cols=195  Identities=15%  Similarity=0.218  Sum_probs=151.0

Q ss_pred             ccCCccccccccCccceec---cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         65 QMGKKRHNTSHLGAGAAYD---TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      .+|.|.++.++.|......   ......||+|.+..  ........+.+|+.+++.++||||+++++++...+..     
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~-----   74 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK--SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDES-----   74 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcc--hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCc-----
Confidence            4667777777665421110   12345688998864  2334456788899999999999999999999876554     


Q ss_pred             EEEEEeccccc-HHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc--------EEEeecc
Q psy11580        142 VYLVMELMDAN-LCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--------LKILDFG  209 (288)
Q Consensus       142 ~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~--------~kl~dfg  209 (288)
                       ++||||++++ +.+.+..   .+++..+..++.||+.||+|||+++++||||||+||+++.++.        ++++|||
T Consensus        75 -~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          75 -IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             -EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence             9999999875 5555542   3788999999999999999999999999999999999987765        6999999


Q ss_pred             cccccCCCcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchh
Q psy11580        210 LARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRG-GVLFPGTDHID  270 (288)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g-~~p~~~~~~~~  270 (288)
                      .+......   ....++..|+|||++.+ ..++.++|+||||+++|+|++| ..||...+...
T Consensus       154 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~  213 (258)
T cd05078         154 ISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK  213 (258)
T ss_pred             cccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence            88654332   23456788999999987 4578999999999999999998 56776655543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.98  E-value=5.4e-31  Score=220.47  Aligned_cols=203  Identities=31%  Similarity=0.461  Sum_probs=163.8

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .....+++|.++.++.+    .+..++..|++|++.....   ....+.+|+++++.++|+|++++++.+...+..    
T Consensus        22 ~~~~~l~~g~~~~v~~~----~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----   90 (286)
T cd06614          22 KNLEKIGEGASGEVYKA----TDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL----   90 (286)
T ss_pred             hHhHhccCCCCeEEEEE----EEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE----
Confidence            34445555555555443    4455789999999975322   466788999999999999999999999877654    


Q ss_pred             cEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        141 DVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                        ++++||+++ +|.+.+..   .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        91 --~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          91 --WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             --EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence              999999995 56666653   589999999999999999999999999999999999999999999999998865433


Q ss_pred             Cc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        217 TF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       217 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                      .. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.
T Consensus       169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~  229 (286)
T cd06614         169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT  229 (286)
T ss_pred             chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            21 1123356788999999998889999999999999999999999998877655544443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.98  E-value=3.3e-31  Score=222.86  Aligned_cols=210  Identities=21%  Similarity=0.327  Sum_probs=164.7

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.+++|.++.++.+    .+..+++.||||.++.... ......+..|+.++.+. .|+||+++++++....
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~----~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   87 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKM----RFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS   87 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEE----EECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence            4456677888888888777765    3455689999999975322 23345566777767666 5999999999998776


Q ss_pred             cccccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        135 SLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      ..      +++|||+++.+.+.+.   ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||+
T Consensus        88 ~~------~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~  161 (296)
T cd06618          88 DV------FICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI  161 (296)
T ss_pred             eE------EEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcccc
Confidence            54      9999999886655543   348889999999999999999997 5999999999999999999999999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhcCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCc-hhHHHHHH
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIRGGVLFPGTDH-IDQWNKII  276 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slg~il~~l~~g~~p~~~~~~-~~~~~~i~  276 (288)
                      +.............++..|+|||.+.+..    ++.++|+||||+++|+|++|+.||..... .+.+..+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  232 (296)
T cd06618         162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL  232 (296)
T ss_pred             chhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh
Confidence            87654433334445778899999997654    78899999999999999999999976432 33444433

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.98  E-value=8.1e-31  Score=214.78  Aligned_cols=199  Identities=30%  Similarity=0.495  Sum_probs=163.4

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      ..+.++++.++.++.+    .+..++..+++|++.....  .....+.+|+++++.++|+|++++++.+......     
T Consensus         4 ~~~~l~~g~~~~v~~~----~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-----   72 (253)
T cd05122           4 ILEKIGKGGFGEVYKA----RHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL-----   72 (253)
T ss_pred             eeeeeccCCceEEEEE----EECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE-----
Confidence            4455666555555543    3455789999999975322  4567888999999999999999999999776554     


Q ss_pred             EEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        142 VYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       142 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                       ++++||+++ ++.+.+..   .+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        73 -~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          73 -WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             -EEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence             999999995 55555532   5799999999999999999999999999999999999999999999999999876554


Q ss_pred             cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHH
Q psy11580        218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW  272 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~  272 (288)
                      .......++..|+|||.+.+..++.++|+||||+++++|++|+.||...+.....
T Consensus       152 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  206 (253)
T cd05122         152 KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL  206 (253)
T ss_pred             ccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence            3234457788999999999888899999999999999999999999877544433

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.98  E-value=8.4e-31  Score=215.55  Aligned_cols=199  Identities=28%  Similarity=0.433  Sum_probs=164.8

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+.+.++++.++.++.|    .+..+++.|++|++..........+.+.+|++++++++|+||+++++.+....    ..
T Consensus         3 ~~~~~i~~g~~~~v~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~   74 (260)
T cd06606           3 TRGELLGRGSFGSVYLA----LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE----KN   74 (260)
T ss_pred             eeeeEeeecCceEEEEE----EECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC----CC
Confidence            44566667666655554    44567899999999865444466788999999999999999999999998762    12


Q ss_pred             cEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        141 DVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ..++++|++++ ++.+.+.  ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            34999999965 5555544  25899999999999999999999999999999999999999999999999999876554


Q ss_pred             cc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        218 FM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       218 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ..   .....++..|+|||.+.+...+.++|+||||+++++|++|..||...+
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            42   344567889999999998888999999999999999999999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.98  E-value=6.7e-31  Score=217.91  Aligned_cols=209  Identities=26%  Similarity=0.436  Sum_probs=164.9

Q ss_pred             ccccccCCccccccccCccceeccC-CCceEEEEeccCCC--------cchhhHHHHHHHHHHHHH-CCCCCcceeeccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTA-TQQNVAIKKLSRPF--------QNVTHAKRAYREFKLMKL-VNHKNIIGLLNAF  130 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~  130 (288)
                      .+.+.+|.|.++.++.|.    +.. +++.+|+|.+....        ........+..|+.++++ ++||||+++++++
T Consensus         3 ~~~~~ig~G~~~~v~~~~----~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   78 (269)
T cd08528           3 AVLEHLGSGAFGCVYKVR----KKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF   78 (269)
T ss_pred             hhhhhhcCCCCceEEEEE----EcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE
Confidence            455667777766666653    233 57899999886421        122344567788888875 6999999999999


Q ss_pred             cCCCcccccccEEEEEecccc-cHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCc
Q psy11580        131 TPQKSLEEFQDVYLVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCT  202 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~  202 (288)
                      ...+..      +++|||+++ ++.+.+.      ..+++..++.++.|++.+|.+||+ .+++|+||+|+||+++.++.
T Consensus        79 ~~~~~~------~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~  152 (269)
T cd08528          79 LENDRL------YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK  152 (269)
T ss_pred             ccCCeE------EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc
Confidence            877654      999999986 4544432      247888999999999999999996 78999999999999999999


Q ss_pred             EEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        203 LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       203 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ++|+|||.+.............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+....
T Consensus       153 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~  229 (269)
T cd08528         153 VTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV  229 (269)
T ss_pred             EEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence            99999999987655434445678889999999998888999999999999999999999998776655555554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=2.2e-31  Score=222.40  Aligned_cols=203  Identities=25%  Similarity=0.374  Sum_probs=162.2

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|+|.++.++.+.....+..++..||+|+++..... .....+.+|+++++.++|+||+++++++...+.   
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~---   80 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG---   80 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC---
Confidence            4556677888877777776433223456889999999864332 356789999999999999999999998876331   


Q ss_pred             cccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        139 FQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       139 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                       ...+++|||+++ ++.+.+..   .+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 -~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          81 -RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             -CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence             235999999976 56655542   3889999999999999999999999999999999999999999999999999876


Q ss_pred             CCCcc----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        215 GTTFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       215 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      .....    .....++..|+|||.+.+..++.++|+||||+++++|++|..|+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence            52211    11223455699999998888999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=8.4e-31  Score=219.71  Aligned_cols=200  Identities=22%  Similarity=0.359  Sum_probs=156.8

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCc--chhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ--NVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  137 (288)
                      .+.+.+|+|.++.++.+.. +....+|..||+|+++....  .......+..|+++++++ +|+||+++++.+...... 
T Consensus         3 ~~~~~lg~G~~g~v~~~~~-~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~-   80 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRK-VSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL-   80 (290)
T ss_pred             eeeeeeccCCcceEEEEEe-ccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE-
Confidence            4556677776666665421 11134789999999975321  223346678899999999 699999999998776654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++|+||++++ +.+.+.  ..+++..+..++.|++.||++||+.+++||||+|+||+++.++.++|+|||++...
T Consensus        81 -----~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 -----HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             -----EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence                 9999999964 555554  34788899999999999999999999999999999999999999999999998765


Q ss_pred             CCCc--ccCCcccccccCchHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        215 GTTF--MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       215 ~~~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ....  ......++..|+|||.+.+.  .++.++|+||||+++|+|++|..||...+
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~  212 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG  212 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence            4322  12234678899999998753  46789999999999999999999997543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=1.5e-30  Score=215.70  Aligned_cols=184  Identities=24%  Similarity=0.372  Sum_probs=149.6

Q ss_pred             cCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccEEE
Q psy11580         66 MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        66 ~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      +|+|.++.++.+    .+..++..+|+|.+.......       .|+.....+ +||||+++++.+...+..      ++
T Consensus        24 lg~g~~g~v~~~----~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~------~i   86 (267)
T PHA03390         24 LIDGKFGKVSVL----KHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGH------VL   86 (267)
T ss_pred             ecCCCceEEEEE----EEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCee------EE
Confidence            477777766653    567788999999997532111       123333323 799999999999877654      99


Q ss_pred             EEecccc-cHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC-cEEEeecccccccCCCccc
Q psy11580        145 VMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMM  220 (288)
Q Consensus       145 v~e~~~~-~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~  220 (288)
                      ||||+++ +|.+.+..  .+++..+..++.|+++||++||+.+++|+||+|+||+++.++ .++|+|||++......   
T Consensus        87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---  163 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---  163 (267)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence            9999975 67666653  589999999999999999999999999999999999999998 9999999998766443   


Q ss_pred             CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy11580        221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI  269 (288)
Q Consensus       221 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~  269 (288)
                      ....++..|+|||++.+..++.++|+||+|+++|+|++|..||.+....
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~  212 (267)
T PHA03390        164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE  212 (267)
T ss_pred             ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc
Confidence            2346788999999999988999999999999999999999999865543

>KOG0695|consensus

Probab=99.97  E-value=3.1e-31  Score=213.43  Aligned_cols=222  Identities=24%  Similarity=0.384  Sum_probs=178.7

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhh-HHHHHHHHHHHHHC-CCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTH-AKRAYREFKLMKLV-NHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l-~h~~i~~~~~~~~  131 (288)
                      .+..+++.+..+||.|....+.+    +..++|.+.+|+|+++++..+... .+=.+.|-.+..+- +||.+|-++.+|.
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~----~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq  321 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLL----VRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ  321 (593)
T ss_pred             ccccccceeeeeecCcchhhhhh----eehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence            45667777777777776555444    345788899999999986544333 33345676777776 7999999999999


Q ss_pred             CCCcccccccEEEEEecccccHHH-HH--hhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        132 PQKSLEEFQDVYLVMELMDANLCQ-VI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~~l~~-~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      .+..+      ++|.||.+|+-+- .+  ...++++.++.+...|..||.|||++||++||||.+|+|++..|.+||+|+
T Consensus       322 tesrl------ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdy  395 (593)
T KOG0695|consen  322 TESRL------FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDY  395 (593)
T ss_pred             ccceE------EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeeccc
Confidence            88766      9999999986332 22  356999999999999999999999999999999999999999999999999


Q ss_pred             cccccc-CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCC-------CCCchh-HHHHHHHHh
Q psy11580        209 GLARTA-GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP-------GTDHID-QWNKIIGKM  279 (288)
Q Consensus       209 g~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~-------~~~~~~-~~~~i~~~~  279 (288)
                      |.++.. ......++++|||.|.|||++++..|+...|.|+|||+++||+.|+.||.       ..+.++ ..+-|++..
T Consensus       396 gmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq  475 (593)
T KOG0695|consen  396 GMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ  475 (593)
T ss_pred             chhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence            999863 45566788999999999999999999999999999999999999999995       233344 445566666


Q ss_pred             CCCccC
Q psy11580        280 REAHDK  285 (288)
Q Consensus       280 ~~~~~~  285 (288)
                      -.+|..
T Consensus       476 iriprs  481 (593)
T KOG0695|consen  476 IRIPRS  481 (593)
T ss_pred             ccccce
Confidence            555543

>KOG0608|consensus

Probab=99.97  E-value=1.6e-31  Score=230.33  Aligned_cols=208  Identities=25%  Similarity=0.407  Sum_probs=163.0

Q ss_pred             cccccCCccccccccCccc------eeccCCCceEEEEeccC-CCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         62 ISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSR-PFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~------~~~~~~~~~vavK~~~~-~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      -.+.-.+.+..+..+|.|+      |.+..|...+|+|.+.+ +.....+......|-.||..-+.+-||++|-.|.+.+
T Consensus       623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd  702 (1034)
T KOG0608|consen  623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD  702 (1034)
T ss_pred             HhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence            3333344444444455442      45567788999999976 2333344555678999999999999999999999998


Q ss_pred             cccccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        135 SLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      .+      |+||+|++|+..-.++   .-+.+..++.++..+..|+++.|+.|+|||||||+|||||.+|.+||+|||++
T Consensus       703 nL------YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLC  776 (1034)
T KOG0608|consen  703 NL------YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC  776 (1034)
T ss_pred             ce------EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccc
Confidence            77      9999999986433332   33778888999999999999999999999999999999999999999999999


Q ss_pred             ccc---------C--CCc--------------------------------ccCCcccccccCchHhHhcCCCCchhhHHH
Q psy11580        212 RTA---------G--TTF--------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWS  248 (288)
Q Consensus       212 ~~~---------~--~~~--------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s  248 (288)
                      +-+         .  ...                                .....+||+.|+|||++....++...|.||
T Consensus       777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws  856 (1034)
T KOG0608|consen  777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS  856 (1034)
T ss_pred             ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence            521         0  000                                011346899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCchhHHHHH
Q psy11580        249 VGCIMGEMIRGGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       249 lg~il~~l~~g~~p~~~~~~~~~~~~i  275 (288)
                      .|||||||+.|++||...++.+...++
T Consensus       857 ~gvil~em~~g~~pf~~~tp~~tq~kv  883 (1034)
T KOG0608|consen  857 VGVILYEMLVGQPPFLADTPGETQYKV  883 (1034)
T ss_pred             hhHHHHHHhhCCCCccCCCCCcceeee
Confidence            999999999999999887766544433

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=2.4e-30  Score=216.76  Aligned_cols=200  Identities=23%  Similarity=0.344  Sum_probs=157.4

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCc--chhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ--NVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  136 (288)
                      +.+.+.+|+|.++.++.+. ...+..+++.||||++++...  .......+..|+++++++ +||||+++++.+......
T Consensus         2 ~~~~~~ig~G~~~~vy~~~-~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVR-KVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             ceEEEEeccCCCceEEEEE-EeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3456667777766666542 112245678999999974311  223345678899999999 699999999998776654


Q ss_pred             cccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                            ++||||+.+ ++.+.+.  ..+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 ------HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             ------EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence                  999999986 4555554  3478899999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcc--cCCcccccccCchHhHhcCC--CCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        214 AGTTFM--MTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       214 ~~~~~~--~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ......  .....++..|+|||.+.+..  .+.++|+||||+++|+|++|..||...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  211 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD  211 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence            433221  12345788999999987754  678999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0587|consensus

Probab=99.97  E-value=1.4e-30  Score=231.43  Aligned_cols=215  Identities=26%  Similarity=0.417  Sum_probs=176.2

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      .+...+|.|-.+.++.+    ...++++.+|+|+...   ..+...++..|.++|+.. .|||++.+++++...+. .++
T Consensus        22 ei~evig~Gtygkv~k~----k~~~~~~~aa~kI~~~---~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~-~~~   93 (953)
T KOG0587|consen   22 EIIEVIGNGTYGKVYKG----RHVKTGQLAAIKIMDP---TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP-GNG   93 (953)
T ss_pred             EEEEEEeeccceeEEEE----eeeecCceeeeEeecC---CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC-CCC
Confidence            45566666665555544    4577889999999985   445667788899999999 69999999999987765 577


Q ss_pred             ccEEEEEecccccHHHHHh-----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        140 QDVYLVMELMDANLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      .++++|||||.++....+-     ..+.++.+..|++.++.||.+||.+.++|||||-.|||++.++.+||+|||.+...
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            8899999999987554443     34889999999999999999999999999999999999999999999999999876


Q ss_pred             CCCc-ccCCcccccccCchHhHhcC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccCC
Q psy11580        215 GTTF-MMTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL  286 (288)
Q Consensus       215 ~~~~-~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  286 (288)
                      .... ...+.+||+.|||||++...     .|+..+|+||||++..||..|.+|+.+..+.-.   +...-+.||+++
T Consensus       174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---LF~IpRNPPPkL  248 (953)
T KOG0587|consen  174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLIPRNPPPKL  248 (953)
T ss_pred             ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---hccCCCCCCccc
Confidence            5533 34667999999999999763     367899999999999999999999999887544   344456666654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.5e-29  Score=233.35  Aligned_cols=145  Identities=24%  Similarity=0.414  Sum_probs=120.5

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+.||.|.++.++++    .+..+++.||||+++.. .........+..|+.+++.++||||+++++.+...+..
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a----~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   79 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLG----RKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNV   79 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEE----EECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEE
Confidence            34566778888888877775    45668899999999753 22334456788999999999999999999988766544


Q ss_pred             cccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                            ++||||+.+ +|.+++.  ..+++..++.++.||+.||+|||.++|+||||||+|||++.++.++|+|||++.
T Consensus        80 ------~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          80 ------YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             ------EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence                  999999976 5666554  347888999999999999999999999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=3.1e-29  Score=206.86  Aligned_cols=205  Identities=28%  Similarity=0.445  Sum_probs=158.0

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCC---CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP---FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .+.+.+|+|.++.++.+    .+..++..+++|+++..   ........++..|+.+++.++||||+++++++...... 
T Consensus         3 ~i~~~ig~g~~g~v~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-   77 (260)
T cd08222           3 ILQQRLGKGSFGTVYLV----KDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAF-   77 (260)
T ss_pred             eeeeeecCCCCceEEEE----EecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCce-
Confidence            45566777777766654    23444555666666531   11223344577899999999999999999999877654 


Q ss_pred             ccccEEEEEeccccc-HHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                           ++|+||++++ +.+.+.      ..+++..++.++.|++.||+|||+.+++|+||+|+||+++. +.++|+|||+
T Consensus        78 -----~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          78 -----CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             -----EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCc
Confidence                 9999999875 443332      34889999999999999999999999999999999999975 5699999999


Q ss_pred             ccccCCC-cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        211 ARTAGTT-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       211 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                      +...... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+......++.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~  218 (260)
T cd08222         152 SRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV  218 (260)
T ss_pred             eeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            8765332 22234467888999999988888999999999999999999999998766655555443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1025|consensus

Probab=99.97  E-value=2.5e-30  Score=228.43  Aligned_cols=220  Identities=25%  Similarity=0.276  Sum_probs=179.2

Q ss_pred             hhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecccc
Q psy11580         52 WKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        52 ~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  131 (288)
                      +.-....+++..+++|+|.++.++.|...-....-+-+||+|++... ...+...++.+|+-+|.+++|||+++++++|.
T Consensus       690 lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~  768 (1177)
T KOG1025|consen  690 LRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCM  768 (1177)
T ss_pred             eeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcc
Confidence            33334456788999999999999988542222233468999999643 45566788999999999999999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEee
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD  207 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~d  207 (288)
                      ...       +-||++|++. .|++++.   .++.....+.|+.||++||.|||++++|||||.++|||+.....+|+.|
T Consensus       769 ~s~-------~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitd  841 (1177)
T KOG1025|consen  769 LST-------LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITD  841 (1177)
T ss_pred             cch-------HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEe
Confidence            765       2799999995 5777775   4588899999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        208 FGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       208 fg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ||+++......   ........+.|||-|.++...++.++|||||||.+||++| |.-|+.+..-.++-..+...-
T Consensus       842 fgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge  917 (1177)
T KOG1025|consen  842 FGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE  917 (1177)
T ss_pred             cchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc
Confidence            99998754422   2233345678999999999999999999999999999998 999999988776655544433

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.3e-29  Score=206.37  Aligned_cols=171  Identities=26%  Similarity=0.349  Sum_probs=140.8

Q ss_pred             ceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccc-cHHHHHh
Q psy11580         80 AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ  158 (288)
Q Consensus        80 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~  158 (288)
                      .|.+..+++.||+|.++...       ....|...+....||||+++++++......      ++||||+++ +|.+.+.
T Consensus        11 ~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~   77 (237)
T cd05576          11 LVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSV------FLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             EEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeE------EEEEecCCCCCHHHHHH
Confidence            35678899999999997531       223455555566799999999999876654      999999986 4666554


Q ss_pred             --hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhHh
Q psy11580        159 --MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL  236 (288)
Q Consensus       159 --~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~  236 (288)
                        ..+++..+..++.|+++||+|||+++++||||||+||+++.++.++++|||.+.......  ....++..|+|||.+.
T Consensus        78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~~~  155 (237)
T cd05576          78 KFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEVGG  155 (237)
T ss_pred             HhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccccCCcccC
Confidence              348899999999999999999999999999999999999999999999999876554332  2234567799999998


Q ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        237 GMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       237 ~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      +..++.++|+||+|+++|+|++|..|+..
T Consensus       156 ~~~~~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         156 ISEETEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence            88889999999999999999999987653

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=7.1e-29  Score=199.88  Aligned_cols=211  Identities=33%  Similarity=0.526  Sum_probs=169.3

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      +.+.++++.++.++.+    ....+++.+|+|.+...... .....+.+|++.++.++|+|++++++++......     
T Consensus         3 ~~~~i~~g~~~~v~~~----~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~-----   72 (225)
T smart00221        3 LGKKLGEGAFGKVYLA----RDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPL-----   72 (225)
T ss_pred             eeeEeecCCCeEEEEE----EEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCce-----
Confidence            4556666666665554    33456889999999864322 2567888999999999999999999998776554     


Q ss_pred             EEEEEecccc-cHHHHHhh--h-CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        142 VYLVMELMDA-NLCQVIQM--D-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       142 ~~lv~e~~~~-~l~~~~~~--~-~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                       ++++|++++ ++.+.+..  . +++..+..++.+++.++.+||+.+++|+||++.||+++.++.++|+|||.+......
T Consensus        73 -~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       73 -YLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             -EEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence             999999998 66666542  2 788999999999999999999999999999999999999999999999998876544


Q ss_pred             c--ccCCcccccccCchHhH-hcCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCch-hHHHHHHHHhCCCc
Q psy11580        218 F--MMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIRGGVLFPG-TDHI-DQWNKIIGKMREAH  283 (288)
Q Consensus       218 ~--~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slg~il~~l~~g~~p~~~-~~~~-~~~~~i~~~~~~~~  283 (288)
                      .  ......++..|++||.+ ....++.++|+|+||+++++|++|+.||.+ .++. .+.+.|......++
T Consensus       152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (225)
T smart00221      152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLW  222 (225)
T ss_pred             ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccc
Confidence            2  23445677889999998 666778899999999999999999999987 4444 56666665554443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1151|consensus

Probab=99.96  E-value=3.6e-30  Score=214.00  Aligned_cols=208  Identities=25%  Similarity=0.365  Sum_probs=165.1

Q ss_pred             cccccccCCccccccccCcc------ceeccCCCceEEEEeccCCCcch-----hhHHHHHHHHHHHHHCCCCCcceeec
Q psy11580         60 LPISHQMGKKRHNTSHLGAG------AAYDTATQQNVAIKKLSRPFQNV-----THAKRAYREFKLMKLVNHKNIIGLLN  128 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g------~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~  128 (288)
                      +..-..+..+|..+..+|.|      +++|....+.||||+-.....+.     ...+...+|..+.+.|+||.||++|+
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            34445566777777777776      46788889999999986432222     22345778999999999999999999


Q ss_pred             cccCCCcccccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCCEEEccC---
Q psy11580        129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD---  200 (288)
Q Consensus       129 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--ivH~dl~~~nil~~~~---  200 (288)
                      ++..+..     .+|-|+|||+|+.++++.   +-+++.+++.|..||+.||.||.+..  |||-||||.|||+-..   
T Consensus       535 yfslDtd-----sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gtac  609 (775)
T KOG1151|consen  535 YFSLDTD-----SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTAC  609 (775)
T ss_pred             eeeeccc-----cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccc
Confidence            9975442     349999999998777776   34899999999999999999999765  9999999999999653   


Q ss_pred             CcEEEeecccccccCCCc--------ccCCcccccccCchHhHhcC----CCCchhhHHHHHHHHHHHHhCCCCCCCC-C
Q psy11580        201 CTLKILDFGLARTAGTTF--------MMTPYVVTRYYRAPEVILGM----GYKENVDIWSVGCIMGEMIRGGVLFPGT-D  267 (288)
Q Consensus       201 ~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~----~~~~~~Di~slg~il~~l~~g~~p~~~~-~  267 (288)
                      |.+||+|||+++.+....        ..+...||..|++||.+.-.    .++.++||||.|||+|+.+.|+.||... +
T Consensus       610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs  689 (775)
T KOG1151|consen  610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS  689 (775)
T ss_pred             ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence            679999999998765432        23556789999999998642    3678999999999999999999999753 4


Q ss_pred             chhHH
Q psy11580        268 HIDQW  272 (288)
Q Consensus       268 ~~~~~  272 (288)
                      ..+++
T Consensus       690 QQdIL  694 (775)
T KOG1151|consen  690 QQDIL  694 (775)
T ss_pred             HHHHH
Confidence            44443

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.96  E-value=1.4e-29  Score=244.15  Aligned_cols=185  Identities=19%  Similarity=0.287  Sum_probs=145.9

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .....+|+|.++.++.|    .+..++..||||.++....      ....|++.+++++||||++++++|...+..    
T Consensus       693 ~~~~~ig~G~~g~Vy~~----~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~----  758 (968)
T PLN00113        693 KEENVISRGKKGASYKG----KSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGA----  758 (968)
T ss_pred             CcccEEccCCCeeEEEE----EECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCC----
Confidence            33445555555555544    2346789999999974211      123468899999999999999999877655    


Q ss_pred             cEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHH---HCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        141 DVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       141 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                        ++||||++++.+..+...+++..+.+++.|+++||+|||   +.+|+||||||+||+++.++..++. ++........
T Consensus       759 --~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~  835 (968)
T PLN00113        759 --YLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD  835 (968)
T ss_pred             --EEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence              999999997655555556899999999999999999999   6689999999999999998887765 5544332211


Q ss_pred             cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                         ....+++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence               223678899999999998999999999999999999999999853

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=3.1e-28  Score=198.16  Aligned_cols=178  Identities=40%  Similarity=0.689  Sum_probs=152.6

Q ss_pred             ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccc-cHHHHHhhh-
Q psy11580         83 DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD-  160 (288)
Q Consensus        83 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-  160 (288)
                      ...+++.+|+|++........ ...+.+|++.+++++|+|++++++.+......      ++++|++++ ++.+.+... 
T Consensus        10 ~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~------~l~~e~~~~~~L~~~~~~~~   82 (244)
T smart00220       10 DKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKL------YLVMEYCDGGDLFDLLKKRG   82 (244)
T ss_pred             ECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEE------EEEEeCCCCCCHHHHHHhcc
Confidence            345689999999975322211 57888999999999999999999999876544      999999998 666665432 


Q ss_pred             -CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhHhcCC
Q psy11580        161 -LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG  239 (288)
Q Consensus       161 -~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  239 (288)
                       ++...+..++.+++.++++||+.+++|+||+|+||+++.++.++|+|||.+.............++..|++||.+.+..
T Consensus        83 ~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~  162 (244)
T smart00220       83 RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKG  162 (244)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCC
Confidence             7889999999999999999999999999999999999999999999999998776554445567788999999999888


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        240 YKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       240 ~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ++.++|+||||+++++|++|..||....
T Consensus       163 ~~~~~Di~slG~~l~~l~~~~~p~~~~~  190 (244)
T smart00220      163 YGKAVDVWSLGVILYELLTGKPPFPGDD  190 (244)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            8999999999999999999999998733

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1152|consensus

Probab=99.96  E-value=1.8e-29  Score=215.52  Aligned_cols=195  Identities=28%  Similarity=0.454  Sum_probs=159.5

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCc--chhh----HHHHHHHHHHHHHCC---CCCcceeeccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ--NVTH----AKRAYREFKLMKLVN---HKNIIGLLNAF  130 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~--~~~~----~~~~~~e~~~l~~l~---h~~i~~~~~~~  130 (288)
                      +..-..+|.|.++.+++    |.+++....|+||.+.++.-  +.+.    .-..-.|+++|..++   |+||++++++|
T Consensus       563 yttlq~lG~GAyGkV~l----ai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNL----AIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ceeeeeccccccceEEE----eeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            34445555655555555    45566689999999986521  1111    112447999999997   99999999999


Q ss_pred             cCCCcccccccEEEEEecccc--cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEe
Q psy11580        131 TPQKSLEEFQDVYLVMELMDA--NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL  206 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~--~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~  206 (288)
                      .+++.+      |++||-...  +|++++.  .++++.++..|+.|++-|+++||+.||||||||-+|+.++.+|-+||+
T Consensus       639 Eddd~y------yl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  639 EDDDYY------YLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             ecCCee------EEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEe
Confidence            988876      999999876  5788775  569999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCcccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       207 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      |||.+...... ....+.||..|.|||++.|..| +...|||++|+++|-++....||..
T Consensus       713 dfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  713 DFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99998765544 3356799999999999999887 5779999999999999999999863

>KOG1027|consensus

Probab=99.95  E-value=1.9e-28  Score=217.10  Aligned_cols=172  Identities=30%  Similarity=0.438  Sum_probs=144.0

Q ss_pred             cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccEEEEEecccccHHHHHhhh--
Q psy11580         84 TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--  160 (288)
Q Consensus        84 ~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--  160 (288)
                      ...|+.||||.+-.     .....+++|+..|+.. +||||+++++.-.++...      ||+.|.|..+|.+++...  
T Consensus       530 ~ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~------YIalELC~~sL~dlie~~~~  598 (903)
T KOG1027|consen  530 VYEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFL------YIALELCACSLQDLIESSGL  598 (903)
T ss_pred             eeCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceE------EEEehHhhhhHHHHHhcccc
Confidence            45789999999964     4456788999999999 699999999988777665      999999999999888652  


Q ss_pred             ----CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc---C--CcEEEeecccccccCCCc----ccCCccccc
Q psy11580        161 ----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---D--CTLKILDFGLARTAGTTF----MMTPYVVTR  227 (288)
Q Consensus       161 ----~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~---~--~~~kl~dfg~~~~~~~~~----~~~~~~~~~  227 (288)
                          ......+....|+++||++||+.+||||||||.||||+.   +  ..++|+|||+++......    ......||-
T Consensus       599 d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~  678 (903)
T KOG1027|consen  599 DVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTS  678 (903)
T ss_pred             chhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcc
Confidence                111345778999999999999999999999999999986   3  458999999998764422    234567899


Q ss_pred             ccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy11580        228 YYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT  266 (288)
Q Consensus       228 ~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~  266 (288)
                      +|+|||++....-+.++|||||||++|+.++ |..||.+.
T Consensus       679 GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~  718 (903)
T KOG1027|consen  679 GWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS  718 (903)
T ss_pred             cccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence            9999999999888889999999999999888 58899763

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=7.6e-27  Score=210.71  Aligned_cols=198  Identities=19%  Similarity=0.312  Sum_probs=132.5

Q ss_pred             hhcccccccccCCccccccccCccceeccCC----CceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecccc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTAT----QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  131 (288)
                      ...++.+.+.+|+|.++.++.|.    +..+    +..||+|++.....    ...+..  +.++...+.++..++..+.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~----~~~~~~~~~~~vAvK~~~~~~~----~e~~~~--e~l~~~~~~~~~~~~~~~~  199 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKAS----LVNKQSKKEGKYVLKKATEYGA----VEIWMN--ERVRRACPNSCADFVYGFL  199 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEE----EcCCccccCcEEEEEEecccch----hHHHHH--HHHHhhchhhHHHHHHhhh
Confidence            45667788888888888887763    3445    88999999864211    111111  1122222333333333322


Q ss_pred             CCCcccccccEEEEEeccccc-HHHHHhhh----------------------CCHHHHHHHHHHHHHHHHHHHHCCCEee
Q psy11580        132 PQKSLEEFQDVYLVMELMDAN-LCQVIQMD----------------------LDHERMSYLLYQMLCGIKHLHSAGIIHR  188 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~----------------------~~~~~~~~~~~~i~~~l~~LH~~~ivH~  188 (288)
                      ...........++|+||++++ |.+.+...                      .....+..++.||+.||+|||+++|+||
T Consensus       200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR  279 (566)
T PLN03225        200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR  279 (566)
T ss_pred             cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            111112234569999999875 55544321                      1123456799999999999999999999


Q ss_pred             cCCCCCEEEcc-CCcEEEeecccccccCC--CcccCCcccccccCchHhHhcCC----------------------CCch
Q psy11580        189 DLKPSNIVVKS-DCTLKILDFGLARTAGT--TFMMTPYVVTRYYRAPEVILGMG----------------------YKEN  243 (288)
Q Consensus       189 dl~~~nil~~~-~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~----------------------~~~~  243 (288)
                      ||||+|||++. ++.+||+|||++.....  ........+++.|+|||.+....                      ++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999986 57899999999975432  22334567899999999775322                      2345


Q ss_pred             hhHHHHHHHHHHHHhCCCCC
Q psy11580        244 VDIWSVGCIMGEMIRGGVLF  263 (288)
Q Consensus       244 ~Di~slg~il~~l~~g~~p~  263 (288)
                      +|||||||++|||+++..++
T Consensus       360 ~DVwSlGviL~el~~~~~~~  379 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRS  379 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCC
Confidence            69999999999999876654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.2e-26  Score=204.83  Aligned_cols=210  Identities=21%  Similarity=0.312  Sum_probs=148.1

Q ss_pred             hhcccccccccCCccccccccCcc------------ceeccCCCceEEEEeccCCCcch------------hhHHHHHHH
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAG------------AAYDTATQQNVAIKKLSRPFQNV------------THAKRAYRE  111 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g------------~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~e  111 (288)
                      ..+++.+.+.||+|.++.++.|.-            .......++.||||.++......            ...+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            456788999999999999988742            11223456789999987532110            011223457


Q ss_pred             HHHHHHCCCCCc-----ceeeccccCCCc--ccccccEEEEEeccccc-HHHHHhh------------------------
Q psy11580        112 FKLMKLVNHKNI-----IGLLNAFTPQKS--LEEFQDVYLVMELMDAN-LCQVIQM------------------------  159 (288)
Q Consensus       112 ~~~l~~l~h~~i-----~~~~~~~~~~~~--~~~~~~~~lv~e~~~~~-l~~~~~~------------------------  159 (288)
                      +.++.+++|.++     ++++++|.....  .......++|+||++++ |.+.+..                        
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     667777754211  01123469999999864 4443321                        


Q ss_pred             --hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcccC--CcccccccCchHhH
Q psy11580        160 --DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMT--PYVVTRYYRAPEVI  235 (288)
Q Consensus       160 --~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~aPE~~  235 (288)
                        ..++..+..++.|++.+|+|||+.+|+||||||+||+++.++.++|+|||++..........  ...+++.|+|||.+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence              13567788999999999999999999999999999999999999999999997654332222  22347899999998


Q ss_pred             hcCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCCC
Q psy11580        236 LGMGY----------------------KENVDIWSVGCIMGEMIRGGV-LFPG  265 (288)
Q Consensus       236 ~~~~~----------------------~~~~Di~slg~il~~l~~g~~-p~~~  265 (288)
                      .....                      ..+.|+||+||++++|++|.. ||.+
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            64321                      124699999999999999876 7754

>KOG1167|consensus

Probab=99.95  E-value=3.3e-27  Score=195.01  Aligned_cols=217  Identities=23%  Similarity=0.388  Sum_probs=176.9

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  132 (288)
                      ......+...+.+|.|.|..++.+.-.- +....+.||+|.+..    .+...++..|+++|..+ .+.||+++.+++..
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~-~~~~~~~valk~i~~----ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIE-QDTKRRYVALKAIYR----TSSPSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhh-hccccceEeeeeccc----ccCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            4455667788888998888888764211 122678999999964    34456788999999999 58999999999987


Q ss_pred             CCcccccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC-CcEEEeecccc
Q psy11580        133 QKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLA  211 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~-~~~kl~dfg~~  211 (288)
                      ++..      ++|+||++..-...+...++...++.+++.++.||+++|.+|||||||||+|++.+.. +.-.|+|||++
T Consensus       107 nd~v------~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  107 NDQV------AIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             CCee------EEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence            7765      9999999988777777889999999999999999999999999999999999999865 56789999998


Q ss_pred             ccc----------C-------C----------------------------CcccCCcccccccCchHhHhc-CCCCchhh
Q psy11580        212 RTA----------G-------T----------------------------TFMMTPYVVTRYYRAPEVILG-MGYKENVD  245 (288)
Q Consensus       212 ~~~----------~-------~----------------------------~~~~~~~~~~~~~~aPE~~~~-~~~~~~~D  245 (288)
                      ...          .       .                            ....-...||++|.|||++.. ...++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            510          0       0                            000112468999999999987 45689999


Q ss_pred             HHHHHHHHHHHHhCCCCC-CCCCchhHHHHHHHHhCC
Q psy11580        246 IWSVGCIMGEMIRGGVLF-PGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       246 i~slg~il~~l~~g~~p~-~~~~~~~~~~~i~~~~~~  281 (288)
                      |||.|+|+..++++..|| ...++.+.+.+|+-.+|.
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~  297 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGS  297 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhCh
Confidence            999999999999999986 568888999999887764

>KOG1345|consensus

Probab=99.94  E-value=3e-27  Score=185.15  Aligned_cols=195  Identities=25%  Similarity=0.396  Sum_probs=152.3

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  136 (288)
                      +.+.+.+.+|.|.|+...+.    .+..++..+++|-+..+   ......|.+|...=-.| .|.||+.-|+.-..... 
T Consensus        24 d~y~I~k~lgeG~FgkIlL~----eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d-   95 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLA----EHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD-   95 (378)
T ss_pred             hhhhHHHHhcccceeeEEee----eccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc-
Confidence            34578888888888777664    56788899999999853   35567788888766666 58999998887654332 


Q ss_pred             cccccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc--CCcEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~--~~~~kl~dfg~~~  212 (288)
                          .+++++||++.+ |.+.+. ..+.+....+++.|+++|+.|+|++++||||||.+|||+-.  ...+||||||..+
T Consensus        96 ----~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   96 ----AYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             ----eEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence                358999999954 554443 45788888999999999999999999999999999999954  4579999999987


Q ss_pred             ccCCCcccCCcccccccCchHhHhcC-----CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ..+......  .....|.+||.....     ...+.+|+|.||++++.+++|.+||+..
T Consensus       172 k~g~tV~~~--~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka  228 (378)
T KOG1345|consen  172 KVGTTVKYL--EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA  228 (378)
T ss_pred             ccCceehhh--hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence            765543322  335568999987642     2467899999999999999999999853

>KOG1024|consensus

Probab=99.94  E-value=7.6e-26  Score=185.51  Aligned_cols=219  Identities=17%  Similarity=0.254  Sum_probs=174.8

Q ss_pred             hhcccccccccCCccccccccCccceec-cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYD-TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...++.....+.+|.|+.++.|-..--+ -.+.+.|-+|.++.. .++-+...+..|.-++..+.|||+..+.+++....
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY  360 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence            3455777788888888888877432111 123467888888743 44455677888999999999999999999997654


Q ss_pred             cccccccEEEEEeccc-ccHHHHHh----------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcE
Q psy11580        135 SLEEFQDVYLVMELMD-ANLCQVIQ----------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL  203 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~  203 (288)
                           ..+++++.+++ |+|..++.          +.++-.++..++.|++.|+++||+.++||.||.++|+++++...+
T Consensus       361 -----~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV  435 (563)
T KOG1024|consen  361 -----ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV  435 (563)
T ss_pred             -----CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence                 34588999888 45655554          126667788999999999999999999999999999999999999


Q ss_pred             EEeecccccccCC---CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        204 KILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       204 kl~dfg~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ||+|=.+++..-.   .........+..||+||.+....++.++|+||||+++|||++ |+.||..-++.++..-+..+.
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy  515 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY  515 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence            9999999985432   222344556788999999999999999999999999999998 999999999999887777665


Q ss_pred             C
Q psy11580        280 R  280 (288)
Q Consensus       280 ~  280 (288)
                      +
T Consensus       516 R  516 (563)
T KOG1024|consen  516 R  516 (563)
T ss_pred             e
Confidence            4

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.93  E-value=4e-24  Score=169.92  Aligned_cols=167  Identities=39%  Similarity=0.642  Sum_probs=140.3

Q ss_pred             ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEeccc-ccHHHHHhh--
Q psy11580         83 DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM--  159 (288)
Q Consensus        83 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--  159 (288)
                      ...+++.+++|++....... ....+.+|++.++.++|++++++++++......      ++++|+++ +++.+.+..  
T Consensus        14 ~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~------~~~~e~~~~~~l~~~~~~~~   86 (215)
T cd00180          14 DKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHL------YLVMEYCEGGSLKDLLKENE   86 (215)
T ss_pred             ecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeE------EEEEecCCCCcHHHHHHhcc
Confidence            34458999999998532211 356788999999999999999999999876544      99999999 566666654  


Q ss_pred             -hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc-CCcEEEeecccccccCCCc-ccCCcccccccCchHhHh
Q psy11580        160 -DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVIL  236 (288)
Q Consensus       160 -~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~-~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~  236 (288)
                       .++...+..++.+++.++++||+.+++|+||+|.||+++. ++.++|+|||.+....... ......+...|++||...
T Consensus        87 ~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  166 (215)
T cd00180          87 GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL  166 (215)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhc
Confidence             4899999999999999999999999999999999999999 8999999999998665442 123346778899999998


Q ss_pred             cC-CCCchhhHHHHHHHHHHH
Q psy11580        237 GM-GYKENVDIWSVGCIMGEM  256 (288)
Q Consensus       237 ~~-~~~~~~Di~slg~il~~l  256 (288)
                      .. ..+.++|+|++|+++++|
T Consensus       167 ~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         167 GKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             ccCCCCchhhhHHHHHHHHHH
Confidence            86 778999999999999999

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1165|consensus

Probab=99.93  E-value=6.3e-25  Score=176.73  Aligned_cols=212  Identities=21%  Similarity=0.331  Sum_probs=176.4

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQ  133 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  133 (288)
                      +..-.+++|+.||.|.|++-.+|.    +..+++.||||.-...    +...++..|....+.| ..++|..+|-+....
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~----Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG   96 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGK----NLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG   96 (449)
T ss_pred             EecccceeccccccCcceeeeccc----ccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence            344567999999999999999984    5678999999998642    4456788999999999 578999988776554


Q ss_pred             CcccccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC-----cEEE
Q psy11580        134 KSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-----TLKI  205 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~-----~~kl  205 (288)
                      ..-      .+|+|.++.+|.+.+.   +.++..++..+|.|++.-++++|++.+|+|||||+|+||+..+     .+.+
T Consensus        97 ~~N------iLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihi  170 (449)
T KOG1165|consen   97 KYN------ILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHI  170 (449)
T ss_pred             chh------hhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEE
Confidence            443      8999999987665554   6799999999999999999999999999999999999998644     4899


Q ss_pred             eecccccccCCCcc--------cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCchhHHHH
Q psy11580        206 LDFGLARTAGTTFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG---TDHIDQWNK  274 (288)
Q Consensus       206 ~dfg~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~---~~~~~~~~~  274 (288)
                      +|||+++...++..        ..+..||.+||+-....|...+.+.|+-|||.|+++.+-|..||+|   .+..+-+.+
T Consensus       171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK  250 (449)
T KOG1165|consen  171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK  250 (449)
T ss_pred             EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence            99999987654322        2456799999999999999999999999999999999999999998   466677777


Q ss_pred             HHHHhC
Q psy11580        275 IIGKMR  280 (288)
Q Consensus       275 i~~~~~  280 (288)
                      |-+..+
T Consensus       251 IGe~Kr  256 (449)
T KOG1165|consen  251 IGETKR  256 (449)
T ss_pred             hccccc
Confidence            765554

>KOG0576|consensus

Probab=99.93  E-value=2.5e-26  Score=199.21  Aligned_cols=215  Identities=22%  Similarity=0.330  Sum_probs=179.1

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++..-..+|+|..+.++    ++.|+.+++..|+|+++.+  .....+-++.|+-+++.++||||+.+++.+...+.+ 
T Consensus        15 ddyellqrvgsgTygdvy----KaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl-   87 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVY----KARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL-   87 (829)
T ss_pred             cchhheeeecCCcccchh----hhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhcCc-
Confidence            344555667776665544    4678999999999999863  334456677899999999999999999999988876 


Q ss_pred             ccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           +++||||+++.++.+-   ..+++.++..+++..+.||.|||+.|-+|||||-.||++++.|.+||+|||.+...
T Consensus        88 -----wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   88 -----WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQI  162 (829)
T ss_pred             -----EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhh
Confidence                 9999999987655443   56888899999999999999999999999999999999999999999999999876


Q ss_pred             CCCcc-cCCcccccccCchHhHh---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        215 GTTFM-MTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       215 ~~~~~-~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      +.... ...+.||+.|||||+..   ...|+...|+|++|+...|+-.-++|..+..+...+..+....-++|.
T Consensus       163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~  236 (829)
T KOG0576|consen  163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT  236 (829)
T ss_pred             hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc
Confidence            65433 36689999999999975   356889999999999999999999999888888877776665555554

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=1.1e-25  Score=212.28  Aligned_cols=149  Identities=19%  Similarity=0.205  Sum_probs=113.6

Q ss_pred             HCCC-CCcceeeccccCCCcc-cccccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCC
Q psy11580        117 LVNH-KNIIGLLNAFTPQKSL-EEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  191 (288)
Q Consensus       117 ~l~h-~~i~~~~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~  191 (288)
                      .++| .||++++++|.....- .....++.++|+++++|.+++..   .+++..++.++.||++||+|||++||+|||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            3445 5888888887332211 12234588899999999988853   38999999999999999999999999999999


Q ss_pred             CCCEEEccC-------------------CcEEEeecccccccCCC-----------------cccCCcccccccCchHhH
Q psy11580        192 PSNIVVKSD-------------------CTLKILDFGLARTAGTT-----------------FMMTPYVVTRYYRAPEVI  235 (288)
Q Consensus       192 ~~nil~~~~-------------------~~~kl~dfg~~~~~~~~-----------------~~~~~~~~~~~~~aPE~~  235 (288)
                      |+|||++..                   +.+|++|||+++.....                 .......+|+.|+|||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            999999654                   44566666665432110                 000113578889999999


Q ss_pred             hcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        236 LGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       236 ~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      .+..++.++|||||||++|||++|.+|+..
T Consensus       188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        188 NGSSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             ccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence            999999999999999999999999988764

>KOG1163|consensus

Probab=99.92  E-value=2.1e-24  Score=166.67  Aligned_cols=211  Identities=24%  Similarity=0.306  Sum_probs=169.6

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCC-CCcceeeccccCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH-KNIIGLLNAFTPQ  133 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~  133 (288)
                      +....+.+-..||+|.|+..++|.    ...+|+.||||+-+....    ..++.-|.++.+.+++ ..|..+..+....
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~----~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~   83 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGI----SITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEK   83 (341)
T ss_pred             eeccceEEEEeecCCchhheeeee----eccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence            344566777888998888888874    467899999999975322    3457789999999974 6777777777665


Q ss_pred             CcccccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC---CcEEEee
Q psy11580        134 KSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILD  207 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~---~~~kl~d  207 (288)
                      ..-      .+||+.++.+|.+.++   ..++..+++-++.|++.-++|+|.++++||||||+|+|++-+   ..+.|+|
T Consensus        84 ~yn------vlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   84 DYN------VLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             ccc------eeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEe
Confidence            544      9999999987766654   679999999999999999999999999999999999999754   4689999


Q ss_pred             cccccccCCCc--------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CchhHHHHHH
Q psy11580        208 FGLARTAGTTF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT---DHIDQWNKII  276 (288)
Q Consensus       208 fg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~---~~~~~~~~i~  276 (288)
                      ||+|+...+..        ......||.+|.+-....+...+.+.|+-|+|.++.++.-|..||+|.   +..+.+.+|.
T Consensus       158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~  237 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS  237 (341)
T ss_pred             ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence            99998654321        124467899999988888888899999999999999999999999985   4555566666


Q ss_pred             HHh
Q psy11580        277 GKM  279 (288)
Q Consensus       277 ~~~  279 (288)
                      +..
T Consensus       238 EkK  240 (341)
T KOG1163|consen  238 EKK  240 (341)
T ss_pred             Hhh
Confidence            543

>KOG1164|consensus

Probab=99.91  E-value=3e-23  Score=176.09  Aligned_cols=200  Identities=24%  Similarity=0.321  Sum_probs=157.7

Q ss_pred             ccccccccCCccccccccCccceeccCC-CceEEEEeccCCCcchhhHHHHHHHHHHHHHCCC----CCcceeecccc-C
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTAT-QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH----KNIIGLLNAFT-P  132 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~~i~~~~~~~~-~  132 (288)
                      .+.+...+|+|.++.++.+.    +..+ ...+|+|.........  ...+..|..++..+..    +++..+++... .
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~----~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~   92 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVS----DKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST   92 (322)
T ss_pred             ceEEeeeccccCCceEEEEE----ecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence            45677788887777777653    3333 3578999887532221  1267788999988863    68999999884 4


Q ss_pred             CCcccccccEEEEEecccccHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC-----CcE
Q psy11580        133 QKSLEEFQDVYLVMELMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-----CTL  203 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~-----~~~  203 (288)
                      ....      ++||+.++.+|.+...    ..++..++..++.|++.+|++||+.|++||||||.|+.++..     ..+
T Consensus        93 ~~~~------~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   93 EDFN------FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             Ccee------EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceE
Confidence            4433      9999999999888773    458999999999999999999999999999999999999865     358


Q ss_pred             EEeeccccc--ccC-CC----c---c-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        204 KILDFGLAR--TAG-TT----F---M-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       204 kl~dfg~~~--~~~-~~----~---~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      .|.|||+++  ... ..    .   . .....||.+|.++.+..+...+.+.|+||++.++.+++.|..||.+.....
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~  244 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD  244 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence            999999998  321 11    0   1 123459999999999999999999999999999999999999998766433

>KOG0195|consensus

Probab=99.90  E-value=6.3e-24  Score=166.93  Aligned_cols=217  Identities=18%  Similarity=0.271  Sum_probs=175.8

Q ss_pred             cccccccHHHhhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCC
Q psy11580         42 VDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK  121 (288)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~  121 (288)
                      ...+..++.+|..+....+.+-..+...-.+.-+.|      ...|..+++|+++-..-.......|..|.-.|+.+.||
T Consensus       174 tr~rdatlsr~~gid~~~lnl~tkl~e~hsgelwrg------rwqgndivakil~vr~~t~risrdfneefp~lrifshp  247 (448)
T KOG0195|consen  174 TRTRDATLSRYTGIDVSSLNLITKLAESHSGELWRG------RWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHP  247 (448)
T ss_pred             ccccccccccccCcchhhhhhhhhhccCCCcccccc------cccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCC
Confidence            344566788888888899998888988888888877      77889999999986555556667899999999999999


Q ss_pred             CcceeeccccCCCcccccccEEEEEecccc-cHHHHHhhh----CCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCC
Q psy11580        122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSN  194 (288)
Q Consensus       122 ~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~i~~~l~~LH~~~--ivH~dl~~~n  194 (288)
                      ||+.+++.|.....+      .+|..||+. +|+..+...    .+..++.+++.++++|++|||+..  |.---|++..
T Consensus       248 nilpvlgacnsppnl------v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~h  321 (448)
T KOG0195|consen  248 NILPVLGACNSPPNL------VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKH  321 (448)
T ss_pred             chhhhhhhccCCCCc------eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccce
Confidence            999999999888765      999999995 566666533    677889999999999999999876  5666799999


Q ss_pred             EEEccCCcEEEe--ecccccccCCCcccCCcccccccCchHhHhcCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy11580        195 IVVKSDCTLKIL--DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK---ENVDIWSVGCIMGEMIRGGVLFPGTDHI  269 (288)
Q Consensus       195 il~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~---~~~Di~slg~il~~l~~g~~p~~~~~~~  269 (288)
                      ++++++.+.+|+  |--++..      .......+.|++||.+..++-+   .++|||||++++|||.+...||.+.++.
T Consensus       322 vmidedltarismad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm  395 (448)
T KOG0195|consen  322 VMIDEDLTARISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM  395 (448)
T ss_pred             EEecchhhhheecccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence            999999876653  3222211      1234668899999999886543   5799999999999999999999999988


Q ss_pred             hHHHHHH
Q psy11580        270 DQWNKII  276 (288)
Q Consensus       270 ~~~~~i~  276 (288)
                      +.-.+|.
T Consensus       396 ecgmkia  402 (448)
T KOG0195|consen  396 ECGMKIA  402 (448)
T ss_pred             hhhhhhh
Confidence            8766653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=5e-23  Score=174.84  Aligned_cols=162  Identities=19%  Similarity=0.224  Sum_probs=120.3

Q ss_pred             cccccccccCCccccccccCccceeccC-CCceEEEEeccCCCc---chhhHHHHHHHHHHHHHCCCCCcce-eeccccC
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTA-TQQNVAIKKLSRPFQ---NVTHAKRAYREFKLMKLVNHKNIIG-LLNAFTP  132 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~  132 (288)
                      ..+.++..+|+|.++.++.+    ++.. ++..||||+......   .......+.+|+++|++++|+|++. +++.   
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a----~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERG----YFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             CCceEccEEeecCcEEEEEE----EEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            45678888899888888875    3333 677789998753211   2234566889999999999999985 5432   


Q ss_pred             CCcccccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecC-CCCCEEEccCCcEEEeecccc
Q psy11580        133 QKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL-KPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl-~~~nil~~~~~~~kl~dfg~~  211 (288)
                       +.      .++||||++++.+.... ...   ...++.|++++|+|||+.||+|||| ||+||+++.++.++|+|||++
T Consensus        91 -~~------~~LVmE~~~G~~L~~~~-~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 -GK------DGLVRGWTEGVPLHLAR-PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             -CC------cEEEEEccCCCCHHHhC-ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence             22      39999999987554322 111   2567899999999999999999999 999999999999999999999


Q ss_pred             cccCCCcc---------cCCcccccccCchHhHhc
Q psy11580        212 RTAGTTFM---------MTPYVVTRYYRAPEVILG  237 (288)
Q Consensus       212 ~~~~~~~~---------~~~~~~~~~~~aPE~~~~  237 (288)
                      ........         .....+++.|+|||.+..
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            86543211         123456777999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=5.8e-22  Score=153.90  Aligned_cols=115  Identities=25%  Similarity=0.386  Sum_probs=95.0

Q ss_pred             ccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcccCCccccc
Q psy11580        151 ANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTR  227 (288)
Q Consensus       151 ~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  227 (288)
                      |+|.+.+.   ..+++..++.++.|++.||+|||+.+      ||+||+++.++.+++  ||.+.......    ..+++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            34555554   34899999999999999999999998      999999999999999  99987654432    26789


Q ss_pred             ccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-hHHHHHHH
Q psy11580        228 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI-DQWNKIIG  277 (288)
Q Consensus       228 ~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-~~~~~i~~  277 (288)
                      .|+|||++.+..++.++||||||+++|||++|+.||...... ..+..+..
T Consensus        69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  119 (176)
T smart00750       69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN  119 (176)
T ss_pred             cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH
Confidence            999999999999999999999999999999999999765443 33344433

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590|consensus

Probab=99.87  E-value=9.7e-23  Score=183.87  Aligned_cols=249  Identities=23%  Similarity=0.307  Sum_probs=170.5

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcccccccccCCccccccccCccc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGA   80 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~   80 (288)
                      +|..+|.+|.+.++....||+..+........  +............      .+.......+..++.|..+.    ...
T Consensus       269 ~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n--~~~~~~~~~~~~~------~~~~~y~~~~~~~g~ga~g~----~~~  336 (601)
T KOG0590|consen  269 ILKENPSNRLSIEELKLDNWLSSKRNGFSKSN--PCADSLTIAKSPI------GFSEKYGKPGRVLGSGAYGS----VRI  336 (601)
T ss_pred             cccCCchhcccccccccccccccccccccccc--ccccccccccCcc------ccccccCCccceeeecccCc----eEE
Confidence            35578999999999999999976112111111  0110011100000      00011112223333333321    112


Q ss_pred             eeccCCCceEEEEecc----CCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccccHHHH
Q psy11580         81 AYDTATQQNVAIKKLS----RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQV  156 (288)
Q Consensus        81 ~~~~~~~~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~  156 (288)
                      +.+.......+.|.+.    ...........+..|+.+-..+.|+|++..+..+......      .-.|||++++++..
T Consensus       337 ~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~------~~~mE~~~~Dlf~~  410 (601)
T KOG0590|consen  337 AKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI------LQSMEYCPYDLFSL  410 (601)
T ss_pred             EEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc------hhhhhcccHHHHHH
Confidence            3333334444444433    2112222223366788888889999999988888776654      44499999988887


Q ss_pred             Hhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC-----cccCCccccccc
Q psy11580        157 IQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT-----FMMTPYVVTRYY  229 (288)
Q Consensus       157 ~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~~  229 (288)
                      +..  .++..++..++.|++.|++|+|..|+.|||+|++|++++.+|.+|++|||.+......     ......+|+..|
T Consensus       411 ~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY  490 (601)
T KOG0590|consen  411 VMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPY  490 (601)
T ss_pred             HhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcC
Confidence            765  5999999999999999999999999999999999999999999999999998754332     233566889999


Q ss_pred             CchHhHhcCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        230 RAPEVILGMGYKE-NVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       230 ~aPE~~~~~~~~~-~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      +|||++.+..|.+ ..||||.|+++..|.+|+.||.-..
T Consensus       491 ~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~  529 (601)
T KOG0590|consen  491 LAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK  529 (601)
T ss_pred             cCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence            9999999988874 7999999999999999999997543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=1.2e-21  Score=155.26  Aligned_cols=185  Identities=13%  Similarity=0.172  Sum_probs=131.7

Q ss_pred             HHHhhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhh-HHH------HHHHHHHHHHCCCC
Q psy11580         49 VDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTH-AKR------AYREFKLMKLVNHK  121 (288)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~-~~~------~~~e~~~l~~l~h~  121 (288)
                      ..-+..+...+++..+.++.+.++.+++.     +. ++..+|+|++......... ...      +.+|++.+.++.|+
T Consensus        22 ~~~~~~~l~~~y~~~~~l~~~~f~~v~l~-----~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~   95 (232)
T PRK10359         22 KEIFDDFLSYNIKTIKVFRNIDDTKVSLI-----DT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE   95 (232)
T ss_pred             HHHHHHHhhCceEEEEEecCCCceEEEEE-----ec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC
Confidence            34556677778888888888777777763     22 4678999999754332222 122      57899999999999


Q ss_pred             CcceeeccccCCCc--ccccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc
Q psy11580        122 NIIGLLNAFTPQKS--LEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS  199 (288)
Q Consensus       122 ~i~~~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~  199 (288)
                      +|..+.+++.....  .......+++|||++|..+.... ..+.    ....+++.+|..+|+.|++|||++|+||+++.
T Consensus        96 GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~  170 (232)
T PRK10359         96 GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK  170 (232)
T ss_pred             CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence            99999888664321  11223469999999985443332 2232    24669999999999999999999999999999


Q ss_pred             CCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHH
Q psy11580        200 DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM  256 (288)
Q Consensus       200 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l  256 (288)
                      +| ++|+|||.+..........           .+.....++.++|+||||+.+..+
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             CC-EEEEECCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHH
Confidence            88 9999999876543221111           133444567799999999987654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=6e-20  Score=155.81  Aligned_cols=179  Identities=35%  Similarity=0.579  Sum_probs=148.6

Q ss_pred             cCCCceEEEEeccCCCcchh-hHHHHHHHHHHHHHCCCC-CcceeeccccCCCcccccccEEEEEecccccHHH-HHhh-
Q psy11580         84 TATQQNVAIKKLSRPFQNVT-HAKRAYREFKLMKLVNHK-NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ-VIQM-  159 (288)
Q Consensus        84 ~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~-~~~~-  159 (288)
                      ......+++|.+........ ....+.+|+.++..+.|+ +++++.+.+.....      .+++++++.++.+. .... 
T Consensus        19 ~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~------~~~~~~~~~~~~l~~~~~~~   92 (384)
T COG0515          19 ARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS------LYLVMEYVDGGSLEDLLKKI   92 (384)
T ss_pred             EEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE------EEEEEecCCCCcHHHHHHhc
Confidence            33338899999987544433 577899999999999988 79999999965553      49999999976444 3332 


Q ss_pred             ----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC-cEEEeecccccccCCCc-------ccCCccccc
Q psy11580        160 ----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTF-------MMTPYVVTR  227 (288)
Q Consensus       160 ----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~-~~kl~dfg~~~~~~~~~-------~~~~~~~~~  227 (288)
                          .++......+..|++.+++++|+.+++|||+||+||+++..+ .++++|||.+.......       ......++.
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~  172 (384)
T COG0515          93 GRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP  172 (384)
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccccccccccccccc
Confidence                588889999999999999999999999999999999999988 79999999987544322       235678899


Q ss_pred             ccCchHhHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        228 YYRAPEVILG---MGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       228 ~~~aPE~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      .|++||.+.+   ...+...|+||+|+++++++.|..||.....
T Consensus       173 ~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~  216 (384)
T COG0515         173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN  216 (384)
T ss_pred             ccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            9999999988   5778999999999999999999999887764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=2.9e-21  Score=157.55  Aligned_cols=203  Identities=21%  Similarity=0.267  Sum_probs=131.3

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCC----------CCCcceee
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVN----------HKNIIGLL  127 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~----------h~~i~~~~  127 (288)
                      .+..+..|+.+.+..++.    |.+..|++.+|+|++.... ......+++.+|.-....+.          |-.++.-+
T Consensus        13 ~l~~~~~i~~g~~~~v~~----v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~   88 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFE----VTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL   88 (288)
T ss_dssp             EEEEEEEEEEETTEEEEE----EEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred             EEEEccccccCCceEEEE----EEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence            345556666655555444    5688999999999997543 33345666777765555543          22333333


Q ss_pred             ccccCCCccc---cc---c-----cEEEEEecccccHHHHHh---h------hCCHHHHHHHHHHHHHHHHHHHHCCCEe
Q psy11580        128 NAFTPQKSLE---EF---Q-----DVYLVMELMDANLCQVIQ---M------DLDHERMSYLLYQMLCGIKHLHSAGIIH  187 (288)
Q Consensus       128 ~~~~~~~~~~---~~---~-----~~~lv~e~~~~~l~~~~~---~------~~~~~~~~~~~~~i~~~l~~LH~~~ivH  187 (288)
                      +.....+...   ..   +     ..+++|+-+.++|.+.+.   .      .........+..|+...+++||..|++|
T Consensus        89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVH  168 (288)
T PF14531_consen   89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVH  168 (288)
T ss_dssp             EEEEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEe
Confidence            3333221100   00   0     247889999988876653   1      1223445667789999999999999999


Q ss_pred             ecCCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhHhcC--------CCCchhhHHHHHHHHHHHHhC
Q psy11580        188 RDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM--------GYKENVDIWSVGCIMGEMIRG  259 (288)
Q Consensus       188 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~Di~slg~il~~l~~g  259 (288)
                      +||+|+|++++.+|.++|+||+.....+.....  ...+..|.+||.....        .++.+.|.|+||+++|.|+||
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            999999999999999999999988777664443  3455789999988552        468899999999999999999


Q ss_pred             CCCCCCCC
Q psy11580        260 GVLFPGTD  267 (288)
Q Consensus       260 ~~p~~~~~  267 (288)
                      ..||....
T Consensus       247 ~lPf~~~~  254 (288)
T PF14531_consen  247 RLPFGLSS  254 (288)
T ss_dssp             S-STCCCG
T ss_pred             cCCCCCCC
Confidence            99998543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=3.8e-21  Score=150.47  Aligned_cols=139  Identities=17%  Similarity=0.161  Sum_probs=100.7

Q ss_pred             cccCCccccccccCccceeccCCCceEEEEeccCCCcchhh------------------------HHHHHHHHHHHHHCC
Q psy11580         64 HQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTH------------------------AKRAYREFKLMKLVN  119 (288)
Q Consensus        64 ~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~  119 (288)
                      ..+|+|.++.++.+    .+. +|+.||||+++........                        ......|++.+.++.
T Consensus         3 ~~ig~G~~~~Vy~a----~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   77 (190)
T cd05147           3 GCISTGKEANVYHA----TTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV   77 (190)
T ss_pred             CccccccceEEEEE----ECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            45677777776665    233 7999999999754221111                        112345999999998


Q ss_pred             CCCcceeeccccCCCcccccccEEEEEecccccHHH-HH--hhhCCHHHHHHHHHHHHHHHHHH-HHCCCEeecCCCCCE
Q psy11580        120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ-VI--QMDLDHERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNI  195 (288)
Q Consensus       120 h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~-~~--~~~~~~~~~~~~~~~i~~~l~~L-H~~~ivH~dl~~~ni  195 (288)
                      ++++.....+....        .++||||++++.+. ..  ...++...+..++.|++.+|+++ |+.||+||||||+||
T Consensus        78 ~~~v~~p~~~~~~~--------~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NI  149 (190)
T cd05147          78 TAGIPCPEPILLKS--------HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNL  149 (190)
T ss_pred             HCCCCCCcEEEecC--------CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence            87764333222111        18999999986432 21  24588899999999999999999 799999999999999


Q ss_pred             EEccCCcEEEeecccccccCC
Q psy11580        196 VVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       196 l~~~~~~~kl~dfg~~~~~~~  216 (288)
                      +++ ++.++|+|||+|.....
T Consensus       150 li~-~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         150 LYH-DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             EEE-CCcEEEEEccccccCCC
Confidence            998 57899999999875533

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=8.3e-20  Score=141.90  Aligned_cols=186  Identities=15%  Similarity=0.053  Sum_probs=132.2

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcchh--hHHHHHHHHHHHHHCC-CCCcceeeccccCCCcccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVT--HAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~  138 (288)
                      ....++++.|+.+++.      ...+.+++.+.++...-...  ....+.+|+++|+++. ++++++++++.    .   
T Consensus         6 ~~~~l~~~~f~~v~~~------~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----~---   72 (218)
T PRK12274          6 VNEPLKSDTFGRILLV------RGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----G---   72 (218)
T ss_pred             cceeecCCCcceEEEe------ecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----C---
Confidence            4455666666666643      34678888888864221111  1125789999999995 58899998861    1   


Q ss_pred             cccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecC-CCCCEEEccCCcEEEeecccccccCCC
Q psy11580        139 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL-KPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl-~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                         .+++|||+.|..+.....   . ....++.|++.+|+++|++||+|||| ||.||+++.++.++|+|||++......
T Consensus        73 ---~~lvmeyI~G~~L~~~~~---~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         73 ---RHLDRSYLAGAAMYQRPP---R-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ---EEEEEeeecCccHHhhhh---h-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence               299999999865432211   1 12457889999999999999999999 799999999999999999999854432


Q ss_pred             cc--------------cCCcccccccCchHhHhcC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        218 FM--------------MTPYVVTRYYRAPEVILGM-GYK-ENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       218 ~~--------------~~~~~~~~~~~aPE~~~~~-~~~-~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ..              .....+++.+++|+...-. ..+ .+.+.++.|..+|.++|++.++-+.+
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            21              0112357778888876543 344 56788899999999999999875543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=7.2e-20  Score=143.71  Aligned_cols=140  Identities=19%  Similarity=0.209  Sum_probs=104.0

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCCcchhh------------------------HHHHHHHHHHHHHC
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTH------------------------AKRAYREFKLMKLV  118 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l  118 (288)
                      ...+|+|.++.++.+.    +. +|+.||||+++........                        ...+..|.+.+.++
T Consensus         2 ~~~ig~G~~~~Vy~a~----~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   76 (190)
T cd05145           2 NGCISTGKEANVYHAR----TG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL   76 (190)
T ss_pred             CceeecCCCcEEEEEE----cC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence            4567777777777762    33 7999999999864211000                        12235789999999


Q ss_pred             CCCCcceeeccccCCCcccccccEEEEEeccccc-HHHH-H-hhhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCC
Q psy11580        119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-LCQV-I-QMDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSN  194 (288)
Q Consensus       119 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~-~-~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~n  194 (288)
                      .|+++.....+....        .++||||++++ +... + ....+......++.|++.++.++|. .||+||||||+|
T Consensus        77 ~~~~i~~p~~~~~~~--------~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N  148 (190)
T cd05145          77 YEAGVPVPEPILLKK--------NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN  148 (190)
T ss_pred             HhCCCCCceEEEecC--------CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence            998875444333222        18999999986 2222 2 2347778899999999999999999 999999999999


Q ss_pred             EEEccCCcEEEeecccccccCC
Q psy11580        195 IVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       195 il~~~~~~~kl~dfg~~~~~~~  216 (288)
                      |+++ ++.++|+|||++.....
T Consensus       149 Ill~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         149 ILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EEEE-CCCEEEEEcccceecCC
Confidence            9998 88999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603|consensus

Probab=99.82  E-value=4e-21  Score=166.83  Aligned_cols=189  Identities=26%  Similarity=0.421  Sum_probs=152.4

Q ss_pred             eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcccccccEEEEEeccccc-HHHHHh-
Q psy11580         82 YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-LCQVIQ-  158 (288)
Q Consensus        82 ~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~-  158 (288)
                      -....+.-+|+|+.++.............|..++..++ ||.++++...+..+...      +++.++..++ ++.... 
T Consensus        17 ~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl------~l~ld~~rgg~lft~l~~   90 (612)
T KOG0603|consen   17 GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKL------YLILDFLRGGDLFTRLSK   90 (612)
T ss_pred             ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccch------hHhhhhcccchhhhcccc
Confidence            34566788899998864333233335567888888886 99999999999888776      8999999874 544433 


Q ss_pred             -hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhHhc
Q psy11580        159 -MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG  237 (288)
Q Consensus       159 -~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~  237 (288)
                       ..++......+...++-+++.+|+.+++|||+|++||+++.+|.+++.|||+++..-.....   +|+..|||||++. 
T Consensus        91 ~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~-  166 (612)
T KOG0603|consen   91 EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN-  166 (612)
T ss_pred             CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh-
Confidence             33677778888999999999999999999999999999999999999999999876544322   8999999999998 


Q ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        238 MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       238 ~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                       ....++|-||+|+++++|++|..||.+    +..+.|.+..-..|.+
T Consensus       167 -gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~  209 (612)
T KOG0603|consen  167 -GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRE  209 (612)
T ss_pred             -ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchh
Confidence             457899999999999999999999998    6667777655554443

>KOG1240|consensus

Probab=99.81  E-value=3.4e-20  Score=169.47  Aligned_cols=193  Identities=22%  Similarity=0.338  Sum_probs=146.0

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCC--cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF--QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ++...+.+|++.|..+..+      +.....|+||++-+..  .+.....+..+|++ ....++||.+++.-+...+...
T Consensus        24 e~~~~~~LGstRFlKv~r~------k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAA   96 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARA------KDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAA   96 (1431)
T ss_pred             ceeeecccCchhhhhhhhc------cCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHH
Confidence            5677788888777776665      3444569999997643  23344455556666 6666999999998887766655


Q ss_pred             cccccEEEEEecccccHHHHHhhh--CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                            |+|.+|...+|++.+..+  +...+.+.|+.||+.||..+|+.||+|||||.+|||++.-.-+.|+||..-+..
T Consensus        97 ------ylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen   97 ------YLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             ------HHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCc
Confidence                  899999999999888643  667788899999999999999999999999999999999989999999865421


Q ss_pred             --CCCcc------cCCcccccccCchHhHhcC----------C-CCchhhHHHHHHHHHHHHh-CCCCCC
Q psy11580        215 --GTTFM------MTPYVVTRYYRAPEVILGM----------G-YKENVDIWSVGCIMGEMIR-GGVLFP  264 (288)
Q Consensus       215 --~~~~~------~~~~~~~~~~~aPE~~~~~----------~-~~~~~Di~slg~il~~l~~-g~~p~~  264 (288)
                        .....      ..+.....-|.|||.+-..          . .+++-||||+||+++||++ |++||.
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence              11111      0111112239999998541          1 5678999999999999997 899994

>KOG1166|consensus

Probab=99.78  E-value=1.6e-18  Score=160.43  Aligned_cols=212  Identities=23%  Similarity=0.308  Sum_probs=162.8

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC---CCCcceeeccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN---HKNIIGLLNAF  130 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~  130 (288)
                      ++....+.|.+.+|.|.++.+|.|.     ..+|+.||+|+-+....+.-.     -=.+++.+|+   -+.|.++..+.
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~-----~~~~~~~alK~e~P~~~WEfY-----I~~q~~~RLk~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVAT-----HSNGKLVALKVEKPPNPWEFY-----ICLQVMERLKPQMLPSIMHISSAH  763 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEee-----cCCCcEEEEEeecCCCceeee-----ehHHHHHhhchhhhcchHHHHHHH
Confidence            4556678899999999888888874     334999999999865433211     1123344443   35677777777


Q ss_pred             cCCCcccccccEEEEEeccc-ccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc-------C
Q psy11580        131 TPQKSLEEFQDVYLVMELMD-ANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-------D  200 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~-------~  200 (288)
                      ...+.-      ++|+||.+ |+|+++++  +.+++.....+..|++..++.||..+|||+||||+|+++..       .
T Consensus       764 ~~~~~S------~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~  837 (974)
T KOG1166|consen  764 VFQNAS------VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDS  837 (974)
T ss_pred             ccCCcc------eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcc
Confidence            665543      99999998 56888887  44889999999999999999999999999999999999963       2


Q ss_pred             CcEEEeecccccccC---CCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCC-------------CC
Q psy11580        201 CTLKILDFGLARTAG---TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-------------FP  264 (288)
Q Consensus       201 ~~~kl~dfg~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p-------------~~  264 (288)
                      ..++|+|||.+..+.   ........+.+-.+-++|...|.+|+..+|.|.|+.+++.|+.|+.-             |+
T Consensus       838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~~~~~~~  917 (974)
T KOG1166|consen  838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWMVKTNFP  917 (974)
T ss_pred             cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcceeccccch
Confidence            458999999997543   33334556778889999999999999999999999999999998532             33


Q ss_pred             CCCchhHHHHHHHHhCC
Q psy11580        265 GTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       265 ~~~~~~~~~~i~~~~~~  281 (288)
                      ..-..++|.++...+.+
T Consensus       918 Ry~~~~~W~~~F~~lLN  934 (974)
T KOG1166|consen  918 RYWKRDMWNKFFDLLLN  934 (974)
T ss_pred             hhhhHHHHHHHHHHHhC
Confidence            44566777777776655

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=7.8e-18  Score=133.03  Aligned_cols=138  Identities=17%  Similarity=0.143  Sum_probs=97.0

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-----CCCCcceeeccccCCCc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-----NHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~  135 (288)
                      .-...||+|.++.++.      +..++.. +||++...  .......+.+|+++++.+     +||||++++|++.++..
T Consensus         5 ~~~~~LG~G~~~~Vy~------hp~~~~k-~IKv~~~~--~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g   75 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA------HPEDAQR-CIKIVYHR--GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG   75 (210)
T ss_pred             CCcceecCCCceEEEE------CCCCcCe-EEEEEecc--ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence            3445666666555553      2445444 69988752  223456789999999999     57999999999987642


Q ss_pred             ccccccEEEEEeccc---ccHHHHHhhh-CCHHHHHHHHHHHHHHH-HHHHHCCCEeecCCCCCEEEccC----CcEEEe
Q psy11580        136 LEEFQDVYLVMELMD---ANLCQVIQMD-LDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVVKSD----CTLKIL  206 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~---~~l~~~~~~~-~~~~~~~~~~~~i~~~l-~~LH~~~ivH~dl~~~nil~~~~----~~~kl~  206 (288)
                      .  ...+.+|+||.+   ++|.+.+... +++.  ..++.+++.++ +|||+.+|+||||||+||+++..    +.++|+
T Consensus        76 ~--g~v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         76 T--GYVYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             C--eEEEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            1  111247899954   4677776533 3444  35677888777 99999999999999999999743    379999


Q ss_pred             ecccc
Q psy11580        207 DFGLA  211 (288)
Q Consensus       207 dfg~~  211 (288)
                      |++.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            94433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=3.7e-17  Score=130.67  Aligned_cols=136  Identities=22%  Similarity=0.239  Sum_probs=102.1

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchh------hHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVT------HAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+++|.++.++.|      ...+..|++|+.........      ....+..|++++..+.|+++.....++......  
T Consensus         3 ~l~~G~~~~vy~~------~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~--   74 (211)
T PRK14879          3 LIKRGAEAEIYLG------DFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF--   74 (211)
T ss_pred             ccccCceEEEEEE------eeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC--
Confidence            4566666666665      23778899998764221111      124577899999999999887766665544443  


Q ss_pred             cccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        139 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                          +++|||++|..+......... ....++.+++.+|.++|+.+++|+|++|.||+++ ++.++|+|||.+...
T Consensus        75 ----~lv~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         75 ----IIVMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             ----EEEEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence                899999987544333322333 7889999999999999999999999999999999 788999999988764

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=2.5e-17  Score=133.19  Aligned_cols=142  Identities=17%  Similarity=0.185  Sum_probs=102.4

Q ss_pred             cccccccCCccccccccCcccee-ccCCCceEEEEeccCCCcchh----------------------hHHHHHHHHHHHH
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAY-DTATQQNVAIKKLSRPFQNVT----------------------HAKRAYREFKLMK  116 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~-~~~~~~~vavK~~~~~~~~~~----------------------~~~~~~~e~~~l~  116 (288)
                      +.+.+.+|+|.++.++.+    . +..+|+.||+|+++.......                      ....+..|+..++
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a----~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~  105 (237)
T smart00090       30 SAIGGCISTGKEANVYHA----LDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ  105 (237)
T ss_pred             HHhCCeeccCcceeEEEE----EecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            456677777777776664    3 456899999999975321100                      1123568999999


Q ss_pred             HCCCC--CcceeeccccCCCcccccccEEEEEecccccHHHH-Hh--hhCCHHHHHHHHHHHHHHHHHHHHCC-CEeecC
Q psy11580        117 LVNHK--NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQV-IQ--MDLDHERMSYLLYQMLCGIKHLHSAG-IIHRDL  190 (288)
Q Consensus       117 ~l~h~--~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~-~~--~~~~~~~~~~~~~~i~~~l~~LH~~~-ivH~dl  190 (288)
                      ++.+.  .+.++++.   ..       .++||||+++..+.. ..  .......+..++.|++.++++||+.| ++|+||
T Consensus       106 ~L~~~~i~~p~~~~~---~~-------~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Di  175 (237)
T smart00090      106 RLYEAGVPVPKPIAW---RR-------NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDL  175 (237)
T ss_pred             HHHhcCCCCCeeeEe---cC-------ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCC
Confidence            99753  33444432   11       289999999854322 21  23455567889999999999999999 999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      ||+||+++ ++.++|+|||.+...+.
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhccCC
Confidence            99999999 88999999998876544

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=2.4e-16  Score=124.77  Aligned_cols=133  Identities=23%  Similarity=0.283  Sum_probs=95.2

Q ss_pred             cCCccccccccCccceeccCCCceEEEEeccCCCc-c-----hhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         66 MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-N-----VTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        66 ~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +++|.++.++.|      ..++..|++|+...... .     .....++.+|+++++.++|+++....-++......   
T Consensus         2 ig~G~~~~vy~~------~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~---   72 (199)
T TIGR03724         2 IAKGAEAIIYLG------DFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK---   72 (199)
T ss_pred             CCCCceEEEEEe------ecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC---
Confidence            456666666665      24678999999653211 1     11235677899999999887654444344333333   


Q ss_pred             ccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        140 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                         ++||||++|..+.........    .++.+++.+|.+||+.+++|+|++|.||+++ ++.++++|||++....
T Consensus        73 ---~lv~e~~~g~~l~~~~~~~~~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        73 ---TIVMEYIEGKPLKDVIEEGND----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             ---EEEEEEECCccHHHHHhhcHH----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence               899999987544333221111    7899999999999999999999999999999 8899999999887643

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4158|consensus

Probab=99.69  E-value=2e-16  Score=131.05  Aligned_cols=148  Identities=26%  Similarity=0.355  Sum_probs=113.7

Q ss_pred             CCCCcceeeccccCCCc---------------------ccccccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHH
Q psy11580        119 NHKNIIGLLNAFTPQKS---------------------LEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCG  176 (288)
Q Consensus       119 ~h~~i~~~~~~~~~~~~---------------------~~~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~  176 (288)
                      +||||+++.++|.+.-.                     ...+..+|+||.....+|.+++- ...+.....-+..|+++|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLEa  353 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLEA  353 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHHH
Confidence            49999999998875321                     12334689999999999988875 446777788899999999


Q ss_pred             HHHHHHCCCEeecCCCCCEEEcc--CC--cEEEeecccccccCCC-------cccCCcccccccCchHhHhcCC-----C
Q psy11580        177 IKHLHSAGIIHRDLKPSNIVVKS--DC--TLKILDFGLARTAGTT-------FMMTPYVVTRYYRAPEVILGMG-----Y  240 (288)
Q Consensus       177 l~~LH~~~ivH~dl~~~nil~~~--~~--~~kl~dfg~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~-----~  240 (288)
                      +.+||+.||.|||+|++|||+.-  |+  .+.++|||.+---...       ...-..-|+..-||||+....+     .
T Consensus       354 v~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avv  433 (598)
T KOG4158|consen  354 VTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVV  433 (598)
T ss_pred             HHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceee
Confidence            99999999999999999999953  33  3689999987432221       1111224567789999986533     1


Q ss_pred             -CchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        241 -KENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       241 -~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                       -.++|.|+.|.+.||++....||.+.
T Consensus       434 ny~kAD~WA~GalaYEIfg~~NPFY~r  460 (598)
T KOG4158|consen  434 NYEKADTWAAGALAYEIFGRSNPFYKR  460 (598)
T ss_pred             ccchhhhhhhhhhHHHHhccCCccccc
Confidence             24899999999999999999999873

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=4e-16  Score=123.38  Aligned_cols=139  Identities=22%  Similarity=0.236  Sum_probs=100.7

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchh--------------------hHHHHHHHHHHHHHCC
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVT--------------------HAKRAYREFKLMKLVN  119 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~  119 (288)
                      ..+.+.+++|.++.++.+.     ..+|+.||||++........                    .......|..++..+.
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~-----~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   91 (198)
T cd05144          17 ESLGNQIGVGKESDVYLAL-----DPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY   91 (198)
T ss_pred             hhcCCccccCcceEEEEEE-----cCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence            3456778887777777653     23789999999764321110                    1123567888999987


Q ss_pred             CCC--cceeeccccCCCcccccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE
Q psy11580        120 HKN--IIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV  197 (288)
Q Consensus       120 h~~--i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~  197 (288)
                      +++  +...++.    ..      .++||||+++..+..+..   ......++.+++.++.++|+.+++|+||+|.||++
T Consensus        92 ~~~i~v~~~~~~----~~------~~lv~e~~~g~~L~~~~~---~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill  158 (198)
T cd05144          92 EEGFPVPKPIDW----NR------HAVVMEYIDGVELYRVRV---LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV  158 (198)
T ss_pred             HcCCCCCceeec----CC------ceEEEEEeCCcchhhccc---cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE
Confidence            774  4444432    11      289999999865443322   14556789999999999999999999999999999


Q ss_pred             ccCCcEEEeecccccccCC
Q psy11580        198 KSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       198 ~~~~~~kl~dfg~~~~~~~  216 (288)
                      +.++.++|+|||.+.....
T Consensus       159 ~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         159 DDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cCCCcEEEEECCccccCCC
Confidence            9999999999999865544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=8e-16  Score=139.26  Aligned_cols=137  Identities=22%  Similarity=0.249  Sum_probs=100.9

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCC-c-----chhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-Q-----NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...+.+|+|.++.++.|      ...+..+++|+..... .     .......+.+|+++++.++|++++....++....
T Consensus       336 ~~~~~iG~G~~g~Vy~~------~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        336 IPDHLIGKGAEADIKKG------EYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             CccceeccCCcEEEEEE------eecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            45677788877777775      2344455555432111 1     1122356789999999999999988776665544


Q ss_pred             cccccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        135 SLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      ..      ++||||++++.+.....     ....++.+++.+|.+||+.+++||||||+||++ .++.++|+|||++...
T Consensus       410 ~~------~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        410 EK------TIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CC------EEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            33      89999998864433222     456789999999999999999999999999999 6778999999998765


Q ss_pred             C
Q psy11580        215 G  215 (288)
Q Consensus       215 ~  215 (288)
                      .
T Consensus       478 ~  478 (535)
T PRK09605        478 D  478 (535)
T ss_pred             C
Confidence            3

>KOG1023|consensus

Probab=99.66  E-value=2.6e-16  Score=136.64  Aligned_cols=146  Identities=26%  Similarity=0.359  Sum_probs=119.1

Q ss_pred             HHHCCCCCcceeeccccCCCcccccccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCC-Eeec
Q psy11580        115 MKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGI-IHRD  189 (288)
Q Consensus       115 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i-vH~d  189 (288)
                      |+.+.|.|+.+++|.+.+.+..      ++|.+||..+ +.+.+.   .++++.-...+.++|+.||+|||...| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~------~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEM------IVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCce------EEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeee
Confidence            4678899999999999988665      9999999965 555554   347777888899999999999998876 9999


Q ss_pred             CCCCCEEEccCCcEEEeecccccccCCC---cccCCcccccccCchHhHhcCC-------CCchhhHHHHHHHHHHHHhC
Q psy11580        190 LKPSNIVVKSDCTLKILDFGLARTAGTT---FMMTPYVVTRYYRAPEVILGMG-------YKENVDIWSVGCIMGEMIRG  259 (288)
Q Consensus       190 l~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~-------~~~~~Di~slg~il~~l~~g  259 (288)
                      +++.|++++....+||+|||+.......   ...........|.|||.+++..       .+.+.|+||+|++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            9999999999999999999998766421   1112223456699999998731       46789999999999999999


Q ss_pred             CCCCCCC
Q psy11580        260 GVLFPGT  266 (288)
Q Consensus       260 ~~p~~~~  266 (288)
                      +-||...
T Consensus       155 ~~~~~~~  161 (484)
T KOG1023|consen  155 SGPFDLR  161 (484)
T ss_pred             cCccccc
Confidence            9999763

>KOG1033|consensus

Probab=99.65  E-value=5.1e-17  Score=138.96  Aligned_cols=116  Identities=35%  Similarity=0.509  Sum_probs=101.0

Q ss_pred             ccEEEEEeccccc-HHHHHhh-----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        140 QDVYLVMELMDAN-LCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       140 ~~~~lv~e~~~~~-l~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      .++++.|++|... |.+++..     ..++.....++.|++.+++|   ++.+|+|+||.||++..+..+||+|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            4568999999864 5566642     26777889999999999999   9999999999999999999999999999987


Q ss_pred             cCCCc-------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh
Q psy11580        214 AGTTF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR  258 (288)
Q Consensus       214 ~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~  258 (288)
                      .....       ..+...+|..||+||.+.+..|+.++|||+||++++|++.
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            65544       3466789999999999999999999999999999999987

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=2.1e-15  Score=118.16  Aligned_cols=135  Identities=24%  Similarity=0.292  Sum_probs=92.2

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHH----------------------HHHHHHHHHCCC
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRA----------------------YREFKLMKLVNH  120 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h  120 (288)
                      ++.+++|.++.++.+.    + .+++.||||++.............                      ..|.+.+..+.+
T Consensus         2 ~~~lg~G~~g~Vy~a~----~-~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~   76 (187)
T cd05119           2 GGPIGTGKEADVYLAL----D-GDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYE   76 (187)
T ss_pred             CcccccccceeEEEEE----C-CCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHH
Confidence            4556777777776652    2 378999999987532221111111                      345666666643


Q ss_pred             CC--cceeeccccCCCcccccccEEEEEeccccc-----HHHHHhhhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCC
Q psy11580        121 KN--IIGLLNAFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKP  192 (288)
Q Consensus       121 ~~--i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-----l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~  192 (288)
                      ..  +.+.+++.          ..++||||++++     .+.....   ...+..++.+++.++.++|. .+++|+||+|
T Consensus        77 ~~~~~~~~~~~~----------~~~lv~e~~~g~~~~~~~l~~~~~---~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p  143 (187)
T cd05119          77 AGVPVPKPIDLN----------RHVLVMEFIGGDGIPAPRLKDVRL---LEDPEELYDQILELMRKLYREAGLVHGDLSE  143 (187)
T ss_pred             cCCCCCceEecC----------CCEEEEEEeCCCCccChhhhhhhh---cccHHHHHHHHHHHHHHHhhccCcCcCCCCh
Confidence            32  34444321          138999999983     2222111   16778899999999999999 9999999999


Q ss_pred             CCEEEccCCcEEEeecccccccCC
Q psy11580        193 SNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       193 ~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      +||+++ ++.++|+|||.+.....
T Consensus       144 ~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         144 YNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             hhEEEE-CCcEEEEECcccccccC
Confidence            999999 88999999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606|consensus

Probab=99.63  E-value=2.8e-16  Score=143.91  Aligned_cols=112  Identities=36%  Similarity=0.572  Sum_probs=97.9

Q ss_pred             HHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc----------------ccCCcccccccCchHhHhc
Q psy11580        174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF----------------MMTPYVVTRYYRAPEVILG  237 (288)
Q Consensus       174 ~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----------------~~~~~~~~~~~~aPE~~~~  237 (288)
                      +.+++|||..||+|||+||+|.+++.-|.+|++|||+++......                .....++|+.|.|||++..
T Consensus       153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr  232 (1205)
T KOG0606|consen  153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR  232 (1205)
T ss_pred             hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence            778999999999999999999999999999999999997532211                1123489999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        238 MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       238 ~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      +.|+..+|.|++|+|+|+.+.|..||.+.+++++..+.+.-...-|++
T Consensus       233 qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~  280 (1205)
T KOG0606|consen  233 QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE  280 (1205)
T ss_pred             hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence            999999999999999999999999999999999999988877655544

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=4.4e-15  Score=120.38  Aligned_cols=134  Identities=22%  Similarity=0.326  Sum_probs=93.2

Q ss_pred             ccCccceeccC-CCceEEEEeccCCCc-----------chhhHHHHHHHHHHHHHCCCCCc--ceeeccccCCCcccccc
Q psy11580         75 HLGAGAAYDTA-TQQNVAIKKLSRPFQ-----------NVTHAKRAYREFKLMKLVNHKNI--IGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        75 ~~g~g~~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~~~~~~~  140 (288)
                      .+|.|.++... .+..++||.+.....           .......+.+|++++..++|++|  +..+++.......  ..
T Consensus        42 ~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~--~~  119 (239)
T PRK01723         42 AKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGL--FY  119 (239)
T ss_pred             CCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCc--ce
Confidence            44555443322 367899998853210           11234567889999999998775  6666664433221  11


Q ss_pred             cEEEEEecccc--cHHHHHhh-hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        141 DVYLVMELMDA--NLCQVIQM-DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       141 ~~~lv~e~~~~--~l~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      ..++|||++++  ++.+.+.. .++..    .+.+++.+|.+||++||+|+||||.|||++.++.++|+|||.+...
T Consensus       120 ~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        120 RADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             eeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence            23699999996  45554432 23332    3678999999999999999999999999999899999999987664

>KOG1243|consensus

Probab=99.60  E-value=2e-14  Score=126.68  Aligned_cols=165  Identities=22%  Similarity=0.362  Sum_probs=127.6

Q ss_pred             ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccccHHHHHhhhCC
Q psy11580         83 DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD  162 (288)
Q Consensus        83 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~  162 (288)
                      .+.++.+|.|+.++....  .......+.++.|+.++||||+++++.+...+.+      |+|+|.+..  +.......+
T Consensus        33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~------ylvTErV~P--l~~~lk~l~  102 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTL------YLVTERVRP--LETVLKELG  102 (690)
T ss_pred             eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCce------EEEeecccc--HHHHHHHhH
Confidence            467889999999986432  4456778899999999999999999999988866      999998863  222223345


Q ss_pred             HHHHHHHHHHHHHHHHHHH-HCCCEeecCCCCCEEEccCCcEEEeecccccccCCCccc-CCcccccccCchHhHhcCCC
Q psy11580        163 HERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMM-TPYVVTRYYRAPEVILGMGY  240 (288)
Q Consensus       163 ~~~~~~~~~~i~~~l~~LH-~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~  240 (288)
                      ...+...+.||+.||.+|| +++++|++|....|+++..|..||++|.++......... ......-.|..|+.+.... 
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc-
Confidence            6777788999999999998 677999999999999999999999999988665443221 1122223366666554332 


Q ss_pred             CchhhHHHHHHHHHHHHhC
Q psy11580        241 KENVDIWSVGCIMGEMIRG  259 (288)
Q Consensus       241 ~~~~Di~slg~il~~l~~g  259 (288)
                       ...|.|.||+++++++.|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             457999999999999999

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.57  E-value=2.2e-14  Score=108.08  Aligned_cols=129  Identities=20%  Similarity=0.235  Sum_probs=98.8

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCC--CCcceeeccccCCCcccccccE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH--KNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      .+++|....++..      ...+..+++|.......    ...+..|+..++.+++  .++.+++.+....+..      
T Consensus         5 ~i~~g~~~~v~~~------~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~------   68 (155)
T cd05120           5 LLKGGLTNRVYLL------GTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWS------   68 (155)
T ss_pred             ecccccccceEEE------EecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc------
Confidence            3455544444443      12347899999875322    4578889999999976  5889998888765443      


Q ss_pred             EEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHC---CCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        143 YLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       143 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      ++++||+++......    +......++.+++++++.+|..   +++|+|++|.||+++..+.+++.|||.+..
T Consensus        69 ~~v~e~~~g~~~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          69 YLLMEWIEGETLDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEEEecCCeecccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            999999988644322    5567778899999999999984   699999999999999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.46  E-value=1.1e-12  Score=102.08  Aligned_cols=95  Identities=20%  Similarity=0.318  Sum_probs=72.3

Q ss_pred             HHHHHHHHCC--CCCcceeeccccCCCcccccccEEEEEeccccc-HHHH-H-hhhCCHHHHHHHHHHHHHHHHHH-HHC
Q psy11580        110 REFKLMKLVN--HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-LCQV-I-QMDLDHERMSYLLYQMLCGIKHL-HSA  183 (288)
Q Consensus       110 ~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~-~-~~~~~~~~~~~~~~~i~~~l~~L-H~~  183 (288)
                      +|++.|+++.  .-++..++++  ...        ++||||++++ +... + ....+.+....+..+++.+|..+ |+.
T Consensus        75 kE~r~L~rl~~~Gv~vP~pi~~--~~~--------~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~  144 (197)
T cd05146          75 KEMHNLKRMQKAGIPCPEVVVL--KKH--------VLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC  144 (197)
T ss_pred             HHHHHHHHHHHcCCCCCeEEEe--cCC--------EEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC
Confidence            7999999995  3566777765  222        8999999874 2111 1 12344556778889999999988 899


Q ss_pred             CCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       184 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      |+||+||++.||+++ ++.+.|+|||.+....
T Consensus       145 glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         145 NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999999999997 5689999999876654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0590|consensus

Probab=99.44  E-value=1.4e-14  Score=131.35  Aligned_cols=194  Identities=26%  Similarity=0.407  Sum_probs=148.9

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcccccccEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEFQDVY  143 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~  143 (288)
                      .+|++.+..+.+-.   ........+|+|.+...............|..+-+.+. |+|++++++........      +
T Consensus        27 ~ig~gs~~~~~~~~---~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~------~   97 (601)
T KOG0590|consen   27 SIGKGSFSSSALAS---NSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY------L   97 (601)
T ss_pred             cccccccchhhhhh---hcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccc------c
Confidence            35555555444421   11234457778877765444555566667888888886 99999999999877765      8


Q ss_pred             EEEeccccc-HHHHH-hh---hCCHHHHHHHHHHHHHHHHHHH-HCCCEeecCCCCCEEEccCC-cEEEeecccccccCC
Q psy11580        144 LVMELMDAN-LCQVI-QM---DLDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGT  216 (288)
Q Consensus       144 lv~e~~~~~-l~~~~-~~---~~~~~~~~~~~~~i~~~l~~LH-~~~ivH~dl~~~nil~~~~~-~~kl~dfg~~~~~~~  216 (288)
                      +++++..++ ++.-+ ..   ..+...+..++.|+..++.|+| ..++.|+|++|+|.+++..+ ..++.|||+|.....
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999997764 44443 21   3566778889999999999999 99999999999999999999 999999999976543


Q ss_pred             ----CcccCCccc-ccccCchHhHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        217 ----TFMMTPYVV-TRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       217 ----~~~~~~~~~-~~~~~aPE~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                          .......+| ++.|+|||...+.. .....|+||.|+++.-+++|..|+....
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~  234 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS  234 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence                223345677 99999999998853 4678999999999999999999997543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=3e-12  Score=98.58  Aligned_cols=111  Identities=19%  Similarity=0.168  Sum_probs=79.6

Q ss_pred             CCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCc-ceeeccccCCCcccccccEEEEEecccccHHHHHhhhCCHH
Q psy11580         86 TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNI-IGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE  164 (288)
Q Consensus        86 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~  164 (288)
                      .++.|++|+......   .......|+++++.+.+.++ .+++.......        ++|||+++|......     ..
T Consensus        20 ~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~--------~lv~e~i~G~~l~~~-----~~   83 (170)
T cd05151          20 ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPETG--------VLITEFIEGSELLTE-----DF   83 (170)
T ss_pred             CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCCCC--------eEEEEecCCCccccc-----cc
Confidence            468899999864321   22346789999999865443 45555433222        899999998643321     11


Q ss_pred             HHHHHHHHHHHHHHHHHHCCC-----EeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        165 RMSYLLYQMLCGIKHLHSAGI-----IHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       165 ~~~~~~~~i~~~l~~LH~~~i-----vH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      .....+.+++++|+.||..++     +|+|+++.||+++ ++.++++||+.+..
T Consensus        84 ~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          84 SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            123457799999999999885     9999999999999 66899999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601|consensus

Probab=99.34  E-value=2.7e-12  Score=112.04  Aligned_cols=200  Identities=28%  Similarity=0.351  Sum_probs=150.8

Q ss_pred             cccccccccCC--ccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCC
Q psy11580         58 QELPISHQMGK--KRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQK  134 (288)
Q Consensus        58 ~~~~~~~~~~~--~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  134 (288)
                      +.+.+...+|.  |..+.++-+  .+....++..+|+|.-+.....+.....-.+|+...+++ .|+|.++.+..+...+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~--~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKS--RCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhcccccccccCCCCCceeecc--cCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            34444455555  433333332  222367889999999766555444445555778777788 5999999888888877


Q ss_pred             cccccccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHH----HHHHHHHCCCEeecCCCCCEEEccC-CcEEEe
Q psy11580        135 SLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLC----GIKHLHSAGIIHRDLKPSNIVVKSD-CTLKIL  206 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~----~l~~LH~~~ivH~dl~~~nil~~~~-~~~kl~  206 (288)
                      ..      ++-+|.++..+.++...   -+....++....+...    ||..+|..+++|-|++|.||++..+ ...+++
T Consensus       192 ~l------fiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  192 IL------FIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             cc------eeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecC
Confidence            65      99999999887776652   2667788888888888    9999999999999999999999999 889999


Q ss_pred             ecccccccCCCcccC------CcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        207 DFGLARTAGTTFMMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       207 dfg~~~~~~~~~~~~------~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      |||+...++......      ...+...|++||...+ .++.++|+|++|.++.+..++..+....
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCC
Confidence            999998766543211      1256677999999876 4688999999999999988876665443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.33  E-value=8.3e-12  Score=109.84  Aligned_cols=73  Identities=27%  Similarity=0.359  Sum_probs=55.6

Q ss_pred             EEEEecccccHHHHHh-hh-CCHHHHHHHHHHHHH-HHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        143 YLVMELMDANLCQVIQ-MD-LDHERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       143 ~lv~e~~~~~l~~~~~-~~-~~~~~~~~~~~~i~~-~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      ++||||++|..+.... .. ... ....++.+++. .+..+|..|++|+|++|.||+++.++.++++|||++...+.
T Consensus       234 vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       234 VLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999985433221 11 111 23456777766 47889999999999999999999999999999999976653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266|consensus

Probab=99.32  E-value=6.9e-12  Score=102.04  Aligned_cols=164  Identities=20%  Similarity=0.207  Sum_probs=119.3

Q ss_pred             HHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccccHHH-HHh------hhCCHHHHHHHHHHHHHHHHHHHHCC
Q psy11580        112 FKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ-VIQ------MDLDHERMSYLLYQMLCGIKHLHSAG  184 (288)
Q Consensus       112 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~-~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~  184 (288)
                      +.-|-++-|.||++++.++.+.+. ++.....+++|||..+... .+.      ..+......+|+.||++||.|||+..
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~-~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKY-EEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhccccc-ccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            344556679999999999988764 4556678999999865443 332      23777888999999999999999876


Q ss_pred             --CEeecCCCCCEEEccCCcEEEeeccccccc-----CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHH
Q psy11580        185 --IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI  257 (288)
Q Consensus       185 --ivH~dl~~~nil~~~~~~~kl~dfg~~~~~-----~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~  257 (288)
                        |+|+++.-+.|++..+|-+|++.-.....-     ..........+.++|.+||.-.-...+.++|||++|++..+|.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence              999999999999999998888653322211     1111122335678899999866666778999999999999999


Q ss_pred             hCCCC-CCCCCchhHHHHHH
Q psy11580        258 RGGVL-FPGTDHIDQWNKII  276 (288)
Q Consensus       258 ~g~~p-~~~~~~~~~~~~i~  276 (288)
                      .+..- -.+.+..+....|.
T Consensus       277 ilEiq~tnseS~~~~ee~ia  296 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIA  296 (458)
T ss_pred             HheeccCCCcceeehhhhhh
Confidence            88775 44444333333333

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.28  E-value=7.7e-11  Score=88.99  Aligned_cols=97  Identities=25%  Similarity=0.363  Sum_probs=74.1

Q ss_pred             HHHHHHHHHHHHCCC--CCcceeeccccCCCcccccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHC
Q psy11580        106 KRAYREFKLMKLVNH--KNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA  183 (288)
Q Consensus       106 ~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~  183 (288)
                      .+..+|+.++.++.-  -+...++++..+..        .++|||++|.++.......    ...++..+-.-+.-||..
T Consensus        44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~--------~I~me~I~G~~lkd~l~~~----~~~~~r~vG~~vg~lH~~  111 (204)
T COG3642          44 ERTRREARILAKAREAGVPVPIVYDVDPDNG--------LIVMEYIEGELLKDALEEA----RPDLLREVGRLVGKLHKA  111 (204)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC--------EEEEEEeCChhHHHHHHhc----chHHHHHHHHHHHHHHhc
Confidence            456689999999853  45555666655554        8999999998766333222    245677777788889999


Q ss_pred             CCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       184 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      ||+|+||.++||++++++ +.++|||++....
T Consensus       112 givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642         112 GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            999999999999998765 9999999987543

>KOG3087|consensus

Probab=99.24  E-value=1.3e-10  Score=87.48  Aligned_cols=126  Identities=25%  Similarity=0.315  Sum_probs=87.1

Q ss_pred             cCCCceEEEEecc-CCCcc-----hhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccc--cHHH
Q psy11580         84 TATQQNVAIKKLS-RPFQN-----VTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA--NLCQ  155 (288)
Q Consensus        84 ~~~~~~vavK~~~-~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~  155 (288)
                      ...|+.++||.-. +....     .-...+...|++.|.++.--.|..-.-++.+....      .++|||++|  ++.+
T Consensus        27 ~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~------~i~ME~~~g~~~vk~  100 (229)
T KOG3087|consen   27 SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG------QIYMEFIDGASTVKD  100 (229)
T ss_pred             ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC------eEEEEeccchhHHHH
Confidence            4667777777543 21111     12234677899999999644443333333333332      899999998  5555


Q ss_pred             HHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc---EEEeecccccccC
Q psy11580        156 VIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLARTAG  215 (288)
Q Consensus       156 ~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~---~kl~dfg~~~~~~  215 (288)
                      ++..    .........++.+|-+.+.-||.++|+|+||.++||++..++.   +.++|||++....
T Consensus       101 ~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~  167 (229)
T KOG3087|consen  101 FILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR  167 (229)
T ss_pred             HHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence            5542    2333444789999999999999999999999999999987653   5899999987653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.20  E-value=3.4e-10  Score=95.47  Aligned_cols=182  Identities=12%  Similarity=0.144  Sum_probs=124.6

Q ss_pred             cCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcce----eeccccCCCcccccccEEEEEeccc
Q psy11580         76 LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIG----LLNAFTPQKSLEEFQDVYLVMELMD  150 (288)
Q Consensus        76 ~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~----~~~~~~~~~~~~~~~~~~lv~e~~~  150 (288)
                      +|.+.+|....-+..+.|++..+-..  ..  . +-+..|... .||-+-.    -.......+.   .....+.|+.+.
T Consensus        22 Ggea~ly~l~e~~d~VAKIYh~Pppa--~~--a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~---~~~iGflmP~v~   93 (637)
T COG4248          22 GGEADLYTLGEVRDQVAKIYHAPPPA--AQ--A-QKVAELAATPDAPLLNYRVAWPQATLHGGRR---GKVIGFLMPKVS   93 (637)
T ss_pred             CccceeeecchhhchhheeecCCCch--HH--H-HHHHHhccCCCCcchhhhhcccHHHhhCCCc---cceeEEecccCC
Confidence            45556666666677888999753211  11  1 122233333 5654332    1111111111   011467888877


Q ss_pred             c--cHHHHHh--------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCccc
Q psy11580        151 A--NLCQVIQ--------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMM  220 (288)
Q Consensus       151 ~--~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~  220 (288)
                      +  .....++        ...+|.-+++.++.++.+.+.||..|.+-+|++++|+|+++++.+.|.|-..-.........
T Consensus        94 g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~  173 (637)
T COG4248          94 GKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLH  173 (637)
T ss_pred             CccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccCCceE
Confidence            6  3333333        12789999999999999999999999999999999999999999999986654444444444


Q ss_pred             CCcccccccCchHhHh-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Q psy11580        221 TPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIRG-GVLFPG  265 (288)
Q Consensus       221 ~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~il~~l~~g-~~p~~~  265 (288)
                      ...++...|++||.-.     +..-+..+|.|.||+++++++.| +.||.|
T Consensus       174 ~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         174 LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            5668899999999865     33456789999999999999875 999976

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=3.7e-10  Score=87.59  Aligned_cols=99  Identities=30%  Similarity=0.412  Sum_probs=67.3

Q ss_pred             HHHHHHHHHHHHCCCC--CcceeeccccCCCcccccccEEEEEeccc--ccHHHHH-hhhCCHHHHHHHHHHHHHHHHH-
Q psy11580        106 KRAYREFKLMKLVNHK--NIIGLLNAFTPQKSLEEFQDVYLVMELMD--ANLCQVI-QMDLDHERMSYLLYQMLCGIKH-  179 (288)
Q Consensus       106 ~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~-  179 (288)
                      ....+|.+.|+++..-  ++.+++++.  ..        ++||||++  |.....+ ...++.+....++.+++..+.. 
T Consensus        53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~--~~--------~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~  122 (188)
T PF01163_consen   53 EWAKKEFRNLKRLYEAGVPVPKPYDYN--RN--------VIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKM  122 (188)
T ss_dssp             HHHHHHHHHHHHCCCTT-SS--EEEEE--TT--------EEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCccCCcEEEEe--CC--------EEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHH
Confidence            3466899999999755  567776553  22        89999999  5433222 2233355667788888885555 


Q ss_pred             HHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       180 LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      +|..|++|+||++.||+++.+ .+.++|||.+....
T Consensus       123 ~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  123 LHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             HHCTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             HHhcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            679999999999999999877 99999999876654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.11  E-value=1.2e-10  Score=104.10  Aligned_cols=72  Identities=25%  Similarity=0.337  Sum_probs=48.7

Q ss_pred             EEEEEecccccHHHHH---h-hhCCHHHHHHHHHHHHHH-HHHHHHCCCEeecCCCCCEEEccCC----cEEEeeccccc
Q psy11580        142 VYLVMELMDANLCQVI---Q-MDLDHERMSYLLYQMLCG-IKHLHSAGIIHRDLKPSNIVVKSDC----TLKILDFGLAR  212 (288)
Q Consensus       142 ~~lv~e~~~~~l~~~~---~-~~~~~~~~~~~~~~i~~~-l~~LH~~~ivH~dl~~~nil~~~~~----~~kl~dfg~~~  212 (288)
                      .++||||++|.-.+.+   . ...+..   .++...+.. +..+...|++|+|+||.||+++.++    .++++|||.+.
T Consensus       236 ~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg  312 (537)
T PRK04750        236 TVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVG  312 (537)
T ss_pred             ceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEE
Confidence            3899999998543322   1 122221   222222222 3445579999999999999999888    99999999987


Q ss_pred             ccCC
Q psy11580        213 TAGT  216 (288)
Q Consensus       213 ~~~~  216 (288)
                      ..+.
T Consensus       313 ~l~~  316 (537)
T PRK04750        313 SLNK  316 (537)
T ss_pred             ECCH
Confidence            6543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.06  E-value=1.9e-09  Score=88.58  Aligned_cols=127  Identities=15%  Similarity=0.161  Sum_probs=84.9

Q ss_pred             CCceEEEEeccCCCcch---------hhHHHHHHHHHHHHHCCCCCc--ceeeccccCCCcccccccEEEEEeccccc--
Q psy11580         86 TQQNVAIKKLSRPFQNV---------THAKRAYREFKLMKLVNHKNI--IGLLNAFTPQKSLEEFQDVYLVMELMDAN--  152 (288)
Q Consensus        86 ~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~~~~~~~~~~lv~e~~~~~--  152 (288)
                      .|+.+.||.........         .....+.+|...+.+|..-+|  +.++.+...... .....-++|||++++.  
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~-~~~~~s~LVte~l~~~~s  122 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN-PATRTSFIITEDLAPTIS  122 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC-CccceeEEEEeeCCCCcc
Confidence            46789999775321100         001137788888888843333  333334322110 0012238999999984  


Q ss_pred             HHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc-------CCcEEEeecccccc
Q psy11580        153 LCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-------DCTLKILDFGLART  213 (288)
Q Consensus       153 l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~-------~~~~kl~dfg~~~~  213 (288)
                      +.+.+.    ...+......++.+++..+..||..||+|+|++++|||++.       +..+.|+||+.+..
T Consensus       123 L~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        123 LEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            555543    23456677889999999999999999999999999999975       46799999998754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.98  E-value=4.3e-09  Score=84.49  Aligned_cols=123  Identities=18%  Similarity=0.280  Sum_probs=86.1

Q ss_pred             CceEEEEeccCCCcchhhHHHHHHHHHHHHHCCC--CCcceeeccccCCCcccccccEEEEEecccccHHHHHh--hhCC
Q psy11580         87 QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH--KNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MDLD  162 (288)
Q Consensus        87 ~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~  162 (288)
                      |+.+++|+....... .....+..|+++++.+.+  .++.+++.+....+.   ....++|||+++|.......  ..++
T Consensus        22 g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~---~~~~~~v~e~i~G~~l~~~~~~~~~~   97 (223)
T cd05154          22 GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV---LGTPFYVMERVDGRVLRDRLLRPELS   97 (223)
T ss_pred             CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc---cCCceEEEEEeCCEecCCCCCCCCCC
Confidence            578999998643221 234578899999999965  345777777665320   12348999999986433222  2356


Q ss_pred             HHHHHHHHHHHHHHHHHHHH--------------------------------------------------------CCCE
Q psy11580        163 HERMSYLLYQMLCGIKHLHS--------------------------------------------------------AGII  186 (288)
Q Consensus       163 ~~~~~~~~~~i~~~l~~LH~--------------------------------------------------------~~iv  186 (288)
                      ......++.+++.+|..||+                                                        ..++
T Consensus        98 ~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  177 (223)
T cd05154          98 PEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLV  177 (223)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEE
Confidence            66667777777777777773                                                        2269


Q ss_pred             eecCCCCCEEEcc--CCcEEEeecccccc
Q psy11580        187 HRDLKPSNIVVKS--DCTLKILDFGLART  213 (288)
Q Consensus       187 H~dl~~~nil~~~--~~~~kl~dfg~~~~  213 (288)
                      |+|+++.||+++.  ++.+.++||+.+..
T Consensus       178 HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         178 HGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             ECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            9999999999998  56689999997654

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741|consensus

Probab=98.98  E-value=9.6e-09  Score=88.88  Aligned_cols=162  Identities=15%  Similarity=0.217  Sum_probs=119.1

Q ss_pred             ceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccc--cHHHHH
Q psy11580         80 AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA--NLCQVI  157 (288)
Q Consensus        80 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~  157 (288)
                      ++....+|..|++|++...  ..........-+++++++.|+|+|++.+++....  -....+++|++|.++  +|.+..
T Consensus       294 k~~s~~DG~~YvLkRlhg~--r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t--F~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  294 KATSNVDGNAYVLKRLHGD--RDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT--FGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             eeeeccCCceeeeeeeccc--cccCcccchHHHHHHHHhccCceeehhhhhhhhc--cCcceEEEEEecCCCCchHHHHH
Confidence            3566778999999999421  1111123335688999999999999999987332  123456999999986  466554


Q ss_pred             h-----------------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCccc
Q psy11580        158 Q-----------------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMM  220 (288)
Q Consensus       158 ~-----------------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~  220 (288)
                      .                 ...++..++.++.|+..||.++|+.|...+-|.+++|+++++-.++|+.-|.........  
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~--  447 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP--  447 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC--
Confidence            2                 126778999999999999999999999999999999999998888888777665443321  


Q ss_pred             CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCC
Q psy11580        221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGV  261 (288)
Q Consensus       221 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~  261 (288)
                               .  +.+.+   -.+-|.=.||.++..|.+|..
T Consensus       448 ---------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  448 ---------T--EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             ---------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence                     0  11111   236788899999999999844

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=7.9e-09  Score=82.07  Aligned_cols=108  Identities=29%  Similarity=0.344  Sum_probs=79.8

Q ss_pred             HHHHHHHHHHHHHCCCC--CcceeeccccCCCcccccccEEEEEeccccc--HHHHHhh--hCCHHHHHHHHHHHHHHHH
Q psy11580        105 AKRAYREFKLMKLVNHK--NIIGLLNAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQM--DLDHERMSYLLYQMLCGIK  178 (288)
Q Consensus       105 ~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~--l~~~~~~--~~~~~~~~~~~~~i~~~l~  178 (288)
                      .....+|...+..+..-  ...+.+.+.......  ....++|+|.+++.  +.+.+..  ..+......++.+++..++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~--~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGG--GYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC--ceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHH
Confidence            45677888887777432  344455554433211  13448999999873  5554442  2566778899999999999


Q ss_pred             HHHHCCCEeecCCCCCEEEccCC---cEEEeeccccccc
Q psy11580        179 HLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLARTA  214 (288)
Q Consensus       179 ~LH~~~ivH~dl~~~nil~~~~~---~~kl~dfg~~~~~  214 (288)
                      -||+.||+|+|+++.|||++.++   .+.|+||+.+...
T Consensus       133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999999999887   7999999977654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0601|consensus

Probab=98.95  E-value=5e-10  Score=98.06  Aligned_cols=175  Identities=23%  Similarity=0.261  Sum_probs=131.0

Q ss_pred             eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccEEEEEecccccHHH---HH
Q psy11580         82 YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ---VI  157 (288)
Q Consensus        82 ~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~---~~  157 (288)
                      ++..++..+++|...+..........-..|+-+...+ .|.+++..+..|......      ++-.||+++....   ..
T Consensus       286 ~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~------~ip~e~~~~~s~~l~~~~  359 (524)
T KOG0601|consen  286 KRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG------YIPLEFCEGGSSSLRSVT  359 (524)
T ss_pred             ecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc------cCchhhhcCcchhhhhHH
Confidence            3446788999999987666655555666778777777 588999888888766654      7889999875333   23


Q ss_pred             hhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC-CcEEEeecccccccCCCcccCCccccccc-CchHhH
Q psy11580        158 QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTTFMMTPYVVTRYY-RAPEVI  235 (288)
Q Consensus       158 ~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~-~aPE~~  235 (288)
                      ...+++...+++..|++.++.++|+..++|+|++|+||++..+ +..+++||+..+....... .....+..| .++...
T Consensus       360 ~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-~~~~~~r~~p~~~~~~  438 (524)
T KOG0601|consen  360 SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG-VFHHIDRLYPIAEILL  438 (524)
T ss_pred             HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceecc-cccccccccccchhhc
Confidence            3458888899999999999999999999999999999999986 7789999998875322211 111222333 355555


Q ss_pred             hcCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy11580        236 LGMGYKENVDIWSVGCIMGEMIRGGVLF  263 (288)
Q Consensus       236 ~~~~~~~~~Di~slg~il~~l~~g~~p~  263 (288)
                      ....+..+.|++|||.-+.+..++.+.-
T Consensus       439 e~~~~~~~~~~~sl~~~~~e~~~~~~ls  466 (524)
T KOG0601|consen  439 EDYPHLSKADIFSLGLSVDEAITGSPLS  466 (524)
T ss_pred             cccccccccccccccccccccccCcccC
Confidence            5677889999999999998888876643

>KOG0606|consensus

Probab=98.90  E-value=9.2e-10  Score=101.99  Aligned_cols=139  Identities=25%  Similarity=0.333  Sum_probs=110.8

Q ss_pred             EEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC--
Q psy11580        142 VYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--  216 (288)
Q Consensus       142 ~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~--  216 (288)
                      .++++++++++ +...+.  ...+.+-.+.....+..++++||...+.|+|++|.|.+...++..++.||+.....+.  
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            48999999764 333332  2356666777888899999999999999999999999999999999999983321100  


Q ss_pred             ------------------------------CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        217 ------------------------------TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       217 ------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                                                    ........+++.|.+||.+.+......+|.|+.|+++++.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                          01112346788999999999999999999999999999999999999999


Q ss_pred             CchhHHHHHHHHhC
Q psy11580        267 DHIDQWNKIIGKMR  280 (288)
Q Consensus       267 ~~~~~~~~i~~~~~  280 (288)
                      .++.....|.+..-
T Consensus      1039 tpq~~f~ni~~~~~ 1052 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDI 1052 (1205)
T ss_pred             chhhhhhccccCCC
Confidence            99888877775543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.87  E-value=1.7e-08  Score=80.95  Aligned_cols=135  Identities=21%  Similarity=0.246  Sum_probs=89.9

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCc------------------c--hhhHHHHHHHHHHHHHCCCC
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ------------------N--VTHAKRAYREFKLMKLVNHK  121 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~------------------~--~~~~~~~~~e~~~l~~l~h~  121 (288)
                      +|+.||-|-...++.|.     ...|.++|||.-+....                  +  .-.....++|.+.|.+|...
T Consensus        95 iG~~IGvGKEsdVY~~~-----~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~  169 (304)
T COG0478          95 IGTKIGVGKESDVYVAI-----DPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE  169 (304)
T ss_pred             hccccccCccceEEEEE-----CCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence            44444444444433331     23589999997642211                  1  01133567899999999644


Q ss_pred             --CcceeeccccCCCcccccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc
Q psy11580        122 --NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS  199 (288)
Q Consensus       122 --~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~  199 (288)
                        .+.+.+++-          .-.+|||+++|-.+.-.  +++.+....++..|++-+.-+-..|+||+|++.-||+++.
T Consensus       170 G~~VP~P~~~n----------RHaVvMe~ieG~eL~~~--r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         170 GVKVPKPIAWN----------RHAVVMEYIEGVELYRL--RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCCCCccccc----------cceeeeehcccceeecc--cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence              666665552          22899999998533221  2235555667777777777777999999999999999999


Q ss_pred             CCcEEEeecccccc
Q psy11580        200 DCTLKILDFGLART  213 (288)
Q Consensus       200 ~~~~kl~dfg~~~~  213 (288)
                      +|.+.++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999975443

>PRK09902 hypothetical protein; Provisional

Probab=98.76  E-value=1.4e-07  Score=73.90  Aligned_cols=125  Identities=18%  Similarity=0.157  Sum_probs=86.6

Q ss_pred             CceEEEEeccCCC----cchhhHHHHHHHHHHHHHCCC--CCcceeeccccCCCcccccccEEEEEecccc--cHHHHHh
Q psy11580         87 QQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNH--KNIIGLLNAFTPQKSLEEFQDVYLVMELMDA--NLCQVIQ  158 (288)
Q Consensus        87 ~~~vavK~~~~~~----~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~  158 (288)
                      |..+=+|.-.+..    ..+.....+.+|+..++++..  -.+.++. ++..... ...-.-++|+|-+++  +|.+.+.
T Consensus        41 g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~-~~~~rA~LVTe~L~g~~~L~~~l~  118 (216)
T PRK09902         41 GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKI-EGEWRALLVTEDMAGFISIADWYA  118 (216)
T ss_pred             CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeecc-CCceEEEEEEEeCCCCccHHHHHh
Confidence            3457777665211    112345678899999999853  2344544 3321111 112234899999884  5666553


Q ss_pred             h----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc--EEEeecccccc
Q psy11580        159 M----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLART  213 (288)
Q Consensus       159 ~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~--~kl~dfg~~~~  213 (288)
                      .    +.+......+..+++.+++-||+.|+.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       119 ~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        119 QHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             cCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            2    3467777899999999999999999999999999999986667  99999987654

>KOG2137|consensus

Probab=98.75  E-value=1.5e-09  Score=96.73  Aligned_cols=99  Identities=21%  Similarity=0.373  Sum_probs=77.2

Q ss_pred             HHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeecccccccCCCccc----------CCcccccccCchHhHhcCCC
Q psy11580        172 QMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMM----------TPYVVTRYYRAPEVILGMGY  240 (288)
Q Consensus       172 ~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~  240 (288)
                      +.+.||.++|. .++||++|.|++|.++..+.+||+.|+++.........          ........|.|||++.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            34489999996 56999999999999999999999999988654431111          11123456999999999888


Q ss_pred             CchhhHHHHHHHHHHHH-hCCCCCCCCCchh
Q psy11580        241 KENVDIWSVGCIMGEMI-RGGVLFPGTDHID  270 (288)
Q Consensus       241 ~~~~Di~slg~il~~l~-~g~~p~~~~~~~~  270 (288)
                      +.++|+||+|+++|.++ .|+..+.+.+...
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~  217 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLL  217 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcc
Confidence            99999999999999999 4666666654433

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.57  E-value=4.1e-07  Score=71.56  Aligned_cols=121  Identities=20%  Similarity=0.233  Sum_probs=71.1

Q ss_pred             CCCceEEEEeccCCCcchhh-HH------HHHHHHHHHHHCCC---CCcceeeccccCCCcccccccEEEEEecccccHH
Q psy11580         85 ATQQNVAIKKLSRPFQNVTH-AK------RAYREFKLMKLVNH---KNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLC  154 (288)
Q Consensus        85 ~~~~~vavK~~~~~~~~~~~-~~------~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~  154 (288)
                      -+|+.+++|..+....-.+. ..      ...+.+..+.+++.   ..+..++-+..... .......+++|||++|-.+
T Consensus        52 i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~-~~~~~~~~ll~EYIeG~~l  130 (229)
T PF06176_consen   52 IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKI-FRYTSSYVLLMEYIEGVEL  130 (229)
T ss_pred             ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeee-ccceeEEEEEEEEecCeec
Confidence            45788999998753211111 11      12233343444432   22333222222211 1222344789999998533


Q ss_pred             HHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        155 QVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      .... .+++    .++..+.+++..+|+.|++|+|.+|.|++++.+ .+++.|++...
T Consensus       131 ~d~~-~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  131 NDIE-DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             ccch-hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence            2111 1222    245667888999999999999999999999865 49999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.39  E-value=5.8e-06  Score=66.57  Aligned_cols=121  Identities=15%  Similarity=0.152  Sum_probs=71.2

Q ss_pred             ceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCC--CcceeeccccCCCcccccccEEEEEecccccH-HH-
Q psy11580         80 AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK--NIIGLLNAFTPQKSLEEFQDVYLVMELMDANL-CQ-  155 (288)
Q Consensus        80 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l-~~-  155 (288)
                      .+|.. .+..+++|......    ......+|.++++.+..-  .+.+++++....+..      .+|||+++|.. .. 
T Consensus        16 ~~y~~-~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~------glv~e~i~G~~~~~~   84 (226)
T TIGR02172        16 ESYTH-KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRL------GLIYELIVGKRSFSR   84 (226)
T ss_pred             ceeEe-cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCee------eeeeeecCCccchhh
Confidence            34442 35678899986421    234467899999998533  346677777555543      78999999841 11 


Q ss_pred             HHhhhCCHHHHHHHHHHHHHH---------------------------------------HHHHHH----CCCEeecCCC
Q psy11580        156 VIQMDLDHERMSYLLYQMLCG---------------------------------------IKHLHS----AGIIHRDLKP  192 (288)
Q Consensus       156 ~~~~~~~~~~~~~~~~~i~~~---------------------------------------l~~LH~----~~ivH~dl~~  192 (288)
                      ...  .+......++.++++.                                       .++|..    ..++|+|+.|
T Consensus        85 ~~~--~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        85 IIS--DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             hhc--CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence            000  0000001111111111                                       122221    1368999999


Q ss_pred             CCEEEccCCcEEEeeccccccc
Q psy11580        193 SNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       193 ~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      .||++++++ +.++||+.+...
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~~G  183 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFGYG  183 (226)
T ss_pred             CcEEEcCCC-cEEEechhcCcC
Confidence            999999888 999999977543

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.32  E-value=2.2e-06  Score=68.34  Aligned_cols=124  Identities=23%  Similarity=0.221  Sum_probs=81.0

Q ss_pred             eecc--CCCceEEEEeccCCCcchhh--------------------HHH--HHHHHHHHHHCC--CCCcceeeccccCCC
Q psy11580         81 AYDT--ATQQNVAIKKLSRPFQNVTH--------------------AKR--AYREFKLMKLVN--HKNIIGLLNAFTPQK  134 (288)
Q Consensus        81 ~~~~--~~~~~vavK~~~~~~~~~~~--------------------~~~--~~~e~~~l~~l~--h~~i~~~~~~~~~~~  134 (288)
                      ||..  .++..+|+|+++........                    ...  ..+|+.-|+++.  +-.+.+-+.+..   
T Consensus        64 Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~---  140 (268)
T COG1718          64 VYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN---  140 (268)
T ss_pred             EEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC---
Confidence            5553  35899999999753211111                    111  225666777763  333444444431   


Q ss_pred             cccccccEEEEEecccccHH-HHHhh--hCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        135 SLEEFQDVYLVMELMDANLC-QVIQM--DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~l~-~~~~~--~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                             -.+|||+++..-. .-...  +........+..++++.+.-|-. .++||+||+.-|||+. ++.+.++||+-
T Consensus       141 -------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~Q  212 (268)
T COG1718         141 -------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQ  212 (268)
T ss_pred             -------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECcc
Confidence                   1899999986411 00011  23333677788899999988766 8999999999999999 88999999998


Q ss_pred             ccccC
Q psy11580        211 ARTAG  215 (288)
Q Consensus       211 ~~~~~  215 (288)
                      |....
T Consensus       213 aV~~~  217 (268)
T COG1718         213 AVTID  217 (268)
T ss_pred             ccccC
Confidence            76654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.23  E-value=4.8e-05  Score=59.65  Aligned_cols=122  Identities=24%  Similarity=0.294  Sum_probs=83.8

Q ss_pred             ceeccCCCceEEEEeccCCC--------------cchhhHHHHHHHHHHHHHCC------CCCcceeeccccCCCccccc
Q psy11580         80 AAYDTATQQNVAIKKLSRPF--------------QNVTHAKRAYREFKLMKLVN------HKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        80 ~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~~~  139 (288)
                      .||.........||+.....              .......+..+|+.....+.      +.+|.+++|+..++-..   
T Consensus        16 ~cy~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~---   92 (199)
T PF10707_consen   16 DCYQHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGL---   92 (199)
T ss_pred             eEEECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCce---
Confidence            46667777788899998643              11223566677777666665      88999999999887765   


Q ss_pred             ccEEEEEecccc-------cHHHHHhhh-CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC----cEEEee
Q psy11580        140 QDVYLVMELMDA-------NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILD  207 (288)
Q Consensus       140 ~~~~lv~e~~~~-------~l~~~~~~~-~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~----~~kl~d  207 (288)
                         .+|+|.+..       +|.+++... ++.    .+...+-+-.++|-+..|+.+|++|.||++....    .+.|+|
T Consensus        93 ---Glv~e~I~d~dG~~s~TL~~~l~~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen   93 ---GLVVELIRDADGNISPTLEDYLKEGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             ---EEEEEEEECCCCCcCccHHHHHHcCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence               889998752       355554322 333    2333344445788899999999999999997542    477777


Q ss_pred             -cccc
Q psy11580        208 -FGLA  211 (288)
Q Consensus       208 -fg~~  211 (288)
                       ||..
T Consensus       166 G~G~~  170 (199)
T PF10707_consen  166 GLGEK  170 (199)
T ss_pred             CCCCc
Confidence             6643

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.21  E-value=8.3e-06  Score=63.56  Aligned_cols=94  Identities=22%  Similarity=0.275  Sum_probs=77.2

Q ss_pred             HHHHHHHHCCC-CCcceeeccccCCCcccccccEEEEEeccccc-HHH---HH--hhhCCHHHHHHHHHHHHHHHHHHHH
Q psy11580        110 REFKLMKLVNH-KNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-LCQ---VI--QMDLDHERMSYLLYQMLCGIKHLHS  182 (288)
Q Consensus       110 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~---~~--~~~~~~~~~~~~~~~i~~~l~~LH~  182 (288)
                      .|.-+++.+++ +++.+++|+|..          ++|+|+.+.+ +..   .+  ....+|..+.++|.++++.+.+|+.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~   77 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH   77 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence            58889999975 699999999941          7899999853 321   00  1247899999999999999999997


Q ss_pred             ---CCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        183 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       183 ---~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                         ..+.-.|++++|+.+++++.+|++|......
T Consensus        78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence               3488899999999999999999999988754

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.18  E-value=2.1e-05  Score=64.26  Aligned_cols=56  Identities=7%  Similarity=0.035  Sum_probs=38.4

Q ss_pred             CceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcccccccEEEEEecccccH
Q psy11580         87 QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANL  153 (288)
Q Consensus        87 ~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l  153 (288)
                      +..+.+|+.....     .....+|+++++.+. +--+.+++++....+..      ++|||+++|..
T Consensus        22 ~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~------~lv~e~i~G~~   78 (244)
T cd05150          22 NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRA------WLLTSAVPGVP   78 (244)
T ss_pred             CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCcc------EEEEEeeCCcc
Confidence            3678888886421     335667888888883 44566777777654333      89999998853

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576|consensus

Probab=98.16  E-value=6.1e-07  Score=79.91  Aligned_cols=148  Identities=22%  Similarity=0.237  Sum_probs=108.4

Q ss_pred             HHHHHHHHHHHHCCCCC-cceeeccccCCCcccccccEEEEEeccccc--HHHHHh---hhCCHHHHHHHHHHHHHHHHH
Q psy11580        106 KRAYREFKLMKLVNHKN-IIGLLNAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQ---MDLDHERMSYLLYQMLCGIKH  179 (288)
Q Consensus       106 ~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~--l~~~~~---~~~~~~~~~~~~~~i~~~l~~  179 (288)
                      ....-++++|.+++||| .+..++-+..++.      ..++++++.++  ......   ..+..-+...+.+.-++++++
T Consensus       278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~------~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~  351 (829)
T KOG0576|consen  278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY------LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAE  351 (829)
T ss_pred             hhhHHHHHHHHHccCCCCcccccccCCcccc------cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccc
Confidence            34556899999999999 5555555544443      48999999865  111111   123444555667777889999


Q ss_pred             HHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhC
Q psy11580        180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG  259 (288)
Q Consensus       180 LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g  259 (288)
                      +|+..-+|+|    ||+..+ +..+++||+...........+...+++.|+|||+.....+..+.|.|++|+-..++.-|
T Consensus       352 l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~  426 (829)
T KOG0576|consen  352 LHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPG  426 (829)
T ss_pred             cccccccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCC
Confidence            9988778888    776654 67899999988776665556677899999999999999999999999999866666666


Q ss_pred             CCCCC
Q psy11580        260 GVLFP  264 (288)
Q Consensus       260 ~~p~~  264 (288)
                      -+|-.
T Consensus       427 ~pPr~  431 (829)
T KOG0576|consen  427 LPPRS  431 (829)
T ss_pred             CCCCC
Confidence            55543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.11  E-value=2.2e-05  Score=70.18  Aligned_cols=71  Identities=28%  Similarity=0.521  Sum_probs=50.6

Q ss_pred             EEEEeccccc-HHHH--Hh-hhCCHHHHHHHHHHHHHH-HHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        143 YLVMELMDAN-LCQV--IQ-MDLDHERMSYLLYQMLCG-IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       143 ~lv~e~~~~~-l~~~--~~-~~~~~~~~~~~~~~i~~~-l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      +++|||++|- +.+.  +. ...+   ...++..++.+ ++.+=..|+.|.|.+|.||+++.+|.+.+.|||.+...+.
T Consensus       242 VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         242 VLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             EEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            9999999984 2222  11 2344   23344444443 3445568999999999999999999999999999876544

>KOG0665|consensus

Probab=98.06  E-value=2.3e-06  Score=70.02  Aligned_cols=61  Identities=69%  Similarity=1.234  Sum_probs=54.8

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcccc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELP   61 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~   61 (288)
                      ||++||.+|.+++++|.|||++-+.++.++..|+|.+.+...+.++.+..+|++..++++.
T Consensus       293 MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~  353 (369)
T KOG0665|consen  293 MLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQ  353 (369)
T ss_pred             hhccChhhcccHHHHhcCCeeeeecccccccCCCCchhhhhcccccCCHHHHHHHHHHHHH
Confidence            7999999999999999999999888888888888888888899999999999998887764

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.05  E-value=3.7e-05  Score=58.18  Aligned_cols=134  Identities=22%  Similarity=0.284  Sum_probs=91.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcce-eeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG-LLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~  136 (288)
                      ..+.....++.|..+.+++|      .+.|..+|+|+-..+    .....+..|+++|..+.-.++-+ +|.+-.  .  
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~------~~~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg~--~--   87 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLG------EWRGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYGE--D--   87 (201)
T ss_pred             hhhhhhhhhhcccccEEEEe------eccCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEech--h--
Confidence            34566677788888888887      567789999999743    44677889999999998666543 444432  1  


Q ss_pred             cccccEEEEEeccccc-HHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCC-CCCEEEccCCcEEEeeccccccc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK-PSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~-~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                            ++.|||+.|. |.+.... .+...    ...+++.---|-..||-|+.|+ |...++..++.+.|+||..|+..
T Consensus        88 ------~i~me~i~G~~L~~~~~~-~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          88 ------FIRMEYIDGRPLGKLEIG-GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             ------hhhhhhhcCcchhhhhhc-ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence                  6679999984 4333221 12233    3345555445667899999986 55556666669999999998854


Q ss_pred             CC
Q psy11580        215 GT  216 (288)
Q Consensus       215 ~~  216 (288)
                      ..
T Consensus       157 ~~  158 (201)
T COG2112         157 KK  158 (201)
T ss_pred             cC
Confidence            33

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.01  E-value=5.4e-05  Score=61.07  Aligned_cols=58  Identities=21%  Similarity=0.226  Sum_probs=37.0

Q ss_pred             ceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCC--CcceeeccccCCCcccccccEEEEEeccccc
Q psy11580         88 QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK--NIIGLLNAFTPQKSLEEFQDVYLVMELMDAN  152 (288)
Q Consensus        88 ~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~  152 (288)
                      +.+++|.....    .....+..|..+++.+...  .+.+++........   ....+++|+++++.
T Consensus        21 ~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~---~~~~~~~~~~i~g~   80 (239)
T PF01636_consen   21 GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEF---NGFPYLLMEYIPGR   80 (239)
T ss_dssp             SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEE---TSEEEEEEEEESSE
T ss_pred             cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccc---cccceEEEEEeccc
Confidence            59999998641    4456777888888888533  35566654432221   12358999999875

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0660|consensus

Probab=97.93  E-value=7.3e-06  Score=68.05  Aligned_cols=56  Identities=38%  Similarity=0.641  Sum_probs=43.7

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE   59 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~   59 (288)
                      ||..||.||+||+|||.|||++...+|.+++...+.+..  .+.. .+...|++..+.+
T Consensus       293 mL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~--~~~~-~~~~~~r~~i~~e  348 (359)
T KOG0660|consen  293 MLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS--FEHE-LTEEELRELIYKE  348 (359)
T ss_pred             HhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc--cccc-ccHHHHHHHHHHH
Confidence            789999999999999999999999999887655544433  3333 6677887777766

>KOG1235|consensus

Probab=97.83  E-value=0.00038  Score=62.38  Aligned_cols=84  Identities=21%  Similarity=0.388  Sum_probs=57.8

Q ss_pred             cceeeccccCCCcccccccEEEEEeccccc---HHHHHh-hhCCHHHHHHHHHHHHHHH-HHHHHCCCEeecCCCCCEEE
Q psy11580        123 IIGLLNAFTPQKSLEEFQDVYLVMELMDAN---LCQVIQ-MDLDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV  197 (288)
Q Consensus       123 i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~-~~~~~~~~~~~~~~i~~~l-~~LH~~~ivH~dl~~~nil~  197 (288)
                      |.+++-.+....        +++|||++|.   ..+.+. ..++...   ++..+.++. +.+=..|++|.|=+|.||++
T Consensus       266 VP~Vy~~~st~R--------VLtME~~~G~~i~Dl~~i~~~gi~~~~---i~~~l~~~~~~qIf~~GffHaDPHPGNilv  334 (538)
T KOG1235|consen  266 VPKVYWDLSTKR--------VLTMEYVDGIKINDLDAIDKRGISPHD---ILNKLVEAYLEQIFKTGFFHADPHPGNILV  334 (538)
T ss_pred             CCeehhhcCcce--------EEEEEecCCccCCCHHHHHHcCCCHHH---HHHHHHHHHHHHHHhcCCccCCCCCCcEEE
Confidence            666666665443        9999999983   233333 4566654   344444433 33345789999999999999


Q ss_pred             cc----CCcEEEeecccccccCCC
Q psy11580        198 KS----DCTLKILDFGLARTAGTT  217 (288)
Q Consensus       198 ~~----~~~~kl~dfg~~~~~~~~  217 (288)
                      +.    ++.+.+.|||+.......
T Consensus       335 ~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  335 RPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             ecCCCCCccEEEEcccccccccHH
Confidence            94    668999999998766543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.82  E-value=0.00017  Score=58.47  Aligned_cols=31  Identities=29%  Similarity=0.497  Sum_probs=25.8

Q ss_pred             CCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       184 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      .++|+|+++.||+++.++..-|+||+.+...
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g  195 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG  195 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence            3899999999999987665679999976544

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=97.81  E-value=0.00019  Score=68.80  Aligned_cols=61  Identities=13%  Similarity=0.298  Sum_probs=40.6

Q ss_pred             ceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCc--ceeeccccCCCcccccccEEEEEeccccc
Q psy11580         88 QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNI--IGLLNAFTPQKSLEEFQDVYLVMELMDAN  152 (288)
Q Consensus        88 ~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~~~~~~~~~~~lv~e~~~~~  152 (288)
                      ..+++|+..... .......+.+|+++++.+. |.++  .+++.+|.+....   ...|+|||+++|.
T Consensus        66 ~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~---G~~flVME~v~G~  129 (822)
T PLN02876         66 KRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVI---GTAFYIMEYLEGR  129 (822)
T ss_pred             eeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcC---CCceEEEEecCCc
Confidence            467788765321 1122356789999999995 6654  7788887664321   3348999999875

>KOG2270|consensus

Probab=97.64  E-value=0.00041  Score=58.81  Aligned_cols=132  Identities=20%  Similarity=0.259  Sum_probs=86.2

Q ss_pred             cccCcc---ceec--cCCCceEEEEeccCCCc----------------------chhhHHH--HHHHHHHHHHCCCCCcc
Q psy11580         74 SHLGAG---AAYD--TATQQNVAIKKLSRPFQ----------------------NVTHAKR--AYREFKLMKLVNHKNII  124 (288)
Q Consensus        74 ~~~g~g---~~~~--~~~~~~vavK~~~~~~~----------------------~~~~~~~--~~~e~~~l~~l~h~~i~  124 (288)
                      +++.+|   .||+  ..+|..+|||+++.+..                      ++...-.  ..+|+.-|++++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            344444   3665  35788999999975421                      1222222  23677788888655543


Q ss_pred             eeeccccCCCcccccccEEEEEecccccHHHH---HhhhCCHHHHHHHHHHHHHHHHHH-HHCCCEeecCCCCCEEEccC
Q psy11580        125 GLLNAFTPQKSLEEFQDVYLVMELMDANLCQV---IQMDLDHERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVVKSD  200 (288)
Q Consensus       125 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~L-H~~~ivH~dl~~~nil~~~~  200 (288)
                      ----+....        -++||++++++-+-.   -...++...+..+..+++.-|.-| +.+++||.||+--|+|+. +
T Consensus       230 ~PePIlLk~--------hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-d  300 (520)
T KOG2270|consen  230 CPEPILLKN--------HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-D  300 (520)
T ss_pred             CCCceeeec--------ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-C
Confidence            222222211        289999998642211   113466778888899999988877 468899999999999985 6


Q ss_pred             CcEEEeeccccccc
Q psy11580        201 CTLKILDFGLARTA  214 (288)
Q Consensus       201 ~~~kl~dfg~~~~~  214 (288)
                      |.+.++|.+-|...
T Consensus       301 G~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEH  314 (520)
T ss_pred             CEEEEEEccccccC
Confidence            68999999877543

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=97.62  E-value=4.8e-05  Score=65.62  Aligned_cols=58  Identities=81%  Similarity=1.430  Sum_probs=50.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQ   58 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~   58 (288)
                      ||..||++||++.|+|.|||+..++++.+...|.|...+...+++......|++..+.
T Consensus       294 ~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (353)
T cd07850         294 MLVIDPEKRISVDDALQHPYINVWYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIYK  351 (353)
T ss_pred             HcCCChhhCcCHHHHhcChhHhhccCCccCCCCCCCccccccccccccHHHHHHHHHh
Confidence            6889999999999999999999999998888888888888888888888888765443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=97.58  E-value=6.7e-05  Score=65.04  Aligned_cols=59  Identities=66%  Similarity=1.158  Sum_probs=44.5

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE   59 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~   59 (288)
                      ||..||++||++.|+|.||||..++++.....+.|...+...+.++.....|.+..+..
T Consensus       301 mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (364)
T cd07875         301 MLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE  359 (364)
T ss_pred             hcCcCcccCCCHHHHhcCcccccccCcccCCCCCCCCCCccchhhhccHHHHHHHHHHH
Confidence            68899999999999999999998888877665555444555566667777776654443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG1035|consensus

Probab=97.54  E-value=0.00026  Score=67.73  Aligned_cols=158  Identities=18%  Similarity=0.204  Sum_probs=110.6

Q ss_pred             hhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHH
Q psy11580        103 THAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKH  179 (288)
Q Consensus       103 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~  179 (288)
                      .......-|++.+..+.|+|+...+.+-.......  -...+..+++.+. +.+.+.  ...+..+.+.+..++.+||++
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g--~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~  301 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRG--IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAY  301 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcch--HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHH
Confidence            34455667888999999999999988776543220  1112334455442 333222  347888999999999999999


Q ss_pred             HHHCCCEeecCCCC---CEEEccCCcEEEe--ecccccccCCCcccCCcccccccCchHhHhcCCCCc--hhhHHHHHHH
Q psy11580        180 LHSAGIIHRDLKPS---NIVVKSDCTLKIL--DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKE--NVDIWSVGCI  252 (288)
Q Consensus       180 LH~~~ivH~dl~~~---nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~--~~Di~slg~i  252 (288)
                      +|+....|.-+..+   +--.+.++.+..+  ||+.+..............+..+.++|.........  ..|+|++|..
T Consensus       302 ~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  302 LHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             HHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence            99997666666555   4444556666666  888888776665555566777888999887765544  4799999999


Q ss_pred             HHHHHhCCCC
Q psy11580        253 MGEMIRGGVL  262 (288)
Q Consensus       253 l~~l~~g~~p  262 (288)
                      ...+..|..+
T Consensus       382 ~~~~~~~~~i  391 (1351)
T KOG1035|consen  382 LLQLSQGEDI  391 (1351)
T ss_pred             HhhhhhcCcc
Confidence            9998876543

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.50  E-value=0.0005  Score=56.53  Aligned_cols=31  Identities=29%  Similarity=0.500  Sum_probs=26.7

Q ss_pred             CCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       184 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      .++|+|+.+.||++++++ +.|+||+.+....
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~gd  177 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASDGD  177 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCcCC
Confidence            389999999999999877 7899999886543

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.44  E-value=0.0023  Score=50.02  Aligned_cols=133  Identities=18%  Similarity=0.198  Sum_probs=82.9

Q ss_pred             cccccccccCCccc-cccccCccceeccCCCceEEEEeccC---CCc-------c--h-------hhHHHHHHHHHHHHH
Q psy11580         58 QELPISHQMGKKRH-NTSHLGAGAAYDTATQQNVAIKKLSR---PFQ-------N--V-------THAKRAYREFKLMKL  117 (288)
Q Consensus        58 ~~~~~~~~~~~~~~-~~~~~g~g~~~~~~~~~~vavK~~~~---~~~-------~--~-------~~~~~~~~e~~~l~~  117 (288)
                      .++..-+.+|.+.. +.++..      .-.|+.+|+|+++.   ...       .  .       ....-|..|.+...+
T Consensus        37 ~~I~flefLg~g~~~~~V~kv------~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgR  110 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKV------EIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGR  110 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEE------EECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHH
Confidence            45555566666554 322221      34678999999321   100       0  0       112346677777766


Q ss_pred             CC---CCCc--ceeeccccCCC--cc----------cccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHH
Q psy11580        118 VN---HKNI--IGLLNAFTPQK--SL----------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL  180 (288)
Q Consensus       118 l~---h~~i--~~~~~~~~~~~--~~----------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~L  180 (288)
                      |+   +.++  ++++|+..-..  ..          .......||-||+....      .++..    -+.+|.+-|..+
T Consensus       111 Lke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------~~~~~----~~~~~~~dl~~~  180 (207)
T PF13095_consen  111 LKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------PLQIR----DIPQMLRDLKIL  180 (207)
T ss_pred             HHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------ccchh----HHHHHHHHHHHH
Confidence            64   5566  89999985441  11          12234578888877543      12222    355777888899


Q ss_pred             HHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       181 H~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      |..||+-+|+++.|..     .-+|+|||.+
T Consensus       181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHCCeeeccCcccccc-----CCEEEecccC
Confidence            9999999999999987     3488999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.44  E-value=0.0011  Score=53.58  Aligned_cols=30  Identities=27%  Similarity=0.430  Sum_probs=26.4

Q ss_pred             CCEeecCCCCCEEEcc-CCcEEEeecccccc
Q psy11580        184 GIIHRDLKPSNIVVKS-DCTLKILDFGLART  213 (288)
Q Consensus       184 ~ivH~dl~~~nil~~~-~~~~kl~dfg~~~~  213 (288)
                      .++|+|+++.||++++ ++.+.|+||..+..
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            4899999999999998 57899999987654

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.40  E-value=0.0028  Score=53.40  Aligned_cols=127  Identities=17%  Similarity=0.221  Sum_probs=76.3

Q ss_pred             CCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC--CCCcceeeccccCCCcccccccEEEEEecccccHH--------
Q psy11580         85 ATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN--HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLC--------  154 (288)
Q Consensus        85 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~--------  154 (288)
                      .+++.+++. ...............+|..+++.+.  -.-+...++.|.... +   ...+.||++++|...        
T Consensus        46 ~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~-~---g~pf~v~~~veGe~~~~~~~~~~  120 (321)
T COG3173          46 DTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY-L---GTPFYVMEWVEGEVVWSALPPES  120 (321)
T ss_pred             cCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC-C---CCceEEEEEecceeccCcCCccc
Confidence            337778888 3322344455677778888888884  345556677777665 2   345999999987210        


Q ss_pred             -H--HHh----------hh--------------CCHHHHHHHHHHH--------------HHHHHHHHHC--------CC
Q psy11580        155 -Q--VIQ----------MD--------------LDHERMSYLLYQM--------------LCGIKHLHSA--------GI  185 (288)
Q Consensus       155 -~--~~~----------~~--------------~~~~~~~~~~~~i--------------~~~l~~LH~~--------~i  185 (288)
                       .  ...          .+              ....++..+..+.              ..-..+|+.+        .+
T Consensus       121 ~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~l  200 (321)
T COG3173         121 LGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVL  200 (321)
T ss_pred             chHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCcee
Confidence             0  000          00              0001111111111              1123444432        27


Q ss_pred             EeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       186 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      +|+|+.+.|++++.++.+-+.||+.+.....
T Consensus       201 vHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         201 VHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            9999999999999998899999999876543

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.39  E-value=0.0017  Score=54.96  Aligned_cols=31  Identities=39%  Similarity=0.663  Sum_probs=27.5

Q ss_pred             CCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        183 AGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       183 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      .+++|+|+++.|++++.++...|+||+.+..
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            5799999999999999887778999998853

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.25  E-value=0.0039  Score=52.37  Aligned_cols=123  Identities=14%  Similarity=0.110  Sum_probs=68.6

Q ss_pred             CCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCC--CcceeeccccCCCcccccccEEEEEecccccHHHH-------
Q psy11580         86 TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK--NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQV-------  156 (288)
Q Consensus        86 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~-------  156 (288)
                      ++..+++|+...     .....+..|+++++.+.+.  .+.+++............+..++|+++++|.....       
T Consensus        36 ~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~  110 (296)
T cd05153          36 DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCR  110 (296)
T ss_pred             CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHH
Confidence            345789998863     2234566788888888432  24455443221111111234589999998742110       


Q ss_pred             -H-------h---hhC----------CHHHH--H--------HHHHHHHHHHHHHHH-------CCCEeecCCCCCEEEc
Q psy11580        157 -I-------Q---MDL----------DHERM--S--------YLLYQMLCGIKHLHS-------AGIIHRDLKPSNIVVK  198 (288)
Q Consensus       157 -~-------~---~~~----------~~~~~--~--------~~~~~i~~~l~~LH~-------~~ivH~dl~~~nil~~  198 (288)
                       +       .   ..+          .+...  .        .....+..+++++.+       .+++|+|++|.||+++
T Consensus       111 ~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~  190 (296)
T cd05153         111 QIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFD  190 (296)
T ss_pred             HHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEe
Confidence             0       0   000          00000  0        011112334444443       3599999999999999


Q ss_pred             cCCcEEEeecccccc
Q psy11580        199 SDCTLKILDFGLART  213 (288)
Q Consensus       199 ~~~~~kl~dfg~~~~  213 (288)
                      .++.+.|.||+.+..
T Consensus       191 ~~~~~~iIDfe~a~~  205 (296)
T cd05153         191 GDELSGVIDFYFACT  205 (296)
T ss_pred             CCceEEEeehhhhcC
Confidence            887778999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.22  E-value=0.0043  Score=52.77  Aligned_cols=31  Identities=32%  Similarity=0.497  Sum_probs=26.5

Q ss_pred             CCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        183 AGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       183 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      .+++|+|+++.||+++.+...-++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3699999999999999766568999998854

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=97.20  E-value=0.00024  Score=61.30  Aligned_cols=55  Identities=73%  Similarity=1.277  Sum_probs=41.0

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhh
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKEL   55 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~   55 (288)
                      ||..||.+||++.|+|+||||..+.++.+..++.|.......+....+...|.+.
T Consensus       294 mL~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (355)
T cd07874         294 MLVIDPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL  348 (355)
T ss_pred             HhcCCchhcCCHHHHhcCcchhcccChhhccCCCccccccchhhhhccHHHHHHH
Confidence            6889999999999999999999888887766655554444445555555666543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.20  E-value=0.0016  Score=54.94  Aligned_cols=31  Identities=29%  Similarity=0.416  Sum_probs=27.1

Q ss_pred             CCEeecCCCCCEEEccC----CcEEEeeccccccc
Q psy11580        184 GIIHRDLKPSNIVVKSD----CTLKILDFGLARTA  214 (288)
Q Consensus       184 ~ivH~dl~~~nil~~~~----~~~kl~dfg~~~~~  214 (288)
                      .++|+|+.+.||+++.+    +.+.++||+.+...
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            37999999999999985    88999999988643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268|consensus

Probab=97.09  E-value=0.00093  Score=55.78  Aligned_cols=91  Identities=31%  Similarity=0.387  Sum_probs=64.6

Q ss_pred             HHHHHHHHHHCC-CC-CcceeeccccCCCcccccccEEEEEeccccc-HHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCC
Q psy11580        108 AYREFKLMKLVN-HK-NIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG  184 (288)
Q Consensus       108 ~~~e~~~l~~l~-h~-~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~  184 (288)
                      ..+|+..|+.|. |. -+.+.+++..          .++|||++.+- +.+. ..   ......+...+..-+--|...|
T Consensus       157 a~kEfafmkaL~e~gfpVPkpiD~~R----------H~Vvmelv~g~Pl~~v-~~---v~d~~~ly~~lm~~Iv~la~~G  222 (465)
T KOG2268|consen  157 ATKEFAFMKALYERGFPVPKPIDHNR----------HCVVMELVDGYPLRQV-RH---VEDPPTLYDDLMGLIVRLANHG  222 (465)
T ss_pred             HHHHHHHHHHHHHcCCCCCCcccccc----------eeeHHHhhcccceeee-ee---cCChHHHHHHHHHHHHHHHHcC
Confidence            557888888884 32 3455555542          38999999874 3322 11   1222345566666677888999


Q ss_pred             CEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        185 IIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       185 ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      +||+|++-=||++..++.++++||--+.
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechHhh
Confidence            9999999999999999999999996543

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=97.00  E-value=0.0006  Score=58.99  Aligned_cols=53  Identities=64%  Similarity=1.215  Sum_probs=36.9

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhh
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWK   53 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~   53 (288)
                      ||..||.+||++.|+|.|||+..+.++.....++|...+.....+......+.
T Consensus       298 mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (359)
T cd07876         298 MLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWK  350 (359)
T ss_pred             HhccCcccCCCHHHHhcCchhhhhcCcccccCCCccccccccccccccHHHHH
Confidence            68899999999999999999988777766555554444334444444444443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.93  E-value=0.0019  Score=51.40  Aligned_cols=30  Identities=37%  Similarity=0.640  Sum_probs=21.1

Q ss_pred             CCEeecCCCCCEEE-ccCCcEEEeecccccc
Q psy11580        184 GIIHRDLKPSNIVV-KSDCTLKILDFGLART  213 (288)
Q Consensus       184 ~ivH~dl~~~nil~-~~~~~~kl~dfg~~~~  213 (288)
                      .+.|+|+.+.||++ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            37999999999999 8889999999998754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.90  E-value=0.017  Score=50.51  Aligned_cols=30  Identities=27%  Similarity=0.444  Sum_probs=25.8

Q ss_pred             CCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       184 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      .++|||+++.||+++.+ .++++||.++...
T Consensus       224 ~l~HgDl~~gni~~~~~-~~~viD~E~a~~G  253 (401)
T PRK09550        224 ALLHGDLHTGSIFVTEE-ETKVIDPEFAFYG  253 (401)
T ss_pred             ceeeccCCcccEEeeCC-CcEEEeccccccC
Confidence            48999999999999776 6899999977654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.87  E-value=0.0081  Score=49.98  Aligned_cols=30  Identities=27%  Similarity=0.636  Sum_probs=25.4

Q ss_pred             CEeecCCCCCEEEccCCc-EEEeeccccccc
Q psy11580        185 IIHRDLKPSNIVVKSDCT-LKILDFGLARTA  214 (288)
Q Consensus       185 ivH~dl~~~nil~~~~~~-~kl~dfg~~~~~  214 (288)
                      ++|+|+++.||++++++. .-|.||+.+...
T Consensus       187 lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         187 LVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            899999999999997555 469999987654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826|consensus

Probab=96.85  E-value=0.00033  Score=69.05  Aligned_cols=154  Identities=13%  Similarity=0.084  Sum_probs=107.1

Q ss_pred             HHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEEEEecccc-cHHHHHhhh------CCHHHHHHHHHHHHHHHH
Q psy11580        106 KRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD------LDHERMSYLLYQMLCGIK  178 (288)
Q Consensus       106 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~~i~~~l~  178 (288)
                      +....|...++...|+++.....-.......    ..+..++++.+ .+++.+.+.      .+..-+.....+...+..
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~----ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~ 1349 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSEST----EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRN 1349 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCCh----HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccc
Confidence            3344555566667899888776666544332    23777888764 466665432      222233333334356666


Q ss_pred             HHHHCC-----CEeecCCCCCEEEccCCcEEEeecccccc-cCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHH
Q psy11580        179 HLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI  252 (288)
Q Consensus       179 ~LH~~~-----ivH~dl~~~nil~~~~~~~kl~dfg~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~i  252 (288)
                      -+|...     .+|+++++-|.++..+.+++++++|+.+. ...........+++.|+.|++.....++.++|+|..|+-
T Consensus      1350 ~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1350 VILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred             hhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence            666432     79999999999999999999999999983 333333355577888999999888888888999999999


Q ss_pred             HHHHHhCCCCC
Q psy11580        253 MGEMIRGGVLF  263 (288)
Q Consensus       253 l~~l~~g~~p~  263 (288)
                      +|....|..+|
T Consensus      1430 ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1430 LYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHhcccHHH
Confidence            98887776665

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.77  E-value=0.013  Score=49.82  Aligned_cols=71  Identities=18%  Similarity=0.316  Sum_probs=56.6

Q ss_pred             cEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        141 DVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       141 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      ..|++|++.++.+...  ....++++..++.+.+..+.-+..+ ..-|||+.-.||+++ +|++.|+||.+++..
T Consensus       300 y~yl~~kdhgt~is~i--k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         300 YLYLHFKDHGTPISII--KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             EEEEEEecCCceeeee--ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            3588888877764321  2356788888999888888777754 589999999999999 999999999999843

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.67  E-value=0.027  Score=47.68  Aligned_cols=31  Identities=19%  Similarity=0.200  Sum_probs=27.9

Q ss_pred             CCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       184 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      +++|+|+.+.|+++++++.+.++||..+...
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA  227 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence            5999999999999999999999999987643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.44  E-value=0.057  Score=47.24  Aligned_cols=57  Identities=12%  Similarity=0.064  Sum_probs=38.5

Q ss_pred             CceEEEEeccCC-----CcchhhHHHHHHHHHHHHHCC---CCCcceeeccccCCCcccccccEEEEEecccc
Q psy11580         87 QQNVAIKKLSRP-----FQNVTHAKRAYREFKLMKLVN---HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA  151 (288)
Q Consensus        87 ~~~vavK~~~~~-----~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~  151 (288)
                      ++.++||.-...     ...+-...+...|.+.|+.+.   ..++.+++.++.+..        +++||++++
T Consensus        55 ~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~--------vlvME~L~~  119 (418)
T PLN02756         55 SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMA--------LIGMRYLEP  119 (418)
T ss_pred             CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCC--------EEEEeecCC
Confidence            457999987621     111224455566677777774   358888999998554        889999976

>KOG0033|consensus

Probab=96.32  E-value=0.0013  Score=52.36  Aligned_cols=23  Identities=52%  Similarity=0.956  Sum_probs=21.7

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.||++|.|||.|||+..
T Consensus       250 ML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  250 MLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             HhccChhhhccHHHHhCCchhcc
Confidence            78999999999999999999965

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=96.19  E-value=0.004  Score=53.41  Aligned_cols=57  Identities=46%  Similarity=0.896  Sum_probs=38.3

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE   59 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~   59 (288)
                      ||..||.+|+++.|+|.||||....++....  .+.+..............+.+..+.+
T Consensus       281 mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (343)
T cd07878         281 MLVLDSDKRISASEALAHPYFSQYHDPEDEP--EAEPYDESPENKERTIEEWKELTYEE  337 (343)
T ss_pred             HcCCChhhCCCHHHHhcCcchhccCCCcccc--ccCccccchhhhhccHHHHHHHHHHH
Confidence            6889999999999999999998766554322  22334444445555566666554443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.15  E-value=0.021  Score=48.91  Aligned_cols=30  Identities=23%  Similarity=0.465  Sum_probs=26.0

Q ss_pred             CEeecCCCCCEEEcc-CCcEEEeeccccccc
Q psy11580        185 IIHRDLKPSNIVVKS-DCTLKILDFGLARTA  214 (288)
Q Consensus       185 ivH~dl~~~nil~~~-~~~~kl~dfg~~~~~  214 (288)
                      .+|+|+.+.||++++ ++.++++||+.|...
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            799999999999975 578999999988643

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.10  E-value=0.027  Score=47.07  Aligned_cols=57  Identities=11%  Similarity=0.067  Sum_probs=34.3

Q ss_pred             CCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC---CCCcceeeccccCCCcccccccEEEEEeccccc
Q psy11580         85 ATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN---HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN  152 (288)
Q Consensus        85 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~  152 (288)
                      .+++.+.||+-..     .....+..|.+-|+.|.   .-.+.+++++....+..      ++|+||++.+
T Consensus        38 ~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~------fLlle~l~~~   97 (288)
T PF03881_consen   38 TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA------FLLLEFLEMG   97 (288)
T ss_dssp             TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC------EEEEE-----
T ss_pred             CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc------eEEEEeecCC
Confidence            5678899998863     33456778888888883   34577788877655443      9999998743

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=95.91  E-value=0.0054  Score=52.72  Aligned_cols=57  Identities=40%  Similarity=0.820  Sum_probs=43.5

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE   59 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~   59 (288)
                      ||..||.+|+++.+++.||||....++....  .+.+.....+....+..+|+.+...+
T Consensus       281 ~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (343)
T cd07880         281 MLVLDAESRITAAEALAHPYFEEFHDPEDET--EAPPYDDSFDEVDQSLEEWKRLTFTE  337 (343)
T ss_pred             HcCCChhhCCCHHHHhcCccHhhhcCccccc--CCCCccccHHhhccchHHHHHHHHHH
Confidence            5788999999999999999999876654433  23346667778888888888776554

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.85  E-value=0.084  Score=42.24  Aligned_cols=60  Identities=15%  Similarity=0.167  Sum_probs=40.7

Q ss_pred             eeccCCC-ceEEEEeccCCCcchhhHHHHHHHHHHHHHCC---CCCcceeeccccCCCcccccccEEEEEecccc
Q psy11580         81 AYDTATQ-QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN---HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA  151 (288)
Q Consensus        81 ~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~  151 (288)
                      ++...+| ..+-||+-..     .....+..|+.-|+.+.   .-.+.+++.+-...++      .|+|+||++.
T Consensus        32 a~~v~dg~~~~FvK~n~~-----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~------sylVle~L~~   95 (286)
T COG3001          32 AWRLRDGTDPFFVKCNQR-----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDH------SYLVLEYLPT   95 (286)
T ss_pred             eeEeecCCcceEEEecch-----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCe------eEEEEeeccC
Confidence            4445544 5777887643     44567778887777774   4567777777665554      4999999984

>KOG0663|consensus

Probab=95.85  E-value=0.0072  Score=50.44  Aligned_cols=29  Identities=34%  Similarity=0.509  Sum_probs=24.8

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAE   29 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e   29 (288)
                      ||++||.||.+|.|+|.|+||.....|.+
T Consensus       344 llt~dP~kR~tA~~~L~h~~F~e~P~p~~  372 (419)
T KOG0663|consen  344 LLTYDPGKRITAEDGLKHEYFRETPLPID  372 (419)
T ss_pred             HhccCccccccHHHhhcccccccCCCCCC
Confidence            68999999999999999999977555543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=95.79  E-value=0.0086  Score=51.44  Aligned_cols=57  Identities=51%  Similarity=1.014  Sum_probs=41.0

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE   59 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~   59 (288)
                      ||..+|.+||++.+++.||||.....+...  +.+.+.+.+.+........|+++.+.+
T Consensus       281 ~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (343)
T cd07851         281 MLVLDPDKRITAAEALAHPYLAEYHDPEDE--PVAPPYDQSFESRDLTVDEWKELVYKE  337 (343)
T ss_pred             hCCCChhhCCCHHHHhcCCCccccCCCccc--ccccccCcchhhhhcCHHHHHHHhHHH
Confidence            577899999999999999999887666442  224455566666666777776665543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=95.56  E-value=0.0086  Score=51.26  Aligned_cols=55  Identities=40%  Similarity=0.693  Sum_probs=38.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhh
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELI   56 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~   56 (288)
                      ||..+|.+||++.+++.||||....++...+. .+.+.+-+.++..-.....+++.
T Consensus       274 ~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  328 (337)
T cd07858         274 MLVFDPSKRITVEEALAHPYLASLHDPSDEPV-CQTPFSFDFEEDALTEEDIKELI  328 (337)
T ss_pred             HhcCChhhccCHHHHHcCcchhhhcCcccCcc-CCCccchhhhhhhcCHHHHHHHH
Confidence            57789999999999999999998777766433 34455555555554444444433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	288
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-109
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-109
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-109
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-108
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-108
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-108
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-108
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-107
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-107
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-106
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-106
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-105
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-105
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-105
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-105
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-105
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-105
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-105
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-105
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-105
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-105
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-105
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-105
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-104
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-103
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-103
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-103
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-103
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-102
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-101
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-101
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-101
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-65
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-65
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-65
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-65
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-65
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-65
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-64
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-64
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-64
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-64
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-64
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-64
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-64
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-64
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-64
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-64
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-64
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-64
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-64
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-64
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-64
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-64
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-64
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-64
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-64
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-64
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-64
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-64
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-64
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-64
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-64
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-64
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-64
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-64
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-64
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-64
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-64
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-64
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-64
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-64
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-64
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-64
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-64
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-64
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-64
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-63
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-63
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-63
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-63
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-63
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-63
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-63
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-63
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-63
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-63
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-63
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-63
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-63
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-63
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-63
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-62
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-62
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-62
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-62
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-59
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-49
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-49
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-49
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-49
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-49
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-49
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-49
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-49
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-49
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-49
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-49
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-49
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-49
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-48
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-48
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-48
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-48
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-48
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-48
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-47
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-47
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-47
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-47
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-46
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-46
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-46
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-39
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-39
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-38
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-38
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-36
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-34
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-33
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-32
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-32
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-31
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-30
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-30
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-29
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-29
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-29
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-29
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-29
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-29
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-29
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-29
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-29
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-29
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-29
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-29
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-29
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-29
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-29
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-29
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-29
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-29
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-29
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-29
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-29
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-29
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-29
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-29
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-29
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-29
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-29
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-29
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-29
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-29
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-29
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-29
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-29
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-29
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-28
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-28
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-28
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-28
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-28
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-28
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-28
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-28
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-28
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-27
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-27
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-27
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-27
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-26
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-26
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-26
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-26
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-25
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-24
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-24
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-23
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-23
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-23
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-23
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-23
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-23
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-23
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-23
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-23
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-23
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-23
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-23
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-23
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-23
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-23
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-23
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-22
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-22
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-22
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-22
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-22
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-22
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-22
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-22
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-22
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-22
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-22
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-22
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-22
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-22
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-22
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-22
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-22
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-22
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-22
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-21
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-21
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-20
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-20
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-20
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-20
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-20
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-19
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-19
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-19
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-19
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-19
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-19
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-19
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-19
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-19
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-19
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-18
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-18
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-18
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-18
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-18
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-18
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-18
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-18
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-17
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-17
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-17
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-17
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-17
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-17
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-17
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-16
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-16
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-16
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-16
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-16
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-16
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-16
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-16
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		8e-16
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		9e-16
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		9e-16
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		9e-16
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		9e-16
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-15
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-15
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-15
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-15
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-15
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-15
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-15
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-15
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-15
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-15
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-15
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-15
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-15
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-15
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-15
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-15
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-15
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-15
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-15
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-15
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-15
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-15
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-15
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-15
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-15
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-15
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-15
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-15
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-15
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-15
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-15
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-15
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-15
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-15
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-15
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-15
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-15
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-15
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-15
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-15
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-15
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-15
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-15
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-14
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-14
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-14
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-14
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-14
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-14
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-14
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-14
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-14
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-14
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-14
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-14
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-14
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-13
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-13
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-13
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-13
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-13
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-13
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-13
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-12
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-12
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-12
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-11
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-11
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-11
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-11
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-11
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-11
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-11
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-11
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-11
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-11
3soa_A	444	Full-Length Human Camkii Length = 444		5e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-10
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		9e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-08
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-08
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-08
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-07
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-07
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-07
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-07
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-07
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-06
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		4e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-06
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-06
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-06
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-06
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-06

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  392 bits (1006), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 186/218 (85%), Positives = 198/218 (90%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  392 bits (1006), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 186/218 (85%), Positives = 198/218 (90%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  391 bits (1005), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 186/218 (85%), Positives = 198/218 (90%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 204
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct: 205 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 242

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  389 bits (998), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 184/218 (84%), Positives = 197/218 (90%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 145
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMM P+VVTRYYRAPEVILGMGYK
Sbjct: 146 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYK 205
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct: 206 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 243

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  388 bits (997), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 185/218 (84%), Positives = 197/218 (90%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANL QVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  388 bits (996), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 185/218 (84%), Positives = 197/218 (90%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTP VVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  386 bits (991), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 184/218 (84%), Positives = 197/218 (90%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK+VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANL QVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSD TLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  385 bits (988), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 184/218 (84%), Positives = 196/218 (89%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANL QVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSD TLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  383 bits (983), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 183/218 (83%), Positives = 196/218 (89%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK+VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANL QVIQM+LDHERMSYLLYQML GIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSD TLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  380 bits (977), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 182/218 (83%), Positives = 195/218 (89%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK+VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANL QVIQM+LDHERMSYLLYQML GIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSD TLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVG IMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct: 204 ENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  380 bits (975), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 182/218 (83%), Positives = 195/218 (89%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK+VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANL QVIQM+LDHERMSYLLYQML GIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSD TLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVG IMGEMI+GGVLFPGTDHIDQWNK+I ++
Sbjct: 204 ENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  379 bits (973), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 180/218 (82%), Positives = 193/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 241
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 242 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  379 bits (972), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 180/218 (82%), Positives = 193/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 241
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 242 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  378 bits (971), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 180/218 (82%), Positives = 193/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  378 bits (971), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 180/218 (82%), Positives = 193/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 82
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 142
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 143 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 202
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 203 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 240

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  378 bits (971), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 180/218 (82%), Positives = 193/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  378 bits (971), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 180/218 (82%), Positives = 193/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 204
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 205 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 242

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  378 bits (970), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 180/218 (82%), Positives = 193/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 138 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 197
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 198 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 235

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  378 bits (970), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 180/218 (82%), Positives = 193/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  378 bits (970), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 180/218 (82%), Positives = 193/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 204
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 205 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 242

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  378 bits (970), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 180/218 (82%), Positives = 193/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 138 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 197
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 198 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 235

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  377 bits (967), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 179/218 (82%), Positives = 194/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 138 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 197
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVD+WSVGCIMGEM+   +LFPG D+IDQWNK+I ++
Sbjct: 198 ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQL 235

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  376 bits (966), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 179/218 (82%), Positives = 194/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 88
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 148
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 149 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 208
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVD+WSVGCIMGEM+   +LFPG D+IDQWNK+I ++
Sbjct: 209 ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQL 246

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  374 bits (960), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 179/218 (82%), Positives = 192/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSD TLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  372 bits (955), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 178/218 (81%), Positives = 192/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMM P VVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+   +LFPG D+IDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQL 241

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  371 bits (952), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 177/218 (81%), Positives = 192/218 (88%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMM P VVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVD+WSVGCIMGEM+   +LFPG D+IDQWNK+I ++
Sbjct: 204 ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQL 241

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  370 bits (949), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 178/218 (81%), Positives = 191/218 (87%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANL QVIQM+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSD TLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  370 bits (949), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 175/218 (80%), Positives = 190/218 (87%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+      +G+GA      A+DT    NVA+KKLSRPFQN THAKRAYRE  L+K VNHK
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 81
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVI M+LDHERMSYLLYQMLCGIKHLH
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 141
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA T FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 142 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYK 201
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGE+++G V+F GTDHIDQWNK+I ++
Sbjct: 202 ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 239

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  366 bits (940), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 177/218 (81%), Positives = 190/218 (87%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANL QVIQM+LDHERMSYLLYQML GIKHLH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSD TLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  366 bits (939), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 177/218 (81%), Positives = 190/218 (87%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANL QVIQM+LDHERMSYLLYQML GIKHLH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSD TLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  365 bits (938), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 177/218 (81%), Positives = 190/218 (87%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+  N   +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANL QVIQM+LDHERMSYLLYQML GIKHLH
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 136
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSD TLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYK
Sbjct: 137 SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           ENVDIWSVGCIMGEM+R  +LFPG D+IDQWNK+I ++
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  363 bits (933), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 173/218 (79%), Positives = 188/218 (86%), Gaps = 6/218 (2%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           K+      +G+GA      A+DT    NVA+KKLSRPFQN THAKRAYRE  L+K VNHK
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 83
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           NII LLN FTPQK+LEEFQDVYLVMELMDANLCQVI M+LDHERMSYLLYQMLCGIKHLH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 143
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA T FMMTPYVVTRYYRAPEVILGMGY 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYA 203
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
            NVDIWSVGCIMGE+++G V+F GTDHIDQWNK+I ++
Sbjct: 204 ANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQL 241

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  243 bits (621), Expect = 7e-65,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLN 203
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  243 bits (620), Expect = 8e-65,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLN 203
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  243 bits (620), Expect = 8e-65,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  243 bits (620), Expect = 8e-65,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLN 203
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  243 bits (620), Expect = 9e-65,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  243 bits (620), Expect = 9e-65,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 202
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 242

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL- 236
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 237 GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 AMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 203
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 192
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGL 134
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 192
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 159 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 216
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 256

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 158 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 215
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 255

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 201
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 241

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 18  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 77
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 78  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 137
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 138 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 195
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 196 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 235

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 198
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 238

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  242 bits (618), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 198
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 238

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  242 bits (618), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  242 bits (618), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 198
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 238

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  242 bits (618), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 201
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 241

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  242 bits (618), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 202
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 242

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  242 bits (618), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 150 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 207
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 247

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  242 bits (618), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 208
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 248

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  242 bits (618), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 208
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 248

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  242 bits (618), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 202
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 242

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  242 bits (617), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  242 bits (617), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 158 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 215
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 255

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  242 bits (617), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 159 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 216
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 256

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  242 bits (617), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 136 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 193
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 233

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  242 bits (617), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 136 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 193
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 233

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  242 bits (617), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 192
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  242 bits (617), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N + +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 29  EVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 88
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 89  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 148
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 149 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 206
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 207 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 246

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  242 bits (617), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 162 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 219
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 259

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  241 bits (616), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 17  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 76
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 77  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 136
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 137 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 194
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 234

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  241 bits (615), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILD+GLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  241 bits (614), Expect = 4e-64,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 159/220 (72%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLS+PFQ++ HAKR YRE +L+K +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHM 90
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 208
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 248

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  240 bits (613), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   M  YV TR+YRAPE++L 
Sbjct: 162 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGYVATRWYRAPEIMLN 219
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 259

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  240 bits (612), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 120/220 (54%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   M  +V TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  240 bits (612), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 120/220 (54%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   M  +V TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  239 bits (611), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDF LAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  239 bits (611), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 120/220 (54%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   M  +V TR+YRAPE++L 
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLN 192
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  239 bits (611), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKIL FGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  239 bits (610), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 115/209 (55%), Positives = 155/209 (74%), Gaps = 10/209 (4%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G+GA      AYD   +Q VA+KKLSRPFQ++ HA+R YRE +L+K + H+N+IGLL+ 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHR 188
           FTP  S+E+F +VYLV  LM A+L  +++   L  E + +L+YQ+L G+K++HSAGIIHR
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHR 147
Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIW 247
           DLKPSN+ V  DC L+ILDFGLAR A     MT YV TR+YRAPE++L  M Y + VDIW
Sbjct: 148 DLKPSNVAVNEDCELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIW 205
Query: 248 SVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           SVGCIM E+++G  LFPG+D+IDQ  +I+
Sbjct: 206 SVGCIMAELLQGKALFPGSDYIDQLKRIM 234

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  239 bits (610), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILD GLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  239 bits (610), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT  V TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGXVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  239 bits (610), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILD GLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  239 bits (609), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 24  EVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 201
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 241

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  239 bits (609), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  239 bits (609), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 198
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 238

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  239 bits (609), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 202
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 242

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  239 bits (609), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILD GLAR   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  239 bits (609), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 201
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 241

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  238 bits (607), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 121/220 (55%), Positives = 158/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 150 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 207
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 247

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  238 bits (606), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 118/219 (53%), Positives = 153/219 (69%), Gaps = 9/219 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ K   + +H+G+GA      A D  + + VAIKKLSRPFQ+   AKRAYRE  L+K +
Sbjct: 39  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 98
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIK 178
            H+N+IGLL+ FTP  SL  F D YLVM  M  +L +++ M+   E++ YL+YQML G+K
Sbjct: 99  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLK 158
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG- 237
           ++HSAG++HRDLKP N+ V  DC LKILDFGLAR A     MT YVVTR+YRAPEVIL  
Sbjct: 159 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSW 216
Query: 238 MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           M Y + VDIWSVGCIM EM+ G  LF G D++DQ  +I+
Sbjct: 217 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 255

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  238 bits (606), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 120/220 (54%), Positives = 157/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   M   V TR+YRAPE++L 
Sbjct: 159 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGXVATRWYRAPEIMLN 216
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 256

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  237 bits (605), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 120/220 (54%), Positives = 157/220 (71%), Gaps = 10/220 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ ++  N S +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGL 138
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  D  LKILDFGL R   T   MT YV TR+YRAPE++L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDEMTGYVATRWYRAPEIMLN 196
Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 236

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 114/209 (54%), Positives = 154/209 (73%), Gaps = 10/209 (4%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G+GA      AYD   +Q VA+KKLSRPFQ++ HA+R YRE +L+K + H+N+IGLL+ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHR 188
           FTP  S+E+F +VYLV  LM A+L  +++   L  E + +L+YQ+L G+K++HSAGIIHR
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHR 155
Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIW 247
           DLKPSN+ V  D  L+ILDFGLAR A     MT YV TR+YRAPE++L  M Y + VDIW
Sbjct: 156 DLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIW 213
Query: 248 SVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           SVGCIM E+++G  LFPG+D+IDQ  +I+
Sbjct: 214 SVGCIMAELLQGKALFPGSDYIDQLKRIM 242

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 117/219 (53%), Positives = 152/219 (69%), Gaps = 9/219 (4%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ K   + +H+G+GA      A D  + + VAIKKLSRPFQ+   AKRAYRE  L+K +
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIK 178
            H+N+IGLL+ FTP  SL  F D YLVM  M  +L +++ +    E++ YL+YQML G+K
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLK 140
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG- 237
           ++HSAG++HRDLKP N+ V  DC LKILDFGLAR A     MT YVVTR+YRAPEVIL  
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSW 198
Query: 238 MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           M Y + VDIWSVGCIM EM+ G  LF G D++DQ  +I+
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 114/209 (54%), Positives = 154/209 (73%), Gaps = 10/209 (4%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G+GA      AYD   +Q VA+KKLSRPFQ++ HA+R YRE +L+K + H+N+IGLL+ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHR 188
           FTP  S+E+F +VYLV  LM A+L  +++   L  E + +L+YQ+L G+K++HSAGIIHR
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHR 155
Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIW 247
           DLKPSN+ V  D  L+ILDFGLAR A     MT YV TR+YRAPE++L  M Y + VDIW
Sbjct: 156 DLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIW 213
Query: 248 SVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           SVGCIM E+++G  LFPG+D+IDQ  +I+
Sbjct: 214 SVGCIMAELLQGKALFPGSDYIDQLKRIM 242

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 122/245 (49%), Positives = 162/245 (66%), Gaps = 4/245 (1%)
Query: 34  APGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIK 93
           A  P+  S  ER     Q       E+P  +Q      + ++    ++YD  +   +A+K
Sbjct: 23  AAAPFTMSHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVK 82
Query: 94  KLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANL 153
           KLSRPFQ++ HAKR YRE +L+K + H+N+IGLL+ FTP  SLEEF DVYLV  LM A+L
Sbjct: 83  KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADL 142
Query: 154 CQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212
             +++   L  + + +L+YQ+L G+K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR
Sbjct: 143 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 202
Query: 213 TAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ 271
              T   MT YV TR+YRAPE++L  M Y   VDIWSVGCIM E++ G  LFPGTDHI+Q
Sbjct: 203 --HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQ 260
Query: 272 WNKII 276
             +I+
Sbjct: 261 LQQIM 265

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  225 bits (574), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 114/209 (54%), Positives = 150/209 (71%), Gaps = 10/209 (4%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G+GA      A D  T   VAIKKL RPFQ+   AKRAYRE +L+K + H+N+IGLL+ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHR 188
           FTP ++L++F D YLVM  M  +L ++++ + L  +R+ +L+YQML G++++H+AGIIHR
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHR 152
Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIW 247
           DLKP N+ V  DC LKILDFGLAR A +   M   VVTR+YRAPEVIL  M Y + VDIW
Sbjct: 153 DLKPGNLAVNEDCELKILDFGLARQADSE--MXGXVVTRWYRAPEVILNWMRYTQTVDIW 210
Query: 248 SVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           SVGCIM EMI G  LF G+DH+DQ  +I+
Sbjct: 211 SVGCIMAEMITGKTLFKGSDHLDQLKEIM 239

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  191 bits (486), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLAFR 81
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 82  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 244

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  191 bits (485), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 79
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 80  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  191 bits (485), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 29  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 87
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 88  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 146
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 147 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 207 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 250

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  191 bits (485), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 79
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 80  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  191 bits (485), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 81
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 82  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 244

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  191 bits (484), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 99
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 100 HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 158
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 159 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 262

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  190 bits (483), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 26  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 84
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 85  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 143
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 144 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 247

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  190 bits (483), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 27  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 85
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 86  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 144
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 145 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 205 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 248

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  190 bits (483), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 18  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 76
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 77  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 135
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 136 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 196 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 239

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  190 bits (483), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 83
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 84  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  190 bits (483), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 19  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 77
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 78  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 136
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 137 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 240

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  190 bits (483), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 83
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 84  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLK 142
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  190 bits (483), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 19  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 77
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 78  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 136
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 137 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 240

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 97/224 (43%), Positives = 150/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAI+K+S PF++ T+ +R  RE K++    
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKIS-PFEHQTYCQRTLREIKILLRFR 83
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 84  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  187 bits (476), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 97/224 (43%), Positives = 149/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLAFR 81
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 82  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ +   LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 244

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  187 bits (475), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 99/224 (44%), Positives = 148/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 99
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVYLV  LM A+L ++++   L ++ + Y LYQ+L G+K
Sbjct: 100 HENIIGI-NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 158
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ +   LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 159 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 262

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  187 bits (475), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 97/224 (43%), Positives = 149/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 79
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 80  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ +   LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  187 bits (475), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 97/224 (43%), Positives = 149/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 79
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 80  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ +   LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  187 bits (474), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 97/224 (43%), Positives = 149/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 79
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 80  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ +   LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 97/224 (43%), Positives = 149/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 83
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 84  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ +   LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 97/224 (43%), Positives = 149/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYXQRTLREIKILLRFR 83
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 84  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ +   LKI DFGLAR A      T  +T YV TR+YRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 96/224 (42%), Positives = 148/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 83
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 84  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +   V TR+YRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 202
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 96/224 (42%), Positives = 148/224 (66%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +  N S++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE K++    
Sbjct: 26  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFR 84
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+NIIG+ N      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 85  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 143
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +   V TR+YRAPE+
Sbjct: 144 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 203
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 247

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  183 bits (464), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 95/213 (44%), Positives = 136/213 (63%), Gaps = 8/213 (3%)
Query: 72  NTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT 131
           N ++    +A    T Q VAIKK+   F  VT+AKR  RE K++K   H NII + +   
Sbjct: 64  NGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR 123
Query: 132 PQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
           P     EF+ VY+V++LM+++L Q+I     L  E + Y LYQ+L G+K++HSA +IHRD
Sbjct: 124 PTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRD 183
Query: 190 LKPSNIVVKSDCTLKILDFGLARTAGTT-----FMMTPYVVTRYYRAPEVILGM-GYKEN 243
           LKPSN++V  +C LKI DFG+AR   T+     + MT YV TR+YRAPE++L +  Y + 
Sbjct: 184 LKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQA 243
Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           +D+WSVGCI GEM+    LFPG +++ Q   I+
Sbjct: 244 IDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM 276

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 95/213 (44%), Positives = 136/213 (63%), Gaps = 8/213 (3%)
Query: 72  NTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT 131
           N ++    +A    T Q VAIKK+   F  VT+AKR  RE K++K   H NII + +   
Sbjct: 65  NGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR 124
Query: 132 PQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
           P     EF+ VY+V++LM+++L Q+I     L  E + Y LYQ+L G+K++HSA +IHRD
Sbjct: 125 PTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRD 184
Query: 190 LKPSNIVVKSDCTLKILDFGLARTAGTT-----FMMTPYVVTRYYRAPEVILGM-GYKEN 243
           LKPSN++V  +C LKI DFG+AR   T+     + MT YV TR+YRAPE++L +  Y + 
Sbjct: 185 LKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQA 244
Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           +D+WSVGCI GEM+    LFPG +++ Q   I+
Sbjct: 245 IDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM 277

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  181 bits (459), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 93/224 (41%), Positives = 146/224 (65%), Gaps = 14/224 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +G +     ++G GA      AYD   +  VAIKK+S PF++ T+ +R  RE +++    
Sbjct: 41  VGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKIS-PFEHQTYCQRTLREIQILLRFR 99
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIK 178
           H+N+IG+ +      +LE  +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+K
Sbjct: 100 HENVIGIRDILR-ASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLK 158
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----TFMMTPYVVTRYYRAPEV 234
           ++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T  V TR+YRAPE+
Sbjct: 159 YIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 235 IL-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           +L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 262

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 89/233 (38%), Positives = 140/233 (60%), Gaps = 35/233 (15%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLN 128
           LG GA      + D  T + VA+KK+   FQN T A+R +RE  ++ +L  H+NI+ LLN
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIH 187
                      +DVYLV + M+ +L  VI+ + L+     Y++YQ++  IK+LHS G++H
Sbjct: 77  VLRADND----RDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLH 132
Query: 188 RDLKPSNIVVKSDCTLKILDFGLART-----------------AGTTF-----MMTPYVV 225
           RD+KPSNI++ ++C +K+ DFGL+R+                     F     ++T YV 
Sbjct: 133 RDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVA 192
Query: 226 TRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           TR+YRAPE++LG   Y + +D+WS+GCI+GE++ G  +FPG+  ++Q  +IIG
Sbjct: 193 TRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 95/233 (40%), Positives = 126/233 (54%), Gaps = 21/233 (9%)
Query: 74  SHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLL 127
           S LG GA      A    T + VAIKK+  PF     A R  RE K++K   H+NII + 
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITIF 75
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGII 186
           N   P  S E F +VY++ ELM  +L +VI    L  + + Y +YQ L  +K LH + +I
Sbjct: 76  NIQRPD-SFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 187 HRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTTFMMTPYVVTRYYRAPEVI 235
           HRDLKPSN+++ S+C LK+ DFGLAR             G    MT YV TR+YRAPEV+
Sbjct: 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVM 194
Query: 236 L-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLD 287
           L    Y   +D+WS GCI+ E+     +FPG D+  Q   I G +   H   D
Sbjct: 195 LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 94/233 (40%), Positives = 125/233 (53%), Gaps = 21/233 (9%)
Query: 74  SHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLL 127
           S LG GA      A    T + VAIKK+  PF     A R  RE K++K   H+NII + 
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITIF 75
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGII 186
           N   P  S E F +VY++ ELM  +L +VI    L  + + Y +YQ L  +K LH + +I
Sbjct: 76  NIQRPD-SFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 187 HRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTTFMMTPYVVTRYYRAPEVI 235
           HRDLKPSN+++ S+C LK+ DFGLAR             G    MT  V TR+YRAPEV+
Sbjct: 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVM 194
Query: 236 L-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLD 287
           L    Y   +D+WS GCI+ E+     +FPG D+  Q   I G +   H   D
Sbjct: 195 LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 93/233 (39%), Positives = 125/233 (53%), Gaps = 21/233 (9%)
Query: 74  SHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLL 127
           S LG GA      A    T + VAIKK+  PF     A R  RE K++K   H+NII + 
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITIF 75
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGII 186
           N   P  S E F +VY++ ELM  +L +VI    L  + + Y +YQ L  +K LH + +I
Sbjct: 76  NIQRPD-SFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 187 HRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTTFMMTPYVVTRYYRAPEVI 235
           HRDLKPSN+++ S+C LK+ DFGLAR             G    M  +V TR+YRAPEV+
Sbjct: 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVM 194
Query: 236 L-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLD 287
           L    Y   +D+WS GCI+ E+     +FPG D+  Q   I G +   H   D
Sbjct: 195 LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 88/246 (35%), Positives = 137/246 (55%), Gaps = 50/246 (20%)
Query: 70  RHNTSHL-GAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN 122
           R+   HL G G+      AYD   ++ VAIKK+ R F+++   KR  RE  ++  +NH +
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 123 IIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHL 180
           ++ +L+   P K +E+F ++Y+V+E+ D++  ++ +    L    +  LLY +L G+K++
Sbjct: 114 VVKVLDIVIP-KDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172
Query: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--------------------TTF-- 218
           HSAGI+HRDLKP+N +V  DC++K+ DFGLART                       TF  
Sbjct: 173 HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 219 ------MMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIR-----------GG 260
                  +T +VVTR+YRAPE+I L   Y E +D+WS+GCI  E++             G
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292
Query: 261 VLFPGT 266
            LFPG+
Sbjct: 293 PLFPGS 298

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 126/222 (56%), Gaps = 31/222 (13%)
Query: 62  ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           I H +G+  +   +L    AYD  T++NVAIKK++R F+++   KR  RE  ++  +   
Sbjct: 30  IKHLIGRGSYGYVYL----AYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKH 179
            II L +   P   L +F ++Y+V+E+ D++L ++ +    L  E +  +LY +L G   
Sbjct: 86  YIIRLYDLIIPD-DLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----------------------- 216
           +H +GIIHRDLKP+N ++  DC++K+ DFGLART  +                       
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 217 TFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMI 257
              +T +VVTR+YRAPE+I L   Y +++DIWS GCI  E++
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 84/245 (34%), Positives = 133/245 (54%), Gaps = 45/245 (18%)
Query: 62  ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           I H +G+  +   +L    AYD    +NVAIKK++R F+++   KR  RE  ++  +   
Sbjct: 32  IKHLIGRGSYGYVYL----AYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKH 179
            II L +   P+  L +F ++Y+V+E+ D++L ++ +  + L  + +  +LY +L G K 
Sbjct: 88  YIIRLHDLIIPE-DLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----------------------- 216
           +H +GIIHRDLKP+N ++  DC++KI DFGLART  +                       
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 217 ---TFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGE---MIRGGV-------- 261
                 +T +VVTR+YRAPE+I L   Y  ++DIWS GCI  E   M++  +        
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFP 266
Query: 262 LFPGT 266
           LFPG+
Sbjct: 267 LFPGS 271

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  134 bits (336), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 80/206 (38%), Positives = 113/206 (54%), Gaps = 13/206 (6%)
Query: 79  GAAYDTATQQN--VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL 136
           G  Y     Q   VA+K++    ++      A RE  L+K ++H NI+ L++    ++ L
Sbjct: 35  GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 137 EEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
                  LV E M+ +L +V+   +  L   ++   LYQ+L G+ H H   I+HRDLKP 
Sbjct: 95  T------LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQ 148
Query: 194 NIVVKSDCTLKILDFGLARTAGTTFM-MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGC 251
           N+++ SD  LK+ DFGLAR  G      T  VVT +YRAP+V++G   Y  +VDIWS+GC
Sbjct: 149 NLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGC 208
Query: 252 IMGEMIRGGVLFPGTDHIDQWNKIIG 277
           I  EMI G  LFPG    DQ  KI  
Sbjct: 209 IFAEMITGKPLFPGVTDDDQLPKIFS 234

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  133 bits (335), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 80/206 (38%), Positives = 113/206 (54%), Gaps = 13/206 (6%)
Query: 79  GAAYDTATQQN--VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL 136
           G  Y     Q   VA+K++    ++      A RE  L+K ++H NI+ L++    ++ L
Sbjct: 35  GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 137 EEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
                  LV E M+ +L +V+   +  L   ++   LYQ+L G+ H H   I+HRDLKP 
Sbjct: 95  T------LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQ 148
Query: 194 NIVVKSDCTLKILDFGLARTAGTTFM-MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGC 251
           N+++ SD  LK+ DFGLAR  G      T  VVT +YRAP+V++G   Y  +VDIWS+GC
Sbjct: 149 NLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGC 208
Query: 252 IMGEMIRGGVLFPGTDHIDQWNKIIG 277
           I  EMI G  LFPG    DQ  KI  
Sbjct: 209 IFAEMITGKPLFPGVTDDDQLPKIFS 234

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 83/243 (34%), Positives = 132/243 (54%), Gaps = 27/243 (11%)
Query: 66  MGKKRHNTSHLGAG------AAYDTATQQNVAIKK--LSRPFQNVTHAKRAYREFKLMKL 117
           +G +  +   LG G      +A D    + VAIKK  L+ P Q+V HA    RE K+++ 
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHA---LREIKIIRR 64
Query: 118 VNHKNIIGLLNAFTPQKS--------LEEFQDVYLVMELMDANLCQVI-QMDLDHERMSY 168
           ++H NI+ +     P  S        L E   VY+V E M+ +L  V+ Q  L  E    
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTTFM----MTPY 223
            +YQ+L G+K++HSA ++HRDLKP+N+ + + D  LKI DFGLAR     +     ++  
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 224 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA 282
           +VT++YR+P ++L    Y + +D+W+ GCI  EM+ G  LF G   ++Q   I+  +   
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 283 HDK 285
           H++
Sbjct: 245 HEE 247

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 70/178 (39%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 105 AKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE--FQDVYLVMELMDANLCQVI---QM 159
            KR  RE +L+   +H NI+GL + F      EE     +YLV ELM  +L QVI   ++
Sbjct: 73  CKRVLREIRLLNHFHHPNILGLRDIFV---HFEEPAMHKLYLVTELMRTDLAQVIHDQRI 129
Query: 160 DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM 219
            +  + + Y +Y +L G+  LH AG++HRDL P NI++  +  + I DF LAR       
Sbjct: 130 VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 220 MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            T YV  R+YRAPE+++   G+ + VD+WS GC+M EM     LF G+   +Q NKI+
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 70/178 (39%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 105 AKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE--FQDVYLVMELMDANLCQVI---QM 159
            KR  RE +L+   +H NI+GL + F      EE     +YLV ELM  +L QVI   ++
Sbjct: 73  CKRVLREIRLLNHFHHPNILGLRDIFV---HFEEPAMHKLYLVTELMRTDLAQVIHDQRI 129
Query: 160 DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM 219
            +  + + Y +Y +L G+  LH AG++HRDL P NI++  +  + I DF LAR       
Sbjct: 130 VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 220 MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            T YV  R+YRAPE+++   G+ + VD+WS GC+M EM     LF G+   +Q NKI+
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/236 (35%), Positives = 125/236 (52%), Gaps = 20/236 (8%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           Q  +K  N   +G G+        +  T + VAIKK      +    K A RE KL+K +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLC 175
            H+N++ LL     +K        YLV E +D  +   +++    LD++ +   L+Q++ 
Sbjct: 82  RHENLVNLLEVCKKKKRW------YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTTFMMTPYVVTRYYRAPEV 234
           GI   HS  IIHRD+KP NI+V     +K+ DFG ART A    +    V TR+YRAPE+
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195
Query: 235 ILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI---IGKMREAHDKL 286
           ++G + Y + VD+W++GC++ EM  G  LFPG   IDQ   I   +G +   H +L
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 77
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 78  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLG 191
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 192 CIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 29  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 84
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 85  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 138
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 139 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLG 198
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 199 CIFAEMVTRRALFPGDSEIDQLFRIF 224

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 77
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 78  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLSFCHSHRVLHRDLKP 131
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 191
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 192 CIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 26  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 81
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 82  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 135
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 136 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 195
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 196 CIFAEMVTRRALFPGDSEIDQLFRIF 221

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 77
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 78  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 191
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 192 CIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 76
Query: 141 DVYLVME--------LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 77  --YLVFEHVHQDLKTFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 191 CIFAEMVTRRALFPGDSEIDQLFRIF 216

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 76
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 77  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 191 CIFAEMVTRRALFPGDSEIDQLFRIF 216

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 76
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 77  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 191 CIFAEMVTRRALFPGDSEIDQLFRIF 216

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 29  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 84
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 85  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 138
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 139 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 198
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 199 CIFAEMVTRRALFPGDSEIDQLFRIF 224

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 77
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 78  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 191
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 192 CIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 78
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 79  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 133 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 192
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 193 CIFAEMVTRRALFPGDSEIDQLFRIF 218

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 77
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 78  --YLVFEFLHQDLKDFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 132 ENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 191
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 192 CIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 78
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 79  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 133 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 192
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 193 CIFAEMVTRRALFPGDSEIDQLFRIF 218

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 24  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 79
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 80  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 133
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 134 ENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 193
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 194 CIFAEMVTRRALFPGDSEIDQLFRIF 219

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 24  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 79
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 80  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 133
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 134 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 193
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 194 CIFAEMVTRRALFPGDSEIDQLFRIF 219

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 78
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 79  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 133 ENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 192
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 193 CIFAEMVTRRALFPGDSEIDQLFRIF 218

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 76
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 77  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 191 CIFAEMVTRRALFPGDSEIDQLFRIF 216

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 77
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 78  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 191
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 192 CIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 77
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 78  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 191
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 192 CIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 77
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 78  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 191
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 192 CIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 77
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 78  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 191
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 192 CIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 80
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 81  --YLVFEFLSMDLKDFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 135 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 194
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 195 CIFAEMVTRRALFPGDSEIDQLFRIF 220

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 80
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 81  --YLVFEFLSMDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 135 ENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 194
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 195 CIFAEMVTRRALFPGDSEIDQLFRIF 220

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 78
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 79  --YLVFEFLSMDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 133 ENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 192
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 193 CIFAEMVTRRALFPGDSEIDQLFRIF 218

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 76
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 77  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 191 CIFAEMVTRRALFPGDSEIDQLFRIF 216

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 80
Query: 141 DVYLVME--------LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 81  --YLVFEHVDQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 135 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 194
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 195 CIFAEMVTRRALFPGDSEIDQLFRIF 220

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 24  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 79
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 80  --YLVFEFLSMDLKDFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 133
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 134 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 193
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 194 CIFAEMVTRRALFPGDSEIDQLFRIF 219

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 80
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 81  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 135 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 194
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 195 CIFAEMVTRRALFPGDSEIDQLFRIF 220

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 24  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 79
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 80  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 133
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 134 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 193
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 194 CIFAEMVTRRALFPGDSEIDQLFRIF 219

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 26  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 81
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 82  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 135
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 136 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 195
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 196 CIFAEMVTRRALFPGDSEIDQLFRIF 221

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  124 bits (310), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 78
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 79  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 133 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 192
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 193 CIFAEMVTRRALFPGDSEIDQLFRIF 218

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  124 bits (310), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 80
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 81  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 135 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 194
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 195 CIFAEMVTRRALFPGDSEIDQLFRIF 220

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  124 bits (310), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 80
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 81  --YLVFEFLHQDLKTFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G       + VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 135 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 194
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 195 CIFAEMVTRRALFPGDSEIDQLFRIF 220

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 108/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+ K+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 22  ARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 77
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 78  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 191
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 192 CIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/206 (37%), Positives = 108/206 (52%), Gaps = 20/206 (9%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+ K+    +       A RE  L+K +NH NI+ LL+    +  L    
Sbjct: 21  ARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 76
Query: 141 DVYLVMEL--------MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             YLV E         MDA+    I + L    +   L+Q+L G+   HS  ++HRDLKP
Sbjct: 77  --YLVFEFLHQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVG 250
            N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    VDIWS+G
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI  EM+    LFPG   IDQ  +I 
Sbjct: 191 CIFAEMVTRRALFPGDSEIDQLFRIF 216

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 81/225 (36%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 66  MGKKRHN-TSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           M   R+   + +G GA      A D  +   VA+K +  P           RE  L++ +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 119 N---HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLY 171
               H N++ L++     ++  E + V LV E +D +L   +       L  E +  L+ 
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIK-VTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRA 231
           Q L G+  LH+  I+HRDLKP NI+V S  T+K+ DFGLAR       + P VVT +YRA
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRA 179
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           PEV+L   Y   VD+WSVGCI  EM R   LF G    DQ  KI 
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 224

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 81/232 (34%), Positives = 113/232 (48%), Gaps = 17/232 (7%)
Query: 61  PISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAK---RAYRE 111
           P+      +    + +G GA      A D  +   VA+K +  P              RE
Sbjct: 2   PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE 61
Query: 112 FKLMKLVN---HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHE 164
             L++ +    H N++ L++     ++  E + V LV E +D +L   +       L  E
Sbjct: 62  VALLRRLEAFEHPNVVRLMDVCATSRTDREIK-VTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
            +  L+ Q L G+  LH+  I+HRDLKP NI+V S  T+K+ DFGLAR       +TP V
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           VT +YRAPEV+L   Y   VD+WSVGCI  EM R   LF G    DQ  KI 
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 81/225 (36%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 66  MGKKRHN-TSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           M   R+   + +G GA      A D  +   VA+K +  P           RE  L++ +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 119 N---HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLY 171
               H N++ L++     ++  E + V LV E +D +L   +       L  E +  L+ 
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIK-VTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRA 231
           Q L G+  LH+  I+HRDLKP NI+V S  T+K+ DFGLAR       + P VVT +YRA
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRA 179
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           PEV+L   Y   VD+WSVGCI  EM R   LF G    DQ  KI 
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 224

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/225 (36%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 66  MGKKRHN-TSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           M   R+   + +G GA      A D  +   VA+K +  P           RE  L++ +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 119 N---HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLY 171
               H N++ L++     ++  E + V LV E +D +L   +       L  E +  L+ 
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIK-VTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRA 231
           Q L G+  LH+  I+HRDLKP NI+V S  T+K+ DFGLAR       + P VVT +YRA
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRA 179
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           PEV+L   Y   VD+WSVGCI  EM R   LF G    DQ  KI 
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 224

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 97/166 (58%), Gaps = 5/166 (3%)
Query: 115 MKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLC----QVIQMDLDHERMSYLL 170
           ++   H N++ L +  T  ++  E + + LV E +D +L     +V +  +  E +  ++
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR 230
           +Q+L G+  LHS  ++HRDLKP NI+V S   +K+ DFGLAR       +T  VVT +YR
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 186
Query: 231 APEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           APEV+L   Y   VD+WSVGCI  EM R   LF G+  +DQ  KI+
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  121 bits (303), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 97/166 (58%), Gaps = 5/166 (3%)
Query: 115 MKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLC----QVIQMDLDHERMSYLL 170
           ++   H N++ L +  T  ++  E + + LV E +D +L     +V +  +  E +  ++
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR 230
           +Q+L G+  LHS  ++HRDLKP NI+V S   +K+ DFGLAR       +T  VVT +YR
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 186
Query: 231 APEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           APEV+L   Y   VD+WSVGCI  EM R   LF G+  +DQ  KI+
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  121 bits (303), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 97/166 (58%), Gaps = 5/166 (3%)
Query: 115 MKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLC----QVIQMDLDHERMSYLL 170
           ++   H N++ L +  T  ++  E + + LV E +D +L     +V +  +  E +  ++
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR 230
           +Q+L G+  LHS  ++HRDLKP NI+V S   +K+ DFGLAR       +T  VVT +YR
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 186
Query: 231 APEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           APEV+L   Y   VD+WSVGCI  EM R   LF G+  +DQ  KI+
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 76/219 (34%), Positives = 110/219 (50%), Gaps = 16/219 (7%)
Query: 68  KKRHNTSHLGAGAAYDTATQQN-----VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN 122
           +K H    +G G        QN      A+KK+    ++        RE  ++K + H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 123 IIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKH 179
           I+ L +    +K L       LV E +D +L +++ +    L+       L Q+L GI +
Sbjct: 62  IVKLYDVIHTKKRL------VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM-MTPYVVTRYYRAPEVILGM 238
            H   ++HRDLKP N+++  +  LKI DFGLAR  G      T  VVT +YRAP+V++G 
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 239 -GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
             Y   +DIWSVGCI  EM+ G  LFPG    DQ  +I 
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIF 214

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/224 (35%), Positives = 122/224 (54%), Gaps = 20/224 (8%)
Query: 67  GKKRHNTSHLGAG------AAYDTATQQNVAIKKLS---RPFQNVTHAKRAYREFKLMKL 117
            K+      LG G       A D  T Q VAIKK+    R        + A RE KL++ 
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 118 VNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQML 174
           ++H NIIGLL+AF   KS     ++ LV + M+ +L  +I+   + L    +   +   L
Sbjct: 69  LSHPNIIGLLDAFG-HKS-----NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPY-VVTRYYRAPE 233
            G+++LH   I+HRDLKP+N+++  +  LK+ DFGLA++ G+      + VVTR+YRAPE
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPE 182
Query: 234 VILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           ++ G   Y   VD+W+VGCI+ E++      PG   +DQ  +I 
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 226

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 76/219 (34%), Positives = 110/219 (50%), Gaps = 16/219 (7%)
Query: 68  KKRHNTSHLGAGAAYDTATQQN-----VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN 122
           +K H    +G G        QN      A+KK+    ++        RE  ++K + H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 123 IIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKH 179
           I+ L +    +K L       LV E +D +L +++ +    L+       L Q+L GI +
Sbjct: 62  IVKLYDVIHTKKRL------VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM-MTPYVVTRYYRAPEVILGM 238
            H   ++HRDLKP N+++  +  LKI DFGLAR  G      T  VVT +YRAP+V++G 
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 239 -GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
             Y   +DIWSVGCI  EM+ G  LFPG    DQ  +I 
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 75/219 (34%), Positives = 110/219 (50%), Gaps = 16/219 (7%)
Query: 68  KKRHNTSHLGAGAAYDTATQQN-----VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN 122
           +K H    +G G        QN      A+KK+    ++        RE  ++K + H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 123 IIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKH 179
           I+ L +    +K L       LV E +D +L +++ +    L+       L Q+L GI +
Sbjct: 62  IVKLYDVIHTKKRL------VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM-MTPYVVTRYYRAPEVILGM 238
            H   ++HRDLKP N+++  +  LKI DFGLAR  G      T  +VT +YRAP+V++G 
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 239 -GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
             Y   +DIWSVGCI  EM+ G  LFPG    DQ  +I 
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/224 (34%), Positives = 115/224 (51%), Gaps = 7/224 (3%)
Query: 68  KKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLL 127
           +K  N ++       +  T   VA+K++    +  T +  A RE  LMK + H+NI+ L 
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST-AIREISLMKELKHENIVRLY 69
Query: 128 NAFTPQKSLE---EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG 184
           +    +  L    EF D  L  + MD+         L+   + Y  +Q+L G+   H   
Sbjct: 70  DVIHTENKLTLVFEFMDNDL-KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILG-MGYKE 242
           I+HRDLKP N+++     LK+ DFGLAR  G      +  VVT +YRAP+V++G   Y  
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYST 188
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL 286
           ++DIWS GCI+ EMI G  LFPGT+  +Q   I   M   ++ L
Sbjct: 189 SIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 125/257 (48%), Gaps = 27/257 (10%)
Query: 29  EVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQ 88
           E     PG    S      ++D+++ +         ++G+  +   +     A DT T +
Sbjct: 13  EAQTQGPGSMSVSAAPSATSIDRYRRIT--------KLGEGTYGEVY----KAIDTVTNE 60
Query: 89  NVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
            VAIK++    +       A RE  L+K + H+NII L      +  +     ++L+ E 
Sbjct: 61  TVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIEL------KSVIHHNHRLHLIFEY 114
Query: 149 MDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCT--- 202
            + +L + +    D+    +   LYQ++ G+   HS   +HRDLKP N+++  SD +   
Sbjct: 115 AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP 174
Query: 203 -LKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRG 259
            LKI DFGLAR  G      T  ++T +YR PE++LG   Y  +VDIWS+ CI  EM+  
Sbjct: 175 VLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234
Query: 260 GVLFPGTDHIDQWNKII 276
             LFPG   IDQ  KI 
Sbjct: 235 TPLFPGDSEIDQLFKIF 251

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 105/202 (51%), Gaps = 12/202 (5%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+K++     +      A RE  L+K + HKNI+ L +     K L    
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT--- 77
Query: 141 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
              LV E  D +L +       DLD E +   L+Q+L G+   HS  ++HRDLKP N+++
Sbjct: 78  ---LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI 134
Query: 198 KSDCTLKILDFGLARTAGTTFMM-TPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGE 255
             +  LK+ +FGLAR  G      +  VVT +YR P+V+ G   Y  ++D+WS GCI  E
Sbjct: 135 NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 194
Query: 256 MIRGG-VLFPGTDHIDQWNKII 276
           +   G  LFPG D  DQ  +I 
Sbjct: 195 LANAGRPLFPGNDVDDQLKRIF 216

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 12/202 (5%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+K++     +      A RE  L+K + HKNI+ L +     K L    
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT--- 77
Query: 141 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
              LV E  D +L +       DLD E +   L+Q+L G+   HS  ++HRDLKP N+++
Sbjct: 78  ---LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI 134
Query: 198 KSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGE 255
             +  LK+ DFGLAR  G      +  VVT +YR P+V+ G   Y  ++D+WS GCI  E
Sbjct: 135 NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 194
Query: 256 MIRGG-VLFPGTDHIDQWNKII 276
           +      LFPG D  DQ  +I 
Sbjct: 195 LANAARPLFPGNDVDDQLKRIF 216

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 108/201 (53%), Gaps = 26/201 (12%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
           VAIKK+   + F+N        RE ++M++V H N++ L   F      ++   + LV+E
Sbjct: 67  VAIKKVLQDKRFKN--------RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118
Query: 148 LMD----------ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
            +           A L Q + M L    +   +YQ+L  + ++HS GI HRD+KP N+++
Sbjct: 119 YVPETVYRASRHYAKLKQTMPMLL----IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174
Query: 198 KSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGE 255
                 LK++DFG A+           + +RYYRAPE+I G   Y  N+DIWS GC+M E
Sbjct: 175 DPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAE 234
Query: 256 MIRGGVLFPGTDHIDQWNKII 276
           +++G  LFPG   IDQ  +II
Sbjct: 235 LMQGQPLFPGESGIDQLVEII 255

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 122/250 (48%), Gaps = 52/250 (20%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G+       +D  + +  A+KK+      +   +   RE  +MK+++H NII L++ 
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 130 F---------TPQKS---------------------LEEFQDVYL--VMELMDANLCQVI 157
           F          PQ                       +   Q+ YL  +ME +   L +V+
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 158 QMDLDHER------MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGL 210
           +  +   R      +S  +YQ+   +  +HS GI HRD+KP N++V S D TLK+ DFG 
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGS 188
Query: 211 ARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
           A+    +      + +R+YRAPE++LG   Y  ++D+WS+GC+ GE+I G  LF G   I
Sbjct: 189 AKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI 248
Query: 270 DQWNKIIGKM 279
           DQ  +II  M
Sbjct: 249 DQLVRIIQIM 258

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 113/235 (48%), Gaps = 20/235 (8%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           M +K      +G G+        +  T Q VAIKK      +    K A RE +++K + 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCG 176
           H N++ LL  F  ++ L      +LV E  D  +   +   Q  +    +  + +Q L  
Sbjct: 61  HPNLVNLLEVFRRKRRL------HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQA 114
Query: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPYVVTRYYRAPEVI 235
           +   H    IHRD+KP NI++     +K+ DFG AR   G +      V TR+YR+PE++
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL 174
Query: 236 LG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW---NKIIGKMREAHDKL 286
           +G   Y   VD+W++GC+  E++ G  L+PG   +DQ     K +G +   H ++
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 109/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 48  VAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 97
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 157
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+          Y+ +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 218 LGQPIFPGDSGVDQLVEII 236

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 109/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 48  VAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 97
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 157
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+          Y+ +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 218 LGQPIFPGDSGVDQLVEII 236

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 109/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 82  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 131
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 191
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+          Y+ +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 192 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 252 LGQPIFPGDSGVDQLVEII 270

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 109/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 76  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 125
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 126 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 185
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+          Y+ +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 186 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 245
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 246 LGQPIFPGDSGVDQLVEII 264

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 109/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 84  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 133
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 134 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 193
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+          Y+ +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 194 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 253
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 254 LGQPIFPGDSGVDQLVEII 272

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 109/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 53  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 102
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 103 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 162
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+          Y+ +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 163 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 222
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 223 LGQPIFPGDSGVDQLVEII 241

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 109/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 86  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 135
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 136 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 195
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+          Y+ +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 196 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 255
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 256 LGQPIFPGDSGVDQLVEII 274

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 109/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 127 VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 176
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 177 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 236
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+          Y+ +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 237 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 296
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 297 LGQPIFPGDSGVDQLVEII 315

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 109/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 61  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 110
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 111 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 170
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+          Y+ +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 171 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 230
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 231 LGQPIFPGDSGVDQLVEII 249

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 109/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 48  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 97
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 157
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+          Y+ +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 218 LGQPIFPGDSGVDQLVEII 236

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 109/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 48  VAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 97
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ + A + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 98  LDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 157
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+           + +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 218 LGQPIFPGDSGVDQLVEII 236

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 111/210 (52%), Gaps = 32/210 (15%)
Query: 73  TSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 120
           +  LG+GA      A++  T + VAIK +S+    +  A+ A        E +++K +NH
Sbjct: 14  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 73
Query: 121 KNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLC 175
             II + N F       + +D Y+V+ELM+    ++    + ++R+         YQML 
Sbjct: 74  PCIIKIKNFF-------DAEDYYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            +++LH  GIIHRDLKP N+++ S   DC +KI DFG ++  G T +M     T  Y AP
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 184
Query: 233 EVILGM---GYKENVDIWSVGCIMGEMIRG 259
           EV++ +   GY   VD WS+G I+   + G
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 111/210 (52%), Gaps = 32/210 (15%)
Query: 73  TSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 120
           +  LG+GA      A++  T + VAIK +S+    +  A+ A        E +++K +NH
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 121 KNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLC 175
             II + N F       + +D Y+V+ELM+    ++    + ++R+         YQML 
Sbjct: 75  PCIIKIKNFF-------DAEDYYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            +++LH  GIIHRDLKP N+++ S   DC +KI DFG ++  G T +M     T  Y AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 233 EVILGM---GYKENVDIWSVGCIMGEMIRG 259
           EV++ +   GY   VD WS+G I+   + G
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 111/210 (52%), Gaps = 32/210 (15%)
Query: 73  TSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 120
           +  LG+GA      A++  T + VAIK +S+    +  A+ A        E +++K +NH
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 121 KNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLC 175
             II + N F       + +D Y+V+ELM+    ++    + ++R+         YQML 
Sbjct: 75  PCIIKIKNFF-------DAEDYYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            +++LH  GIIHRDLKP N+++ S   DC +KI DFG ++  G T +M     T  Y AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 233 EVILGM---GYKENVDIWSVGCIMGEMIRG 259
           EV++ +   GY   VD WS+G I+   + G
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 111/210 (52%), Gaps = 32/210 (15%)
Query: 73  TSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 120
           +  LG+GA      A++  T + VAIK +S+    +  A+ A        E +++K +NH
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 121 KNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLC 175
             II + N F       + +D Y+V+ELM+    ++    + ++R+         YQML 
Sbjct: 75  PCIIKIKNFF-------DAEDYYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            +++LH  GIIHRDLKP N+++ S   DC +KI DFG ++  G T +M     T  Y AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 233 EVILGM---GYKENVDIWSVGCIMGEMIRG 259
           EV++ +   GY   VD WS+G I+   + G
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 109/204 (53%), Gaps = 32/204 (15%)
Query: 73  TSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 120
           +  LG+GA      A++  T + VAIK +S+    +  A+ A        E +++K +NH
Sbjct: 21  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 80
Query: 121 KNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLC 175
             II + N F       + +D Y+V+ELM+    ++    + ++R+         YQML 
Sbjct: 81  PCIIKIKNFF-------DAEDYYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            +++LH  GIIHRDLKP N+++ S   DC +KI DFG ++  G T +M     T  Y AP
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 191
Query: 233 EVILGM---GYKENVDIWSVGCIM 253
           EV++ +   GY   VD WS+G I+
Sbjct: 192 EVLVSVGTAGYNRAVDCWSLGVIL 215

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/164 (37%), Positives = 89/164 (54%), Gaps = 11/164 (6%)
Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHE 164
           A RE  L+K + H NI+ L +    +KSL       LV E +D +L Q +      ++  
Sbjct: 47  AIREVSLLKDLKHANIVTLHDIIHTEKSLT------LVFEYLDKDLKQYLDDCGNIINMH 100
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-TFMMTPY 223
            +   L+Q+L G+ + H   ++HRDLKP N+++     LK+ DFGLAR     T      
Sbjct: 101 NVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160
Query: 224 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGT 266
           VVT +YR P+++LG   Y   +D+W VGCI  EM  G  LFPG+
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 82  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 131
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 191
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+           + +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 192 DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 252 LGQPIFPGDSGVDQLVEII 270

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 111/210 (52%), Gaps = 32/210 (15%)
Query: 73  TSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 120
           +  LG+GA      A++  T + VAI+ +S+    +  A+ A        E +++K +NH
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 121 KNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLC 175
             II + N F       + +D Y+V+ELM+    ++    + ++R+         YQML 
Sbjct: 200 PCIIKIKNFF-------DAEDYYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFYQMLL 250
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            +++LH  GIIHRDLKP N+++ S   DC +KI DFG ++  G T +M     T  Y AP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 233 EVILGM---GYKENVDIWSVGCIMGEMIRG 259
           EV++ +   GY   VD WS+G I+   + G
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 60  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 109
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 110 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 169
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+           + +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 170 DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 230 LGQPIFPGDSGVDQLVEII 248

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 111/210 (52%), Gaps = 32/210 (15%)
Query: 73  TSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRA------YREFKLMKLVNH 120
           +  LG+GA      A++  T + VAI+ +S+    +  A+ A        E +++K +NH
Sbjct: 154 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 213
Query: 121 KNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLC 175
             II + N F       + +D Y+V+ELM+    ++    + ++R+         YQML 
Sbjct: 214 PCIIKIKNFF-------DAEDYYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFYQMLL 264
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            +++LH  GIIHRDLKP N+++ S   DC +KI DFG ++  G T +M     T  Y AP
Sbjct: 265 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 324
Query: 233 EVILGM---GYKENVDIWSVGCIMGEMIRG 259
           EV++ +   GY   VD WS+G I+   + G
Sbjct: 325 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 56  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 105
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 106 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 165
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+           + +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 166 DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 225
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 226 LGQPIFPGDSGVDQLVEII 244

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 67  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 116
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 117 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 176
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+           + +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 177 DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 236
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 237 LGQPIFPGDSGVDQLVEII 255

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 60  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 109
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 110 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 169
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+           + +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 170 DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 230 LGQPIFPGDSGVDQLVEII 248

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 48  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 97
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 157
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+           + +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 218 LGQPIFPGDSGVDQLVEII 236

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 48  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 97
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 157
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+           + +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 218 LGQPIFPGDSGVDQLVEII 236

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 52  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 101
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 102 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 161
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+           + +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 162 DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 221
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 222 LGQPIFPGDSGVDQLVEII 240

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 22/199 (11%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL--V 145
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F    S E+  +VYL  V
Sbjct: 49  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFF--YSSGEKKDEVYLNLV 98
Query: 146 MELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           ++ +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  
Sbjct: 99  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 158
Query: 200 D-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 257
           D   LK+ DFG A+           + +RYYRAPE+I G   Y  ++D+WS GC++ E++
Sbjct: 159 DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 218
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G  +FPG   +DQ  +II
Sbjct: 219 LGQPIFPGDSGVDQLVEII 237

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 105/197 (53%), Gaps = 18/197 (9%)
Query: 90  VAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
           VAIKK+   + F+N        RE ++M+ ++H NI+ L   F      ++   + LV++
Sbjct: 48  VAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLD 99
Query: 148 LMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD- 200
            +   + +V       +  L    +   +YQ+   + ++HS GI HRD+KP N+++  D 
Sbjct: 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT 159
Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRG 259
             LK+ DFG A+           + +RYYRAPE+I G   Y  ++D+WS GC++ E++ G
Sbjct: 160 AVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 260 GVLFPGTDHIDQWNKII 276
             +FPG   +DQ  +II
Sbjct: 220 QPIFPGDSGVDQLVEII 236

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 83  DTATQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD 141
           D  T Q  A+K +S R  +  T  +   RE +L+K ++H NI+ L   F  +       +
Sbjct: 70  DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 129
Query: 142 VYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-- 199
           VY   EL D  + +    ++D  R   ++ Q+L GI ++H   I+HRDLKP N++++S  
Sbjct: 130 VYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKNKIVHRDLKPENLLLESKS 186
Query: 200 -DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
            D  ++I+DFGL+     +  M   + T YY APEV+ G  Y E  D+WS G I+  ++ 
Sbjct: 187 KDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLS 245
Query: 259 GGVLFPGTDHIDQWNKI 275
           G   F G +  D   K+
Sbjct: 246 GCPPFNGANEYDILKKV 262

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 116/227 (51%), Gaps = 20/227 (8%)
Query: 62  ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           +    G+    T  LG     + +T  +VAIKK+    Q+     R  +  + + +++H 
Sbjct: 27  VERMAGQGTFGTVQLGK----EKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHHP 79
Query: 122 NIIGLLNAFTPQKSLEEFQDVYL--VMELMDANLCQVI------QMDLDHERMSYLLYQM 173
           NI+ L + F      +  +D+YL  VME +   L +        Q+      +   L+Q+
Sbjct: 80  NIVQLQSYFYTLGERDR-RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 174 L--CGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR 230
           +   G  HL S  + HRD+KP N++V ++D TLK+ DFG A+    +     Y+ +RYYR
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR 198
Query: 231 APEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           APE+I G   Y   VDIWSVGCI  EM+ G  +F G +   Q ++I+
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 83  DTATQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD 141
           D  T Q  A+K +S R  +  T  +   RE +L+K ++H NI+ L   F  +       +
Sbjct: 47  DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106
Query: 142 VYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-- 199
           VY   EL D  + +    ++D  R   ++ Q+L GI ++H   I+HRDLKP N++++S  
Sbjct: 107 VYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKNKIVHRDLKPENLLLESKS 163
Query: 200 -DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
            D  ++I+DFGL+     +  M   + T YY APEV+ G  Y E  D+WS G I+  ++ 
Sbjct: 164 KDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLS 222
Query: 259 GGVLFPGTDHIDQWNKI 275
           G   F G +  D   K+
Sbjct: 223 GCPPFNGANEYDILKKV 239

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           D  TQQ  A+K +++            RE +L+K ++H NI+ L        S     ++
Sbjct: 43  DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 143 YLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--- 199
           Y   EL D  + +    + D  R   ++ Q+  GI ++H   I+HRDLKP NI+++S   
Sbjct: 103 YTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159
Query: 200 DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           DC +KI+DFGL+        M   + T YY APEV+ G  Y E  D+WS G I+  ++ G
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSG 218
Query: 260 GVLFPGTDHIDQWNKI 275
              F G +  D   ++
Sbjct: 219 TPPFYGKNEYDILKRV 234

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           D  TQQ  A+K +++            RE +L+K ++H NI+ L        S     ++
Sbjct: 43  DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 143 YLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--- 199
           Y   EL D  + +    + D  R   ++ Q+  GI ++H   I+HRDLKP NI+++S   
Sbjct: 103 YTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159
Query: 200 DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           DC +KI+DFGL+        M   + T YY APEV+ G  Y E  D+WS G I+  ++ G
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSG 218
Query: 260 GVLFPGTDHIDQWNKI 275
              F G +  D   ++
Sbjct: 219 TPPFYGKNEYDILKRV 234

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 83  DTATQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD 141
           D  T Q  A+K +S R  +  T  +   RE +L+K ++H NI+ L   F  +       +
Sbjct: 71  DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 130
Query: 142 VYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-- 199
           VY   EL D  + +    ++D  R   ++ Q+L GI ++H   I+HRDLKP N++++S  
Sbjct: 131 VYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKNKIVHRDLKPENLLLESKS 187
Query: 200 -DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
            D  ++I+DFGL+     +  M   + T YY APEV+ G  Y E  D+WS G I+  ++ 
Sbjct: 188 KDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLS 246
Query: 259 GGVLFPGTDHIDQWNKI 275
           G   F G +  D   K+
Sbjct: 247 GCPPFNGANEYDILKKV 263

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 83  DTATQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD 141
           D  T Q  A+K +S R  +  T  +   RE +L+K ++H NI+ L   F  +       +
Sbjct: 53  DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 112
Query: 142 VYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-- 199
           VY   EL D  + +    ++D  R   ++ Q+L GI ++H   I+HRDLKP N++++S  
Sbjct: 113 VYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKNKIVHRDLKPENLLLESKS 169
Query: 200 -DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
            D  ++I+DFGL+     +  M   + T YY APEV+ G  Y E  D+WS G I+  ++ 
Sbjct: 170 KDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLS 228
Query: 259 GGVLFPGTDHIDQWNKI 275
           G   F G +  D   K+
Sbjct: 229 GCPPFNGANEYDILKKV 245

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           D  TQQ  A+K +++            RE +L+K ++H NI+ L        S     ++
Sbjct: 43  DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 143 YLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--- 199
           Y   EL D  + +    + D  R   ++ Q+  GI ++H   I+HRDLKP NI+++S   
Sbjct: 103 YTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159
Query: 200 DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           DC +KI+DFGL+        M   + T YY APEV+ G  Y E  D+WS G I+  ++ G
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSG 218
Query: 260 GVLFPGTDHIDQWNKI 275
              F G +  D   ++
Sbjct: 219 TPPFYGKNEYDILKRV 234

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 83  DTATQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD 141
           D  T Q  A+K +S R  +  T  +   RE +L+K ++H NI  L   F  +       +
Sbjct: 47  DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGE 106
Query: 142 VYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-- 199
           VY   EL D  + +    ++D  R   ++ Q+L GI + H   I+HRDLKP N++++S  
Sbjct: 107 VYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYXHKNKIVHRDLKPENLLLESKS 163
Query: 200 -DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
            D  ++I+DFGL+     +      + T YY APEV+ G  Y E  D+WS G I+  ++ 
Sbjct: 164 KDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLS 222
Query: 259 GGVLFPGTDHIDQWNKI 275
           G   F G +  D   K+
Sbjct: 223 GCPPFNGANEYDILKKV 239

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 93/176 (52%), Gaps = 24/176 (13%)
Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ--------- 158
           A RE  L++ + H N+I L   F         + V+L+ +  + +L  +I+         
Sbjct: 65  ACREIALLRELKHPNVISLQKVFLSHAD----RKVWLLFDYAEHDLWHIIKFHRASKANK 120
Query: 159 --MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLAR 212
             + L    +  LLYQ+L GI +LH+  ++HRDLKP+NI+V  +      +KI D G AR
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 213 TAGTTFM----MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLF 263
              +       + P VVT +YRAPE++LG   Y + +DIW++GCI  E++    +F
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T + VAIK + +   N T  ++ +RE ++MK++NH NI+ L      +K+L      YL+
Sbjct: 36  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL------YLI 89
Query: 146 MELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           ME   A+  +V    + H RM          Q++  +++ H   I+HRDLK  N+++ +D
Sbjct: 90  MEY--ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD 147
Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRG 259
             +KI DFG +        +  +  +  Y APE+  G  Y    VD+WS+G I+  ++ G
Sbjct: 148 MNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207
Query: 260 GVLFPGTDHIDQWNKII-GKMR 280
            + F G +  +   +++ GK R
Sbjct: 208 SLPFDGQNLKELRERVLRGKYR 229

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T + VA+K + +   N T  ++ +RE ++MK++NH NI+ L      +K+L      YLV
Sbjct: 39  TGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL------YLV 92
Query: 146 MELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           ME   A+  +V    + H RM          Q++  +++ H   I+HRDLK  N+++  D
Sbjct: 93  MEY--ASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGD 150
Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRG 259
             +KI DFG +        +  +  +  Y APE+  G  Y    VD+WS+G I+  ++ G
Sbjct: 151 MNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
Query: 260 GVLFPGTDHIDQWNKII-GKMR 280
            + F G +  +   +++ GK R
Sbjct: 211 SLPFDGQNLKELRERVLRGKYR 232

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T + VAIK + +   N T  ++ +RE ++MK++NH NI+ L      +K+L      YL+
Sbjct: 39  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL------YLI 92
Query: 146 MELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           ME   A+  +V    + H RM          Q++  +++ H   I+HRDLK  N+++ +D
Sbjct: 93  MEY--ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD 150
Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRG 259
             +KI DFG +        +  +     Y APE+  G  Y    VD+WS+G I+  ++ G
Sbjct: 151 MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
Query: 260 GVLFPGTDHIDQWNKII-GKMR 280
            + F G +  +   +++ GK R
Sbjct: 211 SLPFDGQNLKELRERVLRGKYR 232

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG+GA        D  T    AIK + +   + +   +   E  ++KL++H NI+ L + 
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 130 FTPQKSLEEFQDVYLVMELMDAN--LCQVI-QMDLDHERMSYLLYQMLCGIKHLHSAGII 186
           F      E+ ++ YLVME         ++I +M  +    + ++ Q+L G+ +LH   I+
Sbjct: 105 F------EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 187 HRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKEN 243
           HRDLKP N++++S   D  +KI+DFGL+        M   + T YY APEV L   Y E 
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRKKYDEK 217
Query: 244 VDIWSVGCIMGEMIRGGVLFPG 265
            D+WS+G I+  ++ G   F G
Sbjct: 218 CDVWSIGVILFILLAGYPPFGG 239

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 59  ELPISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREF 112
           E P   ++ K     + +G G       A    T Q VA+KK+    +       A RE 
Sbjct: 10  ECPFCDEVSK-YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 68
Query: 113 KLMKLVNHKNIIGLLNAFTPQKSLEEF--QDVYLVMELMD---ANLCQVIQMDLDHERMS 167
           K+++L+ H+N++ L+     + S        +YLV +  +   A L   + +      + 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 128
Query: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP----- 222
            ++  +L G+ ++H   I+HRD+K +N+++  D  LK+ DFGLAR         P     
Sbjct: 129 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 223 YVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 256
            VVT +YR PE++LG   Y   +D+W  GCIM EM
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 59  ELPISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREF 112
           E P   ++ K     + +G G       A    T Q VA+KK+    +       A RE 
Sbjct: 10  ECPFCDEVSK-YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 68
Query: 113 KLMKLVNHKNIIGLLNAFTPQKSLEEF--QDVYLVMELMD---ANLCQVIQMDLDHERMS 167
           K+++L+ H+N++ L+     + S        +YLV +  +   A L   + +      + 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 128
Query: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP----- 222
            ++  +L G+ ++H   I+HRD+K +N+++  D  LK+ DFGLAR         P     
Sbjct: 129 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 223 YVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 256
            VVT +YR PE++LG   Y   +D+W  GCIM EM
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 59  ELPISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREF 112
           E P   ++ K     + +G G       A    T Q VA+KK+    +       A RE 
Sbjct: 9   ECPFCDEVSK-YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 67
Query: 113 KLMKLVNHKNIIGLLNAFTPQKSLEEF--QDVYLVMELMD---ANLCQVIQMDLDHERMS 167
           K+++L+ H+N++ L+     + S        +YLV +  +   A L   + +      + 
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127
Query: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP----- 222
            ++  +L G+ ++H   I+HRD+K +N+++  D  LK+ DFGLAR         P     
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 223 YVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 256
            VVT +YR PE++LG   Y   +D+W  GCIM EM
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 93/182 (51%), Gaps = 11/182 (6%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF--QDVY 143
           T Q VA+KK+    +       A RE K+++L+ H+N++ L+     + S        +Y
Sbjct: 42  TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 101
Query: 144 LVMELMD---ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           LV +  +   A L   + +      +  ++  +L G+ ++H   I+HRD+K +N+++  D
Sbjct: 102 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD 161
Query: 201 CTLKILDFGLARTAGTTFMMTP-----YVVTRYYRAPEVILG-MGYKENVDIWSVGCIMG 254
             LK+ DFGLAR         P      VVT +YR PE++LG   Y   +D+W  GCIM 
Sbjct: 162 GVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 221
Query: 255 EM 256
           EM
Sbjct: 222 EM 223

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T + VA+K + +   N +  ++ +RE ++MK++NH NI+ L      +K+L      YLV
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTL------YLV 91
Query: 146 MELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           ME   A+  +V    + H RM          Q++  +++ H   I+HRDLK  N+++ +D
Sbjct: 92  MEY--ASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDAD 149
Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRG 259
             +KI DFG +        +  +  +  Y APE+  G  Y    VD+WS+G I+  ++ G
Sbjct: 150 MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209
Query: 260 GVLFPGTDHIDQWNKII-GKMR 280
            + F G +  +   +++ GK R
Sbjct: 210 SLPFDGQNLKELRERVLRGKYR 231

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T + VA+K + +   N +  ++ +RE ++MK++NH NI+ L      +K+L      YLV
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTL------YLV 91
Query: 146 MELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           ME   A+  +V    + H RM          Q++  +++ H   I+HRDLK  N+++ +D
Sbjct: 92  MEY--ASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDAD 149
Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRG 259
             +KI DFG +        +  +  +  Y APE+  G  Y    VD+WS+G I+  ++ G
Sbjct: 150 MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209
Query: 260 GVLFPGTDHIDQWNKII-GKMR 280
            + F G +  +   +++ GK R
Sbjct: 210 SLPFDGQNLKELRERVLRGKYR 231

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T + VA+K + +   N +  ++ +RE ++MK++NH NI+ L      +K+L      YLV
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTL------YLV 91
Query: 146 MELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           ME   A+  +V    + H RM          Q++  +++ H   I+HRDLK  N+++ +D
Sbjct: 92  MEY--ASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDAD 149
Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRG 259
             +KI DFG +        +  +     Y APE+  G  Y    VD+WS+G I+  ++ G
Sbjct: 150 MNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209
Query: 260 GVLFPGTDHIDQWNKII-GKMR 280
            + F G +  +   +++ GK R
Sbjct: 210 SLPFDGQNLKELRERVLRGKYR 231

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T + VA++ + +   N +  ++ +RE ++MK++NH NI+ L      +K+L      YLV
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTL------YLV 91
Query: 146 MELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           ME   A+  +V    + H RM          Q++  +++ H   I+HRDLK  N+++ +D
Sbjct: 92  MEY--ASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDAD 149
Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRG 259
             +KI DFG +        +  +  +  Y APE+  G  Y    VD+WS+G I+  ++ G
Sbjct: 150 MNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209
Query: 260 GVLFPGTDHIDQWNKII-GKMR 280
            + F G +  +   +++ GK R
Sbjct: 210 SLPFDGQNLKELRERVLRGKYR 231

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T + VA++ + +   N +  ++ +RE ++MK++NH NI+ L      +K+L      YLV
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTL------YLV 91
Query: 146 MELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           ME   A+  +V    + H RM          Q++  +++ H   I+HRDLK  N+++ +D
Sbjct: 92  MEY--ASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDAD 149
Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRG 259
             +KI DFG +        +  +  +  Y APE+  G  Y    VD+WS+G I+  ++ G
Sbjct: 150 MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209
Query: 260 GVLFPGTDHIDQWNKII-GKMR 280
            + F G +  +   +++ GK R
Sbjct: 210 SLPFDGQNLKELRERVLRGKYR 231

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/219 (34%), Positives = 110/219 (50%), Gaps = 22/219 (10%)
Query: 63  SHQMGK---KRHN-TSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHA-KRAYRE 111
           SH +GK   +R+     LG G       A DT     VAIK +  P +      KR  RE
Sbjct: 2   SHMIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFERE 61
Query: 112 FKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--DLDHERMSY 168
                 ++H+NI+ +++        EE    YLVME ++   L + I+    L  +    
Sbjct: 62  VHNSSQLSHQNIVSMIDVD------EEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN 115
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTTFMMTPYVV-T 226
              Q+L GIKH H   I+HRD+KP NI++ S+ TLKI DFG+A+  + T+   T +V+ T
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT 175
Query: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
             Y +PE   G    E  DI+S+G ++ EM+ G   F G
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/186 (33%), Positives = 94/186 (50%), Gaps = 17/186 (9%)
Query: 109 YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQM-DLDHER 165
           Y E  L+K ++H NII L + F  +K        YLV E  +      Q+I     D   
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVFEDKKYF------YLVTEFYEGGELFEQIINRHKFDECD 147
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL---KILDFGLARTAGTTFMMTP 222
            + ++ Q+L GI +LH   I+HRD+KP NI++++  +L   KI+DFGL+      + +  
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA 282
            + T YY APEV L   Y E  D+WS G IM  ++ G   F G +  D    II K+ + 
Sbjct: 208 RLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD----IIKKVEKG 262
Query: 283 HDKLDY 288
               D+
Sbjct: 263 KYYFDF 268

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T + VA+K + +   N +  ++ +RE ++MK++NH NI+ L      +K+L      YLV
Sbjct: 31  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTL------YLV 84
Query: 146 MELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           ME   A+  +V    + H  M          Q++  +++ H   I+HRDLK  N+++ +D
Sbjct: 85  MEY--ASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDAD 142
Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRG 259
             +KI DFG +        +  +  +  Y APE+  G  Y    VD+WS+G I+  ++ G
Sbjct: 143 MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202
Query: 260 GVLFPGTDHIDQWNKII-GKMR 280
            + F G +  +   +++ GK R
Sbjct: 203 SLPFDGQNLKELRERVLRGKYR 224

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 81  AYDTATQQNVAIKKL---SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE 137
           AYD    Q+VA+K +    R  +      R     +     N  N+I +L  FT      
Sbjct: 116 AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT------ 169
Query: 138 EFQD-VYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
            F++ + +  EL+  NL ++I+ +         +    + +L  +  LH   IIH DLKP
Sbjct: 170 -FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKP 228
Query: 193 SNIVVKSD--CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 250
            NI++K      +K++DFG   +      +   + +R+YRAPEVILG  Y   +D+WS+G
Sbjct: 229 ENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLG 286
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI+ E++ G  L PG D  DQ   +I
Sbjct: 287 CILAELLTGYPLLPGEDEGDQLACMI 312

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 115/244 (47%), Gaps = 27/244 (11%)
Query: 54  ELIYQELPISH--QMGKKRHNTSH------LGAGAAYDTATQQNV---------AIKKLS 96
           E + +E+ I+H  + G ++ + SH      LG G+       + V         A+K L 
Sbjct: 6   EGVLKEISITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLK 65
Query: 97  RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQ 155
           +    V    R   E  ++  VNH  ++ L  AF  +  L      YL+++ +   +L  
Sbjct: 66  KATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKL------YLILDFLRGGDLFT 119
Query: 156 VIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
            +  +     E + + L ++  G+ HLHS GII+RDLKP NI++  +  +K+ DFGL++ 
Sbjct: 120 RLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 179
Query: 214 A-GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW 272
           A         +  T  Y APEV+   G+  + D WS G +M EM+ G + F G D  +  
Sbjct: 180 AIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETM 239
Query: 273 NKII 276
             I+
Sbjct: 240 TLIL 243

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 81  AYDTATQQNVAIKKL---SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE 137
           AYD    Q+VA+K +    R  +      R     +     N  N+I +L  FT      
Sbjct: 116 AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT------ 169
Query: 138 EFQD-VYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
            F++ + +  EL+  NL ++I+ +         +    + +L  +  LH   IIH DLKP
Sbjct: 170 -FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKP 228
Query: 193 SNIVVKSD--CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 250
            NI++K      +K++DFG   +      +   + +R+YRAPEVILG  Y   +D+WS+G
Sbjct: 229 ENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLG 286
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI+ E++ G  L PG D  DQ   +I
Sbjct: 287 CILAELLTGYPLLPGEDEGDQLACMI 312

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 81  AYDTATQQNVAIKKL---SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE 137
           AYD    Q+VA+K +    R  +      R     +     N  N+I +L  FT      
Sbjct: 116 AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT------ 169
Query: 138 EFQD-VYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
            F++ + +  EL+  NL ++I+ +         +    + +L  +  LH   IIH DLKP
Sbjct: 170 -FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKP 228
Query: 193 SNIVVKSD--CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 250
            NI++K      +K++DFG +            + +R+YRAPEVILG  Y   +D+WS+G
Sbjct: 229 ENILLKQQGRSGIKVIDFGSSCYEHQRVYXX--IQSRFYRAPEVILGARYGMPIDMWSLG 286
Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKII 276
           CI+ E++ G  L PG D  DQ   +I
Sbjct: 287 CILAELLTGYPLLPGEDEGDQLACMI 312

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 108/214 (50%), Gaps = 33/214 (15%)
Query: 81  AYDTATQQNVAIK--KLSRPFQNVTHAKRAYREFKLMKLVNHKN------IIGLLNAFTP 132
           AYD   Q+ VAIK  K  + F N     +A  E +L++L+N  +      I+ L   F  
Sbjct: 73  AYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127
Query: 133 QKSLEEFQDVYLVMELMDANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSA--G 184
           +  L       LV E++  NL  +++      + L+  R      QM   +  L +    
Sbjct: 128 RNHL------CLVFEMLSYNLYDLLRNTNFRGVSLNLTRK--FAQQMCTALLFLATPELS 179
Query: 185 IIHRDLKPSNIVV--KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IIH DLKP NI++       +KI+DFG +   G        + +R+YR+PEV+LGM Y  
Sbjct: 180 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX--IQSRFYRSPEVLLGMPYDL 237
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            +D+WS+GCI+ EM  G  LF G + +DQ NKI+
Sbjct: 238 AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 108/214 (50%), Gaps = 33/214 (15%)
Query: 81  AYDTATQQNVAIK--KLSRPFQNVTHAKRAYREFKLMKLVNHKN------IIGLLNAFTP 132
           AYD   Q+ VAIK  K  + F N     +A  E +L++L+N  +      I+ L   F  
Sbjct: 54  AYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 108
Query: 133 QKSLEEFQDVYLVMELMDANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSA--G 184
           +  L       LV E++  NL  +++      + L+  R      QM   +  L +    
Sbjct: 109 RNHL------CLVFEMLSYNLYDLLRNTNFRGVSLNLTRK--FAQQMCTALLFLATPELS 160
Query: 185 IIHRDLKPSNIVV--KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IIH DLKP NI++       +KI+DFG +   G        + +R+YR+PEV+LGM Y  
Sbjct: 161 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX--IQSRFYRSPEVLLGMPYDL 218
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            +D+WS+GCI+ EM  G  LF G + +DQ NKI+
Sbjct: 219 AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 252

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 108/214 (50%), Gaps = 33/214 (15%)
Query: 81  AYDTATQQNVAIK--KLSRPFQNVTHAKRAYREFKLMKLVNHKN------IIGLLNAFTP 132
           AYD   Q+ VAIK  K  + F N     +A  E +L++L+N  +      I+ L   F  
Sbjct: 73  AYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127
Query: 133 QKSLEEFQDVYLVMELMDANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSA--G 184
           +  L       LV E++  NL  +++      + L+  R      QM   +  L +    
Sbjct: 128 RNHL------CLVFEMLSYNLYDLLRNTNFRGVSLNLTRK--FAQQMCTALLFLATPELS 179
Query: 185 IIHRDLKPSNIVV--KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IIH DLKP NI++       +KI+DFG +   G        + +R+YR+PEV+LGM Y  
Sbjct: 180 IIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQX--IQSRFYRSPEVLLGMPYDL 237
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            +D+WS+GCI+ EM  G  LF G + +DQ NKI+
Sbjct: 238 AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 96/191 (50%), Gaps = 21/191 (10%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDVYL 144
           + Q  A+K +S+  +  T      +E   +KL   H NI+ L   F  Q         +L
Sbjct: 35  SNQAFAVKIISKRMEANTQ-----KEITALKLCEGHPNIVKLHEVFHDQ------LHTFL 83
Query: 145 VMELMDAN-LCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---K 198
           VMEL++   L + I+          SY++ +++  + H+H  G++HRDLKP N++     
Sbjct: 84  VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN 143
Query: 199 SDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
            +  +KI+DFG AR        + TP   T +Y APE++   GY E+ D+WS+G I+  M
Sbjct: 144 DNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLNQNGYDESCDLWSLGVILYTM 202
Query: 257 IRGGVLFPGTD 267
           + G V F   D
Sbjct: 203 LSGQVPFQSHD 213

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/160 (36%), Positives = 89/160 (55%), Gaps = 18/160 (11%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-MSYLL 170
           L++   H NII L + +      ++ + VYLV ELM     L ++++     ER  S++L
Sbjct: 74  LLRYGQHPNIITLKDVY------DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL 127
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVV-----KSDCTLKILDFGLART--AGTTFMMTPY 223
           + +   +++LHS G++HRDLKPSNI+        +C L+I DFG A+   A    +MTP 
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTP- 185
Query: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
             T  + APEV+   GY E  DIWS+G ++  M+ G   F
Sbjct: 186 CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/160 (36%), Positives = 89/160 (55%), Gaps = 18/160 (11%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-MSYLL 170
           L++   H NII L + +      ++ + VYLV ELM     L ++++     ER  S++L
Sbjct: 74  LLRYGQHPNIITLKDVY------DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL 127
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVV-----KSDCTLKILDFGLART--AGTTFMMTPY 223
           + +   +++LHS G++HRDLKPSNI+        +C L+I DFG A+   A    +MTP 
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTP- 185
Query: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
             T  + APEV+   GY E  DIWS+G ++  M+ G   F
Sbjct: 186 CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T + VA+K + +   N +  ++ +RE ++ K++NH NI+ L      +K+L      YLV
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTL------YLV 91
Query: 146 MELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
            E   A+  +V    + H R           Q++  +++ H   I+HRDLK  N+++ +D
Sbjct: 92  XEY--ASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDAD 149
Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRG 259
             +KI DFG +        +  +     Y APE+  G  Y    VD+WS+G I+  ++ G
Sbjct: 150 XNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209
Query: 260 GVLFPGTDHIDQWNKII-GKMR 280
            + F G +  +   +++ GK R
Sbjct: 210 SLPFDGQNLKELRERVLRGKYR 231

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 91/185 (49%), Gaps = 16/185 (8%)
Query: 86  TQQNVAIKKLSRPFQNVTHAK-RAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           TQQ VA+K +SR     +    R  RE   +KL+ H +II L +  T         D+ +
Sbjct: 33  TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP------TDIVM 86
Query: 145 VMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           V+E     L   I   ++ +RM+         Q++C I++ H   I+HRDLKP N+++  
Sbjct: 87  VIEYAGGELFDYI---VEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDD 143
Query: 200 DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIR 258
           +  +KI DFGL+        +     +  Y APEVI G  Y    VD+WS G ++  M+ 
Sbjct: 144 NLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV 203
Query: 259 GGVLF 263
           G + F
Sbjct: 204 GRLPF 208

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 85/155 (54%), Gaps = 14/155 (9%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVI-----QMDLDH 163
           +E  L+K +NH N+I    +F       E  ++ +V+EL DA +L ++I     Q  L  
Sbjct: 81  KEIDLLKQLNHPNVIKYYASFI------EDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134
Query: 164 ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMT 221
           ER  +  +  LC  ++H+HS  ++HRD+KP+N+ + +   +K+ D GL R  +  T    
Sbjct: 135 ERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 194
Query: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
             V T YY +PE I   GY    DIWS+GC++ EM
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 10/195 (5%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
            +Q  A+K L +    V    R   E  ++  VNH  I+ L  AF  +  L      YL+
Sbjct: 51  ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL------YLI 104
Query: 146 MELM-DANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
           ++ +   +L   +  +     E + + L ++   + HLHS GII+RDLKP NI++  +  
Sbjct: 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH 164
Query: 203 LKILDFGLARTA-GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGV 261
           +K+ DFGL++ +         +  T  Y APEV+   G+ ++ D WS G +M EM+ G +
Sbjct: 165 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
Query: 262 LFPGTDHIDQWNKII 276
            F G D  +    I+
Sbjct: 225 PFQGKDRKETMTMIL 239

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 71  HNTSHLGAGAAYDTATQQNVAIKKLSR--PFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
            NT   G+      A Q+   I++ ++  P   V    R  +E ++MK ++H NII L  
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 129 AFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGI 185
            F      E+  D+YLVMEL        +V+   +  E   + ++  +L  + + H   +
Sbjct: 74  TF------EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 186 IHRDLKPSNIVV---KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
            HRDLKP N +      D  LK++DFGLA       MM   V T YY +P+V+ G+ Y  
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGP 186
Query: 243 NVDIWSVGCIMGEMIRG 259
             D WS G +M  ++ G
Sbjct: 187 ECDEWSAGVMMYVLLCG 203

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 10/195 (5%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
            +Q  A+K L +    V    R   E  ++  VNH  I+ L  AF  +  L      YL+
Sbjct: 52  ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL------YLI 105
Query: 146 MELM-DANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
           ++ +   +L   +  +     E + + L ++   + HLHS GII+RDLKP NI++  +  
Sbjct: 106 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH 165
Query: 203 LKILDFGLARTA-GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGV 261
           +K+ DFGL++ +         +  T  Y APEV+   G+ ++ D WS G +M EM+ G +
Sbjct: 166 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 225
Query: 262 LFPGTDHIDQWNKII 276
            F G D  +    I+
Sbjct: 226 PFQGKDRKETMTMIL 240

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 95/189 (50%), Gaps = 19/189 (10%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A D  TQ+ VAIK +++             E  ++  + H NI+ L + 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHPNIVALDDI 84
Query: 130 FTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGII 186
           +      E    +YL+M+L+       ++++     ER  S L++Q+L  +K+LH  GI+
Sbjct: 85  Y------ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 187 HRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKEN 243
           HRDLKP N++  S   D  + I DFGL++      +++    T  Y APEV+    Y + 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 198
Query: 244 VDIWSVGCI 252
           VD WS+G I
Sbjct: 199 VDCWSIGVI 207

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 10/195 (5%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
            +Q  A+K L +    V    R   E  ++  VNH  I+ L  AF  +  L      YL+
Sbjct: 51  ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL------YLI 104
Query: 146 MELM-DANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
           ++ +   +L   +  +     E + + L ++   + HLHS GII+RDLKP NI++  +  
Sbjct: 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH 164
Query: 203 LKILDFGLARTA-GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGV 261
           +K+ DFGL++ +         +  T  Y APEV+   G+ ++ D WS G +M EM+ G +
Sbjct: 165 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
Query: 262 LFPGTDHIDQWNKII 276
            F G D  +    I+
Sbjct: 225 PFQGKDRKETMTMIL 239

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 71  HNTSHLGAGAAYDTATQQNVAIKKLSR--PFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
            NT   G+      A Q+   I++ ++  P   V    R  +E ++MK ++H NII L  
Sbjct: 31  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 90
Query: 129 AFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGI 185
            F      E+  D+YLVMEL        +V+   +  E   + ++  +L  + + H   +
Sbjct: 91  TF------EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 144
Query: 186 IHRDLKPSNIVV---KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
            HRDLKP N +      D  LK++DFGLA       MM   V T YY +P+V+ G+ Y  
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGP 203
Query: 243 NVDIWSVGCIMGEMIRG 259
             D WS G +M  ++ G
Sbjct: 204 ECDEWSAGVMMYVLLCG 220

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 95/189 (50%), Gaps = 19/189 (10%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A D  TQ+ VAIK +++             E  ++  + H NI+ L + 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME-NEIAVLHKIKHPNIVALDDI 84
Query: 130 FTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGII 186
           +      E    +YL+M+L+       ++++     ER  S L++Q+L  +K+LH  GI+
Sbjct: 85  Y------ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 187 HRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKEN 243
           HRDLKP N++  S   D  + I DFGL++      +++    T  Y APEV+    Y + 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 198
Query: 244 VDIWSVGCI 252
           VD WS+G I
Sbjct: 199 VDCWSIGVI 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 95/189 (50%), Gaps = 19/189 (10%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A D  TQ+ VAIK +++             E  ++  + H NI+ L + 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME-NEIAVLHKIKHPNIVALDDI 84
Query: 130 FTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGII 186
           +      E    +YL+M+L+       ++++     ER  S L++Q+L  +K+LH  GI+
Sbjct: 85  Y------ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 187 HRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKEN 243
           HRDLKP N++  S   D  + I DFGL++      +++    T  Y APEV+    Y + 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 198
Query: 244 VDIWSVGCI 252
           VD WS+G I
Sbjct: 199 VDCWSIGVI 207

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 95/189 (50%), Gaps = 19/189 (10%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A D  TQ+ VAIK +++             E  ++  + H NI+ L + 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME-NEIAVLHKIKHPNIVALDDI 84
Query: 130 FTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGII 186
           +      E    +YL+M+L+       ++++     ER  S L++Q+L  +K+LH  GI+
Sbjct: 85  Y------ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 187 HRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKEN 243
           HRDLKP N++  S   D  + I DFGL++      +++    T  Y APEV+    Y + 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 198
Query: 244 VDIWSVGCI 252
           VD WS+G I
Sbjct: 199 VDCWSIGVI 207

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 95/188 (50%), Gaps = 6/188 (3%)
Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           A  D + Q  +AIK++  P ++  +++  + E  L K + HKNI+  L +F+    ++ F
Sbjct: 40  AGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97
Query: 140 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
            +      L      +   +  + + + +   Q+L G+K+LH   I+HRD+K  N+++ +
Sbjct: 98  MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 157
Query: 200 -DCTLKILDFGLA-RTAGTTFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGE 255
               LKI DFG + R AG       +  T  Y APE+I     GY +  DIWS+GC + E
Sbjct: 158 YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217
Query: 256 MIRGGVLF 263
           M  G   F
Sbjct: 218 MATGKPPF 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 95/188 (50%), Gaps = 6/188 (3%)
Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           A  D + Q  +AIK++  P ++  +++  + E  L K + HKNI+  L +F+    ++ F
Sbjct: 26  AGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 83
Query: 140 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
            +      L      +   +  + + + +   Q+L G+K+LH   I+HRD+K  N+++ +
Sbjct: 84  MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 143
Query: 200 -DCTLKILDFGLA-RTAGTTFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGE 255
               LKI DFG + R AG       +  T  Y APE+I     GY +  DIWS+GC + E
Sbjct: 144 YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 203
Query: 256 MIRGGVLF 263
           M  G   F
Sbjct: 204 MATGKPPF 211

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 106/221 (47%), Gaps = 20/221 (9%)
Query: 55  LIYQELPISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRA 108
           L +Q L   +Q  KK      LG+GA        D  T    AIK + +     T    A
Sbjct: 14  LYFQGLSDRYQRVKK------LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA 67
Query: 109 Y-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS 167
              E  ++K ++H NI+ L   F  +++     +VY   EL D  + +    ++D    +
Sbjct: 68  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVD---AA 124
Query: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYV 224
            ++ Q+L G  +LH   I+HRDLKP N++++S   D  +KI+DFGL+        M   +
Sbjct: 125 VIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL 184
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
            T YY APEV L   Y E  D+WS G I+  ++ G   F G
Sbjct: 185 GTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPFGG 224

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           KK      +G GA      A D AT Q VAI++++   Q     +    E  +M+   + 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVME-LMDANLCQVI-QMDLDHERMSYLLYQMLCGIKH 179
           NI+  L+++     L      ++VME L   +L  V+ +  +D  +++ +  + L  ++ 
Sbjct: 78  NIVNYLDSYLVGDEL------WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEF 131
Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVVTRYYRAPEVILGM 238
           LHS  +IHRD+K  NI++  D ++K+ DFG  A+        +  V T Y+ APEV+   
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRK 191
Query: 239 GYKENVDIWSVGCIMGEMIRG 259
            Y   VDIWS+G +  EMI G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           KK      +G GA      A D AT Q VAI++++   Q     +    E  +M+   + 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVME-LMDANLCQVI-QMDLDHERMSYLLYQMLCGIKH 179
           NI+  L+++     L      ++VME L   +L  V+ +  +D  +++ +  + L  ++ 
Sbjct: 78  NIVNYLDSYLVGDEL------WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEF 131
Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVVTRYYRAPEVILGM 238
           LHS  +IHRD+K  NI++  D ++K+ DFG  A+        +  V T Y+ APEV+   
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 239 GYKENVDIWSVGCIMGEMIRG 259
            Y   VDIWS+G +  EMI G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           KK      +G GA      A D AT Q VAI++++   Q     +    E  +M+   + 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVME-LMDANLCQVI-QMDLDHERMSYLLYQMLCGIKH 179
           NI+  L+++     L      ++VME L   +L  V+ +  +D  +++ +  + L  ++ 
Sbjct: 78  NIVNYLDSYLVGDEL------WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEF 131
Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVVTRYYRAPEVILGM 238
           LHS  +IHRD+K  NI++  D ++K+ DFG  A+        +  V T Y+ APEV+   
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRK 191
Query: 239 GYKENVDIWSVGCIMGEMIRG 259
            Y   VDIWS+G +  EMI G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 68  KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK 121
           KK      +G GA      A D AT Q VAI++++   Q     +    E  +M+   + 
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 78
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVME-LMDANLCQVI-QMDLDHERMSYLLYQMLCGIKH 179
           NI+  L+++     L      ++VME L   +L  V+ +  +D  +++ +  + L  ++ 
Sbjct: 79  NIVNYLDSYLVGDEL------WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEF 132
Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVVTRYYRAPEVILGM 238
           LHS  +IHRD+K  NI++  D ++K+ DFG  A+        +  V T Y+ APEV+   
Sbjct: 133 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRK 192
Query: 239 GYKENVDIWSVGCIMGEMIRG 259
            Y   VDIWS+G +  EMI G
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEG 213

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY-REFKLMKLV 118
           +  +      LG+GA        D  T    AIK + +     T    A   E  ++K +
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIK 178
           +H NI+ L   F  +++     +VY   EL D  + +    ++D    + ++ Q+L G  
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVD---AAVIMKQVLSGTT 118
Query: 179 HLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI 235
           +LH   I+HRDLKP N++++S   D  +KI+DFGL+        M   + T YY APEV 
Sbjct: 119 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEV- 177
Query: 236 LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
           L   Y E  D+WS G I+  ++ G   F G
Sbjct: 178 LRKKYDEKCDVWSCGVILYILLCGYPPFGG 207

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 47/217 (21%)
Query: 115 MKLVNHKNIIGLLNAFTPQKSLEEFQD---VYLVMELMDANLCQVIQMD------LDHER 165
           ++++ H N     + F   + LE F+    + +V EL+  +    I+ +      LDH R
Sbjct: 62  IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV-VKSDCT------------------LKIL 206
              + YQ+   +  LHS  + H DLKP NI+ V+SD T                  +K++
Sbjct: 122 K--MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT 266
           DFG A         +  V TR+YRAPEVIL +G+ +  D+WS+GCI+ E   G  +FP  
Sbjct: 180 DFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237
Query: 267 D---HIDQWNKIIG--------KMREA----HDKLDY 288
           D   H+    +I+G        K R+     HD+LD+
Sbjct: 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDW 274

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 96/182 (52%), Gaps = 11/182 (6%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A +  T + VA+KK+    +     +  + E  +M+  +H N++ + +++     L    
Sbjct: 64  ATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDEL---- 117
Query: 141 DVYLVMELMDANLCQ--VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
             ++VME ++       V    ++ E+++ +   +L  + +LH+ G+IHRD+K  +I++ 
Sbjct: 118 --WVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 175
Query: 199 SDCTLKILDFGL-ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
           SD  +K+ DFG  A+ +         V T Y+ APEVI  + Y   VDIWS+G ++ EMI
Sbjct: 176 SDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 235
Query: 258 RG 259
            G
Sbjct: 236 DG 237

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 20/218 (9%)
Query: 54  ELIYQELPISHQMG---KKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTH 104
           E I ++L I   +G   KK      +G GA      A D AT Q VAI++++   Q    
Sbjct: 4   EEILEKLRIIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPK 61
Query: 105 AKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME-LMDANLCQVI-QMDLD 162
            +    E  +M+   + NI+  L+++     L      ++VME L   +L  V+ +  +D
Sbjct: 62  KELIINEILVMRENKNPNIVNYLDSYLVGDEL------WVVMEYLAGGSLTDVVTETCMD 115
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMT 221
             +++ +  + L  ++ LHS  +IHR++K  NI++  D ++K+ DFG  A+        +
Sbjct: 116 EGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 175
Query: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
             V T Y+ APEV+    Y   VDIWS+G +  EMI G
Sbjct: 176 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 86  TQQNVAIKKLSR-PFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEFQDVY 143
           T   VA+K L+R   +++    +  RE + +KL  H +II L     TP        D++
Sbjct: 40  TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS-------DIF 92
Query: 144 LVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +VME +        +C+  ++D    R   L  Q+L G+ + H   ++HRDLKP N+++ 
Sbjct: 93  MVMEYVSGGELFDYICKNGRLDEKESRR--LFQQILSGVDYCHRHMVVHRDLKPENVLLD 150
Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMI 257
           +    KI DFGL+        +     +  Y APEVI G  Y    VDIWS G I+  ++
Sbjct: 151 AHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALL 210
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G + F   DH+    K I
Sbjct: 211 CGTLPF-DDDHVPTLFKKI 228

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 87/159 (54%), Gaps = 16/159 (10%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-MSYLL 170
           L++   H NII L + +      ++ + VY+V ELM     L ++++     ER  S +L
Sbjct: 69  LLRYGQHPNIITLKDVY------DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL 122
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILDFGLART--AGTTFMMTPYV 224
           + +   +++LH+ G++HRDLKPSNI+   +     +++I DFG A+   A    +MTP  
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-C 181
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
            T  + APEV+   GY    DIWS+G ++  M+ G   F
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 89/165 (53%), Gaps = 7/165 (4%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
           L  L+   NI+ LL+    Q S    +   L+ E ++    +V+   L    + Y +Y++
Sbjct: 79  LQNLMGGPNIVKLLDIVRDQHS----KTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYEL 134
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 135 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 194
Query: 233 EVILGM-GYKENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKI 275
           E+++ +  Y  ++D+WS+GC+   MI R    F G D+ DQ  KI
Sbjct: 195 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 239

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 94/177 (53%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +K+ DFGLA R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 88/165 (53%), Gaps = 7/165 (4%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
           L  L    NI+ LL+    Q S    +   L+ E ++    +V+   L    + Y +Y++
Sbjct: 81  LQNLCGGPNIVKLLDIVRDQHS----KTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYEL 136
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 137 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 196
Query: 233 EVILGM-GYKENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKI 275
           E+++ +  Y  ++D+WS+GC+   MI R    F G D+ DQ  KI
Sbjct: 197 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 241

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 88/165 (53%), Gaps = 7/165 (4%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
           L  L    NI+ LL+    Q S    +   L+ E ++    +V+   L    + Y +Y++
Sbjct: 79  LQNLCGGPNIVKLLDIVRDQHS----KTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYEL 134
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 135 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 194
Query: 233 EVILGM-GYKENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKI 275
           E+++ +  Y  ++D+WS+GC+   MI R    F G D+ DQ  KI
Sbjct: 195 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 239

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 88/165 (53%), Gaps = 7/165 (4%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
           L  L    NI+ LL+    Q S    +   L+ E ++    +V+   L    + Y +Y++
Sbjct: 80  LQNLCGGPNIVKLLDIVRDQHS----KTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYEL 135
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 195
Query: 233 EVILGM-GYKENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKI 275
           E+++ +  Y  ++D+WS+GC+   MI R    F G D+ DQ  KI
Sbjct: 196 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 88/165 (53%), Gaps = 7/165 (4%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
           L  L    NI+ LL+    Q S    +   L+ E ++    +V+   L    + Y +Y++
Sbjct: 79  LQNLXGGPNIVKLLDIVRDQHS----KTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYEL 134
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 135 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 194
Query: 233 EVILGM-GYKENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKI 275
           E+++ +  Y  ++D+WS+GC+   MI R    F G D+ DQ  KI
Sbjct: 195 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 239

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 88/165 (53%), Gaps = 7/165 (4%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
           L  L    NI+ LL+    Q S    +   L+ E ++    +V+   L    + Y +Y++
Sbjct: 79  LQNLCGGPNIVKLLDIVRDQHS----KTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYEL 134
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 135 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 194
Query: 233 EVILGM-GYKENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKI 275
           E+++ +  Y  ++D+WS+GC+   MI R    F G D+ DQ  KI
Sbjct: 195 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 239

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 88/165 (53%), Gaps = 7/165 (4%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
           L  L    NI+ LL+    Q S    +   L+ E ++    +V+   L    + Y +Y++
Sbjct: 79  LQNLXGGPNIVKLLDIVRDQHS----KTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYEL 134
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 135 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 194
Query: 233 EVILGM-GYKENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKI 275
           E+++ +  Y  ++D+WS+GC+   MI R    F G D+ DQ  KI
Sbjct: 195 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 239

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 88/165 (53%), Gaps = 7/165 (4%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
           L  L    NI+ LL+    Q S    +   L+ E ++    +V+   L    + Y +Y++
Sbjct: 79  LQNLXGGPNIVKLLDIVRDQHS----KTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYEL 134
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 135 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 194
Query: 233 EVILGM-GYKENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKI 275
           E+++ +  Y  ++D+WS+GC+   MI R    F G D+ DQ  KI
Sbjct: 195 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 239

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 88/165 (53%), Gaps = 7/165 (4%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
           L  L    NI+ LL+    Q S    +   L+ E ++    +V+   L    + Y +Y++
Sbjct: 80  LQNLXGGPNIVKLLDIVRDQHS----KTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYEL 135
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 195
Query: 233 EVILGM-GYKENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKI 275
           E+++ +  Y  ++D+WS+GC+   MI R    F G D+ DQ  KI
Sbjct: 196 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 88/165 (53%), Gaps = 7/165 (4%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
           L  L    NI+ LL+    Q S    +   L+ E ++    +V+   L    + Y +Y++
Sbjct: 100 LQNLXGGPNIVKLLDIVRDQHS----KTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYEL 155
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 156 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 215
Query: 233 EVILGM-GYKENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKI 275
           E+++ +  Y  ++D+WS+GC+   MI R    F G D+ DQ  KI
Sbjct: 216 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 260

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-----ANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME M      ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYMPGGDMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +K+ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 115 MKLVNHKNIIGLLNAFTPQKSLEEFQD---VYLVMELMDANLCQVIQMD------LDHER 165
           ++++ H N     + F   + LE F+    + +V EL+  +    I+ +      LDH R
Sbjct: 62  IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV-VKSDCT------------------LKIL 206
              + YQ+   +  LHS  + H DLKP NI+ V+SD T                  +K++
Sbjct: 122 K--MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT 266
           DFG A         +  V  R+YRAPEVIL +G+ +  D+WS+GCI+ E   G  +FP  
Sbjct: 180 DFGSATYDDE--HHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237
Query: 267 D---HIDQWNKIIG--------KMREA----HDKLDY 288
           D   H+    +I+G        K R+     HD+LD+
Sbjct: 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDW 274

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-----ANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME M      ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYMPGGDMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +K+ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 94/192 (48%), Gaps = 24/192 (12%)
Query: 74  SHLGAGAAY------DTATQQNVAIKKLSRPFQNVTHAKRAYR-EFKLMKLVNHKNIIGL 126
           S LG GA           TQ+  A+K L +     T  K+  R E  ++  ++H NII L
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 127 LNAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSA 183
              F      E   ++ LV+EL+       ++++     ER  +  + Q+L  + +LH  
Sbjct: 114 KEIF------ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 184 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           GI+HRDLKP N++  +   D  LKI DFGL++      +M     T  Y APE++ G  Y
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY 227
Query: 241 KENVDIWSVGCI 252
              VD+WSVG I
Sbjct: 228 GPEVDMWSVGII 239

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +K+ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFSEPHAR 145
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +K+ DFG A R  G T+ +    
Sbjct: 146 --FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG-- 201
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 202 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 120/257 (46%), Gaps = 27/257 (10%)
Query: 29  EVHAPAPGPYDHS-VDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQ 87
           ++ AP P P+DH  V  ++  V+ +  +   E+     +G  R    H       +TAT 
Sbjct: 65  DIPAP-PAPFDHRIVTAKQGAVNSFYTVSKTEI-----LGGGRFGQVH----KCEETATG 114
Query: 88  QNVAIKKL-SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
             +A K + +R  ++    K    E  +M  ++H N+I L +AF      E   D+ LVM
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKN---EISVMNQLDHANLIQLYDAF------ESKNDIVLVM 165
Query: 147 ELMDAN--LCQVIQMDLDHERMSYLLY--QMLCGIKHLHSAGIIHRDLKPSNIV-VKSDC 201
           E +D      ++I    +   +  +L+  Q+  GI+H+H   I+H DLKP NI+ V  D 
Sbjct: 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDA 225
Query: 202 T-LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
             +KI+DFGLAR       +     T  + APEV+         D+WSVG I   ++ G 
Sbjct: 226 KQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285
Query: 261 VLFPGTDHIDQWNKIIG 277
             F G +  +  N I+ 
Sbjct: 286 SPFLGDNDAETLNNILA 302

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +K+ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 84/153 (54%), Gaps = 12/153 (7%)
Query: 135 SLEEFQDVYLVMEL-----MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
           S ++  ++Y+VME      M ++L ++ +    H R  +   Q++   ++LHS  +I+RD
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR--FYAAQIVLTFEYLHSLDLIYRD 167
Query: 190 LKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 248
           LKP N+++     +K+ DFG A R  G T+ +     T  Y APE+IL  GY + VD W+
Sbjct: 168 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIILSKGYNKAVDWWA 224
Query: 249 VGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
           +G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 94/177 (53%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFGLA R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 84/153 (54%), Gaps = 12/153 (7%)
Query: 135 SLEEFQDVYLVMEL-----MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
           S ++  ++Y+VME      M ++L ++ +    H R  +   Q++   ++LHS  +I+RD
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR--FYAAQIVLTFEYLHSLDLIYRD 167
Query: 190 LKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 248
           LKP N+++     +K+ DFG A R  G T+ +     T  Y APE+IL  GY + VD W+
Sbjct: 168 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIILSKGYNKAVDWWA 224
Query: 249 VGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
           +G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 94/177 (53%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F   + I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVR 256

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFXEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +K+ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 93/186 (50%), Gaps = 23/186 (12%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVI------QMDLDH 163
           E  L++ + H NI+   +    + +      +Y+VME  +  +L  VI      +  LD 
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTN----TTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 164 ERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 216
           E +  ++ Q+   +K  H        ++HRDLKP+N+ +     +K+ DFGLAR     T
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           +F  T +V T YY +PE +  M Y E  DIWS+GC++ E+     L P      Q  ++ 
Sbjct: 171 SFAKT-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC---ALMPPFTAFSQ-KELA 225
Query: 277 GKMREA 282
           GK+RE 
Sbjct: 226 GKIREG 231

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L      + S ++  ++Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKL------EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L      + S ++  ++Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKL------EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 84/153 (54%), Gaps = 12/153 (7%)
Query: 135 SLEEFQDVYLVMEL-----MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
           S ++  ++Y+VME      M ++L ++ +    H R  +   Q++   ++LHS  +I+RD
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHAR--FYAAQIVLTFEYLHSLDLIYRD 167
Query: 190 LKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 248
           LKP N+++     +K+ DFG A R  G T+ +     T  Y APE+IL  GY + VD W+
Sbjct: 168 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIILSKGYNKAVDWWA 224
Query: 249 VGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
           +G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L      + S ++  ++Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKL------EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L      + S ++  ++Y+VME      M ++L ++ +    H R
Sbjct: 112 EKRILQAVNFPFLVKL------EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 165
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 166 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCG-- 221
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 222 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 277

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHAR 137
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 138 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 193
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 194 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 249

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 146 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 201
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 202 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 146 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 201
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 202 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 146 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 201
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 202 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 146 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 201
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 202 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 77  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHAR 130
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 131 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-- 186
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 187 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 242

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 140 QDVYLVMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           ++++ VME ++  +L   IQ     D  R ++   +++ G++ LHS GI++RDLK  NI+
Sbjct: 92  ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 151
Query: 197 VKSDCTLKILDFGLARTAGTTFMMT-PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
           +  D  +KI DFG+ +        T  +  T  Y APE++LG  Y  +VD WS G ++ E
Sbjct: 152 LDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 211
Query: 256 MIRGGVLFPGTDHIDQWNKI 275
           M+ G   F G D  + ++ I
Sbjct: 212 MLIGQSPFHGQDEEELFHSI 231

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 94/191 (49%), Gaps = 23/191 (12%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR--------EFKLMKLVNHKNIIGLL 127
           LG GA  +    +  A  KL   F      K+A +        E  +++ + H+NI+ L 
Sbjct: 30  LGTGAFSEVVLAEEKATGKL---FAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALE 86
Query: 128 NAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAG 184
           + +      E    +YLVM+L+       ++++     E+  S L+ Q+L  + +LH  G
Sbjct: 87  DIY------ESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMG 140
Query: 185 IIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           I+HRDLKP N++  S   +  + I DFGL++  G   +M+    T  Y APEV+    Y 
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYS 200
Query: 242 ENVDIWSVGCI 252
           + VD WS+G I
Sbjct: 201 KAVDCWSIGVI 211

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 146 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-- 201
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 202 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 145
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 146 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 201
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 202 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 78  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 131
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 132 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCG-- 187
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 188 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 243

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 84/153 (54%), Gaps = 12/153 (7%)
Query: 135 SLEEFQDVYLVMEL-----MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
           S ++  ++Y+V+E      M ++L ++ +    H R  +   Q++   ++LHS  +I+RD
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHAR--FYAAQIVLTFEYLHSLDLIYRD 167
Query: 190 LKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 248
           LKP N+++     +K+ DFG A R  G T+ +     T  Y APE+IL  GY + VD W+
Sbjct: 168 LKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIILSKGYNKAVDWWA 224
Query: 249 VGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
           +G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L      + S ++  ++Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKL------EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 140 QDVYLVMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           ++++ VME ++  +L   IQ     D  R ++   +++ G++ LHS GI++RDLK  NI+
Sbjct: 91  ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 150
Query: 197 VKSDCTLKILDFGLARTAGTTFMMT-PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
           +  D  +KI DFG+ +        T  +  T  Y APE++LG  Y  +VD WS G ++ E
Sbjct: 151 LDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210
Query: 256 MIRGGVLFPGTDHIDQWNKI 275
           M+ G   F G D  + ++ I
Sbjct: 211 MLIGQSPFHGQDEEELFHSI 230

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L      + S ++  ++Y+VME      M ++L ++ +    H R
Sbjct: 112 EKRILQAVNFPFLVKL------EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 165
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 166 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 221
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 222 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 277

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+I+  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFXEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L      + S ++  ++Y+VME      M ++L ++ +    H R
Sbjct: 84  EKRILQAVNFPFLVKL------EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHAR 137
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 138 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 193
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 194 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 249

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFXEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFXEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 86  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFXEPHAR 139
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 140 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 195
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 196 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 251

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFXEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFXEPHAR 145
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 146 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 201
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 202 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFAEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 90/185 (48%), Gaps = 21/185 (11%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVI------QMDLDH 163
           E  L++ + H NI+   +    + +      +Y+VME  +  +L  VI      +  LD 
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTN----TTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 164 ERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TT 217
           E +  ++ Q+   +K  H        ++HRDLKP+N+ +     +K+ DFGLAR     T
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
                +V T YY +PE +  M Y E  DIWS+GC++ E+     L P      Q  ++ G
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC---ALMPPFTAFSQ-KELAG 226
Query: 278 KMREA 282
           K+RE 
Sbjct: 227 KIREG 231

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFXEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L      + S ++  ++Y+VME      M ++L ++ +    H R
Sbjct: 112 EKRILQAVNFPFLVKL------EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR 165
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 166 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 221
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 222 -TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 277

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 16/184 (8%)
Query: 100 QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM 159
           +N         E  +++ V H  I+ L+ AF     L      YL++E +       + M
Sbjct: 60  RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL------YLILEYLSGG---ELFM 110
Query: 160 DLDHERM------SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
            L+ E +       + L ++   + HLH  GII+RDLKP NI++     +K+ DFGL + 
Sbjct: 111 QLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170
Query: 214 AGTTFMMT-PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW 272
           +     +T  +  T  Y APE+++  G+   VD WS+G +M +M+ G   F G +     
Sbjct: 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
Query: 273 NKII 276
           +KI+
Sbjct: 231 DKIL 234

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 16/184 (8%)
Query: 100 QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM 159
           +N         E  +++ V H  I+ L+ AF     L      YL++E +       + M
Sbjct: 60  RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL------YLILEYLSGG---ELFM 110
Query: 160 DLDHERM------SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
            L+ E +       + L ++   + HLH  GII+RDLKP NI++     +K+ DFGL + 
Sbjct: 111 QLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170
Query: 214 AGTTFMMT-PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW 272
           +     +T  +  T  Y APE+++  G+   VD WS+G +M +M+ G   F G +     
Sbjct: 171 SIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
Query: 273 NKII 276
           +KI+
Sbjct: 231 DKIL 234

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 93/177 (52%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y APE+IL  GY + VD W++G ++ +M  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 81  AYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLN---AFTPQKSL 136
           A D    ++VA+K L     ++ +   R  RE +    +NH  I+ + +   A TP   L
Sbjct: 31  ARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90
Query: 137 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
                 Y+VME +D   L  ++  +  +  +R   ++      +   H  GIIHRD+KP+
Sbjct: 91  P-----YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA 145
Query: 194 NIVVKSDCTLKILDFGLART---AGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 249
           NI++ +   +K++DFG+AR    +G +   T  V+ T  Y +PE   G       D++S+
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 250 GCIMGEMIRGGVLFPG 265
           GC++ E++ G   F G
Sbjct: 206 GCVLYEVLTGEPPFTG 221

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 81  AYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLN---AFTPQKSL 136
           A D    ++VA+K L     ++ +   R  RE +    +NH  I+ + +   A TP   L
Sbjct: 31  ARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90
Query: 137 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
                 Y+VME +D   L  ++  +  +  +R   ++      +   H  GIIHRD+KP+
Sbjct: 91  P-----YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA 145
Query: 194 NIVVKSDCTLKILDFGLART---AGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 249
           NI++ +   +K++DFG+AR    +G +   T  V+ T  Y +PE   G       D++S+
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 250 GCIMGEMIRGGVLFPG 265
           GC++ E++ G   F G
Sbjct: 206 GCVLYEVLTGEPPFTG 221

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 81  AYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLN---AFTPQKSL 136
           A D    ++VA+K L     ++ +   R  RE +    +NH  I+ + +   A TP   L
Sbjct: 31  ARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90
Query: 137 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
                 Y+VME +D   L  ++  +  +  +R   ++      +   H  GIIHRD+KP+
Sbjct: 91  P-----YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA 145
Query: 194 NIVVKSDCTLKILDFGLART---AGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 249
           NI++ +   +K++DFG+AR    +G +   T  V+ T  Y +PE   G       D++S+
Sbjct: 146 NILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 250 GCIMGEMIRGGVLFPG 265
           GC++ E++ G   F G
Sbjct: 206 GCVLYEVLTGEPPFTG 221

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 79/136 (58%), Gaps = 5/136 (3%)
Query: 144 LVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDC 201
           LV E ++  +  Q+ Q+  D + + + +Y++L  + + HS GI+HRD+KP N+++     
Sbjct: 112 LVFEYINNTDFKQLYQILTDFD-IRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQK 170
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 171 KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRR 230
Query: 260 GVLFPGTDHIDQWNKI 275
              F G D+ DQ  +I
Sbjct: 231 EPFFHGQDNYDQLVRI 246

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 81  AYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLN---AFTPQKSL 136
           A D    ++VA+K L     ++ +   R  RE +    +NH  I+ + +   A TP   L
Sbjct: 31  ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90
Query: 137 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
                 Y+VME +D   L  ++  +  +  +R   ++      +   H  GIIHRD+KP+
Sbjct: 91  P-----YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA 145
Query: 194 NIVVKSDCTLKILDFGLART---AGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 249
           NI++ +   +K++DFG+AR    +G +   T  V+ T  Y +PE   G       D++S+
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 250 GCIMGEMIRGGVLFPG 265
           GC++ E++ G   F G
Sbjct: 206 GCVLYEVLTGEPPFTG 221

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 94/179 (52%), Gaps = 22/179 (12%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMM--TP 222
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +  TP
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
             +     APE+IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 203 EAL-----APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 79/136 (58%), Gaps = 5/136 (3%)
Query: 144 LVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDC 201
           LV E ++  +  Q+ Q+  D + + + +Y++L  + + HS GI+HRD+KP N+++     
Sbjct: 117 LVFEYINNTDFKQLYQILTDFD-IRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQK 175
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 176 KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRR 235
Query: 260 GVLFPGTDHIDQWNKI 275
              F G D+ DQ  +I
Sbjct: 236 EPFFHGQDNYDQLVRI 251

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-------LCQVIQMDLDH 163
           E +++K ++H NII +   F      E++ ++Y+VME  +           Q     L  
Sbjct: 70  EIEVLKSLDHPNIIKIFEVF------EDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTTFMM 220
             ++ L+ QM+  + + HS  ++H+DLKP NI+ +       +KI+DFGLA    +    
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 221 TPYVVTRYYRAPEVILGMGYKENV----DIWSVGCIMGEMIRGGVLFPGTD 267
           T    T  Y APEV     +K +V    DIWS G +M  ++ G + F GT 
Sbjct: 184 TNAAGTALYMAPEV-----FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 92/177 (51%), Gaps = 18/177 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHER 165
           E ++++ VN   ++ L  +F    +L      Y+VME      M ++L ++ +    H R
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMTPYV 224
             +   Q++   ++LHS  +I+RDLKP N+++     +++ DFG A R  G T+ +    
Sbjct: 145 --FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG-- 200
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
            T  Y AP +IL  GY + VD W++G ++ EM  G   F     I  + KI+ GK+R
Sbjct: 201 -TPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 81  AYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLN---AFTPQKSL 136
           A D    ++VA+K L     ++ +   R  RE +    +NH  I+ + +   A TP   L
Sbjct: 48  ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 107
Query: 137 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
                 Y+VME +D   L  ++  +  +  +R   ++      +   H  GIIHRD+KP+
Sbjct: 108 P-----YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA 162
Query: 194 NIVVKSDCTLKILDFGLART---AGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 249
           NI++ +   +K++DFG+AR    +G +   T  V+ T  Y +PE   G       D++S+
Sbjct: 163 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 222
Query: 250 GCIMGEMIRGGVLFPG 265
           GC++ E++ G   F G
Sbjct: 223 GCVLYEVLTGEPPFTG 238

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 111 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 169
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 170 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 230 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 257

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 110 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 168
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 169 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 229 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 256

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 111 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 169
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 170 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 230 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 257

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 111 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHR 169
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 170 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 230 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 257

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+KK+    +     +  + E  +M+   H+N++ + N++          ++++VME +
Sbjct: 179 VAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL------VGDELWVVMEFL 230
Query: 150 DANLCQ--VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
           +       V    ++ E+++ +   +L  +  LH+ G+IHRD+K  +I++  D  +K+ D
Sbjct: 231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSD 290
Query: 208 FGL-ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           FG  A+ +         V T Y+ APE+I  + Y   VDIWS+G ++ EM+ G
Sbjct: 291 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 111 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 169
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 170 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 230 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 257

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 111 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 169
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 170 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 230 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 257

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 109 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 167
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 168 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 228 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 255

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 110 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 168
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 169 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 229 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 256

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 35/212 (16%)
Query: 77  GAGAAYDTATQQ---NVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ 133
           G G  ++   +    N AIK++  P + +   K   RE K +  + H  I+   NA+  +
Sbjct: 17  GFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK-VMREVKALAKLEHPGIVRYFNAWLEK 75
Query: 134 KSLEEFQ----DVYLVMELMDANLCQVIQMD--------LDHERMSYLLY---QMLCGIK 178
            + E+ Q     VYL +++    LC+   +         ++    S  L+   Q+   ++
Sbjct: 76  NTTEKLQPSSPKVYLYIQM---QLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTTFMMTPY---------VV 225
            LHS G++HRDLKPSNI    D  +K+ DFGL     +      ++TP          V 
Sbjct: 133 FLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVG 192
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
           T+ Y +PE I G  Y   VDI+S+G I+ E++
Sbjct: 193 TKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 111 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 169
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 170 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 230 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 257

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 111 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 169
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 170 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 230 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 257

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 111 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 169
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 170 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 230 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 257

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 111 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 169
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 170 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 230 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 257

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 42/238 (17%)
Query: 76  LGAGAAYDTATQQNV------AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA       +N       AIKK+    + ++       E  L+  +NH+ ++    A
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNHQYVVRYYAA 70
Query: 130 F-------TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD-LDHERMSY--LLYQMLCGIK 178
           +        P  ++++   +++ ME  +   L  +I  + L+ +R  Y  L  Q+L  + 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------------GTTFMMTPY 223
           ++HS GIIHRDLKP NI +     +KI DFGLA+                 G++  +T  
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 224 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR 280
           + T  Y A EV+ G G Y E +D++S+G I  EMI     +P +  +++ N I+ K+R
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-----YPFSTGMERVN-ILKKLR 242

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 81  AYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLL---NAFTPQKSL 136
           A D    ++VA+K L     ++ +   R  RE +    +NH  I+ +     A TP   L
Sbjct: 31  ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPL 90
Query: 137 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
                 Y+VME +D   L  ++  +  +  +R   ++      +   H  GIIHRD+KP+
Sbjct: 91  P-----YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA 145
Query: 194 NIVVKSDCTLKILDFGLART---AGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 249
           NI++ +   +K++DFG+AR    +G +   T  V+ T  Y +PE   G       D++S+
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 250 GCIMGEMIRGGVLFPG 265
           GC++ E++ G   F G
Sbjct: 206 GCVLYEVLTGEPPFTG 221

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 82/148 (55%), Gaps = 4/148 (2%)
Query: 144 LVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CT 202
           LV E ++    + ++  L    + + +Y++L  + + HS GI+HRD+KP N+++  +   
Sbjct: 111 LVFEHVNNTDFKQLRQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK 170
Query: 203 LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RGG 260
           L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R  
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 261 VLFPGTDHIDQWNKIIGKMREAHDKLDY 288
             F G D+ DQ  + I K+    D  DY
Sbjct: 231 PFFHGHDNYDQLVR-IAKVLGTEDLYDY 257

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 111 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 169
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 170 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 230 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 257

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 63  SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAK-RAYREFKLMKLVNHK 121
           ++Q+ K     S      AY T T Q VA+K +++     +  + R  RE   ++L+ H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ-VIQMD-LDHERMSYLLYQMLCGIKH 179
           +II L +     KS +E   + +V+E     L   ++Q D +  +       Q++  +++
Sbjct: 69  HIIKLYDVI---KSKDE---IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEY 122
Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
            H   I+HRDLKP N+++     +KI DFGL+        +     +  Y APEVI G  
Sbjct: 123 CHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 182
Query: 240 YK-ENVDIWSVGCIMGEMI 257
           Y    VD+WS G I+  M+
Sbjct: 183 YAGPEVDVWSCGVILYVML 201

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 63  SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAK-RAYREFKLMKLVNHK 121
           ++Q+ K     S      AY T T Q VA+K +++     +  + R  RE   ++L+ H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ-VIQMD-LDHERMSYLLYQMLCGIKH 179
           +II L +     KS +E   + +V+E     L   ++Q D +  +       Q++  +++
Sbjct: 65  HIIKLYDVI---KSKDE---IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEY 118
Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
            H   I+HRDLKP N+++     +KI DFGL+        +     +  Y APEVI G  
Sbjct: 119 CHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 178
Query: 240 YK-ENVDIWSVGCIMGEMI 257
           Y    VD+WS G I+  M+
Sbjct: 179 YAGPEVDVWSCGVILYVML 197

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 16/192 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAK-RAYREFKLMKLVNHKNIIGLLN 128
           LG G+      AY T T Q VA+K +++     +  + R  RE   ++L+ H +II L +
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQ-VIQMD-LDHERMSYLLYQMLCGIKHLHSAGII 186
                KS +E   + +V+E     L   ++Q D +  +       Q++  +++ H   I+
Sbjct: 82  VI---KSKDE---IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIV 135
Query: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVD 245
           HRDLKP N+++     +KI DFGL+        +     +  Y APEVI G  Y    VD
Sbjct: 136 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVD 195
Query: 246 IWSVGCIMGEMI 257
           +WS G I+  M+
Sbjct: 196 VWSCGVILYVML 207

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 16/192 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAK-RAYREFKLMKLVNHKNIIGLLN 128
           LG G+      AY T T Q VA+K +++     +  + R  RE   ++L+ H +II L +
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQ-VIQMD-LDHERMSYLLYQMLCGIKHLHSAGII 186
                KS +E   + +V+E     L   ++Q D +  +       Q++  +++ H   I+
Sbjct: 81  VI---KSKDE---IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIV 134
Query: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVD 245
           HRDLKP N+++     +KI DFGL+        +     +  Y APEVI G  Y    VD
Sbjct: 135 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVD 194
Query: 246 IWSVGCIMGEMI 257
           +WS G I+  M+
Sbjct: 195 VWSCGVILYVML 206

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 144 LVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-C 201
           LV E + + +  Q+ Q   D++ + + +Y++L  + + HS GI+HRD+KP N+++  +  
Sbjct: 116 LVFEHVNNTDFKQLYQTLTDYD-IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 174
Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-RG 259
            L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  MI R 
Sbjct: 175 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 234
Query: 260 GVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
              F G D+ DQ  + I K+    D  DY
Sbjct: 235 EPFFHGHDNYDQLVR-IAKVLGTEDLYDY 262

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 90/173 (52%), Gaps = 11/173 (6%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+KK+    +     +  + E  +M+   H+N++ + N++     L      ++VME +
Sbjct: 59  VAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL------WVVMEFL 110
Query: 150 DANLCQ--VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
           +       V    ++ E+++ +   +L  +  LH+ G+IHRD+K  +I++  D  +K+ D
Sbjct: 111 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSD 170
Query: 208 FGL-ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           FG  A+ +         V T Y+ APE+I  + Y   VDIWS+G ++ EM+ G
Sbjct: 171 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 90/173 (52%), Gaps = 11/173 (6%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+KK+    +     +  + E  +M+   H+N++ + N++     L      ++VME +
Sbjct: 57  VAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL------WVVMEFL 108
Query: 150 DANLCQ--VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
           +       V    ++ E+++ +   +L  +  LH+ G+IHRD+K  +I++  D  +K+ D
Sbjct: 109 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSD 168
Query: 208 FGL-ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           FG  A+ +         V T Y+ APE+I  + Y   VDIWS+G ++ EM+ G
Sbjct: 169 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 90/173 (52%), Gaps = 11/173 (6%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+KK+    +     +  + E  +M+   H+N++ + N++     L      ++VME +
Sbjct: 102 VAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL------WVVMEFL 153
Query: 150 DANLCQ--VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
           +       V    ++ E+++ +   +L  +  LH+ G+IHRD+K  +I++  D  +K+ D
Sbjct: 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSD 213
Query: 208 FGL-ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           FG  A+ +         V T Y+ APE+I  + Y   VDIWS+G ++ EM+ G
Sbjct: 214 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 85  ATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           A+Q+  A+K LS+ F+ +  +  A+   E  +M   N   ++ L  AF   K L      
Sbjct: 98  ASQKVYAMKLLSK-FEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL------ 150
Query: 143 YLVMELM-DANLCQVI-QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           Y+VME M   +L  ++   D+  +   +   +++  +  +HS G+IHRD+KP N+++   
Sbjct: 151 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH 210
Query: 201 CTLKILDFGLARTAGTTFMM--TPYVVTRYYRAPEVILGMG----YKENVDIWSVGCIMG 254
             LK+ DFG       T M+     V T  Y +PEV+   G    Y    D WSVG  + 
Sbjct: 211 GHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 270
Query: 255 EMIRGGVLFPGTDHIDQWNKII 276
           EM+ G   F     +  ++KI+
Sbjct: 271 EMLVGDTPFYADSLVGTYSKIM 292

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 42/238 (17%)
Query: 76  LGAGAAYDTATQQNV------AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA       +N       AIKK+    + ++       E  L+  +NH+ ++    A
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNHQYVVRYYAA 70
Query: 130 F-------TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD-LDHERMSY--LLYQMLCGIK 178
           +        P  ++++   +++ ME  +   L  +I  + L+ +R  Y  L  Q+L  + 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------------GTTFMMTPY 223
           ++HS GIIHRDLKP NI +     +KI DFGLA+                 G++  +T  
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 224 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR 280
           + T  Y A EV+ G G Y E +D++S+G I  EMI     +P +  +++ N I+ K+R
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-----YPFSTGMERVN-ILKKLR 242

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 90/173 (52%), Gaps = 11/173 (6%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+KK+    +     +  + E  +M+   H+N++ + N++     L      ++VME +
Sbjct: 52  VAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL------WVVMEFL 103
Query: 150 DANLCQ--VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
           +       V    ++ E+++ +   +L  +  LH+ G+IHRD+K  +I++  D  +K+ D
Sbjct: 104 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSD 163
Query: 208 FGL-ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           FG  A+ +         V T Y+ APE+I  + Y   VDIWS+G ++ EM+ G
Sbjct: 164 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 90/173 (52%), Gaps = 11/173 (6%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+KK+    +     +  + E  +M+   H+N++ + N++     L      ++VME +
Sbjct: 48  VAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL------WVVMEFL 99
Query: 150 DANLCQ--VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
           +       V    ++ E+++ +   +L  +  LH+ G+IHRD+K  +I++  D  +K+ D
Sbjct: 100 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSD 159
Query: 208 FGL-ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           FG  A+ +         V T Y+ APE+I  + Y   VDIWS+G ++ EM+ G
Sbjct: 160 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 89/180 (49%), Gaps = 12/180 (6%)
Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
            T   +   IK+++    +    + + RE  ++  + H NI+        ++S EE   +
Sbjct: 45  STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY------RESFEENGSL 98
Query: 143 YLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
           Y+VM+  +  +L + I          +++     Q+   +KH+H   I+HRD+K  NI +
Sbjct: 99  YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL 158
Query: 198 KSDCTLKILDFGLARTAGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
             D T+++ DFG+AR   +T  +    + T YY +PE+     Y    DIW++GC++ E+
Sbjct: 159 TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIK--KLSRPFQNV----THAKRAYREF 112
           +  +K    S LG+GA      A D    + V +K  K  +  ++         +   E 
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 113 KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSY 168
            ++  V H NII +L+ F  Q   +      LVME   + L     +D    LD    SY
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQ------LVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
           +  Q++  + +L    IIHRD+K  NIV+  D T+K++DFG A       +   +  T  
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE 194
Query: 229 YRAPEVILGMGYK-ENVDIWSVGCIM 253
           Y APEV++G  Y+   +++WS+G  +
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTL 220

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 21/185 (11%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVI------QMDLDH 163
           E  L++ + H NI+   +    + +      +Y+VME  +  +L  VI      +  LD 
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTN----TTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 164 ERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TT 217
           E +  ++ Q+   +K  H        ++HRDLKP+N+ +     +K+ DFGLAR      
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE 170
Query: 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
                +V T YY +PE +  M Y E  DIWS+GC++ E+     L P      Q  ++ G
Sbjct: 171 DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC---ALMPPFTAFSQ-KELAG 226
Query: 278 KMREA 282
           K+RE 
Sbjct: 227 KIREG 231

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 84/159 (52%), Gaps = 16/159 (10%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-MSYLL 170
           L++   H NII L + +      ++ + VY+V EL      L ++++     ER  S +L
Sbjct: 69  LLRYGQHPNIITLKDVY------DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVL 122
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILDFGLART--AGTTFMMTPYV 224
           + +   +++LH+ G++HRDLKPSNI+   +     +++I DFG A+   A    + TP  
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTP-C 181
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
            T  + APEV+   GY    DIWS+G ++   + G   F
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF 220

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 23/252 (9%)
Query: 32  APAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVA 91
           AP   P +    ++++   + ++   ++  I   +GK +    +L    A +  ++  +A
Sbjct: 8   APENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYL----AREKQSKFILA 63
Query: 92  IKKLSRP---FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           +K L +       V H  R  RE ++   + H NI+ L   F       +   VYL++E 
Sbjct: 64  LKVLFKAQLEKAGVEHQLR--REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY 115
Query: 149 MDANLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
             A L  V +        D +R +  + ++   + + HS  +IHRD+KP N+++ S   L
Sbjct: 116 --APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGEL 173
Query: 204 KILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
           KI DFG +  A ++   T    T  Y  PE+I G  + E VD+WS+G +  E + G   F
Sbjct: 174 KIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232
Query: 264 PGTDHIDQWNKI 275
               + + + +I
Sbjct: 233 EANTYQETYKRI 244

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 95/183 (51%), Gaps = 17/183 (9%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-MS 167
           E  ++K + H+NI+ L + +      E     YLVM+L+       ++++  +  E+  S
Sbjct: 56  EIAVLKKIKHENIVTLEDIY------ESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS 109
Query: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTTFMMTPYV 224
            ++ Q+L  +K+LH  GI+HRDLKP N++    + +  + I DFGL++      M T   
Sbjct: 110 LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA-C 168
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD 284
            T  Y APEV+    Y + VD WS+G I   ++ G   F    + +  +K+  K++E + 
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF----YEETESKLFEKIKEGYY 224
Query: 285 KLD 287
           + +
Sbjct: 225 EFE 227

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 86/168 (51%), Gaps = 17/168 (10%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLD------ 162
           RE  +  ++ H +I+ LL  ++    L      Y+V E MD A+LC  I    D      
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGML------YMVFEFMDGADLCFEIVKRADAGFVYS 128
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFM 219
               S+ + Q+L  +++ H   IIHRD+KP N+++ S      +K+ DFG+A   G + +
Sbjct: 129 EAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL 188
Query: 220 MT-PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT 266
           +    V T ++ APEV+    Y + VD+W  G I+  ++ G + F GT
Sbjct: 189 VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSY 168
           L K  +H+NI     AF  +        ++LVME   A ++  +I+      L  E ++Y
Sbjct: 74  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAG--TTFMMTP 222
           +  ++L G+ HLH   +IHRD+K  N+++  +  +K++DFG++    RT G   TF+ TP
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 193
Query: 223 YVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIRGG 260
                Y+ APEVI         Y    D+WS+G    EM  G 
Sbjct: 194 -----YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 38/165 (23%)
Query: 144 LVMELMDANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
           +  EL+  N  + ++ +      L H R  ++ YQ+   ++ LH   + H DLKP NI+ 
Sbjct: 108 IAFELLGKNTFEFLKENNFQPYPLPHVR--HMAYQLCHALRFLHENQLTHTDLKPENILF 165
Query: 198 KS-------------------DCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVI 235
            +                   + ++++ DFG A     TF     T  V TR+YR PEVI
Sbjct: 166 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-----TFDHEHHTTIVATRHYRPPEVI 220
Query: 236 LGMGYKENVDIWSVGCIMGEMIRGGVLF---PGTDHIDQWNKIIG 277
           L +G+ +  D+WS+GCI+ E  RG  LF      +H+    KI+G
Sbjct: 221 LELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 265

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLVN-HK 121
           LG GA       + V I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 43  LGEGAFGQVVMAEAVGIDK-DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   + E+     + E + A     ++   D      E+M++     
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  +KI DFGLAR              R 
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRL 221
Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 38/165 (23%)
Query: 144 LVMELMDANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
           +  EL+  N  + ++ +      L H R  ++ YQ+   ++ LH   + H DLKP NI+ 
Sbjct: 131 IAFELLGKNTFEFLKENNFQPYPLPHVR--HMAYQLCHALRFLHENQLTHTDLKPENILF 188
Query: 198 KS-------------------DCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVI 235
            +                   + ++++ DFG A     TF     T  V TR+YR PEVI
Sbjct: 189 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-----TFDHEHHTTIVATRHYRPPEVI 243
Query: 236 LGMGYKENVDIWSVGCIMGEMIRGGVLF---PGTDHIDQWNKIIG 277
           L +G+ +  D+WS+GCI+ E  RG  LF      +H+    KI+G
Sbjct: 244 LELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 288

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 38/165 (23%)
Query: 144 LVMELMDANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
           +  EL+  N  + ++ +      L H R  ++ YQ+   ++ LH   + H DLKP NI+ 
Sbjct: 99  IAFELLGKNTFEFLKENNFQPYPLPHVR--HMAYQLCHALRFLHENQLTHTDLKPENILF 156
Query: 198 KS-------------------DCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVI 235
            +                   + ++++ DFG A     TF     T  V TR+YR PEVI
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-----TFDHEHHTTIVATRHYRPPEVI 211
Query: 236 LGMGYKENVDIWSVGCIMGEMIRGGVLF---PGTDHIDQWNKIIG 277
           L +G+ +  D+WS+GCI+ E  RG  LF      +H+    KI+G
Sbjct: 212 LELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 256

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLVN-HK 121
           LG GA       + V I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 43  LGEGAFGQVVMAEAVGIDK-DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   + E+     + E + A     ++   D      E+M++     
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  +KI DFGLAR              R 
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRL 221
Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           AAY    ++ VAIK+++   +  T      +E + M   +H NI+    +F  +  L   
Sbjct: 33  AAYCAPKKEKVAIKRINLE-KCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL--- 88
Query: 140 QDVYLVMELMDA-NLCQVIQ----------MDLDHERMSYLLYQMLCGIKHLHSAGIIHR 188
              +LVM+L+   ++  +I+            LD   ++ +L ++L G+++LH  G IHR
Sbjct: 89  ---WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR 145
Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMT------PYVVTRYYRAPEVILGM-GYK 241
           D+K  NI++  D +++I DFG++    T   +T       +V T  + APEV+  + GY 
Sbjct: 146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD 205
Query: 242 ENVDIWSVGCIMGEMIRGGVLF 263
              DIWS G    E+  G   +
Sbjct: 206 FKADIWSFGITAIELATGAAPY 227

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 67/122 (54%), Gaps = 9/122 (7%)
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLAR-----TAGTTF 218
           +S ++ Q+   + +LH+ GI HRD+KP N +  ++ +  +K++DFGL++       G  +
Sbjct: 170 ISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 219 MMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            MT    T Y+ APEV+      Y    D WS G ++  ++ G V FPG +  D  ++++
Sbjct: 230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL 289
Query: 277 GK 278
            K
Sbjct: 290 NK 291

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-M 166
           RE ++ +L+ H NI+ L ++     S E F   YLV +L+        ++  +   E   
Sbjct: 52  REARICRLLKHSNIVRLHDSI----SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADA 105
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLA-RTAGTTFMMTP 222
           S+ + Q+L  + H H  G++HRDLKP N+++ S C    +K+ DFGLA    G       
Sbjct: 106 SHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG 165
Query: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           +  T  Y +PEV+    Y + VDIW+ G I+  ++ G
Sbjct: 166 FAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           AAY    ++ VAIK+++   +  T      +E + M   +H NI+    +F  +  L   
Sbjct: 28  AAYCAPKKEKVAIKRINLE-KCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL--- 83
Query: 140 QDVYLVMELMDA-NLCQVIQ----------MDLDHERMSYLLYQMLCGIKHLHSAGIIHR 188
              +LVM+L+   ++  +I+            LD   ++ +L ++L G+++LH  G IHR
Sbjct: 84  ---WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR 140
Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMT------PYVVTRYYRAPEVILGM-GYK 241
           D+K  NI++  D +++I DFG++    T   +T       +V T  + APEV+  + GY 
Sbjct: 141 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD 200
Query: 242 ENVDIWSVGCIMGEMIRGGVLF 263
              DIWS G    E+  G   +
Sbjct: 201 FKADIWSFGITAIELATGAAPY 222

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLVN-HK 121
           LG GA       + V I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 43  LGEGAFGQVVMAEAVGIDK-DKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHK 101
Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   + E+     + E + A     ++   D      E+M++     
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  +KI DFGLAR              R 
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 74  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 125
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 126 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLC 184
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 185 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 235

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 62  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 113
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLC 172
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 173 GTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 17/186 (9%)
Query: 86  TQQNVAIKKLSR-PFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEFQDVY 143
           T   VA+K L+R   +++    +  RE + +KL  H +II L     TP        D +
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT-------DFF 87
Query: 144 LVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +VME +     ++      H R+       L  Q+L  + + H   ++HRDLKP N+++ 
Sbjct: 88  MVMEYVSGG--ELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD 145
Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMI 257
           +    KI DFGL+        +     +  Y APEVI G  Y    VDIWS G I+  ++
Sbjct: 146 AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL 205
Query: 258 RGGVLF 263
            G + F
Sbjct: 206 CGTLPF 211

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 83/156 (53%), Gaps = 16/156 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ--VIQMDLDHE---- 164
           E K++  V+ + I+ L  AF      E   D+ LVM +M+    +  +  +D D+     
Sbjct: 235 EKKILAKVHSRFIVSLAYAF------ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 165 -RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTTFMMT 221
            R  +   Q++ G++HLH   II+RDLKP N+++  D  ++I D GLA    AG T    
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTK 347
Query: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
            Y  T  + APE++LG  Y  +VD +++G  + EMI
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 83/156 (53%), Gaps = 16/156 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ--VIQMDLDHE---- 164
           E K++  V+ + I+ L  AF      E   D+ LVM +M+    +  +  +D D+     
Sbjct: 235 EKKILAKVHSRFIVSLAYAF------ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 165 -RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTTFMMT 221
            R  +   Q++ G++HLH   II+RDLKP N+++  D  ++I D GLA    AG T    
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTK 347
Query: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
            Y  T  + APE++LG  Y  +VD +++G  + EMI
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 83/156 (53%), Gaps = 16/156 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ--VIQMDLDHE---- 164
           E K++  V+ + I+ L  AF      E   D+ LVM +M+    +  +  +D D+     
Sbjct: 235 EKKILAKVHSRFIVSLAYAF------ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 165 -RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTTFMMT 221
            R  +   Q++ G++HLH   II+RDLKP N+++  D  ++I D GLA    AG T    
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTK 347
Query: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
            Y  T  + APE++LG  Y  +VD +++G  + EMI
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLVN-HK 121
           LG GA       + V I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 43  LGEGAFGQVVMAEAVGIDK-DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   + E+     + E + A     ++   D      E+M++     
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  +KI DFGLAR              R 
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRL 221
Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLVN-HK 121
           LG GA       + V I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 43  LGEGAFGQVVMAEAVGIDK-DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   + E+     + E + A     ++   D      E+M++     
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  +KI DFGLAR              R 
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 17/186 (9%)
Query: 86  TQQNVAIKKLSR-PFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEFQDVY 143
           T   VA+K L+R   +++    +  RE + +KL  H +II L     TP        D +
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT-------DFF 87
Query: 144 LVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +VME +     ++      H R+       L  Q+L  + + H   ++HRDLKP N+++ 
Sbjct: 88  MVMEYVSGG--ELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD 145
Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMI 257
           +    KI DFGL+        +     +  Y APEVI G  Y    VDIWS G I+  ++
Sbjct: 146 AHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL 205
Query: 258 RGGVLF 263
            G + F
Sbjct: 206 CGTLPF 211

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 54  ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRA---YR 110
           ++ + +L I  ++G     T H       D      VA+K L    +   HA+R     R
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEWHGSD------VAVKIL---MEQDFHAERVNEFLR 83
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME-LMDANLCQVI-----QMDLDHE 164
           E  +MK + H NI+  + A T   +L       +V E L   +L +++     +  LD  
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKSGAREQLDER 137
Query: 165 RMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP 222
           R   + Y +  G+ +LH+    I+HR+LK  N++V    T+K+ DFGL+R   +TF+ + 
Sbjct: 138 RRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK 197
Query: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
               T  + APEV+      E  D++S G I+ E+
Sbjct: 198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 54  ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRA---YR 110
           ++ + +L I  ++G     T H       D      VA+K L    +   HA+R     R
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEWHGSD------VAVKIL---MEQDFHAERVNEFLR 83
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME-LMDANLCQVI-----QMDLDHE 164
           E  +MK + H NI+  + A T   +L       +V E L   +L +++     +  LD  
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKSGAREQLDER 137
Query: 165 RMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP 222
           R   + Y +  G+ +LH+    I+HRDLK  N++V    T+K+ DFGL+R   + F+ + 
Sbjct: 138 RRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSK 197
Query: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
               T  + APEV+      E  D++S G I+ E+
Sbjct: 198 XAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 115/252 (45%), Gaps = 23/252 (9%)
Query: 32  APAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVA 91
           AP   P +    ++++   + ++   ++  I   +GK +    +L    A +  ++  +A
Sbjct: 8   APENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYL----AREKQSKFILA 63
Query: 92  IKKLSRP---FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           +K L +       V H  R  RE ++   + H NI+ L   F       +   VYL++E 
Sbjct: 64  LKVLFKAQLEKAGVEHQLR--REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY 115
Query: 149 MDANLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
             A L  V +        D +R +  + ++   + + HS  +IHRD+KP N+++ S   L
Sbjct: 116 --APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGEL 173
Query: 204 KILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
           KI DFG +  A ++        T  Y  PE+I G  + E VD+WS+G +  E + G   F
Sbjct: 174 KIADFGWSVHAPSS-RRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232
Query: 264 PGTDHIDQWNKI 275
               + + + +I
Sbjct: 233 EANTYQETYKRI 244

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 70/138 (50%), Gaps = 30/138 (21%)
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV-VKSDCTL------------------KI 205
           ++ ++ +Q+   +K LH   + H DLKP NI+ V SD  L                  ++
Sbjct: 138 QVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRV 197
Query: 206 LDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL 262
           +DFG A     TF     +  V TR+YRAPEVIL +G+ +  D+WS+GCI+ E   G  L
Sbjct: 198 VDFGSA-----TFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTL 252
Query: 263 FPGTD---HIDQWNKIIG 277
           F   D   H+    +I+G
Sbjct: 253 FQTHDNREHLAMMERILG 270

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 62  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 113
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLC 172
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 57  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 108
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLC 167
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 10/169 (5%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM--DLDHERM 166
           RE ++   + H NI+ L   F       +   VYL++E      + + +Q     D +R 
Sbjct: 62  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEYAPRGEVYKELQKLSKFDEQRT 115
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVT 226
           +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T    T
Sbjct: 116 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLCGT 174
Query: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
             Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 57  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 108
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTELC 167
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 60  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 111
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLC 170
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 83/156 (53%), Gaps = 16/156 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ--VIQMDLDHE---- 164
           E K++  V+ + I+ L  AF      E   D+ LVM +M+    +  +  +D D+     
Sbjct: 235 EKKILAKVHSRFIVSLAYAF------ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 165 -RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTTFMMT 221
            R  +   Q++ G++HLH   II+RDLKP N+++  D  ++I D GLA    AG T    
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTK 347
Query: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
            Y  T  + APE++LG  Y  +VD +++G  + EMI
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 58/100 (58%), Gaps = 1/100 (1%)
Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFM 219
           LD  +++ +L ++L G+ +LHS   IHRD+K +N+++     +K+ DFG+A +   T   
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
              +V T ++ APEVI    Y    DIWS+G    E+ RG
Sbjct: 176 RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 57  REVEIQSHLRHPNILRLYGYF------HDSTRVYLILEY--APLGTVYRELQKLSKFDEQ 108
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++       
Sbjct: 109 RTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRAALC 167
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + D + +I
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRI 218

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLVN-HK 121
           LG GA       + V I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 43  LGEGAFGQVVMAEAVGIDK-DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   + E+     + E + A     ++   D      E+M++     
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  ++I DFGLAR              R 
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRL 221
Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 58  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 109
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLC 168
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 11/161 (6%)
Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDLD 162
           A  E ++++ VN + ++ L  A+  + +L       LV+ LM+       +  + Q    
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDAL------CLVLTLMNGGDLKFHIYHMGQAGFP 284
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP 222
             R  +   ++ CG++ LH   I++RDLKP NI++     ++I D GLA        +  
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344
Query: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
            V T  Y APEV+    Y  + D W++GC++ EMI G   F
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 62  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 113
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLC 172
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 58  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 109
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSS-RRTTLS 168
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 61  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 112
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 113 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLC 171
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 222

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 56  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 107
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 108 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLC 166
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 167 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 217

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 58/100 (58%), Gaps = 1/100 (1%)
Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFM 219
           LD  +++ +L ++L G+ +LHS   IHRD+K +N+++     +K+ DFG+A +   T   
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
              +V T ++ APEVI    Y    DIWS+G    E+ RG
Sbjct: 161 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 200

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLVN-HK 121
           LG GA       + V I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 43  LGEGAFGQVVMAEAVGIDK-DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   + E+     + E + A     ++   D      E+M++     
Sbjct: 102 NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  +KI DFGLAR              R 
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 57  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 108
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTXLC 167
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 58/100 (58%), Gaps = 1/100 (1%)
Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFM 219
           LD  +++ +L ++L G+ +LHS   IHRD+K +N+++     +K+ DFG+A +   T   
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
              +V T ++ APEVI    Y    DIWS+G    E+ RG
Sbjct: 161 RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 200

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 60  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 111
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLC 170
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEIXINKMLNHENVV----K 69
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 126
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 187 EPVDVWSCGIVLTAMLAG 204

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 57  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 108
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLC 167
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEIXINKMLNHENVV----K 68
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 125
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 186 EPVDVWSCGIVLTAMLAG 203

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 11/161 (6%)
Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDLD 162
           A  E ++++ VN + ++ L  A+  + +L       LV+ LM+       +  + Q    
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDAL------CLVLTLMNGGDLKFHIYHMGQAGFP 284
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP 222
             R  +   ++ CG++ LH   I++RDLKP NI++     ++I D GLA        +  
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344
Query: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
            V T  Y APEV+    Y  + D W++GC++ EMI G   F
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 58/100 (58%), Gaps = 1/100 (1%)
Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFM 219
           LD  +++ +L ++L G+ +LHS   IHRD+K +N+++     +K+ DFG+A +   T   
Sbjct: 121 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 180
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
              +V T ++ APEVI    Y    DIWS+G    E+ RG
Sbjct: 181 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 220

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 57  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 108
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLC 167
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEIXINKMLNHENVV----K 68
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 125
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 186 EPVDVWSCGIVLTAMLAG 203

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 54  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 105
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 106 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLC 164
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 165 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 215

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 82/154 (53%), Gaps = 9/154 (5%)
Query: 109 YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ--VIQMDLDHERM 166
           + E  +M+   H N++ +  ++   + L      +++ME +        V Q+ L+ E++
Sbjct: 90  FNEVVIMRDYQHFNVVEMYKSYLVGEEL------WVLMEFLQGGALTDIVSQVRLNEEQI 143
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVV 225
           + +   +L  + +LH+ G+IHRD+K  +I++  D  +K+ DFG  A+ +         V 
Sbjct: 144 ATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVG 203
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           T Y+ APEVI    Y   VDIWS+G ++ EM+ G
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T + VAIK+  +   +  + +R   E ++MK +NH N++         + L       L 
Sbjct: 39  TGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 97
Query: 146 MELMDA-----------NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
           ME  +            N C      L    +  LL  +   +++LH   IIHRDLKP N
Sbjct: 98  MEYCEGGDLRKYLNQFENCC-----GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 152
Query: 195 IVVKSDCTL---KILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
           IV++        KI+D G A+      + T +V T  Y APE++    Y   VD WS G 
Sbjct: 153 IVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 212
Query: 252 IMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK 285
           +  E I G   F       QW+   GK+RE  ++
Sbjct: 213 LAFECITGFRPFLPNWQPVQWH---GKVREKSNE 243

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T + VAIK+  +   +  + +R   E ++MK +NH N++         + L       L 
Sbjct: 38  TGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96
Query: 146 MELMDA-----------NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
           ME  +            N C      L    +  LL  +   +++LH   IIHRDLKP N
Sbjct: 97  MEYCEGGDLRKYLNQFENCC-----GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 151
Query: 195 IVVKSDCTL---KILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
           IV++        KI+D G A+      + T +V T  Y APE++    Y   VD WS G 
Sbjct: 152 IVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 252 IMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK 285
           +  E I G   F       QW+   GK+RE  ++
Sbjct: 212 LAFECITGFRPFLPNWQPVQWH---GKVREKSNE 242

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLVN-HK 121
           LG G        + V I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 30  LGEGCFGQVVMAEAVGIDK-DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 88
Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   + E+     + E + A     ++   D      E+M++     
Sbjct: 89  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  +KI DFGLAR              R 
Sbjct: 149 CTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 208
Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 209 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 249

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 54  ELIYQELPISHQMGKKRHNTSHLGAGAAY---DTATQQNVAIKKLSRPF-QNVTHAKRAY 109
           EL +++ P   ++        H   GA Y   D    + VAIKK+S    Q+    +   
Sbjct: 45  ELFFKDDP--EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM---DANLCQVIQMDLDHERM 166
           +E + ++ + H N I     +  + +       +LVME      ++L +V +  L    +
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHT------AWLVMEYCLGSASDLLEVHKKPLQEVEI 156
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP---Y 223
           + + +  L G+ +LHS  +IHRD+K  NI++     +K+ DFG A       +M P   +
Sbjct: 157 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANXF 210
Query: 224 VVTRYYRAPEVILGMG---YKENVDIWSVG--CI 252
           V T Y+ APEVIL M    Y   VD+WS+G  CI
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 244

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 54  ELIYQELPISHQMGKKRHNTSHLGAGAAY---DTATQQNVAIKKLSRPF-QNVTHAKRAY 109
           EL +++ P   ++        H   GA Y   D    + VAIKK+S    Q+    +   
Sbjct: 6   ELFFKDDP--EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM---DANLCQVIQMDLDHERM 166
           +E + ++ + H N I     +  + +       +LVME      ++L +V +  L    +
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHT------AWLVMEYCLGSASDLLEVHKKPLQEVEI 117
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP---Y 223
           + + +  L G+ +LHS  +IHRD+K  NI++     +K+ DFG A       +M P   +
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANXF 171
Query: 224 VVTRYYRAPEVILGMG---YKENVDIWSVG--CI 252
           V T Y+ APEVIL M    Y   VD+WS+G  CI
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 85  ATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           +T++  A+K LS+ F+ +  +  A+   E  +M   N   ++ L  AF   + L      
Sbjct: 92  STRKVYAMKLLSK-FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL------ 144
Query: 143 YLVMELM-DANLCQVI-QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           Y+VME M   +L  ++   D+  +   +   +++  +  +HS G IHRD+KP N+++   
Sbjct: 145 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 204
Query: 201 CTLKILDFGLARTAGTTFMM--TPYVVTRYYRAPEVILGMG----YKENVDIWSVGCIMG 254
             LK+ DFG         M+     V T  Y +PEV+   G    Y    D WSVG  + 
Sbjct: 205 GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 264
Query: 255 EMIRGGVLFPGTDHIDQWNKII 276
           EM+ G   F     +  ++KI+
Sbjct: 265 EMLVGDTPFYADSLVGTYSKIM 286

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 79  GAAYDTATQQNVAIKKLSRPFQN------VTHAKRAYREFKLMKLVNHKNIIGLLNAFTP 132
           G  Y    +QN  I  L   F++      V H  R  RE ++   + H NI+ + N F  
Sbjct: 29  GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR--REIEIQSHLRHPNILRMYNYFHD 86
Query: 133 QKSLEEFQDVYLVMELMD-ANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
           +K       +YL++E      L + +Q     D +R +  + ++   + + H   +IHRD
Sbjct: 87  RKR------IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRD 140
Query: 190 LKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
           +KP N+++     LKI DFG +  A  +        T  Y  PE+I G  + E VD+W  
Sbjct: 141 IKPENLLMGYKGELKIADFGWSVHA-PSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCA 199
Query: 250 GCIMGEMIRGGVLFPGTDHIDQWNKII 276
           G +  E + G   F    H +   +I+
Sbjct: 200 GVLCYEFLVGMPPFDSPSHTETHRRIV 226

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLVN-HK 121
           LG G        + V I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 89  LGEGCFGQVVMAEAVGIDK-DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   + E+     + E + A     ++   D      E+M++     
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  +KI DFGLAR              R 
Sbjct: 208 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 267
Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLVN-HK 121
           LG G        + V I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 35  LGEGCFGQVVMAEAVGIDK-DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 93
Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   + E+     + E + A     ++   D      E+M++     
Sbjct: 94  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  +KI DFGLAR              R 
Sbjct: 154 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 213
Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 214 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLVN-HK 121
           LG G        + V I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 32  LGEGCFGQVVMAEAVGIDK-DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 90
Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   + E+     + E + A     ++   D      E+M++     
Sbjct: 91  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  +KI DFGLAR              R 
Sbjct: 151 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 210
Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 211 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 251

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 79  GAAYDTATQQNVAIKKLSRPFQN------VTHAKRAYREFKLMKLVNHKNIIGLLNAFTP 132
           G  Y    +QN  I  L   F++      V H  R  RE ++   + H NI+ + N F  
Sbjct: 28  GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR--REIEIQSHLRHPNILRMYNYFHD 85
Query: 133 QKSLEEFQDVYLVMELMD-ANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
           +K       +YL++E      L + +Q     D +R +  + ++   + + H   +IHRD
Sbjct: 86  RKR------IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRD 139
Query: 190 LKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
           +KP N+++     LKI DFG +  A  +        T  Y  PE+I G  + E VD+W  
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVHA-PSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCA 198
Query: 250 GCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           G +  E + G   F    H +   +I+ 
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTETHRRIVN 226

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 68
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 125
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 186 EPVDVWSCGIVLTAMLAG 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 69
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 126
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 187 EPVDVWSCGIVLTAMLAG 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 68
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 125
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 186 EPVDVWSCGIVLTAMLAG 203

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHER-M 166
           RE ++ +L+ H NI+ L ++     S E F   YLV +L+        ++  +   E   
Sbjct: 79  REARICRLLKHPNIVRLHDSI----SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADA 132
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLA-RTAGTTFMMTP 222
           S+ ++Q+L  + H+H   I+HRDLKP N+++ S C    +K+ DFGLA    G       
Sbjct: 133 SHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG 192
Query: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           +  T  Y +PEV+    Y + VDIW+ G I+  ++ G
Sbjct: 193 FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 85  ATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           +T++  A+K LS+ F+ +  +  A+   E  +M   N   ++ L  AF   + L      
Sbjct: 97  STRKVYAMKLLSK-FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL------ 149
Query: 143 YLVMELM-DANLCQVI-QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           Y+VME M   +L  ++   D+  +   +   +++  +  +HS G IHRD+KP N+++   
Sbjct: 150 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 209
Query: 201 CTLKILDFGLARTAGTTFMM--TPYVVTRYYRAPEVILGMG----YKENVDIWSVGCIMG 254
             LK+ DFG         M+     V T  Y +PEV+   G    Y    D WSVG  + 
Sbjct: 210 GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 269
Query: 255 EMIRGGVLFPGTDHIDQWNKII 276
           EM+ G   F     +  ++KI+
Sbjct: 270 EMLVGDTPFYADSLVGTYSKIM 291

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 13/223 (5%)
Query: 61  PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLV 118
           P   + GK     S      A + AT +  AIK L +    +   K  Y  RE  +M  +
Sbjct: 7   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRL 65
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCG 176
           +H   + L   F   + L      + +    +  L + I+     D     +   +++  
Sbjct: 66  DHPFFVKLYFTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120
Query: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPE 233
           +++LH  GIIHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 180
Query: 234 VILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           ++      ++ D+W++GCI+ +++ G   F   +    + KII
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 223

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 84/171 (49%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 61  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSRFDEQ 112
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S+  LKI DFG +  A ++   T   
Sbjct: 113 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS-RRTTLC 171
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI 222

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 67
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 68  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 124
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 185 EPVDVWSCGIVLTAMLAG 202

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 68
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 125
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 186 EPVDVWSCGIVLTAMLAG 203

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 85  ATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           +T++  A+K LS+ F+ +  +  A+   E  +M   N   ++ L  AF   + L      
Sbjct: 97  STRKVYAMKLLSK-FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL------ 149
Query: 143 YLVMELM-DANLCQVI-QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           Y+VME M   +L  ++   D+  +   +   +++  +  +HS G IHRD+KP N+++   
Sbjct: 150 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 209
Query: 201 CTLKILDFGLARTAGTTFMM--TPYVVTRYYRAPEVILGMG----YKENVDIWSVGCIMG 254
             LK+ DFG         M+     V T  Y +PEV+   G    Y    D WSVG  + 
Sbjct: 210 GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 269
Query: 255 EMIRGGVLFPGTDHIDQWNKII 276
           EM+ G   F     +  ++KI+
Sbjct: 270 EMLVGDTPFYADSLVGTYSKIM 291

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 30/167 (17%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER----- 165
           E  + + + H++++G    F      E+   V++V+EL     C+   +   H+R     
Sbjct: 71  EISIHRSLAHQHVVGFHGFF------EDNDFVFVVLEL-----CRRRSLLELHKRRKALT 119
Query: 166 ---MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------GT 216
                Y L Q++ G ++LH   +IHRDLK  N+ +  D  +KI DFGLA           
Sbjct: 120 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 179
Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
           T   TP      Y APEV+   G+   VD+WS+GCIM  ++ G   F
Sbjct: 180 TLCGTP-----NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 221

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 68
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 125
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 186 EPVDVWSCGIVLTAMLAG 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 68
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 125
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 186 EPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 69
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 126
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 187 EPVDVWSCGIVLTAMLAG 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 69
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 126
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 187 EPVDVWSCGIVLTAMLAG 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 68
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 125
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 186 EPVDVWSCGIVLTAMLAG 203

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 13/223 (5%)
Query: 61  PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLV 118
           P   + GK     S      A + AT +  AIK L +    +   K  Y  RE  +M  +
Sbjct: 8   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRL 66
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCG 176
           +H   + L   F   + L      + +    +  L + I+     D     +   +++  
Sbjct: 67  DHPFFVKLYFTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 121
Query: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPE 233
           +++LH  GIIHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE
Sbjct: 122 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 181
Query: 234 VILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           ++      ++ D+W++GCI+ +++ G   F   +    + KII
Sbjct: 182 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 224

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 58  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 109
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++   T   
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT-LC 168
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 13/223 (5%)
Query: 61  PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLV 118
           P   + GK     S      A + AT +  AIK L +    +   K  Y  RE  +M  +
Sbjct: 9   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRL 67
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCG 176
           +H   + L   F   + L      + +    +  L + I+     D     +   +++  
Sbjct: 68  DHPFFVKLYFTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 122
Query: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPE 233
           +++LH  GIIHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE
Sbjct: 123 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 182
Query: 234 VILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           ++      ++ D+W++GCI+ +++ G   F   +    + KII
Sbjct: 183 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 225

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 68
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 125
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 186 EPVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 68
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 125
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 186 EPVDVWSCGIVLTAMLAG 203

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERM-----SY 168
           ++ +V H  II +   F      ++ Q ++++M+ ++    ++  +    +R       +
Sbjct: 59  MLSIVTHPFIIRMWGTF------QDAQQIFMIMDYIEGG--ELFSLLRKSQRFPNPVAKF 110
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPYVVTR 227
              ++   +++LHS  II+RDLKP NI++  +  +KI DFG A+     T+ +     T 
Sbjct: 111 YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXL---CGTP 167
Query: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
            Y APEV+    Y +++D WS G ++ EM+ G   F  ++ +  + KI+ 
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 69
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 126
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 187 EPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 69
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 126
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 187 EPVDVWSCGIVLTAMLAG 204

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGAA------YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GAA       +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 68
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 125
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 186 EPVDVWSCGIVLTAMLAG 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 69
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 126
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 187 EPVDVWSCGIVLTAMLAG 204

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 13/223 (5%)
Query: 61  PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLV 118
           P   + GK     S      A + AT +  AIK L +    +   K  Y  RE  +M  +
Sbjct: 6   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRL 64
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCG 176
           +H   + L   F   + L      + +    +  L + I+     D     +   +++  
Sbjct: 65  DHPFFVKLYFTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 119
Query: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPE 233
           +++LH  GIIHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE
Sbjct: 120 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 179
Query: 234 VILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           ++      ++ D+W++GCI+ +++ G   F   +    + KII
Sbjct: 180 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 222

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 88/177 (49%), Gaps = 19/177 (10%)
Query: 90  VAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           +  KKLS R FQ +       RE ++ + + H NI+ L        S++E    YLV +L
Sbjct: 38  INTKKLSARDFQKLE------REARICRKLQHPNIVRL------HDSIQEESFHYLVFDL 85
Query: 149 MDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CT 202
           +        ++  +   E   S+ + Q+L  I + HS GI+HR+LKP N+++ S      
Sbjct: 86  VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAA 145
Query: 203 LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           +K+ DFGLA     +     +  T  Y +PEV+    Y + VDIW+ G I+  ++ G
Sbjct: 146 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 16/156 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD----HERM 166
           E  ++   +H NI+ LL+AF  + +L      ++++E         + ++L+      ++
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNL------WILIEFCAGGAVDAVMLELERPLTESQI 137
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVV 225
             +  Q L  + +LH   IIHRDLK  NI+   D  +K+ DFG+ A+   T      ++ 
Sbjct: 138 QVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 197
Query: 226 TRYYRAPEVILGMGYKE-----NVDIWSVGCIMGEM 256
           T Y+ APEV++    K+       D+WS+G  + EM
Sbjct: 198 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 30/167 (17%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER----- 165
           E  + + + H++++G    F      E+   V++V+EL     C+   +   H+R     
Sbjct: 67  EISIHRSLAHQHVVGFHGFF------EDNDFVFVVLEL-----CRRRSLLELHKRRKALT 115
Query: 166 ---MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------GT 216
                Y L Q++ G ++LH   +IHRDLK  N+ +  D  +KI DFGLA           
Sbjct: 116 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 175
Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
           T   TP      Y APEV+   G+   VD+WS+GCIM  ++ G   F
Sbjct: 176 TLCGTP-----NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV----K 68
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 125
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 186 EPVDVWSCGIVLTAMLAG 203

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 30/167 (17%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER----- 165
           E  + + + H++++G    F      E+   V++V+EL     C+   +   H+R     
Sbjct: 67  EISIHRSLAHQHVVGFHGFF------EDNDFVFVVLEL-----CRRRSLLELHKRRKALT 115
Query: 166 ---MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------GT 216
                Y L Q++ G ++LH   +IHRDLK  N+ +  D  +KI DFGLA           
Sbjct: 116 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 175
Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
           T   TP      Y APEV+   G+   VD+WS+GCIM  ++ G   F
Sbjct: 176 TLCGTP-----NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 88/177 (49%), Gaps = 19/177 (10%)
Query: 90  VAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           +  KKLS R FQ +       RE ++ + + H NI+ L        S++E    YLV +L
Sbjct: 39  INTKKLSARDFQKLE------REARICRKLQHPNIVRL------HDSIQEESFHYLVFDL 86
Query: 149 MDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CT 202
           +        ++  +   E   S+ + Q+L  I + HS GI+HR+LKP N+++ S      
Sbjct: 87  VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAA 146
Query: 203 LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           +K+ DFGLA     +     +  T  Y +PEV+    Y + VDIW+ G I+  ++ G
Sbjct: 147 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 88/177 (49%), Gaps = 19/177 (10%)
Query: 90  VAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           +  KKLS R FQ +       RE ++ + + H NI+ L        S++E    YLV +L
Sbjct: 39  INTKKLSARDFQKLE------REARICRKLQHPNIVRL------HDSIQEESFHYLVFDL 86
Query: 149 MDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CT 202
           +        ++  +   E   S+ + Q+L  I + HS GI+HR+LKP N+++ S      
Sbjct: 87  VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAA 146
Query: 203 LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           +K+ DFGLA     +     +  T  Y +PEV+    Y + VDIW+ G I+  ++ G
Sbjct: 147 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 59  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 110
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI +FG +  A ++   T   
Sbjct: 111 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS-RRTTLC 169
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 220

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 57  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 108
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++       
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRAALC 167
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 98
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 99  FTFQDDEKL-----YFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASK 213
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 214 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 247

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLVN-HK 121
           LG GA       + V I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 43  LGEGAFGQVVMAEAVGIDK-DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   +  +     + E + A     ++   D      E+M++     
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  +KI DFGLAR              R 
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 60  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 111
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++       
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRAALC 170
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 60  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 111
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI +FG +  A ++   T   
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS-RRTTLC 170
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 97  FTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACK 211
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 212 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 245

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 76  LGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR-------------EFKLMKLVN-HK 121
           LG GA       + V I K  +P + VT A +  +             E ++MK++  HK
Sbjct: 43  LGEGAFGQVVMAEAVGIDK-DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 122 NIIGLLNAFT---PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-----HERMSY----- 168
           NII LL A T   P   +  +     + E + A     ++   D      E+M++     
Sbjct: 102 NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY 228
             YQ+  G+++L S   IHRDL   N++V  +  +KI DFGLAR              R 
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 229 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
              + APE +    Y    D+WS G +M E+   GG  +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 81/162 (50%), Gaps = 11/162 (6%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERM 166
           RE +++   N   I+G   AF          ++ + ME MD  +L QV++    +  E +
Sbjct: 63  RELQVLHECNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLKEAKRIPEEIL 116
Query: 167 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
             +   +L G+ +L     I+HRD+KPSNI+V S   +K+ DFG++     + M   +V 
Sbjct: 117 GKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVG 175
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
           TR Y APE + G  Y    DIWS+G  + E+  G    P  D
Sbjct: 176 TRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPD 217

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 95
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 96  FTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 210
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 211 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 244

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 90  VAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           +  KKLS R FQ +       RE ++ + + H NI+ L        S++E    YLV +L
Sbjct: 62  INTKKLSARDFQKLE------REARICRKLQHPNIVRL------HDSIQEESFHYLVFDL 109
Query: 149 MDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CT 202
           +        ++  +   E   S+ + Q+L  I + HS GI+HR+LKP N+++ S      
Sbjct: 110 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAA 169
Query: 203 LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
           +K+ DFGLA     +     +  T  Y +PEV+    Y + VDIW+ G I+
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 99
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 100 FTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 214
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 215 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 248

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 103
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 104 FCFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 158
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 159 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 218
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 219 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 252

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 80
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 81  FTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 135
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 136 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 195
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 196 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 229

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 97  FTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 211
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 212 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 245

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 59  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 110
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++       
Sbjct: 111 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRXXLC 169
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 220

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 97  FTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 211
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 212 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 245

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 98
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 99  FTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 214 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 247

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 98
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 99  FTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 214 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 247

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 99
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 100 FTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 214
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 215 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 248

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 10/169 (5%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM--DLDHERM 166
           RE ++   + H NI+ L   F       +   VYL++E      + + +Q     D +R 
Sbjct: 62  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEYAPRGEVYKELQKLSKFDEQRT 115
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVT 226
           +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++        T
Sbjct: 116 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRXXLXGT 174
Query: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
             Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 97  FTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 211
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 212 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 245

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 95
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 96  FTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 210
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 211 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 244

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLL 127
           LG G+      A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLY 98
Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGI 185
             F   + L      + +    +  L + I+     D     +   +++  +++LH  GI
Sbjct: 99  FTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 214 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 247

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 57  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 108
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++       
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRXXLC 167
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS--- 167
           E  + + + H++++G    F      E+   V++V+EL     C+   +   H+R     
Sbjct: 91  EISIHRSLAHQHVVGFHGFF------EDNDFVFVVLEL-----CRRRSLLELHKRRKALT 139
Query: 168 -----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP 222
                Y L Q++ G ++LH   +IHRDLK  N+ +  D  +KI DFGLA           
Sbjct: 140 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 199
Query: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
            +  T  Y APEV+   G+   VD+WS+GCIM  ++ G   F
Sbjct: 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 110/237 (46%), Gaps = 26/237 (10%)
Query: 41  SVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ 100
           S+D      D+W E+   ++ + H++G  ++   + G    Y       VA+K L    +
Sbjct: 2   SMDPSSPNYDKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---E 53
Query: 101 NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ- 158
           +    +   +E  +MK + H N++ LL   T +         Y+++E M   NL   ++ 
Sbjct: 54  DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRE 107
Query: 159 ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 214
               +++   + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   
Sbjct: 108 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 167
Query: 215 GTTFMMTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
           G T+  T +   ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 168 GDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/139 (33%), Positives = 72/139 (51%), Gaps = 24/139 (17%)
Query: 160 DLDHERMSY--LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--- 214
           +L+ +R  Y  L  Q+L  + ++HS GIIHR+LKP NI +     +KI DFGLA+     
Sbjct: 110 NLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 215 ------------GTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGV 261
                       G++  +T  + T  Y A EV+ G G Y E +D +S+G I  E I    
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---- 225
Query: 262 LFPGTDHIDQWNKIIGKMR 280
            +P +   ++ N I+ K+R
Sbjct: 226 -YPFSTGXERVN-ILKKLR 242

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 28/231 (12%)
Query: 58  QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKL-SRPFQNVTHAKRAYREFKLMK 116
           ++  + + +GK     S  G   A    T   VAIK +  +        +R   E K+  
Sbjct: 11  EDFKVGNLLGKG----SFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 117 LVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHERMSYLLY 171
            + H +I+ L N F      E+   VYLV+E+     M+  L   ++   ++E   + ++
Sbjct: 67  QLKHPSILELYNYF------EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE-ARHFMH 119
Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPY------VV 225
           Q++ G+ +LHS GI+HRDL  SN+++  +  +KI DFGLA     T +  P+        
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCG 174
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           T  Y +PE+     +    D+WS+GC+   ++ G   F      +  NK++
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV 225

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS--- 167
           E  + + + H++++G    F      E+   V++V+EL     C+   +   H+R     
Sbjct: 89  EISIHRSLAHQHVVGFHGFF------EDNDFVFVVLEL-----CRRRSLLELHKRRKALT 137
Query: 168 -----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP 222
                Y L Q++ G ++LH   +IHRDLK  N+ +  D  +KI DFGLA           
Sbjct: 138 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 197
Query: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
            +  T  Y APEV+   G+   VD+WS+GCIM  ++ G   F
Sbjct: 198 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLLNAFTPQKSLEE 138
           A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L   F   + L  
Sbjct: 54  ARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL-- 110
Query: 139 FQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
               + +    +  L + I+     D     +   +++  +++LH  GIIHRDLKP NI+
Sbjct: 111 ---YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL 167
Query: 197 VKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
           +  D  ++I DFG A+             +V T  Y +PE++      ++ D+W++GCI+
Sbjct: 168 LNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCII 227
Query: 254 GEMIRGGVLFPGTDHIDQWNKII 276
            +++ G   F   +    + KII
Sbjct: 228 YQLVAGLPPFRAGNEYLIFQKII 250

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 60  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 111
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++       
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRXXLC 170
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 84/171 (49%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 61  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSRFDEQ 112
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S+  LKI DFG +  A ++   T   
Sbjct: 113 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT-LC 171
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI 222

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLLNAFTPQKSLEE 138
           A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L   F   + L  
Sbjct: 51  ARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL-- 107
Query: 139 FQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
               + +    +  L + I+     D     +   +++  +++LH  GIIHRDLKP NI+
Sbjct: 108 ---YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL 164
Query: 197 VKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
           +  D  ++I DFG A+             +V T  Y +PE++      ++ D+W++GCI+
Sbjct: 165 LNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCII 224
Query: 254 GEMIRG 259
            +++ G
Sbjct: 225 YQLVAG 230

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 109/231 (47%), Gaps = 28/231 (12%)
Query: 48  TVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKR 107
           ++D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    + 
Sbjct: 2   SLDKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEE 53
Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERM 166
             +E  +MK + H N++ LL   T +         Y++ E M   NL   ++ + + + +
Sbjct: 54  FLKEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLR-ECNRQEV 106
Query: 167 S-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMM 220
           S     Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G TF  
Sbjct: 107 SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTF-- 164
Query: 221 TPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
           T +   ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 165 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 215

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 89/180 (49%), Gaps = 12/180 (6%)
Query: 100 QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ 158
           + V H  R  RE ++   ++H NI+ L N F  ++       +YL++E      L + +Q
Sbjct: 64  EGVEHQLR--REIEIQAHLHHPNILRLYNYFYDRRR------IYLILEYAPRGELYKELQ 115
Query: 159 MD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
                D +R + ++ ++   + + H   +IHRD+KP N+++     LKI DFG +  A +
Sbjct: 116 KSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPS 175
Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
               T    T  Y  PE+I G  + E VD+W +G +  E++ G   F    H + + +I+
Sbjct: 176 LRRKT-MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIV 234

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE 164
           RE ++   + H NI+ L   F       +   VYL++E   A L  V +        D +
Sbjct: 60  REVEIQSHLRHPNILRLYGYF------HDATRVYLILEY--APLGTVYRELQKLSKFDEQ 111
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           R +  + ++   + + HS  +IHRD+KP N+++ S   LKI DFG +  A ++       
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRDDLC 170
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T  Y  PE+I G  + E VD+WS+G +  E + G   F    + + + +I
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 57/100 (57%), Gaps = 1/100 (1%)
Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFM 219
            D  +++ +L ++L G+ +LHS   IHRD+K +N+++     +K+ DFG+A +   T   
Sbjct: 117 FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 176
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
              +V T ++ APEVI    Y    DIWS+G    E+ +G
Sbjct: 177 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 216

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS--- 167
           E  + + + H++++G    F      E+   V++V+EL     C+   +   H+R     
Sbjct: 65  EISIHRSLAHQHVVGFHGFF------EDNDFVFVVLEL-----CRRRSLLELHKRRKALT 113
Query: 168 -----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP 222
                Y L Q++ G ++LH   +IHRDLK  N+ +  D  +KI DFGLA           
Sbjct: 114 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173
Query: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
            +  T  Y APEV+   G+   VD+WS+GCIM  ++ G   F
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 215

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 109/237 (45%), Gaps = 26/237 (10%)
Query: 41  SVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ 100
           S+D      D+W E+   ++ + H++G  ++   + G    Y       VA+K L    +
Sbjct: 2   SMDPSSPNYDKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---E 53
Query: 101 NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ- 158
           +    +   +E  +MK + H N++ LL   T +         Y++ E M   NL   ++ 
Sbjct: 54  DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRE 107
Query: 159 ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 214
               +++   + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   
Sbjct: 108 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 167
Query: 215 GTTFMMTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
           G T+  T +   ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 168 GDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 30/186 (16%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL----MDANLCQVIQMDLDHER 165
           +E +L++ + HKN+I L++        EE Q +Y+VME     M   L  V +      +
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYN----EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQ 110
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
                 Q++ G+++LHS GI+H+D+KP N+++ +  TLKI   G+A        + P+  
Sbjct: 111 AHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA------LHPFAA 164
Query: 226 ---------TRYYRAPEVILGM----GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW 272
                    +  ++ PE+  G+    G+K  VDIWS G  +  +  G   F G D+I + 
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFK--VDIWSAGVTLYNITTGLYPFEG-DNIYKL 221
Query: 273 NKIIGK 278
            + IGK
Sbjct: 222 FENIGK 227

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 110/232 (47%), Gaps = 28/232 (12%)
Query: 47  HTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAK 106
            ++D+W E+   ++ + H++G  ++   ++G    Y       VA+K L    ++    +
Sbjct: 22  QSMDKW-EMERTDITMKHKLGGGQYGEVYVGVWKKYSL----TVAVKTLK---EDTMEVE 73
Query: 107 RAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHER 165
              +E  +MK + H N++ LL   T +         Y+V E M   NL   ++ + + E 
Sbjct: 74  EFLKEAAVMKEIKHPNLVQLLGVCTLEPPF------YIVTEYMPYGNLLDYLR-ECNREE 126
Query: 166 MS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFM 219
           ++     Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G T+ 
Sbjct: 127 VTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTY- 185
Query: 220 MTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
            T +   ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 186 -TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 236

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 16/156 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD----HERM 166
           E  ++   +H NI+ LL+AF  + +L      ++++E         + ++L+      ++
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNL------WILIEFCAGGAVDAVMLELERPLTESQI 137
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVV 225
             +  Q L  + +LH   IIHRDLK  NI+   D  +K+ DFG+ A+          ++ 
Sbjct: 138 QVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIG 197
Query: 226 TRYYRAPEVILGMGYKE-----NVDIWSVGCIMGEM 256
           T Y+ APEV++    K+       D+WS+G  + EM
Sbjct: 198 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 22/198 (11%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  +  ++NH+N++     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINAMLNHENVV----K 69
Query: 130 FTPQKSLEEFQDVYLVM----ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F   +     Q ++L      EL D     +   + D +R     +Q++ G+ +LH  GI
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIGI 126
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
            HRD+KP N+++     LKI DFGLA   R      ++     T  Y APE++    +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 242 ENVDIWSVGCIMGEMIRG 259
           E VD+WS G ++  M+ G
Sbjct: 187 EPVDVWSCGIVLTAMLAG 204

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 11/162 (6%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERM 166
           RE +++   N   I+G   AF          ++ + ME MD  +L QV++    +  + +
Sbjct: 115 RELQVLHECNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLKKAGRIPEQIL 168
Query: 167 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
             +   ++ G+ +L     I+HRD+KPSNI+V S   +K+ DFG++       M   +V 
Sbjct: 169 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVG 227
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
           TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 228 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 269

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 20/174 (11%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-LCQVIQMD--LDHERMSYLL 170
           L+K V H  ++GL  +F     L      Y V++ ++   L   +Q +      R  +  
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKL------YFVLDYINGGELFYHLQRERCFLEPRARFYA 145
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTTFMMTPYV 224
            ++   + +LHS  I++RDLKP NI++ S   + + DFGL +      +  +TF  TP  
Sbjct: 146 AEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTP-- 203
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
               Y APEV+    Y   VD W +G ++ EM+ G   F   +  + ++ I+ K
Sbjct: 204 ---EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 42/232 (18%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN-----------IIGLLNA 129
           A D     +VA+K +     +  + + A  E KL++ VN  +           I+ LL+ 
Sbjct: 38  AKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94
Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLY------QMLCGIKHLHS- 182
           F  +        V +V E++  NL  +I+   +H  +  L+Y      Q+L G+ ++H  
Sbjct: 95  FNHKGP--NGVHVVMVFEVLGENLLALIK-KYEHRGIP-LIYVKQISKQLLLGLDYMHRR 150
Query: 183 AGIIHRDLKPSNIVVK------SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL 236
            GIIH D+KP N++++      +   +KI D G A      +  T  + TR YR+PEV+L
Sbjct: 151 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--TNSIQTREYRSPEVLL 208
Query: 237 GMGYKENVDIWSVGCIMGEMIRGGVLF---------PGTDHIDQWNKIIGKM 279
           G  +    DIWS  C++ E+I G  LF            DHI Q  +++G++
Sbjct: 209 GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 260

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS--- 167
           E  + K +++ +++G    F      E+   VY+V+E+     C+   +   H+R     
Sbjct: 92  EIAIHKSLDNPHVVGFHGFF------EDDDFVYVVLEI-----CRRRSLLELHKRRKAVT 140
Query: 168 -----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------AGT 216
                Y + Q + G+++LH+  +IHRDLK  N+ +  D  +KI DFGLA           
Sbjct: 141 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKK 200
Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
           T   TP      Y APEV+   G+   VDIWS+GCI+  ++ G   F
Sbjct: 201 TLCGTP-----NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 42/232 (18%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN-----------IIGLLNA 129
           A D     +VA+K +     +  + + A  E KL++ VN  +           I+ LL+ 
Sbjct: 38  AKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94
Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLY------QMLCGIKHLHS- 182
           F  +        V +V E++  NL  +I+   +H  +  L+Y      Q+L G+ ++H  
Sbjct: 95  FNHKGP--NGVHVVMVFEVLGENLLALIK-KYEHRGIP-LIYVKQISKQLLLGLDYMHRR 150
Query: 183 AGIIHRDLKPSNIVVK------SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL 236
            GIIH D+KP N++++      +   +KI D G A      +  T  + TR YR+PEV+L
Sbjct: 151 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--TNSIQTREYRSPEVLL 208
Query: 237 GMGYKENVDIWSVGCIMGEMIRGGVLF---------PGTDHIDQWNKIIGKM 279
           G  +    DIWS  C++ E+I G  LF            DHI Q  +++G++
Sbjct: 209 GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 260

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 9/156 (5%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
           L K+  H NII L + +          D+    EL D    +V   + +  ++   L ++
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPE 233
           +C    LH   I+HRDLKP NI++  D  +K+ DFG +        +     T  Y APE
Sbjct: 137 ICA---LHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPE 193
Query: 234 VILGM------GYKENVDIWSVGCIMGEMIRGGVLF 263
           +I         GY + VD+WS G IM  ++ G   F
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAY--REFKLMKLVNHKNIIGLLNAFTPQKSLEE 138
           A + AT +  AIK L +    +   K  Y  RE  +M  ++H   + L   F   + L  
Sbjct: 51  ARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL-- 107
Query: 139 FQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
               + +    +  L + I+     D     +   +++  +++LH  GIIHRDLKP NI+
Sbjct: 108 ---YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL 164
Query: 197 VKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
           +  D  ++I DFG A+             +V T  Y +PE++      ++ D+W++GCI+
Sbjct: 165 LNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCII 224
Query: 254 GEMIRG 259
            +++ G
Sbjct: 225 YQLVAG 230

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 9/156 (5%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
           L K+  H NII L + +          D+    EL D    +V   + +  ++   L ++
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPE 233
           +C    LH   I+HRDLKP NI++  D  +K+ DFG +        +     T  Y APE
Sbjct: 137 ICA---LHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 234 VILGM------GYKENVDIWSVGCIMGEMIRGGVLF 263
           +I         GY + VD+WS G IM  ++ G   F
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 16/156 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD----HERM 166
           E  ++   +H NI+ LL+AF  + +L      ++++E         + ++L+      ++
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNL------WILIEFCAGGAVDAVMLELERPLTESQI 137
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVV 225
             +  Q L  + +LH   IIHRDLK  NI+   D  +K+ DFG+ A+          ++ 
Sbjct: 138 QVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIG 197
Query: 226 TRYYRAPEVILGMGYKE-----NVDIWSVGCIMGEM 256
           T Y+ APEV++    K+       D+WS+G  + EM
Sbjct: 198 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 17/168 (10%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLD------ 162
           RE  +  ++ H +I+ LL  ++    L      Y+V E MD A+LC  I    D      
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGML------YMVFEFMDGADLCFEIVKRADAGFVYS 128
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFM 219
               S+ + Q+L  +++ H   IIHRD+KP  +++ S      +K+  FG+A   G + +
Sbjct: 129 EAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188
Query: 220 MTP-YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT 266
           +    V T ++ APEV+    Y + VD+W  G I+  ++ G + F GT
Sbjct: 189 VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 11/162 (6%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERM 166
           RE +++   N   I+G   AF          ++ + ME MD  +L QV++    +  + +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLKKAGRIPEQIL 106
Query: 167 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
             +   ++ G+ +L     I+HRD+KPSNI+V S   +K+ DFG++     + M   +V 
Sbjct: 107 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVG 165
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
           TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 100/254 (39%), Gaps = 74/254 (29%)
Query: 77  GAGAAYDTATQQ---NVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAF--- 130
           G G  ++   +    N AIK++  P + +   K   RE K +  + H  I+   NA+   
Sbjct: 18  GFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK-VMREVKALAKLEHPGIVRYFNAWLET 76
Query: 131 TPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS---------------------YL 169
            P+K  EE  +++L  E  D  L     MD    ++                      YL
Sbjct: 77  PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYL 136
Query: 170 LYQM-LC--------------------------------GIKHLHSAGIIHRDLKPSNIV 196
             QM LC                                 ++ LHS G++HRDLKPSNI 
Sbjct: 137 YIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIF 196
Query: 197 VKSDCTLKILDFGLA----RTAGTTFMMTPY---------VVTRYYRAPEVILGMGYKEN 243
              D  +K+ DFGL     +      ++TP          V T+ Y +PE I G  Y   
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHK 256
Query: 244 VDIWSVGCIMGEMI 257
           VDI+S+G I+ E++
Sbjct: 257 VDIFSLGLILFELL 270

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 124/278 (44%), Gaps = 29/278 (10%)
Query: 2   LVIDPEKRISVDDALMHPYINVWFDD--AEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           L +  E R +    L+H +  V  D     +H PAP     +V       D+W E+   +
Sbjct: 203 LYVSSESRFNTLAELVHHHSTV-ADGLITTLHYPAPKRNKPTVYGVSPNYDKW-EMERTD 260
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           + + H++G  ++   + G    Y       VA+K L    ++    +   +E  +MK + 
Sbjct: 261 ITMKHKLGGGQYGEVYEGVWKKYSLT----VAVKTLK---EDTMEVEEFLKEAAVMKEIK 313
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHERMSYLLYQML 174
           H N++ LL   T +         Y++ E M   NL   ++     +++   + Y+  Q+ 
Sbjct: 314 HPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 367
Query: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPYVVTRY---YR 230
             +++L     IHR+L   N +V  +  +K+ DFGL+R   G T+  T +   ++   + 
Sbjct: 368 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWT 425
Query: 231 APEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
           APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 426 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 463

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 125/279 (44%), Gaps = 31/279 (11%)
Query: 2   LVIDPEKRISVDDALMHPYINVWFDD--AEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           L +  E R +    L+H +  V  D     +H PAP     ++       D+W E+   +
Sbjct: 164 LYVSSESRFNTLAELVHHHSTV-ADGLITTLHYPAPKRNKPTIYGVSPNYDKW-EMERTD 221
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           + + H++G  ++   + G    Y       VA+K L    ++    +   +E  +MK + 
Sbjct: 222 ITMKHKLGGGQYGEVYEGVWKKYSLT----VAVKTLK---EDTMEVEEFLKEAAVMKEIK 274
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMS-----YLLYQM 173
           H N++ LL   T +         Y++ E M   NL   ++ + + + +S     Y+  Q+
Sbjct: 275 HPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQI 327
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPYVVTRY---Y 229
              +++L     IHR+L   N +V  +  +K+ DFGL+R   G T+  T +   ++   +
Sbjct: 328 SSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKW 385
Query: 230 RAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
            APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 11/162 (6%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--DLDHERM 166
           RE +++   N   I+G   AF          ++ + ME MD  +L QV++    +  + +
Sbjct: 80  RELQVLHECNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLKKAGRIPEQIL 133
Query: 167 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
             +   ++ G+ +L     I+HRD+KPSNI+V S   +K+ DFG++     + M   +V 
Sbjct: 134 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVG 192
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
           TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 23/235 (9%)
Query: 47  HTVDQWKELIYQELPISHQMGKKRHNT-SHLGAGA------AYDTATQQNVAIKKLSRPF 99
           +  D WK+   Q + I H      ++    LG GA        + AT  N A K +  P 
Sbjct: 29  YVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH 88
Query: 100 QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM 159
           ++     R  +E + M ++ H  ++ L +AF      E+  ++ ++ E M          
Sbjct: 89  ESDKETVR--KEIQTMSVLRHPTLVNLHDAF------EDDNEMVMIYEFMSGGELFEKVA 140
Query: 160 DLDHERMSY-----LLYQMLCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLAR 212
           D +H +MS       + Q+  G+ H+H    +H DLKP NI+   K    LK++DFGL  
Sbjct: 141 D-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 199
Query: 213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
                  +     T  + APEV  G       D+WSVG +   ++ G   F G +
Sbjct: 200 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 254

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 17/168 (10%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLD------ 162
           RE  +  ++ H +I+ LL  ++    L      Y+V E MD A+LC  I    D      
Sbjct: 77  REASICHMLKHPHIVELLETYSSDGML------YMVFEFMDGADLCFEIVKRADAGFVYS 130
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFM 219
               S+ + Q+L  +++ H   IIHRD+KP  +++ S      +K+  FG+A   G + +
Sbjct: 131 EAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 190
Query: 220 MTP-YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT 266
           +    V T ++ APEV+    Y + VD+W  G I+  ++ G + F GT
Sbjct: 191 VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 238

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 111 EFKLMKLVN-HKNIIGLLNAFT---PQKSLEEFQDVYLVMELMDA----------NLCQV 156
           E ++MK++  HKNII LL A T   P   + E+     + E + A          N    
Sbjct: 72  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 131
Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--- 213
            +  L  + +    YQ+  G+++L S   IHRDL   N++V  D  +KI DFGLAR    
Sbjct: 132 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 191
Query: 214 ----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT 266
                 TT    P      + APE +    Y    D+WS G ++ E+   GG  +PG 
Sbjct: 192 IDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 245

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 11/162 (6%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERM 166
           RE +++   N   I+G   AF          ++ + ME MD  +L QV++    +  + +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLKKAGRIPEQIL 106
Query: 167 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
             +   ++ G+ +L     I+HRD+KPSNI+V S   +K+ DFG++     + M   +V 
Sbjct: 107 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVG 165
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
           TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 9/156 (5%)
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
           L K+  H NII L + +          D+    EL D    +V   + +  ++   L ++
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPE 233
           +C    LH   I+HRDLKP NI++  D  +K+ DFG +        +     T  Y APE
Sbjct: 124 ICA---LHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 180
Query: 234 VILGM------GYKENVDIWSVGCIMGEMIRGGVLF 263
           +I         GY + VD+WS G IM  ++ G   F
Sbjct: 181 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 11/162 (6%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERM 166
           RE +++   N   I+G   AF          ++ + ME MD  +L QV++    +  + +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLKKAGRIPEQIL 106
Query: 167 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
             +   ++ G+ +L     I+HRD+KPSNI+V S   +K+ DFG++     + M   +V 
Sbjct: 107 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVG 165
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
           TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 110/238 (46%), Gaps = 28/238 (11%)
Query: 41  SVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ 100
           ++D      D+W E+   ++ + H++G  ++   + G    Y       VA+K L    +
Sbjct: 2   AMDPSSPNYDKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---E 53
Query: 101 NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM 159
           +    +   +E  +MK + H N++ LL   T +         Y++ E M   NL   ++ 
Sbjct: 54  DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLR- 106
Query: 160 DLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-T 213
           + + + +S     Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R  
Sbjct: 107 ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 166
Query: 214 AGTTFMMTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
            G T+  T +   ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 167 TGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 111 EFKLMKLVN-HKNIIGLLNAFT---PQKSLEEFQDVYLVMELMDA----------NLCQV 156
           E ++MK++  HKNII LL A T   P   + E+     + E + A          N    
Sbjct: 75  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 134
Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--- 213
            +  L  + +    YQ+  G+++L S   IHRDL   N++V  D  +KI DFGLAR    
Sbjct: 135 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 194
Query: 214 ----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT 266
                 TT    P      + APE +    Y    D+WS G ++ E+   GG  +PG 
Sbjct: 195 IDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 248

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 23/235 (9%)
Query: 47  HTVDQWKELIYQELPISHQMGKKRHNT-SHLGAGA------AYDTATQQNVAIKKLSRPF 99
           +  D WK+   Q + I H      ++    LG GA        + AT  N A K +  P 
Sbjct: 135 YVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH 194
Query: 100 QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM 159
           ++     R  +E + M ++ H  ++ L +AF      E+  ++ ++ E M          
Sbjct: 195 ESDKETVR--KEIQTMSVLRHPTLVNLHDAF------EDDNEMVMIYEFMSGGELFEKVA 246
Query: 160 DLDHERMSY-----LLYQMLCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLAR 212
           D +H +MS       + Q+  G+ H+H    +H DLKP NI+   K    LK++DFGL  
Sbjct: 247 D-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
                  +     T  + APEV  G       D+WSVG +   ++ G   F G +
Sbjct: 306 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 111 EFKLMKLVN-HKNIIGLLNAFT---PQKSLEEFQDVYLVMELMDA----------NLCQV 156
           E ++MK++  HKNII LL A T   P   + E+     + E + A          N    
Sbjct: 76  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 135
Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--- 213
            +  L  + +    YQ+  G+++L S   IHRDL   N++V  D  +KI DFGLAR    
Sbjct: 136 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 195
Query: 214 ----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT 266
                 TT    P      + APE +    Y    D+WS G ++ E+   GG  +PG 
Sbjct: 196 IDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 249

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 109/237 (45%), Gaps = 26/237 (10%)
Query: 41  SVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ 100
           ++D      D+W E+   ++ + H++G  ++   + G    Y       VA+K L    +
Sbjct: 2   AMDPSSPNYDKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---E 53
Query: 101 NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ- 158
           +    +   +E  +MK + H N++ LL   T +         Y++ E M   NL   ++ 
Sbjct: 54  DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRE 107
Query: 159 ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 214
               +++   + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   
Sbjct: 108 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 167
Query: 215 GTTFMMTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
           G T+  T +   ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 168 GDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   
Sbjct: 6   DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEEFL 57
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMS- 167
           +E  +MK + H N++ LL   T +         Y+++E M   NL   ++ + + + +S 
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLR-ECNRQEVSA 110
Query: 168 ----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTP 222
               Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G T+  T 
Sbjct: 111 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TA 168
Query: 223 YVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
           +   ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 111 EFKLMKLVN-HKNIIGLLNAFT---PQKSLEEFQDVYLVMELMDA----------NLCQV 156
           E ++MK++  HKNII LL A T   P   + E+     + E + A          N    
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHN 142
Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---- 212
            +  L  + +    YQ+  G+++L S   IHRDL   N++V  D  +KI DFGLAR    
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 213 ---TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT 266
                 TT    P      + APE +    Y    D+WS G ++ E+   GG  +PG 
Sbjct: 203 IDXXKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 256

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 111 EFKLMKLVN-HKNIIGLLNAFT---PQKSLEEFQDVYLVMELMDA----------NLCQV 156
           E ++MK++  HKNII LL A T   P   + E+     + E + A          N    
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 142
Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--- 213
            +  L  + +    YQ+  G+++L S   IHRDL   N++V  D  +KI DFGLAR    
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 214 ----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT 266
                 TT    P      + APE +    Y    D+WS G ++ E+   GG  +PG 
Sbjct: 203 IDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 256

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 111 EFKLMKLVN-HKNIIGLLNAFT---PQKSLEEFQDVYLVMELMDA----------NLCQV 156
           E ++MK++  HKNII LL A T   P   + E+     + E + A          N    
Sbjct: 68  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 127
Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--- 213
            +  L  + +    YQ+  G+++L S   IHRDL   N++V  D  +KI DFGLAR    
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 214 ----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT 266
                 TT    P      + APE +    Y    D+WS G ++ E+   GG  +PG 
Sbjct: 188 IDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   
Sbjct: 6   DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEEFL 57
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMS- 167
           +E  +MK + H N++ LL   T +         Y+++E M   NL   ++ + + + +S 
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLR-ECNRQEVSA 110
Query: 168 ----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTP 222
               Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G T+  T 
Sbjct: 111 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TA 168
Query: 223 YVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
           +   ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 111 EFKLMKLVN-HKNIIGLLNAFT---PQKSLEEFQDVYLVMELMDA----------NLCQV 156
           E ++MK++  HKNII LL A T   P   + E+     + E + A          N    
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHN 142
Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--- 213
            +  L  + +    YQ+  G+++L S   IHRDL   N++V  D  +KI DFGLAR    
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 214 ----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT 266
                 TT    P      + APE +    Y    D+WS G ++ E+   GG  +PG 
Sbjct: 203 IDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 256

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 108/230 (46%), Gaps = 26/230 (11%)
Query: 48  TVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKR 107
           ++D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    + 
Sbjct: 2   SLDKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEE 53
Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERM 166
             +E  +MK + H N++ LL   T +         Y+++E M   NL   ++ + + + +
Sbjct: 54  FLKEAAVMKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLR-ECNRQEV 106
Query: 167 S-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMT 221
           S     Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   T    T
Sbjct: 107 SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXT 165
Query: 222 PYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
            +   ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 166 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 215

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 11/162 (6%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERM 166
           RE +++   N   I+G   AF          ++ + ME MD  +L QV++    +  + +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLKKAGRIPEQIL 106
Query: 167 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
             +   ++ G+ +L     I+HRD+KPSNI+V S   +K+ DFG++     + M   +V 
Sbjct: 107 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVG 165
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
           TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 11/162 (6%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERM 166
           RE +++   N   I+G   AF          ++ + ME MD  +L QV++    +  + +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLKKAGRIPEQIL 106
Query: 167 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
             +   ++ G+ +L     I+HRD+KPSNI+V S   +K+ DFG++     + M   +V 
Sbjct: 107 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVG 165
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
           TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 103 THAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD- 160
              +  ++E ++M+ + H  ++ L  +F  +      +D+++V++L+   +L   +Q + 
Sbjct: 57  NEVRNVFKELQIMQGLEHPFLVNLWYSFQDE------EDMFMVVDLLLGGDLRYHLQQNV 110
Query: 161 -LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM 219
               E +   + +++  + +L +  IIHRD+KP NI++     + I DF +A        
Sbjct: 111 HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 220 MTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIRG 259
           +T    T+ Y APE+     G GY   VD WS+G    E++RG
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 20/162 (12%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS--- 167
           E  + K +++ +++G    F      E+   VY+V+E+     C+   +   H+R     
Sbjct: 92  EIAIHKSLDNPHVVGFHGFF------EDDDFVYVVLEI-----CRRRSLLELHKRRKAVT 140
Query: 168 -----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP 222
                Y + Q + G+++LH+  +IHRDLK  N+ +  D  +KI DFGLA           
Sbjct: 141 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKK 200
Query: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
            +  T  Y APEV+   G+   VDIWS+GCI+  ++ G   F
Sbjct: 201 XLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            I+ LHS  I HRD+KP N++  S   D  LK+ DFG A+      + TP   T YY AP
Sbjct: 121 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAP 179
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIRGGVLFP 264
           EV+    Y ++ D+WS+G IM  ++ G   FP
Sbjct: 180 EVLGPEKYDKSCDMWSLGVIMYILLCG---FP 208

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 111 EFKLMKLVN-HKNIIGLLNAFT---PQKSLEEFQDVYLVMELMDA----------NLCQV 156
           E ++MK++  HKNII LL A T   P   + E+     + E + A          N    
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 142
Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--- 213
            +  L  + +    YQ+  G+++L S   IHRDL   N++V  D  +KI DFGLAR    
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 214 ----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT 266
                 TT    P      + APE +    Y    D+WS G ++ E+   GG  +PG 
Sbjct: 203 IDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 256

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 13/181 (7%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T Q  A K ++    +    ++  RE ++ +L+ H NI+ L ++     S E F   YLV
Sbjct: 28  TGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI----SEEGFH--YLV 81
Query: 146 MELMDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-- 200
            +L+        ++  +   E   S+ + Q+L  + H H  GI+HRDLKP N+++ S   
Sbjct: 82  FDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSK 141
Query: 201 -CTLKILDFGLA-RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
              +K+ DFGLA    G       +  T  Y +PEV+    Y + VD+W+ G I+  ++ 
Sbjct: 142 GAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLV 201
Query: 259 G 259
           G
Sbjct: 202 G 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 5/109 (4%)
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFM 219
            ER  +   +++  +++LHS  +++RD+K  N+++  D  +KI DFGL +   + G T  
Sbjct: 109 EERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 166
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 167 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 215

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 20/162 (12%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS--- 167
           E  + K +++ +++G    F      E+   VY+V+E+     C+   +   H+R     
Sbjct: 92  EIAIHKSLDNPHVVGFHGFF------EDDDFVYVVLEI-----CRRRSLLELHKRRKAVT 140
Query: 168 -----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMT 221
                Y + Q + G+++LH+  +IHRDLK  N+ +  D  +KI DFGLA +         
Sbjct: 141 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKK 200
Query: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
               T  Y APEV+   G+   VDIWS+GCI+  ++ G   F
Sbjct: 201 DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            I+ LHS  I HRD+KP N++  S   D  LK+ DFG A+      + TP   T YY AP
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAP 198
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIRGGVLFP 264
           EV+    Y ++ D+WS+G IM  ++ G   FP
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCG---FP 227

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 84/164 (51%), Gaps = 10/164 (6%)
Query: 106 KRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDH 163
           ++ Y+E  ++K ++H N++ L+              +Y+V EL++      +     L  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNE----DHLYMVFELVNQGPVMEVPTLKPLSE 136
Query: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTTFMMTP 222
           ++  +    ++ GI++LH   IIHRD+KPSN++V  D  +KI DFG++    G+  +++ 
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 223 YVVTRYYRAPEVI---LGMGYKENVDIWSVGCIMGEMIRGGVLF 263
            V T  + APE +     +   + +D+W++G  +   + G   F
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 13/181 (7%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T Q  A K ++    +    ++  RE ++ +L+ H NI+ L ++     S E F   YLV
Sbjct: 28  TGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI----SEEGFH--YLV 81
Query: 146 MELMDAN--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-- 200
            +L+        ++  +   E   S+ + Q+L  + H H  GI+HRDLKP N+++ S   
Sbjct: 82  FDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSK 141
Query: 201 -CTLKILDFGLA-RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
              +K+ DFGLA    G       +  T  Y +PEV+    Y + VD+W+ G I+  ++ 
Sbjct: 142 GAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLV 201
Query: 259 G 259
           G
Sbjct: 202 G 202

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 106/228 (46%), Gaps = 26/228 (11%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   
Sbjct: 8   DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEEFL 59
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
           +E  +MK + H N++ LL   T +         Y++ E M   NL   ++     +++  
Sbjct: 60  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAV 113
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPY 223
            + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G T+  T +
Sbjct: 114 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAH 171
Query: 224 VVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
              ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 219

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 5/109 (4%)
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFM 219
            ER  +   +++  +++LHS  +++RD+K  N+++  D  +KI DFGL +   + G T  
Sbjct: 104 EERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 162 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 80/177 (45%), Gaps = 26/177 (14%)
Query: 111 EFKLMKLVN-HKNIIGLLNAFT---PQKSLEEFQDVYLVMELMDA----------NLCQV 156
           E ++MK++  HKNII LL A T   P   + E+     + E + A          N    
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--- 213
            +  L  + +    YQ+  G+++L S   IHRDL   N++V  D  +KI DFGLAR    
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243
Query: 214 ----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
                 TT    P      + APE +    Y    D+WS G ++ E+   GG  +PG
Sbjct: 244 IDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 20/162 (12%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS--- 167
           E  + K +++ +++G    F      E+   VY+V+E+     C+   +   H+R     
Sbjct: 76  EIAIHKSLDNPHVVGFHGFF------EDDDFVYVVLEI-----CRRRSLLELHKRRKAVT 124
Query: 168 -----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFMMT 221
                Y + Q + G+++LH+  +IHRDLK  N+ +  D  +KI DFGLA +         
Sbjct: 125 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKK 184
Query: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
               T  Y APEV+   G+   VDIWS+GCI+  ++ G   F
Sbjct: 185 DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 23/165 (13%)
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN---LCQVIQMDLDHERMSYLLYQMLC 175
           NH  ++GL + F  +  L      + V+E ++          Q  L  E   +   ++  
Sbjct: 111 NHPFLVGLHSCFQTESRL------FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 164
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTTFMMTPYVVTRYY 229
            + +LH  GII+RDLK  N+++ S+  +K+ D+G+ +         +TF  TP      Y
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP-----NY 219
Query: 230 RAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP---GTDHIDQ 271
            APE++ G  Y  +VD W++G +M EM+ G   F     +D+ DQ
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 7/154 (4%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYL 169
           RE ++ +L+ H NI+ L ++ + +       D+    EL +  + +    + D    S+ 
Sbjct: 70  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD---ASHC 126
Query: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLA-RTAGTTFMMTPYVV 225
           + Q+L  + H H  G++HRDLKP N+++ S      +K+ DFGLA    G       +  
Sbjct: 127 IQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 186
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           T  Y +PEV+    Y + VD+W+ G I+  ++ G
Sbjct: 187 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 106/228 (46%), Gaps = 26/228 (11%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   
Sbjct: 19  DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEEFL 70
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
           +E  +MK + H N++ LL   T +         Y++ E M   NL   ++     +++  
Sbjct: 71  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAV 124
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPY 223
            + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G T+  T +
Sbjct: 125 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAH 182
Query: 224 VVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
              ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 183 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 230

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 107/229 (46%), Gaps = 28/229 (12%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   
Sbjct: 6   DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEEFL 57
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMS- 167
           +E  +MK + H N++ LL   T +         Y++ E M   NL   ++ + + + +S 
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLR-ECNRQEVSA 110
Query: 168 ----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTP 222
               Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G T+  T 
Sbjct: 111 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TA 168
Query: 223 YVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
           +   ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 106/228 (46%), Gaps = 26/228 (11%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   
Sbjct: 8   DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEEFL 59
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
           +E  +MK + H N++ LL   T +         Y++ E M   NL   ++     +++  
Sbjct: 60  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAV 113
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPY 223
            + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G T+  T +
Sbjct: 114 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAH 171
Query: 224 VVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
              ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 219

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 106/228 (46%), Gaps = 26/228 (11%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   
Sbjct: 10  DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEEFL 61
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
           +E  +MK + H N++ LL   T +         Y++ E M   NL   ++     +++  
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAV 115
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPY 223
            + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G T+  T +
Sbjct: 116 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAH 173
Query: 224 VVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
              ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 107/229 (46%), Gaps = 28/229 (12%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   
Sbjct: 6   DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEEFL 57
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMS- 167
           +E  +MK + H N++ LL   T +         Y++ E M   NL   ++ + + + +S 
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLR-ECNRQEVSA 110
Query: 168 ----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTP 222
               Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G T+  T 
Sbjct: 111 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TA 168
Query: 223 YVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
           +   ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 5/109 (4%)
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFM 219
            ER  +   +++  +++LHS  +++RD+K  N+++  D  +KI DFGL +   + G T  
Sbjct: 107 EERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 164
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 165 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 213

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 106/228 (46%), Gaps = 26/228 (11%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   
Sbjct: 6   DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEEFL 57
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
           +E  +MK + H N++ LL   T +         Y++ E M   NL   ++     +++  
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAV 111
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPY 223
            + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G T+  T +
Sbjct: 112 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAH 169
Query: 224 VVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
              ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 105/230 (45%), Gaps = 13/230 (5%)
Query: 50  DQWKELIYQELPISHQMGKKRHNT-SHLGAGA------AYDTATQQNVAIKKLSRPFQNV 102
           D WK+ + Q + +        ++    LG+GA        + AT +    K ++ P+   
Sbjct: 32  DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD 91
Query: 103 THAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD 162
            +  +   E  +M  ++H  +I L +AF  +  +    +     EL D    +  +M  +
Sbjct: 92  KYTVK--NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS-E 148
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTTFMM 220
            E ++Y+  Q   G+KH+H   I+H D+KP NI+   K   ++KI+DFGLA       ++
Sbjct: 149 AEVINYMR-QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207
Query: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID 270
                T  + APE++         D+W++G +   ++ G   F G D ++
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 257

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 5/109 (4%)
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFM 219
            ER  +   +++  +++LHS  +++RD+K  N+++  D  +KI DFGL +   + G T  
Sbjct: 104 EERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 5/109 (4%)
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFM 219
            ER  +   +++  +++LHS  +++RD+K  N+++  D  +KI DFGL +   + G T  
Sbjct: 104 EERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 162 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN---LCQVIQMDLDHERMSYLLYQMLC 175
           NH  ++GL + F  +  L      + V+E ++          Q  L  E   +   ++  
Sbjct: 64  NHPFLVGLHSCFQTESRL------FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 117
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTTFMMTPYVVTRYYRA 231
            + +LH  GII+RDLK  N+++ S+  +K+ D+G+     R   TT   + +  T  Y A
Sbjct: 118 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 174
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP---GTDHIDQ 271
           PE++ G  Y  +VD W++G +M EM+ G   F     +D+ DQ
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 217

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 5/109 (4%)
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFM 219
            ER  +   +++  +++LHS  +++RD+K  N+++  D  +KI DFGL +   + G T  
Sbjct: 104 EERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 162 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN---LCQVIQMDLDHERMSYLLYQMLC 175
           NH  ++GL + F  +  L      + V+E ++          Q  L  E   +   ++  
Sbjct: 68  NHPFLVGLHSCFQTESRL------FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTTFMMTPYVVTRYYRA 231
            + +LH  GII+RDLK  N+++ S+  +K+ D+G+     R   TT   + +  T  Y A
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 178
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP---GTDHIDQ 271
           PE++ G  Y  +VD W++G +M EM+ G   F     +D+ DQ
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 16/156 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD----HERM 166
           E +++   +H  I+ LL A+     L      ++++E         I ++LD      ++
Sbjct: 58  EIEILATCDHPYIVKLLGAYYHDGKL------WIMIEFCPGGAVDAIMLELDRGLTEPQI 111
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVV 225
             +  QML  +  LHS  IIHRDLK  N+++  +  +++ DFG+ A+   T      ++ 
Sbjct: 112 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG 171
Query: 226 TRYYRAPEVILGMGYKEN-----VDIWSVGCIMGEM 256
           T Y+ APEV++    K+       DIWS+G  + EM
Sbjct: 172 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 16/156 (10%)
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD----HERM 166
           E +++   +H  I+ LL A+     L      ++++E         I ++LD      ++
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKL------WIMIEFCPGGAVDAIMLELDRGLTEPQI 119
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTTFMMTPYVV 225
             +  QML  +  LHS  IIHRDLK  N+++  +  +++ DFG+ A+   T      ++ 
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG 179
Query: 226 TRYYRAPEVILGMGYKEN-----VDIWSVGCIMGEM 256
           T Y+ APEV++    K+       DIWS+G  + EM
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 59/109 (54%), Gaps = 5/109 (4%)
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTTFM 219
            ER  +   +++  +++LHS  +++RD+K  N+++  D  +KI DFGL +     G T  
Sbjct: 104 EERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 106/228 (46%), Gaps = 26/228 (11%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   
Sbjct: 6   DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEEFL 57
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
           +E  +MK + H N++ LL   T +         Y++ E M   NL   ++     +++  
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAV 111
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPY 223
            + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G T+  T +
Sbjct: 112 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAH 169
Query: 224 VVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
              ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 68  KKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLL 127
           K R  ++ L   A +    Q   + + +SR        +   RE  +++ V H N+I L 
Sbjct: 30  KCREKSTGLEYAAKFIKKRQSRASRRGVSR--------EEIEREVSILRQVLHHNVITLH 81
Query: 128 NAFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIKHLHS 182
           + +      E   DV L++EL+        L Q  +  L  E  +  + Q+L G+ +LH+
Sbjct: 82  DVY------ENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT 133
Query: 183 AGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI--- 235
             I H DLKP NI++         +K++DFGLA              T  + APE++   
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 236 -LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
            LG+      D+WS+G I   ++ G   F G
Sbjct: 194 PLGL----EADMWSIGVITYILLSGASPFLG 220

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 84/180 (46%), Gaps = 28/180 (15%)
Query: 106 KRAYREFKLMKLVNHKNII---GLLNAF-----TPQKSLE---------------EFQDV 142
           ++A RE K +  ++H NI+   G  + F     T   SLE               + + +
Sbjct: 50  EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCL 109
Query: 143 YLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
           ++ ME  D   L Q I+      LD      L  Q+  G+ ++HS  +IHRDLKPSNI +
Sbjct: 110 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFL 169
Query: 198 KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
                +KI DFGL  +       T    T  Y +PE I    Y + VD++++G I+ E++
Sbjct: 170 VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 21/195 (10%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G+      A    T Q VAIK++  P +  +  +   +E  +M+  +  +++    +
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQV--PVE--SDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGI 185
           +          D+++VME   A ++  +I++    L  + ++ +L   L G+++LH    
Sbjct: 93  YFKNT------DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV-TRYYRAPEVILGMGYKENV 244
           IHRD+K  NI++ ++   K+ DFG+A            V+ T ++ APEVI  +GY    
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVA 206
Query: 245 DIWSVGCIMGEMIRG 259
           DIWS+G    EM  G
Sbjct: 207 DIWSLGITAIEMAEG 221

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN---LCQVIQMDLDHERMSYLLYQMLC 175
           NH  ++GL + F  +  L      + V+E ++          Q  L  E   +   ++  
Sbjct: 79  NHPFLVGLHSCFQTESRL------FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 132
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTTFMMTPYVVTRYYRA 231
            + +LH  GII+RDLK  N+++ S+  +K+ D+G+     R   TT   + +  T  Y A
Sbjct: 133 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 189
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP---GTDHIDQ 271
           PE++ G  Y  +VD W++G +M EM+ G   F     +D+ DQ
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 232

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/128 (35%), Positives = 70/128 (54%), Gaps = 10/128 (7%)
Query: 142 VYLVMELMDA-NLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           V + MEL++  +L Q++  Q  L  +R  Y L Q L G+++LHS  I+H D+K  N+++ 
Sbjct: 160 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 219
Query: 199 SDCT-LKILDFGLART-----AGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGC 251
           SD +   + DFG A        G + +   Y+  T  + APEV+LG      VD+WS  C
Sbjct: 220 SDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCC 279
Query: 252 IMGEMIRG 259
           +M  M+ G
Sbjct: 280 MMLHMLNG 287

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 57/100 (57%), Gaps = 1/100 (1%)
Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTTFM 219
           L+   ++ +L ++L G+ +LHS   IHRD+K +N+++     +K+ DFG+A +   T   
Sbjct: 113 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 172
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
              +V T ++ APEVI    Y    DIWS+G    E+ +G
Sbjct: 173 RNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 212

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 107/236 (45%), Gaps = 24/236 (10%)
Query: 41  SVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ 100
           ++D      D+W E+   ++ + H++G  ++   + G    Y       VA+K L    +
Sbjct: 2   AMDPSSPNYDKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---E 53
Query: 101 NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ- 158
           +    +   +E  +MK + H N++ LL   T +         Y++ E M   NL   ++ 
Sbjct: 54  DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRE 107
Query: 159 ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215
               +++   + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   
Sbjct: 108 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM- 166
Query: 216 TTFMMTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
           T    T +   ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 167 TGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 105/227 (46%), Gaps = 24/227 (10%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   
Sbjct: 7   DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEEFL 58
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
           +E  +MK + H N++ LL   T +         Y+++E M   NL   ++     +++  
Sbjct: 59  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQEVNAV 112
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
            + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   T    T + 
Sbjct: 113 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHA 171
Query: 225 VTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
             ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 172 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 218

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 79/154 (51%), Gaps = 11/154 (7%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--DLDHERM 166
           RE +++   N   I+G   AF          ++ + ME MD  +L QV++    +  + +
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLKKAGRIPEQIL 125
Query: 167 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
             +   ++ G+ +L     I+HRD+KPSNI+V S   +K+ DFG++     + M   +V 
Sbjct: 126 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVG 184
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           TR Y +PE + G  Y    DIWS+G  + EM  G
Sbjct: 185 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 68  KKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLL 127
           K R  ++ L   A +    Q   + + +SR        +   RE  +++ V H N+I L 
Sbjct: 30  KCREKSTGLEYAAKFIKKRQSRASRRGVSR--------EEIEREVSILRQVLHHNVITLH 81
Query: 128 NAFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIKHLHS 182
           + +      E   DV L++EL+        L Q  +  L  E  +  + Q+L G+ +LH+
Sbjct: 82  DVY------ENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT 133
Query: 183 AGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI--- 235
             I H DLKP NI++         +K++DFGLA              T  + APE++   
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 236 -LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
            LG+      D+WS+G I   ++ G   F G
Sbjct: 194 PLGL----EADMWSIGVITYILLSGASPFLG 220

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 68  KKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLL 127
           K R  ++ L   A +    Q   + + +SR        +   RE  +++ V H N+I L 
Sbjct: 30  KCREKSTGLEYAAKFIKKRQSRASRRGVSR--------EEIEREVSILRQVLHHNVITLH 81
Query: 128 NAFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIKHLHS 182
           + +      E   DV L++EL+        L Q  +  L  E  +  + Q+L G+ +LH+
Sbjct: 82  DVY------ENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT 133
Query: 183 AGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI--- 235
             I H DLKP NI++         +K++DFGLA              T  + APE++   
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 236 -LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
            LG+      D+WS+G I   ++ G   F G
Sbjct: 194 PLGL----EADMWSIGVITYILLSGASPFLG 220

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 35/205 (17%)
Query: 77  GAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL 136
           G G  Y     + +  ++LS   + V+  +   RE  +++ + H NII L + F      
Sbjct: 35  GTGKEY---AAKFIKKRRLSSSRRGVSR-EEIEREVNILREIRHPNIITLHDIF------ 84
Query: 137 EEFQDVYLVMELMDA-NLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
           E   DV L++EL+    L   +  +  L  +  +  L Q+L G+ +LHS  I H DLKP 
Sbjct: 85  ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPE 144
Query: 194 NIVVKS----DCTLKILDFGLART--AGTTF---MMTPYVVTRYYRAPEVI----LGMGY 240
           NI++      +  +K++DFG+A    AG  F     TP  V     APE++    LG+  
Sbjct: 145 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV-----APEIVNYEPLGL-- 197
Query: 241 KENVDIWSVGCIMGEMIRGGVLFPG 265
               D+WS+G I   ++ G   F G
Sbjct: 198 --EADMWSIGVITYILLSGASPFLG 220

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERM 166
           RE +++   N   I+G   AF          ++ + ME MD  +L QV++    +  + +
Sbjct: 56  RELQVLHECNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLKKAGRIPEQIL 109
Query: 167 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
             +   ++ G+ +L     I+HRD+KPSNI+V S   +K+ DFG++       M   +V 
Sbjct: 110 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEMANEFVG 168
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           TR Y +PE + G  Y    DIWS+G  + EM  G
Sbjct: 169 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 202

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 25/186 (13%)
Query: 93  KKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN 152
           K+ SR  +     +   RE  +++ V H N+I L + +      E   DV L++EL+   
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY------ENRTDVVLILELVSGG 100
Query: 153 -----LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----L 203
                L Q  +  L  E  +  + Q+L G+ +LH+  I H DLKP NI++         +
Sbjct: 101 ELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 204 KILDFGLARTAGTTFMMTPYVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRG 259
           K++DFGLA              T  + APE++    LG+      D+WS+G I   ++ G
Sbjct: 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSG 214
Query: 260 GVLFPG 265
              F G
Sbjct: 215 ASPFLG 220

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 15/167 (8%)
Query: 106 KRAYREFKLMKLVNHKNII---GLLNAF-------TPQKSLEEFQDVYLVMELMD-ANLC 154
           ++A RE K +  ++H NI+   G  + F       +   S  + + +++ ME  D   L 
Sbjct: 49  EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
Query: 155 QVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 210
           Q I+      LD      L  Q+  G+ ++HS  +I+RDLKPSNI +     +KI DFGL
Sbjct: 109 QWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGL 168
Query: 211 ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
             +            T  Y +PE I    Y + VD++++G I+ E++
Sbjct: 169 VTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 35/205 (17%)
Query: 77  GAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL 136
           G G  Y     + +  ++LS   + V+  +   RE  +++ + H NII L + F      
Sbjct: 28  GTGKEY---AAKFIKKRRLSSSRRGVSR-EEIEREVNILREIRHPNIITLHDIF------ 77
Query: 137 EEFQDVYLVMELMDAN-LCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
           E   DV L++EL+    L   +  +  L  +  +  L Q+L G+ +LHS  I H DLKP 
Sbjct: 78  ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPE 137
Query: 194 NIVVKS----DCTLKILDFGLART--AGTTF---MMTPYVVTRYYRAPEVI----LGMGY 240
           NI++      +  +K++DFG+A    AG  F     TP  V     APE++    LG+  
Sbjct: 138 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV-----APEIVNYEPLGL-- 190
Query: 241 KENVDIWSVGCIMGEMIRGGVLFPG 265
               D+WS+G I   ++ G   F G
Sbjct: 191 --EADMWSIGVITYILLSGASPFLG 213

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 34/87 (39%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            I++LHS  I HRD+KP N++  S   +  LK+ DFG A+   +   +T    T YY AP
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 193
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIRG 259
           EV+    Y ++ D+WS+G IM  ++ G
Sbjct: 194 EVLGPEKYDKSCDMWSLGVIMYILLCG 220

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-LCQVIQ-MDLDHERMS 167
           +E KL  ++ H NII L      + +L       LVME      L +V+    +  + + 
Sbjct: 55  QEAKLFAMLKHPNIIALRGVCLKEPNL------CLVMEFARGGPLNRVLSGKRIPPDILV 108
Query: 168 YLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVK--------SDCTLKILDFGLARTAGT 216
               Q+  G+ +LH   I   IHRDLK SNI++         S+  LKI DFGLAR    
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
           T  M+       + APEVI    + +  D+WS G ++ E++ G V F G D +
Sbjct: 169 TTKMS-AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 34/87 (39%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            I++LHS  I HRD+KP N++  S   +  LK+ DFG A+   +   +T    T YY AP
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 192
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIRG 259
           EV+    Y ++ D+WS+G IM  ++ G
Sbjct: 193 EVLGPEKYDKSCDMWSLGVIMYILLCG 219

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/124 (36%), Positives = 67/124 (54%), Gaps = 8/124 (6%)
Query: 144 LVMELMDA-NLCQVIQMDLDH---ER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +VME +D   L   IQ   D    ER  S ++  +   I++LHS  I HRD+KP N++  
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 151
Query: 199 S---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
           S   +  LK+ DFG A+   +   +T    T YY APEV+    Y ++ D+WS+G IM  
Sbjct: 152 SKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 211
Query: 256 MIRG 259
           ++ G
Sbjct: 212 LLCG 215

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 25/186 (13%)
Query: 93  KKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN 152
           K+ SR  +     +   RE  +++ V H N+I L + +      E   DV L++EL+   
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY------ENRTDVVLILELVSGG 100
Query: 153 -----LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----L 203
                L Q  +  L  E  +  + Q+L G+ +LH+  I H DLKP NI++         +
Sbjct: 101 ELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 204 KILDFGLARTAGTTFMMTPYVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRG 259
           K++DFGLA              T  + APE++    LG+      D+WS+G I   ++ G
Sbjct: 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSG 214
Query: 260 GVLFPG 265
              F G
Sbjct: 215 ASPFLG 220

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 34/87 (39%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            I++LHS  I HRD+KP N++  S   +  LK+ DFG A+   +   +T    T YY AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIRG 259
           EV+    Y ++ D+WS+G IM  ++ G
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCG 259

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L++EL+    L   +  +  L  E  
Sbjct: 62  REVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEA 115
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 176 IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 218

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 106/230 (46%), Gaps = 26/230 (11%)
Query: 48  TVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKR 107
           ++D+W E+   ++ + H++G  +    + G    Y       VA+K L    ++    + 
Sbjct: 2   SLDKW-EMERTDITMKHKLGGGQFGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEE 53
Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERM 166
             +E  +MK + H N++ LL   T +         Y++ E M   NL   ++ + + + +
Sbjct: 54  FLKEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLR-ECNRQEV 106
Query: 167 S-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMT 221
           S     Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   T    T
Sbjct: 107 SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXT 165
Query: 222 PYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
            +   ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 166 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 215

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L++EL+    L   +  +  L  E  
Sbjct: 62  REVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEA 115
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 176 IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 218

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L++EL+    L   +  +  L  E  
Sbjct: 63  REVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 219

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 34/87 (39%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            I++LHS  I HRD+KP N++  S   +  LK+ DFG A+   +   +T    T YY AP
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 238
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIRG 259
           EV+    Y ++ D+WS+G IM  ++ G
Sbjct: 239 EVLGPEKYDKSCDMWSLGVIMYILLCG 265

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L++EL+    L   +  +  L  E  
Sbjct: 63  REVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 219

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 34/87 (39%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            I++LHS  I HRD+KP N++  S   +  LK+ DFG A+   +   +T    T YY AP
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 188
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIRG 259
           EV+    Y ++ D+WS+G IM  ++ G
Sbjct: 189 EVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L++EL+    L   +  +  L  E  
Sbjct: 63  REVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 219

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 34/87 (39%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            I++LHS  I HRD+KP N++  S   +  LK+ DFG A+   +   +T    T YY AP
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 194
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIRG 259
           EV+    Y ++ D+WS+G IM  ++ G
Sbjct: 195 EVLGPEKYDKSCDMWSLGVIMYILLCG 221

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 105/228 (46%), Gaps = 26/228 (11%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   
Sbjct: 7   DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEEFL 58
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
           +E  +MK + H N++ LL   T +         Y++ E M   NL   ++     +++  
Sbjct: 59  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAV 112
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPY 223
            + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G T+  T  
Sbjct: 113 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAP 170
Query: 224 VVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
              ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 171 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 218

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 34/87 (39%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            I++LHS  I HRD+KP N++  S   +  LK+ DFG A+   +   +T    T YY AP
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAP 186
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIRG 259
           EV+    Y ++ D+WS+G IM  ++ G
Sbjct: 187 EVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 34/87 (39%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            I++LHS  I HRD+KP N++  S   +  LK+ DFG A+   +   +T    T YY AP
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 187
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIRG 259
           EV+    Y ++ D+WS+G IM  ++ G
Sbjct: 188 EVLGPEKYDKSCDMWSLGVIMYILLCG 214

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/118 (37%), Positives = 64/118 (54%), Gaps = 8/118 (6%)
Query: 144 LVMELMDAN-LCQVIQMDLDH---ER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +VME +D   L   IQ   D    ER  S ++  +   I++LHS  I HRD+KP N++  
Sbjct: 106 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 165
Query: 199 S---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
           S   +  LK+ DFG A+   +   +T    T YY APEV+    Y ++ D+WS+G IM
Sbjct: 166 SKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 223

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L++EL+    L   +  +  L  E  
Sbjct: 63  REVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 219

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 25/186 (13%)
Query: 93  KKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN 152
           K+ SR  +     +   RE  +++ V H NII L + +      E   DV L++EL+   
Sbjct: 47  KRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY------ENRTDVVLILELVSGG 100
Query: 153 -----LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----L 203
                L Q  +  L  E  +  + Q+L G+ +LH+  I H DLKP NI++         +
Sbjct: 101 ELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 204 KILDFGLARTAGTTFMMTPYVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRG 259
           K++DFGLA              T  + APE++    LG+      D+WS+G I   ++ G
Sbjct: 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSG 214
Query: 260 GVLFPG 265
              F G
Sbjct: 215 ASPFLG 220

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 34/87 (39%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            I++LHS  I HRD+KP N++  S   +  LK+ DFG A+   +   +T    T YY AP
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 186
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIRG 259
           EV+    Y ++ D+WS+G IM  ++ G
Sbjct: 187 EVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 105/228 (46%), Gaps = 26/228 (11%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+   ++ + H++G  ++   + G    Y       VA+K L    ++    +   
Sbjct: 8   DKW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLK---EDTMEVEEFL 59
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
           +E  +MK + H N++ LL   T +         Y++ E M   NL   ++     +++  
Sbjct: 60  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAV 113
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPY 223
            + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R   G T+  T  
Sbjct: 114 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAP 171
Query: 224 VVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTD 267
              ++   + APE +    +    D+W+ G ++ E+   G+  +PG D
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 219

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 27/168 (16%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE----- 164
           +E K+M+ + H N++  +      K L        + E +     + I   +D +     
Sbjct: 56  KEVKVMRCLEHPNVLKFIGVLYKDKRLN------FITEYIKGGTLRGIIKSMDSQYPWSQ 109
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAGT 216
           R+S+    +  G+ +LHS  IIHRDL   N +V+ +  + + DFGLAR          G 
Sbjct: 110 RVSFA-KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 217 TFMMTP-------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
             +  P        V   Y+ APE+I G  Y E VD++S G ++ E+I
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L++EL+    L   +  +  L  E  
Sbjct: 63  REVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 219

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L++EL+    L   +  +  L  E  
Sbjct: 63  REVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 219

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L++EL+    L   +  +  L  E  
Sbjct: 63  REVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 7/154 (4%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYL 169
           RE ++ +L+ H NI+ L ++ + +       D+    EL +  + +    + D    S+ 
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD---ASHC 115
Query: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLA-RTAGTTFMMTPYVV 225
           + Q+L  + H H  G++HR+LKP N+++ S      +K+ DFGLA    G       +  
Sbjct: 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           T  Y +PEV+    Y + VD+W+ G I+  ++ G
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L++EL+    L   +  +  L  E  
Sbjct: 63  REVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 219

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/128 (35%), Positives = 69/128 (53%), Gaps = 10/128 (7%)
Query: 142 VYLVMELMDA-NLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           V + MEL++  +L Q++  Q  L  +R  Y L Q L G+++LHS  I+H D+K  N+++ 
Sbjct: 141 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 200
Query: 199 SDCT-LKILDFGLART-----AGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGC 251
           SD +   + DFG A        G   +   Y+  T  + APEV+LG      VD+WS  C
Sbjct: 201 SDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCC 260
Query: 252 IMGEMIRG 259
           +M  M+ G
Sbjct: 261 MMLHMLNG 268

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L++EL+    L   +  +  L  E  
Sbjct: 63  REVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 219

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L++EL+    L   +  +  L  E  
Sbjct: 63  REVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 177 IFGTPAFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 219

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L++EL+    L   +  +  L  E  
Sbjct: 63  REVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 219

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 84/172 (48%), Gaps = 31/172 (18%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN-LCQVI--QMDLDHERM 166
           RE  +++ + H NII L + F      E   DV L++EL+    L   +  +  L  +  
Sbjct: 78  REVNILREIRHPNIITLHDIF------ENKTDVVLILELVSGGELFDFLAEKESLTEDEA 131
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS----DCTLKILDFGLART--AGTTF-- 218
           +  L Q+L G+ +LHS  I H DLKP NI++      +  +K++DFG+A    AG  F  
Sbjct: 132 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 191
Query: 219 -MMTPYVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              TP  V     APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 192 IFGTPEFV-----APEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 234

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 12/163 (7%)
Query: 119 NHKNIIGLLNAF-TPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQML 174
           NH  +  L   F TP +       ++ VME ++  +L   IQ     D  R  +   +++
Sbjct: 82  NHPFLTQLFCCFQTPDR-------LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEII 134
Query: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP-YVVTRYYRAPE 233
             +  LH  GII+RDLK  N+++  +   K+ DFG+ +      + T  +  T  Y APE
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194
Query: 234 VILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           ++  M Y   VD W++G ++ EM+ G   F   +  D +  I+
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 12/143 (8%)
Query: 142 VYLVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           +Y VME ++       + QV +    H    +   ++  G+  L S GII+RDLK  N++
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEPH--AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 474
Query: 197 VKSDCTLKILDFGLARTA---GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
           + S+  +KI DFG+ +     G T     +  T  Y APE+I    Y ++VD W+ G ++
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 532
Query: 254 GEMIRGGVLFPGTDHIDQWNKII 276
            EM+ G   F G D  + +  I+
Sbjct: 533 YEMLAGQAPFEGEDEDELFQSIM 555

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 12/143 (8%)
Query: 142 VYLVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           +Y VME ++       + QV +    H    +   ++  G+  L S GII+RDLK  N++
Sbjct: 96  LYFVMEYVNGGDLMYHIQQVGRFKEPH--AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 153
Query: 197 VKSDCTLKILDFGLARTA---GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
           + S+  +KI DFG+ +     G T     +  T  Y APE+I    Y ++VD W+ G ++
Sbjct: 154 LDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 211
Query: 254 GEMIRGGVLFPGTDHIDQWNKII 276
            EM+ G   F G D  + +  I+
Sbjct: 212 YEMLAGQAPFEGEDEDELFQSIM 234

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 99/224 (44%), Gaps = 26/224 (11%)
Query: 57  YQELPIS---HQMGKKRHNTSHLGAGAAYDT-ATQQNVAIKKLSRPFQNVTHA-KRAY-R 110
           + E PIS   ++MG+        G G  Y        VA+KKL+      T   K+ + +
Sbjct: 27  FDERPISVGGNKMGEG-------GFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 79
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM---ELMDANLCQVIQMDLDHERMS 167
           E K+M    H+N++ LL  F+     ++   VY+ M    L+D   C      L      
Sbjct: 80  EIKVMAKCQHENLVELL-GFSSDG--DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTTFMMTPYV 224
            +      GI  LH    IHRD+K +NI++    T KI DFGLAR +     T M +  V
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIV 196
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
            T  Y APE + G       DI+S G ++ E+I G    P  D 
Sbjct: 197 GTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITG---LPAVDE 236

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 73/139 (52%), Gaps = 4/139 (2%)
Query: 142 VYLVMELMDA-NLCQVIQMDLDHERMSYLLY--QMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +Y VME ++  +L   IQ     +    + Y  ++  G+  LH  GII+RDLK  N+++ 
Sbjct: 95  LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLD 154
Query: 199 SDCTLKILDFGLARTAGTTFMMT-PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
           S+  +KI DFG+ +      + T  +  T  Y APE+I    Y ++VD W+ G ++ EM+
Sbjct: 155 SEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML 214
Query: 258 RGGVLFPGTDHIDQWNKII 276
            G   F G D  + +  I+
Sbjct: 215 AGQPPFDGEDEDELFQSIM 233

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/128 (36%), Positives = 71/128 (55%), Gaps = 10/128 (7%)
Query: 142 VYLVMELMDA-NLCQVI-QMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           V + MEL++  +L Q+I QM  L  +R  Y L Q L G+++LH+  I+H D+K  N+++ 
Sbjct: 141 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 200
Query: 199 SDCTLKIL-DFGLART-----AGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGC 251
           SD +   L DFG A        G + +   Y+  T  + APEV++G      VDIWS  C
Sbjct: 201 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCC 260
Query: 252 IMGEMIRG 259
           +M  M+ G
Sbjct: 261 MMLHMLNG 268

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 77/167 (46%), Gaps = 21/167 (12%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERM 166
           RE  ++K + H N+I L   +      E   DV L+ EL+    L   +  +  L  E  
Sbjct: 63  REVSILKEIQHPNVITLHEVY------ENKTDVILIGELVAGGELFDFLAEKESLTEEEA 116
Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTTFMMTP 222
           +  L Q+L G+ +LHS  I H DLKP NI++         +KI+DFGLA           
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 223 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
              T  + APE++    LG+      D+WS+G I   ++ G   F G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASPFLG 219

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 83/181 (45%), Gaps = 26/181 (14%)
Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
           ++VAIK++    ++ +  K    E + +  VNH NI+ L  A            V LVME
Sbjct: 33  KDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGAC--------LNPVCLVME 80
Query: 148 LMDANL-------CQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV- 196
             +           + +        MS+ L Q   G+ +LHS     +IHRDLKP N++ 
Sbjct: 81  YAEGGSLYNVLHGAEPLPYYTAAHAMSWCL-QCSQGVAYLHSMQPKALIHRDLKPPNLLL 139
Query: 197 VKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           V     LKI DFG A    T   MT    +  + APEV  G  Y E  D++S G I+ E+
Sbjct: 140 VAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEV 197
Query: 257 I 257
           I
Sbjct: 198 I 198

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/128 (36%), Positives = 71/128 (55%), Gaps = 10/128 (7%)
Query: 142 VYLVMELMDA-NLCQVI-QMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           V + MEL++  +L Q+I QM  L  +R  Y L Q L G+++LH+  I+H D+K  N+++ 
Sbjct: 139 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 198
Query: 199 SDCTLKIL-DFGLART-----AGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGC 251
           SD +   L DFG A        G + +   Y+  T  + APEV++G      VDIWS  C
Sbjct: 199 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCC 258
Query: 252 IMGEMIRG 259
           +M  M+ G
Sbjct: 259 MMLHMLNG 266

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 83/181 (45%), Gaps = 26/181 (14%)
Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
           ++VAIK++    ++ +  K    E + +  VNH NI+ L  A            V LVME
Sbjct: 32  KDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGAC--------LNPVCLVME 79
Query: 148 LMDANL-------CQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV- 196
             +           + +        MS+ L Q   G+ +LHS     +IHRDLKP N++ 
Sbjct: 80  YAEGGSLYNVLHGAEPLPYYTAAHAMSWCL-QCSQGVAYLHSMQPKALIHRDLKPPNLLL 138
Query: 197 VKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           V     LKI DFG A    T   MT    +  + APEV  G  Y E  D++S G I+ E+
Sbjct: 139 VAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEV 196
Query: 257 I 257
           I
Sbjct: 197 I 197

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/128 (36%), Positives = 71/128 (55%), Gaps = 10/128 (7%)
Query: 142 VYLVMELMDA-NLCQVI-QMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           V + MEL++  +L Q+I QM  L  +R  Y L Q L G+++LH+  I+H D+K  N+++ 
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184
Query: 199 SDCTLKIL-DFGLART-----AGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGC 251
           SD +   L DFG A        G + +   Y+  T  + APEV++G      VDIWS  C
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCC 244
Query: 252 IMGEMIRG 259
           +M  M+ G
Sbjct: 245 MMLHMLNG 252

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 107/256 (41%), Gaps = 43/256 (16%)
Query: 59  ELPISHQMGKKRHNTSH---LGAGA--------AY---DTATQQNVAIKKLSRPFQNVTH 104
           +LP  H+    R+  S    LGAGA        AY    +     VA+K L +P  ++T 
Sbjct: 27  QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTE 85
Query: 105 AKRAYREFKLMK-LVNHKNIIGLLNAFT---PQKSLEEF-------------QDVYLVME 147
            +    E K++  L NH NI+ LL A T   P   + E+             +D ++  +
Sbjct: 86  REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 145
Query: 148 LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
              A +          + +S+  YQ+  G+  L S   IHRDL   NI++      KI D
Sbjct: 146 TSPAIMEDDELALDLEDLLSFS-YQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 204
Query: 208 FGLARTAGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEMIR-GG 260
           FGLAR        + YVV    R      APE I    Y    D+WS G  + E+   G 
Sbjct: 205 FGLARDIKND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 261
Query: 261 VLFPGTDHIDQWNKII 276
             +PG     ++ K+I
Sbjct: 262 SPYPGMPVDSKFYKMI 277

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 107/256 (41%), Gaps = 43/256 (16%)
Query: 59  ELPISHQMGKKRHNTSH---LGAGA--------AY---DTATQQNVAIKKLSRPFQNVTH 104
           +LP  H+    R+  S    LGAGA        AY    +     VA+K L +P  ++T 
Sbjct: 29  QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTE 87
Query: 105 AKRAYREFKLMK-LVNHKNIIGLLNAFT---PQKSLEEF-------------QDVYLVME 147
            +    E K++  L NH NI+ LL A T   P   + E+             +D ++  +
Sbjct: 88  REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 147
Query: 148 LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
              A +          + +S+  YQ+  G+  L S   IHRDL   NI++      KI D
Sbjct: 148 TSPAIMEDDELALDLEDLLSFS-YQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 206
Query: 208 FGLARTAGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEMIR-GG 260
           FGLAR        + YVV    R      APE I    Y    D+WS G  + E+   G 
Sbjct: 207 FGLARDIKND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 263
Query: 261 VLFPGTDHIDQWNKII 276
             +PG     ++ K+I
Sbjct: 264 SPYPGMPVDSKFYKMI 279

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 107/256 (41%), Gaps = 43/256 (16%)
Query: 59  ELPISHQMGKKRHNTSH---LGAGA--------AY---DTATQQNVAIKKLSRPFQNVTH 104
           +LP  H+    R+  S    LGAGA        AY    +     VA+K L +P  ++T 
Sbjct: 34  QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTE 92
Query: 105 AKRAYREFKLMK-LVNHKNIIGLLNAFT---PQKSLEEF-------------QDVYLVME 147
            +    E K++  L NH NI+ LL A T   P   + E+             +D ++  +
Sbjct: 93  REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 152
Query: 148 LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
              A +          + +S+  YQ+  G+  L S   IHRDL   NI++      KI D
Sbjct: 153 TSPAIMEDDELALDLEDLLSFS-YQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 211
Query: 208 FGLARTAGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEMIR-GG 260
           FGLAR        + YVV    R      APE I    Y    D+WS G  + E+   G 
Sbjct: 212 FGLARDIKND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 268
Query: 261 VLFPGTDHIDQWNKII 276
             +PG     ++ K+I
Sbjct: 269 SPYPGMPVDSKFYKMI 284

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 98/224 (43%), Gaps = 26/224 (11%)
Query: 57  YQELPIS---HQMGKKRHNTSHLGAGAAYDT-ATQQNVAIKKLSRPFQNVTHA-KRAY-R 110
           + E PIS   ++MG+        G G  Y        VA+KKL+      T   K+ + +
Sbjct: 27  FDERPISVGGNKMGEG-------GFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 79
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM---ELMDANLCQVIQMDLDHERMS 167
           E K+M    H+N++ LL  F+     ++   VY+ M    L+D   C      L      
Sbjct: 80  EIKVMAKCQHENLVELL-GFSSDG--DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTTFMMTPYV 224
            +      GI  LH    IHRD+K +NI++    T KI DFGLAR +     T M    V
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIV 196
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
            T  Y APE + G       DI+S G ++ E+I G    P  D 
Sbjct: 197 GTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITG---LPAVDE 236

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 107/256 (41%), Gaps = 43/256 (16%)
Query: 59  ELPISHQMGKKRHNTSH---LGAGA--------AY---DTATQQNVAIKKLSRPFQNVTH 104
           +LP  H+    R+  S    LGAGA        AY    +     VA+K L +P  ++T 
Sbjct: 11  QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTE 69
Query: 105 AKRAYREFKLMK-LVNHKNIIGLLNAFT---PQKSLEEF-------------QDVYLVME 147
            +    E K++  L NH NI+ LL A T   P   + E+             +D ++  +
Sbjct: 70  REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 148 LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
              A +          + +S+  YQ+  G+  L S   IHRDL   NI++      KI D
Sbjct: 130 TSPAIMEDDELALDLEDLLSFS-YQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 208 FGLARTAGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEMIR-GG 260
           FGLAR        + YVV    R      APE I    Y    D+WS G  + E+   G 
Sbjct: 189 FGLARDIKND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 261 VLFPGTDHIDQWNKII 276
             +PG     ++ K+I
Sbjct: 246 SPYPGMPVDSKFYKMI 261

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 64/124 (51%), Gaps = 27/124 (21%)
Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVV------KSDCT-------------------LKIL 206
           ++L  + +L    + H DLKP NI++      KS  T                   +K++
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT 266
           DFG A T  + +  +  + TR YRAPEVIL +G+  + D+WS GC++ E+  G +LF   
Sbjct: 205 DFGCA-TFKSDYHGS-IINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262
Query: 267 DHID 270
           +H++
Sbjct: 263 EHME 266

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 21/220 (9%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W  L +++L +  Q+G+        G   A +T     VA+K           AK   
Sbjct: 107 DKWV-LNHEDLVLGEQIGRGNFGEVFSGRLRADNTL----VAVKSCRETLPPDLKAK-FL 160
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSY 168
           +E +++K  +H NI+ L+   T +      Q +Y+VMEL+   +    ++ +    R+  
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQK------QPIYIVMELVQGGDFLTFLRTEGARLRVKT 214
Query: 169 LLYQML----CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTP-- 222
           LL QM+     G+++L S   IHRDL   N +V     LKI DFG++R            
Sbjct: 215 LL-QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGG 273
Query: 223 -YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGV 261
              V   + APE +    Y    D+WS G ++ E    G 
Sbjct: 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGA 313

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 21/220 (9%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W  L +++L +  Q+G+        G   A +T     VA+K           AK   
Sbjct: 107 DKWV-LNHEDLVLGEQIGRGNFGEVFSGRLRADNTL----VAVKSCRETLPPDLKAK-FL 160
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSY 168
           +E +++K  +H NI+ L+   T +      Q +Y+VMEL+   +    ++ +    R+  
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQK------QPIYIVMELVQGGDFLTFLRTEGARLRVKT 214
Query: 169 LLYQML----CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTTFMMTPY 223
           LL QM+     G+++L S   IHRDL   N +V     LKI DFG++R  A   +  +  
Sbjct: 215 LL-QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG 273
Query: 224 V--VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGV 261
           +  V   + APE +    Y    D+WS G ++ E    G 
Sbjct: 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGA 313

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
            I++LHS  I HRD+KP N++  S   +  LK+ DFG A+   +   +T    T YY AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 233 EVILGMGYKENVDIWSVGCI 252
           EV+    Y ++ D WS+G I
Sbjct: 233 EVLGPEKYDKSCDXWSLGVI 252

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 107/256 (41%), Gaps = 43/256 (16%)
Query: 59  ELPISHQMGKKRHNTSH---LGAGA--------AY---DTATQQNVAIKKLSRPFQNVTH 104
           +LP  H+    R+  S    LGAGA        AY    +     VA+K L +P  ++T 
Sbjct: 34  QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTE 92
Query: 105 AKRAYREFKLMK-LVNHKNIIGLLNAFT---PQKSLEEF-------------QDVYLVME 147
            +    E K++  L NH NI+ LL A T   P   + E+             +D ++  +
Sbjct: 93  REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 152
Query: 148 LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
              A +          + +S+  YQ+  G+  L S   IHRDL   NI++      KI D
Sbjct: 153 TSPAIMEDDELALDLEDLLSFS-YQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 211
Query: 208 FGLARTAGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEMIR-GG 260
           FGLAR        + YVV    R      APE I    Y    D+WS G  + E+   G 
Sbjct: 212 FGLARHIKND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 268
Query: 261 VLFPGTDHIDQWNKII 276
             +PG     ++ K+I
Sbjct: 269 SPYPGMPVDSKFYKMI 284

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 9/200 (4%)
Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           D  T++ VA+K + R        +   RE    + + H NI+           L    + 
Sbjct: 41  DKLTKELVAVKYIER---GAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97
Query: 143 YLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
               EL +  +C   +   D  R  +   Q+L G+ + HS  I HRDLK  N ++     
Sbjct: 98  ASGGELYE-RICNAGRFSEDEAR--FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA 154
Query: 203 --LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIRG 259
             LKI DFG ++++         V T  Y APEV+L   Y   + D+WS G  +  M+ G
Sbjct: 155 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
Query: 260 GVLFPGTDHIDQWNKIIGKM 279
              F   +    + K I ++
Sbjct: 215 AYPFEDPEEPRDYRKTIQRI 234

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 161 LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 216
              +R  +   +++  + +LHS   +++RDLK  N+++  D  +KI DFGL +     G 
Sbjct: 245 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304
Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           T  M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 305 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 161 LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 216
              +R  +   +++  + +LHS   +++RDLK  N+++  D  +KI DFGL +     G 
Sbjct: 248 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 307
Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           T  M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 308 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 357

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 67/127 (52%), Gaps = 11/127 (8%)
Query: 141 DVYLVMELMDANLCQVIQMDLDHER------MSYLLYQMLCGIKHLHSA-GIIHRDLKPS 193
           DV++ MELMD +L +  +  +D  +      +  +   ++  ++HLHS   +IHRD+KPS
Sbjct: 124 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 183
Query: 194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG----MGYKENVDIWSV 249
           N+++ +   +K+ DFG++     +   T     + Y APE I       GY    DIWS+
Sbjct: 184 NVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSL 243
Query: 250 GCIMGEM 256
           G  M E+
Sbjct: 244 GITMIEL 250

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 75  HLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQ 133
           H   G  +     +  A +      + V  A R  RE  +++ V  H +II L++++   
Sbjct: 115 HRATGHEFAVKIMEVTAERLSPEQLEEVREATR--RETHILRQVAGHPHIITLIDSY--- 169
Query: 134 KSLEEFQDVYLVMELM-DANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL 190
              E    ++LV +LM    L   +  ++ L  +    ++  +L  +  LH+  I+HRDL
Sbjct: 170 ---ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDL 226
Query: 191 KPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM------GYKENV 244
           KP NI++  +  +++ DFG +        +     T  Y APE++         GY + V
Sbjct: 227 KPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEV 286
Query: 245 DIWSVGCIMGEMIRGGVLF 263
           D+W+ G I+  ++ G   F
Sbjct: 287 DLWACGVILFTLLAGSPPF 305

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           VAIK L      V + ++  R+F     +M   +H N++ L    T  K       V +V
Sbjct: 74  VAIKTL-----KVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKP------VMIV 122
Query: 146 MELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSDC 201
           +E M+           D +     L  ML GI    ++L   G +HRDL   NI+V S+ 
Sbjct: 123 IEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNL 182
Query: 202 TLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
             K+ DFGL+R         +  T   +   + APE I    +    D+WS G +M E++
Sbjct: 183 VCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 242
Query: 258 RGG 260
             G
Sbjct: 243 SYG 245

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 77/183 (42%), Gaps = 23/183 (12%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +V
Sbjct: 53  VAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKP------VMIV 101
Query: 146 MELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSDC 201
            E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+ 
Sbjct: 102 TEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNL 161
Query: 202 TLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
             K+ DFGL+R         +      +   + APE I    +    D+WS G +M E++
Sbjct: 162 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVV 221
Query: 258 RGG 260
             G
Sbjct: 222 SYG 224

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 161 LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 216
              +R  +   +++  + +LHS   +++RDLK  N+++  D  +KI DFGL +     G 
Sbjct: 107 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 166
Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           T  M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 167 T--MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 216

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 161 LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 216
              +R  +   +++  + +LHS   +++RDLK  N+++  D  +KI DFGL +     G 
Sbjct: 106 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 165
Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           T  M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 166 T--MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 215

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 161 LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 216
              +R  +   +++  + +LHS   +++RDLK  N+++  D  +KI DFGL +     G 
Sbjct: 105 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 164
Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH 268
           T  M  +  T  Y APEV+    Y   VD W +G +M EM+ G + F   DH
Sbjct: 165 T--MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 214

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 18/172 (10%)
Query: 115 MKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLL 170
           M+  +H +I+ L+   T          V+++MEL       +  QV +  LD   +    
Sbjct: 445 MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTTFMMTPYVVTRY 228
           YQ+   + +L S   +HRD+   N++V S+  +K+ DFGL+R     T +  +   +   
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKIIGKM 279
           + APE I    +    D+W  G  M E++  GV  F G  +    N +IG++
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRI 605

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 14/229 (6%)
Query: 59  ELPISHQMGK----KRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK 113
           +LPI H   +    K   + + G A    D  + + VA+K + R  +   + KR   E  
Sbjct: 11  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKR---EII 67
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
             + + H NI+           L    +     EL +  +C   +   D  R  +   Q+
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQL 124
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTTFMMTPYVVTRYYRA 231
           + G+ + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y A
Sbjct: 125 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 184
Query: 232 PEVILGMGYKENV-DIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           PEV+L   Y   V D+WS G  +  M+ G   F   +    + K I ++
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 62/106 (58%), Gaps = 5/106 (4%)
Query: 162 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTTFM 219
           +HE   Y+  +++  ++HLH  GII+RD+K  NI++ S+  + + DFGL++   A  T  
Sbjct: 158 EHEVQIYV-GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216
Query: 220 MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLF 263
              +  T  Y AP+++ G   G+ + VD WS+G +M E++ G   F
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 9/169 (5%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K+   PF+      R     KL ++ +H+ +         +++ EE   +YL  EL  
Sbjct: 86  AVKRSMSPFRGPKDRAR-----KLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG 140
Query: 151 ANL---CQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
            +L   C+     L   ++   L   L  + HLHS G++H D+KP+NI +      K+ D
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGD 200
Query: 208 FGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           FGL    GT            Y APE++ G  Y    D++S+G  + E+
Sbjct: 201 FGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEV 248

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/141 (34%), Positives = 70/141 (49%), Gaps = 19/141 (13%)
Query: 140 QDVYLVMEL--MDANLCQVIQMDLDH-ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           Q +Y+VME   +D N     +  +D  ER SY    ML  +  +H  GI+H DLKP+N +
Sbjct: 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQHGIVHSDLKPANFL 187
Query: 197 VKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGM-GYKEN--------- 243
           +  D  LK++DFG+A   +   T+ +    V T  Y  PE I  M   +EN         
Sbjct: 188 I-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 246
Query: 244 -VDIWSVGCIMGEMIRGGVLF 263
             D+WS+GCI+  M  G   F
Sbjct: 247 KSDVWSLGCILYYMTYGKTPF 267

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 97/223 (43%), Gaps = 26/223 (11%)
Query: 57  YQELPIS---HQMGKKRHNTSHLGAGAAYDT-ATQQNVAIKKLSRPFQNVTHA-KRAY-R 110
           + E PIS   ++MG+        G G  Y        VA+KKL+      T   K+ + +
Sbjct: 21  FDERPISVGGNKMGEG-------GFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 73
Query: 111 EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM---ELMDANLCQVIQMDLDHERMS 167
           E K+M    H+N++ LL  F+     ++   VY+ M    L+D   C      L      
Sbjct: 74  EIKVMAKCQHENLVELL-GFSSDG--DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 130
Query: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTTFMMTPYV 224
            +      GI  LH    IHRD+K +NI++    T KI DFGLAR +       M    V
Sbjct: 131 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIV 190
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
            T  Y APE + G       DI+S G ++ E+I G    P  D
Sbjct: 191 GTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITG---LPAVD 229

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/141 (34%), Positives = 70/141 (49%), Gaps = 19/141 (13%)
Query: 140 QDVYLVMEL--MDANLCQVIQMDLDH-ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           Q +Y+VME   +D N     +  +D  ER SY    ML  +  +H  GI+H DLKP+N +
Sbjct: 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQHGIVHSDLKPANFL 187
Query: 197 VKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGM-GYKEN--------- 243
           +  D  LK++DFG+A   +   T+ +    V T  Y  PE I  M   +EN         
Sbjct: 188 I-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 246
Query: 244 -VDIWSVGCIMGEMIRGGVLF 263
             D+WS+GCI+  M  G   F
Sbjct: 247 KSDVWSLGCILYYMTYGKTPF 267

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/141 (34%), Positives = 70/141 (49%), Gaps = 19/141 (13%)
Query: 140 QDVYLVMEL--MDANLCQVIQMDLDH-ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           Q +Y+VME   +D N     +  +D  ER SY    ML  +  +H  GI+H DLKP+N +
Sbjct: 82  QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQHGIVHSDLKPANFL 140
Query: 197 VKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGM-GYKEN--------- 243
           +  D  LK++DFG+A   +   T+ +    V T  Y  PE I  M   +EN         
Sbjct: 141 I-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 199
Query: 244 -VDIWSVGCIMGEMIRGGVLF 263
             D+WS+GCI+  M  G   F
Sbjct: 200 KSDVWSLGCILYYMTYGKTPF 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 82/179 (45%), Gaps = 26/179 (14%)
Query: 107 RAYREFK-LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME-LMDANLCQVIQMD--LD 162
           R +RE + L +   +KNI+ L+  F      E+    YLV E L   ++   IQ     +
Sbjct: 56  RVFREVETLYQCQGNKNILELIEFF------EDDTRFYLVFEKLQGGSILAHIQKQKHFN 109
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDF----GLARTAG 215
               S ++  +   +  LH+ GI HRDLKP NI+ +S      +KI DF    G+     
Sbjct: 110 EREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNS 169
Query: 216 TTFMMTPYVVT----RYYRAPEVI-----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG 265
            T + TP + T      Y APEV+         Y +  D+WS+G ++  M+ G   F G
Sbjct: 170 CTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVG 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 47  HTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAK 106
           H + Q++E   + L    Q+GK    +  +         T + VA+KKL    +   H +
Sbjct: 20  HNMTQFEE---RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLR 74
Query: 107 RAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLD 162
              RE +++K + H NI+               +++ L+ME +      +  Q  +  +D
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERID 130
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTF 218
           H ++     Q+  G+++L +   IHRDL   NI+V+++  +KI DFGL +          
Sbjct: 131 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 190
Query: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
           +  P     ++ APE +    +    D+WS G ++ E+ 
Sbjct: 191 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 88/187 (47%), Gaps = 24/187 (12%)
Query: 108 AYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVI-QMDLDHER 165
           A RE +L++  + H N+I     F  +K   +FQ  Y+ +EL  A L + + Q D  H  
Sbjct: 64  ADREVQLLRESDEHPNVI---RYFCTEKD-RQFQ--YIAIELCAATLQEYVEQKDFAHLG 117
Query: 166 MS--YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-----SDCTLKILDFGLARTAGT-- 216
           +    LL Q   G+ HLHS  I+HRDLKP NI++            I DFGL +      
Sbjct: 118 LEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 217 -TFMMTPYVV-TRYYRAPEVILGMGYKEN----VDIWSVGCIMGEMIRGGVLFPGTDHID 270
            +F     V  T  + APE +L    KEN    VDI+S GC+   +I  G    G     
Sbjct: 178 HSFSRRSGVPGTEGWIAPE-MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR 236
Query: 271 QWNKIIG 277
           Q N ++G
Sbjct: 237 QANILLG 243

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 47  HTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAK 106
           H + Q++E   + L    Q+GK    +  +         T + VA+KKL    +   H +
Sbjct: 20  HNMTQFEE---RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLR 74
Query: 107 RAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLD 162
              RE +++K + H NI+               +++ L+ME +      +  Q  +  +D
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERID 130
Query: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTF 218
           H ++     Q+  G+++L +   IHRDL   NI+V+++  +KI DFGL +          
Sbjct: 131 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 190
Query: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
           +  P     ++ APE +    +    D+WS G ++ E+ 
Sbjct: 191 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/141 (34%), Positives = 70/141 (49%), Gaps = 19/141 (13%)
Query: 140 QDVYLVMEL--MDANLCQVIQMDLDH-ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           Q +Y+VME   +D N     +  +D  ER SY    ML  +  +H  GI+H DLKP+N +
Sbjct: 101 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQHGIVHSDLKPANFL 159
Query: 197 VKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGM-GYKEN--------- 243
           +  D  LK++DFG+A   +   T+ +    V T  Y  PE I  M   +EN         
Sbjct: 160 I-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 218
Query: 244 -VDIWSVGCIMGEMIRGGVLF 263
             D+WS+GCI+  M  G   F
Sbjct: 219 KSDVWSLGCILYYMTYGKTPF 239

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/141 (34%), Positives = 70/141 (49%), Gaps = 19/141 (13%)
Query: 140 QDVYLVMEL--MDANLCQVIQMDLDH-ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           Q +Y+VME   +D N     +  +D  ER SY    ML  +  +H  GI+H DLKP+N +
Sbjct: 85  QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQHGIVHSDLKPANFL 143
Query: 197 VKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGM-GYKEN--------- 243
           +  D  LK++DFG+A   +   T+ +    V T  Y  PE I  M   +EN         
Sbjct: 144 I-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 202
Query: 244 -VDIWSVGCIMGEMIRGGVLF 263
             D+WS+GCI+  M  G   F
Sbjct: 203 KSDVWSLGCILYYMTYGKTPF 223

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 86  TQQNVAIKKLSRPFQNVTH---AKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           + +N A+    +  +N T     ++  +E   M+  +H +I+ L+   T          V
Sbjct: 30  SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-------V 82
Query: 143 YLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +++MEL       +  QV +  LD   +    YQ+   + +L S   +HRD+   N++V 
Sbjct: 83  WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 142
Query: 199 SDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           S+  +K+ DFGL+R     T +  +   +   + APE I    +    D+W  G  M E+
Sbjct: 143 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 202
Query: 257 IRGGVL-FPGTDHIDQWNKIIGKM 279
           +  GV  F G  +    N +IG++
Sbjct: 203 LMHGVKPFQGVKN----NDVIGRI 222

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 59/97 (60%), Gaps = 6/97 (6%)
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPY-- 223
           M +   +++ G++H+H+  +++RDLKP+NI++     ++I D GLA          P+  
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 350
Query: 224 VVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRG 259
           V T  Y APEV+  G+ Y  + D +S+GC++ +++RG
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 59/97 (60%), Gaps = 6/97 (6%)
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPY-- 223
           M +   +++ G++H+H+  +++RDLKP+NI++     ++I D GLA          P+  
Sbjct: 293 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 349
Query: 224 VVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRG 259
           V T  Y APEV+  G+ Y  + D +S+GC++ +++RG
Sbjct: 350 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 59/97 (60%), Gaps = 6/97 (6%)
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPY-- 223
           M +   +++ G++H+H+  +++RDLKP+NI++     ++I D GLA          P+  
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 350
Query: 224 VVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRG 259
           V T  Y APEV+  G+ Y  + D +S+GC++ +++RG
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 59/97 (60%), Gaps = 6/97 (6%)
Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPY-- 223
           M +   +++ G++H+H+  +++RDLKP+NI++     ++I D GLA          P+  
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 350
Query: 224 VVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRG 259
           V T  Y APEV+  G+ Y  + D +S+GC++ +++RG
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 86  TQQNVAIKKLSRPFQNVTH---AKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           + +N A+    +  +N T     ++  +E   M+  +H +I+ L+   T          V
Sbjct: 35  SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-------V 87
Query: 143 YLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +++MEL       +  QV +  LD   +    YQ+   + +L S   +HRD+   N++V 
Sbjct: 88  WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 147
Query: 199 SDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           S+  +K+ DFGL+R     T +  +   +   + APE I    +    D+W  G  M E+
Sbjct: 148 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 207
Query: 257 IRGGVL-FPGTDHIDQWNKIIGKM 279
           +  GV  F G  +    N +IG++
Sbjct: 208 LMHGVKPFQGVKN----NDVIGRI 227

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 15  LKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 72
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +   +L + +Q     +DH ++     Q+  
Sbjct: 73  HDNIVKYKGVCYSAGR----RNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICK 128
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTFMMTPYVVTRYYRA 231
           G+++L +   IHRDL   NI+V+++  +KI DFGL +          +  P     ++ A
Sbjct: 129 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 38/236 (16%)
Query: 36  GPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKL 95
           GP D ++ E  H            L    Q+GK    +  L         T   VA+K+L
Sbjct: 1   GPQDPTIFEERH------------LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 48
Query: 96  --SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN-AFTPQKSLEEFQDVYLVMELMDA- 151
             S P Q     +   RE +++K ++   I+     ++ P +     Q + LVME + + 
Sbjct: 49  QHSGPDQQ----RDFQREIQILKALHSDFIVKYRGVSYGPGR-----QSLRLVMEYLPSG 99
Query: 152 ---NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 208
              +  Q  +  LD  R+     Q+  G+++L S   +HRDL   NI+V+S+  +KI DF
Sbjct: 100 CLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 159
Query: 209 GLARTAGTTFMMTPYVVTR-------YYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
           GLA+      +   Y V R       ++ APE +    +    D+WS G ++ E+ 
Sbjct: 160 GLAKLLP---LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 86  TQQNVAIKKLSRPFQNVTH---AKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           + +N A+    +  +N T     ++  +E   M+  +H +I+ L+   T          V
Sbjct: 36  SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-------V 88
Query: 143 YLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +++MEL       +  QV +  LD   +    YQ+   + +L S   +HRD+   N++V 
Sbjct: 89  WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 148
Query: 199 SDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           S+  +K+ DFGL+R     T +  +   +   + APE I    +    D+W  G  M E+
Sbjct: 149 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 208
Query: 257 IRGGVL-FPGTDHIDQWNKIIGKM 279
           +  GV  F G  +    N +IG++
Sbjct: 209 LMHGVKPFQGVKN----NDVIGRI 228

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 21/196 (10%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
             AIK LSR    +   +   RE  LM+ +NH N++ L+    P + L       L+  +
Sbjct: 51  QCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV----LLPYM 105
Query: 149 MDANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
              +L Q I+    +  +  L+    Q+  G+++L     +HRDL   N ++    T+K+
Sbjct: 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKV 165
Query: 206 LDFGLARTAGTTFMMTPYVVT--RYYRAP------EVILGMGYKENVDIWSVGCIMGEMI 257
            DFGLAR          Y V   R+ R P      E +    +    D+WS G ++ E++
Sbjct: 166 ADFGLAR---DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
Query: 258 RGGVLFPGTDHIDQWN 273
             G   P   HID ++
Sbjct: 223 TRGA--PPYRHIDPFD 236

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 86  TQQNVAIKKLSRPFQNVTH---AKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           + +N A+    +  +N T     ++  +E   M+  +H +I+ L+   T          V
Sbjct: 33  SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-------V 85
Query: 143 YLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +++MEL       +  QV +  LD   +    YQ+   + +L S   +HRD+   N++V 
Sbjct: 86  WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 145
Query: 199 SDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           S+  +K+ DFGL+R     T +  +   +   + APE I    +    D+W  G  M E+
Sbjct: 146 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 205
Query: 257 IRGGVL-FPGTDHIDQWNKIIGKM 279
           +  GV  F G  +    N +IG++
Sbjct: 206 LMHGVKPFQGVKN----NDVIGRI 225

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           +VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +
Sbjct: 75  SVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMI 123
Query: 145 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
           V E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+
Sbjct: 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183
Query: 201 CTLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
              K+ DFGLAR         +      +   + +PE I    +    D+WS G ++ E+
Sbjct: 184 LVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 257 IRGG 260
           +  G
Sbjct: 244 MSYG 247

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 86  TQQNVAIKKLSRPFQNVTH---AKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           + +N A+    +  +N T     ++  +E   M+  +H +I+ L+   T          V
Sbjct: 38  SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-------V 90
Query: 143 YLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +++MEL       +  QV +  LD   +    YQ+   + +L S   +HRD+   N++V 
Sbjct: 91  WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 150
Query: 199 SDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           S+  +K+ DFGL+R     T +  +   +   + APE I    +    D+W  G  M E+
Sbjct: 151 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 210
Query: 257 IRGGVL-FPGTDHIDQWNKIIGKM 279
           +  GV  F G  +    N +IG++
Sbjct: 211 LMHGVKPFQGVKN----NDVIGRI 230

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 14/229 (6%)
Query: 59  ELPISHQMGK----KRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK 113
           +LPI H   +    K   + + G A    D  + + VA+K + R  +   + KR   E  
Sbjct: 10  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKR---EII 66
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
             + + H NI+           L    +     EL +  +C   +   D  R  +   Q+
Sbjct: 67  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQL 123
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTTFMMTPYVVTRYYRA 231
           + G+ + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y A
Sbjct: 124 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 183
Query: 232 PEVILGMGYKENV-DIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           PEV+L   Y   V D+WS G  +  M+ G   F   +    + K I ++
Sbjct: 184 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 232

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/141 (34%), Positives = 70/141 (49%), Gaps = 19/141 (13%)
Query: 140 QDVYLVMEL--MDANLCQVIQMDLDH-ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           Q +Y+VME   +D N     +  +D  ER SY    ML  +  +H  GI+H DLKP+N +
Sbjct: 81  QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQHGIVHSDLKPANFL 139
Query: 197 VKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGM-GYKEN--------- 243
           +  D  LK++DFG+A   +   T+ +    V T  Y  PE I  M   +EN         
Sbjct: 140 I-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 198
Query: 244 -VDIWSVGCIMGEMIRGGVLF 263
             D+WS+GCI+  M  G   F
Sbjct: 199 KSDVWSLGCILYYMTYGKTPF 219

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 18/172 (10%)
Query: 115 MKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLL 170
           M+  +H +I+ L+   T          V+++MEL       +  QV +  LD   +    
Sbjct: 65  MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTTFMMTPYVVTRY 228
           YQ+   + +L S   +HRD+   N++V S+  +K+ DFGL+R     T +  +   +   
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKIIGKM 279
           + APE I    +    D+W  G  M E++  GV  F G  +    N +IG++
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRI 225

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           +VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +
Sbjct: 75  SVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMI 123
Query: 145 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
           V E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+
Sbjct: 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSN 183
Query: 201 CTLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
              K+ DFGL+R         +      +   + +PE I    +    D+WS G ++ E+
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 257 IRGG 260
           +  G
Sbjct: 244 MSYG 247

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 86  TQQNVAIKKLSRPFQNVTH---AKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           + +N A+    +  +N T     ++  +E   M+  +H +I+ L+   T          V
Sbjct: 61  SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-------V 113
Query: 143 YLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +++MEL       +  QV +  LD   +    YQ+   + +L S   +HRD+   N++V 
Sbjct: 114 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 173
Query: 199 SDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           S+  +K+ DFGL+R     T +  +   +   + APE I    +    D+W  G  M E+
Sbjct: 174 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 233
Query: 257 IRGGVL-FPGTDHIDQWNKIIGKMREAH 283
           +  GV  F G  +    N +IG++    
Sbjct: 234 LMHGVKPFQGVKN----NDVIGRIENGE 257

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 33/203 (16%)
Query: 76  LGAG-------AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LGAG       A Y+  T+  VA+K + +P      A  A  E  +MK + H  ++ L  
Sbjct: 190 LGAGQFGEVWMATYNKHTK--VAVKTM-KPGSMSVEAFLA--EANVMKTLQHDKLVKLHA 244
Query: 129 AFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHE----RMSYLLYQMLCGIKHLHSA 183
             T +        +Y++ E M   +L   ++ D   +    ++     Q+  G+  +   
Sbjct: 245 VVTKEP-------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 297
Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKEN 243
             IHRDL+ +NI+V +    KI DFGLAR  G  F +        + APE I    +   
Sbjct: 298 NYIHRDLRAANILVSASLVCKIADFGLARV-GAKFPIK-------WTAPEAINFGSFTIK 349
Query: 244 VDIWSVGCIMGEMIR-GGVLFPG 265
            D+WS G ++ E++  G + +PG
Sbjct: 350 SDVWSFGILLMEIVTYGRIPYPG 372

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 115 MKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLL 170
           M+  +H +I+ L+   T          V+++MEL       +  QV +  LD   +    
Sbjct: 445 MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTTFMMTPYVVTRY 228
           YQ+   + +L S   +HRD+   N++V +   +K+ DFGL+R     T +  +   +   
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKIIGKM 279
           + APE I    +    D+W  G  M E++  GV  F G  +    N +IG++
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRI 605

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 65  QMGKKRHNTSHLGAGAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKN 122
           Q+GK    +  L         T   VA+K+L  S P Q     +   RE +++K ++   
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILKALHSDF 72
Query: 123 IIGLLN-AFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMDLDHERMSYLLYQMLCGI 177
           I+     ++ P +     Q + LVME + +    +  Q  +  LD  R+     Q+  G+
Sbjct: 73  IVKYRGVSYGPGR-----QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 127
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTR-------YYR 230
           ++L S   +HRDL   NI+V+S+  +KI DFGLA+      +   Y V R       ++ 
Sbjct: 128 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY 184
Query: 231 APEVILGMGYKENVDIWSVGCIMGEMI 257
           APE +    +    D+WS G ++ E+ 
Sbjct: 185 APESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 30/200 (15%)
Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAY-REFKLMK-LVNHKNIIGLLNAFTPQKSLEE 138
           A D  + +  A+K+L     N     RA  +E   MK L  H NI+   +A +  K   +
Sbjct: 47  AQDVGSGREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103
Query: 139 F--QDVYLVMELMDANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLH--SAGIIHRD 189
               +  L+ EL    L + ++       L  + +  + YQ    ++H+H     IIHRD
Sbjct: 104 TGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRD 163
Query: 190 LKPSNIVVKSDCTLKILDFGLART---------AGTTFMMTPYVVTR----YYRAPEVI- 235
           LK  N+++ +  T+K+ DFG A T         +     +    +TR     YR PE+I 
Sbjct: 164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223
Query: 236 --LGMGYKENVDIWSVGCIM 253
                   E  DIW++GCI+
Sbjct: 224 LYSNFPIGEKQDIWALGCIL 243

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 115 MKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLL 170
           M+  +H +I+ L+   T          V+++MEL       +  QV +  LD   +    
Sbjct: 65  MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTTFMMTPYVVTRY 228
           YQ+   + +L S   +HRD+   N++V S+  +K+ DFGL+R     T    +   +   
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKIIGKM 279
           + APE I    +    D+W  G  M E++  GV  F G  +    N +IG++
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRI 225

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 65  QMGKKRHNTSHLGAGAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKN 122
           Q+GK    +  L         T   VA+K+L  S P Q     +   RE +++K ++   
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILKALHSDF 85
Query: 123 IIGLLN-AFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMDLDHERMSYLLYQMLCGI 177
           I+     ++ P +     Q + LVME + +    +  Q  +  LD  R+     Q+  G+
Sbjct: 86  IVKYRGVSYGPGR-----QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTR-------YYR 230
           ++L S   +HRDL   NI+V+S+  +KI DFGLA+      +   Y V R       ++ 
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY 197
Query: 231 APEVILGMGYKENVDIWSVGCIMGEMI 257
           APE +    +    D+WS G ++ E+ 
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 76/183 (41%), Gaps = 23/183 (12%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           VAIK L        + +R  R+F     +M   +H NII L    T  +         +V
Sbjct: 80  VAIKAL-----KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL------AMIV 128
Query: 146 MELMDANLCQVIQMDLDHERMSYLLYQML----CGIKHLHSAGIIHRDLKPSNIVVKSDC 201
            E M+           D +     L  ML     G+++L   G +HRDL   N++V S+ 
Sbjct: 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL 188
Query: 202 TLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
             K+ DFGL+R         +  T   +   + APE I    +    D+WS G +M E++
Sbjct: 189 VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
Query: 258 RGG 260
             G
Sbjct: 249 AYG 251

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           +VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +
Sbjct: 75  SVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMI 123
Query: 145 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
           V E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+
Sbjct: 124 VTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSN 183
Query: 201 CTLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
              K+ DFGL+R         +      +   + +PE I    +    D+WS G ++ E+
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 257 IRGG 260
           +  G
Sbjct: 244 MSYG 247

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 69/141 (48%), Gaps = 19/141 (13%)
Query: 140 QDVYLVMEL--MDANLCQVIQMDLDH-ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           Q +Y+VME   +D N     +  +D  ER SY    ML  +  +H  GI+H DLKP+N +
Sbjct: 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQHGIVHSDLKPANFL 187
Query: 197 VKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGM-GYKEN--------- 243
           +  D  LK++DFG+A   +   T+ +    V    Y  PE I  M   +EN         
Sbjct: 188 I-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP 246
Query: 244 -VDIWSVGCIMGEMIRGGVLF 263
             D+WS+GCI+  M  G   F
Sbjct: 247 KSDVWSLGCILYYMTYGKTPF 267

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 141 DVYLVMELMDANLCQ-------VIQMDLDHERMSYLLYQMLCGIKHL-HSAGIIHRDLKP 192
           D ++ MELM  +  +       V+   +  E +  +    +  + HL  +  IIHRD+KP
Sbjct: 95  DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKP 154
Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI----LGMGYKENVDIWS 248
           SNI++     +K+ DFG++     +   T     R Y APE I       GY    D+WS
Sbjct: 155 SNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWS 214
Query: 249 VGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE 281
           +G  + E+  G   +P      +WN +  ++ +
Sbjct: 215 LGITLYELATGRFPYP------KWNSVFDQLTQ 241

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 19/181 (10%)
Query: 90  VAIKKLSRPFQNVTHAKRA--YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
           VAIK L   +   T  +R     E  +M   +H NII L      +  + +++ + ++ E
Sbjct: 76  VAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRL------EGVISKYKPMMIITE 126
Query: 148 LMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSDCTL 203
            M+         + D E     L  ML GI    K+L +   +HRDL   NI+V S+   
Sbjct: 127 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC 186
Query: 204 KILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           K+ DFGL+R        T+  +   +   + APE I    +    D+WS G +M E++  
Sbjct: 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 246
Query: 260 G 260
           G
Sbjct: 247 G 247

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 72
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +      +  Q  +  +DH ++     Q+  
Sbjct: 73  HDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 128
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTFMMTPYVVTRYYRA 231
           G+++L +   IHRDL   NI+V+++  +KI DFGL +          +  P     ++ A
Sbjct: 129 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 79  GAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT-PQKSLE 137
           G  Y      +VA+K L+         +    E  +++   H NI+  +   T PQ ++ 
Sbjct: 24  GTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIV 83
Query: 138 ----EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
               E   +Y  + +++     +  +D+          Q   G+ +LH+  IIHRDLK +
Sbjct: 84  TQWCEGSSLYHHLHIIETKFEMIKLIDIAR--------QTAQGMDYLHAKSIIHRDLKSN 135
Query: 194 NIVVKSDCTLKILDFGLA-------------RTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           NI +  D T+KI DFGLA             + +G+   M P V+    + P       Y
Sbjct: 136 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP-------Y 188
Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
               D+++ G ++ E++ G + +   ++ DQ   ++G+
Sbjct: 189 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 226

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 17  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 74
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +      +  Q  +  +DH ++     Q+  
Sbjct: 75  HDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 130
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTFMMTPYVVTRYYRA 231
           G+++L +   IHRDL   NI+V+++  +KI DFGL +          +  P     ++ A
Sbjct: 131 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 190
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 191 PESLTESKFSVASDVWSFGVVLYELF 216

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 79  GAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT-PQKSLE 137
           G  Y      +VA+K L+         +    E  +++   H NI+  +   T PQ ++ 
Sbjct: 27  GTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIV 86
Query: 138 ----EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
               E   +Y  + +++     +  +D+          Q   G+ +LH+  IIHRDLK +
Sbjct: 87  TQWCEGSSLYHHLHIIETKFEMIKLIDIAR--------QTAQGMDYLHAKSIIHRDLKSN 138
Query: 194 NIVVKSDCTLKILDFGLA-------------RTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           NI +  D T+KI DFGLA             + +G+   M P V+    + P       Y
Sbjct: 139 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP-------Y 191
Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
               D+++ G ++ E++ G + +   ++ DQ   ++G+
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 229

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 10  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 67
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +      +  Q  +  +DH ++     Q+  
Sbjct: 68  HDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 123
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTFMMTPYVVTRYYRA 231
           G+++L +   IHRDL   NI+V+++  +KI DFGL +          +  P     ++ A
Sbjct: 124 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 183
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 184 PESLTESKFSVASDVWSFGVVLYELF 209

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 72
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +      +  Q     +DH ++     Q+  
Sbjct: 73  HDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICK 128
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTFMMTPYVVTRYYRA 231
           G+++L +   IHRDL   NI+V+++  +KI DFGL +          +  P     ++ A
Sbjct: 129 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 11  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 68
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +      +  Q  +  +DH ++     Q+  
Sbjct: 69  HDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 124
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTFMMTPYVVTRYYRA 231
           G+++L +   IHRDL   NI+V+++  +KI DFGL +          +  P     ++ A
Sbjct: 125 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 184
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 185 PESLTESKFSVASDVWSFGVVLYELF 210

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 79  GAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT-PQKSLE 137
           G  Y      +VA+K L+         +    E  +++   H NI+  +   T PQ ++ 
Sbjct: 22  GTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIV 81
Query: 138 ----EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
               E   +Y  + +++     +  +D+          Q   G+ +LH+  IIHRDLK +
Sbjct: 82  TQWCEGSSLYHHLHIIETKFEMIKLIDIAR--------QTAQGMDYLHAKSIIHRDLKSN 133
Query: 194 NIVVKSDCTLKILDFGLA-------------RTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           NI +  D T+KI DFGLA             + +G+   M P V+    + P       Y
Sbjct: 134 NIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP-------Y 186
Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
               D+++ G ++ E++ G + +   ++ DQ   ++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           +VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +
Sbjct: 73  SVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMI 121
Query: 145 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
           V E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+
Sbjct: 122 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 181
Query: 201 CTLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
              K+ DFGL+R         +      +   + +PE I    +    D+WS G ++ E+
Sbjct: 182 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 241
Query: 257 IRGG 260
           +  G
Sbjct: 242 MSYG 245

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 3/110 (2%)
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL---KILDFGLARTAGTTFMMTPYVV 225
           L+ Q+L G+ +LH   I+H DLKP NI++ S   L   KI+DFG++R  G    +   + 
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG 195
Query: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           T  Y APE++         D+W++G I   ++     F G D+ + +  I
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 79  GAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT-PQKSLE 137
           G  Y      +VA+K L+         +    E  +++   H NI+  +   T PQ ++ 
Sbjct: 22  GTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIV 81
Query: 138 ----EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
               E   +Y  + +++     +  +D+          Q   G+ +LH+  IIHRDLK +
Sbjct: 82  TQWCEGSSLYHHLHIIETKFEMIKLIDIAR--------QTAQGMDYLHAKSIIHRDLKSN 133
Query: 194 NIVVKSDCTLKILDFGLA-------------RTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           NI +  D T+KI DFGLA             + +G+   M P V+    + P       Y
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP-------Y 186
Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
               D+++ G ++ E++ G + +   ++ DQ   ++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 18  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 75
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +      +  Q  +  +DH ++     Q+  
Sbjct: 76  HDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 131
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTFMMTPYVVTRYYRA 231
           G+++L +   IHRDL   NI+V+++  +KI DFGL +          +  P     ++ A
Sbjct: 132 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 191
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 192 PESLTESKFSVASDVWSFGVVLYELF 217

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 16  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 73
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +      +  Q  +  +DH ++     Q+  
Sbjct: 74  HDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 129
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTFMMTPYVVTRYYRA 231
           G+++L +   IHRDL   NI+V+++  +KI DFGL +          +  P     ++ A
Sbjct: 130 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 189
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 190 PESLTESKFSVASDVWSFGVVLYELF 215

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           +VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +
Sbjct: 75  SVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMI 123
Query: 145 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
           V E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+
Sbjct: 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183
Query: 201 CTLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
              K+ DFGL+R         +      +   + +PE I    +    D+WS G ++ E+
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 257 IRGG 260
           +  G
Sbjct: 244 MSYG 247

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 79  GAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT-PQKSLE 137
           G  Y      +VA+K L+         +    E  +++   H NI+  +   T PQ ++ 
Sbjct: 27  GTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIV 86
Query: 138 ----EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
               E   +Y  + +++     +  +D+          Q   G+ +LH+  IIHRDLK +
Sbjct: 87  TQWCEGSSLYHHLHIIETKFEMIKLIDIAR--------QTAQGMDYLHAKSIIHRDLKSN 138
Query: 194 NIVVKSDCTLKILDFGLA-------------RTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           NI +  D T+KI DFGLA             + +G+   M P V+    + P       Y
Sbjct: 139 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP-------Y 191
Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
               D+++ G ++ E++ G + +   ++ DQ   ++G+
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 229

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 19  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 76
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +      +  Q  +  +DH ++     Q+  
Sbjct: 77  HDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 132
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTFMMTPYVVTRYYRA 231
           G+++L +   IHRDL   NI+V+++  +KI DFGL +          +  P     ++ A
Sbjct: 133 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 192
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 193 PESLTESKFSVASDVWSFGVVLYELF 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 69
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +      +  Q  +  +DH ++     Q+  
Sbjct: 70  HDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTFMMTPYVVTRYYRA 231
           G+++L +   IHRDL   NI+V+++  +KI DFGL +          +  P     ++ A
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELF 211

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 79  GAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT-PQKSLE 137
           G  Y      +VA+K L+         +    E  +++   H NI+  +   T PQ ++ 
Sbjct: 50  GTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIV 109
Query: 138 ----EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
               E   +Y  + +++     +  +D+          Q   G+ +LH+  IIHRDLK +
Sbjct: 110 TQWCEGSSLYHHLHIIETKFEMIKLIDIAR--------QTAQGMDYLHAKSIIHRDLKSN 161
Query: 194 NIVVKSDCTLKILDFGLA-------------RTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           NI +  D T+KI DFGLA             + +G+   M P V+    + P       Y
Sbjct: 162 NIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP-------Y 214
Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
               D+++ G ++ E++ G + +   ++ DQ   ++G+
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 252

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 109/254 (42%), Gaps = 32/254 (12%)
Query: 37  PYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYD-TATQQNVAIKKL 95
           P D   +   +   +W E     L +   +G+              D TAT + VA+K L
Sbjct: 7   PLDEHCERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 65
Query: 96  SRPFQNVTHAK-RAY-REFK-LMKLVNHKNIIGLLNAFT----PQKSLEEFQ-----DVY 143
               +  TH++ RA   E K L+ + +H N++ LL A T    P   + EF        Y
Sbjct: 66  K---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 122
Query: 144 LVMELMDANLCQVIQMDL--DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           L  +  +    +V   DL  D   + +L+   +Q+  G++ L S   IHRDL   NI++ 
Sbjct: 123 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182
Query: 199 SDCTLKILDFGLARTAGTTFMMTPYV------VTRYYRAPEVILGMGYKENVDIWSVGCI 252
               +KI DFGLAR     +    YV      +   + APE I    Y    D+WS G +
Sbjct: 183 EKNVVKICDFGLAR---DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 253 MGEMIR-GGVLFPG 265
           + E+   G   +PG
Sbjct: 240 LWEIFSLGASPYPG 253

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 43  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 100
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +      +  Q  +  +DH ++     Q+  
Sbjct: 101 HDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTFMMTPYVVTRYYRA 231
           G+++L +   IHRDL   NI+V+++  +KI DFGL +          +  P     ++ A
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 216
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELF 242

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 108/255 (42%), Gaps = 34/255 (13%)
Query: 37  PYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYD-TATQQNVAIKKL 95
           P D   +   +   +W E     L +   +G+              D TAT + VA+K L
Sbjct: 7   PLDEHCERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 65
Query: 96  SRPFQNVTHAK-RAY-REFK-LMKLVNHKNIIGLLNAFT----PQKSLEEFQ-----DVY 143
               +  TH++ RA   E K L+ + +H N++ LL A T    P   + EF        Y
Sbjct: 66  K---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 122
Query: 144 LVMELMDANLCQVIQMDL--DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           L  +  +    +V   DL  D   + +L+   +Q+  G++ L S   IHRDL   NI++ 
Sbjct: 123 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182
Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTR-------YYRAPEVILGMGYKENVDIWSVGC 251
               +KI DFGLAR         P  V +        + APE I    Y    D+WS G 
Sbjct: 183 EKNVVKICDFGLAR----DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 252 IMGEMIR-GGVLFPG 265
           ++ E+   G   +PG
Sbjct: 239 LLWEIFSLGASPYPG 253

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 79  GAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT-PQKSLE 137
           G  Y      +VA+K L+         +    E  +++   H NI+  +   T PQ ++ 
Sbjct: 49  GTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIV 108
Query: 138 ----EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
               E   +Y  + +++     +  +D+          Q   G+ +LH+  IIHRDLK +
Sbjct: 109 TQWCEGSSLYHHLHIIETKFEMIKLIDIAR--------QTAQGMDYLHAKSIIHRDLKSN 160
Query: 194 NIVVKSDCTLKILDFGLA-------------RTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           NI +  D T+KI DFGLA             + +G+   M P V+    + P       Y
Sbjct: 161 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP-------Y 213
Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
               D+++ G ++ E++ G + +   ++ DQ   ++G+
Sbjct: 214 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 251

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 79  GAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT-PQKSLE 137
           G  Y      +VA+K L+         +    E  +++   H NI+  +   T PQ ++ 
Sbjct: 42  GTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIV 101
Query: 138 ----EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
               E   +Y  + +++     +  +D+          Q   G+ +LH+  IIHRDLK +
Sbjct: 102 TQWCEGSSLYHHLHIIETKFEMIKLIDIAR--------QTAQGMDYLHAKSIIHRDLKSN 153
Query: 194 NIVVKSDCTLKILDFGLA-------------RTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           NI +  D T+KI DFGLA             + +G+   M P V+    + P       Y
Sbjct: 154 NIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP-------Y 206
Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
               D+++ G ++ E++ G + +   ++ DQ   ++G+
Sbjct: 207 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 244

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 79  GAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT-PQKSLE 137
           G  Y      +VA+K L+         +    E  +++   H NI+  +   T PQ ++ 
Sbjct: 50  GTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIV 109
Query: 138 ----EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
               E   +Y  + +++     +  +D+          Q   G+ +LH+  IIHRDLK +
Sbjct: 110 TQWCEGSSLYHHLHIIETKFEMIKLIDIAR--------QTAQGMDYLHAKSIIHRDLKSN 161
Query: 194 NIVVKSDCTLKILDFGLA-------------RTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           NI +  D T+KI DFGLA             + +G+   M P V+    + P       Y
Sbjct: 162 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP-------Y 214
Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
               D+++ G ++ E++ G + +   ++ DQ   ++G+
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 252

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           +VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +
Sbjct: 75  SVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMI 123
Query: 145 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
           V E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+
Sbjct: 124 VTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183
Query: 201 CTLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
              K+ DFGL+R         +      +   + +PE I    +    D+WS G ++ E+
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 257 IRGG 260
           +  G
Sbjct: 244 MSYG 247

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 79  GAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT-PQKSLE 137
           G  Y      +VA+K L+         +    E  +++   H NI+  +   T PQ ++ 
Sbjct: 22  GTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIV 81
Query: 138 ----EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
               E   +Y  + +++     +  +D+          Q   G+ +LH+  IIHRDLK +
Sbjct: 82  TQWCEGSSLYHHLHIIETKFEMIKLIDIAR--------QTAQGMDYLHAKSIIHRDLKSN 133
Query: 194 NIVVKSDCTLKILDFGLA-------------RTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           NI +  D T+KI DFGLA             + +G+   M P V+    + P       Y
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP-------Y 186
Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
               D+++ G ++ E++ G + +   ++ DQ   ++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 69
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +      +  Q  +  +DH ++     Q+  
Sbjct: 70  HDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTFMMTPYVVTRYYRA 231
           G+++L +   IHRDL   NI+V+++  +KI DFGL +          +  P     ++ A
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELF 211

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           +VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +
Sbjct: 75  SVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMI 123
Query: 145 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
           V E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+
Sbjct: 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183
Query: 201 CTLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
              K+ DFGL+R         +      +   + +PE I    +    D+WS G ++ E+
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 257 IRGG 260
           +  G
Sbjct: 244 MSYG 247

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           +VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +
Sbjct: 75  SVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMI 123
Query: 145 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
           V E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+
Sbjct: 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183
Query: 201 CTLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
              K+ DFGL+R         +      +   + +PE I    +    D+WS G ++ E+
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 257 IRGG 260
           +  G
Sbjct: 244 MSYG 247

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 69
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +      +  Q  +  +DH ++     Q+  
Sbjct: 70  HDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTTFMMT--PYVVTRYYRA 231
           G+++L +   IHRDL   NI+V+++  +KI DFGL +       F     P     ++ A
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 30/206 (14%)
Query: 84  TATQQNVAIKKLSRPFQNVTHAK-RAY-REFK-LMKLVNHKNIIGLLNAFT----PQKSL 136
           TAT + VA+K L    +  TH++ RA   E K L+ + +H N++ LL A T    P   +
Sbjct: 45  TATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 101
Query: 137 EEFQ-----DVYLVMELMDANLCQVIQMDL--DHERMSYLL---YQMLCGIKHLHSAGII 186
            EF        YL  +  +    +V   DL  D   + +L+   +Q+  G++ L S   I
Sbjct: 102 TEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 161
Query: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV------VTRYYRAPEVILGMGY 240
           HRDL   NI++     +KI DFGLAR     +    YV      +   + APE I    Y
Sbjct: 162 HRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKGDARLPLKWMAPETIFDRVY 218
Query: 241 KENVDIWSVGCIMGEMIR-GGVLFPG 265
               D+WS G ++ E+   G   +PG
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           +VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +
Sbjct: 75  SVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMI 123
Query: 145 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
           V E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+
Sbjct: 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183
Query: 201 CTLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
              K+ DFGL+R         +      +   + +PE I    +    D+WS G ++ E+
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 257 IRGG 260
           +  G
Sbjct: 244 MSYG 247

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 32/207 (15%)
Query: 84  TATQQNVAIKKLSRPFQNVTHAK-RAY-REFK-LMKLVNHKNIIGLLNAFT----PQKSL 136
           TAT + VA+K L    +  TH++ RA   E K L+ + +H N++ LL A T    P   +
Sbjct: 45  TATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 101
Query: 137 EEFQ-----DVYLVMELMDANLCQVIQMDL--DHERMSYLL---YQMLCGIKHLHSAGII 186
            EF        YL  +  +    +V   DL  D   + +L+   +Q+  G++ L S   I
Sbjct: 102 TEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 161
Query: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTR-------YYRAPEVILGMG 239
           HRDL   NI++     +KI DFGLAR         P  V +        + APE I    
Sbjct: 162 HRDLAARNILLSEKNVVKICDFGLAR----DIXKDPDXVRKGDARLPLKWMAPETIFDRV 217
Query: 240 YKENVDIWSVGCIMGEMIR-GGVLFPG 265
           Y    D+WS G ++ E+   G   +PG
Sbjct: 218 YTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 108/255 (42%), Gaps = 34/255 (13%)
Query: 37  PYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYD-TATQQNVAIKKL 95
           P D   +   +   +W E     L +   +G+              D TAT + VA+K L
Sbjct: 7   PLDEHCERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 65
Query: 96  SRPFQNVTHAK-RAY-REFK-LMKLVNHKNIIGLLNAFT----PQKSLEEFQ-----DVY 143
               +  TH++ RA   E K L+ + +H N++ LL A T    P   + EF        Y
Sbjct: 66  K---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 122
Query: 144 LVMELMDANLCQVIQMDL--DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           L  +  +    +V   DL  D   + +L+   +Q+  G++ L S   IHRDL   NI++ 
Sbjct: 123 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182
Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTR-------YYRAPEVILGMGYKENVDIWSVGC 251
               +KI DFGLAR         P  V +        + APE I    Y    D+WS G 
Sbjct: 183 EKNVVKICDFGLAR----DIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 252 IMGEMIR-GGVLFPG 265
           ++ E+   G   +PG
Sbjct: 239 LLWEIFSLGASPYPG 253

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 116/271 (42%), Gaps = 38/271 (14%)
Query: 20  YINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAG 79
           Y+++  D  E+      P D   +   +   +W E     L +   +G+           
Sbjct: 33  YLSIVMDPDEL------PLDEHCERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADA 85
Query: 80  AAYD-TATQQNVAIKKLSRPFQNVTHAK-RAY-REFK-LMKLVNHKNIIGLLNAFT---- 131
              D TAT + VA+K L    +  TH++ RA   E K L+ + +H N++ LL A T    
Sbjct: 86  FGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142
Query: 132 PQKSLEEFQ-----DVYLVMELMDANLCQVIQMDL--DHERMSYLL---YQMLCGIKHLH 181
           P   + EF        YL  +  +    +V   DL  D   + +L+   +Q+  G++ L 
Sbjct: 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 202
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV------VTRYYRAPEVI 235
           S   IHRDL   NI++     +KI DFGLAR     +    YV      +   + APE I
Sbjct: 203 SRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKGDARLPLKWMAPETI 259
Query: 236 LGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
               Y    D+WS G ++ E+   G   +PG
Sbjct: 260 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 30/206 (14%)
Query: 84  TATQQNVAIKKLSRPFQNVTHAK-RAY-REFK-LMKLVNHKNIIGLLNAFT----PQKSL 136
           TAT + VA+K L    +  TH++ RA   E K L+ + +H N++ LL A T    P   +
Sbjct: 45  TATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 101
Query: 137 EEFQ-----DVYLVMELMDANLCQVIQMDL--DHERMSYLL---YQMLCGIKHLHSAGII 186
            EF        YL  +  +    +V   DL  D   + +L+   +Q+  G++ L S   I
Sbjct: 102 TEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 161
Query: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV------VTRYYRAPEVILGMGY 240
           HRDL   NI++     +KI DFGLAR     +    YV      +   + APE I    Y
Sbjct: 162 HRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKGDARLPLKWMAPETIFDRVY 218
Query: 241 KENVDIWSVGCIMGEMIR-GGVLFPG 265
               D+WS G ++ E+   G   +PG
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 20  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 79
Query: 128 NAFTPQKSLEEFQDVYLVMELMDA--NLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSA 183
           + F    S        L++E M+   +L   I  +  L  E      +Q+L  ++H H+ 
Sbjct: 80  DWFERPDSF------VLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 184 GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY-K 241
           G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    Y  
Sbjct: 134 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHG 192
Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
            +  +WS+G ++ +M+ G + F   + I
Sbjct: 193 RSAAVWSLGILLYDMVCGDIPFEHDEEI 220

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 16/230 (6%)
Query: 59  ELPISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREF 112
           +LPI H    +      +GAG         D    + VA+K + R  +   + KR   E 
Sbjct: 11  DLPIMHD-SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKR---EI 66
Query: 113 KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQ 172
              + + H NI+           L    +     EL +  +C   +   D  R  +   Q
Sbjct: 67  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQ 123
Query: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTTFMMTPYVVTRYYR 230
           ++ G+ + H+  + HRDLK  N ++       LKI DFG ++ +         V T  Y 
Sbjct: 124 LISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYI 183
Query: 231 APEVILGMGYKENV-DIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           APEV+L   Y   V D+WS G  +  M+ G   F   +    + K I ++
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 115 MKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLL 170
           M+  +H +I+ L+   T          V+++MEL       +  QV +  LD   +    
Sbjct: 65  MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTTFMMTPYVVTRY 228
           YQ+   + +L S   +HRD+   N++V +   +K+ DFGL+R     T +  +   +   
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKIIGKM 279
           + APE I    +    D+W  G  M E++  GV  F G  +    N +IG++
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRI 225

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 77/184 (41%), Gaps = 23/184 (12%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           +VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +
Sbjct: 75  SVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMI 123
Query: 145 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
           V E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+
Sbjct: 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183
Query: 201 CTLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
              K+ DFGL R         +      +   + +PE I    +    D+WS G ++ E+
Sbjct: 184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 257 IRGG 260
           +  G
Sbjct: 244 MSYG 247

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           +VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +
Sbjct: 46  SVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMI 94
Query: 145 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
           V E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+
Sbjct: 95  VTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 154
Query: 201 CTLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
              K+ DFGL+R         +      +   + +PE I    +    D+WS G ++ E+
Sbjct: 155 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 214
Query: 257 IRGG 260
           +  G
Sbjct: 215 MSYG 218

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 141 DVYLVMELMDANLCQVIQMDLD------HERMSYLLYQMLCGIKHLHSA-GIIHRDLKPS 193
           DV++ MELMD +L +  +  +D       + +  +   ++  ++HLHS   +IHRD+KPS
Sbjct: 80  DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 139
Query: 194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG----MGYKENVDIWSV 249
           N+++ +   +K+ DFG++               + Y APE I       GY    DIWS+
Sbjct: 140 NVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSL 199
Query: 250 GCIMGEM 256
           G  M E+
Sbjct: 200 GITMIEL 206

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           +VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +
Sbjct: 46  SVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMI 94
Query: 145 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
           V E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+
Sbjct: 95  VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 154
Query: 201 CTLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
              K+ DFGL+R         +      +   + +PE I    +    D+WS G ++ E+
Sbjct: 155 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 214
Query: 257 IRGG 260
           +  G
Sbjct: 215 MSYG 218

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 14/203 (6%)
Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA------------FTPQK 134
           + + AIK++        H   A     L KL +H NII LL A            + P  
Sbjct: 42  RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 101
Query: 135 SLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
           +L +F     V+E   A  +       L  +++ +    +  G+ +L     IHRDL   
Sbjct: 102 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 161
Query: 194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
           NI+V  +   KI DFGL+R        T   +   + A E +    Y  N D+WS G ++
Sbjct: 162 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 221
Query: 254 GEMIR-GGVLFPGTDHIDQWNKI 275
            E++  GG  + G    + + K+
Sbjct: 222 WEIVSLGGTPYCGMTCAELYEKL 244

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 41/213 (19%)
Query: 75  HLGAGAA-------YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLL 127
            LGAG A       Y+  T+  VA+K L    Q          E  LMK + H+ ++ L 
Sbjct: 20  RLGAGQAGEVWMGYYNGHTK--VAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 128 NAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHS 182
              T +        +Y++ E M+  +L   ++    + L   ++  +  Q+  G+  +  
Sbjct: 75  AVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPE 233
              IHRDL+ +NI+V    + KI DFGLAR       TA  G  F +        + APE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK-------WTAPE 180
Query: 234 VILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
            I    +    D+WS G ++ E++  G + +PG
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 65  QMGKKRHNTSHLGAGAAYDTATQQNVAIKKL--SRPFQNVTHAKRAYREFKLMKLVNHKN 122
           Q+GK    +  L         T   VA+K+L  S P Q     +   RE +++K ++   
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILKALHSDF 69
Query: 123 IIGLLN-AFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMDLDHERMSYLLYQMLCGI 177
           I+     ++ P +      ++ LVME + +    +  Q  +  LD  R+     Q+  G+
Sbjct: 70  IVKYRGVSYGPGRP-----ELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 124
Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTTFMMTPYVVTRYYRAPE 233
           ++L S   +HRDL   NI+V+S+  +KI DFGLA+          +  P     ++ APE
Sbjct: 125 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE 184
Query: 234 VILGMGYKENVDIWSVGCIMGEMI 257
            +    +    D+WS G ++ E+ 
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+  + L +  ++G  +     +G    Y+  T+  VA+K L    Q         
Sbjct: 12  DEW-EVPRETLKLVERLGAGQFGEVWMGY---YNGHTK--VAVKSLK---QGSMSPDAFL 62
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
            E  LMK + H+ ++ L    T +        +Y++ E M+  +L   ++    + L   
Sbjct: 63  AEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
           ++  +  Q+  G+  +     IHRDL+ +NI+V    + KI DFGLAR       TA  G
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 175
Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
             F +        + APE I    +    D+WS G ++ E++  G + +PG
Sbjct: 176 AKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+  + L +  ++G  +     +G    Y+  T+  VA+K L    Q         
Sbjct: 8   DEW-EVPRETLKLVERLGAGQFGEVWMGY---YNGHTK--VAVKSLK---QGSMSPDAFL 58
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
            E  LMK + H+ ++ L    T +        +Y++ E M+  +L   ++    + L   
Sbjct: 59  AEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTIN 111
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
           ++  +  Q+  G+  +     IHRDL+ +NI+V    + KI DFGLAR       TA  G
Sbjct: 112 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 171
Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
             F +        + APE I    +    D+WS G ++ E++  G + +PG
Sbjct: 172 AKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 215

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           +VAIK L      V + ++  R+F     +M   +H NII L    T  K       V +
Sbjct: 63  SVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMI 111
Query: 145 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
           V E M+           D +     L  ML GI    K+L   G +HRDL   NI++ S+
Sbjct: 112 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 171
Query: 201 CTLKILDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
              K+ DFGL+R         +      +   + +PE I    +    D+WS G ++ E+
Sbjct: 172 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 231
Query: 257 IRGG 260
           +  G
Sbjct: 232 MSYG 235

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+  + L +  ++G  +     +G    Y+  T+  VA+K L    Q         
Sbjct: 6   DEW-EVPRETLKLVERLGAGQFGEVWMGY---YNGHTK--VAVKSLK---QGSMSPDAFL 56
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
            E  LMK + H+ ++ L    T +        +Y++ E M+  +L   ++    + L   
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
           ++  +  Q+  G+  +     IHRDL+ +NI+V    + KI DFGLAR       TA  G
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
             F +        + APE I    +    D+WS G ++ E++  G + +PG
Sbjct: 170 AKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 14/203 (6%)
Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA------------FTPQK 134
           + + AIK++        H   A     L KL +H NII LL A            + P  
Sbjct: 52  RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 111
Query: 135 SLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
           +L +F     V+E   A  +       L  +++ +    +  G+ +L     IHRDL   
Sbjct: 112 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171
Query: 194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
           NI+V  +   KI DFGL+R        T   +   + A E +    Y  N D+WS G ++
Sbjct: 172 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231
Query: 254 GEMIR-GGVLFPGTDHIDQWNKI 275
            E++  GG  + G    + + K+
Sbjct: 232 WEIVSLGGTPYCGMTCAELYEKL 254

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 32/207 (15%)
Query: 84  TATQQNVAIKKLSRPFQNVTHAK-RAY-REFK-LMKLVNHKNIIGLLNAFT----PQKSL 136
           TAT + VA+K L    +  TH++ RA   E K L+ + +H N++ LL A T    P   +
Sbjct: 45  TATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 101
Query: 137 EEFQ-----DVYLVMELMDANLCQVIQMDL--DHERMSYLL---YQMLCGIKHLHSAGII 186
            EF        YL  +  +    +V   DL  D   + +L+   +Q+  G++ L S   I
Sbjct: 102 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 161
Query: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTR-------YYRAPEVILGMG 239
           HRDL   NI++     +KI DFGLAR         P  V +        + APE I    
Sbjct: 162 HRDLAARNILLSEKNVVKICDFGLAR----DIXKDPDXVRKGDARLPLKWMAPETIFDRV 217
Query: 240 YKENVDIWSVGCIMGEMIR-GGVLFPG 265
           Y    D+WS G ++ E+   G   +PG
Sbjct: 218 YTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+  + L +  ++G  +     +G    Y+  T+  VA+K L    Q         
Sbjct: 11  DEW-EVPRETLKLVERLGAGQFGEVWMGY---YNGHTK--VAVKSLK---QGSMSPDAFL 61
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
            E  LMK + H+ ++ L    T +        +Y++ E M+  +L   ++    + L   
Sbjct: 62  AEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTIN 114
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
           ++  +  Q+  G+  +     IHRDL+ +NI+V    + KI DFGLAR       TA  G
Sbjct: 115 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 174
Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
             F +        + APE I    +    D+WS G ++ E++  G + +PG
Sbjct: 175 AKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 218

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+  + L +  ++G  +     +G    Y+  T+  VA+K L    Q         
Sbjct: 12  DEW-EVPRETLKLVERLGAGQFGEVWMGY---YNGHTK--VAVKSLK---QGSMSPDAFL 62
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
            E  LMK + H+ ++ L    T +        +Y++ E M+  +L   ++    + L   
Sbjct: 63  AEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
           ++  +  Q+  G+  +     IHRDL+ +NI+V    + KI DFGLAR       TA  G
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 175
Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
             F +        + APE I    +    D+WS G ++ E++  G + +PG
Sbjct: 176 AKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+  + L +  ++G  +     +G    Y+  T+  VA+K L    Q         
Sbjct: 6   DEW-EVPRETLKLVERLGAGQFGEVWMGY---YNGHTK--VAVKSLK---QGSMSPDAFL 56
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
            E  LMK + H+ ++ L    T +        +Y++ E M+  +L   ++    + L   
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
           ++  +  Q+  G+  +     IHRDL+ +NI+V    + KI DFGLAR       TA  G
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
             F +        + APE I    +    D+WS G ++ E++  G + +PG
Sbjct: 170 AKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 11/169 (6%)
Query: 117 LVN--HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQML 174
           LVN   K I  L  AF    +L    D Y+  +L+   L    +  L  E   + L +M+
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL--TLLSKFEDRLPEEMARFYLAEMV 185
Query: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG--LARTAGTTFMMTPYVVTRYYRAP 232
             I  +H    +HRD+KP NI++  +  +++ DFG  L      T   +  V T  Y +P
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 233 EVILGMG-----YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           E++  M      Y    D WS+G  M EM+ G   F     ++ + KI+
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+  + L +  ++G  +     +G    Y+  T+  VA+K L    Q         
Sbjct: 14  DEW-EVPRETLKLVERLGAGQFGEVWMGY---YNGHTK--VAVKSLK---QGSMSPDAFL 64
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
            E  LMK + H+ ++ L    T +        +Y++ E M+  +L   ++    + L   
Sbjct: 65  AEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTIN 117
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
           ++  +  Q+  G+  +     IHRDL+ +NI+V    + KI DFGLAR       TA  G
Sbjct: 118 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 177
Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
             F +        + APE I    +    D+WS G ++ E++  G + +PG
Sbjct: 178 AKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 221

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 26/202 (12%)
Query: 84  TATQQNVAIKKLSRPFQNVTHAK-RAY-REFK-LMKLVNHKNIIGLLNAFT----PQKSL 136
           TAT + VA+K L    +  TH++ RA   E K L+ + +H N++ LL A T    P   +
Sbjct: 54  TATXRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110
Query: 137 EEFQDVYLVMELMDANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 190
            EF     +   + +   + +         L  E +    +Q+  G++ L S   IHRDL
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDL 170
Query: 191 KPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV------VTRYYRAPEVILGMGYKENV 244
              NI++     +KI DFGLAR     +    YV      +   + APE I    Y    
Sbjct: 171 AARNILLSEKNVVKIXDFGLAR---DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 227
Query: 245 DIWSVGCIMGEMIR-GGVLFPG 265
           D+WS G ++ E+   G   +PG
Sbjct: 228 DVWSFGVLLWEIFSLGASPYPG 249

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+  + L +  ++G  +     +G    Y+  T+  VA+K L    Q         
Sbjct: 16  DEW-EVPRETLKLVERLGAGQFGEVWMGY---YNGHTK--VAVKSLK---QGSMSPDAFL 66
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
            E  LMK + H+ ++ L    T +        +Y++ E M+  +L   ++    + L   
Sbjct: 67  AEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTIN 119
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
           ++  +  Q+  G+  +     IHRDL+ +NI+V    + KI DFGLAR       TA  G
Sbjct: 120 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 179
Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
             F +        + APE I    +    D+WS G ++ E++  G + +PG
Sbjct: 180 AKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 223

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 116/256 (45%), Gaps = 58/256 (22%)
Query: 76  LGAGAAYDTATQQN-----VAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLNA 129
           LG G++     Q +     VA+K++   F ++     A  E KL+ +  +H N+I    +
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRYYCS 77
Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSY--------LLYQMLCGIKHL 180
            T  + L      Y+ +EL + NL  +++  ++  E +          LL Q+  G+ HL
Sbjct: 78  ETTDRFL------YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 181 HSAGIIHRDLKPSNIVVKSDC-----------TLKIL--DFGLAR------TAGTTFMMT 221
           HS  IIHRDLKP NI+V +              L+IL  DFGL +      ++  T +  
Sbjct: 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 222 PYVVTRYYRAPEVI-------LGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNK 274
           P   T  +RAPE++              ++DI+S+GC+   ++  G    G  +  + N 
Sbjct: 192 P-SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 275 IIG-----KMREAHDK 285
           I G     +M+  HD+
Sbjct: 251 IRGIFSLDEMKCLHDR 266

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+  + L +  ++G  +     +G    Y+  T+  VA+K L    Q         
Sbjct: 6   DEW-EVPRETLKLVERLGAGQFGEVWMGY---YNGHTK--VAVKSLK---QGSMSPDAFL 56
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
            E  LMK + H+ ++ L    T +        +Y++ E M+  +L   ++    + L   
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
           ++  +  Q+  G+  +     IHRDL+ +NI+V    + KI DFGLAR       TA  G
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169
Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
             F +        + APE I    +    D+WS G ++ E++  G + +PG
Sbjct: 170 AKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+  + L +  ++G  +     +G    Y+  T+  VA+K L    Q         
Sbjct: 15  DEW-EVPRETLKLVERLGAGQFGEVWMGY---YNGHTK--VAVKSLK---QGSMSPDAFL 65
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
            E  LMK + H+ ++ L    T +        +Y++ E M+  +L   ++    + L   
Sbjct: 66  AEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTIN 118
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
           ++  +  Q+  G+  +     IHRDL+ +NI+V    + KI DFGLAR       TA  G
Sbjct: 119 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 178
Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
             F +        + APE I    +    D+WS G ++ E++  G + +PG
Sbjct: 179 AKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 222

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+  + L +  ++G  +     +G    Y+  T+  VA+K L    Q         
Sbjct: 7   DEW-EVPRETLKLVERLGAGQFGEVWMGY---YNGHTK--VAVKSLK---QGSMSPDAFL 57
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
            E  LMK + H+ ++ L    T +        +Y++ E M+  +L   ++    + L   
Sbjct: 58  AEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTIN 110
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
           ++  +  Q+  G+  +     IHRDL+ +NI+V    + KI DFGLAR       TA  G
Sbjct: 111 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 170
Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
             F +        + APE I    +    D+WS G ++ E++  G + +PG
Sbjct: 171 AKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 214

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 106 KRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM------ 159
           + A RE  + +L NH NI+ L+ A+  ++   + +   L+       L   I+       
Sbjct: 71  EEAQREADMHRLFNHPNILRLV-AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN 129
Query: 160 DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL--------- 210
            L  +++ +LL  +  G++ +H+ G  HRDLKP+NI++  +    ++D G          
Sbjct: 130 FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 211 -ARTAGTTFMMTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMIRG 259
            +R A T         T  YRAPE+     +    E  D+WS+GC++  M+ G
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 81/181 (44%), Gaps = 17/181 (9%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNII---GLLNAFTPQKSLEEFQDVYLVM 146
           VAIK L   +      +    E  +M   +H N+I   G++   TP   + EF +   + 
Sbjct: 64  VAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 122
Query: 147 ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +  N  Q   + L       +L  +  G+K+L     +HRDL   NI+V S+   K+ 
Sbjct: 123 SFLRQNDGQFTVIQL-----VGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVS 177
Query: 207 DFGLAR-----TAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           DFGL+R     T+  T+   +   +  R + APE I    +    D+WS G +M E++  
Sbjct: 178 DFGLSRFLEDDTSDPTYTSALGGKIPIR-WTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 236
Query: 260 G 260
           G
Sbjct: 237 G 237

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 106/237 (44%), Gaps = 39/237 (16%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D W E+  + + +  ++G  +     +G    Y+ +T+  VA+K L    +  T + +A+
Sbjct: 6   DAW-EIPRESIKLVKRLGAGQFGEVWMGY---YNNSTK--VAVKTL----KPGTMSVQAF 55
Query: 110 -REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHE--- 164
             E  LMK + H  ++ L    T +      + +Y++ E M   +L   ++ D   +   
Sbjct: 56  LEEANLMKTLQHDKLVRLYAVVTRE------EPIYIITEYMAKGSLLDFLKSDEGGKVLL 109
Query: 165 -RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---------A 214
            ++     Q+  G+ ++     IHRDL+ +N++V      KI DFGLAR           
Sbjct: 110 PKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 169
Query: 215 GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHID 270
           G  F +        + APE I    +    D+WS G ++ E++  G + +PG  + D
Sbjct: 170 GAKFPIK-------WTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNAD 219

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 103/253 (40%), Gaps = 32/253 (12%)
Query: 37  PYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYD-TATQQNVAIKKL 95
           P D   +   +   +W E     L +   +G+              D TAT + VA+K L
Sbjct: 9   PLDEHCERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML 67
Query: 96  SRPFQNVTHAK-RAY-REFK-LMKLVNHKNIIGLLNAFT----PQKSLEEFQDVYLVMEL 148
               +  TH++ RA   E K L+ + +H N++ LL A T    P   + EF     +   
Sbjct: 68  K---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 124
Query: 149 MDANLCQVIQMD--------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           + +   + +           L  E +    +Q+  G++ L S   IHRDL   NI++   
Sbjct: 125 LRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEK 184
Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTR-------YYRAPEVILGMGYKENVDIWSVGCIM 253
             +KI DFGLAR         P  V +        + APE I    Y    D+WS G ++
Sbjct: 185 NVVKICDFGLAR----DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 254 GEMIR-GGVLFPG 265
            E+   G   +PG
Sbjct: 241 WEIFSLGASPYPG 253

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 78/186 (41%), Gaps = 29/186 (15%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           VAIK L        + +R  R+F     +M   +H NII L    T  +         +V
Sbjct: 80  VAIKAL-----KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL------AMIV 128
Query: 146 MELMDANLCQVIQMDLDHERMSYLLYQML----CGIKHLHSAGIIHRDLKPSNIVVKSDC 201
            E M+           D +     L  ML     G+++L   G +HRDL   N++V S+ 
Sbjct: 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL 188
Query: 202 TLKILDFGLAR-------TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
             K+ DFGL+R        A TT   T   +   + APE I    +    D+WS G +M 
Sbjct: 189 VCKVSDFGLSRVLEDDPDAAXTT---TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMW 245
Query: 255 EMIRGG 260
           E++  G
Sbjct: 246 EVLAYG 251

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 105/254 (41%), Gaps = 28/254 (11%)
Query: 33  PAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYD-TATQQNVA 91
           P   P D   +   +   +W E     L +   +G+              D TAT + VA
Sbjct: 3   PDELPLDEHCERLPYDASKW-EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVA 61
Query: 92  IKKLSRPFQNVTHAK-RAY-REFK-LMKLVNHKNIIGLLNAFT----PQKSLEEFQDVYL 144
           +K L    +  TH++ RA   E K L+ + +H N++ LL A T    P   + EF     
Sbjct: 62  VKMLK---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 145 VMELMDANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +   + +   + +         L  E +    +Q+  G++ L S   IHRDL   NI++ 
Sbjct: 119 LSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLS 178
Query: 199 SDCTLKILDFGLARTAGTTFMMTPYV------VTRYYRAPEVILGMGYKENVDIWSVGCI 252
               +KI DFGLAR     +    YV      +   + APE I    Y    D+WS G +
Sbjct: 179 EKNVVKICDFGLAR---DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 235
Query: 253 MGEMIR-GGVLFPG 265
           + E+   G   +PG
Sbjct: 236 LWEIFSLGASPYPG 249

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY 109
           D+W E+  + L +  ++G  +     +G    Y+  T+  VA+K L    Q         
Sbjct: 1   DEW-EVPRETLKLVERLGAGQFGEVWMGY---YNGHTK--VAVKSLK---QGSMSPDAFL 51
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MDLDHE 164
            E  LMK + H+ ++ L    T +        +Y++ E M+  +L   ++    + L   
Sbjct: 52  AEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTIN 104
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
           ++  +  Q+  G+  +     IHRDL+ +NI+V    + KI DFGLAR       TA  G
Sbjct: 105 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 164
Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
             F +        + APE I    +    D+WS G ++ E++  G + +PG
Sbjct: 165 AKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 208

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 19  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 78
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 79  DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 129
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 130 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 188
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
           Y   +  +WS+G ++ +M+ G + F   + I
Sbjct: 189 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 219

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 20  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 79
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 80  DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 130
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 189
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 190 YHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 21  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 80
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 81  DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 131
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 190
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
           Y   +  +WS+G ++ +M+ G + F   + I
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 35  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 94
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 95  DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 145
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 204
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 205 YHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 68/141 (48%), Gaps = 19/141 (13%)
Query: 140 QDVYLVMEL--MDANLCQVIQMDLDH-ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           Q +Y+VME   +D N     +  +D  ER SY    ML  +  +H  GI+H DLKP+N +
Sbjct: 101 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQHGIVHSDLKPANFL 159
Query: 197 VKSDCTLKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGM-GYKEN--------- 243
           +  D  LK++DFG+A   +      +    V T  Y  PE I  M   +EN         
Sbjct: 160 I-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 218
Query: 244 -VDIWSVGCIMGEMIRGGVLF 263
             D+WS+GCI+  M  G   F
Sbjct: 219 KSDVWSLGCILYYMTYGKTPF 239

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 35  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 94
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 95  DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 145
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 204
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 205 YHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 16  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 75
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 76  DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 126
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 185
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
           Y   +  +WS+G ++ +M+ G + F   + I
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 16  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 75
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 76  DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 126
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 185
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
           Y   +  +WS+G ++ +M+ G + F   + I
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 21  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 80
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 81  DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 131
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 190
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 36  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 95
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 96  DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 146
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 205
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 115/251 (45%), Gaps = 52/251 (20%)
Query: 76  LGAGAAYDTATQ-----QNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLNA 129
           LG G++     Q     + VA+K++   F ++     A  E KL+ +  +H N+I    +
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRYYCS 95
Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSY--------LLYQMLCGIKHL 180
            T  + L      Y+ +EL + NL  +++  ++  E +          LL Q+  G+ HL
Sbjct: 96  ETTDRFL------YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 149
Query: 181 HSAGIIHRDLKPSNIVVKSDC-----------TLKIL--DFGLAR---TAGTTFM--MTP 222
           HS  IIHRDLKP NI+V +              L+IL  DFGL +   +    F   +  
Sbjct: 150 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 223 YVVTRYYRAPEVILGMGYK---ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG-- 277
              T  +RAPE++     +    ++DI+S+GC+   ++  G    G  +  + N I G  
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 269
Query: 278 ---KMREAHDK 285
              +M+  HD+
Sbjct: 270 SLDEMKCLHDR 280

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 36  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 95
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 96  DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 146
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 205
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 21  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 80
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 81  DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 131
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 190
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
           Y   +  +WS+G ++ +M+ G + F   + I
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 43  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 102
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 103 DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 153
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 154 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 212
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 213 YHGRSAAVWSLGILLYDMVCGDIPF 237

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 36  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 95
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 96  DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 146
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 205
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 115/251 (45%), Gaps = 52/251 (20%)
Query: 76  LGAGAAYDTATQ-----QNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLNA 129
           LG G++     Q     + VA+K++   F ++     A  E KL+ +  +H N+I    +
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRYYCS 95
Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSY--------LLYQMLCGIKHL 180
            T  + L      Y+ +EL + NL  +++  ++  E +          LL Q+  G+ HL
Sbjct: 96  ETTDRFL------YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 149
Query: 181 HSAGIIHRDLKPSNIVVKSDC-----------TLKIL--DFGLAR---TAGTTFM--MTP 222
           HS  IIHRDLKP NI+V +              L+IL  DFGL +   +    F   +  
Sbjct: 150 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 223 YVVTRYYRAPEVILGMGYK---ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG-- 277
              T  +RAPE++     +    ++DI+S+GC+   ++  G    G  +  + N I G  
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 269
Query: 278 ---KMREAHDK 285
              +M+  HD+
Sbjct: 270 SLDEMKCLHDR 280

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 16  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 75
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 76  DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 126
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 127 HNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 185
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
           Y   +  +WS+G ++ +M+ G + F   + I
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 60/120 (50%), Gaps = 20/120 (16%)
Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------RTAGTTF 218
           Q   G+ +LH+  IIHRDLK +NI +  D T+KI DFGLA             + +G+  
Sbjct: 116 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 175
Query: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
            M P V+      P       Y    D+++ G ++ E++ G + +   ++ DQ  +++G+
Sbjct: 176 WMAPEVIRMQDSNP-------YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 228

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 9/161 (5%)
Query: 123 IIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS 182
           I  L  AF  +  L    D Y+  +L+   L    +  L  +   + + +M+  I  +H 
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLL--TLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFG--LARTAGTTFMMTPYVVTRYYRAPEVIL---- 236
              +HRD+KP N+++  +  +++ DFG  L      T   +  V T  Y +PE++     
Sbjct: 210 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 237 GMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           GMG Y    D WS+G  M EM+ G   F     ++ + KI+
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 310

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 48  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 107
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 108 DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 158
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 217
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 49  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 108
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 109 DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 159
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 218
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 49  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 108
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 109 DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 159
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 218
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 48  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 107
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 108 DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 158
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 217
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 49  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 108
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 109 DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 159
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 218
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 48  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 107
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 108 DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 158
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 217
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 60/120 (50%), Gaps = 20/120 (16%)
Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------RTAGTTF 218
           Q   G+ +LH+  IIHRDLK +NI +  D T+KI DFGLA             + +G+  
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
            M P V+      P       Y    D+++ G ++ E++ G + +   ++ DQ  +++G+
Sbjct: 188 WMAPEVIRMQDSNP-------YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 49  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 108
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 109 DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 159
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 218
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 48  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 107
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 108 DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 158
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 217
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 9/161 (5%)
Query: 123 IIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS 182
           I  L  AF  +  L    D Y+  +L+   L    +  L  +   + + +M+  I  +H 
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLL--TLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFG--LARTAGTTFMMTPYVVTRYYRAPEVIL---- 236
              +HRD+KP N+++  +  +++ DFG  L      T   +  V T  Y +PE++     
Sbjct: 194 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 237 GMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           GMG Y    D WS+G  M EM+ G   F     ++ + KI+
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 34/193 (17%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+VME
Sbjct: 44  RVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVME 92
Query: 148 LMDAN-LCQVIQMDL-DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            M    L   ++ ++  + R+  L+    Q+  G+ ++     +HRDL+ +NI+V  +  
Sbjct: 93  YMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 152
Query: 203 LKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++
Sbjct: 153 CKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 205
Query: 254 GEM-IRGGVLFPG 265
            E+  +G V +PG
Sbjct: 206 TELTTKGRVPYPG 218

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 55  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 115 DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 165
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 166 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 224
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 225 YHGRSAAVWSLGILLYDMVCGDIPF 249

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 14/229 (6%)
Query: 59  ELPISHQMGK----KRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK 113
           +LPI H   +    K   + + G A    D  + + VA+K + R  +   + KR   E  
Sbjct: 11  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKR---EII 67
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
             + + H NI+           L    +     EL +  +C   +   D  R  +   Q+
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQL 124
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTTFMMTPYVVTRYYRA 231
           + G+ + H+  + HRDLK  N ++       LKI  FG ++++         V T  Y A
Sbjct: 125 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIA 184
Query: 232 PEVILGMGYKENV-DIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           PEV+L   Y   V D+WS G  +  M+ G   F   +    + K I ++
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 63  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 122
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 123 DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 173
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 232
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 233 YHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 58/111 (52%), Gaps = 3/111 (2%)
Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFM 219
           L  E      +Q+L  ++H H+ G++HRD+K  NI++  +   LK++DFG       T +
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-V 212
Query: 220 MTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
            T +  TR Y  PE I    Y   +  +WS+G ++ +M+ G + F   + I
Sbjct: 213 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 263

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 60/120 (50%), Gaps = 20/120 (16%)
Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------RTAGTTF 218
           Q   G+ +LH+  IIHRDLK +NI +  D T+KI DFGLA             + +G+  
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
            M P V+      P       Y    D+++ G ++ E++ G + +   ++ DQ  +++G+
Sbjct: 188 WMAPEVIRMQDSNP-------YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 63  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 122
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 123 DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 173
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 232
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 233 YHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 34/193 (17%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E
Sbjct: 44  RVAIKTL----KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEEP-------IYIVTE 92
Query: 148 LMD-ANLCQVIQMDL-DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            M   +L   ++ ++  + R+  L+    Q+  G+ ++     +HRDL+ +NI+V  +  
Sbjct: 93  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 152
Query: 203 LKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++
Sbjct: 153 CKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 205
Query: 254 GEM-IRGGVLFPG 265
            E+  +G V +PG
Sbjct: 206 TELTTKGRVPYPG 218

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 77  GAGAAYD---TATQQNVAIKKLSRP----FQNVTHAKRAYREFKLMKLVNH--KNIIGLL 127
           G G+ Y     +    VAIK + +     +  + +  R   E  L+K V+     +I LL
Sbjct: 68  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 127
Query: 128 NAFTPQKSL-------EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           + F    S        E  QD++  +    A         L  E      +Q+L  ++H 
Sbjct: 128 DWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHC 178
Query: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I    
Sbjct: 179 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 237
Query: 240 Y-KENVDIWSVGCIMGEMIRGGVLF 263
           Y   +  +WS+G ++ +M+ G + F
Sbjct: 238 YHGRSAAVWSLGILLYDMVCGDIPF 262

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 14/229 (6%)
Query: 59  ELPISHQMGK----KRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK 113
           +LPI H   +    K   + + G A    D  + + VA+K + R  +   + KR   E  
Sbjct: 11  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKR---EII 67
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 173
             + + H NI+           L    +     EL +  +C   +   D  R  +   Q+
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQL 124
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTTFMMTPYVVTRYYRA 231
           + G+ + H+  + HRDLK  N ++       LKI  FG ++++         V T  Y A
Sbjct: 125 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIA 184
Query: 232 PEVILGMGYKENV-DIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM 279
           PEV+L   Y   V D+WS G  +  M+ G   F   +    + K I ++
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 94/193 (48%), Gaps = 34/193 (17%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V+E
Sbjct: 44  RVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVIE 92
Query: 148 LMD-ANLCQVIQMDL-DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            M   +L   ++ ++  + R+  L+    Q+  G+ ++     +HRDL+ +NI+V  +  
Sbjct: 93  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 152
Query: 203 LKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++
Sbjct: 153 CKVADFGLARLIEDNEXTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 205
Query: 254 GEM-IRGGVLFPG 265
            E+  +G V +PG
Sbjct: 206 TELTTKGRVPYPG 218

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSY 168
           +E  ++ +  H+NI+ L  +F   +S+EE   ++  +  +D          +L+   +  
Sbjct: 50  KEISILNIARHRNILHLHESF---ESMEELVMIFEFISGLDIFERINTSAFELNEREIVS 106
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLAR--TAGTTFMMTPYV 224
            ++Q+   ++ LHS  I H D++P NI+   +   T+KI++FG AR    G  F +  + 
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-FT 165
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
              YY APEV          D+WS+G ++  ++ G
Sbjct: 166 APEYY-APEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    Q+GK    +  +         T + VA+KKL    +   H +   RE +++K + 
Sbjct: 13  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQ 70
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLC 175
           H NI+               +++ L+ME +      +  Q  +  +DH ++     Q+  
Sbjct: 71  HDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 126
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT----FMMTPYVVTRYYRA 231
           G+++L +   IHR+L   NI+V+++  +KI DFGL +          +  P     ++ A
Sbjct: 127 GMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 186
Query: 232 PEVILGMGYKENVDIWSVGCIMGEMI 257
           PE +    +    D+WS G ++ E+ 
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYELF 212

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 94/193 (48%), Gaps = 34/193 (17%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V+E
Sbjct: 44  RVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVIE 92
Query: 148 LMD-ANLCQVIQMDL-DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            M   +L   ++ ++  + R+  L+    Q+  G+ ++     +HRDL+ +NI+V  +  
Sbjct: 93  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 152
Query: 203 LKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++
Sbjct: 153 CKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 205
Query: 254 GEM-IRGGVLFPG 265
            E+  +G V +PG
Sbjct: 206 TELTTKGRVPYPG 218

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 14/203 (6%)
Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA------------FTPQK 134
           + + AIK++        H   A     L KL +H NII LL A            + P  
Sbjct: 49  RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 108
Query: 135 SLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
           +L +F     V+E   A  +       L  +++ +    +  G+ +L     IHR+L   
Sbjct: 109 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAAR 168
Query: 194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
           NI+V  +   KI DFGL+R        T   +   + A E +    Y  N D+WS G ++
Sbjct: 169 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 228
Query: 254 GEMIR-GGVLFPGTDHIDQWNKI 275
            E++  GG  + G    + + K+
Sbjct: 229 WEIVSLGGTPYCGMTCAELYEKL 251

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 33/190 (17%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNI--------------IGLLNAFT 131
           T + VA+K L +P     H     +E ++++ + H+NI              I L+  F 
Sbjct: 49  TGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 107
Query: 132 PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 191
           P  SL+E    YL       NL Q ++  +          Q+  G+ +L S   +HRDL 
Sbjct: 108 PSGSLKE----YLPKNKNKINLKQQLKYAV----------QICKGMDYLGSRQYVHRDLA 153
Query: 192 PSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTR----YYRAPEVILGMGYKENVDIW 247
             N++V+S+  +KI DFGL +   T          R    ++ APE ++   +    D+W
Sbjct: 154 ARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVW 213
Query: 248 SVGCIMGEMI 257
           S G  + E++
Sbjct: 214 SFGVTLHELL 223

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 108/254 (42%), Gaps = 32/254 (12%)
Query: 37  PYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYD-TATQQNVAIKKL 95
           P D   +   +   +W E     L +   +G+              D TAT + VA+K L
Sbjct: 9   PLDEHCERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 67
Query: 96  SRPFQNVTHAK-RAY-REFK-LMKLVNHKNIIGLLNAFT----PQKSLEEFQ-----DVY 143
               +  TH++ RA   E K L+ + +H N++ LL A T    P   + EF        Y
Sbjct: 68  K---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 124
Query: 144 LVMELMDANLCQVIQMDL--DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           L  +  +    +    DL  D   + +L+   +Q+  G++ L S   IHRDL   NI++ 
Sbjct: 125 LRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 184
Query: 199 SDCTLKILDFGLARTAGTTFMMTPYV------VTRYYRAPEVILGMGYKENVDIWSVGCI 252
               +KI DFGLAR     +    YV      +   + APE I    Y    D+WS G +
Sbjct: 185 EKNVVKICDFGLAR---DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 241
Query: 253 MGEMIR-GGVLFPG 265
           + E+   G   +PG
Sbjct: 242 LWEIFSLGASPYPG 255

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 103/254 (40%), Gaps = 33/254 (12%)
Query: 37  PYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYD-TATQQNVAIKKL 95
           P D   +   +   +W E     L +   +G+              D TAT + VA+K L
Sbjct: 8   PLDEHCERLPYDASKW-EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 66
Query: 96  SRPFQNVTHAK-RAY-REFK-LMKLVNHKNIIGLLNAFT----PQKSLEEFQDVYLVMEL 148
               +  TH++ RA   E K L+ + +H N++ LL A T    P   + EF     +   
Sbjct: 67  K---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 123
Query: 149 MDANLCQVIQMD---------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           + +   + +            L  E +    +Q+  G++ L S   IHRDL   NI++  
Sbjct: 124 LRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183
Query: 200 DCTLKILDFGLARTAGTTFMMTPYVVTR-------YYRAPEVILGMGYKENVDIWSVGCI 252
              +KI DFGLAR         P  V +        + APE I    Y    D+WS G +
Sbjct: 184 KNVVKICDFGLAR----DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 253 MGEMIR-GGVLFPG 265
           + E+   G   +PG
Sbjct: 240 LWEIFSLGASPYPG 253

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 34/193 (17%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E
Sbjct: 35  RVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVTE 83
Query: 148 LMD-ANLCQVIQMDL-DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            M   +L   ++ ++  + R+  L+    Q+  G+ ++     +HRDL+ +NI+V  +  
Sbjct: 84  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 143
Query: 203 LKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++
Sbjct: 144 CKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 196
Query: 254 GEM-IRGGVLFPG 265
            E+  +G V +PG
Sbjct: 197 TELTTKGRVPYPG 209

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 28/175 (16%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY- 168
           REF+++K +NHKNI+ L        ++EE       + +M+   C  +   L+    +Y 
Sbjct: 56  REFEVLKKLNHKNIVKLF-------AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG 108
Query: 169 --------LLYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSD--CTLKILDFGLARTAGT 216
                   +L  ++ G+ HL   GI+HR++KP NI  V+  D     K+ DFG AR    
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 217 TFMMTPYVVTRYYRAPEV----IL----GMGYKENVDIWSVGCIMGEMIRGGVLF 263
                    T  Y  P++    +L       Y   VD+WS+G        G + F
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 34/193 (17%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E
Sbjct: 33  RVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVTE 81
Query: 148 LMD-ANLCQVIQMDL-DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            M   +L   ++ ++  + R+  L+    Q+  G+ ++     +HRDL+ +NI+V  +  
Sbjct: 82  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 141
Query: 203 LKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++
Sbjct: 142 CKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 194
Query: 254 GEM-IRGGVLFPG 265
            E+  +G V +PG
Sbjct: 195 TELTTKGRVPYPG 207

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 33/190 (17%)
Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNI--------------IGLLNAFT 131
           T + VA+K L +P     H     +E ++++ + H+NI              I L+  F 
Sbjct: 37  TGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 95
Query: 132 PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 191
           P  SL+E    YL       NL Q ++  +          Q+  G+ +L S   +HRDL 
Sbjct: 96  PSGSLKE----YLPKNKNKINLKQQLKYAV----------QICKGMDYLGSRQYVHRDLA 141
Query: 192 PSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTR----YYRAPEVILGMGYKENVDIW 247
             N++V+S+  +KI DFGL +   T          R    ++ APE ++   +    D+W
Sbjct: 142 ARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVW 201
Query: 248 SVGCIMGEMI 257
           S G  + E++
Sbjct: 202 SFGVTLHELL 211

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 42/218 (19%)
Query: 76  LGAG-------AAYDTATQQNVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLL 127
           LGAG         Y+ +T+  VA+K L    +  T + +A+  E  LMK + H  ++ L 
Sbjct: 20  LGAGQFGEVWMGYYNNSTK--VAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLY 73
Query: 128 NAFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHE----RMSYLLYQMLCGIKHLHS 182
              T +      + +Y++ E M   +L   ++ D   +    ++     Q+  G+ ++  
Sbjct: 74  AVVTKE------EPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 127
Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLART---------AGTTFMMTPYVVTRYYRAPE 233
              IHRDL+ +N++V      KI DFGLAR           G  F +        + APE
Sbjct: 128 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPE 180
Query: 234 VILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHID 270
            I    +    ++WS G ++ E++  G + +PG  + D
Sbjct: 181 AINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNAD 218

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 41/212 (19%)
Query: 76  LGAG-------AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LGAG       A Y+  T+  VA+K + +P      A  A  E  +MK + H  ++ L  
Sbjct: 196 LGAGQFGEVWMATYNKHTK--VAVKTM-KPGSMSVEAFLA--EANVMKTLQHDKLVKLHA 250
Query: 129 AFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHE----RMSYLLYQMLCGIKHLHSA 183
             T +        +Y++ E M   +L   ++ D   +    ++     Q+  G+  +   
Sbjct: 251 VVTKEP-------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLART---------AGTTFMMTPYVVTRYYRAPEV 234
             IHRDL+ +NI+V +    KI DFGLAR           G  F +        + APE 
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEA 356
Query: 235 ILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
           I    +    D+WS G ++ E++  G + +PG
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 34/193 (17%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E
Sbjct: 44  RVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVTE 92
Query: 148 LMD-ANLCQVIQMDL-DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            M   +L   ++ ++  + R+  L+    Q+  G+ ++     +HRDL+ +NI+V  +  
Sbjct: 93  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 152
Query: 203 LKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++
Sbjct: 153 CKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 205
Query: 254 GEM-IRGGVLFPG 265
            E+  +G V +PG
Sbjct: 206 TELTTKGRVPYPG 218

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 76  LGAG-------AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LGAG       A Y+  T+  VA+K + +P      A  A  E  +MK + H  ++ L  
Sbjct: 23  LGAGQFGEVWMATYNKHTK--VAVKTM-KPGSMSVEAFLA--EANVMKTLQHDKLVKLHA 77
Query: 129 AFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHE----RMSYLLYQMLCGIKHLHSA 183
             T +        +Y++ E M   +L   ++ D   +    ++     Q+  G+  +   
Sbjct: 78  VVTKE-------PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 130
Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLART---------AGTTFMMTPYVVTRYYRAPEV 234
             IHRDL+ +NI+V +    KI DFGLAR           G  F +        + APE 
Sbjct: 131 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEA 183
Query: 235 ILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDH 268
           I    +    D+WS G ++ E++  G + +PG  +
Sbjct: 184 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 218

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 103/235 (43%), Gaps = 22/235 (9%)
Query: 46  EHTVDQWKELIYQELPISHQMGKKRHNTSHLG--AGAAYDTATQQNVAIKKLSRPFQNVT 103
           +H   + KE+    +    ++G+ R    + G   G A    TQ  VAIK L    +   
Sbjct: 14  QHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQA-VAIKTLKDKAEGPL 72
Query: 104 HAKRAYR-EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV--------YLVMELMDANLC 154
             +  +R E  L   + H N++ LL   T  + L              +LVM    +++ 
Sbjct: 73  --REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVG 130
Query: 155 -----QVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 209
                + ++  L+     +L+ Q+  G+++L S  ++H+DL   N++V     +KI D G
Sbjct: 131 STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG 190
Query: 210 LAR---TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGV 261
           L R    A    ++   ++   + APE I+   +  + DIWS G ++ E+   G+
Sbjct: 191 LFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 245

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 91/192 (47%), Gaps = 34/192 (17%)
Query: 90  VAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E 
Sbjct: 294 VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVTEY 342
Query: 149 MD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
           M   +L   ++ +    L   ++  +  Q+  G+ ++     +HRDL+ +NI+V  +   
Sbjct: 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 402
Query: 204 KILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
           K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++ 
Sbjct: 403 KVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILLT 455
Query: 255 EM-IRGGVLFPG 265
           E+  +G V +PG
Sbjct: 456 ELTTKGRVPYPG 467

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 52/102 (50%), Gaps = 10/102 (9%)
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV---TR 227
           +Q+  G++ L S   IHRDL   NI++  +  +KI DFGLAR     +    YV    TR
Sbjct: 206 FQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKNPDYVRKGDTR 262
Query: 228 Y---YRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
               + APE I    Y    D+WS G ++ E+   GG  +PG
Sbjct: 263 LPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPG 304

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 22/189 (11%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VAIK L          +    E ++MK + H  ++ L    + +        +Y+V E M
Sbjct: 36  VAIKTLK---PGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEP-------IYIVTEYM 85
Query: 150 DANLCQVIQMDLDHERMSY-----LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204
           +         D +   +       +  Q+  G+ ++     IHRDL+ +NI+V +    K
Sbjct: 86  NKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICK 145
Query: 205 ILDFGLAR----TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-RG 259
           I DFGLAR       T      + +   + APE  L   +    D+WS G ++ E++ +G
Sbjct: 146 IADFGLARLIEDNEXTARQGAKFPIK--WTAPEAALYGRFTIKSDVWSFGILLTELVTKG 203
Query: 260 GVLFPGTDH 268
            V +PG ++
Sbjct: 204 RVPYPGMNN 212

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 113/255 (44%), Gaps = 56/255 (21%)
Query: 76  LGAGAAYDTATQ-----QNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLNA 129
           LG G++     Q     + VA+K++   F ++     A  E KL+ +  +H N+I    +
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRYYCS 77
Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSY--------LLYQMLCGIKHL 180
            T  + L      Y+ +EL + NL  +++  ++  E +          LL Q+  G+ HL
Sbjct: 78  ETTDRFL------YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 181 HSAGIIHRDLKPSNIVVKSDC-----------TLKIL--DFGLARTAGT-----TFMMTP 222
           HS  IIHRDLKP NI+V +              L+IL  DFGL +   +        +  
Sbjct: 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 223 YVVTRYYRAPEVI-------LGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
              T  +RAPE++              ++DI+S+GC+   ++  G    G  +  + N I
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 276 IG-----KMREAHDK 285
            G     +M+  HD+
Sbjct: 252 RGIFSLDEMKCLHDR 266

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 34/193 (17%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E
Sbjct: 41  RVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVTE 89
Query: 148 LMD-ANLCQVIQMDL-DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            M+  +L   ++ +   + R+  L+    Q+  G+ ++     +HRDL+ +NI+V  +  
Sbjct: 90  YMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLV 149
Query: 203 LKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++
Sbjct: 150 CKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 202
Query: 254 GEM-IRGGVLFPG 265
            E+  +G V +PG
Sbjct: 203 TELTTKGRVPYPG 215

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 34/193 (17%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E
Sbjct: 44  RVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVCE 92
Query: 148 LMD-ANLCQVIQMDL-DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            M   +L   ++ ++  + R+  L+    Q+  G+ ++     +HRDL+ +NI+V  +  
Sbjct: 93  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 152
Query: 203 LKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++
Sbjct: 153 CKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 205
Query: 254 GEM-IRGGVLFPG 265
            E+  +G V +PG
Sbjct: 206 TELTTKGRVPYPG 218

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 34/193 (17%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E
Sbjct: 41  RVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVTE 89
Query: 148 LMD-ANLCQVIQMDL-DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            M+  +L   ++ +   + R+  L+    Q+  G+ ++     +HRDL+ +NI+V  +  
Sbjct: 90  YMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLV 149
Query: 203 LKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++
Sbjct: 150 CKVADFGLARLIEDNEWTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 202
Query: 254 GEM-IRGGVLFPG 265
            E+  +G V +PG
Sbjct: 203 TELTTKGRVPYPG 215

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 76/184 (41%), Gaps = 23/184 (12%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNII---GLLNAFTPQKSLEEFQDV 142
           VAIK L        + +R  REF     +M    H NII   G++    P   L EF + 
Sbjct: 45  VAIKTLKG-----GYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMEN 99
Query: 143 YLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
             +   +  N  Q   + L       +L  +  G+++L     +HRDL   NI+V S+  
Sbjct: 100 GALDSFLRLNDGQFTVIQLVG-----MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLV 154
Query: 203 LKILDFGLARTAGTTFMMTPYV------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
            K+ DFGL+R          Y       +   + APE I    +    D WS G +M E+
Sbjct: 155 CKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEV 214
Query: 257 IRGG 260
           +  G
Sbjct: 215 MSFG 218

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 54  ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK 113
           EL  +E+ +  ++G  +     LG         Q +VA+K +    +        ++E +
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKG-----QYDVAVKMIK---EGSMSEDEFFQEAQ 55
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM-----DLDHERMSY 168
            M  ++H  ++      + +        +Y+V E + +N C +  +      L+  ++  
Sbjct: 56  TMMKLSHPKLVKFYGVCSKE------YPIYIVTEYI-SNGCLLNYLRSHGKGLEPSQLLE 108
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFM 219
           + Y +  G+  L S   IHRDL   N +V  D  +K+ DFG+ R         + GT F 
Sbjct: 109 MCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP 168
Query: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
           +        + APEV     Y    D+W+ G +M E+   G
Sbjct: 169 VK-------WSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG 202

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 90  VAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E 
Sbjct: 211 VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVTEY 259
Query: 149 MD-ANLCQVIQMDL-DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
           M   +L   ++ +   + R+  L+    Q+  G+ ++     +HRDL+ +NI+V  +   
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 319
Query: 204 KILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
           K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++ 
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILLT 372
Query: 255 EM-IRGGVLFPG 265
           E+  +G V +PG
Sbjct: 373 ELTTKGRVPYPG 384

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 91/192 (47%), Gaps = 34/192 (17%)
Query: 90  VAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E 
Sbjct: 211 VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVTEY 259
Query: 149 MD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
           M   +L   ++ +    L   ++  +  Q+  G+ ++     +HRDL+ +NI+V  +   
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 319
Query: 204 KILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
           K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++ 
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILLT 372
Query: 255 EM-IRGGVLFPG 265
           E+  +G V +PG
Sbjct: 373 ELTTKGRVPYPG 384

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 28/175 (16%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY- 168
           REF+++K +NHKNI+ L        ++EE       + +M+   C  +   L+    +Y 
Sbjct: 56  REFEVLKKLNHKNIVKLF-------AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG 108
Query: 169 --------LLYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSD--CTLKILDFGLARTAGT 216
                   +L  ++ G+ HL   GI+HR++KP NI  V+  D     K+ DFG AR    
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 217 TFMMTPYVVTRYYRAPEV----IL----GMGYKENVDIWSVGCIMGEMIRGGVLF 263
                    T  Y  P++    +L       Y   VD+WS+G        G + F
Sbjct: 169 DEQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 57  YQELPISHQMGKKRHNTSHLGAGAAYDT-ATQQNVAIKKLSRPFQNVTHA-KRAY-REFK 113
           + E PIS  +G  +      G G  Y        VA+KKL+      T   K+ + +E K
Sbjct: 18  FDERPIS--VGGNKXGEG--GFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 73
Query: 114 LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM------ELMDANLCQVIQMDLDHERMS 167
           +     H+N++ LL  F+      +  D+ LV        L+D   C      L      
Sbjct: 74  VXAKCQHENLVELL-GFS-----SDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRC 127
Query: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTTFMMTPYV 224
            +      GI  LH    IHRD+K +NI++    T KI DFGLAR +         +  V
Sbjct: 128 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIV 187
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
            T  Y APE + G       DI+S G ++ E+I G    P  D
Sbjct: 188 GTTAYXAPEALRGE-ITPKSDIYSFGVVLLEIITG---LPAVD 226

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 34/193 (17%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E
Sbjct: 37  RVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-------PIYIVTE 85
Query: 148 LMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            M   +L   ++ +    L   ++  +  Q+  G+ ++     +HRDL+ +NI+V  +  
Sbjct: 86  YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 145
Query: 203 LKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++
Sbjct: 146 CKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 198
Query: 254 GEM-IRGGVLFPG 265
            E+  +G V +PG
Sbjct: 199 TELTTKGRVPYPG 211

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 25/185 (13%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNII---GLLNAFTPQKSLEEFQDV 142
           VAIK L        + +R  REF     +M    H NII   G++    P   L EF + 
Sbjct: 47  VAIKTLKG-----GYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMEN 101
Query: 143 YLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
             +   +  N  Q   + L       +L  +  G+++L     +HRDL   NI+V S+  
Sbjct: 102 GALDSFLRLNDGQFTVIQLVG-----MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLV 156
Query: 203 LKILDFGLAR-------TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
            K+ DFGL+R           T  +   +  R+  APE I    +    D WS G +M E
Sbjct: 157 CKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT-APEAIAFRKFTSASDAWSYGIVMWE 215
Query: 256 MIRGG 260
           ++  G
Sbjct: 216 VMSFG 220

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 106/256 (41%), Gaps = 39/256 (15%)
Query: 42  VDEREHTVDQWKELIYQELPISHQMGK----KRHNTSHLGAGAAYDTATQQNVAIKKLSR 97
           VD RE+  D   E   + L     +G     K  N +  G      T     VA+K L  
Sbjct: 29  VDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISK---TGVSIQVAVKMLKE 85
Query: 98  PFQNVTHAKRAYREFKLM-KLVNHKNIIGLLNAFT---PQKSLEEFQDVYLVMELMDANL 153
              + +  +    E K+M +L +H+NI+ LL A T   P   + E+     ++  + +  
Sbjct: 86  K-ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144
Query: 154 CQVIQMDLDHERMSYL-----------------LYQMLCGIKHLHSAGIIHRDLKPSNIV 196
            +  + ++++E    L                  YQ+  G++ L     +HRDL   N++
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204
Query: 197 VKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVG 250
           V     +KI DFGLAR   +    + YVV    R      APE +    Y    D+WS G
Sbjct: 205 VTHGKVVKICDFGLARDIMSD---SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 261
Query: 251 CIMGEMIRGGV-LFPG 265
            ++ E+   GV  +PG
Sbjct: 262 ILLWEIFSLGVNPYPG 277

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 72/179 (40%), Gaps = 15/179 (8%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VAIK L   + +    +    E  +M   +H NII L    T  K       V ++ E M
Sbjct: 60  VAIKTLKAGYTD-KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKP------VMIITEYM 112
Query: 150 DANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
           +           D       L  ML GI    K+L     +HRDL   NI+V S+   K+
Sbjct: 113 ENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKV 172
Query: 206 LDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            DFG++R         +      +   + APE I    +    D+WS G +M E++  G
Sbjct: 173 SDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 231

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 105/234 (44%), Gaps = 40/234 (17%)
Query: 56  IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM 115
           I +++ +  Q+GK R+    +G          + VA+K         T     +RE ++ 
Sbjct: 35  IAKQIQMVKQIGKGRYGEVWMGKWRG------EKVAVKVFF-----TTEEASWFRETEIY 83
Query: 116 K--LVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL-MDANLCQVIQ-MDLDHERMSYLLY 171
           +  L+ H+NI+G + A    K    +  +YL+ +   + +L   ++   LD + M  L Y
Sbjct: 84  QTVLMRHENILGFIAADI--KGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAY 141
Query: 172 QMLCGIKHLHS--------AGIIHRDLKPSNIVVKSDCTLKILDFGLA-----RTAGTTF 218
             + G+ HLH+          I HRDLK  NI+VK + T  I D GLA      T     
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 219 MMTPYVVTRYYRAPEVI---LGMGYKEN---VDIWSVGCIMGEMIR----GGVL 262
                V T+ Y  PEV+   L   + ++    D++S G I+ E+ R    GG++
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 34/193 (17%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E
Sbjct: 44  RVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVTE 92
Query: 148 LMD-ANLCQVIQMDL-DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            M   +L   ++ ++  + R+  L+    Q+  G+ ++     +HRDL  +NI+V  +  
Sbjct: 93  YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLV 152
Query: 203 LKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++
Sbjct: 153 CKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 205
Query: 254 GEM-IRGGVLFPG 265
            E+  +G V +PG
Sbjct: 206 TELTTKGRVPYPG 218

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 34/193 (17%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E
Sbjct: 44  RVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVTE 92
Query: 148 LMDAN-LCQVIQMDL-DHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            M    L   ++ ++  + R+  L+    Q+  G+ ++     +HRDL+ +NI+V  +  
Sbjct: 93  YMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 152
Query: 203 LKILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++
Sbjct: 153 CKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 205
Query: 254 GEM-IRGGVLFPG 265
            E+  +G V +PG
Sbjct: 206 TELTTKGRVPYPG 218

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 91/192 (47%), Gaps = 34/192 (17%)
Query: 90  VAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           VAIK L    +  T +  A+ +E ++MK + H+ ++ L    + +        +Y+V E 
Sbjct: 211 VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVGEY 259
Query: 149 MD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
           M   +L   ++ +    L   ++  +  Q+  G+ ++     +HRDL+ +NI+V  +   
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 319
Query: 204 KILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
           K+ DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++ 
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILLT 372
Query: 255 EM-IRGGVLFPG 265
           E+  +G V +PG
Sbjct: 373 ELTTKGRVPYPG 384

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 22/228 (9%)
Query: 53  KELIYQELPISHQMGKKRHNTSHLG--AGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYR 110
           KE+    +    ++G+ R    + G   G A    TQ  VAIK L    +     +  +R
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQA-VAIKTLKDKAEGPL--REEFR 60
Query: 111 -EFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV--------YLVMELMDANLC-----QV 156
            E  L   + H N++ LL   T  + L              +LVM    +++      + 
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 157 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---T 213
           ++  L+     +L+ Q+  G+++L S  ++H+DL   N++V     +KI D GL R    
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 214 AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGV 261
           A    ++   ++   + APE I+   +  + DIWS G ++ E+   G+
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 228

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 17/181 (9%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNII---GLLNAFTPQKSLEEFQDVYLVM 146
           VAIK L   +      +    E  +M   +H N+I   G++   TP   + EF +   + 
Sbjct: 38  VAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 96
Query: 147 ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +  N  Q   + L       +L  +  G+K+L     +HR L   NI+V S+   K+ 
Sbjct: 97  SFLRQNDGQFTVIQL-----VGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVS 151
Query: 207 DFGLAR-----TAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
           DFGL+R     T+  T+   +   +  R + APE I    +    D+WS G +M E++  
Sbjct: 152 DFGLSRFLEDDTSDPTYTSALGGKIPIR-WTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 210
Query: 260 G 260
           G
Sbjct: 211 G 211

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 31/206 (15%)
Query: 69  KRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           K   T   G         Q +VAIK +    +          E K+M  ++H+ ++ L  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSYLLYQM---LC-GIKHLHSA 183
             T Q+       ++++ E M AN C +  + ++ H   +  L +M   +C  +++L S 
Sbjct: 71  VCTKQRP------IFIITEYM-ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 123
Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYVVTRYYRAPEV 234
             +HRDL   N +V     +K+ DFGL+R         + G+ F +        +  PEV
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPEV 176
Query: 235 ILGMGYKENVDIWSVGCIMGEMIRGG 260
           ++   +    DIW+ G +M E+   G
Sbjct: 177 LMYSKFSSKSDIWAFGVLMWEIYSLG 202

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 69  KRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           K   T   G         Q +VAIK +    +          E K+M  ++H+ ++ L  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSYLLYQM---LC-GIKHLHSA 183
             T Q+       ++++ E M AN C +  + ++ H   +  L +M   +C  +++L S 
Sbjct: 87  VCTKQRP------IFIITEYM-ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTTFMMTPYVVTRYYRAPEVILGMG 239
             +HRDL   N +V     +K+ DFGL+R       T+ + + + V   +  PEV++   
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR--WSPPEVLMYSK 197
Query: 240 YKENVDIWSVGCIMGEMIRGG 260
           +    DIW+ G +M E+   G
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLG 218

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 61/126 (48%), Gaps = 4/126 (3%)
Query: 159 MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF 218
            +L  + +   +  + CG+++L S   IHRDL   N ++  D T+ + DFGL+R   +  
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 219 MMTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGE-MIRGGVLFPGTDHIDQWNK 274
                  ++    + A E +    Y  + D+W+ G  M E M RG   + G ++ + +N 
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 275 IIGKMR 280
           +IG  R
Sbjct: 252 LIGGNR 257

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 33/236 (13%)
Query: 59  ELPISHQMGKKRHNTSH---LGAGAAYDTAT-------QQNVAIKKLSRPFQNVTHA--K 106
           +LP + +    R+N      LGAGA             +++  +K   +  ++  HA  K
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 93
Query: 107 RAY-REFKLMK-LVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE 164
            A   E K+M  L  H+NI+ LL A T    +    +     +L++  L +  + DLD E
Sbjct: 94  EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF-LRRKAEADLDKE 152
Query: 165 -----RMSYLLY---QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
                 +  LL+   Q+  G+  L S   IHRD+   N+++ +    KI DFGLAR    
Sbjct: 153 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 212
Query: 217 TFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEMIRGGV-LFPG 265
               + Y+V    R      APE I    Y    D+WS G ++ E+   G+  +PG
Sbjct: 213 D---SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 72/179 (40%), Gaps = 15/179 (8%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VAIK L   + +    +    E  +M   +H NII L    T  K       V ++ E M
Sbjct: 45  VAIKTLKAGYTD-KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKP------VMIITEYM 97
Query: 150 DANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
           +           D       L  ML GI    K+L     +HRDL   NI+V S+   K+
Sbjct: 98  ENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKV 157
Query: 206 LDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            DFG++R         +      +   + APE I    +    D+WS G +M E++  G
Sbjct: 158 SDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 38/230 (16%)
Query: 53  KELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREF 112
           +  + +++ +   +GK R+     G+         +NVA+K  S         K  +RE 
Sbjct: 32  QRTVARQITLLECVGKGRYGEVWRGSWQG------ENVAVKIFSS-----RDEKSWFRET 80
Query: 113 KLMKLV--NHKNIIGLLNA-FTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSY 168
           +L   V   H+NI+G + +  T + S  +   +    E+   +L   +Q+  LD      
Sbjct: 81  ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM--GSLYDYLQLTTLDTVSCLR 138
Query: 169 LLYQMLCGIKHLH--------SAGIIHRDLKPSNIVVKSDCTLKILDFGLA-----RTAG 215
           ++  +  G+ HLH           I HRDLK  NI+VK +    I D GLA      T  
Sbjct: 139 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 198
Query: 216 TTFMMTPYVVTRYYRAPEVILGM-------GYKENVDIWSVGCIMGEMIR 258
                 P V T+ Y APEV+           YK  VDIW+ G ++ E+ R
Sbjct: 199 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVAR 247

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 31/206 (15%)
Query: 69  KRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           K   T   G         Q +VAIK +    +          E K+M  ++H+ ++ L  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSYLLYQM---LC-GIKHLHSA 183
             T Q+       ++++ E M AN C +  + ++ H   +  L +M   +C  +++L S 
Sbjct: 72  VCTKQRP------IFIITEYM-ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 124
Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYVVTRYYRAPEV 234
             +HRDL   N +V     +K+ DFGL+R         + G+ F +        +  PEV
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPEV 177
Query: 235 ILGMGYKENVDIWSVGCIMGEMIRGG 260
           ++   +    DIW+ G +M E+   G
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLG 203

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 74/142 (52%), Gaps = 20/142 (14%)
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           L+ AF  + SL +F    +V       LC + +      R    L++ + G+K  H   I
Sbjct: 99  LITAFHEKGSLSDFLKANVVSW---NELCHIAET---MARGLAYLHEDIPGLKDGHKPAI 152
Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTTFMMTPYVVTRYYRAPEVILG-M 238
            HRD+K  N+++K++ T  I DFGLA      ++AG T      V TR Y APEV+ G +
Sbjct: 153 SHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH---GQVGTRRYMAPEVLEGAI 209
Query: 239 GYKEN----VDIWSVGCIMGEM 256
            ++ +    +D++++G ++ E+
Sbjct: 210 NFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 31/206 (15%)
Query: 69  KRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           K   T   G         Q +VAIK +    +          E K+M  ++H+ ++ L  
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSYLLYQM---LC-GIKHLHSA 183
             T Q+       ++++ E M AN C +  + ++ H   +  L +M   +C  +++L S 
Sbjct: 78  VCTKQRP------IFIITEYM-ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 130
Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYVVTRYYRAPEV 234
             +HRDL   N +V     +K+ DFGL+R         + G+ F +        +  PEV
Sbjct: 131 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPEV 183
Query: 235 ILGMGYKENVDIWSVGCIMGEMIRGG 260
           ++   +    DIW+ G +M E+   G
Sbjct: 184 LMYSKFSSKSDIWAFGVLMWEIYSLG 209

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 31/206 (15%)
Query: 69  KRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           K   T   G         Q +VAIK +    +          E K+M  ++H+ ++ L  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSYLLYQM---LC-GIKHLHSA 183
             T Q+       ++++ E M AN C +  + ++ H   +  L +M   +C  +++L S 
Sbjct: 67  VCTKQRP------IFIITEYM-ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYVVTRYYRAPEV 234
             +HRDL   N +V     +K+ DFGL+R         + G+ F +        +  PEV
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPEV 172
Query: 235 ILGMGYKENVDIWSVGCIMGEMIRGG 260
           ++   +    DIW+ G +M E+   G
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLG 198

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 31/206 (15%)
Query: 69  KRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           K   T   G         Q +VAIK +    +          E K+M  ++H+ ++ L  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSYLLYQM---LC-GIKHLHSA 183
             T Q+       ++++ E M AN C +  + ++ H   +  L +M   +C  +++L S 
Sbjct: 87  VCTKQRP------IFIITEYM-ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYVVTRYYRAPEV 234
             +HRDL   N +V     +K+ DFGL+R         + G+ F +        +  PEV
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPEV 192
Query: 235 ILGMGYKENVDIWSVGCIMGEMIRGG 260
           ++   +    DIW+ G +M E+   G
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLG 218

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 33/236 (13%)
Query: 59  ELPISHQMGKKRHNTSH---LGAGAAYDTAT-------QQNVAIKKLSRPFQNVTHA--K 106
           +LP + +    R+N      LGAGA             +++  +K   +  ++  HA  K
Sbjct: 26  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 85
Query: 107 RAY-REFKLMK-LVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE 164
            A   E K+M  L  H+NI+ LL A T    +    +     +L++  L +  + DLD E
Sbjct: 86  EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF-LRRKAEADLDKE 144
Query: 165 -----RMSYLLY---QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
                 +  LL+   Q+  G+  L S   IHRD+   N+++ +    KI DFGLAR    
Sbjct: 145 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 204
Query: 217 TFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEMIRGGV-LFPG 265
               + Y+V    R      APE I    Y    D+WS G ++ E+   G+  +PG
Sbjct: 205 D---SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 72/179 (40%), Gaps = 15/179 (8%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VAIK L   + +    +    E  +M   +H NII L    T  K       V ++ E M
Sbjct: 39  VAIKTLKAGYTD-KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKP------VMIITEYM 91
Query: 150 DANLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
           +           D       L  ML GI    K+L     +HRDL   NI+V S+   K+
Sbjct: 92  ENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKV 151
Query: 206 LDFGLART----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            DFG++R         +      +   + APE I    +    D+WS G +M E++  G
Sbjct: 152 SDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 210

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 85/191 (44%), Gaps = 32/191 (16%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VA+K L    Q          E  LMK + H+ ++ L    T +        +Y++ E M
Sbjct: 36  VAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYM 85
Query: 150 D-ANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204
           +  +L   ++    + L   ++  +  Q+  G+  +     IHR+L+ +NI+V    + K
Sbjct: 86  ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCK 145
Query: 205 ILDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
           I DFGLAR       TA  G  F +        + APE I    +    D+WS G ++ E
Sbjct: 146 IADFGLARLIEDNEYTAREGAKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTE 198
Query: 256 MIR-GGVLFPG 265
           ++  G + +PG
Sbjct: 199 IVTHGRIPYPG 209

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 82/171 (47%), Gaps = 29/171 (16%)
Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDL-DHERMS 167
           +E ++MK + H+ ++ L    + +        +Y+V E M   +L   ++ ++  + R+ 
Sbjct: 229 QEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVTEYMSKGSLLDFLKGEMGKYLRLP 281
Query: 168 YLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA--G 215
            L+    Q+  G+ ++     +HRDL+ +NI+V  +   K+ DFGL R       TA  G
Sbjct: 282 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQG 341
Query: 216 TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM-IRGGVLFPG 265
             F +        + APE  L   +    D+WS G ++ E+  +G V +PG
Sbjct: 342 AKFPIK-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 385

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 38/230 (16%)
Query: 53  KELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREF 112
           +  + +++ +   +GK R+     G+         +NVA+K  S         K  +RE 
Sbjct: 3   QRTVARDITLLECVGKGRYGEVWRGSWQG------ENVAVKIFSS-----RDEKSWFRET 51
Query: 113 KLMKLV--NHKNIIGLLNA-FTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSY 168
           +L   V   H+NI+G + +  T + S  +   +    E+   +L   +Q+  LD      
Sbjct: 52  ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM--GSLYDYLQLTTLDTVSCLR 109
Query: 169 LLYQMLCGIKHLH--------SAGIIHRDLKPSNIVVKSDCTLKILDFGLA-----RTAG 215
           ++  +  G+ HLH           I HRDLK  NI+VK +    I D GLA      T  
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 216 TTFMMTPYVVTRYYRAPEVILGM-------GYKENVDIWSVGCIMGEMIR 258
                 P V T+ Y APEV+           YK  VDIW+ G ++ E+ R
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVAR 218

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 31/206 (15%)
Query: 69  KRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           K   T   G         Q +VAIK +    +          E K+M  ++H+ ++ L  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSYLLYQM---LC-GIKHLHSA 183
             T Q+       ++++ E M AN C +  + ++ H   +  L +M   +C  +++L S 
Sbjct: 72  VCTKQRP------IFIITEYM-ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 124
Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYVVTRYYRAPEV 234
             +HRDL   N +V     +K+ DFGL+R         + G+ F +        +  PEV
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR-------WSPPEV 177
Query: 235 ILGMGYKENVDIWSVGCIMGEMIRGG 260
           ++   +    DIW+ G +M E+   G
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLG 203

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 62/114 (54%), Gaps = 8/114 (7%)
Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTTFMMTPYVVTR 227
           Q   G+ +LH+  IIHRD+K +NI +    T+KI DFGLA    R +G+  +  P   + 
Sbjct: 140 QTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP-TGSV 198
Query: 228 YYRAPEVIL---GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
            + APEVI       +    D++S G ++ E++ G + +   ++ DQ   ++G+
Sbjct: 199 LWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR 252

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 106/264 (40%), Gaps = 43/264 (16%)
Query: 36  GPYDHSVDEREHTVDQWKELIYQELPISHQMGKK------RHNTSHLGAGAAYDTATQQN 89
           GP   SVD  +   D   E   + L +   +G+       +    HL   A Y T     
Sbjct: 1   GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT----- 55
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA------------FTPQKSLE 137
           VA+K L +   + +  +    EF ++K VNH ++I L  A            +    SL 
Sbjct: 56  VAVKML-KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 138 EF-QDVYLVMELMDANLCQVIQMDLDH--ER------MSYLLYQMLCGIKHLHSAGIIHR 188
            F ++   V      +        LDH  ER      +    +Q+  G+++L    ++HR
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174
Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP------EVILGMGYKE 242
           DL   NI+V     +KI DFGL+R     +    YV     R P      E +    Y  
Sbjct: 175 DLAARNILVAEGRKMKISDFGLSR---DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTT 231
Query: 243 NVDIWSVGCIMGEMIR-GGVLFPG 265
             D+WS G ++ E++  GG  +PG
Sbjct: 232 QSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 90/190 (47%), Gaps = 28/190 (14%)
Query: 89  NVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFT--PQKSLEEFQDVYLV 145
            VAIK L    +  T +  A+ +E ++MK + H+ ++ L    +  P   + E+     +
Sbjct: 34  RVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIXIVTEYMSKGSL 89
Query: 146 MELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
           ++ +     + +++     ++  +  Q+  G+ ++     +HRDL+ +NI+V  +   K+
Sbjct: 90  LDFLKGETGKYLRLP----QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 145
Query: 206 LDFGLAR-------TA--GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
            DFGLAR       TA  G  F +        + APE  L   +    D+WS G ++ E+
Sbjct: 146 ADFGLARLIEDNEXTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILLTEL 198
Query: 257 -IRGGVLFPG 265
             +G V +PG
Sbjct: 199 TTKGRVPYPG 208

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 58  QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 117
            EL    ++G  +    HLG     D      VAIK +    +     +    E ++M  
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKD-----KVAIKTIR---EGAMSEEDFIEEAEVMMK 58
Query: 118 VNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQM 173
           ++H  ++ L      Q        + LV E M+    ++  +  +     E +  +   +
Sbjct: 59  LSHPKLVQLYGVCLEQAP------ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 112
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYV 224
             G+ +L  A +IHRDL   N +V  +  +K+ DFG+ R         + GT F +    
Sbjct: 113 CEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--- 169
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
               + +PEV     Y    D+WS G +M E+   G
Sbjct: 170 ----WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 201

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 85/195 (43%), Gaps = 32/195 (16%)
Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLMKLV--NHKNIIGLLNA-FTPQKSLEEFQDVYL 144
           +NVA+K  S         K  +RE +L   V   H+NI+G + +  T + S  +   +  
Sbjct: 32  ENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86
Query: 145 VMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLH--------SAGIIHRDLKPSNI 195
             E+   +L   +Q+  LD      ++  +  G+ HLH           I HRDLK  NI
Sbjct: 87  YHEM--GSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNI 144
Query: 196 VVKSDCTLKILDFGLA-----RTAGTTFMMTPYVVTRYYRAPEVILGM-------GYKEN 243
           +VK +    I D GLA      T        P V T+ Y APEV+           YK  
Sbjct: 145 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR- 203
Query: 244 VDIWSVGCIMGEMIR 258
           VDIW+ G ++ E+ R
Sbjct: 204 VDIWAFGLVLWEVAR 218

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 23/213 (10%)
Query: 58  QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 117
           +EL +   +GK       LG            VA+K +    +N   A+    E  +M  
Sbjct: 12  KELKLLQTIGKGEFGDVMLG------DYRGNKVAVKCI----KNDATAQAFLAEASVMTQ 61
Query: 118 VNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQ 172
           + H N++ LL        +EE   +Y+V E M   +L   ++      L  + +      
Sbjct: 62  LRHSNLVQLLGVI-----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 116
Query: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           +   +++L     +HRDL   N++V  D   K+ DFGL + A +T       V   + AP
Sbjct: 117 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--WTAP 174
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIR-GGVLFP 264
           E +    +    D+WS G ++ E+   G V +P
Sbjct: 175 EALREAAFSTKSDVWSFGILLWEIYSFGRVPYP 207

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 58  QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 117
            EL    ++G  +    HLG     D      VAIK +    +     +    E ++M  
Sbjct: 10  SELTFVQEIGSGQFGLVHLGYWLNKD-----KVAIKTIR---EGAMSEEDFIEEAEVMMK 61
Query: 118 VNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQM 173
           ++H  ++ L      Q        + LV E M+    ++  +  +     E +  +   +
Sbjct: 62  LSHPKLVQLYGVCLEQAP------ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 115
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYV 224
             G+ +L  A +IHRDL   N +V  +  +K+ DFG+ R         + GT F +    
Sbjct: 116 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--- 172
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
               + +PEV     Y    D+WS G +M E+   G
Sbjct: 173 ----WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 204

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 58  QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 117
            EL    ++G  +    HLG     D      VAIK +    +     +    E ++M  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKD-----KVAIKTIR---EGAMSEEDFIEEAEVMMK 56
Query: 118 VNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQM 173
           ++H  ++ L      Q        + LV E M+    ++  +  +     E +  +   +
Sbjct: 57  LSHPKLVQLYGVCLEQAP------ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 110
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYV 224
             G+ +L  A +IHRDL   N +V  +  +K+ DFG+ R         + GT F +    
Sbjct: 111 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--- 167
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
               + +PEV     Y    D+WS G +M E+   G
Sbjct: 168 ----WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 47/228 (20%)
Query: 69  KRHNT---SHLGAGA--------AYDTATQQN---VAIKKLSRPFQNVTHAKRAYREFKL 114
           KRHN      LG GA         Y+   +Q+   VA+K L     N    K  +RE +L
Sbjct: 11  KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAEL 68
Query: 115 MKLVNHKNII---GLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM-------DLDHE 164
           +  + H++I+   G+     P   + E+     + + + A+    + M       +L   
Sbjct: 69  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQS 128
Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
           +M ++  Q+  G+ +L S   +HRDL   N +V  +  +KI DFG++R   +        
Sbjct: 129 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS-------- 180
Query: 225 VTRYYRA------------PEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            T YYR             PE I+   +    D+WS+G ++ E+   G
Sbjct: 181 -TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYG 227

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 58  QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 117
            EL    ++G  +    HLG     D      VAIK +    +     +    E ++M  
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKD-----KVAIKTIR---EGAMSEEDFIEEAEVMMK 58
Query: 118 VNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQM 173
           ++H  ++ L      Q        + LV E M+    ++  +  +     E +  +   +
Sbjct: 59  LSHPKLVQLYGVCLEQAP------ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 112
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYV 224
             G+ +L  A +IHRDL   N +V  +  +K+ DFG+ R         + GT F +    
Sbjct: 113 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--- 169
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
               + +PEV     Y    D+WS G +M E+   G
Sbjct: 170 ----WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 201

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 58  QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 117
            EL    ++G  +    HLG     D      VAIK +    +     +    E ++M  
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKD-----KVAIKTIR---EGAMSEEDFIEEAEVMMK 59
Query: 118 VNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQM 173
           ++H  ++ L      Q        + LV E M+    ++  +  +     E +  +   +
Sbjct: 60  LSHPKLVQLYGVCLEQAP------ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYV 224
             G+ +L  A +IHRDL   N +V  +  +K+ DFG+ R         + GT F +    
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--- 170
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
               + +PEV     Y    D+WS G +M E+   G
Sbjct: 171 ----WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 106/261 (40%), Gaps = 37/261 (14%)
Query: 36  GPYDHSVDEREHTVDQWKELIYQELPISHQMGKK------RHNTSHLGAGAAYDTATQQN 89
           GP   SVD  +   D   E   + L +   +G+       +    HL   A Y T     
Sbjct: 1   GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT----- 55
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA------------FTPQKSLE 137
           VA+K L +   + +  +    EF ++K VNH ++I L  A            +    SL 
Sbjct: 56  VAVKML-KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 138 EF-QDVYLVMELMDANLCQVIQMDLDH--ER------MSYLLYQMLCGIKHLHSAGIIHR 188
            F ++   V      +        LDH  ER      +    +Q+  G+++L    ++HR
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHR 174
Query: 189 DLKPSNIVVKSDCTLKILDFGLARTA---GTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
           DL   NI+V     +KI DFGL+R      +    +   +   + A E +    Y    D
Sbjct: 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSD 234
Query: 246 IWSVGCIMGEMIR-GGVLFPG 265
           +WS G ++ E++  GG  +PG
Sbjct: 235 VWSFGVLLWEIVTLGGNPYPG 255

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 23/213 (10%)
Query: 58  QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 117
           +EL +   +GK       LG            VA+K +    +N   A+    E  +M  
Sbjct: 193 KELKLLQTIGKGEFGDVMLG------DYRGNKVAVKCI----KNDATAQAFLAEASVMTQ 242
Query: 118 VNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQ 172
           + H N++ LL        +EE   +Y+V E M   +L   ++      L  + +      
Sbjct: 243 LRHSNLVQLLGVI-----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 297
Query: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           +   +++L     +HRDL   N++V  D   K+ DFGL + A +T       V   + AP
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--WTAP 355
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIR-GGVLFP 264
           E +    +    D+WS G ++ E+   G V +P
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 33/229 (14%)
Query: 53  KELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSR-------PFQN-VTH 104
           +E    E  +   +GK    T      A +    +  VAIK + R       P  + VT 
Sbjct: 26  REAFEAEYRLGPLLGKGGFGTVF----AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 105 AKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME--LMDANLCQVI--QMD 160
                  +K+     H  +I LL+ F  Q+         LV+E  L   +L   I  +  
Sbjct: 82  PLEVALLWKVGAGGGHPGVIRLLDWFETQEGF------MLVLERPLPAQDLFDYITEKGP 135
Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLARTAGTTF 218
           L          Q++  I+H HS G++HRD+K  NI++  +  C  K++DFG    +G   
Sbjct: 136 LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA-KLIDFG----SGALL 190
Query: 219 MMTPYV---VTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIRGGVLF 263
              PY     TR Y  PE I    Y      +WS+G ++ +M+ G + F
Sbjct: 191 HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF 239

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 23/213 (10%)
Query: 58  QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 117
           +EL +   +GK       LG            VA+K +    +N   A+    E  +M  
Sbjct: 21  KELKLLQTIGKGEFGDVMLG------DYRGNKVAVKCI----KNDATAQAFLAEASVMTQ 70
Query: 118 VNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQ 172
           + H N++ LL        +EE   +Y+V E M   +L   ++      L  + +      
Sbjct: 71  LRHSNLVQLLGVI-----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125
Query: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           +   +++L     +HRDL   N++V  D   K+ DFGL + A +T       V   + AP
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--WTAP 183
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIR-GGVLFP 264
           E +    +    D+WS G ++ E+   G V +P
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 216

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 106/261 (40%), Gaps = 37/261 (14%)
Query: 36  GPYDHSVDEREHTVDQWKELIYQELPISHQMGKK------RHNTSHLGAGAAYDTATQQN 89
           GP   SVD  +   D   E   + L +   +G+       +    HL   A Y T     
Sbjct: 1   GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT----- 55
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA------------FTPQKSLE 137
           VA+K L +   + +  +    EF ++K VNH ++I L  A            +    SL 
Sbjct: 56  VAVKML-KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 138 EF-QDVYLVMELMDANLCQVIQMDLDH--ER------MSYLLYQMLCGIKHLHSAGIIHR 188
            F ++   V      +        LDH  ER      +    +Q+  G+++L    ++HR
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174
Query: 189 DLKPSNIVVKSDCTLKILDFGLARTA---GTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
           DL   NI+V     +KI DFGL+R      +    +   +   + A E +    Y    D
Sbjct: 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSD 234
Query: 246 IWSVGCIMGEMIR-GGVLFPG 265
           +WS G ++ E++  GG  +PG
Sbjct: 235 VWSFGVLLWEIVTLGGNPYPG 255

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 23/213 (10%)
Query: 58  QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 117
           +EL +   +GK       LG            VA+K +    +N   A+    E  +M  
Sbjct: 6   KELKLLQTIGKGEFGDVMLG------DYRGNKVAVKCI----KNDATAQAFLAEASVMTQ 55
Query: 118 VNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQ 172
           + H N++ LL        +EE   +Y+V E M   +L   ++      L  + +      
Sbjct: 56  LRHSNLVQLLGVI-----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 110
Query: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           +   +++L     +HRDL   N++V  D   K+ DFGL + A +T       V   + AP
Sbjct: 111 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--WTAP 168
Query: 233 EVILGMGYKENVDIWSVGCIMGEMIR-GGVLFP 264
           E +    +    D+WS G ++ E+   G V +P
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 11/127 (8%)
Query: 141 DVYLVMELMDANLCQVIQMDLDHER------MSYLLYQMLCGIKHLHSA-GIIHRDLKPS 193
           DV++  EL D +L +  +  +D  +      +  +   ++  ++HLHS   +IHRD+KPS
Sbjct: 107 DVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 166
Query: 194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG----MGYKENVDIWSV 249
           N+++ +   +K  DFG++               + Y APE I       GY    DIWS+
Sbjct: 167 NVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSL 226
Query: 250 GCIMGEM 256
           G    E+
Sbjct: 227 GITXIEL 233

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 27/178 (15%)
Query: 109 YREFKLMK--LVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ-MDLDHE 164
           +RE ++    L+ H NI+G +   +   S      ++L+    +  +L   +Q   L+  
Sbjct: 48  FRETEIYNTVLLRHDNILGFIA--SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPH 105
Query: 165 RMSYLLYQMLCGIKHLH--------SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTA 214
               L     CG+ HLH           I HRD K  N++VKS+    I D GLA   + 
Sbjct: 106 LALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQ 165
Query: 215 GTTFM---MTPYVVTRYYRAPEVI-------LGMGYKENVDIWSVGCIMGEMIRGGVL 262
           G+ ++     P V T+ Y APEV+           YK   DIW+ G ++ E+ R  ++
Sbjct: 166 GSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWT-DIWAFGLVLWEIARRTIV 222

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 58  QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL 117
            EL    ++G  +    HLG     D      VAIK +    +          E ++M  
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKD-----KVAIKTIK---EGSMSEDDFIEEAEVMMK 78
Query: 118 VNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQM 173
           ++H  ++ L      Q        + LV E M+    ++  +  +     E +  +   +
Sbjct: 79  LSHPKLVQLYGVCLEQAP------ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 132
Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTTFMMTPYV 224
             G+ +L  A +IHRDL   N +V  +  +K+ DFG+ R         + GT F +    
Sbjct: 133 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--- 189
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
               + +PEV     Y    D+WS G +M E+   G
Sbjct: 190 ----WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 221

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 49/102 (48%), Gaps = 10/102 (9%)
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV------ 224
           +Q+  G++ L S   IHRDL   NI++     +KI DFGLAR     +    YV      
Sbjct: 205 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKGDAR 261
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
           +   + APE I    Y    D+WS G ++ E+   G   +PG
Sbjct: 262 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 303

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 49/102 (48%), Gaps = 10/102 (9%)
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV------ 224
           +Q+  G++ L S   IHRDL   NI++     +KI DFGLAR     +    YV      
Sbjct: 207 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKGDAR 263
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
           +   + APE I    Y    D+WS G ++ E+   G   +PG
Sbjct: 264 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 305

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+M+LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 83  LLGICLTST-------VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 196 IYTHQSDVWSYGVTVWELMTFG 217

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 49/102 (48%), Gaps = 10/102 (9%)
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV------ 224
           +Q+  G++ L S   IHRDL   NI++     +KI DFGLAR     +    YV      
Sbjct: 198 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKGDAR 254
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
           +   + APE I    Y    D+WS G ++ E+   G   +PG
Sbjct: 255 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 296

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 49/102 (48%), Gaps = 10/102 (9%)
Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV------ 224
           +Q+  G++ L S   IHRDL   NI++     +KI DFGLAR     +    YV      
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKGDAR 256
Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPG 265
           +   + APE I    Y    D+WS G ++ E+   G   +PG
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLN 128
           LG GA        +  T Q  A+K + +   ++    R +RE +++ +   H+N++ L+ 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLELIE 78
Query: 129 AFTPQKSLEEFQDVYLVMELMDAN--LCQV-IQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
            F  +         YLV E M     L  +  +   +    S ++  +   +  LH+ GI
Sbjct: 79  FFEEEDRF------YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 186 IHRDLKPSNIVVKSD---CTLKILDFGLAR----TAGTTFMMTPYVVT----RYYRAPEV 234
            HRDLKP NI+ +       +KI DFGL          + + TP ++T      Y APEV
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 235 ILGMG-----YKENVDIWSVGCIMGEMIRGGVLFPG 265
           +         Y +  D+WS+G I+  ++ G   F G
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 101/239 (42%), Gaps = 35/239 (14%)
Query: 59  ELPISHQMGKKRHNTSH---LGAGAAYDTAT-------QQNVAIKKLSRPFQNVTHA--K 106
           +LP + +    R+N      LGAGA             +++  +K   +  ++  HA  K
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 93
Query: 107 RAY-REFKLMK-LVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD--ANLCQVIQMD-- 160
            A   E K+M  L  H+NI+ LL A T    +    +     +L++      +V++ D  
Sbjct: 94  EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA 153
Query: 161 -------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
                  L    + +   Q+  G+  L S   IHRD+   N+++ +    KI DFGLAR 
Sbjct: 154 FAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 214 AGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEMIRGGV-LFPG 265
                  + Y+V    R      APE I    Y    D+WS G ++ E+   G+  +PG
Sbjct: 214 IMND---SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 80/185 (43%), Gaps = 22/185 (11%)
Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
           Q +VAIK L +  +     +   RE ++M  +++  I+ L+          + + + LVM
Sbjct: 37  QIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVC-------QAEALMLVM 88
Query: 147 ELMDANLCQVIQMDLDHE----RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
           E+          +    E     ++ LL+Q+  G+K+L     +HRDL   N+++ +   
Sbjct: 89  EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY 148
Query: 203 LKILDFGLARTAGTTFMMTPYVVTRY-------YRAPEVILGMGYKENVDIWSVGCIMGE 255
            KI DFGL++  G       Y   R        + APE I    +    D+WS G  M E
Sbjct: 149 AKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 205
Query: 256 MIRGG 260
            +  G
Sbjct: 206 ALSYG 210

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+M+LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 86  LLGICL-------TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 199 IYTHQSDVWSYGVTVWELMTFG 220

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+M+LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 83  LLGICLTST-------VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 196 IYTHQSDVWSYGVTVWELMTFG 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+M+LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 84  LLGICLTST-------VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFG 218

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+M+LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 85  LLGICLTST-------VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFG 219

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+M+LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 82  LLGICLTST-------VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFG 216

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 63/135 (46%), Gaps = 23/135 (17%)
Query: 141 DVYLVMELMDA---NLCQVIQMDLDHE---RMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
           DV++ MELM      L + +Q  +      +M+  + + L  +K  H  G+IHRD+KPSN
Sbjct: 98  DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSN 155
Query: 195 IVVKSDCTLKILDFGLA----------RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENV 244
           I++     +K+ DFG++          R+AG    M P  +      P       Y    
Sbjct: 156 ILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERID-----PPDPTKPDYDIRA 210
Query: 245 DIWSVGCIMGEMIRG 259
           D+WS+G  + E+  G
Sbjct: 211 DVWSLGISLVELATG 225

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 61  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 114
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K+L S   +HRDL   N ++    T+K+ 
Sbjct: 115 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVA 174
Query: 207 DFGLAR-----TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 175 DFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 234
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 235 PPYPDVNTFD 244

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VAIK+L R   +    K    E  +M  V++ ++  LL              V L+M+LM
Sbjct: 54  VAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLIMQLM 105
Query: 150 D-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
               L   ++   D+    YLL    Q+  G+ +L    ++HRDL   N++VK+   +KI
Sbjct: 106 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 165
Query: 206 LDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            DFGLA+  G     +      V   + A E IL   Y    D+WS G  + E++  G
Sbjct: 166 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 223

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 39/205 (19%)
Query: 109 YREFKLMKLV--NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVI-QMDLDHE 164
           +RE ++ + V   H+NI+G + A    K    +  ++LV +  +  +L   + +  +  E
Sbjct: 44  FREAEIYQTVMLRHENILGFIAA--DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE 101
Query: 165 RMSYLLYQMLCGIKHLH--------SAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RT 213
            M  L      G+ HLH           I HRDLK  NI+VK + T  I D GLA    +
Sbjct: 102 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 161
Query: 214 AGTTFMMTP--YVVTRYYRAPEVI---LGMGYKEN---VDIWSVGCIMGEMIR----GGV 261
           A  T  + P   V T+ Y APEV+   + M + E+    DI+++G +  E+ R    GG+
Sbjct: 162 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 221
Query: 262 ----------LFPGTDHIDQWNKII 276
                     L P    +++  K++
Sbjct: 222 HEDYQLPYYDLVPSDPSVEEMRKVV 246

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 39/205 (19%)
Query: 109 YREFKLMKLV--NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVI-QMDLDHE 164
           +RE ++ + V   H+NI+G + A    K    +  ++LV +  +  +L   + +  +  E
Sbjct: 82  FREAEIYQTVMLRHENILGFIAA--DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE 139
Query: 165 RMSYLLYQMLCGIKHLH--------SAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RT 213
            M  L      G+ HLH           I HRDLK  NI+VK + T  I D GLA    +
Sbjct: 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199
Query: 214 AGTTFMMTP--YVVTRYYRAPEVI---LGMGYKEN---VDIWSVGCIMGEMIR----GGV 261
           A  T  + P   V T+ Y APEV+   + M + E+    DI+++G +  E+ R    GG+
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
Query: 262 ----------LFPGTDHIDQWNKII 276
                     L P    +++  K++
Sbjct: 260 HEDYQLPYYDLVPSDPSVEEMRKVV 284

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 39/205 (19%)
Query: 109 YREFKLMKLV--NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVI-QMDLDHE 164
           +RE ++ + V   H+NI+G + A    K    +  ++LV +  +  +L   + +  +  E
Sbjct: 49  FREAEIYQTVMLRHENILGFIAA--DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE 106
Query: 165 RMSYLLYQMLCGIKHLH--------SAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RT 213
            M  L      G+ HLH           I HRDLK  NI+VK + T  I D GLA    +
Sbjct: 107 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 166
Query: 214 AGTTFMMTP--YVVTRYYRAPEVI---LGMGYKEN---VDIWSVGCIMGEMIR----GGV 261
           A  T  + P   V T+ Y APEV+   + M + E+    DI+++G +  E+ R    GG+
Sbjct: 167 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 226
Query: 262 ----------LFPGTDHIDQWNKII 276
                     L P    +++  K++
Sbjct: 227 HEDYQLPYYDLVPSDPSVEEMRKVV 251

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 39/205 (19%)
Query: 109 YREFKLMKLV--NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVI-QMDLDHE 164
           +RE ++ + V   H+NI+G + A    K    +  ++LV +  +  +L   + +  +  E
Sbjct: 46  FREAEIYQTVMLRHENILGFIAA--DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE 103
Query: 165 RMSYLLYQMLCGIKHLH--------SAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RT 213
            M  L      G+ HLH           I HRDLK  NI+VK + T  I D GLA    +
Sbjct: 104 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 163
Query: 214 AGTTFMMTP--YVVTRYYRAPEVI---LGMGYKEN---VDIWSVGCIMGEMIR----GGV 261
           A  T  + P   V T+ Y APEV+   + M + E+    DI+++G +  E+ R    GG+
Sbjct: 164 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 223
Query: 262 ----------LFPGTDHIDQWNKII 276
                     L P    +++  K++
Sbjct: 224 HEDYQLPYYDLVPSDPSVEEMRKVV 248

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 39/205 (19%)
Query: 109 YREFKLMKLV--NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVI-QMDLDHE 164
           +RE ++ + V   H+NI+G + A    K    +  ++LV +  +  +L   + +  +  E
Sbjct: 43  FREAEIYQTVMLRHENILGFIAA--DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE 100
Query: 165 RMSYLLYQMLCGIKHLH--------SAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RT 213
            M  L      G+ HLH           I HRDLK  NI+VK + T  I D GLA    +
Sbjct: 101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160
Query: 214 AGTTFMMTP--YVVTRYYRAPEVI---LGMGYKEN---VDIWSVGCIMGEMIR----GGV 261
           A  T  + P   V T+ Y APEV+   + M + E+    DI+++G +  E+ R    GG+
Sbjct: 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220
Query: 262 ----------LFPGTDHIDQWNKII 276
                     L P    +++  K++
Sbjct: 221 HEDYQLPYYDLVPSDPSVEEMRKVV 245

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 39/205 (19%)
Query: 109 YREFKLMKLV--NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVI-QMDLDHE 164
           +RE ++ + V   H+NI+G + A    K    +  ++LV +  +  +L   + +  +  E
Sbjct: 69  FREAEIYQTVMLRHENILGFIAA--DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE 126
Query: 165 RMSYLLYQMLCGIKHLH--------SAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RT 213
            M  L      G+ HLH           I HRDLK  NI+VK + T  I D GLA    +
Sbjct: 127 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 186
Query: 214 AGTTFMMTP--YVVTRYYRAPEVI---LGMGYKEN---VDIWSVGCIMGEMIR----GGV 261
           A  T  + P   V T+ Y APEV+   + M + E+    DI+++G +  E+ R    GG+
Sbjct: 187 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 246
Query: 262 ----------LFPGTDHIDQWNKII 276
                     L P    +++  K++
Sbjct: 247 HEDYQLPYYDLVPSDPSVEEMRKVV 271

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 51/240 (21%)
Query: 47  HTVDQWKELIYQELPISHQMGKKRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHA 105
           +  D+W E+  +++ +S ++G+      + G A        +  VAIK +     N   +
Sbjct: 15  YVPDEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAAS 68
Query: 106 KRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDL 161
            R   EF     +MK  N  +++ LL   +      + Q   ++MELM     +     L
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVS------QGQPTLVIMELMTRGDLKSYLRSL 122
Query: 162 DHE-------------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 208
             E             +M  +  ++  G+ +L++   +HRDL   N +V  D T+KI DF
Sbjct: 123 RPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 182
Query: 209 GLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGEM 256
           G+ R             T YYR            +PE +    +    D+WS G ++ E+
Sbjct: 183 GMTRDI---------YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 80/185 (43%), Gaps = 22/185 (11%)
Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
           Q +VAIK L +  +     +   RE ++M  +++  I+ L+          + + + LVM
Sbjct: 363 QIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRLIGVC-------QAEALMLVM 414
Query: 147 ELMDANLCQVIQMDLDHE----RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
           E+          +    E     ++ LL+Q+  G+K+L     +HR+L   N+++ +   
Sbjct: 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY 474
Query: 203 LKILDFGLARTAGTTFMMTPYVVTRY-------YRAPEVILGMGYKENVDIWSVGCIMGE 255
            KI DFGL++  G       Y   R        + APE I    +    D+WS G  M E
Sbjct: 475 AKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 531
Query: 256 MIRGG 260
            +  G
Sbjct: 532 ALSYG 536

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 38/203 (18%)
Query: 84  TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA------------FT 131
           T  +  VA+K L  P   +   K   RE +L+  + H++I+                 + 
Sbjct: 42  TKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 99
Query: 132 PQKSLEEFQDVYL--VMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
               L +F   +    M L+D    Q  + +L   +M ++  Q+  G+ +L S   +HRD
Sbjct: 100 KHGDLNKFLRAHGPDAMILVDGQPRQA-KGELGLSQMLHIASQIASGMVYLASQHFVHRD 158
Query: 190 LKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRA------------PEVILG 237
           L   N +V ++  +KI DFG++R   +         T YYR             PE I+ 
Sbjct: 159 LATRNCLVGANLLVKIGDFGMSRDVYS---------TDYYRVGGHTMLPIRWMPPESIMY 209
Query: 238 MGYKENVDIWSVGCIMGEMIRGG 260
             +    D+WS G I+ E+   G
Sbjct: 210 RKFTTESDVWSFGVILWEIFTYG 232

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 51/237 (21%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHAKRA 108
           D+W E+  +++ +S ++G+      + G A        +  VAIK +     N   + R 
Sbjct: 12  DEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRE 65
Query: 109 YREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE 164
             EF     +MK  N  +++ LL   +      + Q   ++MELM     +     L  E
Sbjct: 66  RIEFLNEASVMKEFNCHHVVRLLGVVS------QGQPTLVIMELMTRGDLKSYLRSLRPE 119
Query: 165 -------------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
                        +M  +  ++  G+ +L++   +HRDL   N +V  D T+KI DFG+ 
Sbjct: 120 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 212 RTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGEM 256
           R             T YYR            +PE +    +    D+WS G ++ E+
Sbjct: 180 RDI---------YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 61  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 114
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K+L S   +HRDL   N ++    T+K+ 
Sbjct: 115 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVA 174
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 175 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 234
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 235 PPYPDVNTFD 244

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 99/241 (41%), Gaps = 37/241 (15%)
Query: 59  ELPISHQMGKKRHNTSH---LGAGAAYDTAT-------QQNVAIKKLSRPFQNVTHA--K 106
           +LP + +    R+N      LGAGA             +++  +K   +  ++  HA  K
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 93
Query: 107 RAY-REFKLMK-LVNHKNIIGLLNAFT---PQKSLEEFQDVYLVMELM----------DA 151
            A   E K+M  L  H+NI+ LL A T   P   + E+     ++  +            
Sbjct: 94  EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSY 153
Query: 152 NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
           N     +  L    + +   Q+  G+  L S   IHRD+   N+++ +    KI DFGLA
Sbjct: 154 NPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 213
Query: 212 RTAGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEMIRGGV-LFP 264
           R        + Y+V    R      APE I    Y    D+WS G ++ E+   G+  +P
Sbjct: 214 RDIMND---SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 270
Query: 265 G 265
           G
Sbjct: 271 G 271

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 16/192 (8%)
Query: 89  NVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           + A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  
Sbjct: 55  HCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPY 108
Query: 149 MD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204
           M   +L   I+ +  +  +  L+    Q+  G+K+L S   +HRDL   N ++    T+K
Sbjct: 109 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVK 168
Query: 205 ILDFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIR 258
           + DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M R
Sbjct: 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 228
Query: 259 GGVLFPGTDHID 270
           G   +P  +  D
Sbjct: 229 GAPPYPDVNTFD 240

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 51/237 (21%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHAKRA 108
           D+W E+  +++ +S ++G+      + G A        +  VAIK +     N   + R 
Sbjct: 11  DEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRE 64
Query: 109 YREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE 164
             EF     +MK  N  +++ LL   +      + Q   ++MELM     +     L  E
Sbjct: 65  RIEFLNEASVMKEFNCHHVVRLLGVVS------QGQPTLVIMELMTRGDLKSYLRSLRPE 118
Query: 165 -------------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
                        +M  +  ++  G+ +L++   +HRDL   N +V  D T+KI DFG+ 
Sbjct: 119 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 178
Query: 212 RTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGEM 256
           R             T YYR            +PE +    +    D+WS G ++ E+
Sbjct: 179 RDI---------YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 51/237 (21%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHAKRA 108
           D+W E+  +++ +S ++G+      + G A        +  VAIK +     N   + R 
Sbjct: 9   DEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRE 62
Query: 109 YREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE 164
             EF     +MK  N  +++ LL   +      + Q   ++MELM     +     L  E
Sbjct: 63  RIEFLNEASVMKEFNCHHVVRLLGVVS------QGQPTLVIMELMTRGDLKSYLRSLRPE 116
Query: 165 -------------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
                        +M  +  ++  G+ +L++   +HRDL   N +V  D T+KI DFG+ 
Sbjct: 117 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 176
Query: 212 RTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGEM 256
           R             T YYR            +PE +    +    D+WS G ++ E+
Sbjct: 177 RD---------IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 51/237 (21%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHAKRA 108
           D+W E+  +++ +S ++G+      + G A        +  VAIK +     N   + R 
Sbjct: 5   DEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRE 58
Query: 109 YREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE 164
             EF     +MK  N  +++ LL   +      + Q   ++MELM     +     L  E
Sbjct: 59  RIEFLNEASVMKEFNCHHVVRLLGVVS------QGQPTLVIMELMTRGDLKSYLRSLRPE 112
Query: 165 -------------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
                        +M  +  ++  G+ +L++   +HRDL   N +V  D T+KI DFG+ 
Sbjct: 113 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 172
Query: 212 RTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGEM 256
           R             T YYR            +PE +    +    D+WS G ++ E+
Sbjct: 173 RDI---------YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLN 128
           LG GA        +  T Q  A+K + +   ++    R +RE +++ +   H+N++ L+ 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLELIE 78
Query: 129 AFTPQKSLEEFQDVYLVMELMDAN--LCQV-IQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
            F  +         YLV E M     L  +  +   +    S ++  +   +  LH+ GI
Sbjct: 79  FFEEEDRF------YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 186 IHRDLKPSNIVVKSD---CTLKILDF----GLARTAGTTFMMTPYVVT----RYYRAPEV 234
            HRDLKP NI+ +       +KI DF    G+      + + TP ++T      Y APEV
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 235 ILGMG-----YKENVDIWSVGCIMGEMIRGGVLFPG 265
           +         Y +  D+WS+G I+  ++ G   F G
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 62  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 115
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K+L S   +HRDL   N ++    T+K+ 
Sbjct: 116 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVA 175
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 176 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 235
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 236 PPYPDVNTFD 245

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+ +LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 82  LLGICLTST-------VQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFG 216

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 80  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 133
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K+L S   +HRDL   N ++    T+K+ 
Sbjct: 134 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVA 193
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 194 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 253
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 254 PPYPDVNTFD 263

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 60  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 113
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K+L S   +HRDL   N ++    T+K+ 
Sbjct: 114 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVA 173
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 174 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 233
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 234 PPYPDVNTFD 243

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 59  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 112
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K+L S   +HRDL   N ++    T+K+ 
Sbjct: 113 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVA 172
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 173 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 233 PPYPDVNTFD 242

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 62  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 115
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K+L S   +HRDL   N ++    T+K+ 
Sbjct: 116 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVA 175
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 176 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 235
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 236 PPYPDVNTFD 245

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 54  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 107
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K+L S   +HRDL   N ++    T+K+ 
Sbjct: 108 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVA 167
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 168 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 227
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 228 PPYPDVNTFD 237

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 96/228 (42%), Gaps = 33/228 (14%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHAKRA 108
           D+W E+  +++ +S ++G+      + G A        +  VAIK +     N   + R 
Sbjct: 3   DEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRE 56
Query: 109 YREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE 164
             EF     +MK  N  +++ LL   +      + Q   ++MELM     +     L  E
Sbjct: 57  RIEFLNEASVMKEFNCHHVVRLLGVVS------QGQPTLVIMELMTRGDLKSYLRSLRPE 110
Query: 165 -------------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
                        +M  +  ++  G+ +L++   +HRDL   N +V  D T+KI DFG+ 
Sbjct: 111 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 170
Query: 212 RTAGTTFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           R    T         ++   + +PE +    +    D+WS G ++ E+
Sbjct: 171 RDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 111/289 (38%), Gaps = 73/289 (25%)
Query: 41  SVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAG------AAYDTATQQNVAIKK 94
           S DE +     + +  Y  + I      + H    LG G        +D   ++ VA+K 
Sbjct: 4   SDDEEQEDPADYCKGGYHPVKIGDLFNGRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMK- 62
Query: 95  LSRPFQNVTHAKRAYREFKLMKLV--------NHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
           + +  Q+ T  + A  E KL+K V        N   ++ L++ F  + S      V +V 
Sbjct: 63  VVKSAQHYT--ETALDEIKLLKCVRESDPSDPNKDMVVQLIDDF--KISGMNGIHVCMVF 118
Query: 147 ELMDANLCQVI----QMDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSD- 200
           E++  +L + I       L    +  ++ Q+L G+ +LHS   IIH D+KP NI++  D 
Sbjct: 119 EVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDD 178
Query: 201 ----------------------------------------------CTLKILDFGLARTA 214
                                                           +KI D G A   
Sbjct: 179 AYVRRMAAEATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWV 238
Query: 215 GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF 263
              F  T  + TR YR+ EV++G GY    DIWS  C+  E+  G  LF
Sbjct: 239 HKHF--TEDIQTRQYRSIEVLIGAGYSTPADIWSTACMAFELATGDYLF 285

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 96/228 (42%), Gaps = 33/228 (14%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHAKRA 108
           D+W E+  +++ +S ++G+      + G A        +  VAIK +     N   + R 
Sbjct: 12  DEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRE 65
Query: 109 YREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE 164
             EF     +MK  N  +++ LL   +      + Q   ++MELM     +     L  E
Sbjct: 66  RIEFLNEASVMKEFNCHHVVRLLGVVS------QGQPTLVIMELMTRGDLKSYLRSLRPE 119
Query: 165 -------------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
                        +M  +  ++  G+ +L++   +HRDL   N +V  D T+KI DFG+ 
Sbjct: 120 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 212 RTAGTTFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
           R    T         ++   + +PE +    +    D+WS G ++ E+
Sbjct: 180 RDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 51/237 (21%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHAKRA 108
           D+W E+  +++ +S ++G+      + G A        +  VAIK +     N   + R 
Sbjct: 11  DEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRE 64
Query: 109 YREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE 164
             EF     +MK  N  +++ LL   +      + Q   ++MELM     +     L  E
Sbjct: 65  RIEFLNEASVMKEFNCHHVVRLLGVVS------QGQPTLVIMELMTRGDLKSYLRSLRPE 118
Query: 165 -------------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
                        +M  +  ++  G+ +L++   +HRDL   N +V  D T+KI DFG+ 
Sbjct: 119 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 178
Query: 212 RTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGEM 256
           R             T YYR            +PE +    +    D+WS G ++ E+
Sbjct: 179 RD---------IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 62  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 115
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K L S   +HRDL   N ++    T+K+ 
Sbjct: 116 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVA 175
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 176 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 235
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 236 PPYPDVNTFD 245

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 60  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 113
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K L S   +HRDL   N ++    T+K+ 
Sbjct: 114 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVA 173
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 174 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 233
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 234 PPYPDVNTFD 243

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 81  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 134
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K+L S   +HRDL   N ++    T+K+ 
Sbjct: 135 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVA 194
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 195 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 254
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 255 PPYPDVNTFD 264

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 67  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 120
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K L S   +HRDL   N ++    T+K+ 
Sbjct: 121 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVA 180
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 181 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 240
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 241 PPYPDVNTFD 250

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 51/237 (21%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHAKRA 108
           D+W E+  +++ +S ++G+      + G A        +  VAIK +     N   + R 
Sbjct: 40  DEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRE 93
Query: 109 YREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE 164
             EF     +MK  N  +++ LL   +      + Q   ++MELM     +     L  E
Sbjct: 94  RIEFLNEASVMKEFNCHHVVRLLGVVS------QGQPTLVIMELMTRGDLKSYLRSLRPE 147
Query: 165 -------------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
                        +M  +  ++  G+ +L++   +HRDL   N +V  D T+KI DFG+ 
Sbjct: 148 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 207
Query: 212 RTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGEM 256
           R             T YYR            +PE +    +    D+WS G ++ E+
Sbjct: 208 RDI---------YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 63  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 116
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K L S   +HRDL   N ++    T+K+ 
Sbjct: 117 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVA 176
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 177 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 236
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 237 PPYPDVNTFD 246

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 62  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 115
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K L S   +HRDL   N ++    T+K+ 
Sbjct: 116 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVA 175
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 176 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 235
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 236 PPYPDVNTFD 245

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 121 AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 174
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K L S   +HRDL   N ++    T+K+ 
Sbjct: 175 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVA 234
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 294
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 295 PPYPDVNTFD 304

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 35/239 (14%)
Query: 59  ELPISHQMGKKRHNTSH---LGAGAAYDTAT-------QQNVAIKKLSRPFQNVTHA--K 106
           +LP + +    R+N      LGAGA             +++  +K   +  ++  HA  K
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 93
Query: 107 RAY-REFKLMK-LVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD--ANLCQVIQMD-- 160
            A   E K+M  L  H+NI+ LL A T    +    +     +L++      +V++ D  
Sbjct: 94  EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA 153
Query: 161 -------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
                       + +   Q+  G+  L S   IHRD+   N+++ +    KI DFGLAR 
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 214 AGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEMIRGGV-LFPG 265
                  + Y+V    R      APE I    Y    D+WS G ++ E+   G+  +PG
Sbjct: 214 IMND---SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTTFMMTPYVVTRYYRAP 232
           G+ +LH+  IIHRD+K  NI++  +   KI DFG+++     G T +      T  Y  P
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDP 210
Query: 233 EVILGMGYKENVDIWSVGCIMGEMI 257
           E  +     E  D++S G ++ E++
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 16/190 (8%)
Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
           A+K L+R   ++    +   E  +MK  +H N++ LL        L       +V+  M 
Sbjct: 63  AVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMK 116
Query: 151 -ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
             +L   I+ +  +  +  L+    Q+  G+K L S   +HRDL   N ++    T+K+ 
Sbjct: 117 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVA 176
Query: 207 DFGLARTA-----GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MIRGG 260
           DFGLAR        +    T   +   + A E +    +    D+WS G ++ E M RG 
Sbjct: 177 DFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 236
Query: 261 VLFPGTDHID 270
             +P  +  D
Sbjct: 237 PPYPDVNTFD 246

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 64/134 (47%), Gaps = 15/134 (11%)
Query: 138 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
           E +   LVME+ +   L + +Q +  +  + +  L++Q+  G+K+L  +  +HRDL   N
Sbjct: 440 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 499
Query: 195 IVVKSDCTLKILDFGLART--------AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
           +++ +    KI DFGL++            T    P    ++Y APE I    +    D+
Sbjct: 500 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP---VKWY-APECINYYKFSSKSDV 555
Query: 247 WSVGCIMGEMIRGG 260
           WS G +M E    G
Sbjct: 556 WSFGVLMWEAFSYG 569

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 64/134 (47%), Gaps = 15/134 (11%)
Query: 138 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
           E +   LVME+ +   L + +Q +  +  + +  L++Q+  G+K+L  +  +HRDL   N
Sbjct: 441 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 500
Query: 195 IVVKSDCTLKILDFGLART--------AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
           +++ +    KI DFGL++            T    P    ++Y APE I    +    D+
Sbjct: 501 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP---VKWY-APECINYYKFSSKSDV 556
Query: 247 WSVGCIMGEMIRGG 260
           WS G +M E    G
Sbjct: 557 WSFGVLMWEAFSYG 570

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 12/100 (12%)
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------AGTTFMM 220
           L++Q+  G+K+L  +  +HRDL   N+++ +    KI DFGL++            T   
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            P    ++Y APE I    +    D+WS G +M E    G
Sbjct: 192 WP---VKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYG 227

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 12/100 (12%)
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------AGTTFMM 220
           L++Q+  G+K+L  +  +HRDL   N+++ +    KI DFGL++            T   
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            P    ++Y APE I    +    D+WS G +M E    G
Sbjct: 192 WP---VKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYG 227

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 51/237 (21%)
Query: 50  DQWKELIYQELPISHQMGKKRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHAKRA 108
           D+W E+  +++ +S ++G+      + G A        +  VAIK +     N   + R 
Sbjct: 5   DEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRE 58
Query: 109 YREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE 164
             EF     +MK  N  +++ LL   +      + Q   ++MELM     +     L  E
Sbjct: 59  RIEFLNEASVMKEFNCHHVVRLLGVVS------QGQPTLVIMELMTRGDLKSYLRSLRPE 112
Query: 165 -------------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
                        +M  +  ++  G+ +L++   +HRDL   N  V  D T+KI DFG+ 
Sbjct: 113 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMT 172
Query: 212 RTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGEM 256
           R             T YYR            +PE +    +    D+WS G ++ E+
Sbjct: 173 RDI---------YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+ +LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 82  LLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFG 216

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+ +LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 84  LLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFG 218

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 60  LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           L    ++G+    T + G     DT T   VA  +L       +  +R   E + +K + 
Sbjct: 28  LKFDIEIGRGSFKTVYKG----LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQ 83
Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYL---LYQMLCG 176
           H NI+   +++  + +++  + + LV EL  +   +         ++  L     Q+L G
Sbjct: 84  HPNIVRFYDSW--ESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKG 141
Query: 177 IKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAPE 233
           ++ LH+    IIHRDLK  NI +     ++KI D GLA     +F     + T  + APE
Sbjct: 142 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFXAPE 200
Query: 234 VILGMGYKENVDIWSVG 250
                 Y E+VD+++ G
Sbjct: 201 X-YEEKYDESVDVYAFG 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+ +LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 92  LLGICLTS-------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 145 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 204
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 205 IYTHQSDVWSYGVTVWELMTFG 226

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+ +LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 85  LLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFG 219

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 12/100 (12%)
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------AGTTFMM 220
           L++Q+  G+K+L  +  +HRDL   N+++ +    KI DFGL++            T   
Sbjct: 130 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 189
Query: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            P    ++Y APE I    +    D+WS G +M E    G
Sbjct: 190 WP---VKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYG 225

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+ +LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 85  LLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFG 219

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+ +LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 76  LLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFG 210

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+ +LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 88  LLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 141 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 200
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 201 IYTHQSDVWSYGVTVWELMTFG 222

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+ +LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 107 LLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 160 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 219
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 220 IYTHQSDVWSYGVTVWELMTFG 241

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 71/144 (49%), Gaps = 21/144 (14%)
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDAN-LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG 184
           L+ AF  + SL +    YL   ++  N LC V +       +SYL   +       H   
Sbjct: 90  LITAFHDKGSLTD----YLKGNIITWNELCHVAETM--SRGLSYLHEDVPWCRGEGHKPS 143
Query: 185 IIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTTFMMTPYVVTRYYRAPEVILG- 237
           I HRD K  N+++KSD T  + DFGLA      +  G T      V TR Y APEV+ G 
Sbjct: 144 IAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ---VGTRRYMAPEVLEGA 200
Query: 238 MGYKEN----VDIWSVGCIMGEMI 257
           + ++ +    +D++++G ++ E++
Sbjct: 201 INFQRDAFLRIDMYAMGLVLWELV 224

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 12/100 (12%)
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------AGTTFMM 220
           L++Q+  G+K+L  +  +HRDL   N+++ +    KI DFGL++            T   
Sbjct: 112 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            P    ++Y APE I    +    D+WS G +M E    G
Sbjct: 172 WP---VKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYG 207

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+M+LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 84  LLGICLTST-------VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFG A+  G     +      V   + A E IL  
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFG 218

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+ +LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 85  LLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFG 219

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+M+LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 84  LLGICLTST-------VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFG A+  G     +      V   + A E IL  
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFG 218

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 16/154 (10%)
Query: 139 FQD---VYLVMEL-MDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 191
           FQD   +YLVME  +  +L  ++      +  E   + L +++  I  +H  G +HRD+K
Sbjct: 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIK 189
Query: 192 PSNIVVKSDCTLKILDFG--LARTAGTTFMMTPYVVTRYYRAPEVILGMGYKE------- 242
           P NI++     +++ DFG  L   A  T      V T  Y +PE++  +G          
Sbjct: 190 PDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP 249
Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
             D W++G    EM  G   F      + + KI+
Sbjct: 250 ECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+M+LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 86  LLGICLTST-------VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFG A+  G     +      V   + A E IL  
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 199 IYTHQSDVWSYGVTVWELMTFG 220

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 12/100 (12%)
Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------AGTTFMM 220
           L++Q+  G+K+L  +  +HRDL   N+++ +    KI DFGL++            T   
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            P    ++Y APE I    +    D+WS G +M E    G
Sbjct: 182 WP---VKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYG 217

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 79/178 (44%), Gaps = 15/178 (8%)
Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VAIK+L R   +    K    E  +M  V++ ++  LL              V L+ +LM
Sbjct: 47  VAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQLM 98
Query: 150 D-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
               L   ++   D+    YLL    Q+  G+ +L    ++HRDL   N++VK+   +KI
Sbjct: 99  PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 158
Query: 206 LDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            DFGLA+  G     +      V   + A E IL   Y    D+WS G  + E++  G
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 66  MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G     T + G         +  VAIK+L R   +    K    E  +M  V++ ++  
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH 181
           LL              V L+ +LM    L   ++   D+    YLL    Q+  G+ +L 
Sbjct: 89  LLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGM 238
              ++HRDL   N++VK+   +KI DFGLA+  G     +      V   + A E IL  
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 239 GYKENVDIWSVGCIMGEMIRGG 260
            Y    D+WS G  + E++  G
Sbjct: 202 IYTHQSDVWSYGVTVWELMTFG 223
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	288
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-129
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-22
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-127
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-23
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-120
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-19
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-119
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-19
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-117
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-19
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-114
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-113
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-113
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-18
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-111
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-109
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-07
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-104
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-89
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-83
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-06
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-82
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-80
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-05
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-78
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-75
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-05
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-68
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-05
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-65
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-04
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-62
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-04
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-60
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-04
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-60
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-04
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-59
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-05
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-59
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-04
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-59
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-06
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-58
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-05
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-58
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-04
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-58
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-04
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-58
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-04
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-56
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-04
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-50
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-45
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-04
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-45
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-44
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-44
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-43
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-04
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-43
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-43
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-43
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-42
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-41
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-41
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-04
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-41
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-41
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-04
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-41
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-40
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-40
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-40
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-39
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-39
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-39
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-39
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-04
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-39
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-39
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-04
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-39
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-39
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-39
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-04
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-39
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-38
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-38
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-38
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-37
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-37
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-37
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-37
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-37
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-37
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-37
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-37
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-37
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-04
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-37
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-36
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-36
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-36
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-04
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-36
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-35
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-35
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-35
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-34
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-34
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-34
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-34
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-34
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-34
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-04
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-34
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-04
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-33
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-33
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-33
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-33
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-33
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-32
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-32
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-32
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-32
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-31
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-31
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-30
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-30
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-04
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-30
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-30
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-04
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-30
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-30
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-30
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-30
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-29
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-29
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-29
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-29
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-29
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-29
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-28
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-28
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-27
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-27
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-27
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-26
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-26
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-25
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-24
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-24
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-24
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-24
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-24
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-24
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-24
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-23
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-23
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-23
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-23
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-23
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-22
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-20
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-18
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-18
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-17
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-16
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-16
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-16
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-16
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-16
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-15
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-15
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-14
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-14
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-14
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-14
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-14
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-13
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-13
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-13
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-13
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-10
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-08
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-08
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	2e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	3e-04

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  369 bits (950), Expect = e-129
 Identities = 186/216 (86%), Positives = 196/216 (90%), Gaps = 6/216 (2%)

Query: 67  GKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 120
            K+  N   +G+GA      AYD   ++NVAIKKLSRPFQN THAKRAYRE  LMK VNH
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 121 KNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
           KNIIGLLN FTPQKSLEEFQDVY+VMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHL
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143

Query: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
           HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGY
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203

Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           KENVDIWSVGCIMGEMI+GGVLFPGTDHIDQWNK+I
Sbjct: 204 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 94.0 bits (234), Expect = 3e-22
 Identities = 39/59 (66%), Positives = 47/59 (79%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           MLVID  KRISVD+AL HPYINVW+D +E  AP P   D  +DEREHT+++WKELIY+E
Sbjct: 302 MLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 360

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  368 bits (947), Expect = e-127
 Identities = 183/250 (73%), Positives = 199/250 (79%), Gaps = 2/250 (0%)

Query: 27  DAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTAT 86
           D    A         VD + ++V+         +   +Q  K   + +     AAYD   
Sbjct: 29  DVSYIAKHYNMSKSKVDNQFYSVEVGDST--FTVLKRYQNLKPIGSGAQGIVCAAYDAVL 86

Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
            +NVAIKKLSRPFQN THAKRAYRE  LMK VNHKNII LLN FTPQK+LEEFQDVYLVM
Sbjct: 87  DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146

Query: 147 ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
           ELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL
Sbjct: 147 ELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206

Query: 207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT 266
           DFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM+R  +LFPG 
Sbjct: 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266

Query: 267 DHIDQWNKII 276
           D+IDQWNK+I
Sbjct: 267 DYIDQWNKVI 276

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 96.5 bits (240), Expect = 9e-23
 Identities = 44/59 (74%), Positives = 50/59 (84%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           MLVIDP KRISVDDAL HPYINVW+D AEV AP P  YD  +DEREHT+++WKELIY+E
Sbjct: 339 MLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 397

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  348 bits (894), Expect = e-120
 Identities = 117/219 (53%), Positives = 152/219 (69%), Gaps = 9/219 (4%)

Query: 65  QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++ K   + +H+G+GA      A D  + + VAIKKLSRPFQ+   AKRAYRE  L+K +
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80

Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIK 178
            H+N+IGLL+ FTP  SL  F D YLVM  M  +L +++ +    E++ YL+YQML G+K
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLK 140

Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG- 237
           ++HSAG++HRDLKP N+ V  DC LKILDFGLAR A     MT YVVTR+YRAPEVIL  
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSW 198

Query: 238 MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           M Y + VDIWSVGCIM EM+ G  LF G D++DQ  +I+
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 85.0 bits (211), Expect = 3e-19
 Identities = 23/59 (38%), Positives = 36/59 (61%), Gaps = 1/59 (1%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           ML +D +KR++   AL HP+   + D  E    A  P+D S++  + TVD+WK+ IY+E
Sbjct: 289 MLELDVDKRLTAAQALTHPFFEPFRDPEE-ETEAQQPFDDSLEHEKLTVDEWKQHIYKE 346

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  345 bits (886), Expect = e-119
 Identities = 116/219 (52%), Positives = 154/219 (70%), Gaps = 10/219 (4%)

Query: 66  MGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN 119
           +     +   +G+GA      A D  T   VAIKKL RPFQ+   AKRAYRE +L+K + 
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82

Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIK 178
           H+N+IGLL+ FTP ++L++F D YLVM  M  +L ++++ + L  +R+ +L+YQML G++
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 142

Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG- 237
           ++H+AGIIHRDLKP N+ V  DC LKILDFGLAR A +   MT YVVTR+YRAPEVIL  
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNW 200

Query: 238 MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           M Y + VDIWSVGCIM EMI G  LF G+DH+DQ  +I+
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 2/59 (3%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           MLV+D E+R++  +AL HPY     D  +   P    YD S D+ + T+D+WK + Y+E
Sbjct: 291 MLVLDAEQRVTAGEALAHPYFESLHDTED--EPQVQKYDDSFDDVDRTLDEWKRVTYKE 347

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  340 bits (875), Expect = e-117
 Identities = 121/220 (55%), Positives = 157/220 (71%), Gaps = 4/220 (1%)

Query: 59  ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           E+P  +Q      + ++    AA+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85

Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGI 177
            H+N+IGLL+ FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145

Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           K++HSA IIHRDLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L 
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TADEMTGYVATRWYRAPEIMLN 203

Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y + VDIWSVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 85.5 bits (212), Expect = 3e-19
 Identities = 24/59 (40%), Positives = 34/59 (57%), Gaps = 2/59 (3%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           MLV+D +KRI+   AL H Y   + D  +   P   PYD S++ R+  +D+WK L Y E
Sbjct: 295 MLVLDSDKRITAAQALAHAYFAQYHDPDD--EPVADPYDQSLESRDLLIDEWKSLTYDE 351

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  331 bits (852), Expect = e-114
 Identities = 90/224 (40%), Positives = 145/224 (64%), Gaps = 8/224 (3%)

Query: 59  ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV 118
           ++   +         ++    +AYD   +  VAIKK+S PF++ T+ +R  RE K++   
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRF 82

Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSYLLYQMLCGI 177
            H+NIIG+ +      ++E+ +DVY+V +LM+ +L ++++   L ++ + Y LYQ+L G+
Sbjct: 83  RHENIIGINDIIRAP-TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141

Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTTFMMTPYVVTRYYRAPE 233
           K++HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

Query: 234 VILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           ++L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 82.3 bits (204), Expect = 4e-18
 Identities = 20/59 (33%), Positives = 35/59 (59%), Gaps = 1/59 (1%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           ML  +P KRI V+ AL HPY+  ++D ++    A  P+   ++  +   ++ KELI++E
Sbjct: 297 MLTFNPHKRIEVEQALAHPYLEQYYDPSD-EPIAEAPFKFDMELDDLPKEKLKELIFEE 354

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  330 bits (848), Expect = e-113
 Identities = 89/220 (40%), Positives = 120/220 (54%), Gaps = 21/220 (9%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A    T + VAIKK+  PF     A R  RE K++K   H+NII + N 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNI 77

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSYLLYQMLCGIKHLHSAGIIHR 188
             P  S E F +VY++ ELM  +L +VI    L  + + Y +YQ L  +K LH + +IHR
Sbjct: 78  QRPD-SFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136

Query: 189 DLKPSNIVVKSDCTLKILDFGLARTA-----------GTTFMMTPYVVTRYYRAPEVILG 237
           DLKPSN+++ S+C LK+ DFGLAR             G    M  +V TR+YRAPEV+L 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196

Query: 238 -MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
              Y   +D+WS GCI+ E+     +FPG D+  Q   I 
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 79.6 bits (197), Expect = 3e-17
 Identities = 20/62 (32%), Positives = 30/62 (48%), Gaps = 3/62 (4%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAE---VHAPAPGPYDHSVDEREHTVDQWKELIY 57
           MLV DP KRI+  +AL HPY+  + D  +        P  ++    +   T    K+LI+
Sbjct: 289 MLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIW 348

Query: 58  QE 59
            E
Sbjct: 349 NE 350

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  329 bits (846), Expect = e-113
 Identities = 76/232 (32%), Positives = 115/232 (49%), Gaps = 21/232 (9%)

Query: 64  HQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKL---------SRPFQNVTHAKRA 108
           H M         + +G+        D+     VAIK++              +    KR 
Sbjct: 18  HAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76

Query: 109 YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHER 165
            RE +L+   +H NI+GL + F           +YLV ELM  +L QVI   ++ +  + 
Sbjct: 77  LREIRLLNHFHHPNILGLRDIFVHF-EEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135

Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV 225
           + Y +Y +L G+  LH AG++HRDL P NI++  +  + I DF LAR        T YV 
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195

Query: 226 TRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            R+YRAPE+++   G+ + VD+WS GC+M EM     LF G+   +Q NKI+
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.9 bits (208), Expect = 1e-18
 Identities = 17/59 (28%), Positives = 25/59 (42%), Gaps = 2/59 (3%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           ML  +P++RIS + AL HPY    FD  ++            DE    V    ++   E
Sbjct: 300 MLEFNPQRRISTEQALRHPYFESLFDPLDL--TEGLSERFHFDESVTDVYDMHKIFTAE 356

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  326 bits (837), Expect = e-111
 Identities = 88/241 (36%), Positives = 139/241 (57%), Gaps = 35/241 (14%)

Query: 67  GKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMK-LVN 119
            +K      LG GA      + D  T + VA+KK+   FQN T A+R +RE  ++  L  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67

Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM-DLDHERMSYLLYQMLCGIK 178
           H+NI+ LLN        +  +DVYLV + M+ +L  VI+   L+     Y++YQ++  IK
Sbjct: 68  HENIVNLLNVLRA----DNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIK 123

Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----------------------AGT 216
           +LHS G++HRD+KPSNI++ ++C +K+ DFGL+R+                         
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183

Query: 217 TFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
             ++T YV TR+YRAPE++LG   Y + +D+WS+GCI+GE++ G  +FPG+  ++Q  +I
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243

Query: 276 I 276
           I
Sbjct: 244 I 244

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 18/60 (30%), Positives = 36/60 (60%), Gaps = 2/60 (3%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFD-DAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           +L  +P KRIS +DAL HP+++++ + + E +         + D  +H++D ++ L+Y E
Sbjct: 312 LLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSE 370

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  319 bits (820), Expect = e-109
 Identities = 78/231 (33%), Positives = 122/231 (52%), Gaps = 23/231 (9%)

Query: 67  GKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 120
           G +  +   LG G       A D    + VAIKK+     +    K A RE K+++ ++H
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67

Query: 121 KNIIGLLNAFTPQ--------KSLEEFQDVYLVMELMDANLCQVI-QMDLDHERMSYLLY 171
            NI+ +     P          SL E   VY+V E M+ +L  V+ Q  L  E     +Y
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127

Query: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTTF----MMTPYVVT 226
           Q+L G+K++HSA ++HRDLKP+N+ + + D  LKI DFGLAR     +     ++  +VT
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187

Query: 227 RYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           ++YR+P ++L    Y + +D+W+ GCI  EM+ G  LF G   ++Q   I+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 8/29 (27%), Positives = 18/29 (62%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAE 29
           +L   P  R++ ++AL HPY++++    +
Sbjct: 289 ILTFSPMDRLTAEEALSHPYMSIYSFPMD 317

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  308 bits (792), Expect = e-104
 Identities = 88/293 (30%), Positives = 139/293 (47%), Gaps = 61/293 (20%)

Query: 44  EREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSR 97
              H     +E +Y +   +  +         +G G+      AYD  T++NVAIKK++R
Sbjct: 2   HHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR 61

Query: 98  PFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVI 157
            F+++   KR  RE  ++  +    II L +   P   L +F ++Y+V+E+ D++L ++ 
Sbjct: 62  MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIP-DDLLKFDELYIVLEIADSDLKKLF 120

Query: 158 --QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 214
              + L  E +  +LY +L G   +H +GIIHRDLKP+N ++  DC++K+ DFGLART  
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180

Query: 215 ----------------------GTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGC 251
                                      +T +VVTR+YRAPE+IL    Y +++DIWS GC
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240

Query: 252 IMGEMIRGGV-----------LFPGT-----------------DHIDQWNKII 276
           I  E++               LFPG+                  + DQ N I 
Sbjct: 241 IFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIF 293

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 15/60 (25%), Positives = 25/60 (41%), Gaps = 2/60 (3%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDE-REHTVDQWKELIYQE 59
           ML  +P KRI++D AL HPY+            +        D+    +  Q + +  +E
Sbjct: 345 MLKFNPNKRITIDQALDHPYLKDVRKKKLE-NFSTKKIILPFDDWMVLSETQLRYIFLKE 403

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  272 bits (697), Expect = 2e-89
 Identities = 82/261 (31%), Positives = 131/261 (50%), Gaps = 49/261 (18%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G+      AYD   ++ VAIKK+ R F+++   KR  RE  ++  +NH +++ +L+ 
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIH 187
             P K +E+F ++Y+V+E+ D++  ++    + L    +  LLY +L G+K++HSAGI+H
Sbjct: 121 VIP-KDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILH 179

Query: 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTTF----------------------------M 219
           RDLKP+N +V  DC++K+ DFGLART                                  
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQ 239

Query: 220 MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGV-----------LFPGTD 267
           +T +VVTR+YRAPE+IL    Y E +D+WS+GCI  E++               LFPG+ 
Sbjct: 240 LTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS 299

Query: 268 HIDQWNKIIGKMREAHDKLDY 288
                                
Sbjct: 300 CFPLSPDQKAGNDFKFHTRGN 320

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 67.5 bits (165), Expect = 6e-13
 Identities = 13/60 (21%), Positives = 23/60 (38%), Gaps = 2/60 (3%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDE-REHTVDQWKELIYQE 59
           MLV +P KRI++++ L HP+             A        ++       Q +    +E
Sbjct: 380 MLVFNPNKRITINECLAHPFFKEVRIAEV-ETNATEKVRLPFNDWMNMDEPQLRYAFVKE 438

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  254 bits (651), Expect = 7e-83
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 24/217 (11%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G+      A    + + VAIKK+ +        +   RE ++M+ ++H NI+ L   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYF 115

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVI--------QMDLDHERMSYLLYQMLCGIKHLH 181
           F      ++   + LV++ +   + +V          + + + +    +YQ+   + ++H
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK--LYMYQLFRSLAYIH 173

Query: 182 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MG 239
           S GI HRD+KP N+++  D   LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 233

Query: 240 YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           Y  ++D+WS GC++ E++ G  +FPG   +DQ  +II
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 10/59 (16%), Positives = 22/59 (37%), Gaps = 3/59 (5%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFD-DAEVHA--PAPGPYDHSVDEREHTVDQWKELI 56
           +L   P  R++  +A  H + +   D + ++      P  ++ +  E          LI
Sbjct: 320 LLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILI 378

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  249 bits (639), Expect = 7e-82
 Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 26/221 (11%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
            G G         + +T  +VAIKK+    Q+     R  +  + + +++H NI+ L + 
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHHPNIVQLQSY 87

Query: 130 FTPQKSLEEFQDVYL--VMELMDANLCQVI--------QMDLDHERMSYLLYQMLCGIK- 178
           F       + +D+YL  VME +   L +                 +    L+Q++  I  
Sbjct: 88  FYTLGE-RDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK--VFLFQLIRSIGC 144

Query: 179 -HLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL 236
            HL S  + HRD+KP N++V ++D TLK+ DFG A+    +     Y+ +RYYRAPE+I 
Sbjct: 145 LHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIF 204

Query: 237 G-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           G   Y   VDIWSVGCI  EM+ G  +F G +   Q ++I+
Sbjct: 205 GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 14/63 (22%), Positives = 27/63 (42%), Gaps = 4/63 (6%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFD-DAEVHAPAPGP---YDHSVDEREHTVDQWKELI 56
           +L   PE+R+   +AL HPY +   D   ++      P   +    +E E   +  K  +
Sbjct: 298 LLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKL 357

Query: 57  YQE 59
            ++
Sbjct: 358 VRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  246 bits (630), Expect = 3e-80
 Identities = 69/249 (27%), Positives = 117/249 (46%), Gaps = 56/249 (22%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G+       +D  + +  A+KK+ +        +   RE  +MK+++H NII L++ 
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNIIKLVDY 68

Query: 130 FTPQK--------------------------------SLEEFQDVYLVMELMDANLCQVI 157
           F                                    +  + + + ++ME +   L +V+
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 158 --------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDF 208
                    + ++       +YQ+   +  +HS GI HRD+KP N++V   D TLK+ DF
Sbjct: 129 KSFIRSGRSIPMNLIS--IYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 209 GLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTD 267
           G A+    +     Y+ +R+YRAPE++LG   Y  ++D+WS+GC+ GE+I G  LF G  
Sbjct: 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGET 246

Query: 268 HIDQWNKII 276
            IDQ  +II
Sbjct: 247 SIDQLVRII 255

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 43.6 bits (103), Expect = 4e-05
 Identities = 12/78 (15%), Positives = 31/78 (39%), Gaps = 13/78 (16%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAE------------VHAPAPGPYDHSVDEREH- 47
           +L  +P+ RI+  +A+ HP+ +   +  E            V+   P  ++ S  E    
Sbjct: 305 ILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSII 364

Query: 48  TVDQWKELIYQELPISHQ 65
             +    ++ +    +++
Sbjct: 365 PGNVLNRILPKNFSPNYK 382

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  242 bits (620), Expect = 1e-78
 Identities = 75/268 (27%), Positives = 126/268 (47%), Gaps = 33/268 (12%)

Query: 25  FDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGA---- 80
             +A ++     P D      +      K    ++  I++   K       +G G+    
Sbjct: 5   MSNAPLNGVKLNPLDDPNKVIKVLASDGKTG--EQREIAYTNCKV------IGNGSFGVV 56

Query: 81  --AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE 138
             A    + + VAIKK+ +        +   RE ++M++V H N++ L   F      ++
Sbjct: 57  FQAKLVESDE-VAIKKVLQ------DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109

Query: 139 FQDVYLVMELMDANLCQVI--------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL 190
              + LV+E +   + +           M +   +    +YQ+L  + ++HS GI HRD+
Sbjct: 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIK--LYMYQLLRSLAYIHSIGICHRDI 167

Query: 191 KPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWS 248
           KP N+++      LK++DFG A+          Y+ +RYYRAPE+I G   Y  N+DIWS
Sbjct: 168 KPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWS 227

Query: 249 VGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            GC+M E+++G  LFPG   IDQ  +II
Sbjct: 228 TGCVMAELMQGQPLFPGESGIDQLVEII 255

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 15/66 (22%), Positives = 27/66 (40%), Gaps = 11/66 (16%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDD-----AEVHA--PAPGPYDHSVDEREHTVDQWK 53
           +L   P  R++  +AL HP+    FD+     A +      P  ++ + +E     D   
Sbjct: 305 LLEYTPSARLTAIEALCHPF----FDELRTGEARMPNGRELPPLFNWTKEELSVRPDLIS 360

Query: 54  ELIYQE 59
            L+ Q 
Sbjct: 361 RLVPQH 366

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  233 bits (596), Expect = 1e-75
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 13/201 (6%)

Query: 80  AAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMK-LVNHKNIIGLLNAFTPQKSLEE 138
            A +    + V +K L +P +     K+  RE K+++ L    NII L +      S   
Sbjct: 54  EAINITNNEKVVVKIL-KPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVS--- 105

Query: 139 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV- 197
                +   + + +  Q+ Q  L    + + +Y++L  + + HS GI+HRD+KP N+++ 
Sbjct: 106 RTPALVFEHVNNTDFKQLYQ-TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 164

Query: 198 KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 256
                L+++D+GLA            V +RY++ PE+++    Y  ++D+WS+GC++  M
Sbjct: 165 HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 224

Query: 257 I-RGGVLFPGTDHIDQWNKII 276
           I R    F G D+ DQ  +I 
Sbjct: 225 IFRKEPFFHGHDNYDQLVRIA 245

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 43.0 bits (102), Expect = 6e-05
 Identities = 7/20 (35%), Positives = 13/20 (65%)

Query: 1   MLVIDPEKRISVDDALMHPY 20
           +L  D + R++  +A+ HPY
Sbjct: 303 LLRYDHQSRLTAREAMEHPY 322

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  212 bits (543), Expect = 6e-68
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 11/201 (5%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
             +  T Q VAIKK      +    K A RE +++K + H N++ LL  F  ++ L    
Sbjct: 22  CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRL---- 77

Query: 141 DVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
             +LV E  D  +   +   Q  +    +  + +Q L  +   H    IHRD+KP NI++
Sbjct: 78  --HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI 135

Query: 198 KSDCTLKILDFGLARTAGT-TFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGE 255
                +K+ DFG AR     +      V TR+YR+PE+++G   Y   VD+W++GC+  E
Sbjct: 136 TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAE 195

Query: 256 MIRGGVLFPGTDHIDQWNKII 276
           ++ G  L+PG   +DQ   I 
Sbjct: 196 LLSGVPLWPGKSDVDQLYLIR 216

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 42.6 bits (101), Expect = 7e-05
 Identities = 10/41 (24%), Positives = 19/41 (46%), Gaps = 6/41 (14%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHS 41
            L +DP +R++ +  L HPY    F++  +        +H 
Sbjct: 268 CLHMDPTERLTCEQLLHHPY----FEN--IREIEDLAKEHD 302

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  205 bits (525), Expect = 6e-65
 Identities = 74/201 (36%), Positives = 109/201 (54%), Gaps = 11/201 (5%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
             +  T + VAIKK      +    K A RE KL+K + H+N++ LL     +K      
Sbjct: 44  CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW---- 99

Query: 141 DVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
             YLV E +D  +   ++     LD++ +   L+Q++ GI   HS  IIHRD+KP NI+V
Sbjct: 100 --YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV 157

Query: 198 KSDCTLKILDFGLARTAGT-TFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGE 255
                +K+ DFG ART      +    V TR+YRAPE+++G   Y + VD+W++GC++ E
Sbjct: 158 SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTE 217

Query: 256 MIRGGVLFPGTDHIDQWNKII 276
           M  G  LFPG   IDQ   I+
Sbjct: 218 MFMGEPLFPGDSDIDQLYHIM 238

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 41.8 bits (99), Expect = 1e-04
 Identities = 8/20 (40%), Positives = 11/20 (55%)

Query: 1   MLVIDPEKRISVDDALMHPY 20
            L IDP+KR    + L H +
Sbjct: 290 CLHIDPDKRPFCAELLHHDF 309

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  197 bits (504), Expect = 3e-62
 Identities = 76/209 (36%), Positives = 105/209 (50%), Gaps = 19/209 (9%)

Query: 81  AYDTATQQNVAIKKL-------SRPFQNVTHAKRAYREFKLMK---LVNHKNIIGLLNAF 130
           A D  +   VA+K +             ++      RE  L++      H N++ L++  
Sbjct: 28  ARDPHSGHFVALKSVRVPNGGGGGGGLPIS----TVREVALLRRLEAFEHPNVVRLMDVC 83

Query: 131 TPQKSLEEFQDVYLVMELMDANLCQVI----QMDLDHERMSYLLYQMLCGIKHLHSAGII 186
              ++  E + V LV E +D +L   +       L  E +  L+ Q L G+  LH+  I+
Sbjct: 84  ATSRTDREIK-VTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIV 142

Query: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
           HRDLKP NI+V S  T+K+ DFGLAR       +TP VVT +YRAPEV+L   Y   VD+
Sbjct: 143 HRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDM 202

Query: 247 WSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           WSVGCI  EM R   LF G    DQ  KI
Sbjct: 203 WSVGCIFAEMFRRKPLFCGNSEADQLGKI 231

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 41.8 bits (99), Expect = 1e-04
 Identities = 13/35 (37%), Positives = 14/35 (40%), Gaps = 7/35 (20%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAP 35
           ML  +P KRIS   AL H Y        E     P
Sbjct: 280 MLTFNPHKRISAFRALQHSY----LHKDE---GNP 307

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 41.7 bits (99), Expect = 1e-04
 Identities = 16/37 (43%), Positives = 17/37 (45%), Gaps = 8/37 (21%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGP 37
           ML  DP KRIS   AL HP+    F D       P P
Sbjct: 267 MLHYDPNKRISAKAALAHPF----FQD----VTKPVP 295

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  192 bits (491), Expect = 9e-60
 Identities = 76/205 (37%), Positives = 117/205 (57%), Gaps = 18/205 (8%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKR-----AYREFKLMKLVNHKNIIGLLNAFTPQKS 135
           A D  T Q VAIKK+     + + AK      A RE KL++ ++H NIIGLL+AF  + +
Sbjct: 29  ARDKNTNQIVAIKKI--KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86

Query: 136 LEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
           +       LV + M+ +L  +I    + L    +   +   L G+++LH   I+HRDLKP
Sbjct: 87  I------SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 140

Query: 193 SNIVVKSDCTLKILDFGLARTAGT-TFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVG 250
           +N+++  +  LK+ DFGLA++ G+     T  VVTR+YRAPE++ G   Y   VD+W+VG
Sbjct: 141 NNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVG 200

Query: 251 CIMGEMIRGGVLFPGTDHIDQWNKI 275
           CI+ E++      PG   +DQ  +I
Sbjct: 201 CILAELLLRVPFLPGDSDLDQLTRI 225

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 41.8 bits (99), Expect = 1e-04
 Identities = 10/41 (24%), Positives = 15/41 (36%), Gaps = 10/41 (24%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHS 41
           + + +P  RI+   AL   Y    F +       PGP    
Sbjct: 275 LFLFNPCARITATQALKMKY----FSN------RPGPTPGC 305

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  191 bits (487), Expect = 2e-59
 Identities = 69/203 (33%), Positives = 108/203 (53%), Gaps = 16/203 (7%)

Query: 85  ATQQNVAIKKLSRPFQ----NVTHAKRAYREFKLMK---LVNHKNIIGLLNAFTPQKSLE 137
              + VA+K++          ++      RE  +++      H N++ L +  T  ++  
Sbjct: 35  NGGRFVALKRVRVQTGEEGMPLS----TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90

Query: 138 EFQDVYLVMELMDANLCQVI----QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
           E + + LV E +D +L   +    +  +  E +  +++Q+L G+  LHS  ++HRDLKP 
Sbjct: 91  ETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ 149

Query: 194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
           NI+V S   +K+ DFGLAR       +T  VVT +YRAPEV+L   Y   VD+WSVGCI 
Sbjct: 150 NILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF 209

Query: 254 GEMIRGGVLFPGTDHIDQWNKII 276
            EM R   LF G+  +DQ  KI+
Sbjct: 210 AEMFRRKPLFRGSSDVDQLGKIL 232

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 43.0 bits (102), Expect = 6e-05
 Identities = 14/37 (37%), Positives = 15/37 (40%), Gaps = 4/37 (10%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGP 37
            L  +P KRIS   AL HPY    F D E        
Sbjct: 280 CLTFNPAKRISAYSALSHPY----FQDLERCKENLDS 312

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  188 bits (481), Expect = 6e-59
 Identities = 73/208 (35%), Positives = 105/208 (50%), Gaps = 26/208 (12%)

Query: 81  AYDTATQQNVAIKKLSR-------PFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ 133
           A +  T + VA+K++         P         A RE  L+K + HKNI+ L +     
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSS-------ALREICLLKELKHKNIVRLHDVLHSD 73

Query: 134 KSLEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL 190
           K L       LV E  D +L +       DLD E +   L+Q+L G+   HS  ++HRDL
Sbjct: 74  KKL------TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127

Query: 191 KPSNIVVKSDCTLKILDFGLARTAGT-TFMMTPYVVTRYYRAPEVILGM-GYKENVDIWS 248
           KP N+++  +  LK+ +FGLAR  G      +  VVT +YR P+V+ G   Y  ++D+WS
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187

Query: 249 VGCIMGEMIRGGV-LFPGTDHIDQWNKI 275
            GCI  E+   G  LFPG D  DQ  +I
Sbjct: 188 AGCIFAELANAGRPLFPGNDVDDQLKRI 215

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 41.4 bits (98), Expect = 2e-04
 Identities = 13/35 (37%), Positives = 18/35 (51%), Gaps = 8/35 (22%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAP 35
           +L  +P +RIS ++AL HPY    F D       P
Sbjct: 266 LLKCNPVQRISAEEALQHPY----FSD----FCPP 292

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  189 bits (482), Expect = 8e-59
 Identities = 73/208 (35%), Positives = 106/208 (50%), Gaps = 23/208 (11%)

Query: 81  AYDTATQQNVAIKKLSRPFQ---NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE 137
             +  T   VA+K++    +     T    A RE  LMK + H+NI+ L +    +  L 
Sbjct: 24  GLNKTTGVYVALKEVKLDSEEGTPST----AIREISLMKELKHENIVRLYDVIHTENKL- 78

Query: 138 EFQDVYLVMELMDANLCQVI--------QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
                 LV E MD +L + +           L+   + Y  +Q+L G+   H   I+HRD
Sbjct: 79  -----TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRD 133

Query: 190 LKPSNIVVKSDCTLKILDFGLARTAGT-TFMMTPYVVTRYYRAPEVILGM-GYKENVDIW 247
           LKP N+++     LK+ DFGLAR  G      +  VVT +YRAP+V++G   Y  ++DIW
Sbjct: 134 LKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIW 193

Query: 248 SVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           S GCI+ EMI G  LFPGT+  +Q   I
Sbjct: 194 SCGCILAEMITGKPLFPGTNDEEQLKLI 221

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 46.0 bits (110), Expect = 6e-06
 Identities = 13/40 (32%), Positives = 20/40 (50%), Gaps = 4/40 (10%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDH 40
           +L ++P+ R+S   AL HP+    F +   HA   G   H
Sbjct: 277 LLQLNPDMRLSAKQALHHPW----FAEYYHHASMGGSRSH 312

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  187 bits (478), Expect = 1e-58
 Identities = 70/199 (35%), Positives = 103/199 (51%), Gaps = 19/199 (9%)

Query: 86  TQQNVAIKKLSRPFQ----NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD 141
             +  A+KK+    +      T      RE  ++K + H NI+ L +    +K L     
Sbjct: 25  YGETFALKKIRLEKEDEGIPST----TIREISILKELKHSNIVKLYDVIHTKKRL----- 75

Query: 142 VYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
             LV E +D +L +++   +  L+       L Q+L GI + H   ++HRDLKP N+++ 
Sbjct: 76  -VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN 134

Query: 199 SDCTLKILDFGLARTAGT-TFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEM 256
            +  LKI DFGLAR  G      T  +VT +YRAP+V++G   Y   +DIWSVGCI  EM
Sbjct: 135 REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

Query: 257 IRGGVLFPGTDHIDQWNKI 275
           + G  LFPG    DQ  +I
Sbjct: 195 VNGTPLFPGVSEADQLMRI 213

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 42.1 bits (100), Expect = 8e-05
 Identities = 11/27 (40%), Positives = 15/27 (55%), Gaps = 4/27 (14%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDD 27
           ML +DP +RI+   AL H Y    F +
Sbjct: 264 MLKLDPNQRITAKQALEHAY----FKE 286

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  188 bits (481), Expect = 2e-58
 Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 18/203 (8%)

Query: 81  AYDTATQQNVAIKKLSRPFQ---NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE 137
                T   VA+K++    +     T    A RE  L+K + H NI+ L +    +KSL 
Sbjct: 21  GKSKLTDNLVALKEIRLEHEEGAPCT----AIREVSLLKDLKHANIVTLHDIIHTEKSL- 75

Query: 138 EFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
                 LV E +D +L Q +      ++   +   L+Q+L G+ + H   ++HRDLKP N
Sbjct: 76  -----TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQN 130

Query: 195 IVVKSDCTLKILDFGLARTAGT-TFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCI 252
           +++     LK+ DFGLAR     T      VVT +YR P+++LG   Y   +D+W VGCI
Sbjct: 131 LLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCI 190

Query: 253 MGEMIRGGVLFPGTDHIDQWNKI 275
             EM  G  LFPG+   +Q + I
Sbjct: 191 FYEMATGRPLFPGSTVEEQLHFI 213

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 40.7 bits (96), Expect = 3e-04
 Identities = 9/27 (33%), Positives = 14/27 (51%), Gaps = 4/27 (14%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDD 27
           +L  +   RIS +DA+ HP+    F  
Sbjct: 265 LLQFEGRNRISAEDAMKHPF----FLS 287

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  186 bits (476), Expect = 6e-58
 Identities = 80/207 (38%), Positives = 113/207 (54%), Gaps = 26/207 (12%)

Query: 81  AYDTATQQNVAIKKLSR-------PFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ 133
           A D+   + VA+K++         P         A RE  L+K ++H NI+ L++    +
Sbjct: 40  AKDS-QGRIVALKRIRLDAEDEGIPST-------AIREISLLKELHHPNIVSLIDVIHSE 91

Query: 134 KSLEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL 190
           + L       LV E M+ +L +V+   +  L   ++   LYQ+L G+ H H   I+HRDL
Sbjct: 92  RCL------TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDL 145

Query: 191 KPSNIVVKSDCTLKILDFGLARTAGT-TFMMTPYVVTRYYRAPEVILGM-GYKENVDIWS 248
           KP N+++ SD  LK+ DFGLAR  G      T  VVT +YRAP+V++G   Y  +VDIWS
Sbjct: 146 KPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWS 205

Query: 249 VGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           +GCI  EMI G  LFPG    DQ  KI
Sbjct: 206 IGCIFAEMITGKPLFPGVTDDDQLPKI 232

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 41.4 bits (98), Expect = 2e-04
 Identities = 15/27 (55%), Positives = 16/27 (59%), Gaps = 4/27 (14%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDD 27
           ML  DP KRIS  DA+ HPY    F D
Sbjct: 284 MLCFDPNKRISARDAMNHPY----FKD 306

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  187 bits (477), Expect = 7e-58
 Identities = 75/209 (35%), Positives = 105/209 (50%), Gaps = 25/209 (11%)

Query: 81  AYDTATQQNVAIKKLSRPFQ-----NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS 135
           A DT T + VAIK++ R          T    A RE  L+K + H+NII L +       
Sbjct: 53  AIDTVTNETVAIKRI-RLEHEEEGVPGT----AIREVSLLKELQHRNIIELKSVIHHNHR 107

Query: 136 LEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
           L      +L+ E  + +L + +    D+    +   LYQ++ G+   HS   +HRDLKP 
Sbjct: 108 L------HLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQ 161

Query: 194 NIVVKSDCT-----LKILDFGLARTAGT-TFMMTPYVVTRYYRAPEVILGM-GYKENVDI 246
           N+++          LKI DFGLAR  G      T  ++T +YR PE++LG   Y  +VDI
Sbjct: 162 NLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDI 221

Query: 247 WSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           WS+ CI  EM+    LFPG   IDQ  KI
Sbjct: 222 WSIACIWAEMLMKTPLFPGDSEIDQLFKI 250

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 14/27 (51%), Positives = 16/27 (59%), Gaps = 4/27 (14%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDD 27
           ML +DP KRIS  +AL HPY    F  
Sbjct: 302 MLEMDPVKRISAKNALEHPY----FSH 324

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  183 bits (467), Expect = 3e-56
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 23/212 (10%)

Query: 81  AYDTATQQNVAIKKLSRPFQN------VTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK 134
           A    T Q VA+KK+    +N      +T    A RE K+++L+ H+N++ L+     + 
Sbjct: 36  ARHRKTGQKVALKKV--LMENEKEGFPIT----ALREIKILQLLKHENVVNLIEICRTKA 89

Query: 135 SLEEFQ--DVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
           S        +YLV +  + +L  ++    +      +  ++  +L G+ ++H   I+HRD
Sbjct: 90  SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRD 149

Query: 190 LKPSNIVVKSDCTLKILDFGLARTAGT-----TFMMTPYVVTRYYRAPEVILGM-GYKEN 243
           +K +N+++  D  LK+ DFGLAR             T  VVT +YR PE++LG   Y   
Sbjct: 150 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP 209

Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           +D+W  GCIM EM     +  G     Q   I
Sbjct: 210 IDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 11/20 (55%), Positives = 15/20 (75%)

Query: 1   MLVIDPEKRISVDDALMHPY 20
           +LV+DP +RI  DDAL H +
Sbjct: 295 LLVLDPAQRIDSDDALNHDF 314

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  170 bits (433), Expect = 1e-50
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 37/223 (16%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           D    ++ A+K++     +++    A RE  L++ + H N+I L   F         + V
Sbjct: 44  DGKDDKDYALKQIEGTGISMS----ACREIALLRELKHPNVISLQKVFLSHAD----RKV 95

Query: 143 YLVMELMDANLCQVIQMDLDHERMSY-----------LLYQMLCGIKHLHSAGIIHRDLK 191
           +L+ +  + +L  +I+     +               LLYQ+L GI +LH+  ++HRDLK
Sbjct: 96  WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLK 155

Query: 192 PSNIVVKSDC----TLKILDFGLARTAG----TTFMMTPYVVTRYYRAPEVILGMG-YKE 242
           P+NI+V  +      +KI D G AR           + P VVT +YRAPE++LG   Y +
Sbjct: 156 PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTK 215

Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTD---------HIDQWNKII 276
            +DIW++GCI  E++    +F             H DQ ++I 
Sbjct: 216 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 40.9 bits (96), Expect = 3e-04
 Identities = 22/99 (22%), Positives = 39/99 (39%), Gaps = 15/99 (15%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDA-----EVHAPAPGPYDHSVDEREHTVDQWKEL 55
           +L +DP KRI+ + A+  PY    F +      +V A    PY              +E 
Sbjct: 317 LLTMDPIKRITSEQAMQDPY----FLEDPLPTSDVFAGCQIPYPK------REFLTEEEP 366

Query: 56  IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKK 94
             +    + Q  +  ++T+  G     D++  Q   +KK
Sbjct: 367 DDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLKK 405

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  157 bits (400), Expect = 1e-45
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 45/229 (19%)

Query: 74  SHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYR-----EFKLMKLVNHK- 121
             +G G+      AYD    Q+VA+K        +   ++ +      E ++++ +  + 
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK--------MVRNEKRFHRQAAEEIRILEHLRKQD 154

Query: 122 -----NIIGLLNAFTPQKSLEEFQD-VYLVMELMDANLCQVIQ------MDLDHERMSYL 169
                N+I +L  F        F++ + +  EL+  NL ++I+        L   R    
Sbjct: 155 KDNTMNVIHMLENF-------TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK--F 205

Query: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTTFMMTPYVVTR 227
            + +L  +  LH   IIH DLKP NI++K      +K++DFG +        +  Y+ +R
Sbjct: 206 AHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYTYIQSR 263

Query: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           +YRAPEVILG  Y   +D+WS+GCI+ E++ G  L PG D  DQ   +I
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 8/21 (38%), Positives = 12/21 (57%)

Query: 1   MLVIDPEKRISVDDALMHPYI 21
            L  DP  R++   AL HP++
Sbjct: 392 CLEWDPAVRMTPGQALRHPWL 412

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  152 bits (387), Expect = 5e-45
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 29/221 (13%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G+G       A      +   IK++    +       A RE K +  ++H NI+     
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDHVNIVHYNGC 72

Query: 130 F----------TPQKSLEEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQML 174
           +          +   S  + + +++ ME  D   L Q I+      LD      L  Q+ 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132

Query: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEV 234
            G+ ++HS  +I+RDLKPSNI +     +KI DFGL  +       T    T  Y +PE 
Sbjct: 133 KGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQ 192

Query: 235 ILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           I    Y + VD++++G I+ E++         +    +  +
Sbjct: 193 ISSQDYGKEVDLYALGLILAELLHVC--DTAFETSKFFTDL 231

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  153 bits (389), Expect = 7e-44
 Identities = 61/243 (25%), Positives = 93/243 (38%), Gaps = 33/243 (13%)

Query: 58  QELPISHQMGKKRHNTSH-LGAGA-----AYDTATQQNVAIKKLSRPFQNVTHAKRAYRE 111
            E      +GK        LG GA            ++VA+K++            A RE
Sbjct: 13  DEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADRE 67

Query: 112 FKLMK-LVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMS 167
            +L++    H N+I            ++ Q  Y+ +EL  A L + ++            
Sbjct: 68  VQLLRESDEHPNVIRYFCTE------KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI 121

Query: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-----SDCTLKILDFGLAR----TAGTTF 218
            LL Q   G+ HLHS  I+HRDLKP NI++            I DFGL +       +  
Sbjct: 122 TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181

Query: 219 MMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
             +    T  + APE++           VDI+S GC+   +I  G    G     Q N +
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241

Query: 276 IGK 278
           +G 
Sbjct: 242 LGA 244

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  150 bits (381), Expect = 7e-44
 Identities = 54/213 (25%), Positives = 84/213 (39%), Gaps = 20/213 (9%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK-LMKLVNHKNIIGLLN 128
           LG G+             +  A+K+   PF+      R   E     K+  H   + L  
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGI 185
           A+      EE   +YL  EL   +L Q  +     L   ++   L   L  + HLHS G+
Sbjct: 125 AW------EEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL 178

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
           +H D+KP+NI +      K+ DFGL    GT            Y APE++ G  Y    D
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAAD 237

Query: 246 IWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
           ++S+G  + E+     L       + W ++   
Sbjct: 238 VFSLGLTILEVACNMELP---HGGEGWQQLRQG 267

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  151 bits (382), Expect = 2e-43
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 56/288 (19%)

Query: 17  MHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHL 76
                N++F     H      Y+   D+  +      + I +      +   +    S +
Sbjct: 12  DLGTENLYFQSMSSHKKERKVYNDGYDDDNY------DYIVK---NGEKWMDRYEIDSLI 62

Query: 77  GAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYR-----EFKLMKLVNH----- 120
           G G+      AYD   Q+ VAIK        +   K+A+      E +L++L+N      
Sbjct: 63  GKGSFGQVVKAYDRVEQEWVAIK--------IIKNKKAFLNQAQIEVRLLELMNKHDTEM 114

Query: 121 -KNIIGLLNAFTPQKSLEEFQD-VYLVMELMDANLCQVIQ------MDLDHERMSYLLYQ 172
              I+ L   F        F++ + LV E++  NL  +++      + L+  R      Q
Sbjct: 115 KYYIVHLKRHF-------MFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK--FAQQ 165

Query: 173 MLCGIKHLHS--AGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTTFMMTPYVVTRY 228
           M   +  L +    IIH DLKP NI++ +     +KI+DFG +   G    +  Y+ +R+
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRF 223

Query: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           YR+PEV+LGM Y   +D+WS+GCI+ EM  G  LF G + +DQ NKI+
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 9/21 (42%), Positives = 11/21 (52%)

Query: 1   MLVIDPEKRISVDDALMHPYI 21
           ML  DP+ RI    AL H + 
Sbjct: 356 MLDYDPKTRIQPYYALQHSFF 376

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  149 bits (379), Expect = 3e-43
 Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 18/214 (8%)

Query: 75  HLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
            +G G+         T   +   IK+++    +    + + RE  ++  + H NI+    
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 129 AFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA 183
           +F      EE   +Y+VM+  +  +L + I          +++     Q+   +KH+H  
Sbjct: 91  SF------EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV-TRYYRAPEVILGMGYKE 242
            I+HRD+K  NI +  D T+++ DFG+AR   +T  +    + T YY +PE+     Y  
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204

Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
             DIW++GC++ E+      F      +   KII
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  155 bits (392), Expect = 4e-43
 Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 22/221 (9%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G            T + VAIK+  +   +  + +R   E ++MK +NH N++     
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYL--------LYQMLCGIKHL 180
               + L       L ME  +  +L + +      E    L        L  +   +++L
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN---QFENCCGLKEGPIRTLLSDISSALRYL 137

Query: 181 HSAGIIHRDLKPSNIVVKSDC---TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           H   IIHRDLKP NIV++        KI+D G A+      + T +V T  Y APE++  
Sbjct: 138 HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ 197

Query: 238 MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
             Y   VD WS G +  E I G   F       QW+  + +
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  147 bits (374), Expect = 5e-43
 Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 34/231 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G       A +     N AIK++  P + +   ++  RE K +  + H  I+   NA
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKLEHPGIVRYFNA 71

Query: 130 F------TPQKSLEEFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGI 177
           +         +       +Y+ M+L    NL   +       + +     ++  Q+   +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMM-------------TPYV 224
           + LHS G++HRDLKPSNI    D  +K+ DFGL                       T  V
Sbjct: 132 EFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV 191

Query: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            T+ Y +PE I G  Y   VDI+S+G I+ E++         + +     +
Sbjct: 192 GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP--FSTQMERVRTLTDV 240

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  146 bits (370), Expect = 8e-42
 Identities = 31/246 (12%), Positives = 69/246 (28%), Gaps = 40/246 (16%)

Query: 76  LGAGA------AYDTATQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           L  G         D    ++ A+K  +     + +  +R +        +  ++     +
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 129 AF--------------------TPQKSLEEFQDVYLVMELMDANLCQVIQM--------- 159
                                 +P +      +  L+M     +L  +            
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 160 DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM 219
           D     +  L  Q++    +L S G++H    P N+ +  D  L + D       GT   
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG- 248

Query: 220 MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
                V   Y   E +      +   ++ W +G  +  +    + F       + +    
Sbjct: 249 -PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP 307

Query: 278 KMREAH 283
            +R   
Sbjct: 308 SLRVPG 313

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  143 bits (363), Expect = 2e-41
 Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 23/221 (10%)

Query: 75  HLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
            +G G+          +  + +  K+L          +    E  L++ + H NI+   +
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 129 AFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD------LDHERMSYLLYQMLCGIKHLH 181
                        +Y+VME  +  +L  VI         LD E +  ++ Q+   +K  H
Sbjct: 73  RII----DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128

Query: 182 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV-TRYYRAPEVI 235
                   ++HRDLKP+N+ +     +K+ DFGLAR            V T YY +PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188

Query: 236 LGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
             M Y E  DIWS+GC++ E+      F      +   KI 
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 229

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  145 bits (369), Expect = 4e-41
 Identities = 69/203 (33%), Positives = 102/203 (50%), Gaps = 36/203 (17%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR------PFQNVTHAKRAYREFKLMKLVNHKNI 123
           LG+GA      A++  T + VAI+ +S+        +    A     E +++K +NH  I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 124 IGLLNAFTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDHERM-SYLLYQMLCG 176
           I + N F       + +D Y+V+ELM      D     V+      E       YQML  
Sbjct: 203 IKIKNFF-------DAEDYYIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQMLLA 251

Query: 177 IKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPE 233
           +++LH  GIIHRDLKP N+++ S   DC +KI DFG ++  G T +M     T  Y APE
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311

Query: 234 VILGM---GYKENVDIWSVGCIM 253
           V++ +   GY   VD WS+G I+
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVIL 334

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 11/30 (36%), Positives = 19/30 (63%), Gaps = 4/30 (13%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEV 30
           +LV+DP+ R + ++AL HP    W  D ++
Sbjct: 383 LLVVDPKARFTTEEALRHP----WLQDEDM 408

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  143 bits (363), Expect = 4e-41
 Identities = 70/203 (34%), Positives = 102/203 (50%), Gaps = 36/203 (17%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR------PFQNVTHAKRAYREFKLMKLVNHKNI 123
           LG+GA      A++  T + VAIK +S+        +    A     E +++K +NH  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 124 IGLLNAFTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDHERM-SYLLYQMLCG 176
           I + N F       + +D Y+V+ELM      D     V+      E       YQML  
Sbjct: 78  IKIKNFF-------DAEDYYIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQMLLA 126

Query: 177 IKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPE 233
           +++LH  GIIHRDLKP N+++ S   DC +KI DFG ++  G T +M     T  Y APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186

Query: 234 VILGM---GYKENVDIWSVGCIM 253
           V++ +   GY   VD WS+G I+
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 41.1 bits (97), Expect = 2e-04
 Identities = 11/30 (36%), Positives = 19/30 (63%), Gaps = 4/30 (13%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEV 30
           +LV+DP+ R + ++AL HP    W  D ++
Sbjct: 258 LLVVDPKARFTTEEALRHP----WLQDEDM 283

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  144 bits (364), Expect = 8e-41
 Identities = 67/246 (27%), Positives = 111/246 (45%), Gaps = 50/246 (20%)

Query: 74  SHLGAGA------AYDTATQQNVAIKKLSRPFQNVTH-AKRAYREFKLMKLVN------- 119
             LG G       A D     +VA+K +    +      + A  E KL++ VN       
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 120 ----HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ------MDLDHERMSYL 169
                 +I+ LL+ F  +        V +V E++  NL  +I+      + L + +   +
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVH--VVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--I 136

Query: 170 LYQMLCGIKHLHS-AGIIHRDLKPSNIVVK------SDCTLKILDFGLARTAGTTFMMTP 222
             Q+L G+ ++H   GIIH D+KP N++++      +   +KI D G A      +  T 
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--TN 194

Query: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG---------TDHIDQWN 273
            + TR YR+PEV+LG  +    DIWS  C++ E+I G  LF            DHI Q  
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254

Query: 274 KIIGKM 279
           +++G++
Sbjct: 255 ELLGEL 260

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 8/22 (36%), Positives = 12/22 (54%)

Query: 1   MLVIDPEKRISVDDALMHPYIN 22
           ML +DP KR      + HP++ 
Sbjct: 317 MLQLDPRKRADAGGLVNHPWLK 338

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  142 bits (360), Expect = 9e-41
 Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 38/233 (16%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +    +  AIKK+    + ++       E  L+  +NH+ ++    A
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS---EVMLLASLNHQYVVRYYAA 70

Query: 130 F-------TPQKSLEEFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIK 178
           +        P  ++++   +++ ME  +   L  +I    ++   +    L  Q+L  + 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130

Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF---------------MMTPY 223
           ++HS GIIHRDLKP NI +     +KI DFGLA+    +                 +T  
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190

Query: 224 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           + T  Y A EV+ G G Y E +D++S+G I  EMI       G + ++   K+
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKL 241

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  143 bits (363), Expect = 1e-40
 Identities = 52/254 (20%), Positives = 96/254 (37%), Gaps = 73/254 (28%)

Query: 74  SHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYR-----EFKLMKLVNH-- 120
             +G G             ++  A+K        V    + Y      E  ++K + +  
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVK--------VVRNIKKYTRSAKIEADILKKIQNDD 92

Query: 121 ---KNIIGLLNAFTPQKSLEEFQD-VYLVMELMDANLCQVIQ------MDLDHERMSYLL 170
               NI+     F        + D + L+ E +  +L ++I         ++  ++    
Sbjct: 93  INNNNIVKYHGKF-------MYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKL--YC 143

Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKS-------------------------DCTLKI 205
            ++L  + +L    + H DLKP NI++                              +K+
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 206 LDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL 262
           +DFG       TF        + TR YRAPEVIL +G+  + D+WS GC++ E+  G +L
Sbjct: 204 IDFG-----CATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258

Query: 263 FPGTDHIDQWNKII 276
           F   +H++    + 
Sbjct: 259 FRTHEHMEHLAMME 272

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  140 bits (356), Expect = 6e-40
 Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 25/193 (12%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLN 128
           LG G        +   T Q  A+K L         + +A +E     +     +I+ +L+
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLLYD-------SPKARQEVDHHWQASGGPHIVCILD 89

Query: 129 AFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDH---ERM-SYLLYQMLCGIKHLHSA 183
            +  +      + + ++ME M+   L   IQ   D    ER  + ++  +   I+ LHS 
Sbjct: 90  VY--ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147

Query: 184 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
            I HRD+KP N++  S   D  LK+ DFG A+      + TP   T YY APEV+    Y
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEKY 206

Query: 241 KENVDIWSVGCIM 253
            ++ D+WS+G IM
Sbjct: 207 DKSCDMWSLGVIM 219

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  140 bits (354), Expect = 6e-40
 Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 29/194 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG+GA           T +  A+K + +             E  ++K + H+NI+ L + 
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKK--SPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 130 FTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDHERM-SYLLYQMLCGIKHLHS 182
           +      E     YLVM+L+      D    ++++  +  E+  S ++ Q+L  +K+LH 
Sbjct: 75  Y------ESTTHYYLVMQLVSGGELFD----RILERGVYTEKDASLVIQQVLSAVKYLHE 124

Query: 183 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
            GI+HRDLKP N++  +   +  + I DFGL++      M T    T  Y APEV+    
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA-CGTPGYVAPEVLAQKP 183

Query: 240 YKENVDIWSVGCIM 253
           Y + VD WS+G I 
Sbjct: 184 YSKAVDCWSIGVIT 197

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  139 bits (352), Expect = 2e-39
 Identities = 54/232 (23%), Positives = 87/232 (37%), Gaps = 35/232 (15%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA           T    AIK  +     +       REF+++K +NHKNI+ L   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYL--------LYQMLCGIKHL 180
                +    +   L+ME     +L  V++   +      L        L  ++ G+ HL
Sbjct: 76  EEETTT----RHKVLIMEFCPCGSLYTVLE---EPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 181 HSAGIIHRDLKPSNIVVKS----DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI- 235
              GI+HR++KP NI+           K+ DFG AR             T  Y  P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 236 -------LGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR 280
                      Y   VD+WS+G        G + F   +   +  +++ K+ 
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  140 bits (355), Expect = 2e-39
 Identities = 54/232 (23%), Positives = 87/232 (37%), Gaps = 35/232 (15%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA           T    AIK  +     +       REF+++K +NHKNI+ L   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYL--------LYQMLCGIKHL 180
                +    +   L+ME     +L  V++   +      L        L  ++ G+ HL
Sbjct: 76  EEETTT----RHKVLIMEFCPCGSLYTVLE---EPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 181 HSAGIIHRDLKPSNIVVKS----DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI- 235
              GI+HR++KP NI+           K+ DFG AR             T  Y  P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 236 -------LGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR 280
                      Y   VD+WS+G        G + F   +   +  +++ K+ 
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  141 bits (356), Expect = 3e-39
 Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 53/254 (20%)

Query: 76  LGAGA-----AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLNA 129
           LG G+        +   + VA+K++   F        A  E KL+ +  +H N+I    +
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPNVIRYYCS 77

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQ---------MDLDHERMSYLLYQMLCGIKHL 180
                     + +Y+ +EL + NL  +++                   LL Q+  G+ HL
Sbjct: 78  E------TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 181 HSAGIIHRDLKPSNIVVKS-------------DCTLKILDFGLAR------TAGTTFMMT 221
           HS  IIHRDLKP NI+V +             +  + I DFGL +      ++  T +  
Sbjct: 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191

Query: 222 PYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNK 274
           P   T  +RAPE++              ++DI+S+GC+   ++  G    G  +  + N 
Sbjct: 192 P-SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250

Query: 275 IIGKMREAHDKLDY 288
           I G       K  +
Sbjct: 251 IRGIFSLDEMKCLH 264

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  139 bits (352), Expect = 3e-39
 Identities = 59/247 (23%), Positives = 98/247 (39%), Gaps = 63/247 (25%)

Query: 74  SHLGAGA------AYDTA-TQQNVAIKKLSRPFQNVTHAKRAYR-----EFKLMKLVNHK 121
            +LG G         D A  +  VA+K        +      YR     E  ++K +  K
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALK--------IIRNVGKYREAARLEINVLKKIKEK 76

Query: 122 ------NIIGLLNAFTPQKSLEEFQD-VYLVMELMDANLCQVIQ------MDLDHERMSY 168
                   + + + F        F   + +  EL+  N  + ++        L H R   
Sbjct: 77  DKENKFLCVLMSDWF-------NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRH-- 127

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-------------------DCTLKILDFG 209
           + YQ+   ++ LH   + H DLKP NI+  +                   + ++++ DFG
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187

Query: 210 LARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
            A         T  V TR+YR PEVIL +G+ +  D+WS+GCI+ E  RG  LF   ++ 
Sbjct: 188 SATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245

Query: 270 DQWNKII 276
           +    + 
Sbjct: 246 EHLVMME 252

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 39.2 bits (92), Expect = 9e-04
 Identities = 11/37 (29%), Positives = 19/37 (51%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGP 37
           ML  DP +RI++ +AL+HP+      +      +  P
Sbjct: 317 MLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNP 353

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  137 bits (347), Expect = 4e-39
 Identities = 63/194 (32%), Positives = 95/194 (48%), Gaps = 27/194 (13%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G+        D  TQQ  A+K +++            RE +L+K ++H NI+ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 130 FTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDHERM-SYLLYQMLCGIKHLHS 182
                  E+    Y+V EL       D    ++I+     E   + ++ Q+  GI ++H 
Sbjct: 90  L------EDSSSFYIVGELYTGGELFD----EIIKRKRFSEHDAARIIKQVFSGITYMHK 139

Query: 183 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
             I+HRDLKP NI+++S   DC +KI+DFGL+        M   + T YY APEV+ G  
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-T 198

Query: 240 YKENVDIWSVGCIM 253
           Y E  D+WS G I+
Sbjct: 199 YDEKCDVWSAGVIL 212

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  138 bits (350), Expect = 6e-39
 Identities = 62/250 (24%), Positives = 99/250 (39%), Gaps = 69/250 (27%)

Query: 74  SHLGAGA------AYDTATQ-QNVAIKKLSRPFQNVTHAKRAYR-----EFKLMKLVNHK 121
             LG GA        D     ++VA+K        +      Y      E ++++ +N  
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVK--------IVKNVDRYCEAARSEIQVLEHLNTT 71

Query: 122 ------NIIGLLNAFTPQKSLEEFQD-VYLVMELMDANLCQVIQ------MDLDHERMSY 168
                   + +L  F       E    + +V EL+  +    I+        LDH R   
Sbjct: 72  DPNSTFRCVQMLEWF-------EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRK-- 122

Query: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-------------------DCTLKILDFG 209
           + YQ+   +  LHS  + H DLKP NI+                      +  +K++DFG
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182

Query: 210 LARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT 266
                  T+     +  V TR+YRAPEVIL +G+ +  D+WS+GCI+ E   G  +FP  
Sbjct: 183 -----SATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237

Query: 267 DHIDQWNKII 276
           D  +    + 
Sbjct: 238 DSKEHLAMME 247

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 40.3 bits (95), Expect = 4e-04
 Identities = 11/24 (45%), Positives = 17/24 (70%)

Query: 1   MLVIDPEKRISVDDALMHPYINVW 24
           ML  DP KRI++ +AL HP+ ++ 
Sbjct: 312 MLEYDPAKRITLREALKHPFFDLL 335

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  137 bits (347), Expect = 8e-39
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 26/210 (12%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN--IIGLLNAFTPQKSLEEFQDVY 143
            +Q  AIK ++    +         E   +  +   +  II L +           Q +Y
Sbjct: 51  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE------ITDQYIY 104

Query: 144 LVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
           +VME  + +L   ++    +D          ML  +  +H  GI+H DLKP+N ++  D 
Sbjct: 105 MVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDG 163

Query: 202 TLKILDFGLAR---TAGTTFMMTPYVVTRYYRAPEVILGMGYKEN-----------VDIW 247
            LK++DFG+A       T+ +    V T  Y  PE I  M                 D+W
Sbjct: 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223

Query: 248 SVGCIMGEMIRGGVLFPG-TDHIDQWNKII 276
           S+GCI+  M  G   F    + I + + II
Sbjct: 224 SLGCILYYMTYGKTPFQQIINQISKLHAII 253

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  136 bits (345), Expect = 8e-39
 Identities = 61/195 (31%), Positives = 90/195 (46%), Gaps = 31/195 (15%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G+      A    T+   A KK+ +    V    R  +E ++MK ++H NII L   
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQ-------VIQMDLDHERM-SYLLYQMLCGIKHLH 181
           F      E+  D+YLVMEL     C        V+   +  E   + ++  +L  + + H
Sbjct: 75  F------EDNTDIYLVMEL-----CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH 123

Query: 182 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM 238
              + HRDLKP N +  +   D  LK++DFGLA       MM   V T YY +P+V+ G 
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG- 182

Query: 239 GYKENVDIWSVGCIM 253
            Y    D WS G +M
Sbjct: 183 LYGPECDEWSAGVMM 197

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  136 bits (345), Expect = 9e-39
 Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 28/195 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA           T    A K ++    +    ++  RE ++ + + H NI+ L ++
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 130 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSY-------LLYQMLCGIKHLH 181
                  +E    YLV +L+    L + I       R  Y        + Q+L  I + H
Sbjct: 74  I------QEESFHYLVFDLVTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCH 122

Query: 182 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM 238
           S GI+HR+LKP N+++ S      +K+ DFGLA     +     +  T  Y +PEV+   
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182

Query: 239 GYKENVDIWSVGCIM 253
            Y + VDIW+ G I+
Sbjct: 183 PYSKPVDIWACGVIL 197

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 39.1 bits (92), Expect = 8e-04
 Identities = 14/34 (41%), Positives = 19/34 (55%), Gaps = 4/34 (11%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPA 34
           ML ++P+KRI+ D AL  P    W  + E  A A
Sbjct: 245 MLTVNPKKRITADQALKVP----WICNRERVASA 274

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  137 bits (348), Expect = 9e-39
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 31/218 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LG G         D  T++  A K + +         ++   E  + + + H++++G   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSA 183
            F      E+   V++V+EL       ++++    + ++     Y L Q++ G ++LH  
Sbjct: 109 FF------EDNDFVFVVLEL--CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT------TFMMTPYVVTRYYRAPEVILG 237
            +IHRDLK  N+ +  D  +KI DFGLA               TP      Y APEV+  
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP-----NYIAPEVLSK 215

Query: 238 MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            G+   VD+WS+GCIM  ++ G   F  +   + + +I
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  137 bits (347), Expect = 2e-38
 Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 28/195 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA           T    A K ++    +    ++  RE ++ + + H NI+ L ++
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 130 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSY-------LLYQMLCGIKHLH 181
                  +E    YLV +L+    L + I       R  Y        + Q+L  I + H
Sbjct: 97  I------QEESFHYLVFDLVTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCH 145

Query: 182 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM 238
           S GI+HR+LKP N+++ S      +K+ DFGLA     +     +  T  Y +PEV+   
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 205

Query: 239 GYKENVDIWSVGCIM 253
            Y + VDIW+ G I+
Sbjct: 206 PYSKPVDIWACGVIL 220

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  135 bits (343), Expect = 2e-38
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 33/219 (15%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LG G         D  T++  A K + +         ++   E  + + + H++++G   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 129 AFTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS 182
            F      E+   V++V+E      L++       +  L      Y L Q++ G ++LH 
Sbjct: 83  FF------EDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT------TFMMTPYVVTRYYRAPEVIL 236
             +IHRDLK  N+ +  D  +KI DFGLA               TP      Y APEV+ 
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP-----NYIAPEVLS 188

Query: 237 GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
             G+   VD+WS+GCIM  ++ G   F  +   + + +I
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 227

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  134 bits (340), Expect = 4e-38
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 32/198 (16%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG+GA        + ++     IK +++  ++    ++   E +++K ++H NII +   
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 130 FTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDHERMS-----YLLYQMLCGIK 178
           F      E++ ++Y+VME        +    +++      + +S      L+ QM+  + 
Sbjct: 89  F------EDYHNMYIVMETCEGGELLE----RIVSAQARGKALSEGYVAELMKQMMNALA 138

Query: 179 HLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI 235
           + HS  ++H+DLKP NI+ +       +KI+DFGLA    +    T    T  Y APEV 
Sbjct: 139 YFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF 198

Query: 236 LGMGYKENVDIWSVGCIM 253
                    DIWS G +M
Sbjct: 199 KR-DVTFKCDIWSAGVVM 215

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  135 bits (342), Expect = 4e-38
 Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 20/191 (10%)

Query: 79  GAAY---DTATQQNVAIKKLSRPFQNVTHAKR-AYREFKLMKLVNHKNIIGLLNAFTPQK 134
              Y          VA+KK+         A+    +E  L+K +NH N+I    +F    
Sbjct: 46  SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF---- 101

Query: 135 SLEEFQDVYLVMELMDA-NLCQVIQMDLDHER-------MSYLLYQMLCGIKHLHSAGII 186
              E  ++ +V+EL DA +L ++I+     +R         Y   Q+   ++H+HS  ++
Sbjct: 102 --IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF-VQLCSALEHMHSRRVM 158

Query: 187 HRDLKPSNIVVKSDCTLKILDFGLART-AGTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
           HRD+KP+N+ + +   +K+ D GL R  +  T      V T YY +PE I   GY    D
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 218

Query: 246 IWSVGCIMGEM 256
           IWS+GC++ EM
Sbjct: 219 IWSLGCLLYEM 229

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  135 bits (341), Expect = 9e-38
 Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 26/210 (12%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN--IIGLLNAFTPQKSLEEFQDVY 143
            +Q  AIK ++    +         E   +  +   +  II L +           Q +Y
Sbjct: 32  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE------ITDQYIY 85

Query: 144 LVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
           +VME  + +L   ++    +D          ML  +  +H  GI+H DLKP+N ++    
Sbjct: 86  MVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM 145

Query: 202 TLKILDFGLAR---TAGTTFMMTPYVVTRYYRAPEVILGMGYKEN-----------VDIW 247
            LK++DFG+A       T+ +    V T  Y  PE I  M                 D+W
Sbjct: 146 -LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204

Query: 248 SVGCIMGEMIRGGVLFPG-TDHIDQWNKII 276
           S+GCI+  M  G   F    + I + + II
Sbjct: 205 SLGCILYYMTYGKTPFQQIINQISKLHAII 234

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  135 bits (341), Expect = 1e-37
 Identities = 62/195 (31%), Positives = 88/195 (45%), Gaps = 32/195 (16%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA           TQ+  A+K L +        K    E  ++  ++H NII L   
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKK----TVDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 130 FTPQKSLEEFQDVYLVMELMDAN-LCQVIQMDLDHERMSY-------LLYQMLCGIKHLH 181
           F      E   ++ LV+EL+    L   I      E+  Y        + Q+L  + +LH
Sbjct: 117 F------ETPTEISLVLELVTGGELFDRIV-----EKGYYSERDAADAVKQILEAVAYLH 165

Query: 182 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM 238
             GI+HRDLKP N++  +   D  LKI DFGL++      +M     T  Y APE++ G 
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC 225

Query: 239 GYKENVDIWSVGCIM 253
            Y   VD+WSVG I 
Sbjct: 226 AYGPEVDMWSVGIIT 240

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  136 bits (343), Expect = 1e-37
 Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 32/213 (15%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN--IIGLLNAFTPQKSLEEFQDVY 143
            +Q  AIK ++    +         E   +  +   +  II L +           Q +Y
Sbjct: 79  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE------ITDQYIY 132

Query: 144 LVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
           +VME  + +L   ++     + +           ML  +  +H  GI+H DLKP+N ++ 
Sbjct: 133 MVMECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI- 188

Query: 199 SDCTLKILDFGLAR---TAGTTFMMTPYVVTRYYRAPEVILGMGYKEN-----------V 244
            D  LK++DFG+A       T+ +    V    Y  PE I  M                 
Sbjct: 189 VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248

Query: 245 DIWSVGCIMGEMIRGGVLFPG-TDHIDQWNKII 276
           D+WS+GCI+  M  G   F    + I + + II
Sbjct: 249 DVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  135 bits (342), Expect = 2e-37
 Identities = 59/194 (30%), Positives = 93/194 (47%), Gaps = 26/194 (13%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMK-LVNHKNIIGLLN 128
           LG G        ++  TQ+  A+K L           +A RE +L        +I+ +++
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVD 122

Query: 129 AFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDH---ERM-SYLLYQMLCGIKHLHSA 183
            +  +      + + +VME +D   L   IQ   D    ER  S ++  +   I++LHS 
Sbjct: 123 VY--ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180

Query: 184 GIIHRDLKPSNIVVKS---DCTLKILDFGLAR-TAGTTFMMTPYVVTRYYRAPEVILGMG 239
            I HRD+KP N++  S   +  LK+ DFG A+ T     + TP   T YY APEV+    
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVLGPEK 239

Query: 240 YKENVDIWSVGCIM 253
           Y ++ D+WS+G IM
Sbjct: 240 YDKSCDMWSLGVIM 253

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  133 bits (337), Expect = 2e-37
 Identities = 42/196 (21%), Positives = 80/196 (40%), Gaps = 24/196 (12%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
                     A+K++          + A RE  + +L NH NI+ L+     ++      
Sbjct: 48  VEGLHDGHFYALKRI--LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER--GAKH 103

Query: 141 DVYLVMELMDA-NLCQVIQ-MDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPS 193
           + +L++       L   I+ +      ++     +LL  +  G++ +H+ G  HRDLKP+
Sbjct: 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPT 163

Query: 194 NIVVKSDCTLKILDFGLARTAG------TTFMMTPYVVTR----YYRAPEVILGMGYK-- 241
           NI++  +    ++D G    A          +       +     YRAPE+     +   
Sbjct: 164 NILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVI 223

Query: 242 -ENVDIWSVGCIMGEM 256
            E  D+WS+GC++  M
Sbjct: 224 DERTDVWSLGCVLYAM 239

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  131 bits (333), Expect = 4e-37
 Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 34/220 (15%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR-PFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LG G+      A    T   VAIK + +         +R   E K+   + H +I+ L N
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 129 AFTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS 182
            F      E+   VYLV+E      +      +            + ++Q++ G+ +LHS
Sbjct: 79  YF------EDSNYVYLVLEMCHNGEMNR--YLKNRVKPFSENEARHFMHQIITGMLYLHS 130

Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTTFMMT-----PYVVTRYYRAPEVI 235
            GI+HRDL  SN+++  +  +KI DFGLA           T      Y+      +PE+ 
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI------SPEIA 184

Query: 236 LGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
               +    D+WS+GC+   ++ G   F      +  NK+
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  135 bits (342), Expect = 6e-37
 Identities = 51/196 (26%), Positives = 85/196 (43%), Gaps = 29/196 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA             Q  A   ++    +    ++  RE ++ +L+ H NI+ L ++
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 130 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSY-------LLYQMLCGIKHLH 181
                   E    YL+ +L+    L + I       R  Y        + Q+L  + H H
Sbjct: 79  I------SEEGHHYLIFDLVTGGELFEDIV-----AREYYSEADASHCIQQILEAVLHCH 127

Query: 182 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLART-AGTTFMMTPYVVTRYYRAPEVILG 237
             G++HR+LKP N+++ S      +K+ DFGLA    G       +  T  Y +PEV+  
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187

Query: 238 MGYKENVDIWSVGCIM 253
             Y + VD+W+ G I+
Sbjct: 188 DPYGKPVDLWACGVIL 203

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  135 bits (343), Expect = 6e-37
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 29/217 (13%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG+GA        D  T    AIK + +   + +   +   E  ++KL++H NI+ L + 
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQ-------VIQMDLDHERM-SYLLYQMLCGIKHLH 181
           F      E+ ++ YLVME       +       +I     +E   + ++ Q+L G+ +LH
Sbjct: 105 F------EDKRNYYLVMEC-----YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH 153

Query: 182 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM 238
              I+HRDLKP N++++S   D  +KI+DFGL+        M   + T YY APEV+   
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK- 212

Query: 239 GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            Y E  D+WS+G I+  ++ G   F G    +   K+
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  135 bits (342), Expect = 8e-37
 Identities = 62/195 (31%), Positives = 93/195 (47%), Gaps = 29/195 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G+        D  TQQ  A+K +++            RE +L+K ++H NI+ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQ-------VIQMDLDHERM-SYLLYQMLCGIKHLH 181
                  E+    Y+V EL              +I+     E   + ++ Q+  GI ++H
Sbjct: 90  L------EDSSSFYIVGEL-----YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138

Query: 182 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM 238
              I+HRDLKP NI+++S   DC +KI+DFGL+        M   + T YY APEV+ G 
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG- 197

Query: 239 GYKENVDIWSVGCIM 253
            Y E  D+WS G I+
Sbjct: 198 TYDEKCDVWSAGVIL 212

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  132 bits (335), Expect = 9e-37
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 37/198 (18%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLN 128
           +G G+          AT    A+K + +        +    E +++ +   H NII L +
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHPNIITLKD 83

Query: 129 AFTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDHERM-SYLLYQMLCGIKHLH 181
            +      ++ + VY+V ELM      D     +++     ER  S +L+ +   +++LH
Sbjct: 84  VY------DDGKYVYVVTELMKGGELLDK----ILRQKFFSEREASAVLFTITKTVEYLH 133

Query: 182 SAGIIHRDLKPSNIVVKSD----CTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVI 235
           + G++HRDLKPSNI+   +     +++I DFG A+   A    +MTP   T  + APEV+
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-CYTANFVAPEVL 192

Query: 236 LGMGYKENVDIWSVGCIM 253
              GY    DIWS+G ++
Sbjct: 193 ERQGYDAACDIWSLGVLL 210

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  132 bits (335), Expect = 9e-37
 Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 28/199 (14%)

Query: 76  LGAGA------AYDTATQQNVAIK---KLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGL 126
           +G G         +  T Q  A+K               +   RE  +  ++ H +I+ L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 127 LNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSY-------LLYQMLCGIK 178
           L  +           +Y+V E MD A+LC  I +        Y        + Q+L  ++
Sbjct: 92  LETY------SSDGMLYMVFEFMDGADLCFEI-VKRADAGFVYSEAVASHYMRQILEALR 144

Query: 179 HLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLART-AGTTFMMTPYVVTRYYRAPEV 234
           + H   IIHRD+KP  +++ S      +K+  FG+A     +  +    V T ++ APEV
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204

Query: 235 ILGMGYKENVDIWSVGCIM 253
           +    Y + VD+W  G I+
Sbjct: 205 VKREPYGKPVDVWGCGVIL 223

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 40.7 bits (96), Expect = 3e-04
 Identities = 13/35 (37%), Positives = 21/35 (60%), Gaps = 4/35 (11%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAP 35
           ML++DP +RI+V +AL HP    W  + + +A   
Sbjct: 270 MLMLDPAERITVYEALNHP----WLKERDRYAYKI 300

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  135 bits (342), Expect = 9e-37
 Identities = 68/218 (31%), Positives = 105/218 (48%), Gaps = 30/218 (13%)

Query: 76  LGAGA------AYDTATQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LG G+        D  T Q  A+K +S R  +  T  +   RE +L+K ++H NI+ L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQ-------VIQMDLDHERM-SYLLYQMLCGIKHL 180
            F      E+    YLV E+              +I      E   + ++ Q+L GI ++
Sbjct: 94  FF------EDKGYFYLVGEV-----YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 142

Query: 181 HSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG 237
           H   I+HRDLKP N++++S   D  ++I+DFGL+     +  M   + T YY APEV+ G
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG 202

Query: 238 MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
             Y E  D+WS G I+  ++ G   F G +  D   K+
Sbjct: 203 -TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  132 bits (333), Expect = 1e-36
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 35/197 (17%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLN 128
           LG G+           + Q  A+K +S+            +E   +KL   H NI+ L  
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHE 73

Query: 129 AFTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDHERM-SYLLYQMLCGIKHLH 181
            F       +    +LVMEL+      +    ++ +     E   SY++ +++  + H+H
Sbjct: 74  VF------HDQLHTFLVMELLNGGELFE----RIKKKKHFSETEASYIMRKLVSAVSHMH 123

Query: 182 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVIL 236
             G++HRDLKP N++      +  +KI+DFG AR        + TP   T +Y APE++ 
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLN 182

Query: 237 GMGYKENVDIWSVGCIM 253
             GY E+ D+WS+G I+
Sbjct: 183 QNGYDESCDLWSLGVIL 199

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  134 bits (339), Expect = 3e-36
 Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 30/201 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR-----------PFQNVTHAKRAYREFKLMKLV 118
           LG+GA        +       AIK + +                   +  Y E  L+K +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHERM-SYLLYQMLC 175
           +H NII L + F      E+ +  YLV E  +      Q+I      E   + ++ Q+L 
Sbjct: 104 DHPNIIKLFDVF------EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS 157

Query: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP 232
           GI +LH   I+HRD+KP NI++++      +KI+DFGL+      + +   + T YY AP
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217

Query: 233 EVILGMGYKENVDIWSVGCIM 253
           EV+    Y E  D+WS G IM
Sbjct: 218 EVLKK-KYNEKCDVWSCGVIM 237

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  130 bits (328), Expect = 3e-36
 Identities = 54/205 (26%), Positives = 83/205 (40%), Gaps = 37/205 (18%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRA-------YREFKLMKLVN-HK 121
           LG G            T +  A+K +         A+          +E  +++ V+ H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDHERM-SYLLYQML 174
           NII L + +      E     +LV +LM      D     + +     E+    ++  +L
Sbjct: 85  NIIQLKDTY------ETNTFFFLVFDLMKKGELFDY----LTEKVTLSEKETRKIMRALL 134

Query: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEV 234
             I  LH   I+HRDLKP NI++  D  +K+ DFG +        +     T  Y APE+
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194

Query: 235 ILGM------GYKENVDIWSVGCIM 253
           I         GY + VD+WS G IM
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIM 219

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 39.2 bits (92), Expect = 9e-04
 Identities = 10/31 (32%), Positives = 18/31 (58%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVH 31
            LV+ P+KR + ++AL HP+   +  +   H
Sbjct: 267 FLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  131 bits (331), Expect = 5e-36
 Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 36/204 (17%)

Query: 76  LGAGA------AYDTATQQNVAIK-----KLSRPFQNVTHAKRA-YREFKLMK-LVNHKN 122
           +G G           AT    A+K           + +   + A  RE  +++ +  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 123 IIGLLNAFTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDHERM-SYLLYQMLC 175
           II L++++      E    ++LV +LM      D     + +     E+    ++  +L 
Sbjct: 162 IITLIDSY------ESSSFMFLVFDLMRKGELFDY----LTEKVALSEKETRSIMRSLLE 211

Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI 235
            +  LH+  I+HRDLKP NI++  +  +++ DFG +        +     T  Y APE++
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271

Query: 236 LGM------GYKENVDIWSVGCIM 253
                    GY + VD+W+ G I+
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVIL 295

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  130 bits (328), Expect = 5e-36
 Identities = 58/276 (21%), Positives = 95/276 (34%), Gaps = 79/276 (28%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G       A +     N AIK++  P + +   ++  RE K +  + H  I+   NA
Sbjct: 14  MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKLEHPGIVRYFNA 72

Query: 130 FTP---------------------------------------------------QKSLEE 138
           +                                                      +    
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 139 FQDVYLVMELMDA-NLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
              +Y+ M+L    NL   +       D +H    ++  Q+   ++ LHS G++HRDLKP
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192

Query: 193 SNIVVKSDCTLKILDFGLART-------------AGTTFMMTPYVVTRYYRAPEVILGMG 239
           SNI    D  +K+ DFGL                       T  V T+ Y +PE I G  
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252

Query: 240 YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           Y   VDI+S+G I+ E++         + +     +
Sbjct: 253 YSHKVDIFSLGLILFELLYS--FSTQMERVRIITDV 286

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  128 bits (324), Expect = 1e-35
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 21/213 (9%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAK---RAYREFKLMKLVNHKNIIGL 126
           LG G       A +  ++  +A+K L +    +  A    +  RE ++   + H NI+ L
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFK--AQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 127 LNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA 183
              F       +   VYL++E      + + +Q     D +R +  + ++   + + HS 
Sbjct: 75  YGYF------HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKEN 243
            +IHRD+KP N+++ S   LKI DFG +  A ++        T  Y  PE+I G  + E 
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGRMHDEK 187

Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           VD+WS+G +  E + G   F    + + + +I 
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  127 bits (322), Expect = 2e-35
 Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 31/199 (15%)

Query: 76  LGAGA------AYDTATQQNVAIK----KLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           LG+G            T +  A K    +     +     +   RE  +++ + H NII 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 126 LLNAFTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDHERM-SYLLYQMLCGIK 178
           L + F      E   DV L++EL+      D     + + +   E   +  L Q+L G+ 
Sbjct: 73  LHDIF------ENKTDVVLILELVSGGELFD----FLAEKESLTEDEATQFLKQILDGVH 122

Query: 179 HLHSAGIIHRDLKPSNIVVKS----DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEV 234
           +LHS  I H DLKP NI++      +  +K++DFG+A              T  + APE+
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182

Query: 235 ILGMGYKENVDIWSVGCIM 253
           +         D+WS+G I 
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  126 bits (319), Expect = 7e-35
 Identities = 43/236 (18%), Positives = 81/236 (34%), Gaps = 50/236 (21%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYRE-FKLMKLVNHKNIIGLLN 128
           +G+G                 AIK+  +P       + A RE +    L  H +++   +
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78

Query: 129 AFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD------LDHERMSYLLYQMLCGIKHLH 181
           A+       E   + +  E  +  +L   I  +           +  LL Q+  G++++H
Sbjct: 79  AW------AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 182 SAGIIHRDLKPSNI-------------------VVKSDCTLKILDFGLARTAGTTFMM-- 220
           S  ++H D+KPSNI                      +    KI D G      +  +   
Sbjct: 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEG 192

Query: 221 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
                   + A EV+     +    DI+++   +        L     + DQW++I
Sbjct: 193 DS-----RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHEI 240

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  127 bits (321), Expect = 7e-35
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 31/199 (15%)

Query: 76  LGAGA------AYDTATQQNVAIK----KLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           LG+G         + +T    A K    + ++  +     +   RE  ++K + H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 126 LLNAFTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDHERM-SYLLYQMLCGIK 178
           L   +      E   DV L++EL+      D     + + +   E   +  L Q+L G+ 
Sbjct: 79  LHEVY------ENKTDVILILELVAGGELFD----FLAEKESLTEEEATEFLKQILNGVY 128

Query: 179 HLHSAGIIHRDLKPSNIVVKS----DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEV 234
           +LHS  I H DLKP NI++         +KI+DFGLA              T  + APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188

Query: 235 ILGMGYKENVDIWSVGCIM 253
           +         D+WS+G I 
Sbjct: 189 VNYEPLGLEADMWSIGVIT 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  126 bits (319), Expect = 1e-34
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 31/199 (15%)

Query: 76  LGAGA------AYDTATQQNVAIK----KLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           LG+G         + +T    A K    + SR  +     +   RE  +++ V H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 126 LLNAFTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDHERM-SYLLYQMLCGIK 178
           L + +      E   DV L++EL+      D     + Q +   E   +  + Q+L G+ 
Sbjct: 80  LHDVY------ENRTDVVLILELVSGGELFD----FLAQKESLSEEEATSFIKQILDGVN 129

Query: 179 HLHSAGIIHRDLKPSNIVVKS----DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEV 234
           +LH+  I H DLKP NI++         +K++DFGLA              T  + APE+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189

Query: 235 ILGMGYKENVDIWSVGCIM 253
           +         D+WS+G I 
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  127 bits (321), Expect = 1e-34
 Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 31/199 (15%)

Query: 76  LGAGA------AYDTATQQNVAIK----KLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
           LG+G         + +T    A K    + SR  +     +   RE  +++ V H NII 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 126 LLNAFTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDHERM-SYLLYQMLCGIK 178
           L + +      E   DV L++EL+      D     + Q +   E   +  + Q+L G+ 
Sbjct: 80  LHDVY------ENRTDVVLILELVSGGELFD----FLAQKESLSEEEATSFIKQILDGVN 129

Query: 179 HLHSAGIIHRDLKPSNIVVKS----DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEV 234
           +LH+  I H DLKP NI++         +K++DFGLA              T  + APE+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189

Query: 235 ILGMGYKENVDIWSVGCIM 253
           +         D+WS+G I 
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  129 bits (327), Expect = 2e-34
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 21/241 (8%)

Query: 26  DDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSH-LGAGA---- 80
           D  E      G    S +   +  D WK+   Q + I H      ++    LG GA    
Sbjct: 114 DVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVV 173

Query: 81  --AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE 138
               + AT  N A K +     + +  +   +E + M ++ H  ++ L +AF      E+
Sbjct: 174 HRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAF------ED 225

Query: 139 FQDVYLVMELMD-ANLCQVIQMDLDH--ERM-SYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
             ++ ++ E M    L + +  + +   E      + Q+  G+ H+H    +H DLKP N
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285

Query: 195 I--VVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
           I    K    LK++DFGL         +     T  + APEV  G       D+WSVG +
Sbjct: 286 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

Query: 253 M 253
            
Sbjct: 346 S 346

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  125 bits (317), Expect = 3e-34
 Identities = 42/194 (21%), Positives = 82/194 (42%), Gaps = 29/194 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G         +T++++    K +     +    K+   E  ++ +  H+NI+ L  +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHLHES 69

Query: 130 FTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDH-ERM-SYLLYQMLCGIKHLH 181
           F      E  +++ ++ E +      +    ++     +  ER     ++Q+   ++ LH
Sbjct: 70  F------ESMEELVMIFEFISGLDIFE----RINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 182 SAGIIHRDLKPSNIVV--KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           S  I H D++P NI+   +   T+KI++FG AR                Y APEV     
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179

Query: 240 YKENVDIWSVGCIM 253
                D+WS+G ++
Sbjct: 180 VSTATDMWSLGTLV 193

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  124 bits (313), Expect = 4e-34
 Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 81  AYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           A +   +  +A+K L +   +      +  RE ++   + H NI+ + N F  +K     
Sbjct: 33  AREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK----- 87

Query: 140 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
             +YL++E      L + +Q     D +R +  + ++   + + H   +IHRD+KP N++
Sbjct: 88  -RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL 146

Query: 197 VKSDCTLKILDFGLARTAGTTFMMT-----PYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
           +     LKI DFG +  A +    T      Y+       PE+I G  + E VD+W  G 
Sbjct: 147 MGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPEMIEGKTHDEKVDLWCAGV 200

Query: 252 IMGEMIRGGVLFPGTDHIDQWNKII 276
           +  E + G   F    H +   +I+
Sbjct: 201 LCYEFLVGMPPFDSPSHTETHRRIV 225

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  125 bits (315), Expect = 4e-34
 Identities = 58/212 (27%), Positives = 87/212 (41%), Gaps = 50/212 (23%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMK-LVNHKNIIGLLN 128
           LG GA        +  T Q  A+K + +  Q      R +RE +++     H+N++ L+ 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 129 AFTPQKSLEEFQDVYLVMELMDAN-LCQVIQMDLDH--------ERM-SYLLYQMLCGIK 178
            F      EE    YLV E M    +       L H        E   S ++  +   + 
Sbjct: 79  FF------EEEDRFYLVFEKMRGGSI-------LSHIHKRRHFNELEASVVVQDVASALD 125

Query: 179 HLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLAR---------TAGTTFMMTPYVVT 226
            LH+ GI HRDLKP NI+ +       +KI DF L              T  ++TP   +
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP-CGS 184

Query: 227 RYYRAPEVILGM-----GYKENVDIWSVGCIM 253
             Y APEV+         Y +  D+WS+G I+
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  125 bits (317), Expect = 7e-34
 Identities = 47/194 (24%), Positives = 83/194 (42%), Gaps = 28/194 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG+GA        + AT +    K ++              E  +M  ++H  +I L +A
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPKLINLHDA 116

Query: 130 FTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDH-ERM-SYLLYQMLCGIKHLH 181
           F      E+  ++ L++E +      D    ++   D    E      + Q   G+KH+H
Sbjct: 117 F------EDKYEMVLILEFLSGGELFD----RIAAEDYKMSEAEVINYMRQACEGLKHMH 166

Query: 182 SAGIIHRDLKPSNIVV--KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG 239
              I+H D+KP NI+   K   ++KI+DFGLA       ++     T  + APE++    
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 226

Query: 240 YKENVDIWSVGCIM 253
                D+W++G + 
Sbjct: 227 VGFYTDMWAIGVLG 240

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 14/64 (21%), Positives = 26/64 (40%), Gaps = 4/64 (6%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL 60
           +L  +P KR++V DAL HP    W      +  +  P       R+   +++ +    + 
Sbjct: 288 LLQKEPRKRLTVHDALEHP----WLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQP 343

Query: 61  PISH 64
            I  
Sbjct: 344 AIGR 347

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  124 bits (314), Expect = 7e-34
 Identities = 47/197 (23%), Positives = 79/197 (40%), Gaps = 29/197 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH-KNIIGLLN 128
           LG G           +T Q  A K L +  +          E  +++L      +I L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 129 AFTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDH--ERM-SYLLYQMLCGIKH 179
            +      E   ++ L++E               +    +   E     L+ Q+L G+ +
Sbjct: 97  VY------ENTSEIILILEYAAGGEIFS----LCLPELAEMVSENDVIRLIKQILEGVYY 146

Query: 180 LHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL 236
           LH   I+H DLKP NI++ S      +KI+DFG++R  G    +   + T  Y APE++ 
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206

Query: 237 GMGYKENVDIWSVGCIM 253
                   D+W++G I 
Sbjct: 207 YDPITTATDMWNIGIIA 223

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 39.9 bits (94), Expect = 5e-04
 Identities = 12/45 (26%), Positives = 21/45 (46%), Gaps = 5/45 (11%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDER 45
           +LV +PEKR + +  L H ++  W  +   H     P + S   +
Sbjct: 271 LLVKNPEKRPTAEICLSHSWLQQWDFENLFH-----PEETSSSSQ 310

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  124 bits (312), Expect = 1e-33
 Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 29/200 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G+        D  T    A+KK       V        E      ++   I+ L  A
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKK-------VRLEVFRVEELVACAGLSSPRIVPLYGA 118

Query: 130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGII 186
                 +       + MEL++  +L Q+I+    L  +R  Y L Q L G+++LH+  I+
Sbjct: 119 VREGPWV------NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172

Query: 187 HRDLKPSNIVVKSD-CTLKILDFGLAR-----TAGTTFMMTPYVV-TRYYRAPEVILGMG 239
           H D+K  N+++ SD     + DFG A        G + +   Y+  T  + APEV++G  
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232

Query: 240 YKENVDIWSVGCIMGEMIRG 259
               VDIWS  C+M  M+ G
Sbjct: 233 CDAKVDIWSSCCMMLHMLNG 252

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  122 bits (309), Expect = 2e-33
 Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 16/196 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G+        DT T   VA  +L       +  +R   E +++K + H NI+   ++
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAG-- 184
           +    +++  + + LV ELM +  L   ++    +  + +     Q+L G++ LH+    
Sbjct: 94  WE--STVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151

Query: 185 IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKEN 243
           IIHRDLK  NI +     ++KI D GLA     +F     + T  + APE+     Y E+
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMYEE-KYDES 209

Query: 244 VDIWSVGCIMGEMIRG 259
           VD+++ G  M EM   
Sbjct: 210 VDVYAFGMCMLEMATS 225

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  125 bits (315), Expect = 2e-33
 Identities = 29/244 (11%), Positives = 67/244 (27%), Gaps = 44/244 (18%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRP--------------------FQNVTHAKRAY 109
           LG         A D  T ++  +                           + + + K+A 
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEF--QDVYLVMELMDANLCQVIQM-------- 159
              + +   +             +    +      + +   M +NL    ++        
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 160 -DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF 218
             L H     L  Q++  +  LH  G++H  L+P +IV+     + +  F      G + 
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA 265

Query: 219 MM--TPYVVTRYYRAPEVILGMGYKEN-----VDIWSVGCIMGEMIRGGVLFPGTDHIDQ 271
           +             A  ++    +         D W++G  +  +    +       +  
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325

Query: 272 WNKI 275
              I
Sbjct: 326 SEWI 329

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  123 bits (311), Expect = 3e-33
 Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 67/262 (25%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRP---FQNVTHAKRAYREFKLMKLVNHKNIIGL 126
           +G G+      A +  T+   AIK +++      N    +R   E +LMK ++H NI  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 127 LNAFTPQKSLEEFQDVYLVMELM------------------------------------D 150
              +      E+ Q + LVMEL                                     +
Sbjct: 94  YEVY------EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147

Query: 151 ANLCQVIQMDLDHERMSY-------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--C 201
             +   I    +             ++ Q+   + +LH+ GI HRD+KP N +  ++   
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207

Query: 202 TLKILDFGLAR-----TAGTTFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMG 254
            +K++DFGL++       G  + MT    T Y+ APEV+      Y    D WS G ++ 
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267

Query: 255 EMIRGGVLFPGTDHIDQWNKII 276
            ++ G V FPG +  D  ++++
Sbjct: 268 LLLMGAVPFPGVNDADTISQVL 289

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  124 bits (312), Expect = 3e-33
 Identities = 58/199 (29%), Positives = 87/199 (43%), Gaps = 28/199 (14%)

Query: 71  HNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNII 124
             T  LG G         +TAT   +A K +    + +   +    E  +M  ++H N+I
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLDHANLI 149

Query: 125 GLLNAFTPQKSLEEFQDVYLVMELM------DANLCQVIQMDLDH-ERM-SYLLYQMLCG 176
            L +AF      E   D+ LVME +      D    ++I    +  E      + Q+  G
Sbjct: 150 QLYDAF------ESKNDIVLVMEYVDGGELFD----RIIDESYNLTELDTILFMKQICEG 199

Query: 177 IKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEV 234
           I+H+H   I+H DLKP NI+   +    +KI+DFGLAR       +     T  + APEV
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259

Query: 235 ILGMGYKENVDIWSVGCIM 253
           +         D+WSVG I 
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  123 bits (311), Expect = 3e-33
 Identities = 41/234 (17%), Positives = 76/234 (32%), Gaps = 46/234 (19%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD- 141
           D   +Q   +K          +     +  + +K       +   +A         FQ+ 
Sbjct: 91  DAKNKQKFVLKVQKPANPWEFYIGT--QLMERLKPSMQHMFMKFYSAH-------LFQNG 141

Query: 142 VYLVMELMDA-NLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
             LV EL     L   I +        +    +     +ML  I+ +H   IIH D+KP 
Sbjct: 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD 201

Query: 194 NIVVKSDCT-----------LKILDFGLA---RTAGTTFMMTPYVVTRYYRAPEVILGMG 239
           N ++ +              L ++D G +   +      + T    T  ++  E++    
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261

Query: 240 YKENVDIWSVGCIMGEMIRGG--------------VLFPGTDHIDQWNKIIGKM 279
           +   +D + V   +  M+ G                LF    H+D WN+    M
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVM 315

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  123 bits (310), Expect = 3e-33
 Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 28/202 (13%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMK-LVNHKNIIGLLNAFT--PQKSLE 137
           A D  + +  A+K+L          +   +E   MK L  H NI+   +A +   ++S  
Sbjct: 47  AQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104

Query: 138 EFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAG--IIHRDL 190
              +  L+ EL    L + ++       +S      + YQ    ++H+H     IIHRDL
Sbjct: 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDL 164

Query: 191 KPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTR-------------YYRAPEVILG 237
           K  N+++ +  T+K+ DFG A T       +     R              YR PE+I  
Sbjct: 165 KVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL 224

Query: 238 MGYK---ENVDIWSVGCIMGEM 256
                  E  DIW++GCI+  +
Sbjct: 225 YSNFPIGEKQDIWALGCILYLL 246

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  121 bits (306), Expect = 7e-33
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 15/187 (8%)

Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
            +VA+K L     +        RE  +MK + H NI+  + A T   +L       +V E
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL------SIVTE 114

Query: 148 LMDA-NLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKS 199
            +   +L +++        LD  R   + Y +  G+ +LH+    I+HR+LK  N++V  
Sbjct: 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK 174

Query: 200 DCTLKILDFGLART-AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
             T+K+ DFGL+R  A T         T  + APEV+      E  D++S G I+ E+  
Sbjct: 175 KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

Query: 259 GGVLFPG 265
               +  
Sbjct: 235 LQQPWGN 241

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  120 bits (304), Expect = 1e-32
 Identities = 58/194 (29%), Positives = 80/194 (41%), Gaps = 24/194 (12%)

Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
           ++VAIK++    +     K    E + +  VNH NI+ L  A            V LVME
Sbjct: 32  KDVAIKQIESESER----KAFIVELRQLSRVNHPNIVKLYGACL--------NPVCLVME 79

Query: 148 LMDA-NLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI-VV 197
             +  +L  V+                   Q   G+ +LHS     +IHRDLKP N+ +V
Sbjct: 80  YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV 139

Query: 198 KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 257
                LKI DFG A    T   MT    +  + APEV  G  Y E  D++S G I+ E+I
Sbjct: 140 AGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI 197

Query: 258 RGGVLFPGTDHIDQ 271
                F        
Sbjct: 198 TRRKPFDEIGGPAF 211

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  122 bits (307), Expect = 1e-32
 Identities = 38/249 (15%), Positives = 75/249 (30%), Gaps = 53/249 (21%)

Query: 76  LGAGA------AYDTATQQNVAIK-----------------------KLSRPFQNVTHAK 106
           LG         A D  T ++  +                        +L R  +N   AK
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 107 RAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERM 166
              R      LV       ++     ++ +      + +   M +NL    ++ L H   
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS-RFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 167 S---------YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT 217
                      L  Q++  +  LH  G++H  L+P +IV+     + +  F      G  
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR 259

Query: 218 FMMTPYVVTRYYRAPEVILGMG-----------YKENVDIWSVGCIMGEMIRGGVLFPGT 266
            +     V+R +  PE+                   + D W++G ++  +    +     
Sbjct: 260 VVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD 316

Query: 267 DHIDQWNKI 275
             +     I
Sbjct: 317 AALGGSEWI 325

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  119 bits (300), Expect = 4e-32
 Identities = 51/234 (21%), Positives = 98/234 (41%), Gaps = 25/234 (10%)

Query: 48  TVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKR 107
             D W E+   ++ +  ++G     T + G           +VA+K L+         + 
Sbjct: 15  AADDW-EIPDGQITVGQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPTPQQLQA 66

Query: 108 AYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD---LDH 163
              E  +++   H NI+  +   T  +       + +V +  +  +L   +       + 
Sbjct: 67  FKNEVGVLRKTRHVNILLFMGYSTAPQ-------LAIVTQWCEGSSLYHHLHASETKFEM 119

Query: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF---MM 220
           +++  +  Q   G+ +LH+  IIHRDLK +NI +  D T+KI DFGLA            
Sbjct: 120 KKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179

Query: 221 TPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ 271
                +  + APEVI       Y    D+++ G ++ E++ G + +   ++ DQ
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  120 bits (302), Expect = 4e-32
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 35/217 (16%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR------PFQNVTHAKRAYREFKLMKLVNHKNI 123
           LG+GA      A D    + V +K + +       +       +   E  ++  V H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 124 IGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDL-----DHERMS-----YLLYQM 173
           I +L+ F      E      LVME           +DL      H R+      Y+  Q+
Sbjct: 92  IKVLDIF------ENQGFFQLVMEKH------GSGLDLFAFIDRHPRLDEPLASYIFRQL 139

Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPE 233
           +  + +L    IIHRD+K  NIV+  D T+K++DFG A       +   +  T  Y APE
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE 199

Query: 234 VILGMGYK-ENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
           V++G  Y+   +++WS+G  +  ++     F   +  
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET 236

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  120 bits (302), Expect = 4e-32
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 22/214 (10%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G       A    T + VAIK + +   N T  ++ +RE ++MK++NH NI+ L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSA 183
                 +E  + +YL+ME      +   +     H RM          Q++  +++ H  
Sbjct: 83  ------IETEKTLYLIMEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQK 133

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-E 242
            I+HRDLK  N+++ +D  +KI DFG +        +  +     Y APE+  G  Y   
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193

Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            VD+WS+G I+  ++ G + F G +  +   +++
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 227

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  119 bits (301), Expect = 5e-32
 Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 39/219 (17%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR----PFQNVTHAKRAYREFKLMKLVNHK--NI 123
           LG+G           +    VAIK + +     +  + +  R   E  L+K V+     +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 124 IGLLNAF-TPQKSLEEFQDVYLVMELMDANLCQVIQMDL-----DHERMS-----YLLYQ 172
           I LL+ F  P           L++E  +         DL     +   +         +Q
Sbjct: 111 IRLLDWFERPDS-------FVLILERPEPV------QDLFDFITERGALQEELARSFFWQ 157

Query: 173 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRA 231
           +L  ++H H+ G++HRD+K  NI++  +   LK++DFG       T     +  TR Y  
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSP 216

Query: 232 PEVILGMGYK-ENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
           PE I    Y   +  +WS+G ++ +M+ G + F   + I
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 255

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  119 bits (301), Expect = 5e-32
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 35/202 (17%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKR---AYREFKLMKLVNHKNIIGL 126
           +G G+      A +  + + VA+K +     ++   +R    + E  +M+   H N++ +
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM-----DLRKQQRRELLFNEVVIMRDYQHFNVVEM 107

Query: 127 LNAFTPQKSLEEFQDVYLVMELMDANLCQ--VIQMDLDHERMSYLLYQMLCGIKHLHSAG 184
             ++   + L      +++ME +        V Q+ L+ E+++ +   +L  + +LH+ G
Sbjct: 108 YKSYLVGEEL------WVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 185 IIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TTFMMTPYVVTRYYRAPEVILGM 238
           +IHRD+K  +I++  D  +K+ DFG    +++      + + TP     Y+ APEVI   
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP-----YWMAPEVISRS 216

Query: 239 GYKENVDIWSVGCIMG-EMIRG 259
            Y   VDIWS+G IM  EM+ G
Sbjct: 217 LYATEVDIWSLG-IMVIEMVDG 237

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (299), Expect = 6e-32
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 35/202 (17%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKR---AYREFKLMKLVNHKNIIGL 126
           +G GA      A D AT Q VAI+++     N+    +      E  +M+   + NI+  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM-----NLQQQPKKELIINEILVMRENKNPNIVNY 82

Query: 127 LNAFTPQKSLEEFQDVYLVMELMDANLCQ--VIQMDLDHERMSYLLYQMLCGIKHLHSAG 184
           L+++     L      ++VME +        V +  +D  +++ +  + L  ++ LHS  
Sbjct: 83  LDSYLVGDEL------WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 185 IIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTTFMMTPYVVTRYYRAPEVILGM 238
           +IHRD+K  NI++  D ++K+ DFG        ++  +T + TP     Y+ APEV+   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP-----YWMAPEVVTRK 191

Query: 239 GYKENVDIWSVGCIMG-EMIRG 259
            Y   VDIWS+G IM  EMI G
Sbjct: 192 AYGPKVDIWSLG-IMAIEMIEG 212

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  117 bits (294), Expect = 2e-31
 Identities = 52/248 (20%), Positives = 94/248 (37%), Gaps = 32/248 (12%)

Query: 41  SVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKL-SRPF 99
           ++   E    +   L   E+    Q+GK      H G         +  VAIK L     
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKG----RLVKDKSVVAIKSLILGDS 57

Query: 100 QNVTHAKRAYREFK----LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLC 154
           +  T     ++EF+    +M  +NH NI+ L                 +VME +   +L 
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--------NPPRMVMEFVPCGDLY 109

Query: 155 QVIQ---MDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV-----KSDCTLK 204
             +      +       L+  +  GI+++ +    I+HRDL+  NI +      +    K
Sbjct: 110 HRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169

Query: 205 ILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIRGGVL 262
           + DFGL++ +  +  ++  +    + APE I      Y E  D +S   I+  ++ G   
Sbjct: 170 VADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

Query: 263 FPGTDHID 270
           F    +  
Sbjct: 228 FDEYSYGK 235

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  117 bits (295), Expect = 3e-31
 Identities = 49/200 (24%), Positives = 83/200 (41%), Gaps = 29/200 (14%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           T + + +K+L R  +     +R + +E K+M+ + H N++  +      K L        
Sbjct: 34  TGEVMVMKELIRFDEE---TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL------NF 84

Query: 145 VMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
           + E +    L  +I+         +       +  G+ +LHS  IIHRDL   N +V+ +
Sbjct: 85  ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN 144

Query: 201 CTLKILDFGLAR---------------TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
             + + DFGLAR                          V   Y+ APE+I G  Y E VD
Sbjct: 145 KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVD 204

Query: 246 IWSVGCIMGEMIRGGVLFPG 265
           ++S G ++ E+I      P 
Sbjct: 205 VFSFGIVLCEIIGRVNADPD 224

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  116 bits (292), Expect = 4e-31
 Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 22/193 (11%)

Query: 88  QNVAIKKL-SRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
             VA+K     P ++++       +E KL  ++ H NII L      + +L       LV
Sbjct: 31  DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL------CLV 84

Query: 146 MELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV--- 197
           ME      L +V+    +  + +     Q+  G+ +LH      IIHRDLK SNI++   
Sbjct: 85  MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144

Query: 198 -----KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
                 S+  LKI DFGLAR    T  M+       + APEVI    + +  D+WS G +
Sbjct: 145 VENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWMAPEVIRASMFSKGSDVWSYGVL 203

Query: 253 MGEMIRGGVLFPG 265
           + E++ G V F G
Sbjct: 204 LWELLTGEVPFRG 216

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  116 bits (292), Expect = 6e-31
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 24/200 (12%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G         D + Q  +AIK++  P ++  +++  + E  L K + HKNI+  L +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 130 FTPQKSLEEFQDVYLVMELMD----ANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSA 183
           F+    +       + ME +     + L +     +  + + + +   Q+L G+K+LH  
Sbjct: 88  FSENGFI------KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141

Query: 184 GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTTFMMTPYVV-TRYYRAPEVILGM--G 239
            I+HRD+K  N+++ +    LKI DFG ++        T     T  Y APE+I     G
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201

Query: 240 YKENVDIWSVGCIMGEMIRG 259
           Y +  DIWS+GC + EM  G
Sbjct: 202 YGKAADIWSLGCTIIEMATG 221

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  116 bits (293), Expect = 9e-31
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 38/231 (16%)

Query: 53  KELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAY--- 109
           +  I +++ +  Q+GK R+    +G    +     + VA+K         T  + ++   
Sbjct: 32  QRTIAKQIQMVKQIGKGRYGEVWMGK---WR---GEKVAVKVFF------TTEEASWFRE 79

Query: 110 REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ-MDLDHERMS 167
            E     L+ H+NI+G + A    K    +  +YL+ +  +  +L   ++   LD + M 
Sbjct: 80  TEIYQTVLMRHENILGFIAADI--KGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSML 137

Query: 168 YLLYQMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TA 214
            L Y  + G+ HLH+          I HRDLK  NI+VK + T  I D GLA      T 
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197

Query: 215 GTTFMMTPYVVTRYYRAPEVILGMGYKEN------VDIWSVGCIMGEMIRG 259
                    V T+ Y  PEV+     + +       D++S G I+ E+ R 
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  116 bits (293), Expect = 1e-30
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 28/200 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLN 128
           +G G+      A D    + VAIKK+S   +      +   +E + ++ + H N I    
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGI 185
            +  + +       +LVME    +   ++++    L    ++ + +  L G+ +LHS  +
Sbjct: 122 CYLREHTA------WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAG--TTFMMTPYVVTRYYRAPEVILGM---GY 240
           IHRD+K  NI++     +K+ DFG A       +F+ TP     Y+ APEVIL M    Y
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP-----YWMAPEVILAMDEGQY 230

Query: 241 KENVDIWSVGCIMG-EMIRG 259
              VD+WS+G I   E+   
Sbjct: 231 DGKVDVWSLG-ITCIELAER 249

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  115 bits (290), Expect = 1e-30
 Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 41/221 (18%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR----PFQNVTHAKRAYREFKLMKLVN----HK 121
           LG G        +    +  VAIK + R     +  ++ +     E  L+  V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 122 NIIGLLNAF-TPQKSLEEFQDVYLVMELMDANLCQVIQMDL-----DHERMS-----YLL 170
            +I LL+ F T +          LV+E            DL     +   +         
Sbjct: 99  GVIRLLDWFETQEG-------FMLVLERPLPA------QDLFDYITEKGPLGEGPSRCFF 145

Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTTFMMTPYVVTRYY 229
            Q++  I+H HS G++HRD+K  NI++       K++DFG             +  TR Y
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVY 204

Query: 230 RAPEVILGMGYK-ENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
             PE I    Y      +WS+G ++ +M+ G + F     I
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI 245

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 40.0 bits (94), Expect = 5e-04
 Identities = 10/45 (22%), Positives = 20/45 (44%), Gaps = 2/45 (4%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVH--APAPGPYDHSVD 43
            L   P  R S+++ L+ P++    +D  ++     P P   S+ 
Sbjct: 267 CLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSLL 311

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  115 bits (290), Expect = 2e-30
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 37/225 (16%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRP--FQNVTHAKRAYREFKLMKLVNHKNIIGLL 127
           LG G+        D+ T    A+K L +    +         +E +L++ + HKN+I L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHS 182
           +        EE Q +Y+VME     + +++   +  +R           Q++ G+++LHS
Sbjct: 73  DVLYN----EEKQKMYMVMEYCVCGMQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHS 127

Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--------TTFMMTPYVVTRYYRAPEV 234
            GI+H+D+KP N+++ +  TLKI   G+A             T   +P      ++ PE+
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP-----AFQPPEI 182

Query: 235 ILGM----GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
             G+    G+K  VDIWS G  +  +  G   F G +    +  I
Sbjct: 183 ANGLDTFSGFK--VDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 16/57 (28%), Positives = 22/57 (38%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIY 57
           ML  +P KR S+     H +       AE   P P   D     R  TV  + E ++
Sbjct: 247 MLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDLH 303

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  116 bits (292), Expect = 2e-30
 Identities = 32/207 (15%), Positives = 68/207 (32%), Gaps = 44/207 (21%)

Query: 86  TQQNVAIKKLSR---------------PFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAF 130
             +  A+KK  +                    +       E +++  + ++  +      
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112

Query: 131 TPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKH 179
                   + +VY++ E      ++  +    +        +       ++  +L    +
Sbjct: 113 ------TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166

Query: 180 LHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TTFMMTPYVVTRYYRAPEV 234
           +H+   I HRD+KPSNI++  +  +K+ DFG +             T       +  PE 
Sbjct: 167 IHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTY-----EFMPPEF 221

Query: 235 ILGMG--YKENVDIWSVGCIMGEMIRG 259
                      VDIWS+G  +  M   
Sbjct: 222 FSNESSYNGAKVDIWSLGICLYVMFYN 248

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  114 bits (288), Expect = 2e-30
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 38/206 (18%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVVKFY-- 71

Query: 130 FTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA 183
                   E    YL +E      L D  +   I M     +     +Q++ G+ +LH  
Sbjct: 72  ----GHRREGNIQYLFLEYCSGGELFD-RIEPDIGMPEPDAQ--RFFHQLMAGVVYLHGI 124

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTTFMMT-----PYVVTRYYRAPEV 234
           GI HRD+KP N+++     LKI DFGLA           +       PYV      APE+
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV------APEL 178

Query: 235 ILGMGYK-ENVDIWSVGCIMGEMIRG 259
           +    +  E VD+WS G ++  M+ G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAG 204

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  115 bits (289), Expect = 2e-30
 Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 29/191 (15%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           A    T Q VAIK++      V    +   +E  +M+  +  +++    ++     L   
Sbjct: 48  AIHKETGQIVAIKQV-----PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL--- 99

Query: 140 QDVYLVMELMDA----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
              ++VME   A    ++ ++    L  + ++ +L   L G+++LH    IHRD+K  NI
Sbjct: 100 ---WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNI 156

Query: 196 VVKSDCTLKILDFG----LARTAG--TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
           ++ ++   K+ DFG    L  T     T + TP     ++ APEVI  +GY    DIWS+
Sbjct: 157 LLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTP-----FWMAPEVIQEIGYNCVADIWSL 211

Query: 250 GCIMG-EMIRG 259
           G I   EM  G
Sbjct: 212 G-ITAIEMAEG 221

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  114 bits (288), Expect = 2e-30
 Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 36/227 (15%)

Query: 56  IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM 115
           + +++ +   +GK R+     G      +   +NVA+K  S         K  +RE +L 
Sbjct: 6   VARDITLLECVGKGRYGEVWRG------SWQGENVAVKIFSSR-----DEKSWFRETELY 54

Query: 116 KLV--NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM-DLDHERMSYLLY 171
             V   H+NI+G + +     S      ++L+    +  +L   +Q+  LD      ++ 
Sbjct: 55  NTVMLRHENILGFIASDM--TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVL 112

Query: 172 QMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMM--- 220
            +  G+ HLH           I HRDLK  NI+VK +    I D GLA     +      
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172

Query: 221 --TPYVVTRYYRAPEVILG------MGYKENVDIWSVGCIMGEMIRG 259
              P V T+ Y APEV+            + VDIW+ G ++ E+ R 
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  118 bits (297), Expect = 4e-30
 Identities = 44/188 (23%), Positives = 78/188 (41%), Gaps = 9/188 (4%)

Query: 81  AYDTA-TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF 139
           A D     + V +K L     +      A  E + +  V H +I+ + N F         
Sbjct: 99  ALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN-FVEHTDRHGD 156

Query: 140 QDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
              Y+VME +   +L +     L        L ++L  + +LHS G+++ DLKP NI++ 
Sbjct: 157 PVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT 216

Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
            +  LK++D G      +   +     T  ++APE++   G     DI++VG  +  +  
Sbjct: 217 EE-QLKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTL 271

Query: 259 GGVLFPGT 266
                 G 
Sbjct: 272 DLPTRNGR 279

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  113 bits (285), Expect = 9e-30
 Identities = 44/245 (17%), Positives = 89/245 (36%), Gaps = 33/245 (13%)

Query: 36  GPYDHSVDE-REHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKK 94
           G + H      +   +         L +     + R                 + VA+K 
Sbjct: 2   GHHHHHHSSGVDLGTENL-YFQSMPLQLLEVKARGRFGCVWKA------QLLNEYVAVKI 54

Query: 95  LSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NL 153
                     + +   E   +  + H+NI+  + A    +      D++L+    +  +L
Sbjct: 55  FPI---QDKQSWQNEYEVYSLPGMKHENILQFIGAEK--RGTSVDVDLWLITAFHEKGSL 109

Query: 154 CQVIQMD-LDHERMSYLLYQMLCGIKHLHSA----------GIIHRDLKPSNIVVKSDCT 202
              ++ + +    + ++   M  G+ +LH             I HRD+K  N+++K++ T
Sbjct: 110 SDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169

Query: 203 LKILDFGLART---AGTTFMMTPYVVTRYYRAPEVI-----LGMGYKENVDIWSVGCIMG 254
             I DFGLA       +       V TR Y APEV+             +D++++G ++ 
Sbjct: 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229

Query: 255 EMIRG 259
           E+   
Sbjct: 230 ELASR 234

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  113 bits (285), Expect = 1e-29
 Identities = 48/261 (18%), Positives = 101/261 (38%), Gaps = 34/261 (13%)

Query: 26  DDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTA 85
            +  +   +   +     +    + +W ++ +++L I   +GK R    + G    +   
Sbjct: 2   PEMNLSLLSARSFPRKASQTSIFLQEW-DIPFEQLEIGELIGKGRFGQVYHGR---WH-- 55

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
               VAI+ +     N    K   RE    +   H+N++  + A      L       ++
Sbjct: 56  --GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL------AII 107

Query: 146 MELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
             L     L  V++   + LD  +   +  +++ G+ +LH+ GI+H+DLK  N+    + 
Sbjct: 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNG 166

Query: 202 TLKILDFGLARTAGTTF------MMTPYVVTRYYRAPEVILGMG---------YKENVDI 246
            + I DFGL   +G          +        + APE+I  +          + ++ D+
Sbjct: 167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226

Query: 247 WSVGCIMGEMIRGGVLFPGTD 267
           +++G I  E+      F    
Sbjct: 227 FALGTIWYELHAREWPFKTQP 247

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  113 bits (284), Expect = 1e-29
 Identities = 54/242 (22%), Positives = 102/242 (42%), Gaps = 52/242 (21%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR------------------------PFQNVTHA 105
           +G G+      AY+       A+K LS+                          Q     
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 106 KRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDH 163
           ++ Y+E  ++K ++H N++ L+     P +       +Y+V EL++   + +V       
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNED-----HLYMVFELVNQGPVMEVPT----L 131

Query: 164 ERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGT 216
           + +S     +    ++ GI++LH   IIHRD+KPSN++V  D  +KI DFG++       
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 217 TFMMTPYVVTRYYRAPEVILGM--GYK-ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWN 273
             +    V T  + APE +      +  + +D+W++G  +   + G   F     +   +
Sbjct: 192 ALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250

Query: 274 KI 275
           KI
Sbjct: 251 KI 252

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  113 bits (284), Expect = 1e-29
 Identities = 51/193 (26%), Positives = 83/193 (43%), Gaps = 45/193 (23%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLN 128
           LG G        ++  TQ+  A+K L           +A RE +L  +     +I+ +++
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVD 78

Query: 129 AFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDH---ERM-SYLLYQMLCGIKHLHSA 183
            +  +      + + +VME +D   L   IQ   D    ER  S ++  +   I++LHS 
Sbjct: 79  VY--ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136

Query: 184 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
            I HRD+KP N++  S   +  LK+ DFG                     A E   G  Y
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKET-TGEKY 175

Query: 241 KENVDIWSVGCIM 253
            ++ D+WS+G IM
Sbjct: 176 DKSCDMWSLGVIM 188

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  113 bits (284), Expect = 1e-29
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 38/206 (18%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 130 FTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA 183
                   E    YL +E      L D  +   I M     +     +Q++ G+ +LH  
Sbjct: 74  ------RREGNIQYLFLEYCSGGELFD-RIEPDIGMPEPDAQ--RFFHQLMAGVVYLHGI 124

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTTFMMT-----PYVVTRYYRAPEV 234
           GI HRD+KP N+++     LKI DFGLA           +       PYV      APE+
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV------APEL 178

Query: 235 ILGMGYK-ENVDIWSVGCIMGEMIRG 259
           +    +  E VD+WS G ++  M+ G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAG 204

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  114 bits (287), Expect = 1e-29
 Identities = 42/194 (21%), Positives = 75/194 (38%), Gaps = 21/194 (10%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
           A    T + V +++++    +         E  + KL NH NI+     F     L    
Sbjct: 46  ARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL---- 101

Query: 141 DVYLVMELMDA----NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
             ++V   M      +L     MD ++   ++Y+L  +L  + ++H  G +HR +K S+I
Sbjct: 102 --WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 159

Query: 196 VVKSDCTLKILDFGLA--------RTAGTTFMMTPYVVTRYYRAPEVI--LGMGYKENVD 245
           ++  D  + +              R           V    + +PEV+     GY    D
Sbjct: 160 LISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 219

Query: 246 IWSVGCIMGEMIRG 259
           I+SVG    E+  G
Sbjct: 220 IYSVGITACELANG 233

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  113 bits (285), Expect = 1e-29
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 22/213 (10%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LG G+      A    TQQ VA+K +SR   +      R  RE   +KL+ H +II L +
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSA 183
                  +    D+ +V+E     L   I   ++ +RM+         Q++C I++ H  
Sbjct: 77  V------ITTPTDIVMVIEYAGGELFDYI---VEKKRMTEDEGRRFFQQIICAIEYCHRH 127

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-E 242
            I+HRDLKP N+++  +  +KI DFGL+        +     +  Y APEVI G  Y   
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187

Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            VD+WS G ++  M+ G + F      + + K+
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV 220

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  112 bits (282), Expect = 2e-29
 Identities = 69/205 (33%), Positives = 98/205 (47%), Gaps = 18/205 (8%)

Query: 73  TSHLGAG------AAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIG 125
              LG G       A DT     VAIK +  P  +     KR  RE      ++H+NI+ 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHS 182
           +++        EE    YLVME ++   L + I+    L  +       Q+L GIKH H 
Sbjct: 76  MID------VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129

Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV--TRYYRAPEVILGMGY 240
             I+HRD+KP NI++ S+ TLKI DFG+A+    T +     V  T  Y +PE   G   
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 241 KENVDIWSVGCIMGEMIRGGVLFPG 265
            E  DI+S+G ++ EM+ G   F G
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNG 214

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  112 bits (282), Expect = 2e-29
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 34/202 (16%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY----REFKLMKLVNHKNIIG 125
           +G G+        D  TQ+ VAIK +     ++  A+       +E  ++   +   +  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKII-----DLEEAEDEIEDIQQEITVLSQCDSPYVTK 84

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDANLCQ--VIQMDLDHERMSYLLYQMLCGIKHLHSA 183
              ++     L      +++ME +        +    LD  +++ +L ++L G+ +LHS 
Sbjct: 85  YYGSYLKDTKL------WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE 138

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TTFMMTPYVVTRYYRAPEVILG 237
             IHRD+K +N+++     +K+ DFG    L  T     TF+ TP     ++ APEVI  
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP-----FWMAPEVIKQ 193

Query: 238 MGYKENVDIWSVGCIMGEMIRG 259
             Y    DIWS+G    E+ RG
Sbjct: 194 SAYDSKADIWSLGITAIELARG 215

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  112 bits (283), Expect = 2e-29
 Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 31/207 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G            T Q  AIK +          K+      L K  +H+NI     A
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM--LKKYSHHRNIATYYGA 89

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERM-----SYLLYQMLCGIKHLHSAG 184
           F  +        ++LVME   A     +  +     +     +Y+  ++L G+ HLH   
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 149

Query: 185 IIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TTFMMTPYVVTRYYRAPEVILGM 238
           +IHRD+K  N+++  +  +K++DFG    L RT G   TF+ TP     Y+ APEVI   
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP-----YWMAPEVIACD 204

Query: 239 -----GYKENVDIWSVGCIMG-EMIRG 259
                 Y    D+WS+G I   EM  G
Sbjct: 205 ENPDATYDFKSDLWSLG-ITAIEMAEG 230

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  113 bits (284), Expect = 2e-29
 Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 26/198 (13%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LGAG            +   +A K +           +  RE +++   N   I+G   A
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSAG-I 185
           F       +  ++ + ME MD      +      +  + +  +   ++ G+ +L     I
Sbjct: 100 F-----YSD-GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 153

Query: 186 IHRDLKPSNIVVKSDCTLKILDFG----LARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           +HRD+KPSNI+V S   +K+ DFG    L  +   +F     V TR Y +PE + G  Y 
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTRSYMSPERLQGTHYS 208

Query: 242 ENVDIWSVGCIMGEMIRG 259
              DIWS+G  + EM  G
Sbjct: 209 VQSDIWSMGLSLVEMAVG 226

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  111 bits (280), Expect = 2e-29
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 31/218 (14%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LG G            T   VA+K L+R   +++    +  RE + +KL  H +II L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSA 183
                  +    D ++VME    +  ++      H R+       L  Q+L  + + H  
Sbjct: 79  V------ISTPTDFFMVMEY--VSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGT---TFMMTPYVVTRYYRAPEVILGM 238
            ++HRDLKP N+++ +    KI DFGL+   + G    T   +P      Y APEVI G 
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP-----NYAAPEVISGR 185

Query: 239 GYK-ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
            Y    VDIWS G I+  ++ G + F        + KI
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  110 bits (278), Expect = 4e-29
 Identities = 33/190 (17%), Positives = 68/190 (35%), Gaps = 22/190 (11%)

Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT--PQKSLEEFQDVYLV 145
            ++ +K L     +   ++    E   +++ +H N++ +L A    P           L+
Sbjct: 34  NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP------TLI 87

Query: 146 MELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK 198
              M   +L  V+       +D  +       M  G+  LH+    I    L   ++++ 
Sbjct: 88  THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID 147

Query: 199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKEN---VDIWSVGCIMGE 255
            D T +I    +      +F     +    + APE +       N    D+WS   ++ E
Sbjct: 148 EDMTARISMADVKF----SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWE 203

Query: 256 MIRGGVLFPG 265
           ++   V F  
Sbjct: 204 LVTREVPFAD 213

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  110 bits (276), Expect = 1e-28
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 36/206 (17%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T    A K +    ++    +    E +++   +H  I+ LL A
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 130 FTPQKSLEEFQDVYLVMELMDA----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           +     L      ++++E         +   +   L   ++  +  QML  +  LHS  I
Sbjct: 85  YYHDGKL------WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 138

Query: 186 IHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TTFMMTPYVVTRYYRAPEVIL--- 236
           IHRDLK  N+++  +  +++ DFG      +T     +F+ TP     Y+ APEV++   
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP-----YWMAPEVVMCET 193

Query: 237 --GMGYKENVDIWSVGCIMG-EMIRG 259
                Y    DIWS+G I   EM + 
Sbjct: 194 MKDTPYDYKADIWSLG-ITLIEMAQI 218

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  109 bits (275), Expect = 2e-28
 Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 25/212 (11%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK-LMKLVNHKNIIGLLN 128
           LG GA           + Q +A+K++ R   N    KR   +    M+ V+    +    
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER------MSYLLYQMLCGIKHLHS 182
           A        E  DV++ MELMD +L +  +  +D  +      +  +   ++  ++HLHS
Sbjct: 74  AL-----FRE-GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127

Query: 183 AG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM--- 238
              +IHRD+KPSN+++ +   +K+ DFG++               + Y APE I      
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 239 -GYKENVDIWSVGCIMGEMIRGGVLFPGTDHI 269
            GY    DIWS+G  M E+      +      
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  110 bits (276), Expect = 3e-28
 Identities = 55/228 (24%), Positives = 87/228 (38%), Gaps = 32/228 (14%)

Query: 53  KELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREF 112
           +  I + + +   +GK R      G          + VA+K      +      R   E 
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRG------KWRGEEVAVKIF--SSREERSWFRE-AEI 87

Query: 113 KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ-MDLDHERMSYLL 170
               ++ H+NI+G + A    K    +  ++LV +  +  +L   +    +  E M  L 
Sbjct: 88  YQTVMLRHENILGFIAADN--KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA 145

Query: 171 YQMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTT 217
                G+ HLH           I HRDLK  NI+VK + T  I D GLA      T    
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205

Query: 218 FMMTPYVVTRYYRAPEVILGMG------YKENVDIWSVGCIMGEMIRG 259
                 V T+ Y APEV+            +  DI+++G +  E+ R 
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  112 bits (282), Expect = 3e-28
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 22/214 (10%)

Query: 85  ATQQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEF 139
           AT +  A KKL +      +    A     E ++++ VN + ++ L  A+ T        
Sbjct: 207 ATGKMYACKKLEKKRIKKRKGEAMALN---EKQILEKVNSRFVVSLAYAYETKDA----- 258

Query: 140 QDVYLVMELMDA-----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
             + LV+ LM+      ++  + Q      R  +   ++ CG++ LH   I++RDLKP N
Sbjct: 259 --LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPEN 316

Query: 195 IVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
           I++     ++I D GLA        +   V T  Y APEV+    Y  + D W++GC++ 
Sbjct: 317 ILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLY 376

Query: 255 EMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
           EMI G   F       +  ++   ++E     +Y
Sbjct: 377 EMIAGQSPFQQRKKKIKREEVERLVKE--VPEEY 408

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  109 bits (274), Expect = 4e-28
 Identities = 48/203 (23%), Positives = 81/203 (39%), Gaps = 26/203 (12%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK-LMKLVNHKNIIGLLN 128
           +G GA           + Q +A+K++ R   +    K+   +   +M+  +   I+    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERM-------SYLLYQMLCGIKHLH 181
           A        E  D ++ MELM  +  +  +                 +    +  + HL 
Sbjct: 89  AL-----FRE-GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 182 SAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI----L 236
               IIHRD+KPSNI++     +K+ DFG++     +   T     R Y APE I     
Sbjct: 143 ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 237 GMGYKENVDIWSVGCIMGEMIRG 259
             GY    D+WS+G  + E+  G
Sbjct: 203 RQGYDVRSDVWSLGITLYELATG 225

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  108 bits (273), Expect = 4e-28
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 49/217 (22%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAY----REFKLMKLVNHKNIIG 125
           +G+GA      AY    ++ VAIK++     N+   + +     +E + M   +H NI+ 
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRI-----NLEKCQTSMDELLKEIQAMSQCHHPNIVS 77

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDA-----------NLCQVIQMDLDHERMSYLLYQML 174
              +F  +  L      +LVM+L+                +     LD   ++ +L ++L
Sbjct: 78  YYTSFVVKDEL------WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG-------TTFMMTPY 223
            G+++LH  G IHRD+K  NI++  D +++I DFG    LA            TF+ TP 
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP- 190

Query: 224 VVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRG 259
                + APEV+    GY    DIWS G    E+  G
Sbjct: 191 ----CWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  111 bits (278), Expect = 7e-28
 Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 45/227 (19%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LG G            T   VA+K L+R   +++    +  RE + +KL  H +II L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 129 AFTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMS-----YLLYQMLCGI 177
                  +    D+++VME      L D  +C+       + R+       L  Q+L G+
Sbjct: 84  V------ISTPSDIFMVMEYVSGGELFD-YICK-------NGRLDEKESRRLFQQILSGV 129

Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTTFMMT-----PYVVTRYYRA 231
            + H   ++HRDLKP N+++ +    KI DFGL+   +   F+ T      Y       A
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA------A 183

Query: 232 PEVILGMGYK-ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG 277
           PEVI G  Y    VDIWS G I+  ++ G + F        + KI  
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD 230

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  108 bits (271), Expect = 8e-28
 Identities = 44/200 (22%), Positives = 81/200 (40%), Gaps = 23/200 (11%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK-LMKLVNHKNIIGLLN 128
           +G+G            T   +A+K++ R      + KR   +   ++K  +   I+    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN-KRILMDLDVVLKSHDCPYIVQCFG 91

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA-G 184
            F     +    DV++ MELM     ++ +     +    +  +   ++  + +L    G
Sbjct: 92  TF-----ITN-TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG 145

Query: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI-----LGMG 239
           +IHRD+KPSNI++     +K+ DFG++                 Y APE I         
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205

Query: 240 YKENVDIWSVGCIMGEMIRG 259
           Y    D+WS+G  + E+  G
Sbjct: 206 YDIRADVWSLGISLVELATG 225

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  107 bits (269), Expect = 1e-27
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 20/206 (9%)

Query: 73  TSHLGAG------AAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIG 125
              +G G       A DT  ++ VA+K +S     +     R  RE +    +   +++ 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 126 LLNAFTPQKSLEEFQDV-YLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLH 181
           + +         E     Y+ M L++  +L  +++    L   R   ++ Q+   +   H
Sbjct: 99  IHDF-------GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH 151

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM-MTPYVV-TRYYRAPEVILGMG 239
           +AG  HRD+KP NI+V +D    ++DFG+A       +      V T YY APE      
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211

Query: 240 YKENVDIWSVGCIMGEMIRGGVLFPG 265
                DI+++ C++ E + G   + G
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQG 237

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  106 bits (268), Expect = 2e-27
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 16/207 (7%)

Query: 73  TSHLGAG------AAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIG 125
              LG G       A D    ++VA+K L     ++ +   R  RE +    +NH  I+ 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHS 182
           + +  T +         Y+VME +D   L  ++  +  +  +R   ++      +   H 
Sbjct: 77  VYD--TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 134

Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFMMTPYVV-TRYYRAPEVILGM 238
            GIIHRD+KP+NI++ +   +K++DFG+AR    +G +   T  V+ T  Y +PE   G 
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194

Query: 239 GYKENVDIWSVGCIMGEMIRGGVLFPG 265
                 D++S+GC++ E++ G   F G
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTG 221

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  107 bits (270), Expect = 2e-27
 Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 39/229 (17%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G+G         D  T++ VA+K + R        +   RE    + + H NI+     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER---GAAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 130 F-TPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMS-----YLLYQMLCGI 177
             TP         + ++ME      L +  +C          R S     +   Q+L G+
Sbjct: 85  ILTPTH-------LAIIMEYASGGELYE-RICN-------AGRFSEDEARFFFQQLLSGV 129

Query: 178 KHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI 235
            + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 189

Query: 236 LGMGYK-ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH 283
           L   Y  +  D+WS G  +  M+ G   F   +    + K I ++    
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK 238

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  107 bits (268), Expect = 3e-27
 Identities = 47/202 (23%), Positives = 78/202 (38%), Gaps = 37/202 (18%)

Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFK---LMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL 144
           + VA+K  S         ++ +   K    + L+ H NI   +       +    +   L
Sbjct: 37  RPVAVKVFS------FANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME-YLL 89

Query: 145 VMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSA---------GIIHRDLKPS 193
           VME     +L + + +   D      L + +  G+ +LH+           I HRDL   
Sbjct: 90  VMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSR 149

Query: 194 NIVVKSDCTLKILDFGLARTAGTTFM---------MTPYVVTRYYRAPEVILG------- 237
           N++VK+D T  I DFGL+       +             V T  Y APEV+ G       
Sbjct: 150 NVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDX 209

Query: 238 MGYKENVDIWSVGCIMGEMIRG 259
               + VD++++G I  E+   
Sbjct: 210 ESALKQVDMYALGLIYWEIFMR 231

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  109 bits (273), Expect = 4e-27
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 25/217 (11%)

Query: 85  ATQQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEF 139
           AT +  A KKL++      +    A     E K++  V+ + I+ L  AF T        
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMV---EKKILAKVHSRFIVSLAYAFETKTD----- 259

Query: 140 QDVYLVMELMDA-----NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
             + LVM +M+      ++  V + +      R  +   Q++ G++HLH   II+RDLKP
Sbjct: 260 --LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP 317

Query: 193 SNIVVKSDCTLKILDFGLARTAGTTFMMTP-YVVTRYYRAPEVILGMGYKENVDIWSVGC 251
            N+++  D  ++I D GLA         T  Y  T  + APE++LG  Y  +VD +++G 
Sbjct: 318 ENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGV 377

Query: 252 IMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
            + EMI     F       +  ++  ++ E    + Y
Sbjct: 378 TLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTY 412

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  104 bits (262), Expect = 2e-26
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 41/213 (19%)

Query: 85  ATQQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEF 139
           AT +  AIK L +        V +  R   E  +M  ++H   + L   F   +K     
Sbjct: 53  ATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKLYFTFQDDEK----- 104

Query: 140 QDVYLVM------ELMDANLCQVIQMDLDHERMSYLLY--QMLCGIKHLHSAGIIHRDLK 191
             +Y  +      EL+   + ++   D    R     Y  +++  +++LH  GIIHRDLK
Sbjct: 105 --LYFGLSYAKNGELLKY-IRKIGSFDETCTR----FYTAEIVSALEYLHGKGIIHRDLK 157

Query: 192 PSNIVVKSDCTLKILDFGLARTAGT--------TFMMTPYVVTRYYRAPEVILGMGYKEN 243
           P NI++  D  ++I DFG A+            +F+ T       Y +PE++      ++
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA-----QYVSPELLTEKSACKS 212

Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            D+W++GCI+ +++ G   F   +    + KII
Sbjct: 213 SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 245

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  103 bits (259), Expect = 8e-26
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 33/210 (15%)

Query: 86  TQQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD 141
           +  + A+K L +      + + H      E ++++ VN   ++ L  +F    +L     
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLN---EKRILQAVNFPFLVKLEFSFKDNSNL----- 116

Query: 142 VYLVMELMD-----ANLCQVIQMDLDHERMSYLLY--QMLCGIKHLHSAGIIHRDLKPSN 194
            Y+VME +      ++L ++ +    H R     Y  Q++   ++LHS  +I+RDLKP N
Sbjct: 117 -YMVMEYVAGGEMFSHLRRIGRFSEPHAR----FYAAQIVLTFEYLHSLDLIYRDLKPEN 171

Query: 195 IVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
           +++     +++ DFG A+       T   TP        APE+IL  GY + VD W++G 
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP-----EALAPEIILSKGYNKAVDWWALGV 226

Query: 252 IMGEMIRGGVLFPGTDHIDQWNKII-GKMR 280
           ++ EM  G   F     I  + KI+ GK+R
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  100 bits (252), Expect = 5e-25
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 44/222 (19%)

Query: 86  TQQNVAIKKLSRPF--QNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEFQDV 142
           T +  A+K L +    +N         E  +++ V H  I+ L+ AF T  K       +
Sbjct: 44  TGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK-------L 96

Query: 143 YLVM------ELMDANLCQVIQMDLDHERMSYLLY--QMLCGIKHLHSAGIIHRDLKPSN 194
           YL++      EL    L +      D        Y  ++   + HLH  GII+RDLKP N
Sbjct: 97  YLILEYLSGGELF-MQLEREGIFMEDTAC----FYLAEISMALGHLHQKGIIYRDLKPEN 151

Query: 195 IVVKSDCTLKILDFGLA--------RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
           I++     +K+ DFGL          T   TF  T       Y APE+++  G+   VD 
Sbjct: 152 IMLNHQGHVKLTDFGLCKESIHDGTVT--HTFCGTI-----EYMAPEILMRSGHNRAVDW 204

Query: 247 WSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
           WS+G +M +M+ G   F G +     +KI+        KL+ 
Sbjct: 205 WSLGALMYDMLTGAPPFTGENRKKTIDKIL------KCKLNL 240

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 99.2 bits (248), Expect = 2e-24
 Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 49/225 (21%)

Query: 85  ATQQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEF 139
           AT +  A+K L +        V H      E ++++   H  +  L  AF T  +     
Sbjct: 28  ATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNTRHPFLTALKYAFQTHDR----- 79

Query: 140 QDVYLVME------LMDANLCQVIQMDLDHERMSYLLY--QMLCGIKHLHSAGIIHRDLK 191
             +  VME      L   +L +      +  R     Y  +++  +++LHS  +++RD+K
Sbjct: 80  --LCFVMEYANGGELF-FHLSRERVFTEERAR----FYGAEIVSALEYLHSRDVVYRDIK 132

Query: 192 PSNIVVKSDCTLKILDFGL--------ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKEN 243
             N+++  D  +KI DFGL        A     TF  TP      Y APEV+    Y   
Sbjct: 133 LENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTP-----EYLAPEVLEDNDYGRA 185

Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
           VD W +G +M EM+ G + F   DH   +  I+       +++ +
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------MEEIRF 224

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 99.2 bits (248), Expect = 3e-24
 Identities = 52/192 (27%), Positives = 84/192 (43%), Gaps = 42/192 (21%)

Query: 114 LMKLVNHKNIIGLLNAF-TPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERM 166
           L    NH  +  L   F TP +       ++ VME      LM  ++ +  + D    R 
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDR-------LFFVMEFVNGGDLM-FHIQKSRRFDEARAR- 127

Query: 167 SYLLY--QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTAGT 216
               Y  +++  +  LH  GII+RDLK  N+++  +   K+ DFG+          T   
Sbjct: 128 ---FYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--A 182

Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           TF  TP      Y APE++  M Y   VD W++G ++ EM+ G   F   +  D +  I+
Sbjct: 183 TFCGTP-----DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237

Query: 277 GKMREAHDKLDY 288
                 +D++ Y
Sbjct: 238 ------NDEVVY 243

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 99.2 bits (248), Expect = 3e-24
 Identities = 56/190 (29%), Positives = 85/190 (44%), Gaps = 38/190 (20%)

Query: 114 LMKLVNHKNIIGLLNAF-TPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERM 166
           L     H  +  +   F T +        ++ VME      LM  ++    + DL     
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKEN-------LFFVMEYLNGGDLM-YHIQSCHKFDLSRATF 122

Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTAGTTF 218
            Y   +++ G++ LHS GI++RDLK  NI++  D  +KI DFG+         +T   TF
Sbjct: 123 -YAA-EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTF 178

Query: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
             TP      Y APE++LG  Y  +VD WS G ++ EM+ G   F G D  + ++ I   
Sbjct: 179 CGTP-----DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-- 231

Query: 279 MREAHDKLDY 288
                D   Y
Sbjct: 232 ----MDNPFY 237

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 98.8 bits (247), Expect = 3e-24
 Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 42/195 (21%)

Query: 111 EFKLMKLVNHKNIIGLLNAF-TPQKSLEEFQDVYLVM------ELMDANLCQVIQMDLDH 163
           E  ++  VNH  I+ L  AF T  K       +YL++      +L    L + +    + 
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGK-------LYLILDFLRGGDLF-TRLSKEVMFTEED 127

Query: 164 ERMSYLLY--QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RT 213
            +     Y  ++   + HLHS GII+RDLKP NI++  +  +K+ DFGL+        + 
Sbjct: 128 VK----FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183

Query: 214 AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWN 273
              +F  T       Y APEV+   G+ ++ D WS G +M EM+ G + F G D  +   
Sbjct: 184 --YSFCGTV-----EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236

Query: 274 KIIGKMREAHDKLDY 288
            I+        KL  
Sbjct: 237 MIL------KAKLGM 245

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 99.6 bits (249), Expect = 3e-24
 Identities = 53/192 (27%), Positives = 83/192 (43%), Gaps = 42/192 (21%)

Query: 114 LMKLVNHKNIIGLLNAF-TPQKSLEEFQDVYLVM------ELMDANLCQVIQMDLDHERM 166
           L+K V H  ++GL  +F T  K       +Y V+      EL   +L +         R 
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADK-------LYFVLDYINGGELF-YHLQRERCFLEPRAR- 142

Query: 167 SYLLY--QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTAGT 216
               Y  ++   + +LHS  I++RDLKP NI++ S   + + DFGL          T  +
Sbjct: 143 ---FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--S 197

Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           TF  TP      Y APEV+    Y   VD W +G ++ EM+ G   F   +  + ++ I+
Sbjct: 198 TFCGTP-----EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252

Query: 277 GKMREAHDKLDY 288
                 +  L  
Sbjct: 253 ------NKPLQL 258

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =   99 bits (249), Expect = 8e-24
 Identities = 48/184 (26%), Positives = 88/184 (47%), Gaps = 17/184 (9%)

Query: 85  ATQQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEF 139
            T +  A+K L +      Q  T A        L+   +   I+ +  AF TP K     
Sbjct: 212 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK----- 266

Query: 140 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
             +  +++LM+  +L   +          M +   +++ G++H+H+  +++RDLKP+NI+
Sbjct: 267 --LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324

Query: 197 VKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGE 255
           +     ++I D GLA            V T  Y APEV+  G+ Y  + D +S+GC++ +
Sbjct: 325 LDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 383

Query: 256 MIRG 259
           ++RG
Sbjct: 384 LLRG 387

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 98.8 bits (246), Expect = 8e-24
 Identities = 64/283 (22%), Positives = 106/283 (37%), Gaps = 84/283 (29%)

Query: 74  SHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV--------N 119
             LG G       ++D   ++ VA+K +        + + A  E +L+K V        N
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPN 99

Query: 120 HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLC 175
            + ++ LL+ F           + +V E++  +L + I       L    +  ++ Q+L 
Sbjct: 100 REMVVQLLDDFKISGVNGTH--ICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157

Query: 176 GIKHLHS-AGIIHRDLKPSNIVVKSD---------------------------------- 200
           G+ +LH+   IIH D+KP NI++  +                                  
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217

Query: 201 ---------------CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
                            +KI D G A      F  T  + TR YR+ EV++G GY    D
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIGSGYNTPAD 275

Query: 246 IWSVGCIMGEMIRGGVLFPGT---------DHIDQWNKIIGKM 279
           IWS  C+  E+  G  LF            DHI    +++GK+
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV 318

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 98.1 bits (245), Expect = 8e-24
 Identities = 54/190 (28%), Positives = 82/190 (43%), Gaps = 38/190 (20%)

Query: 114 LMKLVNHKNIIGLLNAF-TPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERM 166
           L        +  L + F T  +       +Y VME      LM  ++ QV +    H   
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDR-------LYFVMEYVNGGDLM-YHIQQVGRFKEPHAVF 125

Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTAGTTF 218
            Y   ++  G+  L S GII+RDLK  N+++ S+  +KI DFG+          T   TF
Sbjct: 126 -YAA-EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KTF 181

Query: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
             TP      Y APE+I    Y ++VD W+ G ++ EM+ G   F G D  + +  I+  
Sbjct: 182 CGTP-----DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-- 234

Query: 279 MREAHDKLDY 288
                  + Y
Sbjct: 235 ----EHNVAY 240

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 47/210 (22%), Positives = 81/210 (38%), Gaps = 28/210 (13%)

Query: 85  ATQQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEF 139
            T Q  A+K +++        V+  +    E  ++   + + I  L  AF          
Sbjct: 84  QTGQVYAMKIMNKWDMLKRGEVSCFRE---ERDVLVNGDRRWITQLHFAFQDENY----- 135

Query: 140 QDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
             +YLVME         L       +  E   + L +++  I  +H  G +HRD+KP NI
Sbjct: 136 --LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNI 193

Query: 196 VVKSDCTLKILDFGLARTAGTTFMMTPYVV--TRYYRAPEVILGMG-------YKENVDI 246
           ++     +++ DFG          +   V   T  Y +PE++  +G       Y    D 
Sbjct: 194 LLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDW 253

Query: 247 WSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           W++G    EM  G   F      + + KI+
Sbjct: 254 WALGVFAYEMFYGQTPFYADSTAETYGKIV 283

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 98.7 bits (246), Expect = 1e-23
 Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 36/219 (16%)

Query: 85  ATQQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEF 139
           AT +  A+K L +        V H      E ++++   H  +  L  +F T  +     
Sbjct: 171 ATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVLQNSRHPFLTALKYSFQTHDR----- 222

Query: 140 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNI 195
             +  VME  +   L   +  +     +R  +   +++  + +LHS   +++RDLK  N+
Sbjct: 223 --LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 280

Query: 196 VVKSDCTLKILDFGLAR------TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
           ++  D  +KI DFGL +          TF  TP      Y APEV+    Y   VD W +
Sbjct: 281 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE-----YLAPEVLEDNDYGRAVDWWGL 335

Query: 250 GCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
           G +M EM+ G + F   DH   +  I+       +++ +
Sbjct: 336 GVVMYEMMCGRLPFYNQDHEKLFELIL------MEEIRF 368

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 97.1 bits (242), Expect = 3e-23
 Identities = 49/210 (23%), Positives = 83/210 (39%), Gaps = 30/210 (14%)

Query: 85  ATQQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEF 139
              +  A+K L++            +    E  ++   + K I  L  AF          
Sbjct: 97  NADKVFAMKILNKWEMLKRAETACFRE---ERDVLVNGDSKWITTLHYAFQDDNN----- 148

Query: 140 QDVYLVM------ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
             +YLVM      +L+   L    +  L  E   + L +M+  I  +H    +HRD+KP 
Sbjct: 149 --LYLVMDYYVGGDLL--TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPD 204

Query: 194 NIVVKSDCTLKILDFGLARTAGTTFMMTPYVV--TRYYRAPEVILGM-----GYKENVDI 246
           NI++  +  +++ DFG          +   V   T  Y +PE++  M      Y    D 
Sbjct: 205 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264

Query: 247 WSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           WS+G  M EM+ G   F     ++ + KI+
Sbjct: 265 WSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 95.7 bits (239), Expect = 4e-23
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 54/225 (24%)

Query: 86  TQQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEFQ 140
             +  A+K L +      + V H      E  ++ +V H  II +   F   Q+      
Sbjct: 30  NGRYYAMKVLKKEIVVRLKQVEHTND---ERLMLSIVTHPFIIRMWGTFQDAQQ------ 80

Query: 141 DVYLVMELMDANLCQVIQMDLDHERMSYL------------LY--QMLCGIKHLHSAGII 186
            ++++M+ ++             E  S L             Y  ++   +++LHS  II
Sbjct: 81  -IFMIMDYIEGG-----------ELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII 128

Query: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGMGYKEN 243
           +RDLKP NI++  +  +KI DFG A+       T   TP      Y APEV+    Y ++
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP-----DYIAPEVVSTKPYNKS 183

Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
           +D WS G ++ EM+ G   F  ++ +  + KI+      + +L +
Sbjct: 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL------NAELRF 222

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 97.8 bits (243), Expect = 5e-23
 Identities = 53/190 (27%), Positives = 82/190 (43%), Gaps = 38/190 (20%)

Query: 114 LMKLVNHKNIIGLLNAF-TPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERM 166
           L        +  L + F T  +       +Y VME      LM  ++ QV +    H   
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDR-------LYFVMEYVNGGDLM-YHIQQVGRFKEPHAV- 445

Query: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTAGTTF 218
            +   ++  G+  L S GII+RDLK  N+++ S+  +KI DFG+          T   TF
Sbjct: 446 -FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KTF 502

Query: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
             TP      Y APE+I    Y ++VD W+ G ++ EM+ G   F G D  + +  I+  
Sbjct: 503 CGTP-----DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-- 555

Query: 279 MREAHDKLDY 288
                  + Y
Sbjct: 556 ----EHNVAY 561

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 96.2 bits (240), Expect = 6e-23
 Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 35/174 (20%)

Query: 102 VTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEFQDVYLVMELMDA-----NLCQ 155
           V +  +   E ++M+ + H  ++ L  +F   +        +++V++L+       +L Q
Sbjct: 59  VRNVFK---ELQIMQGLEHPFLVNLWYSFQDEED-------MFMVVDLLLGGDLRYHLQQ 108

Query: 156 VIQMDLDHERMSYLLY--QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR- 212
            +    +  +    L+  +++  + +L +  IIHRD+KP NI++     + I DF +A  
Sbjct: 109 NVHFKEETVK----LFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164

Query: 213 ----TAGTTFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIRG 259
               T  TT   T       Y APE+     G GY   VD WS+G    E++RG
Sbjct: 165 LPRETQITTMAGTK-----PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 93.4 bits (233), Expect = 3e-22
 Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 36/175 (20%)

Query: 114 LMKLVNHKNIIGLLNAF-TPQKSLEEFQDVYLVM------ELMDANLCQVIQMDLDHERM 166
             +  NH  ++GL + F T  +       ++ V+      +LM  ++ +  ++  +H R 
Sbjct: 63  FEQASNHPFLVGLHSCFQTESR-------LFFVIEYVNGGDLM-FHMQRQRKLPEEHAR- 113

Query: 167 SYLLY--QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTAGT 216
               Y  ++   + +LH  GII+RDLK  N+++ S+  +K+ D+G+          T  +
Sbjct: 114 ---FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--S 168

Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ 271
           TF  TP      Y APE++ G  Y  +VD W++G +M EM+ G   F      D 
Sbjct: 169 TFCGTP-----NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 94.4 bits (235), Expect = 3e-22
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 37/212 (17%)

Query: 85  ATQQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNHKNIIGLLNAF-TPQKSLEEF 139
           +T++  A+K LS+       +         E  +M   N   ++ L  AF   +      
Sbjct: 92  STRKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFANSPWVVQLFYAFQDDRY----- 143

Query: 140 QDVYLVMELMDA----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
             +Y+VME M      NL      D+  +   +   +++  +  +HS G IHRD+KP N+
Sbjct: 144 --LYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 199

Query: 196 VVKSDCTLKILDFGLA-------RTAGTTFMMTPYVVTRYYRAPEVILGMG----YKENV 244
           ++     LK+ DFG              T + TP      Y +PEV+   G    Y    
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP-----DYISPEVLKSQGGDGYYGREC 254

Query: 245 DIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           D WSVG  + EM+ G   F     +  ++KI+
Sbjct: 255 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 48/175 (27%), Positives = 83/175 (47%), Gaps = 36/175 (20%)

Query: 114 LMKLVNHKNIIGLLNAF-TPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERM 166
             +  NH  ++GL + F T  +       ++ V+E      LM  ++ +  ++  +H R 
Sbjct: 106 FEQASNHPFLVGLHSCFQTESR-------LFFVIEYVNGGDLM-FHMQRQRKLPEEHAR- 156

Query: 167 SYLLY--QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTAGT 216
               Y  ++   + +LH  GII+RDLK  N+++ S+  +K+ D+G+          T  +
Sbjct: 157 ---FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--S 211

Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ 271
           TF  TP      Y APE++ G  Y  +VD W++G +M EM+ G   F      D 
Sbjct: 212 TFCGTP-----NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 88.6 bits (220), Expect = 8e-21
 Identities = 24/203 (11%), Positives = 50/203 (24%), Gaps = 40/203 (19%)

Query: 74  SHLGAGA------AYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGL 126
              G         A DTA  + VA+  +           +        +  ++   +  +
Sbjct: 37  IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 127 LNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
           L+       +       +V E +   +L +V             +  +       H AG+
Sbjct: 97  LDV------VHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
                 PS + V  D  + +        A               +              D
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPATMPDAN-------------PQD-------------D 184

Query: 246 IWSVGCIMGEMIRGGVLFPGTDH 268
           I  +G  +  ++      P    
Sbjct: 185 IRGIGASLYALLVNRWPLPEAGV 207

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 87.7 bits (218), Expect = 4e-20
 Identities = 51/224 (22%), Positives = 98/224 (43%), Gaps = 40/224 (17%)

Query: 86  TQQNVAIKKLSRPF--QNVTHAKRAYREFKLMKLVNHKN-IIGLLNAF-TPQKSLEEFQD 141
           T +  A+K L +    Q     +    E ++++ +     ++ L  AF T  K       
Sbjct: 81  TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK------- 133

Query: 142 VYLVM------ELMDANLCQVIQMDLDHERMSYLLY--QMLCGIKHLHSAGIIHRDLKPS 193
           ++L++      EL   +L Q  +      +    +Y  +++  ++HLH  GII+RD+K  
Sbjct: 134 LHLILDYINGGELF-THLSQRERFTEHEVQ----IYVGEIVLALEHLHKLGIIYRDIKLE 188

Query: 194 NIVVKSDCTLKILDFGLAR-------TAGTTFMMTPYVVTRYYRAPEVILGM--GYKENV 244
           NI++ S+  + + DFGL++            F  T       Y AP+++ G   G+ + V
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI-----EYMAPDIVRGGDSGHDKAV 243

Query: 245 DIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLDY 288
           D WS+G +M E++ G   F      +   +I  ++     +  Y
Sbjct: 244 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEPPY 285

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 57/257 (22%), Positives = 94/257 (36%), Gaps = 44/257 (17%)

Query: 33  PAPGPYDHSVDEREHTVDQWKELIYQELPISH-QMGKKRHNTSHLGAGA------AYDTA 85
           PAP     ++       D+W      E+  +   M  K      LG G            
Sbjct: 196 PAPKRNKPTIYGVSPNYDKW------EMERTDITMKHK------LGGGQYGEVYEGVWKK 243

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
               VA+K L    ++    +   +E  +MK + H N++ LL   T           Y++
Sbjct: 244 YSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT------REPPFYII 294

Query: 146 MELMDA-NLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
            E M   NL   ++     E  + +L  M   I    ++L     IHR+L   N +V  +
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN 354

Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMG 254
             +K+ DFGL+R          Y      +      APE +    +    D+W+ G ++ 
Sbjct: 355 HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 410

Query: 255 EMI-RGGVLFPGTDHID 270
           E+   G   +PG D   
Sbjct: 411 EIATYGMSPYPGIDLSQ 427

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 85.5 bits (212), Expect = 2e-19
 Identities = 53/259 (20%), Positives = 99/259 (38%), Gaps = 55/259 (21%)

Query: 27  DAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISH-QMGKKRHNTSHLGAGA----- 80
           D ++       +  ++       D        +    H +  ++      LG G      
Sbjct: 11  DYDIPTTENLYFQGAMGSAFEDRDPT------QFEERHLKFLQQ------LGKGNFGSVE 58

Query: 81  -----AYDTATQQNVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQK 134
                     T + VA+KKL     +     R + RE +++K + H NI+          
Sbjct: 59  MCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115

Query: 135 SLEEFQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 190
                +++ L+ME +   +L   +Q     +DH ++     Q+  G+++L +   IHRDL
Sbjct: 116 R----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 171

Query: 191 KPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGM 238
              NI+V+++  +KI DFGL +               YY+            APE +   
Sbjct: 172 ATRNILVENENRVKIGDFGLTKVLPQD--------KEYYKVKEPGESPIFWYAPESLTES 223

Query: 239 GYKENVDIWSVGCIMGEMI 257
            +    D+WS G ++ E+ 
Sbjct: 224 KFSVASDVWSFGVVLYELF 242

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 85.1 bits (211), Expect = 3e-19
 Identities = 56/250 (22%), Positives = 92/250 (36%), Gaps = 55/250 (22%)

Query: 36  GPYDHSVDEREHTVDQWKELIYQELPISH-QMGKKRHNTSHLGAGA----------AYDT 84
           G + H   +     D             H +   +      LG G               
Sbjct: 2   GHHHHHHAQLYACQDPT------IFEERHLKYISQ------LGKGNFGSVELCRYDPLGD 49

Query: 85  ATQQNVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
            T   VA+K+L     +    +R + RE +++K ++   I+               Q + 
Sbjct: 50  NTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR----QSLR 102

Query: 144 LVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
           LVME + +  L   +Q     LD  R+     Q+  G+++L S   +HRDL   NI+V+S
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES 162

Query: 200 DCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIW 247
           +  +KI DFGLA+               YY             APE +    +    D+W
Sbjct: 163 EAHVKIADFGLAKLLPLD--------KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVW 214

Query: 248 SVGCIMGEMI 257
           S G ++ E+ 
Sbjct: 215 SFGVVLYELF 224

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 84.3 bits (209), Expect = 5e-19
 Identities = 43/188 (22%), Positives = 84/188 (44%), Gaps = 29/188 (15%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           T + VA+K L +P     H     +E ++++ + H+NI+      T     +    + L+
Sbjct: 49  TGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE----DGGNGIKLI 103

Query: 146 MELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
           ME + + +L + +  +   ++ ++      Q+  G+ +L S   +HRDL   N++V+S+ 
Sbjct: 104 MEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 163

Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSV 249
            +KI DFGL +               YY             APE ++   +    D+WS 
Sbjct: 164 QVKIGDFGLTKAI--------ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215

Query: 250 GCIMGEMI 257
           G  + E++
Sbjct: 216 GVTLHELL 223

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 83.1 bits (206), Expect = 9e-19
 Identities = 51/241 (21%), Positives = 90/241 (37%), Gaps = 56/241 (23%)

Query: 50  DQWKELIYQELPISH-QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNV 102
           D+W      E+  +   M  K      LG G                VA+K L    ++ 
Sbjct: 6   DKW------EMERTDITMKHK------LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDT 50

Query: 103 THAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM-----DANLCQVI 157
              +   +E  +MK + H N++ LL   T +         Y++ E M        L +  
Sbjct: 51  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECN 104

Query: 158 QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT 217
           + ++    + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R     
Sbjct: 105 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR----- 159

Query: 218 FMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFP 264
                 +    Y             APE +    +    D+W+ G ++ E+   G   +P
Sbjct: 160 -----LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 214

Query: 265 G 265
           G
Sbjct: 215 G 215

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 46/192 (23%), Positives = 79/192 (41%), Gaps = 26/192 (13%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
               VAIK L          +   +E ++MK + H+ ++ L    + +        +Y+V
Sbjct: 290 GTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIV 339

Query: 146 MELMDA-NLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
            E M   +L   ++ +         L  M   I     ++     +HRDL+ +NI+V  +
Sbjct: 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 399

Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMG 254
              K+ DFGLAR          Y   +  +      APE  L   +    D+WS G ++ 
Sbjct: 400 LVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 455

Query: 255 EMI-RGGVLFPG 265
           E+  +G V +PG
Sbjct: 456 ELTTKGRVPYPG 467

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 82.8 bits (205), Expect = 2e-18
 Identities = 44/208 (21%), Positives = 83/208 (39%), Gaps = 33/208 (15%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           +   VA+K L       +  +   RE   MK  +H ++  L+      ++        ++
Sbjct: 50  SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVI 109

Query: 146 MELMD---------ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
           +  M          A+       +L  + +   +  + CG+++L S   IHRDL   N +
Sbjct: 110 LPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169

Query: 197 VKSDCTLKILDFGLARTAGTTFMMTPYVVTR-YYR------------APEVILGMGYKEN 243
           +  D T+ + DFGL+R           + +  YYR            A E +    Y  +
Sbjct: 170 LAEDMTVCVADFGLSR----------KIYSGDYYRQGCASKLPVKWLALESLADNLYTVH 219

Query: 244 VDIWSVGCIMGEMI-RGGVLFPGTDHID 270
            D+W+ G  M E++ RG   + G ++ +
Sbjct: 220 SDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 82.0 bits (203), Expect = 2e-18
 Identities = 50/236 (21%), Positives = 93/236 (39%), Gaps = 55/236 (23%)

Query: 50  DQWKELIYQELPISH-QMGKKRHNTSHLGAGA----------AYDTATQQNVAIKKLSRP 98
           D        +    H +  ++      LG G                T + VA+KKL   
Sbjct: 3   DPT------QFEERHLKFLQQ------LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-- 48

Query: 99  FQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQV 156
             +     R + RE +++K + H NI+               +++ L+ME +   +L   
Sbjct: 49  -HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR----RNLKLIMEYLPYGSLRDY 103

Query: 157 IQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
           +Q     +DH ++     Q+  G+++L +   IHRDL   NI+V+++  +KI DFGL + 
Sbjct: 104 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163

Query: 214 AGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGEMI 257
                         +++            APE +    +    D+WS G ++ E+ 
Sbjct: 164 LPQD--------KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 82.0 bits (203), Expect = 3e-18
 Identities = 47/211 (22%), Positives = 82/211 (38%), Gaps = 37/211 (17%)

Query: 74  SHLGAGA----------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNI 123
             LG G             +  T + VA+K L +      H     +E  +++ + H++I
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 124 IGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLH 181
           I          +      + LVME +   +L   +    +   ++     Q+  G+ +LH
Sbjct: 96  IKYKGCCEDAGA----ASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH 151

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR----------- 230
           +   IHRDL   N+++ +D  +KI DFGLA+               YYR           
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--------HEYYRVREDGDSPVFW 203

Query: 231 -APEVILGMGYKENVDIWSVGCIMGEMIRGG 260
            APE +    +    D+WS G  + E++   
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHC 234

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 82.5 bits (204), Expect = 5e-18
 Identities = 46/191 (24%), Positives = 79/191 (41%), Gaps = 26/191 (13%)

Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
              VAIK L          +   +E ++MK + H+ ++ L    + +        +Y+V 
Sbjct: 208 TTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYIVT 257

Query: 147 ELMDA-NLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSDC 201
           E M   +L   ++ +         L  M   I     ++     +HRDL+ +NI+V  + 
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 317

Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGE 255
             K+ DFGLAR          Y   +  +      APE  L   +    D+WS G ++ E
Sbjct: 318 VCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 373

Query: 256 MI-RGGVLFPG 265
           +  +G V +PG
Sbjct: 374 LTTKGRVPYPG 384

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 43/190 (22%), Positives = 72/190 (37%), Gaps = 29/190 (15%)

Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
             VA+K +         A+    E  +M  + H N++ LL         EE   +Y+V E
Sbjct: 217 NKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIV-----EEKGGLYIVTE 267

Query: 148 LMDA-NLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSDCT 202
            M   +L   ++           L +    +    ++L     +HRDL   N++V  D  
Sbjct: 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 327

Query: 203 LKILDFGLARTAGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEM 256
            K+ DFGL + A               +      APE +    +    D+WS G ++ E+
Sbjct: 328 AKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379

Query: 257 I-RGGVLFPG 265
              G V +P 
Sbjct: 380 YSFGRVPYPR 389

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 78.8 bits (195), Expect = 2e-17
 Identities = 50/238 (21%), Positives = 85/238 (35%), Gaps = 44/238 (18%)

Query: 44  EREHTVDQWKELIYQELPISH-QMGKKRHNTSHLGAGA----AYDTATQQNVAIKKLSRP 98
           + E     W       L +   ++ +       +G G              VA+K +   
Sbjct: 8   QDEFYRSGW------ALNMKELKLLQT------IGKGEFGDVMLGDYRGNKVAVKCI--- 52

Query: 99  FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVI 157
            +N   A+    E  +M  + H N++ LL         EE   +Y+V E M   +L   +
Sbjct: 53  -KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV-----EEKGGLYIVTEYMAKGSLVDYL 106

Query: 158 QMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR- 212
           +           L +    +    ++L     +HRDL   N++V  D   K+ DFGL + 
Sbjct: 107 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166

Query: 213 ----TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
                        P   T    APE +    +    D+WS G ++ E+   G V +P 
Sbjct: 167 ASSTQDTGKL---PVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 78.8 bits (195), Expect = 5e-17
 Identities = 54/220 (24%), Positives = 86/220 (39%), Gaps = 50/220 (22%)

Query: 76  LGAGA----------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHK 121
           LG+GA                +  VAIK+L         + +A +E      +M  V++ 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-----REATSPKANKEILDEAYVMASVDNP 77

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLL---YQMLCGI 177
           ++  LL              V L+ +LM    L   ++   D+    YLL    Q+  G+
Sbjct: 78  HVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------- 230
            +L    ++HRDL   N++VK+   +KI DFGLA+              + Y        
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEEKEYHAEGGKVP 182

Query: 231 ----APEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
               A E IL   Y    D+WS G  + E++  G   + G
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 79.4 bits (196), Expect = 6e-17
 Identities = 46/194 (23%), Positives = 77/194 (39%), Gaps = 32/194 (16%)

Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
              VA+K +          +    E  +MK + H  ++ L    T +        +Y++ 
Sbjct: 212 HTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP-------IYIIT 261

Query: 147 ELMDA-NLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSDC 201
           E M   +L   ++ D   ++    L      I      +     IHRDL+ +NI+V +  
Sbjct: 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL 321

Query: 202 TLKILDFGLAR---------TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
             KI DFGLAR           G  F +        + APE I    +    D+WS G +
Sbjct: 322 VCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEAINFGSFTIKSDVWSFGIL 374

Query: 253 MGEMI-RGGVLFPG 265
           + E++  G + +PG
Sbjct: 375 LMEIVTYGRIPYPG 388

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 77.7 bits (192), Expect = 1e-16
 Identities = 49/270 (18%), Positives = 98/270 (36%), Gaps = 56/270 (20%)

Query: 34  APGPYDHSVDEREHTVDQWKELIYQELPISH-QMGKKRHNTSHLGAGA---------AYD 83
           + G      +E ++ ++         +  +   +GK       LG G            +
Sbjct: 11  SSGLVPRGSEELQNKLEDV------VIDRNLLILGKI------LGEGEFGSVMEGNLKQE 58

Query: 84  TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY 143
             T   VA+K +     +    +    E   MK  +H N+I LL     + S +      
Sbjct: 59  DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI-EMSSQGIPKPM 117

Query: 144 LVMELMD---------ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
           +++  M           +  +     +  + +   +  +  G+++L +   +HRDL   N
Sbjct: 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARN 177

Query: 195 IVVKSDCTLKILDFGLARTAGTTFMMTPYVVTR-YYR------------APEVILGMGYK 241
            +++ D T+ + DFGL++           + +  YYR            A E +    Y 
Sbjct: 178 CMLRDDMTVCVADFGLSK----------KIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 227

Query: 242 ENVDIWSVGCIMGEMI-RGGVLFPGTDHID 270
              D+W+ G  M E+  RG   +PG  + +
Sbjct: 228 SKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 56/244 (22%), Positives = 89/244 (36%), Gaps = 60/244 (24%)

Query: 50  DQWKELIYQELPISH-QMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNV 102
           D+W       L      +G++      +G G           A    VA+K         
Sbjct: 107 DKW------VLNHEDLVLGEQ------IGRGNFGEVFSGRLRADNTLVAVKSC-----RE 149

Query: 103 THAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVI 157
           T       +F    +++K  +H NI+ L+   T +      Q +Y+VMEL+   +    +
Sbjct: 150 TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK------QPIYIVMELVQGGDFLTFL 203

Query: 158 QMDLDHERMSYLLY---QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214
           + +    R+  LL        G+++L S   IHRDL   N +V     LKI DFG++R  
Sbjct: 204 RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263

Query: 215 GTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGEMIRGGVL 262
                        Y              APE +    Y    D+WS G ++ E    G  
Sbjct: 264 ADGV---------YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGAS 314

Query: 263 -FPG 265
            +P 
Sbjct: 315 PYPN 318

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 76.6 bits (189), Expect = 2e-16
 Identities = 45/204 (22%), Positives = 79/204 (38%), Gaps = 46/204 (22%)

Query: 90  VAIKKLSRPFQNVTHAKRA--YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVME 147
           VAIK ++   +  +  +R     E  +MK  N  +++ LL   +  +         ++ME
Sbjct: 58  VAIKTVN---EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT------LVIME 108

Query: 148 LMD-------------ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
           LM              A     +       +M  +  ++  G+ +L++   +HRDL   N
Sbjct: 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 168

Query: 195 IVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYKE 242
            +V  D T+KI DFG+ R             T YYR            +PE +    +  
Sbjct: 169 CMVAEDFTVKIGDFGMTRDIYE---------TDYYRKGGKGLLPVRWMSPESLKDGVFTT 219

Query: 243 NVDIWSVGCIMGEMI-RGGVLFPG 265
             D+WS G ++ E+       + G
Sbjct: 220 YSDVWSFGVVLWEIATLAEQPYQG 243

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 76.1 bits (188), Expect = 2e-16
 Identities = 43/196 (21%), Positives = 79/196 (40%), Gaps = 36/196 (18%)

Query: 87  QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
           Q +VA+K +    +        ++E + M  ++H  ++      + +        +Y+V 
Sbjct: 32  QYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP------IYIVT 82

Query: 147 ELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
           E +    L   ++     L+  ++  + Y +  G+  L S   IHRDL   N +V  D  
Sbjct: 83  EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC 142

Query: 203 LKILDFGLARTAGTTFMMTPYVV-TRYYR-----------APEVILGMGYKENVDIWSVG 250
           +K+ DFG+ R          YV+  +Y             APEV     Y    D+W+ G
Sbjct: 143 VKVSDFGMTR----------YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFG 192

Query: 251 CIMGEMI-RGGVLFPG 265
            +M E+   G + +  
Sbjct: 193 ILMWEVFSLGKMPYDL 208

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 77.6 bits (191), Expect = 3e-16
 Identities = 48/196 (24%), Positives = 78/196 (39%), Gaps = 41/196 (20%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           VAIK           +     +F      M+  +H +I+ L+   T          V+++
Sbjct: 421 VAIKTC-----KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-------VWII 468

Query: 146 MELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
           MEL     L   +Q+    LD   +    YQ+   + +L S   +HRD+   N++V S+ 
Sbjct: 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND 528

Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYR-----------APEVILGMGYKENVDIWSVG 250
            +K+ DFGL+R             + YY+           APE I    +    D+W  G
Sbjct: 529 CVKLGDFGLSRYMED---------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 579

Query: 251 CIMGEMI-RGGVLFPG 265
             M E++  G   F G
Sbjct: 580 VCMWEILMHGVKPFQG 595

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 75.7 bits (187), Expect = 4e-16
 Identities = 53/250 (21%), Positives = 90/250 (36%), Gaps = 65/250 (26%)

Query: 47  HTVDQWKELIYQELPISH-QMGKKRHNTSHLGAGA---------AYDTATQQNVAIKKLS 96
            +   +      E+     ++G+       +G G                   VAIK   
Sbjct: 5   SSTRDY------EIQRERIELGRC------IGEGQFGDVHQGIYMSPENPALAVAIKTC- 51

Query: 97  RPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM--- 149
                   +     +F      M+  +H +I+ L+   T          V+++MEL    
Sbjct: 52  ----KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-------VWIIMELCTLG 100

Query: 150 --DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
              + L QV +  LD   +    YQ+   + +L S   +HRD+   N++V S+  +K+ D
Sbjct: 101 ELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 159

Query: 208 FGLARTAGTTFMMTPYVVTRYYR-----------APEVILGMGYKENVDIWSVGCIMGEM 256
           FGL+R             + YY+           APE I    +    D+W  G  M E+
Sbjct: 160 FGLSRYMED---------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 210

Query: 257 I-RGGVLFPG 265
           +  G   F G
Sbjct: 211 LMHGVKPFQG 220

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 76.2 bits (188), Expect = 4e-16
 Identities = 65/280 (23%), Positives = 101/280 (36%), Gaps = 76/280 (27%)

Query: 33  PAPGPYDHSVDEREHTVDQWKELIYQELPISH-QMGKKRHNTSHLGAGA----------- 80
           P   P D   +   +   +W      E P    ++GK       LG GA           
Sbjct: 3   PDELPLDEHCERLPYDASKW------EFPRDRLKLGKP------LGRGAFGQVIEADAFG 50

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRA--YREFKLMK-LVNHKNIIGLLNAFTPQKSLE 137
              TAT + VA+K L    +  TH++      E K++  + +H N++ LL A T     +
Sbjct: 51  IDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACT-----K 102

Query: 138 EFQDVYLVMELM-------------------DANLCQVIQMDLDHERMSYLLYQMLCGIK 178
               + +++E                           + +  L  E +    +Q+  G++
Sbjct: 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 162

Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR-------- 230
            L S   IHRDL   NI++     +KI DFGLAR                Y         
Sbjct: 163 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK---------DPDYVRKGDARLP 213

Query: 231 ----APEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
               APE I    Y    D+WS G ++ E+   G   +PG
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 76.2 bits (188), Expect = 4e-16
 Identities = 56/250 (22%), Positives = 90/250 (36%), Gaps = 63/250 (25%)

Query: 56  IYQELPISH-QMGKKRHNTSHLGAGA--------AYDTATQQNVAIKKLSRPFQNVTHAK 106
           IY  L  +  +          +G G               + + AIK++         +K
Sbjct: 18  IYPVLDWNDIKFQDV------IGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASK 66

Query: 107 RAYREF----KLMK-LVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM------------ 149
             +R+F    +++  L +H NII LL A   +  L      YL +E              
Sbjct: 67  DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL------YLAIEYAPHGNLLDFLRKS 120

Query: 150 -------DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
                     +       L  +++ +    +  G+ +L     IHRDL   NI+V  +  
Sbjct: 121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180

Query: 203 LKILDFGLARTAGTTFMMTPYVVTRYYR------APEVILGMGYKENVDIWSVGCIMGEM 256
            KI DFGL+R          YV     R      A E +    Y  N D+WS G ++ E+
Sbjct: 181 AKIADFGLSRGQEV------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

Query: 257 I-RGGVLFPG 265
           +  GG  + G
Sbjct: 235 VSLGGTPYCG 244

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 76.2 bits (188), Expect = 4e-16
 Identities = 51/196 (26%), Positives = 81/196 (41%), Gaps = 40/196 (20%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           VAIK+L         + +A +E      +M  V++ ++  LL              V L+
Sbjct: 47  VAIKEL-----REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLI 94

Query: 146 MELMDA-NLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
            +LM    L   ++   D+    YLL    Q+  G+ +L    ++HRDL   N++VK+  
Sbjct: 95  TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ 154

Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYR-----------APEVILGMGYKENVDIWSVG 250
            +KI DFGLA+  G           + Y            A E IL   Y    D+WS G
Sbjct: 155 HVKITDFGLAKLLGAE--------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206

Query: 251 CIMGEMI-RGGVLFPG 265
             + E++  G   + G
Sbjct: 207 VTVWELMTFGSKPYDG 222

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 75.8 bits (187), Expect = 6e-16
 Identities = 40/221 (18%), Positives = 78/221 (35%), Gaps = 52/221 (23%)

Query: 76  LGAGA----------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHK 121
           LG+G               + +  V IK +          +++++        +  ++H 
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVI-----EDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLL---YQMLCGI 177
           +I+ LL              + LV + +   +L   ++          LL    Q+  G+
Sbjct: 76  HIVRLLGLCPGSS-------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------- 230
            +L   G++HR+L   N+++KS   +++ DFG+A                          
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP---------DDKQLLYSEAKT 179

Query: 231 -----APEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
                A E I    Y    D+WS G  + E++  G   + G
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 75.4 bits (186), Expect = 6e-16
 Identities = 67/263 (25%), Positives = 92/263 (34%), Gaps = 75/263 (28%)

Query: 50  DQWKELIYQELPISH-QMGKKRHNTSHLGAGA--------AYDTATQQN---VAIKKLSR 97
            +W      E P +    GK       LGAGA        AY          VA+K L +
Sbjct: 16  HKW------EFPRNRLSFGKT------LGAGAFGKVVEATAYGLIKSDAAMTVAVKML-K 62

Query: 98  PFQNVTHAKRAYREFKLMK-LVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM------- 149
           P  ++T  +    E K++  L NH NI+ LL A T            ++ E         
Sbjct: 63  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT------LVITEYCCYGDLLN 116

Query: 150 --------------DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
                            + +  ++ LD E +    YQ+  G+  L S   IHRDL   NI
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176

Query: 196 VVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYKEN 243
           ++      KI DFGLAR                Y             APE I    Y   
Sbjct: 177 LLTHGRITKICDFGLARDIKN---------DSNYVVKGNARLPVKWMAPESIFNCVYTFE 227

Query: 244 VDIWSVGCIMGEMI-RGGVLFPG 265
            D+WS G  + E+   G   +PG
Sbjct: 228 SDVWSYGIFLWELFSLGSSPYPG 250

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 75.0 bits (185), Expect = 8e-16
 Identities = 47/219 (21%), Positives = 84/219 (38%), Gaps = 44/219 (20%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQD 141
            + + A+K L     N         +F     +MK  +H N++ LL      +       
Sbjct: 52  KKIHCAVKSL-----NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS----- 101

Query: 142 VYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
             +V+  M   +L   I+    +   + +     Q+  G+K+L S   +HRDL   N ++
Sbjct: 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML 161

Query: 198 KSDCTLKILDFGLARTAGTTFMMTPYVVTR-YYR--------------APEVILGMGYKE 242
               T+K+ DFGLAR           +  + YY               A E +    +  
Sbjct: 162 DEKFTVKVADFGLAR----------DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211

Query: 243 NVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKIIGKMR 280
             D+WS G ++ E++ RG   +P  +  D    ++   R
Sbjct: 212 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 250

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 75.0 bits (185), Expect = 8e-16
 Identities = 48/201 (23%), Positives = 84/201 (41%), Gaps = 36/201 (17%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
            AIK L      +   +   RE  LM+ +NH N++ L+    P + L      ++++  M
Sbjct: 52  CAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL-----PHVLLPYM 105

Query: 150 DA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
              +L Q I+    +   + +     Q+  G+++L     +HRDL   N ++    T+K+
Sbjct: 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKV 165

Query: 206 LDFGLARTAGTTFMMTPYVVTR-YYR--------------APEVILGMGYKENVDIWSVG 250
            DFGLAR           ++ R YY               A E +    +    D+WS G
Sbjct: 166 ADFGLAR----------DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFG 215

Query: 251 CIMGEMI-RGGVLFPGTDHID 270
            ++ E++ RG   +   D  D
Sbjct: 216 VLLWELLTRGAPPYRHIDPFD 236

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 58/246 (23%), Positives = 99/246 (40%), Gaps = 58/246 (23%)

Query: 45  REHTVDQWKELIYQELPISH-QMGKKRHNTSHLGAG-------AAYDTATQQNVAIKKLS 96
           +    D+W      E+P    ++ ++      LGAG         Y+  T+  VA+K L 
Sbjct: 1   KPWWEDEW------EVPRETLKLVER------LGAGQFGEVWMGYYNGHTK--VAVKSLK 46

Query: 97  RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQ 155
              Q          E  LMK + H+ ++ L    T +        +Y++ E M+  +L  
Sbjct: 47  ---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-------IYIITEYMENGSLVD 96

Query: 156 VIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
            ++    + L   ++  +  Q+  G+  +     IHRDL+ +NI+V    + KI DFGLA
Sbjct: 97  FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156

Query: 212 RTAGTTFMMTPYVVTRYYR-----------APEVILGMGYKENVDIWSVGCIMGEMI-RG 259
           R               Y             APE I    +    D+WS G ++ E++  G
Sbjct: 157 RLIED---------NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207

Query: 260 GVLFPG 265
            + +PG
Sbjct: 208 RIPYPG 213

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 74.2 bits (183), Expect = 1e-15
 Identities = 43/197 (21%), Positives = 76/197 (38%), Gaps = 36/197 (18%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
            +  VAIK +    +     +    E ++M  ++H  ++ L      Q        + LV
Sbjct: 31  NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP------ICLV 81

Query: 146 MELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
            E M+   L   ++        E +  +   +  G+ +L  A +IHRDL   N +V  + 
Sbjct: 82  TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ 141

Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSV 249
            +K+ DFG+ R          +V+   Y             +PEV     Y    D+WS 
Sbjct: 142 VIKVSDFGMTR----------FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 191

Query: 250 GCIMGEMI-RGGVLFPG 265
           G +M E+   G + +  
Sbjct: 192 GVLMWEVFSEGKIPYEN 208

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 74.3 bits (183), Expect = 2e-15
 Identities = 45/202 (22%), Positives = 77/202 (38%), Gaps = 55/202 (27%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           VA+K L         ++ A ++F    +L+ ++ H++I+      T      E + + +V
Sbjct: 74  VAVKALK------EASESARQDFQREAELLTMLQHQHIVRFFGVCT------EGRPLLMV 121

Query: 146 MELM------------------DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIH 187
            E M                   A    V    L   ++  +  Q+  G+ +L     +H
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVH 181

Query: 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVI 235
           RDL   N +V     +KI DFG++R   +         T YYR             PE I
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYS---------TDYYRVGGRTMLPIRWMPPESI 232

Query: 236 LGMGYKENVDIWSVGCIMGEMI 257
           L   +    D+WS G ++ E+ 
Sbjct: 233 LYRKFTTESDVWSFGVVLWEIF 254

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 45/213 (21%), Positives = 80/213 (37%), Gaps = 32/213 (15%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQD 141
            + + A+K L     N         +F     +MK  +H N++ LL      +       
Sbjct: 116 KKIHCAVKSL-----NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS----- 165

Query: 142 VYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
             +V+  M   +L   I+    +   + +     Q+  G+K L S   +HRDL   N ++
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 225

Query: 198 KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR---------APEVILGMGYKENVDIWS 248
               T+K+ DFGLAR          +                A E +    +    D+WS
Sbjct: 226 DEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 281

Query: 249 VGCIMGEMI-RGGVLFPGTDHIDQWNKIIGKMR 280
            G ++ E++ RG   +P  +  D    ++   R
Sbjct: 282 FGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 314

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 73.4 bits (181), Expect = 2e-15
 Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 67/228 (29%)

Query: 76  LGAGA-----------AYDTATQQNVAIKKLSRPFQNVTHAKRA--YREFKLMKLVNHKN 122
           LG GA              T  +  VA+K L    ++ T A R    RE +L+  + H++
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL----KDPTLAARKDFQREAELLTNLQHEH 78

Query: 123 IIGLLNAFTPQKSLEEFQDVYLVMELM-------------------DANLCQVIQMDLDH 163
           I+             +   + +V E M                        +  + +L  
Sbjct: 79  IVKFYGVCG------DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132

Query: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPY 223
            +M ++  Q+  G+ +L S   +HRDL   N +V ++  +KI DFG++R           
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----------- 181

Query: 224 VVTR--YYR------------APEVILGMGYKENVDIWSVGCIMGEMI 257
            V    YYR             PE I+   +    D+WS G I+ E+ 
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 73.4 bits (181), Expect = 2e-15
 Identities = 40/196 (20%), Positives = 78/196 (39%), Gaps = 34/196 (17%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
            Q +VAIK +    +          E K+M  ++H+ ++ L    T Q+       ++++
Sbjct: 47  GQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP------IFII 97

Query: 146 MELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
            E M      N  + ++     +++  +   +   +++L S   +HRDL   N +V    
Sbjct: 98  TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 157

Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYR-----------APEVILGMGYKENVDIWSVG 250
            +K+ DFGL+R               Y              PEV++   +    DIW+ G
Sbjct: 158 VVKVSDFGLSRYVLD---------DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 208

Query: 251 CIMGEMI-RGGVLFPG 265
            +M E+   G + +  
Sbjct: 209 VLMWEIYSLGKMPYER 224

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 73.4 bits (181), Expect = 3e-15
 Identities = 46/197 (23%), Positives = 72/197 (36%), Gaps = 39/197 (19%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           VA+K L     +V     A  +F      M  ++H+N+I L               + +V
Sbjct: 49  VAVKCLK---PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-------MKMV 98

Query: 146 MELMDA-NLCQVIQMDLDHERMSYLLY---QMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
            EL    +L   ++    H  +  L     Q+  G+ +L S   IHRDL   N+++ +  
Sbjct: 99  TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD 158

Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSV 249
            +KI DFGL R               +Y             APE +    +    D W  
Sbjct: 159 LVKIGDFGLMRALPQN--------DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMF 210

Query: 250 GCIMGEMI-RGGVLFPG 265
           G  + EM   G   + G
Sbjct: 211 GVTLWEMFTYGQEPWIG 227

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 73.9 bits (182), Expect = 3e-15
 Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 45/229 (19%)

Query: 75  HLGAGA---------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHK 121
            +GAG             +  + +VAIK L      V + ++  R+F     +M   +H 
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHP 106

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGI 177
           NII L    T  K       V +V E M+     +  +         ++  +L  +  G+
Sbjct: 107 NIIRLEGVVTKSKP------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------- 230
           K+L   G +HRDL   NI++ S+   K+ DFGL R      ++       Y         
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR------VLEDDPEAAYTTRGGKIPI 214

Query: 231 ---APEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKI 275
              +PE I    +    D+WS G ++ E++  G   +    + D    +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 73.1 bits (180), Expect = 4e-15
 Identities = 48/196 (24%), Positives = 82/196 (41%), Gaps = 38/196 (19%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           VAIK L        + ++   +F     +M   +H NII L    +      +++ + ++
Sbjct: 76  VAIKTL-----KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS------KYKPMMII 124

Query: 146 MELMDA-NLCQVIQMDLDHERMSYLLYQMLCGI----KHLHSAGIIHRDLKPSNIVVKSD 200
            E M+   L + ++       +  L+  ML GI    K+L +   +HRDL   NI+V S+
Sbjct: 125 TEYMENGALDKFLREKDGEFSVLQLV-GMLRGIAAGMKYLANMNYVHRDLAARNILVNSN 183

Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYR----------APEVILGMGYKENVDIWSVG 250
              K+ DFGL+R      ++       Y            APE I    +    D+WS G
Sbjct: 184 LVCKVSDFGLSR------VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFG 237

Query: 251 CIMGEMI-RGGVLFPG 265
            +M E++  G   +  
Sbjct: 238 IVMWEVMTYGERPYWE 253

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 45/193 (23%), Positives = 79/193 (40%), Gaps = 33/193 (17%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VAIK L +        +   RE ++M  +++  I+ L+     +        + LVME+ 
Sbjct: 366 VAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-------LMLVMEMA 417

Query: 150 DA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
               L + +     ++    ++ LL+Q+  G+K+L     +HR+L   N+++ +    KI
Sbjct: 418 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKI 477

Query: 206 LDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIM 253
            DFGL++  G            YY             APE I    +    D+WS G  M
Sbjct: 478 SDFGLSKALGAD--------DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 529

Query: 254 GEMI-RGGVLFPG 265
            E +  G   +  
Sbjct: 530 WEALSYGQKPYKK 542

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 72.3 bits (178), Expect = 8e-15
 Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 53/211 (25%)

Query: 90  VAIKKLSRPFQNVTHAKRA--YREFKLMK-LVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
           VA+K L     + T    +    E ++MK +  HKNII LL A T    L      Y+++
Sbjct: 70  VAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL------YVIV 120

Query: 147 ELM-------------------DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIH 187
           E                       ++ +V +  +  + +    YQ+  G+++L S   IH
Sbjct: 121 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 180

Query: 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVI 235
           RDL   N++V  +  +KI DFGLAR               YY+            APE +
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINN---------IDYYKKTTNGRLPVKWMAPEAL 231

Query: 236 LGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
               Y    D+WS G +M E+   GG  +PG
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 72.0 bits (177), Expect = 1e-14
 Identities = 58/211 (27%), Positives = 84/211 (39%), Gaps = 53/211 (25%)

Query: 90  VAIKKLSRPFQNVTHAKRA--YREFKLMK-LVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
           VA+K L     + T    +    E ++MK +  HKNII LL A T    L      Y+++
Sbjct: 104 VAVKMLK---SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL------YVIV 154

Query: 147 ELM-------------------DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIH 187
           E                       N     +  L  + +    YQ+  G+++L S   IH
Sbjct: 155 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 214

Query: 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVI 235
           RDL   N++V  D  +KI DFGLAR               YY+            APE +
Sbjct: 215 RDLAARNVLVTEDNVMKIADFGLARDIHH---------IDYYKKTTNGRLPVKWMAPEAL 265

Query: 236 LGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
               Y    D+WS G ++ E+   GG  +PG
Sbjct: 266 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 71.5 bits (176), Expect = 1e-14
 Identities = 63/285 (22%), Positives = 102/285 (35%), Gaps = 85/285 (29%)

Query: 36  GPYDHSVDEREHTV-DQWKELIYQELPISH-QMGKKRHNTSHLGAGA--------AYDTA 85
           GP   SVD  +     +W      E P  +  +GK       LG G         A+   
Sbjct: 1   GPLSLSVDAFKILEDPKW------EFPRKNLVLGKT------LGEGEFGKVVKATAFHLK 48

Query: 86  TQQN---VAIKKLSRPFQNVTHAKRA--YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
            +     VA+K L    +N + ++      EF ++K VNH ++I L  A +    L    
Sbjct: 49  GRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL---- 101

Query: 141 DVYLVMELM---------------------------DANLCQVIQMDLDHERMSYLLYQM 173
              L++E                              ++L    +  L    +    +Q+
Sbjct: 102 --LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159

Query: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR--- 230
             G+++L    ++HRDL   NI+V     +KI DFGL+R                Y    
Sbjct: 160 SQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE---------EDSYVKRS 210

Query: 231 ---------APEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
                    A E +    Y    D+WS G ++ E++  GG  +PG
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 71.2 bits (175), Expect = 2e-14
 Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 53/211 (25%)

Query: 90  VAIKKLSRPFQNVTHAKRA--YREFKLMK-LVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
           VA+K L     + T    +    E ++MK +  HKNII LL A T    L      Y+++
Sbjct: 116 VAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL------YVIV 166

Query: 147 ELM-------------------DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIH 187
           E                       ++ +V +  +  + +    YQ+  G+++L S   IH
Sbjct: 167 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 226

Query: 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVI 235
           RDL   N++V  +  +KI DFGLAR               YY+            APE +
Sbjct: 227 RDLAARNVLVTENNVMKIADFGLARDINN---------IDYYKKTTNGRLPVKWMAPEAL 277

Query: 236 LGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
               Y    D+WS G +M E+   GG  +PG
Sbjct: 278 FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 70.7 bits (174), Expect = 2e-14
 Identities = 43/203 (21%), Positives = 75/203 (36%), Gaps = 55/203 (27%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           VAIK L               EF     L   + H N++ LL   T      + Q + ++
Sbjct: 42  VAIKTL-----KDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT------KDQPLSMI 90

Query: 146 MELM-------------------DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGII 186
                                    +  + ++  L+     +L+ Q+  G+++L S  ++
Sbjct: 91  FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVV 150

Query: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR------------APEV 234
           H+DL   N++V     +KI D GL R      +        YY+            APE 
Sbjct: 151 HKDLATRNVLVYDKLNVKISDLGLFR-----EVYA----ADYYKLLGNSLLPIRWMAPEA 201

Query: 235 ILGMGYKENVDIWSVGCIMGEMI 257
           I+   +  + DIWS G ++ E+ 
Sbjct: 202 IMYGKFSIDSDIWSYGVVLWEVF 224

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 70.3 bits (173), Expect = 3e-14
 Identities = 40/196 (20%), Positives = 71/196 (36%), Gaps = 41/196 (20%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREF----KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
           VA+K                 +F     +MK ++H +I+ L+     +         +++
Sbjct: 43  VAVKTC-----KKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-------TWII 90

Query: 146 MELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
           MEL       +  +  +  L    +     Q+   + +L S   +HRD+   NI+V S  
Sbjct: 91  MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE 150

Query: 202 TLKILDFGLARTAGTTFMMTPYVVTRYYR-----------APEVILGMGYKENVDIWSVG 250
            +K+ DFGL+R               YY+           +PE I    +    D+W   
Sbjct: 151 CVKLGDFGLSRYIED---------EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFA 201

Query: 251 CIMGEMI-RGGVLFPG 265
             M E++  G   F  
Sbjct: 202 VCMWEILSFGKQPFFW 217

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 70.8 bits (174), Expect = 3e-14
 Identities = 68/283 (24%), Positives = 100/283 (35%), Gaps = 81/283 (28%)

Query: 36  GPYDHSVDEREHTVD-QWKELIYQELPISH-QMGKKRHNTSHLGAGA--------AYD-- 83
                 VD RE+  D +W      E P  + + GK       LG+GA        AY   
Sbjct: 23  DNEYFYVDFREYEYDLKW------EFPRENLEFGKV------LGSGAFGKVMNATAYGIS 70

Query: 84  -TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMK-LVNHKNIIGLLNAFTPQKSLEEFQD 141
            T     VA+K L +   + +  +    E K+M  L +H+NI+ LL A T    +     
Sbjct: 71  KTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI----- 124

Query: 142 VYLVMELM--------------------------DANLCQVIQMDLDHERMSYLLYQMLC 175
            YL+ E                                 +     L  E +    YQ+  
Sbjct: 125 -YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183

Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR----- 230
           G++ L     +HRDL   N++V     +KI DFGLAR   +            Y      
Sbjct: 184 GMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS---------DSNYVVRGNA 234

Query: 231 -------APEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
                  APE +    Y    D+WS G ++ E+   G   +PG
Sbjct: 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 70.4 bits (173), Expect = 4e-14
 Identities = 48/227 (21%), Positives = 82/227 (36%), Gaps = 41/227 (18%)

Query: 75  HLGAGA---------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 125
            +G+G                   VAIK L +        +    E  +M   +H NII 
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH 181
           L    T  +         +V E M+  +L   ++         ++  +L  +  G+++L 
Sbjct: 115 LEGVVTRGRL------AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR----------- 230
             G +HRDL   N++V S+   K+ DFGL+R                             
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSR--------VLEDDPDAAYTTTGGKIPIRW 220

Query: 231 -APEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKI 275
            APE I    +    D+WS G +M E++  G   +    + D  + +
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 69.6 bits (171), Expect = 5e-14
 Identities = 45/196 (22%), Positives = 82/196 (41%), Gaps = 33/196 (16%)

Query: 87  QQNVAIKKLSRPFQNVTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
            + VA+K L +   N    K     E  +M+ +++  I+ ++     +          LV
Sbjct: 44  VKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-------WMLV 95

Query: 146 MELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
           ME+ +   L + +Q    +  + +  L++Q+  G+K+L  +  +HRDL   N+++ +   
Sbjct: 96  MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY 155

Query: 203 LKILDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVG 250
            KI DFGL++               YY+            APE I    +    D+WS G
Sbjct: 156 AKISDFGLSKALRAD--------ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 207

Query: 251 CIMGEMI-RGGVLFPG 265
            +M E    G   + G
Sbjct: 208 VLMWEAFSYGQKPYRG 223

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 70.0 bits (172), Expect = 6e-14
 Identities = 54/234 (23%), Positives = 81/234 (34%), Gaps = 62/234 (26%)

Query: 76  LGAGA--------AYDTATQQN---VAIKKLSRPFQNVTHAKRA--YREFKLMK-LVNHK 121
           LGAGA        A+    +     VA+K L          ++     E K+M  L  H+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQHE 110

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELM-----------------DANLCQVIQMDLDHE 164
           NI+ LL A T    +       ++ E                         +        
Sbjct: 111 NIVNLLGACTHGGPV------LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164

Query: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYV 224
            + +   Q+  G+  L S   IHRD+   N+++ +    KI DFGLAR      +M    
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMN--- 216

Query: 225 VTRYYR------------APEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
               Y             APE I    Y    D+WS G ++ E+   G   +PG
Sbjct: 217 -DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 69.2 bits (170), Expect = 7e-14
 Identities = 45/193 (23%), Positives = 77/193 (39%), Gaps = 33/193 (17%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELM 149
           VAIK L +        +   RE ++M  +++  I+ L+     +        + LVME+ 
Sbjct: 40  VAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-------LMLVMEMA 91

Query: 150 DA----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
                       + ++    ++ LL+Q+  G+K+L     +HRDL   N+++ +    KI
Sbjct: 92  GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKI 151

Query: 206 LDFGLARTAGTTFMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIM 253
            DFGL++  G            YY             APE I    +    D+WS G  M
Sbjct: 152 SDFGLSKALGAD--------DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 203

Query: 254 GEMI-RGGVLFPG 265
            E +  G   +  
Sbjct: 204 WEALSYGQKPYKK 216

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 68.5 bits (168), Expect = 1e-13
 Identities = 34/239 (14%), Positives = 73/239 (30%), Gaps = 58/239 (24%)

Query: 56  IYQELPISH-QMGKKRHNTSHLGAGA-------------AYDTATQQNVAIKKLSRPFQN 101
           ++ ++        +       LG G               Y    +  V +K L    + 
Sbjct: 1   VFHKIRNEDLIFNES------LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KA 51

Query: 102 VTHAKRAY-REFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ- 158
             +   ++     +M  ++HK+++                   LV E +   +L   ++ 
Sbjct: 52  HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE------NILVQEFVKFGSLDTYLKK 105

Query: 159 --MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL--------KILDF 208
               ++      +  Q+   +  L    +IH ++   NI++  +           K+ D 
Sbjct: 106 NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165

Query: 209 GLARTAGTTFMMTPYVVTRYYR------APEVIL-GMGYKENVDIWSVGCIMGEMIRGG 260
           G++ T          +     +       PE I          D WS G  + E+  GG
Sbjct: 166 GISIT---------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGG 215

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 45/211 (21%), Positives = 71/211 (33%), Gaps = 59/211 (27%)

Query: 88  QNVAIKKLSRPFQNVTHAKRA--YREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
             VA+K L    +  +   +A   RE  LM   ++ NI+ LL      K +       L+
Sbjct: 78  TMVAVKMLK---EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM------CLL 128

Query: 146 MELM---------------------------DANLCQVIQMDLDHERMSYLLYQMLCGIK 178
            E M                            A +       L       +  Q+  G+ 
Sbjct: 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 188

Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYR-------- 230
           +L     +HRDL   N +V  +  +KI DFGL+R   +           YY+        
Sbjct: 189 YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS---------ADYYKADGNDAIP 239

Query: 231 ----APEVILGMGYKENVDIWSVGCIMGEMI 257
                PE I    Y    D+W+ G ++ E+ 
Sbjct: 240 IRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 67.4 bits (165), Expect = 6e-13
 Identities = 44/231 (19%), Positives = 80/231 (34%), Gaps = 61/231 (26%)

Query: 76  LGAGA-----------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNH 120
           LG GA             +  +   VA+K L         +++   +F     ++   NH
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-----PEVCSEQDELDFLMEALIISKFNH 133

Query: 121 KNIIGLLNAFTPQKSLEEFQDVYLVMELM----------DANLCQVIQMDLDHERMSYLL 170
           +NI+  +          +    ++++ELM          +          L    + ++ 
Sbjct: 134 QNIVRCIGVSL------QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTTFMMTPYVVTR 227
             + CG ++L     IHRD+   N ++         KI DFG+AR      +        
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYR----AG 238

Query: 228 YYR------------APEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
           YYR             PE  +   +    D WS G ++ E+   G + +P 
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 66.9 bits (164), Expect = 6e-13
 Identities = 45/231 (19%), Positives = 79/231 (34%), Gaps = 61/231 (26%)

Query: 76  LGAGA-----------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREF----KLMKLVNH 120
           LG GA             +  +   VA+K L         +++   +F     ++   NH
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-----PEVCSEQDELDFLMEALIISKFNH 92

Query: 121 KNIIGLLNAFTPQKSLEEFQDVYLVMELM----------DANLCQVIQMDLDHERMSYLL 170
           +NI+  +          +    +++MELM          +          L    + ++ 
Sbjct: 93  QNIVRCIGVSL------QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146

Query: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTTFMMTPYVVTR 227
             + CG ++L     IHRD+   N ++         KI DFG+AR               
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---------AS 197

Query: 228 YYR------------APEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFPG 265
           YYR             PE  +   +    D WS G ++ E+   G + +P 
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 66.6 bits (163), Expect = 7e-13
 Identities = 33/142 (23%), Positives = 66/142 (46%), Gaps = 21/142 (14%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ 140
             +  T + VAIK         + A + + E++  K +   + I  +  F P     ++ 
Sbjct: 28  GKNLYTNEYVAIKLEPMK----SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC---GKYN 80

Query: 141 DVYLVMELMDANLCQVIQMDLDHERMSY-----LLYQMLCGIKHLHSAGIIHRDLKPSNI 195
              +V+EL+  +L  +   DL     S      +  Q++  ++++HS  +I+RD+KP N 
Sbjct: 81  --AMVLELLGPSLEDL--FDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENF 136

Query: 196 VV-----KSDCTLKILDFGLAR 212
           ++     K+   + I+DF LA+
Sbjct: 137 LIGRPGNKTQQVIHIIDFALAK 158

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 62.6 bits (153), Expect = 2e-11
 Identities = 54/197 (27%), Positives = 79/197 (40%), Gaps = 46/197 (23%)

Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFK----LMKLVNHKNIIGLLN------------AFT 131
             VA+KKL+         +   ++F     +M    H+N++ LL              + 
Sbjct: 55  TTVAVKKLAA--MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112

Query: 132 PQKSLEEFQDVYLVMELMDANLCQVIQMDLD-HERMSYLLYQMLC-----GIKHLHSAGI 185
           P  SL +         L   +        L  H R        +      GI  LH    
Sbjct: 113 PNGSLLDR--------LSCLDGTPP----LSWHMRCK------IAQGAANGINFLHENHH 154

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTTFMMTPYVV-TRYYRAPEVILGMGYKE 242
           IHRD+K +NI++    T KI DFGLAR +      +MT  +V T  Y APE + G     
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITP 213

Query: 243 NVDIWSVGCIMGEMIRG 259
             DI+S G ++ E+I G
Sbjct: 214 KSDIYSFGVVLLEIITG 230

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 61.6 bits (150), Expect = 3e-11
 Identities = 34/154 (22%), Positives = 66/154 (42%), Gaps = 27/154 (17%)

Query: 75  HLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
            +G G+        +    Q VAIK   R     + A +   E++  KL+     I  + 
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVY 72

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY-----LLYQMLCGIKHLHSA 183
            F  +          LV++L+  +L  +  +DL   + S         QML  ++ +H  
Sbjct: 73  YFGQE---GLHN--VLVIDLLGPSLEDL--LDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 184 GIIHRDLKPSNIVV-----KSDCTLKILDFGLAR 212
            +++RD+KP N ++     K+   + ++DFG+ +
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.5 bits (149), Expect = 5e-11
 Identities = 41/181 (22%), Positives = 68/181 (37%), Gaps = 22/181 (12%)

Query: 98  PFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVI 157
           P++      R  +++     V+ K  +  + +     S    ++  L     +     + 
Sbjct: 127 PYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186

Query: 158 QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT 217
           +  L  E +    +Q+  G++ L S   IHRDL   NI++     +KI DFGLAR     
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK- 245

Query: 218 FMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGEMI-RGGVLFP 264
                      Y             APE I    Y    D+WS G ++ E+   G   +P
Sbjct: 246 --------DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297

Query: 265 G 265
           G
Sbjct: 298 G 298

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 60.5 bits (147), Expect = 9e-11
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 25/152 (16%)

Query: 75  HLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
            +G+G+        D A  + VAIK         T   + + E K+ K++     I  + 
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIR 71

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY-----LLYQMLCGIKHLHSA 183
               +    ++    +VMEL+  +L  +   +    + S      L  QM+  I+++HS 
Sbjct: 72  WCGAE---GDYN--VMVMELLGPSLEDLF--NFCSRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 184 GIIHRDLKPSNIVV---KSDCTLKILDFGLAR 212
             IHRD+KP N ++   K    + I+DFGLA+
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 27/152 (17%), Positives = 57/152 (37%), Gaps = 26/152 (17%)

Query: 81  AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL---- 136
           A+ T   +  A   +             + E K  + V  K+ I           L    
Sbjct: 56  AFPTNKPEKDARHVVKV---EYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112

Query: 137 ------EEFQDV---YLVMELMDANLCQVIQMDLDHERMSY-----LLYQMLCGIKHLHS 182
                  EF+     ++VME +  +L ++      +          L  +ML  ++++H 
Sbjct: 113 FYGSGLTEFKGRSYRFMVMERLGIDLQKISG---QNGTFKKSTVLQLGIRMLDVLEYIHE 169

Query: 183 AGIIHRDLKPSNIVV--KSDCTLKILDFGLAR 212
              +H D+K +N+++  K+   + + D+GL+ 
Sbjct: 170 NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.8 bits (145), Expect = 2e-10
 Identities = 24/150 (16%), Positives = 58/150 (38%), Gaps = 22/150 (14%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL------ 136
           D  + ++V            +     + E K  +       I         K L      
Sbjct: 55  DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114

Query: 137 ----EEFQDV---YLVMELMDANLCQVIQMDLDHERMSY-----LLYQMLCGIKHLHSAG 184
                +       +++M+   ++L ++   + + +R S      L  ++L  ++++H   
Sbjct: 115 GSGLHDKNGKSYRFMIMDRFGSDLQKIY--EANAKRFSRKTVLQLSLRILDILEYIHEHE 172

Query: 185 IIHRDLKPSNIVV--KSDCTLKILDFGLAR 212
            +H D+K SN+++  K+   + ++D+GLA 
Sbjct: 173 YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 58.6 bits (142), Expect = 4e-10
 Identities = 19/149 (12%), Positives = 52/149 (34%), Gaps = 11/149 (7%)

Query: 74  SHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ 133
           +            +Q  ++K  ++  +         R  K +++   K +        P 
Sbjct: 62  APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121

Query: 134 ---KSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY-----LLYQMLCGIKHLHSAGI 185
                + + +  +LV+  +  +L   + +      +S      +  ++L  ++ LH    
Sbjct: 122 CMGFGVHQDKYRFLVLPSLGRSLQSALDV-SPKHVLSERSVLQVACRLLDALEFLHENEY 180

Query: 186 IHRDLKPSNIVV--KSDCTLKILDFGLAR 212
           +H ++   NI V  +    + +  +G A 
Sbjct: 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.5 bits (141), Expect = 7e-10
 Identities = 35/152 (23%), Positives = 69/152 (45%), Gaps = 25/152 (16%)

Query: 75  HLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
            +G+G+        +  T + VAIK  +      T   +   E K+ +++     I  + 
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKIYRILQGGTGIPNVR 69

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY-----LLYQMLCGIKHLHSA 183
            F  +    ++    LVM+L+  +L  +   +    ++S      L  QM+  ++ +HS 
Sbjct: 70  WFGVE---GDYN--VLVMDLLGPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 184 GIIHRDLKPSNIVV---KSDCTLKILDFGLAR 212
             +HRD+KP N ++   +    + I+DFGLA+
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 54.9 bits (133), Expect = 6e-09
 Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 7/89 (7%)

Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY-----YR 230
           G+ +LH+  IIHRD+K  NI++  +   KI DFG+++  GT    T ++ T       Y 
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK-GTELDQT-HLSTVVKGTLGYI 208

Query: 231 APEVILGMGYKENVDIWSVGCIMGEMIRG 259
            PE  +     E  D++S G ++ E++  
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.5 bits (130), Expect = 1e-08
 Identities = 24/194 (12%), Positives = 55/194 (28%), Gaps = 32/194 (16%)

Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ-------DVY 143
            +  LS    N T           ++      ++   + +   K     +        ++
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 144 LVMELMDAN--LCQVIQMDLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSD 200
           +V+E       L Q+            +L+Q+   +    ++    HRDL   N+++K  
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198

Query: 201 CTLKILDFGLAR-----TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
              K+      +     + G    +  Y ++R                        +  +
Sbjct: 199 SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE-----------------RDGIVVFCD 241

Query: 256 MIRGGVLFPGTDHI 269
           +     LF G    
Sbjct: 242 VSMDEDLFTGDGDY 255

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 53.0 bits (128), Expect = 3e-08
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 13/93 (13%)

Query: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRY---- 228
           G+ +LH      IIHRD+K +NI++  +    + DFGLA+        T +V T      
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK--DT-HVTTAVRGTI 199

Query: 229 -YRAPE-VILGMGYKENVDIWSVGCIMGEMIRG 259
            + APE +  G    E  D++  G ++ E+I G
Sbjct: 200 GHIAPEYLSTGK-SSEKTDVFGYGVMLLELITG 231

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 22/106 (20%), Positives = 50/106 (47%), Gaps = 15/106 (14%)

Query: 106 KRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER 165
           + A  EF+ ++ +    +        P+  +  ++   ++MEL+DA     ++++   E 
Sbjct: 149 RSARNEFRALQKLQGLAV--------PK--VYAWEGNAVLMELIDAKELYRVRVENPDE- 197

Query: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
              +L  +L  +   +  GI+H DL   N++V  +  + I+DF  +
Sbjct: 198 ---VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS 239

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 13/33 (39%), Positives = 18/33 (54%), Gaps = 2/33 (6%)

Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212
           LH   +IH DL  SN +   D  +  +DFGL +
Sbjct: 447 LHKNDVIHNDLTTSNFIFDKDLYI--IDFGLGK 477

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	288
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.66
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.1
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.1
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.06
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.68
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.51
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.49
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.14
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.82
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.77
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.7
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.69
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	97.6
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	97.57
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.53
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	97.47
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.35
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.29
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	97.25
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	97.22
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	97.08
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	97.07
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.03
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	97.01
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	96.94
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	96.88
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.85
3rp9_A	458	Mitogen-activated protein kinase; structural genom	96.73
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.73
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.6
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.6
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	96.4
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.35
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	95.91
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	95.82
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	95.66
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	95.4
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	95.22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	95.1
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	94.85
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	94.64
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	94.4
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	94.4
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	93.61
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	93.36
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	93.34
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	92.96
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	92.84
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	92.71
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	92.69
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	92.66
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	92.64
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	92.62
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	92.55
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	92.53
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	92.47
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	92.43
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	92.41
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	92.36
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	91.77
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	91.76
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	91.7
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	91.62
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	91.0
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	90.81
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	90.7
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	90.37
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	90.36
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	90.34
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	90.32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	90.23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	90.14
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	90.13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	89.98
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	89.92
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	89.88
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.83
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	89.81
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	89.7
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.62
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	89.4
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	89.17
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	89.05
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	88.75
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	88.47
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	88.21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	87.89
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	87.75
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	86.84
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	86.71
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	86.33
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.04
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	85.86
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	85.46
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	84.02
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	83.93
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	83.51
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	83.35
3mes_A	424	Choline kinase; malaria, structural genomics, stru	83.05
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	83.05
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	82.92
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	82.1

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.5e-52  Score=347.65  Aligned_cols=219  Identities=25%  Similarity=0.419  Sum_probs=190.7

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      +++.+.+.||+|.++.++++    .+..+++.||||++++.. ........+.+|+++|++++||||+++++++.+.+.+
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a----~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLA----RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             cccEEEEEEecccCeEEEEE----EECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            56788999999998888875    577899999999997532 2234456789999999999999999999999887765


Q ss_pred             cccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                            |+||||++| +|.+.+.  ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus       108 ------yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          108 ------YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             ------EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ------EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence                  999999986 6777765  3599999999999999999999999999999999999999999999999999987


Q ss_pred             cCC---CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccCC
Q psy11580        214 AGT---TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL  286 (288)
Q Consensus       214 ~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  286 (288)
                      ...   .....+.+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+++.+|.+.--..|+.+
T Consensus       182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~  257 (311)
T 4aw0_A          182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKF  257 (311)
T ss_dssp             CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTC
T ss_pred             cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            643   2234567899999999999999999999999999999999999999999999999999988766666543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.2e-51  Score=337.44  Aligned_cols=218  Identities=25%  Similarity=0.411  Sum_probs=174.6

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+.||+|.++.++++    .+..+|+.||||++++... .......+.+|+++|++++||||+++++++.+.+.+
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   88 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLA----YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI   88 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEE----ECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             eCeEEEEEEecCcCeEEEEE----EECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            35677888888888887775    5678899999999976432 233456789999999999999999999999887765


Q ss_pred             cccccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                            |+||||++|++++.+.  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        89 ------~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  162 (275)
T 3hyh_A           89 ------IMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM  162 (275)
T ss_dssp             ------EEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred             ------EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence                  9999999999998876  45999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCcccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      .......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+..++|.+....+|..
T Consensus       163 ~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~  234 (275)
T 3hyh_A          163 TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF  234 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             CCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            66655667799999999999999876 579999999999999999999999999888888888776666554

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.2e-51  Score=346.35  Aligned_cols=213  Identities=25%  Similarity=0.420  Sum_probs=182.1

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++.+.+.||+|.++.++++    .+..+|+.||||+++...........+.+|+++|++++|||||++++++.+.+.+ 
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~-   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILV----KSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSL-   98 (350)
T ss_dssp             CCEEEEEEC------CEEEE----EETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE-
T ss_pred             cceEEeEEEecCCCeEEEEE----EECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE-
Confidence            46678888999888888875    5678899999999987656666778899999999999999999999999877655 


Q ss_pred             ccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                           |+|||||+| +|.+.+..    .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus        99 -----yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~  173 (350)
T 4b9d_A           99 -----YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR  173 (350)
T ss_dssp             -----EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred             -----EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccce
Confidence                 999999986 67777742    26889999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        213 TAGTTF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       213 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ...... .....+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+++.+|++...
T Consensus       174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~  242 (350)
T 4b9d_A          174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF  242 (350)
T ss_dssp             CCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred             eecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence            765432 23456899999999999999999999999999999999999999999999999988887543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-50  Score=346.13  Aligned_cols=223  Identities=43%  Similarity=0.756  Sum_probs=190.7

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.||+|.++.+++    |.+..+|+.||||++++..........+.+|+++|+.++||||+++++++........
T Consensus        55 ~Y~~~~~lG~G~fG~V~~----a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSS----ARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             SEEEEEEEEECSSCEEEE----EEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred             CeEEEEEEecccCeEEEE----EEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence            345556666666666555    4577899999999998765566667788999999999999999999999887655455


Q ss_pred             cccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      ..++|+||||++|+|.+.+.  ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus       131 ~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          131 FKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             CCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             CCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            56789999999999998886  4599999999999999999999999999999999999999999999999999986533


Q ss_pred             -----CcccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        217 -----TFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       217 -----~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                           .......+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+..+++..|.+..+.++..
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence                 2233567899999999999885 46899999999999999999999999999999999999998877643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-50  Score=342.44  Aligned_cols=209  Identities=24%  Similarity=0.439  Sum_probs=180.2

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.||+|.++.++++    .+..+|+.||||+++..  .....+.+.+|+++|+.++|||||++++++.+.+.+  
T Consensus        75 ~y~~~~~iG~G~fG~V~~a----~~~~tg~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~--  146 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIA----TVRSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL--  146 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEE----EETTTCCEEEEEEEEGG--GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEE--
T ss_pred             hcEEeEEeecCcCeEEEEE----EECCCCCEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE--
Confidence            3556667777777777764    56789999999999753  223345688999999999999999999999887765  


Q ss_pred             cccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                          |+|||||+++ |.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus       147 ----~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          147 ----WVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             ----EEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ----EEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence                9999999975 555554 4599999999999999999999999999999999999999999999999999987654


Q ss_pred             C-cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        217 T-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       217 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      . ......+||+.|||||++.+..++.++|||||||++|||++|++||.+.+..+.+..|.+..
T Consensus       223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~  286 (346)
T 4fih_A          223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL  286 (346)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred             CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence            3 34466799999999999999999999999999999999999999999999988888887654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2e-50  Score=336.59  Aligned_cols=219  Identities=21%  Similarity=0.313  Sum_probs=183.4

Q ss_pred             hhhhcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      .+..+++.+++.||+|.++.+++|.-. ..+..++..||||+++.  .+....+++.+|+++|++++|||||+++++|.+
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--CChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            455678889999999999999988532 22345788999999975  344556789999999999999999999999988


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHhh---------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEE
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQM---------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV  196 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~---------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil  196 (288)
                      .+..      ++|||||++ +|.+++..               .+++..+..++.|+++||+|||+++||||||||+|||
T Consensus        87 ~~~~------~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NIL  160 (299)
T 4asz_A           87 GDPL------IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCL  160 (299)
T ss_dssp             SSSE------EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             CCEE------EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEE
Confidence            7765      999999986 56666642               3899999999999999999999999999999999999


Q ss_pred             EccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHH
Q psy11580        197 VKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQW  272 (288)
Q Consensus       197 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~  272 (288)
                      ++.++.+||+|||+|+......   ......||+.|||||++.+..++.++|||||||++|||++ |+.||.+.+..+++
T Consensus       161 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  240 (299)
T 4asz_A          161 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI  240 (299)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             ECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999999999998654322   1233468999999999999999999999999999999998 99999999999988


Q ss_pred             HHHHHHhC
Q psy11580        273 NKIIGKMR  280 (288)
Q Consensus       273 ~~i~~~~~  280 (288)
                      ..+.+...
T Consensus       241 ~~i~~~~~  248 (299)
T 4asz_A          241 ECITQGRV  248 (299)
T ss_dssp             HHHHHTCC
T ss_pred             HHHHcCCC
Confidence            88887654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.3e-51  Score=338.72  Aligned_cols=222  Identities=27%  Similarity=0.430  Sum_probs=182.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.||+|.++.++++. ...+..+++.||||++++.........++.+|+++|++++||||+++++++.+.+.+ 
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~-~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~-  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL-  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEE-ECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE-
T ss_pred             cccEEEEEEecCCCeEEEEEE-EccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE-
Confidence            457888999999988888763 112345788999999986543434445688899999999999999999999877665 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           |+||||++| +|.+.+.  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus       102 -----~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          102 -----YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             -----EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             -----EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence                 999999986 5667665  35899999999999999999999999999999999999999999999999999865


Q ss_pred             CC-CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccCC
Q psy11580        215 GT-TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL  286 (288)
Q Consensus       215 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  286 (288)
                      .. .....+.+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.+|.+.....|..+
T Consensus       177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~  249 (304)
T 3ubd_A          177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL  249 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred             cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcC
Confidence            33 3334567899999999999999999999999999999999999999999999999999988766666543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=343.84  Aligned_cols=209  Identities=24%  Similarity=0.439  Sum_probs=180.4

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.||+|.++.++++    .+..+|+.||||++...  .....+.+.+|+++|+.++|||||+++++|.+.+.+  
T Consensus       152 ~y~~~~~iG~G~fG~V~~a----~~~~tg~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~--  223 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIA----TVRSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL--  223 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEE----EETTTCCEEEEEEEEST--TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEE--
T ss_pred             hcEeeeEeccCcCcEEEEE----EECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEE--
Confidence            3556667777777777664    56788999999999763  223346688999999999999999999999887665  


Q ss_pred             cccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                          |+|||||+|+ |.+.+. ..+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|.....
T Consensus       224 ----~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          224 ----WVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             ----EEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             ----EEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence                9999999975 555554 4599999999999999999999999999999999999999999999999999987654


Q ss_pred             C-cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        217 T-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       217 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      . ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|....
T Consensus       300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~  363 (423)
T 4fie_A          300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL  363 (423)
T ss_dssp             SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred             CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence            3 33466789999999999999999999999999999999999999999999998888887654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-49  Score=329.48  Aligned_cols=211  Identities=24%  Similarity=0.337  Sum_probs=176.4

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++..+++.+++.||+|.++.++.|.       ....||||+++....+....+.|.+|+++|++++|||||++++++..+
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~-------~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  104 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGK-------WHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD  104 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEE-------SSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEE-------ECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC
Confidence            6788899999999999888888762       234699999986656667778899999999999999999999998653


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                       .      +++|||||++ +|.+.+.   ..+++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||
T Consensus       105 -~------~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFG  177 (307)
T 3omv_A          105 -N------LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFG  177 (307)
T ss_dssp             -S------CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred             -e------EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeecc
Confidence             3      3999999996 5666664   348999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC---CcccCCcccccccCchHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        210 LARTAGT---TFMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       210 ~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      +|+....   .......+||+.|||||++.+.   .++.++|||||||++|||++|+.||.+.+....+..++..
T Consensus       178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~  252 (307)
T 3omv_A          178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR  252 (307)
T ss_dssp             SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT
T ss_pred             CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence            9986543   2223456899999999999753   5899999999999999999999999998877766666544

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-49  Score=333.38  Aligned_cols=222  Identities=23%  Similarity=0.326  Sum_probs=184.5

Q ss_pred             hhhhhhcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccc
Q psy11580         52 WKELIYQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAF  130 (288)
Q Consensus        52 ~~~~~~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  130 (288)
                      +.++...++.+.+.||+|.++.++.|.-. ..+..+++.||||+++... .....++|.+|+.++++++|||||+++|+|
T Consensus        20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~   98 (308)
T 4gt4_A           20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVV   98 (308)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence            34566778888999999999999988532 2234678899999997542 334467899999999999999999999999


Q ss_pred             cCCCcccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCC
Q psy11580        131 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  191 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~  191 (288)
                      ...+..      ++|||||++ +|.+++..                  .+++..+..++.||++||+|||+++|||||||
T Consensus        99 ~~~~~~------~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK  172 (308)
T 4gt4_A           99 TKDQPL------SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLA  172 (308)
T ss_dssp             CSSSSC------EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EECCEE------EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            887765      999999986 56666632                  37899999999999999999999999999999


Q ss_pred             CCCEEEccCCcEEEeecccccccCCC---cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy11580        192 PSNIVVKSDCTLKILDFGLARTAGTT---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTD  267 (288)
Q Consensus       192 ~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~  267 (288)
                      |+|||++.++.+||+|||+|+.....   .......||+.|||||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus       173 ~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          173 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             GGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             ccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999765332   22345678999999999999999999999999999999998 899999999


Q ss_pred             chhHHHHHHHHhC
Q psy11580        268 HIDQWNKIIGKMR  280 (288)
Q Consensus       268 ~~~~~~~i~~~~~  280 (288)
                      ..+++..|.+...
T Consensus       253 ~~~~~~~i~~~~~  265 (308)
T 4gt4_A          253 NQDVVEMIRNRQV  265 (308)
T ss_dssp             HHHHHHHHHTTCC
T ss_pred             HHHHHHHHHcCCC
Confidence            9888888876543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-49  Score=335.12  Aligned_cols=219  Identities=21%  Similarity=0.322  Sum_probs=178.6

Q ss_pred             hhhhcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      .+...++.+.+.||+|.++.++.|.-. ..+..++..||||+++.  .+....++|.+|+++|++++|||||+++++|.+
T Consensus        37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~  114 (329)
T 4aoj_A           37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTE  114 (329)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            345577888999999999999988532 23456789999999975  345556789999999999999999999999988


Q ss_pred             CCcccccccEEEEEeccccc-HHHHHhh-----------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCC
Q psy11580        133 QKSLEEFQDVYLVMELMDAN-LCQVIQM-----------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN  194 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~n  194 (288)
                      .+..      ++|||||+++ |.+++..                 .+++.++..++.|+++||+|||+++||||||||+|
T Consensus       115 ~~~~------~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~N  188 (329)
T 4aoj_A          115 GRPL------LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN  188 (329)
T ss_dssp             SSSE------EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCEE------EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhh
Confidence            7765      9999999964 6665532                 38899999999999999999999999999999999


Q ss_pred             EEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchh
Q psy11580        195 IVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHID  270 (288)
Q Consensus       195 il~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~  270 (288)
                      ||++.++.+||+|||+|+......   ......||+.|||||++.+..++.++|||||||++|||++ |+.||.+.+..+
T Consensus       189 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~  268 (329)
T 4aoj_A          189 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE  268 (329)
T ss_dssp             EEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred             EEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999998653322   2234578999999999999999999999999999999998 999999999999


Q ss_pred             HHHHHHHHhC
Q psy11580        271 QWNKIIGKMR  280 (288)
Q Consensus       271 ~~~~i~~~~~  280 (288)
                      .+..|.+...
T Consensus       269 ~~~~i~~g~~  278 (329)
T 4aoj_A          269 AIDCITQGRE  278 (329)
T ss_dssp             HHHHHHHTCC
T ss_pred             HHHHHHcCCC
Confidence            8888887653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-48  Score=324.00  Aligned_cols=206  Identities=26%  Similarity=0.358  Sum_probs=169.5

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .+...||+|.++.++.|    .+..++..||+|++............+.+|+++|++++|||||+++++|....  ....
T Consensus        29 ~~~~~iG~G~fg~Vy~a----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~--~~~~  102 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKG----LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV--KGKK  102 (290)
T ss_dssp             EEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE--TTEE
T ss_pred             EeeeEEecCcCcEEEEE----EECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc--CCCc
Confidence            45556777777777664    46788999999999865555566778999999999999999999999986421  1123


Q ss_pred             cEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCCEEEcc-CCcEEEeeccccccc
Q psy11580        141 DVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKS-DCTLKILDFGLARTA  214 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--ivH~dl~~~nil~~~-~~~~kl~dfg~~~~~  214 (288)
                      .+++|||||++ +|.+.+.  ..+++..+..++.||+.||+|||+++  |+||||||+|||++. ++.+||+|||+|+..
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            46999999986 5666665  35899999999999999999999998  999999999999985 789999999999865


Q ss_pred             CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHH
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNK  274 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~  274 (288)
                      ... .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+.+....+.+
T Consensus       183 ~~~-~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~  240 (290)
T 3fpq_A          183 RAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR  240 (290)
T ss_dssp             CTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred             CCC-ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHH
Confidence            443 3345689999999999876 699999999999999999999999987665544433

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.4e-49  Score=330.82  Aligned_cols=205  Identities=26%  Similarity=0.300  Sum_probs=173.8

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.||+|.++.++++    .+..+|+.||||+++....       ..+|+.+++.++|||||++++++.+.+.+ 
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a----~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~-  125 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRM----KDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWV-  125 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEE-
T ss_pred             hheEeCcEeccCCCeEEEEE----EECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEE-
Confidence            45667778888888888775    5678899999999985322       23699999999999999999999877655 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC-cEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~-~~kl~dfg~~~~  213 (288)
                           |+||||++| +|.+.+.  ..+++..+..++.||+.||+|||+++||||||||+|||++.+| .+||+|||+|+.
T Consensus       126 -----~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~  200 (336)
T 4g3f_A          126 -----NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC  200 (336)
T ss_dssp             -----EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred             -----EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence                 999999996 5777665  3599999999999999999999999999999999999999987 599999999986


Q ss_pred             cCCCc------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        214 AGTTF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       214 ~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      .....      .....+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+++.+|.+..
T Consensus       201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~  272 (336)
T 4g3f_A          201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP  272 (336)
T ss_dssp             C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC
T ss_pred             ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC
Confidence            54321      1233579999999999999999999999999999999999999999988888888887643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.7e-47  Score=325.71  Aligned_cols=224  Identities=25%  Similarity=0.398  Sum_probs=182.4

Q ss_pred             cHHHhhhhhhcccccccccCCccccccccCcccee-ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCC-CCcce
Q psy11580         48 TVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAY-DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH-KNIIG  125 (288)
Q Consensus        48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~  125 (288)
                      ....| ++..+++.+++.||+|.|+.++.|..... ...+++.||||+++.. ........+.+|+++|++++| ||||+
T Consensus        55 ~~~~w-Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           55 DASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CHHHH-BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCccc-EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            34566 78889999999999999999998753222 2345678999999753 233456779999999999965 89999


Q ss_pred             eeccccCCCcccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCE
Q psy11580        126 LLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGII  186 (288)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~iv  186 (288)
                      ++|+|...+.     .+++|||||++ +|.+++..                  .+++..+..++.||++||+|||+++||
T Consensus       133 l~g~~~~~~~-----~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~ii  207 (353)
T 4ase_A          133 LLGACTKPGG-----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI  207 (353)
T ss_dssp             EEEEECCTTS-----CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEEEEecCC-----EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCee
Confidence            9999976432     24999999996 46666532                  278999999999999999999999999


Q ss_pred             eecCCCCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCC
Q psy11580        187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVL  262 (288)
Q Consensus       187 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p  262 (288)
                      ||||||+|||++.++.+||+|||+|+......   ......+|+.|||||++.+..++.++|||||||++|||++ |+.|
T Consensus       208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P  287 (353)
T 4ase_A          208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  287 (353)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence            99999999999999999999999998654322   2345578999999999999999999999999999999998 9999


Q ss_pred             CCCCCchhHH-HHHHHH
Q psy11580        263 FPGTDHIDQW-NKIIGK  278 (288)
Q Consensus       263 ~~~~~~~~~~-~~i~~~  278 (288)
                      |.+.+..+.+ +.+.+.
T Consensus       288 f~~~~~~~~~~~~i~~g  304 (353)
T 4ase_A          288 YPGVKIDEEFCRRLKEG  304 (353)
T ss_dssp             STTCCCSHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHHHHcC
Confidence            9987654444 444443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.8e-46  Score=308.73  Aligned_cols=201  Identities=27%  Similarity=0.402  Sum_probs=155.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc-
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL-  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-  136 (288)
                      .++.+.+.||+|.++.++++    .+..+|+.||||+++... .....+.+.+|+++|++++||||+++++++...+.. 
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a----~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~   79 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEA----KNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE   79 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEE----EETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred             hhCEEeeEEecCCCeEEEEE----EECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence            45677788999888888875    467889999999997542 334456789999999999999999999998754421 


Q ss_pred             -----cccccEEEEEecccc-cHHHHHhh-----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEE
Q psy11580        137 -----EEFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI  205 (288)
Q Consensus       137 -----~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl  205 (288)
                           .....+|+||||+++ +|.+.+..     ..++..++.++.||++||+|||++||+||||||+|||++.++.+||
T Consensus        80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence                 112346999999986 56666653     2455678899999999999999999999999999999999999999


Q ss_pred             eecccccccCCCc-------------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        206 LDFGLARTAGTTF-------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       206 ~dfg~~~~~~~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      +|||+|+......             .....+||+.|||||++.+..++.++|||||||++|||++   ||.+.
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            9999998654321             1234579999999999999999999999999999999996   77653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.9e-45  Score=310.99  Aligned_cols=212  Identities=22%  Similarity=0.445  Sum_probs=173.0

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  136 (288)
                      +.+.+.+.||+|.++.++++... .+..+++.||+|++...    ....++.+|+++|+.+ +||||+++++++...+.+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~-~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQ-LQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEE-BTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEc-ccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            45778888888888888876321 12346789999998643    2345678999999999 699999999999877655


Q ss_pred             cccccEEEEEeccccc-HHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC-CcEEEeeccccccc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTA  214 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~-~~~kl~dfg~~~~~  214 (288)
                            |+||||++++ |.+.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        96 ------~lvmE~~~g~~L~~~~-~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           96 ------VIAMPYLEHESFLDIL-NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             ------EEEEECCCCCCHHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             ------EEEEeCCCcccHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence                  9999999865 55544 679999999999999999999999999999999999999877 79999999999754


Q ss_pred             CCC-----------------------------cccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Q psy11580        215 GTT-----------------------------FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFP  264 (288)
Q Consensus       215 ~~~-----------------------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~  264 (288)
                      ...                             ....+.+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            321                             112345799999999999875 48999999999999999999999984


Q ss_pred             -CCCchhHHHHHHHHhCC
Q psy11580        265 -GTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       265 -~~~~~~~~~~i~~~~~~  281 (288)
                       +.++.+++.+|.+.+|.
T Consensus       249 ~~~~~~~~l~~I~~~~G~  266 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGS  266 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCH
T ss_pred             CCCCHHHHHHHHHHhcCC
Confidence             56777888888887764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.2e-44  Score=327.16  Aligned_cols=214  Identities=23%  Similarity=0.380  Sum_probs=184.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++.+.+.||+|.++.+++    |.+..+|+.||+|++...  .......+.+|+++|+.++||||+++++++.+.+.+ 
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~----~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-  229 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHR----VTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM-  229 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEE----EEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE-
T ss_pred             cccEEEEEEeeccCeEEEE----EEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE-
Confidence            3456667777777766665    457789999999999763  344456788999999999999999999999887765 


Q ss_pred             ccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC--CcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~--~~~kl~dfg~~  211 (288)
                           ++|||||+| +|++.+.   ..+++..+..++.||+.||+|||+++|+||||||+|||++.+  +.+||+|||+|
T Consensus       230 -----~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a  304 (573)
T 3uto_A          230 -----VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT  304 (573)
T ss_dssp             -----EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred             -----EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccce
Confidence                 999999986 5777774   348899999999999999999999999999999999999854  88999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.+|.+....++
T Consensus       305 ~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~  376 (573)
T 3uto_A          305 AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD  376 (573)
T ss_dssp             EECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             eEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence            988766666667899999999999999999999999999999999999999999999999999887655444

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.2e-45  Score=307.83  Aligned_cols=196  Identities=27%  Similarity=0.359  Sum_probs=155.1

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+++.||+|.++.++.|      ..+|+.||||+++..   .........|+..+.+++||||++++++|...+.  
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~------~~~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~--   71 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRG------KWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG--   71 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEE------EETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS--
T ss_pred             cEEEEEEEEeeCCCeEEEEE------EECCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC--
Confidence            35678899999999999987      346899999999742   2222233456666778899999999999976541  


Q ss_pred             ccccEEEEEecccc-cHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHC--------CCEeecCCCCCEEEccCCcEEEee
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDCTLKILD  207 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--------~ivH~dl~~~nil~~~~~~~kl~d  207 (288)
                      ....+++||||+++ +|.+.+. ..++++.+.+++.|++.||+|||++        +||||||||+|||++.++++||+|
T Consensus        72 ~~~~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           72 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CceEEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            12346999999996 5666664 4589999999999999999999987        899999999999999999999999


Q ss_pred             cccccccCCCc-----ccCCcccccccCchHhHhcC------CCCchhhHHHHHHHHHHHHhCCCCCC
Q psy11580        208 FGLARTAGTTF-----MMTPYVVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMIRGGVLFP  264 (288)
Q Consensus       208 fg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slg~il~~l~~g~~p~~  264 (288)
                      ||+|+......     .....+||+.|||||++.+.      .++.++|||||||++|||++|.+||.
T Consensus       152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~  219 (303)
T 3hmm_A          152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence            99997653321     12345799999999999864      35779999999999999999977653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.5e-44  Score=316.41  Aligned_cols=222  Identities=79%  Similarity=1.231  Sum_probs=188.9

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.+|+|.++.++.    +++..+++.||||++...........++.+|+++++.++||||+++++++...+..+.
T Consensus        63 ~y~~~~~lG~G~~g~V~~----a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           63 RYQNLKPIGSGAQGIVCA----AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             TEEEEEEEEECSSCEEEE----EEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             CeEEEEEeecCCCeEEEE----EEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            344555566655555554    3577889999999998765566677889999999999999999999999987766556


Q ss_pred             cccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        139 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                      ....++||||+++++.+.+...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       139 ~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  218 (464)
T 3ttj_A          139 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  218 (464)
T ss_dssp             CCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred             CCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence            67789999999999999888889999999999999999999999999999999999999999999999999998877665


Q ss_pred             ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+.+|++.++.+++
T Consensus       219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  284 (464)
T ss_dssp             CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            566778999999999999999999999999999999999999999999999999999999887653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.5e-44  Score=322.34  Aligned_cols=218  Identities=22%  Similarity=0.317  Sum_probs=175.0

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc----chhhHHHHHHHHHHHHHCCCCCcceeecccc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ----NVTHAKRAYREFKLMKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  131 (288)
                      ..+++.+.+.||+|.++.++++    .+..+|+.||||++++...    ..........++.+++.++||||++++++|.
T Consensus       187 slddf~i~k~LG~G~fG~V~la----~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGC----RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             chHHeEEEEEEecccCeEEEEE----EECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            4466788888888888888874    5678999999999974211    1122223334567777889999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      +.+.+      |+||||++| +|.+.+.  ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+||
T Consensus       263 ~~~~l------ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DF  336 (689)
T 3v5w_A          263 TPDKL------SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDL  336 (689)
T ss_dssp             CSSEE------EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             ECCEE------EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEeccc
Confidence            88765      999999986 5766665  35999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hhHHHHHHHHhCCCcc
Q psy11580        209 GLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDH---IDQWNKIIGKMREAHD  284 (288)
Q Consensus       209 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~---~~~~~~i~~~~~~~~~  284 (288)
                      |+|........ .+.+||+.|||||++.+ ..++.++|+|||||++|||++|.+||.+.+.   ..+...+...-...|+
T Consensus       337 GlA~~~~~~~~-~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~  415 (689)
T 3v5w_A          337 GLACDFSKKKP-HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD  415 (689)
T ss_dssp             TTCEECSSCCC-CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT
T ss_pred             ceeeecCCCCC-CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc
Confidence            99987655433 45699999999999964 6799999999999999999999999987543   2344455444444443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4e-42  Score=296.82  Aligned_cols=222  Identities=82%  Similarity=1.281  Sum_probs=180.2

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.    +++..+++.||||++............+.+|+.+++.++||||+++++++...+...
T Consensus        25 ~~y~~~~~lG~G~~g~V~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCA----AYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEE----EEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred             hheeEeeeeEecCCEEEEE----EEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence            3445555566665555554    356778999999999875556666778899999999999999999999998776555


Q ss_pred             ccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      .....++||||+++++.+.+...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus       101 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  180 (371)
T 2xrw_A          101 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  180 (371)
T ss_dssp             TCCEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred             cccceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence            55677999999999999988888999999999999999999999999999999999999999999999999999877655


Q ss_pred             cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+.++++.++.++
T Consensus       181 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  246 (371)
T 2xrw_A          181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC  246 (371)
T ss_dssp             ---------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCC
T ss_pred             cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            445567889999999999999999999999999999999999999999999999999988776553

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.7e-42  Score=289.97  Aligned_cols=217  Identities=25%  Similarity=0.464  Sum_probs=187.2

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++++    .+..+|+.||||++.....+......+.+|+++++.++||||+++++++...+.. 
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~-   89 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLA----RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL-   89 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE-
T ss_pred             CCEEEEEEEeeCCCEEEEEE----EECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE-
Confidence            45677788888887777765    4568899999999987555666677899999999999999999999999877654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||+++ ++.+.+.  ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++...
T Consensus        90 -----~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           90 -----YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF  164 (328)
T ss_dssp             -----EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred             -----EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence                 999999975 6666664  45899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCcccCCcccccccCchHhHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ..........+++.|+|||++.+..++ .++||||||+++|+|++|+.||.+.+..+....+.+.....|.
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~  235 (328)
T 3fe3_A          165 TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF  235 (328)
T ss_dssp             SSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred             CCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            665555667899999999999988765 7999999999999999999999999988888888776555443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-41  Score=293.69  Aligned_cols=221  Identities=38%  Similarity=0.749  Sum_probs=180.2

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.+|+|.++.++.+    .+..+++.||||++............+.+|+.+++.+. ||||+++++++...+
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~----~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKS----IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             HHTTEEEEEC-------CEEEE----EETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             ccCceEEEEEeeeCCCeEEEEE----EECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            3456777888888888777764    56788999999999766556677788899999999997 999999999997543


Q ss_pred             cccccccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        135 SLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      .    ...++||||+++++.+.+. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           83 D----RDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             S----SCEEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             C----CEEEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            1    3459999999999888776 4589999999999999999999999999999999999999999999999999975


Q ss_pred             cCC----------------------CcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        214 AGT----------------------TFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       214 ~~~----------------------~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      ...                      ........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            432                      112234578999999999987 678999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCcc
Q psy11580        271 QWNKIIGKMREAHD  284 (288)
Q Consensus       271 ~~~~i~~~~~~~~~  284 (288)
                      .+..|++.++.++.
T Consensus       239 ~~~~i~~~~~~p~~  252 (388)
T 3oz6_A          239 QLERIIGVIDFPSN  252 (388)
T ss_dssp             HHHHHHHHHCCCCH
T ss_pred             HHHHHHHhcCCCCH
Confidence            99999988876653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-41  Score=291.81  Aligned_cols=221  Identities=51%  Similarity=0.869  Sum_probs=185.8

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+|+.||||++............+.+|+++++.++||||+++++++.......
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  100 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSA----VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD  100 (367)
T ss_dssp             SSEEEEEEC------CEEEE----EETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred             ceEEEeEEeeecCCeEEEEE----EECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence            34566677777777666654    56788999999999765556566778899999999999999999999998776544


Q ss_pred             ccccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      ....+++|||++++++.+.+. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       101 ~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          101 DFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             TCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             cCceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            455679999999888877765 4589999999999999999999999999999999999999999999999999987654


Q ss_pred             CcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        217 TFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      .  .....+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+..+.+.+|++.++.++.
T Consensus       181 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~  247 (367)
T 1cm8_A          181 E--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA  247 (367)
T ss_dssp             S--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             c--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            3  344678999999999988 67899999999999999999999999999999999999998887664

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.6e-41  Score=284.11  Aligned_cols=218  Identities=36%  Similarity=0.625  Sum_probs=182.0

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ..+++.+.+.+|+|.++.++.+.    + .+++.||+|++............+.+|++++++++||||+++++++...+.
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~----~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   93 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAK----D-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC   93 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEE----E-TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred             hHhhhHhhhhccCCCCeEEEEEE----E-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence            44566777778887777777653    2 458999999998654444556778899999999999999999999987765


Q ss_pred             ccccccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      .      ++||||+++++.+.+..   .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        94 ~------~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           94 L------TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             E------EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             E------EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence            5      99999999998887763   38999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCC-cccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        213 TAGTT-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       213 ~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ..... .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+.+.++.+.++.+++
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  241 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP  241 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCT
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCCh
Confidence            76533 22344578999999999987 56899999999999999999999999999999999999998876554

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.1e-42  Score=292.84  Aligned_cols=221  Identities=24%  Similarity=0.391  Sum_probs=181.0

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHC-CCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  131 (288)
                      .+...++.+.+.+|+|.++.++++    .+..+++.||||++++.. ........+..|.++++.+ +||||+++++++.
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~----~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~   94 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLA----RVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ   94 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEE----EEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence            455677888899999888888875    456789999999997531 1223456678899999998 7999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      ..+..      ++||||+++ +|...+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~------~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DF  168 (353)
T 3txo_A           95 TPDRL------FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADF  168 (353)
T ss_dssp             CSSEE------EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCEE------EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccc
Confidence            77655      999999986 5666554  45899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC-CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        209 GLARTAGT-TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       209 g~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      |++..... .......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+.+.+|.+.....|.
T Consensus       169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~  245 (353)
T 3txo_A          169 GMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT  245 (353)
T ss_dssp             TTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred             cceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99986432 33345568999999999999988999999999999999999999999999999999998876655554

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9.6e-41  Score=282.27  Aligned_cols=216  Identities=35%  Similarity=0.601  Sum_probs=173.8

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|+++... .......+.+|++++++++||||+++++++...+.. 
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-   78 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKG----LNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKL-   78 (317)
T ss_dssp             --------------CEEEEE----ECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEE-
T ss_pred             cceeEeeEECCCCCEEEEEE----EECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeE-
Confidence            45677788888888877765    456789999999997542 223346788999999999999999999999877654 


Q ss_pred             ccccEEEEEecccccHHHHHhh--------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                           ++||||+++++.+.+..        .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus        79 -----~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  153 (317)
T 2pmi_A           79 -----TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFG  153 (317)
T ss_dssp             -----EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCS
T ss_pred             -----EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCc
Confidence                 99999999998887752        38899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-cccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        210 LARTAGTT-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       210 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ++...... .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+.+..|.+.++.++.
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  230 (317)
T 2pmi_A          154 LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE  230 (317)
T ss_dssp             SCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCT
T ss_pred             cceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            99876433 22345578999999999987 46899999999999999999999999999999999999988776543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3e-41  Score=287.15  Aligned_cols=219  Identities=25%  Similarity=0.358  Sum_probs=183.9

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.+|+|.++.++++    .+..+++.||+|++++.. ........+.+|+++++.++||||+++++++...+
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~   78 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILV----REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             ChHHeEEEEEEecCCCeEEEEE----EECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence            3466788888999888888775    456789999999997521 12234567889999999999999999999998776


Q ss_pred             cccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      ..      ++||||+++ +|...+.  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        79 ~~------~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a  152 (337)
T 1o6l_A           79 RL------CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC  152 (337)
T ss_dssp             EE------EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EE------EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccch
Confidence            55      999999987 5656554  34899999999999999999999999999999999999999999999999999


Q ss_pred             cccC-CCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        212 RTAG-TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       212 ~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      .... ........+||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.......|.......|.
T Consensus       153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~  226 (337)
T 1o6l_A          153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR  226 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred             hhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            8643 333345678999999999999999999999999999999999999999998888888777765444443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.2e-40  Score=278.44  Aligned_cols=217  Identities=34%  Similarity=0.570  Sum_probs=185.1

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++.+.+.+|+|.++.++.+    .+..+++.||+|++............+.+|++++++++||||+++++++...+.. 
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKA----KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL-   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEE----EETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE-
T ss_pred             CCceeeeEecCCCCeEEEEE----EECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEE-
Confidence            34567778888887777765    4667899999999987655656667889999999999999999999999876654 


Q ss_pred             ccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||+++++.+.+.   ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        77 -----~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 -----TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             -----EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             -----EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence                 9999999999888775   45899999999999999999999999999999999999999999999999999876


Q ss_pred             CCC-cccCCcccccccCchHhHhcCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCchhHHHHHHHHhCCCcc
Q psy11580        215 GTT-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       215 ~~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~il~~l~~g~~p-~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ... .......+++.|+|||++.+.. ++.++||||||+++|+|++|..| |.+.+..+.+.++.+.++.++.
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~  224 (292)
T 3o0g_A          152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            533 2234567899999999998765 79999999999999999987666 6778888888999988776543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-40  Score=285.28  Aligned_cols=215  Identities=25%  Similarity=0.361  Sum_probs=184.5

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+++.||+|++............+.+|+++++.++||||+++++++...+.. 
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~----~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~-  103 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRC----VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH-  103 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE-
T ss_pred             cCeEEeeEEecCCCeEEEEE----EECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE-
Confidence            45677788888877777764    4567899999999987555556677899999999999999999999999877654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC---cEEEeecccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~---~~kl~dfg~~  211 (288)
                           ++||||+.+ +|.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++   .+||+|||++
T Consensus       104 -----~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          104 -----YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             -----EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             -----EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence                 999999986 5767665  3489999999999999999999999999999999999998654   5999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+....+.++.......
T Consensus       179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~  249 (362)
T 2bdw_A          179 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY  249 (362)
T ss_dssp             BCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             eEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            87766555556789999999999999899999999999999999999999999988888888877665443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.5e-41  Score=287.50  Aligned_cols=220  Identities=53%  Similarity=0.914  Sum_probs=174.2

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+|+.||||++............+.+|+++++.++||||+++++++.......
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAA----FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             TTEEEEEECC----CCEEEE----EETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CceEEeeEEeecCCeEEEEE----EECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence            45566777777777766654    46788999999999876556666778899999999999999999999998765545


Q ss_pred             ccccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      .....++|+|+++++|.+.+. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       105 ~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          105 EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             GCCCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             cCCeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            556679999999888777665 4589999999999999999999999999999999999999999999999999987543


Q ss_pred             CcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        217 TFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .  .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+.+..|.+.++.++
T Consensus       185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  250 (367)
T 2fst_X          185 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  250 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             c--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            3  344578999999999987 6789999999999999999999999999999999999999887664

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=279.60  Aligned_cols=223  Identities=35%  Similarity=0.521  Sum_probs=183.1

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc---chhhHHHHHHHHHHHHHC---CCCCcceeeccc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ---NVTHAKRAYREFKLMKLV---NHKNIIGLLNAF  130 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~  130 (288)
                      ..++.+.+.+|+|.++.++.+    .+..+++.||+|++.....   .......+.+|+++++++   +||||+++++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~   83 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKA----RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC   83 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEE----ECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEE----EECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence            345667777777777766664    4668899999999974321   111234556677776666   599999999999


Q ss_pred             cCCCcccccccEEEEEecccccHHHHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEe
Q psy11580        131 TPQKSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL  206 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~  206 (288)
                      ..... ......++|||++++++.+.+...    +++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+
T Consensus        84 ~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           84 ATSRT-DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             EECCS-SSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             eccCC-CCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence            76542 122346999999999988887632    8999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       207 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      |||++.............+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+.++.+.++.++.
T Consensus       163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            999998776655556678899999999999999999999999999999999999999999999999999998876553

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.7e-40  Score=284.98  Aligned_cols=215  Identities=24%  Similarity=0.367  Sum_probs=181.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcch----hhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV----THAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+|+.||+|+++......    .....+.+|+.+++.++||||+++++++...
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~----~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKC----REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             hceEEeeEEeeCcCEEEEEE----EECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            34567777888777777664    466789999999998643221    1356788999999999999999999999876


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC----cEEEe
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKIL  206 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~----~~kl~  206 (288)
                      +..      ++||||+++ +|.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||+++.++    .+||+
T Consensus        88 ~~~------~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~  161 (361)
T 2yab_A           88 TDV------VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (361)
T ss_dssp             SEE------EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             CEE------EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence            654      999999975 6777665  3489999999999999999999999999999999999998876    79999


Q ss_pred             ecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       207 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      |||++.............||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..|.......
T Consensus       162 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~  237 (361)
T 2yab_A          162 DFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF  237 (361)
T ss_dssp             CCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred             ecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            9999987766555566789999999999999899999999999999999999999999998888888877654433

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-40  Score=292.65  Aligned_cols=222  Identities=39%  Similarity=0.728  Sum_probs=171.6

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.||+|.++.++.+    .+..+++.||||++............+.+|+++|+.++||||+++++++..... .
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~----~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~  127 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEA----YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV-E  127 (458)
T ss_dssp             TTEEECCC-------CEEEE----EECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT-T
T ss_pred             CCeEEeeEeeecCCeEEEEE----EECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc-c
Confidence            44667777777777766654    567789999999998765666677889999999999999999999999965432 2


Q ss_pred             ccccEEEEEecccccHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      .....|+|||++++++.+.+..  .+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....
T Consensus       128 ~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          128 KFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             TCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             cCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            3345799999999999888764  48999999999999999999999999999999999999999999999999998654


Q ss_pred             CCc----------------------------ccCCcccccccCchHhHh-cCCCCchhhHHHHHHHHHHHHh--------
Q psy11580        216 TTF----------------------------MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIR--------  258 (288)
Q Consensus       216 ~~~----------------------------~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slg~il~~l~~--------  258 (288)
                      ...                            .....++|+.|+|||++. +..++.++|||||||++|||++        
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            211                            223457799999999874 5678999999999999999998        


Q ss_pred             ---CCCCCCCCC--------------------chhHHHHHHHHhCCCcc
Q psy11580        259 ---GGVLFPGTD--------------------HIDQWNKIIGKMREAHD  284 (288)
Q Consensus       259 ---g~~p~~~~~--------------------~~~~~~~i~~~~~~~~~  284 (288)
                         |+++|.+.+                    ..+.+..|.+.++.++.
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~  336 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSE  336 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCH
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCH
Confidence               788887765                    25677888888876653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-40  Score=277.88  Aligned_cols=213  Identities=33%  Similarity=0.560  Sum_probs=178.6

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.+|+|.++.++.+.    + .+++.||+|++............+.+|+++++.++||||+++++++...+..  
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~----~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--   75 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQ----N-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL--   75 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEE----E-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCE--
T ss_pred             cchhhhhcccCCCEEEEEEE----c-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeE--
Confidence            45667788888887777752    3 5789999999976544444457788999999999999999999999877654  


Q ss_pred             cccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++|||++++++.+.+.   ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        76 ----~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           76 ----VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (288)
T ss_dssp             ----EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             ----EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence                9999999999888775   358999999999999999999999999999999999999999999999999997654


Q ss_pred             CC-cccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        216 TT-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       216 ~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .. .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+.+.++.+.++.+
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  220 (288)
T 1ob3_A          152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP  220 (288)
T ss_dssp             C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCC
Confidence            32 223445789999999999874 58999999999999999999999999999999999998877654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.2e-40  Score=287.09  Aligned_cols=221  Identities=24%  Similarity=0.381  Sum_probs=177.2

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHH-HHHCCCCCcceeeccccC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKL-MKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~  132 (288)
                      ....++.+.+.+|+|.++.++++    .+..+++.||+|++++... .......+..|..+ ++.++||||+++++++..
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~----~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~  110 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLA----RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT  110 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEE----EETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC
T ss_pred             CChhheEEEEEEeeCCCeEEEEE----EEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence            44567888999999988888875    4567889999999976422 22334556667776 567899999999999987


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .+..      ++||||+++ +|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus       111 ~~~~------~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG  184 (373)
T 2r5t_A          111 ADKL------YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG  184 (373)
T ss_dssp             SSEE------EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CCEE------EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCc
Confidence            7655      999999987 5666654  348999999999999999999999999999999999999999999999999


Q ss_pred             ccccc-CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        210 LARTA-GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       210 ~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      ++... .........+||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+.+.+|.+.....++.
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  261 (373)
T 2r5t_A          185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN  261 (373)
T ss_dssp             BCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSS
T ss_pred             cccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCC
Confidence            99863 23334456789999999999999999999999999999999999999999999988888888765544443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=280.14  Aligned_cols=217  Identities=24%  Similarity=0.414  Sum_probs=183.7

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.+|+|.++.++++    .+..+|+.||+|++++... .......+.+|..+++.++||||+++++++.+.+
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   79 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLI----RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   79 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             ChHHcEEEEEEeeCCCEEEEEE----EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence            3466788888999888887765    4567899999999975211 1233566788999999999999999999998776


Q ss_pred             cccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      ..      ++||||+++ +|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        80 ~~------~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a  153 (318)
T 1fot_A           80 QI------FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA  153 (318)
T ss_dssp             EE------EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             EE------EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcc
Confidence            54      999999986 5666665  35899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ......  ....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+.+.+|.+.....|+
T Consensus       154 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~  224 (318)
T 1fot_A          154 KYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP  224 (318)
T ss_dssp             EECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT
T ss_pred             eecCCc--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            876543  23458999999999999999999999999999999999999999999988888888876544443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.4e-40  Score=277.18  Aligned_cols=213  Identities=27%  Similarity=0.385  Sum_probs=173.7

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.+|+|.++.++.+      ..++..||||++............+.+|++++++++||||+++++++...
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRA------EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEE------EETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             cCChhHceeeeEeecCCCeEEEEE------EECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            455667788899999888888876      34688999999987655666677899999999999999999999999877


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh-----hCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCCEEEccCCcEEE
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKI  205 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~--ivH~dl~~~nil~~~~~~~kl  205 (288)
                      +..      ++||||+++ +|.+.+..     .+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||
T Consensus       107 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL  180 (309)
T 3p86_A          107 PNL------SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV  180 (309)
T ss_dssp             TCC------EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEE
T ss_pred             Cce------EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEE
Confidence            765      999999986 56666642     2899999999999999999999999  999999999999999999999


Q ss_pred             eecccccccCCCc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        206 LDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       206 ~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      +|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus       181 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  254 (309)
T 3p86_A          181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK  254 (309)
T ss_dssp             CCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS
T ss_pred             CCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            9999997654332 234457899999999999999999999999999999999999999998887776665433

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.9e-40  Score=283.93  Aligned_cols=221  Identities=24%  Similarity=0.372  Sum_probs=184.5

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHC-CCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLV-NHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  131 (288)
                      .+...++.+.+.+|+|.++.++++    .+..+++.||+|++++... .......+..|..+++.+ +||||+++++++.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~----~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   91 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLS----ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   91 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEE----EETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEE----EECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence            455677888899999888888775    4566789999999975311 223356678899999988 8999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      ..+..      ++||||+++ +|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+||
T Consensus        92 ~~~~~------~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DF  165 (353)
T 2i0e_A           92 TMDRL------YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF  165 (353)
T ss_dssp             CSSEE------EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             cCCEE------EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeC
Confidence            77654      999999986 5666665  35899999999999999999999999999999999999999999999999


Q ss_pred             ccccccC-CCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        209 GLARTAG-TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       209 g~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      |++.... ........+||+.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+.+.+|.+.....|.
T Consensus       166 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~  242 (353)
T 2i0e_A          166 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK  242 (353)
T ss_dssp             TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred             CcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            9998643 233345668999999999999999999999999999999999999999999998888888876555544

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.3e-40  Score=280.30  Aligned_cols=224  Identities=27%  Similarity=0.462  Sum_probs=187.5

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc--
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS--  135 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--  135 (288)
                      .++.+.+.+|+|.++.++++    .+..+++.||+|++............+.+|+++++.++||||+++++++.....  
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKA----RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   92 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEE----EETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred             cceeEEEEEecCCCcEEEEE----EECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence            45677888888888887775    456789999999997655555556678899999999999999999999976432  


Q ss_pred             ccccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      .......++||||+++++.+.+.   ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        93 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             ----CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            11124569999999998888775   358999999999999999999999999999999999999999999999999997


Q ss_pred             ccCC-----CcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        213 TAGT-----TFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       213 ~~~~-----~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      ....     ........+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+.+.++.++++
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            6542     222344578999999999987 457999999999999999999999999999999999999998877654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.7e-40  Score=282.13  Aligned_cols=220  Identities=28%  Similarity=0.439  Sum_probs=183.5

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHC-CCCCcceeeccccC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTP  132 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  132 (288)
                      +...++.+.+.+|+|.++.++++    .+..+++.||+|++++.. ........+..|..+++.+ +||||+++++++..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~   89 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLA----EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT   89 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEE----EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CChHHeEEEEEEeeCCCeEEEEE----EECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence            45567788899999888888875    456789999999997521 1123355677899999887 99999999999987


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .+..      ++||||+++ +|.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~------~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           90 KENL------FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             SSEE------EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             CCEE------EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeECh
Confidence            7654      999999976 5666665  358999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC-CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        210 LARTAGT-TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       210 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ++..... .......+||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+.+.+|.......|.
T Consensus       164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~  239 (345)
T 1xjd_A          164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR  239 (345)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred             hhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence            9986432 23345568999999999999999999999999999999999999999999988888888765544443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.6e-40  Score=274.26  Aligned_cols=209  Identities=27%  Similarity=0.430  Sum_probs=173.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+++.||+|++...  .......+.+|+.+++.++||||+++++++...+.. 
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-   92 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTA----MDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL-   92 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEE----EBTTTCCEEEEEEEEGG--GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE-
T ss_pred             hceeeeeeeccCCCeEEEEE----EECCCCcEEEEEEeecc--cccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE-
Confidence            34556666666666666554    46788999999999753  223356788999999999999999999999876654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                           ++||||+++ +|.+.+. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        93 -----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           93 -----WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             -----EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             -----EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence                 999999976 5655554 348999999999999999999999999999999999999999999999999987655


Q ss_pred             CCc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        216 TTF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       216 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+...
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  231 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN  231 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH
T ss_pred             CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            432 234567899999999999999999999999999999999999999988877766655544

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.7e-40  Score=287.93  Aligned_cols=216  Identities=23%  Similarity=0.359  Sum_probs=183.6

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++.+.+.+|+|.++.++.+    .+..+|+.||+|++............+.+|+++++.++||||+++++++...+.. 
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~----~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~-   85 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRC----VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH-   85 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEE----EETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE-
T ss_pred             CCeEEEEEeccCCCeEEEEE----EECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE-
Confidence            45677888888888777764    5678899999999987655556677899999999999999999999999877655 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEc---cCCcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~---~~~~~kl~dfg~~  211 (288)
                           ++||||+.+ +|.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||+++   .++.+||+|||++
T Consensus        86 -----~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           86 -----YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             -----EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             -----EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence                 999999986 5666665  4489999999999999999999999999999999999998   4578999999999


Q ss_pred             cccCCCc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        212 RTAGTTF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       212 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+.++.......+
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  233 (444)
T 3soa_A          161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP  233 (444)
T ss_dssp             BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred             EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC
Confidence            7665432 23456899999999999999999999999999999999999999999998888888887665444

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.5e-41  Score=287.41  Aligned_cols=201  Identities=29%  Similarity=0.461  Sum_probs=172.1

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+.+|+|.++.++++    .+..+++.||+|++..... .......+.+|+++++.++||||+++++++...+..
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLA----THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCEEEEEEEecCCCeEEEEE----EECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            45567778888777777765    4667899999999974211 112245788999999999999999999999877654


Q ss_pred             cccccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                            ++||||+++++.+.+.  ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        85 ------~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~  158 (336)
T 3h4j_B           85 ------VMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM  158 (336)
T ss_dssp             ------EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred             ------EEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence                  9999999999988875  45899999999999999999999999999999999999999999999999999887


Q ss_pred             CCCcccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      .........+|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~  213 (336)
T 3h4j_B          159 TDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI  213 (336)
T ss_dssp             TTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS
T ss_pred             cCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH
Confidence            66666667789999999999988776 6899999999999999999999987543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.4e-40  Score=283.46  Aligned_cols=220  Identities=51%  Similarity=0.867  Sum_probs=185.1

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|+|.++.++.+    .+..+|+.||||++............+.+|+.+++.++||||+++++++...+....
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSA----IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             cEEEEeEEecCCCeEEEEE----EECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            4455566666666665553    567789999999998765566667889999999999999999999999987765444


Q ss_pred             cccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        139 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                      ....++||||+++++.+.+...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus       119 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-  197 (371)
T 4exu_A          119 FYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-  197 (371)
T ss_dssp             CCCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred             ceeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-
Confidence            4456999999999998888888999999999999999999999999999999999999999999999999999865443 


Q ss_pred             ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        219 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                       .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+.+.++.+..+.++.
T Consensus       198 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  263 (371)
T 4exu_A          198 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT  263 (371)
T ss_dssp             ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             -cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence             234578999999999987 67899999999999999999999999999999999999887776543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4e-40  Score=285.36  Aligned_cols=202  Identities=24%  Similarity=0.400  Sum_probs=170.4

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHC-CCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLV-NHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  131 (288)
                      .+..+++.+.+.||+|.++.++++    .+..+++.||+|++++... .......+..|..+++++ +||||+++++++.
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~----~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~  123 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLV----RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ  123 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEE----EECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence            455677888899999888888875    4567889999999986422 223345678899999887 8999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      ..+..      ++||||+++ +|...+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus       124 ~~~~~------~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DF  197 (396)
T 4dc2_A          124 TESRL------FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY  197 (396)
T ss_dssp             CSSEE------EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ECCEE------EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeec
Confidence            77655      999999987 5655554  45899999999999999999999999999999999999999999999999


Q ss_pred             cccccc-CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        209 GLARTA-GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       209 g~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      |+++.. .........+||+.|+|||++.+..++.++|+||||+++|+|++|+.||.+
T Consensus       198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             ceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            999863 333445667899999999999999999999999999999999999999964

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.8e-40  Score=278.91  Aligned_cols=200  Identities=25%  Similarity=0.396  Sum_probs=171.1

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHC-CCCCcceeeccccCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQ  133 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  133 (288)
                      ..+++.+.+.+|+|.++.++++    .+..+++.||+|++++.. ........+.+|..+++++ +||||+++++++...
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~   82 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLV----RLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE   82 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             chhheEEEEEEEecCCeEEEEE----EECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence            4466788888999888887775    456789999999998643 2334556788999999998 899999999999877


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      +..      ++||||+++ +|.+.+.  ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~------~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~  156 (345)
T 3a8x_A           83 SRL------FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM  156 (345)
T ss_dssp             SEE------EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred             CEE------EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccc
Confidence            655      999999986 5666654  3589999999999999999999999999999999999999999999999999


Q ss_pred             ccccC-CCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        211 ARTAG-TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       211 ~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      +.... ........+||+.|+|||++.+..++.++|+||||+++|+|++|..||..
T Consensus       157 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          157 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            98633 23334566899999999999999999999999999999999999999975

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.1e-41  Score=290.83  Aligned_cols=214  Identities=26%  Similarity=0.428  Sum_probs=178.7

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.+|+|.++.++++    .+..+++.||+|++++.. ........+.+|+.+++.++||||+++++++.+.+
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~----~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLV----RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CccccEEEEEEEcCCCEEEEEE----EECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            3456777788888877777764    456789999999996421 11122345778999999999999999999998776


Q ss_pred             cccccccEEEEEecccc-cHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      ..      ++||||+++ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus       143 ~~------~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          143 YL------YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EE------EEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EE------EEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            55      999999976 5666554 458999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCc--ccCCcccccccCchHhHhcCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        213 TAGTTF--MMTPYVVTRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       213 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ......  .....+||+.|+|||++.+..    ++.++|+||||+++|+|++|+.||.+.+..+.+.+|++..
T Consensus       217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  289 (410)
T 3v8s_A          217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK  289 (410)
T ss_dssp             ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence            765432  234668999999999998765    7889999999999999999999999999999999988654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.3e-40  Score=281.00  Aligned_cols=215  Identities=23%  Similarity=0.372  Sum_probs=181.3

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+.+|+|.++.++++    .+..+++.||+|++++.. ........+.+|+++++.++||||+++++++.+.+..
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLV----KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             HHCEEEEEeecCcCcEEEEE----EECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            45666777777777766664    456789999999997421 1223456788999999999999999999999877654


Q ss_pred             cccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                            ++||||+++ +|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus       117 ------~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~  190 (350)
T 1rdq_E          117 ------YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             ------EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ------EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEccccccee
Confidence                  999999975 6766665  3589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        214 AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       214 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ....  .....||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+.+.+|.+.....|.
T Consensus       191 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~  259 (350)
T 1rdq_E          191 VKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS  259 (350)
T ss_dssp             CSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred             ccCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            6543  23458999999999999999999999999999999999999999999988888888876555544

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-40  Score=277.94  Aligned_cols=212  Identities=21%  Similarity=0.354  Sum_probs=181.2

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|+++.   .......+.+|+++++.++||||+++++++...+.. 
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~----~~~~~~~~~a~K~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-   76 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRC----VETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFESMEEL-   76 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEECC---CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE-
T ss_pred             hceEeeeEEecCCCeEEEEE----EECCCCcEEEEEEEec---CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE-
Confidence            45567777888777777664    4677899999999974   234456788999999999999999999999876654 


Q ss_pred             ccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc--CCcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~--~~~~kl~dfg~~  211 (288)
                           ++||||+++ +|.+.+..   .+++..+..++.|++.||+|||++||+||||||+||+++.  ++.+||+|||++
T Consensus        77 -----~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a  151 (321)
T 1tki_A           77 -----VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA  151 (321)
T ss_dssp             -----EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred             -----EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence                 999999986 67777653   4899999999999999999999999999999999999997  789999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+.+.....
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  222 (321)
T 1tki_A          152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF  222 (321)
T ss_dssp             EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC
T ss_pred             eECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC
Confidence            87765555555678999999999999888999999999999999999999999999888888887655443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-39  Score=286.94  Aligned_cols=222  Identities=38%  Similarity=0.703  Sum_probs=181.6

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||||+++...........+.+|+++|+.++||||+++++++...+. .
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a----~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~  100 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLA----YDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL-L  100 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEE----EETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT-T
T ss_pred             CCEEEEEEEeecCCEEEEEE----EECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC-C
Confidence            45677778888777777764    567889999999998765566667889999999999999999999999976532 2


Q ss_pred             ccccEEEEEecccccHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      .....++|||+++++|.+.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       101 ~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          101 KFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             TCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             cCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            2345699999999999888874  38999999999999999999999999999999999999999999999999998654


Q ss_pred             CCc-----------------------ccCCcccccccCchHhHh-cCCCCchhhHHHHHHHHHHHHh-----------CC
Q psy11580        216 TTF-----------------------MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIR-----------GG  260 (288)
Q Consensus       216 ~~~-----------------------~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slg~il~~l~~-----------g~  260 (288)
                      ...                       ......+|+.|+|||++. +..++.++|||||||++|||++           |.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~  260 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF  260 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence            321                       225568899999999974 5668999999999999999997           55


Q ss_pred             CCCCCCC-----------------chhHHHHHHHHhCCCcc
Q psy11580        261 VLFPGTD-----------------HIDQWNKIIGKMREAHD  284 (288)
Q Consensus       261 ~p~~~~~-----------------~~~~~~~i~~~~~~~~~  284 (288)
                      ++|.+.+                 ..+.+..|.+.++.++.
T Consensus       261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~  301 (432)
T 3n9x_A          261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTE  301 (432)
T ss_dssp             CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCH
T ss_pred             ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCH
Confidence            6666654                 36778888888887654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-39  Score=276.58  Aligned_cols=224  Identities=25%  Similarity=0.395  Sum_probs=175.3

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc--chhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ--NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      +...++.+.+.+|+|.++.++.+.- ..+..+++.||+|++++...  .......+.+|+++++.++||||+++++++..
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRK-VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEE-CSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEE-eccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            4456778888899888887776531 11236889999999986421  22344567889999999999999999999987


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .+..      ++||||+++ +|.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           93 GGKL------YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             SSCE------EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             CCEE------EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCC
Confidence            7655      999999985 5666664  348899999999999999999999999999999999999999999999999


Q ss_pred             cccccCC-CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        210 LARTAGT-TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       210 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      ++..... ........|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+.++.+.....|+.
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~  243 (327)
T 3a62_A          167 LCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY  243 (327)
T ss_dssp             CC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             cccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence            9875432 223345678999999999999889999999999999999999999999999888888888766555543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=278.52  Aligned_cols=213  Identities=29%  Similarity=0.405  Sum_probs=176.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+...+.||+|.++.++.+    .+..+|+.||+|+++..  .......+.+|++++++++||||+++++++...+.. 
T Consensus        89 ~~~~~~~~lG~G~~g~Vy~a----~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-  161 (373)
T 2x4f_A           89 YTVSKTEILGGGRFGQVHKC----EETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI-  161 (373)
T ss_dssp             EEEEEEEECC-----CEEEE----EETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE-
T ss_pred             eeeecceEEecCcCEEEEEE----EEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE-
Confidence            34455667888777777764    45678999999999863  334567789999999999999999999999877654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE--ccCCcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~--~~~~~~kl~dfg~~  211 (288)
                           ++||||+++ +|.+.+.   ..+++..+..++.||+.||+|||+.+|+||||||+||++  +.++.+||+|||++
T Consensus       162 -----~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a  236 (373)
T 2x4f_A          162 -----VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA  236 (373)
T ss_dssp             -----EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred             -----EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence                 999999986 5666554   358999999999999999999999999999999999999  45678999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+.+|......+
T Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  307 (373)
T 2x4f_A          237 RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL  307 (373)
T ss_dssp             EECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS
T ss_pred             eecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Confidence            87766555556679999999999998889999999999999999999999999999988888888765443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.2e-40  Score=279.18  Aligned_cols=219  Identities=34%  Similarity=0.543  Sum_probs=176.8

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ...++.+.+.+|+|.++.++.+    .+..+++.||||+++...........+.+|++++++++||||+++++++...+.
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKA----IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEE----EETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             chhhEEEEEEEEecCCeEEEEE----EECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            3456788888888888887765    467789999999998654444555678899999999999999999999987765


Q ss_pred             ccccccEEEEEecccccHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEc-----cCCcEEEeec
Q psy11580        136 LEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-----SDCTLKILDF  208 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~-----~~~~~kl~df  208 (288)
                      .      ++||||+++++.+.+..  .+++..+..++.||+.||+|||+++|+||||||+||+++     .++.+||+||
T Consensus       108 ~------~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          108 L------HLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             E------EEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             E------EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            4      99999999999888763  589999999999999999999999999999999999995     4456999999


Q ss_pred             ccccccCCC-cccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        209 GLARTAGTT-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       209 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      |++...... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+.+.++.+.++.++.
T Consensus       182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  259 (329)
T 3gbz_A          182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD  259 (329)
T ss_dssp             THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred             CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence            999865432 223445779999999999874 4799999999999999999999999999999999999988775543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.3e-40  Score=283.20  Aligned_cols=203  Identities=23%  Similarity=0.427  Sum_probs=173.0

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      +...++.+.+.+|+|.++.++++    .+..+++.||+|++.+.. ........+.+|+++++.++||||+++++++...
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~----~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIV----QKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CChHHeEEEEEEeeCCCeEEEEE----EECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            44567788899999888888774    467789999999997421 1223456788999999999999999999999877


Q ss_pred             CcccccccEEEEEeccccc-HHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        134 KSLEEFQDVYLVMELMDAN-LCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      +..      ++||||+.++ |...+..  .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        88 ~~~------~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~  161 (384)
T 4fr4_A           88 EDM------FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI  161 (384)
T ss_dssp             SEE------EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEE------EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccce
Confidence            655      9999999764 5555543  489999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      +.............||+.|+|||++.+   ..++.++||||||+++|+|++|..||.+.+
T Consensus       162 a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~  221 (384)
T 4fr4_A          162 AAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS  221 (384)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred             eeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence            988766656667789999999999974   458899999999999999999999998543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.5e-40  Score=289.89  Aligned_cols=215  Identities=29%  Similarity=0.510  Sum_probs=177.7

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.||+|.++.++.+    .+..+++.||||++....      ....+|+++++.++||||+++++++...+....
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~----~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQA----KLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             eEEeeeEEeeCCCEEEEEE----EECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            4566777888777777765    456789999999997432      123369999999999999999999865332222


Q ss_pred             cccEEEEEecccccHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC-CcEEEeecccc
Q psy11580        139 FQDVYLVMELMDANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLA  211 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~-~~~kl~dfg~~  211 (288)
                      ....++||||+++++.+.+.      ..+++..++.++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||++
T Consensus       125 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          125 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            34468999999998776553      348899999999999999999999999999999999999965 56899999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      +............+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+.+|++.++.++
T Consensus       205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~  277 (420)
T 1j1b_A          205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT  277 (420)
T ss_dssp             EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            876555455567889999999999875 689999999999999999999999999999999999998877543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=274.62  Aligned_cols=213  Identities=24%  Similarity=0.351  Sum_probs=179.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcch----hhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV----THAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+++.||+|+++......    .....+.+|+.+++.++||||+++++++...
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~----~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKC----REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEE----EETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             cceEeceEEeeCCCeEEEEE----EECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            34567788888888777764    466789999999997543221    2356788999999999999999999999876


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC----cEEEe
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKIL  206 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~----~~kl~  206 (288)
                      +..      ++||||+++ +|.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++    .+||+
T Consensus        87 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  160 (326)
T 2y0a_A           87 TDV------ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII  160 (326)
T ss_dssp             SEE------EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred             CEE------EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence            654      999999975 6767665  3489999999999999999999999999999999999999887    79999


Q ss_pred             ecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       207 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      |||++.............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+.....
T Consensus       161 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~  234 (326)
T 2y0a_A          161 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY  234 (326)
T ss_dssp             CCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC
T ss_pred             ECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC
Confidence            99999877655455566899999999999998999999999999999999999999999888777777665443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=280.00  Aligned_cols=219  Identities=51%  Similarity=0.866  Sum_probs=182.8

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|+|.++.++.+    .+..+|+.||||++............+.+|+.+++.++||||+++++++...+....
T Consensus        25 ~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSA----IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             eEEEeeeEecCCCeEEEEE----EECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence            3455566666666655553    456789999999998765555667788999999999999999999999988765444


Q ss_pred             cccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        139 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                      ....++|||++++++.+.+...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus       101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-  179 (353)
T 3coi_A          101 FYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-  179 (353)
T ss_dssp             CCCCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred             ceeEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence            4566999999999888877777999999999999999999999999999999999999999999999999999865433 


Q ss_pred             ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        219 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       219 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                       .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+.+..+.++
T Consensus       180 -~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  244 (353)
T 3coi_A          180 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  244 (353)
T ss_dssp             -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred             -ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence             234578999999999987 6789999999999999999999999999999999999888766543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-39  Score=282.47  Aligned_cols=217  Identities=32%  Similarity=0.583  Sum_probs=180.6

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ...+.+.+.+|+|.++.++.+    .+..+++.||||++.....      ...+|+++++.++||||+++++++...+..
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a----~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEV----FDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEE----EETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             cceEEEEEEEEeccCEEEEEE----EECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            346678888888888887764    4678899999999975321      223699999999999999999998654321


Q ss_pred             --------------------------------cccccEEEEEecccccHHHHHh------hhCCHHHHHHHHHHHHHHHH
Q psy11580        137 --------------------------------EEFQDVYLVMELMDANLCQVIQ------MDLDHERMSYLLYQMLCGIK  178 (288)
Q Consensus       137 --------------------------------~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~  178 (288)
                                                      ......++||||+++++.+.+.      ..+++..+..++.||+.||+
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                            1223468999999998776654      34899999999999999999


Q ss_pred             HHHHCCCEeecCCCCCEEEc-cCCcEEEeecccccccCCCcccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHH
Q psy11580        179 HLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEM  256 (288)
Q Consensus       179 ~LH~~~ivH~dl~~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l  256 (288)
                      |||++||+||||||+||+++ .++.+||+|||++.............+++.|+|||++.+. .++.++||||+|+++|+|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            99999999999999999998 5889999999999877665555667889999999999875 489999999999999999


Q ss_pred             HhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        257 IRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       257 ~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ++|+.||.+.+..+.+.+|++.++.++
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~  262 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPT  262 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999999999999999999999887654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.1e-39  Score=278.51  Aligned_cols=219  Identities=27%  Similarity=0.439  Sum_probs=180.4

Q ss_pred             hhhhcccccccccCCccccccccCcccee---ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAY---DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNA  129 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  129 (288)
                      ++...++.+++.+|+|.++.++++.....   ...++..||||+++.. ........+.+|+++++++ +||||++++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            34556778889999999888887743211   1245678999999754 3445567899999999999 89999999999


Q ss_pred             ccCCCcccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                      +...+..      ++||||+++ +|.+++..                  .+++..+..++.||+.||+|||+++|+||||
T Consensus       156 ~~~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl  229 (370)
T 2psq_A          156 CTQDGPL------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL  229 (370)
T ss_dssp             ECSSSSC------EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             EccCCCE------EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence            9887765      999999987 67666643                  2688999999999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT  266 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~  266 (288)
                      ||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus       230 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~  309 (370)
T 2psq_A          230 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  309 (370)
T ss_dssp             CGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999998654322   1233456788999999999999999999999999999998 99999998


Q ss_pred             CchhHHHHHHHHh
Q psy11580        267 DHIDQWNKIIGKM  279 (288)
Q Consensus       267 ~~~~~~~~i~~~~  279 (288)
                      +..+....+....
T Consensus       310 ~~~~~~~~~~~~~  322 (370)
T 2psq_A          310 PVEELFKLLKEGH  322 (370)
T ss_dssp             CGGGHHHHHHTTC
T ss_pred             CHHHHHHHHhcCC
Confidence            8877776665543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.5e-40  Score=290.17  Aligned_cols=214  Identities=23%  Similarity=0.323  Sum_probs=178.5

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.||+|.++.++++    .+..+++.||+|++++.. ........+.+|..+++.++||||++++++|.+.+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~----~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVV----KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             ChhheEEEEEEEeCCCEEEEEE----EEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            4466778888888888887775    456778999999997421 11122234788999999999999999999998776


Q ss_pred             cccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      ..      ++||||+++ +|.+.+.   ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus       148 ~~------~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          148 NL------YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             EE------EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EE------EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            55      999999975 5666664   3589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc--ccCCcccccccCchHhHh-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        211 ARTAGTTF--MMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       211 ~~~~~~~~--~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      +.......  .....+||+.|+|||++.     +..++.++||||||+++|||++|+.||.+.+..+.+.+|++..
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  297 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK  297 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence            97654332  224468999999999997     4568999999999999999999999999999999999887643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-40  Score=286.03  Aligned_cols=213  Identities=23%  Similarity=0.306  Sum_probs=177.6

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.||+|.++.++++    .+..+++.||+|++++.. ........+.+|..++..++||||+++++++.+.+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~----~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVV----KMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN  134 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEE----EETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             ChhhEEEEEEEeeCCCeEEEEE----EECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            4456777778888777777664    456789999999997421 11223345789999999999999999999998776


Q ss_pred             cccccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      ..      ++||||+++ +|.+.+..   .+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus       135 ~~------~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          135 YL------YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             EE------EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EE------EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence            55      999999965 67666653   589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc--cCCcccccccCchHhHh-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        211 ARTAGTTFM--MTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       211 ~~~~~~~~~--~~~~~~~~~~~aPE~~~-------~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      +........  ....+||+.|+|||++.       +..++.++|+||||+++|||++|+.||.+.+..+.+.+|+..
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  285 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY  285 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            987644322  23458999999999998       346889999999999999999999999999999988888864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=272.56  Aligned_cols=215  Identities=29%  Similarity=0.511  Sum_probs=177.0

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++.+.+.+|+|.++.++.+    .+..+++.||+|++............+.+|++++++++||||+++++++...+.. 
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKC----RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRL-   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE-
T ss_pred             ccceEeeEEeecCCeEEEEE----EeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeE-
Confidence            34566777888777777664    4667899999999977655555567788999999999999999999999876654 


Q ss_pred             ccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||++++++..+.   ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus        78 -----~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  152 (311)
T 4agu_A           78 -----HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL  152 (311)
T ss_dssp             -----EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             -----EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence                 9999999988666553   34899999999999999999999999999999999999999999999999999876


Q ss_pred             CCC-cccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        215 GTT-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       215 ~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+.+.++.+
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  222 (311)
T 4agu_A          153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL  222 (311)
T ss_dssp             C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccc
Confidence            532 22345578999999999987 567999999999999999999999999999999888888877654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.8e-39  Score=270.40  Aligned_cols=206  Identities=33%  Similarity=0.448  Sum_probs=163.7

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      +.+.+.+|+|.++.+++    +.+..+++.||+|++.... ........+.+|+.++++++||||+++++++...+..  
T Consensus        13 y~i~~~lg~G~~g~V~~----~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~--   86 (294)
T 4eqm_A           13 YKIVDKLGGGGMSTVYL----AEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY--   86 (294)
T ss_dssp             EEEEEEEEEETTEEEEE----EEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE--
T ss_pred             EEEEEEEccCCCEEEEE----EEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE--
Confidence            44445555554444444    3466789999999986532 3445567889999999999999999999999877654  


Q ss_pred             cccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++||||+++ +|.+.+.  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        87 ----~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           87 ----YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             ----EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             ----EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence                999999987 5666665  348999999999999999999999999999999999999999999999999998664


Q ss_pred             CCc--ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHH
Q psy11580        216 TTF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       216 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i  275 (288)
                      ...  ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+...+.
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~  224 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH  224 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            432  223456899999999999999999999999999999999999999988766544333

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.1e-39  Score=276.88  Aligned_cols=215  Identities=23%  Similarity=0.432  Sum_probs=179.4

Q ss_pred             ccccccccCCccccccccCcc---c---eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-----CCCcceee
Q psy11580         59 ELPISHQMGKKRHNTSHLGAG---A---AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-----HKNIIGLL  127 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g---~---~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~  127 (288)
                      .+..+..+..+|.....+|.|   .   +.+..+++.||||+++.   .......+..|+.+++.++     ||||++++
T Consensus        26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            344444555555554444444   1   34567899999999974   3355567788999999996     99999999


Q ss_pred             ccccCCCcccccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc----
Q psy11580        128 NAFTPQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS----  199 (288)
Q Consensus       128 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~----  199 (288)
                      +++...+..      ++|||+++++|.+.+..    .+++..+..++.||+.||+|||+++|+||||||+|||++.    
T Consensus       103 ~~~~~~~~~------~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          103 GKFMYYDHM------CLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEETTEE------EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred             ceeeECCee------EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence            999876654      99999998888888763    3889999999999999999999999999999999999975    


Q ss_pred             ---------------------CCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh
Q psy11580        200 ---------------------DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR  258 (288)
Q Consensus       200 ---------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~  258 (288)
                                           ++.+||+|||++......  .....+++.|+|||++.+..++.++||||||+++|+|++
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence                                 788999999999865443  234578999999999999999999999999999999999


Q ss_pred             CCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        259 GGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       259 g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      |+.||.+.+..+.+..+.+..+++|.
T Consensus       255 g~~pf~~~~~~~~~~~~~~~~~~~p~  280 (360)
T 3llt_A          255 GSLLFRTHEHMEHLAMMESIIQPIPK  280 (360)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHTCCCCH
T ss_pred             CCCCCCCCcHHHHHHHHHHhcCCCCH
Confidence            99999999999999999988887764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.8e-40  Score=289.88  Aligned_cols=221  Identities=24%  Similarity=0.359  Sum_probs=173.7

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      +...++.+.+.||+|.++.++++    .+..+++.||||+++... ........+.+|+.+++.++||||+++++++...
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~  220 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILV----KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH  220 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET
T ss_pred             CChHHcEEeEEEeeCcCEEEEEE----EEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC
Confidence            34566778888888888777764    457789999999997431 1233445678899999999999999999999877


Q ss_pred             CcccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      +..      ++||||++++ |.+.+.  ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||
T Consensus       221 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG  294 (446)
T 4ejn_A          221 DRL------CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFG  294 (446)
T ss_dssp             TEE------EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred             CEE------EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCC
Confidence            654      9999999874 555554  348999999999999999999998 999999999999999999999999999


Q ss_pred             cccccCC-CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        210 LARTAGT-TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       210 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      ++..... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+.......|..
T Consensus       295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~  371 (446)
T 4ejn_A          295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT  371 (446)
T ss_dssp             CCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred             CceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            9976432 333455689999999999999999999999999999999999999999998888888877665554443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.5e-40  Score=277.96  Aligned_cols=215  Identities=32%  Similarity=0.529  Sum_probs=175.3

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.+|+|.++.++.+    .+..+++.||+|++..... ......+.+|+++++.++||||+++++++...+..  
T Consensus         3 ~y~~~~~lG~G~~g~V~~~----~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--   75 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKG----KSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL--   75 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCE--
T ss_pred             ceEEEEEEcCCCCEEEEEE----EECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEE--
Confidence            4567778888887777765    4567899999999975321 11122455799999999999999999999877655  


Q ss_pred             cccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++||||+++++.+.+..   .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        76 ----~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           76 ----TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             ----EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             ----EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence                99999999998887763   38899999999999999999999999999999999999999999999999997654


Q ss_pred             CC-cccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        216 TT-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       216 ~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      .. .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+.+..+.+.++.+++
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  222 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE  222 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            32 22344578999999999987 56899999999999999999999999999999999999998886654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-39  Score=287.36  Aligned_cols=217  Identities=28%  Similarity=0.431  Sum_probs=183.8

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+++.+|+|.++.++.+    .+..+|+.||||++..... .......+.+|+++++.++||||+++++++...+..
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a----~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVG----KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEE----EETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             cCEEEEEEEeeCCCeEEEEE----EECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45677888888888877775    4567899999999974211 122346788999999999999999999999877654


Q ss_pred             cccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                            ++||||+++ +|.+.+.  ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||++..
T Consensus        92 ------~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           92 ------FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             ------EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             ------EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence                  999999975 5766665  3589999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCcccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        214 AGTTFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       214 ~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ..........+|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+......+|.+.....|.
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~  237 (476)
T 2y94_A          166 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ  237 (476)
T ss_dssp             CCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT
T ss_pred             ccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc
Confidence            766555566789999999999998765 68999999999999999999999998888888888776555444

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.4e-39  Score=272.26  Aligned_cols=217  Identities=35%  Similarity=0.556  Sum_probs=181.2

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ...++.+.+.+|+|.++.++.+    .+..+++.||+|++............+.+|+++++.++||||+++++++...+.
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKC----RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR   98 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEE----EETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhhhheeeeEEeecCCEEEEEE----EECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence            3456778888888888877765    466789999999997655555556778899999999999999999999987665


Q ss_pred             ccccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      .      ++||||++++++..+.   ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        99 ~------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  172 (331)
T 4aaa_A           99 W------YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR  172 (331)
T ss_dssp             E------EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             E------EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCce
Confidence            4      9999999998777653   458999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCC-cccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        213 TAGTT-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       213 ~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ..... .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+.+..++...+.+
T Consensus       173 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (331)
T 4aaa_A          173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNL  244 (331)
T ss_dssp             -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             eecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            65432 223455789999999999875 68999999999999999999999999999999888888776654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.8e-39  Score=275.95  Aligned_cols=220  Identities=40%  Similarity=0.743  Sum_probs=182.0

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|+|.++.++.+    .+..++..||||++... ........+.+|++++++++||||+++++++..... ..
T Consensus        28 ~y~~~~~lG~G~~g~V~~~----~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~  101 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSA----YDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI-EQ  101 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST-TT
T ss_pred             cEEEEEEeecCCCeEEEEE----EECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc-cc
Confidence            3455566666665555543    56778999999999743 234455778899999999999999999999976542 22


Q ss_pred             cccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ....++|||++++++.+.+. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus       102 ~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          102 MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             CCCEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             cceEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            34569999999999888776 45899999999999999999999999999999999999999999999999999865433


Q ss_pred             cc----cCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        218 FM----MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       218 ~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ..    .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+.+.+|++.++.++.
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            21    244578999999998765 45899999999999999999999999999999999999988876653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.1e-39  Score=275.45  Aligned_cols=207  Identities=25%  Similarity=0.369  Sum_probs=174.5

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .+...+.+|+|.++.++.+    .+..+++.||||++.... ........+.+|++++++++||||+++++++...+.. 
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-  129 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFA----RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA-  129 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE-
T ss_pred             heeeeeEEccCCCEEEEEE----EEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeE-
Confidence            3556677777777776664    356789999999997542 2334456788999999999999999999999876654 


Q ss_pred             ccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||+.+++.+.+.   ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++...
T Consensus       130 -----~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          130 -----WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  204 (348)
T ss_dssp             -----EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             -----EEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence                 9999999998887764   45899999999999999999999999999999999999999999999999999776


Q ss_pred             CCCcccCCcccccccCchHhHh---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ...   ....+++.|+|||++.   +..++.++||||||+++|+|++|..||.+.+..+.+..+...
T Consensus       205 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  268 (348)
T 1u5q_A          205 APA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN  268 (348)
T ss_dssp             SSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             CCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Confidence            543   3457899999999996   456889999999999999999999999988877766666554

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-38  Score=265.45  Aligned_cols=216  Identities=25%  Similarity=0.357  Sum_probs=182.6

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++.+.+.+|+|.++.++.+    .+..+++.||+|++............+.+|++++++++||||+++++++...+.. 
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-   80 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRC----VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH-   80 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE-
T ss_pred             hhhhhhhhhcCcCCeEEEEE----EEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE-
Confidence            45566677777766666654    4567899999999986555556677889999999999999999999999876654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc---EEEeecccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~---~kl~dfg~~  211 (288)
                           ++||||+++ ++.+.+.  ..+++..+..++.|++.||+|||+++++||||||+||+++.++.   +||+|||++
T Consensus        81 -----~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~  155 (284)
T 3kk8_A           81 -----YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA  155 (284)
T ss_dssp             -----EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             -----EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence                 999999987 5656554  34899999999999999999999999999999999999987655   999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.......|
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  227 (284)
T 3kk8_A          156 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP  227 (284)
T ss_dssp             EECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC
Confidence            877766555667899999999999999999999999999999999999999999888888877776654433

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-39  Score=274.47  Aligned_cols=216  Identities=35%  Similarity=0.584  Sum_probs=177.5

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcch---hhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV---THAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+|+.||||++.......   .....+.+|+++++.++||||+++++++...+
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKA----RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEE----ECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cccEEEeEEeecCCEEEEEE----EECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            45567777888777777664    456789999999997532211   12346789999999999999999999998776


Q ss_pred             cccccccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        135 SLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      ..      ++||||+++++.+.+..   .+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++
T Consensus        86 ~~------~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NI------SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CC------EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ce------EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            65      99999999998887763   3889999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC-cccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        212 RTAGTT-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       212 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ...... .......+++.|+|||++.+. .++.++||||||+++|+|++|.+||.+.+..+.+.++.+.++.++
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~  233 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT  233 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            876433 233456789999999999764 478999999999999999999999999999999999998876554

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-39  Score=277.94  Aligned_cols=210  Identities=23%  Similarity=0.386  Sum_probs=174.5

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|+|.++.++.+    .+..+++.||+|++...  .......+.+|+++++.++||||+++++++...+..  
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~----~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~--  123 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRC----VEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM--  123 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE--
T ss_pred             ceEEEEEEecCCCEEEEEE----EECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE--
Confidence            3445555666555555543    45678999999999753  233456788999999999999999999999876654  


Q ss_pred             cccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc--CCcEEEeeccccc
Q psy11580        139 FQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLAR  212 (288)
Q Consensus       139 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~--~~~~kl~dfg~~~  212 (288)
                          ++||||+++ +|.+.+..   .+++..+..++.||+.||+|||++||+||||||+||+++.  ++.+||+|||++.
T Consensus       124 ----~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          124 ----VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             ----EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             ----EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccce
Confidence                999999986 56666642   5899999999999999999999999999999999999974  4679999999998


Q ss_pred             ccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ............+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+.+...
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~  267 (387)
T 1kob_A          200 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW  267 (387)
T ss_dssp             ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC
T ss_pred             ecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence            77655444556789999999999999999999999999999999999999999888888777766543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.4e-39  Score=296.58  Aligned_cols=221  Identities=24%  Similarity=0.371  Sum_probs=185.1

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHC-CCCCcceeeccccC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTP  132 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  132 (288)
                      +...++.+.+.||+|.++.++++    .+..+++.||||++++.. ........+..|..++..+ +||+|+.+++++..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~----~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~  413 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLS----ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT  413 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEE----EESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC
T ss_pred             ccccceEEEEEEccCCCEEEEEE----EECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe
Confidence            34566777888888888887775    456788999999997531 1223456678899999988 79999999999987


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .+.+      ++||||+++ +|.+.+.  ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus       414 ~~~~------~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          414 MDRL------YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             SSEE------EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCT
T ss_pred             CCEE------EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecc
Confidence            7655      999999986 5666654  458999999999999999999999999999999999999999999999999


Q ss_pred             cccccC-CCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        210 LARTAG-TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       210 ~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      ++.... .........||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+..+++.+|++.....|..
T Consensus       488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~  564 (674)
T 3pfq_A          488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS  564 (674)
T ss_dssp             TCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTT
T ss_pred             eeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            998632 3333456789999999999999999999999999999999999999999999999999998766655544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-39  Score=275.71  Aligned_cols=223  Identities=19%  Similarity=0.292  Sum_probs=181.0

Q ss_pred             HhhhhhhcccccccccCCccccccccCcccee-ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecc
Q psy11580         51 QWKELIYQELPISHQMGKKRHNTSHLGAGAAY-DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA  129 (288)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  129 (288)
                      ...++...++.+.+.+|+|.++.++.+.-... +..++..||||+++.. ........+.+|+.++++++||||++++++
T Consensus        64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  142 (367)
T 3l9p_A           64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGV  142 (367)
T ss_dssp             GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            44456667788899999999988888742211 3457889999999753 234556678899999999999999999999


Q ss_pred             ccCCCcccccccEEEEEecccc-cHHHHHhh---------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS  199 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~  199 (288)
                      +...+..      ++||||+++ +|.+.+..         .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus       143 ~~~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~  216 (367)
T 3l9p_A          143 SLQSLPR------FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC  216 (367)
T ss_dssp             ECSSSSC------EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred             EecCCCC------EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEec
Confidence            9877665      999999976 67766653         2889999999999999999999999999999999999995


Q ss_pred             CC---cEEEeecccccccCC---CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHH
Q psy11580        200 DC---TLKILDFGLARTAGT---TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQW  272 (288)
Q Consensus       200 ~~---~~kl~dfg~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~  272 (288)
                      ++   .+||+|||++.....   ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+..
T Consensus       217 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~  296 (367)
T 3l9p_A          217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL  296 (367)
T ss_dssp             SSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             CCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            55   599999999974321   222234567889999999999999999999999999999998 99999998888877


Q ss_pred             HHHHHHhC
Q psy11580        273 NKIIGKMR  280 (288)
Q Consensus       273 ~~i~~~~~  280 (288)
                      ..+.....
T Consensus       297 ~~i~~~~~  304 (367)
T 3l9p_A          297 EFVTSGGR  304 (367)
T ss_dssp             HHHHTTCC
T ss_pred             HHHHcCCC
Confidence            77765543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.9e-39  Score=276.03  Aligned_cols=211  Identities=27%  Similarity=0.396  Sum_probs=172.2

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCC---cchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF---QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ...+.+.+.+|+|.++.++.+    .+..+++.||||++....   ........+.+|+++++.++||||+++++++...
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   98 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRC----INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD   98 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ccceEEeeEEeeCCCEEEEEE----EECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            345677888888888877765    467789999999986321   1112356788999999999999999999999876


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc---E
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---L  203 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~---~  203 (288)
                      +..      ++||||+++ +|.+.+..      .+++..+..++.||+.||+|||+++|+||||||+||+++.++.   +
T Consensus        99 ~~~------~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~v  172 (351)
T 3c0i_A           99 GML------YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV  172 (351)
T ss_dssp             TEE------EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCE
T ss_pred             CEE------EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcE
Confidence            654      999999985 56555532      2799999999999999999999999999999999999987654   9


Q ss_pred             EEeecccccccCCCcc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        204 KILDFGLARTAGTTFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       204 kl~dfg~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+ .+....+...
T Consensus       173 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~  247 (351)
T 3c0i_A          173 KLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKG  247 (351)
T ss_dssp             EECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHT
T ss_pred             EEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcC
Confidence            9999999987654332 345679999999999999999999999999999999999999998753 3444555443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6e-39  Score=281.76  Aligned_cols=212  Identities=31%  Similarity=0.554  Sum_probs=180.2

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC------CCCCcceeeccccC
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV------NHKNIIGLLNAFTP  132 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~  132 (288)
                      ++.+.+.||+|.++.++.+    .+..+++.||||+++.   .......+.+|+++++.+      +|+||+++++++..
T Consensus        98 ry~~~~~LG~G~fg~V~~a----~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKA----YDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEE----EETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             cEEEEEEcccCccEEEEEE----EECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            3555666666666666553    4677899999999974   334456777888888887      57799999999987


Q ss_pred             CCcccccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc--EEEe
Q psy11580        133 QKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKIL  206 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~--~kl~  206 (288)
                      .+..      ++|||++++++.+.+..    .+++..++.++.||+.||+|||+++|+||||||+|||++.++.  +||+
T Consensus       171 ~~~~------~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          171 RNHI------CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             TTEE------EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred             CCeE------EEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEe
Confidence            7654      99999999999888763    3899999999999999999999999999999999999999887  9999


Q ss_pred             ecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       207 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      |||++......  .....+++.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+++.++.++.+
T Consensus       245 DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~  321 (429)
T 3kvw_A          245 DFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK  321 (429)
T ss_dssp             CCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            99999765443  234578999999999999999999999999999999999999999999999999999998877653

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3e-39  Score=280.82  Aligned_cols=215  Identities=31%  Similarity=0.539  Sum_probs=176.3

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.+.    +.. +..||+|++.....      ...+|+++++.++||||+++++++...+...
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~----~~~-~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAK----LVE-SDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEE----ETT-TEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             ceEEEeEEEeeCCCeEEEEEE----ECC-CCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            345677777777777776652    333 34589998864321      1236999999999999999999996554322


Q ss_pred             ccccEEEEEecccccHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEc-cCCcEEEeeccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGL  210 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~-~~~~~kl~dfg~  210 (288)
                      .....++||||+++++.+.+.      ..+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||+
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            333468999999998776553      3588999999999999999999999999999999999999 789999999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      +.............+++.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+.+.+|++.++.++
T Consensus       189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  262 (394)
T 4e7w_A          189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS  262 (394)
T ss_dssp             CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9877655555667889999999999875 589999999999999999999999999999999999998877654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.3e-39  Score=275.16  Aligned_cols=222  Identities=33%  Similarity=0.613  Sum_probs=176.4

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc---------chhhHHHHHHHHHHHHHCCCCCccee
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ---------NVTHAKRAYREFKLMKLVNHKNIIGL  126 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~  126 (288)
                      ....+.+.+.+|+|.++.++.+.    + .+++.||||++.....         .......+.+|++++++++||||+++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~----~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   94 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGV----D-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL   94 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEE----C-TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             hccceEEeEEeccCCCEEEEEEE----C-CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence            45677888888888888777653    2 4589999999964322         12234778999999999999999999


Q ss_pred             eccccCCCcccccccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcE
Q psy11580        127 LNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL  203 (288)
Q Consensus       127 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~  203 (288)
                      ++++...+. ......++||||+++++.+.+..   .+++..+..++.||+.||+|||+++|+||||||+||+++.++.+
T Consensus        95 ~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~  173 (362)
T 3pg1_A           95 RDIFVHFEE-PAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDI  173 (362)
T ss_dssp             SEEEEECCT-TTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             eeeEEeccC-CCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCE
Confidence            999854332 22245699999999999888763   48999999999999999999999999999999999999999999


Q ss_pred             EEeecccccccCCCcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        204 KILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       204 kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ||+|||++.............+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+.+.++++..+.+
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             EECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9999999986655555556688999999999987 678999999999999999999999999999999999998877755


Q ss_pred             c
Q psy11580        283 H  283 (288)
Q Consensus       283 ~  283 (288)
                      +
T Consensus       254 ~  254 (362)
T 3pg1_A          254 K  254 (362)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.2e-39  Score=274.96  Aligned_cols=202  Identities=26%  Similarity=0.391  Sum_probs=157.5

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++++    .+..+++.||+|++....   .....+.+|+.+++.++||||+++++++...+.. 
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~----~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-   91 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLM----RDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTPTHL-   91 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEE----EETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE-
T ss_pred             CcEEEEEEeccCCCEEEEEE----EECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE-
Confidence            45677888888888877765    467789999999997532   2345688999999999999999999999877654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc--EEEeeccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLAR  212 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~--~kl~dfg~~~  212 (288)
                           ++||||+++ +|.+.+.  ..+++..++.++.|++.||+|||++||+||||||+||+++.++.  +||+|||++.
T Consensus        92 -----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           92 -----AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             -----EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             -----EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence                 999999976 5666654  45899999999999999999999999999999999999987765  9999999998


Q ss_pred             ccCCCcccCCcccccccCchHhHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchhHH
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGGVLFPGTDHIDQW  272 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slg~il~~l~~g~~p~~~~~~~~~~  272 (288)
                      ............+++.|+|||++.+..++.+ +||||||+++|+|++|+.||.+.+....+
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  227 (361)
T 3uc3_A          167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY  227 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH
T ss_pred             cccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH
Confidence            6554444455689999999999998887655 89999999999999999999886554333

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2e-38  Score=272.41  Aligned_cols=223  Identities=25%  Similarity=0.408  Sum_probs=180.4

Q ss_pred             HHHhhhhhhcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCccee
Q psy11580         49 VDQWKELIYQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGL  126 (288)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~  126 (288)
                      ...| ++...++.+.+.+|+|.++.++.+.-. ..+..+++.||||+++.. ........+.+|+++++++ +||||+++
T Consensus        14 ~~~~-~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           14 ASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             HHHH-BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccc-cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            4445 677788999999999999998887421 114567789999999754 2334457789999999999 79999999


Q ss_pred             eccccCCCcccccccEEEEEecccc-cHHHHHhhh---------------------------------------------
Q psy11580        127 LNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD---------------------------------------------  160 (288)
Q Consensus       127 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------------------------------------  160 (288)
                      ++++...+.     ..++||||+++ +|.+.+...                                             
T Consensus        92 ~~~~~~~~~-----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (359)
T 3vhe_A           92 LGACTKPGG-----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG  166 (359)
T ss_dssp             EEEECSTTS-----CCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred             eeeeecCCC-----ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence            999987553     24999999987 566665421                                             


Q ss_pred             -----------------------CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        161 -----------------------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       161 -----------------------~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                                             +++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||++......
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                                   888999999999999999999999999999999999999999999999999865332


Q ss_pred             ---cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        218 ---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       218 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                         .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+.....+..
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  311 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE  311 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc
Confidence               12344567889999999999999999999999999999998 99999987755544444433

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.3e-39  Score=273.03  Aligned_cols=197  Identities=20%  Similarity=0.276  Sum_probs=166.8

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||||++....    ....+.+|+++++++ +||||+++++++...+..
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLG----KNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEE----EETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             CCeEEEEEeeccCCceEEEE----EECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            45677778888877777765    356789999999997532    234578999999999 999999999999776654


Q ss_pred             cccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc-----EEEeec
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-----LKILDF  208 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~-----~kl~df  208 (288)
                            ++||||++++|.+.+.   ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.     +||+||
T Consensus        81 ------~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DF  154 (330)
T 2izr_A           81 ------AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDF  154 (330)
T ss_dssp             ------EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred             ------EEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence                  9999999778887775   45999999999999999999999999999999999999998887     999999


Q ss_pred             ccccccCCCcc--------cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        209 GLARTAGTTFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       209 g~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      |++........        .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~  222 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA  222 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence            99986533221        2456789999999999999999999999999999999999999998544

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.4e-39  Score=278.49  Aligned_cols=233  Identities=27%  Similarity=0.416  Sum_probs=183.7

Q ss_pred             ccccHHHhhhhhhcccccccccCCccccccccCccc------eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC
Q psy11580         45 REHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV  118 (288)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l  118 (288)
                      ..+....|....+..+.+++.+..+|.....+|.|.      +.+..+++.||||+++.   .......+.+|+++++.+
T Consensus        14 ~~e~~~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l   90 (397)
T 1wak_A           14 EQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSV   90 (397)
T ss_dssp             --------CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHH
T ss_pred             cccccccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHH
Confidence            334445555555666777777777777776666662      44567899999999974   334567788999999999


Q ss_pred             C--------CCCcceeeccccCCCcccccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHC-CC
Q psy11580        119 N--------HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA-GI  185 (288)
Q Consensus       119 ~--------h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~-~i  185 (288)
                      +        |+||+++++++...+  ......++|||++++++++.+..    .+++..++.++.||+.||+|||++ ||
T Consensus        91 ~~~~~~~~~~~~iv~~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~gi  168 (397)
T 1wak_A           91 RNSDPNDPNREMVVQLLDDFKISG--VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI  168 (397)
T ss_dssp             HHSCTTCGGGGGBCCEEEEEEEEE--TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred             hhcCCCCCCcceeeeeecceeecC--CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence            5        788999999987332  12245699999999998887753    389999999999999999999998 99


Q ss_pred             EeecCCCCCEEEccCC-------------------------------------------------cEEEeecccccccCC
Q psy11580        186 IHRDLKPSNIVVKSDC-------------------------------------------------TLKILDFGLARTAGT  216 (288)
Q Consensus       186 vH~dl~~~nil~~~~~-------------------------------------------------~~kl~dfg~~~~~~~  216 (288)
                      +||||||+|||++.++                                                 .+||+|||++.....
T Consensus       169 vHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~  248 (397)
T 1wak_A          169 IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK  248 (397)
T ss_dssp             ECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB
T ss_pred             ecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc
Confidence            9999999999998775                                                 799999999987654


Q ss_pred             CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chhHHHHHHHHhCCCcc
Q psy11580        217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD------HIDQWNKIIGKMREAHD  284 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~------~~~~~~~i~~~~~~~~~  284 (288)
                      .  .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+      ..+.+..+.+.++.+|.
T Consensus       249 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~  320 (397)
T 1wak_A          249 H--FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPR  320 (397)
T ss_dssp             C--SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCH
T ss_pred             c--CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCCh
Confidence            3  344578999999999999999999999999999999999999998755      45677888888887664

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.4e-39  Score=290.84  Aligned_cols=200  Identities=28%  Similarity=0.409  Sum_probs=167.0

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+.||+|.++.++++    .+..+|+.||+|++.+.. ........+.+|+++|+.++||||+++++++...+..
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a----~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCAC----QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cceEEEEEEeeCCCEEEEEE----EECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            44555666666666665554    456789999999996421 1223345678999999999999999999999877655


Q ss_pred             cccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                            ++||||+++ +|.+.+..    .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       260 ------~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          260 ------CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             ------EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ------EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccc
Confidence                  999999976 56555542    2899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      .............||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+
T Consensus       334 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          334 VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             EECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             eecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            87765544455689999999999999889999999999999999999999998764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.6e-39  Score=286.10  Aligned_cols=216  Identities=26%  Similarity=0.343  Sum_probs=172.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..+.+.+.||+|.++.++++    .+..+|+.||+|++.+... .......+..|++++++++||||+++++++...+..
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a----~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFAC----QMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hheEEEEEEeeCCCeEEEEE----EECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            44455556666666665554    4567899999999975211 123346788999999999999999999999877654


Q ss_pred             cccccEEEEEecccc-cHHHHHhh------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                            ++||||+++ +|.+.+..      .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus       261 ------~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          261 ------CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             ------EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ------EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence                  999999986 56555532      48899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chhHHHHHHHHhCCCc
Q psy11580        210 LARTAGTTFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD----HIDQWNKIIGKMREAH  283 (288)
Q Consensus       210 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~----~~~~~~~i~~~~~~~~  283 (288)
                      ++........ ....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+    ..++.+.+.......|
T Consensus       335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p  413 (543)
T 3c4z_A          335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP  413 (543)
T ss_dssp             TCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC
T ss_pred             eeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC
Confidence            9987654333 344589999999999999999999999999999999999999998764    3445555555444443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=267.58  Aligned_cols=200  Identities=26%  Similarity=0.376  Sum_probs=170.0

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +...++.+++.+|+|.++.++.+    .+..+++.||+|++..  ........+.+|++++++++||||+++++++...+
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~----~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   80 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKV----THRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK   80 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEE----EETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             eChhHeeccceecCCCCEEEEEE----EECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence            34567788899999888888765    4667899999999864  35566778999999999999999999999998766


Q ss_pred             cccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      ..      ++||||+++ +|.+.+.   ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  154 (310)
T 3s95_A           81 RL------NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGL  154 (310)
T ss_dssp             EE------EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred             ee------EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccc
Confidence            54      999999987 5666654   3589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccc---------------CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        211 ARTAGTTFMM---------------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       211 ~~~~~~~~~~---------------~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      +.........               ....||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~  225 (310)
T 3s95_A          155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY  225 (310)
T ss_dssp             CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred             ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence            9765432211               1457899999999999999999999999999999999999998763

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.3e-39  Score=273.78  Aligned_cols=208  Identities=28%  Similarity=0.418  Sum_probs=157.0

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+++.||||+++..    ...+.+.+|++++++++||||+++++++...+.. 
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~----~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-  123 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRC----KQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI-  123 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEE-
T ss_pred             CcEEEeeEEeeCCCEEEEEE----EECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE-
Confidence            44667777888777777765    45667899999999753    2345677899999999999999999999876654 


Q ss_pred             ccccEEEEEecccc-cHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc---CCcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~---~~~~kl~dfg~~  211 (288)
                           ++||||+++ +|.+.+..  .+++..+..++.|++.||+|||+++|+||||||+||+++.   ++.+||+|||++
T Consensus       124 -----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          124 -----SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             -----EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             -----EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence                 999999985 66666653  4899999999999999999999999999999999999975   889999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh-HHHHHHHHh
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID-QWNKIIGKM  279 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~-~~~~i~~~~  279 (288)
                      .............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+ .+..+.+..
T Consensus       199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~  267 (349)
T 2w4o_A          199 KIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE  267 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC
T ss_pred             cccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC
Confidence            87665544456678999999999999899999999999999999999999998766554 555555443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.5e-38  Score=284.02  Aligned_cols=213  Identities=22%  Similarity=0.370  Sum_probs=180.1

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.||+|.++.++.|.    +..++..||||+++...   .....+.+|+++|++++||||++++++|...
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGV----WKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEE----EGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEE----EcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            5566788899999999998888763    45568899999998532   3457789999999999999999999999887


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      +..      ++||||+++ +|.+++.    ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus       289 ~~~------~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          289 PPF------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             SSC------EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred             CcE------EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeec
Confidence            765      999999985 6777665    24889999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        209 GLARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       209 g~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      |++........  .....++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+.+..
T Consensus       363 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~  436 (495)
T 1opk_A          363 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY  436 (495)
T ss_dssp             TCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             ccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99987643322  223345678999999999899999999999999999998 999999988777766665443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=269.17  Aligned_cols=198  Identities=26%  Similarity=0.315  Sum_probs=162.8

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  135 (288)
                      .+.+.+.+.+|+|.++.++.+    .+..+++.||||++...............|+..+..+ +||||+++++++...+.
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~  131 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKV----RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI  131 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEE----EETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhheeeeheeccCCCeEEEEE----EECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence            345667777777777777664    4567899999999876555555555666676666666 89999999999987665


Q ss_pred             ccccccEEEEEecccccHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      .      ++|||++++++.+.+..   .+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++.
T Consensus       132 ~------~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          132 L------YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             E------EEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             E------EEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeee
Confidence            4      99999999998887753   48999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      ............||+.|+|||++.+ .++.++||||||+++|+|++|..|+.+
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~  257 (311)
T 3p1a_A          206 ELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG  257 (311)
T ss_dssp             ECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred             ecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            7766555556678999999999987 789999999999999999999776654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.7e-38  Score=268.83  Aligned_cols=206  Identities=23%  Similarity=0.436  Sum_probs=171.0

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      .....+|+|.++.++.+    .+..+|+.||||++...  .......+.+|+.+++.++||||+++++++...+..    
T Consensus        48 ~~~~~lg~G~~g~V~~a----~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----  117 (321)
T 2c30_A           48 DSYVKIGEGSTGIVCLA----REKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL----  117 (321)
T ss_dssp             EEEEEEEEETTEEEEEE----EETTTCCEEEEEEEETT--TCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE----
T ss_pred             hccEEeccCCCeEEEEE----EECCCCcEEEEEEEecc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE----
Confidence            34446666666666654    34568999999999753  233456788999999999999999999999876654    


Q ss_pred             cEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        141 DVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       141 ~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                        ++||||++++ +.+.+. ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++.......
T Consensus       118 --~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  195 (321)
T 2c30_A          118 --WVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  195 (321)
T ss_dssp             --EEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             --EEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence              9999999875 545443 358999999999999999999999999999999999999999999999999987665432


Q ss_pred             -ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        219 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       219 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                       ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  256 (321)
T 2c30_A          196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS  256 (321)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence             234567899999999999989999999999999999999999999988877776666543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.8e-39  Score=271.10  Aligned_cols=215  Identities=24%  Similarity=0.395  Sum_probs=169.2

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      +.+.+.+.+|+|.++.++++    .+..+++.||||+++.... .......+.+|++++++++||||+++++++..... 
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-   86 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLA----RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-   86 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-
T ss_pred             CcEEEEEEEccCCCEEEEEE----EECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-
Confidence            44566777777777766664    4567899999999986432 33445678899999999999999999999875542 


Q ss_pred             cccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                       .....++||||+++ +|.+.+.  ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++..
T Consensus        87 -~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           87 -AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             -TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             -CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence             12345999999975 5666654  3489999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCc----ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        214 AGTTF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       214 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      .....    ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+...++...
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~  234 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE  234 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC
Confidence            54321    223356899999999999999999999999999999999999999998877766555543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.6e-39  Score=277.69  Aligned_cols=210  Identities=21%  Similarity=0.281  Sum_probs=172.9

Q ss_pred             cccccccccCCc--cccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         58 QELPISHQMGKK--RHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        58 ~~~~~~~~~~~~--~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      .++.+.+.+|+|  .++.++++    .+..+++.||||+++...........+.+|+++++.++||||+++++++...+.
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLA----RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEE----EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CcEEEEecccCCcCCceEEEEE----EEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            456777788887  66666654    456789999999998755555667788899999999999999999999987765


Q ss_pred             ccccccEEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      .      ++||||+++ ++.+.+.    ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||.
T Consensus       101 ~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B          101 L------WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             E------EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             E------EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence            4      999999986 5555554    3489999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC--------CcccCCcccccccCchHhHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        211 ARTAGT--------TFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       211 ~~~~~~--------~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      +.....        ........+++.|+|||++.+  ..++.++||||||+++|+|++|+.||.+.+..+.+.+++.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  251 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN  251 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            864321        111233478899999999988  5789999999999999999999999999877776655543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=269.41  Aligned_cols=201  Identities=26%  Similarity=0.406  Sum_probs=167.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+++.||||+++... .......+.+|++++++++||||+++++++.....  
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   81 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRG----RHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT--   81 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT--
T ss_pred             CCEEEEEEecCCCCeEEEEE----EECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC--
Confidence            45677777888777777765    456789999999997532 22335677899999999999999999999876542  


Q ss_pred             ccccEEEEEecccc-cHHHHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE----ccCCcEEEee
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILD  207 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~----~~~~~~kl~d  207 (288)
                        ...++||||+++ +|.+.+...     +++..++.++.||+.||+|||+++|+||||||+||++    +.++.+||+|
T Consensus        82 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           82 --RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             --ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence              245999999985 566666421     8999999999999999999999999999999999999    7778899999


Q ss_pred             cccccccCCCcccCCcccccccCchHhHh--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        208 FGLARTAGTTFMMTPYVVTRYYRAPEVIL--------GMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ||++.............+++.|+|||++.        +..++.++||||||+++|+|++|+.||...+
T Consensus       160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  227 (319)
T 4euu_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (319)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99998876655555668999999999997        4678999999999999999999999997543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=276.48  Aligned_cols=212  Identities=32%  Similarity=0.565  Sum_probs=163.3

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccE
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      +..||+|.++.++.+.  ..+..+++.||||++....    ....+.+|+++|++++||||+++++++.....    ...
T Consensus        26 g~~lG~G~~g~Vy~~~--~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~~   95 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAK--RKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHAD----RKV   95 (405)
T ss_dssp             SCCCC-----EEEEEE--ESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTT----TEE
T ss_pred             CcEeeecCCeEEEEEE--EccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCC----CeE
Confidence            5678888888777752  1133578899999997532    23467899999999999999999999954221    235


Q ss_pred             EEEEecccccHHHHHhh-----------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE----ccCCcEEEee
Q psy11580        143 YLVMELMDANLCQVIQM-----------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILD  207 (288)
Q Consensus       143 ~lv~e~~~~~l~~~~~~-----------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~----~~~~~~kl~d  207 (288)
                      ++||||+++++.+.+..           .+++..++.++.||+.||+|||+++|+||||||+|||+    +.++.+||+|
T Consensus        96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A           96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99999999998887641           28999999999999999999999999999999999999    6778999999


Q ss_pred             cccccccCCC----cccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------hhHHH
Q psy11580        208 FGLARTAGTT----FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDH---------IDQWN  273 (288)
Q Consensus       208 fg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~---------~~~~~  273 (288)
                      ||++......    .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.         .+.+.
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            9999865432    223446789999999999884 589999999999999999999999987654         47888


Q ss_pred             HHHHHhCCCcc
Q psy11580        274 KIIGKMREAHD  284 (288)
Q Consensus       274 ~i~~~~~~~~~  284 (288)
                      .|++.++.++.
T Consensus       256 ~i~~~~g~p~~  266 (405)
T 3rgf_A          256 RIFNVMGFPAD  266 (405)
T ss_dssp             HHHHHHCCCCT
T ss_pred             HHHHhhCCCCh
Confidence            89988886654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.1e-38  Score=268.36  Aligned_cols=214  Identities=23%  Similarity=0.374  Sum_probs=180.1

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcch----hhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV----THAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+++.||+|+++......    .....+.+|+++++.++||||+++++++...
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKC----REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccEEEeeEeeecCCEEEEEE----EECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            34567778888877777664    456789999999997643221    1356788999999999999999999999876


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC----cEEEe
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKIL  206 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~----~~kl~  206 (288)
                      +..      ++||||+++ +|.+.+.  ..+++..+..++.|++.||+|||++||+||||||+||+++.++    .++|+
T Consensus        88 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~  161 (321)
T 2a2a_A           88 TDV------VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (321)
T ss_dssp             SEE------EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             CEE------EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence            654      999999975 6766665  3478999999999999999999999999999999999999887    79999


Q ss_pred             ecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCC
Q psy11580        207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       207 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  281 (288)
                      |||++.............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+.+....
T Consensus       162 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  236 (321)
T 2a2a_A          162 DFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD  236 (321)
T ss_dssp             CCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred             cCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc
Confidence            999998776655555667899999999999989999999999999999999999999998888877777655443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=270.16  Aligned_cols=219  Identities=24%  Similarity=0.320  Sum_probs=177.0

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.+|+|.++.++.|.-. .....+..||||+++... .......+.+|+++++.++||||+++++++...
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLR-VPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEEC-CTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEe-cCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            455567788888999888888776311 011334569999997532 345567789999999999999999999999776


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      +..      ++||||+++ +|.+.+.   ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||
T Consensus       123 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  196 (325)
T 3kul_A          123 RLA------MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG  196 (325)
T ss_dssp             GCC------EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             Ccc------EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCC
Confidence            654      999999976 5666664   358999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc----ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        210 LARTAGTTF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       210 ~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ++.......    ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus       197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  272 (325)
T 3kul_A          197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR  272 (325)
T ss_dssp             SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC
Confidence            998654322    1223345678999999999899999999999999999998 9999999888888777766543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.9e-38  Score=261.92  Aligned_cols=213  Identities=28%  Similarity=0.436  Sum_probs=179.7

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +.+.+.+.+|+|.++.++.+    .+..++..||+|++...  .......+.+|++++++++||||+++++++...+.. 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~~a~k~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-   81 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIA----VQKGTRIRRAAKKIPKY--FVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI-   81 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEEGG--GCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE-
T ss_pred             hhEEeeeEEeecCCEEEEEE----EeCCCCcEEEEEeehhh--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE-
Confidence            45677778888887777765    45677889999999753  223457788999999999999999999999877654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE---ccCCcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~---~~~~~~kl~dfg~~  211 (288)
                           ++||||+++ ++.+.+.  ..+++..+..++.|++.||+|||+++++|+||||+||++   +.++.++|+|||++
T Consensus        82 -----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~  156 (277)
T 3f3z_A           82 -----YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA  156 (277)
T ss_dssp             -----EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             -----EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence                 999999986 5666554  348999999999999999999999999999999999999   77889999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .............+++.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+...++.+.....|
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  227 (277)
T 3f3z_A          157 ARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP  227 (277)
T ss_dssp             EECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             eeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            877665555667899999999998765 89999999999999999999999999888887777776554443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.4e-38  Score=265.87  Aligned_cols=210  Identities=25%  Similarity=0.477  Sum_probs=173.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|+++.     .....+.+|++++++++ ||||+++++++..... 
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~-  105 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEA----INITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVS-  105 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT-
T ss_pred             CceEEEEEecccCCeEEEEE----EECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC-
Confidence            34556666777666666654    4567899999999974     22467889999999997 9999999999976321 


Q ss_pred             cccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC-cEEEeecccccccC
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAG  215 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~-~~kl~dfg~~~~~~  215 (288)
                         ...++||||++++.+..+...+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++....
T Consensus       106 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          106 ---RTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             ---CCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             ---CceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence               24599999999876666667799999999999999999999999999999999999999777 89999999998766


Q ss_pred             CCcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCchhHHHHHHHHhC
Q psy11580        216 TTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFP-GTDHIDQWNKIIGKMR  280 (288)
Q Consensus       216 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~-~~~~~~~~~~i~~~~~  280 (288)
                      .........+++.|+|||++.+ ..++.++||||||+++|+|++|..||. +.+..+.+..+.+.++
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~  249 (330)
T 3nsz_A          183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG  249 (330)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred             CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC
Confidence            5555566688999999999987 668999999999999999999999984 4566666666666554

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.8e-38  Score=264.02  Aligned_cols=214  Identities=21%  Similarity=0.336  Sum_probs=177.7

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.+|+|.++.++.+.     ..++..||+|+++...   .....+.+|+++++.++||||+++++++...
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   91 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGK-----WRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   91 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEE-----ETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEE-----EcCCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence            4566778889999999998888763     3467789999998533   2346788999999999999999999999877


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      +..      ++||||+++ ++.+.+.   ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||
T Consensus        92 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg  165 (283)
T 3gen_A           92 RPI------FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG  165 (283)
T ss_dssp             SSE------EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred             CCe------EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccc
Confidence            655      999999975 5666664   458999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhCC
Q psy11580        210 LARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       210 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~~  281 (288)
                      ++........  .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+.+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~  240 (283)
T 3gen_A          166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL  240 (283)
T ss_dssp             GGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             ccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC
Confidence            9986544221  223355778999999999899999999999999999998 99999998888887777766543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.2e-38  Score=283.23  Aligned_cols=213  Identities=29%  Similarity=0.463  Sum_probs=176.2

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|+|.++.++++    .+..++..||+|++............+.+|+++++.++||||+++++++...+..  
T Consensus        38 ~y~~~~~lG~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~--  111 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLC----RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY--  111 (494)
T ss_dssp             HEEEEEEEECC---EEEEE----EETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE--
T ss_pred             CeEEeeEEecCCCEEEEEE----EECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE--
Confidence            4567778888877777764    4677899999999986544445567889999999999999999999999877654  


Q ss_pred             cccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC---CcEEEeeccccc
Q psy11580        139 FQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLAR  212 (288)
Q Consensus       139 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~---~~~kl~dfg~~~  212 (288)
                          ++||||+.+ ++.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||+++..   +.+||+|||++.
T Consensus       112 ----~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          112 ----YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             ----EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             ----EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence                999999986 5666654  458999999999999999999999999999999999999764   459999999998


Q ss_pred             ccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ............+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+.+.++.+.....
T Consensus       188 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  256 (494)
T 3lij_A          188 VFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF  256 (494)
T ss_dssp             ECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             ECCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            7766555566789999999999874 68999999999999999999999999999988888887765443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-38  Score=261.62  Aligned_cols=213  Identities=23%  Similarity=0.340  Sum_probs=178.4

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      .+...++.+.+.+|+|.++.++.+.     ..+++.||+|++....   ...+.+.+|++++++++||||+++++++...
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (269)
T 4hcu_A            6 VIDPSELTFVQEIGSGQFGLVHLGY-----WLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   77 (269)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEE-----ETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EeChhhceeeheecCCCccEEEEEE-----ecCCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            3455677888899998888888763     2357789999998543   2346788999999999999999999999877


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      +..      ++||||+++ ++.+.+.   ..+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||
T Consensus        78 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  151 (269)
T 4hcu_A           78 API------CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG  151 (269)
T ss_dssp             SSE------EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTT
T ss_pred             Cce------EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccc
Confidence            655      999999987 4666654   238999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc--ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        210 LARTAGTTF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       210 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ++.......  ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~  225 (269)
T 4hcu_A          152 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR  225 (269)
T ss_dssp             GGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred             ccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc
Confidence            998654432  1233456778999999999999999999999999999999 9999999888888777776544

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1e-38  Score=275.98  Aligned_cols=214  Identities=24%  Similarity=0.367  Sum_probs=177.2

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      .+...++.+.+.+|+|.++.++.|.    +..+++.||||+++.. ........+.+|++++++++||||+++++++...
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGR----LRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEE----ETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEE----EecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            4556677888888888888877763    4557899999999753 2334456788999999999999999999999877


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      +..      ++||||+++ +|.+.+.   ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||
T Consensus       185 ~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          185 QPI------YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             SSC------EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             CCc------EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCC
Confidence            665      999999985 6666664   348999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccc---CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        210 LARTAGTTFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       210 ~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ++.........   ....+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+.+.
T Consensus       259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~  331 (377)
T 3cbl_A          259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG  331 (377)
T ss_dssp             GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT
T ss_pred             CceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99765433221   12235678999999998889999999999999999998 99999998877666555443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.5e-38  Score=283.75  Aligned_cols=212  Identities=31%  Similarity=0.508  Sum_probs=178.2

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +.+.+.+.+|+|.++.++.+    .+..+++.||||++............+.+|++++++++||||+++++++...+.. 
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-   96 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKC----KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF-   96 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEE----EETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE-
T ss_pred             cceEEeEEEeecCCEEEEEE----EECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE-
Confidence            45677888999888888765    4667899999999975333334567789999999999999999999999877654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEc---cCCcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~---~~~~~kl~dfg~~  211 (288)
                           ++||||+.+ ++.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||+++   .++.+||+|||++
T Consensus        97 -----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A           97 -----YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             -----EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             -----EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence                 999999986 5666554  4589999999999999999999999999999999999995   4567999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      .............+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+.+.++.....
T Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  239 (486)
T 3mwu_A          172 TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY  239 (486)
T ss_dssp             TTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             eECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence            87766555566789999999999987 589999999999999999999999999998888888776543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=267.43  Aligned_cols=216  Identities=24%  Similarity=0.416  Sum_probs=170.4

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcc------------------------hhhHHHHHHHH
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN------------------------VTHAKRAYREF  112 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~e~  112 (288)
                      ..++.+.+.+|+|.++.++.+    .+..+++.||||++......                        ......+.+|+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   87 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLA----YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI   87 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEE----EETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEE----EECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence            356678888888888877765    46778999999999753211                        11235688999


Q ss_pred             HHHHHCCCCCcceeeccccCCCcccccccEEEEEecccccHHHHH-h-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        113 KLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVI-Q-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       113 ~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~-~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                      +++++++||||+++++++.....    ...++||||++++.+..+ . ..+++..+..++.||+.||+|||+++|+||||
T Consensus        88 ~~l~~l~h~~iv~~~~~~~~~~~----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  163 (298)
T 2zv2_A           88 AILKKLDHPNVVKLVEVLDDPNE----DHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI  163 (298)
T ss_dssp             HHHHTCCCTTBCCEEEEEECSSS----SEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             HHHHhCCCCCCCeEEEEEEcCCC----CEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence            99999999999999999976321    345999999987533322 2 45899999999999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCc-ccCCcccccccCchHhHhcCC---CCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ||+||+++.++.+||+|||++....... ......+++.|+|||++.+..   .+.++||||||+++|+|++|+.||.+.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999998754432 234567899999999998755   378899999999999999999999988


Q ss_pred             CchhHHHHHHHHhC
Q psy11580        267 DHIDQWNKIIGKMR  280 (288)
Q Consensus       267 ~~~~~~~~i~~~~~  280 (288)
                      +.......+.....
T Consensus       244 ~~~~~~~~~~~~~~  257 (298)
T 2zv2_A          244 RIMCLHSKIKSQAL  257 (298)
T ss_dssp             SHHHHHHHHHHCCC
T ss_pred             cHHHHHHHHhcccC
Confidence            77666666655433

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.8e-38  Score=272.80  Aligned_cols=222  Identities=31%  Similarity=0.503  Sum_probs=176.1

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ....++.+.+.+|+|.++.++.+    .+..+++.||||++...   ......+.++++.++.++||||+++++++...+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~   92 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLG----KEKSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG   92 (360)
T ss_dssp             HHHTTEEEC----------CEEE----EETTTCCEEEEEEEECC---TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred             hhccceEEEEEEecCCCeEEEEE----EECCCCCEEEEEEEecC---ccccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence            34467888999999998888875    45678999999998653   233345677888899999999999999986533


Q ss_pred             c-ccccccEEEEEecccccHHHHHh------hhCCHHHHHHHHHHHHHHHHHHH--HCCCEeecCCCCCEEEcc-CCcEE
Q psy11580        135 S-LEEFQDVYLVMELMDANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKS-DCTLK  204 (288)
Q Consensus       135 ~-~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH--~~~ivH~dl~~~nil~~~-~~~~k  204 (288)
                      . .......++||||+++++...+.      ..+++..+..++.|++.||+|||  ++||+||||||+||+++. ++.+|
T Consensus        93 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           93 ERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             SSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence            2 11122358999999998776543      24788999999999999999999  999999999999999997 89999


Q ss_pred             EeecccccccCCCcccCCcccccccCchHhHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        205 ILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       205 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      |+|||++.............+++.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+..+.+.++++.++.++
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            99999998876665556678899999999997654 79999999999999999999999999999999999998877664

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2e-38  Score=264.44  Aligned_cols=213  Identities=21%  Similarity=0.322  Sum_probs=161.0

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +...++.+.+.+|+|.++.++.+    .+..+++.||+|+++...........+.++...++.++||||+++++++...+
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~   79 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKM----RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG   79 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEE----EecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC
Confidence            44567788888888888877764    45678999999999865444444445556666688889999999999998776


Q ss_pred             cccccccEEEEEecccccHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCCEEEccCCcEEEee
Q psy11580        135 SLEEFQDVYLVMELMDANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILD  207 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~-~ivH~dl~~~nil~~~~~~~kl~d  207 (288)
                      ..      ++||||+++++.+.+.      ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|
T Consensus        80 ~~------~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~D  153 (290)
T 3fme_A           80 DV------WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCD  153 (290)
T ss_dssp             SE------EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCC
T ss_pred             CE------EEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEee
Confidence            54      9999999998876654      3589999999999999999999998 999999999999999999999999


Q ss_pred             cccccccCCCcccCCcccccccCchHhH----hcCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCchhHHHHHHH
Q psy11580        208 FGLARTAGTTFMMTPYVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPG-TDHIDQWNKIIG  277 (288)
Q Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Di~slg~il~~l~~g~~p~~~-~~~~~~~~~i~~  277 (288)
                      ||++.............+++.|+|||++    .+..++.++||||||+++|+|++|+.||.+ ......+.++..
T Consensus       154 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  228 (290)
T 3fme_A          154 FGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE  228 (290)
T ss_dssp             C---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH
T ss_pred             cCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc
Confidence            9999876665555556789999999997    456788999999999999999999999986 344444444433

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=274.80  Aligned_cols=217  Identities=19%  Similarity=0.266  Sum_probs=172.4

Q ss_pred             hhcccccccccCCccccccccCccce-eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC---CCCcceeecccc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAA-YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN---HKNIIGLLNAFT  131 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~  131 (288)
                      ....+.+.+.+|+|.++.++.+.-.. .+..+++.||+|+++..     ....+..|+++++.++   |+||+++++++.
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            34556777788888888877763211 24678899999999752     3456778888888886   999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh-------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc----
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ-------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS----  199 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~----  199 (288)
                      ..+..      ++||||+++ +|.+.+.       ..+++..++.++.||+.||+|||+++|+||||||+|||++.    
T Consensus       138 ~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          138 FQNGS------VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             CSSCE------EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred             cCCCc------EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence            77765      999999985 6666664       24899999999999999999999999999999999999998    


Q ss_pred             -------CCcEEEeecccccccC---CCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC---
Q psy11580        200 -------DCTLKILDFGLARTAG---TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT---  266 (288)
Q Consensus       200 -------~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~---  266 (288)
                             ++.+||+|||++....   .........||+.|+|||++.+..++.++||||||+++|+|++|+.||...   
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   8999999999996432   333345568999999999999999999999999999999999999988532   


Q ss_pred             -----------CchhHHHHHHHHhCCCc
Q psy11580        267 -----------DHIDQWNKIIGKMREAH  283 (288)
Q Consensus       267 -----------~~~~~~~~i~~~~~~~~  283 (288)
                                 ...+.+..++..+-..+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~  319 (365)
T 3e7e_A          292 ECKPEGLFRRLPHLDMWNEFFHVMLNIP  319 (365)
T ss_dssp             EEEECSCCTTCSSHHHHHHHHHHHHCCC
T ss_pred             ceeechhccccCcHHHHHHHHHHHcCCC
Confidence                       23456677666665443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-38  Score=272.31  Aligned_cols=219  Identities=29%  Similarity=0.442  Sum_probs=181.1

Q ss_pred             hhhhcccccccccCCccccccccCcccee---ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAY---DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNA  129 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  129 (288)
                      ++...++.+.+.+|+|.++.++++.-...   ...++..||+|+++.. ........+.+|+++++++ +||||++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            55567788889999988888887642111   1234568999999754 3445567899999999999 99999999999


Q ss_pred             ccCCCcccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                      +...+..      ++||||+++ +|.+.+..                  .+++..++.++.||+.||+|||+++|+||||
T Consensus       144 ~~~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl  217 (382)
T 3tt0_A          144 CTQDGPL------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL  217 (382)
T ss_dssp             ECSSSSC------EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             eccCCce------EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence            9887765      999999986 67766642                  2889999999999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT  266 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~  266 (288)
                      ||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus       218 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          218 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             CGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999998654322   2234456788999999999999999999999999999999 99999998


Q ss_pred             CchhHHHHHHHHh
Q psy11580        267 DHIDQWNKIIGKM  279 (288)
Q Consensus       267 ~~~~~~~~i~~~~  279 (288)
                      +..+....+.+..
T Consensus       298 ~~~~~~~~~~~~~  310 (382)
T 3tt0_A          298 PVEELFKLLKEGH  310 (382)
T ss_dssp             CHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHcCC
Confidence            8777766665543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-37  Score=266.84  Aligned_cols=220  Identities=38%  Similarity=0.668  Sum_probs=179.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||||++... ........+.+|+++++.++||||+++++++..... .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~   84 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSA----THKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF-E   84 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS-T
T ss_pred             cceEEeeEEcCCCCeEEEEE----EECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc-C
Confidence            34566666777666666654    45678999999999643 334456678899999999999999999998875421 2


Q ss_pred             ccccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                      .....++|||++++++.+.+. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        85 ~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           85 NFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             TCCCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ccceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            334569999999999888776 4589999999999999999999999999999999999999999999999999976543


Q ss_pred             Ccc-----------cCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        217 TFM-----------MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       217 ~~~-----------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ...           .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+....+.++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            211           123467999999999875 6789999999999999999999999999999888888888777654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.1e-38  Score=278.97  Aligned_cols=209  Identities=24%  Similarity=0.398  Sum_probs=174.5

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.+|+|.++.++.|      ..+++.||||+++..    ...+.+.+|++++++++||||+++++++...
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~------~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  258 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLG------DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE  258 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEE------EETTEEEEEEEESSC----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred             ccChHHeEEEeeecCcCCeeEEEE------EecCCeEEEEEeCCc----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence            456677888888999888888876      335789999999753    2456789999999999999999999998765


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      +.     ..++||||+++ +|.+++...    +++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus       259 ~~-----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~Df  333 (450)
T 1k9a_A          259 KG-----GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF  333 (450)
T ss_dssp             TS-----CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCC
T ss_pred             CC-----ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeC
Confidence            42     24999999986 677766532    689999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        209 GLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       209 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      |++.......  ....++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+.+..
T Consensus       334 G~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~  403 (450)
T 1k9a_A          334 GLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY  403 (450)
T ss_dssp             TTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC
T ss_pred             CCcccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9998654322  22356788999999999999999999999999999998 999999988777777766544

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.7e-38  Score=268.05  Aligned_cols=220  Identities=32%  Similarity=0.548  Sum_probs=179.4

Q ss_pred             cccccccccCCccccccccCccceec-cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC---CCCCcceeeccccCC
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYD-TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV---NHKNIIGLLNAFTPQ  133 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~  133 (288)
                      .++.+.+.+|+|.++.++.+    .+ ..+++.||+|+++...........+.+|+.+++.+   +||||+++++++...
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKA----RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEE----EETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             hceeeeeeecccccEEEEEE----EecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            45667777888777777665    23 25678999999975332222233556677776666   899999999998621


Q ss_pred             CcccccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .. ......++|||++++++.+.+..    .+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||
T Consensus        87 ~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           87 RT-DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             EC-SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cc-CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence            10 12244699999999998887753    38999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        210 LARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      ++.............+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+.++++.++.+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (326)
T 1blx_A          166 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  238 (326)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9987665544556688999999999999899999999999999999999999999999999999998876644

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-38  Score=268.39  Aligned_cols=218  Identities=22%  Similarity=0.294  Sum_probs=178.9

Q ss_pred             hhhhcccccccccCCccccccccCccce-eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAA-YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      ++...++.+.+.+|+|.++.++.+.... ....+++.||+|+++... .......+.+|++++++++||||+++++++..
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            5566778888899998888888764211 111456899999997542 34456788999999999999999999999987


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHhh--------------------------hCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQM--------------------------DLDHERMSYLLYQMLCGIKHLHSAGI  185 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~--------------------------~~~~~~~~~~~~~i~~~l~~LH~~~i  185 (288)
                      .+..      ++||||+++ +|.+++..                          .+++..++.++.||++||+|||+++|
T Consensus       122 ~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i  195 (343)
T 1luf_A          122 GKPM------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF  195 (343)
T ss_dssp             SSSC------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CCce------EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            7665      999999986 66666542                          47889999999999999999999999


Q ss_pred             EeecCCCCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCC
Q psy11580        186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGV  261 (288)
Q Consensus       186 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~  261 (288)
                      +||||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            999999999999999999999999997643321   2234467889999999999899999999999999999998 999


Q ss_pred             CCCCCCchhHHHHHHHH
Q psy11580        262 LFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       262 p~~~~~~~~~~~~i~~~  278 (288)
                      ||.+.+..+....+.+.
T Consensus       276 p~~~~~~~~~~~~~~~~  292 (343)
T 1luf_A          276 PYYGMAHEEVIYYVRDG  292 (343)
T ss_dssp             TTTTSCHHHHHHHHHTT
T ss_pred             cCCCCChHHHHHHHhCC
Confidence            99998887777666554

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.2e-38  Score=271.07  Aligned_cols=219  Identities=24%  Similarity=0.332  Sum_probs=169.9

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.+|+|.++.++.|.-.. ...++..||||+++... .......+.+|++++++++||||+++++++...
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKL-PSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBC-TTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEec-CCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            4455678889999999888888774211 12457889999997532 345567899999999999999999999999877


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      +..      ++||||+++ +|.+.+..   .+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||
T Consensus       119 ~~~------~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  192 (373)
T 2qol_A          119 KPV------MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG  192 (373)
T ss_dssp             SSC------EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             Cce------EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCc
Confidence            665      999999975 66666643   48999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        210 LARTAGTTFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       210 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ++........    .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+.....
T Consensus       193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~  268 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR  268 (373)
T ss_dssp             ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE
T ss_pred             cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            9986543211    122234678999999999999999999999999999997 9999999888777776665543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.8e-38  Score=259.41  Aligned_cols=213  Identities=23%  Similarity=0.366  Sum_probs=176.7

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.+|+|.++.++.+.     ..++..||+|+++...   .....+.+|++++++++||||+++++++...
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGK-----WKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE   75 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEE-----ETTTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             EechhheeeeeeeccCCCceEEEEE-----ecCceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            3455677888889998888887762     3456789999998532   2346788999999999999999999999877


Q ss_pred             CcccccccEEEEEeccccc-HHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDAN-LCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      +..      ++||||++++ +.+.+..   .+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||
T Consensus        76 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg  149 (268)
T 3sxs_A           76 YPI------YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG  149 (268)
T ss_dssp             SSE------EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTT
T ss_pred             Cce------EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCc
Confidence            654      9999999764 6666542   48999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        210 LARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       210 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ++........  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+...++.....
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~  223 (268)
T 3sxs_A          150 MTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR  223 (268)
T ss_dssp             CEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred             cceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC
Confidence            9986544322  233345678999999999889999999999999999998 9999998887777666665443

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.9e-38  Score=266.73  Aligned_cols=218  Identities=25%  Similarity=0.361  Sum_probs=180.4

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ...+.+.+.+|+|.++.++.+    .+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  115 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEI----SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF  115 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCceEEEEEEeeCCCeEEEEE----EECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            356677788888777776654    466788999999997532 233456778899999999999999999999987765


Q ss_pred             ccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      .      ++||||+++ ++.+.+.  ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||++.
T Consensus       116 ~------~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          116 V------FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             E------EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             E------EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence            4      999999986 5666554  348999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCC-cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        213 TAGTT-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       213 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ..... .......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+.+.....|.
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  262 (335)
T 2owb_A          190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK  262 (335)
T ss_dssp             ECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT
T ss_pred             ecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc
Confidence            65432 2234457899999999999988999999999999999999999999988877777666655444443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=268.53  Aligned_cols=201  Identities=27%  Similarity=0.393  Sum_probs=171.9

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcch------hhHHHHHHHHHHHHHCCCCCcceeec
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV------THAKRAYREFKLMKLVNHKNIIGLLN  128 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~  128 (288)
                      ....++.+.+.+|+|.++.++.+    .+..+++.||||+++......      .....+.+|++++++++||||+++++
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~   96 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTA----VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD   96 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEE----EETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEE
T ss_pred             ccccceEEEeEEEecCCEEEEEE----EECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            34467788899999988888875    467789999999998643211      13446778999999999999999999


Q ss_pred             cccCCCcccccccEEEEEecccc--cHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEE
Q psy11580        129 AFTPQKSLEEFQDVYLVMELMDA--NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  204 (288)
Q Consensus       129 ~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~k  204 (288)
                      ++...+..      ++|||++.+  ++.+.+..  .+++..+..++.||+.||+|||+++|+||||||+||+++.++.+|
T Consensus        97 ~~~~~~~~------~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k  170 (335)
T 3dls_A           97 IFENQGFF------QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIK  170 (335)
T ss_dssp             EEECSSEE------EEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEE
T ss_pred             EEeeCCEE------EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEE
Confidence            99877654      999999865  56666653  589999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCcccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        205 ILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       205 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      |+|||++.............+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+
T Consensus       171 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             ECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             EeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            999999987766555556689999999999998877 7899999999999999999999965

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.3e-38  Score=266.02  Aligned_cols=221  Identities=21%  Similarity=0.338  Sum_probs=164.5

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCC---ceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecccc
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQ---QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  131 (288)
                      +...++.+.+.+|+|.++.++.+.    +..++   ..||||+++...........+.+|++++++++||||+++++++.
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQ----LKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEE----C-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             cChhHeEEeceecccCCeEEEEEE----EcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            344567788888888888777753    33333   38999999875555566788999999999999999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHhh--------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT  202 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~  202 (288)
                      ...........++||||+.+ ++.+.+..        .+++..+..++.|++.||+|||++||+||||||+||+++.++.
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence            76543333345899999987 56665532        4889999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        203 LKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       203 ~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      +||+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+...
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            99999999976543322   123355778999999999999999999999999999999 99999998888877777654


Q ss_pred             h
Q psy11580        279 M  279 (288)
Q Consensus       279 ~  279 (288)
                      .
T Consensus       256 ~  256 (323)
T 3qup_A          256 N  256 (323)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.9e-38  Score=261.46  Aligned_cols=219  Identities=25%  Similarity=0.385  Sum_probs=179.0

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      +...++.+.+.+|+|.++.++.+    .+..++..||+|++..... .......+.+|+.++++++||||+++++++...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLA----REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   81 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             eecccEEEeeEEecCCCeEEEEE----EEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence            34466788888888888887765    4567889999999964211 122245688999999999999999999999877


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      +..      ++||||+++ ++.+.+.  ..+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||+
T Consensus        82 ~~~------~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~  155 (279)
T 3fdn_A           82 TRV------YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW  155 (279)
T ss_dssp             SEE------EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred             CEE------EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccc
Confidence            654      999999986 5655554  4589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      +....... .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.+.....|.
T Consensus       156 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  228 (279)
T 3fdn_A          156 SVHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD  228 (279)
T ss_dssp             ESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT
T ss_pred             cccCCccc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC
Confidence            86654432 23457899999999999988999999999999999999999999999888888877766555544

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.3e-38  Score=282.45  Aligned_cols=213  Identities=31%  Similarity=0.479  Sum_probs=181.0

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ...+.+.+.+|+|.++.++.+    .+..+++.||||++..... .......+.+|++++++++||||+++++++...+.
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILC----KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cCceEEeeEEecCCCEEEEEE----EECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            345677788888888777764    4677899999999975432 23456788999999999999999999999987765


Q ss_pred             ccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE---ccCCcEEEeecc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFG  209 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~---~~~~~~kl~dfg  209 (288)
                      .      ++||||+.+ ++.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||++   +.++.+||+|||
T Consensus       101 ~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A          101 F------YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             E------EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             E------EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            4      999999986 5666664  458999999999999999999999999999999999999   467899999999


Q ss_pred             cccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        210 LARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ++.............+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+.+.++.+...
T Consensus       175 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  244 (484)
T 3nyv_A          175 LSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY  244 (484)
T ss_dssp             HHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             eeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC
Confidence            9987766555555689999999999987 689999999999999999999999999999888888876543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.5e-37  Score=262.03  Aligned_cols=218  Identities=27%  Similarity=0.376  Sum_probs=180.3

Q ss_pred             hhhhcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  131 (288)
                      ++...++.+.+.+|+|.++.++.+... ..+..+++.||+|+++.. ........+.+|+++++++ +||||+++++++.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            455667888999999999888877421 224567889999999754 2334567889999999999 9999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHhh--------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQM--------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                      ..+..      ++||||+++ +|.+.+..                    .+++..++.++.||+.||+|||+++++||||
T Consensus        98 ~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl  171 (313)
T 1t46_A           98 IGGPT------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL  171 (313)
T ss_dssp             SSSSC------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCCc------EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence            87765      999999986 67766643                    2789999999999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT  266 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~  266 (288)
                      ||+||+++.++.+||+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus       172 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            99999999999999999999986654322   234456788999999999999999999999999999998 99999987


Q ss_pred             CchhHHHHHHHH
Q psy11580        267 DHIDQWNKIIGK  278 (288)
Q Consensus       267 ~~~~~~~~i~~~  278 (288)
                      +......+++..
T Consensus       252 ~~~~~~~~~~~~  263 (313)
T 1t46_A          252 PVDSKFYKMIKE  263 (313)
T ss_dssp             CSSHHHHHHHHH
T ss_pred             cchhHHHHHhcc
Confidence            765555444443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.7e-38  Score=278.15  Aligned_cols=212  Identities=22%  Similarity=0.375  Sum_probs=178.8

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.+|+|.++.++.|.     ..++..||||+++...   ...+.+.+|++++++++||||+++++++...
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~-----~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~  255 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMAT-----YNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTKE  255 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEE-----ETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             eechHHeEEEEEcccCCceEEEEEE-----ECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCC
Confidence            5666788899999999998888873     2357789999998532   3467899999999999999999999998633


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                       .      .++||||+.+ +|.+++.    ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus       256 -~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          256 -P------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             -S------CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECST
T ss_pred             -c------cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeC
Confidence             3      3999999986 6777665    25889999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        209 GLARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       209 g~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      |++........  .....++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+....+.+...
T Consensus       329 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~  403 (454)
T 1qcf_A          329 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR  403 (454)
T ss_dssp             TGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC
T ss_pred             CCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99987644221  223345778999999999899999999999999999999 9999999988888777776544

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.2e-38  Score=267.42  Aligned_cols=201  Identities=25%  Similarity=0.435  Sum_probs=165.5

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++++    .+..+++.||+|++.... .......+.+|+.+++.++||||+++++++...+.. 
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~----~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-   80 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLA----VNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ-   80 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE-
T ss_pred             hhceeeeEEecCCCEEEEEE----EECCCCcEEEEEEEEccc-ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE-
Confidence            45677888888888777765    456789999999997532 223346788999999999999999999999877654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||+++ ++.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        81 -----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           81 -----YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             -----EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             -----EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence                 999999986 5655554  34899999999999999999999999999999999999999999999999999754


Q ss_pred             CC---CcccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy11580        215 GT---TFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPGTDHI  269 (288)
Q Consensus       215 ~~---~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~  269 (288)
                      ..   ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  214 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS  214 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence            32   222345678999999999998775 77999999999999999999999876543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.1e-38  Score=264.93  Aligned_cols=218  Identities=24%  Similarity=0.367  Sum_probs=179.8

Q ss_pred             hhhhcccccccccCCccccccccCcccee-ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAY-DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      ++...++.+.+.+|+|.++.++.+.-... ...++..||+|++... ........+.+|+++++.++||||+++++++..
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            44566788889999998888887643211 1356689999999753 344556788999999999999999999999987


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHhh--------------------------hCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQM--------------------------DLDHERMSYLLYQMLCGIKHLHSAGI  185 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~--------------------------~~~~~~~~~~~~~i~~~l~~LH~~~i  185 (288)
                      .+..      ++||||+++ +|.+.+..                          .+++..++.++.||+.||+|||+++|
T Consensus        98 ~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  171 (314)
T 2ivs_A           98 DGPL------LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL  171 (314)
T ss_dssp             SSSC------EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             CCce------EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            7665      999999985 66666642                          27889999999999999999999999


Q ss_pred             EeecCCCCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCC
Q psy11580        186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGV  261 (288)
Q Consensus       186 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~  261 (288)
                      +||||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999997654322   1233456788999999999889999999999999999999 999


Q ss_pred             CCCCCCchhHHHHHHHH
Q psy11580        262 LFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       262 p~~~~~~~~~~~~i~~~  278 (288)
                      ||.+.+.......+...
T Consensus       252 p~~~~~~~~~~~~~~~~  268 (314)
T 2ivs_A          252 PYPGIPPERLFNLLKTG  268 (314)
T ss_dssp             SSTTCCGGGHHHHHHTT
T ss_pred             CCCCCCHHHHHHHhhcC
Confidence            99998877766665544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-37  Score=258.99  Aligned_cols=212  Identities=24%  Similarity=0.376  Sum_probs=174.0

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcch----hhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV----THAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|+++......    .....+.+|++++++++||||+++++++...
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   80 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKC----RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK   80 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhHHhhcccCceEEEEE----EEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence            45677788888887777764    456689999999997543221    2357788999999999999999999999876


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC----cEEEe
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKIL  206 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~----~~kl~  206 (288)
                      +..      ++|||++++ ++.+.+.  ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++    .++|+
T Consensus        81 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           81 TDV------VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             SEE------EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CeE------EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEE
Confidence            654      999999974 6766664  3489999999999999999999999999999999999998877    79999


Q ss_pred             ecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       207 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      |||++.............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+....
T Consensus       155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  227 (283)
T 3bhy_A          155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN  227 (283)
T ss_dssp             CCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred             ecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc
Confidence            9999987665544455678999999999999899999999999999999999999999988877776665443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.7e-38  Score=264.25  Aligned_cols=236  Identities=18%  Similarity=0.283  Sum_probs=173.6

Q ss_pred             CcccccccHHHhhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCC
Q psy11580         41 SVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH  120 (288)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h  120 (288)
                      +.++.......+ .+....+.+.+.+|+|.++.++.+.- ..+..++..||+|+++...........+.+|+.++++++|
T Consensus        18 ~~eel~~~~~~~-~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h   95 (313)
T 3brb_A           18 GSEELQNKLEDV-VIDRNLLILGKILGEGEFGSVMEGNL-KQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH   95 (313)
T ss_dssp             ------CCTTTT-BCCGGGEEEEEEEEC-CCCCEEEEEE-ECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCC
T ss_pred             chHhhhhhHHhc-ccCHHHeeeccceeecCCeEEEEEEE-eccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCC
Confidence            333333333333 45667788889999988888876531 1122356789999998765566667789999999999999


Q ss_pred             CCcceeeccccCCCcccccccEEEEEecccc-cHHHHHh--------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCC
Q psy11580        121 KNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ--------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  191 (288)
Q Consensus       121 ~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~  191 (288)
                      |||+++++++...+. ......++||||+++ ++.+.+.        ..+++..++.++.||+.||+|||+++|+|||||
T Consensus        96 ~~iv~~~~~~~~~~~-~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dik  174 (313)
T 3brb_A           96 PNVIRLLGVCIEMSS-QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLA  174 (313)
T ss_dssp             TTBCCCCEEEEC--------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCS
T ss_pred             CCeeeeeEEEeeccc-cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            999999999976543 122345999999986 5666552        248899999999999999999999999999999


Q ss_pred             CCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy11580        192 PSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTD  267 (288)
Q Consensus       192 ~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~  267 (288)
                      |+||+++.++.+||+|||++.......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+
T Consensus       175 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  254 (313)
T 3brb_A          175 ARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ  254 (313)
T ss_dssp             GGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence            999999999999999999997654321   1233456788999999999999999999999999999999 999999988


Q ss_pred             chhHHHHHHHHh
Q psy11580        268 HIDQWNKIIGKM  279 (288)
Q Consensus       268 ~~~~~~~i~~~~  279 (288)
                      ..+....+....
T Consensus       255 ~~~~~~~~~~~~  266 (313)
T 3brb_A          255 NHEMYDYLLHGH  266 (313)
T ss_dssp             GGGHHHHHHTTC
T ss_pred             HHHHHHHHHcCC
Confidence            877777666543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-37  Score=279.04  Aligned_cols=211  Identities=30%  Similarity=0.484  Sum_probs=173.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcch-----------hhHHHHHHHHHHHHHCCCCCccee
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV-----------THAKRAYREFKLMKLVNHKNIIGL  126 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~  126 (288)
                      ..+.+.+.+|+|.++.++++    .+..+++.||+|++.......           .....+.+|++++++++||||+++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLC----KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEE----EETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             cceEEEeEecccCCeEEEEE----EECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            34455666666666555553    467789999999997643221           335678899999999999999999


Q ss_pred             eccccCCCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC--
Q psy11580        127 LNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--  201 (288)
Q Consensus       127 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~--  201 (288)
                      ++++...+..      ++||||+++ +|.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++  
T Consensus       112 ~~~~~~~~~~------~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~  185 (504)
T 3q5i_A          112 FDVFEDKKYF------YLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSL  185 (504)
T ss_dssp             EEEEECSSEE------EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCC
T ss_pred             EEEEEcCCEE------EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCC
Confidence            9999877654      999999986 5666664  4589999999999999999999999999999999999999776  


Q ss_pred             -cEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        202 -TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       202 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                       .+||+|||++.............+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+.+..+.+..
T Consensus       186 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  263 (504)
T 3q5i_A          186 LNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK  263 (504)
T ss_dssp             SSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             ccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence             699999999988766655566789999999999875 68999999999999999999999999999888888877654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.4e-37  Score=258.60  Aligned_cols=216  Identities=25%  Similarity=0.367  Sum_probs=177.7

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+..
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEI----SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceEEEEEEeecCCEEEEEE----EECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            45567777777777666654    466788999999997532 2334567788999999999999999999999876654


Q ss_pred             cccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                            ++||||+++ ++.+.+.  ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        91 ------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  164 (294)
T 2rku_A           91 ------FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK  164 (294)
T ss_dssp             ------EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ------EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence                  999999985 5655554  3489999999999999999999999999999999999999999999999999986


Q ss_pred             cCCC-cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        214 AGTT-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       214 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .... .......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+.......|
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  235 (294)
T 2rku_A          165 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP  235 (294)
T ss_dssp             CCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC
T ss_pred             cccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc
Confidence            5432 223445789999999999998899999999999999999999999998887776666655444443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.5e-39  Score=281.30  Aligned_cols=204  Identities=15%  Similarity=0.169  Sum_probs=154.0

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHH---HHHHCCCCCcceeecccc--
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFK---LMKLVNHKNIIGLLNAFT--  131 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~---~l~~l~h~~i~~~~~~~~--  131 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+|+.||||++... .......+.+.+|++   +++.++||||+++++.+.  
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEA----TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEE----EC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             ceEEEcceeecCCCEEEEEE----EECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            34455666666666665554    44577999999999753 234445678889994   555557999999985443  


Q ss_pred             -----CCCc------cccc-----ccEEEEEecccccHHHHHhh--hCCH-------HHHHHHHHHHHHHHHHHHHCCCE
Q psy11580        132 -----PQKS------LEEF-----QDVYLVMELMDANLCQVIQM--DLDH-------ERMSYLLYQMLCGIKHLHSAGII  186 (288)
Q Consensus       132 -----~~~~------~~~~-----~~~~lv~e~~~~~l~~~~~~--~~~~-------~~~~~~~~~i~~~l~~LH~~~iv  186 (288)
                           ..+.      ....     ...++||||++++|.+.+..  .++.       ..+..++.||+.||+|||+++|+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             SEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence                 3221      0000     13689999999888888763  3444       78888999999999999999999


Q ss_pred             eecCCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhHhcC-----------CCCchhhHHHHHHHHHH
Q psy11580        187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM-----------GYKENVDIWSVGCIMGE  255 (288)
Q Consensus       187 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~Di~slg~il~~  255 (288)
                      ||||||+|||++.++.+||+|||++...+..  .....| +.|+|||++.+.           .++.++||||||+++|+
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR--VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTCE--EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCCc--ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            9999999999999999999999999865442  234466 999999999987           79999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q psy11580        256 MIRGGVLFPGTDH  268 (288)
Q Consensus       256 l~~g~~p~~~~~~  268 (288)
                      |++|+.||.+.+.
T Consensus       306 lltg~~Pf~~~~~  318 (377)
T 3byv_A          306 IWCADLPITKDAA  318 (377)
T ss_dssp             HHHSSCCC-----
T ss_pred             HHHCCCCCccccc
Confidence            9999999987553

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.9e-38  Score=265.85  Aligned_cols=211  Identities=23%  Similarity=0.357  Sum_probs=174.3

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCccccccc
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      ++.+|+|.++.++.+    .+..+++.||+|+++...........+.+|+.+++.+ +||||+++++++...+..     
T Consensus        34 ~~~lG~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~-----  104 (327)
T 3lm5_A           34 SKELGRGKFAVVRQC----ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI-----  104 (327)
T ss_dssp             EEEEEEETTEEEEEE----EETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE-----
T ss_pred             cceeCCCCCeEEEEE----EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE-----
Confidence            377888877777764    4677899999999986544555567889999999999 569999999999876654     


Q ss_pred             EEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc---CCcEEEeecccccc
Q psy11580        142 VYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLART  213 (288)
Q Consensus       142 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~---~~~~kl~dfg~~~~  213 (288)
                       ++||||+.+ ++.+.+.    ..+++..++.++.||+.||+|||++||+||||||+||+++.   ++.+||+|||++..
T Consensus       105 -~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          105 -ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             -EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred             -EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence             999999987 4555543    34899999999999999999999999999999999999997   78999999999987


Q ss_pred             cCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        214 AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       214 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ...........+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......+
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  253 (327)
T 3lm5_A          184 IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS  253 (327)
T ss_dssp             C---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             cCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC
Confidence            7665555566899999999999999999999999999999999999999999988888777776655443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.4e-38  Score=265.79  Aligned_cols=190  Identities=31%  Similarity=0.570  Sum_probs=143.3

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCccccccc
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      ++.+|+|.++.++.+    .+..+++.||||++..     .....+.+|+.+++.+. ||||+++++++.+....     
T Consensus        16 ~~~lG~G~~g~V~~~----~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~-----   81 (325)
T 3kn6_A           16 DKPLGEGSFSICRKC----VHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT-----   81 (325)
T ss_dssp             SCCSEEETTEEEEEE----EETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE-----
T ss_pred             CCccccCCCeEEEEE----EECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE-----
Confidence            567888777777764    4667899999999974     34567789999999996 99999999999877654     


Q ss_pred             EEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC---cEEEeecccccccC
Q psy11580        142 VYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLARTAG  215 (288)
Q Consensus       142 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~---~~kl~dfg~~~~~~  215 (288)
                       ++||||+++ +|.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++   .+||+|||++....
T Consensus        82 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           82 -FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             -EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             -EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence             999999987 6666665  3489999999999999999999999999999999999998765   79999999998654


Q ss_pred             CC-cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        216 TT-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       216 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      .. .......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  213 (325)
T 3kn6_A          161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD  213 (325)
T ss_dssp             C----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred             CCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence            32 22345578999999999999999999999999999999999999998754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9e-38  Score=258.12  Aligned_cols=210  Identities=29%  Similarity=0.388  Sum_probs=162.7

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcc--hhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN--VTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      +...++.+.+.+|+|.++.++.+      ..+++.||+|+++.....  ......+.+|+++++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRA------FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK   77 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEE------EETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             cchhheeeeeeeccCCCeEEEEE------EEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            34567788888999888888876      235889999999753221  2335678899999999999999999999987


Q ss_pred             CCcccccccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCC---CEeecCCCCCEEEcc--------
Q psy11580        133 QKSLEEFQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS--------  199 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---ivH~dl~~~nil~~~--------  199 (288)
                      .+..      ++||||++++ +.+.+. ..+++..+..++.|++.||+|||+++   ++||||||+||+++.        
T Consensus        78 ~~~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~  151 (271)
T 3dtc_A           78 EPNL------CLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS  151 (271)
T ss_dssp             C--C------EEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred             CCce------EEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence            7665      9999999865 444443 45899999999999999999999999   899999999999986        


Q ss_pred             CCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        200 DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       200 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      ++.++|+|||++........ ....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+..
T Consensus       152 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  228 (271)
T 3dtc_A          152 NKILKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM  228 (271)
T ss_dssp             SCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT
T ss_pred             CcceEEccCCcccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc
Confidence            67899999999986554332 345789999999999999999999999999999999999999998776665554443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-37  Score=259.36  Aligned_cols=211  Identities=24%  Similarity=0.386  Sum_probs=164.0

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++....+.+.+.+|+|.++.++.+       .....||+|+++...........+.+|++++++++||||+++++++...
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKG-------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP   92 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEE-------ESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccCccceeeeeEecCCCCeEEEEE-------EEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC
Confidence            455566778888888777766664       3445699999987666667778899999999999999999999976443


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .       .++||||+++ ++.+.+.   ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||
T Consensus        93 ~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg  165 (289)
T 3og7_A           93 Q-------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFG  165 (289)
T ss_dssp             S-------CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             c-------cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccce
Confidence            3       3999999986 5656553   458999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC---CcccCCcccccccCchHhHh---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        210 LARTAGT---TFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       210 ~~~~~~~---~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ++.....   ........+++.|+|||++.   +..++.++||||||+++|+|++|+.||.+.+..+.+.+++..
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  240 (289)
T 3og7_A          166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR  240 (289)
T ss_dssp             ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred             eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence            9975443   22223457899999999997   566888999999999999999999999987766665555544

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.3e-37  Score=260.47  Aligned_cols=216  Identities=34%  Similarity=0.622  Sum_probs=171.0

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc---
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS---  135 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---  135 (288)
                      ++.+.+.+|+|.++.++.+    .+..+++.||+|++..  ........+.+|++++++++||||+++++++...+.   
T Consensus        12 ~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A           12 RYMDLKPLGCGGNGLVFSA----VDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             TEEEEEECC-----CEEEE----EETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             ceeEEEEeccCCCeEEEEE----EECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            3455556666655555543    4567899999999975  344556788999999999999999999998854321   


Q ss_pred             -----ccccccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEc-cCCcEEEeec
Q psy11580        136 -----LEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDF  208 (288)
Q Consensus       136 -----~~~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~-~~~~~kl~df  208 (288)
                           .......++||||+++++.+.+. ..+++..++.++.|++.||+|||++||+||||||+||+++ .++.+||+||
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             C----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             cccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence                 12234569999999998888776 4588999999999999999999999999999999999997 5678999999


Q ss_pred             ccccccCCC----cccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        209 GLARTAGTT----FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       209 g~~~~~~~~----~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      |++......    .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.+...
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  242 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP  242 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999865432    12234467889999999876 6789999999999999999999999999998888888876654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-37  Score=258.96  Aligned_cols=217  Identities=24%  Similarity=0.385  Sum_probs=180.0

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.+|+|.++.++.+    .+..++..||+|++..... .......+.+|+++++.++||||+++++++...+
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLA----REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK   87 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhceeeheecCCCCeEEEEE----EEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence            4456778888888888777765    4566788999999964211 1222467889999999999999999999998766


Q ss_pred             cccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      ..      ++||||+++ ++.+.+.  ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++
T Consensus        88 ~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~  161 (284)
T 2vgo_A           88 RI------YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS  161 (284)
T ss_dssp             EE------EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EE------EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccccc
Confidence            54      999999986 6766665  34899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ....... .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......|
T Consensus       162 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  232 (284)
T 2vgo_A          162 VHAPSLR-RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP  232 (284)
T ss_dssp             EECSSSC-BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC
T ss_pred             ccCcccc-cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC
Confidence            7654432 2445789999999999998899999999999999999999999999888777777766544443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6e-38  Score=268.00  Aligned_cols=214  Identities=27%  Similarity=0.473  Sum_probs=172.4

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCC---cchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF---QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ..++.+.+.+|+|.++.++.+    .+..+++.||+|++....   ........+.+|++++++++||||+++++++...
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVA----IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEE----EETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhheeecceeeecCCeEEEEE----EECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            356788899999988888775    467889999999996421   1334567889999999999999999999999876


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh------------------------------------------hhCCHHHHHHHH
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ------------------------------------------MDLDHERMSYLL  170 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~------------------------------------------~~~~~~~~~~~~  170 (288)
                      +..      ++||||+++ +|.+.+.                                          ..+++..++.++
T Consensus       101 ~~~------~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  174 (345)
T 3hko_A          101 QYI------CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM  174 (345)
T ss_dssp             SEE------EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred             CeE------EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence            654      999999976 4555542                                          113567788999


Q ss_pred             HHHHHHHHHHHHCCCEeecCCCCCEEEccCC--cEEEeecccccccCC-----CcccCCcccccccCchHhHhc--CCCC
Q psy11580        171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGT-----TFMMTPYVVTRYYRAPEVILG--MGYK  241 (288)
Q Consensus       171 ~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~--~~kl~dfg~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~--~~~~  241 (288)
                      .||+.||+|||+++|+||||||+||+++.++  .+||+|||++.....     ........+++.|+|||++.+  ..++
T Consensus       175 ~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  254 (345)
T 3hko_A          175 RQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG  254 (345)
T ss_dssp             HHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred             HHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence            9999999999999999999999999998776  899999999975422     112345578999999999976  6788


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhC
Q psy11580        242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       242 ~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      .++||||||+++|+|++|+.||.+.+..+...++.+...
T Consensus       255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (345)
T 3hko_A          255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL  293 (345)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc
Confidence            999999999999999999999999888888777776554

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-37  Score=259.02  Aligned_cols=208  Identities=27%  Similarity=0.410  Sum_probs=168.2

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +.+.+.+.+|+|.++.++++    .+..++..||+|++.... .......+.+|++++++++||||+++++++...+.. 
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-   95 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLV----EERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM-   95 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEE----EETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE-
T ss_pred             hheeecceeccCCCeEEEEE----EEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE-
Confidence            45577888888888877764    456789999999997542 223457788999999999999999999999876654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE---ccCCcEEEee
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD  207 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~---~~~~~~kl~d  207 (288)
                           ++||||+++ ++.+.+.      ..+++..+..++.|++.||+|||+++|+||||||+||++   +.++.+||+|
T Consensus        96 -----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~D  170 (285)
T 3is5_A           96 -----YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID  170 (285)
T ss_dssp             -----EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred             -----EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEe
Confidence                 999999986 5666553      348999999999999999999999999999999999999   4567899999


Q ss_pred             cccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        208 FGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      ||++.............+++.|+|||++.+ .++.++||||||+++|+|++|+.||.+.+..+....+..
T Consensus       171 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~  239 (285)
T 3is5_A          171 FGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY  239 (285)
T ss_dssp             CCCCCC----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             eecceecCCcccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc
Confidence            999987665555556678999999999864 688999999999999999999999998877666555543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-37  Score=265.74  Aligned_cols=217  Identities=26%  Similarity=0.386  Sum_probs=175.6

Q ss_pred             hhhhcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  131 (288)
                      ++...++.+.+.+|+|.++.++.+.-. ..+..++..||+|++.... .......+.+|+.+++++ +||||+++++++.
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            566678889999999988888876421 1123466789999997532 334457789999999999 8999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHhhh-------------------------CCHHHHHHHHHHHHHHHHHHHHCCC
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQMD-------------------------LDHERMSYLLYQMLCGIKHLHSAGI  185 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-------------------------~~~~~~~~~~~~i~~~l~~LH~~~i  185 (288)
                      ..+..      ++||||+++ +|.+.+...                         +++..++.++.||+.||+|||++||
T Consensus       120 ~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  193 (344)
T 1rjb_A          120 LSGPI------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC  193 (344)
T ss_dssp             SSSSC------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             eCCcc------EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            87665      999999976 677766432                         6889999999999999999999999


Q ss_pred             EeecCCCCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCC
Q psy11580        186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGV  261 (288)
Q Consensus       186 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~  261 (288)
                      +||||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  273 (344)
T 1rjb_A          194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN  273 (344)
T ss_dssp             EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence            999999999999999999999999997653322   1234456788999999999999999999999999999998 999


Q ss_pred             CCCCCCchhHHHHHHH
Q psy11580        262 LFPGTDHIDQWNKIIG  277 (288)
Q Consensus       262 p~~~~~~~~~~~~i~~  277 (288)
                      ||.+.+......+++.
T Consensus       274 p~~~~~~~~~~~~~~~  289 (344)
T 1rjb_A          274 PYPGIPVDANFYKLIQ  289 (344)
T ss_dssp             SSTTCCCSHHHHHHHH
T ss_pred             CcccCCcHHHHHHHHh
Confidence            9998776555544444

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.3e-37  Score=257.88  Aligned_cols=213  Identities=23%  Similarity=0.380  Sum_probs=179.4

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.+|+|.++.++.+    .+..++..||+|++..   .......+.+|++++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEG----VWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   81 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEE----EEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cccccceeEEeecCCCCceeEEEe----EecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            345567788888999888888875    4566789999999975   334567888999999999999999999999877


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      +..      ++|||++++ ++.+.+.    ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+||
T Consensus        82 ~~~------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Df  155 (288)
T 3kfa_A           82 PPF------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF  155 (288)
T ss_dssp             SSE------EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             CCE------EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccC
Confidence            655      999999985 6766664    23899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        209 GLARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       209 g~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      |++........  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+....
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~  229 (288)
T 3kfa_A          156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY  229 (288)
T ss_dssp             CGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             ccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC
Confidence            99987654322  233456778999999999999999999999999999999 999999888777666665543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=9.6e-38  Score=271.74  Aligned_cols=192  Identities=28%  Similarity=0.412  Sum_probs=149.3

Q ss_pred             cccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHH-CCCCCcceeeccccCCCcccccccE
Q psy11580         64 HQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL-VNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        64 ~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      +.+|.|.++.++.    +.+..+++.||||++..       ...+.+|++++.+ .+||||+++++++....  .....+
T Consensus        68 ~~LG~G~~g~V~~----~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~--~~~~~~  134 (400)
T 1nxk_A           68 QVLGLGINGKVLQ----IFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY--AGRKCL  134 (400)
T ss_dssp             EEEEEETTEEEEE----EEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE--TTEEEE
T ss_pred             ceeeeccCeEEEE----EEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecc--cCCcEE
Confidence            3445554444443    34677899999999963       2356678888744 58999999999986411  112346


Q ss_pred             EEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc---CCcEEEeeccccccc
Q psy11580        143 YLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTA  214 (288)
Q Consensus       143 ~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~---~~~~kl~dfg~~~~~  214 (288)
                      ++||||+++ +|.+.+..    .+++..+..++.||+.||+|||+++|+||||||+|||++.   ++.+||+|||++...
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~  214 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  214 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence            999999986 67777653    3899999999999999999999999999999999999997   788999999999876


Q ss_pred             CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      .........++|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.
T Consensus       215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  268 (400)
T 1nxk_A          215 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  268 (400)
T ss_dssp             C-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred             CCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence            655555567889999999999999999999999999999999999999987554

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-37  Score=262.92  Aligned_cols=219  Identities=22%  Similarity=0.297  Sum_probs=171.1

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++....+.+.+.+|+|.++.++.|.-...+...+..||+|+++... .......+.+|++++++++||||+++++++...
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            4455666778888888888887764222222334579999997532 334556788999999999999999999999876


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      +..      ++||||+++ +|.+.+.   ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus       119 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          119 KPM------MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             SSE------EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             CCc------EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence            654      999999987 5666654   348999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        210 LARTAGTTFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       210 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ++........    .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.+..
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  267 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF  267 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred             cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC
Confidence            9986543211    122345778999999999999999999999999999998 999999888877777666543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-37  Score=275.47  Aligned_cols=212  Identities=24%  Similarity=0.380  Sum_probs=172.5

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.+|+|.++.++.|.     ...+..||||+++...   ...+.+.+|++++++++||||+++++++.. 
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~-----~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-  250 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-  250 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEE-----ETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccChhHceeeeeecCCCCeEEEEEE-----ECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence            4566778889999999988888873     2335679999998532   234678999999999999999999999876 


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      +.      .++||||+++ +|.+++..    .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus       251 ~~------~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          251 EP------IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             SS------CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             Cc------eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCC
Confidence            33      3999999986 67776652    3899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        209 GLARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       209 g~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      |++........  .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.+...
T Consensus       325 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~  399 (452)
T 1fmk_A          325 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR  399 (452)
T ss_dssp             CTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99986543221  223346778999999999999999999999999999999 9999999888887777765543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=264.98  Aligned_cols=199  Identities=25%  Similarity=0.348  Sum_probs=163.0

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCC--CCcceeeccccCCC
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH--KNIIGLLNAFTPQK  134 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~  134 (288)
                      ...+.+.+.||+|.++.++.+.     ..+++.||||++............+.+|+++++.++|  |||+++++++...+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~   82 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVL-----NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ   82 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEE-----CTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             cCEEEEEEEEecCCCeEEEEEE-----eCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence            3456677778887777777652     2568899999998765566667889999999999976  99999999998776


Q ss_pred             cccccccEEEEEecccccHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        135 SLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      ..      ++|||+.+++|.+.+..  .+++..+..++.||+.||+|||+++|+||||||+|||++ ++.+||+|||++.
T Consensus        83 ~~------~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~  155 (343)
T 3dbq_A           83 YI------YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  155 (343)
T ss_dssp             EE------EEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             EE------EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence            54      99999888888888763  488999999999999999999999999999999999997 6789999999998


Q ss_pred             ccCCCc---ccCCcccccccCchHhHhc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        213 TAGTTF---MMTPYVVTRYYRAPEVILG-----------MGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       213 ~~~~~~---~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ......   ......|++.|+|||++.+           ..++.++||||||+++|+|++|+.||.+..
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  224 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  224 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence            654332   2235578999999999975           567899999999999999999999998743

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.7e-37  Score=269.37  Aligned_cols=207  Identities=25%  Similarity=0.363  Sum_probs=166.8

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC--CCCcceeeccccCCCc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN--HKNIIGLLNAFTPQKS  135 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~  135 (288)
                      ..+.+.+.||+|.++.++.+.    + .+++.||||++............+.+|+++++.++  ||||+++++++...+.
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~----~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVL----N-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEE----C-TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CceEEEEEEccCCCeEEEEEE----c-CCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            456777888888877777652    3 34889999999875556666788999999999996  5999999999987765


Q ss_pred             ccccccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        136 LEEFQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      .      ++|||+.+++|.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+|||++ ++.+||+|||++..
T Consensus       131 ~------~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          131 I------YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  203 (390)
T ss_dssp             E------EEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred             E------EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence            4      9999987778888776  3478889999999999999999999999999999999995 58999999999986


Q ss_pred             cCCCc---ccCCcccccccCchHhHhc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hhHHHHHH
Q psy11580        214 AGTTF---MMTPYVVTRYYRAPEVILG-----------MGYKENVDIWSVGCIMGEMIRGGVLFPGTDH-IDQWNKII  276 (288)
Q Consensus       214 ~~~~~---~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~slg~il~~l~~g~~p~~~~~~-~~~~~~i~  276 (288)
                      .....   ......||+.|+|||++.+           ..++.++||||||+++|+|++|..||.+... ...+..++
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~  281 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  281 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence            54322   2345679999999999976           3578999999999999999999999987543 23344443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-38  Score=268.84  Aligned_cols=203  Identities=22%  Similarity=0.270  Sum_probs=167.6

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      .+...++.+.+.+|+|.++.++.+      ...++.||||+++.   ..........|+.++++++||||+++++++...
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~------~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKA------QLLNEYVAVKIFPI---QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEE------EETTEEEEEEEECG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             ccchhhchhhheecccCceEEEEE------EECCCEEEEEEeec---CchHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            345578899999999999998887      33478999999974   234445566799999999999999999999765


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHC----------CCEeecCCCCCEEEccCC
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSA----------GIIHRDLKPSNIVVKSDC  201 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~----------~ivH~dl~~~nil~~~~~  201 (288)
                      ..  ....+++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+.          +|+||||||+||+++.++
T Consensus        91 ~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           91 TS--VDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             CS--SSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CC--CCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence            42  12346999999987 6766665 4589999999999999999999999          999999999999999999


Q ss_pred             cEEEeecccccccCCCcc---cCCcccccccCchHhHhcC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        202 TLKILDFGLARTAGTTFM---MTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       202 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      .+||+|||++........   .....+++.|+|||++.+.     .++.++||||||+++|+|++|+.||.+..
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  242 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV  242 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999976543222   2345789999999999873     45678999999999999999999997643

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.7e-37  Score=258.81  Aligned_cols=203  Identities=16%  Similarity=0.216  Sum_probs=166.2

Q ss_pred             hhhhhcccccccccCCccccccccCccceeccCCC-------ceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcce
Q psy11580         53 KELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQ-------QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG  125 (288)
Q Consensus        53 ~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~  125 (288)
                      .++..+++.+.+.+|+|.++.++.+.    +..++       ..||+|++..  ........+.+|++++++++||||++
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~   76 (289)
T 4fvq_A            3 HKIRNEDLIFNESLGQGTFTKIFKGV----RREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAASMMSKLSHKHLVL   76 (289)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEE----EEEECGGGCEEEEEEEEEEECG--GGGGGHHHHHHHHHHHHTSCCTTBCC
T ss_pred             EEechhHeeeeeeeccCCCceEEEEE----Eecccccccccchhhhhhhccc--ccHHHHHHHHHHHHHHHhCCCCCEeE
Confidence            34556778888899998888888763    23333       5799999975  23445677899999999999999999


Q ss_pred             eeccccCCCcccccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC
Q psy11580        126 LLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC  201 (288)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~  201 (288)
                      +++++...+..      ++||||+++ +|.+.+..   .+++..+..++.||+.||+|||+++|+||||||+||+++.++
T Consensus        77 ~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~  150 (289)
T 4fvq_A           77 NYGVCVCGDEN------ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREE  150 (289)
T ss_dssp             EEEEECCTTCC------EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECC
T ss_pred             EEEEEEeCCCC------EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCC
Confidence            99999877665      999999985 67666652   389999999999999999999999999999999999999888


Q ss_pred             c--------EEEeecccccccCCCcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchh
Q psy11580        202 T--------LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRG-GVLFPGTDHID  270 (288)
Q Consensus       202 ~--------~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g-~~p~~~~~~~~  270 (288)
                      .        +||+|||++......   ....+++.|+|||++.+ ..++.++||||||+++|+|++| .+||...+...
T Consensus       151 ~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~  226 (289)
T 4fvq_A          151 DRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR  226 (289)
T ss_dssp             BGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             cccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH
Confidence            7        999999998765433   23457888999999988 6789999999999999999995 45555544433

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.9e-38  Score=262.43  Aligned_cols=206  Identities=24%  Similarity=0.356  Sum_probs=167.9

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      .+...++.+.+.+|+|.++.++++.-...+..+++.||||++..  ........+.+|++++++++||||+++++++...
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            34556778889999998888888754344677899999999975  3445567889999999999999999999998643


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      +.    ...++||||+++ +|.+.+.   ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||
T Consensus        84 ~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           84 GR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             HH----TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CC----CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence            21    235999999976 6766664   348999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc----ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        210 LARTAGTTF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       210 ~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      ++.......    ......++..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  219 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  219 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence            998654321    12334567779999999999999999999999999999999998865

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.8e-37  Score=262.88  Aligned_cols=219  Identities=27%  Similarity=0.441  Sum_probs=179.2

Q ss_pred             hhhhcccccccccCCccccccccCcccee---ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAY---DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNA  129 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  129 (288)
                      ++...++.+.+.+|+|.++.++.+.-...   ...++..||+|+++.. ........+.+|+++++++ +||||++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            45567788999999999888888743211   1256789999999754 2445567889999999999 89999999999


Q ss_pred             ccCCCcccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                      +...+..      ++||||+++ +|.+++..                  .+++..++.++.||+.||+|||+++|+||||
T Consensus       110 ~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl  183 (334)
T 2pvf_A          110 CTQDGPL------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL  183 (334)
T ss_dssp             ECSSSCC------EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             EccCCce------EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence            9877665      999999986 67666642                  2788999999999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT  266 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~  266 (288)
                      ||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus       184 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            9999999999999999999998654432   1233456788999999999889999999999999999999 99999998


Q ss_pred             CchhHHHHHHHHh
Q psy11580        267 DHIDQWNKIIGKM  279 (288)
Q Consensus       267 ~~~~~~~~i~~~~  279 (288)
                      +..+....+.+..
T Consensus       264 ~~~~~~~~~~~~~  276 (334)
T 2pvf_A          264 PVEELFKLLKEGH  276 (334)
T ss_dssp             CHHHHHHHHHHTC
T ss_pred             CHHHHHHHHhcCC
Confidence            8777766665543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-37  Score=263.11  Aligned_cols=198  Identities=20%  Similarity=0.290  Sum_probs=165.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+.     ..+++.||+|++...  .......+.+|+++++.++||||+++++++...+.. 
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-  110 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGV-----LRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM-  110 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEE-----CTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC-
T ss_pred             hccCccceeecCCCeeEEEEE-----ECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE-
Confidence            456677778887777777653     346899999998753  334567789999999999999999999999877665 


Q ss_pred             ccccEEEEEecccc-cHHHHHhh------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                           ++||||+++ +|.+.+..      .+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+
T Consensus       111 -----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          111 -----ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             -----EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             -----EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence                 999999986 55555432      388999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC---cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        211 ARTAGTT---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       211 ~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      +......   .......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+..+
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~  246 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP  246 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence            9764322   122344689999999999998999999999999999999999999976543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-37  Score=258.20  Aligned_cols=218  Identities=27%  Similarity=0.423  Sum_probs=170.2

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ..++.+.+.+|+|.++.++.+    .+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIG----EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             eccEEEEeeecCCCCeEEEEE----EECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            345667777888777776665    345689999999996421 122334578899999999999999999999987665


Q ss_pred             ccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      .      ++|||++++ +|.+.+.  ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        86 ~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  159 (276)
T 2h6d_A           86 F------FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN  159 (276)
T ss_dssp             E------EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred             E------EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccc
Confidence            4      999999975 6777664  358999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      ............+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......|.
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  232 (276)
T 2h6d_A          160 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE  232 (276)
T ss_dssp             CCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred             ccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch
Confidence            7765544455678999999999988765 68999999999999999999999988877777776655444443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-37  Score=285.40  Aligned_cols=206  Identities=22%  Similarity=0.304  Sum_probs=166.7

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      .||+|.++.++.|.  ..+..+++.||||+++...........+.+|++++++++||||+++++++....       .++
T Consensus       376 ~LG~G~fG~Vy~~~--~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-------~~l  446 (635)
T 4fl3_A          376 ELGSGNFGTVKKGY--YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-------WML  446 (635)
T ss_dssp             EEEECSSEEEEEEE--EECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-------EEE
T ss_pred             EeccCCCEEEEEEE--EcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-------EEE
Confidence            56666666666542  123456789999999865555555688999999999999999999999986433       489


Q ss_pred             EEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc---
Q psy11580        145 VMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF---  218 (288)
Q Consensus       145 v~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---  218 (288)
                      ||||+++ +|.+++.  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......   
T Consensus       447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            9999986 4666654  348999999999999999999999999999999999999999999999999998654322   


Q ss_pred             -ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        219 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       219 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                       ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+....+.+..
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~  589 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE  589 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence             1223345788999999999999999999999999999998 999999998888777766554

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.7e-37  Score=263.48  Aligned_cols=213  Identities=24%  Similarity=0.421  Sum_probs=176.7

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcc------hhhHHHHHHHHHHHHHC-CCCCcceeecc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN------VTHAKRAYREFKLMKLV-NHKNIIGLLNA  129 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  129 (288)
                      ..++.+.+.+|+|.++.++.+    .+..+|+.||||++......      ......+.+|+.+++++ +||||++++++
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a----~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRC----VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhcccceEEecCCCEEEEEE----EECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            455677788888777777664    35568999999999754211      12245678999999999 79999999999


Q ss_pred             ccCCCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEe
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL  206 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~  206 (288)
                      +...+..      ++||||+++ ++.+.+.  ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+
T Consensus       169 ~~~~~~~------~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          169 YESSSFM------FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEBSSEE------EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EeeCCEE------EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEE
Confidence            9776654      999999987 5666665  358999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCcccCCcccccccCchHhHhcC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       207 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      |||++.............+++.|+|||++.+.      .++.++||||||+++|+|++|..||.+.+....+..+....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~  321 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ  321 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence            99999877665555667899999999999743      57889999999999999999999999888777777666544

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3e-37  Score=261.24  Aligned_cols=218  Identities=21%  Similarity=0.317  Sum_probs=179.3

Q ss_pred             hhhhcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      ++...++.+.+.+|+|.++.++.+.-. ..+..+++.||+|++... ........+.+|+++++.++||||+++++++..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            445567788999999998888877532 223356789999999753 233455678899999999999999999999987


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHhh------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQM------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS  199 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~  199 (288)
                      .+..      ++|||++++ +|.+.+..            .+++..+..++.|++.||+|||++||+||||||+||+++.
T Consensus       100 ~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~  173 (322)
T 1p4o_A          100 GQPT------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE  173 (322)
T ss_dssp             SSSC------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred             CCcc------EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcC
Confidence            7655      999999986 66666542            2588999999999999999999999999999999999999


Q ss_pred             CCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHH
Q psy11580        200 DCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       200 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i  275 (288)
                      ++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence            9999999999997553322   1233456888999999999899999999999999999999 89999998877776666


Q ss_pred             HHH
Q psy11580        276 IGK  278 (288)
Q Consensus       276 ~~~  278 (288)
                      .+.
T Consensus       254 ~~~  256 (322)
T 1p4o_A          254 MEG  256 (322)
T ss_dssp             HTT
T ss_pred             HcC
Confidence            543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.8e-37  Score=256.09  Aligned_cols=211  Identities=16%  Similarity=0.246  Sum_probs=176.7

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      .+...++.+.+.+|+|.++.++.+.      .+++.||+|+++...........+.+|+.++++++||||+++++++...
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   79 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGR------WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP   79 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEE------ETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEE------ECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence            4456677888999999888888773      3588999999987655666677899999999999999999999999876


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCCEEEccCCcEEEe
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKIL  206 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--ivH~dl~~~nil~~~~~~~kl~  206 (288)
                      +.    ...++||||+++ +|.+.+..    .+++..+..++.|++.||+|||+++  ++||||||+||+++.++.++|+
T Consensus        80 ~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~  155 (271)
T 3kmu_A           80 PA----PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARIS  155 (271)
T ss_dssp             TS----SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEE
T ss_pred             CC----CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEE
Confidence            21    234999999986 77777753    2799999999999999999999999  9999999999999999999999


Q ss_pred             ecccccccCCCcccCCcccccccCchHhHhcCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        207 DFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKE---NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       207 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      |||++.....    ....+++.|+|||++.+...+.   ++||||||+++|+|++|+.||.+.+..+....+...
T Consensus       156 ~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  226 (271)
T 3kmu_A          156 MADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE  226 (271)
T ss_dssp             GGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS
T ss_pred             eccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc
Confidence            9988755332    3347789999999998865544   899999999999999999999998877776666543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.5e-37  Score=262.32  Aligned_cols=210  Identities=27%  Similarity=0.448  Sum_probs=172.8

Q ss_pred             cccccccCCccccccccCccceec-cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCC------CcceeeccccC
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYD-TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK------NIIGLLNAFTP  132 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~  132 (288)
                      +.+.+.+|+|.++.++.+    .+ ..+++.||+|+++.   .......+.+|+++++.++|+      +++++++++..
T Consensus        16 y~~~~~lg~G~~g~V~~~----~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           16 YEIVDTLGEGAFGKVVEC----IDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             EEEEEEEEEETTEEEEEE----EETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             eEEEEEEecCCCeEEEEE----EecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            344444444444444332    33 45788999999974   334567788999999998765      49999999977


Q ss_pred             CCcccccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc---------
Q psy11580        133 QKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---------  199 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~---------  199 (288)
                      .+..      ++|||++++++.+.+..    .+++..+..++.||+.||+|||+++|+||||||+||+++.         
T Consensus        89 ~~~~------~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           89 HGHI------CIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             TTEE------EEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             CCcE------EEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            6654      99999998899888763    3789999999999999999999999999999999999987         


Q ss_pred             ----------CCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy11580        200 ----------DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI  269 (288)
Q Consensus       200 ----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~  269 (288)
                                ++.+||+|||++......  .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                      667999999999875443  23457899999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHhCCCcc
Q psy11580        270 DQWNKIIGKMREAHD  284 (288)
Q Consensus       270 ~~~~~i~~~~~~~~~  284 (288)
                      +....+.+.++++|.
T Consensus       241 ~~~~~~~~~~~~~p~  255 (339)
T 1z57_A          241 EHLAMMERILGPLPK  255 (339)
T ss_dssp             HHHHHHHHHHCSCCH
T ss_pred             HHHHHHHHHhCCCCH
Confidence            988888888887664

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.2e-38  Score=269.56  Aligned_cols=210  Identities=11%  Similarity=0.133  Sum_probs=162.2

Q ss_pred             hhhcccccccccCCccccccccCccce-eccCCCceEEEEeccCCCcchhh---------HHHHHHHHHHHHHCCCCCcc
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAA-YDTATQQNVAIKKLSRPFQNVTH---------AKRAYREFKLMKLVNHKNII  124 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~-~~~~~~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~  124 (288)
                      .....+.+.+.+|+|.++.++.+.-.. .....++.||||++.........         ......|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            444577888889998888888763211 01124689999998753211100         11233455667777899999


Q ss_pred             eeeccccCCCcccccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEc--c
Q psy11580        125 GLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK--S  199 (288)
Q Consensus       125 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~--~  199 (288)
                      ++++++.....  .....++||||++++|.+.+.   ..+++..++.++.||+.||+|||+++|+||||||+|||++  .
T Consensus       112 ~~~~~~~~~~~--~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          112 KYWGSGLHDKN--GKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             CEEEEEEEEET--TEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred             eEEeeeeeccC--CcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence            99999876431  123469999999777777765   3489999999999999999999999999999999999999  8


Q ss_pred             CCcEEEeecccccccCCCcc--------cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        200 DCTLKILDFGLARTAGTTFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       200 ~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ++.+||+|||++........        .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            89999999999976533211        13345899999999999999999999999999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.3e-37  Score=256.71  Aligned_cols=214  Identities=25%  Similarity=0.390  Sum_probs=174.7

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|++............+.+|++++++++||||+++++++....   
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---   78 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKI----RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---   78 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEE----EETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---
T ss_pred             hheeeehhccCCCCcEEEEE----EECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---
Confidence            45667778888777776664    45678999999999875555566778999999999999999999999875321   


Q ss_pred             ccccEEEEEecccc-cHHHHHhh------hCCHHHHHHHHHHHHHHHHHHHHCC-----CEeecCCCCCEEEccCCcEEE
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKI  205 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~-----ivH~dl~~~nil~~~~~~~kl  205 (288)
                       ....++||||+++ +|.+.+..      .+++..++.++.|++.||+|||+.+     ++|+||+|+||+++.++.+||
T Consensus        79 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl  157 (279)
T 2w5a_A           79 -NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL  157 (279)
T ss_dssp             -GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEE
T ss_pred             -CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence             1345999999986 67666642      2899999999999999999999999     999999999999999999999


Q ss_pred             eecccccccCCCcc-cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        206 LDFGLARTAGTTFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       206 ~dfg~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      +|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.+..
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~  232 (279)
T 2w5a_A          158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK  232 (279)
T ss_dssp             CCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc
Confidence            99999976544321 233468899999999999899999999999999999999999999988777766666543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.7e-37  Score=253.84  Aligned_cols=212  Identities=24%  Similarity=0.345  Sum_probs=176.7

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +...++.+.+.+|+|.++.++.+.     ..+++.||+|++.....   ..+.+.+|++++++++||||+++++++...+
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   76 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGY-----WLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   76 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEE-----ETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             EchhheeeeeEecCCCceeEEEEE-----ecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            445667788888888888877763     23577899999986332   3467889999999999999999999998776


Q ss_pred             cccccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      ..      ++|||++++ ++.+.+..   .+++..+..++.|++.||++||+++++|+||||+||+++.++.++|+|||+
T Consensus        77 ~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~  150 (267)
T 3t9t_A           77 PI------CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM  150 (267)
T ss_dssp             SC------EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred             Ce------EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccc
Confidence            65      999999986 56666653   388999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc--ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        211 ARTAGTTF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       211 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      +.......  ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~  223 (267)
T 3t9t_A          151 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR  223 (267)
T ss_dssp             GGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred             ccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc
Confidence            98654321  1233456778999999999899999999999999999999 9999999888777777765543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.7e-37  Score=258.75  Aligned_cols=221  Identities=25%  Similarity=0.404  Sum_probs=177.9

Q ss_pred             cHHHhhhhhhcccccccccCCccccccccCccce-eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcce
Q psy11580         48 TVDQWKELIYQELPISHQMGKKRHNTSHLGAGAA-YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIG  125 (288)
Q Consensus        48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~  125 (288)
                      ....| ++...++.+.+.+|+|.++.++.+.-.. .+..+++.||+|+++.. ........+.+|+++++++ +||||++
T Consensus        18 ~~~~~-~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           18 DASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CHHHH-BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccce-ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            33444 5566788899999999888888764211 13467789999999754 2334556789999999999 7999999


Q ss_pred             eeccccCCCcccccccEEEEEecccc-cHHHHHhhh------------------CCHHHHHHHHHHHHHHHHHHHHCCCE
Q psy11580        126 LLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD------------------LDHERMSYLLYQMLCGIKHLHSAGII  186 (288)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~------------------~~~~~~~~~~~~i~~~l~~LH~~~iv  186 (288)
                      +++++...+.     ..++||||+++ +|.+.+...                  +++..+..++.|++.||+|||+++|+
T Consensus        96 ~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~  170 (316)
T 2xir_A           96 LLGACTKPGG-----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI  170 (316)
T ss_dssp             EEEEECCTTS-----CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEEEecCCC-----ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            9999876543     24999999986 666666522                  78899999999999999999999999


Q ss_pred             eecCCCCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCC
Q psy11580        187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVL  262 (288)
Q Consensus       187 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p  262 (288)
                      ||||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p  250 (316)
T 2xir_A          171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  250 (316)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999997654322   2234567889999999999999999999999999999998 9999


Q ss_pred             CCCCCchhHHHHH
Q psy11580        263 FPGTDHIDQWNKI  275 (288)
Q Consensus       263 ~~~~~~~~~~~~i  275 (288)
                      |.+.+..+.....
T Consensus       251 ~~~~~~~~~~~~~  263 (316)
T 2xir_A          251 YPGVKIDEEFCRR  263 (316)
T ss_dssp             STTCCCSHHHHHH
T ss_pred             CcccchhHHHHHH
Confidence            9887654444333

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4e-37  Score=258.47  Aligned_cols=217  Identities=23%  Similarity=0.343  Sum_probs=174.5

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCc--chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ--NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|+++....  .......+.+|+++++.++||||+++++++.... 
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~----~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   79 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEV----LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE-   79 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEE----EBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred             cceeEeeEEecCCCeEEEEE----EECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-
Confidence            45667777888777776654    4677899999999974211  1234567899999999999999999999985332 


Q ss_pred             ccccccEEEEEecccccHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        136 LEEFQDVYLVMELMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                         ....++||||+++++.+.+.    ..+++..+..++.||+.||+|||+++++|+||||+||+++.++.++|+|||++
T Consensus        80 ---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           80 ---KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             -----CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             ---CCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccc
Confidence               12359999999998777664    34899999999999999999999999999999999999999999999999999


Q ss_pred             cccCC---CcccCCcccccccCchHhHhcCCC--CchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        212 RTAGT---TFMMTPYVVTRYYRAPEVILGMGY--KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       212 ~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~--~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .....   ........+++.|+|||++.+...  +.++||||||+++|+|++|..||.+.+..+....+.+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  232 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI  232 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCC
Confidence            76542   222244568999999999987543  779999999999999999999999988777766666544333

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.8e-37  Score=259.71  Aligned_cols=197  Identities=19%  Similarity=0.297  Sum_probs=164.8

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  135 (288)
                      ..++.+.+.+|+|.++.++.+    .+..+++.||+|++...    .....+.+|+.+++.+ +|+|++++++++.....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEG----TNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEE----EETTTTEEEEEEEEECC----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             ccceEEEEEEeecCCEEEEEE----EECCCCcEEEEEEeccC----CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            345667777777777666654    45678999999999743    2234578899999999 79999999999876654


Q ss_pred             ccccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc-----EEEee
Q psy11580        136 LEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-----LKILD  207 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~-----~kl~d  207 (288)
                      .      ++|||+++++|.+.+.   ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.     +||+|
T Consensus        81 ~------~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D  154 (298)
T 1csn_A           81 N------VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD  154 (298)
T ss_dssp             E------EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             e------EEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence            4      9999999778888776   34899999999999999999999999999999999999987776     99999


Q ss_pred             cccccccCCCc--------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        208 FGLARTAGTTF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       208 fg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ||++.......        ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  222 (298)
T 1csn_A          155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  222 (298)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence            99997654321        1244578999999999999999999999999999999999999998843

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.1e-37  Score=255.62  Aligned_cols=217  Identities=24%  Similarity=0.358  Sum_probs=166.0

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.+|+|.++.++.+.-.. ....+..||+|+++.. ........+.+|+.++++++||||+++++++...
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMS-PENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN   88 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC-C--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEec-CCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEccC
Confidence            4555677888899998888887763110 1224567999999753 2345567789999999999999999999998543


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                       .      .++||||+++ ++.+.+..   .+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||
T Consensus        89 -~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  161 (281)
T 1mp8_A           89 -P------VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  161 (281)
T ss_dssp             -S------CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             -c------cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccc
Confidence             2      3999999986 56666642   48999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        210 LARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       210 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ++........  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~  234 (281)
T 1mp8_A          162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE  234 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC
Confidence            9986644322  233356778999999999999999999999999999996 999999988887777766543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.5e-37  Score=262.49  Aligned_cols=201  Identities=28%  Similarity=0.387  Sum_probs=162.7

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc-
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL-  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-  136 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||||+++... .......+.+|++++++++||||+++++++...+.. 
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a----~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEA----KNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEE----EETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred             hcCceeeEecCCCCeEEEEE----EEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence            56678888888888887775    456789999999997543 334567889999999999999999999998654320 


Q ss_pred             --------------------------------------------------cccccEEEEEecccc-cHHHHHhh-----h
Q psy11580        137 --------------------------------------------------EEFQDVYLVMELMDA-NLCQVIQM-----D  160 (288)
Q Consensus       137 --------------------------------------------------~~~~~~~lv~e~~~~-~l~~~~~~-----~  160 (288)
                                                                        ......++||||+++ ++.+.+..     .
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                              111236999999987 56665542     2


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc-------------ccCCccccc
Q psy11580        161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-------------MMTPYVVTR  227 (288)
Q Consensus       161 ~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-------------~~~~~~~~~  227 (288)
                      .++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||++.......             ......+++
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            5666789999999999999999999999999999999999999999999998665431             223457899


Q ss_pred             ccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy11580        228 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF  263 (288)
Q Consensus       228 ~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~  263 (288)
                      .|+|||++.+..++.++||||||+++|+|++|..|+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence            999999999999999999999999999999987775

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.4e-37  Score=263.36  Aligned_cols=211  Identities=25%  Similarity=0.419  Sum_probs=172.9

Q ss_pred             ccccccccCCccccccccCccceeccCCC-ceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCC------cceeecccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQ-QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN------IIGLLNAFT  131 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~  131 (288)
                      ++.+.+.+|+|.++.++.    +.+..++ ..||+|+++.   .......+.+|+++++.++|++      ++.+++++.
T Consensus        20 ~y~~~~~lg~G~~g~V~~----~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVE----CLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             TEEEEEEEEEETTEEEEE----EEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             cEEEEEEeeccCCeEEEE----EEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            334444444444444443    2344555 6899999974   3345667888999999997665      888888887


Q ss_pred             CCCcccccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE----------
Q psy11580        132 PQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----------  197 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~----------  197 (288)
                      ..+..      ++|||++++++++.+..    .+++..+..++.||+.||+|||+++|+||||||+||++          
T Consensus        93 ~~~~~------~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           93 FHGHM------CIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             ETTEE------EEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             eCCeE------EEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence            66654      99999999998887753    48999999999999999999999999999999999999          


Q ss_pred             ---------ccCCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        198 ---------KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       198 ---------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                               +.++.+||+|||++......  .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                     56789999999999865443  2345789999999999999999999999999999999999999999999


Q ss_pred             hhHHHHHHHHhCCCcc
Q psy11580        269 IDQWNKIIGKMREAHD  284 (288)
Q Consensus       269 ~~~~~~i~~~~~~~~~  284 (288)
                      .+.+..+.+.++++|.
T Consensus       245 ~~~~~~~~~~~~~~p~  260 (355)
T 2eu9_A          245 REHLVMMEKILGPIPS  260 (355)
T ss_dssp             HHHHHHHHHHHCCCCH
T ss_pred             HHHHHHHHHHcCCCcH
Confidence            9988888888887764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.2e-37  Score=262.75  Aligned_cols=211  Identities=24%  Similarity=0.292  Sum_probs=165.4

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCc----eEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecccc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQ----NVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  131 (288)
                      ...++.+.+.+|+|.++.++.|.    +..+++    .||+|.+... ........+.+|+.++++++||||+++++++.
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   87 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGL----WIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICL   87 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEE----ECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             CHHHcccceEEeeCCCeEEEEEE----EcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence            34567788888888888887763    233444    4688888643 23345678899999999999999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEee
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD  207 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~d  207 (288)
                      ...       .++|+|++.+ ++.+.+.   ..+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+|
T Consensus        88 ~~~-------~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~D  160 (327)
T 3poz_A           88 TST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITD  160 (327)
T ss_dssp             SSS-------EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECC
T ss_pred             cCC-------eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEcc
Confidence            654       3788999886 5666654   3489999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        208 FGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       208 fg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+...
T Consensus       161 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  235 (327)
T 3poz_A          161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG  235 (327)
T ss_dssp             TTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             CcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC
Confidence            999986543322   223355778999999999999999999999999999999 99999988776665555443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.9e-37  Score=266.64  Aligned_cols=211  Identities=34%  Similarity=0.565  Sum_probs=174.3

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CC-----CcceeeccccC
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HK-----NIIGLLNAFTP  132 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~  132 (288)
                      ++.+.+.+|+|.++.++.    +.+..+++.||||+++.   .......+..|+++++.++ |+     +|+++++++..
T Consensus        55 ~y~~~~~lG~G~~g~V~~----~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVK----AYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TEEEEEEEEEETTEEEEE----EEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             eEEEEEEEeecCCEEEEE----EEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            344445555555444444    34567889999999974   3344567788999998885 55     38999999877


Q ss_pred             CCcccccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHH--HCCCEeecCCCCCEEEc--cCCcEE
Q psy11580        133 QKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVK--SDCTLK  204 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH--~~~ivH~dl~~~nil~~--~~~~~k  204 (288)
                      .+..      ++|||++++++.+.+..    .+++..+..++.|++.||+|||  +.+|+||||||+|||++  .++.+|
T Consensus       128 ~~~~------~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          128 RNHL------CLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             TTEE------EEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             CCce------EEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence            6654      99999999999888763    3899999999999999999999  57899999999999995  477899


Q ss_pred             EeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        205 ILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       205 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      |+|||++......  .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+.+|++.++.+|.
T Consensus       202 L~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          202 IVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             ECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             EEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9999999876543  23457899999999999999999999999999999999999999999999999999998876654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7e-37  Score=259.63  Aligned_cols=225  Identities=19%  Similarity=0.296  Sum_probs=177.6

Q ss_pred             cHHHhhhhhhcccccccccCCccccccccCcccee-ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCccee
Q psy11580         48 TVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAY-DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGL  126 (288)
Q Consensus        48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~  126 (288)
                      +.....++...++.+.+.+|+|.++.++.+.-... +..++..||||++... ........+.+|+.++++++||||+++
T Consensus        20 s~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~   98 (327)
T 2yfx_A           20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRC   98 (327)
T ss_dssp             CGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             chhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeE
Confidence            34455567778889999999999988888642211 4567889999999743 234556678899999999999999999


Q ss_pred             eccccCCCcccccccEEEEEecccc-cHHHHHhh---------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEE
Q psy11580        127 LNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV  196 (288)
Q Consensus       127 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil  196 (288)
                      ++++...+..      ++||||+++ +|.+++..         .+++..++.++.|++.||+|||+++|+||||||+||+
T Consensus        99 ~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIl  172 (327)
T 2yfx_A           99 IGVSLQSLPR------FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL  172 (327)
T ss_dssp             EEEECSSSSC------EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             EEEEcCCCCc------EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEE
Confidence            9999877665      999999965 67776653         2788999999999999999999999999999999999


Q ss_pred             Ecc---CCcEEEeecccccccCCC---cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch
Q psy11580        197 VKS---DCTLKILDFGLARTAGTT---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHI  269 (288)
Q Consensus       197 ~~~---~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~  269 (288)
                      ++.   +..++|+|||++......   .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus       173 i~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  252 (327)
T 2yfx_A          173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ  252 (327)
T ss_dssp             ESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH
Confidence            984   446999999998753221   12233467889999999999899999999999999999998 99999988877


Q ss_pred             hHHHHHHHHh
Q psy11580        270 DQWNKIIGKM  279 (288)
Q Consensus       270 ~~~~~i~~~~  279 (288)
                      +....+....
T Consensus       253 ~~~~~~~~~~  262 (327)
T 2yfx_A          253 EVLEFVTSGG  262 (327)
T ss_dssp             HHHHHHHTTC
T ss_pred             HHHHHHhcCC
Confidence            7766665543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3e-37  Score=259.25  Aligned_cols=211  Identities=27%  Similarity=0.410  Sum_probs=174.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+++.||+|+++..  .......+.+|+.+++.++||||+++++++...+.. 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-   81 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLV----KQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHY-   81 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE-
T ss_pred             ccceeeeeccCCCCceEEEE----EECCCCCEEEEEEEecc--cccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEE-
Confidence            45667778888777777764    45678999999999853  223345688999999999999999999999876654 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE---ccCCcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~---~~~~~~kl~dfg~~  211 (288)
                           ++||||+++ ++.+.+.  ..+++..+..++.|++.||+|||++|++|+||||+||++   +.++.++|+|||++
T Consensus        82 -----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~  156 (304)
T 2jam_A           82 -----YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS  156 (304)
T ss_dssp             -----EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred             -----EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence                 999999975 6766664  348999999999999999999999999999999999999   77889999999998


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCC
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  281 (288)
                      ...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.+....
T Consensus       157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  225 (304)
T 2jam_A          157 KMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE  225 (304)
T ss_dssp             CCCCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC
T ss_pred             eecCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence            765433 223446899999999999988999999999999999999999999998888877777765543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.2e-38  Score=272.42  Aligned_cols=199  Identities=26%  Similarity=0.410  Sum_probs=165.5

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+++.||||+++... .......+.+|++++++++||||+++++++...+.  
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~----~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--   81 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRG----RHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT--   81 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT--
T ss_pred             CceEEEEEEEcCCCeEEEEE----EECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC--
Confidence            45667777788777777765    467789999999997532 22335677899999999999999999999876542  


Q ss_pred             ccccEEEEEecccc-cHHHHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE----ccCCcEEEee
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILD  207 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~----~~~~~~kl~d  207 (288)
                        ...++||||+++ +|.+.+...     +++..++.++.||+.||+|||+++|+||||||+||++    +.++.+||+|
T Consensus        82 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           82 --RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             --CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             --CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence              245999999986 566665421     8999999999999999999999999999999999999    7777899999


Q ss_pred             cccccccCCCcccCCcccccccCchHhHhc--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        208 FGLARTAGTTFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      ||++.............+++.|+|||++.+        ..++.++||||||+++|+|++|+.||..
T Consensus       160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             GGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             CCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            999988766655566789999999999875        4567899999999999999999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=8.8e-37  Score=254.28  Aligned_cols=202  Identities=25%  Similarity=0.324  Sum_probs=165.9

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhH-----HHHHHHHHHHHHCCCCCcceeecc
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHA-----KRAYREFKLMKLVNHKNIIGLLNA  129 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~  129 (288)
                      +...++.+.+.+|+|.++.++.+    .+..+++.||+|++..........     ..+.+|++++++++||||++++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKG----RLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL   91 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEE----EETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhccceehhccccCCceeEEEE----EEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence            33456777888888888877765    456789999999997543222211     678899999999999999999999


Q ss_pred             ccCCCcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCCEEEccCCc-
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT-  202 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--ivH~dl~~~nil~~~~~~-  202 (288)
                      +....        ++||||+++ ++.+.+.   ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++. 
T Consensus        92 ~~~~~--------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~  163 (287)
T 4f0f_A           92 MHNPP--------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDEN  163 (287)
T ss_dssp             ETTTT--------EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTT
T ss_pred             ecCCC--------eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCC
Confidence            97654        799999984 6766664   34899999999999999999999999  999999999999988776 


Q ss_pred             ----EEEeecccccccCCCcccCCcccccccCchHhHh--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        203 ----LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       203 ----~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                          +||+|||++......  .....+++.|+|||++.  ...++.++||||||+++|+|++|+.||.+.+...
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  235 (287)
T 4f0f_A          164 APVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK  235 (287)
T ss_dssp             CSCCEEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred             CceeEEeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence                999999999755443  33457899999999984  4557889999999999999999999998765443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-36  Score=254.65  Aligned_cols=216  Identities=25%  Similarity=0.397  Sum_probs=179.7

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcc-------hhhHHHHHHHHHHHHHCC-CCCcceee
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN-------VTHAKRAYREFKLMKLVN-HKNIIGLL  127 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~~i~~~~  127 (288)
                      ...++.+.+.+|+|.++.++.+    .+..+++.||||+++.....       ......+.+|+++++++. ||||++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRC----IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhccceeeeecCCCceEEEEE----EEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            3456778888888888777765    45678999999999753211       123456789999999995 99999999


Q ss_pred             ccccCCCcccccccEEEEEecccc-cHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEE
Q psy11580        128 NAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  204 (288)
Q Consensus       128 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~k  204 (288)
                      +++...+..      ++||||+++ +|.+.+..  .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++
T Consensus        91 ~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  164 (298)
T 1phk_A           91 DTYETNTFF------FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK  164 (298)
T ss_dssp             EEEECSSEE------EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             eeeccCCeE------EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEE
Confidence            999776654      999999985 67776653  589999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCcccCCcccccccCchHhHh------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        205 ILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL------GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       205 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      |+|||++.............+++.|+|||++.      ...++.++||||||+++|+|++|..||.+.+..+....+...
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            99999998766555555667899999999986      346788999999999999999999999998887777777665


Q ss_pred             hCC
Q psy11580        279 MRE  281 (288)
Q Consensus       279 ~~~  281 (288)
                      ...
T Consensus       245 ~~~  247 (298)
T 1phk_A          245 NYQ  247 (298)
T ss_dssp             CCC
T ss_pred             Ccc
Confidence            433

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.9e-37  Score=254.33  Aligned_cols=217  Identities=30%  Similarity=0.499  Sum_probs=181.3

Q ss_pred             hhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecccc
Q psy11580         52 WKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        52 ~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  131 (288)
                      ........+.+.+.+|+|.++.++.+    .+..+++.||+|++............+.+|++++++++||||+++++++.
T Consensus        16 ~~~~~~~~y~i~~~lg~G~~g~V~~~----~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           16 FQGTFAERYNIVCMLGKGSFGEVLKC----KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HTHHHHHHEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             HHHHHhhcceeeEEEcCCCCEEEEEE----EEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            34445567788888888888777765    45668999999999765444455678899999999999999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC---CcEEE
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKI  205 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~---~~~kl  205 (288)
                      ..+..      ++|||++++ ++.+.+.  ..+++..+..++.||+.||+|||++|++|+||+|+||+++.+   +.+||
T Consensus        92 ~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL  165 (287)
T 2wei_A           92 DSSSF------YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKI  165 (287)
T ss_dssp             CSSEE------EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCeE------EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEE
Confidence            76654      999999975 5666654  458999999999999999999999999999999999999764   46999


Q ss_pred             eecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        206 LDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       206 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      +|||++.............+++.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+....+....
T Consensus       166 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  238 (287)
T 2wei_A          166 IDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK  238 (287)
T ss_dssp             CSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             eccCcceeecCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            999999876655444556789999999998774 8899999999999999999999999988887777776544

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.7e-37  Score=254.00  Aligned_cols=210  Identities=24%  Similarity=0.405  Sum_probs=174.4

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++....+.+.+.+|+|.++.++.+.     ..++..||+|+++...   .....+.+|+++++.++||||+++++++...
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   80 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGY-----YNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE   80 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEE-----ETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEE-----EcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcCC
Confidence            4455677888899998888888763     2356789999997532   3356788999999999999999999998744


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      .       .++|||++++ +|.+.+..    .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+||
T Consensus        81 ~-------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df  153 (279)
T 1qpc_A           81 P-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF  153 (279)
T ss_dssp             S-------CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             C-------cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCC
Confidence            3       3999999975 66666642    5899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        209 GLARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       209 g~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      |++........  .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.+.
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  226 (279)
T 1qpc_A          154 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG  226 (279)
T ss_dssp             TTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred             cccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc
Confidence            99987654322  233456778999999998889999999999999999999 99999998877776666554

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.3e-37  Score=277.71  Aligned_cols=211  Identities=23%  Similarity=0.375  Sum_probs=176.5

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.||+|.++.++.|.     ...+..||||+++...   ...+.+.+|+++|++++||||+++++++.. 
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~-----~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-  333 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-  333 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEE-----ETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ecchhhhhhheecccCCCeEEEEEE-----ECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            5566778888999999888888773     2335679999998532   234678999999999999999999999876 


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      +.      .++||||+.+ +|.+++..    .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus       334 ~~------~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          334 EP------IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             SS------CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCT
T ss_pred             cc------ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccc
Confidence            33      3999999986 67776652    3899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        209 GLARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       209 g~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      |++........  .....++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+.+..+.+..
T Consensus       408 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~  481 (535)
T 2h8h_A          408 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY  481 (535)
T ss_dssp             TSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             ccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99987654221  123356778999999999899999999999999999999 999999988888777776554

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.1e-37  Score=262.85  Aligned_cols=216  Identities=24%  Similarity=0.347  Sum_probs=173.9

Q ss_pred             hhhhhhcccccccccCCccccccccCccceeccCCCceE--EEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeec
Q psy11580         52 WKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNV--AIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLN  128 (288)
Q Consensus        52 ~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~  128 (288)
                      |..+...++.+.+.+|+|.++.++.+    .+..++..+  |+|.++.. ........+.+|+++++++ +||||+++++
T Consensus        19 ~p~~~~~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   93 (327)
T 1fvr_A           19 YPVLDWNDIKFQDVIGEGNFGQVLKA----RIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLG   93 (327)
T ss_dssp             SSBCCGGGCEEEEEEECGGGCEEEEE----EEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred             cccccHHHccceeeeecCCCceEEEE----EEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhce
Confidence            33455677888999999888888775    345566644  99999743 2334456788999999999 8999999999


Q ss_pred             cccCCCcccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeec
Q psy11580        129 AFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRD  189 (288)
Q Consensus       129 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~d  189 (288)
                      ++...+..      ++||||+++ +|.+.+..                  .+++..++.++.||+.||+|||++||+|||
T Consensus        94 ~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~d  167 (327)
T 1fvr_A           94 ACEHRGYL------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD  167 (327)
T ss_dssp             EEEETTEE------EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             eeeeCCce------EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence            99776654      999999976 67776642                  488999999999999999999999999999


Q ss_pred             CCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q psy11580        190 LKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDH  268 (288)
Q Consensus       190 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~  268 (288)
                      |||+||+++.++.+||+|||++.............+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus       168 lkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~  247 (327)
T 1fvr_A          168 LAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  247 (327)
T ss_dssp             CSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             CccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence            999999999999999999999976544433344566888999999999889999999999999999998 9999999887


Q ss_pred             hhHHHHHHHH
Q psy11580        269 IDQWNKIIGK  278 (288)
Q Consensus       269 ~~~~~~i~~~  278 (288)
                      .+....+...
T Consensus       248 ~~~~~~~~~~  257 (327)
T 1fvr_A          248 AELYEKLPQG  257 (327)
T ss_dssp             HHHHHHGGGT
T ss_pred             HHHHHHhhcC
Confidence            7766665543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.8e-37  Score=264.57  Aligned_cols=205  Identities=26%  Similarity=0.429  Sum_probs=166.3

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  136 (288)
                      +.+.+.+.+|+|.++.++.+    .+..+++.||+|++++...      ...+|++++.++ +||||+++++++.+.+..
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~----~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRC----IHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             ccEEEEEEEeeCCCEEEEEE----EECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            45677788888887777764    4677899999999975422      234688888888 799999999999876654


Q ss_pred             cccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC----CcEEEeecc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD----CTLKILDFG  209 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~----~~~kl~dfg  209 (288)
                            ++||||+++ ++.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||++..+    +.+||+|||
T Consensus        92 ------~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           92 ------YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             ------EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             ------EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence                  999999986 6777665  348999999999999999999999999999999999998543    359999999


Q ss_pred             cccccCCC-cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CchhHHHHHHHH
Q psy11580        210 LARTAGTT-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT---DHIDQWNKIIGK  278 (288)
Q Consensus       210 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~---~~~~~~~~i~~~  278 (288)
                      ++...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.   +..++...|...
T Consensus       166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  238 (342)
T 2qr7_A          166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG  238 (342)
T ss_dssp             TCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC
T ss_pred             CcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC
Confidence            99865432 2334567899999999999888899999999999999999999999863   344455555443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.8e-37  Score=261.08  Aligned_cols=211  Identities=20%  Similarity=0.250  Sum_probs=168.8

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCce----EEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecccc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQN----VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  131 (288)
                      ...++.+.+.+|+|.++.++.+.    +..+++.    ||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   85 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGV----WIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP   85 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEE----ECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CHhHceeeeeeeecCCceEEEEE----EcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence            34567788888888888887763    3344444    7888875432 2233456778999999999999999999986


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEee
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD  207 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~d  207 (288)
                      ...       .++||||+.+ ++.+.+.   ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|
T Consensus        86 ~~~-------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~D  158 (325)
T 3kex_A           86 GSS-------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVAD  158 (325)
T ss_dssp             BSS-------EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECS
T ss_pred             CCc-------cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECC
Confidence            432       4899999985 5666664   3589999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        208 FGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       208 fg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ||++.......   ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+...
T Consensus       159 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  233 (325)
T 3kex_A          159 FGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG  233 (325)
T ss_dssp             CSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT
T ss_pred             CCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence            99998764332   2234466788999999999999999999999999999999 99999998877766666544

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.8e-37  Score=255.55  Aligned_cols=213  Identities=22%  Similarity=0.304  Sum_probs=169.2

Q ss_pred             hccccccc-ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         57 YQELPISH-QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~-~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ...+.+.+ .+|+|.++.++.+.  ..+..+++.||||+++...........+.+|+++++.++||||+++++++.. +.
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   91 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGY--YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES   91 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEE--EECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SS
T ss_pred             chhhhhccCccccccCeeeEeee--ecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-CC
Confidence            34556666 78888777777652  1234567899999998654455557789999999999999999999999843 32


Q ss_pred             ccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                            .++|||++++ +|.+.+.  ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||++.
T Consensus        92 ------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           92 ------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             ------EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             ------cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence                  4999999985 5666665  348999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCcc----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        213 TAGTTFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       213 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      .......    .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~  236 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG  236 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            6543321    122345688999999999889999999999999999999 99999998877666555543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.5e-36  Score=253.34  Aligned_cols=204  Identities=27%  Similarity=0.377  Sum_probs=167.8

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+...+|+|.++.++.+    .+..++..||+|++............+.+|+.+++.++||||+++++++....  ...
T Consensus        28 ~~~~~~lg~G~~g~Vy~~----~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~  101 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKG----LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV--KGK  101 (290)
T ss_dssp             EEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES--SSC
T ss_pred             EEeeeeccCCCCeEEEEe----EecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc--CCC
Confidence            456667777777776664    46678899999999865556666788999999999999999999999886432  122


Q ss_pred             ccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCCEEEc-cCCcEEEeecccccc
Q psy11580        140 QDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLART  213 (288)
Q Consensus       140 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--ivH~dl~~~nil~~-~~~~~kl~dfg~~~~  213 (288)
                      ...++||||+++ +|.+.+.  ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++ .++.+||+|||++..
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            446999999976 6666665  35899999999999999999999999  99999999999998 788999999999976


Q ss_pred             cCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhH
Q psy11580        214 AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ  271 (288)
Q Consensus       214 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  271 (288)
                      ...... ....+++.|+|||++.+ .++.++||||||+++|+|++|+.||.+......
T Consensus       182 ~~~~~~-~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  237 (290)
T 1t4h_A          182 KRASFA-KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ  237 (290)
T ss_dssp             CCTTSB-EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred             cccccc-ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH
Confidence            544322 34578999999998875 589999999999999999999999988554443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2e-36  Score=251.37  Aligned_cols=216  Identities=20%  Similarity=0.272  Sum_probs=172.2

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      .+...++.+.+.+|+|.++.++.+.-. .+..++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   85 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYT-NHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE   85 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEE-CTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEc-CCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence            344567788888898888887776311 012234579999998642 345567889999999999999999999998654


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .       .++|||++++ ++.+.+.   ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.+||+|||
T Consensus        86 ~-------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           86 P-------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             S-------CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             C-------CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence            3       2899999985 5666664   238999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        210 LARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       210 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      ++........  .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~  230 (281)
T 3cc6_A          159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG  230 (281)
T ss_dssp             GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT
T ss_pred             CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC
Confidence            9986544322  233456788999999999899999999999999999998 99999887777766665544

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2e-36  Score=254.10  Aligned_cols=208  Identities=25%  Similarity=0.382  Sum_probs=174.6

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|+|.++.++.|    .+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+..  
T Consensus        23 ~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--   95 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKG----IDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL--   95 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEE----EETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE--
T ss_pred             HHHHhhhhcccCCeEEEEE----EECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE--
Confidence            3566778888887777765    4567899999999975432 34467889999999999999999999999876654  


Q ss_pred             cccEEEEEecccc-cHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        139 FQDVYLVMELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       139 ~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                          ++||||+++ ++.+.+. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        96 ----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           96 ----WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             ----EEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             ----EEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence                999999987 5555554 4589999999999999999999999999999999999999999999999999976544


Q ss_pred             Cc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        217 TF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       217 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      .. ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.+
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  233 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK  233 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc
Confidence            32 23455789999999999998999999999999999999999999998877666555443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.4e-37  Score=263.69  Aligned_cols=216  Identities=27%  Similarity=0.412  Sum_probs=172.2

Q ss_pred             HHHhhhhhhcccccccccCCccccccccCcc---c---eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCC
Q psy11580         49 VDQWKELIYQELPISHQMGKKRHNTSHLGAG---A---AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN  122 (288)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g---~---~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~  122 (288)
                      ...+..+......++.....+|.....+|.|   .   +.+..++..||+|++.... .......+.+|+++++.++|||
T Consensus        14 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~   92 (360)
T 3eqc_A           14 RKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPY   92 (360)
T ss_dssp             HHHHHHHHHHHHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTT
T ss_pred             hhhHHHHhhhhhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCC
Confidence            3344444444555555555555555555544   2   3456789999999998642 3455678899999999999999


Q ss_pred             cceeeccccCCCcccccccEEEEEecccc-cHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCCEEEc
Q psy11580        123 IIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVK  198 (288)
Q Consensus       123 i~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~-~ivH~dl~~~nil~~  198 (288)
                      |+++++++...+..      ++||||+++ +|.+.+..  .+++..+..++.|++.||+|||++ +|+||||||+||+++
T Consensus        93 iv~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~  166 (360)
T 3eqc_A           93 IVGFYGAFYSDGEI------SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN  166 (360)
T ss_dssp             BCCEEEEEEETTEE------EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC
T ss_pred             EEEEeEEEEECCEE------EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC
Confidence            99999999876654      999999986 67666653  589999999999999999999986 999999999999999


Q ss_pred             cCCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHH
Q psy11580        199 SDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQW  272 (288)
Q Consensus       199 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~  272 (288)
                      .++.++|+|||++...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+..
T Consensus       167 ~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  239 (360)
T 3eqc_A          167 SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE  239 (360)
T ss_dssp             TTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH
T ss_pred             CCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999999999998654322 223457899999999999999999999999999999999999999987765543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.9e-36  Score=254.97  Aligned_cols=200  Identities=28%  Similarity=0.462  Sum_probs=156.6

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ..++.+.+.+|+|.++.++.+    .+..+++.||+|++... .........+.+|++++++++||||+++++++...+.
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRA----ACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEE----EETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ccceEEEEeecCCCCceEEEE----EEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence            356678888888887777765    34578999999999753 2344556778899999999999999999999987665


Q ss_pred             ccccccEEEEEecccc-cHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      .      ++|||++++ ++.+.+.      ..+++..++.++.|++.||+|||+++++|+||+|+||+++.++.++|+||
T Consensus       107 ~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Df  180 (310)
T 2wqm_A          107 L------NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDL  180 (310)
T ss_dssp             E------EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             E------EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEec
Confidence            4      999999987 5655553      23889999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        209 GLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       209 g~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      |++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus       181 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          181 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             cceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            9987654322 223457899999999999999999999999999999999999999764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.8e-37  Score=253.51  Aligned_cols=208  Identities=25%  Similarity=0.394  Sum_probs=166.5

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      .+...++.+.+.+|+|.++.++.+      ..+++.||+|+++..    ...+.+.+|++++++++||||+++++++...
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~------~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLG------DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE   86 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEE------EETTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             cCChhhceEEeEEecCCCceEEEE------EEcCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            345577888899999888888876      335889999999743    2456788999999999999999999997654


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      +     ...++||||+++ +|.+.+..    .+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+||
T Consensus        87 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Df  161 (278)
T 1byg_A           87 K-----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF  161 (278)
T ss_dssp             -------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             C-----CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeec
Confidence            3     124999999987 67766653    2889999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        209 GLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       209 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      |++.......  ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.+.
T Consensus       162 g~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~  230 (278)
T 1byg_A          162 GLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG  230 (278)
T ss_dssp             CC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred             cccccccccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence            9987654432  23356888999999999999999999999999999998 99999988777666655443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-37  Score=256.91  Aligned_cols=204  Identities=25%  Similarity=0.402  Sum_probs=147.1

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|++..... .......+.+|++++++++||||+++++++...+..
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRA----ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccceeeeeecCCCceEEEEE----EEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            45677788888777777665    3557899999999964211 112246788999999999999999999999876654


Q ss_pred             cccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                            ++||||+++ ++.+.+.   ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        87 ------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  160 (278)
T 3cok_A           87 ------YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLAT  160 (278)
T ss_dssp             ------EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ------EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeeccee
Confidence                  999999976 5666554   348999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhH
Q psy11580        213 TAGTTF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ  271 (288)
Q Consensus       213 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  271 (288)
                      ...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  220 (278)
T 3cok_A          161 QLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT  220 (278)
T ss_dssp             ECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--
T ss_pred             eccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH
Confidence            764322 22345789999999999988889999999999999999999999987654433

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-36  Score=258.51  Aligned_cols=218  Identities=23%  Similarity=0.328  Sum_probs=176.3

Q ss_pred             hhhhcccccccccCCccccccccCccceec-cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYD-TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  131 (288)
                      ++...++.+.+.+|+|.++.++.+...... ......||+|++.... .......+.+|+++++.+ +||||+++++++.
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            556677889999999988888876421111 1233589999997532 334567789999999999 8999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHhh----------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCC
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQM----------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN  194 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~n  194 (288)
                      ..+..      ++||||+++ +|.+.+..                .+++..+..++.|++.||+|||+++|+||||||+|
T Consensus       121 ~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  194 (333)
T 2i1m_A          121 HGGPV------LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARN  194 (333)
T ss_dssp             SSSSC------EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             cCCce------EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccce
Confidence            77765      999999986 66666542                26889999999999999999999999999999999


Q ss_pred             EEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchh
Q psy11580        195 IVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHID  270 (288)
Q Consensus       195 il~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~  270 (288)
                      |+++.++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.....
T Consensus       195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  274 (333)
T 2i1m_A          195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS  274 (333)
T ss_dssp             CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred             EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence            999999999999999997543321   1234456788999999999899999999999999999998 999999876655


Q ss_pred             HHHHHHHH
Q psy11580        271 QWNKIIGK  278 (288)
Q Consensus       271 ~~~~i~~~  278 (288)
                      ...+++..
T Consensus       275 ~~~~~~~~  282 (333)
T 2i1m_A          275 KFYKLVKD  282 (333)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHhc
Confidence            55555443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.4e-37  Score=270.82  Aligned_cols=203  Identities=33%  Similarity=0.520  Sum_probs=155.4

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc------chhhHHHHHHHHHHHHHCCCCCcceeecc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ------NVTHAKRAYREFKLMKLVNHKNIIGLLNA  129 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  129 (288)
                      ...++.+.+.+|+|.++.++++    .+..+++.||||++.....      .......+.+|+++|++++||||++++++
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  208 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLA----FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF  208 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEE----EETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             hhccEEEEeEEeeCCCeEEEEE----EECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3455666777777777666654    5678899999999975321      11222357899999999999999999999


Q ss_pred             ccCCCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC---cE
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TL  203 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~---~~  203 (288)
                      +....       .++||||+++ +|.+.+.  ..+++..+..++.|++.||+|||+++|+||||||+|||++.++   .+
T Consensus       209 ~~~~~-------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~  281 (419)
T 3i6u_A          209 FDAED-------YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI  281 (419)
T ss_dssp             EESSE-------EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCE
T ss_pred             EecCc-------eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceE
Confidence            85433       4999999986 5555553  4589999999999999999999999999999999999997544   59


Q ss_pred             EEeecccccccCCCcccCCcccccccCchHhHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy11580        204 KILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI  269 (288)
Q Consensus       204 kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~  269 (288)
                      ||+|||++.............+++.|+|||++.+   ..++.++||||||+++|+|++|..||.+....
T Consensus       282 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  350 (419)
T 3i6u_A          282 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  350 (419)
T ss_dssp             EECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred             EEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence            9999999988766655566789999999999864   56788999999999999999999999875443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-36  Score=253.60  Aligned_cols=193  Identities=31%  Similarity=0.417  Sum_probs=157.6

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +...++.+.+.+|+|.++.++.+      ...++.||+|++..    ......+.+|++++++++||||+++++++.+. 
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~------~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-   73 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKA------KWRAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLNP-   73 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEE------EETTEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT-
T ss_pred             CCHhHeeeeeEeecCCCceEEEE------EECCeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-
Confidence            44567788899999888888876      33578999999964    24457789999999999999999999998743 


Q ss_pred             cccccccEEEEEecccc-cHHHHHhh-----hCCHHHHHHHHHHHHHHHHHHHH---CCCEeecCCCCCEEEccCCc-EE
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT-LK  204 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~---~~ivH~dl~~~nil~~~~~~-~k  204 (288)
                       .      ++||||+++ +|.+.+..     .++...+..++.|+++||+|||+   ++|+||||||+||+++.++. +|
T Consensus        74 -~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~k  146 (307)
T 2eva_A           74 -V------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK  146 (307)
T ss_dssp             -T------EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEE
T ss_pred             -c------EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEE
Confidence             2      999999986 67666652     26788999999999999999999   89999999999999998886 79


Q ss_pred             EeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        205 ILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       205 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      |+|||++......  .....+++.|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus       147 l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  207 (307)
T 2eva_A          147 ICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG  207 (307)
T ss_dssp             ECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred             Ecccccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence            9999999765433  233468999999999999999999999999999999999999998643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.4e-37  Score=260.16  Aligned_cols=199  Identities=22%  Similarity=0.296  Sum_probs=166.3

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      .....++.+.+.+|+|.++.++.+.     ..+++.||||++...... .....+.+|+++++.++||||+++++++...
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   99 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGR-----LADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP   99 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEEC-----CSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred             HHHhhccccceeEecCCCcEEEEEE-----ecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence            4455677888888888888888763     346899999999753221 2233688999999999999999999999877


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh------hCCHHHHHHHHHHHHHHHHHHHHC---CCEeecCCCCCEEEccCCcE
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL  203 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~ivH~dl~~~nil~~~~~~~  203 (288)
                      +..      ++||||+++ ++.+.+..      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus       100 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A          100 TER------LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             SCC------EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             Cce------EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            665      999999987 56666542      288999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCC--cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy11580        204 KILDFGLARTAGTT--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP  264 (288)
Q Consensus       204 kl~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~  264 (288)
                      ||+|||++......  .......+++.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            99999999865432  22344568999999999999889999999999999999999999995

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=278.21  Aligned_cols=205  Identities=23%  Similarity=0.316  Sum_probs=164.4

Q ss_pred             ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEEE
Q psy11580         65 QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYL  144 (288)
Q Consensus        65 ~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~l  144 (288)
                      .||+|.++.++.|.-  ....++..||||+++.. ........+.+|+++|++++||||+++++++....       .++
T Consensus       343 ~LG~G~fG~Vy~~~~--~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-------~~l  412 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVY--RMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-------LML  412 (613)
T ss_dssp             EEEECSSSEEEEEEE--ECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSS-------EEE
T ss_pred             EEecCCCcEEEEEEE--ecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCC-------eEE
Confidence            567766666665521  11245678999999864 23345678999999999999999999999997532       499


Q ss_pred             EEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCcc-
Q psy11580        145 VMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM-  219 (288)
Q Consensus       145 v~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~-  219 (288)
                      ||||++++ |.+++.   ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ 
T Consensus       413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred             EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence            99999875 666654   3489999999999999999999999999999999999999999999999999986543221 


Q ss_pred             ---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        220 ---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       220 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                         .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+....+.+..
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~  556 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK  556 (613)
T ss_dssp             ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC
T ss_pred             eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence               122345678999999999999999999999999999998 999999998888877776554

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.7e-37  Score=265.81  Aligned_cols=202  Identities=14%  Similarity=0.127  Sum_probs=149.5

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHC--CCCCcceeeccc-----
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLV--NHKNIIGLLNAF-----  130 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~-----  130 (288)
                      .+.+.+.+|+|.++.++.+    .+..+++.||||++..... .......+.+|+++++.+  +||||++++..+     
T Consensus        63 ~y~~~~~lG~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLV----RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred             eeeeeeeccCCCCEEEEEE----EECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence            3567777888777777765    4567899999999987543 334456677785555555  699988865333     


Q ss_pred             --cCCCc-----------ccccccEEEEEecccccHHHHHhh---hCCHHHH------HHHHHHHHHHHHHHHHCCCEee
Q psy11580        131 --TPQKS-----------LEEFQDVYLVMELMDANLCQVIQM---DLDHERM------SYLLYQMLCGIKHLHSAGIIHR  188 (288)
Q Consensus       131 --~~~~~-----------~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~------~~~~~~i~~~l~~LH~~~ivH~  188 (288)
                        ...+.           .......++||||++++|.+++..   .+....+      ..++.||+.||+|||+++|+||
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr  218 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG  218 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence              22221           001134699999999988888763   2555555      6788999999999999999999


Q ss_pred             cCCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       189 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ||||+|||++.++.+||+|||++...+....  ...+++.|+|||++.+  ..++.++||||||+++|+|++|+.||.+.
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGP--ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEEE--GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCcc--CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999999999999999999987654322  3466799999999987  67899999999999999999999999876

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-36  Score=251.72  Aligned_cols=211  Identities=24%  Similarity=0.327  Sum_probs=170.3

Q ss_pred             ccccccc-ccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISH-QMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~-~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+ .+|+|.++.++.+.-  ....++..||+|+++.. ........+.+|++++++++||||+++++++... . 
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~--~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~-   83 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVY--RMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A-   83 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEE--C---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S-
T ss_pred             HHhhhhhccccccCceeEEEeEe--ccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCC-C-
Confidence            3444444 788887777776521  12346788999999864 2445567899999999999999999999999433 2 


Q ss_pred             cccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                           .++|||++++ +|.+.+.   ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.
T Consensus        84 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           84 -----LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             -----EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             -----cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence                 4999999987 5666653   348999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcc----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q psy11580        213 TAGTTFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       213 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~  278 (288)
                      .......    .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~  229 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG  229 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC
Confidence            6543221    223355788999999998889999999999999999998 99999998887777666554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.5e-36  Score=256.33  Aligned_cols=193  Identities=26%  Similarity=0.434  Sum_probs=154.9

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCccccccc
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      ++.+|+|.++.++.+    .+..+++.||||++...  .......+.+|+++++++ +||||+++++++...+..     
T Consensus        18 ~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~-----   86 (316)
T 2ac3_A           18 EDVLGEGAHARVQTC----INLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF-----   86 (316)
T ss_dssp             CCCCCCCSSEEEEEE----ECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE-----
T ss_pred             CceecCCceEEEEEE----EEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE-----
Confidence            356677766666654    45678999999999753  233456788999999995 799999999999876654     


Q ss_pred             EEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc---EEEeecccccccC
Q psy11580        142 VYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLARTAG  215 (288)
Q Consensus       142 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~---~kl~dfg~~~~~~  215 (288)
                       ++||||+++ ++.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.   +||+|||++....
T Consensus        87 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           87 -YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             -EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             -EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence             999999985 6766665  34899999999999999999999999999999999999998776   9999999987543


Q ss_pred             CC--------cccCCcccccccCchHhHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        216 TT--------FMMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       216 ~~--------~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ..        .......+++.|+|||++.+     ..++.++||||||+++|+|++|..||.+.+
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence            21        11223468999999999975     457889999999999999999999998764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.6e-37  Score=257.12  Aligned_cols=204  Identities=23%  Similarity=0.348  Sum_probs=160.4

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ...++.+.+.+|+|.++.++.+    .+..+++.||+|++..... .......+.+|++++++++||||+++++++...+
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEA----EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEE----EETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             EeccEEEEEEEcCCCCeeEEEE----EEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            3466778888888887777765    4567889999999975422 2334577889999999999999999999998766


Q ss_pred             cccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      ..      ++|||++++ +|.+.+.  ..+++..+..++.|++.||+|||+++|+|+||+|+||+++.++.+||+|||++
T Consensus       108 ~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          108 QL------YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             EE------EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             eE------EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccC
Confidence            54      999999986 6666665  34899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCc--ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy11580        212 RTAGTTF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI  269 (288)
Q Consensus       212 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~  269 (288)
                      .......  ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  241 (309)
T 2h34_A          182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS  241 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH
T ss_pred             ccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH
Confidence            7654432  223457899999999999988999999999999999999999999886654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.5e-37  Score=259.32  Aligned_cols=204  Identities=22%  Similarity=0.303  Sum_probs=169.7

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ..+.+.+.+|+|.++.++++.-.+.+..+++.||||+++.. ........+.+|++++++++||||+++++++...+.  
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--  107 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA--  107 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT--
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC--
Confidence            33578888999999888877555666778999999999864 344556778999999999999999999999976432  


Q ss_pred             ccccEEEEEecccc-cHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                        ...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+++|+|+||||+||+++.++.+||+|||++....
T Consensus       108 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          108 --ASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             --TEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             --ceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence              245999999986 6666665 348999999999999999999999999999999999999999999999999998765


Q ss_pred             CCc----ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        216 TTF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       216 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ...    ......++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence            432    123445778899999999988999999999999999999999998753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.7e-37  Score=259.39  Aligned_cols=205  Identities=25%  Similarity=0.323  Sum_probs=171.2

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      ..+++.+.+.+|+|.++.++++.-...+..+++.||||++...  .......+.+|++++++++||||+++++++...+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            4467788899999998888887543446778999999999753  44556778999999999999999999998864322


Q ss_pred             ccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                          ...++||||+++ +|.+.+.   ..+++..++.++.|++.||+|||+++|+|+||||+||+++.++.+||+|||++
T Consensus        99 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           99 ----QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             ----CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             ----ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence                335999999965 5666654   34899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc----ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        212 RTAGTTF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       212 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      .......    ......+++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  233 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP  233 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence            8654322    223446778899999999988999999999999999999999998654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.8e-37  Score=261.33  Aligned_cols=210  Identities=25%  Similarity=0.366  Sum_probs=155.2

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~  132 (288)
                      ++...++.+.+.+|+|.++.++.+    .+..+++.||+|++..  ........+.+|+.+++++. ||||+++++++..
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEA----QDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEE----EETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             eccCceEEEEEEEccCCceEEEEE----EECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            444457788888999888887775    4566899999999864  23455677889999999995 9999999999843


Q ss_pred             CCc--ccccccEEEEEecccccHHHHHhh-----hCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCCEEEccCCcE
Q psy11580        133 QKS--LEEFQDVYLVMELMDANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTL  203 (288)
Q Consensus       133 ~~~--~~~~~~~~lv~e~~~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~--ivH~dl~~~nil~~~~~~~  203 (288)
                      ...  ......+++||||+++++.+.+..     .+++..++.++.||+.||+|||+.+  |+||||||+||+++.++.+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             cccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence            221  122234699999999998887752     4899999999999999999999999  9999999999999999999


Q ss_pred             EEeecccccccCCCccc-------------CCcccccccCchHhH---hcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        204 KILDFGLARTAGTTFMM-------------TPYVVTRYYRAPEVI---LGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       204 kl~dfg~~~~~~~~~~~-------------~~~~~~~~~~aPE~~---~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ||+|||++.........             ....+++.|+|||++   .+..++.++||||||+++|+|++|+.||.+.+
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            99999999865432211             134588999999999   56678899999999999999999999997654


Q ss_pred             ch
Q psy11580        268 HI  269 (288)
Q Consensus       268 ~~  269 (288)
                      ..
T Consensus       258 ~~  259 (337)
T 3ll6_A          258 KL  259 (337)
T ss_dssp             --
T ss_pred             HH
Confidence            43

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=253.89  Aligned_cols=208  Identities=25%  Similarity=0.397  Sum_probs=168.0

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ......+.+.+.+|+|.++.++.+    .+..+++.||+|++...    .....+.+|+++++.++||||+++++++...
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   96 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKA----IHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKN   96 (314)
T ss_dssp             -----CEEEEEECC----CEEEEE----EETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             hcchhhhhhheeeccCCCeEEEEE----EECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            334456777888888887777765    45678999999999753    2346788999999999999999999999876


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      +..      ++||||+++ ++.+.+.   ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||
T Consensus        97 ~~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg  170 (314)
T 3com_A           97 TDL------WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG  170 (314)
T ss_dssp             TEE------EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             CEE------EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecc
Confidence            654      999999987 5665554   358999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHH
Q psy11580        210 LARTAGTT-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       210 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i  275 (288)
                      ++...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  237 (314)
T 3com_A          171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI  237 (314)
T ss_dssp             TCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             cchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99765433 2234457899999999999988999999999999999999999999887765544433

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=260.26  Aligned_cols=205  Identities=14%  Similarity=0.124  Sum_probs=159.4

Q ss_pred             hhhcccccccccCCccccccccCccceeccC---CCceEEEEeccCCCcchh---------hHHHHHHHHHHHHHCCCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTA---TQQNVAIKKLSRPFQNVT---------HAKRAYREFKLMKLVNHKN  122 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~---~~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~  122 (288)
                      +...++.+.+.+|+|.++.++.+.    +..   ++..||+|++........         ....+.+|+..++.++|||
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n  109 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAF----PTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG  109 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEE----ESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEE----ecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence            334567788888888887777753    333   678999999975422111         1223667888999999999


Q ss_pred             cceeeccccCCCcccccccEEEEEecccccHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC
Q psy11580        123 IIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD  200 (288)
Q Consensus       123 i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~  200 (288)
                      |+++++++....  ......++||||++++|.+.+..  .+++..++.++.||+.||+|||+++|+||||||+||+++.+
T Consensus       110 i~~~~~~~~~~~--~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          110 IPLFYGSGLTEF--KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             CCCEEEEEEEES--SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS
T ss_pred             cceeeccccccc--CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC
Confidence            999999987621  11234699999997778777653  58999999999999999999999999999999999999988


Q ss_pred             C--cEEEeecccccccCCCc--------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        201 C--TLKILDFGLARTAGTTF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       201 ~--~~kl~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      +  .+||+|||++.......        ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            7  99999999997653221        11345789999999999999999999999999999999999999965

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-36  Score=255.26  Aligned_cols=213  Identities=26%  Similarity=0.406  Sum_probs=164.4

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  136 (288)
                      ..+.+.+.+|+|.++.++.+    .+..+++.||+|++....   .....+.+|+.+++++ +||||+++++++......
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKG----RHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CcEEEEEEeccCCCEEEEEE----EECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            34566777777777766664    456689999999997532   3356788999999999 799999999999764322


Q ss_pred             cccccEEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      ......++||||+++ +|.+.+.    ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence            223456999999987 6666664    34889999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCc-ccCCcccccccCchHhHh-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q psy11580        212 RTAGTTF-MMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIG  277 (288)
Q Consensus       212 ~~~~~~~-~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~  277 (288)
                      ....... ......+++.|+|||++.     +..++.++||||||+++|+|++|..||.+.+.......+.+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  248 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR  248 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence            7654322 234457899999999997     45678999999999999999999999998877666555543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.5e-36  Score=253.94  Aligned_cols=195  Identities=29%  Similarity=0.367  Sum_probs=161.0

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCC--cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF--QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      ++.+|+|.++.++.|      ..+++.||+|++....  ........+.+|+++++.++||||+++++++...+..    
T Consensus        36 ~~~lg~G~~g~Vy~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~----  105 (307)
T 2nru_A           36 GNKMGEGGFGVVYKG------YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL----  105 (307)
T ss_dssp             CCEEEECSSEEEEEE------ESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC----
T ss_pred             CCccccCCCeEEEEE------EECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce----
Confidence            366777776666665      3468899999997532  2334567788999999999999999999999877665    


Q ss_pred             cEEEEEecccc-cHHHHHh-----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        141 DVYLVMELMDA-NLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                        ++||||+++ ++.+.+.     ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||++...
T Consensus       106 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  183 (307)
T 2nru_A          106 --CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS  183 (307)
T ss_dssp             --EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             --EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccc
Confidence              999999975 5666654     23889999999999999999999999999999999999999999999999999765


Q ss_pred             CCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        215 GTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       215 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      ....   ......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+...
T Consensus       184 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  241 (307)
T 2nru_A          184 EKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ  241 (307)
T ss_dssp             CSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred             ccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence            4321   2234578999999999876 47899999999999999999999998755433

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.9e-37  Score=258.80  Aligned_cols=198  Identities=29%  Similarity=0.441  Sum_probs=160.2

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHH--CCCCCcceeeccccCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL--VNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~  133 (288)
                      ...++.+.+.+|+|.++.++.|      ..+++.||||++..     .....+..|.+++..  ++||||+++++++...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~------~~~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRG------SWQGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTS   74 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEE------EETTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEE------EECCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence            4456778888888888888776      34689999999964     234556667777777  7999999999997643


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh-hhCCHHHHHHHHHHHHHHHHHHH--------HCCCEeecCCCCCEEEccCCcE
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLH--------SAGIIHRDLKPSNIVVKSDCTL  203 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH--------~~~ivH~dl~~~nil~~~~~~~  203 (288)
                      .  ......++||||+++ +|.+.+. ..+++..+..++.|++.||+|||        +.+|+||||||+||+++.++.+
T Consensus        75 ~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           75 R--HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             E--TTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             c--CCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCE
Confidence            2  223456999999986 6766665 45899999999999999999999        9999999999999999999999


Q ss_pred             EEeecccccccCCCcc-----cCCcccccccCchHhHhcC------CCCchhhHHHHHHHHHHHHhC----------CCC
Q psy11580        204 KILDFGLARTAGTTFM-----MTPYVVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMIRG----------GVL  262 (288)
Q Consensus       204 kl~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slg~il~~l~~g----------~~p  262 (288)
                      ||+|||++........     .....+|+.|+|||++.+.      .++.++||||||+++|+|++|          ..|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            9999999975433211     2334789999999999886      455799999999999999999          889


Q ss_pred             CCCC
Q psy11580        263 FPGT  266 (288)
Q Consensus       263 ~~~~  266 (288)
                      |.+.
T Consensus       233 f~~~  236 (301)
T 3q4u_A          233 FYDV  236 (301)
T ss_dssp             TTTT
T ss_pred             cccc
Confidence            8653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-36  Score=252.06  Aligned_cols=196  Identities=19%  Similarity=0.254  Sum_probs=164.7

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|+++...........+.+|+..+..+ +||||+++++++...+..
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKC----VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             chhhhhhhhcCCCceEEEEE----EEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            45677888888888777765    4567899999999987655566677889999999999 999999999999876654


Q ss_pred             cccccEEEEEecccc-cHHHHHhh------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC---------
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---------  200 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~---------  200 (288)
                            ++||||+++ +|.+.+..      .+++..++.++.||+.||+|||+++|+||||||+||+++.+         
T Consensus        87 ------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           87 ------LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             ------EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------
T ss_pred             ------EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccc
Confidence                  999999976 67776653      38999999999999999999999999999999999999844         


Q ss_pred             ----------CcEEEeecccccccCCCcccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        201 ----------CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       201 ----------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                                ..++|+|||.+.......   ...+++.|+|||++.+. .++.++||||||+++|+|++|.+|+...
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             cccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence                      479999999998765542   34689999999999875 5668999999999999999999877543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9e-37  Score=263.36  Aligned_cols=216  Identities=30%  Similarity=0.451  Sum_probs=175.6

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-----------CCCccee
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-----------HKNIIGL  126 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~  126 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||||++..   .......+.+|++++++++           ||||+++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLA----KDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CeEEEEEeeeecCCeEEEEE----EecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            45567777777777777664    4567899999999974   3344567888999999886           8999999


Q ss_pred             eccccCCCcccccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCCEEEcc--
Q psy11580        127 LNAFTPQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKS--  199 (288)
Q Consensus       127 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~-~ivH~dl~~~nil~~~--  199 (288)
                      ++++...+  .+....++|||++++++.+.+..    .+++..+..++.||+.||+|||++ ||+||||||+||+++.  
T Consensus        92 ~~~~~~~~--~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           92 LDHFNHKG--PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             CEEEEEEE--TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             HHHhhccC--CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence            99997643  22235699999998888887753    389999999999999999999998 9999999999999954  


Q ss_pred             ----CCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------ch
Q psy11580        200 ----DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD------HI  269 (288)
Q Consensus       200 ----~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~------~~  269 (288)
                          .+.+||+|||++......  .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+      ..
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence                347999999999876543  234578999999999999999999999999999999999999998754      56


Q ss_pred             hHHHHHHHHhCCCcc
Q psy11580        270 DQWNKIIGKMREAHD  284 (288)
Q Consensus       270 ~~~~~i~~~~~~~~~  284 (288)
                      +.+.++++.++.+|.
T Consensus       248 ~~~~~~~~~~~~~p~  262 (373)
T 1q8y_A          248 DHIAQIIELLGELPS  262 (373)
T ss_dssp             HHHHHHHHHHCSCCH
T ss_pred             HHHHHHHHhcCCCCH
Confidence            677888888887765

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=8.3e-37  Score=259.16  Aligned_cols=203  Identities=23%  Similarity=0.383  Sum_probs=148.5

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHH-HHHHCCCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFK-LMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~  132 (288)
                      .+...++.+.+.+|+|.++.++.+    .+..+++.||||+++.... .....++..|+. +++.++||||+++++++..
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~   92 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKM----VHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR   92 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEE----EETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred             ccCHHHhhehheeccCCCEEEEEE----EEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence            445567788888888888877765    4567899999999986432 233445555655 7777899999999999987


Q ss_pred             CCcccccccEEEEEecccccHHHHHh-------hhCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCCEEEccCCcEE
Q psy11580        133 QKSLEEFQDVYLVMELMDANLCQVIQ-------MDLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLK  204 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~-~ivH~dl~~~nil~~~~~~~k  204 (288)
                      .+..      ++||||+++++.+.+.       ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus        93 ~~~~------~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~k  166 (327)
T 3aln_A           93 EGDC------WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK  166 (327)
T ss_dssp             SSEE------EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEE
T ss_pred             CCce------EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEE
Confidence            7654      9999999998777664       3488999999999999999999998 999999999999999999999


Q ss_pred             EeecccccccCCCcccCCcccccccCchHhH----hcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        205 ILDFGLARTAGTTFMMTPYVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       205 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      |+|||++.............+++.|+|||++    .+..++.++||||||+++|+|++|+.||.+.+
T Consensus       167 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (327)
T 3aln_A          167 LCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN  233 (327)
T ss_dssp             ECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred             EccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            9999999876555444555789999999998    45668899999999999999999999997643

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.8e-36  Score=253.32  Aligned_cols=214  Identities=20%  Similarity=0.281  Sum_probs=156.3

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ....++.+.+.+|+|.++.++.+    .+..+++.||||++............+.++..+++.++||||+++++++...+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKM----RFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEE----EETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hhhccccccceeeecCCeeEEEE----EEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            34456677788888888777765    45678999999999865434333444555666788889999999999998776


Q ss_pred             cccccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        135 SLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~-~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      ..      ++||||+++.+.....   ..+++..+..++.|++.||+|||++ |++|+||||+||+++.++.+||+|||+
T Consensus        98 ~~------~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  171 (318)
T 2dyl_A           98 DV------FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI  171 (318)
T ss_dssp             EE------EEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             cE------EEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence            54      9999999655544433   4589999999999999999999995 999999999999999999999999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHh-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchhHHHHHHHH
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIRGGVLFPGT-DHIDQWNKIIGK  278 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~-~~~~~~~~i~~~  278 (288)
                      +.............+++.|+|||++.     +..++.++||||||+++|+|++|+.||... +..+.+.++.+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  245 (318)
T 2dyl_A          172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE  245 (318)
T ss_dssp             C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS
T ss_pred             chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc
Confidence            97765544445567899999999995     456788999999999999999999999874 444555555544

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.7e-37  Score=256.77  Aligned_cols=211  Identities=26%  Similarity=0.433  Sum_probs=154.2

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      .+...++.+.+.+|+|.++.++.+    .+..+++.||||++.... .......+.+|++++++++||||+++++++...
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   85 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAA----YCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK   85 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEE----EC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS
T ss_pred             ccchhhhhhhheeccccceEEEEE----EECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence            455677888899999888877765    456688999999997532 223456788999999999999999999999877


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh----------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM----------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT  202 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~  202 (288)
                      +..      ++||||+++ ++.+.+..          .+++..+..++.||+.||+|||++|++|+||+|+||+++.++.
T Consensus        86 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~  159 (303)
T 2vwi_A           86 DEL------WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS  159 (303)
T ss_dssp             SCE------EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC
T ss_pred             CCc------EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC
Confidence            655      999999975 56665542          2889999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccCCC------cccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHH
Q psy11580        203 LKILDFGLARTAGTT------FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI  275 (288)
Q Consensus       203 ~kl~dfg~~~~~~~~------~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i  275 (288)
                      ++|+|||++......      .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+........
T Consensus       160 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  239 (303)
T 2vwi_A          160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT  239 (303)
T ss_dssp             EEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH
T ss_pred             EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH
Confidence            999999998755332      11234578999999999976 56899999999999999999999999987766554443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-36  Score=257.49  Aligned_cols=202  Identities=33%  Similarity=0.518  Sum_probs=163.6

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc------chhhHHHHHHHHHHHHHCCCCCcceeeccc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ------NVTHAKRAYREFKLMKLVNHKNIIGLLNAF  130 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  130 (288)
                      ..++.+.+.+|+|.++.++.+    .+..+++.||||++.....      .......+.+|++++++++||||+++++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   84 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLA----FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF   84 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhceeEeeEEecCCCEEEEEE----EEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence            356678888888888777765    4567889999999975321      112234578999999999999999999998


Q ss_pred             cCCCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc---EE
Q psy11580        131 TPQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LK  204 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~---~k  204 (288)
                      ....       .++||||+++ ++.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.   +|
T Consensus        85 ~~~~-------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           85 DAED-------YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             ESSS-------EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEE
T ss_pred             cCCc-------eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEE
Confidence            6543       4999999986 5666664  35899999999999999999999999999999999999987664   99


Q ss_pred             EeecccccccCCCcccCCcccccccCchHhHh---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy11580        205 ILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI  269 (288)
Q Consensus       205 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~  269 (288)
                      |+|||++.............+++.|+|||++.   ...++.++||||||+++|+|++|..||.+....
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  225 (322)
T 2ycf_A          158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  225 (322)
T ss_dssp             ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred             EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence            99999998776554444557899999999985   456789999999999999999999999875543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-36  Score=261.74  Aligned_cols=213  Identities=22%  Similarity=0.317  Sum_probs=159.9

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.+|+|.++.++.|.-.. ....+..||+|.++.. ........+.+|+.++++++||||+++++++...+.    
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~----  164 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLD-NDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG----  164 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEE-TTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS----
T ss_pred             eecCcEeeeCCCeEEEEEEEEC-CCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC----
Confidence            3456777777777777653110 1112357899999753 344566789999999999999999999998764431    


Q ss_pred             ccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        140 QDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       140 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                       ..++||||+++ +|.+++..   .+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++....
T Consensus       165 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          165 -SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             -CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             -CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence             24999999986 67776652   37889999999999999999999999999999999999999999999999997553


Q ss_pred             CCc-----ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        216 TTF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       216 ~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ...     ......+++.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+....+.+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~  313 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR  313 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC
Confidence            321     1223456788999999999999999999999999999999 788998877766666655443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.8e-36  Score=249.28  Aligned_cols=214  Identities=23%  Similarity=0.290  Sum_probs=165.7

Q ss_pred             hhcccccccccCCccccccccCccceeccCCC--ceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQ--QNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      ...++.+.+.+|+|.++.++.+.   .+..++  ..||+|+++... ........+.+|++++++++||||+++++++..
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~---~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGE---WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEE---EECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhHeeeeeeecCCCceeEEEEE---eccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            44567888888888888877753   112233  369999997542 233556788999999999999999999999986


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      ..       .++|+|++++ ++.+.+.   ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.+||+||
T Consensus        93 ~~-------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Df  165 (291)
T 1u46_A           93 PP-------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF  165 (291)
T ss_dssp             SS-------CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             CC-------ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccc
Confidence            54       3899999985 6766664   34899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcc----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        209 GLARTAGTTFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       209 g~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      |++........    .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+....
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~  241 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG  241 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence            99976544321    223456778999999999889999999999999999999 999999988877777766543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-37  Score=264.16  Aligned_cols=205  Identities=21%  Similarity=0.355  Sum_probs=163.9

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc--chhhHHHHHHHHHHHHHC-CCCCcceeeccccC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ--NVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTP  132 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  132 (288)
                      ...++.+.+.||+|.++.++++... ....+++.||||+++....  .......+.+|+++++.+ +||||+++++++..
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKI-SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEEC-SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cccceEEEEEeccCCCEEEEEEEEc-ccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            3456777888888887777765311 1135789999999975321  223345677899999999 69999999999977


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .+..      ++||||+++ +|.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||
T Consensus       131 ~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          131 ETKL------HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             TTEE------EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             CceE------EEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCC
Confidence            6654      999999986 5666665  358999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC--cccCCcccccccCchHhHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        210 LARTAGTT--FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       210 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ++......  .......+++.|+|||++.+  ..++.++||||||+++|+|++|..||...+
T Consensus       205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  266 (355)
T 1vzo_A          205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG  266 (355)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred             CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence            99765432  22234578999999999986  346889999999999999999999997644

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.4e-36  Score=252.50  Aligned_cols=203  Identities=22%  Similarity=0.309  Sum_probs=165.5

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ...+.+.+.+|+|.++.++.+.-...+..+++.||+|++.... .......+.+|+++++.++||||+++++++...+. 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-   97 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG-   97 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC-
Confidence            3456788889998888888764323356789999999997542 33445778899999999999999999999986532 


Q ss_pred             cccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                         ...++||||+++ +|.+.+.   ..+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||++.
T Consensus        98 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           98 ---NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             ---ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence               235999999986 6666663   348999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCc----ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy11580        213 TAGTTF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP  264 (288)
Q Consensus       213 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~  264 (288)
                      ......    ......++..|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence            664432    2234567788999999999999999999999999999999988763

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.5e-36  Score=253.30  Aligned_cols=208  Identities=23%  Similarity=0.348  Sum_probs=164.8

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|+|.++.++.+    .+..+++.||+|++...  .......+.+|+++++.++||||+++++++...+..  
T Consensus        20 ~y~i~~~lg~G~~g~V~~~----~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--   91 (302)
T 2j7t_A           20 VWEIVGELGDGAFGKVYKA----KNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL--   91 (302)
T ss_dssp             TEEEEEEEECSTTCCEEEE----EETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE--
T ss_pred             ceeecceeccCCCeEEEEE----EEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE--
Confidence            4456666777776666654    45677899999999753  334467788999999999999999999999877654  


Q ss_pred             cccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                          ++||||++++ +.+.+.   ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        92 ----~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           92 ----WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             ----EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             ----EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence                9999999875 444433   45899999999999999999999999999999999999999999999999987543


Q ss_pred             CC-CcccCCcccccccCchHhHh-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q psy11580        215 GT-TFMMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK  278 (288)
Q Consensus       215 ~~-~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~  278 (288)
                      .. ........+++.|+|||++.     +..++.++||||||+++|+|++|..||.+.+......++...
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  237 (302)
T 2j7t_A          168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS  237 (302)
T ss_dssp             HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc
Confidence            21 11123457899999999984     567889999999999999999999999988877766665543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.5e-36  Score=252.54  Aligned_cols=196  Identities=24%  Similarity=0.304  Sum_probs=161.3

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|++.....    ...+.+|+.+++.++|++++..+..+...+   
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~---   77 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLG----TDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEG---   77 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEE----EETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEET---
T ss_pred             cEEEEEEEEccCCCeEEEEE----EEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCC---
Confidence            44566777777776666664    4567899999999875322    245789999999999988777777664333   


Q ss_pred             ccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE---ccCCcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~---~~~~~~kl~dfg~~  211 (288)
                        ...++||||++++|.+.+.   ..+++..+..++.|++.||+|||+++|+||||||+||++   +.++.+||+|||++
T Consensus        78 --~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           78 --DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             --TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             --CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence              3359999999878887775   458999999999999999999999999999999999999   47889999999999


Q ss_pred             cccCCCcc--------cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        212 RTAGTTFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       212 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ........        .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  218 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL  218 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence            76543321        24457899999999999999999999999999999999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=8.2e-36  Score=249.72  Aligned_cols=215  Identities=22%  Similarity=0.311  Sum_probs=168.6

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.+|+|.++.++.|.-. .+..++..||+|.+... ........+.+|+.++++++||||+++++++...+.   
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---  100 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLL-DNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC------CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS---
T ss_pred             ehhhcceeeecCCceEEEEEEe-cCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC---
Confidence            4567788888887777765310 01223446899999753 344556788999999999999999999998654332   


Q ss_pred             cccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        139 FQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       139 ~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                        ..++||||+++ +|.+.+.   ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++...
T Consensus       101 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          101 --SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             --CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             --ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence              24999999987 6666664   34789999999999999999999999999999999999999999999999999765


Q ss_pred             CCCc-----ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        215 GTTF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       215 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ....     ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+..+....+.+...
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR  250 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence            4322     1233456788999999999999999999999999999999 7778888777776666655544

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.3e-37  Score=259.33  Aligned_cols=217  Identities=23%  Similarity=0.335  Sum_probs=173.1

Q ss_pred             HHHhhhhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeec
Q psy11580         49 VDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN  128 (288)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~  128 (288)
                      ...| ++...++.+.+.+|+|.++.++.|.       .+..||+|+++...........+.+|+.++++++||||+++++
T Consensus        25 ~~~~-~i~~~~~~~~~~lg~G~~g~V~~~~-------~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   96 (319)
T 2y4i_B           25 LQEW-DIPFEQLEIGELIGKGRFGQVYHGR-------WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG   96 (319)
T ss_dssp             GGGS-SSCCSCEECCCBCCCSSSSEEEEEE-------ESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred             cccc-cCCHHHeEEeeEeccCCceEEEEEE-------EcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence            3444 5667788899999998887777652       2346999999865444455566788999999999999999999


Q ss_pred             cccCCCcccccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEE
Q psy11580        129 AFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  204 (288)
Q Consensus       129 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~k  204 (288)
                      ++...+..      ++||||+++ ++.+.+..   .+++..+..++.|++.||+|||+++++||||||+||+++ ++.++
T Consensus        97 ~~~~~~~~------~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~  169 (319)
T 2y4i_B           97 ACMSPPHL------AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVV  169 (319)
T ss_dssp             EEECSSCE------EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCE
T ss_pred             EEecCCce------EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEE
Confidence            99877654      999999986 56666543   488999999999999999999999999999999999998 67999


Q ss_pred             EeecccccccCC------CcccCCcccccccCchHhHhc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy11580        205 ILDFGLARTAGT------TFMMTPYVVTRYYRAPEVILG---------MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHI  269 (288)
Q Consensus       205 l~dfg~~~~~~~------~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~  269 (288)
                      |+|||++.....      ........+++.|+|||++.+         ..++.++||||||+++|+|++|..||.+.+..
T Consensus       170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  249 (319)
T 2y4i_B          170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE  249 (319)
T ss_dssp             ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred             EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999865422      112233468899999999975         34788999999999999999999999998887


Q ss_pred             hHHHHHHHHhC
Q psy11580        270 DQWNKIIGKMR  280 (288)
Q Consensus       270 ~~~~~i~~~~~  280 (288)
                      ....++.....
T Consensus       250 ~~~~~~~~~~~  260 (319)
T 2y4i_B          250 AIIWQMGTGMK  260 (319)
T ss_dssp             HHHHHHHTTCC
T ss_pred             HHHHHhccCCC
Confidence            77766665544

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.1e-36  Score=252.89  Aligned_cols=197  Identities=24%  Similarity=0.307  Sum_probs=161.6

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||||++...    .....+.+|+++++.++|++++..+..+...+   
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~---   77 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLG----TDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEG---   77 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEE----EETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEET---
T ss_pred             CceEEeeeecCCCCeEEEEE----EEcCCCceEEEEeeccc----ccchHHHHHHHHHHHhcCCCCCCeeeeecCCC---
Confidence            45677778888777777765    45678999999997643    22345788999999999988888777765333   


Q ss_pred             ccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE---ccCCcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~---~~~~~~kl~dfg~~  211 (288)
                        ...++|||++++++.+.+.   ..+++..+..++.||+.||+|||+++|+||||||+||++   +.++.+||+|||++
T Consensus        78 --~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           78 --DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             --TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             --CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence              3359999999888887775   458999999999999999999999999999999999999   78899999999999


Q ss_pred             cccCCCc--------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        212 RTAGTTF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       212 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      .......        ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence            7654321        1234578999999999999999999999999999999999999998744

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.8e-36  Score=248.30  Aligned_cols=201  Identities=25%  Similarity=0.436  Sum_probs=167.3

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|++.... .......+.+|+.+++.++||||+++++++...+.. 
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-   80 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLA----VNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ-   80 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEE----EETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE-
T ss_pred             cceEEEEEeecCCCcEEEEE----EECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEE-
Confidence            45677788888887777765    456789999999997432 224457788999999999999999999999776554 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++|||++++ ++.+.+.  ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 -----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           81 -----YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             -----EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             -----EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence                 999999986 5666554  35899999999999999999999999999999999999999999999999999754


Q ss_pred             CCC---cccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy11580        215 GTT---FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPGTDHI  269 (288)
Q Consensus       215 ~~~---~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~  269 (288)
                      ...   .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  214 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS  214 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Confidence            321   22345578999999999988765 67999999999999999999999876543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=261.14  Aligned_cols=198  Identities=13%  Similarity=0.164  Sum_probs=153.1

Q ss_pred             ccccccccCCccccccccCccceeccC--------CCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTA--------TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAF  130 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  130 (288)
                      ++.+.+.+|+|.++.++.+    .+..        .++.||+|++...       ..+.+|++++++++||||+++++.+
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~----~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~  111 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEA----APTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKL  111 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEE----EECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             eEEEEEEecCCCCeEEEEE----eecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhh
Confidence            4445555555555554443    2333        4889999999742       4677899999999999999854433


Q ss_pred             cCCCc---------c-cccccEEEEEecccccHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEE
Q psy11580        131 TPQKS---------L-EEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV  196 (288)
Q Consensus       131 ~~~~~---------~-~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil  196 (288)
                      .....         . ......++||||++++|.+.+..    .+++..+..++.||+.||+|||+++|+||||||+||+
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence            22110         0 01234699999997788887763    4899999999999999999999999999999999999


Q ss_pred             EccCC--cEEEeecccccccCCCc--------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        197 VKSDC--TLKILDFGLARTAGTTF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       197 ~~~~~--~~kl~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ++.++  .+||+|||++.......        ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  89999999997654321        123447899999999999999999999999999999999999999876


Q ss_pred             C
Q psy11580        267 D  267 (288)
Q Consensus       267 ~  267 (288)
                      .
T Consensus       272 ~  272 (352)
T 2jii_A          272 L  272 (352)
T ss_dssp             T
T ss_pred             C
Confidence            4

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-36  Score=253.78  Aligned_cols=212  Identities=24%  Similarity=0.290  Sum_probs=165.4

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCce----EEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeecccc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQN----VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  131 (288)
                      ...++.+.+.+|+|.++.++.+.    +..+++.    ||+|.+... ........+.+|+.+++.++||||+++++++.
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   87 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGL----WIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICL   87 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEE----ECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred             CHhHceEEEEeeeCCCeEEEEEE----EcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence            34567788888888888877753    3445554    577777542 23345678899999999999999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEee
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD  207 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~d  207 (288)
                      ...       .++|++++.+ ++.+.+.   ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|
T Consensus        88 ~~~-------~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~D  160 (327)
T 3lzb_A           88 TST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITD  160 (327)
T ss_dssp             SSS-------EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECC
T ss_pred             cCC-------ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEcc
Confidence            654       3788899876 5666664   3488999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        208 FGLARTAGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       208 fg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+....
T Consensus       161 fG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  236 (327)
T 3lzb_A          161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE  236 (327)
T ss_dssp             TTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             CcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence            999986543222   223355778999999999999999999999999999999 999999988777665555443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.6e-36  Score=253.96  Aligned_cols=206  Identities=24%  Similarity=0.351  Sum_probs=169.3

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      .+....+.+.+.+|+|.++.++.+.-...+..+++.||+|++..  ........+.+|++++++++||||+++++++...
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS--CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            34456678888899988888877643333567899999999975  3445567899999999999999999999998764


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      +.    ...++|||++++ +|.+.+..   .+++..+..++.|++.||++||+++|+||||||+||+++.++.+||+|||
T Consensus       115 ~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          115 GR----RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             -------CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             CC----CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence            41    234999999986 67776653   38999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        210 LARTAGTTFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       210 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      ++........    .....++..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            9987644321    2334567789999999998899999999999999999999998864

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.7e-36  Score=249.96  Aligned_cols=198  Identities=25%  Similarity=0.299  Sum_probs=164.5

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc-
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS-  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-  135 (288)
                      ..++.+.+.+|+|.++.++.+    .+..+++.||+|+++...      ..+.+|++++++++||||+++++++..... 
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   79 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKA----KHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD   79 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEE----EETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred             ccccceeeeeccCCceEEEEE----EEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence            345677777888777777765    455689999999997532      356789999999999999999998854110 


Q ss_pred             ---------ccccccEEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC
Q psy11580        136 ---------LEEFQDVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC  201 (288)
Q Consensus       136 ---------~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~  201 (288)
                               .......++||||+++ +|.+.+.    ..+++..+..++.||+.||+|||+++|+|+||||+||+++.++
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred             cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC
Confidence                     0123446999999997 6777664    2488999999999999999999999999999999999999999


Q ss_pred             cEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy11580        202 TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP  264 (288)
Q Consensus       202 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~  264 (288)
                      .++|+|||++.............+++.|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus       160 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence            999999999987765544555678999999999999999999999999999999999998874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-35  Score=243.97  Aligned_cols=213  Identities=23%  Similarity=0.315  Sum_probs=167.1

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +..++.+|+|.++.++.+.-. .+..++..||+|++... ........+.+|+++++.++||||+++++++...+..   
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~-~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~---   97 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYI-DQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL---   97 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEE-CSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC---
T ss_pred             EccCceeccCCCceEEEEEEe-cCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC---
Confidence            345577888777777765210 01233447999999753 3445567889999999999999999999999765432   


Q ss_pred             ccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        140 QDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       140 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                        .++|||++.+ ++.+.+.   ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus        98 --~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           98 --PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             --CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             --cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence              3899999865 6766665   348899999999999999999999999999999999999999999999999997543


Q ss_pred             CC-----cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        216 TT-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       216 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ..     .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+..+....+....
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~  245 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR  245 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC
Confidence            32     12234467889999999999999999999999999999999 556666666666655555443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=248.09  Aligned_cols=197  Identities=28%  Similarity=0.424  Sum_probs=158.1

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      ......+|+|.++.++.+    .+..++..||+|++...  .......+.+|+.+++.++||||+++++++...+..   
T Consensus        24 ~~~~~~lg~G~~g~Vy~~----~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---   94 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAG----RDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI---   94 (295)
T ss_dssp             TSSBCEEEECSSSEEEEE----EETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE---
T ss_pred             CCCcEEEeecCcEEEEEE----EECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE---
Confidence            334446777766666654    45678899999999753  334457788999999999999999999999776654   


Q ss_pred             ccEEEEEecccc-cHHHHHhh-----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc-CCcEEEeeccccc
Q psy11580        140 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLAR  212 (288)
Q Consensus       140 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~-~~~~kl~dfg~~~  212 (288)
                         ++|||++++ ++.+.+..     ..++..+..++.|++.||+|||+++++|+||+|+||+++. ++.++|+|||++.
T Consensus        95 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A           95 ---KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             ---EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             ---EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccc
Confidence               999999975 56555542     3568889999999999999999999999999999999987 8999999999998


Q ss_pred             ccCCCc-ccCCcccccccCchHhHhcCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        213 TAGTTF-MMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       213 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      ...... ......+++.|+|||++.+..  ++.++||||||+++|+|++|+.||.+.+.
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  230 (295)
T 2clq_A          172 RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE  230 (295)
T ss_dssp             ESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred             ccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence            654422 234457899999999997743  78999999999999999999999976543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.6e-37  Score=261.13  Aligned_cols=213  Identities=20%  Similarity=0.308  Sum_probs=172.6

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchh---------------hHHHHHHHHHHHHHCCCC
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVT---------------HAKRAYREFKLMKLVNHK  121 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~e~~~l~~l~h~  121 (288)
                      ..++.+.+.+|+|.++.++.+.    +  +++.||+|++........               ....+.+|++++++++||
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~----~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  103 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCE----K--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE  103 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEE----E--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred             cCceEEEEEEcCCCCeEEEEEE----c--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence            3566777788888777777752    2  899999999974211111               117889999999999999


Q ss_pred             CcceeeccccCCCcccccccEEEEEecccc-cHHHH------Hh----hhCCHHHHHHHHHHHHHHHHHHHH-CCCEeec
Q psy11580        122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQV------IQ----MDLDHERMSYLLYQMLCGIKHLHS-AGIIHRD  189 (288)
Q Consensus       122 ~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~------~~----~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~d  189 (288)
                      ||+++++++...+..      ++||||+++ +|.+.      +.    ..+++..+..++.|++.||+|||+ +|++|+|
T Consensus       104 ~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d  177 (348)
T 2pml_X          104 YCLTCEGIITNYDEV------YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD  177 (348)
T ss_dssp             TBCCCSEEEESSSEE------EEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCC
T ss_pred             CcceEEEEEeeCCeE------EEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecC
Confidence            999999999877654      999999987 55544      32    348999999999999999999999 9999999


Q ss_pred             CCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhHhcC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        190 LKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM-GYKE-NVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       190 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      |+|+||+++.++.++|+|||.+...... ......+++.|+|||++.+. .++. ++||||||+++|+|++|..||.+.+
T Consensus       178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          178 VKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999999875443 33456789999999999887 5666 9999999999999999999999877


Q ss_pred             c-hhHHHHHHHHhCCC
Q psy11580        268 H-IDQWNKIIGKMREA  282 (288)
Q Consensus       268 ~-~~~~~~i~~~~~~~  282 (288)
                      . .+....+.......
T Consensus       257 ~~~~~~~~i~~~~~~~  272 (348)
T 2pml_X          257 SLVELFNNIRTKNIEY  272 (348)
T ss_dssp             CSHHHHHHHTSCCCCC
T ss_pred             cHHHHHHHHhccCcCC
Confidence            6 56666665443333

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.1e-35  Score=261.85  Aligned_cols=198  Identities=23%  Similarity=0.321  Sum_probs=161.4

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCC-cceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN-IIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~  135 (288)
                      ..++.+.+.||+|.++.++++    .+..+++.||||++.....    ..++..|+++++.++|++ +..+..++...+ 
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a----~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~-   76 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLG----TNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGD-   76 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEE----EETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETT-
T ss_pred             CCcEEEEEEEeeCCCEEEEEE----EECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCC-
Confidence            345677788888877777765    4567899999999875322    235788999999998754 444544444333 


Q ss_pred             ccccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE---ccCCcEEEeecc
Q psy11580        136 LEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFG  209 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~---~~~~~~kl~dfg  209 (288)
                           ..++||||+.++|.+++.   ..+++..++.++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||
T Consensus        77 -----~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG  151 (483)
T 3sv0_A           77 -----YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (483)
T ss_dssp             -----EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             -----EEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCC
Confidence                 349999999888888775   459999999999999999999999999999999999999   588999999999


Q ss_pred             cccccCCCcc--------cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        210 LARTAGTTFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       210 ~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      ++........        .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+...
T Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~  218 (483)
T 3sv0_A          152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (483)
T ss_dssp             TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence            9976543221        1256789999999999999999999999999999999999999988544

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.5e-36  Score=262.92  Aligned_cols=192  Identities=29%  Similarity=0.413  Sum_probs=148.6

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      ...+.+|+|.++.++..     ...+|+.||||++..     .....+.+|+++++++ +||||+++++++...+..   
T Consensus        18 ~~~~~LG~G~~g~V~~~-----~~~~g~~vAvK~~~~-----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~---   84 (434)
T 2rio_A           18 VSEKILGYGSSGTVVFQ-----GSFQGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL---   84 (434)
T ss_dssp             EEEEEEEECSTTCEEEE-----EESSSSEEEEEEEEG-----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE---
T ss_pred             eccCeEeeCCCeEEEEE-----EEECCeEEEEEEEcH-----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE---
Confidence            44566677666655431     256789999999964     2245678899999886 899999999999776654   


Q ss_pred             ccEEEEEecccccHHHHHhhhC---------CHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC----------
Q psy11580        140 QDVYLVMELMDANLCQVIQMDL---------DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD----------  200 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~~~~---------~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~----------  200 (288)
                         ++|||+++++|.+.+....         ++..+..++.||+.||+|||+++|+||||||+||+++.+          
T Consensus        85 ---~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           85 ---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             ---EEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             ---EEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence               9999999998888876321         222456799999999999999999999999999999754          


Q ss_pred             ---CcEEEeecccccccCCCcc-----cCCcccccccCchHhHhc-------CCCCchhhHHHHHHHHHHHHh-CCCCCC
Q psy11580        201 ---CTLKILDFGLARTAGTTFM-----MTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIR-GGVLFP  264 (288)
Q Consensus       201 ---~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slg~il~~l~~-g~~p~~  264 (288)
                         +.+||+|||++........     .....||+.|+|||++.+       ..++.++||||||+++|+|++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               4799999999987654321     234578999999999976       568899999999999999998 999997


Q ss_pred             CCCc
Q psy11580        265 GTDH  268 (288)
Q Consensus       265 ~~~~  268 (288)
                      +...
T Consensus       242 ~~~~  245 (434)
T 2rio_A          242 DKYS  245 (434)
T ss_dssp             STTT
T ss_pred             Cchh
Confidence            6543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.3e-35  Score=268.14  Aligned_cols=217  Identities=24%  Similarity=0.358  Sum_probs=173.4

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.+|+|.++.++.|.-.. ....+..||+|+++.. ........+.+|+.++++++||||+++++++...
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  463 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMS-PENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN  463 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECC-SSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEec-CCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4455667788888888888887763110 1234568999998753 2344557789999999999999999999998543


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                       .      .++||||+++ +|.+.+..   .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus       464 -~------~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          464 -P------VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             -S------CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             -c------eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecC
Confidence             2      3999999985 56666642   48899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        210 LARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       210 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      ++........  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+.+..+....
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~  609 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE  609 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Confidence            9987644322  223456788999999999999999999999999999997 999999988888877776654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.6e-35  Score=246.92  Aligned_cols=201  Identities=25%  Similarity=0.344  Sum_probs=162.7

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC--CCCcceeeccccC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN--HKNIIGLLNAFTP  132 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~  132 (288)
                      +....+.+.+.+|+|.++.++.+.    + .+++.||+|++............+.+|++++++++  |+||+++++++..
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~----~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVL----N-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEE----C-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eccceEEEEEEecCCCCEEEEEEE----c-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            344567777888888777777652    2 45889999999865556666788999999999997  5999999999987


Q ss_pred             CCcccccccEEEEEecccccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        133 QKSLEEFQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      .+..      ++|||+.+++|.+.+.  ..+++..+..++.|+++||+|||+++|+||||||+||+++ ++.+||+|||+
T Consensus       100 ~~~~------~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~  172 (313)
T 3cek_A          100 DQYI------YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGI  172 (313)
T ss_dssp             SSEE------EEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred             CCEE------EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccc
Confidence            7654      9999988788888876  3488999999999999999999999999999999999996 58999999999


Q ss_pred             ccccCCCc---ccCCcccccccCchHhHhc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        211 ARTAGTTF---MMTPYVVTRYYRAPEVILG-----------MGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       211 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      +.......   ......+++.|+|||++.+           ..++.++||||||+++|+|++|..||.+..
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence            98654322   1234578999999999976           467889999999999999999999998754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.9e-35  Score=267.20  Aligned_cols=205  Identities=27%  Similarity=0.348  Sum_probs=172.2

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.+|+|.++.++.+    .+..+|+.||||+++.. ........+.+|++++++++||||+++++++.......
T Consensus        14 grY~i~~~LG~G~fG~Vyla----~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRW----IHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCC----CCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred             CCeEEEEEEeeCCCeEEEEE----EECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence            45678888999888888776    35678999999999754 34455677899999999999999999999987644333


Q ss_pred             ccccEEEEEecccc-cHHHHHhh-----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCc---EEEeec
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDF  208 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~---~kl~df  208 (288)
                      .....++||||+++ +|.+.+..     .+++..++.++.|++.||+|||+.||+||||||+||+++.++.   ++|+||
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence            34556999999976 66666653     4889999999999999999999999999999999999997765   899999


Q ss_pred             ccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        209 GLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       209 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      |++.............+++.|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus       169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~  227 (676)
T 3qa8_A          169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW  227 (676)
T ss_dssp             CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc
Confidence            99988766655566789999999999999999999999999999999999999997653

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5e-36  Score=263.16  Aligned_cols=197  Identities=26%  Similarity=0.321  Sum_probs=153.9

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQ  133 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  133 (288)
                      +....+.+.+.+|+|.++.+..     ....+++.||||++....     ...+.+|+++|+.+ +||||+++++++...
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~-----~~~~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~   90 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVY-----RGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKDR   90 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEE-----EEESSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred             EccEEEecCCeeecCcCEEEEE-----EEEeCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            3445677778888887776432     225678999999997532     22356899999999 799999999998776


Q ss_pred             CcccccccEEEEEecccccHHHHHhhh---CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc-----CCcEEE
Q psy11580        134 KSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-----DCTLKI  205 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~-----~~~~kl  205 (288)
                      ...      ++|||++++++.+.+...   .....+..++.||+.||+|||+++|+||||||+||+++.     ...+||
T Consensus        91 ~~~------~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL  164 (432)
T 3p23_A           91 QFQ------YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI  164 (432)
T ss_dssp             TEE------EEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred             CEE------EEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEE
Confidence            654      999999999998888632   445567889999999999999999999999999999953     235889


Q ss_pred             eecccccccCCC----cccCCcccccccCchHhHhc---CCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy11580        206 LDFGLARTAGTT----FMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIR-GGVLFPGTD  267 (288)
Q Consensus       206 ~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slg~il~~l~~-g~~p~~~~~  267 (288)
                      +|||++......    .......||+.|+|||++.+   ..++.++||||||+++|+|++ |..||....
T Consensus       165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~  234 (432)
T 3p23_A          165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL  234 (432)
T ss_dssp             CCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred             ecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence            999999865432    22344578999999999974   567889999999999999999 999996543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=251.18  Aligned_cols=204  Identities=23%  Similarity=0.379  Sum_probs=164.1

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      .+...++.+.+.+|+|.++.++.+    .+..+++.||+|++..  ........+.+|+++++.++||||+++++++...
T Consensus        25 ~i~~~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (317)
T 2buj_A           25 IIDNKHYLFIQKLGEGGFSYVDLV----EGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRE   98 (317)
T ss_dssp             EETTEEEEEEEEEEC--CEEEEEE----EETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred             EECCeEEEEEEEecCCCCeEEEEE----EecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence            345567788888888888877765    4567899999999865  3445567889999999999999999999998632


Q ss_pred             CcccccccEEEEEecccc-cHHHHHhh------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEe
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL  206 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~  206 (288)
                      .  ......++||||+++ +|.+.+..      .+++..++.++.||+.||+|||+++|+||||||+||+++.++.++|+
T Consensus        99 ~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~  176 (317)
T 2buj_A           99 R--GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLM  176 (317)
T ss_dssp             E--TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             c--CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEE
Confidence            2  112346999999987 66665542      38999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCcc----------cCCcccccccCchHhHhcCC---CCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        207 DFGLARTAGTTFM----------MTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       207 dfg~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      |||++........          .....+++.|+|||++.+..   ++.++||||||+++|+|++|+.||..
T Consensus       177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            9999876532111          11234688999999987654   68899999999999999999999954

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.8e-35  Score=245.26  Aligned_cols=194  Identities=27%  Similarity=0.436  Sum_probs=154.3

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc--
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS--  135 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--  135 (288)
                      .++.+.+.+|+|.++.++.+    .+..+++.||+|++..   .......+.+|+++++.++||||+++++++.....  
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKA----RNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred             ccchhhheeccCCcEEEEEE----EEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence            45677788888887777765    4567899999999963   34556788999999999999999999998865321  


Q ss_pred             -----ccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEe
Q psy11580        136 -----LEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL  206 (288)
Q Consensus       136 -----~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~  206 (288)
                           .......++||||+++ +|.+.+.   ..+++..++.++.|++.||+|||+++++|+||||+||+++.++.++|+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence                 1223557999999986 6777665   247788999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCC---------------cccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHh
Q psy11580        207 DFGLARTAGTT---------------FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIR  258 (288)
Q Consensus       207 dfg~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~  258 (288)
                      |||++......               .......+++.|+|||++.+. .++.++||||||+++|+|++
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            99999765421               122345688999999999875 68999999999999999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-35  Score=246.59  Aligned_cols=201  Identities=28%  Similarity=0.404  Sum_probs=157.4

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcch----hhHHHHHHHHHHHHHC----CCCCcce
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV----THAKRAYREFKLMKLV----NHKNIIG  125 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~~i~~  125 (288)
                      +....++.+.+.+|+|.++.++.+    .+..+++.||+|++.......    .....+.+|+.+++++    +||||++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~  102 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAG----HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR  102 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEE----ECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEE----EEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence            334456788888888888777765    456789999999997532211    2233456799999999    8999999


Q ss_pred             eeccccCCCcccccccEEEEEec-cc-ccHHHHHhh--hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEc-cC
Q psy11580        126 LLNAFTPQKSLEEFQDVYLVMEL-MD-ANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SD  200 (288)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~lv~e~-~~-~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~-~~  200 (288)
                      +++++...+..      ++|+|+ +. +++.+.+..  .+++..+..++.||+.||+|||+++|+||||||+||+++ .+
T Consensus       103 ~~~~~~~~~~~------~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  176 (312)
T 2iwi_A          103 LLDWFETQEGF------MLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR  176 (312)
T ss_dssp             EEEEC-----C------EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTT
T ss_pred             EEEEEecCCeE------EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCC
Confidence            99999877655      999998 55 467776653  489999999999999999999999999999999999999 78


Q ss_pred             CcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       201 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      +.++|+|||++........ ....+++.|+|||++.+..+. .++||||||+++|+|++|+.||.+
T Consensus       177 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          177 GCAKLIDFGSGALLHDEPY-TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             TEEEECCCSSCEECCSSCB-CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             CeEEEEEcchhhhcccCcc-cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            9999999999987655432 445789999999999887664 589999999999999999999965

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.6e-35  Score=251.34  Aligned_cols=200  Identities=27%  Similarity=0.401  Sum_probs=164.2

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHH--CCCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKL--VNHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~  131 (288)
                      ......+.+.+.+|+|.++.++.+      ..+++.||||++..     .....+.+|.++++.  ++||||+++++++.
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~------~~~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRG------KWRGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEE------EETTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             ccccccEEEEeeecCCCCcEEEEE------EEcCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            334567788889999888888876      23689999999964     334667889999988  68999999999998


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh-hhCCHHHHHHHHHHHHHHHHHHH--------HCCCEeecCCCCCEEEccCC
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLH--------SAGIIHRDLKPSNIVVKSDC  201 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH--------~~~ivH~dl~~~nil~~~~~  201 (288)
                      ....  .....++||||+++ +|.+.+. ..+++..+..++.|++.||+|||        +.+|+||||||+||+++.++
T Consensus       107 ~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          107 KDNG--TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCCS--SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred             ccCC--ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence            7651  12345999999987 6777665 45899999999999999999999        89999999999999999999


Q ss_pred             cEEEeecccccccCCCc-----ccCCcccccccCchHhHhcCC------CCchhhHHHHHHHHHHHHhC----------C
Q psy11580        202 TLKILDFGLARTAGTTF-----MMTPYVVTRYYRAPEVILGMG------YKENVDIWSVGCIMGEMIRG----------G  260 (288)
Q Consensus       202 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~------~~~~~Di~slg~il~~l~~g----------~  260 (288)
                      .+||+|||++.......     ......+++.|+|||++.+..      ++.++||||||+++|+|++|          .
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            99999999997654332     224457899999999998752      34689999999999999999          7


Q ss_pred             CCCCCC
Q psy11580        261 VLFPGT  266 (288)
Q Consensus       261 ~p~~~~  266 (288)
                      .||.+.
T Consensus       265 ~p~~~~  270 (342)
T 1b6c_B          265 LPYYDL  270 (342)
T ss_dssp             CTTTTT
T ss_pred             cCcccc
Confidence            898764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-35  Score=248.75  Aligned_cols=200  Identities=29%  Similarity=0.432  Sum_probs=158.2

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC--CCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV--NHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~  131 (288)
                      .....++.+.+.+|+|.++.++.+      ..+++.||||++..     ........|.+++..+  +||||+++++++.
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~------~~~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~  101 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMG------KWRGEKVAVKVFFT-----TEEASWFRETEIYQTVLMRHENILGFIAADI  101 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEE------EETTEEEEEEEEEG-----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             cccccceEEEeEeecCCCeEEEEE------EECCceEEEEEEec-----cccchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence            334567788888888888888876      33589999999964     2234445566666555  8999999999987


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHC--------CCEeecCCCCCEEEccCC
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDC  201 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--------~ivH~dl~~~nil~~~~~  201 (288)
                      ...  ......++||||+++ +|.+.+. ..+++..+..++.|++.||+|||++        +|+||||||+||+++.++
T Consensus       102 ~~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          102 KGT--GSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             ESC--GGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             cCC--CCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence            653  122456999999987 6777665 4589999999999999999999998        999999999999999999


Q ss_pred             cEEEeecccccccCCCcc-----cCCcccccccCchHhHhcCCCCch------hhHHHHHHHHHHHHhC----------C
Q psy11580        202 TLKILDFGLARTAGTTFM-----MTPYVVTRYYRAPEVILGMGYKEN------VDIWSVGCIMGEMIRG----------G  260 (288)
Q Consensus       202 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~------~Di~slg~il~~l~~g----------~  260 (288)
                      .+||+|||++........     .....+++.|+|||++.+...+..      +||||||+++|+|++|          +
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            999999999976543221     134578999999999988665554      9999999999999999          7


Q ss_pred             CCCCCC
Q psy11580        261 VLFPGT  266 (288)
Q Consensus       261 ~p~~~~  266 (288)
                      .||...
T Consensus       260 ~p~~~~  265 (337)
T 3mdy_A          260 LPYHDL  265 (337)
T ss_dssp             CTTTTT
T ss_pred             ccHhhh
Confidence            788653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9.5e-36  Score=253.46  Aligned_cols=199  Identities=26%  Similarity=0.315  Sum_probs=154.2

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHH--HHHCCCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKL--MKLVNHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~  131 (288)
                      .+...++.+.+.+|+|.++.++.|      ..+++.||||+++..     ....+..|.++  ++.++||||+++++.+.
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~------~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~   77 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKG------SLDERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDE   77 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEE------EETTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             CcChHHhheeeecccCCCeEEEEE------EECCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheeccc
Confidence            345567888999999999988887      347899999999742     22334444444  45589999999997543


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHC---------CCEeecCCCCCEEEccC
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSA---------GIIHRDLKPSNIVVKSD  200 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---------~ivH~dl~~~nil~~~~  200 (288)
                      .... .....+++||||+++ +|.+.+. ...++..+..++.||+.||+|||+.         +|+||||||+||+++.+
T Consensus        78 ~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~  156 (336)
T 3g2f_A           78 RVTA-DGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND  156 (336)
T ss_dssp             EECT-TSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred             cccc-CCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence            2111 112345899999976 6766665 4478899999999999999999999         99999999999999999


Q ss_pred             CcEEEeecccccccCCC---------cccCCcccccccCchHhHhc-------CCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy11580        201 CTLKILDFGLARTAGTT---------FMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIRGGVLFP  264 (288)
Q Consensus       201 ~~~kl~dfg~~~~~~~~---------~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slg~il~~l~~g~~p~~  264 (288)
                      +.+||+|||++......         .......+|+.|+|||++.+       ..++.++||||||+++|+|++|..||.
T Consensus       157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            99999999999765432         11234578999999999987       345678999999999999999966653

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.8e-35  Score=249.06  Aligned_cols=199  Identities=27%  Similarity=0.440  Sum_probs=163.7

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcch----hhHHHHHHHHHHHHHCC--CCCcceeecc
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV----THAKRAYREFKLMKLVN--HKNIIGLLNA  129 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~i~~~~~~  129 (288)
                      ...++.+.+.+|+|.++.++.+    .+..+++.||||++.......    .....+.+|+.++++++  |+||++++++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSG----IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEE----EETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCceEEEEEEeeCCCeEEEEE----EECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            3455677777888777777664    456789999999997532211    12345678999999996  5999999999


Q ss_pred             ccCCCcccccccEEEEEeccc--ccHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEc-cCCcEE
Q psy11580        130 FTPQKSLEEFQDVYLVMELMD--ANLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLK  204 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~-~~~~~k  204 (288)
                      +...+..      ++|+|++.  +++.+.+.  ..+++..++.++.|++.||+|||+++|+||||||+||+++ .++.+|
T Consensus       117 ~~~~~~~------~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          117 FERPDSF------VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             EECSSEE------EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCcE------EEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEE
Confidence            9877654      99999997  56777765  3589999999999999999999999999999999999999 778999


Q ss_pred             EeecccccccCCCcccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        205 ILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       205 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      |+|||++........ ....+++.|+|||++.+..+ +.++||||||+++|+|++|+.||.+
T Consensus       191 L~Dfg~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  251 (320)
T 3a99_A          191 LIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH  251 (320)
T ss_dssp             ECCCTTCEECCSSCB-CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             EeeCccccccccccc-cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence            999999987654332 34578999999999988766 6889999999999999999999975

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=8.1e-36  Score=260.72  Aligned_cols=204  Identities=16%  Similarity=0.146  Sum_probs=154.0

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCC-CcchhhHHHHHHHHHHHHHCCC-CCcceeecc-------
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNH-KNIIGLLNA-------  129 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~-------  129 (288)
                      .+..++.||+|.++.++.+    .+..+|+.||||+++.. .......+.+.+|+.+++.++| +|...+..+       
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a----~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEA----TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             eEEEecccccCCCEEEEEE----EecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            4566777777777777764    46778999999999842 2233346778899999999987 333222221       


Q ss_pred             --------------ccCCCcccccccEEEEEecccccHHHHHh---------hhCCHHHHHHHHHHHHHHHHHHHHCCCE
Q psy11580        130 --------------FTPQKSLEEFQDVYLVMELMDANLCQVIQ---------MDLDHERMSYLLYQMLCGIKHLHSAGII  186 (288)
Q Consensus       130 --------------~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---------~~~~~~~~~~~~~~i~~~l~~LH~~~iv  186 (288)
                                    +..... .....++++|+.+.+++.+.+.         ..+++..+..++.||+.||+|||+++|+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii  233 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERD-MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  233 (413)
T ss_dssp             EEEECCC----------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhcccCCCCccccccCCCcc-ccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence                          111100 0123468999999998887773         3477888999999999999999999999


Q ss_pred             eecCCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhH----------hcCCCCchhhHHHHHHHHHHH
Q psy11580        187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVI----------LGMGYKENVDIWSVGCIMGEM  256 (288)
Q Consensus       187 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~Di~slg~il~~l  256 (288)
                      ||||||+|||++.++.+||+|||++...+..  .....| +.|+|||++          .+..++.++||||||+++|+|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            9999999999999999999999998876544  344567 999999999          445578899999999999999


Q ss_pred             HhCCCCCCCCCchh
Q psy11580        257 IRGGVLFPGTDHID  270 (288)
Q Consensus       257 ~~g~~p~~~~~~~~  270 (288)
                      ++|+.||.+.+..+
T Consensus       311 ltg~~Pf~~~~~~~  324 (413)
T 3dzo_A          311 WCADLPNTDDAALG  324 (413)
T ss_dssp             HHSSCCCCTTGGGS
T ss_pred             HHCCCCCCCcchhh
Confidence            99999998765443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8e-35  Score=247.86  Aligned_cols=199  Identities=25%  Similarity=0.371  Sum_probs=136.5

Q ss_pred             cccc-ccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPI-SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~-~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+ .+.+|+|.++.++.+    .+..+++.||||++...   .   ....+....++.++||||+++++++....  .
T Consensus        29 ~y~i~~~~lG~G~~g~V~~~----~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~--~   96 (336)
T 3fhr_A           29 DYQLSKQVLGLGVNGKVLEC----FHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENMH--H   96 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEE--T
T ss_pred             eeEecceeeeeCCCeEEEEE----EECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhcc--C
Confidence            3344 445788777777664    46678999999999742   1   22223334567779999999999986522  1


Q ss_pred             ccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc---CCcEEEeecc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFG  209 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~---~~~~kl~dfg  209 (288)
                      .....++||||+++ +|.+.+..    .+++..++.++.||+.||+|||++||+||||||+||+++.   ++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            12346999999987 67777653    4899999999999999999999999999999999999986   4559999999


Q ss_pred             cccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        210 LARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      ++....... .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+...
T Consensus       177 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  236 (336)
T 3fhr_A          177 FAKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA  236 (336)
T ss_dssp             TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cceeccccc-cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh
Confidence            998665432 234578999999999988888999999999999999999999997765443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-34  Score=268.19  Aligned_cols=199  Identities=22%  Similarity=0.273  Sum_probs=156.5

Q ss_pred             cccccccCCccccccccCcc---ce---eccC-CCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         60 LPISHQMGKKRHNTSHLGAG---AA---YDTA-TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g---~~---~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      +..++.+..+|.....+|.|   .|   .+.. +++.||||++... ........+.+|++++++++||||+++++++..
T Consensus        72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  150 (681)
T 2pzi_A           72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH  150 (681)
T ss_dssp             SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence            34455555555555544444   23   3333 6899999999753 234556678899999999999999999999986


Q ss_pred             CCcccccccEEEEEeccccc-HHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        133 QKSLEEFQDVYLVMELMDAN-LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      .+.. .....|+||||++++ |.+.+...+++..++.++.||+.||+|||++||+||||||+||+++.+ .+||+|||++
T Consensus       151 ~~~~-~~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          151 TDRH-GDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             ECTT-SCEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             cCCC-CCceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccc
Confidence            5531 111249999999864 555555679999999999999999999999999999999999999875 8999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG  265 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  265 (288)
                      ......   ....||+.|+|||++.+.. +.++||||||+++|+|++|..||.+
T Consensus       229 ~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          229 SRINSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             EETTCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             hhcccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence            876544   4457899999999998754 8999999999999999999999865

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.5e-34  Score=236.47  Aligned_cols=174  Identities=13%  Similarity=0.083  Sum_probs=143.6

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .+.+.+.+|+|.++.++.+    .+..+++.||||++..... .......+.+|+.+++.++||||+++++++...+.. 
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~-  106 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQA----LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG-  106 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEE----EETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE-
T ss_pred             cEEEEEEEcccCCeEEEEE----EecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE-
Confidence            3455566666666665554    4667899999999986433 244557889999999999999999999999876654 


Q ss_pred             ccccEEEEEecccc-cHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                           ++||||+++ +|.+.+.......++..++.|++.||+|||++||+||||||+||+++.++.+||++++.      
T Consensus       107 -----~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~------  175 (286)
T 3uqc_A          107 -----LVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT------  175 (286)
T ss_dssp             -----EEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC------
T ss_pred             -----EEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc------
Confidence                 999999985 67777766677778999999999999999999999999999999999999999985542      


Q ss_pred             CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       217 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                                   ++       .++.++||||||+++|+|++|+.||.+.+.
T Consensus       176 -------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~  207 (286)
T 3uqc_A          176 -------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV  207 (286)
T ss_dssp             -------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred             -------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                         22       368899999999999999999999987654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.2e-35  Score=251.32  Aligned_cols=199  Identities=15%  Similarity=0.156  Sum_probs=155.0

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc------chhhHHHHHHHHHHHHHCC---------C
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ------NVTHAKRAYREFKLMKLVN---------H  120 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h  120 (288)
                      ...++.+.+.+|+|.++.++.+.      .+++.||||+++....      .......+.+|+.+++.++         |
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h   91 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTI------ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT   91 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEE------ETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred             ccccchheeeecccCceEEEEEE------eCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence            34566788899999988888872      3789999999986422      2233477889999999886         4


Q ss_pred             -----------------CCcceeeccccCCCc-------ccccccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHH
Q psy11580        121 -----------------KNIIGLLNAFTPQKS-------LEEFQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQML  174 (288)
Q Consensus       121 -----------------~~i~~~~~~~~~~~~-------~~~~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~  174 (288)
                                       |||+++++++.....       .......++||||++++ +++.+. ..+++..++.++.||+
T Consensus        92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLT  171 (336)
T ss_dssp             CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHH
T ss_pred             CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHH
Confidence                             555555555543100       00124569999999764 555443 5589999999999999


Q ss_pred             HHHHHHH-HCCCEeecCCCCCEEEccCC--------------------cEEEeecccccccCCCcccCCcccccccCchH
Q psy11580        175 CGIKHLH-SAGIIHRDLKPSNIVVKSDC--------------------TLKILDFGLARTAGTTFMMTPYVVTRYYRAPE  233 (288)
Q Consensus       175 ~~l~~LH-~~~ivH~dl~~~nil~~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE  233 (288)
                      .||+||| +++|+||||||+|||++.++                    .+||+|||+++.....    ...||+.|+|||
T Consensus       172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE  247 (336)
T 2vuw_A          172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSG
T ss_pred             HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChh
Confidence            9999999 99999999999999999987                    8999999999876543    347899999999


Q ss_pred             hHhcCCCCchhhHHHHHHH-HHHHHhCCCCCCC
Q psy11580        234 VILGMGYKENVDIWSVGCI-MGEMIRGGVLFPG  265 (288)
Q Consensus       234 ~~~~~~~~~~~Di~slg~i-l~~l~~g~~p~~~  265 (288)
                      ++.+.. +.++||||++++ .++++.|..||.+
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence            999876 899999998776 6778889999854

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2e-33  Score=253.90  Aligned_cols=169  Identities=17%  Similarity=0.142  Sum_probs=123.1

Q ss_pred             eeccCCCceEEEEeccCCCc--------chhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcccccccEEEEEecccc
Q psy11580         81 AYDTATQQNVAIKKLSRPFQ--------NVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA  151 (288)
Q Consensus        81 ~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~  151 (288)
                      +.+...|+.||+|++.+...        .....+++.+|+++|+++ .|+||+++++++.+++..      ||||||++|
T Consensus       253 ~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~------yLVMEyv~G  326 (569)
T 4azs_A          253 SRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG------WLVMEKLPG  326 (569)
T ss_dssp             CEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE------EEEEECCCS
T ss_pred             cccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE------EEEEecCCC
Confidence            45566799999999976421        223346789999999999 799999999999887765      999999998


Q ss_pred             c-HHHHHhhh--CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC-cccCCccccc
Q psy11580        152 N-LCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT-FMMTPYVVTR  227 (288)
Q Consensus       152 ~-l~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~  227 (288)
                      + |.+.+...  ++.   .+|+.||++||+|+|++|||||||||+|||++.+|.+||+|||+++..... ......+||+
T Consensus       327 ~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp  403 (569)
T 4azs_A          327 RLLSDMLAAGEEIDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSF  403 (569)
T ss_dssp             EEHHHHHHTTCCCCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHH
T ss_pred             CcHHHHHHhCCCCCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceech
Confidence            5 66665532  443   358999999999999999999999999999999999999999999866443 2345568999


Q ss_pred             ccCchHhHhcCCCCchhhHHHHHHHHHHHHhC
Q psy11580        228 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRG  259 (288)
Q Consensus       228 ~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g  259 (288)
                      .|+|||++.+. +..++|+||+|++++++.++
T Consensus       404 ~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          404 FVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             HHHHHHHC------------------CCCCTT
T ss_pred             hhccHHHhCCC-CCCcccccccccchhhhccc
Confidence            99999999874 56789999999987766544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=1.6e-31  Score=223.81  Aligned_cols=170  Identities=27%  Similarity=0.419  Sum_probs=136.9

Q ss_pred             cccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHH-HHCCCCCcceeeccccCCCcccccccE
Q psy11580         64 HQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLNAFTPQKSLEEFQDV  142 (288)
Q Consensus        64 ~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~~~~~~  142 (288)
                      +.+|+|.++.++.+    .+..+++.||+|+++.       ...+.+|++++ +..+||||+++++++....  ......
T Consensus        24 ~~lg~G~~g~V~~~----~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~--~~~~~~   90 (299)
T 3m2w_A           24 QVLGLGINGKVLQI----FNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY--AGRKCL   90 (299)
T ss_dssp             EEEEEETTEEEEEE----EETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE--TTEEEE
T ss_pred             cccccCCCeEEEEE----EEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc--CCCceE
Confidence            55666666666553    4667899999999964       24566888888 5569999999999986511  112346


Q ss_pred             EEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc---CCcEEEeeccccccc
Q psy11580        143 YLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTA  214 (288)
Q Consensus       143 ~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~---~~~~kl~dfg~~~~~  214 (288)
                      ++||||+++ +|.+.+..    .+++..+..++.|++.||+|||+++|+||||||+||+++.   ++.++|+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  170 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  170 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence            999999986 67777653    4899999999999999999999999999999999999998   788999999988654


Q ss_pred             CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD  267 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  267 (288)
                      ..                     ..++.++||||||+++|+|++|..||.+.+
T Consensus       171 ~~---------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~  202 (299)
T 3m2w_A          171 TG---------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNH  202 (299)
T ss_dssp             TT---------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred             cc---------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            32                     346789999999999999999999997643

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=7.5e-27  Score=209.91  Aligned_cols=182  Identities=20%  Similarity=0.218  Sum_probs=136.8

Q ss_pred             ccccCCccccccccCccceeccCCCceEEEEeccCCCcch------hhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         63 SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV------THAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        63 ~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .+.+|+|.++.++.+      ...+..+++|+........      ...+++.+|++++++++||||+++..++...+..
T Consensus       341 ~~~LG~G~fg~Vy~~------~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~  414 (540)
T 3en9_A          341 EHLIGKGAEADIKRD------SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK  414 (540)
T ss_dssp             -------CCEEEEEE------ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT
T ss_pred             CCEEeeCCCEEEEEE------EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc
Confidence            557788777777766      4567889999875422111      1234578999999999999999554444444443


Q ss_pred             cccccEEEEEecccc-cHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                            ++||||+++ +|.+.+..      +..++.|+++||+|||+++|+||||||+|||++.  .+||+|||+++...
T Consensus       415 ------~lVmE~~~ggsL~~~l~~------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          415 ------RIMMSYINGKLAKDVIED------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             ------EEEEECCCSEEHHHHSTT------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             ------EEEEECCCCCCHHHHHHH------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence                  999999985 56655544      6789999999999999999999999999999998  99999999998876


Q ss_pred             CCcc--------cCCcccccccCchHhHhc--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy11580        216 TTFM--------MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGGVLFP  264 (288)
Q Consensus       216 ~~~~--------~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~  264 (288)
                      ....        .....||+.|+|||++.+  ..|+...|+||...-..+-..++.+|.
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            5322        135678999999999987  567788999998888888777776664

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=4.1e-23  Score=170.98  Aligned_cols=142  Identities=20%  Similarity=0.281  Sum_probs=105.9

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcch----------------hhHHHHHHHHHHHHHCCCCCcce
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV----------------THAKRAYREFKLMKLVNHKNIIG  125 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~~i~~  125 (288)
                      +++.+|+|.++.++.+    .+ .+|+.||+|+++......                .....+.+|++++++++  | ++
T Consensus        94 ~~~~iG~G~~g~Vy~~----~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           94 IGKLMGEGKESAVFNC----YS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             EEEEEEECSSEEEEEE----EE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             ecCEeccCCCceEEEE----Ee-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            4466777666666654    23 678999999997432111                13566889999999999  5 66


Q ss_pred             eeccccCCCcccccccEEEEEecccc-cHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEE
Q psy11580        126 LLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  204 (288)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~k  204 (288)
                      +.+++.. +.      .++||||+++ +|.+ +    .......++.|++.||++||++||+||||||+||+++ ++.+|
T Consensus       166 v~~~~~~-~~------~~lvmE~~~g~~L~~-l----~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          166 VPKVYAW-EG------NAVLMELIDAKELYR-V----RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             SCCEEEE-ET------TEEEEECCCCEEGGG-C----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred             cCeEEec-cc------eEEEEEecCCCcHHH-c----chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence            6665532 22      3999999987 4544 2    2234567999999999999999999999999999999 99999


Q ss_pred             EeecccccccCCCcccCCcccccccCchHhHh
Q psy11580        205 ILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL  236 (288)
Q Consensus       205 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~  236 (288)
                      |+|||++..            +..+.|||.+.
T Consensus       233 l~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          233 IIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             ECCCTTCEE------------TTSTTHHHHHH
T ss_pred             EEECCCCeE------------CCCCCHHHHHH
Confidence            999998853            23468899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=1.9e-19  Score=147.24  Aligned_cols=137  Identities=15%  Similarity=0.202  Sum_probs=98.2

Q ss_pred             ccccccCCccccccccCccceeccCCCce--EEEEeccCCCcch----------------------hhHHHHHHHHHHHH
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQN--VAIKKLSRPFQNV----------------------THAKRAYREFKLMK  116 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~  116 (288)
                      .+...+|+|.++.++.+.    +..+|+.  ||||+++......                      .....+.+|+..|+
T Consensus        50 ~i~~~ig~G~~g~Vy~a~----~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  125 (258)
T 1zth_A           50 AMGGVISTGKEANVFYAD----GVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE  125 (258)
T ss_dssp             EEEEEEEECSSEEEEEEE----EEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeecceEEEEEEE----EcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence            355667777666666652    3357888  9999976432111                      11235788999999


Q ss_pred             HCCCCCc--ceeeccccCCCcccccccEEEEEecccc------cHHHHHhhhCCHHHHHHHHHHHHHHHHHHH-HCCCEe
Q psy11580        117 LVNHKNI--IGLLNAFTPQKSLEEFQDVYLVMELMDA------NLCQVIQMDLDHERMSYLLYQMLCGIKHLH-SAGIIH  187 (288)
Q Consensus       117 ~l~h~~i--~~~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~ivH  187 (288)
                      ++.|+++  ..+++.    +.      .++||||+++      .+.+.. ...++..+..++.|++.+|++|| +.||+|
T Consensus       126 ~l~~~~i~~p~~~~~----~~------~~lVmE~~g~~g~~~~~L~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~givH  194 (258)
T 1zth_A          126 RAKEAGVSVPQPYTY----MK------NVLLMEFIGEDELPAPTLVELG-RELKELDVEGIFNDVVENVKRLYQEAELVH  194 (258)
T ss_dssp             HHHHTTCCCCCEEEE----ET------TEEEEECCEETTEECCBHHHHG-GGGGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred             HHHhCCCCCCeEEEc----CC------CEEEEEecCCCCCccccHHHHh-hccChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence            9988754  334432    12      2999999953      344432 23345577889999999999999 999999


Q ss_pred             ecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        188 RDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       188 ~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      |||||.|||++.  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  8999999998765

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.66  E-value=5.6e-17  Score=138.14  Aligned_cols=146  Identities=16%  Similarity=0.133  Sum_probs=87.5

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcc------------hhhHHHHHHHHHHHHHCCCCCcceeec
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN------------VTHAKRAYREFKLMKLVNHKNIIGLLN  128 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~  128 (288)
                      .++..||.|.++.++.+.     ..+|+.||||+++....+            ......+..++++.....|+|+.+++.
T Consensus        98 ~I~~~IG~Gk~a~VY~a~-----d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~  172 (397)
T 4gyi_A           98 SVGSRIGVGKESDIMIVA-----DEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE  172 (397)
T ss_dssp             EEEEEEEECSSEEEEEEE-----CTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EecCEeeeCCceEEEEEE-----CCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence            455556665555555542     256899999998642111            001112222222222233444444433


Q ss_pred             cccCCCcccccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC-------
Q psy11580        129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-------  201 (288)
Q Consensus       129 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~-------  201 (288)
                      .......+-.....++||||++|..+..+   ........++.|++.+|.+||++|||||||||.|||++.++       
T Consensus       173 ~gv~vp~p~~~~~~~LVME~i~G~~L~~l---~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~  249 (397)
T 4gyi_A          173 EGFPVPEPIAQSRHTIVMSLVDALPMRQV---SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSS  249 (397)
T ss_dssp             TTCSCCCEEEEETTEEEEECCSCEEGGGC---CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTS
T ss_pred             cCCCCCeeeeccCceEEEEecCCccHhhh---cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccc
Confidence            32221111111112799999998543222   22234567889999999999999999999999999999876       


Q ss_pred             ---cEEEeeccccccc
Q psy11580        202 ---TLKILDFGLARTA  214 (288)
Q Consensus       202 ---~~kl~dfg~~~~~  214 (288)
                         .+.|+||+-+...
T Consensus       250 ~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          250 ITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEEEECCCTTCEET
T ss_pred             cccceEEEEeCCcccC
Confidence               3899999977543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.21  E-value=3.5e-11  Score=98.12  Aligned_cols=118  Identities=21%  Similarity=0.210  Sum_probs=87.4

Q ss_pred             CCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcccccccEEEEEecccccHHHHHhhhCCHH
Q psy11580         86 TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE  164 (288)
Q Consensus        86 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~  164 (288)
                      .++.+++|+......  .....+.+|+++++.+. +..+.++++++...+.      .++|||+++|..+....  .+..
T Consensus        36 ~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~------~~lv~e~i~G~~l~~~~--~~~~  105 (263)
T 3tm0_A           36 ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW------SNLLMSEADGVLCSEEY--EDEQ  105 (263)
T ss_dssp             SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE------EEEEEECCSSEEHHHHC--CTTT
T ss_pred             CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc------eEEEEEecCCeehhhcc--CCcc
Confidence            368999999864211  12345888999999994 6778889888865544      49999999986443321  1223


Q ss_pred             HHHHHHHHHHHHHHHHHH-----------------------------------------------------------CCC
Q psy11580        165 RMSYLLYQMLCGIKHLHS-----------------------------------------------------------AGI  185 (288)
Q Consensus       165 ~~~~~~~~i~~~l~~LH~-----------------------------------------------------------~~i  185 (288)
                      ....++.+++++|+.||+                                                           ..+
T Consensus       106 ~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l  185 (263)
T 3tm0_A          106 SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVF  185 (263)
T ss_dssp             CHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEE
T ss_pred             cHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceE
Confidence            345788999999999998                                                           348


Q ss_pred             EeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        186 IHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       186 vH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      +|+|+++.||++++++.+.|+||+.+..
T Consensus       186 ~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          186 SHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             ECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ECCCCCcCcEEEECCcEEEEEEchhccc
Confidence            9999999999998765567999997644

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.10  E-value=8.5e-11  Score=95.56  Aligned_cols=113  Identities=14%  Similarity=0.108  Sum_probs=82.1

Q ss_pred             CCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCC--cceeeccccCCCcccccccEEEEEecccccHHHHHhhhCC
Q psy11580         85 ATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKN--IIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD  162 (288)
Q Consensus        85 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~  162 (288)
                      .+|..+++|+....     ....+..|+.+++.+.+.+  +.+++++....+.      .++|||+++|..++ . ...+
T Consensus        42 ~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~------~~~v~e~i~G~~l~-~-~~~~  108 (264)
T 1nd4_A           42 QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR------DWLLLGEVPGQDLL-S-SHLA  108 (264)
T ss_dssp             TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC------EEEEEECCSSEETT-T-SCCC
T ss_pred             CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC------CEEEEEecCCcccC-c-CcCC
Confidence            35678999998642     2245778999999985434  5568887765543      49999999986543 1 1122


Q ss_pred             HHHHHHHHHHHHHHHHHHHHCC----------------------------------------------------------
Q psy11580        163 HERMSYLLYQMLCGIKHLHSAG----------------------------------------------------------  184 (288)
Q Consensus       163 ~~~~~~~~~~i~~~l~~LH~~~----------------------------------------------------------  184 (288)
                         ...++.+++..|+.||+..                                                          
T Consensus       109 ---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  185 (264)
T 1nd4_A          109 ---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLV  185 (264)
T ss_dssp             ---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEE
T ss_pred             ---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeE
Confidence               2356778888888888643                                                          


Q ss_pred             CEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        185 IIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       185 ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      ++|+|++|.||++++++.+.|+||+.+..
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhccc
Confidence            99999999999998776677999998654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.10  E-value=2.9e-10  Score=97.04  Aligned_cols=123  Identities=15%  Similarity=0.282  Sum_probs=90.1

Q ss_pred             CceEEEEecc--CCCcchhhHHHHHHHHHHHHHCC--CCCcceeeccccCCCcccccccEEEEEecccccHH-HHHhhhC
Q psy11580         87 QQNVAIKKLS--RPFQNVTHAKRAYREFKLMKLVN--HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLC-QVIQMDL  161 (288)
Q Consensus        87 ~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~-~~~~~~~  161 (288)
                      +..+++|+..  .. ........+.+|+.+++.+.  +..+.+++.++.+....   ...++|||+++|..+ +.....+
T Consensus        61 ~~~~vlr~~~~p~~-~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~---g~~~~vme~v~G~~l~~~~~~~l  136 (359)
T 3dxp_A           61 GQTYVMRAKPGPKS-KLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI---GRAFYIMEFVSGRVLWDQSLPGM  136 (359)
T ss_dssp             SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT---SSCEEEEECCCCBCCCCTTCTTC
T ss_pred             CceEEEEeCCCCCC-CCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc---CCeEEEEEecCCeecCCCccccC
Confidence            4688899886  32 11123457788999999996  45678888888765321   234999999998643 2223457


Q ss_pred             CHHHHHHHHHHHHHHHHHHHH----------------------------------------------------------C
Q psy11580        162 DHERMSYLLYQMLCGIKHLHS----------------------------------------------------------A  183 (288)
Q Consensus       162 ~~~~~~~~~~~i~~~l~~LH~----------------------------------------------------------~  183 (288)
                      +......++.+++..|+.||+                                                          .
T Consensus       137 ~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  216 (359)
T 3dxp_A          137 SPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLT  216 (359)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCC
T ss_pred             CHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCc
Confidence            788888999999999999997                                                          3


Q ss_pred             CCEeecCCCCCEEEccCCc--EEEeecccccc
Q psy11580        184 GIIHRDLKPSNIVVKSDCT--LKILDFGLART  213 (288)
Q Consensus       184 ~ivH~dl~~~nil~~~~~~--~kl~dfg~~~~  213 (288)
                      .++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       217 ~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          217 SIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             EEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             eEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            5899999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.06  E-value=1.2e-09  Score=90.98  Aligned_cols=170  Identities=15%  Similarity=0.184  Sum_probs=109.5

Q ss_pred             ceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCC--cceeeccccCCCcccccccEEEEEecccccHH-HHHhhhCCH
Q psy11580         88 QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKN--IIGLLNAFTPQKSLEEFQDVYLVMELMDANLC-QVIQMDLDH  163 (288)
Q Consensus        88 ~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~-~~~~~~~~~  163 (288)
                      ..+++|+...    ......+..|.++|+.+. +..  +.+++......+.   ....|+||++++|..+ ......++.
T Consensus        41 ~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~---~~~~~~vm~~i~G~~l~~~~~~~l~~  113 (304)
T 3sg8_A           41 RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSET---YQMSFAGFTKIKGVPLTPLLLNNLPK  113 (304)
T ss_dssp             TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSS---CSCSCEEEECCCCEECCHHHHHTSCH
T ss_pred             CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCC---CCcceEEEcccCCeECCccccccCCH
Confidence            5789999753    244567889999998883 332  4445544433221   1234889999998533 333456788


Q ss_pred             HHHHHHHHHHHHHHHHHHH----------------------------------------------------------CCC
Q psy11580        164 ERMSYLLYQMLCGIKHLHS----------------------------------------------------------AGI  185 (288)
Q Consensus       164 ~~~~~~~~~i~~~l~~LH~----------------------------------------------------------~~i  185 (288)
                      ++...++.+++..|+.||+                                                          ..+
T Consensus       114 ~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~  193 (304)
T 3sg8_A          114 QSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCL  193 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEE
T ss_pred             HHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCcee
Confidence            8888999999999999996                                                          126


Q ss_pred             EeecCCCCCEEEcc--CCcEEEeecccccccCCCcccCCcccccccCchHhHh----cCC----------CCchhhHHHH
Q psy11580        186 IHRDLKPSNIVVKS--DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL----GMG----------YKENVDIWSV  249 (288)
Q Consensus       186 vH~dl~~~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~----------~~~~~Di~sl  249 (288)
                      +|+|+++.||+++.  .+.+.|+||+.+.......-.........-..|+...    ...          .....+.|++
T Consensus       194 ~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l  273 (304)
T 3sg8_A          194 IHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSF  273 (304)
T ss_dssp             ECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHH
Confidence            99999999999998  4567899999886543210000000000001222211    110          1223689999


Q ss_pred             HHHHHHHHhCCCCCC
Q psy11580        250 GCIMGEMIRGGVLFP  264 (288)
Q Consensus       250 g~il~~l~~g~~p~~  264 (288)
                      +.++|.+.+|..+|-
T Consensus       274 ~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          274 EKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHcCCHHHH
Confidence            999999999987763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.51  E-value=1.5e-06  Score=72.33  Aligned_cols=120  Identities=17%  Similarity=0.179  Sum_probs=81.1

Q ss_pred             CceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCC---CcceeeccccCCCcccccccEEEEEecccccHHHH-HhhhCC
Q psy11580         87 QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHK---NIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQV-IQMDLD  162 (288)
Q Consensus        87 ~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~-~~~~~~  162 (288)
                      ++.+++|+..    .......+..|.++|+.+.+.   .+.+++.++....     ...++|||+++|..... ....++
T Consensus        39 g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~-----g~~~~v~e~i~G~~l~~~~~~~l~  109 (306)
T 3tdw_A           39 NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD-----GNPFVGYRKVQGQILGEDGMAVLP  109 (306)
T ss_dssp             TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT-----SCEEEEEECCCSEECHHHHHTTSC
T ss_pred             CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC-----CceEEEEeccCCeECchhhhhhCC
Confidence            5778999864    223456788999999999642   3455565553211     23489999999864332 223345


Q ss_pred             HHHHHHHHHHHHHHHHHHHHC-----------------------------------------------------------
Q psy11580        163 HERMSYLLYQMLCGIKHLHSA-----------------------------------------------------------  183 (288)
Q Consensus       163 ~~~~~~~~~~i~~~l~~LH~~-----------------------------------------------------------  183 (288)
                      ......++.++...|+.||+.                                                           
T Consensus       110 ~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~  189 (306)
T 3tdw_A          110 DDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYT  189 (306)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCC
Confidence            555666666666666666642                                                           


Q ss_pred             -CCEeecCCCCCEEEcc---CCc-EEEeecccccccC
Q psy11580        184 -GIIHRDLKPSNIVVKS---DCT-LKILDFGLARTAG  215 (288)
Q Consensus       184 -~ivH~dl~~~nil~~~---~~~-~kl~dfg~~~~~~  215 (288)
                       .++|+|+++.||+++.   ++. +.|+||+.+....
T Consensus       190 ~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          190 PRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             CEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             CeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence             2599999999999987   455 4899999886543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.49  E-value=1.4e-06  Score=71.04  Aligned_cols=118  Identities=11%  Similarity=0.151  Sum_probs=82.3

Q ss_pred             CCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcccccccEEEEEecccccHHHHHhhhCCH
Q psy11580         85 ATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH  163 (288)
Q Consensus        85 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~  163 (288)
                      ..+..+++|+-..     .....+..|...|+.+. +-.+.+++.++.+.+..      ++|||+++|......... ..
T Consensus        48 ~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~------~lvme~l~G~~~~~~~~~-~~  115 (272)
T 4gkh_A           48 PNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA------WLLTTAIPGKTAFQVLEE-YP  115 (272)
T ss_dssp             TTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE------EEEEECCCSEEHHHHHHH-CG
T ss_pred             CCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE------EEEEEeeCCccccccccC-CH
Confidence            4467899998763     34566788999999884 33467788887766543      999999998543322211 22


Q ss_pred             HHHHHHHHHHHHHHHHHHHC----------------------------------------------------------CC
Q psy11580        164 ERMSYLLYQMLCGIKHLHSA----------------------------------------------------------GI  185 (288)
Q Consensus       164 ~~~~~~~~~i~~~l~~LH~~----------------------------------------------------------~i  185 (288)
                      .....++.+++..|+.||..                                                          .+
T Consensus       116 ~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l  195 (272)
T 4gkh_A          116 DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVV  195 (272)
T ss_dssp             GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEE
T ss_pred             HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEE
Confidence            23345566666767777642                                                          15


Q ss_pred             EeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        186 IHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       186 vH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      +|+|+++.||+++.++.+-|+||+.+...
T Consensus       196 ~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          196 THGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             ECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             EcCCCCCCeEEEECCeEEEEEECcccccC
Confidence            89999999999998777789999987543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.82  E-value=1.5e-05  Score=67.66  Aligned_cols=63  Identities=16%  Similarity=0.187  Sum_probs=38.7

Q ss_pred             CceEEEEeccCCCc-chhhHHHHHHHHHHHHHCC-C--CCcceeeccccCCCcccccccEEEEEeccccc
Q psy11580         87 QQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVN-H--KNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN  152 (288)
Q Consensus        87 ~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~  152 (288)
                      ++.+++|+...... .......+..|+.+++.+. +  -.+.+++.++.+....   ...++|||+++|.
T Consensus        52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~---g~~~~v~e~l~G~  118 (357)
T 3ats_A           52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL---GTPFFLMDYVEGV  118 (357)
T ss_dssp             EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT---SSCEEEEECCCCB
T ss_pred             CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc---CCceEEEEecCCC
Confidence            56889998753210 0001245677888888884 2  3567788776554211   2348999999873

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.70  E-value=0.0001  Score=63.40  Aligned_cols=32  Identities=25%  Similarity=0.338  Sum_probs=26.6

Q ss_pred             CCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       183 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      ..++|+|+++.||+++.+ .++++||..+....
T Consensus       227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G~  258 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFYGP  258 (397)
T ss_dssp             CEEECSCCSGGGEEECSS-CEEECCCTTCEEEC
T ss_pred             CceeeCCCCcCcEEEeCC-CeEEEeCcccccCC
Confidence            458999999999999876 48999998876543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.69  E-value=0.00055  Score=57.30  Aligned_cols=32  Identities=13%  Similarity=0.285  Sum_probs=28.1

Q ss_pred             CCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       183 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      ..++|+|+++.||+++.++.+.|+||+.+...
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g  253 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD  253 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence            46999999999999988888999999988543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=97.60  E-value=1.8e-05  Score=69.75  Aligned_cols=61  Identities=72%  Similarity=1.251  Sum_probs=42.5

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcccc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELP   61 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~   61 (288)
                      ||..||.+|+++.|+|+||||..+.++.+...+.+...+...+........|++..+.++.
T Consensus       339 mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~  399 (464)
T 3ttj_A          339 MLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM  399 (464)
T ss_dssp             HSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSCCC-----------CCCHHHHHHHHHHHHH
T ss_pred             HcCCChhhCCCHHHHhcChhhhhccCcccccCCCCccCCcchhhccCCHHHHHHHHHHHHH
Confidence            6889999999999999999999988888777777777777777777888888877766553

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=97.57  E-value=1.2e-05  Score=68.71  Aligned_cols=61  Identities=64%  Similarity=1.117  Sum_probs=50.5

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcccc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELP   61 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~   61 (288)
                      ||..||.+||++.|+|+||||..+.++.+...+.|.......++.......|++..+.++.
T Consensus       302 mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (371)
T 2xrw_A          302 MLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVM  362 (371)
T ss_dssp             HSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHHH
T ss_pred             HCcCChhhCCCHHHHhCCcchhhhcCccccCCCCCCCCChhhccccCcHHHHHHHHHHHHH
Confidence            6889999999999999999999988887766666666667777778888899887776553

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.53  E-value=0.00069  Score=55.85  Aligned_cols=30  Identities=17%  Similarity=0.188  Sum_probs=25.4

Q ss_pred             CEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       185 ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      ++|+|+.+.||+ ..++.+.++||..+....
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~  204 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGMND  204 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence            799999999999 566778999999886543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=97.47  E-value=4.7e-05  Score=65.54  Aligned_cols=57  Identities=32%  Similarity=0.536  Sum_probs=37.9

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQ   58 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~   58 (288)
                      ||..||.+|++|.|+|+||||....+|.+.+. ...+.+...+....+...+++..++
T Consensus       328 mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~-~~~~~~~~~~~~~~~~~~~k~~i~~  384 (398)
T 4b99_A          328 MLRFEPSARISAAAALRHPFLAKYHDPDDEPD-CAPPFDFAFDREALTRERIKEAIVA  384 (398)
T ss_dssp             HSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCC-CSSCCCCHHHHSCCCHHHHHHHHHH
T ss_pred             HCcCChhHCcCHHHHhcCHhhCcCCCCccccC-CCCCCCCccchhhcCHHHHHHHHHH
Confidence            68999999999999999999998877765433 2334444443333444455444333

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.35  E-value=0.00092  Score=57.93  Aligned_cols=33  Identities=21%  Similarity=0.407  Sum_probs=28.3

Q ss_pred             HCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       182 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      ...++|+|+++.||+++.++ +.++||+.+....
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~  263 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP  263 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence            45699999999999998876 9999999887654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.29  E-value=0.00075  Score=56.47  Aligned_cols=33  Identities=21%  Similarity=0.424  Sum_probs=27.8

Q ss_pred             CCCEeecCCCCCEEEccC----CcEEEeecccccccC
Q psy11580        183 AGIIHRDLKPSNIVVKSD----CTLKILDFGLARTAG  215 (288)
Q Consensus       183 ~~ivH~dl~~~nil~~~~----~~~kl~dfg~~~~~~  215 (288)
                      ..++|+|+++.||+++.+    +.+.|+||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            359999999999999874    678999999886543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=97.25  E-value=0.00015  Score=62.20  Aligned_cols=59  Identities=31%  Similarity=0.661  Sum_probs=38.6

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCc-ccccccHHHhhhhhhccc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSV-DEREHTVDQWKELIYQEL   60 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~   60 (288)
                      ||..||.+|+++.|+|+||||....++.+.+.. +.+...+. +....+...|+...+.++
T Consensus       312 ~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (388)
T 3oz6_A          312 LLQFNPNKRISANDALKHPFVSIFHNPNEEPNC-DHIITIPINDNVKHSIDDYRNLVYSEI  371 (388)
T ss_dssp             HCCSSGGGSCCHHHHTTSTTTTTTCCGGGCCCC-SSCCCCC------CCHHHHHHHHHHHH
T ss_pred             hhccCcccCCCHHHHhCCHHHHHhcCCccCCCC-CCCCCCCccccccCCHHHHHHHHHHHH
Confidence            688999999999999999999987777664332 22222222 234456667776666554

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=97.22  E-value=0.00016  Score=61.64  Aligned_cols=59  Identities=39%  Similarity=0.776  Sum_probs=43.9

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcccc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQELP   61 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~   61 (288)
                      ||..||.+||++.|+|.||||....++.+.+...  |.+.+.+........|+...+.++.
T Consensus       295 mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~e~~  353 (367)
T 2fst_X          295 MLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD--PYDQSLESRDLLIDEWKSLTYDEVI  353 (367)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCC--CCCGGGSSCCCCHHHHHHHHHHHHH
T ss_pred             hCCCCcccCcCHHHHhcChhhhhccCCCCCCCCC--CCCcchhhccCCHHHHHHHHHHHHH
Confidence            6889999999999999999999888776643332  4555666666677777776666543

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.17  E-value=0.0017  Score=53.86  Aligned_cols=56  Identities=18%  Similarity=0.157  Sum_probs=40.9

Q ss_pred             CCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC---CCCcceeeccccCCCcccccccEEEEEeccccc
Q psy11580         86 TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN---HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN  152 (288)
Q Consensus        86 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~  152 (288)
                      +++.+++|+...     .....+..|...|+.+.   ...+.+++.++...+.      .++|||++++.
T Consensus        58 ~~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~------~~lvme~l~G~  116 (312)
T 3jr1_A           58 EVQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGH------SFLLLEALNKS  116 (312)
T ss_dssp             SSCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSE------EEEEEECCCCC
T ss_pred             CCCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCc------eEEEEEeccCC
Confidence            467889998863     23566788999888883   3567788887765443      49999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=97.08  E-value=0.00027  Score=60.17  Aligned_cols=58  Identities=38%  Similarity=0.765  Sum_probs=36.1

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhccc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL   60 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~   60 (288)
                      ||..||.+|+++.|+|+||||....++.+.+..  .+.+.+.+........|+...+.++
T Consensus       291 mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  348 (367)
T 1cm8_A          291 MLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV--QKYDDSFDDVDRTLDEWKRVTYKEV  348 (367)
T ss_dssp             HSCSSTTTSCCHHHHHHSGGGTTTC------CC--CCCCCC-----CCHHHHHHHHHHHH
T ss_pred             HccCChhHCCCHHHHhcChHHHhhcCCccCCCC--CCCCCChhhhcCCHHHHHHHHHHHH
Confidence            688999999999999999999987776553322  2445555666666777777666554

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=97.07  E-value=0.00043  Score=58.88  Aligned_cols=57  Identities=39%  Similarity=0.743  Sum_probs=42.2

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQ   58 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~   58 (288)
                      ||..||.+||++.|+|+||||.....+.+. .....+.+...+........|+...+.
T Consensus       307 ~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (371)
T 4exu_A          307 MLELDVDKRLTAAQALTHPFFEPFRDPEEE-TEAQQPFDDSLEHEKLTVDEWKQHIYK  363 (371)
T ss_dssp             HSCSCTTTSCCHHHHHTSGGGTTTCCGGGC-CCCSSCCCCTTSSCCCCHHHHHHHHHH
T ss_pred             HCCCChhhcCCHHHHhcCcccccCCCcccc-cccccCcCcchhhcccchHHHHHHHHH
Confidence            688999999999999999999987776553 344455566666666666677665544

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.03  E-value=0.0011  Score=55.16  Aligned_cols=41  Identities=32%  Similarity=0.398  Sum_probs=31.2

Q ss_pred             HHHHHHHHHH-------CCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        173 MLCGIKHLHS-------AGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       173 i~~~l~~LH~-------~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      +...++.+.+       .+++|+|+++.||+++.++.+.++||+.+..
T Consensus       170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            3445555553       3589999999999998876668999998754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=97.01  E-value=0.00053  Score=57.84  Aligned_cols=58  Identities=40%  Similarity=0.751  Sum_probs=42.7

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE   59 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~   59 (288)
                      ||..||.+||++.|+++||||.....+.+. .....+...+.+....+...|....+.+
T Consensus       289 ~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (353)
T 3coi_A          289 MLELDVDKRLTAAQALTHPFFEPFRDPEEE-TEAQQPFDDSLEHEKLTVDEWKQHIYKE  346 (353)
T ss_dssp             HSCSCTTTSCCHHHHHTSGGGTTTCCGGGC-CCCSSCCCCTTTTCCCCHHHHHHHHHHH
T ss_pred             HcCCCcccCCCHHHHhcCcchhhccCcccc-ccCCCCCccchhhccCCHHHHHHHHHHH
Confidence            588999999999999999999987766553 3334455666666666777776655543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=96.94  E-value=0.00062  Score=57.70  Aligned_cols=58  Identities=34%  Similarity=0.725  Sum_probs=37.3

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE   59 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~   59 (288)
                      ||..||.+||++.|+|+||||...+++.+.+. ...|.....+....+...+.+..+++
T Consensus       297 ~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~e  354 (364)
T 3qyz_A          297 MLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI-AEAPFKFDMELDDLPKEKLKELIFEE  354 (364)
T ss_dssp             HTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCC-CSSCCCCC-----CCHHHHHHHHHHH
T ss_pred             HcCCChhhCCCHHHHhcCcchhhccCcccccC-CCCcCCcccccccCCHHHHHHHHHHH
Confidence            68899999999999999999999887766433 33344444444444455555554443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=96.88  E-value=0.00079  Score=58.55  Aligned_cols=29  Identities=41%  Similarity=0.666  Sum_probs=25.5

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAE   29 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e   29 (288)
                      ||..||.+||++.|+|+||||.....+..
T Consensus       345 mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~  373 (432)
T 3n9x_A          345 MLKFNPNKRITIDQALDHPYLKDVRKKKL  373 (432)
T ss_dssp             HSCSSTTTSCCHHHHHTCGGGTTTCCTTT
T ss_pred             HhcCCcccCCCHHHHhcChhhhhccCccc
Confidence            68999999999999999999998666544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.85  E-value=0.0037  Score=53.31  Aligned_cols=114  Identities=16%  Similarity=0.184  Sum_probs=69.2

Q ss_pred             CceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcccccccEEEEEecccccHHH----------
Q psy11580         87 QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQ----------  155 (288)
Q Consensus        87 ~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~----------  155 (288)
                      ++.+++|+.-.   .........+|..+++.+. +.-..++++++.  +        .+|+||++|..+.          
T Consensus        82 ~~~~vlR~~g~---~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--------g~v~e~i~G~~l~~~~l~~p~~~  148 (379)
T 3feg_A           82 PREVLLRLYGA---ILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--------GRLEQYIPSRPLKTQELREPVLS  148 (379)
T ss_dssp             CSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--------EEEEECCSEEECCGGGGGCHHHH
T ss_pred             CCeEEEEECCC---ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--------ccEEEEecCccCChhHhCCHHHH
Confidence            57899999742   1223455668999988884 333356666653  2        4899999863111          


Q ss_pred             -HHh------hh--------CC--HHHHHHHHHHHHH-------------------HHHHHH----HC----CCEeecCC
Q psy11580        156 -VIQ------MD--------LD--HERMSYLLYQMLC-------------------GIKHLH----SA----GIIHRDLK  191 (288)
Q Consensus       156 -~~~------~~--------~~--~~~~~~~~~~i~~-------------------~l~~LH----~~----~ivH~dl~  191 (288)
                       .+.      ..        ..  +.++.++..++..                   .++.|.    ..    .++|+|+.
T Consensus       149 ~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~  228 (379)
T 3feg_A          149 AAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQ  228 (379)
T ss_dssp             HHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCC
T ss_pred             HHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCC
Confidence             110      00        11  3445555444321                   233332    22    38999999


Q ss_pred             CCCEEEccC----CcEEEeecccccc
Q psy11580        192 PSNIVVKSD----CTLKILDFGLART  213 (288)
Q Consensus       192 ~~nil~~~~----~~~kl~dfg~~~~  213 (288)
                      +.||+++.+    +.+.++||..+..
T Consensus       229 ~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          229 EGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             GGGEEEESCC---CCEEECCCTTCEE
T ss_pred             CCeEEEcCCCCccCcEEEEecccCCc
Confidence            999999876    6899999998853

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=96.73  E-value=0.0011  Score=58.05  Aligned_cols=29  Identities=34%  Similarity=0.637  Sum_probs=25.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAE   29 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e   29 (288)
                      ||..||.+|+++.|+|+||||.....+..
T Consensus       380 mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~  408 (458)
T 3rp9_A          380 MLVFNPNKRITINECLAHPFFKEVRIAEV  408 (458)
T ss_dssp             HSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred             HhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence            68999999999999999999998665544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.73  E-value=0.0026  Score=54.04  Aligned_cols=29  Identities=31%  Similarity=0.647  Sum_probs=24.2

Q ss_pred             CCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        184 GIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       184 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      .++|+|+++.||+++.++ +.|+||+.+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            489999999999998654 89999988753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.60  E-value=0.0038  Score=51.00  Aligned_cols=56  Identities=14%  Similarity=0.035  Sum_probs=36.6

Q ss_pred             cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCC---CCcceeeccccCCCcccccccEEEEEecccc
Q psy11580         84 TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH---KNIIGLLNAFTPQKSLEEFQDVYLVMELMDA  151 (288)
Q Consensus        84 ~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~  151 (288)
                      ..+|+.|++|+.....  ......+..|...|+.+..   -.+.+++.+.  ..        ++|||++++
T Consensus        36 l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~--------~lv~e~l~~   94 (288)
T 3f7w_A           36 LADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--DR--------TLAMEWVDE   94 (288)
T ss_dssp             ETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--TT--------EEEEECCCC
T ss_pred             ECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc--Cc--------eEEEEeecc
Confidence            3578999999876422  2223457789999998842   2345555542  22        889999874

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.60  E-value=0.0067  Score=50.39  Aligned_cols=29  Identities=28%  Similarity=0.332  Sum_probs=25.0

Q ss_pred             CCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       184 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      .++|+|+++.||+++ + .+.++||+.+...
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            478999999999998 4 8999999887643

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=96.40  E-value=0.002  Score=54.15  Aligned_cols=31  Identities=45%  Similarity=0.843  Sum_probs=26.2

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVH   31 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~   31 (288)
                      ||..||.+||++.|+++||||.....+....
T Consensus       289 ~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~  319 (353)
T 2b9h_A          289 MLVFDPAKRITAKEALEHPYLQTYHDPNDEP  319 (353)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGTTTCCTTSSC
T ss_pred             hcCcCcccCCCHHHHhcCccccccCCccccc
Confidence            5889999999999999999998866665433

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.35  E-value=0.019  Score=44.58  Aligned_cols=96  Identities=16%  Similarity=0.073  Sum_probs=61.0

Q ss_pred             HHHHhhhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeecccccccCCCcccCCcccccccCch
Q psy11580        154 CQVIQMDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAP  232 (288)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aP  232 (288)
                      ++.+..++++++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+|+|...+ +.+.           .....+.||
T Consensus        39 L~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~~~~~p  106 (229)
T 2yle_A           39 LRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEPPPVAG  106 (229)
T ss_dssp             HHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------------
T ss_pred             HHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccccCCCCh
Confidence            34445779999999999999999877632 2222334456889999999987663 1110           112235677


Q ss_pred             HhHhcCCCCchhhHHHHHHHHHHHHhCCCC
Q psy11580        233 EVILGMGYKENVDIWSVGCIMGEMIRGGVL  262 (288)
Q Consensus       233 E~~~~~~~~~~~Di~slg~il~~l~~g~~p  262 (288)
                      |... ...+.+.=|||||+++|.-+--..|
T Consensus       107 e~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          107 KLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             hhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            7653 2346788899999999998864444

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=95.91  E-value=0.0044  Score=52.27  Aligned_cols=36  Identities=36%  Similarity=0.678  Sum_probs=30.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPG   36 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~   36 (288)
                      ||..||.+||++.|+++||||....++.+.....+.
T Consensus       300 ~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~  335 (362)
T 3pg1_A          300 MLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSE  335 (362)
T ss_dssp             HTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTCCC
T ss_pred             HhcCChhhCCCHHHHHcCchhhhccCcccccccccc
Confidence            588999999999999999999998888776655443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=95.82  E-value=0.0031  Score=53.11  Aligned_cols=29  Identities=38%  Similarity=0.599  Sum_probs=25.6

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAE   29 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e   29 (288)
                      ||..||.+||++.|+|+||||....++..
T Consensus       298 ~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          298 LLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             HTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             HhccCccccCCHHHHhcCccccccCCccc
Confidence            68899999999999999999988766654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=95.66  E-value=0.0091  Score=49.77  Aligned_cols=29  Identities=28%  Similarity=0.528  Sum_probs=24.5

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAE   29 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e   29 (288)
                      ||..||.+||++.|+++||||.......+
T Consensus       248 ~L~~dP~~R~t~~eil~h~~~~~~~~~~~  276 (328)
T 3fe3_A          248 FLVLNPIKRGTLEQIMKDRWINAGHEEDE  276 (328)
T ss_dssp             HCCSSTTTSCCHHHHTTCTTTTTTCTTCC
T ss_pred             HCCCChhHCcCHHHHhcCHhhcCCCcccc
Confidence            58899999999999999999987554433

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=95.40  E-value=0.0053  Score=50.98  Aligned_cols=27  Identities=30%  Similarity=0.532  Sum_probs=23.3

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDD   27 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~   27 (288)
                      ||..||.+||++.|+|+||||......
T Consensus       265 ~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          265 LLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             HcCcCcccCCCHHHHhcChhhhhcccc
Confidence            688999999999999999999764443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=95.22  E-value=0.0083  Score=51.50  Aligned_cols=27  Identities=33%  Similarity=0.461  Sum_probs=23.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDD   27 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~   27 (288)
                      ||..||.+||++.|+|+||||.....+
T Consensus       317 ~L~~dP~~R~ta~e~L~hp~f~~~~~~  343 (405)
T 3rgf_A          317 LLTMDPIKRITSEQAMQDPYFLEDPLP  343 (405)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGTSSSCC
T ss_pred             HccCCcccCCCHHHHhcChhhccCCCC
Confidence            688999999999999999999764443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=95.10  E-value=0.0044  Score=52.88  Aligned_cols=26  Identities=23%  Similarity=0.299  Sum_probs=22.2

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFD   26 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~   26 (288)
                      ||..||.+||++.|+|+||||.....
T Consensus       317 ~L~~dP~~Rpta~ell~hp~f~~~~~  342 (389)
T 3gni_B          317 CLQRNPDARPSASTLLNHSFFKQIKR  342 (389)
T ss_dssp             HTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred             HhhcCcccCCCHHHHhcCHHHHHHhh
Confidence            68899999999999999999987443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=94.85  E-value=0.013  Score=49.03  Aligned_cols=27  Identities=22%  Similarity=0.369  Sum_probs=23.1

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDD   27 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~   27 (288)
                      ||..||.+||++.|+|+||||.....+
T Consensus       275 ~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          275 LFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             HHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             HhccChhhCCCHHHHhcChhhhcCCCC
Confidence            578999999999999999999764443

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=94.64  E-value=0.017  Score=49.34  Aligned_cols=27  Identities=26%  Similarity=0.511  Sum_probs=23.8

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDD   27 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~   27 (288)
                      ||..||.+||++.|++.||||.....+
T Consensus       305 ~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          305 LLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             HCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             HhCCChhhCCCHHHHhcChhhhhhccc
Confidence            588999999999999999999875554

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=94.40  E-value=0.012  Score=49.69  Aligned_cols=24  Identities=29%  Similarity=0.490  Sum_probs=21.7

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVW   24 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~   24 (288)
                      ||..||.+||++.|+++||||...
T Consensus       258 ~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          258 IFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HccCChhHCcCHHHHHhCcchhcC
Confidence            588999999999999999999653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=94.40  E-value=0.016  Score=52.20  Aligned_cols=27  Identities=30%  Similarity=0.614  Sum_probs=23.7

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDD   27 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~   27 (288)
                      ||..||.+|+++.|+|+||||.....+
T Consensus       394 ~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          394 LLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             TSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             HccCChhHCcCHHHHhcCcCcCCCCCC
Confidence            789999999999999999999764444

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=93.61  E-value=0.026  Score=47.66  Aligned_cols=23  Identities=39%  Similarity=0.801  Sum_probs=21.2

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|+|+||||..
T Consensus       256 ~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          256 LLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             HSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             HCCCChhHCcCHHHHhcCcCcCC
Confidence            68899999999999999999964

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=93.36  E-value=0.029  Score=46.92  Aligned_cols=24  Identities=38%  Similarity=0.700  Sum_probs=22.0

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVW   24 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~   24 (288)
                      ||..||.+||++.|+++||||...
T Consensus       242 ~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          242 MIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             TSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HcCCChhHCcCHHHHHhChhhccC
Confidence            788999999999999999999753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=93.34  E-value=0.058  Score=44.64  Aligned_cols=23  Identities=30%  Similarity=0.505  Sum_probs=21.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|+++||||..
T Consensus       245 ~L~~dP~~R~t~~eil~h~~~~~  267 (323)
T 3tki_A          245 ILVENPSARITIPDIKKDRWYNK  267 (323)
T ss_dssp             HSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HccCChhhCcCHHHHhhChhhcc
Confidence            58899999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=92.96  E-value=0.012  Score=50.14  Aligned_cols=26  Identities=27%  Similarity=0.579  Sum_probs=22.8

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFD   26 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~   26 (288)
                      ||..||.+||++.|+|+||||....+
T Consensus       305 ~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          305 ILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             HccCChhhCCCHHHHhcCHHHHHHHh
Confidence            58899999999999999999986433

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=92.84  E-value=0.042  Score=47.36  Aligned_cols=27  Identities=22%  Similarity=0.375  Sum_probs=23.9

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDD   27 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~   27 (288)
                      ||..||.+|+++.|++.||||....++
T Consensus       320 ~L~~dP~~R~t~~e~l~hp~f~~~~~~  346 (420)
T 1j1b_A          320 LLEYTPTARLTPLEACAHSFFDELRDP  346 (420)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hccCChhHCCCHHHHhCCHhhcccccc
Confidence            688999999999999999999875554

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=92.71  E-value=0.052  Score=44.78  Aligned_cols=23  Identities=39%  Similarity=0.801  Sum_probs=21.3

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|++.||||..
T Consensus       256 ~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          256 LLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             TSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             HcCCChhhCcCHHHHhcCccccC
Confidence            68899999999999999999954

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=92.66  E-value=0.046  Score=45.19  Aligned_cols=23  Identities=22%  Similarity=0.523  Sum_probs=21.2

Q ss_pred             CcccCCCCCC-----CHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRI-----SVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~-----~~~~~l~~p~~~~   23 (288)
                      ||..||.+|+     ++++++.||||..
T Consensus       237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          237 LITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            5789999999     8999999999986

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=92.64  E-value=0.029  Score=46.55  Aligned_cols=23  Identities=48%  Similarity=0.970  Sum_probs=21.1

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|+|+||||..
T Consensus       255 ~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          255 LLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             HSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             HccCChhhCCCHHHHhcCCCccC
Confidence            58899999999999999999954

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=92.62  E-value=0.065  Score=44.78  Aligned_cols=31  Identities=23%  Similarity=0.419  Sum_probs=27.5

Q ss_pred             CCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       184 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      .++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            4899999999999998888999999887654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=92.55  E-value=0.022  Score=47.26  Aligned_cols=23  Identities=22%  Similarity=0.550  Sum_probs=21.3

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|+++||||..
T Consensus       254 ~L~~dP~~Rpt~~ell~h~w~~~  276 (325)
T 3kn6_A          254 LLTVDPNKRLKMSGLRYNEWLQD  276 (325)
T ss_dssp             HHCCCTTTCCCTTTSTTCGGGCT
T ss_pred             HCCCChhHCCCHHHHhcChhhcc
Confidence            57899999999999999999966

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=92.53  E-value=0.028  Score=45.88  Aligned_cols=23  Identities=26%  Similarity=0.681  Sum_probs=21.3

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|+++||||..
T Consensus       240 ~l~~dP~~Rps~~e~l~hp~~~~  262 (299)
T 3m2w_A          240 LLKTEPTQRMTITEFMNHPWIMQ  262 (299)
T ss_dssp             HTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HcccChhhCCCHHHHhcChhhcc
Confidence            57899999999999999999965

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=92.47  E-value=0.063  Score=45.78  Aligned_cols=24  Identities=42%  Similarity=0.720  Sum_probs=22.0

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVW   24 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~   24 (288)
                      ||..||.+||++.|+|+||||...
T Consensus       288 ~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          288 LLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             TSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HcCCChhHCcCHHHHhhCccccCC
Confidence            688999999999999999999763

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=92.43  E-value=0.041  Score=46.03  Aligned_cols=23  Identities=39%  Similarity=0.700  Sum_probs=21.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.++++||||..
T Consensus       261 ~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          261 MLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HCCCChhHCcCHHHHhcCCeecC
Confidence            58899999999999999999965

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=92.41  E-value=0.025  Score=46.90  Aligned_cols=24  Identities=29%  Similarity=0.624  Sum_probs=21.9

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVW   24 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~   24 (288)
                      ||..||.+||++.|+|+||||...
T Consensus       241 ~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          241 LLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             TSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HcCCChhHCcCHHHHhcChhhccC
Confidence            688999999999999999999653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=92.36  E-value=0.042  Score=46.05  Aligned_cols=23  Identities=39%  Similarity=0.830  Sum_probs=21.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|+|+||||..
T Consensus       289 ~L~~dP~~Rpt~~e~l~hp~~~~  311 (349)
T 2w4o_A          289 LIVLDPKKRLTTFQALQHPWVTG  311 (349)
T ss_dssp             TSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HccCChhhCcCHHHHhcCcccCC
Confidence            68899999999999999999954

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=91.77  E-value=0.057  Score=44.51  Aligned_cols=23  Identities=39%  Similarity=0.898  Sum_probs=21.1

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.++++||||..
T Consensus       258 ~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          258 LLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             HcccCHhhCCCHHHHhhCcCcCC
Confidence            57899999999999999999954

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=91.76  E-value=0.036  Score=46.27  Aligned_cols=27  Identities=37%  Similarity=0.682  Sum_probs=22.6

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDD   27 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~   27 (288)
                      ||..||.+||++.|+++||||.....+
T Consensus       257 ~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          257 CLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             HTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             HcCCChhHCCCHHHHHhCccccccCCc
Confidence            578999999999999999999754433

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=91.70  E-value=0.025  Score=47.55  Aligned_cols=23  Identities=26%  Similarity=0.423  Sum_probs=21.2

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|+|+||||..
T Consensus       260 ~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          260 LFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             HTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HccCChhHCcCHHHHhcCHHhhc
Confidence            58899999999999999999964

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=91.62  E-value=0.057  Score=46.99  Aligned_cols=23  Identities=52%  Similarity=0.924  Sum_probs=21.2

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|+|+||||..
T Consensus       251 ~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          251 MLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HcCCChhHCCCHHHHhcCccccC
Confidence            58899999999999999999964

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=91.00  E-value=0.061  Score=46.59  Aligned_cols=23  Identities=39%  Similarity=0.725  Sum_probs=21.2

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.++++||||..
T Consensus       267 ~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          267 MIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             HHhCCHhhCCCHHHHHhCccccC
Confidence            57899999999999999999965

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=90.81  E-value=0.16  Score=44.42  Aligned_cols=52  Identities=25%  Similarity=0.222  Sum_probs=32.2

Q ss_pred             CceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCc-ceeeccccCCCcccccccEEEEEecccc
Q psy11580         87 QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNI-IGLLNAFTPQKSLEEFQDVYLVMELMDA  151 (288)
Q Consensus        87 ~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~~~~lv~e~~~~  151 (288)
                      +..+++|+.....   ...-.-..|..+++.+...++ .++++++.  +        .+|+||++|
T Consensus       133 ~~~~vLRi~g~~~---~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--------G~v~e~I~G  185 (458)
T 2qg7_A          133 QAKYLIRLYGPKT---DEIINREREKKISCILYNKNIAKKIYVFFT--N--------GRIEEFMDG  185 (458)
T ss_dssp             TEEEEEEEECC-C---CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--------EEEEECCCS
T ss_pred             CceEEEEECCCCh---hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--------eEEEEeeCC
Confidence            3688999885321   111112478899998864444 56776652  2        469999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=90.70  E-value=0.079  Score=44.07  Aligned_cols=23  Identities=22%  Similarity=0.559  Sum_probs=21.2

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.++++||||..
T Consensus       258 ~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          258 LLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             HTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             HccCChhhCcCHHHHhcCccccC
Confidence            57899999999999999999965

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=90.37  E-value=0.097  Score=44.79  Aligned_cols=23  Identities=30%  Similarity=0.583  Sum_probs=20.9

Q ss_pred             CcccCCCCCCCH------HHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISV------DDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~------~~~l~~p~~~~   23 (288)
                      ||..||.+|+++      .|++.||||..
T Consensus       296 lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          296 FLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             HTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             HhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            588999999996      79999999987

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=90.36  E-value=0.087  Score=44.06  Aligned_cols=23  Identities=30%  Similarity=0.583  Sum_probs=20.9

Q ss_pred             CcccCCCCCCCH------HHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISV------DDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~------~~~l~~p~~~~   23 (288)
                      ||..||.+|+++      .+++.||||..
T Consensus       253 lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          253 FLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             HTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             HhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            588999999996      79999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=90.34  E-value=0.042  Score=45.78  Aligned_cols=23  Identities=35%  Similarity=0.771  Sum_probs=21.3

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|+++||||..
T Consensus       271 ~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          271 LLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             HSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HCCCChhHCcCHHHHhcCccccc
Confidence            57899999999999999999965

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=90.32  E-value=0.059  Score=47.53  Aligned_cols=24  Identities=46%  Similarity=0.751  Sum_probs=21.9

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVW   24 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~   24 (288)
                      ||..+|.+||++.|+|+||||...
T Consensus       275 ~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          275 MLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HCCCChhhCccHHHHhcCcccccC
Confidence            588999999999999999999763

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=90.23  E-value=0.059  Score=45.96  Aligned_cols=24  Identities=42%  Similarity=0.801  Sum_probs=21.7

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVW   24 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~   24 (288)
                      ||..||.+||++.|+|+||||...
T Consensus       304 ~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          304 CLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             HTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HcccChhhCCCHHHHhhCcCcccc
Confidence            578999999999999999999653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=90.14  E-value=0.061  Score=45.08  Aligned_cols=23  Identities=48%  Similarity=0.917  Sum_probs=21.3

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.++|+||||..
T Consensus       270 ~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          270 MLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HCCCChhHCcCHHHHhcChhhcC
Confidence            58899999999999999999965

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=90.13  E-value=0.061  Score=47.55  Aligned_cols=23  Identities=35%  Similarity=0.497  Sum_probs=21.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|+|+||||..
T Consensus       285 ~L~~dp~~R~t~~e~l~h~~~~~  307 (504)
T 3q5i_A          285 MLTYDYNKRCTAEEALNSRWIKK  307 (504)
T ss_dssp             HTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             HcCCChhHCCCHHHHhcCHhhhh
Confidence            58899999999999999999965

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=89.98  E-value=0.059  Score=47.39  Aligned_cols=23  Identities=39%  Similarity=0.722  Sum_probs=21.3

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|+|.||||..
T Consensus       260 ~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          260 MLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             HTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             HcCCChhhCcCHHHHhcCHhhcc
Confidence            58899999999999999999965

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=89.92  E-value=0.12  Score=43.13  Aligned_cols=23  Identities=22%  Similarity=0.543  Sum_probs=21.3

Q ss_pred             CcccCCCCCC-----CHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRI-----SVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~-----~~~~~l~~p~~~~   23 (288)
                      ||..||.+|+     ++.|+++||||..
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            5789999999     8999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=89.88  E-value=0.071  Score=44.82  Aligned_cols=23  Identities=22%  Similarity=0.547  Sum_probs=21.3

Q ss_pred             CcccCCCCCCCH------HHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISV------DDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~------~~~l~~p~~~~   23 (288)
                      ||..||.+|+++      .++++||||..
T Consensus       258 lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          258 FMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             HTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             HhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            588999999999      89999999987

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.83  E-value=0.69  Score=35.68  Aligned_cols=83  Identities=11%  Similarity=0.005  Sum_probs=55.6

Q ss_pred             CCCCcceeeccccCCCcccccccEEEEEecccc-cHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEE
Q psy11580        119 NHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV  197 (288)
Q Consensus       119 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~  197 (288)
                      .||+++.. .+-...+.+      .+.++.-+. ..+.. ....+....++++.+|+...+++  ..-+|--|+|+|+++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v------~~~y~~~~~~~~f~~-ik~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSF------QIHYDINDNHTPFDN-IKSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEE------EEEECCCTTSEEGGG-GGGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEE------EEEEEcCcccCCHHH-HHhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEE
Confidence            57888866 344444422      333333221 12222 25688899999999998877444  334888999999999


Q ss_pred             ccCCcEEEeecccc
Q psy11580        198 KSDCTLKILDFGLA  211 (288)
Q Consensus       198 ~~~~~~kl~dfg~~  211 (288)
                      +.++.+++.-.|+.
T Consensus       113 ~~~~~p~i~~RGik  126 (215)
T 4ann_A          113 TRDGLPIAKTRGLQ  126 (215)
T ss_dssp             CTTSCEEESCCEET
T ss_pred             cCCCCEEEEEccCc
Confidence            99999999977753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=89.81  E-value=0.054  Score=44.21  Aligned_cols=23  Identities=39%  Similarity=0.746  Sum_probs=21.0

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|++.||||..
T Consensus       245 ~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          245 LLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             HHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             HcCCChhHCcCHHHHhcCccccC
Confidence            57889999999999999999955

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=89.70  E-value=0.1  Score=45.12  Aligned_cols=51  Identities=14%  Similarity=0.236  Sum_probs=33.0

Q ss_pred             CceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCc-ceeeccccCCCcccccccEEEEEecccc
Q psy11580         87 QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNI-IGLLNAFTPQKSLEEFQDVYLVMELMDA  151 (288)
Q Consensus        87 ~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~~~~lv~e~~~~  151 (288)
                      ++.+++|+....  ..  ...+..|..+++.+...++ .++++.+.  +        .+|+||++|
T Consensus       105 ~~~~vlRi~~~~--~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--------g~v~e~l~G  156 (429)
T 1nw1_A          105 PNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--------GRLEEYIPS  156 (429)
T ss_dssp             CSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--------EEEECCCCE
T ss_pred             CceEEEEEeCCC--Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--------CEEEEEeCC
Confidence            578999998531  11  1445579998888843333 56666543  2        578999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=89.40  E-value=0.054  Score=47.58  Aligned_cols=24  Identities=46%  Similarity=0.671  Sum_probs=21.8

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVW   24 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~   24 (288)
                      ||..+|.+||++.|+|.||||...
T Consensus       265 ~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          265 MLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             HTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             HCCCChhHCcCHHHHhhChhhccc
Confidence            688999999999999999999753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=89.17  E-value=0.15  Score=44.78  Aligned_cols=23  Identities=35%  Similarity=0.609  Sum_probs=21.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|++.||||..
T Consensus       250 ~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          250 MLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             HTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             HcCCCchhCcCHHHHHhCHHhhh
Confidence            58899999999999999999965

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=89.05  E-value=0.095  Score=45.35  Aligned_cols=23  Identities=35%  Similarity=0.400  Sum_probs=21.0

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.++++||||..
T Consensus       279 ~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          279 MIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HhhCChhhCCCHHHHHhCCccCC
Confidence            57899999999999999999954

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=88.75  E-value=0.08  Score=43.97  Aligned_cols=27  Identities=22%  Similarity=0.400  Sum_probs=23.2

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDD   27 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~   27 (288)
                      ||..||.+||++.|+++||||.....+
T Consensus       275 ~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          275 MLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             HTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             HccCChhHCcCHHHHhcCccccCCCcc
Confidence            578999999999999999999765443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=88.47  E-value=0.067  Score=45.08  Aligned_cols=23  Identities=48%  Similarity=0.814  Sum_probs=21.2

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.++|.||||..
T Consensus       268 ~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          268 MLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HcCCChhhCcCHHHHhcCcccCC
Confidence            58899999999999999999964

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=88.21  E-value=0.1  Score=43.21  Aligned_cols=23  Identities=17%  Similarity=0.465  Sum_probs=21.0

Q ss_pred             CcccCCCCCC-----CHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRI-----SVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~-----~~~~~l~~p~~~~   23 (288)
                      ||..||.+|+     ++.+++.||||..
T Consensus       255 ~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          255 LLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            5789999999     8899999999976

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=87.89  E-value=0.092  Score=44.94  Aligned_cols=23  Identities=26%  Similarity=0.681  Sum_probs=21.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|++.||||..
T Consensus       305 ~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          305 LLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             TSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HCCCChhHCcCHHHHhcCccccC
Confidence            68899999999999999999964

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=87.75  E-value=0.19  Score=42.09  Aligned_cols=23  Identities=30%  Similarity=0.514  Sum_probs=21.2

Q ss_pred             CcccCCCCCCC-----HHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRIS-----VDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~-----~~~~l~~p~~~~   23 (288)
                      ||..||.+|++     +.++++||||..
T Consensus       272 lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            58899999998     999999999986

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=86.84  E-value=0.27  Score=42.05  Aligned_cols=29  Identities=24%  Similarity=0.422  Sum_probs=24.8

Q ss_pred             CEeecCCCCCEEEc------cCCcEEEeecccccc
Q psy11580        185 IIHRDLKPSNIVVK------SDCTLKILDFGLART  213 (288)
Q Consensus       185 ivH~dl~~~nil~~------~~~~~kl~dfg~~~~  213 (288)
                      ++|+|+.+.||++.      .+..+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            67999999999993      456799999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=86.71  E-value=0.19  Score=45.98  Aligned_cols=23  Identities=17%  Similarity=0.433  Sum_probs=21.3

Q ss_pred             CcccCCCCCCC-----HHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRIS-----VDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~-----~~~~l~~p~~~~   23 (288)
                      ||..||.+|++     +.|+++||||+.
T Consensus       428 lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          428 LLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             HccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            68899999998     799999999987

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=86.33  E-value=0.48  Score=41.04  Aligned_cols=28  Identities=14%  Similarity=0.379  Sum_probs=22.4

Q ss_pred             CcccCCCC--CCCHHHHhcCCCcCC-ccCCc
Q psy11580          1 MLVIDPEK--RISVDDALMHPYINV-WFDDA   28 (288)
Q Consensus         1 ~l~~~~~~--r~~~~~~l~~p~~~~-~~~~~   28 (288)
                      ||..+|.+  |++++|+++||||.. .|+..
T Consensus       320 lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          320 LICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             TSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             HhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence            56677887  999999999999987 34443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.04  E-value=2.9  Score=32.30  Aligned_cols=51  Identities=14%  Similarity=0.090  Sum_probs=41.9

Q ss_pred             hhCCHHHHHHHHHHHHHHHH-HHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        159 MDLDHERMSYLLYQMLCGIK-HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       159 ~~~~~~~~~~~~~~i~~~l~-~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      ...+....++++.+|+.... ++  ..-+|--|+|+|++++.++.+++.-.|.-
T Consensus        80 ~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A           80 RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTCCEEESCCEET
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCCcEEEEEcCCc
Confidence            56888999999888887554 33  44688899999999999999999988864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=85.86  E-value=0.52  Score=40.44  Aligned_cols=28  Identities=29%  Similarity=0.400  Sum_probs=22.2

Q ss_pred             CcccCCCCC---CCHHHHhcCCCcCC-ccCCcc
Q psy11580          1 MLVIDPEKR---ISVDDALMHPYINV-WFDDAE   29 (288)
Q Consensus         1 ~l~~~~~~r---~~~~~~l~~p~~~~-~~~~~e   29 (288)
                      ||. +|.+|   +++.|++.||||.. .|+...
T Consensus       309 lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          309 LLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             TSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred             HcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence            576 89988   58999999999987 455443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=85.46  E-value=0.14  Score=42.83  Aligned_cols=23  Identities=22%  Similarity=0.257  Sum_probs=20.8

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.++++|||+..
T Consensus       289 ~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          289 CLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             HTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HcccChhhCcCHHHHhhChhhhc
Confidence            57889999999999999999944

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=84.02  E-value=0.14  Score=42.83  Aligned_cols=23  Identities=39%  Similarity=0.690  Sum_probs=21.3

Q ss_pred             CcccCCCCCCCHH-HHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVD-DALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~-~~l~~p~~~~   23 (288)
                      ||..||.+|+++. ++++||||..
T Consensus       252 lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          252 LFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             HSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HhcCCHhHcCCChHHHHcCccccC
Confidence            5789999999998 9999999987

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=83.93  E-value=0.38  Score=40.30  Aligned_cols=23  Identities=22%  Similarity=0.450  Sum_probs=20.5

Q ss_pred             CcccCCCCCCC-----HHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRIS-----VDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~-----~~~~l~~p~~~~   23 (288)
                      ||..||.+|++     +.+++.||||..
T Consensus       255 lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          255 LMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            57899999995     699999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=83.51  E-value=0.33  Score=44.66  Aligned_cols=29  Identities=21%  Similarity=0.425  Sum_probs=23.8

Q ss_pred             CcccCCCCCCCH-----HHHhcCCCcCC-ccCCcc
Q psy11580          1 MLVIDPEKRISV-----DDALMHPYINV-WFDDAE   29 (288)
Q Consensus         1 ~l~~~~~~r~~~-----~~~l~~p~~~~-~~~~~e   29 (288)
                      ||..||.+|+++     .|+++||||+. .|+..+
T Consensus       576 lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~  610 (674)
T 3pfq_A          576 LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE  610 (674)
T ss_dssp             HSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHT
T ss_pred             HccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHH
Confidence            688999999998     99999999987 344433

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=83.35  E-value=0.53  Score=40.37  Aligned_cols=23  Identities=17%  Similarity=0.244  Sum_probs=20.2

Q ss_pred             CcccCCCC--CCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEK--RISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~--r~~~~~~l~~p~~~~   23 (288)
                      ||..+|.+  |+++.|+++||||+.
T Consensus       311 lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          311 FLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             HSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             HccChhhhCCCCCHHHHhcCccccC
Confidence            46677888  999999999999987

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=83.05  E-value=0.46  Score=40.98  Aligned_cols=28  Identities=18%  Similarity=0.570  Sum_probs=25.3

Q ss_pred             CEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        185 IIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       185 ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      ++|+|+.+.||+ +.++.+.++||..+..
T Consensus       264 ~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          264 FAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             EECCCCCcccee-cCCCcEEEEecccCCc
Confidence            899999999999 7788899999998863

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=83.05  E-value=0.37  Score=40.98  Aligned_cols=23  Identities=35%  Similarity=0.670  Sum_probs=21.1

Q ss_pred             CcccCCCCCCC-HHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRIS-VDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~-~~~~l~~p~~~~   23 (288)
                      ||..||.+|++ +.+++.||||..
T Consensus       254 lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          254 LLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             HSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             HhcCCHhHhcccHHHHHcChhhhc
Confidence            57899999998 899999999987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=82.92  E-value=0.36  Score=44.27  Aligned_cols=23  Identities=13%  Similarity=0.033  Sum_probs=18.6

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.+++.||||..
T Consensus       281 mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          281 MLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             HSCSSCC---CCTTCCCCTTHHH
T ss_pred             HccCCHhhCcCHHHHhcCHHHHH
Confidence            57899999999999999999987

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=82.10  E-value=0.24  Score=44.57  Aligned_cols=23  Identities=30%  Similarity=0.582  Sum_probs=21.2

Q ss_pred             CcccCCCCCC-----CHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRI-----SVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~-----~~~~~l~~p~~~~   23 (288)
                      ||..||.+|+     ++.|+++||||..
T Consensus       423 lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          423 LLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             hccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            5889999999     7899999999986

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	288
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-55
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-18
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-06
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-47
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	0.002
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	0.003
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-47
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	0.003
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-05
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-46
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-46
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-12
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-45
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-44
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-04
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-09
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-43
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-13
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	0.002
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-04
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-41
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	0.003
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	0.002
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-04
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-04
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	0.001
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	0.001
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	0.002
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-37
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-35
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-35
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-04
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	0.001
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-34
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-34
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-34
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-33
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-33
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-33
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-33
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-33
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-32
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-32
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-31
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-31
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-31
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-31
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-30
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-30
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-28
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-27
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-25
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-22
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-05
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-17

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 3e-55
 Identities = 178/207 (85%), Positives = 188/207 (90%), Gaps = 6/207 (2%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G+GA      AYD    +NVAIKKLSRPFQN THAKRAYRE  LMK VNHKNII LLN 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
           FTPQK+LEEFQDVYLVMELMDANLCQVIQM+LDHERMSYLLYQMLCGIKHLHSAGIIHRD
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 144

Query: 190 LKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
           LKPSNIVVKSDCTLKILDFGLARTAGT+FMMTPYVVTRYYRAPEVILGMGYKENVDIWSV
Sbjct: 145 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204

Query: 250 GCIMGEMIRGGVLFPGTDHIDQWNKII 276
           GCIMGEM+R  +LFPG D+IDQWNK+I
Sbjct: 205 GCIMGEMVRHKILFPGRDYIDQWNKVI 231

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.5 bits (200), Expect = 2e-18
 Identities = 44/59 (74%), Positives = 50/59 (84%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           MLVIDP KRISVDDAL HPYINVW+D AEV AP P  YD  +DEREHT+++WKELIY+E
Sbjct: 294 MLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 352

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (402), Expect = 4e-48
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 17/210 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR-PFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LG G       A +  ++  +A+K L +   +      +  RE ++   + H NI+ L  
Sbjct: 14  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73

Query: 129 AFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGI 185
            F       +   VYL++E      + + +Q     D +R +  + ++   + + HS  +
Sbjct: 74  YF------HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
           IHRD+KP N+++ S   LKI DFG +  A ++   T    T  Y  PE+I G  + E VD
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVD 186

Query: 246 IWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           +WS+G +  E + G   F    + + + +I
Sbjct: 187 LWSLGVLCYEFLVGKPPFEANTYQETYKRI 216

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  160 bits (406), Expect = 9e-48
 Identities = 58/239 (24%), Positives = 101/239 (42%), Gaps = 21/239 (8%)

Query: 50  DQWKELIYQELPISHQMGKKRHN-TSHLGAGA------AYDTATQQNVAIKKLSRPFQNV 102
           D WK+   Q + I H      ++    LG GA        + AT  N A K +  P ++ 
Sbjct: 7   DIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES- 65

Query: 103 THAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD- 160
              +   +E + M ++ H  ++ L +AF      E+  ++ ++ E M    L + +  + 
Sbjct: 66  -DKETVRKEIQTMSVLRHPTLVNLHDAF------EDDNEMVMIYEFMSGGELFEKVADEH 118

Query: 161 --LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLARTAGT 216
             +  +     + Q+  G+ H+H    +H DLKP NI+   K    LK++DFGL      
Sbjct: 119 NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178

Query: 217 TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
              +     T  + APEV  G       D+WSVG +   ++ G   F G +  +    +
Sbjct: 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 237

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 45.5 bits (107), Expect = 3e-06
 Identities = 16/71 (22%), Positives = 28/71 (39%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL 60
           +L+ DP  R+++  AL HP++                Y    D  +   D W E +    
Sbjct: 263 LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLG 322

Query: 61  PISHQMGKKRH 71
            IS+    ++H
Sbjct: 323 RISNYSSLRKH 333

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 2e-47
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 18/215 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LGAG            +   +A K +    +      +  RE +++   N   I+G   A
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGA 72

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA-GI 185
           F          ++ + ME MD      +      +  + +  +   ++ G+ +L     I
Sbjct: 73  F------YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
           +HRD+KPSNI+V S   +K+ DFG++     +   + +V TR Y +PE + G  Y    D
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTHYSVQSD 185

Query: 246 IWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR 280
           IWS+G  + EM  G    P  D  +       ++ 
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 5/21 (23%), Positives = 12/21 (57%)

Query: 1   MLVIDPEKRISVDDALMHPYI 21
            L+ +P +R  +   ++H +I
Sbjct: 281 CLIKNPAERADLKQLMVHAFI 301

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-47
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 17/210 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G GA      A D AT Q VAI++++   Q     +    E  +M+   + NI+  L++
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIH 187
           +          ++++VME +       +  +  +D  +++ +  + L  ++ LHS  +IH
Sbjct: 86  Y------LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 139

Query: 188 RDLKPSNIVVKSDCTLKILDFGLART-AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
           RD+K  NI++  D ++K+ DFG            +  V T Y+ APEV+    Y   VDI
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 247 WSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           WS+G +  EMI G   +   + +     I 
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIA 229

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.1 bits (83), Expect = 0.003
 Identities = 8/23 (34%), Positives = 13/23 (56%)

Query: 1   MLVIDPEKRISVDDALMHPYINV 23
            L +D EKR S  + L H ++ +
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKI 275

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  158 bits (400), Expect = 7e-47
 Identities = 55/252 (21%), Positives = 105/252 (41%), Gaps = 27/252 (10%)

Query: 38  YDHSVDEREHTVDQWKELIYQELPISHQMGKKRHN-TSHLGAGA------AYDTATQQNV 90
           YD   +      D WK+ + Q + +        ++    LG+GA        + AT +  
Sbjct: 4   YDKFYE------DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVF 57

Query: 91  AIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD 150
             K ++ P+           E  +M  ++H  +I L +AF      E+  ++ L++E + 
Sbjct: 58  VAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAF------EDKYEMVLILEFLS 109

Query: 151 ----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLK 204
                +        +    +   + Q   G+KH+H   I+H D+KP NI+   K   ++K
Sbjct: 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVK 169

Query: 205 ILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP 264
           I+DFGLA       ++     T  + APE++         D+W++G +   ++ G   F 
Sbjct: 170 IIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229

Query: 265 GTDHIDQWNKII 276
           G D ++    + 
Sbjct: 230 GEDDLETLQNVK 241

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 36.2 bits (83), Expect = 0.003
 Identities = 10/21 (47%), Positives = 16/21 (76%)

Query: 1   MLVIDPEKRISVDDALMHPYI 21
           +L  +P KR++V DAL HP++
Sbjct: 266 LLQKEPRKRLTVHDALEHPWL 286

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (396), Expect = 1e-46
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 22/214 (10%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRP-FQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           +G G+      A D    + VAIKK+S    Q+    +   +E + ++ + H N I    
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 129 AFTPQKSLEEFQDVYLVMELMDAN---LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 185
            +            +LVME    +   L +V +  L    ++ + +  L G+ +LHS  +
Sbjct: 83  CY------LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG---YKE 242
           IHRD+K  NI++     +K+ DFG A           +V T Y+ APEVIL M    Y  
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDG 193

Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            VD+WS+G    E+          + +     I 
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.8 bits (95), Expect = 9e-05
 Identities = 9/59 (15%), Positives = 21/59 (35%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
            L   P+ R + +  L H ++        +        D   +       + K++++QE
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQE 308

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 2e-46
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 23/220 (10%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G+          +  + +  K+L          +    E  L++ + H NI+   + 
Sbjct: 12  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71

Query: 130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHS 182
              + +      +Y+VME  +  +L  VI         LD E +  ++ Q+   +K  H 
Sbjct: 72  IIDRTN----TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127

Query: 183 AG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TTFMMTPYVVTRYYRAPEVIL 236
                  ++HRDLKP+N+ +     +K+ DFGLAR     T     +V T YY +PE + 
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 187

Query: 237 GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            M Y E  DIWS+GC++ E+      F      +   KI 
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 227

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-46
 Identities = 116/209 (55%), Positives = 152/209 (72%), Gaps = 10/209 (4%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G+GA      A D  T   VAIKKL RPFQ+   AKRAYRE +L+K + H+N+IGLL+ 
Sbjct: 26  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHR 188
           FTP ++L++F D YLVM  M  +L ++++ + L  +R+ +L+YQML G++++H+AGIIHR
Sbjct: 86  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHR 145

Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIW 247
           DLKP N+ V  DC LKILDFGLAR A +   MT YVVTR+YRAPEVIL  M Y + VDIW
Sbjct: 146 DLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIW 203

Query: 248 SVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           SVGCIM EMI G  LF G+DH+DQ  +I+
Sbjct: 204 SVGCIMAEMITGKTLFKGSDHLDQLKEIM 232

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.9 bits (152), Expect = 6e-12
 Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 2/59 (3%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           MLV+D E+R++  +AL HPY     D  +   P    YD S D+ + T+D+WK + Y+E
Sbjct: 284 MLVLDAEQRVTAGEALAHPYFESLHDTEDE--PQVQKYDDSFDDVDRTLDEWKRVTYKE 340

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 6e-46
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 24/217 (11%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T    A K +    ++    +    E  ++   +H NI+ LL+A
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGI 185
           F  + +L      ++++E         + ++    L   ++  +  Q L  + +LH   I
Sbjct: 78  FYYENNL------WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 131

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGM-----G 239
           IHRDLK  NI+   D  +K+ DFG++     T      ++ T Y+ APEV++        
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191

Query: 240 YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           Y    D+WS+G  + EM          + +    KI 
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 5e-45
 Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 19/214 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLS-RPFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LG G+      A + AT +  AIK L  R            RE  +M  ++H   + L  
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGI 185
            F   + L      Y  +                  D     +   +++  +++LH  GI
Sbjct: 76  TFQDDEKL------YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
           IHRDLKP NI++  D  ++I DFG A+             +V T  Y +PE++      +
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189

Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           + D+W++GCI+ +++ G   F   +    + KII
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 223

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 3e-44
 Identities = 65/235 (27%), Positives = 107/235 (45%), Gaps = 18/235 (7%)

Query: 59  ELPISHQMGKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREF 112
           E P   ++ K     + +G G       A    T Q VA+KK+    +       A RE 
Sbjct: 2   ECPFCDEVSKYE-KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60

Query: 113 KLMKLVNHKNIIGLLNAFTPQKS--LEEFQDVYLVMELMDANL---CQVIQMDLDHERMS 167
           K+++L+ H+N++ L+     + S        +YLV +  + +L      + +      + 
Sbjct: 61  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120

Query: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTTFMMTP 222
            ++  +L G+ ++H   I+HRD+K +N+++  D  LK+ DFGLAR             T 
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 223 YVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            VVT +YR PE++LG   Y   +D+W  GCIM EM     +  G     Q   I 
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.3 bits (88), Expect = 6e-04
 Identities = 11/21 (52%), Positives = 15/21 (71%)

Query: 1   MLVIDPEKRISVDDALMHPYI 21
           +LV+DP +RI  DDAL H + 
Sbjct: 288 LLVLDPAQRIDSDDALNHDFF 308

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 3e-44
 Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 20/225 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A +  T++ VA+K +    + V   +   +E  + K++NH+N++     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71

Query: 130 FTPQKSLEEFQDVYLVMELMDANLC-QVIQMD--LDHERMSYLLYQMLCGIKHLHSAGII 186
                        YL +E          I+ D  +         +Q++ G+ +LH  GI 
Sbjct: 72  RREGNIQ------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125

Query: 187 HRDLKPSNIVVKSDCTLKILDFGLARTA---GTTFMMTPYVVTRYYRAPEVILGMGYK-E 242
           HRD+KP N+++     LKI DFGLA          ++     T  Y APE++    +  E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185

Query: 243 NVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLD 287
            VD+WS G ++  M+ G + +       Q      + +   +   
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-44
 Identities = 98/227 (43%), Positives = 148/227 (65%), Gaps = 14/227 (6%)

Query: 67  GKKRHNTSHLGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH 120
           G +  N S++G GA      AYD   +  VAIKK+  PF++ T+ +R  RE K++    H
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRH 65

Query: 121 KNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKH 179
           +NIIG+ +      ++E+ +DVYLV  LM A+L ++++   L ++ + Y LYQ+L G+K+
Sbjct: 66  ENIIGINDIIR-APTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TTFMMTPYVVTRYYRAPEVI 235
           +HSA ++HRDLKPSN+++ + C LKI DFGLAR A      T  +T YV TR+YRAPE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 236 L-GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE 281
           L   GY +++DIWSVGCI+ EM+    +FPG  ++DQ N I+G +  
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.6 bits (133), Expect = 2e-09
 Identities = 20/59 (33%), Positives = 35/59 (59%), Gaps = 1/59 (1%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           ML  +P KRI V+ AL HPY+  ++D ++    A  P+   ++  +   ++ KELI++E
Sbjct: 278 MLTFNPHKRIEVEQALAHPYLEQYYDPSDE-PIAEAPFKFDMELDDLPKEKLKELIFEE 335

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 4e-43
 Identities = 119/209 (56%), Positives = 152/209 (72%), Gaps = 10/209 (4%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G+GA      A+DT T   VA+KKLSRPFQ++ HAKR YRE +L+K + H+N+IGLL+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHR 188
           FTP +SLEEF DVYLV  LM A+L  +++   L  + + +L+YQ+L G+K++HSA IIHR
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 145

Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMG-YKENVDIW 247
           DLKPSN+ V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L    Y + VDIW
Sbjct: 146 DLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203

Query: 248 SVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           SVGCIM E++ G  LFPGTDHIDQ   I+
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLIL 232

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.0 bits (165), Expect = 1e-13
 Identities = 24/59 (40%), Positives = 33/59 (55%), Gaps = 2/59 (3%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE 59
           MLV+D +KRI+   AL H Y   + D  +   P   PYD S + R+  +D+WK L Y E
Sbjct: 284 MLVLDSDKRITAAQALAHAYFAQYHDPDD--EPVADPYDQSFESRDLLIDEWKSLTYDE 340

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 5e-43
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 16/215 (7%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G+        DT T   VA  +L       +  +R   E +++K + H NI+   ++
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG-- 184
           +  + +++  + + LV ELM +   +        +  + +     Q+L G++ LH+    
Sbjct: 77  W--ESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 134

Query: 185 IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKEN 243
           IIHRDLK  NI +     ++KI D GLA     +F     + T  + APE+     Y E+
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMYEE-KYDES 192

Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
           VD+++ G  M EM      +    +  Q  + +  
Sbjct: 193 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 7e-43
 Identities = 45/213 (21%), Positives = 91/213 (42%), Gaps = 21/213 (9%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G         +T++++    K +     +    K+   E  ++ +  H+NI+ L  +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHLHES 69

Query: 130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGI 185
           F      E  +++ ++ E +   ++ + I     +L+   +   ++Q+   ++ LHS  I
Sbjct: 70  F------ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123

Query: 186 IHRDLKPSNIVV--KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKEN 243
            H D++P NI+   +   T+KI++FG AR                Y APEV         
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183

Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            D+WS+G ++  ++ G   F    +      I+
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.9 bits (85), Expect = 0.002
 Identities = 7/21 (33%), Positives = 15/21 (71%)

Query: 1   MLVIDPEKRISVDDALMHPYI 21
           +LV + + R++  +AL HP++
Sbjct: 241 LLVKERKSRMTASEALQHPWL 261

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 1e-42
 Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 20/215 (9%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G+      A    + + VAIKK+ +        +   RE ++M+ ++H NI+ L   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYF 81

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVI------QMDLDHERMSYLLYQMLCGIKHLHSA 183
           F      ++   + LV++ +   + +V       +  L    +   +YQ+   + ++HS 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141

Query: 184 GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILG-MGYK 241
           GI HRD+KP N+++  D   LK+ DFG A+          Y+ +RYYRAPE+I G   Y 
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYT 201

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            ++D+WS GC++ E++ G  +FPG   +DQ  +II
Sbjct: 202 SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 4e-04
 Identities = 8/52 (15%), Positives = 21/52 (40%), Gaps = 1/52 (1%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFD-DAEVHAPAPGPYDHSVDEREHTVDQ 51
           +L   P  R++  +A  H + +   D + ++      P   +   +E + + 
Sbjct: 286 LLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP 337

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 3e-42
 Identities = 54/243 (22%), Positives = 104/243 (42%), Gaps = 33/243 (13%)

Query: 50  DQWKELIYQELPISH-QMGKKRHNTSHLGAGA---AYDTATQQNVAIKKLSRPFQNVTHA 105
           D W      E+P     +G++      +G+G+    Y      +VA+K L+         
Sbjct: 1   DDW------EIPDGQITVGQR------IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL 48

Query: 106 KRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDL 161
           +    E  +++   H NI+  +   T          + +V +  +     +   +I+   
Sbjct: 49  QAFKNEVGVLRKTRHVNILLFMGYSTAP-------QLAIVTQWCEGSSLYHHLHIIETKF 101

Query: 162 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TTF 218
           +  ++  +  Q   G+ +LH+  IIHRDLK +NI +  D T+KI DFGLA        + 
Sbjct: 102 EMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161

Query: 219 MMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
                  +  + APEVI       Y    D+++ G ++ E++ G + +   ++ DQ   +
Sbjct: 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 221

Query: 276 IGK 278
           +G+
Sbjct: 222 VGR 224

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (362), Expect = 1e-41
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 19/213 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG GA      A D  TQ+ VAIK +++             E  ++  + H NI+ L + 
Sbjct: 17  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 130 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGII 186
           +      E    +YL+M+L+    L   I           S L++Q+L  +K+LH  GI+
Sbjct: 76  Y------ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 129

Query: 187 HRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKEN 243
           HRDLKP N++  S   D  + I DFGL++      +++    T  Y APEV+    Y + 
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189

Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           VD WS+G I   ++ G   F   +    + +I+
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 222

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.2 bits (83), Expect = 0.003
 Identities = 10/21 (47%), Positives = 15/21 (71%)

Query: 1   MLVIDPEKRISVDDALMHPYI 21
           ++  DPEKR + + AL HP+I
Sbjct: 247 LMEKDPEKRFTCEQALQHPWI 267

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 2e-41
 Identities = 74/215 (34%), Positives = 112/215 (52%), Gaps = 15/215 (6%)

Query: 76  LGAGA------AYDTAT-QQNVAIKKLSRPFQNVTHAKRAYREFKLMKL---VNHKNIIG 125
           +G GA      A D     + VA+K++              RE  +++      H N++ 
Sbjct: 15  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDAN----LCQVIQMDLDHERMSYLLYQMLCGIKHLH 181
           L +  T  ++ +    + LV E +D +    L +V +  +  E +  +++Q+L G+  LH
Sbjct: 75  LFDVCTVSRT-DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           S  ++HRDLKP NI+V S   +K+ DFGLAR       +T  VVT +YRAPEV+L   Y 
Sbjct: 134 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA 193

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
             VD+WSVGCI  EM R   LF G+  +DQ  KI+
Sbjct: 194 TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.002
 Identities = 11/22 (50%), Positives = 12/22 (54%)

Query: 1   MLVIDPEKRISVDDALMHPYIN 22
            L  +P KRIS   AL HPY  
Sbjct: 276 CLTFNPAKRISAYSALSHPYFQ 297

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-41
 Identities = 77/215 (35%), Positives = 118/215 (54%), Gaps = 20/215 (9%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTH---AKRAYREFKLMKLVNHKNIIGL 126
           LG G       A D  T Q VAIKK+    ++       + A RE KL++ ++H NIIGL
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 127 LNAFTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSA 183
           L+AF          ++ LV + M+ +L  +I    + L    +   +   L G+++LH  
Sbjct: 66  LDAF------GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFM-MTPYVVTRYYRAPEVILGM-GYK 241
            I+HRDLKP+N+++  +  LK+ DFGLA++ G+     T  VVTR+YRAPE++ G   Y 
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
             VD+W+VGCI+ E++      PG   +DQ  +I 
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 2e-04
 Identities = 9/37 (24%), Positives = 14/37 (37%), Gaps = 6/37 (16%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGP 37
           + + +P  RI+   AL   Y +          P PG 
Sbjct: 263 LFLFNPCARITATQALKMKYFS------NRPGPTPGC 293

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 6e-41
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 24/226 (10%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLN 128
           LG G        ++  TQ+  A+K L           +A RE +L  +     +I+ +++
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVD 72

Query: 129 AFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSA 183
            +  +      + + +VME +D   L   IQ            S ++  +   I++LHS 
Sbjct: 73  VY--ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130

Query: 184 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY 240
            I HRD+KP N++  S   +  LK+ DFG A+   +   +T    T YY APEV+    Y
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190

Query: 241 KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL 286
            ++ D+WS+G IM  ++ G   F     +     +  ++R    + 
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (92), Expect = 3e-04
 Identities = 9/70 (12%), Positives = 25/70 (35%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL 60
           +L  +P +R+++ + + HP+I       +             +  E   ++    +    
Sbjct: 255 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR 314

Query: 61  PISHQMGKKR 70
               Q+  K+
Sbjct: 315 VDYEQIKIKK 324

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  139 bits (352), Expect = 1e-40
 Identities = 57/224 (25%), Positives = 88/224 (39%), Gaps = 29/224 (12%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAK-------RAYREFKLM-KLVNHK 121
           LG G            T +  A+K +         A+          +E  ++ K+  H 
Sbjct: 11  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70

Query: 122 NIIGLLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIK 178
           NII L + +      E     +LV +LM    L   +     L  +    ++  +L  I 
Sbjct: 71  NIIQLKDTY------ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM 238
            LH   I+HRDLKP NI++  D  +K+ DFG +        +     T  Y APE+I   
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184

Query: 239 ------GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
                 GY + VD+WS G IM  ++ G   F     +     I+
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  139 bits (351), Expect = 2e-40
 Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 16/215 (7%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LG G       A D    ++VA+K L     ++ +   R  RE +    +NH  I+ + +
Sbjct: 15  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 74

Query: 129 AFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGI 185
               +         Y+VME +D   L  ++  +  +  +R   ++      +   H  GI
Sbjct: 75  TGEAETPAGPL--PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI 132

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTTFMMTPYVVTRYYRAPEVILGMGYK 241
           IHRD+KP+NI++ +   +K++DFG+AR    +  +       + T  Y +PE   G    
Sbjct: 133 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD 192

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
              D++S+GC++ E++ G   F G   +    + +
Sbjct: 193 ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 1e-39
 Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 23/228 (10%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNHKNIIG 125
           LG+G         + +T    A K + +      +     +   RE  ++K + H N+I 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS 182
           L   +      E   DV L++EL+          +   L  E  +  L Q+L G+ +LHS
Sbjct: 78  LHEVY------ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131

Query: 183 AGIIHRDLKPSNIVVKSD----CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM 238
             I H DLKP NI++         +KI+DFGLA              T  + APE++   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191

Query: 239 GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL 286
                 D+WS+G I   ++ G   F G    +    +     E  D+ 
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.4 bits (86), Expect = 0.001
 Identities = 12/40 (30%), Positives = 20/40 (50%), Gaps = 4/40 (10%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDH 40
           +LV DP+KR+++ D+L HP    W    +        + H
Sbjct: 254 LLVKDPKKRMTIQDSLQHP----WIKPKDTQQALSSAWSH 289

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 1e-39
 Identities = 76/213 (35%), Positives = 111/213 (52%), Gaps = 18/213 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G       A +  T + VA+KK+    +       A RE  L+K +NH NI+ LL+ 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVI----QMDLDHERMSYLLYQMLCGIKHLHSAGI 185
              +  L      YLV E +  +L + +       +    +   L+Q+L G+   HS  +
Sbjct: 70  IHTENKL------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYK-EN 243
           +HRDLKP N+++ ++  +K+ DFGLAR  G      T  VVT +YRAPE++LG  Y    
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183

Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
           VDIWS+GCI  EM+    LFPG   IDQ  +I 
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.001
 Identities = 15/35 (42%), Positives = 17/35 (48%), Gaps = 6/35 (17%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAP 35
           ML  DP KRIS   AL HP+        +V  P P
Sbjct: 266 MLHYDPNKRISAKAALAHPFF------QDVTKPVP 294

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 4e-37
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 18/212 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR-PFQNVTHAKRAYREFK-LMKLVNHKNIIGLL 127
           LG G+      A    T Q  AIK L +         +    E + L     H  +  + 
Sbjct: 10  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69

Query: 128 NAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG 184
             F      +  ++++ VME ++  +L   IQ     D  R ++   +++ G++ LHS G
Sbjct: 70  CTF------QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TTFMMTPYVVTRYYRAPEVILGMGYKEN 243
           I++RDLK  NI++  D  +KI DFG+ +           +  T  Y APE++LG  Y  +
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183

Query: 244 VDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           VD WS G ++ EM+ G   F G D  + ++ I
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 215

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  131 bits (329), Expect = 5e-37
 Identities = 69/196 (35%), Positives = 103/196 (52%), Gaps = 11/196 (5%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
             +  A+KK+    ++        RE  ++K + H NI+ L +    +K L       LV
Sbjct: 25  YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL------VLV 78

Query: 146 MELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202
            E +D +L +++   +  L+       L Q+L GI + H   ++HRDLKP N+++  +  
Sbjct: 79  FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE 138

Query: 203 LKILDFGLARTAG-TTFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGG 260
           LKI DFGLAR  G      T  +VT +YRAP+V++G   Y   +DIWSVGCI  EM+ G 
Sbjct: 139 LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

Query: 261 VLFPGTDHIDQWNKII 276
            LFPG    DQ  +I 
Sbjct: 199 PLFPGVSEADQLMRIF 214

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 36.8 bits (84), Expect = 0.002
 Identities = 10/21 (47%), Positives = 13/21 (61%)

Query: 1   MLVIDPEKRISVDDALMHPYI 21
           ML +DP +RI+   AL H Y 
Sbjct: 264 MLKLDPNQRITAKQALEHAYF 284

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 7e-37
 Identities = 44/201 (21%), Positives = 81/201 (40%), Gaps = 17/201 (8%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
               VA+K +         A+    E  +M  + H N++ LL         EE   +Y+V
Sbjct: 29  RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIV-----EEKGGLYIV 79

Query: 146 MELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
            E M   +L   ++      L  + +      +   +++L     +HRDL   N++V  D
Sbjct: 80  TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 139

Query: 201 CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG 260
              K+ DFGL + A +T       +   + APE +    +    D+WS G ++ E+   G
Sbjct: 140 NVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197

Query: 261 VL-FPGTDHIDQWNKIIGKMR 280
            + +P     D   ++    +
Sbjct: 198 RVPYPRIPLKDVVPRVEKGYK 218

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  129 bits (325), Expect = 4e-36
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 18/211 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR-PFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LG G+             +  A+K L +     +   +    E  ++ +V H  II +  
Sbjct: 12  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGI 185
            F      ++ Q ++++M+ ++      +        +    +   ++   +++LHS  I
Sbjct: 72  TF------QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125

Query: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVD 245
           I+RDLKP NI++  +  +KI DFG A+      +      T  Y APEV+    Y +++D
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSID 183

Query: 246 IWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            WS G ++ EM+ G   F  ++ +  + KI+
Sbjct: 184 WWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 214

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  129 bits (324), Expect = 1e-35
 Identities = 49/219 (22%), Positives = 92/219 (42%), Gaps = 21/219 (9%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPF----QNVTHAKRAYREFKLMKLVNHKNIIG 125
           +G G            T +  A+K L +      Q  T A        L+   +   I+ 
Sbjct: 12  IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 71

Query: 126 LLNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDH--ERMSYLLYQMLCGIKHLHS 182
           +  AF           +  +++LM+  +L   +          M +   +++ G++H+H+
Sbjct: 72  MSYAF------HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVIL-GMGYK 241
             +++RDLKP+NI++     ++I D GLA            V T  Y APEV+  G+ Y 
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYD 184

Query: 242 ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMR 280
            + D +S+GC++ +++RG   F      D+       + 
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 2e-35
 Identities = 46/203 (22%), Positives = 81/203 (39%), Gaps = 18/203 (8%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
               VA+K L +   +         E  LMK + H+ ++ L    T +        +Y++
Sbjct: 36  GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQE-------PIYII 85

Query: 146 MELMDANLCQVI-----QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
            E M+             + L   ++  +  Q+  G+  +     IHRDL+ +NI+V   
Sbjct: 86  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT 145

Query: 201 CTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 258
            + KI DFGLAR                  + APE I    +    D+WS G ++ E++ 
Sbjct: 146 LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

Query: 259 GGVL-FPGTDHIDQWNKIIGKMR 280
            G + +PG  + +    +    R
Sbjct: 206 HGRIPYPGMTNPEVIQNLERGYR 228

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 2e-35
 Identities = 41/201 (20%), Positives = 78/201 (38%), Gaps = 15/201 (7%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
                + VA+K L     +         E  +M+ +++  I+ ++          E +  
Sbjct: 30  MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-------EAESW 82

Query: 143 YLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
            LVME+ +             +  + +  L++Q+  G+K+L  +  +HRDL   N+++ +
Sbjct: 83  MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT 142

Query: 200 DCTLKILDFGLARTAGTTFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
               KI DFGL++            T       + APE I    +    D+WS G +M E
Sbjct: 143 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202

Query: 256 MIRGGVL-FPGTDHIDQWNKI 275
               G   + G    +    +
Sbjct: 203 AFSYGQKPYRGMKGSEVTAML 223

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 3e-35
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 12/210 (5%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G       A +  T + VA+K++     +      A RE  L+K + HKNI+ L + 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
               K   +   V+   +            DLD E +   L+Q+L G+   HS  ++HRD
Sbjct: 70  LHSDK---KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRD 126

Query: 190 LKPSNIVVKSDCTLKILDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMG-YKENVDIW 247
           LKP N+++  +  LK+ +FGLAR  G      +  VVT +YR P+V+ G   Y  ++D+W
Sbjct: 127 LKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMW 186

Query: 248 SVGCIMGEMIRGGV-LFPGTDHIDQWNKII 276
           S GCI  E+   G  LFPG D  DQ  +I 
Sbjct: 187 SAGCIFAELANAGRPLFPGNDVDDQLKRIF 216

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 9e-04
 Identities = 10/26 (38%), Positives = 17/26 (65%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFD 26
           +L  +P +RIS ++AL HPY + +  
Sbjct: 266 LLKCNPVQRISAEEALQHPYFSDFCP 291

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 4e-35
 Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 25/219 (11%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR----PFQNVTHAKRAYREFKLMKLVN--HKNI 123
           LG+G           +    VAIK + +     +  + +  R   E  L+K V+     +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71

Query: 124 IGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKH 179
           I LL+ F    S        L++E  +        +     L  E      +Q+L  ++H
Sbjct: 72  IRLLDWFERPDSF------VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 180 LHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM 238
            H+ G++HRD+K  NI++  +   LK++DFG       T + T +  TR Y  PE I   
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 184

Query: 239 GYK-ENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            Y   +  +WS+G ++ +M+ G + F   + I +     
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 223

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (317), Expect = 6e-35
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 19/214 (8%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMK-LVNHKNIIGLLN 128
           LG G       A +    + V +K L          K+  RE K+++ L    NII L +
Sbjct: 43  LGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLAD 97

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHR 188
                 S    +   LV E ++    + +   L    + + +Y++L  + + HS GI+HR
Sbjct: 98  IVKDPVS----RTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHR 153

Query: 189 DLKPSNIVVKSD-CTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGM-GYKENVDI 246
           D+KP N+++  +   L+++D+GLA            V +RY++ PE+++    Y  ++D+
Sbjct: 154 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 213

Query: 247 WSVGCIMGEMIRGGV-LFPGTDHIDQWNKIIGKM 279
           WS+GC++  MI      F G D+ DQ  +I   +
Sbjct: 214 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 37.1 bits (85), Expect = 0.001
 Identities = 7/20 (35%), Positives = 13/20 (65%)

Query: 1   MLVIDPEKRISVDDALMHPY 20
           +L  D + R++  +A+ HPY
Sbjct: 302 LLRYDHQSRLTAREAMEHPY 321

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-34
 Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 25/219 (11%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G            T + VAIK L     +    +   +E ++MK + H+ ++ L   
Sbjct: 25  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAG 184
            +        + +Y+V E M              + +       +  Q+  G+ ++    
Sbjct: 81  VS-------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133

Query: 185 IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
            +HRDL+ +NI+V  +   K+ DFGLAR                  + APE  L   +  
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193

Query: 243 NVDIWSVGCIMGEMIRGG-VLFPGTDHIDQWNKIIGKMR 280
             D+WS G ++ E+   G V +PG  + +  +++    R
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 232

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-34
 Identities = 65/280 (23%), Positives = 105/280 (37%), Gaps = 40/280 (14%)

Query: 29  EVHAPAPGPYDHSVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLG-AGAAYDTATQ 87
           +V   +   Y + VD RE+  D   E   + L     +G           A     T   
Sbjct: 9   QVTGSSDNEYFY-VDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVS 67

Query: 88  QNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLNAFTPQKSLEEFQDVYLVM 146
             VA+K L     + +  +    E K+M +L +H+NI+ LL A            +YL+ 
Sbjct: 68  IQVAVKMLKEKADS-SEREALMSELKMMTQLGSHENIVNLLGAC------TLSGPIYLIF 120

Query: 147 ELMD-ANLCQVIQMD-------------------------LDHERMSYLLYQMLCGIKHL 180
           E     +L   ++                           L  E +    YQ+  G++ L
Sbjct: 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 180

Query: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFMMTPYVVTRYYRAPEVILG 237
                +HRDL   N++V     +KI DFGLAR   +     +     +   + APE +  
Sbjct: 181 EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240

Query: 238 MGYKENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKII 276
             Y    D+WS G ++ E+   GV  +PG      + K+I
Sbjct: 241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-34
 Identities = 45/202 (22%), Positives = 83/202 (41%), Gaps = 17/202 (8%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
               Q +VAIK L +  +     +   RE ++M  +++  I+ L+          + + +
Sbjct: 32  MRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVC-------QAEAL 83

Query: 143 YLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
            LVME+             + ++    ++ LL+Q+  G+K+L     +HRDL   N+++ 
Sbjct: 84  MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV 143

Query: 199 SDCTLKILDFGLARTAG----TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
           +    KI DFGL++  G         +       + APE I    +    D+WS G  M 
Sbjct: 144 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 203

Query: 255 EMIRGGVL-FPGTDHIDQWNKI 275
           E +  G   +      +    I
Sbjct: 204 EALSYGQKPYKKMKGPEVMAFI 225

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  123 bits (310), Expect = 3e-34
 Identities = 48/240 (20%), Positives = 101/240 (42%), Gaps = 11/240 (4%)

Query: 41  SVDEREHTVDQWKELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ 100
           ++D      D+W E+   ++ + H++G  ++   + G            VA+K L     
Sbjct: 1   AMDPSSPNYDKW-EMERTDITMKHKLGGGQYGEVYEG----VWKKYSLTVAVKTLKE--- 52

Query: 101 NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD 160
           +    +   +E  +MK + H N++ LL   T +       + ++    +   L +  + +
Sbjct: 53  DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE-FMTYGNLLDYLRECNRQE 111

Query: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTTF 218
           +    + Y+  Q+   +++L     IHRDL   N +V  +  +K+ DFGL+R  T  T  
Sbjct: 112 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171

Query: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
                     + APE +    +    D+W+ G ++ E+   G+       + Q  +++ K
Sbjct: 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (312), Expect = 5e-34
 Identities = 49/219 (22%), Positives = 92/219 (42%), Gaps = 12/219 (5%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR-PFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LG G+           +  + A+K L +     +   +    E ++++ VN   ++ L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHR 188
           +F    +L    +     E+   +L ++ +    H R  +   Q++   ++LHS  +I+R
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFS-HLRRIGRFSEPHAR--FYAAQIVLTFEYLHSLDLIYR 165

Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 248
           DLKP N+++     +++ DFG A+                  APE+IL  GY + VD W+
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP--EALAPEIILSKGYNKAVDWWA 223

Query: 249 VGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKLD 287
           +G ++ EM  G   F     I  + KI+           
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS 262

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 6e-34
 Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 11/209 (5%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSR-PFQNVTHAKRAYREFKLMKLVNHKNIIGLLN 128
           LG G         + AT +  A+K L +              E ++++   H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 129 AFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHR 188
           AF     L    +     EL         +     ER  +   +++  +++LHS  +++R
Sbjct: 73  AFQTHDRLCFVMEYANGGELFF---HLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129

Query: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVV-TRYYRAPEVILGMGYKENVDIW 247
           D+K  N+++  D  +KI DFGL +   +          T  Y APEV+    Y   VD W
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189

Query: 248 SVGCIMGEMIRGGVLFPGTDHIDQWNKII 276
            +G +M EM+ G + F   DH   +  I+
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELIL 218

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  122 bits (307), Expect = 1e-33
 Identities = 41/222 (18%), Positives = 84/222 (37%), Gaps = 31/222 (13%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G G+        +    Q VAIK   R     + A +   E++  KL+     I  +  
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 130 FTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGII 186
           F      +E     LV++L+  +L  ++ +       + ++    QML  ++ +H   ++
Sbjct: 69  FG-----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123

Query: 187 HRDLKPSNIVVKSDCT-----LKILDFGLAR--------TAGTTFMMTPYVVTRYYRAPE 233
           +RD+KP N ++    +     + ++DFG+ +                     T  Y +  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 234 VILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
             LG       D+ ++G +    +RG + + G        K 
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 1e-33
 Identities = 47/204 (23%), Positives = 74/204 (36%), Gaps = 17/204 (8%)

Query: 83  DTATQQNVAIKKLSR-PFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD 141
            +    +VA+K L               RE   M  ++H+N+I L               
Sbjct: 32  PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV-------LTPP 84

Query: 142 VYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
           + +V EL       +  +  Q       +S    Q+  G+ +L S   IHRDL   N+++
Sbjct: 85  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 144

Query: 198 KSDCTLKILDFGLAR----TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
            +   +KI DFGL R          M     V   + APE +    +    D W  G  +
Sbjct: 145 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204

Query: 254 GEMI-RGGVLFPGTDHIDQWNKII 276
            EM   G   + G +     +KI 
Sbjct: 205 WEMFTYGQEPWIGLNGSQILHKID 228

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 1e-33
 Identities = 39/202 (19%), Positives = 82/202 (40%), Gaps = 16/202 (7%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
            Q +VAIK +     +         E K+M  ++H+ ++ L           + + ++++
Sbjct: 27  GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVC------TKQRPIFII 77

Query: 146 MELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
            E M      N  + ++     +++  +   +   +++L S   +HRDL   N +V    
Sbjct: 78  TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 137

Query: 202 TLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
            +K+ DFGL+R                  +  PEV++   +    DIW+ G +M E+   
Sbjct: 138 VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 197

Query: 260 GVL-FPGTDHIDQWNKIIGKMR 280
           G + +    + +    I   +R
Sbjct: 198 GKMPYERFTNSETAEHIAQGLR 219

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (303), Expect = 4e-33
 Identities = 51/225 (22%), Positives = 84/225 (37%), Gaps = 27/225 (12%)

Query: 76  LGAGA------AYDTATQQN---VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGL 126
           +GAG        +     +    VAIK L   +      +    E  +M   +H N+I L
Sbjct: 34  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHL 92

Query: 127 LNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHS 182
                      +   V ++ E M+                  ++  +L  +  G+K+L  
Sbjct: 93  EGVV------TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146

Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTTFMMTPYVVTRYYRAPEVIL 236
              +HRDL   NI+V S+   K+ DFGL+R      +  T        +   + APE I 
Sbjct: 147 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 206

Query: 237 GMGYKENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKIIGKMR 280
              +    D+WS G +M E++  G   +    + D  N I    R
Sbjct: 207 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  120 bits (301), Expect = 7e-33
 Identities = 47/220 (21%), Positives = 83/220 (37%), Gaps = 29/220 (13%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           +G+G+        D A  + VAIK      ++     + + E K+ K++     I  +  
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRW 70

Query: 130 FTPQKSLEEFQDVYLVMELMDANL---CQVIQMDLDHERMSYLLYQMLCGIKHLHSAGII 186
                   E     +VMEL+  +L             + +  L  QM+  I+++HS   I
Sbjct: 71  CG-----AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125

Query: 187 HRDLKPSNIVVKS---DCTLKILDFGLARTAG--------TTFMMTPYVVTRYYRAPEVI 235
           HRD+KP N ++        + I+DFGLA+                     T  Y +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 236 LGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKI 275
           LG+      D+ S+G ++     G + + G     +  K 
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 3e-32
 Identities = 42/205 (20%), Positives = 78/205 (38%), Gaps = 15/205 (7%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
            +  VAIK +     +    +    E ++M  ++H  ++ L           E   + LV
Sbjct: 28  NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVC------LEQAPICLV 78

Query: 146 MELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
            E M+    ++  +  +     E +  +   +  G+ +L  A +IHRDL   N +V  + 
Sbjct: 79  FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ 138

Query: 202 TLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 259
            +K+ DFG+ R          T       + +PEV     Y    D+WS G +M E+   
Sbjct: 139 VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 198

Query: 260 GVLFPGTDHIDQWNKIIGKMREAHD 284
           G +        +  + I      + 
Sbjct: 199 GKIPYENRSNSEVVEDISTGFRLYK 223

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 8e-32
 Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 28/219 (12%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLNAFTPQKSLEEFQD 141
               + + AIK++ + + +    +    E +++ KL +H NII LL A   +  L     
Sbjct: 33  KDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL----- 86

Query: 142 VYLVMELMDA-NLCQVIQMD------------------LDHERMSYLLYQMLCGIKHLHS 182
            YL +E     NL   ++                    L  +++ +    +  G+ +L  
Sbjct: 87  -YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 145

Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKE 242
              IHRDL   NI+V  +   KI DFGL+R        T   +   + A E +    Y  
Sbjct: 146 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT 205

Query: 243 NVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKIIGKMR 280
           N D+WS G ++ E++  G   + G    + + K+    R
Sbjct: 206 NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 1e-31
 Identities = 43/208 (20%), Positives = 81/208 (38%), Gaps = 15/208 (7%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
           +   + + A+K L+R   ++    +   E  +MK  +H N++ LL        L      
Sbjct: 51  NDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC-----LRSEGSP 104

Query: 143 YLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
            +V+  M      N  +    +   + +     Q+  G+K L S   +HRDL   N ++ 
Sbjct: 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 164

Query: 199 SDCTLKILDFGLAR-----TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
              T+K+ DFGLAR        +    T   +   + A E +    +    D+WS G ++
Sbjct: 165 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224

Query: 254 GEMIRGGVLFPGTDHIDQWNKIIGKMRE 281
            E++  G       +       + + R 
Sbjct: 225 WELMTRGAPPYPDVNTFDITVYLLQGRR 252

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 3e-31
 Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 24/221 (10%)

Query: 76  LGAGA------AYDTATQQN---VAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGL 126
           +G G           + +     VAIK       +    ++  +E   M+  +H +I+ L
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKL 73

Query: 127 LNAFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS 182
           +   T          V+++MEL       +  QV +  LD   +    YQ+   + +L S
Sbjct: 74  IGVITEN-------PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126

Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGMGY 240
              +HRD+   N++V S+  +K+ DFGL+R     T +  +   +   + APE I    +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 241 KENVDIWSVGCIMGEMI-RGGVLFPGTDHIDQWNKIIGKMR 280
               D+W  G  M E++  G   F G  + D   +I    R
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 227

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 5e-31
 Identities = 56/220 (25%), Positives = 86/220 (39%), Gaps = 33/220 (15%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLM-KLVNHKNIIGLLNAFTPQKSLEEFQD 141
            +     VA+K L +P  ++T  +    E K++  L NH NI+ LL A T          
Sbjct: 49  KSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT----- 102

Query: 142 VYLVMELMD---------------------ANLCQVIQMDLDHERMSYLLYQMLCGIKHL 180
             ++ E                          + +  ++ LD E +    YQ+  G+  L
Sbjct: 103 -LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161

Query: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFMMTPYVVTRYYRAPEVILG 237
            S   IHRDL   NI++      KI DFGLAR         +     +   + APE I  
Sbjct: 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221

Query: 238 MGYKENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKII 276
             Y    D+WS G  + E+   G   +PG     ++ K+I
Sbjct: 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 7e-31
 Identities = 46/202 (22%), Positives = 81/202 (40%), Gaps = 15/202 (7%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
               +  VAIK L   +           E  +M   +H NII L    +      +++ +
Sbjct: 32  SGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVIS------KYKPM 84

Query: 143 YLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
            ++ E M+         +        ++  +L  +  G+K+L +   +HRDL   NI+V 
Sbjct: 85  MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 144

Query: 199 SDCTLKILDFGLARTAG----TTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
           S+   K+ DFGL+R        T+  +   +   + APE I    +    D+WS G +M 
Sbjct: 145 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 204

Query: 255 EMIRGGVLFPGTDHIDQWNKII 276
           E++  G          +  K I
Sbjct: 205 EVMTYGERPYWELSNHEVMKAI 226

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  114 bits (285), Expect = 2e-30
 Identities = 46/225 (20%), Positives = 77/225 (34%), Gaps = 38/225 (16%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
                  VA+K L              RE  LM   ++ NI+ LL      K +      
Sbjct: 39  PYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM------ 91

Query: 143 YLVMELMD-ANLCQVIQ--------------------------MDLDHERMSYLLYQMLC 175
            L+ E M   +L + ++                            L       +  Q+  
Sbjct: 92  CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 151

Query: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFMMTPYVVTRYYRAP 232
           G+ +L     +HRDL   N +V  +  +KI DFGL+R   +A          +   +  P
Sbjct: 152 GMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211

Query: 233 EVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKII 276
           E I    Y    D+W+ G ++ E+   G+  + G  H +    + 
Sbjct: 212 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 256

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-30
 Identities = 49/219 (22%), Positives = 82/219 (37%), Gaps = 23/219 (10%)

Query: 76  LGAGA------AYDTATQQNVAIK---KLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGL 126
           LG+GA             + V I    K  R   +    K    E  +M  V++ ++  L
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76

Query: 127 LNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHS 182
           L              V L+ +LM          +    +  + +     Q+  G+ +L  
Sbjct: 77  LGIC-------LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTTFMMTPYVVTRYYRAPEVILGMG 239
             ++HRDL   N++VK+   +KI DFGLA+        +      V   + A E IL   
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189

Query: 240 YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGK 278
           Y    D+WS G  + E++  G          + + I+ K
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 1e-28
 Identities = 50/222 (22%), Positives = 85/222 (38%), Gaps = 26/222 (11%)

Query: 86  TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLV 145
             + VA+K  S   +     +    E     ++ H+NI+G + A    K    +  ++LV
Sbjct: 25  RGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENILGFIAADN--KDNGTWTQLWLV 79

Query: 146 MELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSA--------GIIHRDLKPSNI 195
            +  +  +L   +    +  E M  L      G+ HLH           I HRDLK  NI
Sbjct: 80  SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139

Query: 196 VVKSDCTLKILDFGLAR-----TAGTTFMMTPYVVTRYYRAPEVILGM------GYKENV 244
           +VK + T  I D GLA      T          V T+ Y APEV+            +  
Sbjct: 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199

Query: 245 DIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL 286
           DI+++G +  E+ R   +    +        +     + +++
Sbjct: 200 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 3e-28
 Identities = 47/248 (18%), Positives = 99/248 (39%), Gaps = 26/248 (10%)

Query: 47  HTVDQWKELIYQELPISHQMGKKRHNTSHLG-AGAAYDTATQQNVAIKKLSRPFQNVTHA 105
           +  D+W E+  +++ +S ++G+      + G A        +  VAIK +     ++   
Sbjct: 10  YVPDEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRER 67

Query: 106 KRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---- 160
                E  +MK  N  +++ LL   +  +         ++MELM   +L   ++      
Sbjct: 68  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPT------LVIMELMTRGDLKSYLRSLRPAM 121

Query: 161 --------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212
                       +M  +  ++  G+ +L++   +HRDL   N +V  D T+KI DFG+ R
Sbjct: 122 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 181

Query: 213 ---TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVL-FPGTDH 268
                         ++   + +PE +    +    D+WS G ++ E+       + G  +
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241

Query: 269 IDQWNKII 276
                 ++
Sbjct: 242 EQVLRFVM 249

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 1e-27
 Identities = 46/229 (20%), Positives = 98/229 (42%), Gaps = 23/229 (10%)

Query: 76  LGAGA---------AYDTATQQNVAIKKLSRP--FQNVTHAKRAYREFKLMKLVNHKNII 124
           LG GA              T +  A+K L +    Q     +    E ++++ +     +
Sbjct: 32  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91

Query: 125 GLLNAFTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIKHLH 181
             L+        +    ++L+++ ++          +       +   + +++  ++HLH
Sbjct: 92  VTLHYA-----FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 146

Query: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTTFMMTPYVVTRYYRAPEVILGM- 238
             GII+RD+K  NI++ S+  + + DFGL++   A  T     +  T  Y AP+++ G  
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206

Query: 239 -GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL 286
            G+ + VD WS+G +M E++ G   F      +   +I  ++ ++    
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 2e-25
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 31/215 (14%)

Query: 90  VAIKKLSRPFQNVTHAKRAYREFKLMK-LVNHKNIIGLLNAFTPQKSLEEFQDVYLVMEL 148
           VA+K L +             E ++MK +  HKNII LL A        +   +Y+++E 
Sbjct: 48  VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC------TQDGPLYVIVEY 100

Query: 149 MD-ANLCQVIQMD------------------LDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
               NL + +Q                    L  + +    YQ+  G+++L S   IHRD
Sbjct: 101 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 160

Query: 190 LKPSNIVVKSDCTLKILDFGLAR---TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
           L   N++V  D  +KI DFGLAR           T   +   + APE +    Y    D+
Sbjct: 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 220

Query: 247 WSVGCIMGEMI-RGGVLFPGTDHIDQWNKIIGKMR 280
           WS G ++ E+   GG  +PG    + +  +    R
Sbjct: 221 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 255

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =   99 bits (248), Expect = 3e-25
 Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 28/219 (12%)

Query: 83  DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDV 142
            TAT + VA+K L     +  H         L+ + +H N++ LL A T     +    +
Sbjct: 39  KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT-----KPGGPL 93

Query: 143 YLVMELMD-ANLCQVIQMD------------------LDHERMSYLLYQMLCGIKHLHSA 183
            +++E     NL   ++                    L  E +    +Q+  G++ L S 
Sbjct: 94  MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153

Query: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTTFMMTPYVVTRYYRAPEVILGMGY 240
             IHRDL   NI++     +KI DFGLAR               +   + APE I    Y
Sbjct: 154 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 213

Query: 241 KENVDIWSVGCIMGEMIRGGVL-FPGTDHIDQWNKIIGK 278
               D+WS G ++ E+   G   +PG    +++ + + +
Sbjct: 214 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 92.0 bits (227), Expect = 5e-22
 Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 40/239 (16%)

Query: 76  LGAGA------AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNA 129
           LG G       A D     +VA+K +     +  + + A  E KL++ VN  +     + 
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 130 FTPQ-----KSLEEFQDVYLVMELMDANLCQVIQMDLDH--------ERMSYLLYQMLCG 176
                              + + ++   L + +   +            +  +  Q+L G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 177 IKHLH-SAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTTFMMTPYVVTRYY 229
           + ++H   GIIH D+KP N++++          +KI D G A      +     + TR Y
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--SIQTREY 195

Query: 230 RAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPG---------TDHIDQWNKIIGKM 279
           R+PEV+LG  +    DIWS  C++ E+I G  LF            DHI Q  +++G++
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 43.9 bits (102), Expect = 1e-05
 Identities = 12/43 (27%), Positives = 17/43 (39%)

Query: 1   MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVD 43
           ML +DP KR      + HP++       E+  P    Y    D
Sbjct: 311 MLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSD 353

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 75.6 bits (185), Expect = 3e-17
 Identities = 26/178 (14%), Positives = 54/178 (30%), Gaps = 27/178 (15%)

Query: 86  TQQNVAIKKL--------SRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE 137
                 +K              +                    + +  L     P+    
Sbjct: 23  KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV--Y 80

Query: 138 EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
            ++   ++MEL+DA     ++++        +L  +L  +   +  GI+H DL   N++V
Sbjct: 81  AWEGNAVLMELIDAKELYRVRVE----NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV 136

Query: 198 KSDCTLKILDFGLART-----AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 250
            S+  + I+DF  +                  +  Y+          Y+   DI S  
Sbjct: 137 -SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT-------YRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	288
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.22
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	97.98
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.89
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.59
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	97.41
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	97.33
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.12
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	96.98
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.93
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.17
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	95.72
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	95.55
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	95.12
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	94.48
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	93.64
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	93.47
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	92.94
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	92.93
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	92.52
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	92.19
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	90.56
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	88.3

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=322.82  Aligned_cols=218  Identities=25%  Similarity=0.390  Sum_probs=187.1

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      .+++.+.+.||+|.++.++.+    .+..+++.||+|++.+.. ........+.+|++++++++||||+++++++.+.+.
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   80 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLA----REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   80 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhHeEEEEEEecCCCcEEEEE----EECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE
Confidence            456788899999988888875    567889999999986422 122335678899999999999999999999988776


Q ss_pred             ccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      .      ++||||+++ +|.+.+.  ..+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|.
T Consensus        81 ~------~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~  154 (263)
T d2j4za1          81 V------YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV  154 (263)
T ss_dssp             E------EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred             E------EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceee
Confidence            5      999999986 5666654  458999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      ....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.+|.+.....|+.
T Consensus       155 ~~~~~~~-~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~  226 (263)
T d2j4za1         155 HAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF  226 (263)
T ss_dssp             CCCCCCC-EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTT
T ss_pred             ecCCCcc-cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence            7654432 44689999999999999999999999999999999999999999999999988888766555543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-48  Score=320.23  Aligned_cols=209  Identities=27%  Similarity=0.421  Sum_probs=178.1

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.||+|.++.++++    .+..+|+.||||+++..  .....+.+.+|++++++++||||+++++++...+..  
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a----~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~--   92 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTA----MDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL--   92 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEE----EBTTTCCEEEEEEEEGG--GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE--
T ss_pred             ccEEEEEEecCcCcEEEEE----EECCCCCEEEEEEEecc--cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEE--
Confidence            3566667777777777664    46788999999999753  223356789999999999999999999999877655  


Q ss_pred             cccEEEEEeccccc-HHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCC
Q psy11580        139 FQDVYLVMELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (288)
Q Consensus       139 ~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~  216 (288)
                          ++||||++++ |.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus        93 ----~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          93 ----WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             ----EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ----EEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence                9999999875 554443 4589999999999999999999999999999999999999999999999999987643


Q ss_pred             C-cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        217 T-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       217 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      . .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~  232 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG  232 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC
T ss_pred             ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC
Confidence            3 33456689999999999999999999999999999999999999999998888877777654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=321.91  Aligned_cols=218  Identities=25%  Similarity=0.426  Sum_probs=183.9

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      +++.+.+.||+|.++.++++    .+..+++.||||++++.. ........+.+|++++++++||||+++++++.+.+..
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~   83 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLA----RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL   83 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred             CCCEEEEEEeeCCCeEEEEE----EECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence            45778889999888887775    467789999999997422 1233456788999999999999999999999877655


Q ss_pred             cccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                            ++||||+++ +|.+.+.  ..+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||+|+.
T Consensus        84 ------~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          84 ------YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             ------EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ------EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEeccccccee
Confidence                  999999986 5666655  4599999999999999999999999999999999999999999999999999987


Q ss_pred             cCCC---cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        214 AGTT---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       214 ~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      ....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++.+|.+.....|..
T Consensus       158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~  232 (288)
T d1uu3a_         158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK  232 (288)
T ss_dssp             CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTT
T ss_pred             cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCcc
Confidence            6432   22345679999999999999999999999999999999999999999999999999988766555544

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-48  Score=315.12  Aligned_cols=214  Identities=25%  Similarity=0.402  Sum_probs=171.8

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++.+.+.||+|.++.++.+    .+..+|+.||||++.....+....+.+.+|++++++++||||+++++++.+...  
T Consensus         4 edy~~~~~iG~G~fg~Vy~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~--   77 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKI----RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN--   77 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-----
T ss_pred             hhCEEeEEEecCCCeEEEEE----EECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC--
Confidence            45677788999888888765    567889999999998765566667789999999999999999999999865321  


Q ss_pred             ccccEEEEEecccc-cHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCC-----CEeecCCCCCEEEccCCcEEE
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKI  205 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~-----ivH~dl~~~nil~~~~~~~kl  205 (288)
                        ..+++||||+++ +|.+.+.      ..+++..++.++.||+.||+|||+++     |+||||||+|||++.++.+||
T Consensus        78 --~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl  155 (269)
T d2java1          78 --TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL  155 (269)
T ss_dssp             ---CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred             --CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence              235999999986 5666553      24899999999999999999999876     999999999999999999999


Q ss_pred             eecccccccCCCc-ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        206 LDFGLARTAGTTF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       206 ~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      +|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++..+|.+..
T Consensus       156 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~  230 (269)
T d2java1         156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK  230 (269)
T ss_dssp             CCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred             eeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence            9999998765432 3345689999999999999999999999999999999999999999999988888887654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-47  Score=317.62  Aligned_cols=209  Identities=24%  Similarity=0.365  Sum_probs=178.7

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      +...+.||+|.++.++.+    .+..+++.||||+++.... .....+.+.+|+++|++++||||+++++++.+.+..  
T Consensus        17 y~~l~~lG~G~fg~Vy~a----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~--   90 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFA----RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA--   90 (309)
T ss_dssp             EEEEEEEEECSSSEEEEE----EETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE--
T ss_pred             cEeeEEEecCCCeEEEEE----EECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEE--
Confidence            455677888888887775    4678899999999976432 334456788999999999999999999999877655  


Q ss_pred             cccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++||||+.++++..+.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus        91 ----~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          91 ----WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             ----EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             ----EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence                9999999988766543   458999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcccCCcccccccCchHhHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCC
Q psy11580        216 TTFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMRE  281 (288)
Q Consensus       216 ~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  281 (288)
                      ..   ....||+.|+|||++.+   ..++.++|||||||++|+|++|..||.+.+..+.+.++.+...+
T Consensus       167 ~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~  232 (309)
T d1u5ra_         167 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP  232 (309)
T ss_dssp             SB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             CC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence            43   34589999999999975   35789999999999999999999999999988888887765543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=312.52  Aligned_cols=212  Identities=24%  Similarity=0.354  Sum_probs=174.4

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+++.||+|.++.++.|       ..+..||||+++....+....+.+.+|+++|++++||||+++++++...
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~   76 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKG-------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP   76 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEE-------ESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccccccEEEEEEEeeCCCcEEEEE-------EECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc
Confidence            456677888888998888777775       2345799999987666667788899999999999999999999987643


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .       .++||||+++ +|.+.+.   ..+++..+..++.||++||+|||+++||||||||+|||++.++.+||+|||
T Consensus        77 ~-------~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          77 Q-------LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             S-------CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             E-------EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEcccc
Confidence            2       3999999995 5667664   348999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC---cccCCcccccccCchHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        210 LARTAGTT---FMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       210 ~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      +|......   .......||+.|+|||++.+.   .++.++|||||||++|||++|+.||.+.+....+..++...
T Consensus       150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~  225 (276)
T d1uwha_         150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG  225 (276)
T ss_dssp             CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT
T ss_pred             ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC
Confidence            99765432   223455789999999999753   47899999999999999999999999988777666665543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.9e-48  Score=321.87  Aligned_cols=219  Identities=23%  Similarity=0.396  Sum_probs=187.3

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +.+++.+.+.||+|.++.++++    .+..+|+.||||++++.. ......+.+.+|+.++++++||||+++++++.+.+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a----~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLI----RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             chhHeEEEEEEecCcCcEEEEE----EECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            3467788899999988888775    567889999999997432 12234567889999999999999999999998877


Q ss_pred             cccccccEEEEEecccccHH-HHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        135 SLEEFQDVYLVMELMDANLC-QVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~l~-~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      ..      ++||||++|+.+ ..+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus        78 ~~------~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a  151 (316)
T d1fota_          78 QI------FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA  151 (316)
T ss_dssp             EE------EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             ee------eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccc
Confidence            65      999999997644 4433  34788899999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccCC
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL  286 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  286 (288)
                      ......  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.+|.+.-...|+.+
T Consensus       152 ~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  224 (316)
T d1fota_         152 KYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF  224 (316)
T ss_dssp             EECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred             eEeccc--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCC
Confidence            876543  2346899999999999999999999999999999999999999999999999999887766665543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=322.29  Aligned_cols=220  Identities=25%  Similarity=0.358  Sum_probs=189.8

Q ss_pred             hhcccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      ..+++.+.+.||+|.++.++++    .+..+|+.||||++++.. .......++.+|+++|++++||||+++++++.+.+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~----~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   78 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILV----REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             chHhcEEEEEEecCcCeEEEEE----EECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence            3467788899999988888875    567899999999997532 12334677889999999999999999999998887


Q ss_pred             cccccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        135 SLEEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                      .+      ++||||++++ |.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus        79 ~~------~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a  152 (337)
T d1o6la_          79 RL------CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC  152 (337)
T ss_dssp             EE------EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cc------ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccc
Confidence            65      9999999975 555554  34899999999999999999999999999999999999999999999999999


Q ss_pred             cccCC-CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccC
Q psy11580        212 RTAGT-TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDK  285 (288)
Q Consensus       212 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  285 (288)
                      +.... .......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..++.+++......+|..
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~  227 (337)
T d1o6la_         153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT  227 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred             cccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCcc
Confidence            87543 334456789999999999999999999999999999999999999999999999888888776666554

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=317.48  Aligned_cols=208  Identities=25%  Similarity=0.357  Sum_probs=177.2

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.||+|.++.++.+    .+..+++.||||+++..  .....+.+.+|+++|++++||||+++++++.+.+..   
T Consensus        14 Y~i~~~iG~G~fg~Vy~~----~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~---   84 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKA----QNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL---   84 (288)
T ss_dssp             EEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEE---
T ss_pred             eEEeEEEeeCCCcEEEEE----EECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeE---
Confidence            466778888888887775    46788999999999763  345567889999999999999999999999877655   


Q ss_pred             ccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        140 QDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       140 ~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                         ++||||++++ |.+.+.   ..+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus        85 ---~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          85 ---WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             ---EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred             ---EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccC
Confidence               9999999875 444443   348999999999999999999999999999999999999999999999999997654


Q ss_pred             CC-cccCCcccccccCchHhHh-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        216 TT-FMMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       216 ~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      .. .......||+.|+|||++.     +..++.++|||||||++|+|++|+.||.+.+..+.+.++.+..
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~  231 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE  231 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence            32 2234568999999999995     3457899999999999999999999999999999888887654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-47  Score=317.67  Aligned_cols=215  Identities=28%  Similarity=0.412  Sum_probs=167.2

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +.+.+.+.||+|.++.++++    .+..+++.||||++.+.... .....+.+|+++|++++||||+++++++.+.+.. 
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~----~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~-   82 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILA----EDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL-   82 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEE----EETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEE-
T ss_pred             cceEEEEEEeeccCeEEEEE----EECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE-
Confidence            34677888999888888875    46778999999999764322 2345678999999999999999999999877665 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEc---cCCcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~---~~~~~kl~dfg~~  211 (288)
                           ++||||+++ +|.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+||++.   .++.+||+|||+|
T Consensus        83 -----~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a  157 (307)
T d1a06a_          83 -----YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS  157 (307)
T ss_dssp             -----EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred             -----EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecccee
Confidence                 999999985 6777775  3599999999999999999999999999999999999995   4788999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....|.+....++
T Consensus       158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~  229 (307)
T d1a06a_         158 KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD  229 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC
T ss_pred             EEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC
Confidence            877666555667899999999999999999999999999999999999999999998888888887655443

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-48  Score=314.64  Aligned_cols=203  Identities=25%  Similarity=0.430  Sum_probs=169.0

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++.+.+.||+|.++.++++    .+..+|+.||||+++... .....+.+.+|+++|++++||||+++++++.+.+.. 
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~----~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~-   78 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLA----VNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ-   78 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE-
T ss_pred             cceEEEEEEecCcCeEEEEE----EECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee-
Confidence            45677888999888888775    467889999999997642 223346788999999999999999999999877655 


Q ss_pred             ccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           ++||||+++ +|.+.+.  ..+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        79 -----~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          79 -----YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             -----EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             -----EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheee
Confidence                 999999986 5666664  35899999999999999999999999999999999999999999999999999865


Q ss_pred             CC---CcccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhH
Q psy11580        215 GT---TFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ  271 (288)
Q Consensus       215 ~~---~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  271 (288)
                      ..   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~  214 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ  214 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH
Confidence            32   222355689999999999998876 5789999999999999999999987654443

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8e-47  Score=312.24  Aligned_cols=211  Identities=23%  Similarity=0.369  Sum_probs=176.4

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++...++.+.+.||+|.++.++.|    .+..+++.||||+++..   ....+++.+|+++|++++||||++++++|.+.
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a----~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEG----VWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   85 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEE----EEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEE----EECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence            567778899999999999998886    45678899999999753   23456789999999999999999999999887


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      +..      ++||||+++ ++.+.+.    ..+++..+..++.|+++||+|||+++|+||||||+|||++.++.+||+||
T Consensus        86 ~~~------~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          86 PPF------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             SSC------EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             Cee------EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccc
Confidence            765      999999996 4566554    34899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCchhHHHHHHH
Q psy11580        209 GLARTAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLF-PGTDHIDQWNKIIG  277 (288)
Q Consensus       209 g~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~-~~~~~~~~~~~i~~  277 (288)
                      |+|+.......  .....+++.|+|||++.+..++.++||||||+++|||++|..|| .+.+...+.+.+.+
T Consensus       160 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~  231 (287)
T d1opja_         160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK  231 (287)
T ss_dssp             CCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             cceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc
Confidence            99987654322  23345788999999999999999999999999999999966655 55555444444443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.7e-47  Score=320.90  Aligned_cols=214  Identities=23%  Similarity=0.375  Sum_probs=186.3

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++.+.+.||+|.++.++++    .+..+|+.||||++...  .....+.+.+|+++|++++||||+++++++.+.+.+ 
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~----~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~-   98 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRV----TERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM-   98 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEE----EETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE-
T ss_pred             cCeEEEEEEecCcCeEEEEE----EECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE-
Confidence            35677888999888888875    56788999999999763  334456788999999999999999999999877655 


Q ss_pred             ccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc--CCcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~--~~~~kl~dfg~~  211 (288)
                           ++||||+++ +|.+.+.   ..+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||++
T Consensus        99 -----~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a  173 (350)
T d1koaa2          99 -----VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT  173 (350)
T ss_dssp             -----EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred             -----EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchh
Confidence                 999999986 5667663   24899999999999999999999999999999999999964  578999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.+|.+....++
T Consensus       174 ~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  245 (350)
T d1koaa2         174 AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD  245 (350)
T ss_dssp             EECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC
T ss_pred             eecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            987766666667899999999999999999999999999999999999999999999999999887765444

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.1e-47  Score=320.21  Aligned_cols=215  Identities=23%  Similarity=0.384  Sum_probs=186.6

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +.+.+.+.||+|.++.++++    .+..+|+.||||+++..  .......+.+|+++|++++||||+++++++.+.+.+ 
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a----~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~-  101 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRC----VEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM-  101 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE-
T ss_pred             cceEEEEEEecCCCeEEEEE----EECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE-
Confidence            34677888888888887774    56788999999999763  234456788999999999999999999999877655 


Q ss_pred             ccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEc--cCCcEEEeecccc
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK--SDCTLKILDFGLA  211 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~--~~~~~kl~dfg~~  211 (288)
                           ++||||+++ +|.+.+.   ..+++..++.++.||+.||+|||++||+||||||+|||++  .++.+||+|||+|
T Consensus       102 -----~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla  176 (352)
T d1koba_         102 -----VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA  176 (352)
T ss_dssp             -----EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             -----EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccc
Confidence                 999999996 4666554   2489999999999999999999999999999999999998  5789999999999


Q ss_pred             cccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        212 RTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      .............+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.+|.+....++.
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  249 (352)
T d1koba_         177 TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE  249 (352)
T ss_dssp             EECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred             eecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence            9887666666678999999999999999999999999999999999999999999999999998877655544

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=304.70  Aligned_cols=213  Identities=21%  Similarity=0.334  Sum_probs=182.3

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      .+++.+.+.||+|.++.++.|.     .++++.||||++++..   ...+.+.+|++++++++||||++++++|.+.+.+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~-----~~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~   74 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGK-----WRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   74 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEE-----ETTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSE
T ss_pred             hHHCEEeEEEecCCCeEEEEEE-----ECCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Confidence            3577889999999999999884     2467899999998643   3356789999999999999999999999877665


Q ss_pred             cccccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                            ++||||++++ +...+.   ..+++..+.+++.|+++||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        75 ------~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          75 ------FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             ------EEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             ------EEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhhe
Confidence                  9999999865 455533   458899999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        213 TAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       213 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .......  .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..++..++.+....+.
T Consensus       149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~  222 (258)
T d1k2pa_         149 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR  222 (258)
T ss_dssp             BCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred             eccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            6544322  234578899999999999999999999999999999998 8999999999998888887655433

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=306.75  Aligned_cols=209  Identities=26%  Similarity=0.378  Sum_probs=170.1

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      ++...||+|.++.++.+    .+..++..||+|++..........+.+.+|+++|++++||||+++++++....  ....
T Consensus        12 ~~~~~iG~G~fg~Vy~~----~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~~   85 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKG----LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV--KGKK   85 (270)
T ss_dssp             EEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES--SSCE
T ss_pred             EeeeEEecCcCcEEEEE----EECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc--ccCC
Confidence            44556788777777764    46778999999999865555566778999999999999999999999986422  1223


Q ss_pred             cEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCCEEEcc-CCcEEEeeccccccc
Q psy11580        141 DVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKS-DCTLKILDFGLARTA  214 (288)
Q Consensus       141 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--ivH~dl~~~nil~~~-~~~~kl~dfg~~~~~  214 (288)
                      .+++||||+++ +|.+.+.  ..+++..++.++.||++||+|||+++  |+||||||+|||+++ ++.+||+|||+|+..
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            46999999987 5656654  35899999999999999999999998  999999999999974 789999999999865


Q ss_pred             CCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhH-HHHHHH
Q psy11580        215 GTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ-WNKIIG  277 (288)
Q Consensus       215 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-~~~i~~  277 (288)
                      .... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.... .+.+.+
T Consensus       166 ~~~~-~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~  227 (270)
T d1t4ha_         166 RASF-AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS  227 (270)
T ss_dssp             CTTS-BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred             cCCc-cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc
Confidence            4432 245689999999999876 589999999999999999999999987655444 444443

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-47  Score=319.72  Aligned_cols=204  Identities=26%  Similarity=0.397  Sum_probs=173.3

Q ss_pred             hhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         55 LIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      +.-+++.+.+.||+|.++.++.+    .+..+|+.||+|+++... ......++.+|+++|++++||||++++++|.+.+
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~----~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   77 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKV----SHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   77 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEE----EETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred             CCccCCEEEEEEecCCCeEEEEE----EECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            34456778888999988888875    567889999999997643 3344578899999999999999999999998877


Q ss_pred             cccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      ..      ++||||+++ +|.+.+.  ..+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus        78 ~~------~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGl  151 (322)
T d1s9ja_          78 EI------SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV  151 (322)
T ss_dssp             EE------EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             EE------EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCC
Confidence            55      999999997 5666554  359999999999999999999997 5999999999999999999999999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHID  270 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  270 (288)
                      |....... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+
T Consensus       152 a~~~~~~~-~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~  210 (322)
T d1s9ja_         152 SGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE  210 (322)
T ss_dssp             CHHHHHHT-C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred             ccccCCCc-cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            98654322 245689999999999999999999999999999999999999998866443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-46  Score=310.45  Aligned_cols=215  Identities=24%  Similarity=0.345  Sum_probs=184.6

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcc----hhhHHHHHHHHHHHHHCCCCCcceeeccccCCC
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN----VTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQK  134 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  134 (288)
                      .+.+++.||+|.++.++.+    .+..+|+.||||++++....    ....+.+.+|+++|++++||||+++++++.+.+
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~----~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKC----REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   86 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEE----EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CEEEeEEEecCCCeEEEEE----EECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            4577788888888887765    46788999999999754221    223577899999999999999999999998877


Q ss_pred             cccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC----cEEEee
Q psy11580        135 SLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILD  207 (288)
Q Consensus       135 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~----~~kl~d  207 (288)
                      ..      ++||||+++ +|.+.+.  ..+++..++.++.|++.||+|||+++|+||||||+||+++.++    .+||+|
T Consensus        87 ~~------~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~D  160 (293)
T d1jksa_          87 DV------ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID  160 (293)
T ss_dssp             EE------EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred             EE------EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecc
Confidence            65      999999986 5666664  3599999999999999999999999999999999999998776    499999


Q ss_pred             cccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        208 FGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ||++.............+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.+|.+.....+
T Consensus       161 fG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1jksa_         161 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE  236 (293)
T ss_dssp             CTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             hhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            9999887766666677899999999999999999999999999999999999999999999988888877654433

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=305.99  Aligned_cols=212  Identities=24%  Similarity=0.344  Sum_probs=169.7

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ..++.+.+.||+|.++.++.|.     ..++..||||+++...   ...+++.+|++++++++||||++++|+|...+..
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~-----~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~   75 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGY-----WLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   75 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEE-----ETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEE-----ECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCce
Confidence            3567788899999998888873     3457789999998532   3346789999999999999999999999887765


Q ss_pred             cccccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                            ++||||++++ |.+.+.   ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus        76 ------~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          76 ------CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             ------EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             ------EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchhe
Confidence                  9999999865 555554   337899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcc--cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhCCC
Q psy11580        213 TAGTTFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMREA  282 (288)
Q Consensus       213 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~  282 (288)
                      .......  .....+|+.|+|||++.+..++.++||||||+++|||++ |.+||.+.+..+.+..+.+.....
T Consensus       150 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~  222 (263)
T d1sm2a_         150 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY  222 (263)
T ss_dssp             ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC
T ss_pred             eccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            6544322  234578899999999999999999999999999999998 677788888888888877765443

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-46  Score=311.09  Aligned_cols=216  Identities=24%  Similarity=0.310  Sum_probs=170.5

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCC---ceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQ---QNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAF  130 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  130 (288)
                      ++....+.+.+.||+|.++.++.|.    +..++   ..||||.+... ......+.+.+|+++|++++||||+++++++
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~----~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~   96 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGH----LKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVV   96 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEE----ECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEE----EeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            3455677888999999988888863    23333   36899998653 3445567899999999999999999999999


Q ss_pred             cCCCcccccccEEEEEeccccc-HHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEe
Q psy11580        131 TPQKSLEEFQDVYLVMELMDAN-LCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL  206 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~  206 (288)
                      ...+..      ++||||++++ |.+.+..   .+++.++..++.||++||+|||+++|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~------~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~  170 (299)
T d1jpaa_          97 TKSTPV------MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVS  170 (299)
T ss_dssp             CSSSSC------EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             eeCCEE------EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEEC
Confidence            887765      9999999976 4444442   48999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCccc------CCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        207 DFGLARTAGTTFMM------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       207 dfg~~~~~~~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      |||+++........      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+++..+.+..
T Consensus       171 DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~  250 (299)
T d1jpaa_         171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY  250 (299)
T ss_dssp             CC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred             CcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999865432211      12356889999999999999999999999999999997 899999999988888887665


Q ss_pred             C
Q psy11580        280 R  280 (288)
Q Consensus       280 ~  280 (288)
                      .
T Consensus       251 ~  251 (299)
T d1jpaa_         251 R  251 (299)
T ss_dssp             C
T ss_pred             C
Confidence            4

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=306.92  Aligned_cols=212  Identities=24%  Similarity=0.411  Sum_probs=177.3

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++..+++.+.+.||+|.++.++.|.     .+++..||||+++...   ...+.+.+|++++++++||||+++++++..+
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~-----~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   80 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGY-----YNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE   80 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEE-----ETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEE-----ECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence            5666788899999999999998874     3467889999997532   3356799999999999999999999988654


Q ss_pred             CcccccccEEEEEeccccc-HHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        134 KSLEEFQDVYLVMELMDAN-LCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~-l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      .       .++||||++++ |.+.+.    ..+++..+..++.||++||+|||+++|+||||||+|||++.++.+||+||
T Consensus        81 ~-------~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DF  153 (272)
T d1qpca_          81 P-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF  153 (272)
T ss_dssp             S-------CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             C-------eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccc
Confidence            3       38999999975 444443    24899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCc--ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        209 GLARTAGTTF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       209 g~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      |+|+......  ......+++.|+|||++.+..++.++||||||+++|||++ |.+||...+..+.+..+.+...
T Consensus       154 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~  228 (272)
T d1qpca_         154 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR  228 (272)
T ss_dssp             TTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred             cceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Confidence            9998765432  2344578899999999999899999999999999999998 5666777777777777766544

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-46  Score=316.99  Aligned_cols=217  Identities=23%  Similarity=0.372  Sum_probs=184.3

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      +++.+.+.||+|.++.++++    .+..+|+.||||++++.. ........+.+|+++|+.++||||+++++++......
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a----~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  116 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLV----KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEE----EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             cCeEEEEEeecCcCcEEEEE----EECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence            34566677777777776664    567889999999996421 2234456788999999999999999999999877765


Q ss_pred             cccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        137 EEFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                            ++||||+.++ +...+.  ..+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+.
T Consensus       117 ------~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         117 ------YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             ------EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ------ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence                  9999999875 555554  3599999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccCC
Q psy11580        214 AGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL  286 (288)
Q Consensus       214 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  286 (288)
                      ....  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.+|......+|..+
T Consensus       191 ~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  261 (350)
T d1rdqe_         191 VKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF  261 (350)
T ss_dssp             CSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTC
T ss_pred             cccc--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccC
Confidence            6543  2356899999999999999999999999999999999999999999999999999988776666543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-46  Score=309.58  Aligned_cols=211  Identities=36%  Similarity=0.615  Sum_probs=176.8

Q ss_pred             cccCCccccccccCccceeccCCCceEEEEeccCCCcch---hhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccc
Q psy11580         64 HQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNV---THAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQ  140 (288)
Q Consensus        64 ~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  140 (288)
                      +.||+|.++.++.+    .+..+|+.||||+++......   .....+.+|++++++++||||+++++++...+..    
T Consensus         4 ~~lG~G~fg~Vy~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~----   75 (299)
T d1ua2a_           4 DFLGEGQFATVYKA----RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI----   75 (299)
T ss_dssp             EEEEEETTEEEEEE----ECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC----
T ss_pred             eEeccCcCeEEEEE----EECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce----
Confidence            45777777776664    567889999999997532221   1234688999999999999999999999988766    


Q ss_pred             cEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        141 DVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       141 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                        ++||||+.+++...+.   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        76 --~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          76 --SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  153 (299)
T ss_dssp             --EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             --eehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC
Confidence              9999999998777664   34889999999999999999999999999999999999999999999999999876543


Q ss_pred             c-ccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        218 F-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       218 ~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      . ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.++.+.+.+|.+.++.++.
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~  222 (299)
T d1ua2a_         154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE  222 (299)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            3 33456789999999999764 5799999999999999999999999999999999999998876654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=307.46  Aligned_cols=207  Identities=22%  Similarity=0.305  Sum_probs=169.4

Q ss_pred             cccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccccccEE
Q psy11580         64 HQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQDVY  143 (288)
Q Consensus        64 ~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~  143 (288)
                      +.||+|.++.++.|.  ..+..+++.||||+++....+....+.+.+|+++|++++||||++++++|..++       .+
T Consensus        13 k~iG~G~fG~Vy~~~--~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~-------~~   83 (277)
T d1xbba_          13 KELGSGNFGTVKKGY--YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-------WM   83 (277)
T ss_dssp             EEEEECSSEEEEEEE--EECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS-------EE
T ss_pred             CCcccCCCeEEEEEE--EccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC-------EE
Confidence            468888888888763  123456788999999865555566778999999999999999999999986543       38


Q ss_pred             EEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc--
Q psy11580        144 LVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF--  218 (288)
Q Consensus       144 lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--  218 (288)
                      +||||++++ |.+++.  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......  
T Consensus        84 lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          84 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             EEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            999999875 556554  448999999999999999999999999999999999999999999999999998654321  


Q ss_pred             --ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q psy11580        219 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       219 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~  279 (288)
                        ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..++...+.+..
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~  227 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE  227 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC
Confidence              1233468899999999999999999999999999999997 999999998888777776644

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-46  Score=305.89  Aligned_cols=214  Identities=24%  Similarity=0.320  Sum_probs=175.9

Q ss_pred             hcccccccc-cCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCc
Q psy11580         57 YQELPISHQ-MGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        57 ~~~~~~~~~-~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  135 (288)
                      .+++.+.+. ||+|.++.++.|.-  ....++..||||+++.. ......+.+.+|+++|++++||||+++++++..+. 
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-   82 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVY--RMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-   82 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEE--C---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             ccCeEECCcEEecccCeEEEEEEE--ecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCe-
Confidence            345666664 89988888888731  12344568999999754 34455678999999999999999999999986543 


Q ss_pred             ccccccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccc
Q psy11580        136 LEEFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~  211 (288)
                            +++||||++++ |.+++.   ..+++..+..++.|+++||+|||+++|+||||||+||+++.++.+||+|||++
T Consensus        83 ------~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          83 ------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             ------EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             ------EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhh
Confidence                  49999999974 555543   35899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc----ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        212 RTAGTTF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       212 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      +......    ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...|.+...
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~  230 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR  230 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC
T ss_pred             hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            8764422    1234467899999999999999999999999999999998 9999999988888887776544

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=306.99  Aligned_cols=216  Identities=34%  Similarity=0.599  Sum_probs=183.2

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++.+.+.+|+|.++.++.+    .+..+|+.||||+++..........++.+|+++|++++||||+++++++.+.+.. 
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~-   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL-   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEE----EETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE-
T ss_pred             CCCEeccEEecCcCeEEEEE----EECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccce-
Confidence            35667788898888887765    5678899999999976544444567889999999999999999999999887665 


Q ss_pred             ccccEEEEEecccccHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                           ++||||+++++.+...    ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||.|..
T Consensus        77 -----~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~  151 (298)
T d1gz8a_          77 -----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA  151 (298)
T ss_dssp             -----EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             -----eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCccee
Confidence                 9999999998777654    3489999999999999999999999999999999999999999999999999987


Q ss_pred             cCCC-cccCCcccccccCchHhHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        214 AGTT-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       214 ~~~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .... .......+++.|+|||++.... ++.++||||+|+++|+|++|+.||.+.+..+.+.++.+..+.+.
T Consensus       152 ~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~  223 (298)
T d1gz8a_         152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD  223 (298)
T ss_dssp             HCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            6543 3345568999999999988766 47899999999999999999999999999999999988877644

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=302.95  Aligned_cols=220  Identities=22%  Similarity=0.273  Sum_probs=170.4

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++....+.+.+.||+|.++.++.|.-...+......||||+++.. ........+.+|++++++++||||++++|++...
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            444566778889999999888887432222233357999999753 3344556789999999999999999999999877


Q ss_pred             CcccccccEEEEEecccccHHH-HHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDANLCQ-VIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~l~~-~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      +..      ++||||+.++++. .+.   ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus        82 ~~~------~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          82 KPM------MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             SSE------EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             Cce------EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccc
Confidence            665      9999999986443 332   358999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc----ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchhHHHHHHHHhC
Q psy11580        210 LARTAGTTF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG-GVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       210 ~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g-~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      +++......    ......||+.|+|||++.+..++.++||||||+++|||++| .+|+.+.+..+....+.+...
T Consensus       156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~  231 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR  231 (283)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred             hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC
Confidence            998653321    22334678999999999999999999999999999999985 555666777777777666544

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.7e-45  Score=301.37  Aligned_cols=219  Identities=23%  Similarity=0.373  Sum_probs=175.0

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      ++.+.+.+|+|.++.++.+    .+..+++.||||+++.... +......+.+|+++++.++||||+++++++...+.  
T Consensus         8 rY~i~~~lG~G~fg~Vy~a----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~--   81 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLA----RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP--   81 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS--
T ss_pred             eeEEeEEEeeCCCeEEEEE----EECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC--
Confidence            4567778888877777765    4678899999999986433 34456678999999999999999999999976542  


Q ss_pred             ccccEEEEEeccccc-HHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDAN-LCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                      ....+|+||||++++ |.+.+.  ..+++.+++.++.||+.||+|||++||+||||||+||+++.++..+++|||.+...
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence            123469999999975 554444  35899999999999999999999999999999999999999999999999998654


Q ss_pred             CCC----cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        215 GTT----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       215 ~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ...    .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++++.-..++
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~  234 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP  234 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC
Confidence            332    233456799999999999999999999999999999999999999999998888888776554433

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-45  Score=306.28  Aligned_cols=217  Identities=27%  Similarity=0.432  Sum_probs=182.1

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCC-cchhhHHHHHHHHHHHH-HCCCCCcceeeccccCCCc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPF-QNVTHAKRAYREFKLMK-LVNHKNIIGLLNAFTPQKS  135 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~  135 (288)
                      +++.+.+.||+|.++.++++    .+..+++.||||++++.. ........+..|..++. .++||||+++++++.+.+.
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~----~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~   77 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLA----EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   77 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEE----EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCeEEeeEEecCCCcEEEEE----EECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCc
Confidence            45678889999998888875    467899999999997421 12233455667777665 6899999999999988776


Q ss_pred             ccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        136 LEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       136 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                      .      |+||||+++ +|.+.+.  ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus        78 ~------yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          78 L------FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             E------EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             e------eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhh
Confidence            5      999999987 5666654  458999999999999999999999999999999999999999999999999998


Q ss_pred             ccCC-CcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        213 TAGT-TFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       213 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      .... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++.+|...-...|.
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~  224 (320)
T d1xjda_         152 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR  224 (320)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred             hcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence            6543 33345568999999999999999999999999999999999999999999999988888765444443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-45  Score=306.68  Aligned_cols=214  Identities=21%  Similarity=0.360  Sum_probs=184.5

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  136 (288)
                      ++++.+.+.||+|.++.++.+    .+..+++.||||+++..   ......+.+|+++|++++||||+++++++.+.+.+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~----~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRC----VETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             ccceEEEEEEecCCCeEEEEE----EECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            345677788888888877764    56788999999999863   23345678999999999999999999999877655


Q ss_pred             cccccEEEEEecccc-cHHHHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC--CcEEEeeccc
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGL  210 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~--~~~kl~dfg~  210 (288)
                            |+||||+++ +|.+.+..   .+++.++..++.||+.||+|||++||+||||||+|||++.+  ..+||+|||+
T Consensus        77 ------~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~  150 (321)
T d1tkia_          77 ------VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             ------EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             ------EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccch
Confidence                  999999996 67777752   48999999999999999999999999999999999999854  4799999999


Q ss_pred             ccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        211 ARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      +.............+++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+.+.+|.+....++
T Consensus       151 ~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~  223 (321)
T d1tkia_         151 ARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD  223 (321)
T ss_dssp             CEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred             hhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            9887665555666889999999999999999999999999999999999999999999999999987665444

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-45  Score=307.72  Aligned_cols=219  Identities=26%  Similarity=0.377  Sum_probs=178.1

Q ss_pred             hhhhcccccccccCCccccccccCcccee-ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAY-DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFT  131 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  131 (288)
                      ++..+++.+++.||+|.++.++.|.-... +......||+|++.... .......+.+|+.+++++ +||||+++++++.
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            56778899999999999999888742211 11223479999987532 334456788999999998 8999999999999


Q ss_pred             CCCcccccccEEEEEecccc-cHHHHHhh-------------------------hCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy11580        132 PQKSLEEFQDVYLVMELMDA-NLCQVIQM-------------------------DLDHERMSYLLYQMLCGIKHLHSAGI  185 (288)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-------------------------~~~~~~~~~~~~~i~~~l~~LH~~~i  185 (288)
                      ..+..      ++||||+++ +|.+.+..                         .+++..++.++.|+++||+|||+++|
T Consensus       112 ~~~~~------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~I  185 (325)
T d1rjba_         112 LSGPI------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC  185 (325)
T ss_dssp             SSSSC------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             eCCeE------EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            88766      999999986 56666542                         27889999999999999999999999


Q ss_pred             EeecCCCCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCC
Q psy11580        186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGV  261 (288)
Q Consensus       186 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~  261 (288)
                      +||||||+||+++.++.+||+|||+|+......   ......+|+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus       186 iHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~  265 (325)
T d1rjba_         186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN  265 (325)
T ss_dssp             EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             eeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC
Confidence            999999999999999999999999997654322   2234567999999999999999999999999999999997 899


Q ss_pred             CCCCCCchhHHHHHHHHh
Q psy11580        262 LFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       262 p~~~~~~~~~~~~i~~~~  279 (288)
                      ||.+.+..+.+.++++.-
T Consensus       266 Pf~~~~~~~~~~~~~~~~  283 (325)
T d1rjba_         266 PYPGIPVDANFYKLIQNG  283 (325)
T ss_dssp             SSTTCCCSHHHHHHHHTT
T ss_pred             CCCCCCHHHHHHHHHhcC
Confidence            999988777777766543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-44  Score=296.24  Aligned_cols=216  Identities=25%  Similarity=0.397  Sum_probs=184.4

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcc-------hhhHHHHHHHHHHHHHCC-CCCcceeec
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN-------VTHAKRAYREFKLMKLVN-HKNIIGLLN  128 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~~i~~~~~  128 (288)
                      ++++.+.+.||+|.++.++++    .+..+++.||||++++....       ......+.+|+.++++++ ||||+++++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~----~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~   77 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRC----IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD   77 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             cccCEEceEEecCcCeEEEEE----EECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence            356778888999888887764    56778999999999764322       122346889999999997 999999999


Q ss_pred             cccCCCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEE
Q psy11580        129 AFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI  205 (288)
Q Consensus       129 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl  205 (288)
                      ++.+++..      ++||||+++ +|.+.+.  ..+++..++.++.||++||+|||++||+||||||+||+++.++.+||
T Consensus        78 ~~~~~~~~------~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          78 TYETNTFF------FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             EEECSSEE------EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred             ecccCcce------EEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEE
Confidence            99887765      999999986 6777664  45899999999999999999999999999999999999999999999


Q ss_pred             eecccccccCCCcccCCcccccccCchHhHhc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        206 LDFGLARTAGTTFMMTPYVVTRYYRAPEVILG------MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       206 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      +|||++.............||+.|+|||.+.+      ..++.++||||+||++|+|++|+.||.+.++.+....|.+.-
T Consensus       152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            99999998776655666789999999999974      346789999999999999999999999999999888888765


Q ss_pred             CCC
Q psy11580        280 REA  282 (288)
Q Consensus       280 ~~~  282 (288)
                      ..+
T Consensus       232 ~~~  234 (277)
T d1phka_         232 YQF  234 (277)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            443

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-45  Score=305.08  Aligned_cols=221  Identities=32%  Similarity=0.542  Sum_probs=182.9

Q ss_pred             cccccccccCCccccccccCccceeccCC-CceEEEEeccCCCcchhhHHHHHHHHHHHHHC---CCCCcceeeccccCC
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTAT-QQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV---NHKNIIGLLNAFTPQ  133 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~  133 (288)
                      +++.+.+.||+|.++.++++    .+..+ ++.||||+++...........+.+|+++++.+   +||||++++++|...
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a----~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKA----RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEE----EETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CCEEEEEEEecccCeEEEEE----EEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            35567778888888877764    45444 56799999975433333344566777776665   799999999998643


Q ss_pred             CcccccccEEEEEecccccHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .. ......+++||+++++++....    ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus        83 ~~-~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          83 RT-DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             EC-SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cc-ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence            21 2234569999999998766543    348999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        210 LARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ++.............||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+.+.+|.+.++.++
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  235 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  235 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence            99877666666778999999999999999999999999999999999999999999999999999998877544

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=307.99  Aligned_cols=222  Identities=79%  Similarity=1.231  Sum_probs=184.5

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +.+.+.+.||+|.++.++++    .+..+|+.||||+++....+.....++.+|+.++++++||||+++++++...+..+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~----~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAA----YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEE----EETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             CCeEEEEEeecCcCeEEEEE----EECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence            34556666777666666654    57789999999999876666677778999999999999999999999998776655


Q ss_pred             ccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        138 EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ...++|+||||+.+++++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||++......
T Consensus        93 ~~~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          93 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             TCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             cCceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence            66788999999999999999888999999999999999999999999999999999999999999999999999877766


Q ss_pred             cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      .......+|+.|+|||++.+..++.++||||+||++++|++|++||.+.+......++++.+..++
T Consensus       173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~  238 (355)
T d2b1pa1         173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  238 (355)
T ss_dssp             --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence            666777899999999999999999999999999999999999999999999999999988776544

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-45  Score=299.07  Aligned_cols=212  Identities=24%  Similarity=0.381  Sum_probs=171.1

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++..+++.+++.||+|.++.++.|.     ..++..||||+++...   ...+.+.+|+.++++++||||+++++++...
T Consensus        13 ~i~~~~~~i~~~iG~G~fg~Vy~~~-----~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~   84 (285)
T d1fmka3          13 EIPRESLRLEVKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE   84 (285)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEE-----ETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             EcCHHHEEEeeEEeeCCCeEEEEEE-----ECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEecC
Confidence            4566789999999999999998873     2345679999997533   3346799999999999999999999998654


Q ss_pred             CcccccccEEEEEeccccc-HHHHHh----hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        134 KSLEEFQDVYLVMELMDAN-LCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~-l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      + .      ++||||++++ +...+.    ..+++..++.++.||+.||+|||+++|+||||||+|||++.++++||+||
T Consensus        85 ~-~------~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~Df  157 (285)
T d1fmka3          85 P-I------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF  157 (285)
T ss_dssp             S-C------EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             C-e------EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEccc
Confidence            3 3      8999999976 444443    24899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCc--ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        209 GLARTAGTTF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       209 g~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      |+++......  ......+++.|+|||++.+..++.++||||||+++|||++ |.+|+.+.+..+.+..+.+...
T Consensus       158 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~  232 (285)
T d1fmka3         158 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR  232 (285)
T ss_dssp             CTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred             chhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Confidence            9998654332  2334578999999999999999999999999999999999 5566677777777777766544

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=301.69  Aligned_cols=220  Identities=51%  Similarity=0.865  Sum_probs=186.0

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.||+|.++.++++    .+..+|+.||||+++....+....+.+.+|+++|+.++||||++++++|...+....
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSA----VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             SEEEEEEC------CEEEE----EETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             cEEEEEEEecCCCeEEEEE----EECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            4455666777777766664    567889999999998766666667889999999999999999999999988776555


Q ss_pred             cccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ..++++||||++..+..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus        95 ~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~  174 (346)
T d1cm8a_          95 FTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE  174 (346)
T ss_dssp             CCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             cceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc
Confidence            66779999999877776664 46999999999999999999999999999999999999999999999999999877554


Q ss_pred             cccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        218 FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                        .....+++.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+.+..+.+..+.+|.
T Consensus       175 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         175 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA  240 (346)
T ss_dssp             --CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             --cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence              3456889999999999874 5689999999999999999999999999999999999888876654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-44  Score=293.94  Aligned_cols=218  Identities=24%  Similarity=0.353  Sum_probs=169.8

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++..+++.+++.||+|.++.++.|.-. ....++..||||.++.. ........+.+|++++++++||||+++++++...
T Consensus         3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~-~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~   80 (273)
T d1mp8a_           3 EIQRERIELGRCIGEGQFGDVHQGIYM-SPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN   80 (273)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEC-CC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CcCHHHeEEEEEEeeCCCcEEEEEEEe-cCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            456678899999999999988876311 11233567999998653 3445567799999999999999999999999643


Q ss_pred             CcccccccEEEEEeccccc-HHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        134 KSLEEFQDVYLVMELMDAN-LCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                       .      .++||||++++ +.+.+.   ..+++..++.++.||++||+|||+++|+||||||+||+++.++.+||+|||
T Consensus        81 -~------~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          81 -P------VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             -S------CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             -e------EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch
Confidence             3      39999999975 444433   348999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc--ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        210 LARTAGTTF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       210 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      +|+......  ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||.+.+..+.+.++.+...
T Consensus       154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~  227 (273)
T d1mp8a_         154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER  227 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             hheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence            998754322  2234567899999999999999999999999999999997 8999999999999888877654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.2e-44  Score=304.98  Aligned_cols=204  Identities=23%  Similarity=0.355  Sum_probs=167.6

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcc----hhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN----VTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      .+++.+.+.||+|.++.++++    .+..+|+.||||++.+....    .........++++++.++||||+++++++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~----~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~   78 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGC----RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT   78 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEE----EETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             HHhCeeeeEEecCCCeEEEEE----EECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE
Confidence            456788889999988888875    56788999999998642111    1112223345777778889999999999988


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecc
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg  209 (288)
                      .+..      ++||||+++ +|.+.+.  ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~------~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          79 PDKL------SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             SSEE------EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCT
T ss_pred             CCEE------EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeec
Confidence            7765      999999986 5666654  348899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhH
Q psy11580        210 LARTAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ  271 (288)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  271 (288)
                      +|........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus       153 la~~~~~~~~-~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~  214 (364)
T d1omwa3         153 LACDFSKKKP-HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK  214 (364)
T ss_dssp             TCEECSSSCC-CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH
T ss_pred             eeeecCCCcc-cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9987655433 45689999999999975 5689999999999999999999999988665443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=292.43  Aligned_cols=210  Identities=24%  Similarity=0.398  Sum_probs=171.3

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQ  133 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  133 (288)
                      ++..+++.+.+.||+|.++.++.|      ..+|..||||+++++    ...+.+.+|++++++++||||++++|+|...
T Consensus         3 ~i~~~~~~~~~~lG~G~fg~Vy~~------~~~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (262)
T d1byga_           3 ALNMKELKLLQTIGKGEFGDVMLG------DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE   72 (262)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEE------EETTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             ccCHHHeEEeEEEecCCCeEEEEE------EECCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence            567788899999999999999887      335789999999753    3346788999999999999999999998654


Q ss_pred             CcccccccEEEEEeccccc-HHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        134 KSLEEFQDVYLVMELMDAN-LCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~~-l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      ..     .+++||||++++ +.+++..    .+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+||
T Consensus        73 ~~-----~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~df  147 (262)
T d1byga_          73 KG-----GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF  147 (262)
T ss_dssp             -------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             CC-----cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccc
Confidence            31     239999999864 6665532    3899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        209 GLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       209 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      |++......  .....+++.|+|||++.+..++.++||||||+++|||++ |++||.+.+..++...|.+...
T Consensus       148 g~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~  218 (262)
T d1byga_         148 GLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK  218 (262)
T ss_dssp             CC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC
T ss_pred             ccceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999875443  233467889999999999999999999999999999998 8999999988888888766443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.8e-44  Score=295.62  Aligned_cols=214  Identities=33%  Similarity=0.565  Sum_probs=181.4

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+-+.||+|.++.++.+.    + .+++.||||+++..........++.+|+++|++++||||+++++++...+..  
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~----~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~--   75 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQ----N-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL--   75 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEE----E-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCE--
T ss_pred             CceeccEEecCCCcEEEEEE----e-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCce--
Confidence            45667778888888888763    2 4789999999987555555567899999999999999999999999888765  


Q ss_pred             cccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                          ++++|++.++++..+.   ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||.+....
T Consensus        76 ----~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~  151 (286)
T d1ob3a_          76 ----VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (286)
T ss_dssp             ----EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             ----eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecc
Confidence                9999999998877664   448999999999999999999999999999999999999999999999999998765


Q ss_pred             CCc-ccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        216 TTF-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       216 ~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.+.+..+.+.++.+.++.++
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~  221 (286)
T d1ob3a_         152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN  221 (286)
T ss_dssp             C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence            432 23445788999999999875 468999999999999999999999999999999999998887654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=301.99  Aligned_cols=214  Identities=29%  Similarity=0.509  Sum_probs=180.9

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +...+.||+|.++.++++    .+..+|+.||||+++....      ...+|+++|++++||||++++++|.......+.
T Consensus        22 Y~~~k~LG~G~fg~Vy~a----~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          22 YTDTKVIGNGSFGVVYQA----KLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             cEeeeEEeeCcCeEEEEE----EECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence            345567888888888775    5678899999999975322      223699999999999999999999765443444


Q ss_pred             ccEEEEEecccccHHHHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC-cEEEeeccccc
Q psy11580        140 QDVYLVMELMDANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR  212 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~-~~kl~dfg~~~  212 (288)
                      .+.++||||+++++.+.+.      ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence            5679999999998766553      2489999999999999999999999999999999999999875 89999999998


Q ss_pred             ccCCCcccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        213 TAGTTFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                      ............+++.|+|||.+.+ ..++.++||||+||++|||++|..||.+.+..+.+.+|++.++.++
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~  243 (350)
T d1q5ka_         172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT  243 (350)
T ss_dssp             ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCCh
Confidence            8766666667789999999999876 4689999999999999999999999999999999999998887654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=290.69  Aligned_cols=215  Identities=23%  Similarity=0.291  Sum_probs=168.5

Q ss_pred             hhcccccccccCCccccccccCccceeccCC--CceEEEEeccCCCc-chhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         56 IYQELPISHQMGKKRHNTSHLGAGAAYDTAT--QQNVAIKKLSRPFQ-NVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      ...++.+.+.||+|.++.++.|.   ++..+  ...||||++++... .....+.+.+|+++|++++||||+++++++.+
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~---~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~   82 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGE---WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   82 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEE---EECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chHHeEEEEEEecCCCeEEEEEE---EECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            34678888999999999988873   22232  34799999976432 33445789999999999999999999999975


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeec
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  208 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~df  208 (288)
                      . ..      ++||||+++ ++.+.+.   ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+||
T Consensus        83 ~-~~------~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df  155 (273)
T d1u46a_          83 P-PM------KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF  155 (273)
T ss_dssp             S-SC------EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             c-ch------heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence            4 33      899999986 4554443   45999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcc----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        209 GLARTAGTTFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       209 g~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      |++........    .....++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+...+|.+...
T Consensus       156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~  232 (273)
T d1u46a_         156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE  232 (273)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred             hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC
Confidence            99987544321    233456788999999999999999999999999999997 8999999999998888876543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=297.47  Aligned_cols=215  Identities=24%  Similarity=0.291  Sum_probs=169.8

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      .++.+.+.||+|.++.++.|.-..........||+|.++.. .+....+.+.+|++++++++||||++++++|.....  
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~--   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV--   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE--
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe--
Confidence            45778889999988888877421111222336899988643 233456789999999999999999999999986542  


Q ss_pred             ccccEEEEEeccc-ccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        138 EFQDVYLVMELMD-ANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       138 ~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                           ++++|++. +++.+.+.   ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus        86 -----~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          86 -----QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             -----EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             -----eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence                 66777766 56766654   3488999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcc---cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhC
Q psy11580        214 AGTTFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       214 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~  280 (288)
                      ......   .....+|+.|+|||++.+..++.++||||||+++|||++ |.+||.+.+..++...+.+...
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~  231 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER  231 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence            543222   233467899999999999999999999999999999998 8999999888887777766554

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-43  Score=294.65  Aligned_cols=220  Identities=21%  Similarity=0.287  Sum_probs=183.1

Q ss_pred             hhhhcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      ++..+++.+.+.||+|.++.++.|.-. ..+..+++.||||+++.. .......++.+|+++|++++||||++++++|..
T Consensus         9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            556678999999999999999988532 223456789999999753 344556789999999999999999999999988


Q ss_pred             CCcccccccEEEEEecccc-cHHHHHhh--------------------------hCCHHHHHHHHHHHHHHHHHHHHCCC
Q psy11580        133 QKSLEEFQDVYLVMELMDA-NLCQVIQM--------------------------DLDHERMSYLLYQMLCGIKHLHSAGI  185 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~--------------------------~~~~~~~~~~~~~i~~~l~~LH~~~i  185 (288)
                      .+..      +++||++++ ++.+.+..                          .+++..+..++.|++.||+|||++++
T Consensus        88 ~~~~------~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~i  161 (301)
T d1lufa_          88 GKPM------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF  161 (301)
T ss_dssp             SSSC------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CCce------EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCe
Confidence            7765      999999986 45555531                          27888999999999999999999999


Q ss_pred             EeecCCCCCEEEccCCcEEEeecccccccCCC---cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCC-C
Q psy11580        186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTT---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGG-V  261 (288)
Q Consensus       186 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~-~  261 (288)
                      |||||||+|||++.++.+||+|||+|......   .......+++.|+|||.+.+..++.++||||||+++|||++|. +
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            99999999999999999999999999754332   2223457889999999999999999999999999999999975 6


Q ss_pred             CCCCCCchhHHHHHHHHhC
Q psy11580        262 LFPGTDHIDQWNKIIGKMR  280 (288)
Q Consensus       262 p~~~~~~~~~~~~i~~~~~  280 (288)
                      ||.+.++.+....+.+...
T Consensus       242 p~~~~~~~e~~~~v~~~~~  260 (301)
T d1lufa_         242 PYYGMAHEEVIYYVRDGNI  260 (301)
T ss_dssp             TTTTSCHHHHHHHHHTTCC
T ss_pred             CCCCCCHHHHHHHHHcCCC
Confidence            8999999888888776544

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-44  Score=301.48  Aligned_cols=205  Identities=27%  Similarity=0.387  Sum_probs=165.8

Q ss_pred             cccc-ccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccccCCCcc
Q psy11580         59 ELPI-SHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        59 ~~~~-~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  136 (288)
                      ++.+ ++.||+|.++.++++    .+..+++.||||+++.       ...+.+|++++.++ +||||+++++++.+..  
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a----~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~--   78 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQI----FNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY--   78 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEE----EETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE--
T ss_pred             CEEEeeEEeeeccCeEEEEE----EECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc--
Confidence            3443 456888887777774    5678899999999964       24567899987655 8999999999986421  


Q ss_pred             cccccEEEEEecccc-cHHHHHhh----hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc---CCcEEEeec
Q psy11580        137 EEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDF  208 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~---~~~~kl~df  208 (288)
                      .....+|+|||||+| +|.+.+..    .+++..++.++.||+.||+|||++||+||||||+|||++.   .+.+||+||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence            122456999999986 67777753    4899999999999999999999999999999999999986   457999999


Q ss_pred             ccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q psy11580        209 GLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKII  276 (288)
Q Consensus       209 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~  276 (288)
                      |+++............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~  226 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK  226 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            99988766666667789999999999999999999999999999999999999998876555444433

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=292.33  Aligned_cols=225  Identities=27%  Similarity=0.464  Sum_probs=184.1

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcc-
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSL-  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-  136 (288)
                      .++.+.+.+|+|.++.++.+    .+..+|+.||||++...........++.+|+++|++++||||+++++++...... 
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKA----RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEE----EETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             CCEEEEEEEecCcCeEEEEE----EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            34567788899888887775    5678899999999976555555667788999999999999999999998654321 


Q ss_pred             -cccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccc
Q psy11580        137 -EEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (288)
Q Consensus       137 -~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~  212 (288)
                       ....+.++|||++++++.....   ..+++..++.++.|+++||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence             1224569999999998877664   358899999999999999999999999999999999999999999999999997


Q ss_pred             ccCCC-----cccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCccCC
Q psy11580        213 TAGTT-----FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHDKL  286 (288)
Q Consensus       213 ~~~~~-----~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  286 (288)
                      .....     .......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.++.+....+.+.++.++++.
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            55431     222345789999999999875 689999999999999999999999999999999999999988776543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-43  Score=290.88  Aligned_cols=219  Identities=29%  Similarity=0.438  Sum_probs=177.9

Q ss_pred             hhhhcccccccccCCccccccccCccceec---cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeecc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYD---TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNA  129 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  129 (288)
                      ++..+++.+++.||+|.++.++.+.....+   ..++..||||+++... .......+..|+..+.++ +||||++++++
T Consensus         9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            567788899999999999999987543222   2344689999997643 345567788899999888 89999999999


Q ss_pred             ccCCCcccccccEEEEEeccccc-HHHHHh------------------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q psy11580        130 FTPQKSLEEFQDVYLVMELMDAN-LCQVIQ------------------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL  190 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~------------------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl  190 (288)
                      |.+++..      ++||||++++ +.+.+.                  ..+++.+++.++.||+.||+|||+++||||||
T Consensus        88 ~~~~~~~------~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDi  161 (299)
T d1fgka_          88 CTQDGPL------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL  161 (299)
T ss_dssp             ECSSSSC------EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cccCCeE------EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeee
Confidence            9987766      9999999864 666553                  13799999999999999999999999999999


Q ss_pred             CCCCEEEccCCcEEEeecccccccCCCc---ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy11580        191 KPSNIVVKSDCTLKILDFGLARTAGTTF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLFPGT  266 (288)
Q Consensus       191 ~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~  266 (288)
                      ||+|||++.++.+||+|||++.......   ......+++.|+|||.+.+..++.++||||||+++|||++ |.+||.+.
T Consensus       162 Kp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~  241 (299)
T d1fgka_         162 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  241 (299)
T ss_dssp             SGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence            9999999999999999999998654322   2344578899999999999999999999999999999997 79999998


Q ss_pred             CchhHHHHHHHHh
Q psy11580        267 DHIDQWNKIIGKM  279 (288)
Q Consensus       267 ~~~~~~~~i~~~~  279 (288)
                      +..++...+.+..
T Consensus       242 ~~~~~~~~i~~~~  254 (299)
T d1fgka_         242 PVEELFKLLKEGH  254 (299)
T ss_dssp             CHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHcCC
Confidence            8887777766543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-42  Score=291.15  Aligned_cols=218  Identities=41%  Similarity=0.746  Sum_probs=178.2

Q ss_pred             cccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccc
Q psy11580         60 LPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEF  139 (288)
Q Consensus        60 ~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  139 (288)
                      +.+.+.||+|.++.++.+    .+..+|+.||||++++.. .....+.+.+|+++|++++||||+++++++..... ...
T Consensus        10 Y~~~~~LG~G~fg~Vy~~----~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~-~~~   83 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSA----YDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI-EQM   83 (345)
T ss_dssp             EEEEEECC---CCCEEEE----EETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST-TTC
T ss_pred             eEEEEEEeeccCeEEEEE----EECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc-ccc
Confidence            456667777776666664    577899999999997532 34556678899999999999999999999976543 233


Q ss_pred             ccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCCc
Q psy11580        140 QDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTTF  218 (288)
Q Consensus       140 ~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~  218 (288)
                      ...++++++++++|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          84 KDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             CCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             ceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            4467888878788888875 569999999999999999999999999999999999999999999999999997654322


Q ss_pred             ----ccCCcccccccCchHhHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCc
Q psy11580        219 ----MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAH  283 (288)
Q Consensus       219 ----~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  283 (288)
                          ......+++.|+|||++.. ..++.++||||+|+++|+|++|..||.+.+..+....+...+..+.
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~  233 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS  233 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence                2345578999999999855 5678999999999999999999999999998888888887776553

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-42  Score=287.25  Aligned_cols=223  Identities=25%  Similarity=0.386  Sum_probs=171.1

Q ss_pred             HHHhhhhhhcccccccccCCccccccccCcccee-ccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCccee
Q psy11580         49 VDQWKELIYQELPISHQMGKKRHNTSHLGAGAAY-DTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGL  126 (288)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~  126 (288)
                      ...| ++..+++.+.+.||+|.++.++.|..... +..+++.||||+++... .......+..|...+.++ +|+||+.+
T Consensus         5 ~~~w-ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           5 ASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             HHHH-BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             Cccc-cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            3456 67778899999999999999988753322 24466899999997532 334456777888888777 68999999


Q ss_pred             eccccCCCcccccccEEEEEecccc-cHHHHHhh------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEe
Q psy11580        127 LNAFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAGIIH  187 (288)
Q Consensus       127 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH  187 (288)
                      ++++...+.     ..++||||+++ +|.+++..                  .+++..+..++.||++||+|||+++|+|
T Consensus        83 ~~~~~~~~~-----~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivH  157 (299)
T d1ywna1          83 LGACTKPGG-----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH  157 (299)
T ss_dssp             EEEECSTTS-----CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             eeeeccCCC-----eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence            999876542     24999999986 46665532                  2788999999999999999999999999


Q ss_pred             ecCCCCCEEEccCCcEEEeecccccccCCC---cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhC-CCCC
Q psy11580        188 RDLKPSNIVVKSDCTLKILDFGLARTAGTT---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG-GVLF  263 (288)
Q Consensus       188 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g-~~p~  263 (288)
                      |||||+|||++.++.+||+|||+|+.....   .......||+.|+|||++.+..++.++|||||||++|||++| .+||
T Consensus       158 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~  237 (299)
T d1ywna1         158 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  237 (299)
T ss_dssp             SCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence            999999999999999999999999765332   223445789999999999999999999999999999999985 6789


Q ss_pred             CCCCchhHHHHHHHH
Q psy11580        264 PGTDHIDQWNKIIGK  278 (288)
Q Consensus       264 ~~~~~~~~~~~i~~~  278 (288)
                      .+.+..+.+.+++..
T Consensus       238 ~~~~~~~~~~~~~~~  252 (299)
T d1ywna1         238 PGVKIDEEFCRRLKE  252 (299)
T ss_dssp             TTCCCSHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHhc
Confidence            887766655555443

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-43  Score=292.68  Aligned_cols=216  Identities=24%  Similarity=0.334  Sum_probs=176.5

Q ss_pred             hhhhcccccccccCCccccccccCccceeccCCCc--eEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeeccc
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAAYDTATQQ--NVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLNAF  130 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  130 (288)
                      .+.++++.+++.||+|.++.++.|.    ...++.  .||||+++.. ......+.+.+|+++|+++ +||||++++++|
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~----~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~   80 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKAR----IKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC   80 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEE----EEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEE----ECCCCeEEEEEEEEECcc-cChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence            4566888999999999999988763    344554  5788887643 2334456789999999999 799999999999


Q ss_pred             cCCCcccccccEEEEEecccc-cHHHHHh------------------hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCC
Q psy11580        131 TPQKSLEEFQDVYLVMELMDA-NLCQVIQ------------------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  191 (288)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------------------~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~  191 (288)
                      ...+..      ++||||+++ +|.+.+.                  ..+++..+..++.||+.||.|||+++|+|||||
T Consensus        81 ~~~~~~------~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlk  154 (309)
T d1fvra_          81 EHRGYL------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA  154 (309)
T ss_dssp             EETTEE------EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ecCCee------EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccc
Confidence            877655      999999996 5666553                  237899999999999999999999999999999


Q ss_pred             CCCEEEccCCcEEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchh
Q psy11580        192 PSNIVVKSDCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG-GVLFPGTDHID  270 (288)
Q Consensus       192 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g-~~p~~~~~~~~  270 (288)
                      |+|||++.++.+||+|||++.............+|..|+|||.+.+..++.++||||||+++|||++| .+||.+.+..+
T Consensus       155 p~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~  234 (309)
T d1fvra_         155 ARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  234 (309)
T ss_dssp             GGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             cceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH
Confidence            99999999999999999999876655555556789999999999999999999999999999999995 56899998888


Q ss_pred             HHHHHHHHhC
Q psy11580        271 QWNKIIGKMR  280 (288)
Q Consensus       271 ~~~~i~~~~~  280 (288)
                      ++..+.+...
T Consensus       235 ~~~~i~~~~~  244 (309)
T d1fvra_         235 LYEKLPQGYR  244 (309)
T ss_dssp             HHHHGGGTCC
T ss_pred             HHHHHHhcCC
Confidence            8887776543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-42  Score=286.97  Aligned_cols=220  Identities=27%  Similarity=0.401  Sum_probs=184.4

Q ss_pred             HhhhhhhcccccccccCCccccccccCccc-eeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHC-CCCCcceeec
Q psy11580         51 QWKELIYQELPISHQMGKKRHNTSHLGAGA-AYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLV-NHKNIIGLLN  128 (288)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~  128 (288)
                      .| ++..+++.+++.||+|.++.++.|.-. ..+..+++.||||+++... .......+.+|+.+++.+ +||||+++++
T Consensus        17 ~~-~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          17 KW-EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GG-BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cc-cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            45 577788999999999999999988542 2345678899999997543 445566789999999999 6999999999


Q ss_pred             cccCCCcccccccEEEEEeccccc-HHHHHhh--------------------hCCHHHHHHHHHHHHHHHHHHHHCCCEe
Q psy11580        129 AFTPQKSLEEFQDVYLVMELMDAN-LCQVIQM--------------------DLDHERMSYLLYQMLCGIKHLHSAGIIH  187 (288)
Q Consensus       129 ~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH  187 (288)
                      ++...+..      ++||||++++ +.+.+..                    .+++..+..++.||+.||+|||+++++|
T Consensus        95 ~~~~~~~~------~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivH  168 (311)
T d1t46a_          95 ACTIGGPT------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH  168 (311)
T ss_dssp             EECSSSSC------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEeeCCEE------EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            99887765      9999999875 4454432                    3788999999999999999999999999


Q ss_pred             ecCCCCCEEEccCCcEEEeecccccccCCC---cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHh-CCCCC
Q psy11580        188 RDLKPSNIVVKSDCTLKILDFGLARTAGTT---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GGVLF  263 (288)
Q Consensus       188 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~-g~~p~  263 (288)
                      |||||+||+++.++.+|++|||.+......   .......+|+.|+|||++.+..++.++||||||+++|||++ |.+||
T Consensus       169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~  248 (311)
T d1t46a_         169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY  248 (311)
T ss_dssp             SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence            999999999999999999999999865432   22344578999999999999999999999999999999998 77778


Q ss_pred             CCCCchhHHHHHHHH
Q psy11580        264 PGTDHIDQWNKIIGK  278 (288)
Q Consensus       264 ~~~~~~~~~~~i~~~  278 (288)
                      .+.+..+.+.++++.
T Consensus       249 ~~~~~~~~~~~~i~~  263 (311)
T d1t46a_         249 PGMPVDSKFYKMIKE  263 (311)
T ss_dssp             TTCCSSHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHhc
Confidence            888877777776654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-42  Score=287.53  Aligned_cols=220  Identities=20%  Similarity=0.298  Sum_probs=185.0

Q ss_pred             hhhhcccccccccCCccccccccCccce-eccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccC
Q psy11580         54 ELIYQELPISHQMGKKRHNTSHLGAGAA-YDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTP  132 (288)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  132 (288)
                      ++..+++.+++.||+|.++.++.|.-.. .+..++..||||+++.. ........+.+|++++++++||||+++++++..
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            6777899999999999999998875432 23345689999999754 344556678999999999999999999999987


Q ss_pred             CCcccccccEEEEEeccccc-HHHHHhh------------hCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc
Q psy11580        133 QKSLEEFQDVYLVMELMDAN-LCQVIQM------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS  199 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~------------~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~  199 (288)
                      .+..      ++||||+.++ +.+++..            ..++..+..++.|+++||.|||+++|+||||||+|||++.
T Consensus        95 ~~~~------~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          95 GQPT------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE  168 (308)
T ss_dssp             SSSC------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred             CCce------eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecC
Confidence            7765      9999999865 5554431            2588899999999999999999999999999999999999


Q ss_pred             CCcEEEeecccccccCCC---cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchhHHHHH
Q psy11580        200 DCTLKILDFGLARTAGTT---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG-GVLFPGTDHIDQWNKI  275 (288)
Q Consensus       200 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g-~~p~~~~~~~~~~~~i  275 (288)
                      ++++||+|||+++.....   .......+++.|+|||.+.+..++.++||||||+++|||++| .+||.+.+..+.+..+
T Consensus       169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i  248 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  248 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999999765332   223444689999999999999999999999999999999997 6899999999988888


Q ss_pred             HHHhC
Q psy11580        276 IGKMR  280 (288)
Q Consensus       276 ~~~~~  280 (288)
                      .+...
T Consensus       249 ~~~~~  253 (308)
T d1p4oa_         249 MEGGL  253 (308)
T ss_dssp             HTTCC
T ss_pred             HhCCC
Confidence            76554

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=289.78  Aligned_cols=220  Identities=52%  Similarity=0.900  Sum_probs=183.9

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      ++.+.+.||+|.++.++++    .+..+|+.||||++++...+.....++.+|+++|++++||||+++++++......+.
T Consensus        19 rY~i~~~LG~G~fg~Vy~a----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAA----FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEE----EETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             CeEEEEEEecCCCeEEEEE----EECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence            4566777888877777764    567899999999998766666777789999999999999999999999987665444


Q ss_pred             cccEEEEEecccccHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        139 FQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      ....++++++.+++|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++......
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~  174 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  174 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred             CceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence            55567777777677877765 56999999999999999999999999999999999999999999999999999766443


Q ss_pred             cccCCcccccccCchHhHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhCCCcc
Q psy11580        218 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       218 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  284 (288)
                        .....+++.|+|||.+.+.. ++.++||||||+++|+|++|++||.+.+.......|.+..+.++.
T Consensus       175 --~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         175 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  240 (348)
T ss_dssp             --GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             --cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence              34457899999999987754 588999999999999999999999999999999999888776543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=285.71  Aligned_cols=197  Identities=27%  Similarity=0.452  Sum_probs=163.2

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcc----hhhHHHHHHHHHHHHHCC--CCCcceeeccccC
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN----VTHAKRAYREFKLMKLVN--HKNIIGLLNAFTP  132 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~  132 (288)
                      ++.+++.||+|.++.++.+    .+..+|+.||||++++....    .....++.+|+.++++++  ||||+++++++.+
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~   80 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSG----IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER   80 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEE----EETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             eEEEeEEEeeCCCeEEEEE----EECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence            4677888888888887765    56788999999999753211    122344678999999996  8999999999988


Q ss_pred             CCcccccccEEEEEecccc--cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccC-CcEEEee
Q psy11580        133 QKSLEEFQDVYLVMELMDA--NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILD  207 (288)
Q Consensus       133 ~~~~~~~~~~~lv~e~~~~--~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~-~~~kl~d  207 (288)
                      .+..      ++|||++.+  .+.+.+.  ..+++..++.++.||++||+|||+++|+||||||+||+++.+ +.+||+|
T Consensus        81 ~~~~------~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~D  154 (273)
T d1xwsa_          81 PDSF------VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  154 (273)
T ss_dssp             SSEE------EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             CCeE------EEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECc
Confidence            7765      999999975  4555554  458999999999999999999999999999999999999854 7899999


Q ss_pred             cccccccCCCcccCCcccccccCchHhHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q psy11580        208 FGLARTAGTTFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGGVLFPGT  266 (288)
Q Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~  266 (288)
                      ||+|....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus       155 FG~a~~~~~~~-~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (273)
T d1xwsa_         155 FGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  213 (273)
T ss_dssp             CTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             cccceeccccc-ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence            99998765443 345689999999999988765 57799999999999999999999763

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-41  Score=278.20  Aligned_cols=217  Identities=33%  Similarity=0.567  Sum_probs=183.1

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++.+.+.||+|.++.++++    .+..+++.||||+++..........++.+|+.+|+.++||||+++++++...... 
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~-   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKA----KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL-   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEE----EETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE-
T ss_pred             CCCEeeeEEecCcCeEEEEE----EECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccce-
Confidence            35667788888888888775    5778999999999987656666778899999999999999999999999887765 


Q ss_pred             ccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccccccc
Q psy11580        138 EFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (288)
Q Consensus       138 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~  214 (288)
                           +++++++.++.+..+.   ..+++..++.++.|+++||+|||+++|+||||||+|||++.++.+||+|||.+...
T Consensus        77 -----~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          77 -----TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             -----EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             -----eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcc
Confidence                 9999999987665553   45889999999999999999999999999999999999999999999999999876


Q ss_pred             CCCc-ccCCcccccccCchHhHhcCC-CCchhhHHHHHHHHHHHHhCCCCC-CCCCchhHHHHHHHHhCCCcc
Q psy11580        215 GTTF-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGGVLF-PGTDHIDQWNKIIGKMREAHD  284 (288)
Q Consensus       215 ~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~il~~l~~g~~p~-~~~~~~~~~~~i~~~~~~~~~  284 (288)
                      .... ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.|| .+.+..+...++....+.++.
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (292)
T d1unla_         152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCCh
Confidence            5533 234446678899999998765 689999999999999999998885 566777777887777766543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-40  Score=280.94  Aligned_cols=210  Identities=25%  Similarity=0.464  Sum_probs=174.3

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~  136 (288)
                      +++.+.+.||+|.++.++++    .+..+++.||||+++.     ....++.+|+++|+.++ ||||+++++++..... 
T Consensus        35 d~y~i~~~LG~G~fg~V~~a----~~~~~~~~vAiK~i~~-----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~-  104 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEA----INITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVS-  104 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEE----EETTTTEEEEEEEECS-----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT-
T ss_pred             cCeEEEEEEecCcCeEEEEE----EECCCCCEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCC-
Confidence            34566777777777777765    5678899999999975     22467889999999995 9999999999874432 


Q ss_pred             cccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCC-cEEEeecccccccC
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAG  215 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~-~~kl~dfg~~~~~~  215 (288)
                         ...++||||++++.+..+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|....
T Consensus       105 ---~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         105 ---RTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             ---CSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             ---CceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence               24599999999876666667899999999999999999999999999999999999998765 58999999998876


Q ss_pred             CCcccCCcccccccCchHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-CchhHHHHHHHHhC
Q psy11580        216 TTFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGGVLFPGT-DHIDQWNKIIGKMR  280 (288)
Q Consensus       216 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~-~~~~~~~~i~~~~~  280 (288)
                      .........+|+.|+|||.+.+. .++.++||||+|+++++|++|+.||... +..+....+.+.++
T Consensus       182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g  248 (328)
T d3bqca1         182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG  248 (328)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred             CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHC
Confidence            66556677899999999999875 4799999999999999999999999765 45556666666554

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-41  Score=278.46  Aligned_cols=212  Identities=21%  Similarity=0.289  Sum_probs=161.4

Q ss_pred             cccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccccccc
Q psy11580         62 ISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEEFQD  141 (288)
Q Consensus        62 ~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  141 (288)
                      .++.||+|.++.++.|.-.- ...+...||||+++.. .+.....++.+|+++|++++||||++++|++...+.     .
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~-~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-----~  103 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLD-NDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-----S  103 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC-----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT-----E
T ss_pred             cceEEeecCCeEEEEEEEEC-CCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC-----c
Confidence            36677888777777763110 0112346999999753 355667889999999999999999999999865431     2


Q ss_pred             EEEEEecccccHHH-HHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeecccccccCCC
Q psy11580        142 VYLVMELMDANLCQ-VIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTT  217 (288)
Q Consensus       142 ~~lv~e~~~~~l~~-~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~  217 (288)
                      .++||||++++.+. ++.   ...++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       104 ~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             EEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             eEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            49999999976444 443   23678889999999999999999999999999999999999999999999999865432


Q ss_pred             cc-----cCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCchhHHHHHHHHhC
Q psy11580        218 FM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFP-GTDHIDQWNKIIGKMR  280 (288)
Q Consensus       218 ~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~-~~~~~~~~~~i~~~~~  280 (288)
                      ..     .....+++.|+|||.+....++.++||||||+++|||++|..||. ..+..+....+.+...
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~  252 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR  252 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence            21     223467899999999999999999999999999999999666664 4555566666665543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.5e-41  Score=277.39  Aligned_cols=197  Identities=19%  Similarity=0.286  Sum_probs=163.7

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCC-CCcceeeccccCCCcc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNH-KNIIGLLNAFTPQKSL  136 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~  136 (288)
                      .++.+.+.||+|.++.++++    .+..+|+.||||+++...    ....+.+|++.++.++| +|++.+++++......
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a----~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEG----TNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEE----EETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEE----EECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            34567777788777777765    467789999999986532    23456789999999965 8999999998766654


Q ss_pred             cccccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc-----CCcEEEeec
Q psy11580        137 EEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-----DCTLKILDF  208 (288)
Q Consensus       137 ~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~-----~~~~kl~df  208 (288)
                            ++|||++++++.+.+.   ..++..++..++.|++.||+|||++||+||||||+||+++.     ++.+||+||
T Consensus        77 ------~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          77 ------VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             ------EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             ------EEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccc
Confidence                  9999999998887775   35899999999999999999999999999999999999974     568999999


Q ss_pred             ccccccCCC--------cccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy11580        209 GLARTAGTT--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDH  268 (288)
Q Consensus       209 g~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  268 (288)
                      |+|+.....        .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~  218 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  218 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence            999864321        122345799999999999999999999999999999999999999986543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-40  Score=276.83  Aligned_cols=200  Identities=23%  Similarity=0.283  Sum_probs=159.5

Q ss_pred             ccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCcccc
Q psy11580         59 ELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLEE  138 (288)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  138 (288)
                      .+.+.+.||+|.++.++.|    .+..+|+.||||++....    ...++..|+++++.++|+|++..+..+...+    
T Consensus         8 rY~l~~~iG~G~fG~Vy~a----~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~----   75 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLG----TDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEG----   75 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEE----EETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEET----
T ss_pred             EEEEeEEEeeCCCcEEEEE----EECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecC----
Confidence            3566777788777777765    467789999999987532    2345788999999998877666655554332    


Q ss_pred             cccEEEEEecccccHHHHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEcc---CCcEEEeeccccc
Q psy11580        139 FQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLAR  212 (288)
Q Consensus       139 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~---~~~~kl~dfg~~~  212 (288)
                       ...++|||++++++...+.   ..+++..+..++.|++.||+|||++||+||||||+||+++.   +..++|+|||+|.
T Consensus        76 -~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          76 -DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             -TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             -CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence             2359999999998877664   45999999999999999999999999999999999999864   4579999999998


Q ss_pred             ccCCCc--------ccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhH
Q psy11580        213 TAGTTF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQ  271 (288)
Q Consensus       213 ~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  271 (288)
                      ......        ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~  221 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK  221 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence            654321        22445799999999999999999999999999999999999999987655443

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-41  Score=280.58  Aligned_cols=196  Identities=27%  Similarity=0.353  Sum_probs=154.6

Q ss_pred             cccccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCcceeeccccCCCccc
Q psy11580         58 QELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQKSLE  137 (288)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  137 (288)
                      +++.+.+.||+|.++.++.|      ..+|+.||||+++..   .........|+..+++++||||+++++++...+.  
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~------~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~--   71 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRG------KWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG--   71 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEE------EETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS--
T ss_pred             cEEEEEEEEeeCCCeEEEEE------EECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC--
Confidence            45677888999999988887      357899999999642   1222223345556667899999999999986542  


Q ss_pred             ccccEEEEEecccc-cHHHHHh-hhCCHHHHHHHHHHHHHHHHHHHH--------CCCEeecCCCCCEEEccCCcEEEee
Q psy11580        138 EFQDVYLVMELMDA-NLCQVIQ-MDLDHERMSYLLYQMLCGIKHLHS--------AGIIHRDLKPSNIVVKSDCTLKILD  207 (288)
Q Consensus       138 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--------~~ivH~dl~~~nil~~~~~~~kl~d  207 (288)
                      .....++||||+++ +|.+.+. ..+++..+..++.|++.||+|||.        ++|+||||||+|||++.++.+||+|
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D  151 (303)
T d1vjya_          72 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             cceEEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence            22346999999986 5666665 368999999999999999999996        5899999999999999999999999


Q ss_pred             cccccccCCCc-----ccCCcccccccCchHhHhcCC------CCchhhHHHHHHHHHHHHhCCCCCC
Q psy11580        208 FGLARTAGTTF-----MMTPYVVTRYYRAPEVILGMG------YKENVDIWSVGCIMGEMIRGGVLFP  264 (288)
Q Consensus       208 fg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~------~~~~~Di~slg~il~~l~~g~~p~~  264 (288)
                      ||++.......     ......||+.|+|||++.+..      ++.++||||||+++|||++|..||.
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            99997653321     234467899999999997643      5678999999999999999988774

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-41  Score=280.72  Aligned_cols=216  Identities=21%  Similarity=0.355  Sum_probs=175.0

Q ss_pred             hcccccccccCCccccccccCccceeccCCCceEEEEeccCCCc--chhhHHHHHHHHHHHHHCCC-CCcceeeccccCC
Q psy11580         57 YQELPISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQ--NVTHAKRAYREFKLMKLVNH-KNIIGLLNAFTPQ  133 (288)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~  133 (288)
                      .+++.+.+.||+|.++.++++.. ..+..+|+.||||++++...  .....+.+.+|++++++++| |||+++++++.+.
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~-~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRK-ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEE-CSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             hhceEEEEEEecCCCeEEEEEEE-CccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            46678889999999888887631 12255789999999975321  22335668899999999976 8999999999877


Q ss_pred             CcccccccEEEEEecccc-cHHHHHh--hhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEEEeeccc
Q psy11580        134 KSLEEFQDVYLVMELMDA-NLCQVIQ--MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (288)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~kl~dfg~  210 (288)
                      ...      +++|||+.+ +|.+.+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~------~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         102 TKL------HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             TEE------EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             Cce------eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccc
Confidence            655      999999986 4656554  3478899999999999999999999999999999999999999999999999


Q ss_pred             ccccCC--CcccCCcccccccCchHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q psy11580        211 ARTAGT--TFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIGKM  279 (288)
Q Consensus       211 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~~  279 (288)
                      +.....  ........+++.|+|||.+.+.  .++.++|||||||++|+|++|..||.+.+..+...++.+..
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~  248 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI  248 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            976543  2233456789999999999864  36789999999999999999999999887777666665543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.7e-35  Score=249.23  Aligned_cols=211  Identities=31%  Similarity=0.453  Sum_probs=156.7

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-----------CCCcceeecc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-----------HKNIIGLLNA  129 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~  129 (288)
                      .+.+.||+|.++.+++    |.+..+|+.||||++++.   ....+.+.+|+++++.++           |+||++++++
T Consensus        16 ~i~~~LG~G~fg~Vy~----~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          16 ILVRKLGWGHFSTVWL----AKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             EEEEEEEECSSEEEEE----EEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             EEEEEEeeCCCeEEEE----EEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            3344444444444443    346788999999999853   234467788999988885           5789999988


Q ss_pred             ccCCCcccccccEEEEEeccc--ccHHHHHh----hhCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCCEEEccCCc
Q psy11580        130 FTPQKSLEEFQDVYLVMELMD--ANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCT  202 (288)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~-~~ivH~dl~~~nil~~~~~~  202 (288)
                      +...+.    ...+++++++.  ++......    ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus        89 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          89 FNHKGP----NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             EEEEET----TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             eeeccc----cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCc
Confidence            864331    12245555543  33333222    348889999999999999999998 88999999999999987653


Q ss_pred             ------EEEeecccccccCCCcccCCcccccccCchHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chh
Q psy11580        203 ------LKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGGVLFPGTD------HID  270 (288)
Q Consensus       203 ------~kl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~------~~~  270 (288)
                            ++++|||.+......  .....+++.|+|||++.+..++.++||||+|+++++|++|+.||...+      ..+
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ccccceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence                  899999999866543  245689999999999999999999999999999999999999997532      445


Q ss_pred             HHHHHHHHhCCCcc
Q psy11580        271 QWNKIIGKMREAHD  284 (288)
Q Consensus       271 ~~~~i~~~~~~~~~  284 (288)
                      .+.+++..++.+|.
T Consensus       243 ~~~~~~~~lg~~~~  256 (362)
T d1q8ya_         243 HIAQIIELLGELPS  256 (362)
T ss_dssp             HHHHHHHHHCSCCH
T ss_pred             HHHHHHHHhCCCCH
Confidence            66777777776654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=1.1e-23  Score=162.75  Aligned_cols=163  Identities=19%  Similarity=0.200  Sum_probs=117.4

Q ss_pred             ccccccCCccccccccCccceeccCCCceEEEEeccCCCcc----------------hhhHHHHHHHHHHHHHCCCCCcc
Q psy11580         61 PISHQMGKKRHNTSHLGAGAAYDTATQQNVAIKKLSRPFQN----------------VTHAKRAYREFKLMKLVNHKNII  124 (288)
Q Consensus        61 ~~~~~~~~~~~~~~~~g~g~~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~~i~  124 (288)
                      .+++.||+|.++.++.|.     ..+|+.||||+++.....                .........|...+.++.|.+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~-----~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~   77 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCY-----SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVP   77 (191)
T ss_dssp             EEEEEEEECSSEEEEEEE-----ETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSC
T ss_pred             hhCCEeeeCcceEEEEEE-----CCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcc
Confidence            367888898888888763     257899999987632111                01123345788999999999999


Q ss_pred             eeeccccCCCcccccccEEEEEecccccHHHHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCCEEEccCCcEE
Q psy11580        125 GLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  204 (288)
Q Consensus       125 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH~dl~~~nil~~~~~~~k  204 (288)
                      ..+++..  .        +++||++++....    .++......++.|++.+|++||++||+||||||+|||++++ .++
T Consensus        78 ~~~~~~~--~--------~lvme~~~~~~~~----~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          78 KVYAWEG--N--------AVLMELIDAKELY----RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             CEEEEET--T--------EEEEECCCCEEGG----GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEE
T ss_pred             eEEEecC--C--------EEEEEeecccccc----chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEE
Confidence            8876631  1        8999999986432    35566677899999999999999999999999999999865 589


Q ss_pred             EeecccccccCCCcccCCcccccccCch------HhHhcCCCCchhhHHHHHH
Q psy11580        205 ILDFGLARTAGTTFMMTPYVVTRYYRAP------EVILGMGYKENVDIWSVGC  251 (288)
Q Consensus       205 l~dfg~~~~~~~~~~~~~~~~~~~~~aP------E~~~~~~~~~~~Di~slg~  251 (288)
                      |+|||.|.....+....       |...      +. ....++.++|+||+.-
T Consensus       143 liDFG~a~~~~~~~~~~-------~l~rd~~~~~~~-f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         143 IIDFPQSVEVGEEGWRE-------ILERDVRNIITY-FSRTYRTEKDINSAID  187 (191)
T ss_dssp             ECCCTTCEETTSTTHHH-------HHHHHHHHHHHH-HHHHHCCCCCHHHHHH
T ss_pred             EEECCCcccCCCCCcHH-------HHHHHHHHHHHH-HcCCCCCcccHHHHHH
Confidence            99999987654332111       1111      11 1345778899999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.22  E-value=2.9e-06  Score=66.78  Aligned_cols=118  Identities=21%  Similarity=0.186  Sum_probs=75.1

Q ss_pred             CCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcccccccEEEEEecccccHHHHHhhhCCHH
Q psy11580         86 TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE  164 (288)
Q Consensus        86 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~  164 (288)
                      ++..+++|+....  .......+.+|...++.+. +-.+.+++.+....+.      .++||++++|........  +..
T Consensus        36 ~~~~~vlk~~~~~--~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~------~~lv~~~l~G~~~~~~~~--~~~  105 (263)
T d1j7la_          36 ENENLYLKMTDSR--YKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW------SNLLMSEADGVLCSEEYE--DEQ  105 (263)
T ss_dssp             SSCEEEEEEECGG--GTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE------EEEEEECCSSEEHHHHTT--TCS
T ss_pred             CCCeEEEEEcCCC--cccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc------eEEEEEeccccccccccc--ccc
Confidence            4567888988642  2222335677888888774 4346677776655544      399999999864432211  111


Q ss_pred             HHHHHHHHHHHHHHHHHHC-----------------------------------------------------------CC
Q psy11580        165 RMSYLLYQMLCGIKHLHSA-----------------------------------------------------------GI  185 (288)
Q Consensus       165 ~~~~~~~~i~~~l~~LH~~-----------------------------------------------------------~i  185 (288)
                      ....++.+++..++.||+.                                                           .+
T Consensus       106 ~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l  185 (263)
T d1j7la_         106 SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVF  185 (263)
T ss_dssp             CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEE
T ss_pred             cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEE
Confidence            1223444555555555531                                                           15


Q ss_pred             EeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        186 IHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       186 vH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      +|+|+.+.||++++++.+-|+||+.+..
T Consensus       186 ~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         186 SHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             ECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEeeccCcceeecCCceEEEeechhccc
Confidence            8999999999999776667999997654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.98  E-value=1e-06  Score=72.82  Aligned_cols=59  Identities=75%  Similarity=1.297  Sum_probs=45.7

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE   59 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~   59 (288)
                      ||..||++||+|+|+|+||||....++.+...++|...+...++.+.+...|+...+++
T Consensus       294 mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (355)
T d2b1pa1         294 MLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE  352 (355)
T ss_dssp             HSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCCC-------CCCCCCHHHHHHHHHHH
T ss_pred             HCcCChhHCcCHHHHhcCcccCCCCCcccccCCCCCCCCcchhhhhcCHHHHHHHHHHH
Confidence            68999999999999999999999888888888888888888888888888887766554

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.89  E-value=1.1e-05  Score=62.86  Aligned_cols=57  Identities=9%  Similarity=0.036  Sum_probs=38.0

Q ss_pred             CCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC--CCCcceeeccccCCCcccccccEEEEEeccccc
Q psy11580         85 ATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN--HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN  152 (288)
Q Consensus        85 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~  152 (288)
                      ..+..+++|.....     ....+..|...++.+.  .-.+.+++.+....+.      .++||++++|.
T Consensus        33 ~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~------~~~v~~~i~G~   91 (255)
T d1nd4a_          33 QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR------DWLLLGEVPGQ   91 (255)
T ss_dssp             TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC------EEEEEECCSSE
T ss_pred             CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccc------eEEEEEeeecc
Confidence            44667888987642     2234677888888774  2345667777665554      39999999863

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.59  E-value=0.00012  Score=60.93  Aligned_cols=31  Identities=26%  Similarity=0.318  Sum_probs=26.4

Q ss_pred             CCEeecCCCCCEEEccCCcEEEeecccccccC
Q psy11580        184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (288)
Q Consensus       184 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~  215 (288)
                      .++|+|+++.|||+++++ ++|+||..+....
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G~  254 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYGP  254 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhcccCC
Confidence            489999999999998764 8999999886544

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.41  E-value=3.5e-05  Score=63.06  Aligned_cols=57  Identities=40%  Similarity=0.800  Sum_probs=41.6

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQE   59 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~   59 (288)
                      ||..||.+|++|.|+|+||||....++.+.+  ...+...+.+..+....+++.+.+++
T Consensus       284 mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~k~~~~~e  340 (348)
T d2gfsa1         284 MLVLDSDKRITAAQALAHAYFAQYHDPDDEP--VADPYDQSFESRDLLIDEWKSLTYDE  340 (348)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC--CCCCCCCGGGGCCCCHHHHHHHHHHH
T ss_pred             HCcCChhhCcCHHHHhcCHhhCCCCCCccCC--CCCCCCCcccchhcCHHHHHHHHHHH
Confidence            6889999999999999999998766654433  23344556666677777777665544

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.33  E-value=4.8e-05  Score=62.23  Aligned_cols=58  Identities=38%  Similarity=0.776  Sum_probs=34.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhccc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQEL   60 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~   60 (288)
                      ||..||.+|||+.|+|+||||....++.+.+ .. ...+.+.+....+...|+...++++
T Consensus       284 mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~-~~-~~~~~~~~~~~~~~~e~k~~~~~e~  341 (346)
T d1cm8a_         284 MLVLDAEQRVTAGEALAHPYFESLHDTEDEP-QV-QKYDDSFDDVDRTLDEWKRVTYKEV  341 (346)
T ss_dssp             HSCSSTTTSCCHHHHHHSGGGTTTC-------CC-CCCCCC-----CCHHHHHHHHHHHH
T ss_pred             HCcCChhHCcCHHHHhcChhhCcCCCccccc-cC-CCCCCchhhhhcCHHHHHHHHHHHh
Confidence            6889999999999999999998765544322 22 2334444555566677766655543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.12  E-value=0.00038  Score=56.17  Aligned_cols=64  Identities=9%  Similarity=0.064  Sum_probs=38.0

Q ss_pred             cCCCceEEEEeccCCCcchhhHHHHHHHHHHHHHCCCCCc--ceeeccccCCCcccccccEEEEEecccc
Q psy11580         84 TATQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNI--IGLLNAFTPQKSLEEFQDVYLVMELMDA  151 (288)
Q Consensus        84 ~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~~~~~~~~~~lv~e~~~~  151 (288)
                      ..+|..|++|+....   .....++..|...+..|....+  +..+.. ............+.++++++|
T Consensus        43 ~~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~-~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          43 DEDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             CTTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEECCCC
T ss_pred             cCCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCceec-CCCeeeeeeeEEEEEEeecCC
Confidence            357888999999742   2345667788888888743222  222211 111222334456889999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.98  E-value=0.00023  Score=58.02  Aligned_cols=57  Identities=33%  Similarity=0.717  Sum_probs=33.6

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCCccCCCCCCCCCcCCcccccccHHHhhhhhhc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDDAEVHAPAPGPYDHSVDEREHTVDQWKELIYQ   58 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~~e~~~~~p~~~~~~~~~~~~~~~~~~~~~~~   58 (288)
                      ||..||.+||++.|+|+||||.....+.+... .+.+...+.+..+.+..+..++.++
T Consensus       278 ~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~  334 (345)
T d1pmea_         278 MLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI-AEAPFKFDMELDDLPKEKLKELIFE  334 (345)
T ss_dssp             HSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCC-CSSCC--------CCHHHHHHHHHH
T ss_pred             HccCChhHCcCHHHHhcCHhhccCCCCccCcc-ccCccCCChhhhhCCHHHHHHHHHH
Confidence            68999999999999999999987666654332 2223333333334444455554443

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.93  E-value=0.0011  Score=54.97  Aligned_cols=53  Identities=13%  Similarity=0.137  Sum_probs=34.5

Q ss_pred             CCceEEEEeccCCCcchhhHHHHHHHHHHHHHCC-CCCcceeeccccCCCcccccccEEEEEeccccc
Q psy11580         86 TQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVN-HKNIIGLLNAFTPQKSLEEFQDVYLVMELMDAN  152 (288)
Q Consensus        86 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~  152 (288)
                      ..+.|.+++.-..    .......+|..+++.+. +.-..++++++.  +        .+|+||++|.
T Consensus        73 ~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--------g~I~efi~g~  126 (395)
T d1nw1a_          73 EPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--------GRLEEYIPSR  126 (395)
T ss_dssp             CCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--------EEEECCCCEE
T ss_pred             CCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--------ceEEEEeccc
Confidence            4467888887521    22334557888888884 433457777763  2        7899999863

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.17  E-value=0.0033  Score=50.02  Aligned_cols=31  Identities=35%  Similarity=0.493  Sum_probs=27.3

Q ss_pred             CCCEeecCCCCCEEEccCCcEEEeecccccc
Q psy11580        183 AGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (288)
Q Consensus       183 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~  213 (288)
                      .|+||+|+.++||+++++...-+.||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            3599999999999999887778999998853

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.72  E-value=0.0019  Score=52.38  Aligned_cols=27  Identities=22%  Similarity=0.375  Sum_probs=23.7

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDD   27 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~   27 (288)
                      ||..||.+||+|.|+|+||||....++
T Consensus       286 mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         286 LLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             HccCChhHCcCHHHHhcCHhhccccCC
Confidence            688999999999999999999875544

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=95.55  E-value=0.0024  Score=51.90  Aligned_cols=27  Identities=30%  Similarity=0.614  Sum_probs=23.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCccCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWFDD   27 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~~~   27 (288)
                      ||..||.+||++.|+|+||||.....+
T Consensus       263 ~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         263 LLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             HCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             HccCChhHCcCHHHHhcCcccCCCCCC
Confidence            688999999999999999999764443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=95.12  E-value=0.0041  Score=50.46  Aligned_cols=25  Identities=40%  Similarity=0.690  Sum_probs=22.6

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCCcc
Q psy11580          1 MLVIDPEKRISVDDALMHPYINVWF   25 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~~~   25 (288)
                      ||..||.+||++.|+|+||||...+
T Consensus       266 ~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         266 LLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             TSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HccCChhHCcCHHHHhcCHhhCCCc
Confidence            7899999999999999999997643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=94.48  E-value=0.0042  Score=49.35  Aligned_cols=23  Identities=43%  Similarity=0.797  Sum_probs=21.2

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|+|+||||..
T Consensus       247 ~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         247 LMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HccCCHhHCcCHHHHhcCHhhCC
Confidence            68899999999999999999954

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=93.64  E-value=0.005  Score=48.95  Aligned_cols=23  Identities=22%  Similarity=0.257  Sum_probs=21.1

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||+++|+|+||||..
T Consensus       250 ~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         250 CLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             HTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HCcCChhHCcCHHHHHhCHHhcC
Confidence            58899999999999999999954

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.47  E-value=0.0083  Score=47.90  Aligned_cols=23  Identities=30%  Similarity=0.702  Sum_probs=21.4

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+|+++.|+|+||||..
T Consensus       241 ~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         241 LLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             TSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             HccCChhHCcCHHHHhcCHhhcc
Confidence            68899999999999999999954

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=92.94  E-value=0.015  Score=47.22  Aligned_cols=23  Identities=17%  Similarity=0.433  Sum_probs=21.4

Q ss_pred             CcccCCCCCCC-----HHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRIS-----VDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~-----~~~~l~~p~~~~   23 (288)
                      ||..||.+|++     |+|+++||||+.
T Consensus       243 ~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         243 LLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HcccCHHHhCCCcccCHHHHHcCccccC
Confidence            68899999999     799999999987

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=92.93  E-value=0.019  Score=45.58  Aligned_cols=23  Identities=22%  Similarity=0.523  Sum_probs=20.8

Q ss_pred             CcccCCCCCC-----CHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRI-----SVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~-----~~~~~l~~p~~~~   23 (288)
                      ||..||.+|+     +++++|+||||+.
T Consensus       235 ~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         235 LITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HhhhCHHhccccchhhHHHHHcCccccc
Confidence            5788999996     9999999999987

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.52  E-value=0.011  Score=47.55  Aligned_cols=23  Identities=26%  Similarity=0.681  Sum_probs=21.1

Q ss_pred             CcccCCCCCCCHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~~~l~~p~~~~   23 (288)
                      ||..||.+||++.|+|.||||..
T Consensus       255 ~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         255 LLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             HSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             HccCChhHCcCHHHHHcCHHhhC
Confidence            68899999999999999999954

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=92.19  E-value=0.023  Score=45.82  Aligned_cols=23  Identities=30%  Similarity=0.514  Sum_probs=20.9

Q ss_pred             CcccCCCCCC-----CHHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRI-----SVDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~-----~~~~~l~~p~~~~   23 (288)
                      ||..||.||+     +++++++||||..
T Consensus       272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HhhhCHHhccccccccHHHHHcCccccC
Confidence            5889999995     8999999999987

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.56  E-value=0.046  Score=43.71  Aligned_cols=23  Identities=22%  Similarity=0.541  Sum_probs=20.8

Q ss_pred             CcccCCCCCCC-----HHHHhcCCCcCC
Q psy11580          1 MLVIDPEKRIS-----VDDALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~-----~~~~l~~p~~~~   23 (288)
                      ||..||.+|++     +.|+++||||..
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             hccCCchhhcccccccHHHHHcCccccc
Confidence            58899999994     899999999976

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.30  E-value=0.029  Score=44.54  Aligned_cols=23  Identities=39%  Similarity=0.690  Sum_probs=20.9

Q ss_pred             CcccCCCCCCCHH-HHhcCCCcCC
Q psy11580          1 MLVIDPEKRISVD-DALMHPYINV   23 (288)
Q Consensus         1 ~l~~~~~~r~~~~-~~l~~p~~~~   23 (288)
                      ||..||.+||++. ++++||||+.
T Consensus       237 ~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         237 LFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             HSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             hcccCCCCCcCHHHHHHhCchhcc
Confidence            5889999999996 8999999986